{"text_format":"1","workbook":"xlsx","n_sheets":14,"sheets":["Instructions","Assessment and action plan","Dropdowns","QS Data","Monitoring change (i)","Monitoring change (ii)","Monitoring change (iii)","Monitoring change (iv)","Monitoring change (v)","Monitoring change (vi)","Monitoring change (vii)","Monitoring change (viii)","Monitoring change (ix)","Monitoring change (x)"],"not_rendered":{"charts":30,"images":5,"macros":1,"external_links":0,"defined_names":269,"comments":12,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Instructions","index":0,"n_rows":94,"n_cols":2,"rows_kept":94,"cut":false,"hidden":false,"merged":[[93,0,93,1],[91,0,91,1]]}
["Quality standard service improvement template"]
["Updated: 31st January 2024"]
[]
[]
["How to use this quality standard service improvement template"]
["Introduction"]
[null,"This template allows providers to form an assessment of how their service compares with statements from a range of quality standards. Details on how to use this workbook are shown below."]
[]
["Assessment and action plan"]
["Overview"]
[null,"This sheet is where the quality standards and statements to be examined are selected."]
[]
["Instructions on use"]
[null," - Users should select quality statements relating to areas of interest for their organisation (the template allows for up to 5 statements). These may be from a single quality standard or from a range of quality standards. "]
[null," - Use the 'assessment and action plan' worksheet to make an initial assessment of current practice in relation to each chosen statement.  Enter the assessment in the column E-H. Sources to support an initial assessment could include:"]
[null,"• A complete baseline assessment plan for related guidance"]
[null,"• Feedback from users or team members"]
[null,"• Prescribing or activity data"]
[null," - An initial assessment of how a service compares with selected quality statements can be helpful in a number of ways:"]
[null,"• An assessment showing that the service is in line with a quality statement, informed by readily available evidence, can provide assurance to the provider organisation's board and commissioners of the service."]
[null,"• An assessment indicating areas needing improvement can help inform local quality improvement planning."]
[null,"• The assessment can help inform local risk management. This should be in collaboration with the service's commissioners."]
[null," - If an organisation is not currently meeting a quality statement and there is local agreement that quality improvement work should take place an action plan can be developed.  Use columns J-O in the worksheet to record the action plan and monitor delivery."]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
["Monitoring change"]
["Overview"]
[null,"Each quality statement is accompanied by measures that can be used to monitor change/quality improvement over time. The 'Monitoring change' worksheets allow for recording against the measures associated with the selected statements. The tool allows for up to 3 structure measures, 3 process measures and 3 outcome measures. "]
[]
["Instructions on use"]
[null," - Select the measures being used into the teal coloured cells from the dropdown menu.  "]
[null," - Where dropdowns are not populated (i.e. empty) it can mean that there are no measures for the selected quality statement. \nCaution: if a selected quality statement is changed, previously selected measures on the associated monitoring change sheet will be deleted. If a new quality standard or statement is selected, data entered previously may need to be removed (deleted) manually from the associated monitoring change worksheet. "]
[null," - Enter locally collected data into the appropriate cells. For the process measures inserting the numerator and denominator will calculate the measure (blue cells) and automatically populate the charts. The method and frequency of data collection should be determined locally.  "]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
["The tool has been developed in line with the Into practice guide which provides practical advice on how to use quality standards to achieve high quality care."]
[]
["National Institute for Health and Care Excellence\nLevel 1A, City Tower, Piccadilly Plaza, Manchester M1 4BT; www.nice.org.uk\n© NICE 2024. All rights reserved. See Notice of rights.\n\n"]

{"sheet":"Assessment and action plan","index":1,"n_rows":16,"n_cols":15,"rows_kept":16,"cut":false,"hidden":false,"merged":[[3,1,3,2]]}
[]
[null,"Quality standard template: Assessment and action plan",null,null,null,null,"Assessor:"]
[]
[null,"Instructions on use"]
[null,null,null,null,"Initial assessment",null,null,null,null,"Action plan"]
[null,"Ref","Quality standard","Selected statement","How does the current service compare with the statement?","What is the source of evidence to support this?","What are the risks associated with not making these improvements?\nThis should be an initial high-level assessment","Has this statement been prioritised for quality improvement?\nIf no, record a date for the review of the decision; if yes, use the remaining columns to record an action plan and monitor delivery",null,"Action(s) to improve the service to meet the statement","Date action decided (dd/mm/yyyy)","Person responsible","Deadline for action (dd/mm/yyyy)","Progress \n(Provide examples of actions in progress, changes in practices etc)","Change stage\n(e.g. Not yet actioned, Action in progress, Action completed, Never actioned)"]
[null,"(i)"]
[null,"(ii)"]
[null,"(iii)"]
[null,"(iv)"]
[null,"(v)"]
[null,"(vi)"]
[null,"(vii)"]
[null,"(viii)"]
[null,"(ix)"]
[null,"(x)"]

{"sheet":"Dropdowns","index":2,"n_rows":227,"n_cols":43,"rows_kept":227,"cut":false,"hidden":true,"merged":[[29,24,31,24],[23,24,25,24],[26,24,28,24],[23,32,25,32],[26,32,28,32],[20,24,21,29],[2,0,3,10],[4,25,4,35],[4,1,4,11],[4,13,4,23],[20,0,21,7],[20,32,21,37],[47,24,49,24],[50,24,52,24],[32,24,34,24],[35,24,37,24],[38,24,40,24],[41,24,43,24],[44,24,46,24],[44,32,46,32],[47,32,49,32],[50,32,52,32],[4,42,5,42],[4,41,5,41],[4,40,5,40],[4,39,5,39],[4,38,5,38],[29,32,31,32],[32,32,34,32],[35,32,37,32],[38,32,40,32],[41,32,43,32]]}
[]
["Defined ranges - measures within each statement"]
["Populates the dropdowns on the 'Monitoring change' tabs with the measures under each selected statement."]
[]
[null,"Structure",null,null,null,null,null,null,null,null,null,null,null,"Process",null,null,null,null,null,null,null,null,null,null,null,"Outcome",null,null,null,null,null,null,null,null,null,null,null,null,"Selected quality standards","Range name","Statement","QS Number","Statement number"]
[null,0,1,2,3,4,5,6,7,8,9,10,null,0,1,2,3,4,5,6,7,8,9,10,null,0,1,2,3,4,5,6,7,8,9,10]
["1_Structure",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Structure - \", C$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Structure - \", D$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Structure - \", E$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Structure - \", F$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Structure - \", G$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Structure - \", H$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Structure - \", I$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Structure - \", J$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Structure - \", K$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Structure - \", L$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"1_Process",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Process - \", O$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Process - \", P$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Process - \", Q$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Process - \", R$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Process - \", S$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Process - \", T$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Process - \", U$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Process - \", V$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Process - \", W$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Process - \", X$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"1_Outcome",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Outcome - \", AA$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Outcome - \", AB$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Outcome - \", AC$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Outcome - \", AD$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Outcome - \", AE$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Outcome - \", AF$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Outcome - \", AG$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Outcome - \", AH$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Outcome - \", AI$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO7,(FIND(\" \",$AO7))), \"- \", $AM7, \" - Outcome - \", AJ$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},null,null,{"$f":"'Assessment and action plan'!C7","v":0},{"$f":"IFERROR(VLOOKUP(AM7, $A$24:$B$297, 2, FALSE), \"-\")","v":"-"},{"$f":"'Assessment and action plan'!D7","v":0},{"$f":"LEFT(AM7,FIND(\" \",AM7)-1)","v":{"$error":"#VALUE!"}},{"$f":"LEFT(AO7,FIND(\" \",AO7)-1)","v":{"$error":"#VALUE!"}}]
["2_Structure",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Structure - \", C$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Structure - \", D$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Structure - \", E$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Structure - \", F$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Structure - \", G$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Structure - \", H$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Structure - \", I$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Structure - \", J$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Structure - \", K$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Structure - \", L$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"2_Process",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Process - \", O$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Process - \", P$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Process - \", Q$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Process - \", R$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Process - \", S$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Process - \", T$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Process - \", U$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Process - \", V$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Process - \", W$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Process - \", X$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"2_Outcome",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Outcome - \", AA$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Outcome - \", AB$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Outcome - \", AC$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Outcome - \", AD$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Outcome - \", AE$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Outcome - \", AF$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Outcome - \", AG$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Outcome - \", AH$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Outcome - \", AI$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO8,(FIND(\" \",$AO8))), \"- \", $AM8, \" - Outcome - \", AJ$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},null,null,{"$f":"'Assessment and action plan'!C8","v":0},{"$f":"IFERROR(VLOOKUP(AM8, $A$24:$B$297, 2, FALSE), \"-\")","v":"-"},{"$f":"'Assessment and action plan'!D8","v":0},{"$error":"#VALUE!"},{"$error":"#VALUE!"}]
["3_Structure",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Structure - \", C$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Structure - \", D$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Structure - \", E$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Structure - \", F$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Structure - \", G$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Structure - \", H$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Structure - \", I$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Structure - \", J$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Structure - \", K$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Structure - \", L$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"3_Process",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Process - \", O$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Process - \", P$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Process - \", Q$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Process - \", R$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Process - \", S$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Process - \", T$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Process - \", U$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Process - \", V$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Process - \", W$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Process - \", X$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"3_Outcome",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Outcome - \", AA$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Outcome - \", AB$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Outcome - \", AC$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Outcome - \", AD$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Outcome - \", AE$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Outcome - \", AF$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Outcome - \", AG$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Outcome - \", AH$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Outcome - \", AI$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO9,(FIND(\" \",$AO9))), \"- \", $AM9, \" - Outcome - \", AJ$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},null,null,{"$f":"'Assessment and action plan'!C9","v":0},"-",{"$f":"'Assessment and action plan'!D9","v":0},{"$error":"#VALUE!"},{"$error":"#VALUE!"}]
["4_Structure",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Structure - \", C$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Structure - \", D$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Structure - \", E$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Structure - \", F$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Structure - \", G$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Structure - \", H$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Structure - \", I$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Structure - \", J$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Structure - \", K$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Structure - \", L$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"4_Process",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Process - \", O$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Process - \", P$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Process - \", Q$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Process - \", R$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Process - \", S$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Process - \", T$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Process - \", U$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Process - \", V$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Process - \", W$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Process - \", X$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"4_Outcome",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Outcome - \", AA$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Outcome - \", AB$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Outcome - \", AC$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Outcome - \", AD$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Outcome - \", AE$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Outcome - \", AF$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Outcome - \", AG$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Outcome - \", AH$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Outcome - \", AI$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO10,(FIND(\" \",$AO10))), \"- \", $AM10, \" - Outcome - \", AJ$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},null,null,{"$f":"'Assessment and action plan'!C10","v":0},"-",{"$f":"'Assessment and action plan'!D10","v":0},{"$error":"#VALUE!"},{"$error":"#VALUE!"}]
["5_Structure",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Structure - \", C$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Structure - \", D$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Structure - \", E$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Structure - \", F$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Structure - \", G$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Structure - \", H$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Structure - \", I$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Structure - \", J$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Structure - \", K$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Structure - \", L$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"5_Process",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Process - \", O$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Process - \", P$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Process - \", Q$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Process - \", R$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Process - \", S$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Process - \", T$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Process - \", U$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Process - \", V$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Process - \", W$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Process - \", X$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"5_Outcome",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Outcome - \", AA$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Outcome - \", AB$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Outcome - \", AC$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Outcome - \", AD$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Outcome - \", AE$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Outcome - \", AF$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Outcome - \", AG$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Outcome - \", AH$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Outcome - \", AI$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO11,(FIND(\" \",$AO11))), \"- \", $AM11, \" - Outcome - \", AJ$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},null,null,{"$f":"'Assessment and action plan'!C11","v":0},"-",{"$f":"'Assessment and action plan'!D11","v":0},{"$f":"LEFT(AM11,FIND(\" \",AM11)-1)","v":{"$error":"#VALUE!"}},{"$f":"LEFT(AO11,FIND(\" \",AO11)-1)","v":{"$error":"#VALUE!"}}]
["6_Structure",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Structure - \", C$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Structure - \", D$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Structure - \", E$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Structure - \", F$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Structure - \", G$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Structure - \", H$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Structure - \", I$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Structure - \", J$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Structure - \", K$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Structure - \", L$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"6_Process",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Process - \", O$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Process - \", P$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Process - \", Q$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Process - \", R$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Process - \", S$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Process - \", T$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Process - \", U$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Process - \", V$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Process - \", W$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Process - \", X$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"6_Outcome",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Outcome - \", AA$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Outcome - \", AB$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Outcome - \", AC$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Outcome - \", AD$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Outcome - \", AE$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Outcome - \", AF$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Outcome - \", AG$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Outcome - \", AH$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Outcome - \", AI$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO12,(FIND(\" \",$AO12))), \"- \", $AM12, \" - Outcome - \", AJ$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},null,null,{"$f":"'Assessment and action plan'!C12","v":0},"-",{"$f":"'Assessment and action plan'!D12","v":0},{"$error":"#VALUE!"},{"$error":"#VALUE!"}]
["7_Structure",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Structure - \", C$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Structure - \", D$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Structure - \", E$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Structure - \", F$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Structure - \", G$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Structure - \", H$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Structure - \", I$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Structure - \", J$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Structure - \", K$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Structure - \", L$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"7_Process",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Process - \", O$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Process - \", P$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Process - \", Q$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Process - \", R$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Process - \", S$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Process - \", T$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Process - \", U$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Process - \", V$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Process - \", W$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Process - \", X$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"7_Outcome",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Outcome - \", AA$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Outcome - \", AB$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Outcome - \", AC$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Outcome - \", AD$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Outcome - \", AE$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Outcome - \", AF$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Outcome - \", AG$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Outcome - \", AH$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Outcome - \", AI$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO13,(FIND(\" \",$AO13))), \"- \", $AM13, \" - Outcome - \", AJ$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},null,null,{"$f":"'Assessment and action plan'!C13","v":0},"-",{"$f":"'Assessment and action plan'!D13","v":0},{"$error":"#VALUE!"},{"$error":"#VALUE!"}]
["8_Structure",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Structure - \", C$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Structure - \", D$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Structure - \", E$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Structure - \", F$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Structure - \", G$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Structure - \", H$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Structure - \", I$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Structure - \", J$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Structure - \", K$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Structure - \", L$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"8_Process",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Process - \", O$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Process - \", P$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Process - \", Q$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Process - \", R$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Process - \", S$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Process - \", T$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Process - \", U$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Process - \", V$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Process - \", W$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Process - \", X$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"8_Outcome",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Outcome - \", AA$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Outcome - \", AB$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Outcome - \", AC$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Outcome - \", AD$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Outcome - \", AE$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Outcome - \", AF$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Outcome - \", AG$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Outcome - \", AH$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Outcome - \", AI$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO14,(FIND(\" \",$AO14))), \"- \", $AM14, \" - Outcome - \", AJ$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},null,null,{"$f":"'Assessment and action plan'!C14","v":0},"-",{"$f":"'Assessment and action plan'!D14","v":0},{"$error":"#VALUE!"},{"$error":"#VALUE!"}]
["9_Structure",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Structure - \", C$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Structure - \", D$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Structure - \", E$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Structure - \", F$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Structure - \", G$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Structure - \", H$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Structure - \", I$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Structure - \", J$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Structure - \", K$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Structure - \", L$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"9_Process",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Process - \", O$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Process - \", P$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Process - \", Q$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Process - \", R$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Process - \", S$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Process - \", T$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Process - \", U$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Process - \", V$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Process - \", W$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Process - \", X$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"9_Outcome",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Outcome - \", AA$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Outcome - \", AB$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Outcome - \", AC$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Outcome - \", AD$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Outcome - \", AE$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Outcome - \", AF$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Outcome - \", AG$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Outcome - \", AH$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Outcome - \", AI$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO15,(FIND(\" \",$AO15))), \"- \", $AM15, \" - Outcome - \", AJ$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},null,null,{"$f":"'Assessment and action plan'!C15","v":0},"-",{"$f":"'Assessment and action plan'!D15","v":0},{"$error":"#VALUE!"},{"$error":"#VALUE!"}]
["10_Structure",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Structure - \", C$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Structure - \", D$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Structure - \", E$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Structure - \", F$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Structure - \", G$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Structure - \", H$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Structure - \", I$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Structure - \", J$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Structure - \", K$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Structure - \", L$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"10_Process",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Process - \", O$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Process - \", P$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Process - \", Q$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Process - \", R$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Process - \", S$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Process - \", T$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Process - \", U$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Process - \", V$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Process - \", W$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Process - \", X$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},"10_Outcome",null,{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Outcome - \", AA$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Outcome - \", AB$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Outcome - \", AC$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Outcome - \", AD$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Outcome - \", AE$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Outcome - \", AF$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Outcome - \", AG$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Outcome - \", AH$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Outcome - \", AI$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$G$4:$G$4879, MATCH(CONCATENATE(LEFT($AO16,(FIND(\" \",$AO16))), \"- \", $AM16, \" - Outcome - \", AJ$6), 'QS Data'!$L$4:$L$4879, 0)), \"\")","v":""},null,null,{"$f":"'Assessment and action plan'!C16","v":0},"-",{"$f":"'Assessment and action plan'!D16","v":0},{"$error":"#VALUE!"},{"$error":"#VALUE!"}]
[]
[]
[]
["Defined ranges - statements within each QS",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Process measure dropdowns",null,null,null,null,null,null,null,"Outcome measure dropdowns"]
["On entering the QS title and 'Range name' this table populates with each of the statements connected to that QS. These can then be set up as a named range, so that when a dropdown looks for 'QS_1' it finds the correct list of statements.",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Takes the measures selected on the 'Monitoring change' tabs, and updates the numerators and denominators",null,null,null,null,null,null,null,"Takes the measures selected on the 'Monitoring change' tabs, and updates the numerators and denominators"]
[]
["Quality Standard title","Range name",0,1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,null,null,"Measure","Measure number","Identifier","Numerator","Denominator",null,null,null,"Measure","Measure number","Identifier","Numerator","Denominator"]
["QS2 - Stroke in adults","QS_2",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults presenting at an accident and emergency (A&E) department with suspected stroke are admitted to a specialist acute stroke unit within 4 hours of arrival."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults having stroke rehabilitation in hospital or in the community are offered at least 45 minutes of each relevant therapy for a minimum of 5 days a week"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults who have had a stroke have access to a clinical psychologist with expertise in stroke rehabilitation who is part of the core multidisciplinary stroke rehabilitation team"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults who have had a stroke are offered early supported discharge if the core multidisciplinary stroke team assess that it is suitable for them"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults who have had a stroke are offered active management to return to work if they wish to do so"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults who have had a stroke have their rehabilitation goals reviewed at regular intervals"},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Adults who have had a stroke have a structured health and social care review at 6 months and 1 year after the stroke, and then annually"},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX(#REF!,MATCH( CONCATENATE(R$23, \" - \",#REF!),#REF!,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX(#REF!,MATCH( CONCATENATE(S$23, \" - \",#REF!),#REF!,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX(#REF!,MATCH( CONCATENATE(T$23, \" - \",#REF!),#REF!,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX(#REF!,MATCH( CONCATENATE(U$23, \" - \",#REF!),#REF!,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX(#REF!,MATCH( CONCATENATE(V$23, \" - \",#REF!),#REF!,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX(#REF!,MATCH( CONCATENATE(W$23, \" - \",#REF!),#REF!,0))), \"\")","v":""},null,"Tab (i)",{"$f":"'Monitoring change (i)'!$C$27","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_1_Process=Z24,0),0))","v":0},{"$f":"CONCATENATE($AQ$7, \" - \", $AM$7, \" - Process - \", AA24)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB24,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB24,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,"Tab (i)",{"$f":"'Monitoring change (i)'!$C$72","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_1_Outcome=AH24,0),0))","v":0},{"$f":"CONCATENATE($AQ$7, \" - \", $AM$7, \" - Outcome - \", AI24)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ24,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ24,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS5 - Chronic kidney disease in adults","QS_5",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with, or at risk of, chronic kidney disease (CKD) have eGFRcreatinine and albumin:creatinine ratio (ACR) testing at the frequency agreed with their healthcare professional. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with chronic kidney disease (CKD) have their blood pressure maintained within the recommended range. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with chronic kidney disease (CKD) are offered atorvastatin 20 mg."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A24),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (i)'!$C$35","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_1_Process=Z25,0),0))","v":0},{"$f":"CONCATENATE($AQ$7, \" - \", $AM$7, \" - Process - \", AA25)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB25,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB25,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (i)'!$C$78","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_1_Outcome=AH25,0),0))","v":0},{"$f":"CONCATENATE($AQ$7, \" - \", $AM$7, \" - Outcome - \", AI25)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ25,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ25,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS8 - Depression in adults","QS_8",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with suspected depression have a comprehensive assessment."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with a new episode of depression have a discussion with their healthcare professional about the full range of treatment options."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with depression who are at a higher risk of relapse have relapse prevention interventions."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with depression who are stopping antidepressant medication have the dose reduced in stages."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults from minority ethnic backgrounds with depression are supported to access mental health services."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH( CONCATENATE(R$23, \" - \",#REF!),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A25),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (i)'!$C$43","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_1_Process=Z26,0),0))","v":0},{"$f":"CONCATENATE($AQ$7, \" - \", $AM$7, \" - Process - \", AA26)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB26,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB26,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (i)'!$C$84","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_1_Outcome=AH26,0),0))","v":0},{"$error":"#VALUE!"},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ26,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ26,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS9 - Chronic heart failure in adults","QS_9",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults presenting in primary care with suspected heart failure have their N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) measured."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with suspected heart failure have specialist assessment and transthoracic echocardiography within 2 weeks of referral if they have a very high N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) level, or 6 weeks if they have a high NT‑proBNP level."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with chronic heart failure who have reduced ejection fraction receive all appropriate medication at target or optimal tolerated doses."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with chronic heart failure have a review within 2 weeks of any change in the dose or type of their heart failure medication."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with chronic heart failure have a review of their condition at least every 6 months. "},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults with chronic heart failure receive a personalised programme of cardiac rehabilitation."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH( CONCATENATE(S$23, \" - \",#REF!),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,null,null,null,"Tab (ii)",{"$f":"'Monitoring change (ii)'!$C$27","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_2_Process=Z27,0),0))","v":0},{"$f":"CONCATENATE($AQ$8, \" - \", $AM$8, \" - Process - \", AA27)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB27,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB27,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,"Tab (ii)",{"$f":"'Monitoring change (ii)'!$C$71","v":""},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_2_Outcome=AH27,0),0))","v":0},{"$f":"CONCATENATE($AQ$8, \" - \", $AM$8, \" - Outcome - \", AI27)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ27,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ27,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS10 - Chronic obstructive pulmonary disease in adults","QS_10",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People aged over 35 years who present with a risk factor and 1 or more symptoms of chronic obstructive pulmonary disease (COPD) have post‑bronchodilator spirometry."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with chronic obstructive pulmonary disease (COPD) who are prescribed an inhaler have their inhaler technique assessed when starting or changing treatment and then at least annually during treatment."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with stable chronic obstructive pulmonary disease (COPD) and a persistent resting stable oxygen saturation level of 92% or less have their arterial blood gases measured to assess whether they need long‑term oxygen therapy (LTOT)."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with stable chronic obstructive pulmonary disease (COPD) and a score of 3 or above on the Medical Research Council (MRC) dyspnoea scale are referred to a pulmonary rehabilitation programme."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People receiving emergency oxygen for an acute exacerbation of chronic obstructive pulmonary disease (COPD) have their oxygen saturation levels maintained between 88% and 92%."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - People with an acute exacerbation of chronic obstructive pulmonary disease (COPD) and persistent acidotic hypercapnic ventilatory failure that is not improving after 1 hour of optimal medical therapy have non‑invasive ventilation."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - People discharged from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD) receive a hospital discharge care bundle."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH( CONCATENATE(T$23, \" - \",#REF!),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH( CONCATENATE(U$23, \" - \",#REF!),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH( CONCATENATE(V$23, \" - \",#REF!),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH( CONCATENATE(W$23, \" - \",#REF!),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (ii)'!$C$35","v":""},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_2_Process=Z28,0),0))","v":0},{"$f":"CONCATENATE($AQ$8, \" - \", $AM$8, \" - Process - \", AA28)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB28,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB28,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (ii)'!$C$77","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_2_Outcome=AH28,0),0))","v":0},{"$f":"CONCATENATE($AQ$8, \" - \", $AM$8, \" - Outcome - \", AI28)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ28,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ28,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS11 - Alcohol-use disorders: diagnosis and management","QS_11",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults who are being asked about their alcohol use have a validated alcohol questionnaire completed to identify any need for a brief intervention or referral to specialist alcohol services."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults seeking help for an alcohol-use disorder are given information on, and support to access, community support networks and self-help groups. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults accessing specialist alcohol services have a brief triage assessment that includes any treatment needs and associated risks. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults in acute alcohol withdrawal in hospital are assessed and monitored following locally specified protocols."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with moderate or severe alcohol dependence are offered psychological and, if appropriate, pharmacological interventions to prevent relapse following a successful unplanned withdrawal in hospital."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,null,null,null,null,{"$f":"'Monitoring change (ii)'!$C$43","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_2_Process=Z29,0),0))","v":0},{"$f":"CONCATENATE($AQ$8, \" - \", $AM$8, \" - Process - \", AA29)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB29,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB29,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (ii)'!$C$83","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_2_Outcome=AH29,0),0))","v":0},{"$f":"CONCATENATE($AQ$8, \" - \", $AM$8, \" - Outcome - \", AI29)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ29,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ29,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS12 - Breast cancer ","QS_12",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with suspected breast cancer referred to specialist services are offered the triple diagnostic assessment in a single hospital visit."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with biopsy-proven invasive breast cancer or ductal carcinoma in situ (DCIS) are not offered a preoperative MRI scan unless there are specific clinical indications for its use."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with oestrogen receptor-positive (ER-positive), human epidermal growth factor receptor 2-negative (HER2-negative) and lymph node-negative early breast cancer who are at intermediate risk of distant recurrence are offered gene expression profiling with Oncotype DX. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with newly diagnosed invasive breast cancer and those with recurrent breast cancer (if clinically appropriate) have the oestrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status of the tumour assessed. "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with breast cancer who develop metastatic disease have their treatment and care managed by a multidisciplinary team."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with locally advanced, metastatic or distant recurrent breast cancer are assigned a key worker."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A26),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,"Tab (iii)",{"$f":"'Monitoring change (iii)'!$C$27","v":""},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_3_Process=Z30,0),0))","v":0},{"$f":"CONCATENATE($AQ$9, \" - \", $AM$9, \" - Process - \", AA30)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB30,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB30,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,"Tab (iii)",{"$f":"'Monitoring change (iii)'!$C$71","v":""},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_3_Outcome=AH30,0),0))","v":0},{"$f":"CONCATENATE($AQ$9, \" - \", $AM$9, \" - Outcome - \", AI30)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ30,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ30,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS13 - End of life care for adults","QS_13",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults who are likely to be approaching the end of their life are identified using a systematic approach."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults approaching the end of their life have opportunities to discuss advance care planning."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults approaching the end of their life receive care that is coordinated between health and social care practitioners within and across different services and organisations."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults approaching the end of their life and their carers have access to support 24 hours a day, 7 days a week."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Carers providing end of life care to people at home are supported to access local services that can provide assistance."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A27),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (iii)'!$C$35","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_3_Process=Z31,0),0))","v":0},{"$f":"CONCATENATE($AQ$9, \" - \", $AM$9, \" - Process - \", AA31)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB31,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB31,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (iii)'!$C$77","v":""},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_3_Outcome=AH31,0),0))","v":0},{"$f":"CONCATENATE($AQ$9, \" - \", $AM$9, \" - Outcome - \", AI31)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ31,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ31,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS14 - Service user experience in adult mental health services","QS_14",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People using mental health services are treated with empathy, dignity and respect. [2011, updated 2019]"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People using mental health services are supported in shared decision making. [2011, updated 2019]"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People using mental health services are asked about their experiences and their feedback is used to improve services. [2011]"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People using mental health services understand the roles of the members of their multidisciplinary team and know how to contact them about their ongoing healthcare needs. [2011]"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People can access mental health services, including crisis support, when they need them. [2011, updated 2019]"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People using mental health services jointly agree a care plan with health and social care professionals, including a crisis plan if they may be at risk of crisis. [2011, updated 2019]"},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - People in hospital for mental health care have daily one-to-one contact with mental healthcare professionals known to them and regularly see other members of the multidisciplinary mental healthcare team. [2011]"},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - People in hospital for mental health care can access meaningful and culturally appropriate activities 7 days a week, not restricted to 9am to 5pm. [2011]"},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A28),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (iii)'!$C$43","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_3_Process=Z32,0),0))","v":0},{"$f":"CONCATENATE($AQ$9, \" - \", $AM$9, \" - Process - \", AA32)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB32,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB32,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (iii)'!$C$83","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_3_Outcome=AH32,0),0))","v":0},{"$f":"CONCATENATE($AQ$9, \" - \", $AM$9, \" - Outcome - \", AI32)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ32,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ32,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS15 - Patient experience in adult NHS services ","QS_15",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People using adult NHS services are treated with empathy, dignity and respect. [2012]"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People using adult NHS services understand the roles of healthcare professionals involved in their care and know how to contact them about their ongoing healthcare needs. [2012, updated 2019]"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People using adult NHS services experience coordinated care with clear and accurate information exchange between relevant health and social care professionals. [2012]"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People using adult NHS services experience care and treatment that is tailored to their needs and preferences. [2012, updated 2019]"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People using adult NHS services have their preferences for sharing information with their family members and carers established, respected and reviewed throughout their care. [2012]"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People using adult NHS services are supported in shared decision making. [2012, updated 2019]"},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A29),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,"Tab (iv)",{"$f":"'Monitoring change (iv)'!$C$28","v":""},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_4_Process=Z33,0),0))","v":0},{"$f":"CONCATENATE($AQ$10, \" - \", $AM$10, \" - Process - \", AA33)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB33,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB33,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,"Tab (iv)",{"$f":"'Monitoring change (iv)'!$C$72","v":""},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_4_Outcome=AH33,0),0))","v":0},{"$f":"CONCATENATE($AQ$10, \" - \", $AM$10, \" - Outcome - \", AI33)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ33,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ33,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS16 - Hip fracture","QS_16",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with hip fracture are cared for within a Hip Fracture Programme at every stage of the care pathway. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with hip fracture have surgery on a planned trauma list on the day of, or the day after, admission. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - This statement has been removed."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with trochanteric fractures above and including the lesser trochanter, except reverse oblique fractures, receive extramedullary implants in preference to intramedullary nails."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with subtrochanteric fracture are treated with an intramedullary nail."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults with hip fracture start rehabilitation at least once a day, no later than the day after surgery. "},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A30),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (iv)'!$C$36","v":""},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_4_Process=Z34,0),0))","v":0},{"$f":"CONCATENATE($AQ$10, \" - \", $AM$10, \" - Process - \", AA34)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB34,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB34,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (iv)'!$C$78","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_4_Outcome=AH34,0),0))","v":0},{"$f":"CONCATENATE($AQ$10, \" - \", $AM$10, \" - Outcome - \", AI34)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ34,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ34,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS17 - Lung cancer in adults ","QS_17",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Local authorities and healthcare commissioning groups use coordinated campaigns to raise awareness of the symptoms and signs of lung cancer and encourage people to seek medical advice if they need to. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with suspected or confirmed lung cancer who smoke receive evidence-based stop smoking support."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with suspected or confirmed lung cancer have access to a named lung cancer clinical nurse specialist."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with lung cancer being considered for treatment with curative intent have investigations to accurately determine diagnosis and stage, and to assess lung function. "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with non-small-cell lung cancer stage I or II and good performance status have treatment with curative intent"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults with non-small-cell lung cancer stage III or IV who are having tissue sampling, have samples taken that are suitable for pathological diagnosis and assessment of predictive biomarkers."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A31),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (iv)'!$C$44","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_4_Process=Z35,0),0))","v":0},{"$f":"CONCATENATE($AQ$10, \" - \", $AM$10, \" - Process - \", AA35)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB35,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB35,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (iv)'!$C$84","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_4_Outcome=AH35,0),0))","v":0},{"$f":"CONCATENATE($AQ$10, \" - \", $AM$10, \" - Outcome - \", AI35)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ35,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ35,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS18 - Ovarian cancer ","QS_18",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Women aged 50 years or over reporting one or more symptoms occurring persistently or frequently that suggest ovarian cancer are offered a CA125 test."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Women with raised CA125 have an ultrasound of their abdomen and pelvis within 2 weeks of receiving the CA125 test results."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Women with normal CA125, or raised CA125 but normal ultrasound, with no confirmed diagnosis but continuing symptoms, are reassessed by their GP within 1 month."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Women with a risk of malignancy index (RMI I) score of 250 or greater are referred to a specialist gynaecological cancer multidisciplinary team."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Women who are offered staging for ovarian cancer, following ultrasound, are offered computed tomography (CT) of the abdomen and pelvis as the initial staging investigation."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Women who have computed tomography (CT) for staging of ovarian cancer have the results reported by a radiologist who is a core member of the specialist gynaecological cancer multidisciplinary team."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Women with an indeterminate adnexal mass on ultrasound are offered magnetic resonance imaging (MRI) for further characterisation."},null,{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A34),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A32),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,"Tab (v)",{"$f":"'Monitoring change (v)'!$C$27","v":""},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_5_Process=Z36,0),0))","v":0},{"$f":"CONCATENATE($AQ$11, \" - \", $AM$11, \" - Process - \", AA36)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB36,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB36,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,"Tab (v)",{"$f":"'Monitoring change (v)'!$C$70","v":""},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_5_Outcome=AH36,0),0))","v":0},{"$f":"CONCATENATE($AQ$11, \" - \", $AM$11, \" - Outcome - \", AI36)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ36,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ36,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","QS_19",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Parents and carers of children and young people presenting with non-specific symptoms and signs are given 'safety netting' information that includes information on bacterial meningitis and meningococcal septicaemia."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia have their temperature, respiratory rate, pulse, blood pressure, urine output, oxygen saturation and neurological condition monitored at least hourly until stable."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people presenting with a petechial rash receive antibiotics in accordance with NICE guidance."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children and young people with suspected bacterial meningitis or meningococcal septicaemia receive intravenous or intraosseous antibiotics within an hour of arrival at hospital."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Children and young people with suspected bacterial meningitis have a lumbar puncture."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Children and young people with suspected bacterial meningitis have their cerebrospinal fluid (CSF) microsocpy result available within 4 hours of lumbar puncture."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Children and young people with suspected bacterial meningitis or meningococcal septicaemia have whole blood meningococcal polymerase chain reaction (PCR) testing."},null,{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"9 - Children and young people with meningococcal septicaemia undergoing tracheal intubation and mechanical ventilation have the procedure undertaken by an anaesthetist experienced in paediatric airway management."},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"10 - Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia being transferred within or between hospitals are escorted by a healthcare professional trained in advanced paediatric life support."},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"11 - Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia requiring transfer to a paediatric intensive care unit or high dependency unit in another hospital are transferred by a specialist paediatric retrieval team."},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"12 - Children and young people who have had bacterial meningitis or meningococcal septicaemia, and/or their parents and carers, are given information before discharge about the disease, its potential long-term effects and how to access further support."},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"13 - Children and young people who have had bacterial meningitis or meningococcal septicaemia have an audiological assessment before discharge."},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"14 - Children and young people who have had bacterial meningitis or meningococcal septicaemia have a follow-up appointment with a consultant paediatrician within 6 weeks of discharge."},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A33),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (v)'!$C$35","v":""},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_5_Process=Z37,0),0))","v":0},{"$f":"CONCATENATE($AQ$11, \" - \", $AM$11, \" - Process - \", AA37)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB37,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB37,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (v)'!$C$76","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_5_Outcome=AH37,0),0))","v":0},{"$f":"CONCATENATE($AQ$11, \" - \", $AM$11, \" - Outcome - \", AI37)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ37,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ37,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS20 - Colorectal cancer ","QS_20",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with a new diagnosis of colorectal cancer have testing for Lynch syndrome."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with early rectal cancer discuss the implications of all potential treatment options with their healthcare professional."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with metastatic colorectal cancer suitable for systemic anti-cancer treatment have testing to identify tumours with RAS and BRAF V600E mutations."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults who have had potentially curative surgical treatment for non-metastatic colorectal cancer have follow-up for the first 3 years to detect local recurrence and distant metastases. "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH( CONCATENATE(T$23, \" - \",#REF!),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH( CONCATENATE(U$23, \" - \",#REF!),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH( CONCATENATE(V$23, \" - \",#REF!),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH( CONCATENATE(W$23, \" - \",#REF!),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (v)'!$C$43","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_5_Process=Z38,0),0))","v":0},{"$f":"CONCATENATE($AQ$11, \" - \", $AM$11, \" - Process - \", AA38)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB38,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB38,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (v)'!$C$82","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_5_Outcome=AH38,0),0))","v":0},{"$f":"CONCATENATE($AQ$11, \" - \", $AM$11, \" - Outcome - \", AI38)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ38,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ38,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS21 - Stable angina ","QS_21",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with features of typical or atypical angina are offered 64-slice (or above) CT coronary angiography."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with stable angina are offered a short-acting nitrate and either a beta-blocker or calcium-channel blocker as first-line treatment."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with stable angina are prescribed a short-acting nitrate and 1 or 2 anti-anginal drugs as necessary, before revascularisation is considered."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with stable angina who have had coronary angiography, have their treatment options discussed by a multidisciplinary team if there is left main stem disease, anatomically complex three-vessel disease or doubt about the best method of revascularisation."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with stable angina whose symptoms have not responded to treatment are offered a re-evaluation of their diagnosis and treatment."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A35),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,"Tab (vi)",{"$f":"'Monitoring change (vi)'!$C$27","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_6_Process=Z39,0),0))","v":0},{"$f":"CONCATENATE($AQ$12, \" - \", $AM$12, \" - Process - \", AA39)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB39,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB39,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,"Tab (vi)",{"$f":"'Monitoring change (vi)'!$C$27","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_6_Outcome=AH39,0),0))","v":0},{"$f":"CONCATENATE($AQ$12, \" - \", $AM$12, \" - Outcome - \", AI39)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ39,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ39,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS22 - Antenatal care ","QS_22",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Pregnant women are supported to access antenatal care by 10 weeks of pregnancy. [2012, updated 2023]"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Pregnant women have a risk assessment at routine antenatal appointments. [2012, updated 2023]"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Pregnant women have coordinated care from a small team of midwives. [2012, updated 2023]"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Pregnant women are offered vaccinations at routine antenatal appointments. [new 2023]"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Pregnant women and partners who smoke are referred for stop-smoking support and treatment at routine antenatal appointments. [2012, updated 2023]"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A36),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (vi)'!$C$35","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_6_Process=Z40,0),0))","v":0},{"$f":"CONCATENATE($AQ$12, \" - \", $AM$12, \" - Process - \", AA40)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB40,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB40,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (vi)'!$C$35","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_6_Outcome=AH40,0),0))","v":0},{"$f":"CONCATENATE($AQ$12, \" - \", $AM$12, \" - Outcome - \", AI40)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ40,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ40,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS23 - Drug use disorders in adults","QS_23",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People who inject drugs have access to needle and syringe programmes in accordance with NICE guidance."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People in drug treatment are offered a comprehensive assessment. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Families and carers of people with drug use disorders are offered an assessment of their needs."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People accessing drug treatment services are offered testing and referral for treatment for hepatitis B, hepatitis C and HIV and vaccination for hepatitis B. "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People in drug treatment are given information and advice about the following treatment options: harm reduction, maintenance, detoxification and abstinence."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People in drug treatment are offered appropriate psychosocial interventions by their keyworker."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - People in drug treatment are offered support to access services that promote recovery and reintegration including housing, education, employment, personal finance, healthcare and mutual aid."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - People in drug treatment are offered appropriate formal psychosocial interventions and/or psychological treatments."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"9 - People who have achieved abstinence are offered continued treatment or support for at least 6 months."},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"10 - People in drug treatment are given information and advice on the NICE eligibility criteria for residential rehabilitative treatment."},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A37),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (vi)'!$C$43","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_6_Process=Z41,0),0))","v":0},{"$f":"CONCATENATE($AQ$12, \" - \", $AM$12, \" - Process - \", AA41)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB41,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB41,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (vi)'!$C$43","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_6_Outcome=AH41,0),0))","v":0},{"$f":"CONCATENATE($AQ$12, \" - \", $AM$12, \" - Outcome - \", AI41)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ41,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ41,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS24 - Nutrition support in adults ","QS_24",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People in care settings are screened for the risk of malnutrition using a validated screening tool"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People who are malnourished or at risk of malnutrition have a management care plan that aims to meet their complete nutritional requirements"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - All people who are screened for the risk of malnutrition have their screening results and nutrition support goals (if applicable), documented and communicated in writing within and between settings"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People managing their own artificial nutrition support and/or their carers are trained to manage their nutrition delivery system and monitor their wellbeing"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People receiving nutrition support are offered a review of the indications, route, risks, benefits and goals of nutrition support at planned intervals"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A38),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,"Tab (vii)",{"$f":"'Monitoring change (vii)'!$C$27","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_7_Process=Z42,0),0))","v":0},{"$f":"CONCATENATE($AQ$13, \" - \", $AM$13, \" - Process - \", AA42)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB42,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB42,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,"Tab (vii)",{"$f":"'Monitoring change (vii)'!$C$27","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_7_Outcome=AH42,0),0))","v":0},{"$f":"CONCATENATE($AQ$13, \" - \", $AM$13, \" - Outcome - \", AI42)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ42,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ42,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS25 - Asthma ","QS_25",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People aged 5 years and over with suspected asthma have objective tests to support diagnosis."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People aged 5 years and over with asthma discuss and agree a written personalised action plan."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with asthma have their asthma control monitored at every asthma review."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People who receive treatment in an emergency care setting for an asthma attack are followed up by their general practice within 2 working days of discharge."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with suspected severe asthma are referred to a specialist multidisciplinary severe asthma service."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A39),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (vii)'!$C$35","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_7_Process=Z43,0),0))","v":0},{"$f":"CONCATENATE($AQ$13, \" - \", $AM$13, \" - Process - \", AA43)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB43,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB43,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (vii)'!$C$35","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_7_Outcome=AH43,0),0))","v":0},{"$f":"CONCATENATE($AQ$13, \" - \", $AM$13, \" - Outcome - \", AI43)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ43,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ43,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS26 - Replaced by QS211","QS_26",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A40),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (vii)'!$C$43","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_7_Process=Z44,0),0))","v":0},{"$f":"CONCATENATE($AQ$13, \" - \", $AM$13, \" - Process - \", AA44)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB44,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB44,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (vii)'!$C$43","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_7_Outcome=AH44,0),0))","v":0},{"$f":"CONCATENATE($AQ$13, \" - \", $AM$13, \" - Process - \", AI44)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ44,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ44,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS27 - Replaced by QS211","QS_27",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A41),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,"Tab (viii)",{"$f":"'Monitoring change (viii)'!$C$27","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_8_Process=Z45,0),0))","v":0},{"$f":"CONCATENATE($AQ$14, \" - \", $AM$14, \" - Process - \", AA45)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB45,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB45,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,"Tab (viii)",{"$f":"'Monitoring change (viii)'!$C$27","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_1_Outcome=AH45,0),0))","v":0},{"$f":"CONCATENATE($AQ$14, \" - \", $AM$14, \" - Outcome - \", AI45)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ45,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ45,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS28 - Hypertension in adults","QS_28",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with suspected hypertension are offered ambulatory blood pressure monitoring (ABPM) to confirm a diagnosis of hypertension."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with newly diagnosed hypertension receive investigations for target organ damage within 1 month of diagnosis. "},"3 - This statement has been replaced with statements from QS100",{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with treated hypertension have a clinic blood pressure target set to below 140/90 mmHg if aged under 80 years, or below 150/90 mmHg if aged 80 years and over. "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with hypertension are offered a review of risk factors for cardiovascular disease annually.\n"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with resistant hypertension who are receiving 4 antihypertensive drugs and whose blood pressure remains uncontrolled are referred for specialist assessment."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A42),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (viii)'!$C$35","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_8_Process=Z46,0),0))","v":0},{"$f":"CONCATENATE($AQ$14, \" - \", $AM$14, \" - Process - \", AA46)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB46,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB46,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (viii)'!$C$35","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_1_Outcome=AH46,0),0))","v":0},{"$f":"CONCATENATE($AQ$14, \" - \", $AM$14, \" - Outcome - \", AI46)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ46,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ46,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS31 - Looked-after children and young people","QS_31",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Looked-after children and young people experience warm, nurturing care."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Looked-after children and young people receive care from services and professionals that work collaboratively.\n"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Looked-after children and young people live in stable placements that take account of their needs and preferences.\n"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Looked-after children and young people have ongoing opportunities to explore and make sense of their identity and relationships."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Looked-after children and young people receive specialist and dedicated services within agreed timescales."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Looked-after children and young people who move across local authority or health boundaries continue to receive the services they need."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Looked-after children and young people are supported to fulfil their potential."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Care leavers move to independence at their own pace."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,null,{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A43),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (viii)'!$C$43","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_8_Process=Z47,0),0))","v":0},{"$f":"CONCATENATE($AQ$14, \" - \", $AM$14, \" - Process - \", AA47)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB47,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB47,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (viii)'!$C$43","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_1_Outcome=AH47,0),0))","v":0},{"$f":"CONCATENATE($AQ$14, \" - \", $AM$14, \" - Outcome - \", AI47)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ47,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ47,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS32 - Caesarean section ","QS_32",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Pregnant women who have had 1 or more previous caesarean sections have a documented discussion of the option to plan a vaginal birth. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Pregnant women who request a caesarean birth (when there is no medical indication) have a documented discussion with members of the maternity team about the overall benefits and risks of a caesarean birth compared with vaginal birth."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Pregnant women who request a caesarean birth because of anxiety about childbirth are offered a referral to a healthcare professional with expertise in perinatal mental health support."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Pregnant women who may require a planned caesarean birth have consultant involvement in decision-making."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Pregnant women having a planned caesarean birth have the procedure carried out at or after 39 weeks 0 days, unless an earlier delivery is necessary because of maternal or fetal indications."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Women being considered for an unplanned caesarean birth have a consultant obstetrician involved in the decision."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - This statement has been removed."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Women who have had an emergency or unplanned caesarean birth are offered a discussion and are given written information about the reasons for their caesarean birth and birth options for future pregnancies."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"9 - Women who have had a caesarean birth are monitored for postoperative complications."},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A44),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,"Tab (ix)",{"$f":"'Monitoring change (ix)'!$C$27","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_9_Process=Z48,0),0))","v":0},{"$f":"CONCATENATE($AQ$15, \" - \", $AM$15, \" - Process - \", AA48)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB48,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB48,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,"Tab (ix)",{"$f":"'Monitoring change (ix)'!$C$27","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_1_Outcome=AH48,0),0))","v":0},{"$f":"CONCATENATE($AQ$15, \" - \", $AM$15, \" - Outcome - \", AI48)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ48,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ48,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS33 - Rheumatoid arthritis in over 16s","QS_33",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with suspected persistent synovitis affecting more than 1 joint, or the small joints of the hands and feet, are referred to rheumatology services within 3 working days of presenting in primary care."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with active rheumatoid arthritis start conventional disease-modifying anti-rheumatic drug (cDMARD) monotherapy within 6 weeks of referral, with monthly monitoring until their treatment target is met."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with rheumatoid arthritis are given opportunities throughout the course of their disease to take part in educational activities that support self-management."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with rheumatoid arthritis and disease flares or possible treatment-related side effects receive advice within 1-working-day of contacting rheumatology services."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with rheumatoid arthritis have a comprehensive annual review that is coordinated by rheumatology services."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A45),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (ix)'!$C$35","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_9_Process=Z49,0),0))","v":0},{"$f":"CONCATENATE($AQ$15, \" - \", $AM$15, \" - Process - \", AA49)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB49,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB49,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (ix)'!$C$35","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_1_Outcome=AH49,0),0))","v":0},{"$f":"CONCATENATE($AQ$15, \" - \", $AM$15, \" - Outcome - \", AI49)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ49,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ49,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS34 - Self-harm ","QS_34",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People who have self‑harmed are cared for with compassion and the same respect and dignity as any service user."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People who have self‑harmed have an initial assessment of physical health, mental state, safeguarding concerns, social circumstances and immediate concerns about their safety."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People who have self‑harmed receive a psychosocial assessment."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People who have self‑harmed receive the observation they need while in the healthcare setting."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People who have self‑harmed are cared for in a safe physical environment while in the healthcare setting."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People receiving continuing support for self‑harm have a collaboratively developed care plan."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - People receiving continuing support for self‑harm have a discussion with their healthcare professional about the potential benefits of psychological interventions specifically structured for people who self‑harm."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - People receiving continuing support for self‑harm and moving between mental health services have a collaboratively developed plan describing how support will be provided during the transition."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A46),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (ix)'!$C$43","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_9_Process=Z50,0),0))","v":0},{"$f":"CONCATENATE($AQ$15, \" - \", $AM$15, \" - Process - \", AA50)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB50,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB50,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (ix)'!$C$43","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_1_Outcome=AH50,0),0))","v":0},{"$f":"CONCATENATE($AQ$15, \" - \", $AM$15, \" - Outcome - \", AI50)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ50,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ50,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS35 - Hypertension in pregnancy ","QS_35",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Women of childbearing potential with treated hypertension are given information annually about safe antihypertensive treatment during pregnancy. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Pregnant women at increased risk of pre-eclampsia at the booking appointment are offered a prescription of 75–150 mg of aspirin to take daily from 12 weeks until birth."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Pregnant women taking antihypertensive medication have a blood pressure target of 135/85 mmHg or less."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Pregnant women with severe hypertension are admitted for a full assessment, carried out by a healthcare professional trained in managing hypertension in pregnancy. "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Women with pre-eclampsia who have severe hypertension or are at a high risk of adverse events, or if there are any clinical concerns, are admitted to hospital and monitored."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Women with pre-eclampsia have a senior obstetrician involved in any decisions about the timing of birth."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Women who have had hypertension in pregnancy have a plan for ongoing antihypertensive management included in their postnatal care plan, which is communicated to their GP when they are transferred to community care after the birth."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Women who have had gestational hypertension or pre-eclampsia discuss future pregnancy and lifetime cardiovascular risks during a medical review at their 6–8 week postnatal medical check."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,null,null,null,"Tab (x)",{"$f":"'Monitoring change (x)'!$C$27","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_10_Process=Z51,0),0))","v":0},{"$f":"CONCATENATE($AQ$16, \" - \", $AM$16, \" - Process - \", AA51)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB51,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB51,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,"Tab (x)",{"$f":"'Monitoring change (x)'!$C$27","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_1_Outcome=AH51,0),0))","v":0},{"$f":"CONCATENATE($AQ$16, \" - \", $AM$16, \" - Outcome - \", AI51)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ51,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ51,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS36 - Urinary tract infection in children and young people","QS_36",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - This statement has been removed. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Infants, children and young people with a urinary tract infection have risk factors for urinary tract infection and serious underlying pathology recorded as part of their history and examination."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Infants, children and young people with a urinary tract infection caused by coliform bacteria have results of microbiology laboratory testing differentiated by Escherichia coli (E. coli) or non-E. coli organisms."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children and young people who have had a urinary tract infection are given information about how to recognise re-infection and to seek medical advice straight away."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A47),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (x)'!$C$27","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_10_Process=Z52,0),0))","v":0},{"$f":"CONCATENATE($AQ$16, \" - \", $AM$16, \" - Process - \", AA52)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB52,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB52,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (x)'!$C$27","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_1_Outcome=AH52,0),0))","v":0},{"$f":"CONCATENATE($AQ$16, \" - \", $AM$16, \" - Outcome - \", AI52)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ52,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ52,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS37 - Postnatal care","QS_37",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Women who are transferring between services in the postnatal period have relevant information shared between healthcare professionals to support their care. [new 2022]"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Parents are given personalised information and advice about feeding their baby before transfer to community care or before the midwife leaves after a home birth. [2013, updated 2022]"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Parents are given information and advice, before transfer to community care or before the midwife leaves after a home birth, about symptoms and signs of serious illness in the baby that require them to contact emergency services. [2013, updated 2022]"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Parents receive face-to-face feeding support at each routine postnatal contact. [new 2022]"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Parents are given advice about safer practices for bed sharing at each routine postnatal contact. [2013, updated 2022]"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Women have a GP assessment 6 to 8 weeks after giving birth. [new 2022]"},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A48),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"'Monitoring change (x)'!$C$43","v":0},{"$f":"INDEX($N$6:$X$6,MATCH(TRUE,INDEX(_10_Process=Z53,0),0))","v":0},{"$f":"CONCATENATE($AQ$16, \" - \", $AM$16, \" - Process - \", AA53)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AB53,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AB53,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},null,null,null,{"$f":"'Monitoring change (x)'!$C$43","v":0},{"$f":"INDEX($Z$6:$AJ$6,MATCH(TRUE,INDEX(_1_Outcome=AH53,0),0))","v":0},{"$f":"CONCATENATE($AQ$16, \" - \", $AM$16, \" - Outcome - \", AI53)","v":{"$error":"#VALUE!"}},{"$f":"IFERROR(INDEX('QS Data'!$M$4:$M$4879,(MATCH(Dropdowns!AJ53,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""},{"$f":"IFERROR(INDEX('QS Data'!$N$4:$N$4879,(MATCH(Dropdowns!AJ53,'QS Data'!$L$4:$L$4879,0))), \"\")","v":""}]
["QS38 - Acute upper gastrointestinal bleeding in adults","QS_38",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with acute upper gastrointestinal bleeding receive a risk assessment using a validated risk score. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with severe acute upper gastrointestinal bleeding who are haemodynamically unstable are given an endoscopy within 2 hours of optimal resuscitation."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People admitted to hospital with acute upper gastrointestinal bleeding who are haemodynamically stable are given an endoscopy within 24 hours of admission."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with non-variceal acute upper gastrointestinal bleeding and stigmata of recent haemorrhage are offered endoscopic treatments (combination or a mechanical method).  "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with non-variceal acute upper gastrointestinal bleeding who continue to bleed or re-bleed after endoscopic treatment and who are haemodynamically unstable are given interventional radiology treatment."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with suspected or confirmed variceal acute upper gastrointestinal bleeding are given antibiotic therapy at presentation."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - People with acute upper gastrointestinal bleeding from oesophageal varices are given band ligation."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - People with acute upper gastrointestinal bleeding from gastric varices are given an endoscopic injection of N-butyl-2-cyanoacrylate."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"9 - People with uncontrolled acute upper gastrointestinal bleeding from varices are given transjugular intrahepatic portosystemic shunts (TIPS)."},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"10 - People with acute upper gastrointestinal bleeding who take aspirin for secondary prevention of vascular events and in whom haemostasis has been achieved are advised to continue on low-dose aspirin."},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A49),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS39 - Attention deficit hyperactivity disorder ","QS_39",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children and young people with symptoms of attention deficit hyperactivity disorder (ADHD) are referred to an ADHD specialist for assessment."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults who present with symptoms of attention deficit hyperactivity disorder (ADHD) who do not have a childhood diagnosis of ADHD are referred to an ADHD specialist for assessment."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults who were diagnosed with and treated for attention deficit hyperactivity disorder (ADHD) as children or young people and present with symptoms of continuing ADHD are referred to general adult psychiatric services."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Parents or carers of children and young people with symptoms of attention deficit hyperactivity disorder (ADHD) who meet the NICE eligibility criteria are offered a referral to a parent training programme."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with attention deficit hyperactivity disorder (ADHD) who are starting drug treatment have their initial drug dose adjusted and response assessed by an ADHD specialist."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - People with attention deficit hyperactivity disorder (ADHD) who are taking drug treatment have a specialist review at least annually to assess their need for continued treatment."},null,{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A50),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS40 - Psoriasis ","QS_40",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with psoriasis are offered an assessment of disease severity at diagnosis and when response to treatment is assessed."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with psoriasis are offered an assessment of the impact of the disease on physical, psychological and social wellbeing at diagnosis and when response to treatment is assessed."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with psoriasis are referred for assessment by a dermatology specialist if indicated."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with severe psoriasis are offered a cardiovascular risk assessment at diagnosis and at least once every 5 years."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with psoriasis having treatment are offered an annual assessment for psoriatic arthritis."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with psoriasis receiving systemic therapy are monitored in accordance with locally agreed protocols."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A51),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS41 - Familial hypercholesterolaemia ","QS_41",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with a baseline total cholesterol above 7.5 mmol/l are assessed for a clinical diagnosis of familial hypercholesterolaemia (FH)."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with a clinical diagnosis of familial hypercholesterolaemia (FH) are referred for specialist assessment."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with a clinical diagnosis of familial hypercholesterolaemia (FH) are offered DNA testing as part of a specialist assessment."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children at risk of familial hypercholesterolaemia (FH) are offered diagnostic tests by the age of 10 years."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Relatives of people with a confirmed diagnosis of monogenic familial hypercholesterolaemia (FH) are offered DNA testing through a nationwide, systematic cascade process."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults with familial hypercholesterolaemia (FH) receive lipid‑modifying drug treatment to reduce LDL‑C concentration by more than 50% from baseline."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Children with familial hypercholesterolaemia (FH) are assessed for lipid‑modifying drug treatment by a specialist with expertise in FH in a child‑focused setting by the age of 10 years."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - People with familial hypercholesterolaemia (FH) are offered a structured review at least annually."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A52),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS42 - Headaches in over 12s","QS_42",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People diagnosed with a primary headache disorder have their headache type classified as part of the diagnosis."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with a primary headache disorder are given information on the risk of medication overuse headache."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with tension-type headache or migraine are not referred for imaging if they do not have signs or symptoms of secondary headache."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with migraine are advised to take combination therapy with a triptan and either a non-steroidal anti-inflammatory drug (NSAID) or paracetamol."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A53),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS43 - Smoking: supporting people to stop","QS_43",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People are asked if they smoke by their healthcare practitioner, and those who smoke are offered advice on how to stop."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Statement removed"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People in contact with healthcare practitioners who provide stop-smoking support are offered stop-smoking advice and interventions."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People who seek support to stop smoking and who choose to take pharmacotherapy are offered a full course."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People who smoke who have set a quit date have a carbon monoxide test 4 weeks after the quit date."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A54),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS44 - Atopic eczema in under 12s","QS_44",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children with atopic eczema are offered, at diagnosis, an assessment that includes recording of their detailed clinical and treatment histories and identification of potential trigger factors."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children with atopic eczema are offered treatment based on recorded eczema severity using the stepped-care plan, supported by education."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children with atopic eczema have their (and their families') psychological wellbeing and quality of life discussed and recorded at each eczema consultation."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children with atopic eczema are prescribed sufficient quantities (250–500 g weekly) from a choice of unperfumed emollients for daily use."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Children with uncontrolled or unresponsive atopic eczema, including recurring infections, or psychosocial problems related to the atopic eczema are referred for specialist dermatological advice."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Infants and young children with moderate or severe atopic eczema that has not been controlled by optimal treatment are referred for specialist investigation to identify possible food and other allergies."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Children with atopic eczema who have suspected eczema herpeticum receive immediate treatment with systemic aciclovir and are referred for same-day specialist dermatological advice."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A55),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS45 - Lower urinary tract symptoms in men","QS_45",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Men with lower urinary tract symptoms (LUTS) are offered a full physical examination, including a digital rectal examination, as part of their initial assessment"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Men with bothersome lower urinary tract symptoms (LUTS) are asked to complete a urinary frequency and volume chart, as part of their initial assessment."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Men with lower urinary tract symptoms (LUTS) whose symptoms are not bothersome or complicated are given written advice on lifestyle interventions, as part of their initial assessment."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Men with lower urinary tract symptoms (LUTS) who have urinary incontinence are offered a choice of temporary containment products, as part of their initial assessment."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Men with lower urinary tract symptoms (LUTS) who have post-micturition dribble are given information about how to perform urethral milking."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Men with lower urinary tract symptoms (LUTS) who are prescribed drug treatments to manage symptoms receive a timely medication review."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Men with lower urinary tract symptoms (LUTS) are offered a measurement of flow rate and post-void residual volume, as part of their specialist assessment."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Men with voiding symptoms are offered surgery only if voiding symptoms are severe or if drug treatment and conservative management have been unsuccessful or are not appropriate."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A56),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS46 - Multiple pregnancy: twin and triplet pregnancies","QS_46",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Women with a multiple pregnancy have the chorionicity and amnionicity of their pregnancy determined using ultrasound and recorded between 11+2 weeks and 14+1 weeks."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Women with a multiple pregnancy have their fetuses labelled using ultrasound and recorded between 11+2 weeks and 14+1 weeks."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Women with a multiple pregnancy are cared for by a multidisciplinary core team."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Women with a multiple pregnancy have a care plan that specifies the timing of appointments with the multidisciplinary core team appropriate for the chorionicity and amnionicity of their pregnancy."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Women with a multiple pregnancy are monitored for fetal complications according to the chorionicity and amnionicity of their pregnancy."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Women with a higher-risk or complicated multiple pregnancy have a consultant from a tertiary level fetal medicine centre involved in their care."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Women with a multiple pregnancy have a discussion by 24 weeks with one or more members of the multidisciplinary core team about the risks, signs and symptoms of preterm labour and possible outcomes of preterm birth."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Women with a multiple pregnancy have a discussion by 28 weeks with one or more members of the multidisciplinary core team about the timing of birth and possible modes of delivery so that a birth plan can be agreed."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A57),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS47 - Heavy menstrual bleeding ","QS_47",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People presenting with symptoms related to heavy menstrual bleeding have a focused history taken that includes the impact on their quality of life."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with heavy menstrual bleeding and suspected submucosal fibroids, polyps or endometrial pathology are offered outpatient hysteroscopy."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with heavy menstrual bleeding have a discussion with their healthcare professional about all their treatment options."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A58),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS48 - Depression in children and young people","QS_48",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children and young people with suspected depression have a diagnosis confirmed and recorded in their medical records."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children and young people with depression are given information appropriate to their age about the diagnosis and their treatment options."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people with suspected severe depression and at high risk of suicide are assessed by CAMHS (Child and Adolescent Mental Health Services) professionals within a maximum of 24 hours of referral. If necessary, children and young people are provided with a safe place while waiting for the assessment."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children and young people with suspected severe depression but not at high risk of suicide are assessed by CAMHS (Child and Adolescent Mental Health Services) professionals within a maximum of 2 weeks of referral."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Children and young people receiving treatment for depression have their health outcomes recorded at the beginning and end of each step in treatment."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A59),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS49 - Surgical site infection","QS_49",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People having surgery are advised not to remove hair from the surgical site and are advised to have (or are helped to have) a shower, bath or bed bath the day before or on the day of surgery. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People having surgery for which antibiotic prophylaxis is indicated receive this in accordance with the local antibiotic formulary. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults having surgery under general or regional anaesthesia have normothermia maintained before, during (unless active cooling is part of the procedure) and after surgery. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People having surgery are cared for by an operating team that minimises the transfer of microorganisms during the procedure by following best practice in hand hygiene and theatre wear, and by not moving in and out of the operating area unnecessarily."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People having surgery and their carers receive information and advice on wound and dressing care, including how to recognise problems with the wound and who to contact if they are concerned. "},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with a surgical site infection are offered treatment with an antibiotic that covers the likely causative organisms and is selected based on local resistance patterns and the results of microbiological tests. "},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - People having surgery are cared for by healthcare providers that monitor surgical site infection rates (including post-discharge infections) and provide feedback to relevant staff and stakeholders for continuous improvement through adjustment of clinical practice. "},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A60),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS50 - Mental wellbeing of older people in care homes","QS_50",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Older people in care homes are offered opportunities during their day to participate in meaningful activity that promotes their health and mental wellbeing."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Older people in care homes are enabled to maintain and develop their personal identity."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Older people in care homes have the symptoms and signs of mental health conditions recognised and recorded as part of their care plan. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Older people in care homes who have specific needs arising from sensory impairment have these recognised and recorded as part of their care plan."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Older people in care homes have the symptoms and signs of physical problems recognised and recorded as part of their care plan. "},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Older people in care homes have access to the full range of healthcare services when they need them."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A61),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS51 - Autism","QS_51",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with possible autism who are referred to an autism team for a diagnostic assessment have the diagnostic assessment started within 3 months of their referral."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People having a diagnostic assessment for autism are also assessed for coexisting physical health conditions and mental health problems."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with autism have a personalised plan that is developed and implemented in a partnership between them and their family and carers (if appropriate) and the autism team"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with autism are offered a named key worker to coordinate the care and support detailed in their personalised plan."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with autism have a documented discussion with a member of the autism team about opportunities to take part in age-appropriate psychosocial interventions to help address the core features of autism."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with autism are not prescribed medication to address the core features of autism"},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - People with autism who develop behaviour that challenges are assessed for possible triggers, including physical health conditions, mental health problems and environmental factors."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - People with autism and behaviour that challenges are not offered antipsychotic medication for the behaviour unless it is being considered because psychosocial or other interventions are insufficient or cannot be delivered because of the severity of the behaviour."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A62),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS52 - Peripheral arterial disease","QS_52",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People who have symptoms of, or who are at risk of developing, peripheral arterial disease (PAD) are offered a clinical assessment and ankle brachial pressure index (ABPI) measurement."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with peripheral arterial disease (PAD) are offered an assessment for cardiovascular comorbidities and modifiable risk factors."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with intermittent claudication are offered a supervised exercise programme."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with peripheral arterial disease (PAD) being considered for revascularisation who need further imaging after a duplex ultrasound are offered magnetic resonance angiography (MRA)."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with intermittent claudication are offered angioplasty only when imaging has confirmed it is appropriate, after advice on the benefits of modifying risk factors has been given, and after a supervised exercise programme has not improved symptoms."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A63),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS53 - Anxiety disorders","QS_53",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with a suspected anxiety disorder receive an assessment that identifies whether they have a specific anxiety disorder, the severity of symptoms and associated functional impairment."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with an anxiety disorder are offered evidence-based psychological interventions."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with an anxiety disorder are not prescribed benzodiazepines or antipsychotics unless specifically indicated."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People receiving treatment for an anxiety disorder have their response to treatment recorded at each treatment session."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A64),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS54 - Faecal Incontinence in adults","QS_54",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults in high-risk groups for faecal incontinence are asked in a sensitive way, at the time the risk factor is identified and then at times according to local care pathways, whether they have bowel control problems."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults reporting bowel control problems are offered a full baseline assessment, which is carried out by healthcare professionals who do not assume that symptoms are caused by any existing conditions or disabilities."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with faecal incontinence and their carers are offered practical support, advice and a choice of appropriate products for coping with symptoms during the period of assessment and for as long as they experience episodes of faecal incontinence."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with faecal incontinence have an initial management plan that covers any specific conditions causing the incontinence, and diet, bowel habit, toilet access and medication."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults who continue to experience episodes of faecal incontinence after initial management are offered referral for specialised management."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A65),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS55 - Cancer services for children and young people","QS_55",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Young people (aged 16–24 years) with cancer have their diagnosis, treatment and support agreed and delivered by a cancer-site-specific multidisciplinary team and a teenage and young adult multidisciplinary team."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children and young people (aged 0–24 years) with cancer should be offered the opportunity to take part in clinical trials if they are eligible."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people (aged 0–24 years) receiving chemotherapy have it prescribed using an electronic prescribing system."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children and young people (aged 0–24 years) with cancer, and their families and carers, have their psychological and social needs assessed at key points in their care pathway and receive support based on their identified needs"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Children and young people (aged 0–24 years) who have had a central nervous system malignancy receive a specialist neuro-rehabilitation care package."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Children and young people (aged 0–24 years) who have been treated for cancer have an end-of-treatment summary and care plan that includes agreed follow-up and monitoring arrangements"},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Children and young people (aged 0–24 years) with cancer are assessed for potential future fertility problems and advised about their options for fertility preservation before treatment is started."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A66),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS56 - Spinal metastases and metastatic spinal cord compression","QS_56",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with spinal pain suggestive of spinal metastases, but with no neurological symptoms or signs, have an MRI of the whole spine and any necessary treatment plan agreed within 1 week of the suspected diagnosis."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with suspected metastatic spinal cord compression (MSCC) who present with neurological symptoms or signs have an MRI of the whole spine within 24 hours of the suspected diagnosis."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with suspected metastatic spinal cord compression (MSCC) who present with neurological symptoms or signs have their diagnostic investigations coordinated by an MSCC coordinator."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with metastatic spinal cord compression (MSCC) have their ongoing care coordinated by an MSCC coordinator."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults with MSCC that is not suitable for surgery start radiotherapy within 24 hours of the decision to treat (if appropriate)."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Adults with metastatic spinal cord compression (MSCC) have a management plan that includes an assessment of ongoing care and rehabilitation needs."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A67),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS57 - Jaundice in newborn babies under 28 days","QS_57",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Parents or carers of newborn babies have a discussion with healthcare professionals and are given written information about neonatal jaundice within 24 hours of the birth, including what to look for and who to contact if they are concerned."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Babies with suspected jaundice who are more than 24 hours old have their bilirubin level measured within 6 hours of a healthcare professional suspecting jaundice or a parent or carer reporting possible jaundice."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Babies with hyperbilirubinaemia are started on treatment in accordance with standardised threshold tables or charts."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A68),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS58 - Sickle cell disease","QS_58",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People who present at hospital with an acute painful sickle cell episode have a pain assessment, a clinical assessment and appropriate analgesia within 30 minutes of presentation."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with an acute painful sickle cell episode have an assessment of pain relief every 30 minutes until satisfactory pain relief has been achieved and then at least every 4 hours."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with an acute painful sickle cell episode who are taking strong opioids are monitored for adverse events every hour for the first 6 hours after first administration or step up of pain relief and then at least every 4 hours."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with an acute painful sickle cell episode are assessed for acute chest syndrome if they have 1 or more of the following: abnormal respiratory signs or symptoms, chest pain, fever, or signs and symptoms of hypoxia."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Healthcare professionals who care for people with an acute painful sickle cell episode have access to locally agreed protocols on treatment and management and specialist support from designated centres."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with an acute painful sickle cell episode are given information before discharge on how to continue to manage their current episode."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A69),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS59 - Antisocial behaviour and conduct disorders in children and young people ","QS_59",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children aged 3 to 7 years attending school classes where a high proportion of children are identified as at risk of developing a conduct disorder take part in a classroom-based emotional learning and problem-solving programme."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children and young people with a suspected conduct disorder and any significant complicating factors have a comprehensive assessment, including an assessment of the child or young person's parents or carers."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people with a conduct disorder who have been referred for treatment and support have a key worker to oversee their care and facilitate engagement with services."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Parents or carers of children with a conduct disorder aged 3 to 11 years are offered a referral for group or individual parent or carer training programmes."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Children and young people aged 11 to 17 years who have a conduct disorder are offered a referral for multimodal interventions, with the involvement of their parents or carers."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Children and young people with a conduct disorder and severely aggressive behaviour who have been prescribed risperidone have a baseline physical and metabolic investigation and are monitored for efficacy and adverse effects at regular intervals."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A70),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS60 - Inducing labour ","QS_60",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Women who are being offered induction of labour are given personalised information about the benefits and risks for them and their babies, and the alternatives to induction."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Women only have their labour induced as outpatients if safety and support procedures are in place."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Women who have their labour induced have access to pain relief that is appropriate to their level of pain and to the type of pain relief they request."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Pregnant women discuss the option of vaginal examination for membrane sweeping at their antenatal appointments after 39 weeks of pregnancy."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A71),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS61 - Infection prevention and control ","QS_61",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People are prescribed antibiotics in accordance with local antibiotic formularies as part of antimicrobial stewardship."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Organisations that provide healthcare have a strategy for continuous improvement in infection prevention and control, including accountable leadership, multi-agency working and the use of surveillance systems."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People receive healthcare from healthcare workers who decontaminate their hands immediately before and after every episode of direct contact or care."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People who need a urinary catheter have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the catheter and its removal as soon as it is no longer needed."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People who need a vascular access device have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the device and its removal as soon as it is no longer needed."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with a urinary catheter, vascular access device or enteral feeding tube, and their family members or carers (as appropriate), are educated about the safe management of the device or equipment, including techniques to prevent infection. "},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A72),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS62 - Constipation in children and young people ","QS_62",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children and young people with constipation receive a full assessment before a diagnosis of idiopathic constipation is made."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children and young people with idiopathic constipation receive oral macrogols as first-line treatment."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people with idiopathic constipation starting disimpaction therapy have their treatment reviewed by a healthcare professional within 1 week."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children and young people with idiopathic constipation starting maintenance therapy have their first treatment review by a healthcare professional within 6 weeks."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Children and young people with idiopathic constipation starting laxative treatment, or their parents or carers, receive written information about laxatives."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Children and young people with idiopathic constipation that does not respond to initial treatment within 3 months are referred to a healthcare professional with expertise in the problem."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A73),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS63 - Delirium in adults","QS_63",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults newly admitted to hospital or long-term care who are at risk of delirium are assessed for recent changes that affect cognition, perception, physical function or social behaviour."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults newly admitted to hospital or long-term care who are at risk of delirium receive a range of tailored interventions to prevent delirium."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with delirium in hospital or long-term care who are distressed or are a risk to themselves or others are not prescribed antipsychotic medication unless de-escalation techniques are ineffective or inappropriate. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with delirium in hospital or long-term care, and their family members and carers, are given information that explains the condition and describes other people’s experiences of delirium."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with current or resolved delirium who are discharged from hospital have their diagnosis of delirium communicated to their GP."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A74),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS64 - Fever in under 5s","QS_64",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Infants and children under 5 years with unexplained fever have their risk of serious illness assessed and recorded using the traffic light system"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Infants and children under 5 years who are seen in person by a healthcare professional have their temperature, heart rate, respiratory rate and capillary refill time measured and recorded if fever is suspected"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - This statement has been removed. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Parents and carers who are advised that they can care for an infant or child under 5 years with unexplained fever at home are given safety net advice, including information on when to seek further help."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A75),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS65 - Hepatitis B ","QS_65",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People who are at increased risk of hepatitis B infection are offered testing and vaccination."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People who test positive for hepatitis B surface antigen (HBsAg) are referred to specialist care for further assessment. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Pregnant women who are identified as hepatitis B surface antigen (HBsAg)-positive at antenatal screening are assessed by a specialist within 6 weeks of receiving the screening test result."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Babies born to hepatitis B surface antigen (HBsAg)-positive mothers receive a complete course of hepatitis B vaccination and, at age 12 months, receive a blood test for hepatitis B infection."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with chronic hepatitis B infection, and their family members or carers (if appropriate), are offered a personalised care plan outlining the proposed treatment and long-term management of their infection."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with chronic hepatitis B infection who do not meet the criteria for antiviral treatment are monitored regularly at intervals determined by their infection status and age."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Adults with chronic hepatitis B infection who have significant liver fibrosis or cirrhosis are offered 6‑monthly surveillance testing for hepatocellular carcinoma."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A76),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS66 - Intravenous fluid therapy in adults in hospital","QS_66",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Hospitals have an intravenous (IV) fluids lead who has overall responsibility for training, clinical governance, audit and review of IV fluid prescribing, and patient outcomes."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults receiving intravenous (IV) fluid therapy in hospital are cared for by healthcare professionals competent in assessing patients' fluid and electrolyte needs, prescribing and administering IV fluids, and monitoring patient response."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults receiving intravenous (IV) fluid therapy in hospital have an IV fluid management plan, determined by and reviewed by an expert, which includes the fluid and electrolyte prescription over the next 24 hours and arrangements for assessing patients and monitoring their plan."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - For adults who receive intravenous (IV) fluid therapy in hospital, clear incidents of fluid mismanagement are reported as critical incidents"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A77),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS67 - Varicose veins in the legs","QS_67",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with varicose veins that are causing symptoms or complications (including ulceration) are referred to a vascular service."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with varicose veins who are seen by a vascular service are assessed with duplex ultrasound."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with confirmed varicose veins and truncal reflux are offered a suitable treatment in this order: endothermal ablation, ultrasound-guided foam sclerotherapy, surgery, compression hosiery."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A78),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS68 - Acute coronary syndromes in adults","QS_68",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with a suspected acute coronary syndrome are assessed for acute myocardial infarction using the criteria in the universal definition of myocardial infarction."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with non-ST-segment-elevation myocardial infarction (NSTEMI) or unstable angina are assessed for their risk of future adverse cardiovascular events using an established risk scoring system that predicts 6-month mortality to guide clinical management."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with non-ST-segment-elevation myocardial infarction (NSTEMI) or unstable angina who have an intermediate or higher risk of future adverse cardiovascular events who are having coronary angiography (with follow-on percutaneous coronary intervention [PCI] if indicated), have it within 72 hours of first admission to hospital."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with non-ST-segment-elevation myocardial infarction (NSTEMI) or unstable angina who are clinically unstable have coronary angiography (with follow-on percutaneous coronary intervention [PCI] if indicated) as soon as possible, but within 24 hours of becoming clinically unstable.  "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults who are unconscious after cardiac arrest caused by suspected acute ST-segment-elevation myocardial infarction (STEMI) are not excluded from having coronary angiography (with follow–on primary percutaneous coronary intervention [PCI] if indicated)."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults with acute ST-segment-elevation myocardial infarction (STEMI) who present within 12 hours of onset of symptoms have primary percutaneous coronary intervention (PCI), as the preferred coronary reperfusion strategy, as soon as possible but within 120 minutes of the time when fibrinolysis could have been given."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A79),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS69 - Ectopic pregnancy and miscarriage","QS_69",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Women referred to early pregnancy assessment services are seen by the service at least within 24 hours of referral."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Women who are referred with suspected ectopic pregnancy or miscarriage are offered a transvaginal ultrasound scan to identify the location and viability of the pregnancy."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Women with a suspected miscarriage who have had an initial transvaginal ultrasound scan are offered a second assessment to confirm the diagnosis."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A80),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS70 - Bedwetting in children and young people","QS_70",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children and young people who are bedwetting have a comprehensive initial assessment."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children and young people have an agreed review date if they, or their parents or carers, are given advice about changing their daily routine to help with bedwetting."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people, and their parents or carers if appropriate, have a discussion about initial treatment if bedwetting has not improved after changing their daily routine."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children and young people who are bedwetting receive the treatment agreed in their initial treatment plan."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Children and young people whose bedwetting has not responded to courses of initial treatments are referred for a specialist review."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A81),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS71 - Transient loss of consciousness","QS_71",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People who have had a suspected transient loss of consciousness have an initial assessment to record details of the event, clinical history and physical examination."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People who have had a transient loss of consciousness have a 12‑lead electrocardiogram (ECG) during the initial assessment."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People who have had a transient loss of consciousness and 1 or more 'red flag' signs or symptoms identified have an urgent specialist cardiovascular assessment within 24 hours of the initial assessment."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People who have had a transient loss of consciousness are not routinely offered an electroencephalogram (EEG) to investigate the event."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People who have had a transient loss of consciousness are advised not to drive while they are awaiting specialist assessment."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with a suspected cardiac arrhythmic cause of syncope are offered an ambulatory electrocardiogram (ECG) as a first line specialist cardiovascular investigation."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A82),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS72 - Renal replacement therapy services for adults","QS_72",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults preparing for or receiving renal replacement therapy, and their family members or carers, undertake individualised education programmes at specialist renal centres."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults who will need renal replacement therapy are offered a pre‑emptive kidney transplant, if they are medically suitable."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults on dialysis are offered a kidney transplant, if they are medically suitable."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - This statement has been removed"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults who need long‑term dialysis are offered home‑based dialysis."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - This statement has been removed."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Adults who have a suspected acute rejection episode have a transplant kidney biopsy carried out and reported on within 24 hours."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Adults receiving haemodialysis have their vascular access monitored and maintained using systematic assessment. "},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A83),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS73 - Fertility problems","QS_73",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People who are concerned that it is taking longer than expected to conceive are given advice on the impact that lifestyle can have on their chances of getting pregnant."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People are referred for specialist consultation if the woman has not conceived after 1 year of intercourse or after 6 cycles of artificial insemination, or earlier in certain circumstances."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People who are having problems conceiving are offered counselling before, during and after investigation and treatment for their fertility problems."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Services analysing semen samples use methods and reference values in accordance with the most recent World Health Organization laboratory manual."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Women aged under 40 years who meet the criteria for in vitro fertilisation (IVF) are offered 3 full cycles of IVF."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Women aged 40–42 years who meet the criteria for in vitro fertilisation (IVF) are offered 1 full cycle of IVF."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Women having in vitro fertilisation (IVF) are offered intracytoplasmic sperm injection (ICSI) only if there are severe deficits in semen quality, obstructive azoospermia, non-obstructive azoospermia or if previous IVF treatment resulted in failed or very poor fertilisation."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Women having in vitro fertilisation (IVF) have 1 or 2 embryos transferred according to the woman’s or donor’s age, the cycle number and the quality of the embryos."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"9 - People preparing to have treatment for cancer that is likely to result in fertility problems are offered cryopreservation."},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A84),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS74 - Head Injury","QS_74",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People attending an emergency department with a head injury have a CT head scan within 1 hour of a risk factor for brain injury being identified."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - This statement has been removed. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People attending an emergency department with a head injury have a CT cervical spine scan within 1 hour of a risk factor for spinal injury being identified."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People attending an emergency department with a head injury have a provisional written radiology report within 1 hour if a CT head or cervical spine scan is performed"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with a head injury who have a Glasgow Coma Scale (GCS) score of 8 or lower at any time have access to specialist treatment from a neuroscience unit."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People who are in hospital with new cognitive, communicative, emotional, behavioural or physical difficulties that continue 72 hours after a traumatic brain injury have an assessment for inpatient rehabilitation."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Community-based neuro-rehabilitation services provide a range of interventions to help support people (aged 16 and over) with continuing cognitive, communicative, emotional, behavioural or physical difficulties as a result of a traumatic brain injury. "},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A85),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS75 - Neonatal infection","QS_75",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Pregnant women and pregnant people whose babies are at risk of early-onset neonatal infection are offered intrapartum antibiotics and given the first dose within 1 hour of the decision to treat."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Newborn babies are assessed for the risk factors and clinical indicators of early-onset neonatal infection."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Neonates who need intravenous antibiotic treatment for suspected neonatal infection receive it within 1 hour of the decision to treat."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Neonates who start intravenous antibiotic treatment for suspected neonatal infection have their need for it reassessed at 36 hours for early-onset or at 48 hours for late-onset."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Parents or carers of babies that have or have had risk factors for neonatal infection, or whose baby has received intravenous antibiotics, are given verbal and written information about neonatal infection before transfer to community care, before the midwife leaves after a home birth or before discharge."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A86),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS76 - Acute kidney injury","QS_76",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children, young people and adults who are at risk of acute kidney injury are given advice on maintaining kidney health. [2014, updated 2023]"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children, young people and adults at risk of acute kidney injury who are admitted to hospital have their serum creatinine level monitored. [2014, updated 2023]"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with an acute kidney injury warning stage 2 test result have a clinical review within 6 hours if they are acutely ill or admitted to hospital, or within 24 hours if they are clinically stable.[new 2023]"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with an acute kidney injury warning stage 3 test result have a clinical review within 6 hours or, if they are acutely ill in the community, an immediate review to consider admission to hospital. [new 2023]"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Children, young people and adults with acute kidney injury who meet the criteria for renal replacement therapy are referred immediately to a nephrologist or, if appropriate, a critical care specialist. [2014, updated 2023]"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults discharged from hospital after acute kidney injury have a clinical review within 3 months, or sooner if they are at higher risk of poor outcomes. [new 2023]"},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A87),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS77 - Urinary incontinence in women","QS_77",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Women first presenting with urinary incontinence have a physical examination, recording of the type and duration of symptoms, and categorisation of the urinary incontinence.  "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Women first presenting with urinary incontinence are asked to complete a bladder diary for a minimum of 3 days and given advice about the impact that lifestyle changes can have. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Women with urinary incontinence are only offered containment products as a temporary coping strategy, or as long-term management if treatment is unsuccessful. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Women with stress or mixed urinary incontinence are offered a supervised pelvic floor muscle training programme of at least 3 months' duration as first-line treatment."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Women with symptoms of urgency or mixed urinary incontinence are offered bladder training for a minimum of 6 weeks as first-line treatment."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Women with urinary incontinence have indwelling urethral catheters for long-term treatment only if they have an assessment and discussion of the practicalities and potential urological complications."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Women with overactive bladder or stress urinary incontinence symptoms have a multidisciplinary team review before they are offered surgery or other invasive treatment."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A88),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS78 - Sarcoma","QS_78",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Sarcoma advisory groups and sarcoma multidisciplinary teams (MDTs) have pathways for referral and diagnosis in place for people with suspected sarcoma"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults, children and young people with bone sarcoma and adults with soft tissue sarcoma have their care plan confirmed by a sarcoma multidisciplinary team (MDT) and treatment delivered by services designated by the sarcoma advisory group."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Sarcoma multidisciplinary teams (MDTs) publish information about their shared pathways, activity and patient outcomes, including information on site‑specific sarcomas."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with a retroperitoneal sarcoma are referred before having any treatment to a sarcoma treatment centre with special expertise in managing this type of tumour."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Surgeons performing planned resections of sarcomas are core or extended members of a sarcoma multidisciplinary team (MDT)."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with sarcoma are supported by an allocated key worker with specialist knowledge of sarcomas and their treatment."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A89),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS79 - Idiopathic pulmonary fibrosis in adults","QS_79",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People are diagnosed with idiopathic pulmonary fibrosis only with the consensus of a multidisciplinary team with expertise in interstitial lung disease."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with idiopathic pulmonary fibrosis have an interstitial lung disease specialist nurse available to them."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with idiopathic pulmonary fibrosis have an assessment for home and ambulatory oxygen therapy at each follow-up appointment and before they leave hospital following an exacerbation of the disease."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Pulmonary rehabilitation programmes provide services that are designed specifically for idiopathic pulmonary fibrosis."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with idiopathic pulmonary fibrosis and their families and carers have access to services that meet their palliative care needs."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A90),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS80 - Psychosis and schizophrenia in adults","QS_80",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with a first episode of psychosis start treatment in early intervention in psychosis services within 2 weeks of referral."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with psychosis or schizophrenia are offered cognitive behavioural therapy for psychosis (CBTp)."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Family members of adults with psychosis or schizophrenia are offered family intervention."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with schizophrenia that has not responded adequately to treatment with at least 2 antipsychotic drugs are offered clozapine."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with psychosis or schizophrenia who wish to find or return to work are offered supported employment programmes."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults with psychosis or schizophrenia have specific comprehensive physical health assessments."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Adults with psychosis or schizophrenia are offered combined healthy eating and physical activity programmes, and help to stop smoking."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Carers of adults with psychosis or schizophrenia are offered carer‑focused education and support programmes."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A91),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS81 - Inflammatory bowel disease","QS_81",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with suspected inflammatory bowel disease have a specialist assessment within 4 weeks of referral."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Services provide age-appropriate support from a multidisciplinary team for people with inflammatory bowel disease, and their family members or carers."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People having surgery for inflammatory bowel disease have it undertaken by a colorectal surgeon who is a core member of the inflammatory bowel disease multidisciplinary team."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People receiving drug treatment for inflammatory bowel disease are monitored for adverse effects."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A92),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS82 - Smoking: reducing and preventing tobacco use","QS_82",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Schools and colleges deliver combined interventions to stop children and young people taking up smoking by improving their social competence and awareness of social influences."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Schools and colleges do not allow smoking anywhere in their grounds and remove any areas previously designated for smoking."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Trading standards identify and take action against retailers that sell tobacco products to people under 18."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Employers allow employees to access evidence-based ‘stop smoking’ support during working hours without loss of pay."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Healthcare services use contracts that do not allow employees to smoke during working hours or when recognisable as an employee. "},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Healthcare settings do not allow smoking anywhere in their grounds and remove any areas previously designated for smoking."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Secondary healthcare settings ensure that a range of licensed nicotine-containing products and stop smoking pharmacotherapies is available on site for patients, visitors and employees."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Local authorities use regional and local media channels to reinforce national tobacco reduction campaigns. "},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A93),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS83 - Alcohol: preventing harmful use in the community","QS_83",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Local authorities use local crime and related trauma data to map the extent of alcohol-related problems, to inform the development or review of a statement of licensing policy."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Trading standards and the police identify and take action against premises that sell alcohol to people under 18."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Schools and colleges include alcohol education in the curriculum. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Schools and colleges involve parents, carers, children and young people in initiatives to reduce alcohol use. "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A94),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS84 - Physical activity: for NHS staff, patients and carers","QS_84",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults having their NHS Health Check are given brief advice about how to be more physically active."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Parents or carers of children are given advice about physical activity during their child’s Healthy Child Programme 2-year review."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Parents or carers of children are given advice about physical activity as part of the National Child Measurement Programme (NCMP)."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - NHS organisations have an organisation-wide, multi-component programme to encourage and support employees to be more physically active."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A95),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS85 - Medicines management in care homes","QS_85",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People who transfer into a care home have their medicines listed by the care home on the day that they transfer."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Providers of health or social care services send a discharge summary, including details of the person's current medicines, with a person who transfers to or from a care home."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People who live in care homes are supported to self‑administer their medicines if they wish to and it does not put them or others at risk."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Prescribers responsible for people who live in care homes provide comprehensive instructions for using and monitoring all newly prescribed medicines."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People who live in care homes have medication reviews undertaken by a multidisciplinary team."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults who live in care homes and have been assessed as lacking capacity are only administered medicine covertly if a management plan is agreed after a best interests meeting."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A96),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS86 - Falls in older people","QS_86",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Older people are asked about falls when they have routine assessments and reviews with health and social care practitioners, and if they present at hospital."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Older people at risk of falling are offered a multifactorial falls risk assessment. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Older people assessed as being at increased risk of falling have an individualised multifactorial intervention. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Older people who fall during a hospital stay are checked for signs or symptoms of fracture and potential for spinal injury before they are moved."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Older people who fall during a hospital stay and have signs or symptoms of fracture or potential for spinal injury are moved using safe manual handling methods."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Older people who fall during a hospital stay have a medical examination."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Older people who present for medical attention because of a fall have a multifactorial falls risk assessment."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Older people living in the community who have a known history of recurrent falls are referred for strength and balance training."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"9 - Older people who are admitted to hospital after having a fall are offered a home hazard assessment and safety interventions."},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A97),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS87 - Osteoarthritis","QS_87",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults aged 45 or over are diagnosed with osteoarthritis clinically without investigations if they have activity-related joint pain and any morning joint stiffness lasts no longer than 30 minutes."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - This statement has been removed. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with osteoarthritis are given information about their condition and its management at diagnosis and follow-up appointments."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with osteoarthritis are advised to do tailored therapeutic exercise."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with osteoarthritis who are living with overweight or obesity are offered support to lose weight."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults with osteoarthritis discuss and agree their follow-up with their primary healthcare team."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Adults with osteoarthritis are supported with non-surgical core treatments for at least 3 months before any referral for consideration of joint surgery. "},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Healthcare professionals do not use scoring tools to identify which adults with osteoarthritis are eligible for referral for consideration of joint surgery."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A98),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS88 - Personality disorders: borderline and antisocial","QS_88",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Mental health professionals use a structured clinical assessment to diagnose borderline or antisocial personality disorder."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with borderline personality disorder are offered psychological therapies and are involved in choosing the type, duration and intensity of therapy."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with antisocial personality disorder are offered group-based cognitive and behavioural therapies and are involved in choosing the duration and intensity of the therapy."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with borderline or antisocial personality disorders are prescribed antipsychotic or sedative medication only for short-term crisis management or treatment of comorbid conditions. "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with borderline or antisocial personality disorder agree a structured and phased plan with their care provider before their services change or are withdrawn. "},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with borderline or antisocial personality disorder have their long-term goals for education and employment identified in their care plan."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Mental health professionals supporting people with borderline or antisocial personality disorder have an agreed level and frequency of supervision."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A99),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS89 - Pressure ulcers","QS_89",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People admitted to hospital or a care home with nursing have a pressure ulcer risk assessment within 6 hours of admission."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with a risk factor for developing pressure ulcers who are referred to community nursing services have a pressure ulcer risk assessment at the first face to face visit."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People have their risk of developing pressure ulcers reassessed after a surgical or interventional procedure, or after a change in their care environment following a transfer."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People have a skin assessment if they are identified as high risk of developing pressure ulcers. "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People at risk of developing pressure ulcers receive advice on the benefits and frequency of repositioning. "},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People at risk of developing pressure ulcers, who are unable to reposition themselves, are helped to change their position.   "},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - People at high risk of developing pressure ulcers, and their carers, receive information on how to prevent them. "},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - People at high risk of developing pressure ulcers are provided with pressure redistribution devices."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A100),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS90 - Urinary tract infections in adults","QS_90",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Women aged under 65 years are diagnosed with a urinary tract infection (UTI) if they have 2 or more key urinary symptoms and no other excluding causes or warning signs. [new 2023]"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with indwelling urinary catheters do not have dipstick testing to diagnose urinary tract infections (UTIs). [2015, updated 2023]"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Men and non-pregnant women are not prescribed antibiotics to treat asymptomatic bacteriuria. [2015, updated 2023]"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Non-pregnant women with an uncomplicated lower urinary tract infection (UTI) are prescribed a 3-day course of antibiotics, and men and pregnant women with an uncomplicated lower UTI are prescribed a 7-day course of antibiotics. [new 2023]"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Men with a recurrent urinary tract infection (UTI), and women with a recurrent lower UTI where the cause is unknown or a recurrent upper UTI, are referred for specialist advice. [new 2023]"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A101),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS91 - Prostate cancer","QS_91",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with prostate cancer have a discussion about treatment options and adverse effects with a named nurse specialist."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with Cambridge Prognostic Group (CPG) 1 localised prostate cancer for whom radical treatment is suitable are offered active surveillance."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with Cambridge Prognostic Group (CPG) 2, 3, 4 and 5 localised or locally advanced prostate cancer who are offered non‑surgical radical treatment are offered radical radiotherapy and androgen deprivation therapy in combination."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with adverse effects of prostate cancer treatment are referred to specialist services."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with hormone‑relapsed metastatic prostate cancer have their treatment options discussed by the urological cancer multidisciplinary team (MDT)."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A102),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS92 - Smoking: harm reduction","QS_92",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People who are unwilling or not ready to stop smoking are offered a harm‑reduction approach to smoking."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People who are unwilling or not ready to stop smoking are advised that health problems associated with smoking are caused primarily by components in tobacco smoke other than nicotine."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People who are unwilling or not ready to stop smoking are advised about using nicotine‑containing products and supported to obtain licensed nicotine‑containing products."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Stop smoking' services offer harm‑reduction approaches alongside existing approaches to stopping smoking in one step."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A103),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS93 - Atrial fibrillation","QS_93",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with non-valvular atrial fibrillation and a CHA2DS2-VASC stroke risk score of 2 or above are offered anticoagulation."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with atrial fibrillation are not prescribed aspirin as monotherapy for stroke prevention."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with atrial fibrillation who are prescribed anticoagulation discuss the options with their healthcare professional at least once a year."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with atrial fibrillation taking a vitamin K antagonist who have poor anticoagulation control have their anticoagulation reassessed."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with atrial fibrillation whose treatment fails to control their symptoms are referred for specialised management within 4 weeks."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults with atrial fibrillation on long-term vitamin K antagonist therapy are supported to self-manage with a coagulometer."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A104),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","QS_94",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children and young people, and their parents or carers, using vending machines in local authority and NHS venues can buy healthy food and drink options."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children and young people, and their parents or carers, see details of nutritional information on menus at local authority and NHS venues."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people, and their parents or carers, see healthy food and drink choices displayed prominently in local authority and NHS venues."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children and young people, and their parents or carers, have access to a publicly available up‑to‑date list of local lifestyle weight management programmes."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Children and young people identified as being overweight or obese, and their parents or carers as appropriate, are given information about local lifestyle weight management programmes."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Family members or carers of children and young people are invited to attend lifestyle weight management programmes, regardless of their weight."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Children and young people, and their parents or carers, can access data on attendance, outcomes and the views of participants and staff from lifestyle weight management programmes."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A105),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS95 - Bipolar disorder in adults","QS_95",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults presenting in primary care with symptoms of depression are offered a referral for a specialist mental health assessment if they have experienced overactivity or disinhibited behaviour lasting 4 days or more."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with bipolar disorder have their early warning symptoms and triggers of relapse, preferred response during relapse and personal recovery goals specified in their care plan."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Carers of adults with bipolar disorder are involved in care planning, decision-making and information sharing about the person as agreed in the care plan.   "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with bipolar disorder are offered psychological interventions."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with bipolar disorder prescribed lithium have their dosage adjusted if their plasma lithium levels are outside the optimum range. "},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Women of childbearing potential are not offered valproate to treat bipolar disorder unless other treatments are ineffective or not tolerated. "},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Adults with bipolar disorder have a physical health assessment at least annually."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Adults with bipolar disorder who currently work, and those who wish to find or return to work, receive supported employment programmes."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A106),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","QS_96",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with dyspepsia or reflux symptoms who present to community pharmacists are given advice about making lifestyle changes, using over-the-counter medicines and when to consult their GP."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults presenting with dyspepsia or reflux symptoms are referred for urgent direct access endoscopy to take place within 2 weeks if they have dysphagia, or are aged 55 and over with weight loss. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with dyspepsia or reflux symptoms have a 2‑week washout period before a test for Helicobacter pylori if they are receiving proton pump inhibitor therapy."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults aged 55 and over with dyspepsia or reflux symptoms that have not responded to treatment have a discussion with their GP about referral for non-urgent direct access endoscopy."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with persistent, unexplained dyspepsia or reflux symptoms have a discussion with their GP about referral to a specialist service."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A107),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS97 - Drug allergy","QS_97",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with suspected drug allergy have their drug reaction documented using the structured assessment guide."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with a new diagnosis of drug allergy are advised to carry structured information about their drug reaction at all times."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with a suspected or confirmed anaphylactic reaction, or severe non‑immediate cutaneous reaction to a drug, or reaction to a general anaesthetic are referred to a specialist drug allergy service."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with drug allergy have their status documented in their electronic medical record using the recommended coding framework."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with a new diagnosis of drug allergy who are being referred or discharged have their drug allergy status updated in all GP referral and hospital discharge letters."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with a drug allergy have information included on their prescriptions about which drugs or drug classes to avoid."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A108),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS98 - Maternal and child nutrition","QS_98",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Pregnant women attending antenatal and health visitor appointments are given advice on how to eat healthily in pregnancy. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Women with a BMI of 30 or more after childbirth are offered a structured weight-loss programme."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Pregnant women and the parents and carers of children under 4 years who may be eligible for the Healthy Start scheme are given information and support to apply."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Women receive breastfeeding support from a service that uses an evaluated, structured programme. (QS37 - statement 5)"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Parents and carers are given advice on introducing their baby to a variety of nutritious foods to complement breastmilk or formula milk."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Parents and carers receiving Healthy Start food vouchers are offered advice on how to use them to increase the amount of fruit and vegetables in their family’s diet."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A109),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS99 - Secondary prevention after a myocardial infarction ","QS_99",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults admitted to hospital with a myocardial infarction (MI) have an assessment of left ventricular function before discharge"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults admitted to hospital with a myocardial infarction (MI) are referred for cardiac rehabilitation before discharge"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults admitted to hospital with a myocardial infarction (MI) have the results of investigations and a plan for future treatment and monitoring shared with their GP"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults referred to a cardiac rehabilitation programme after a myocardial infarction (MI) have an assessment appointment within 10 days of discharge from hospital"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults referred to a cardiac rehabilitation programme after a myocardial infarction (MI) are offered sessions during and outside working hours and the choice of undertaking the programme at home, in the community or in a hospital setting"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A110),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS100 - Cardiovascular risk assessment and lipid modification ","QS_100",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults aged between 25 and 84 years with an estimated increased risk of cardiovascular disease (CVD) are offered a full formal risk assessment using the QRISK3 tool."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with a 10‑year risk of cardiovascular disease (CVD) of 10% or more are assessed for secondary causes before any offer of statin therapy"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with a 10‑year risk of cardiovascular disease (CVD) of 10% or more receive advice on lifestyle changes before any offer of statin therapy"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with a 10‑year risk of cardiovascular disease (CVD) of 10% or more for whom lifestyle changes are ineffective or inappropriate, discuss the risks and benefits of starting statin therapy with their healthcare professional"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults choosing statin therapy for the primary prevention of cardiovascular disease (CVD) are offered atorvastatin 20 mg"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults with newly diagnosed cardiovascular disease (CVD) are offered atorvastatin 80 mg"},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Adults on a high‑intensity statin who have side effects are offered a lower dose or an alternative statin"},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Adults on lipid-lowering treatment have a repeat measurement of full lipid profile and liver transaminases at 2 to 3 months of treatment."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A111),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS101 - Learning disability: behaviour that challenges","QS_101",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Local authorities and clinical commissioning groups jointly choose a lead person to oversee strategic commissioning of services for all people with a learning disability. [new 2019]"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with a learning disability have an annual health check from their GP. [2015, amended 2019]"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with a learning disability and behaviour that challenges have an initial assessment to identify possible triggers, environmental factors and function of the behaviour. [2015]"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with a learning disability and behaviour that challenges have a named lead practitioner. [2015, updated 2019]"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Families and carers of people with a learning disability and behaviour that challenges are involved in developing the person's care and support plan, which includes how to prevent or respond to a crisis. [new 2019]"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Parents or carers of children aged under 12 years with a learning disability and behaviour that challenges are offered a parent‑training programme. [2015]"},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - People with a learning disability and behaviour that challenges take part in personalised daily activities. [2015]"},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - People with a learning disability and behaviour that challenges have access to specialist behavioural support in the community. [new 2019]"},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"9 - Adults with a learning disability and behaviour that challenges are supported to choose where and how they live."},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"10 - People with a learning disability and behaviour that challenges have a documented review every time a restrictive intervention is used. [2015]"},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"11 - People with a learning disability and behaviour that challenges only receive antipsychotic medication as part of treatment that includes psychosocial interventions. [2015]"},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"12 - People with a learning disability and behaviour that challenges have a multidisciplinary review of their antipsychotic medication 12 weeks after starting treatment and then at least every 6 months. [2015]"},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A112),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","QS_102",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children and young people who are referred to a specialist mental health service with a first episode of psychosis start assessment within 2 weeks."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children and young people with a first episode of psychosis and their family members are offered family intervention. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people newly diagnosed with bipolar depression or a first episode of psychosis are offered a psychological intervention."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Parents and carers of children and young people newly diagnosed with bipolar disorder, psychosis or schizophrenia are given information about carer-focused education and support."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Children and young people with bipolar disorder, psychosis or schizophrenia are given healthy lifestyle advice at diagnosis and at annual review."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Children and young people with bipolar disorder, psychosis or schizophrenia prescribed antipsychotic medication have their treatment monitored for side effects."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Children and young people with bipolar disorder, psychosis or schizophrenia who are in crisis are offered home treatment if it is suitable."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Children and young people with bipolar disorder, psychosis and schizophrenia have arrangements for accessing education or employment-related training included in their care plan."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A113),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS103 - Acute heart failure: diagnosis and management in adults","QS_103",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults presenting to hospital with new suspected acute heart failure have a single measurement of natriuretic peptide."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels have a transthoracic doppler 2D echocardiogram within 48 hours of admission."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults admitted to hospital with acute heart failure have input within 24 hours of admission from a dedicated specialist heart failure team."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta‑blocker treatment during their hospital admission."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults admitted to hospital with acute heart failure and reduced left ventricular ejection fraction are offered an angiotensin‑converting enzyme (ACE) inhibitor and an aldosterone antagonist."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults with acute heart failure have a follow‑up clinical assessment by a member of the community- or hospital‑based specialist heart failure team within 2 weeks of hospital discharge."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A114),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS104 - Gallstone disease","QS_104",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with acute cholecystitis have laparoscopic cholecystectomy within 1 week of diagnosis."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with common bile duct stones causing jaundice have endoscopic retrograde cholangiopancreatography within 72 hours of diagnosis."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with common bile duct stones who need emergency endoscopic retrograde cholangiopancreatography have it within 24 hours."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with symptomatic gallstone disease who have not had their gallbladder or gallstones removed are advised to avoid food and drink that triggers their symptoms."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A115),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS105 - Intrapartum care","QS_105",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Women at low risk of complications during labour are given the choice of all 4 birth settings and information about local birth outcomes."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Women in established labour have one-to-one care and support from an assigned midwife."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - This statement has been removed."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Women at low risk of complications who have cardiotocography because of concern arising from intermittent auscultation have the cardiotocograph removed if the trace is normal for 20 minutes."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Women at low risk of complications are not offered amniotomy or oxytocin if labour is progressing normally."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Women do not have the cord clamped earlier than 1 minute after the birth unless there is concern about cord integrity or the baby’s heartbeat."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Women have skin-to-skin contact with their babies after the birth."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A116),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS106 - Bladder cancer","QS_106",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults who are having transurethral resection of bladder tumour (TURBT) have detrusor muscle obtained during the procedure."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with suspected bladder cancer are offered a single dose of intravesical mitomycin C, given at the same time as the first transurethral resection of bladder tumour (TURBT)."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with bladder cancer have access to a designated clinical nurse specialist."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with newly diagnosed non‑muscle‑invasive bladder cancer have a risk classification of their cancer completed."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with high‑risk non‑muscle‑invasive bladder cancer discuss intravesical Bacille Calmette‑Guérin (BCG) and radical cystectomy with a urologist who performs both treatments and a clinical nurse specialist."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults with muscle‑invasive urothelial bladder cancer discuss neoadjuvant chemotherapy, radical cystectomy and radiotherapy using a radiosensitiser with a urologist who performs radical cystectomy, a clinical oncologist and a clinical nurse specialist."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Adults who have had low‑risk non‑muscle‑invasive bladder cancer and who have no recurrence of the bladder cancer within 12 months of their initial transurethral resection of bladder tumour (TURBT) are discharged to primary care."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A117),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS107 - Preventing unintentional injury in under 15s","QS_107",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Local authority areas have a person responsible for coordinating action to prevent unintentional injuries in children and young people (under 15) in the home."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Households in which children and young people (under 15) are at greater risk of unintentional injury in the home are identified through collaboration between local agencies for a structured home safety assessment."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Households in which children and young people (under 15) have been identified as being at greater risk of unintentional injury in the home have a structured home safety assessment."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Households with children and young people (under 15) that have had a structured home safety assessment at which risks have been identified receive tailored advice or support to reduce the risks."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Households with children and young people (under 15) receive advice on home safety or are referred for a structured home safety assessment by practitioners providing family support on home visits who identify risks of unintentional injury."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A118),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS108 - Multiple sclerosis","QS_108",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with multiple sclerosis (MS) are given support at the time of diagnosis to understand the condition, its progression and the ways it can be managed, by the consultant neurologist making the diagnosis."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with multiple sclerosis (MS) are offered a face‑to‑face follow‑up appointment with a healthcare professional with expertise in MS, to take place within 6 weeks of diagnosis."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with multiple sclerosis (MS) have a single point of contact who coordinates access to care from a multidisciplinary team with expertise in MS."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with multiple sclerosis (MS) who have problems with mobility or fatigue are offered support to remain physically active."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with multiple sclerosis (MS) who have a relapse that would benefit from treatment are offered treatment as soon as possible and within 14 days of the onset of symptoms."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults with multiple sclerosis (MS) are offered a comprehensive review at least once a year by healthcare professionals with expertise in MS."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A119),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS109 - Diabetes in pregnancy","QS_109",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Women with diabetes who are of childbearing potential are offered preconception planning advice at diabetes care reviews."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Women with pre-existing diabetes are seen by members of the joint diabetes and antenatal care team as soon as possible after informing their healthcare professional that they are pregnant."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Pregnant women with type 1 diabetes are offered continuous glucose monitoring."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Women diagnosed with gestational diabetes are offered postnatal testing of blood glucose levels and referred to the National Diabetes Prevention Programme if eligible."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Women diagnosed with gestational diabetes who have negative postnatal testing for diabetes after the birth are offered annual HbA1c testing."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A120),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS110 - Pneumonia in adults","QS_110",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults have a mortality risk assessment using the CRB65 score when they are diagnosed with community‑acquired pneumonia in primary care."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with low‑severity community‑acquired pneumonia are prescribed a 5‑day course of a single antibiotic."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with suspected community‑acquired pneumonia in hospital have a chest X‑ray and receive a diagnosis within 4 hours of presentation."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults have a mortality risk assessment using the CURB65 score when they are diagnosed with community‑acquired pneumonia in hospital."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with community‑acquired pneumonia who are admitted to hospital start antibiotic therapy within 4 hours of presentation."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A121),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS111 - Obesity in adults: prevention and lifestyle weight management programmes","QS_111",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults using vending machines in local authority and NHS venues can buy healthy food and drink options."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults see details of nutritional information on menus at local authority and NHS venues."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults see healthy food and drink choices displayed prominently in local authority and NHS venues."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults have access to a publicly available, up‑to‑date list of local lifestyle weight management programmes."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults can access data on attendance, outcomes and views of participants and staff from locally commissioned lifestyle weight management programmes."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults identified as being overweight or obese are given information about local lifestyle weight management programmes."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Adults identified as overweight or obese with comorbidities are offered a referral to a lifestyle weight management programme."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Adults about to complete a lifestyle weight management programme agree a plan to prevent weight regain."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A122),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS112 - Gastro-oesophageal reflux in children and young people","QS_112",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Parents and carers attending postnatal appointments are given information about gastro‑oesophageal reflux (GOR) in infants. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Breast‑fed infants with frequent regurgitation associated with marked distress have their feeding assessed. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Formula‑fed infants with frequent regurgitation associated with marked distress have their symptoms managed using a stepped‑care approach. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Infants with frequent regurgitation associated with marked distress have a trial of alginate therapy if first‑line management is unsuccessful."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Infants and children are not investigated or treated for gastro‑oesophageal reflux disease (GORD) if they have no visible regurgitation and only 1 associated symptom."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Infants and children are not prescribed acid‑suppressing drugs if visible regurgitation is an isolated symptom. "},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Infants, children and young people do not have an upper gastrointestinal (GI) contrast study to diagnose or assess the severity of gastro‑oesophageal reflux disease (GORD)."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"8 - Infants, children and young people are not prescribed domperidone, metoclopramide or erythromycin to manage gastro‑oesophageal reflux (GOR) or gastro‑oesophageal reflux disease (GORD) without specialist paediatric advice."},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"9 - Infants, children and young people with vomiting or regurgitation and any 'red flag' symptoms are referred to specialist care with investigations as appropriate."},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A123),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS113 - Healthcare-associated infections","QS_113",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Hospitals monitor healthcare-associated infections and other infections of local relevance to drive continuous quality improvement"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Hospitals work with local health and social care organisations to assess and manage the risk of infections in hospitals from community outbreaks and incidents"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Hospital staff have individual objectives and appraisals on infection prevention and control linked to board-level objectives and strategies"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Hospitals involve infection prevention and control teams in the building, refurbishment and maintenance of hospital facilities"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People admitted to, discharged from, or transferred between or within hospitals, have information about any infections and associated treatments shared with health and social care staff to inform their care"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A124),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS114 - Irritable bowel syndrome in adults","QS_114",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with symptoms of irritable bowel syndrome are offered tests for inflammatory markers as first-line investigation to exclude inflammatory causes."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with symptoms of irritable bowel syndrome are given a positive diagnosis if no red flag indicators are present and investigations identify no other cause of symptoms."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with irritable bowel syndrome are offered advice on further dietary management if their symptoms persist after they have followed general lifestyle and dietary advice."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with irritable bowel syndrome agree their follow-up with their healthcare professional. "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A125),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS115 - Antenatal and postnatal mental health ","QS_115",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Women of childbearing potential are not prescribed valproate to treat a mental health problem."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Women of childbearing potential with a severe mental health problem are given information at their annual review about how their mental health problem and its treatment might affect them or their baby if they become pregnant."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Pregnant women with a previous severe mental health problem or any current mental health problem are given information at their booking appointment about how their mental health problem and its treatment might affect them or their baby."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Women are asked about their emotional wellbeing at each routine antenatal and postnatal contact."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Women with a suspected mental health problem in pregnancy or the postnatal period receive a comprehensive mental health assessment."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Women referred for psychological interventions in pregnancy or the postnatal period start treatment within 6 weeks of referral."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - Specialist multidisciplinary perinatal community services and inpatient psychiatric mother and baby units are available to support women with a mental health problem in pregnancy or the postnatal period."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A126),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS116 - Domestic violence and abuse","QS_116",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People presenting to frontline staff with indicators of possible domestic violence or abuse are asked about their experiences in a private discussion."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People experiencing domestic violence and abuse receive a response from level 1 or 2 trained staff."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People experiencing domestic violence or abuse are offered referral to specialist support services. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People who disclose that they are perpetrating domestic violence or abuse are offered referral to specialist services."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A127),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS117 - Preventing excess winter deaths and illness associated with cold homes","QS_117",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Local populations who are vulnerable to the health problems associated with a cold home are identified through year-round planning by local health and social care commissioners and providers."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Local health and social care commissioners and providers share data to identify people who are vulnerable to the health problems associated with a cold home."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People who are vulnerable to the health problems associated with a cold home receive tailored support with help from a local single-point-of-contact health and housing referral service."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People who are vulnerable to the health problems associated with a cold home are asked at least once a year whether they have difficulty keeping warm at home by their primary or community healthcare or home care practitioners."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Hospitals, mental health services and social care services identify people who are vulnerable to health problems associated with a cold home as part of the admission process."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People who are vulnerable to the health problems associated with a cold home who will be discharged to their own home from hospital, or a mental health or social care setting have a discharge plan that includes ensuring that their home is warm enough."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A128),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS118 - Food allergy","QS_118",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children and young people with suspected food allergy have an allergy-focused clinical history taken."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children and young people whose allergy-focused clinical history suggests an IgE-mediated food allergy are offered skin prick or blood tests for IgE antibodies to the suspected food allergens and likely co-allergens. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people whose allergy-focused clinical history suggests a non-IgE-mediated food allergy, and who have not had a severe delayed reaction, are offered a trial elimination of the suspected allergen and subsequent reintroduction."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children and young people are referred to secondary or specialist allergy care when indicated by their allergy-focused clinical history or diagnostic testing.  "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A129),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS119 - Anaphylaxis ","QS_119",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People who have emergency treatment for suspected anaphylaxis are referred to a specialist allergy service. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People who are prescribed an adrenaline auto-injector after emergency treatment for suspected anaphylaxis are given training in how and when to use it before being discharged.  "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People who have a systemic reaction to wasp or bee stings are referred to a specialist allergy service to assess whether venom immunotherapy would be suitable. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A130),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS120 - Medicines optimisation","QS_120",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People are given the opportunity to be involved in making decisions about their medicines."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People who are prescribed medicines are given an explanation on how to identify and report medicines‑related patient safety incidents."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Local health and social care providers monitor medicines-related patient safety incidents to inform their learning in the use of medicines"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People who are inpatients in an acute setting have a reconciled list of their medicines within 24 hours of admission."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People discharged from a care setting have a reconciled list of their medicines in their GP record within 1 week of the GP practice receiving the information, and before a prescription or new supply of medicines is issued."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Local healthcare providers identify people taking medicines who would benefit from a structured medication review."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A131),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS121 - Antimicrobial stewardship","QS_121",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with a self-limiting condition, as assessed by a primary care prescriber, receive advice about self‑management and adverse consequences of overusing antimicrobials"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Prescribers in primary care can use back‑up (delayed) antimicrobial prescribing when there is clinical uncertainty about whether a condition is self‑limiting or is likely to deteriorate"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People prescribed an antimicrobial have the clinical indication, dose and duration of treatment documented in their clinical record"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People in hospital who are prescribed an antimicrobial have a microbiological sample taken and their treatment reviewed when the results are available"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Individuals and teams responsible for antimicrobial stewardship monitor data and provide feedback on prescribing practice at prescriber, team, organisation and commissioner level"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(M$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(M$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(N$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(N$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A132),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS122 - Bronchiolitis in children","QS_122",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A138),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children with bronchiolitis are not prescribed antibiotics to treat the infection."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A138),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Parents and carers of children with bronchiolitis are informed that medication is not being used because the condition is usually self-limiting."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A138),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Parents and carers of children with bronchiolitis are given key safety information about what to expect and when to be concerned if caring for the child at home."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A138),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A138),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A138),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A138),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A138),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A138),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,{"$f":"IFERROR(CONCATENATE(O$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(O$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(P$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(P$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(Q$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(Q$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A133),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS123 - Home care for older people","QS_123",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A139),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Older people using home care services have a home care plan that identifies how their personal priorities and outcomes will be met."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A139),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Older people using home care services have a home care plan that identifies how their home care provider will respond to missed or late visits."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A139),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Older people using home care services receive care from a consistent team of home care workers who are familiar with their needs."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A139),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Older people using home care services have visits of at least 30 minutes except when short visits for specific tasks or checks have been agreed as part of a wider package of support."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A139),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Older people using home care services have a review of the outcomes of their home care plan within 6 weeks of starting to use the service and then at least annually."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A139),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Home care providers have practice-based supervision discussions with home care workers at least every 3 months."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A139),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A139),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A139),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,null,null,null,{"$f":"IFERROR(CONCATENATE(R$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(R$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A134),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS124 - Suspected cancer\n","QS_124",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A140),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - GPs have direct access to diagnostic endoscopy, ultrasound, MRI, X-ray and CT for people with suspected cancer.\n\n"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A140),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People presenting in primary care with symptoms that suggest oesophageal or stomach cancer have an urgent direct access upper gastrointestinal endoscopy.\n\n"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A140),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults presenting in primary care with symptoms that suggest colorectal cancer, who do not meet the referral pathway criteria, have a test for blood in their faeces.\n"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A140),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with suspected cancer who are referred to a cancer service are given written information encouraging them to attend."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A140),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A140),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A140),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A140),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A140),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,null,null,null,null,{"$f":"IFERROR(CONCATENATE(S$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(S$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A135),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS125 - Diabetes in children and young people","QS_125",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A141),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children and young people presenting in primary care with suspected diabetes are referred to and seen by a multidisciplinary paediatric diabetes team on the same day. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A141),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children and young people with type 1 or type 2 diabetes are offered a programme of diabetes education from diagnosis that is updated at least annually."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A141),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people with type 1 diabetes are offered intensive insulin therapy and level 3 carbohydrate counting education at diagnosis. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A141),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children and young people with type 1 diabetes are offered real-time continuous glucose monitoring (rtCGM)."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A141),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Children and young people with type 1 diabetes are offered blood ketone testing strips and a blood ketone meter."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A141),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Children and young people with type 1 or type 2 diabetes are offered access to mental health professionals with an understanding of diabetes. "},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A141),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A141),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(L$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(L$23, \" - \", $A141),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,null,null,null,null,null,{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A136),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS126 - Motor neurone disease","QS_126",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A142),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults diagnosed with motor neurone disease (MND) are given information about the diagnosis, prognosis and management of MND by a consultant neurologist with expertise in treating people with MND"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A142),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with motor neurone disease who have respiratory impairment are offered non‑invasive ventilation based on regular assessments of respiratory function and symptoms"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A142),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with motor neurone disease (MND) receive tailored equipment and adaptions without delay, based on regular multidisciplinary team assessments"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A142),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with motor neurone disease (MND) receive personal care and support from a consistent team of workers who are familiar with their needs"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A142),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with motor neurone disease (MND) are given opportunities to discuss their preferences and concerns about end of life care at diagnosis and key stages of disease progression"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A142),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A142),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A142),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},null,null,null,null,null,null,null,null,{"$f":"IFERROR(CONCATENATE(T$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(T$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(U$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(U$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(V$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(V$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(W$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(W$23, \" - \", $A137),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS127 - Obesity: clinical assessment and management","QS_127",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A143),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People are informed of their body mass index (BMI)  when it is calculated and advised about any associated health risks."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A143),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with obesity for whom tier 2 interventions have been unsuccessful have a discussion about the choice of alternative interventions for weight management, including tier 3 services."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A143),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people who are overweight or obese and have significant comorbidities or complex needs are referred to a paediatrician with a special interest in obesity."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A143),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with a body mass index (BMI) of 35 kg/m2 or more who have been diagnosed with type 2 diabetes within the past 10 years are offered an expedited referral for bariatric surgery assessment."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A143),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with a body mass index (BMI) above 50 kg/m2 are offered a referral for bariatric surgery assessment."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A143),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People who have had bariatric surgery have a postoperative follow-up care package within the bariatric surgery service for a minimum of 2 years. "},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A143),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"7 - People discharged from bariatric surgery service follow-up are offered monitoring of nutritional status at least once a year as part of a shared-care model of management."},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A143),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS128 - Early years: promoting health and wellbeing in under-5s","QS_128",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A144),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Parents and carers of children under 5 have a discussion during each of the 5 key contacts about factors that may pose a risk to their child’s social and emotional wellbeing."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A144),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children have their speech and language skills assessed at their 2–2½ year integrated review."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A144),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A144),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A144),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A144),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A144),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(K$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(K$23, \" - \", $A144),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS129 - Contraception","QS_129",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A145),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Women asking for contraception from contraceptive services are given information about, and offered a choice of, all methods including long-acting reversible contraception"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A145),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Women asking for emergency contraception are told that an intrauterine device is more effective than an oral method."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A145),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Women who request an abortion discuss contraception with a healthcare practitioner and are offered a choice of all methods when they are assessed for abortion and before discharge"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A145),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Women who give birth are given information about, and offered a choice of, all contraceptive methods by their midwife within 7 days of delivery. "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A145),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A145),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A145),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS130 - Skin cancer","QS_130",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A146),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Integrated care boards work with local partners to implement strategies to raise awareness of skin cancer and the risks of over-exposure to sunlight and exposure to artificial UV light, particularly for people in at-risk groups"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A146),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with suspected melanoma, squamous cell carcinoma or a rare skin cancer are referred for an assessment using a suspected cancer pathway to have a diagnosis confirmed or ruled out within 28 days of referral"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A146),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with suspected melanoma undergoing a specialist assessment have the lesion examined using dermoscopy."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A146),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with melanoma, high-risk squamous cell carcinoma or a rare skin cancer have access to a skin cancer clinical nurse specialist. "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A146),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with stage IIB to IV primary melanoma have BRAF analysis of the tumour."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A146),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with stage IIC to IV melanoma have a staging scan."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A146),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS131 - IV fluid therapy in children and young people in hospital","QS_131",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A147),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Term neonates, children and young people receiving intravenous (IV) fluid therapy have their plasma electrolyte concentrations and blood glucose measured when starting IV fluids and then at least every 24 hours."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A147),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Term neonates, children and young people receiving intravenous (IV) fluid therapy have their fluid balance assessed when starting IV fluids and then at least every 12 hours."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A147),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Term neonates, children and young people are not given hypotonic fluids or glucose-containing fluids for intravenous (IV) fluid resuscitation."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A147),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Term neonates, children and young people receiving intravenous (IV) fluids for routine maintenance are not given hypotonic fluids as the initial fluid."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A147),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Hospitals have an intravenous (IV) fluids lead who has overall responsibility for training, clinical governance, audit and review of IV fluid prescribing, and patient outcomes."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A147),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A147),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS132 - Social care for older people with multiple long-term conditions","QS_132",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A148),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Older people with multiple long-term conditions having a care and support needs assessment have their physical and mental health needs included."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A148),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Older people with multiple long-term conditions having a care and support needs assessment discuss services that could help, any cost of these services and how they can be paid for."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A148),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Older people with multiple long-term conditions and eligible social care needs have a named care coordinator."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A148),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Older people with multiple long-term conditions and eligible social care needs have an agreed health and social care plan that includes how their personal priorities and outcomes will be met."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A148),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Older people with multiple long-term conditions and eligible social care needs have a review of their health and social care plan at least once a year."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A148),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A148),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS133 - Childrens attachment","QS_133",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A149),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children and young people who may have attachment difficulties, and their parents or carers, have a comprehensive assessment before any intervention programme."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A149),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children and young people with attachment difficulties have an education plan setting out how they will be supported in school."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A149),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Parents and carers of preschool-age children with or at risk of attachment difficulties are offered a video feedback programme."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A149),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Health and social care provider organisations provide training, education and support programmes for carers of school aged children and young people with attachment difficulties."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A149),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A149),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A149),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS134 - Coeliac disease","QS_134",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A150),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People at increased risk or with symptoms of coeliac disease are offered a serological test for coeliac disease."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A150),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with a positive serological test for coeliac disease are referred to a specialist and advised to continue with a gluten‑containing diet until diagnosis is confirmed."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A150),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People referred to a specialist who need an endoscopic intestinal biopsy to diagnose coeliac disease have it within 6 weeks of referral."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A150),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People newly diagnosed with coeliac disease discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A150),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with coeliac disease are offered an annual review."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A150),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A150),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS135 - Preterm labour and birth","QS_135",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A151),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Pregnant women at increased risk of preterm labour are given information about the potential signs and symptoms."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A151),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Women who have had a previous preterm birth or mid-trimester loss and have a cervical length of 25 mm or less measured between 16+0 and 24+0 weeks of pregnancy are offered a choice of either prophylactic vaginal progesterone or prophylactic cervical cerclage."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A151),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Women having a planned preterm birth are given information about the risks and potential outcomes."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A151),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Women between 26+0 and 33+6 weeks of pregnancy who have intact membranes and are in suspected or diagnosed preterm labour are offered tocolysis."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A151),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Women between 24+0 and 33+6 weeks of pregnancy who are in suspected, diagnosed or established preterm labour, are having a planned preterm birth or have preterm prelabour rupture of membranes (P-PROM) are offered maternal corticosteroids."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A151),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Women between 24+0 and 29+6 weeks of pregnancy who are in established preterm labour or having a planned preterm birth within 24 hours are offered magnesium sulfate."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A151),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","QS_136",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A152),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with social care needs who are admitted to hospital have existing care plans shared with the admitting team."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A152),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Older people with complex needs have a comprehensive geriatric assessment started on admission to hospital."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A152),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with social care needs who are in hospital have a named discharge coordinator."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A152),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with social care needs are given a copy of their agreed discharge plan before leaving hospital."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A152),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with social care needs have family or carers involved in discharge planning if they are providing support after discharge. "},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A152),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A152),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS137 - Mental wellbeing and independence for older people","QS_137",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A153),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Older people who are at risk of a decline in their independence and mental wellbeing are identified by service providers."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A153),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Older people most at risk of a decline in their independence and mental wellbeing are offered tailored, community-based physical activity programmes."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A153),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Older people most at risk of a decline in their independence and mental wellbeing are offered a range of activities to build or maintain social participation"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A153),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A153),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A153),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A153),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS138 - Blood transfusion","QS_138",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A154),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with iron-deficiency anaemia who are having surgery are offered iron supplementation before and after surgery."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A154),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults who are having surgery and are expected to have moderate blood loss are offered tranexamic acid"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A154),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People are clinically reassessed and have their haemoglobin levels checked after each unit of red blood cells they receive, unless they are bleeding or are on a chronic transfusion programme."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A154),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People who may need or who have had a blood transfusion are given verbal and written information about blood transfusion."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A154),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A154),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A154),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS139 - Oral health promotion in the community","QS_139",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A155),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Local authorities carry out oral health needs assessments to identify groups at high risk of poor oral health as part of joint strategic needs assessments."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A155),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Local authorities provide oral health improvement programmes in early years services and schools in areas where children and young people are at high risk of poor oral health."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A155),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Health and social care services include oral health in care plans of people who are receiving health or social care support and at high risk of poor oral health."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A155),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Dental practices providing emergency care to people who do not have a regular dentist give information about the benefits of attending for routine care and how a local dentist can be found."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A155),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A155),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A155),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS140 - Transition from childrens to adults services","QS_140",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A156),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Young people who will move from children's to adults' services start planning their transition with health and social care practitioners by school year 9 (aged 13 to 14 years), or immediately if they enter children's services after school year 9. [2016]"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A156),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Young people who will move from children's to adults' services have a coordinated transition plan. [new 2023]"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A156),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Young people who will move from children's to adults' services have an annual meeting to review transition planning. [2016]"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A156),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Young people who are moving from children's to adults' services have a named worker to coordinate care and support before, during and after transfer. [2016]"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A156),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Young people who are moving from children's to adults' services meet a practitioner from each adults' service they will move to before they transfer. [2016, updated 2023]"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A156),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Young people who have moved from children's to adults' services but do not attend their initial meetings or appointments are contacted by adults' services and given further opportunities to engage. [2016, updated 2023]"},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A156),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS141 - Tuberculosis","QS_141",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A157),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People aged 16 to 35 years who have arrived in the country within the past 5 years, from countries with a high incidence of tuberculosis (TB), are tested for latent TB infection when they register with a GP."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A157),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults aged under 65 years who are diagnosed with HIV, are tested for latent tuberculosis (TB) infection."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A157),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People who are referred to a tuberculosis (TB) service, who meet specific criteria, have rapid diagnostic nucleic acid amplification tests (NAATs)."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A157),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People who have imaging features suggestive of active pulmonary tuberculosis (TB) are assessed by the next working day."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A157),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with active tuberculosis (TB) from under-served groups are offered directly observed therapy."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A157),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with active pulmonary tuberculosis (TB) who are homeless are offered accommodation for the duration of their treatment."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A157),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS142 - Learning disabilities: identifying and managing mental health problems","QS_142",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A158),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Young people and adults with learning disabilities have an annual health check that includes a review of mental health problems."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A158),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with learning disabilities who need a mental health assessment are referred to a professional with expertise in mental health problems in people with learning disabilities."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A158),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with learning disabilities and a serious mental illness have a key worker to coordinate their care."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A158),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with learning disabilities and mental health problems who are receiving psychological interventions have them tailored to their preferences, level of understanding, and strengths and needs."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A158),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with learning disabilities who are taking antipsychotic drugs that are not reduced or stopped have annual documentation on reasons for continuing this prescription."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A158),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A158),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS143 - Menopause","QS_143",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A159),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Women over 45 years presenting with menopausal symptoms are diagnosed with perimenopause or menopause based on their symptoms alone, without confirmatory laboratory tests."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A159),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Women under 40 years presenting with menopausal symptoms have their levels of follicle-stimulating hormone (FSH) measured."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A159),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Women with premature ovarian insufficiency are offered hormone replacement therapy (HRT) or a combined hormonal contraceptive."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A159),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Women having treatment for menopausal symptoms have a review 3 months after starting each treatment and then at least annually."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A159),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Women who are likely to go through menopause as a result of medical or surgical treatment are given information about menopause and fertility before they have their treatment."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A159),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A159),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS144 - Care of dying adults in the last days of life","QS_144",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A160),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults who have signs and symptoms that suggest they may be in the last days of life are monitored for further changes to help determine if they are nearing death, stabilising or recovering."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A160),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults in the last days of life, and the people important to them, are given opportunities to discuss, develop and review an individualised care plan."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A160),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults in the last days of life who are likely to need symptom control are prescribed anticipatory medicines with individualised indications for use, dosage and route of administration."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A160),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults in the last days of life have their hydration status assessed daily, and have a discussion about the risks and benefits of hydration options."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A160),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A160),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A160),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS145 - Vaccine uptake in under 19s","QS_145",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A161),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children and young people who do not attend their vaccination appointment are followed up using the preferred method of contact specified in their record."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A161),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children and young people identified as having missed childhood vaccinations are offered the outstanding vaccinations."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A161),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people receiving a vaccination have it recorded in their GP record, the child health information system (CHIS) and in their personal child health record."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A161),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children and young people have their immunisation status checked at specific educational stages."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A161),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Young offenders have their immunisation status checked within 7 days of arrival into a secure setting and are offered any outstanding vaccinations."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A161),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A161),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS146 - Head and neck cancer","QS_146",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A162),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with cancer of the upper aerodigestive tract have their nutritional status, including the need for a prophylactic tube, assessed at diagnosis.  "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A162),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with specific advanced stage cancers of the upper aerodigestive tract are offered systemic staging using fluorodeoxyglucose positron emission tomography (FDG PET)-CT."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A162),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with early stage oral cavity cancer who do not need cervical access as part of surgical management are offered sentinel lymph node biopsy as an alternative to elective neck dissection."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A162),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with cancer of the upper aerodigestive tract are given the choice of either radiotherapy or surgery if both are suitable options for their type of cancer."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A162),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A162),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A162),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","QS_147",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A163),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Employees work in organisations that have a named senior manager who makes employee health and wellbeing a core priority."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A163),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Employees are managed by people who support their health and wellbeing."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A163),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Employees are managed by people who are trained to recognise and support them when they are experiencing stress."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A163),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Employees have the opportunity to contribute to decision-making through staff engagement forums."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A163),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A163),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A163),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS148 - Community engagement: improving health and wellbeing ","QS_148",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A164),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Members of the local community are involved in setting priorities for health and wellbeing initiatives."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A164),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Members of the local community are involved in monitoring and evaluating health and wellbeing initiatives as soon as the priorities are agreed."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A164),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Members of the local community are involved in identifying the skills, knowledge, networks, relationships and facilities available to health and wellbeing initiatives."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A164),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Members of the local community are actively recruited to take on peer and lay roles for health and wellbeing initiatives."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A164),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A164),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A164),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS149 - Osteoporosis","QS_149",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A165),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults who have had a fragility fracture or use systemic glucocorticoids or have a history of falls have an assessment of their fracture risk."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A165),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults at high risk of fragility fracture are offered drug treatment to reduce fracture risk."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A165),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults prescribed drug treatment to reduce fracture risk are asked about adverse effects and adherence to treatment at each medication review."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A165),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults having long-term bisphosphonate therapy have a review of the need for continuing treatment."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A165),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A165),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A165),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS150 - Haematological cancers","QS_150",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A166),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with haematological cancer have an integrated report produced by a specialist integrated haematological malignancy diagnostic service (SIHMDS) that is shared with the haemato-oncology multidisciplinary team (MDT)."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A166),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Young people and adults with specific subtypes of non-Hodgkin's lymphoma have staging using fluorodeoxyglucose-positron emission tomography-CT (FDG-PET-CT)."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A166),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Young people and adults with localised stage IIA follicular lymphoma have local radiotherapy as first-line treatment."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A166),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Young people and adults who have completed their treatment for non-Hodgkin's lymphoma or myeloma have a discussion about their end-of-treatment summary plan."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A166),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A166),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A166),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS151 - Oral health in care homes","QS_151",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A167),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults who move into a care home have their mouth care needs assessed on admission."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A167),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults living in care homes have their mouth care needs recorded in their personal care plan."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A167),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults living in care homes are supported to clean their teeth twice a day and to carry out daily care for their dentures."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A167),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A167),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A167),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A167),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS152 - Liver disease","QS_152",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A168),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with non‑alcoholic fatty liver disease are given advice on physical activity, diet and alcohol."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A168),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with non‑alcoholic fatty liver disease are offered regular testing for advanced liver fibrosis."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A168),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Young people and adults with risk factors for cirrhosis are offered non‑invasive testing for cirrhosis."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A168),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with cirrhosis are offered 6-monthly surveillance for hepatocellular carcinoma."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A168),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Young people and adults with cirrhosis and upper gastrointestinal bleeding are given prophylactic intravenous antibiotics at presentation."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A168),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A168),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS153 - Multimorbidity","QS_153",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A169),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with multimorbidity are identified by their GP practice."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A169),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with an individualised management plan for multimorbidity are given opportunities to discuss their values, priorities and goals."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A169),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with an individualised management plan for multimorbidity know who is responsible for coordinating their care."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A169),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults having a review of their medicines and other treatments for multimorbidity discuss whether any can be stopped or changed."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A169),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A169),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A169),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS154 - Violent and aggressive behaviours in people with mental health problems","QS_154",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A170),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People in contact with mental health services who have been violent or aggressive are supported to identify triggers and early warning signs for these behaviours."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A170),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People in contact with mental health services who have been violent or aggressive are supported to identify successful de-escalation techniques and make advance statements about the use of restrictive interventions."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A170),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with a mental health problem who are manually restrained have their physical health monitored during and after restraint."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A170),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with a mental health problem who are given rapid tranquillisation have side effects, vital signs, hydration level and consciousness monitored after the intervention."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A170),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with a mental health problem who experience restraint, rapid tranquillisation or seclusion are involved in an immediate post-incident debrief."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A170),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A170),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS155 - Low back pain and sciatica in over 16s","QS_155",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A171),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Primary care services have an approach to risk stratification for young people and adults presenting with a new episode of low back pain with or without sciatica."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A171),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Young people and adults with low back pain with or without sciatica do not have imaging requested by a non-specialist service unless serious underlying pathology is suspected."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A171),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Young people and adults with low back pain with or without sciatica are given advice and information to self-manage their condition."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A171),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Young people and adults are not given paracetamol alone, anticonvulsants or antidepressants to treat low back pain without sciatica."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A171),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Young people and adults are not given opioids to treat chronic low back pain without sciatica."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A171),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Young people and adults do not have spinal injections for low back pain without sciatica with the exception of radiofrequency denervation for people who meet the criteria."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A171),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS156 - Physical health of people in prisons","QS_156",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A172),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People entering or transferring between prisons have a medicines reconciliation carried out before their second-stage health assessment."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A172),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People entering or transferring between prisons have a second-stage health assessment within 7 days."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A172),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People entering or transferring between prisons are tested for blood-borne viruses and assessed for risk of sexually transmitted infections."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A172),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People in prison who have complex health and social care needs have a lead care coordinator."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A172),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People being transferred or discharged from prison are given a minimum of 7 days' prescribed medicines or an FP10 prescription."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A172),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A172),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS157 - HIV testing: encouraging uptake","QS_157",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A173),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Young people and adults are offered an HIV test when admitted to hospital or attending an emergency department in areas of extremely high HIV prevalence, or when having a blood test when admitted to hospital or attending an emergency department in areas of high HIV prevalence."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A173),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Young people and adults in areas of high or extremely high HIV prevalence are offered an HIV test by their GP practice when registering or when having a blood test if they have not had an HIV test in the past 12 months."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A173),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Young people and adults newly diagnosed with an HIV indicator condition are offered an HIV test."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A173),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Young people and adults in at-risk groups who test negative for HIV are advised that the test should be repeated at least annually."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A173),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People who may have been exposed to HIV by a person newly diagnosed with HIV are offered an HIV test."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A173),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A173),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS158 - Rehabilitation after critical illness in adults","QS_158",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A174),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults in critical care at risk of morbidity have their rehabilitation goals agreed within 4 days of admission to critical care or before discharge from critical care, whichever is sooner."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A174),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults at risk of morbidity have a formal handover of care, including their agreed individualised structured rehabilitation programme, when they transfer from critical care to a general ward."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A174),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults who were in critical care and at risk of morbidity are given information based on their rehabilitation goals before they are discharged from hospital."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A174),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults who stayed in critical care for more than 4 days and were at risk of morbidity have a review 2 to 3 months after discharge from critical care."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A174),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A174),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A174),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS159 - Transition between inpatient mental health settings and community or care home settings","QS_159",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A175),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People admitted to an inpatient mental health setting have access to independent advocacy services."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A175),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People admitted to specialist inpatient mental health settings outside the area in which they live have a review of their placement at least every 3 months."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A175),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People discharged from an inpatient mental health setting have their care plan sent within 24 hours to everyone identified in the plan as involved in their ongoing care."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A175),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People who have a risk of suicide identified at preparation for discharge from an inpatient mental health setting are followed up within 48 hours of being discharged."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A175),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A175),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A175),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS160 - End of life care for infants, children and young people","QS_160",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A176),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Infants, children and young people with a life-limiting condition and their parents or carers are involved in developing an advance care plan."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A176),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Infants, children and young people with a life-limiting condition have a named medical specialist who leads and coordinates their care."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A176),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Infants, children and young people with a life-limiting condition and their parents or carers are given information about emotional and psychological support, including how to access it."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A176),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Infants, children and young people with a life-limiting condition are cared for by a multidisciplinary team that includes members of the specialist paediatric palliative care team."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A176),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Parents or carers of infants, children and young people approaching the end of life are offered support for grief and loss when their child is nearing the end of their life and after their death."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A176),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Infants, children and young people approaching the end of life and being cared for at home have 24-hour access to both children's nursing care and advice from a consultant in paediatric palliative care."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A176),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS161 - Sepsis","QS_161",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A177),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with suspected sepsis are assessed using a structured set of observations to stratify risk of severe illness or death."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A177),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with suspected sepsis in acute hospital settings and at least 1 of the criteria indicating high risk of severe illness or death have an immediate review by a senior clinical decision maker and antibiotics given within 1 hour if indicated."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A177),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with suspected sepsis in acute hospital settings who need treatment to restore cardiovascular stability have an intravenous fluid bolus within 1 hour of risk being stratified."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A177),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with suspected sepsis in acute hospital settings who receive intravenous antibiotics or fluid bolus are seen by a consultant if their condition fails to respond within 1 hour of initial treatment."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A177),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with suspected sepsis who have been stratified as at low risk of severe illness or death are given information about symptoms to monitor and how to access medical care."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A177),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A177),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS162 - Cerebral palsy in children and young people","QS_162",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A178),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children with any major risk factor for cerebral palsy have enhanced clinical and developmental follow-up from birth to 2 years."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A178),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children with delayed motor milestones are referred to a child development service."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A178),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Parents and carers of children and young people with cerebral palsy are given information about the diagnosis and management of cerebral palsy."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A178),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children and young people with cerebral palsy have a personal folder to help them make decisions about how their condition is managed."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A178),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A178),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A178),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS163 - Mental health of adults in contact with the criminal justice system","QS_163",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A179),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults in contact with the police because of a suspected offence have any features of mental health problems responded to in a way that reduces the risk of anxiety, self-harm or aggression."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A179),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults in contact with the police because of a suspected offence who have suspected mental health problems are referred for a comprehensive mental health assessment."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A179),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with mental health problems who are in contact with the criminal justice system have a care plan that is shared with relevant services."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A179),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults who have a mental health risk management plan and are transferring within the criminal justice system have their plan reviewed by the receiving service."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A179),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A179),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A179),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS164 - Parkinson's disease","QS_164",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A180),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with Parkinson's disease have a point of contact with specialist services. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A180),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with Parkinson's disease taking dopaminergic therapy are given information about the risk of developing impulse control disorders, when starting treatment and at least annually."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A180),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with Parkinson's disease are referred to physiotherapy, occupational therapy or speech and language therapy if they have problems with balance, motor function, activities of daily living, communication, swallowing or saliva."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A180),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with Parkinson's disease who are in hospital or a care home take levodopa within 30 minutes of their individually prescribed administration time."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A180),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Services for adults with Parkinson's disease provide access to clozapine and patient monitoring for treating hallucinations and delusions."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A180),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A180),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS165 - Drug misuse prevention","QS_165",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A181),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Looked-after children and young people having their annual health plan review are assessed for vulnerability to drug misuse. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A181),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Care leavers having a health assessment as part of planning to leave care are assessed for vulnerability to drug misuse. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A181),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people having a young offender assessment are assessed for vulnerability to drug misuse."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A181),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults assessed as vulnerable to drug misuse are given information about local services and where to find further advice and support. "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A181),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A181),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A181),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS166 - Trauma","QS_166",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A182),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with major trauma who cannot maintain their airway and/or ventilation have drug‑assisted rapid sequence induction (RSI) of anaesthesia and intubation within 45 minutes of the initial call to the emergency services."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A182),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People who have had urgent 3D imaging for major trauma have a provisional written radiology report within 60 minutes of the scan."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A182),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with open fractures of long bones, the hindfoot or midfoot have fixation and definitive soft tissue cover within 72 hours of injury if this cannot be performed at the same time as debridement."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A182),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with full in-line spinal immobilisation have their risk of cervical spine injury assessed using the Canadian C‑spine rule."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A182),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Major trauma centres have a dedicated trauma ward for patients with multisystem injuries and a designated consultant available to contact 24 hours a day, 7 days a week."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A182),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Major trauma centres have acute specialist services for rehabilitation after major trauma, and for children and older people."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A182),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS167 - Promoting health and preventing premature mortality in black, Asian and other minority ethnic groups","QS_167",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A183),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People from Black, Asian and other minority ethnic groups have their views represented in setting priorities and designing local health and wellbeing programmes."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A183),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People from Black, Asian and other minority ethnic groups are represented in peer and lay roles within local health and wellbeing programmes."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A183),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People from Black, Asian and other minority ethnic groups at high risk of type 2 diabetes are referred to an intensive lifestyle change programme."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A183),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People from Black, Asian and other minority ethnic groups referred to a cardiac rehabilitation programme are given a choice of times and settings for the sessions and are followed up if they do not attend."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A183),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People from Black, Asian and other minority ethnic groups can access mental health services in a variety of community-based settings."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A183),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People from Black, Asian and other minority ethnic groups with a serious mental illness have a physical health assessment at least annually."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A183),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS168 - Cystic fibrosis","QS_168",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A184),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with cystic fibrosis have the results of all assessments they have had during the past year reviewed annually by a specialist multidisciplinary team."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A184),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with cystic fibrosis have individual rooms with en‑suite facilities when admitted to hospital as inpatients."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A184),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with cystic fibrosis who have chronic Pseudomonas aeruginosa infection have sustained treatment with an inhaled antibiotic."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A184),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with cystic fibrosis who have clinical evidence of lung disease are prescribed rhDNase as the first choice of mucoactive agent."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A184),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A184),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A184),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS169 - Developmental follow-up of children and young people born preterm","QS_169",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A185),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Parents or carers of a preterm baby have an agreed discharge plan."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A185),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Parents or carers of a preterm baby who is eligible for enhanced developmental support are provided with a single point of contact for outreach care within the neonatal service."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A185),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children born preterm who are eligible for enhanced developmental surveillance have at least 2 follow-up appointments in the first year and an assessment at 2 years that focus on development."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A185),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children born before 28+0 weeks' gestation have a developmental assessment at 4 years."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A185),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A185),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A185),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS170 - Spondyloarthritis","QS_170",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A186),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with suspected axial or peripheral spondyloarthritis are referred to a rheumatologist."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A186),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with suspected axial spondyloarthritis and an X‑ray that does not show sacroiliitis have an MRI using an inflammatory back pain protocol."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A186),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with axial spondyloarthritis are referred to a specialist physiotherapist for a structured exercise programme."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A186),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with spondyloarthritis are given information about their condition, which healthcare professionals will be involved with their care, and how and when to get in touch with them."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A186),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A186),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A186),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS171 - Medicines management for people receiving social care in the community","QS_171",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A187),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults having an assessment for social care in the community have their medicines support needs included in the assessment."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A187),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults receiving medicines support in the community from a social care provider have their general practice and supplying pharmacy informed that support has started. "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A187),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults receiving medicines support in the community from a social care provider have a record of the medicines support that they need in their care plan. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A187),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults receiving medicines support in the community from a social care provider are given information on how to raise any medicines-related problems."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A187),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A187),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A187),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS172 - Endometriosis","QS_172",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A188),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Women presenting with suspected endometriosis have an abdominal and, if appropriate, a pelvic examination."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A188),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Women are referred to a gynaecology service if initial hormonal treatment for endometriosis is not effective, not tolerated or contraindicated."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A188),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Women with suspected or confirmed deep endometriosis involving the bowel, bladder or ureter are referred to a specialist endometriosis service."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A188),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A188),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A188),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A188),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS173 - Intermediate care including reablement","QS_173",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A189),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults being assessed for intermediate care have a discussion about the support the service will and will not provide."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A189),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults accepted for bed-based intermediate care start the service within 2 days of referral."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A189),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults starting intermediate care discuss and agree personalised goals."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A189),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults using intermediate care services discuss and agree a transition plan for when their support ends."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A189),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A189),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A189),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS174 - Emergency and acute medical care in over 16s","QS_174",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A190),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Ambulance services have specialist and advanced paramedic practitioners."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A190),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with undifferentiated medical emergencies who need hospital admission are assessed and initially treated in an acute medical unit (AMU)."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A190),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults admitted with a medical emergency have a timely consultant assessment and review."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A190),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults admitted with a medical emergency have a structured patient handover during transitions of care."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A190),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A190),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A190),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS175 - Eating disorders","QS_175",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A191),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People with suspected eating disorders who are referred to an eating disorder service start assessment and treatment within 4 weeks for children and young people or a locally agreed timeframe for adults."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A191),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with eating disorders have a discussion with a healthcare professional about their options for psychological treatment."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A191),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with binge eating disorder participate in a guided self-help programme as first-line psychological treatment."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A191),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children and young people with bulimia nervosa are offered bulimia-nervosa-focused family therapy (FT-BN)."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A191),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with eating disorders who are being supported by more than one service have a care plan that explains how the services will work together."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A191),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People with eating disorders who are moving between services have their risks assessed."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A191),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS176 - Oesophago-gastric cancer","QS_176",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A192),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with oesophago-gastric cancer have access to an oesophago-gastric clinical nurse specialist."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A192),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with oesophago-gastric cancer have their treatment reviewed by a multidisciplinary team (MDT) that includes an oncologist and a specialist radiologist who both have an interest in oesophago-gastric cancer."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A192),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with oesophageal or gastro-oesophageal junctional tumours (except T1a tumours) for whom radical treatment is suitable, have 18‑fluorodeoxyglucose positron emission tomography (F‑18 FDG PET‑CT) requested and reported within 1 week."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A192),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with oesophago-gastric cancer have tailored specialist dietetic support before and after radical treatment."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A192),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A192),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(J$23, \" - \", $A192),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS177 - Pancreatic cancer","QS_177",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A193),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with suspected pancreatic cancer have their diagnosis and care agreed by a specialist pancreatic cancer multidisciplinary team (MDT)."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A193),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with localised pancreatic cancer on CT have staging using fluorodeoxyglucose positron emission tomography/CT (FDG‑PET/CT) before they have surgery, radiotherapy or systemic therapy."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A193),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with resectable pancreatic cancer and obstructive jaundice have resectional surgery rather than preoperative biliary drainage unless the drainage is specifically indicated."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A193),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with unresectable pancreatic cancer are prescribed enteric-coated pancreatin."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A193),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A193),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS178 - Sexual health","QS_178",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A194),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People are asked about their sexual history at key points of contact."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A194),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People identified as being at risk of sexually transmitted infections have a discussion about prevention and testing."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A194),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Local authorities provide a range of condom distribution schemes tailored to the needs of their populations."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A194),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People contacting a sexual health service about a sexually transmitted infection are offered an appointment that is within 2 working days."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A194),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Men who have sex with men have repeat testing every 3 months if they are at increased risk of sexually transmitted infections."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A194),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - People diagnosed with a sexually transmitted infection are supported to notify their partners."}]
["QS179 - Child abuse and neglect","QS_179",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A195),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children and young people who display marked changes in behaviour or emotional state are encouraged to talk about their wellbeing."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A195),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children and young people who have experienced abuse or neglect receive support from a consistent group of practitioners."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A195),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people who have experienced abuse or neglect have their words accurately represented in notes summarising their conversations with practitioners."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A195),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children and young people who have experienced abuse or neglect agree with practitioners how they will communicate with each other."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A195),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Children and young people who have experienced abuse or neglect are offered therapeutic interventions based on a detailed assessment of therapeutic needs."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A195),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS180 - Serious eye disorders","QS_180",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A196),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with signs of possible glaucoma or related conditions on a routine sight test have additional tests before they are referred for a diagnosis."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A196),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with cataracts are not refused surgery based on visual acuity alone."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A196),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with late age-related macular degeneration (AMD) (wet active) start treatment within 14 days of referral to the macular service."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A196),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with late age-related macular degeneration (AMD) (wet active) have monitoring for both eyes."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A196),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with chronic open angle glaucoma (COAG) or related conditions have reassessment at specific intervals."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A196),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"6 - Adults with serious eye disorders are given a certificate of vision impairment (CVI) as soon as they are eligible."}]
["QS181 - Air pollution: outdoor air quality and health","QS_181",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A197),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Local authorities identify in the Local Plan, local transport plan and other key strategies how they will address air pollution, including enabling zero- and low-emission travel and developing buildings and spaces to reduce exposure to air pollution."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A197),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Local planning authorities assess proposals to minimise and mitigate road-traffic-related air pollution in planning applications for major developments."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A197),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Public sector organisations reduce emissions from their vehicle fleets to address air pollution."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A197),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children, young people and adults with chronic respiratory or cardiovascular conditions are given advice at routine health appointments on what to do when outdoor air quality is poor."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A197),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A197),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS182 - People’s experience using adult social care services","QS_182",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A198),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People's personal strengths, preferences, aspirations and needs are discussed when they have a care and support needs assessment."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A198),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People using adult social care services have as much control as they would like over their personal budget."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A198),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People using adult social care services have continuity of care and support."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A198),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People using adult social care services have their views used to inform service improvement."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A198),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A198),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS183 - Physical activity: encouraging activity in the community","QS_183",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A199),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Local authorities and healthcare commissioning groups have senior level physical activity champions who are responsible for developing and implementing local strategies, policies and plans."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A199),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Local authorities prioritise pedestrians, cyclists and people who use public transport when developing and maintaining connected travel routes."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A199),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Local authorities involve community members in designing and managing public open spaces."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A199),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Workplaces have a physical activity programme to encourage employees to move more and be more physically active."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A199),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Schools and early years settings have active travel plans that are monitored and updated annually."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(I$23, \" - \", $A199),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""}]
["QS184 - Dementia","QS_184",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A200),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People accessing behaviour change interventions and programmes in mid-life are advised that the risk of developing dementia can be reduced by making lifestyle changes. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A200),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with suspected dementia are referred to a specialist dementia diagnostic service if reversible causes of cognitive decline have been investigated."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A200),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with dementia are given the opportunity to discuss advance care planning at diagnosis and at each health and social care review. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A200),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People with dementia have a single named practitioner to coordinate their care."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A200),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People with dementia are supported to choose from a range of activities to promote wellbeing that are tailored to their preferences. "},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A200),'QS Data'!$J$4:$J$4879,0))), \"\")","v":"6 - People with dementia have a structured assessment before starting non-pharmacological or pharmacological treatment for distress."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A200),'QS Data'!$J$4:$J$4879,0))), \"\")","v":"7 - Carers of people with dementia are offered education and skills training."}]
["QS185 - Hearing loss in adults","QS_185",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A201),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with earwax that is contributing to hearing loss or other symptoms, or preventing ear examination or ear canal impressions being taken, have earwax removed in primary care or community ear care services."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A201),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with sudden onset of hearing loss in one or both ears that is not explained by external or middle ear causes are referred for immediate or urgent specialist medical care."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A201),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with rapid worsening of hearing loss in one or both ears that is not explained by external or middle ear causes are referred for urgent specialist medical care."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A201),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults presenting for the first time with hearing difficulties not caused by impacted earwax or acute infection have an audiological assessment."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A201),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults presenting with hearing loss affecting their ability to communicate and hear are offered hearing aids."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A201),'QS Data'!$J$4:$J$4879,0))), \"\")","v":"6 - Adults with hearing aids have a follow-up audiology appointment 6 to 12 weeks after the hearing aids are fitted."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A201),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS186 - Lyme disease","QS_186",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A202),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People presenting with erythema migrans are diagnosed and treated for Lyme disease based on clinical assessment, without laboratory testing."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A202),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People with suspected Lyme disease without erythema migrans who have a negative enzyme-linked immunosorbent assay (ELISA) test carried out within 4 weeks of their symptoms starting have the test repeated 4 to 6 weeks later if Lyme disease is still suspected."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A202),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People with Lyme disease have initial antibiotic treatment, with the antibiotic, dosage and duration determined by their symptoms."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A202),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Local authorities organise health promotion activities with organisations in their area to raise public awareness about how to prevent Lyme disease."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A202),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A202),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A202),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS187 - Learning disability: care and support of people growing older","QS_187",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A203),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People growing older with a learning disability are actively involved when their care and support needs are being assessed."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A203),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People growing older with a learning disability have a named lead practitioner."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A203),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People growing older with a learning disability are involved in developing a plan for the future and reviewing it at least annually."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A203),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People growing older with a learning disability have an annual health check, which is used to update their health action plan."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A203),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People growing older with a learning disability meet hospital staff before any planned hospital admission to agree arrangements that make the stay easier for them."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A203),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A203),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS188 - Coexisting severe mental illness and substance misuse","QS_188",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A204),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People aged 14 and over with suspected or confirmed severe mental illness are asked about their use of alcohol and drugs."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A204),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People aged 14 and over are not excluded from mental health services because of coexisting substance misuse or from substance misuse services because of coexisting severe mental illness."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A204),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People aged 14 and over with coexisting severe mental illness and substance misuse have a care coordinator working in mental health services when they are identified as needing treatment from secondary care mental health services."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A204),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People aged 14 and over with coexisting severe mental illness and substance misuse are followed up if they miss any appointment."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A204),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A204),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A204),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS189 - Suicide prevention","QS_189",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A205),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Multi-agency suicide prevention partnerships have a strategic suicide prevention group and clear governance and accountability structures."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A205),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Multi-agency suicide prevention partnerships reduce access to methods of suicide based on local information."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A205),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Multi-agency suicide prevention partnerships have a local media plan that identifies how they will encourage journalists and editors to follow best practice when reporting on suicide and suicidal behaviour."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A205),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults presenting with suicidal thoughts or plans discuss whether they would like their family, carers or friends to be involved in their care and are made aware of the limits of confidentiality."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A205),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People bereaved or affected by a suspected suicide are given information and offered tailored support."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A205),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A205),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS190 - Flu vaccination: increasing uptake","QS_190",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A206),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Providers use a range of different methods to invite people in eligible groups for flu vaccination."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A206),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People in eligible groups receive invitations for flu vaccination that include information about their situation or clinical risk."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A206),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Non-general practice providers notify the relevant GP practice when they vaccinate their eligible patients."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A206),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Health and social care staff who have direct contact with people using services receive flu vaccination from their employer."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A206),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A206),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A206),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS191 - Cerebral palsy in adults","QS_191",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A207),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with cerebral palsy are referred to a specialist multidisciplinary team if their ability to carry out usual daily activities deteriorates or is expected to deteriorate."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A207),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with cerebral palsy who have complex needs have an annual review with a healthcare professional with expertise in neurodisabilities."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A207),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with cerebral palsy who want support to live independently are referred to a professional with expertise in independent living."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A207),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with cerebral palsy who want support to work are referred to a professional with expertise in vocational skills and independent living."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A207),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with cerebral palsy who have communication difficulties have their need for intervention assessed by speech and language therapy services."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A207),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A207),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS192 - Intrapartum care: existing medical conditions and obstetric complications","QS_192",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A208),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Pregnant women with existing medical conditions or obstetric complications are involved in developing and reviewing their individualised intrapartum care plan."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A208),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Pregnant women with existing medical conditions are cared for by a multidisciplinary team that can access expertise in managing the medical conditions in pregnancy and is led by a named healthcare professional."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A208),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Pregnant women with heart disease have their cardiovascular risk regularly assessed during pregnancy and the intrapartum period."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A208),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Pregnant women in labour with sepsis have an immediate review by a senior clinical decision maker and antibiotics given within 1 hour if indicated."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A208),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Pregnant women who present in labour with no antenatal care have an obstetric assessment and medical examination, and assessment of their medical, psychological, and social history."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A208),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A208),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS193 - Specialist neonatal respiratory care for babies born preterm","QS_193",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A209),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Preterm babies having respiratory support soon after birth and before admission to the neonatal unit are given continuous positive airways pressure (CPAP), if clinically appropriate, rather than invasive ventilation."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A209),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Preterm babies who need surfactant are given it using a minimally invasive technique if they do not need invasive ventilation."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A209),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Preterm babies having invasive ventilation are given volume-targeted ventilation (VTV) in combination with synchronised ventilation."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A209),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Preterm babies have a target oxygen saturation of 91% to 95% after stabilisation."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A209),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Parents and carers of preterm babies who are having respiratory support are helped to care for their baby."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A209),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A209),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS194 - Decision making and mental capacity","QS_194",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A210),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People aged 16 and over who may lack capacity to make decisions are supported with decision making in a way that reﬂects their individual circumstances and meets their particular needs."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A210),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People aged 16 and over at risk of losing capacity to make decisions, and those with fluctuating capacity, are given the opportunity to discuss advance care planning at each health and social care review."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A210),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People aged 16 and over who are assessed as lacking capacity to make a particular decision at the time that decision needs to be made, have a clear record of the reasons why they lack capacity and the practicable steps taken to support them."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A210),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People aged 16 and over who lack capacity to make a particular decision at the time that decision needs to be made have their wishes, feelings, values and beliefs accounted for in best interests decisions."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A210),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A210),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A210),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS195 - Renal and ureteric stones","QS_195",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A211),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults with suspected renal colic have low-dose non-contrast CT within 24 hours of presentation."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A211),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults, children and young people with suspected renal colic receive a non-steroidal anti-inflammatory drug (NSAID) as first-line treatment."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A211),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with ureteric stones and renal colic have surgical treatment within 48 hours of diagnosis or readmission, if pain is ongoing and not tolerated, or the stone is unlikely to pass."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A211),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with renal or ureteric stones have their serum calcium measured."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A211),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults, children and young people with renal or ureteric stones are given advice on diet and fluid intake."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A211),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A211),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS196 - Community pharmacies: promoting health and wellbeing","QS_196",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A212),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People who have a long-term health condition or those who look for support to improve their health and wellbeing are offered advice and education when they use community pharmacy services."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A212),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Community pharmacies and commissioners work together to raise awareness of the health and wellbeing expertise and services available from community pharmacy teams."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A212),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Community pharmacies and commissioners work together to integrate community pharmacy services into care and referral pathways."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A212),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Community pharmacies and commissioners work together to agree health and wellbeing interventions to support people from underserved groups."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A212),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A212),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A212),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS197 - Faltering growth","QS_197",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A213),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Babies and preschool children have their measurements plotted on a growth chart if there are concerns about faltering growth."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A213),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Babies and preschool children have a detailed feeding or eating history taken if there are concerns about faltering growth."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A213),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Babies and preschool children have a management plan with specific goals if there are concerns about faltering growth."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A213),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Mothers are supported to continue breastfeeding if their baby is given supplementation with formula because of concerns about faltering growth."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A213),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A213),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A213),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS198 - Suspected neurological conditions: recognition and referral","QS_198",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A214),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Children under 12 years with headache and 'red flag' symptoms are referred immediately for neurological assessment."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A214),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Children under 4 years with suspected abnormal head size or shape have their head circumference assessed using a standardised growth chart."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A214),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with suspected dystonia are referred for neurological assessment."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A214),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults with transient rotational vertigo on head movement are assessed using the Hallpike manoeuvre."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A214),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults diagnosed with a functional neurological disorder are supported to manage symptoms that are a part of the disorder in non-specialist care."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A214),'QS Data'!$J$4:$J$4879,0))), \"\")","v":"6 - Adults with suspected neurological conditions using NHS services experience care and treatment that is tailored to their needs and preferences."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A214),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS199 - Abortion care","QS_199",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A215),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Healthcare commissioners and providers work together to make abortion services easy to access."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A215),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Women who request an abortion are given a choice between medical and surgical abortion to take place up to and including 23+6 weeks' gestation."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A215),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Women who decide to go ahead with an abortion have the option to have the procedure within 1 week of assessment."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A215),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Women having a medical abortion up to and including 9+6 weeks' gestation are given the option to take misoprostol at home."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A215),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Women having an abortion who want contraception receive their chosen method before discharge, either at the time of their abortion or as soon as possible after expulsion of the pregnancy."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A215),'QS Data'!$J$4:$J$4879,0))), \"\")","v":"6 - Women having an abortion are given advice on how to access care and support after the abortion."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A215),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS200 - Supporting adult carers","QS_200",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A216),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Carers are identified by health and social care organisations and encouraged to recognise their role and rights."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A216),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Carers are supported to actively participate in decision making and care planning for the person they care for."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A216),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Carers having a carer’s assessment are given the opportunity to discuss what matters most to them, including their own health, wellbeing and social care needs, and work, education, or training."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A216),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Carers are regularly given the opportunity to discuss with health and social care practitioners the value of having a break from caring and the options available to them."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A216),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Carers are offered supportive working arrangements by workplaces."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A216),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A216),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS201 - Venous thromboembolism in adults","QS_201",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A217),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - People aged 16 and over who are in hospital and assessed as needing pharmacological venous thromboembolism (VTE) prophylaxis start it as soon as possible and within 14 hours of hospital admission."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A217),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - People aged 16 and over who are discharged with lower limb immobilisation are assessed to identify their risk of venous thromboembolism (VTE)."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A217),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - People aged 18 and over with a deep vein thrombosis (DVT) Wells score of 2 points or more have a proximal leg vein ultrasound scan within 4 hours of it being requested."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A217),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - People aged 18 and over taking anticoagulation treatment after a venous thromboembolism (VTE) have a review at 3 months and then at least once a year if they continue to take it long term. "},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A217),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - People aged 18 and over having outpatient treatment for suspected or confirmed low-risk pulmonary embolism (PE) have an agreed plan for monitoring and follow‑up. "},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A217),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A217),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS202 - Workplace health: long-term sickness absence and capability to work","QS_202",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A218),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Employees work in organisations that develop policies for managing sickness absence and return to work as part of a broader, strategically led approach to promoting employees' health and wellbeing."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A218),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Employees who are assessed as 'not fit for work' are contacted by their employer as soon as possible to provide support and discuss arrangements for keeping in touch during sickness absence."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A218),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Employees have information in their statement of fitness for work about how their reason for sickness absence or their treatment might affect them on their return to work."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A218),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Employees returning from sickness absence have any workplace adjustments recorded in a return-to-work plan that is monitored and reviewed."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A218),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A218),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A218),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS203 - Brain tumours (primary) and brain metastases in adults","QS_203",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A219),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - GPs have direct access to MRI for adults with suspected brain tumour."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A219),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with brain tumours have a named healthcare professional who coordinates their health and social care support."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A219),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults with radiologically enhancing suspected high-grade gliomas that are suitable for resection of all enhancing tumour have 5‑aminolevulinic acid (5‑ALA)-guided resection."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A219),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults who finish treatment for brain tumours have an assessment and discussion about their risk of late effects of treatment at their first follow‑up appointment."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A219),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults with brain tumours have access to neurological rehabilitation in the community and as an outpatient or inpatient."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A219),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A219),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS204 - Fetal alcohol spectrum disorder","QS_204",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A220),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Pregnant women are given advice throughout pregnancy not to drink alcohol."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A220),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Pregnant women are asked about their alcohol use throughout their pregnancy and this is recorded."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A220),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Children and young people with probable prenatal alcohol exposure and significant physical, developmental or behavioural difficulties are referred for assessment."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A220),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Children and young people with confirmed prenatal alcohol exposure or all 3 facial features associated with prenatal alcohol exposure have a neurodevelopmental assessment if there are clinical concerns."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A220),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Children and young people with a diagnosis of fetal alcohol spectrum disorder (FASD) have a management plan to address their needs."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A220),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A220),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS205 - Neonatal parenteral nutrition","QS_205",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A221),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Preterm and term babies who are prescribed neonatal parenteral nutrition are started on a standardised bag."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A221),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Preterm and term babies who are prescribed neonatal parenteral nutrition receive it through bags, infusion sets and syringes that are protected from light."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A221),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Parents and carers of preterm and term babies receiving neonatal parenteral nutrition have regular opportunities to discuss their baby's nutritional care with healthcare professionals."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A221),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Preterm and term babies receiving neonatal parenteral nutrition are cared for by healthcare professionals who have access to a specialist nutritional multidisciplinary team."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A221),'QS Data'!$J$4:$J$4606,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A221),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A221),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS206 - Joint replacement (primary): hip, knee and shoulder","QS_206",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(D$23, \" - \", $A222),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"1 - Adults who will have hip or knee replacement are given advice on preoperative rehabilitation when they are listed for surgery."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(E$23, \" - \", $A222),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"2 - Adults with isolated medial compartmental osteoarthritis who will have knee replacement are given the choice of partial or total replacement."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(F$23, \" - \", $A222),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"3 - Adults having hip or knee replacement are given tranexamic acid during surgery."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(G$23, \" - \", $A222),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"4 - Adults having hip, knee or shoulder replacement have 2 ‘stop moments’ during surgery so that implant details and the compatibility of all components can be checked."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4606,MATCH(CONCATENATE(H$23, \" - \", $A222),'QS Data'!$J$4:$J$4606,0))), \"\")","v":"5 - Adults who have had hip, knee or shoulder replacement are given advice on postoperative rehabilitation before discharge.  "},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A222),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A222),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS207 - Tobacco: treating dependence","QS_207",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(D$23, \" - \", $A223),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"1 - People are asked if they use tobacco at key points of contact with a health or social care professional. "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(E$23, \" - \", $A223),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"2 - People who use tobacco receive advice on quitting."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(F$23, \" - \", $A223),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"3 - People who want to stop using tobacco are offered tobacco cessation support and treatment by a healthcare professional. "},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(G$23, \" - \", $A223),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"4 - People who do not want, or are not ready, to stop using tobacco in one go receive support to adopt a harm-reduction approach."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(H$23, \" - \", $A223),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"5 - People who smoke receive treatment to stop smoking on admission to hospital. "},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A223),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A223),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS208 - Type 1 diabetes in adults","QS_208",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(D$23, \" - \", $A224),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"1 - Adults with type 1 diabetes are offered a structured education programme. [2011, updated 2023] "},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(E$23, \" - \", $A224),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"2 - Adults with type 1 diabetes are offered a choice of real-time or intermittently scanned continuous glucose monitoring. [2023] "},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(F$23, \" - \", $A224),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"3 - Adults with type 1 diabetes aged 40 and over are offered statins for the primary prevention of cardiovascular disease (CVD). [2023]"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(G$23, \" - \", $A224),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"4 - Adults with type 1 diabetes have 9 key care processes completed every 12 months. [new 2023]"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(H$23, \" - \", $A224),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"5 - Adults with type 1 diabetes admitted to hospital have an assessment of their risk of developing a diabetic foot problem. [new 2023] "},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A224),'QS Data'!$J$4:$J$4879,0))), \"\")","v":"6 - Adults with type 1 diabetes admitted to hospital are supported to self-manage their diabetes. [2011, updated 2023]"},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A224),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]
["QS209 - Type 2 diabetes in adults","QS_209",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(D$23, \" - \", $A225),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"1 - Adults at high risk of type 2 diabetes are offered a referral to the NHS Diabetes Prevention Programme. [2016, updated 2023]"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(E$23, \" - \", $A225),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"2 - Adults with type 2 diabetes are offered a structured education programme at diagnosis. [2011, updated 2023]"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(F$23, \" - \", $A225),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"3 - Adults with type 2 diabetes who have multiple daily insulin injections and a condition or disability that means they cannot use capillary blood glucose monitoring are offered continuous glucose monitoring (CGM) to support self-monitoring. [new 2023]"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(G$23, \" - \", $A225),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"4 - Adults with insulin-treated type 2 diabetes having their blood glucose monitored by a care worker or healthcare professional are offered continuous glucose monitoring (CGM). [new 2023]"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(H$23, \" - \", $A225),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"5 - Adults with type 2 diabetes are offered an SGLT2 inhibitor if they would benefit because of co-existing chronic heart failure, cardiovascular disease or chronic kidney disease (CKD). [new 2023] "},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A225),'QS Data'!$J$4:$J$4879,0))), \"\")","v":"6 - Adults with type 2 diabetes have 9 key care processes completed every 12 months. [new 2023]"},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A225),'QS Data'!$J$4:$J$4879,0))), \"\")","v":"7 - Adults with type 2 diabetes admitted to hospital have an assessment of their risk of developing a diabetic foot problem. [new 2023]"}]
["QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)","QS_210",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(D$23, \" - \", $A226),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"1 - Adults first presenting with suspected acute respiratory infection have a documented assessment of symptoms and signs."},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(E$23, \" - \", $A226),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"2 - Adults first presenting with suspected acute respiratory infection are not routinely prescribed antimicrobials based only on remote assessment."},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(F$23, \" - \", $A226),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"3 - Adults prescribed an antibiotic for an acute respiratory infection are given a 5‑day course, or 5 to 10 days if phenoxymethylpenicillin is prescribed for acute sore throat."},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(G$23, \" - \", $A226),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"4 - Adults admitted to an acute respiratory infection virtual ward are given verbal and written information about the service."},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(H$23, \" - \", $A226),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"5 - Adults admitted to an acute respiratory infection virtual ward are cared for by a multidisciplinary team that has access to speciality advice and diagnostics and is led by a named consultant practitioner or GP with suitable expertise."},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A226),'QS Data'!$J$4:$J$4879,0))), \"\")","v":"6 - Adults admitted to an acute respiratory infection virtual ward are supported to self-manage, including having a self-escalation plan."},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A226),'QS Data'!$J$4:$J$4879,0))), \"\")","v":"7 - Adults discharged from an acute respiratory infection virtual ward are given a discharge summary, including follow‑up details, that is also shared with their GP."}]
["QS211 - Epilepsies in children, young people and adults ","QS_211",null,{"$f":"IFERROR(CONCATENATE(D$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(D$23, \" - \", $A227),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"1 - People presenting with a first suspected seizure are seen by a clinician with expertise in epilepsy within 2 weeks of presentation. [2013, updated 2023]"},{"$f":"IFERROR(CONCATENATE(E$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(E$23, \" - \", $A227),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"2 - People who meet the criteria for referral to a tertiary epilepsy service are seen within 4 weeks of referral, or 2 weeks if they meet the criteria for urgent referral. [2013, updated 2023]"},{"$f":"IFERROR(CONCATENATE(F$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(F$23, \" - \", $A227),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"3 - People with epilepsy have access to an epilepsy specialist nurse. [2013, updated 2023]"},{"$f":"IFERROR(CONCATENATE(G$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(G$23, \" - \", $A227),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"4 - People with epilepsy have an up-to-date and agreed comprehensive epilepsy care plan. [2013, updated 2023]"},{"$f":"IFERROR(CONCATENATE(H$23,\" - \",INDEX('QS Data'!$F$4:$F$4887,MATCH(CONCATENATE(H$23, \" - \", $A227),'QS Data'!$J$4:$J$4887,0))), \"\")","v":"5 - People with epilepsy are asked about their memory, mental health, and social and emotional wellbeing at epilepsy appointments. [new 2023]"},{"$f":"IFERROR(CONCATENATE(I$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(I$23, \" - \", $A227),'QS Data'!$J$4:$J$4879,0))), \"\")","v":"6 - Children and young people with epilepsy are asked at epilepsy appointments about neurodevelopment and learning difficulties or changes in their learning progress, and adults who have learning disabilities are asked at epilepsy appointments about changes in their condition and other comorbidities. [new 2023]"},{"$f":"IFERROR(CONCATENATE(J$23,\" - \",INDEX('QS Data'!$F$4:$F$4879,MATCH(CONCATENATE(J$23, \" - \", $A227),'QS Data'!$J$4:$J$4879,0))), \"\")","v":""}]

{"sheet":"QS Data","index":3,"n_rows":4710,"n_cols":15,"rows_kept":4710,"cut":false,"hidden":true,"merged":[[1,1,1,7]]}
[null,"Statements and measures in published quality standards"]
[null,"Blue headings indicate cells to be completed based on the QS team's workbook 'Published statements & measures'\nOrange headings are on columns containing formulas to be copied into the newly added rows\nGreen headings indicate columns containing data which is to be copied from the Nice website"]
[null,"QS Number","Title","Statement Number","Area of care","Statement wording","Measure wording","Measure Type","Identifier","Identifier - Statement","Measure number","Identifier - Measure","Numerator","Denominator"]
[null,"QS2","Stroke in adults",1,null,"Adults presenting at an accident and emergency (A&E) department with suspected stroke are admitted to a specialist acute stroke unit within 4 hours of arrival.","Evidence of local arrangements and written clinical protocols to ensure that adults presenting at an A&E department with suspected stroke are admitted to a specialist acute stroke unit within 4 hours of arrival.","Structure",{"$f":"CONCATENATE(B4, \" - \", C4)","v":"QS2 - Stroke in adults"},{"$f":"CONCATENATE(D4, \" - \", I4)","v":"1 - QS2 - Stroke in adults"},{"$f":"IF(AND(B4=B3, D4=D3, H4=H3)=TRUE, K3+1, 1)","v":1},{"$f":"CONCATENATE(J4, \" - \", H4, \" - \",K4)","v":"1 - QS2 - Stroke in adults - Structure - 1"}]
[null,"QS2","Stroke in adults",1,null,"Adults presenting at an accident and emergency (A&E) department with suspected stroke are admitted to a specialist acute stroke unit within 4 hours of arrival.","Proportion of A&E department presentations of suspected stroke in adults in which the person is admitted to a specialist acute stroke unit within 4 hours of arrival","Process","QS2 - Stroke in adults","1 - QS2 - Stroke in adults",{"$f":"IF(AND(B5=B4, D5=D4, H5=H4)=TRUE, K4+1, 1)","v":1},{"$f":"CONCATENATE(J5, \" - \", H5, \" - \",K5)","v":"1 - QS2 - Stroke in adults - Process - 1"},"The number in the denominator in which the person is admitted to a specialist acute stroke unit within 4 hours of arrival.","The number of A&E department presentations of suspected stroke."]
[null,"QS2","Stroke in adults",1,null,"Adults presenting at an accident and emergency (A&E) department with suspected stroke are admitted to a specialist acute stroke unit within 4 hours of arrival.","Mortality rates of adults who have a stroke","Outcome","QS2 - Stroke in adults","1 - QS2 - Stroke in adults",1,"1 - QS2 - Stroke in adults - Outcome - 1"]
[null,"QS2","Stroke in adults",1,null,"Adults presenting at an accident and emergency (A&E) department with suspected stroke are admitted to a specialist acute stroke unit within 4 hours of arrival.","Change in Modified Rankin Score at 6 months after a stroke","Outcome","QS2 - Stroke in adults","1 - QS2 - Stroke in adults",2,"1 - QS2 - Stroke in adults - Outcome - 2"]
[null,"QS2","Stroke in adults",2,null,"Adults having stroke rehabilitation in hospital or in the community are offered at least 45 minutes of each relevant therapy for a minimum of 5 days a week","Evidence of local arrangements and written clinical protocols to ensure that adults having stroke rehabilitation in hospital or in the community are offered at least 45 minutes of each relevant therapy for a minimum of 5 days a week","Structure","QS2 - Stroke in adults","2 - QS2 - Stroke in adults",1,"2 - QS2 - Stroke in adults - Structure - 1"]
[null,"QS2","Stroke in adults",2,null,"Adults having stroke rehabilitation in hospital or in the community are offered at least 45 minutes of each relevant therapy for a minimum of 5 days a week","Proportion of adults having stroke rehabilitation in hospital who receive at least 45 minutes of each relevant therapy for a minimum of 5 days a week","Process","QS2 - Stroke in adults","2 - QS2 - Stroke in adults",1,"2 - QS2 - Stroke in adults - Process - 1","The number in the denominator who receive at least 45 minutes of each relevant therapy for a minimum of 5 days a week.","The number of adults having stroke rehabilitation in hospital."]
[null,"QS2","Stroke in adults",2,null,"Adults having stroke rehabilitation in hospital or in the community are offered at least 45 minutes of each relevant therapy for a minimum of 5 days a week","Proportion of adults having stroke rehabilitation in the community who receive at least 45 minutes of each relevant therapy for a minimum of 5 days a week","Process","QS2 - Stroke in adults","2 - QS2 - Stroke in adults",2,"2 - QS2 - Stroke in adults - Process - 2","The number in the denominator who receive at least 45 minutes of each relevant therapy for a minimum of 5 days a week.","The number of adults having stroke rehabilitation in the community."]
[null,"QS2","Stroke in adults",2,null,"Adults having stroke rehabilitation in hospital or in the community are offered at least 45 minutes of each relevant therapy for a minimum of 5 days a week","Change in Modified Rankin Score at 6 months after a stroke","Outcome","QS2 - Stroke in adults","2 - QS2 - Stroke in adults",1,"2 - QS2 - Stroke in adults - Outcome - 1"]
[null,"QS2","Stroke in adults",3,null,"Adults who have had a stroke have access to a clinical psychologist with expertise in stroke rehabilitation who is part of the core multidisciplinary stroke rehabilitation team","Evidence of local arrangements and protocols to ensure that services providing stroke care have a core multidisciplinary stroke rehabilitation team that includes a clinical psychologist with expertise in stroke rehabilitation","Structure","QS2 - Stroke in adults","3 - QS2 - Stroke in adults",1,"3 - QS2 - Stroke in adults - Structure - 1"]
[null,"QS2","Stroke in adults",3,null,"Adults who have had a stroke have access to a clinical psychologist with expertise in stroke rehabilitation who is part of the core multidisciplinary stroke rehabilitation team","Quality of life for adults who have had a stroke","Outcome","QS2 - Stroke in adults","3 - QS2 - Stroke in adults",1,"3 - QS2 - Stroke in adults - Outcome - 1"]
[null,"QS2","Stroke in adults",4,null,"Adults who have had a stroke are offered early supported discharge if the core multidisciplinary stroke team assess that it is suitable for them","Evidence of local arrangements and written clinical protocols to ensure that adults who have had a stroke are offered early supported discharge if the core multidisciplinary stroke team assess that it is suitable for them","Structure","QS2 - Stroke in adults","4 - QS2 - Stroke in adults",1,"4 - QS2 - Stroke in adults - Structure - 1"]
[null,"QS2","Stroke in adults",4,null,"Adults who have had a stroke are offered early supported discharge if the core multidisciplinary stroke team assess that it is suitable for them","Proportion of adults who have had a stroke and are assessed as suitable for early supported discharge by the core multidisciplinary stroke team who receive it","Process","QS2 - Stroke in adults","4 - QS2 - Stroke in adults",1,"4 - QS2 - Stroke in adults - Process - 1","The number in the denominator who receive early supported discharge.","The number of adults who have had a stroke and are assessed as suitable for early supported discharge by the core multidisciplinary stroke team."]
[null,"QS2","Stroke in adults",4,null,"Adults who have had a stroke are offered early supported discharge if the core multidisciplinary stroke team assess that it is suitable for them","Proportion of adults who have had stroke who are treated by an early supported discharge team","Process","QS2 - Stroke in adults","4 - QS2 - Stroke in adults",2,"4 - QS2 - Stroke in adults - Process - 2","The number in the denominator who are treated by an early supported discharge team.","The number of adults who have had a stroke."]
[null,"QS2","Stroke in adults",4,null,"Adults who have had a stroke are offered early supported discharge if the core multidisciplinary stroke team assess that it is suitable for them","Length of hospital stay for adults who have had a stroke","Outcome","QS2 - Stroke in adults","4 - QS2 - Stroke in adults",1,"4 - QS2 - Stroke in adults - Outcome - 1"]
[null,"QS2","Stroke in adults",4,null,"Adults who have had a stroke are offered early supported discharge if the core multidisciplinary stroke team assess that it is suitable for them","Quality of life for adults who have had a stroke","Outcome","QS2 - Stroke in adults","4 - QS2 - Stroke in adults",2,"4 - QS2 - Stroke in adults - Outcome - 2"]
[null,"QS2","Stroke in adults",5,null,"Adults who have had a stroke are offered active management to return to work if they wish to do so","Evidence of local arrangements and written clinical protocols to ensure that adults who have had a stroke are offered active management to return to work if they wish to do so","Structure","QS2 - Stroke in adults","5 - QS2 - Stroke in adults",1,"5 - QS2 - Stroke in adults - Structure - 1"]
[null,"QS2","Stroke in adults",5,null,"Adults who have had a stroke are offered active management to return to work if they wish to do so","Proportion of adults who have had a stroke who receive active management to return to work if they wish to do so","Process","QS2 - Stroke in adults","5 - QS2 - Stroke in adults",1,"5 - QS2 - Stroke in adults - Process - 1","The number in the denominator who receive active management to help them return to work.","The number of adults who have had a stroke who wish to return to work."]
[null,"QS2","Stroke in adults",5,null,"Adults who have had a stroke are offered active management to return to work if they wish to do so","Quality of life for adults who have had a stroke","Outcome","QS2 - Stroke in adults","5 - QS2 - Stroke in adults",1,"5 - QS2 - Stroke in adults - Outcome - 1"]
[null,"QS2","Stroke in adults",5,null,"Adults who have had a stroke are offered active management to return to work if they wish to do so","Quality of life for carers of adults who have had a stroke","Outcome","QS2 - Stroke in adults","5 - QS2 - Stroke in adults",2,"5 - QS2 - Stroke in adults - Outcome - 2"]
[null,"QS2","Stroke in adults",6,null,"Adults who have had a stroke have their rehabilitation goals reviewed at regular intervals","Evidence of local arrangements and written clinical protocols to ensure that adults who have had a stroke have their rehabilitation goals reviewed at regular intervals","Structure","QS2 - Stroke in adults","6 - QS2 - Stroke in adults",1,"6 - QS2 - Stroke in adults - Structure - 1"]
[null,"QS2","Stroke in adults",6,null,"Adults who have had a stroke have their rehabilitation goals reviewed at regular intervals","Proportion of adults who have had a stroke who have their rehabilitation goals agreed within 5 days of arrival at A&E","Process","QS2 - Stroke in adults","6 - QS2 - Stroke in adults",1,"6 - QS2 - Stroke in adults - Process - 1","The number in the denominator who have their rehabilitation goals agreed within 5 days of arrival at A&E. ","The number of adults who have had a stroke."]
[null,"QS2","Stroke in adults",6,null,"Adults who have had a stroke have their rehabilitation goals reviewed at regular intervals","Proportion of adults who have had a stroke who have their rehabilitation goals reviewed at regular intervals","Process","QS2 - Stroke in adults","6 - QS2 - Stroke in adults",2,"6 - QS2 - Stroke in adults - Process - 2","The number in the denominator who have their rehabilitation goals reviewed at regular intervals.","The number of adults who have had a stroke with agreed rehabilitation goals."]
[null,"QS2","Stroke in adults",6,null,"Adults who have had a stroke have their rehabilitation goals reviewed at regular intervals","Quality of life for adults who have had a stroke","Outcome","QS2 - Stroke in adults","6 - QS2 - Stroke in adults",1,"6 - QS2 - Stroke in adults - Outcome - 1"]
[null,"QS2","Stroke in adults",6,null,"Adults who have had a stroke have their rehabilitation goals reviewed at regular intervals","Readmission rates of adults who have had a stroke","Outcome","QS2 - Stroke in adults","6 - QS2 - Stroke in adults",2,"6 - QS2 - Stroke in adults - Outcome - 2"]
[null,"QS2","Stroke in adults",7,null,"Adults who have had a stroke have a structured health and social care review at 6 months and 1 year after the stroke, and then annually","Evidence of local arrangements and written protocols to ensure that adults who have had a stroke have a structured health and social care review at 6 months and 1 year after the stroke, and then annually","Structure","QS2 - Stroke in adults","7 - QS2 - Stroke in adults",1,"7 - QS2 - Stroke in adults - Structure - 1"]
[null,"QS2","Stroke in adults",7,null,"Adults who have had a stroke have a structured health and social care review at 6 months and 1 year after the stroke, and then annually","Proportion of adults who have had a stroke who have a structured health and social care review at 6 months after the stroke","Process","QS2 - Stroke in adults","7 - QS2 - Stroke in adults",1,"7 - QS2 - Stroke in adults - Process - 1","The number in the denominator who have a structured health and social care review at 6 months after the stroke.","The number of adults who have had a stroke."]
[null,"QS2","Stroke in adults",7,null,"Adults who have had a stroke have a structured health and social care review at 6 months and 1 year after the stroke, and then annually","Proportion of adults who have had a stroke and had a structured health and social care review at 6 months after the stroke who have a review 1 year after the stroke","Process","QS2 - Stroke in adults","7 - QS2 - Stroke in adults",2,"7 - QS2 - Stroke in adults - Process - 2","The number in the denominator who have a review 1 year after the stroke.","The number of adults who have had a stroke and had a structured health and social care review at 6 months after the stroke."]
[null,"QS2","Stroke in adults",7,null,"Adults who have had a stroke have a structured health and social care review at 6 months and 1 year after the stroke, and then annually","Proportion of adults who have had a stroke and had a structured health and social care review at 6 months and 1 year after the stroke, who have annual reviews thereafter","Process","QS2 - Stroke in adults","7 - QS2 - Stroke in adults",3,"7 - QS2 - Stroke in adults - Process - 3","The number in the denominator who have annual reviews.","The number of adults who have had a stroke and had a structured health and social care review at 6 months and 1 year after the stroke."]
[null,"QS2","Stroke in adults",7,null,"Adults who have had a stroke have a structured health and social care review at 6 months and 1 year after the stroke, and then annually","Quality of life for adults who have had a stroke","Outcome","QS2 - Stroke in adults","7 - QS2 - Stroke in adults",1,"7 - QS2 - Stroke in adults - Outcome - 1"]
[null,"QS2","Stroke in adults",7,null,"Adults who have had a stroke have a structured health and social care review at 6 months and 1 year after the stroke, and then annually","Readmission rates of adults who have had a stroke","Outcome","QS2 - Stroke in adults","7 - QS2 - Stroke in adults",2,"7 - QS2 - Stroke in adults - Outcome - 2"]
[null,"QS5","Chronic kidney disease in adults",1,null,"Adults with, or at risk of, chronic kidney disease (CKD) have eGFRcreatinine and albumin:creatinine ratio (ACR) testing at the frequency agreed with their healthcare professional. ","Evidence of local systems that invite adults with, or at risk of, CKD to have eGFRcreatinine and ACR testing.","Structure",{"$f":"CONCATENATE(B34, \" - \", C34)","v":"QS5 - Chronic kidney disease in adults"},{"$f":"CONCATENATE(D34, \" - \", I34)","v":"1 - QS5 - Chronic kidney disease in adults"},{"$f":"IF(AND(B34=B33, D34=D33, H34=H33)=TRUE, K33+1, 1)","v":1},{"$f":"CONCATENATE(J34, \" - \", H34, \" - \",K34)","v":"1 - QS5 - Chronic kidney disease in adults - Structure - 1"},"",""]
[null,"QS5","Chronic kidney disease in adults",1,null,"Adults with, or at risk of, chronic kidney disease (CKD) have eGFRcreatinine and albumin:creatinine ratio (ACR) testing at the frequency agreed with their healthcare professional. ","Proportion of adults with CKD who had eGFRcreatinine testing in the past year.","Process","QS5 - Chronic kidney disease in adults","1 - QS5 - Chronic kidney disease in adults",1,"1 - QS5 - Chronic kidney disease in adults - Process - 1","The number in the denominator who had eGFRcreatinine testing in the past year.","The number of adults with CKD."]
[null,"QS5","Chronic kidney disease in adults",1,null,"Adults with, or at risk of, chronic kidney disease (CKD) have eGFRcreatinine and albumin:creatinine ratio (ACR) testing at the frequency agreed with their healthcare professional. ","Proportion of adults with CKD who had ACR testing at the frequency agreed with their healthcare professional.","Process","QS5 - Chronic kidney disease in adults","1 - QS5 - Chronic kidney disease in adults",2,"1 - QS5 - Chronic kidney disease in adults - Process - 2","The number in the denominator who had ACR testing at the frequency agreed with their healthcare professional.","The number of adults with CKD."]
[null,"QS5","Chronic kidney disease in adults",1,null,"Adults with, or at risk of, chronic kidney disease (CKD) have eGFRcreatinine and albumin:creatinine ratio (ACR) testing at the frequency agreed with their healthcare professional. ","Proportion of adults at risk of CKD who had eGFRcreatinine testing at the frequency agreed with their healthcare professional.","Process","QS5 - Chronic kidney disease in adults","1 - QS5 - Chronic kidney disease in adults",{"$f":"IF(AND(B37=B36, D37=D36, H37=H36)=TRUE, K36+1, 1)","v":3},{"$f":"CONCATENATE(J37, \" - \", H37, \" - \",K37)","v":"1 - QS5 - Chronic kidney disease in adults - Process - 3"},"The number in the denominator who had eGFRcreatinine testing at the frequency agreed with their healthcare professional.","The number of adults at risk of CKD."]
[null,"QS5","Chronic kidney disease in adults",1,null,"Adults with, or at risk of, chronic kidney disease (CKD) have eGFRcreatinine and albumin:creatinine ratio (ACR) testing at the frequency agreed with their healthcare professional. ","Proportion of adults at risk of CKD who had ACR testing at the frequency agreed with their healthcare professional.","Process","QS5 - Chronic kidney disease in adults","1 - QS5 - Chronic kidney disease in adults",4,"1 - QS5 - Chronic kidney disease in adults - Process - 4","The number in the denominator who had ACR testing at the agreed frequency.","The number of adults at risk of CKD."]
[null,"QS5","Chronic kidney disease in adults",1,null,"Adults with, or at risk of, chronic kidney disease (CKD) have eGFRcreatinine and albumin:creatinine ratio (ACR) testing at the frequency agreed with their healthcare professional. ","Prevalence of undiagnosed CKD.","Outcome","QS5 - Chronic kidney disease in adults","1 - QS5 - Chronic kidney disease in adults",1,"1 - QS5 - Chronic kidney disease in adults - Outcome - 1"]
[null,"QS5","Chronic kidney disease in adults",1,null,"Adults with, or at risk of, chronic kidney disease (CKD) have eGFRcreatinine and albumin:creatinine ratio (ACR) testing at the frequency agreed with their healthcare professional. ","Stage of CKD at diagnosis.","Outcome","QS5 - Chronic kidney disease in adults","1 - QS5 - Chronic kidney disease in adults",2,"1 - QS5 - Chronic kidney disease in adults - Outcome - 2"]
[null,"QS5","Chronic kidney disease in adults",2,null,"Adults with chronic kidney disease (CKD) have their blood pressure maintained within the recommended range. ","Evidence of local systems to identify and invite adults with CKD to have a blood pressure reading.","Structure","QS5 - Chronic kidney disease in adults","2 - QS5 - Chronic kidney disease in adults",1,"2 - QS5 - Chronic kidney disease in adults - Structure - 1"]
[null,"QS5","Chronic kidney disease in adults",2,null,"Adults with chronic kidney disease (CKD) have their blood pressure maintained within the recommended range. ","Evidence of the availability of equipment to take a blood pressure reading from adults with CKD.","Structure",{"$f":"CONCATENATE(B42, \" - \", C42)","v":"QS5 - Chronic kidney disease in adults"},{"$f":"CONCATENATE(D42, \" - \", I42)","v":"2 - QS5 - Chronic kidney disease in adults"},{"$f":"IF(AND(B42=B41, D42=D41, H42=H41)=TRUE, K41+1, 1)","v":2},{"$f":"CONCATENATE(J42, \" - \", H42, \" - \",K42)","v":"2 - QS5 - Chronic kidney disease in adults - Structure - 2"}]
[null,"QS5","Chronic kidney disease in adults",2,null,"Adults with chronic kidney disease (CKD) have their blood pressure maintained within the recommended range. ","Proportion of adults with CKD with an albumin:creatinine ratio (ACR) below 70 mg/mmol whose systolic blood pressure is between 120 mmHg and 139 mmHg and their clinic diastolic blood pressure below 90 mmHg.","Process","QS5 - Chronic kidney disease in adults","2 - QS5 - Chronic kidney disease in adults",1,"2 - QS5 - Chronic kidney disease in adults - Process - 1","The number in the denominator whose systolic blood pressure is between 120–139 mmHg and their diastolic blood pressure below 90 mmHg.","The number of adults with CKD with an ACR below 70 mg/mmol."]
[null,"QS5","Chronic kidney disease in adults",2,null,"Adults with chronic kidney disease (CKD) have their blood pressure maintained within the recommended range. ","Proportion of adults with CKD whose systolic blood pressure is between 120 mmHg and 129 mmHg and their clinic diastolic blood pressure below 80 mmHg.","Process","QS5 - Chronic kidney disease in adults","2 - QS5 - Chronic kidney disease in adults",2,"2 - QS5 - Chronic kidney disease in adults - Process - 2","The number in the denominator whose systolic blood pressure is between 120 mmHg and 129 mmHg and their clinic diastolic blood pressure below 80 mmHg.","The number of adults with CKD "]
[null,"QS5","Chronic kidney disease in adults",2,null,"Adults with chronic kidney disease (CKD) have their blood pressure maintained within the recommended range. ","Proportion of adults with CKD and an ACR of 70 mg/mmol or more whose systolic blood pressure is between 120 mmHg and 129 mmHg and their clinic diastolic blood pressure below 80 mmHg.","Process","QS5 - Chronic kidney disease in adults","2 - QS5 - Chronic kidney disease in adults",3,"2 - QS5 - Chronic kidney disease in adults - Process - 3","The number in the denominator whose systolic blood pressure is between 120 mmHg and 129 mmHg and their clinic diastolic blood pressure below 80 mmHg.","The number of adults with CKD and an ACR of 70 mg/mmol or more."]
[null,"QS5","Chronic kidney disease in adults",2,null,"Adults with chronic kidney disease (CKD) have their blood pressure maintained within the recommended range. ","Prevalence of cardiovascular disease among people with CKD.","Outcome",{"$f":"CONCATENATE(B46, \" - \", C46)","v":"QS5 - Chronic kidney disease in adults"},"2 - QS5 - Chronic kidney disease in adults",1,"2 - QS5 - Chronic kidney disease in adults - Outcome - 1"]
[null,"QS5","Chronic kidney disease in adults",2,null,"Adults with chronic kidney disease (CKD) have their blood pressure maintained within the recommended range. ","Incidence of cardiovascular events for people with CKD.","Outcome","QS5 - Chronic kidney disease in adults","2 - QS5 - Chronic kidney disease in adults",2,"2 - QS5 - Chronic kidney disease in adults - Outcome - 2"]
[null,"QS5","Chronic kidney disease in adults",2,null,"Adults with chronic kidney disease (CKD) have their blood pressure maintained within the recommended range. ","Cardiovascular mortality rates among people with CKD.","Outcome","QS5 - Chronic kidney disease in adults","2 - QS5 - Chronic kidney disease in adults",3,"2 - QS5 - Chronic kidney disease in adults - Outcome - 3"]
[null,"QS5","Chronic kidney disease in adults",2,null,"Adults with chronic kidney disease (CKD) have their blood pressure maintained within the recommended range. ","Incidence of end-stage kidney disease.","Outcome","QS5 - Chronic kidney disease in adults","2 - QS5 - Chronic kidney disease in adults",4,"2 - QS5 - Chronic kidney disease in adults - Outcome - 4"]
[null,"QS5","Chronic kidney disease in adults",3,null,"Adults with chronic kidney disease (CKD) are offered atorvastatin 20 mg.","Evidence of the availability of atorvastatin 20 mg within local service providers.","Structure","QS5 - Chronic kidney disease in adults","3 - QS5 - Chronic kidney disease in adults",1,"3 - QS5 - Chronic kidney disease in adults - Structure - 1"]
[null,"QS5","Chronic kidney disease in adults",3,null,"Adults with chronic kidney disease (CKD) are offered atorvastatin 20 mg.","Evidence of local systems to check whether adults with CKD are taking atorvastatin 20 mg and invite them to discuss starting treatment if not.","Structure","QS5 - Chronic kidney disease in adults","3 - QS5 - Chronic kidney disease in adults",2,"3 - QS5 - Chronic kidney disease in adults - Structure - 2"]
[null,"QS5","Chronic kidney disease in adults",3,null,"Adults with chronic kidney disease (CKD) are offered atorvastatin 20 mg.","Proportion of adults with CKD who receive atorvastatin 20 mg.","Process","QS5 - Chronic kidney disease in adults","3 - QS5 - Chronic kidney disease in adults",1,"3 - QS5 - Chronic kidney disease in adults - Process - 1","The number in the denominator who receive atorvastatin 20 mg.","The number of adults with CKD."]
[null,"QS5","Chronic kidney disease in adults",3,null,"Adults with chronic kidney disease (CKD) are offered atorvastatin 20 mg.","Prevalence of cardiovascular disease among people with CKD.","Outcome","QS5 - Chronic kidney disease in adults","3 - QS5 - Chronic kidney disease in adults",1,"3 - QS5 - Chronic kidney disease in adults - Outcome - 1"]
[null,"QS5","Chronic kidney disease in adults",3,null,"Adults with chronic kidney disease (CKD) are offered atorvastatin 20 mg.","Incidence of cardiovascular events for people with CKD.","Outcome","QS5 - Chronic kidney disease in adults","3 - QS5 - Chronic kidney disease in adults",2,"3 - QS5 - Chronic kidney disease in adults - Outcome - 2"]
[null,"QS5","Chronic kidney disease in adults",3,null,"Adults with chronic kidney disease (CKD) are offered atorvastatin 20 mg.","Cardiovascular mortality rates among people with CKD.","Outcome","QS5 - Chronic kidney disease in adults","3 - QS5 - Chronic kidney disease in adults",3,"3 - QS5 - Chronic kidney disease in adults - Outcome - 3"]
[null,"QS5","Chronic kidney disease in adults",3,null,"Adults with chronic kidney disease (CKD) are offered atorvastatin 20 mg.","Proportion of people with CKD on a statin without a diagnosis of CVD with a greater than 40% reduction in non-high-density lipoprotein (HDL) cholesterol.","Outcome","QS5 - Chronic kidney disease in adults","3 - QS5 - Chronic kidney disease in adults",4,"3 - QS5 - Chronic kidney disease in adults - Outcome - 4","The number in the denominator with a greater than 40% reduction in non-HDL cholesterol.","The number of people with CKD on a statin without a diagnosis of CVD."]
[null,"QS5","Chronic kidney disease in adults",3,null,"Adults with chronic kidney disease (CKD) are offered atorvastatin 20 mg.","Proportion of adults with CKD and CVD on a statin who have a low-density lipoprotein (LDL) cholesterol level of 2.0 mmol per litre or less, or non-HDL cholesterol level of 2.6 mmol per litre or less.","Outcome",{"$f":"CONCATENATE(B57, \" - \", C57)","v":"QS5 - Chronic kidney disease in adults"},{"$f":"CONCATENATE(D57, \" - \", I57)","v":"3 - QS5 - Chronic kidney disease in adults"},5,{"$f":"CONCATENATE(J57, \" - \", H57, \" - \",K57)","v":"3 - QS5 - Chronic kidney disease in adults - Outcome - 5"},"The number in the denominator who have an LDL cholesterol level of 2.0 mmol per litre or less, or non-HDL cholesterol level of 2.6 mmol per litre or less.","The number of adults with CKD and CVD on a statin."]
[null,null,null,null,null,null,null,null," - "," -  - ",{"$f":"IF(AND(B58=B57, D58=D57, H58=H57)=TRUE, K57+1, 1)","v":1}," -  -  -  - 1"]
[null,null,null,null,null,null,null,null," - "," -  - ",2," -  -  -  - 2"]
[null,null,null,null,null,null,null,null," - "," -  - ",3," -  -  -  - 3"]
[null,null,null,null,null,null,null,null," - "," -  - ",4," -  -  -  - 4"]
[null,null,null,null,null,null,null,null," - "," -  - ",5," -  -  -  - 5"]
[null,null,null,null,null,null,null,null," - "," -  - ",6," -  -  -  - 6"]
[null,null,null,null,null,null,null,null," - "," -  - ",7," -  -  -  - 7"]
[null,null,null,null,null,null,null,null," - "," -  - ",8," -  -  -  - 8"]
[null,null,null,null,null,null,null,null," - "," -  - ",9," -  -  -  - 9"]
[null,null,null,null,null,null,null,null," - "," -  - ",10," -  -  -  - 10"]
[null,null,null,null,null,null,null,null," - "," -  - ",11," -  -  -  - 11"]
[null,null,null,null,null,null,null,null," - "," -  - ",12," -  -  -  - 12"]
[null,null,null,null,null,null,null,null," - "," -  - ",13," -  -  -  - 13"]
[null,null,null,null,null,null,null,null," - "," -  - ",14," -  -  -  - 14"]
[null,null,null,null,null,null,null,null," - "," -  - ",15," -  -  -  - 15"]
[null,null,null,null,null,null,null,null," - "," -  - ",16," -  -  -  - 16"]
[null,null,null,null,null,null,null,null," - "," -  - ",17," -  -  -  - 17"]
[null,null,null,null,null,null,null,null," - "," -  - ",18," -  -  -  - 18"]
[null,null,null,null,null,null,null,null," - "," -  - ",19," -  -  -  - 19"]
[null,null,null,null,null,null,null,null," - "," -  - ",20," -  -  -  - 20"]
[null,null,null,null,null,null,null,null," - "," -  - ",21," -  -  -  - 21"]
[null,null,null,null,null,null,null,null," - "," -  - ",22," -  -  -  - 22"]
[null,null,null,null,null,null,null,null," - "," -  - ",23," -  -  -  - 23"]
[null,null,null,null,null,null,null,null," - "," -  - ",24," -  -  -  - 24"]
[null,null,null,null,null,null,null,null," - "," -  - ",25," -  -  -  - 25"]
[null,null,null,null,null,null,null,null," - "," -  - ",26," -  -  -  - 26"]
[null,null,null,null,null,null,null,null," - "," -  - ",27," -  -  -  - 27"]
[null,null,null,null,null,null,null,null," - "," -  - ",28," -  -  -  - 28"]
[null,null,null,null,null,null,null,null," - "," -  - ",29," -  -  -  - 29"]
[null,"QS8","Depression in adults",1,null,"Adults with suspected depression have a comprehensive assessment.","Proportion of adults with a new episode of depression who had a comprehensive assessment before receiving a diagnosis.","Process",{"$f":"CONCATENATE(B87, \" - \", C87)","v":"QS8 - Depression in adults"},{"$f":"CONCATENATE(D87, \" - \", I87)","v":"1 - QS8 - Depression in adults"},{"$f":"IF(AND(B87=B86, D87=D86, H87=H86)=TRUE, K86+1, 1)","v":1},{"$f":"CONCATENATE(J87, \" - \", H87, \" - \",K87)","v":"1 - QS8 - Depression in adults - Process - 1"},"The number in the denominator who had a comprehensive assessment before receiving a diagnosis.","The number of adults with a new episode of depression."]
[null,"QS8","Depression in adults",1,null,"Adults with suspected depression have a comprehensive assessment.","The proportion of adults diagnosed with depression who reported satisfaction with their assessment.","Outcome","QS8 - Depression in adults","1 - QS8 - Depression in adults",{"$f":"IF(AND(B88=B87, D88=D87, H88=H87)=TRUE, K87+1, 1)","v":1},{"$f":"CONCATENATE(J88, \" - \", H88, \" - \",K88)","v":"1 - QS8 - Depression in adults - Outcome - 1"},"The number in the denominator who reported satisfaction with their assessment.","The number of adults diagnosed with depression who had an assessment."]
[null,"QS8","Depression in adults",2,null,"Adults with a new episode of depression have a discussion with their healthcare professional about the full range of treatment options.","Proportion of adults with a new episode of depression who have a discussion with their healthcare professional about the full range of treatment options.","Process","QS8 - Depression in adults","2 - QS8 - Depression in adults",{"$f":"IF(AND(B89=B88, D89=D88, H89=H88)=TRUE, K88+1, 1)","v":1},"2 - QS8 - Depression in adults - Process - 1","The number in the denominator who have a discussion about the full range of treatment options with their healthcare professional.","The number of adults with a new episode of depression."]
[null,"QS8","Depression in adults",2,null,"Adults with a new episode of depression have a discussion with their healthcare professional about the full range of treatment options.","Proportion of adults with a new episode of depression who felt fully involved in decision making about their care.","Outcome","QS8 - Depression in adults","2 - QS8 - Depression in adults",{"$f":"IF(AND(B90=B89, D90=D89, H90=H89)=TRUE, K89+1, 1)","v":1},{"$f":"CONCATENATE(J90, \" - \", H90, \" - \",K90)","v":"2 - QS8 - Depression in adults - Outcome - 1"},"The number in the denominator who felt fully involved in decision making about their care.","The number of adults with a new episode of depression."]
[null,"QS8","Depression in adults",2,null,"Adults with a new episode of depression have a discussion with their healthcare professional about the full range of treatment options.","Proportion of adults with a new episode of depression and a preference for treatment who were offered their preferred treatment.","Outcome","QS8 - Depression in adults","2 - QS8 - Depression in adults",2,"2 - QS8 - Depression in adults - Outcome - 2","The number in the denominator who were offered their preferred treatment.","The number of adults with a new episode of depression and a preference for their treatment."]
[null,"QS8","Depression in adults",3,null,"Adults with depression who are at a higher risk of relapse have relapse prevention interventions.","The proportion of adults with depression who are at a higher risk of relapse who received relapse prevention interventions.","Process",{"$f":"CONCATENATE(B92, \" - \", C92)","v":"QS8 - Depression in adults"},{"$f":"CONCATENATE(D92, \" - \", I92)","v":"3 - QS8 - Depression in adults"},{"$f":"IF(AND(B92=B91, D92=D91, H92=H91)=TRUE, K91+1, 1)","v":1},{"$f":"CONCATENATE(J92, \" - \", H92, \" - \",K92)","v":"3 - QS8 - Depression in adults - Process - 1"},"The number in the denominator who received relapse prevention interventions.","The number of adults with depression who are at a higher risk of relapse."]
[null,"QS8","Depression in adults",3,null,"Adults with depression who are at a higher risk of relapse have relapse prevention interventions.","Rates of relapse within 2 years of their last session among adults who have been treated for depression with psychological therapy.","Outcome","QS8 - Depression in adults","3 - QS8 - Depression in adults",1,"3 - QS8 - Depression in adults - Outcome - 1"]
[null,"QS8","Depression in adults",3,null,"Adults with depression who are at a higher risk of relapse have relapse prevention interventions.","Rates of relapse within 2 years of a review at 9 to 12 months after starting antidepressants among adults who have been treated for a first episode of depression.","Outcome","QS8 - Depression in adults","3 - QS8 - Depression in adults",2,"3 - QS8 - Depression in adults - Outcome - 2"]
[null,"QS8","Depression in adults",3,null,"Adults with depression who are at a higher risk of relapse have relapse prevention interventions.","Rates of relapse within 2 years of a review 2 years after starting antidepressants among adults who have been treated for a second or subsequent episode of depression.","Outcome","QS8 - Depression in adults","3 - QS8 - Depression in adults",3,"3 - QS8 - Depression in adults - Outcome - 3"]
[null,"QS8","Depression in adults",4,null,"Adults with depression who are stopping antidepressant medication have the dose reduced in stages.","The proportion of adults with depression who stopped taking antidepressant medication who had their dose reduced in stages.","Process","QS8 - Depression in adults","4 - QS8 - Depression in adults",1,"4 - QS8 - Depression in adults - Process - 1","The number in the denominator who had their dose reduced in stages.","The number of adults with depression who stopped taking antidepressant medication."]
[null,"QS8","Depression in adults",5,null,"Adults from minority ethnic backgrounds with depression are supported to access mental health services.","Evidence of action plans that identify strategies and measures to support adults from underrepresented groups to access treatment for depression where a need to improve and promote access has been identified from monitoring local data.","Structure","QS8 - Depression in adults","5 - QS8 - Depression in adults",1,"5 - QS8 - Depression in adults - Structure - 1"]
[null,"QS8","Depression in adults",5,null,"Adults from minority ethnic backgrounds with depression are supported to access mental health services.","Rates of access to mental health services among adults with depression, by ethnicity.","Outcome","QS8 - Depression in adults","5 - QS8 - Depression in adults",1,"5 - QS8 - Depression in adults - Outcome - 1"]
[null,"QS8","Depression in adults",5,null,"Adults from minority ethnic backgrounds with depression are supported to access mental health services.","Treatment completion rates for adults with depression, by ethnicity.","Outcome","QS8 - Depression in adults","5 - QS8 - Depression in adults",2,"5 - QS8 - Depression in adults - Outcome - 2"]
[null,"QS8","Depression in adults",5,null,"Adults from minority ethnic backgrounds with depression are supported to access mental health services.","Time from first presentation with symptoms of depression to starting treatment for depression, by ethnicity.","Outcome","QS8 - Depression in adults","5 - QS8 - Depression in adults",3,"5 - QS8 - Depression in adults - Outcome - 3"]
[null,"QS9","Chronic heart failure in adults",1,null,"Adults presenting in primary care with suspected heart failure have their N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) measured.","Proportion of adults diagnosed with heart failure by specialist assessment and echocardiography who had NT‑proBNP measured before diagnosis.","Process","QS9 - Chronic heart failure in adults","1 - QS9 - Chronic heart failure in adults",1,"1 - QS9 - Chronic heart failure in adults - Process - 1","The number in the denominator who had NT‑proBNP measured before diagnosis.","The number of adults diagnosed with heart failure by specialist assessment and echocardiography."]
[null,"QS9","Chronic heart failure in adults",1,null,"Adults presenting in primary care with suspected heart failure have their N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) measured.","Hospital admissions due to heart failure.","Outcome","QS9 - Chronic heart failure in adults","1 - QS9 - Chronic heart failure in adults",1,"1 - QS9 - Chronic heart failure in adults - Outcome - 1"]
[null,"QS9","Chronic heart failure in adults",2,null,"Adults with suspected heart failure have specialist assessment and transthoracic echocardiography within 2 weeks of referral if they have a very high N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) level, or 6 weeks if they have a high NT‑proBNP level.","Evidence of local service pathways and written clinical protocols to ensure that adults with suspected heart failure who have been referred for diagnosis have transthoracic echocardiography and specialist assessment within 2 or 6 weeks based on their NT‑proBNP level.","Structure","QS9 - Chronic heart failure in adults","2 - QS9 - Chronic heart failure in adults",1,"2 - QS9 - Chronic heart failure in adults - Structure - 1"]
[null,"QS9","Chronic heart failure in adults",2,null,"Adults with suspected heart failure have specialist assessment and transthoracic echocardiography within 2 weeks of referral if they have a very high N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) level, or 6 weeks if they have a high NT‑proBNP level."," Proportion of adults with very high levels of NT‑proBNP, who have been referred for diagnosis, who have transthoracic echocardiography and specialist assessment within 2 weeks of referral.","Process","QS9 - Chronic heart failure in adults","2 - QS9 - Chronic heart failure in adults",1,"2 - QS9 - Chronic heart failure in adults - Process - 1","The number in the denominator who have transthoracic echocardiography and specialist assessment within 2 weeks of referral.","The number of adults with very high levels of NT‑proBNP who have been referred for diagnosis."]
[null,"QS9","Chronic heart failure in adults",2,null,"Adults with suspected heart failure have specialist assessment and transthoracic echocardiography within 2 weeks of referral if they have a very high N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) level, or 6 weeks if they have a high NT‑proBNP level.","Proportion of adults with high levels of NT‑proBNP, who have been referred for diagnosis, who have transthoracic echocardiography and specialist assessment within 6 weeks of referral.","Process","QS9 - Chronic heart failure in adults","2 - QS9 - Chronic heart failure in adults",2,"2 - QS9 - Chronic heart failure in adults - Process - 2","The number in the denominator who have transthoracic echocardiography and specialist assessment within 6 weeks of referral.","The number of adults with high levels of NT‑proBNP who have been referred for diagnosis."]
[null,"QS9","Chronic heart failure in adults",2,null,"Adults with suspected heart failure have specialist assessment and transthoracic echocardiography within 2 weeks of referral if they have a very high N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) level, or 6 weeks if they have a high NT‑proBNP level.","Hospital admissions due to heart failure.","Outcome","QS9 - Chronic heart failure in adults","2 - QS9 - Chronic heart failure in adults",1,"2 - QS9 - Chronic heart failure in adults - Outcome - 1"]
[null,"QS9","Chronic heart failure in adults",3,null,"Adults with chronic heart failure who have reduced ejection fraction receive all appropriate medication at target or optimal tolerated doses.","Hospital admissions due to heart failure.","Outcome","QS9 - Chronic heart failure in adults","3 - QS9 - Chronic heart failure in adults",1,"3 - QS9 - Chronic heart failure in adults - Outcome - 1"]
[null,"QS9","Chronic heart failure in adults",3,null,"Adults with chronic heart failure who have reduced ejection fraction receive all appropriate medication at target or optimal tolerated doses.","Mortality due to heart failure with reduced ejection fraction.","Outcome","QS9 - Chronic heart failure in adults","3 - QS9 - Chronic heart failure in adults",2,"3 - QS9 - Chronic heart failure in adults - Outcome - 2"]
[null,"QS9","Chronic heart failure in adults",4,null,"Adults with chronic heart failure have a review within 2 weeks of any change in the dose or type of their heart failure medication.","Proportion of changes to dose or type of chronic heart failure medication in which the person is reviewed within 2 weeks of a change.","Process","QS9 - Chronic heart failure in adults","4 - QS9 - Chronic heart failure in adults",1,"4 - QS9 - Chronic heart failure in adults - Process - 1","The number in the denominator in which the person is reviewed within 2 weeks of the change to dose or type of medication.","The number of changes to dose or type of chronic heart failure medication in adults with chronic heart failure."]
[null,"QS9","Chronic heart failure in adults",4,null,"Adults with chronic heart failure have a review within 2 weeks of any change in the dose or type of their heart failure medication.","Hospital admissions due to heart failure.","Outcome","QS9 - Chronic heart failure in adults","4 - QS9 - Chronic heart failure in adults",1,"4 - QS9 - Chronic heart failure in adults - Outcome - 1"]
[null,"QS9","Chronic heart failure in adults",5,null,"Adults with chronic heart failure have a review of their condition at least every 6 months. ","Proportion of adults with chronic heart failure who had a review of their condition in the past 6 months.","Process","QS9 - Chronic heart failure in adults","5 - QS9 - Chronic heart failure in adults",1,"5 - QS9 - Chronic heart failure in adults - Process - 1","The number in the denominator who had a review of their condition in the past 6 months.","The number of adults with chronic heart failure."]
[null,"QS9","Chronic heart failure in adults",5,null,"Adults with chronic heart failure have a review of their condition at least every 6 months. ","Hospital admissions due to heart failure.","Outcome","QS9 - Chronic heart failure in adults","5 - QS9 - Chronic heart failure in adults",1,"5 - QS9 - Chronic heart failure in adults - Outcome - 1"]
[null,"QS9","Chronic heart failure in adults",6,null,"Adults with chronic heart failure receive a personalised programme of cardiac rehabilitation.","Proportion of adults with chronic heart failure who have a record of referral to a personalised programme of cardiac rehabilitation.","Process","QS9 - Chronic heart failure in adults","6 - QS9 - Chronic heart failure in adults",1,"6 - QS9 - Chronic heart failure in adults - Process - 1","The number in the denominator who have a record of referral to a personalised programme of cardiac rehabilitation.","The number of adults with chronic heart failure."]
[null,"QS9","Chronic heart failure in adults",6,null,"Adults with chronic heart failure receive a personalised programme of cardiac rehabilitation.","Proportion of adults with chronic heart failure who receive a personalised programme of cardiac rehabilitation.","Process","QS9 - Chronic heart failure in adults","6 - QS9 - Chronic heart failure in adults",2,"6 - QS9 - Chronic heart failure in adults - Process - 2","The number in the denominator who receive a personalised programme of cardiac rehabilitation.","The number of adults with chronic heart failure."]
[null,"QS9","Chronic heart failure in adults",6,null,"Adults with chronic heart failure receive a personalised programme of cardiac rehabilitation.","Rates of people with chronic heart failure completing programmes of cardiac rehabilitation.","Outcome","QS9 - Chronic heart failure in adults","6 - QS9 - Chronic heart failure in adults",1,"6 - QS9 - Chronic heart failure in adults - Outcome - 1"]
[null,"QS9","Chronic heart failure in adults",6,null,"Adults with chronic heart failure receive a personalised programme of cardiac rehabilitation.","Patient outcomes following programmes of cardiac rehabilitation.","Outcome","QS9 - Chronic heart failure in adults","6 - QS9 - Chronic heart failure in adults",2,"6 - QS9 - Chronic heart failure in adults - Outcome - 2"]
[null,null,null,null,null,null,null,null," - "," -  - ",1," -  -  -  - 1"]
[null,null,null,null,null,null,null,null," - "," -  - ",2," -  -  -  - 2"]
[null,null,null,null,null,null,null,null," - "," -  - ",3," -  -  -  - 3"]
[null,null,null,null,null,null,null,null," - "," -  - ",4," -  -  -  - 4"]
[null,null,null,null,null,null,null,null," - "," -  - ",5," -  -  -  - 5"]
[null,null,null,null,null,null,null,null," - "," -  - ",6," -  -  -  - 6"]
[null,null,null,null,null,null,null,null," - "," -  - ",7," -  -  -  - 7"]
[null,null,null,null,null,null,null,null," - "," -  - ",8," -  -  -  - 8"]
[null,null,null,null,null,null,null,null," - "," -  - ",9," -  -  -  - 9"]
[null,null,null,null,null,null,null,null," - "," -  - ",10," -  -  -  - 10"]
[null,null,null,null,null,null,null,null," - ",{"$f":"CONCATENATE(D127, \" - \", I127)","v":" -  - "},{"$f":"IF(AND(B127=B126, D127=D126, H127=H126)=TRUE, K126+1, 1)","v":11},{"$f":"CONCATENATE(J127, \" - \", H127, \" - \",K127)","v":" -  -  -  - 11"}]
[null,"QS10","Chronic obstructive pulmonary disease in adults",1,null,"People aged over 35 years who present with a risk factor and 1 or more symptoms of chronic obstructive pulmonary disease (COPD) have post‑bronchodilator spirometry.","Evidence of local arrangements to ensure that healthcare professionals in primary care using post‑bronchodilator spirometry are trained and competent in its use.","Structure","QS10 - Chronic obstructive pulmonary disease in adults",{"$f":"CONCATENATE(D128, \" - \", I128)","v":"1 - QS10 - Chronic obstructive pulmonary disease in adults"},{"$f":"IF(AND(B128=B127, D128=D127, H128=H127)=TRUE, K127+1, 1)","v":1},{"$f":"CONCATENATE(J128, \" - \", H128, \" - \",K128)","v":"1 - QS10 - Chronic obstructive pulmonary disease in adults - Structure - 1"}]
[null,"QS10","Chronic obstructive pulmonary disease in adults",1,null,"People aged over 35 years who present with a risk factor and 1 or more symptoms of chronic obstructive pulmonary disease (COPD) have post‑bronchodilator spirometry.","Proportion of people aged over 35 years presenting with a risk factor and 1 or more symptoms of COPD who have post‑bronchodilator spirometry.","Process","QS10 - Chronic obstructive pulmonary disease in adults","1 - QS10 - Chronic obstructive pulmonary disease in adults",1,"1 - QS10 - Chronic obstructive pulmonary disease in adults - Process - 1","The number in the denominator who have post‑bronchodilator spirometry.","The number of people aged over 35 years presenting with a risk factor and 1 or more symptoms of COPD."]
[null,"QS10","Chronic obstructive pulmonary disease in adults",2,null,"People with chronic obstructive pulmonary disease (COPD) who are prescribed an inhaler have their inhaler technique assessed when starting or changing treatment and then at least annually during treatment.","Proportion of people with COPD prescribed an inhaler who have their inhaler technique assessed at the start of treatment.","Process",{"$f":"CONCATENATE(B130, \" - \", C130)","v":"QS10 - Chronic obstructive pulmonary disease in adults"},"2 - QS10 - Chronic obstructive pulmonary disease in adults",{"$f":"IF(AND(B130=B129, D130=D129, H130=H129)=TRUE, K129+1, 1)","v":1},{"$f":"CONCATENATE(J130, \" - \", H130, \" - \",K130)","v":"2 - QS10 - Chronic obstructive pulmonary disease in adults - Process - 1"},"The number in the denominator who have their inhaler technique assessed at the start of treatment.","The number of people with COPD prescribed an inhaler."]
[null,"QS10","Chronic obstructive pulmonary disease in adults",2,null,"People with chronic obstructive pulmonary disease (COPD) who are prescribed an inhaler have their inhaler technique assessed when starting or changing treatment and then at least annually during treatment.","Proportion of people with COPD prescribed an inhaler who have their inhaler technique assessed at their annual review.","Process","QS10 - Chronic obstructive pulmonary disease in adults","2 - QS10 - Chronic obstructive pulmonary disease in adults",2,"2 - QS10 - Chronic obstructive pulmonary disease in adults - Process - 2","The number in the denominator whose last inhaler annual review was no longer than 12 months since the previous one or since inhaler initiation.","The number of people with COPD who have been prescribed an inhaler."]
[null,"QS10","Chronic obstructive pulmonary disease in adults",2,null,"People with chronic obstructive pulmonary disease (COPD) who are prescribed an inhaler have their inhaler technique assessed when starting or changing treatment and then at least annually during treatment.","Proportion of people with COPD prescribed an inhaler who have their inhaler technique assessed after a change in treatment.","Process","QS10 - Chronic obstructive pulmonary disease in adults","2 - QS10 - Chronic obstructive pulmonary disease in adults",3,"2 - QS10 - Chronic obstructive pulmonary disease in adults - Process - 3","The number in the denominator who had their inhaler technique assessed after a change in treatment.","The number of people with COPD who have been prescribed an inhaler."]
[null,"QS10","Chronic obstructive pulmonary disease in adults",2,null,"People with chronic obstructive pulmonary disease (COPD) who are prescribed an inhaler have their inhaler technique assessed when starting or changing treatment and then at least annually during treatment.","Exacerbation rates.","Outcome","QS10 - Chronic obstructive pulmonary disease in adults","2 - QS10 - Chronic obstructive pulmonary disease in adults",1,"2 - QS10 - Chronic obstructive pulmonary disease in adults - Outcome - 1"]
[null,"QS10","Chronic obstructive pulmonary disease in adults",2,null,"People with chronic obstructive pulmonary disease (COPD) who are prescribed an inhaler have their inhaler technique assessed when starting or changing treatment and then at least annually during treatment.","Hospital admissions for a COPD exacerbation.","Outcome","QS10 - Chronic obstructive pulmonary disease in adults","2 - QS10 - Chronic obstructive pulmonary disease in adults",2,"2 - QS10 - Chronic obstructive pulmonary disease in adults - Outcome - 2"]
[null,"QS10","Chronic obstructive pulmonary disease in adults",3,null,"People with stable chronic obstructive pulmonary disease (COPD) and a persistent resting stable oxygen saturation level of 92% or less have their arterial blood gases measured to assess whether they need long‑term oxygen therapy (LTOT).","Proportion of people with stable COPD and a persistent resting stable oxygen saturation level of 92% or less who have their arterial blood gases measured to assess whether they need LTOT.","Process","QS10 - Chronic obstructive pulmonary disease in adults","3 - QS10 - Chronic obstructive pulmonary disease in adults",{"$f":"IF(AND(B135=B134, D135=D134, H135=H134)=TRUE, K134+1, 1)","v":1},{"$f":"CONCATENATE(J135, \" - \", H135, \" - \",K135)","v":"3 - QS10 - Chronic obstructive pulmonary disease in adults - Process - 1"},"The number in the denominator who have their arterial blood gases measured to assess whether they need LTOT.","The number of people with stable COPD and a persistent resting stable oxygen saturation level of 92% or less."]
[null,"QS10","Chronic obstructive pulmonary disease in adults",3,null,"People with stable chronic obstructive pulmonary disease (COPD) and a persistent resting stable oxygen saturation level of 92% or less have their arterial blood gases measured to assess whether they need long‑term oxygen therapy (LTOT).","Hospital admissions for a COPD exacerbation.","Outcome","QS10 - Chronic obstructive pulmonary disease in adults","3 - QS10 - Chronic obstructive pulmonary disease in adults",1,"3 - QS10 - Chronic obstructive pulmonary disease in adults - Outcome - 1"]
[null,"QS10","Chronic obstructive pulmonary disease in adults",4,null,"People with stable chronic obstructive pulmonary disease (COPD) and a score of 3 or above on the Medical Research Council (MRC) dyspnoea scale are referred to a pulmonary rehabilitation programme.","Proportion of people with stable COPD and a score of 3 or above on the MRC dyspnoea scale who are referred to a pulmonary rehabilitation programme.","Process","QS10 - Chronic obstructive pulmonary disease in adults","4 - QS10 - Chronic obstructive pulmonary disease in adults",{"$f":"IF(AND(B137=B136, D137=D136, H137=H136)=TRUE, K136+1, 1)","v":1},{"$f":"CONCATENATE(J137, \" - \", H137, \" - \",K137)","v":"4 - QS10 - Chronic obstructive pulmonary disease in adults - Process - 1"},"The number in the denominator who are referred to a pulmonary rehabilitation programme.","The number of people with stable COPD and a score of 3 or above on the MRC dyspnoea scale."]
[null,"QS10","Chronic obstructive pulmonary disease in adults",4,null,"People with stable chronic obstructive pulmonary disease (COPD) and a score of 3 or above on the Medical Research Council (MRC) dyspnoea scale are referred to a pulmonary rehabilitation programme.","Proportion of attendances of people with stable COPD and a score of 3 or above on the MRC dyspnoea scale that result in the person completing a pulmonary rehabilitation programme.","Process","QS10 - Chronic obstructive pulmonary disease in adults","4 - QS10 - Chronic obstructive pulmonary disease in adults",2,"4 - QS10 - Chronic obstructive pulmonary disease in adults - Process - 2","The number in the denominator that result in the person completing a pulmonary rehabilitation programme.","The proportion of attendances of people with stable COPD and a score of 3 or above on the MRC dyspnoea scale at pulmonary rehabilitation programmes."]
[null,"QS10","Chronic obstructive pulmonary disease in adults",6,null,"People receiving emergency oxygen for an acute exacerbation of chronic obstructive pulmonary disease (COPD) have their oxygen saturation levels maintained between 88% and 92%.","Proportion of people receiving emergency oxygen for an acute exacerbation of COPD who have their oxygen saturation levels maintained between 88% and 92%.","Process","QS10 - Chronic obstructive pulmonary disease in adults","6 - QS10 - Chronic obstructive pulmonary disease in adults",{"$f":"IF(AND(B139=B138, D139=D138, H139=H138)=TRUE, K138+1, 1)","v":1},{"$f":"CONCATENATE(J139, \" - \", H139, \" - \",K139)","v":"6 - QS10 - Chronic obstructive pulmonary disease in adults - Process - 1"},"The number in the denominator whose oxygen saturation levels are maintained between 88% and 92%.","The number of people with an acute exacerbation of COPD receiving emergency oxygen."]
[null,"QS10","Chronic obstructive pulmonary disease in adults",6,null,"People receiving emergency oxygen for an acute exacerbation of chronic obstructive pulmonary disease (COPD) have their oxygen saturation levels maintained between 88% and 92%.","Frequency of non‑invasive ventilation due to oxygen toxicity.","Outcome","QS10 - Chronic obstructive pulmonary disease in adults","6 - QS10 - Chronic obstructive pulmonary disease in adults",1,"6 - QS10 - Chronic obstructive pulmonary disease in adults - Outcome - 1"]
[null,"QS10","Chronic obstructive pulmonary disease in adults",7,null,"People with an acute exacerbation of chronic obstructive pulmonary disease (COPD) and persistent acidotic hypercapnic ventilatory failure that is not improving after 1 hour of optimal medical therapy have non‑invasive ventilation.","Proportion of people with an exacerbation of COPD and persistent acidotic hypercapnic ventilatory failure that is not improving after 1 hour of optimal medical treatment who have non‑invasive ventilation.","Process","QS10 - Chronic obstructive pulmonary disease in adults","7 - QS10 - Chronic obstructive pulmonary disease in adults",{"$f":"IF(AND(B141=B140, D141=D140, H141=H140)=TRUE, K140+1, 1)","v":1},{"$f":"CONCATENATE(J141, \" - \", H141, \" - \",K141)","v":"7 - QS10 - Chronic obstructive pulmonary disease in adults - Process - 1"},"The number in the denominator who have non‑invasive ventilation.","The number of people with an acute exacerbation of COPD and persistent acidotic hypercapnic ventilatory failure that is not improving after 1 hour of optimal medical therapy."]
[null,"QS10","Chronic obstructive pulmonary disease in adults",7,null,"People with an acute exacerbation of chronic obstructive pulmonary disease (COPD) and persistent acidotic hypercapnic ventilatory failure that is not improving after 1 hour of optimal medical therapy have non‑invasive ventilation.","Mortality rates.","Outcome","QS10 - Chronic obstructive pulmonary disease in adults","7 - QS10 - Chronic obstructive pulmonary disease in adults",1,"7 - QS10 - Chronic obstructive pulmonary disease in adults - Outcome - 1"]
[null,"QS10","Chronic obstructive pulmonary disease in adults",8,null,"People discharged from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD) receive a hospital discharge care bundle.","Proportion of people discharged from hospital after an acute exacerbation of COPD who understand their medication and inhaler use.","Process",{"$f":"CONCATENATE(B143, \" - \", C143)","v":"QS10 - Chronic obstructive pulmonary disease in adults"},{"$f":"CONCATENATE(D143, \" - \", I143)","v":"8 - QS10 - Chronic obstructive pulmonary disease in adults"},{"$f":"IF(AND(B143=B142, D143=D142, H143=H142)=TRUE, K142+1, 1)","v":1},{"$f":"CONCATENATE(J143, \" - \", H143, \" - \",K143)","v":"8 - QS10 - Chronic obstructive pulmonary disease in adults - Process - 1"},"The number in the denominator who understand their medication and inhaler use.","The number of people discharged from hospital after an acute exacerbation of COPD"]
[null,"QS10","Chronic obstructive pulmonary disease in adults",8,null,"People discharged from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD) receive a hospital discharge care bundle.","Proportion of people discharged from hospital after an acute exacerbation of COPD who receive a self-management plan.","Process","QS10 - Chronic obstructive pulmonary disease in adults","8 - QS10 - Chronic obstructive pulmonary disease in adults",2,"8 - QS10 - Chronic obstructive pulmonary disease in adults - Process - 2","The number in the denominator who receive a self-management plan","The number of people discharged from hospital after an acute exacerbation of COPD"]
[null,"QS10","Chronic obstructive pulmonary disease in adults",8,null,"People discharged from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD) receive a hospital discharge care bundle.","Proportion of people discharged from hospital after an acute exacerbation of COPD who smoke and are referred to smoking cessation behavioural change.","Process","QS10 - Chronic obstructive pulmonary disease in adults","8 - QS10 - Chronic obstructive pulmonary disease in adults",3,"8 - QS10 - Chronic obstructive pulmonary disease in adults - Process - 3","The number in the denominator who are referred to smoking cessation behavioural change","The number of people discharged from hospital after an acute exacerbation of COPD who smoke."]
[null,"QS10","Chronic obstructive pulmonary disease in adults",8,null,"People discharged from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD) receive a hospital discharge care bundle.","Proportion of people discharged from hospital after an acute exacerbation of COPD whose condition is assessed for pulmonary rehabilitation suitability.","Process","QS10 - Chronic obstructive pulmonary disease in adults","8 - QS10 - Chronic obstructive pulmonary disease in adults",4,"8 - QS10 - Chronic obstructive pulmonary disease in adults - Process - 4","The number in the denominator whose condition is assessed for pulmonary rehabilitation suitability.","The number of people discharged from hospital after an acute exacerbation of COPD"]
[null,"QS10","Chronic obstructive pulmonary disease in adults",8,null,"People discharged from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD) receive a hospital discharge care bundle.","Proportion of people discharged from hospital after an acute exacerbation of COPD who receive follow-up within 72 hours.","Process","QS10 - Chronic obstructive pulmonary disease in adults","8 - QS10 - Chronic obstructive pulmonary disease in adults",5,"8 - QS10 - Chronic obstructive pulmonary disease in adults - Process - 5","The number in the denominator who receive follow-up within 72 hours","The number of people discharged from hospital after an acute exacerbation of COPD"]
[null,"QS10","Chronic obstructive pulmonary disease in adults",8,null,"People discharged from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD) receive a hospital discharge care bundle.","Hospital readmissions for acute exacerbations.","Outcome","QS10 - Chronic obstructive pulmonary disease in adults","8 - QS10 - Chronic obstructive pulmonary disease in adults",1,"8 - QS10 - Chronic obstructive pulmonary disease in adults - Outcome - 1"]
[null,"QS10","Chronic obstructive pulmonary disease in adults",8,null,"People discharged from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD) receive a hospital discharge care bundle.","Mortality rates.","Outcome","QS10 - Chronic obstructive pulmonary disease in adults","8 - QS10 - Chronic obstructive pulmonary disease in adults",2,"8 - QS10 - Chronic obstructive pulmonary disease in adults - Outcome - 2"]
[null,"QS11","Alcohol-use disorders: diagnosis and management",1,null,"Adults who are being asked about their alcohol use have a validated alcohol questionnaire completed to identify any need for a brief intervention or referral to specialist alcohol services.","Adults who are asked about their alcohol use who have a validated alcohol questionnaire completed.","Process","QS11 - Alcohol-use disorders: diagnosis and management","1 - QS11 - Alcohol-use disorders: diagnosis and management",{"$f":"IF(AND(B150=B142, D150=D142, H150=H142)=TRUE, K142+1, 1)","v":1},"1 - QS11 - Alcohol-use disorders: diagnosis and management - Process - 1","The number in the denominator who have a validated alcohol questionnaire completed.","The number of adults who are asked about their alcohol use."]
[null,"QS11","Alcohol-use disorders: diagnosis and management",1,null,"Adults who are being asked about their alcohol use have a validated alcohol questionnaire completed to identify any need for a brief intervention or referral to specialist alcohol services.","Rates of brief intervention for alcohol use in adults asked about their alcohol use.","Outcome","QS11 - Alcohol-use disorders: diagnosis and management","1 - QS11 - Alcohol-use disorders: diagnosis and management",1,{"$f":"CONCATENATE(J151, \" - \", H151, \" - \",K151)","v":"1 - QS11 - Alcohol-use disorders: diagnosis and management - Outcome - 1"}]
[null,"QS11","Alcohol-use disorders: diagnosis and management",1,null,"Adults who are being asked about their alcohol use have a validated alcohol questionnaire completed to identify any need for a brief intervention or referral to specialist alcohol services.","Rates of referral to specialist alcohol services in adults asked about their alcohol use.","Outcome","QS11 - Alcohol-use disorders: diagnosis and management","1 - QS11 - Alcohol-use disorders: diagnosis and management",2,"1 - QS11 - Alcohol-use disorders: diagnosis and management - Outcome - 2"]
[null,"QS11","Alcohol-use disorders: diagnosis and management",2,null,"Adults seeking help for an alcohol-use disorder are given information on, and support to access, community support networks and self-help groups. ","Proportion of adults seeking help for an alcohol-use disorder who are given information on, and support to access, community support networks and self-help groups.","Process","QS11 - Alcohol-use disorders: diagnosis and management","2 - QS11 - Alcohol-use disorders: diagnosis and management",1,"2 - QS11 - Alcohol-use disorders: diagnosis and management - Process - 1","The number in the denominator who are given information on, and support to access, community support networks and self-help groups.","The number of adults seeking help for an alcohol-use disorder."]
[null,"QS11","Alcohol-use disorders: diagnosis and management",3,null,"Adults accessing specialist alcohol services have a brief triage assessment that includes any treatment needs and associated risks. ","Proportion of referrals to specialist alcohol services where a brief triage assessment was carried out that included any treatment needs and associated risks.","Process","QS11 - Alcohol-use disorders: diagnosis and management","3 - QS11 - Alcohol-use disorders: diagnosis and management",1,"3 - QS11 - Alcohol-use disorders: diagnosis and management - Process - 1","The number in the denominator where a brief triage assessment was carried out that included any treatment needs and associated risks.","The number of referrals to specialist alcohol services."]
[null,"QS11","Alcohol-use disorders: diagnosis and management",3,null,"Adults accessing specialist alcohol services have a brief triage assessment that includes any treatment needs and associated risks. ","Rates of adults accessing specialist alcohol services receiving a referral for treatment of assessed needs.","Outcome","QS11 - Alcohol-use disorders: diagnosis and management","3 - QS11 - Alcohol-use disorders: diagnosis and management",1,"3 - QS11 - Alcohol-use disorders: diagnosis and management - Outcome - 1"]
[null,"QS11","Alcohol-use disorders: diagnosis and management",3,null,"Adults accessing specialist alcohol services have a brief triage assessment that includes any treatment needs and associated risks. ","Rates of successful completion of treatment in specialist alcohol services.","Outcome","QS11 - Alcohol-use disorders: diagnosis and management","3 - QS11 - Alcohol-use disorders: diagnosis and management",2,"3 - QS11 - Alcohol-use disorders: diagnosis and management - Outcome - 2"]
[null,"QS11","Alcohol-use disorders: diagnosis and management",4,null,"Adults in acute alcohol withdrawal in hospital are assessed and monitored following locally specified protocols.","Evidence of local processes and written protocols for the assessment and monitoring of adults in acute alcohol withdrawal in hospital.","Structure","QS11 - Alcohol-use disorders: diagnosis and management","4 - QS11 - Alcohol-use disorders: diagnosis and management",1,"4 - QS11 - Alcohol-use disorders: diagnosis and management - Structure - 1"]
[null,"QS11","Alcohol-use disorders: diagnosis and management",4,null,"Adults in acute alcohol withdrawal in hospital are assessed and monitored following locally specified protocols.","Proportion of adults in acute alcohol withdrawal in hospital assessed following locally specified protocols.","Process","QS11 - Alcohol-use disorders: diagnosis and management","4 - QS11 - Alcohol-use disorders: diagnosis and management",1,"4 - QS11 - Alcohol-use disorders: diagnosis and management - Process - 1","The number in the denominator who are assessed following locally specified protocols.","The number of adults in acute alcohol withdrawal in hospital."]
[null,"QS11","Alcohol-use disorders: diagnosis and management",4,null,"Adults in acute alcohol withdrawal in hospital are assessed and monitored following locally specified protocols.","Proportion of adults in acute alcohol withdrawal in hospital monitored following locally specified protocols.","Process","QS11 - Alcohol-use disorders: diagnosis and management","4 - QS11 - Alcohol-use disorders: diagnosis and management",2,"4 - QS11 - Alcohol-use disorders: diagnosis and management - Process - 2","The number in the denominator who are monitored following locally specified protocols.","The number of adults in acute alcohol withdrawal in hospital."]
[null,"QS11","Alcohol-use disorders: diagnosis and management",4,null,"Adults in acute alcohol withdrawal in hospital are assessed and monitored following locally specified protocols.","Rates of completed withdrawal from alcohol in hospital.","Outcome","QS11 - Alcohol-use disorders: diagnosis and management","4 - QS11 - Alcohol-use disorders: diagnosis and management",1,"4 - QS11 - Alcohol-use disorders: diagnosis and management - Outcome - 1"]
[null,"QS11","Alcohol-use disorders: diagnosis and management",5,null,"Adults with moderate or severe alcohol dependence are offered psychological and, if appropriate, pharmacological interventions to prevent relapse following a successful unplanned withdrawal in hospital.","Proportion of adults with moderate or severe alcohol dependence offered psychological interventions to prevent relapse following a successful unplanned withdrawal in hospital.","Process","QS11 - Alcohol-use disorders: diagnosis and management","5 - QS11 - Alcohol-use disorders: diagnosis and management",1,"5 - QS11 - Alcohol-use disorders: diagnosis and management - Process - 1","The number in the denominator who are offered psychological interventions to prevent relapse.","The number of adults with moderate or severe alcohol dependence who have had a successful unplanned withdrawal in hospital."]
[null,"QS11","Alcohol-use disorders: diagnosis and management",5,null,"Adults with moderate or severe alcohol dependence are offered psychological and, if appropriate, pharmacological interventions to prevent relapse following a successful unplanned withdrawal in hospital.","Proportion of adults with moderate or severe alcohol dependence offered pharmacological interventions to prevent relapse following a successful unplanned withdrawal in hospital.","Process","QS11 - Alcohol-use disorders: diagnosis and management","5 - QS11 - Alcohol-use disorders: diagnosis and management",2,"5 - QS11 - Alcohol-use disorders: diagnosis and management - Process - 2","The number in the denominator who are offered pharmacological interventions to prevent relapse.","The number of adults with moderate or severe alcohol dependence who have had a successful unplanned withdrawal in hospital."]
[null,"QS11","Alcohol-use disorders: diagnosis and management",5,null,"Adults with moderate or severe alcohol dependence are offered psychological and, if appropriate, pharmacological interventions to prevent relapse following a successful unplanned withdrawal in hospital.","Rates of relapse following unplanned withdrawal from alcohol dependence in hospital.","Outcome","QS11 - Alcohol-use disorders: diagnosis and management",{"$f":"CONCATENATE(D163, \" - \", I163)","v":"5 - QS11 - Alcohol-use disorders: diagnosis and management"},1,{"$f":"CONCATENATE(J163, \" - \", H163, \" - \",K163)","v":"5 - QS11 - Alcohol-use disorders: diagnosis and management - Outcome - 1"}]
[null,"QS12","Breast cancer ",1,null,"People with suspected breast cancer referred to specialist services are offered the triple diagnostic assessment in a single hospital visit.","Evidence of local arrangements to ensure that specialist services carry out the triple diagnostic assessment at a single hospital visit in people referred with suspected breast cancer.","Structure",{"$f":"CONCATENATE(B164, \" - \", C164)","v":"QS12 - Breast cancer "},"1 - QS12 - Breast cancer ",1,"1 - QS12 - Breast cancer  - Structure - 1"]
[null,"QS12","Breast cancer ",1,null,"People with suspected breast cancer referred to specialist services are offered the triple diagnostic assessment in a single hospital visit.","Proportion of people with suspected breast cancer referred to specialist services who receive the triple diagnostic assessment in a single visit.","Process","QS12 - Breast cancer ","1 - QS12 - Breast cancer ",1,"1 - QS12 - Breast cancer  - Process - 1","The number in the denominator who receive the triple diagnostic assessment in a single visit.","The number of people with suspected breast cancer referred to specialist services."]
[null,"QS12","Breast cancer ",1,null,"People with suspected breast cancer referred to specialist services are offered the triple diagnostic assessment in a single hospital visit.","Stage at diagnosis of breast cancer.","Outcome","QS12 - Breast cancer ","1 - QS12 - Breast cancer ",{"$f":"IF(AND(B166=B165, D166=D165, H166=H165)=TRUE, K165+1, 1)","v":1},"1 - QS12 - Breast cancer  - Outcome - 1"]
[null,"QS12","Breast cancer ",1,null,"People with suspected breast cancer referred to specialist services are offered the triple diagnostic assessment in a single hospital visit.","Breast cancer survival rates.","Outcome","QS12 - Breast cancer ","1 - QS12 - Breast cancer ",2,"1 - QS12 - Breast cancer  - Outcome - 2"]
[null,"QS12","Breast cancer ",2,null,"People with biopsy-proven invasive breast cancer or ductal carcinoma in situ (DCIS) are not offered a preoperative MRI scan unless there are specific clinical indications for its use.","Evidence of local arrangements to ensure that people with biopsy-proven invasive breast cancer or DCIS do not have an MRI scan for preoperative assessment unless there are specific clinical indications for its use.","Structure","QS12 - Breast cancer ","2 - QS12 - Breast cancer ",1,"2 - QS12 - Breast cancer  - Structure - 1"]
[null,"QS12","Breast cancer ",2,null,"People with biopsy-proven invasive breast cancer or ductal carcinoma in situ (DCIS) are not offered a preoperative MRI scan unless there are specific clinical indications for its use.","Proportion of MRI scans for preoperative assessment of people with biopsy-proven invasive breast cancer or DCIS in which there is a specific clinical indication for its use.","Process","QS12 - Breast cancer ","2 - QS12 - Breast cancer ",1,"2 - QS12 - Breast cancer  - Process - 1","The number in the denominator in which there is a specific clinical indication for preoperative MRI.","The number of MRI scans for preoperative assessment of people with biopsy-proven invasive breast cancer or DCIS."]
[null,"QS12","Breast cancer ",2,null,"People with biopsy-proven invasive breast cancer or ductal carcinoma in situ (DCIS) are not offered a preoperative MRI scan unless there are specific clinical indications for its use.","Patient satisfaction with preoperative treatment of people with biopsy-proven invasive breast cancer or DCIS.","Outcome","QS12 - Breast cancer ","2 - QS12 - Breast cancer ",1,"2 - QS12 - Breast cancer  - Outcome - 1"]
[null,"QS12","Breast cancer ",3,null,"People with oestrogen receptor-positive (ER-positive), human epidermal growth factor receptor 2-negative (HER2-negative) and lymph node-negative early breast cancer who are at intermediate risk of distant recurrence are offered gene expression profiling with Oncotype DX. ","Evidence of local arrangements to provide gene expression profiling with Oncotype DX for people with ER-positive, HER2-negative and lymph node-negative early breast cancer who are at intermediate risk of distant recurrence.","Structure","QS12 - Breast cancer ","3 - QS12 - Breast cancer ",1,"3 - QS12 - Breast cancer  - Structure - 1"]
[null,"QS12","Breast cancer ",3,null,"People with oestrogen receptor-positive (ER-positive), human epidermal growth factor receptor 2-negative (HER2-negative) and lymph node-negative early breast cancer who are at intermediate risk of distant recurrence are offered gene expression profiling with Oncotype DX. ","Proportion of people with ER-positive, HER2-negative and lymph node-negative early breast cancer who are at intermediate risk of distant recurrence who receive gene expression profiling with Oncotype DX.","Process","QS12 - Breast cancer ","3 - QS12 - Breast cancer ",1,"3 - QS12 - Breast cancer  - Process - 1","The number in the denominator who receive gene expression profiling with Oncotype DX.","The number of people with ER-positive, HER2-negative and lymph node-negative early breast cancer who are at intermediate risk of distant recurrence."]
[null,"QS12","Breast cancer ",3,null,"People with oestrogen receptor-positive (ER-positive), human epidermal growth factor receptor 2-negative (HER2-negative) and lymph node-negative early breast cancer who are at intermediate risk of distant recurrence are offered gene expression profiling with Oncotype DX. ","Breast cancer recurrence (distant and local).","Outcome","QS12 - Breast cancer ","3 - QS12 - Breast cancer ",1,"3 - QS12 - Breast cancer  - Outcome - 1"]
[null,"QS12","Breast cancer ",3,null,"People with oestrogen receptor-positive (ER-positive), human epidermal growth factor receptor 2-negative (HER2-negative) and lymph node-negative early breast cancer who are at intermediate risk of distant recurrence are offered gene expression profiling with Oncotype DX. ","Incidence of adverse events from chemotherapy. ","Outcome","QS12 - Breast cancer ","3 - QS12 - Breast cancer ",2,"3 - QS12 - Breast cancer  - Outcome - 2"]
[null,"QS12","Breast cancer ",3,null,"People with oestrogen receptor-positive (ER-positive), human epidermal growth factor receptor 2-negative (HER2-negative) and lymph node-negative early breast cancer who are at intermediate risk of distant recurrence are offered gene expression profiling with Oncotype DX. ","Mortality from breast cancer.","Outcome","QS12 - Breast cancer ",{"$f":"CONCATENATE(D175, \" - \", I175)","v":"3 - QS12 - Breast cancer "},{"$f":"IF(AND(B175=B174, D175=D174, H175=H174)=TRUE, K174+1, 1)","v":3},{"$f":"CONCATENATE(J175, \" - \", H175, \" - \",K175)","v":"3 - QS12 - Breast cancer  - Outcome - 3"}]
[null,"QS12","Breast cancer ",4,null,"People with newly diagnosed invasive breast cancer and those with recurrent breast cancer (if clinically appropriate) have the oestrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status of the tumour assessed. ","Evidence of local arrangements and written clinical protocols to ensure that people with newly diagnosed invasive breast cancer have the ER and HER2 status of the tumour assessed.","Structure",{"$f":"CONCATENATE(B176, \" - \", C176)","v":"QS12 - Breast cancer "},{"$f":"CONCATENATE(D176, \" - \", I176)","v":"4 - QS12 - Breast cancer "},{"$f":"IF(AND(B176=B175, D176=D175, H176=H175)=TRUE, K175+1, 1)","v":1},{"$f":"CONCATENATE(J176, \" - \", H176, \" - \",K176)","v":"4 - QS12 - Breast cancer  - Structure - 1"}]
[null,"QS12","Breast cancer ",4,null,"People with newly diagnosed invasive breast cancer and those with recurrent breast cancer (if clinically appropriate) have the oestrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status of the tumour assessed. ","Evidence of local arrangements and written clinical protocols to ensure that people with recurrent breast cancer have the ER and HER2 status of the tumour assessed, if clinically appropriate.","Structure","QS12 - Breast cancer ","4 - QS12 - Breast cancer ",2,"4 - QS12 - Breast cancer  - Structure - 2"]
[null,"QS12","Breast cancer ",4,null,"People with newly diagnosed invasive breast cancer and those with recurrent breast cancer (if clinically appropriate) have the oestrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status of the tumour assessed. ","Proportion of people with newly diagnosed invasive breast cancer who have the ER status of the tumour assessed.","Process","QS12 - Breast cancer ","4 - QS12 - Breast cancer ",1,"4 - QS12 - Breast cancer  - Process - 1","The number of people in the denominator who have the ER status of the tumour assessed.","The number of people with newly diagnosed invasive breast cancer."]
[null,"QS12","Breast cancer ",4,null,"People with newly diagnosed invasive breast cancer and those with recurrent breast cancer (if clinically appropriate) have the oestrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status of the tumour assessed. ","Proportion of people with newly diagnosed invasive breast cancer who have the HER2 status of the tumour assessed.","Process","QS12 - Breast cancer ","4 - QS12 - Breast cancer ",2,"4 - QS12 - Breast cancer  - Process - 2","The number of people in the denominator who have the HER2 status of the tumour assessed.","The number of people with newly diagnosed invasive breast cancer."]
[null,"QS12","Breast cancer ",4,null,"People with newly diagnosed invasive breast cancer and those with recurrent breast cancer (if clinically appropriate) have the oestrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status of the tumour assessed. ","Proportion of people with histologically confirmed recurrent breast cancer who have the ER status of the tumour assessed, if clinically appropriate.","Process","QS12 - Breast cancer ","4 - QS12 - Breast cancer ",3,"4 - QS12 - Breast cancer  - Process - 3","The number of people in the denominator who have the ER status of the tumour assessed, if clinically appropriate.","The number of people in the denominator who have the ER status of the tumour assessed, if clinically appropriate."]
[null,"QS12","Breast cancer ",4,null,"People with newly diagnosed invasive breast cancer and those with recurrent breast cancer (if clinically appropriate) have the oestrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status of the tumour assessed. ","Proportion of people with histologically confirmed recurrent breast cancer who have the HER2 status of the tumour assessed, if clinically appropriate.","Process","QS12 - Breast cancer ","4 - QS12 - Breast cancer ",4,"4 - QS12 - Breast cancer  - Process - 4","The number of people in the denominator who have the HER2 status of the tumour assessed, if clinically appropriate.","The number of people with histologically confirmed recurrent breast cancer."]
[null,"QS12","Breast cancer ",4,null,"People with newly diagnosed invasive breast cancer and those with recurrent breast cancer (if clinically appropriate) have the oestrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status of the tumour assessed. ","Breast cancer survival rates.","Outcome","QS12 - Breast cancer ","4 - QS12 - Breast cancer ",1,"4 - QS12 - Breast cancer  - Outcome - 1"]
[null,"QS12","Breast cancer ",5,null,"People with breast cancer who develop metastatic disease have their treatment and care managed by a multidisciplinary team.","Evidence of local arrangements to ensure that a multidisciplinary team manages the treatment and care of people with breast cancer who develop metastatic disease.","Structure",{"$f":"CONCATENATE(B183, \" - \", C183)","v":"QS12 - Breast cancer "},{"$f":"CONCATENATE(D183, \" - \", I183)","v":"5 - QS12 - Breast cancer "},{"$f":"IF(AND(B183=B182, D183=D182, H183=H182)=TRUE, K182+1, 1)","v":1},{"$f":"CONCATENATE(J183, \" - \", H183, \" - \",K183)","v":"5 - QS12 - Breast cancer  - Structure - 1"}]
[null,"QS12","Breast cancer ",5,null,"People with breast cancer who develop metastatic disease have their treatment and care managed by a multidisciplinary team.","Proportion of people with breast cancer who develop metastatic disease who have their treatment and care managed by a multidisciplinary team.","Process","QS12 - Breast cancer ","5 - QS12 - Breast cancer ",1,"5 - QS12 - Breast cancer  - Process - 1","The number in the denominator who have their treatment and care managed by a multidisciplinary team.","The number of people with breast cancer who develop metastatic disease."]
[null,"QS12","Breast cancer ",5,null,"People with breast cancer who develop metastatic disease have their treatment and care managed by a multidisciplinary team.","Breast cancer recurrence (distant and local).","Outcome","QS12 - Breast cancer ","5 - QS12 - Breast cancer ",1,"5 - QS12 - Breast cancer  - Outcome - 1"]
[null,"QS12","Breast cancer ",5,null,"People with breast cancer who develop metastatic disease have their treatment and care managed by a multidisciplinary team.","Incidence of adverse events from chemotherapy.","Outcome","QS12 - Breast cancer ","5 - QS12 - Breast cancer ",2,"5 - QS12 - Breast cancer  - Outcome - 2"]
[null,"QS12","Breast cancer ",5,null,"People with breast cancer who develop metastatic disease have their treatment and care managed by a multidisciplinary team.","Mortality from breast cancer.","Outcome","QS12 - Breast cancer ","5 - QS12 - Breast cancer ",3,"5 - QS12 - Breast cancer  - Outcome - 3"]
[null,"QS12","Breast cancer ",6,null,"People with locally advanced, metastatic or distant recurrent breast cancer are assigned a key worker.","Evidence of local arrangements to ensure that people with locally advanced, metastatic or distant recurrent breast cancer are assigned a key worker.","Structure",{"$f":"CONCATENATE(B188, \" - \", C188)","v":"QS12 - Breast cancer "},{"$f":"CONCATENATE(D188, \" - \", I188)","v":"6 - QS12 - Breast cancer "},{"$f":"IF(AND(B188=B187, D188=D187, H188=H187)=TRUE, K187+1, 1)","v":1},{"$f":"CONCATENATE(J188, \" - \", H188, \" - \",K188)","v":"6 - QS12 - Breast cancer  - Structure - 1"}]
[null,"QS12","Breast cancer ",6,null,"People with locally advanced, metastatic or distant recurrent breast cancer are assigned a key worker.","Proportion of people with locally advanced breast cancer with an assigned key worker.","Process","QS12 - Breast cancer ","6 - QS12 - Breast cancer ",1,"6 - QS12 - Breast cancer  - Process - 1","The number in the denominator with an assigned key worker.","The number of people with locally advanced breast cancer."]
[null,"QS12","Breast cancer ",6,null,"People with locally advanced, metastatic or distant recurrent breast cancer are assigned a key worker.","Proportion of people with metastatic breast cancer with an assigned key worker.","Process","QS12 - Breast cancer ","6 - QS12 - Breast cancer ",2,"6 - QS12 - Breast cancer  - Process - 2","The number in the denominator with an assigned key worker.","The number of people with metastatic breast cancer."]
[null,"QS12","Breast cancer ",6,null,"People with locally advanced, metastatic or distant recurrent breast cancer are assigned a key worker.","Proportion of people with distant recurrent breast cancer with an assigned key worker.","Process","QS12 - Breast cancer ","6 - QS12 - Breast cancer ",3,"6 - QS12 - Breast cancer  - Process - 3","The number in the denominator with an assigned key worker.","The number of people with distant recurrent breast cancer."]
[null,"QS12","Breast cancer ",6,null,"People with locally advanced, metastatic or distant recurrent breast cancer are assigned a key worker.","Patient satisfaction with information and support received throughout their care for breast cancer.","Outcome","QS12 - Breast cancer ","6 - QS12 - Breast cancer ",1,"6 - QS12 - Breast cancer  - Outcome - 1"]
[null,"QS13","End of life care for adults",1,null,"Adults who are likely to be approaching the end of their life are identified using a systematic approach.","Evidence of local systems established to systematically identify adults who are likely to be approaching the end of their life.","Structure",{"$f":"CONCATENATE(B193, \" - \", C193)","v":"QS13 - End of life care for adults"},{"$f":"CONCATENATE(D193, \" - \", I193)","v":"1 - QS13 - End of life care for adults"},1,{"$f":"CONCATENATE(J193, \" - \", H193, \" - \",K193)","v":"1 - QS13 - End of life care for adults - Structure - 1"},"",""]
[null,"QS13","End of life care for adults",1,null,"Adults who are likely to be approaching the end of their life are identified using a systematic approach.","The proportion of adults who have died with progressive life-limiting conditions who were on the palliative care register or had evidence of end of life care planning.","Outcome","QS13 - End of life care for adults","1 - QS13 - End of life care for adults",1,"1 - QS13 - End of life care for adults - Outcome - 1","The number in the denominator who were on the palliative care register or had evidence of end of life care planning","The number of adults who have died with progressive life-limiting conditions."]
[null,"QS13","End of life care for adults",2,null,"Adults approaching the end of their life have opportunities to discuss advance care planning."," Evidence of local arrangements to ensure that adults approaching the end of their life have opportunities to discuss advance care planning.","Structure","QS13 - End of life care for adults","2 - QS13 - End of life care for adults",1,"2 - QS13 - End of life care for adults - Structure - 1"]
[null,"QS13","End of life care for adults",2,null,"Adults approaching the end of their life have opportunities to discuss advance care planning."," Evidence of local arrangements to ensure that advance care planning for adults approaching the end of their life takes into account their holistic needs assessment.","Structure","QS13 - End of life care for adults","2 - QS13 - End of life care for adults",2,"2 - QS13 - End of life care for adults - Structure - 2"]
[null,"QS13","End of life care for adults",2,null,"Adults approaching the end of their life have opportunities to discuss advance care planning.","Proportion of adults approaching the end of their life who have documented discussions about advance care planning.","Process","QS13 - End of life care for adults","2 - QS13 - End of life care for adults",1,"2 - QS13 - End of life care for adults - Process - 1","The number in the denominator who have documented discussions about advance care planning.","The number of adults approaching the end of their life."]
[null,"QS13","End of life care for adults",2,null,"Adults approaching the end of their life have opportunities to discuss advance care planning.","Proportion of adults approaching the end of their life whose documented advance care plan takes into account their holistic needs assessment.","Process","QS13 - End of life care for adults","2 - QS13 - End of life care for adults",2,"2 - QS13 - End of life care for adults - Process - 2","The number in the denominator whose documented advance care plan takes into account their holistic needs assessment.","The number of adults approaching the end of their life who have a documented advance care plan."]
[null,"QS13","End of life care for adults",2,null,"Adults approaching the end of their life have opportunities to discuss advance care planning.","Satisfaction of adults approaching the end of their life with the support they receive to plan their future care.","Outcome","QS13 - End of life care for adults","2 - QS13 - End of life care for adults",1,"2 - QS13 - End of life care for adults - Outcome - 1","The number in the denominator who are satisfied with the support they receive to plan their future care.","The number of adults approaching the end of their life."]
[null,"QS13","End of life care for adults",3,null,"Adults approaching the end of their life receive care that is coordinated between health and social care practitioners within and across different services and organisations.","Evidence of local processes to coordinate end of life care.","Structure","QS13 - End of life care for adults","3 - QS13 - End of life care for adults",1,"3 - QS13 - End of life care for adults - Structure - 1"]
[null,"QS13","End of life care for adults",3,null,"Adults approaching the end of their life receive care that is coordinated between health and social care practitioners within and across different services and organisations.","Evidence of local arrangements for relevant information about adults approaching the end of their life to be shared with the members of the multipractitioner team involved in their care.","Structure","QS13 - End of life care for adults","3 - QS13 - End of life care for adults",2,"3 - QS13 - End of life care for adults - Structure - 2"]
[null,"QS13","End of life care for adults",3,null,"Adults approaching the end of their life receive care that is coordinated between health and social care practitioners within and across different services and organisations.","Proportion of adults approaching the end of their life whose advance care plan is shared with the practitioners involved in their care.","Process","QS13 - End of life care for adults","3 - QS13 - End of life care for adults",1,"3 - QS13 - End of life care for adults - Process - 1","The number in the denominator whose advance care plan is shared with the practitioners involved in their care.","The number of adults approaching the end of their life who have an advance care plan."]
[null,"QS13","End of life care for adults",3,null,"Adults approaching the end of their life receive care that is coordinated between health and social care practitioners within and across different services and organisations.","Proportion of adults approaching the end of their life whose care is coordinated through the multipractitioner team.","Process","QS13 - End of life care for adults","3 - QS13 - End of life care for adults",2,"3 - QS13 - End of life care for adults - Process - 2","The number in the denominator whose care is coordinated through the multipractitioner team.","The number of adults approaching the end of their life."]
[null,"QS13","End of life care for adults",3,null,"Adults approaching the end of their life receive care that is coordinated between health and social care practitioners within and across different services and organisations.","Proportion of adults approaching the end of their life who are cared for in their preferred place.","Outcome","QS13 - End of life care for adults","3 - QS13 - End of life care for adults",1,"3 - QS13 - End of life care for adults - Outcome - 1","The number in the denominator who are cared for in their preferred place.","The number of adults approaching the end of their life."]
[null,"QS13","End of life care for adults",3,null,"Adults approaching the end of their life receive care that is coordinated between health and social care practitioners within and across different services and organisations.","Proportion of adults who were identified as approaching the end of their life who had an unplanned admission to hospital.","Outcome","QS13 - End of life care for adults","3 - QS13 - End of life care for adults",2,"3 - QS13 - End of life care for adults - Outcome - 2","The number in the denominator who had an unplanned admission to hospital.","The number of adults identified as approaching the end of their life."]
[null,"QS13","End of life care for adults",3,null,"Adults approaching the end of their life receive care that is coordinated between health and social care practitioners within and across different services and organisations.","Proportion of adults who were identified as approaching the end of their life who died in their preferred place.","Outcome","QS13 - End of life care for adults","3 - QS13 - End of life care for adults",3,"3 - QS13 - End of life care for adults - Outcome - 3","The number in the denominator who died in their preferred place.","The number of adults identified as approaching the end of their life who have died."]
[null,"QS13","End of life care for adults",4,null,"Adults approaching the end of their life and their carers have access to support 24 hours a day, 7 days a week.","Evidence of local arrangements to ensure that adults approaching the end of their life have access to support 24 hours a day, 7 days a week.","Structure","QS13 - End of life care for adults",{"$f":"CONCATENATE(D207, \" - \", I207)","v":"4 - QS13 - End of life care for adults"},1,{"$f":"CONCATENATE(J207, \" - \", H207, \" - \",K207)","v":"4 - QS13 - End of life care for adults - Structure - 1"}]
[null,"QS13","End of life care for adults",4,null,"Adults approaching the end of their life and their carers have access to support 24 hours a day, 7 days a week.","Proportion of adults approaching the end of their life who have access to a healthcare professional 24 hours a day, 7 days a week.","Process","QS13 - End of life care for adults","4 - QS13 - End of life care for adults",1,"4 - QS13 - End of life care for adults - Process - 1","The number in the denominator who have access to a healthcare professional 24 hours a day, 7 days a week.","The number of adults approaching the end of their life."]
[null,"QS13","End of life care for adults",4,null,"Adults approaching the end of their life and their carers have access to support 24 hours a day, 7 days a week.","Proportion of adults approaching the end of their life who have access to an out-of-hours end of life care advice line.","Process","QS13 - End of life care for adults","4 - QS13 - End of life care for adults",2,"4 - QS13 - End of life care for adults - Process - 2","The number in the denominator who have access to an out-of-hours end of life care advice line.","The number of adults approaching the end of their life."]
[null,"QS13","End of life care for adults",4,null,"Adults approaching the end of their life and their carers have access to support 24 hours a day, 7 days a week.","Proportion of adults approaching the end of their life who have access to an out-of-hours pharmacy service that has access to medicines for symptom management in adults approaching the end of their life.","Process","QS13 - End of life care for adults","4 - QS13 - End of life care for adults",3,"4 - QS13 - End of life care for adults - Process - 3","The number in the denominator who have access to an out-of-hours pharmacy service that has access to medicines for symptom management in adults approaching the end of their life.","The number of adults approaching the end of their life."]
[null,"QS13","End of life care for adults",4,null,"Adults approaching the end of their life and their carers have access to support 24 hours a day, 7 days a week.","Emergency hospital admissions in the 3 months before death.","Outcome",{"$f":"CONCATENATE(B211, \" - \", C211)","v":"QS13 - End of life care for adults"},"4 - QS13 - End of life care for adults",1,"4 - QS13 - End of life care for adults - Outcome - 1"]
[null,"QS13","End of life care for adults",4,null,"Adults approaching the end of their life and their carers have access to support 24 hours a day, 7 days a week.","Satisfaction of the person approaching the end of their life, and their carers if appropriate, with the support available.","Outcome","QS13 - End of life care for adults","4 - QS13 - End of life care for adults",2,"4 - QS13 - End of life care for adults - Outcome - 2"]
[null,"QS13","End of life care for adults",5,null,"Carers providing end of life care to people at home are supported to access local services that can provide assistance.","Evidence that local services are in place to support carers providing end of life care to people at home.","Structure","QS13 - End of life care for adults","5 - QS13 - End of life care for adults",1,"5 - QS13 - End of life care for adults - Structure - 1"]
[null,"QS13","End of life care for adults",5,null,"Carers providing end of life care to people at home are supported to access local services that can provide assistance.","Evidence that carers can access support services.","Structure","QS13 - End of life care for adults","5 - QS13 - End of life care for adults",2,"5 - QS13 - End of life care for adults - Structure - 2"]
[null,"QS13","End of life care for adults",5,null,"Carers providing end of life care to people at home are supported to access local services that can provide assistance.","Proportion of carers providing end of life care to people at home who are supported to access local services that can provide assistance.","Process","QS13 - End of life care for adults","5 - QS13 - End of life care for adults",1,"5 - QS13 - End of life care for adults - Process - 1","The number in the denominator who are supported to access local services that can provide assistance.","The number of carers providing end of life care to people at home."]
[null,"QS13","End of life care for adults",5,null,"Carers providing end of life care to people at home are supported to access local services that can provide assistance.","Proportion of carers providing end of life care to people at home who are satisfied with the support they receive.","Outcome","QS13 - End of life care for adults","5 - QS13 - End of life care for adults",1,"5 - QS13 - End of life care for adults - Outcome - 1","The number in the denominator who are satisfied with the support they receive.","The number of carers providing end of life care to people at home."]
[null,"QS13","End of life care for adults",5,null,"Carers providing end of life care to people at home are supported to access local services that can provide assistance.","Carers' quality of life.","Outcome","QS13 - End of life care for adults","5 - QS13 - End of life care for adults",2,"5 - QS13 - End of life care for adults - Outcome - 2"]
[null,"QS14","Service user experience in adult mental health services",1,null,"People using mental health services are treated with empathy, dignity and respect. [2011, updated 2019]","Evidence of local arrangements to ensure that mental health and social care professionals treat people using mental health services with empathy, dignity and respect.","Structure",{"$f":"CONCATENATE(B218, \" - \", C218)","v":"QS14 - Service user experience in adult mental health services"},{"$f":"CONCATENATE(D218, \" - \", I218)","v":"1 - QS14 - Service user experience in adult mental health services"},{"$f":"IF(AND(B218=B217, D218=D217, H218=H217)=TRUE, K217+1, 1)","v":1},{"$f":"CONCATENATE(J218, \" - \", H218, \" - \",K218)","v":"1 - QS14 - Service user experience in adult mental health services - Structure - 1"}]
[null,"QS14","Service user experience in adult mental health services",1,null,"People using mental health services are treated with empathy, dignity and respect. [2011, updated 2019]","Evidence of local arrangements to ensure that a strategy is developed with other local organisations to combat stigma in the community and the NHS associated with mental health problems.","Structure","QS14 - Service user experience in adult mental health services","1 - QS14 - Service user experience in adult mental health services",2,"1 - QS14 - Service user experience in adult mental health services - Structure - 2"]
[null,"QS14","Service user experience in adult mental health services",1,null,"People using mental health services are treated with empathy, dignity and respect. [2011, updated 2019]","Proportion of people who felt they were treated with respect and dignity by NHS mental health services in the past 12 months.","Process","QS14 - Service user experience in adult mental health services","1 - QS14 - Service user experience in adult mental health services",1,"1 - QS14 - Service user experience in adult mental health services - Process - 1","The number in the denominator who felt that they were treated with respect and dignity by NHS mental health services in the past 12 months.","The number of people receiving care from NHS mental health services in the past 12 months."]
[null,"QS14","Service user experience in adult mental health services",1,null,"People using mental health services are treated with empathy, dignity and respect. [2011, updated 2019]","Evidence from experience surveys and feedback that people using mental health services feel they are treated with empathy, dignity and respect.","Outcome","QS14 - Service user experience in adult mental health services","1 - QS14 - Service user experience in adult mental health services",{"$f":"IF(AND(B221=B220, D221=D220, H221=H220)=TRUE, K220+1, 1)","v":1},"1 - QS14 - Service user experience in adult mental health services - Outcome - 1"]
[null,"QS14","Service user experience in adult mental health services",1,null,"People using mental health services are treated with empathy, dignity and respect. [2011, updated 2019]","Evidence from experience surveys and feedback that people using mental health services feel less stigmatised in the community and NHS.","Outcome","QS14 - Service user experience in adult mental health services","1 - QS14 - Service user experience in adult mental health services",2,"1 - QS14 - Service user experience in adult mental health services - Outcome - 2"]
[null,"QS14","Service user experience in adult mental health services",2,null,"People using mental health services are supported in shared decision making. [2011, updated 2019]","Evidence of local arrangements to ensure that people being assessed by mental health services are given information and have their care explained so they understand the assessment process, their diagnosis and treatment options.","Structure","QS14 - Service user experience in adult mental health services","2 - QS14 - Service user experience in adult mental health services",1,"2 - QS14 - Service user experience in adult mental health services - Structure - 1"]
[null,"QS14","Service user experience in adult mental health services",2,null,"People using mental health services are supported in shared decision making. [2011, updated 2019]","Evidence of local arrangements to ensure that people using mental health services, including people formally detained under the Mental Health Act, are supported in shared decision making.","Structure","QS14 - Service user experience in adult mental health services","2 - QS14 - Service user experience in adult mental health services",2,"2 - QS14 - Service user experience in adult mental health services - Structure - 2"]
[null,"QS14","Service user experience in adult mental health services",2,null,"People using mental health services are supported in shared decision making. [2011, updated 2019]","Evidence from experience surveys and feedback that people being assessed by mental health services understand the assessment process, their diagnosis and treatment options.","Outcome","QS14 - Service user experience in adult mental health services","2 - QS14 - Service user experience in adult mental health services",1,"2 - QS14 - Service user experience in adult mental health services - Outcome - 1"]
[null,"QS14","Service user experience in adult mental health services",2,null,"People using mental health services are supported in shared decision making. [2011, updated 2019]","Evidence from experience surveys and feedback that people using mental health services, including people formally detained under the Mental Health Act, feel supported in shared decision making.","Outcome","QS14 - Service user experience in adult mental health services","2 - QS14 - Service user experience in adult mental health services",2,"2 - QS14 - Service user experience in adult mental health services - Outcome - 2"]
[null,"QS14","Service user experience in adult mental health services",2,null,"People using mental health services are supported in shared decision making. [2011, updated 2019]","Evidence from experience surveys and feedback that people using mental health services feel optimistic that their care will be effective.","Outcome","QS14 - Service user experience in adult mental health services","2 - QS14 - Service user experience in adult mental health services",3,"2 - QS14 - Service user experience in adult mental health services - Outcome - 3"]
[null,"QS14","Service user experience in adult mental health services",3,null,"People using mental health services are asked about their experiences and their feedback is used to improve services. [2011]","Evidence of local arrangements to collect and use the views of people who use mental health services to monitor and improve performance.","Structure","QS14 - Service user experience in adult mental health services","3 - QS14 - Service user experience in adult mental health services",1,"3 - QS14 - Service user experience in adult mental health services - Structure - 1"]
[null,"QS14","Service user experience in adult mental health services",3,null,"People using mental health services are asked about their experiences and their feedback is used to improve services. [2011]","Evidence of local arrangements to involve people who use mental health services in monitoring services; for example, using exit interviews undertaken by people who have used services.","Structure","QS14 - Service user experience in adult mental health services","3 - QS14 - Service user experience in adult mental health services",2,"3 - QS14 - Service user experience in adult mental health services - Structure - 2"]
[null,"QS14","Service user experience in adult mental health services",3,null,"People using mental health services are asked about their experiences and their feedback is used to improve services. [2011]","Evidence of local arrangements to provide the executive board with reports on acute and non-acute mental health pathways, with a breakdown of people's experience of care according to gender, sexual orientation, socioeconomic status, age, background (including cultural, ethnic and religious background) and disability.","Structure","QS14 - Service user experience in adult mental health services","3 - QS14 - Service user experience in adult mental health services",3,"3 - QS14 - Service user experience in adult mental health services - Structure - 3"]
[null,"QS14","Service user experience in adult mental health services",3,null,"People using mental health services are asked about their experiences and their feedback is used to improve services. [2011]","Evidence from surveys and feedback that people using mental health services feel that their views are being used to improve services.","Outcome","QS14 - Service user experience in adult mental health services","3 - QS14 - Service user experience in adult mental health services",1,"3 - QS14 - Service user experience in adult mental health services - Outcome - 1"]
[null,"QS14","Service user experience in adult mental health services",4,null,"People using mental health services understand the roles of the members of their multidisciplinary team and know how to contact them about their ongoing healthcare needs. [2011]","Evidence of local arrangements to ensure continuity of support for people using mental health services.","Structure","QS14 - Service user experience in adult mental health services","4 - QS14 - Service user experience in adult mental health services",1,"4 - QS14 - Service user experience in adult mental health services - Structure - 1"]
[null,"QS14","Service user experience in adult mental health services",4,null,"People using mental health services understand the roles of the members of their multidisciplinary team and know how to contact them about their ongoing healthcare needs. [2011]","Evidence of local arrangements to ensure people using mental health services are given information on the roles of the people involved in their care and how to contact them.","Structure","QS14 - Service user experience in adult mental health services","4 - QS14 - Service user experience in adult mental health services",2,"4 - QS14 - Service user experience in adult mental health services - Structure - 2"]
[null,"QS14","Service user experience in adult mental health services",4,null,"People using mental health services understand the roles of the members of their multidisciplinary team and know how to contact them about their ongoing healthcare needs. [2011]","Evidence from experience surveys and feedback that people using mental health services understand the roles of the multidisciplinary team members and know how to contact them.","Outcome","QS14 - Service user experience in adult mental health services","4 - QS14 - Service user experience in adult mental health services",1,"4 - QS14 - Service user experience in adult mental health services - Outcome - 1"]
[null,"QS14","Service user experience in adult mental health services",5,null,"People can access mental health services, including crisis support, when they need them. [2011, updated 2019]","Evidence of local arrangements to ensure agreed referral methods are in place between primary, community and secondary care services.","Structure","QS14 - Service user experience in adult mental health services","5 - QS14 - Service user experience in adult mental health services",1,"5 - QS14 - Service user experience in adult mental health services - Structure - 1"]
[null,"QS14","Service user experience in adult mental health services",5,null,"People can access mental health services, including crisis support, when they need them. [2011, updated 2019]","Evidence of local arrangements to ensure people have access to a local 24-hour helpline staffed by mental health and social care professionals.","Structure","QS14 - Service user experience in adult mental health services","5 - QS14 - Service user experience in adult mental health services",2,"5 - QS14 - Service user experience in adult mental health services - Structure - 2"]
[null,"QS14","Service user experience in adult mental health services",5,null,"People can access mental health services, including crisis support, when they need them. [2011, updated 2019]","Evidence of local arrangements to ensure crisis resolution and home treatment teams are accessible 24 hours a day, 7 days a week, regardless of diagnosis.","Structure","QS14 - Service user experience in adult mental health services","5 - QS14 - Service user experience in adult mental health services",3,"5 - QS14 - Service user experience in adult mental health services - Structure - 3"]
[null,"QS14","Service user experience in adult mental health services",5,null,"People can access mental health services, including crisis support, when they need them. [2011, updated 2019]","Evidence of local arrangements to ensure that people accessing crisis support have a comprehensive assessment, including a crisis plan.","Structure","QS14 - Service user experience in adult mental health services","5 - QS14 - Service user experience in adult mental health services",4,"5 - QS14 - Service user experience in adult mental health services - Structure - 4"]
[null,"QS14","Service user experience in adult mental health services",5,null,"People can access mental health services, including crisis support, when they need them. [2011, updated 2019]","Proportion of people with a non-acute referral to mental health services who had a face-to-face appointment that took place within 3 weeks of referral (or within 2 weeks of any change of date).","Process","QS14 - Service user experience in adult mental health services","5 - QS14 - Service user experience in adult mental health services",1,"5 - QS14 - Service user experience in adult mental health services - Process - 1","The number of people in the denominator who had a face-to-face appointment that took place within 3 weeks of referral (or within 2 weeks of any change of date).","The number of people with a non-acute referral to mental health services."]
[null,"QS14","Service user experience in adult mental health services",5,null,"People can access mental health services, including crisis support, when they need them. [2011, updated 2019]","Proportion of people being assessed by mental health services who were seen within 20 minutes of the agreed appointment time.","Process","QS14 - Service user experience in adult mental health services","5 - QS14 - Service user experience in adult mental health services",2,"5 - QS14 - Service user experience in adult mental health services - Process - 2","The number of people in the denominator who were seen within 20 minutes of the agreed appointment time.","The number of people with an agreed appointment time for a mental health assessment."]
[null,"QS14","Service user experience in adult mental health services",5,null,"People can access mental health services, including crisis support, when they need them. [2011, updated 2019]","Proportion of people in crisis referred to specialist mental health services who were seen within 4 hours.","Process","QS14 - Service user experience in adult mental health services","5 - QS14 - Service user experience in adult mental health services",3,"5 - QS14 - Service user experience in adult mental health services - Process - 3","The number of people in the denominator who were seen within 4 hours.","The number of people in crisis referred to specialist mental health services."]
[null,"QS14","Service user experience in adult mental health services",5,null,"People can access mental health services, including crisis support, when they need them. [2011, updated 2019]","Proportion of people admitted to a 'place of safety' who were assessed under the Mental Health Act within 4 hours.","Process","QS14 - Service user experience in adult mental health services","5 - QS14 - Service user experience in adult mental health services",4,"5 - QS14 - Service user experience in adult mental health services - Process - 4","The number of people in the denominator who were assessed under the Mental Health Act within 4 hours.","The number of people admitted to a 'place of safety'."]
[null,"QS14","Service user experience in adult mental health services",5,null,"People can access mental health services, including crisis support, when they need them. [2011, updated 2019]","Proportion of people accessing crisis support who have a comprehensive assessment.","Process","QS14 - Service user experience in adult mental health services",{"$f":"CONCATENATE(D243, \" - \", I243)","v":"5 - QS14 - Service user experience in adult mental health services"},5,{"$f":"CONCATENATE(J243, \" - \", H243, \" - \",K243)","v":"5 - QS14 - Service user experience in adult mental health services - Process - 5"},"The number of people in the denominator who have a comprehensive assessment.","The number of people accessing crisis support."]
[null,"QS14","Service user experience in adult mental health services",5,null,"People can access mental health services, including crisis support, when they need them. [2011, updated 2019]","Evidence from experience surveys and feedback that people can access a local helpline 24 hours a day.","Outcome","QS14 - Service user experience in adult mental health services","5 - QS14 - Service user experience in adult mental health services",1,"5 - QS14 - Service user experience in adult mental health services - Outcome - 1"]
[null,"QS14","Service user experience in adult mental health services",5,null,"People can access mental health services, including crisis support, when they need them. [2011, updated 2019]","Evidence from experience surveys and feedback that people accessing crisis support were asked about their relationships, their social and living circumstances and level of functioning, as well as their symptoms, behaviour, diagnosis and current treatment.","Outcome","QS14 - Service user experience in adult mental health services","5 - QS14 - Service user experience in adult mental health services",2,"5 - QS14 - Service user experience in adult mental health services - Outcome - 2"]
[null,"QS14","Service user experience in adult mental health services",6,null,"People using mental health services jointly agree a care plan with health and social care professionals, including a crisis plan if they may be at risk of crisis. [2011, updated 2019]","Evidence of local arrangements to ensure that people using mental health services jointly develop a care plan with mental health and social care professionals.","Structure","QS14 - Service user experience in adult mental health services","6 - QS14 - Service user experience in adult mental health services",1,"6 - QS14 - Service user experience in adult mental health services - Structure - 1"]
[null,"QS14","Service user experience in adult mental health services",6,null,"People using mental health services jointly agree a care plan with health and social care professionals, including a crisis plan if they may be at risk of crisis. [2011, updated 2019]","Evidence of local arrangements to ensure that people using mental health services are given a copy of their care plan.","Structure","QS14 - Service user experience in adult mental health services","6 - QS14 - Service user experience in adult mental health services",2,"6 - QS14 - Service user experience in adult mental health services - Structure - 2"]
[null,"QS14","Service user experience in adult mental health services",6,null,"People using mental health services jointly agree a care plan with health and social care professionals, including a crisis plan if they may be at risk of crisis. [2011, updated 2019]","Evidence of local arrangements to ensure that people using mental health services have an agreed date to review their care plan.","Structure",{"$f":"CONCATENATE(B248, \" - \", C248)","v":"QS14 - Service user experience in adult mental health services"},"6 - QS14 - Service user experience in adult mental health services",3,"6 - QS14 - Service user experience in adult mental health services - Structure - 3"]
[null,"QS14","Service user experience in adult mental health services",6,null,"People using mental health services jointly agree a care plan with health and social care professionals, including a crisis plan if they may be at risk of crisis. [2011, updated 2019]","Evidence of local arrangements to ensure that people using mental health services who may be at risk of crisis jointly develop a crisis plan with mental health and social care professionals.","Structure","QS14 - Service user experience in adult mental health services","6 - QS14 - Service user experience in adult mental health services",4,"6 - QS14 - Service user experience in adult mental health services - Structure - 4"]
[null,"QS14","Service user experience in adult mental health services",6,null,"People using mental health services jointly agree a care plan with health and social care professionals, including a crisis plan if they may be at risk of crisis. [2011, updated 2019]","Proportion of people using mental health services who have a jointly agreed care plan with mental health and social care professionals.","Process","QS14 - Service user experience in adult mental health services","6 - QS14 - Service user experience in adult mental health services",1,"6 - QS14 - Service user experience in adult mental health services - Process - 1","The number of people in the denominator who have a jointly agreed care plan with mental health and social care professionals.","The number of people using mental health services."]
[null,"QS14","Service user experience in adult mental health services",6,null,"People using mental health services jointly agree a care plan with health and social care professionals, including a crisis plan if they may be at risk of crisis. [2011, updated 2019]","Proportion of people using mental health services given a copy of their care plan.","Process","QS14 - Service user experience in adult mental health services","6 - QS14 - Service user experience in adult mental health services",2,"6 - QS14 - Service user experience in adult mental health services - Process - 2","The number of people in the denominator given a copy of their care plan.","The number of people using mental health services with a care plan."]
[null,"QS14","Service user experience in adult mental health services",6,null,"People using mental health services jointly agree a care plan with health and social care professionals, including a crisis plan if they may be at risk of crisis. [2011, updated 2019]","Proportion of people using mental health services with an agreed date to review their care plan.","Process","QS14 - Service user experience in adult mental health services","6 - QS14 - Service user experience in adult mental health services",3,"6 - QS14 - Service user experience in adult mental health services - Process - 3","The number of people in the denominator with an agreed date to review their care plan.","the number of people using mental health services with a care plan."]
[null,"QS14","Service user experience in adult mental health services",6,null,"People using mental health services jointly agree a care plan with health and social care professionals, including a crisis plan if they may be at risk of crisis. [2011, updated 2019]","Proportion of people using mental health services who may be at risk of crisis who have a crisis plan.","Process","QS14 - Service user experience in adult mental health services","6 - QS14 - Service user experience in adult mental health services",4,"6 - QS14 - Service user experience in adult mental health services - Process - 4","The number of people in the denominator who have a crisis plan.","The number of people using mental health services who may be at risk of crisis."]
[null,"QS14","Service user experience in adult mental health services",6,null,"People using mental health services jointly agree a care plan with health and social care professionals, including a crisis plan if they may be at risk of crisis. [2011, updated 2019]","Evidence from experience surveys and feedback that people using mental health services jointly developed a care plan with mental health and social care professionals.","Outcome","QS14 - Service user experience in adult mental health services","6 - QS14 - Service user experience in adult mental health services",1,"6 - QS14 - Service user experience in adult mental health services - Outcome - 1"]
[null,"QS14","Service user experience in adult mental health services",6,null,"People using mental health services jointly agree a care plan with health and social care professionals, including a crisis plan if they may be at risk of crisis. [2011, updated 2019]","Evidence from experience surveys and feedback that people using mental health services were given a copy of their care plan.","Outcome","QS14 - Service user experience in adult mental health services","6 - QS14 - Service user experience in adult mental health services",2,"6 - QS14 - Service user experience in adult mental health services - Outcome - 2"]
[null,"QS14","Service user experience in adult mental health services",6,null,"People using mental health services jointly agree a care plan with health and social care professionals, including a crisis plan if they may be at risk of crisis. [2011, updated 2019]","Evidence from experience surveys and feedback that people using mental health services have an agreed date to review their care plan.","Outcome","QS14 - Service user experience in adult mental health services","6 - QS14 - Service user experience in adult mental health services",3,"6 - QS14 - Service user experience in adult mental health services - Outcome - 3"]
[null,"QS14","Service user experience in adult mental health services",6,null,"People using mental health services jointly agree a care plan with health and social care professionals, including a crisis plan if they may be at risk of crisis. [2011, updated 2019]","Evidence from experience surveys and feedback that people using mental health services who may be at risk of crisis jointly develop a crisis plan with mental health and social care professionals.","Outcome","QS14 - Service user experience in adult mental health services","6 - QS14 - Service user experience in adult mental health services",4,"6 - QS14 - Service user experience in adult mental health services - Outcome - 4"]
[null,"QS14","Service user experience in adult mental health services",7,null,"People in hospital for mental health care have daily one-to-one contact with mental healthcare professionals known to them and regularly see other members of the multidisciplinary mental healthcare team. [2011]","Evidence of local arrangements to ensure that people staying in hospital can see a known mental healthcare professional on a one-to-one basis every day for at least 1 hour.","Structure","QS14 - Service user experience in adult mental health services","7 - QS14 - Service user experience in adult mental health services",1,"7 - QS14 - Service user experience in adult mental health services - Structure - 1"]
[null,"QS14","Service user experience in adult mental health services",7,null,"People in hospital for mental health care have daily one-to-one contact with mental healthcare professionals known to them and regularly see other members of the multidisciplinary mental healthcare team. [2011]","Evidence of local arrangements to ensure that people staying in hospital can see their consultant on a one-to-one basis at least once a week for at least 20 minutes.","Structure","QS14 - Service user experience in adult mental health services","7 - QS14 - Service user experience in adult mental health services",2,"7 - QS14 - Service user experience in adult mental health services - Structure - 2"]
[null,"QS14","Service user experience in adult mental health services",7,null,"People in hospital for mental health care have daily one-to-one contact with mental healthcare professionals known to them and regularly see other members of the multidisciplinary mental healthcare team. [2011]","Evidence of local arrangements to ensure that people staying in hospital are given an opportunity to meet a specialist mental health pharmacist.","Structure","QS14 - Service user experience in adult mental health services","7 - QS14 - Service user experience in adult mental health services",3,"7 - QS14 - Service user experience in adult mental health services - Structure - 3"]
[null,"QS14","Service user experience in adult mental health services",7,null,"People in hospital for mental health care have daily one-to-one contact with mental healthcare professionals known to them and regularly see other members of the multidisciplinary mental healthcare team. [2011]",null,"Process","QS14 - Service user experience in adult mental health services","7 - QS14 - Service user experience in adult mental health services",1,"7 - QS14 - Service user experience in adult mental health services - Process - 1","The number of people in the denominator who saw a mental healthcare professional known to the person using services on a one-to-one basis every day for at least 1 hour.","The number of people admitted as inpatients to mental health services."]
[null,"QS14","Service user experience in adult mental health services",7,null,"People in hospital for mental health care have daily one-to-one contact with mental healthcare professionals known to them and regularly see other members of the multidisciplinary mental healthcare team. [2011]",null,"Process","QS14 - Service user experience in adult mental health services","7 - QS14 - Service user experience in adult mental health services",2,"7 - QS14 - Service user experience in adult mental health services - Process - 2","The number of people in the denominator who saw their consultant on a one-to-one basis at least once a week for at least 20 minutes.","The number of people admitted as inpatients to mental health services."]
[null,"QS14","Service user experience in adult mental health services",7,null,"People in hospital for mental health care have daily one-to-one contact with mental healthcare professionals known to them and regularly see other members of the multidisciplinary mental healthcare team. [2011]",null,"Process","QS14 - Service user experience in adult mental health services","7 - QS14 - Service user experience in adult mental health services",3,"7 - QS14 - Service user experience in adult mental health services - Process - 3","The number of people in the denominator who saw a specialist mental health pharmacist.","The number of people admitted as inpatients to mental health services."]
[null,"QS14","Service user experience in adult mental health services",7,null,"People in hospital for mental health care have daily one-to-one contact with mental healthcare professionals known to them and regularly see other members of the multidisciplinary mental healthcare team. [2011]",null,"Outcome","QS14 - Service user experience in adult mental health services","7 - QS14 - Service user experience in adult mental health services",1,"7 - QS14 - Service user experience in adult mental health services - Outcome - 1"]
[null,"QS14","Service user experience in adult mental health services",7,null,"People in hospital for mental health care have daily one-to-one contact with mental healthcare professionals known to them and regularly see other members of the multidisciplinary mental healthcare team. [2011]",null,"Outcome","QS14 - Service user experience in adult mental health services","7 - QS14 - Service user experience in adult mental health services",2,"7 - QS14 - Service user experience in adult mental health services - Outcome - 2"]
[null,"QS14","Service user experience in adult mental health services",7,null,"People in hospital for mental health care have daily one-to-one contact with mental healthcare professionals known to them and regularly see other members of the multidisciplinary mental healthcare team. [2011]",null,"Outcome","QS14 - Service user experience in adult mental health services","7 - QS14 - Service user experience in adult mental health services",3,"7 - QS14 - Service user experience in adult mental health services - Outcome - 3"]
[null,"QS14","Service user experience in adult mental health services",8,null,"People in hospital for mental health care can access meaningful and culturally appropriate activities 7 days a week, not restricted to 9am to 5pm. [2011]","Evidence of local arrangements to ensure that people staying in hospital have access to meaningful and culturally appropriate activities 7 days a week, not restricted to 9am to 5pm.","Structure","QS14 - Service user experience in adult mental health services","8 - QS14 - Service user experience in adult mental health services",1,"8 - QS14 - Service user experience in adult mental health services - Structure - 1"]
[null,"QS14","Service user experience in adult mental health services",8,null,"People in hospital for mental health care can access meaningful and culturally appropriate activities 7 days a week, not restricted to 9am to 5pm. [2011]","Evidence from experience surveys and feedback that people staying in hospital felt they could access meaningful and culturally appropriate activities 7 days a week, not restricted to 9am to 5pm.","Outcome","QS14 - Service user experience in adult mental health services","8 - QS14 - Service user experience in adult mental health services",1,"8 - QS14 - Service user experience in adult mental health services - Outcome - 1"]
[null,"QS15","Patient experience in adult NHS services ",1,null,"People using adult NHS services are treated with empathy, dignity and respect. [2012]","Evidence of local arrangements to provide guidance to staff on how to treat people with empathy, dignity and respect.","Structure","QS15 - Patient experience in adult NHS services ",{"$f":"CONCATENATE(D269, \" - \", I269)","v":"1 - QS15 - Patient experience in adult NHS services "},{"$f":"IF(AND(B269=B268, D269=D268, H269=H268)=TRUE, K268+1, 1)","v":1},{"$f":"CONCATENATE(J269, \" - \", H269, \" - \",K269)","v":"1 - QS15 - Patient experience in adult NHS services  - Structure - 1"}]
[null,"QS15","Patient experience in adult NHS services ",1,null,"People using adult NHS services are treated with empathy, dignity and respect. [2012]","Proportion of people who feel they are treated with respect and dignity while staying in hospital.","Process","QS15 - Patient experience in adult NHS services ","1 - QS15 - Patient experience in adult NHS services ",1,"1 - QS15 - Patient experience in adult NHS services  - Process - 1","The number in the denominator who feel they are treated with respect and dignity.","The number of people who stayed overnight in hospital."]
[null,"QS15","Patient experience in adult NHS services ",1,null,"People using adult NHS services are treated with empathy, dignity and respect. [2012]","Proportion of people who feel they were treated with care and concern by a healthcare professional at their last GP appointment.","Process","QS15 - Patient experience in adult NHS services ","1 - QS15 - Patient experience in adult NHS services ",{"$f":"IF(AND(B271=B270, D271=D270, H271=H270)=TRUE, K270+1, 1)","v":2},"1 - QS15 - Patient experience in adult NHS services  - Process - 2","The number in the denominator who feel the healthcare professional was good or very good at treating them with care and concern.","The number of people reporting on their most recent appointment with their current GP practice."]
[null,"QS15","Patient experience in adult NHS services ",1,null,"People using adult NHS services are treated with empathy, dignity and respect. [2012]","Proportion of people who feel they were treated with respect and dignity by their dentist at their last visit.","Process","QS15 - Patient experience in adult NHS services ","1 - QS15 - Patient experience in adult NHS services ",3,"1 - QS15 - Patient experience in adult NHS services  - Process - 3","The number in the denominator who feel they were treated with respect and dignity by their dentist at their last visit.","The number of people reporting on their last visit to see their dentist."]
[null,"QS15","Patient experience in adult NHS services ",1,null,"People using adult NHS services are treated with empathy, dignity and respect. [2012]","Evidence from patient experience surveys and feedback that people using NHS services feel they have been treated with empathy, dignity and respect.","Outcome","QS15 - Patient experience in adult NHS services ","1 - QS15 - Patient experience in adult NHS services ",1,"1 - QS15 - Patient experience in adult NHS services  - Outcome - 1"]
[null,"QS15","Patient experience in adult NHS services ",2,null,"People using adult NHS services understand the roles of healthcare professionals involved in their care and know how to contact them about their ongoing healthcare needs. [2012, updated 2019]","Evidence of local arrangements to ensure that patients are aware of all healthcare professionals involved in their care. This should include the roles and responsibilities of the members of the healthcare team and how to contact them about ongoing healthcare needs.","Structure","QS15 - Patient experience in adult NHS services ","2 - QS15 - Patient experience in adult NHS services ",1,"2 - QS15 - Patient experience in adult NHS services  - Structure - 1"]
[null,"QS15","Patient experience in adult NHS services ",2,null,"People using adult NHS services understand the roles of healthcare professionals involved in their care and know how to contact them about their ongoing healthcare needs. [2012, updated 2019]","Evidence of local arrangements to ensure continuity of care and that, whenever possible, people see the same healthcare professional or team throughout a single episode of care.","Structure","QS15 - Patient experience in adult NHS services ","2 - QS15 - Patient experience in adult NHS services ",2,"2 - QS15 - Patient experience in adult NHS services  - Structure - 2"]
[null,"QS15","Patient experience in adult NHS services ",2,null,"People using adult NHS services understand the roles of healthcare professionals involved in their care and know how to contact them about their ongoing healthcare needs. [2012, updated 2019]","Proportion of people staying in hospital who knew which nurse was in charge of looking after them.","Process","QS15 - Patient experience in adult NHS services ","2 - QS15 - Patient experience in adult NHS services ",1,"2 - QS15 - Patient experience in adult NHS services  - Process - 1","The number in the denominator who felt they knew which nurse was in charge of looking after them.","The number of people staying overnight in hospital."]
[null,"QS15","Patient experience in adult NHS services ",2,null,"People using adult NHS services understand the roles of healthcare professionals involved in their care and know how to contact them about their ongoing healthcare needs. [2012, updated 2019]","Proportion of people staying in hospital who were told who to contact if they were worried about their condition or treatment after they left hospital.","Process","QS15 - Patient experience in adult NHS services ","2 - QS15 - Patient experience in adult NHS services ",2,"2 - QS15 - Patient experience in adult NHS services  - Process - 2","The number in the denominator who were told who to contact if they were worried about their condition or treatment after they left hospital.","The number of people staying overnight in hospital."]
[null,"QS15","Patient experience in adult NHS services ",2,null,"People using adult NHS services understand the roles of healthcare professionals involved in their care and know how to contact them about their ongoing healthcare needs. [2012, updated 2019]","Proportion of people attending an emergency department who were told who to contact if they were concerned about their condition or treatment after they left.","Process","QS15 - Patient experience in adult NHS services ","2 - QS15 - Patient experience in adult NHS services ",3,"2 - QS15 - Patient experience in adult NHS services  - Process - 3","The number in the denominator who were told who to contact if they were worried about their condition or treatment after they left the department.","The number of people attending a type 1 or type 3 emergency department."]
[null,"QS15","Patient experience in adult NHS services ",2,null,"People using adult NHS services understand the roles of healthcare professionals involved in their care and know how to contact them about their ongoing healthcare needs. [2012, updated 2019]","Evidence from patient experience surveys and feedback that patients were aware of all healthcare professionals involved in their care, and the roles and responsibilities of the members of the healthcare team.","Outcome","QS15 - Patient experience in adult NHS services ","2 - QS15 - Patient experience in adult NHS services ",1,"2 - QS15 - Patient experience in adult NHS services  - Outcome - 1"]
[null,"QS15","Patient experience in adult NHS services ",2,null,"People using adult NHS services understand the roles of healthcare professionals involved in their care and know how to contact them about their ongoing healthcare needs. [2012, updated 2019]","Evidence from patient experience surveys and feedback that patients saw the same healthcare professional or team throughout a single episode of care.","Outcome","QS15 - Patient experience in adult NHS services ","2 - QS15 - Patient experience in adult NHS services ",2,"2 - QS15 - Patient experience in adult NHS services  - Outcome - 2"]
[null,"QS15","Patient experience in adult NHS services ",2,null,"People using adult NHS services understand the roles of healthcare professionals involved in their care and know how to contact them about their ongoing healthcare needs. [2012, updated 2019]","Evidence from patient experience surveys and feedback that patients know who to contact, how to contact them and when to make contact about their ongoing healthcare needs.","Outcome","QS15 - Patient experience in adult NHS services ","2 - QS15 - Patient experience in adult NHS services ",3,"2 - QS15 - Patient experience in adult NHS services  - Outcome - 3"]
[null,"QS15","Patient experience in adult NHS services ",3,null,"People using adult NHS services experience coordinated care with clear and accurate information exchange between relevant health and social care professionals. [2012]","Evidence of local arrangements to support coordinated care through clear and accurate information exchange between relevant health and social care professionals.","Structure","QS15 - Patient experience in adult NHS services ","3 - QS15 - Patient experience in adult NHS services ",1,"3 - QS15 - Patient experience in adult NHS services  - Structure - 1"]
[null,"QS15","Patient experience in adult NHS services ",3,null,"People using adult NHS services experience coordinated care with clear and accurate information exchange between relevant health and social care professionals. [2012]","Proportion of people staying in hospital who thought that the specialist they saw in hospital had been given all the necessary information about their condition or illness from the person who referred them.","Process","QS15 - Patient experience in adult NHS services ","3 - QS15 - Patient experience in adult NHS services ",1,"3 - QS15 - Patient experience in adult NHS services  - Process - 1","The number in the denominator who thought that the specialist they saw in hospital been given all the necessary information about their condition or illness from the person who referred them.","The number of people staying overnight in hospital as a planned admission."]
[null,"QS15","Patient experience in adult NHS services ",3,null,"People using adult NHS services experience coordinated care with clear and accurate information exchange between relevant health and social care professionals. [2012]","Proportion of all cancer patients who thought that their GP was given enough information about their condition and the treatment they had at hospital.","Process","QS15 - Patient experience in adult NHS services ","3 - QS15 - Patient experience in adult NHS services ",2,"3 - QS15 - Patient experience in adult NHS services  - Process - 2","The number in the denominator who thought that their GP was given enough information about their condition and the treatment they had at the hospital.","The number of people with a confirmed primary diagnosis of cancer admitted to hospital as an inpatient or day case for cancer-related treatment."]
[null,"QS15","Patient experience in adult NHS services ",3,null,"People using adult NHS services experience coordinated care with clear and accurate information exchange between relevant health and social care professionals. [2012]","Evidence from patient experience surveys and feedback that people feel that information about their care was shared clearly and accurately between relevant health and social care professionals.","Outcome","QS15 - Patient experience in adult NHS services ","3 - QS15 - Patient experience in adult NHS services ",1,"3 - QS15 - Patient experience in adult NHS services  - Outcome - 1"]
[null,"QS15","Patient experience in adult NHS services ",4,null,"People using adult NHS services experience care and treatment that is tailored to their needs and preferences. [2012, updated 2019]","Evidence of local arrangements to ensure that people have opportunities to discuss their health beliefs, concerns and preferences.","Structure","QS15 - Patient experience in adult NHS services ","4 - QS15 - Patient experience in adult NHS services ",1,"4 - QS15 - Patient experience in adult NHS services  - Structure - 1"]
[null,"QS15","Patient experience in adult NHS services ",4,null,"People using adult NHS services experience care and treatment that is tailored to their needs and preferences. [2012, updated 2019]","Evidence of local arrangements to ensure that people's needs and preferences are assessed, addressed and regularly reviewed.","Structure","QS15 - Patient experience in adult NHS services ",{"$f":"CONCATENATE(D287, \" - \", I287)","v":"4 - QS15 - Patient experience in adult NHS services "},{"$f":"IF(AND(B287=B286, D287=D286, H287=H286)=TRUE, K286+1, 1)","v":2},{"$f":"CONCATENATE(J287, \" - \", H287, \" - \",K287)","v":"4 - QS15 - Patient experience in adult NHS services  - Structure - 2"}]
[null,"QS15","Patient experience in adult NHS services ",4,null,"People using adult NHS services experience care and treatment that is tailored to their needs and preferences. [2012, updated 2019]","Evidence of local arrangements to ensure that care and treatment is tailored to people's needs and personal preferences.","Structure","QS15 - Patient experience in adult NHS services ","4 - QS15 - Patient experience in adult NHS services ",3,"4 - QS15 - Patient experience in adult NHS services  - Structure - 3"]
[null,"QS15","Patient experience in adult NHS services ",4,null,"People using adult NHS services experience care and treatment that is tailored to their needs and preferences. [2012, updated 2019]","Proportion of people given the opportunity to discuss their health beliefs, concerns and preferences.","Process","QS15 - Patient experience in adult NHS services ","4 - QS15 - Patient experience in adult NHS services ",1,"4 - QS15 - Patient experience in adult NHS services  - Process - 1","The number of people in the denominator who were given the opportunity to discuss their health beliefs, concerns and preferences.","The number of people accessing NHS services."]
[null,"QS15","Patient experience in adult NHS services ",4,null,"People using adult NHS services experience care and treatment that is tailored to their needs and preferences. [2012, updated 2019]","Proportion of people with care tailored to their needs and preferences, taking into account their circumstances, their ability to access services and their coexisting conditions.","Process","QS15 - Patient experience in adult NHS services ","4 - QS15 - Patient experience in adult NHS services ",2,"4 - QS15 - Patient experience in adult NHS services  - Process - 2","The number of people in the denominator whose care was tailored to their needs and preferences, taking into account their circumstances, their ability to access services and their coexisting conditions.","The number of people accessing NHS services."]
[null,"QS15","Patient experience in adult NHS services ",4,null,"People using adult NHS services experience care and treatment that is tailored to their needs and preferences. [2012, updated 2019]","Proportion of people accessing NHS services who have their needs and preferences assessed, addressed and regularly reviewed.","Process","QS15 - Patient experience in adult NHS services ","4 - QS15 - Patient experience in adult NHS services ",3,"4 - QS15 - Patient experience in adult NHS services  - Process - 3","The number of people in the denominator who have their physical and psychological needs regularly assessed, addressed and regularly reviewed.","The number of people accessing NHS services."]
[null,"QS15","Patient experience in adult NHS services ",4,null,"People using adult NHS services experience care and treatment that is tailored to their needs and preferences. [2012, updated 2019]","Evidence from patient experience surveys and feedback that people feel their care has been informed by their health beliefs, concerns and preferences.","Outcome",{"$f":"CONCATENATE(B292, \" - \", C292)","v":"QS15 - Patient experience in adult NHS services "},"4 - QS15 - Patient experience in adult NHS services ",1,"4 - QS15 - Patient experience in adult NHS services  - Outcome - 1"]
[null,"QS15","Patient experience in adult NHS services ",4,null,"People using adult NHS services experience care and treatment that is tailored to their needs and preferences. [2012, updated 2019]","Evidence from patient experience surveys and feedback that care was tailored to people's needs and personal preferences, taking into account their circumstances, their ability to access services and their coexisting conditions.","Outcome","QS15 - Patient experience in adult NHS services ","4 - QS15 - Patient experience in adult NHS services ",2,"4 - QS15 - Patient experience in adult NHS services  - Outcome - 2"]
[null,"QS15","Patient experience in adult NHS services ",4,null,"People using adult NHS services experience care and treatment that is tailored to their needs and preferences. [2012, updated 2019]","Evidence from patient experience surveys and feedback that patients feel their physical and psychological needs were assessed, addressed and regularly reviewed.","Outcome","QS15 - Patient experience in adult NHS services ","4 - QS15 - Patient experience in adult NHS services ",3,"4 - QS15 - Patient experience in adult NHS services  - Outcome - 3"]
[null,"QS15","Patient experience in adult NHS services ",5,null,"People using adult NHS services have their preferences for sharing information with their family members and carers established, respected and reviewed throughout their care. [2012]","Evidence of local arrangements to ensure that people's preferences for sharing information with family members and carers are established, respected and reviewed throughout their care.","Structure","QS15 - Patient experience in adult NHS services ","5 - QS15 - Patient experience in adult NHS services ",1,"5 - QS15 - Patient experience in adult NHS services  - Structure - 1"]
[null,"QS15","Patient experience in adult NHS services ",5,null,"People using adult NHS services have their preferences for sharing information with their family members and carers established, respected and reviewed throughout their care. [2012]","Proportion of people using adult NHS services whose preferences for sharing information with family members and carers are established, respected and reviewed throughout their care.","Process","QS15 - Patient experience in adult NHS services ","5 - QS15 - Patient experience in adult NHS services ",1,"5 - QS15 - Patient experience in adult NHS services  - Process - 1","The number in the denominator whose preferences for sharing information with family members and carers are recorded and reviewed throughout their care.","The number of people using adult NHS services."]
[null,"QS15","Patient experience in adult NHS services ",5,null,"People using adult NHS services have their preferences for sharing information with their family members and carers established, respected and reviewed throughout their care. [2012]","Evidence from patient experience surveys and feedback that people's preferences for sharing information with family members and carers were established, respected and reviewed throughout their care.","Outcome","QS15 - Patient experience in adult NHS services ","5 - QS15 - Patient experience in adult NHS services ",1,"5 - QS15 - Patient experience in adult NHS services  - Outcome - 1"]
[null,"QS15","Patient experience in adult NHS services ",6,null,"People using adult NHS services are supported in shared decision making. [2012, updated 2019]","Evidence of a system that supports the use of shared decision making such as appointment systems that allow decisions to be discussed, and patient record systems that can document shared decisions and patient preferences.","Structure","QS15 - Patient experience in adult NHS services ","6 - QS15 - Patient experience in adult NHS services ",1,"6 - QS15 - Patient experience in adult NHS services  - Structure - 1"]
[null,"QS15","Patient experience in adult NHS services ",6,null,"People using adult NHS services are supported in shared decision making. [2012, updated 2019]","Evidence of local arrangements to ensure that healthcare professionals support people to understand their treatment options, including the benefits, risks and potential consequences of relevant treatments.","Structure","QS15 - Patient experience in adult NHS services ","6 - QS15 - Patient experience in adult NHS services ",2,"6 - QS15 - Patient experience in adult NHS services  - Structure - 2"]
[null,"QS15","Patient experience in adult NHS services ",6,null,"People using adult NHS services are supported in shared decision making. [2012, updated 2019]","Evidence of local arrangements to ensure that people are actively involved and supported in shared decision making.","Structure","QS15 - Patient experience in adult NHS services ","6 - QS15 - Patient experience in adult NHS services ",3,"6 - QS15 - Patient experience in adult NHS services  - Structure - 3"]
[null,"QS15","Patient experience in adult NHS services ",6,null,"People using adult NHS services are supported in shared decision making. [2012, updated 2019]","Evidence of local arrangements to ensure that people are made aware of their right to choose, accept or decline treatment and that these decisions are respected and supported.","Structure","QS15 - Patient experience in adult NHS services ","6 - QS15 - Patient experience in adult NHS services ",4,"6 - QS15 - Patient experience in adult NHS services  - Structure - 4"]
[null,"QS15","Patient experience in adult NHS services ",6,null,"People using adult NHS services are supported in shared decision making. [2012, updated 2019]","Evidence of local arrangements to ensure that people are made aware that they can ask for a second opinion.","Structure","QS15 - Patient experience in adult NHS services ","6 - QS15 - Patient experience in adult NHS services ",5,"6 - QS15 - Patient experience in adult NHS services  - Structure - 5"]
[null,"QS15","Patient experience in adult NHS services ",6,null,"People using adult NHS services are supported in shared decision making. [2012, updated 2019]","Proportion of people who reported that a member of staff answered their questions before their operation or procedure in a way they could understand.","Process","QS15 - Patient experience in adult NHS services ","6 - QS15 - Patient experience in adult NHS services ",1,"6 - QS15 - Patient experience in adult NHS services  - Process - 1","The number in the denominator who reported that, before their operation or procedure, a member of staff answered their questions about it in a way they could understand 'completely'.","The number of people having an operation or procedure as an inpatient in hospital."]
[null,"QS15","Patient experience in adult NHS services ",6,null,"People using adult NHS services are supported in shared decision making. [2012, updated 2019]","Proportion of people staying in hospital who reported that they were involved as much as they wanted to be in decisions about their care and treatment in hospital.","Process","QS15 - Patient experience in adult NHS services ","6 - QS15 - Patient experience in adult NHS services ",2,"6 - QS15 - Patient experience in adult NHS services  - Process - 2","The number in the denominator who reported that they were 'definitely' involved as much as they wanted to be in decisions about their care and treatment.","The number of people staying as an inpatient in hospital."]
[null,"QS15","Patient experience in adult NHS services ",6,null,"People using adult NHS services are supported in shared decision making. [2012, updated 2019]","Proportion of people who reported that they were involved as much as they wanted to be in decisions about their discharge from hospital.","Process","QS15 - Patient experience in adult NHS services ","6 - QS15 - Patient experience in adult NHS services ",3,"6 - QS15 - Patient experience in adult NHS services  - Process - 3","The number in the denominator who reported that they felt they were involved as much as they wanted to be in decisions about their discharge from hospital.","The number of people staying as an inpatient in hospital."]
[null,"QS15","Patient experience in adult NHS services ",6,null,"People using adult NHS services are supported in shared decision making. [2012, updated 2019]","Proportion of people who were involved in decisions about their care and treatment as much as they wanted to be at their last GP appointment.","Process","QS15 - Patient experience in adult NHS services ","6 - QS15 - Patient experience in adult NHS services ",4,"6 - QS15 - Patient experience in adult NHS services  - Process - 4","The number in the denominator who were involved in decisions about their care and treatment as much as they wanted to be.","The number of people reporting on their last GP appointment."]
[null,"QS15","Patient experience in adult NHS services ",6,null,"People using adult NHS services are supported in shared decision making. [2012, updated 2019]","Evidence from patient experience surveys and feedback that people feel able to make decisions that reflect what is important to them.","Outcome","QS15 - Patient experience in adult NHS services ","6 - QS15 - Patient experience in adult NHS services ",1,"6 - QS15 - Patient experience in adult NHS services  - Outcome - 1"]
[null,"QS15","Patient experience in adult NHS services ",6,null,"People using adult NHS services are supported in shared decision making. [2012, updated 2019]","Evidence from patient experience surveys and feedback that people know about their right to choose, accept or decline treatment and feel that their decisions were respected and supported.","Outcome","QS15 - Patient experience in adult NHS services ","6 - QS15 - Patient experience in adult NHS services ",2,"6 - QS15 - Patient experience in adult NHS services  - Outcome - 2"]
[null,"QS15","Patient experience in adult NHS services ",6,null,"People using adult NHS services are supported in shared decision making. [2012, updated 2019]","Evidence from patient experience surveys and feedback that people know that they can ask for a second opinion.","Outcome","QS15 - Patient experience in adult NHS services ","6 - QS15 - Patient experience in adult NHS services ",3,"6 - QS15 - Patient experience in adult NHS services  - Outcome - 3"]
[null,null,null,null,null,null,null,null," - ",{"$f":"CONCATENATE(D310, \" - \", I310)","v":" -  - "},{"$f":"IF(AND(B310=B309, D310=D309, H310=H309)=TRUE, K309+1, 1)","v":1},{"$f":"CONCATENATE(J310, \" - \", H310, \" - \",K310)","v":" -  -  -  - 1"}]
[null,"QS16","Hip fracture",1,null,"Adults with hip fracture are cared for within a Hip Fracture Programme at every stage of the care pathway. ","Evidence of local arrangements to ensure that people with hip fracture are cared for within a Hip Fracture Programme at every stage of the care pathway.","Structure",{"$f":"CONCATENATE(B311, \" - \", C311)","v":"QS16 - Hip fracture"},"1 - QS16 - Hip fracture",1,"1 - QS16 - Hip fracture - Structure - 1","",""]
[null,"QS16","Hip fracture",1,null,"Adults with hip fracture are cared for within a Hip Fracture Programme at every stage of the care pathway. ","Proportion of presentations of hip fracture in which the person receives an orthogeriatric assessment prior to surgery.","Process","QS16 - Hip fracture",{"$f":"CONCATENATE(D312, \" - \", I312)","v":"1 - QS16 - Hip fracture"},{"$f":"IF(AND(B312=B311, D312=D311, H312=H311)=TRUE, K311+1, 1)","v":1},{"$f":"CONCATENATE(J312, \" - \", H312, \" - \",K312)","v":"1 - QS16 - Hip fracture - Process - 1"},"The number in the denominator in which the person receives an orthogeriatric assessment prior to surgery.","The number of presentations of hip fracture."]
[null,"QS16","Hip fracture",1,null,"Adults with hip fracture are cared for within a Hip Fracture Programme at every stage of the care pathway. ","Proportion of presentations of hip fracture in which the person has their goals for multidisciplinary rehabilitation identified.","Process","QS16 - Hip fracture","1 - QS16 - Hip fracture",2,"1 - QS16 - Hip fracture - Process - 2","The number in the denominator in which the person has their goals for multidisciplinary rehabilitation identified.","The number of people having surgery for hip fracture."]
[null,"QS16","Hip fracture",1,null,"Adults with hip fracture are cared for within a Hip Fracture Programme at every stage of the care pathway. ","Mortality for people with hip fracture at discharge.","Outcome","QS16 - Hip fracture","1 - QS16 - Hip fracture",1,"1 - QS16 - Hip fracture - Outcome - 1"]
[null,"QS16","Hip fracture",1,null,"Adults with hip fracture are cared for within a Hip Fracture Programme at every stage of the care pathway. ","Functional outcome at 1 year.","Outcome","QS16 - Hip fracture","1 - QS16 - Hip fracture",2,"1 - QS16 - Hip fracture - Outcome - 2"]
[null,"QS16","Hip fracture",2,null,"Adults with hip fracture have surgery on a planned trauma list on the day of, or the day after, admission. ","Evidence of local arrangements to ensure that people with hip fracture have surgery on a planned trauma list.","Structure","QS16 - Hip fracture","2 - QS16 - Hip fracture",1,"2 - QS16 - Hip fracture - Structure - 1"]
[null,"QS16","Hip fracture",2,null,"Adults with hip fracture have surgery on a planned trauma list on the day of, or the day after, admission. ","Evidence of local arrangements to ensure that people with hip fracture have surgery on the day of, or the day after, admission.","Structure","QS16 - Hip fracture","2 - QS16 - Hip fracture",2,"2 - QS16 - Hip fracture - Structure - 2"]
[null,"QS16","Hip fracture",2,null,"Adults with hip fracture have surgery on a planned trauma list on the day of, or the day after, admission. ","Proportion of operations for hip fracture that are performed on a planned trauma list.","Process","QS16 - Hip fracture","2 - QS16 - Hip fracture",1,"2 - QS16 - Hip fracture - Process - 1","The number in the denominator that are performed on a planned trauma list.","The number of operations for hip fracture."]
[null,"QS16","Hip fracture",2,null,"Adults with hip fracture have surgery on a planned trauma list on the day of, or the day after, admission. ","Proportion of operations for hip fracture that are performed on the day of, or the day after, admission. ","Process","QS16 - Hip fracture","2 - QS16 - Hip fracture",2,"2 - QS16 - Hip fracture - Process - 2","The number in the denominator that are performed on the day of, or the day after, admission.","The number of operations for hip fracture."]
[null,"QS16","Hip fracture",2,null,"Adults with hip fracture have surgery on a planned trauma list on the day of, or the day after, admission. ","Postoperative complications for people with hip fracture.","Outcome","QS16 - Hip fracture","2 - QS16 - Hip fracture",1,"2 - QS16 - Hip fracture - Outcome - 1"]
[null,"QS16","Hip fracture",2,null,"Adults with hip fracture have surgery on a planned trauma list on the day of, or the day after, admission. ","Length of hospital stay for people with hip fracture.","Outcome","QS16 - Hip fracture","2 - QS16 - Hip fracture",2,"2 - QS16 - Hip fracture - Outcome - 2"]
[null,"QS16","Hip fracture",3,null,"This statement has been removed.",null,null,"QS16 - Hip fracture","3 - QS16 - Hip fracture",1,"3 - QS16 - Hip fracture -  - 1"]
[null,"QS16","Hip fracture",3,null,"This statement has been removed.",null,null,"QS16 - Hip fracture","3 - QS16 - Hip fracture",2,"3 - QS16 - Hip fracture -  - 2"]
[null,"QS16","Hip fracture",3,null,"This statement has been removed.",null,null,"QS16 - Hip fracture","3 - QS16 - Hip fracture",3,"3 - QS16 - Hip fracture -  - 3"]
[null,"QS16","Hip fracture",4,null,"Adults with trochanteric fractures above and including the lesser trochanter, except reverse oblique fractures, receive extramedullary implants in preference to intramedullary nails.","Evidence of local arrangements to ensure that people with trochanteric fractures above and including the lesser trochanter, except for reverse oblique fractures, receive extramedullary implants.","Structure","QS16 - Hip fracture","4 - QS16 - Hip fracture",1,"4 - QS16 - Hip fracture - Structure - 1"]
[null,"QS16","Hip fracture",4,null,"Adults with trochanteric fractures above and including the lesser trochanter, except reverse oblique fractures, receive extramedullary implants in preference to intramedullary nails.","Proportion of trochanteric fractures above and including the lesser trochanter (excluding reverse oblique fractures) treated with extramedullary implants.","Process","QS16 - Hip fracture","4 - QS16 - Hip fracture",1,"4 - QS16 - Hip fracture - Process - 1","The number in the denominator treated with extramedullary implants.","The number of trochanteric fractures above and including the lesser trochanter (excluding reverse oblique fractures)."]
[null,"QS16","Hip fracture",4,null,"Adults with trochanteric fractures above and including the lesser trochanter, except reverse oblique fractures, receive extramedullary implants in preference to intramedullary nails.","Reoperation rates for people with trochanteric fractures (except reverse oblique fractures).","Outcome","QS16 - Hip fracture","4 - QS16 - Hip fracture",1,"4 - QS16 - Hip fracture - Outcome - 1"]
[null,"QS16","Hip fracture",5,null,"Adults with subtrochanteric fracture are treated with an intramedullary nail.","Evidence of local arrangements to ensure that people with subtrochanteric fracture are treated with an intramedullary nail.","Structure","QS16 - Hip fracture","5 - QS16 - Hip fracture",1,"5 - QS16 - Hip fracture - Structure - 1"]
[null,"QS16","Hip fracture",5,null,"Adults with subtrochanteric fracture are treated with an intramedullary nail.","Proportion of presentations of subtrochanteric fractures treated with an intramedullary nail. ","Process","QS16 - Hip fracture","5 - QS16 - Hip fracture",1,"5 - QS16 - Hip fracture - Process - 1","The number in the denominator that are treated with an intramedullary nail.","The number of presentations of subtrochanteric fractures."]
[null,"QS16","Hip fracture",5,null,"Adults with subtrochanteric fracture are treated with an intramedullary nail.","Number of people with non-union of fracture.","Outcome","QS16 - Hip fracture","5 - QS16 - Hip fracture",1,"5 - QS16 - Hip fracture - Outcome - 1"]
[null,"QS16","Hip fracture",6,null,"Adults with hip fracture start rehabilitation at least once a day, no later than the day after surgery. ","Evidence of local arrangements to ensure that people with hip fracture start rehabilitation at least once a day, no later than the day after surgery.  ","Structure","QS16 - Hip fracture","6 - QS16 - Hip fracture",1,"6 - QS16 - Hip fracture - Structure - 1"]
[null,"QS16","Hip fracture",6,null,"Adults with hip fracture start rehabilitation at least once a day, no later than the day after surgery.","Proportion of hip fracture operations after which the person starts rehabilitation no later than the day after surgery.","Process","QS16 - Hip fracture","6 - QS16 - Hip fracture",1,"6 - QS16 - Hip fracture - Process - 1","The number in the denominator after which the person starts rehabilitation no later than the day after surgery.","The number of hip fracture operations."]
[null,"QS16","Hip fracture",6,null,"Adults with hip fracture start rehabilitation at least once a day, no later than the day after surgery.","Proportion of hip fracture operations after which the person has rehabilitation at least once a day.","Process","QS16 - Hip fracture","6 - QS16 - Hip fracture",2,"6 - QS16 - Hip fracture - Process - 2","The number in the denominator after which the person has rehabilitation at least once a day.","The number of hip fracture operations."]
[null,"QS16","Hip fracture",6,null,"Adults with hip fracture start rehabilitation at least once a day, no later than the day after surgery.","Length of hospital stay for people with hip fracture.","Outcome","QS16 - Hip fracture","6 - QS16 - Hip fracture",1,"6 - QS16 - Hip fracture - Outcome - 1"]
[null,"QS16","Hip fracture",6,null,"Adults with hip fracture start rehabilitation at least once a day, no later than the day after surgery.","Return to the pre-hip fracture place of residence.","Outcome","QS16 - Hip fracture","6 - QS16 - Hip fracture",2,"6 - QS16 - Hip fracture - Outcome - 2"]
[null,"QS16","Hip fracture",6,null,"Adults with hip fracture start rehabilitation at least once a day, no later than the day after surgery.","Return to the pre-hip fracture level of mobility.","Outcome","QS16 - Hip fracture","6 - QS16 - Hip fracture",3,"6 - QS16 - Hip fracture - Outcome - 3"]
[null,"QS17","Lung cancer in adults ",1,null,"Local authorities and healthcare commissioning groups use coordinated campaigns to raise awareness of the symptoms and signs of lung cancer and encourage people to seek medical advice if they need to. ","Evidence of local needs assessment to identify population groups for campaigns to raise awareness of the symptoms and signs of lung cancer and encourage people to seek medical advice if they need to.","Structure","QS17 - Lung cancer in adults ",{"$f":"CONCATENATE(D337, \" - \", I337)","v":"1 - QS17 - Lung cancer in adults "},1,{"$f":"CONCATENATE(J337, \" - \", H337, \" - \",K337)","v":"1 - QS17 - Lung cancer in adults  - Structure - 1"},"",""]
[null,"QS17","Lung cancer in adults ",1,null,"Local authorities and healthcare commissioning groups use coordinated campaigns to raise awareness of the symptoms and signs of lung cancer and encourage people to seek medical advice if they need to. ","Evidence of locally coordinated campaigns to raise awareness of the symptoms and signs of lung cancer and encourage people to seek medical advice if they need to.","Structure","QS17 - Lung cancer in adults ","1 - QS17 - Lung cancer in adults ",2,"1 - QS17 - Lung cancer in adults  - Structure - 2"]
[null,"QS17","Lung cancer in adults ",1,null,"Local authorities and healthcare commissioning groups use coordinated campaigns to raise awareness of the symptoms and signs of lung cancer and encourage people to seek medical advice if they need to. ","Evidence of evaluation of locally coordinated campaigns to raise awareness of the symptoms and signs of lung cancer and encourage people to seek medical advice if they need to.","Structure","QS17 - Lung cancer in adults ","1 - QS17 - Lung cancer in adults ",3,"1 - QS17 - Lung cancer in adults  - Structure - 3"]
[null,"QS17","Lung cancer in adults ",1,null,"Local authorities and healthcare commissioning groups use coordinated campaigns to raise awareness of the symptoms and signs of lung cancer and encourage people to seek medical advice if they need to. ","Proportion of adults in the population who can recognise and recall the symptoms and signs of lung cancer.","Outcome","QS17 - Lung cancer in adults ",{"$f":"CONCATENATE(D340, \" - \", I340)","v":"1 - QS17 - Lung cancer in adults "},{"$f":"IF(AND(B340=B339, D340=D339, H340=H339)=TRUE, K339+1, 1)","v":1},{"$f":"CONCATENATE(J340, \" - \", H340, \" - \",K340)","v":"1 - QS17 - Lung cancer in adults  - Outcome - 1"},"The number in the denominator who can recognise and recall the symptoms and signs of lung cancer.","The number of adults in the population."]
[null,"QS17","Lung cancer in adults ",1,null,"Local authorities and healthcare commissioning groups use coordinated campaigns to raise awareness of the symptoms and signs of lung cancer and encourage people to seek medical advice if they need to. ","Proportion of adults with a new diagnosis of lung cancer who were diagnosed via an emergency route.","Outcome","QS17 - Lung cancer in adults ","1 - QS17 - Lung cancer in adults ",2,"1 - QS17 - Lung cancer in adults  - Outcome - 2","The number in the denominator who were diagnosed via an emergency route.","The number of adults with a new diagnosis of lung cancer."]
[null,"QS17","Lung cancer in adults ",1,null,"Local authorities and healthcare commissioning groups use coordinated campaigns to raise awareness of the symptoms and signs of lung cancer and encourage people to seek medical advice if they need to. ","Proportion of adults with a new diagnosis of lung cancer diagnosed at stage I or II.","Outcome","QS17 - Lung cancer in adults ","1 - QS17 - Lung cancer in adults ",3,"1 - QS17 - Lung cancer in adults  - Outcome - 3","The number in the denominator diagnosed at stage I or II.","The number of adults with a new diagnosis of lung cancer."]
[null,"QS17","Lung cancer in adults ",2,null,"Adults with suspected or confirmed lung cancer who smoke receive evidence-based stop smoking support.","Evidence of local arrangements to ensure that adults with suspected or confirmed lung cancer who smoke are given advice about why it is important to stop smoking.","Structure","QS17 - Lung cancer in adults ","2 - QS17 - Lung cancer in adults ",1,"2 - QS17 - Lung cancer in adults  - Structure - 1",null,""]
[null,"QS17","Lung cancer in adults ",2,null,"Adults with suspected or confirmed lung cancer who smoke receive evidence-based stop smoking support.","Evidence of local arrangements to provide evidence-based support for adults with suspected or confirmed lung cancer to help them to stop smoking.","Structure","QS17 - Lung cancer in adults ","2 - QS17 - Lung cancer in adults ",2,"2 - QS17 - Lung cancer in adults  - Structure - 2"]
[null,"QS17","Lung cancer in adults ",2,null,"Adults with suspected or confirmed lung cancer who smoke receive evidence-based stop smoking support.","Proportion of adults with suspected or confirmed lung cancer who smoke who receive evidence-based support to stop smoking.","Process",{"$f":"CONCATENATE(B345, \" - \", C345)","v":"QS17 - Lung cancer in adults "},"2 - QS17 - Lung cancer in adults ",1,"2 - QS17 - Lung cancer in adults  - Process - 1","The number in the denominator who receive evidence-based support to stop smoking.","The number of adults with suspected or confirmed lung cancer who smoke."]
[null,"QS17","Lung cancer in adults ",2,null,"Adults with suspected or confirmed lung cancer who smoke receive evidence-based stop smoking support.","Smoking rates in adults with lung cancer having treatment with curative intent.","Outcome","QS17 - Lung cancer in adults ","2 - QS17 - Lung cancer in adults ",1,"2 - QS17 - Lung cancer in adults  - Outcome - 1"]
[null,"QS17","Lung cancer in adults ",2,null,"Adults with suspected or confirmed lung cancer who smoke receive evidence-based stop smoking support.","1-year survival rate for adults with lung cancer treated with curative intent.","Outcome","QS17 - Lung cancer in adults ","2 - QS17 - Lung cancer in adults ",2,"2 - QS17 - Lung cancer in adults  - Outcome - 2","",""]
[null,"QS17","Lung cancer in adults ",3,null,"Adults with suspected or confirmed lung cancer have access to a named lung cancer clinical nurse specialist.","Evidence of the availability of clinical nurse specialists who specialise in the care and support of adults with lung cancer.","Structure","QS17 - Lung cancer in adults ","3 - QS17 - Lung cancer in adults ",1,"3 - QS17 - Lung cancer in adults  - Structure - 1"]
[null,"QS17","Lung cancer in adults ",3,null,"Adults with suspected or confirmed lung cancer have access to a named lung cancer clinical nurse specialist.","Evidence of local arrangements to ensure that adults with lung cancer know how to contact the lung cancer clinical nurse specialist between hospital visits.","Structure","QS17 - Lung cancer in adults ","3 - QS17 - Lung cancer in adults ",2,"3 - QS17 - Lung cancer in adults  - Structure - 2"]
[null,"QS17","Lung cancer in adults ",3,null,"Adults with suspected or confirmed lung cancer have access to a named lung cancer clinical nurse specialist.","Proportion of adults with lung cancer who had a lung cancer clinical nurse specialist present at diagnosis.","Process","QS17 - Lung cancer in adults ","3 - QS17 - Lung cancer in adults ",1,"3 - QS17 - Lung cancer in adults  - Process - 1","The number in the denominator who had a lung cancer clinical nurse specialist present at diagnosis.","The number of adults with lung cancer."]
[null,"QS17","Lung cancer in adults ",3,null,"Adults with suspected or confirmed lung cancer have access to a named lung cancer clinical nurse specialist.","Proportion of adults with lung cancer who have had assessment by a lung cancer clinical nurse specialist.","Process","QS17 - Lung cancer in adults ","3 - QS17 - Lung cancer in adults ",2,"3 - QS17 - Lung cancer in adults  - Process - 2","The number in the denominator who have had assessment by a lung cancer clinical nurse specialist.\n","The number of adults with lung cancer."]
[null,"QS17","Lung cancer in adults ",3,null,"Adults with suspected or confirmed lung cancer have access to a named lung cancer clinical nurse specialist.","Proportion of adults with lung cancer who were given the name of a lung cancer clinical nurse specialist who would support them.","Process","QS17 - Lung cancer in adults ","3 - QS17 - Lung cancer in adults ",3,"3 - QS17 - Lung cancer in adults  - Process - 3","The number in the denominator who were given the name of a lung cancer clinical nurse specialist who would support them.","The number of adults with lung cancer."]
[null,"QS17","Lung cancer in adults ",3,null,"Adults with suspected or confirmed lung cancer have access to a named lung cancer clinical nurse specialist.","Proportion of adults with lung cancer who are satisfied with the support provided by a lung cancer clinical nurse specialist.","Outcome","QS17 - Lung cancer in adults ","3 - QS17 - Lung cancer in adults ",1,{"$f":"CONCATENATE(J353, \" - \", H353, \" - \",K353)","v":"3 - QS17 - Lung cancer in adults  - Outcome - 1"},"The number in the denominator who are satisfied with the support provided by a lung cancer clinical nurse specialist.","The number of adults with lung cancer."]
[null,"QS17","Lung cancer in adults ",3,null,"Adults with suspected or confirmed lung cancer have access to a named lung cancer clinical nurse specialist.","Health-related quality of life for adults with lung cancer.","Outcome","QS17 - Lung cancer in adults ","3 - QS17 - Lung cancer in adults ",2,"3 - QS17 - Lung cancer in adults  - Outcome - 2"]
[null,"QS17","Lung cancer in adults ",4,null,"Adults with lung cancer being considered for treatment with curative intent have investigations to accurately determine diagnosis and stage, and to assess lung function. ","Evidence of local processes to record investigations to accurately determine diagnosis and stage and to assess lung function, for adults with lung cancer who are being considered for treatment with curative intent.","Structure","QS17 - Lung cancer in adults ","4 - QS17 - Lung cancer in adults ",1,"4 - QS17 - Lung cancer in adults  - Structure - 1"]
[null,"QS17","Lung cancer in adults ",4,null,"Adults with lung cancer being considered for treatment with curative intent have investigations to accurately determine diagnosis and stage, and to assess lung function. ","Evidence of availability of positron-emission tomography CT (PET-CT) for adults with lung cancer who are being considered for treatment with curative intent.","Structure","QS17 - Lung cancer in adults ","4 - QS17 - Lung cancer in adults ",2,"4 - QS17 - Lung cancer in adults  - Structure - 2"]
[null,"QS17","Lung cancer in adults ",4,null,"Adults with lung cancer being considered for treatment with curative intent have investigations to accurately determine diagnosis and stage, and to assess lung function. ","Evidence of availability of brain imaging for adults with non-small-cell lung cancer stage II or III who are being considered for treatment with curative intent.","Structure","QS17 - Lung cancer in adults ","4 - QS17 - Lung cancer in adults ",3,"4 - QS17 - Lung cancer in adults  - Structure - 3"]
[null,"QS17","Lung cancer in adults ",4,null,"Adults with lung cancer being considered for treatment with curative intent have investigations to accurately determine diagnosis and stage, and to assess lung function. ","Proportion of adults with lung cancer treated with curative intent who had PET-CT before starting treatment.","Process","QS17 - Lung cancer in adults ","4 - QS17 - Lung cancer in adults ",1,"4 - QS17 - Lung cancer in adults  - Process - 1","The number in the denominator who had PET-CT before starting treatment.","The number of adults with lung cancer treated with curative intent."]
[null,"QS17","Lung cancer in adults ",4,null,"Adults with lung cancer being considered for treatment with curative intent have investigations to accurately determine diagnosis and stage, and to assess lung function. ","Proportion of adults with non-small-cell lung cancer stage II or III treated with curative intent who had brain imaging before starting treatment.","Process","QS17 - Lung cancer in adults ","4 - QS17 - Lung cancer in adults ",2,"4 - QS17 - Lung cancer in adults  - Process - 2","The number in the denominator who had brain imaging before starting treatment.","The number of adults with non-small-cell lung cancer stage II or III treated with curative intent."]
[null,"QS17","Lung cancer in adults ",4,null,"Adults with lung cancer being considered for treatment with curative intent have investigations to accurately determine diagnosis and stage, and to assess lung function. ","Proportion of adults with non-small-cell lung cancer treated with curative intent who had spirometry and transfer factor (TLCO) before starting treatment.","Process","QS17 - Lung cancer in adults ","4 - QS17 - Lung cancer in adults ",3,"4 - QS17 - Lung cancer in adults  - Process - 3","The number in the denominator who had spirometry and TLCO before starting treatment.","The number of adults with non-small-cell lung cancer treated with curative intent."]
[null,"QS17","Lung cancer in adults ",4,null,"Adults with lung cancer being considered for treatment with curative intent have investigations to accurately determine diagnosis and stage, and to assess lung function. ","Proportion of adults with lung cancer who had clinical stage and performance status recorded.","Process","QS17 - Lung cancer in adults ","4 - QS17 - Lung cancer in adults ",4,"4 - QS17 - Lung cancer in adults  - Process - 4","The number in the denominator who had clinical stage and performance status recorded.","The number of adults with lung cancer."]
[null,"QS17","Lung cancer in adults ",4,null,"Adults with lung cancer being considered for treatment with curative intent have investigations to accurately determine diagnosis and stage, and to assess lung function. ","1-year survival rate for adults with lung cancer treated with curative intent.","Outcome","QS17 - Lung cancer in adults ","4 - QS17 - Lung cancer in adults ",1,"4 - QS17 - Lung cancer in adults  - Outcome - 1"]
[null,"QS17","Lung cancer in adults ",5,null,"Adults with non-small-cell lung cancer stage I or II and good performance status have treatment with curative intent","Evidence that lung cancer multidisciplinary team meetings include all specialist core members.","Structure","QS17 - Lung cancer in adults ","5 - QS17 - Lung cancer in adults ",1,"5 - QS17 - Lung cancer in adults  - Structure - 1"]
[null,"QS17","Lung cancer in adults ",5,null,"Adults with non-small-cell lung cancer stage I or II and good performance status have treatment with curative intent","Evidence of local processes for discussing options for treatment with curative intent with adults with stage I or II non-small-cell lung cancer and good performance status.","Structure","QS17 - Lung cancer in adults ","5 - QS17 - Lung cancer in adults ",2,"5 - QS17 - Lung cancer in adults  - Structure - 2","",""]
[null,"QS17","Lung cancer in adults ",5,null,"Adults with non-small-cell lung cancer stage I or II and good performance status have treatment with curative intent","Evidence of local arrangements and written clinical protocols to ensure that adults with non-small-cell lung cancer stage I or II and good performance status have treatment with curative intent.","Structure","QS17 - Lung cancer in adults ","5 - QS17 - Lung cancer in adults ",3,"5 - QS17 - Lung cancer in adults  - Structure - 3"]
[null,"QS17","Lung cancer in adults ",5,null,"Adults with non-small-cell lung cancer stage I or II and good performance status have treatment with curative intent","Proportion of adults with non-small-cell lung cancer stage I or II and good performance status who have treatment with curative intent.","Process","QS17 - Lung cancer in adults ","5 - QS17 - Lung cancer in adults ",1,"5 - QS17 - Lung cancer in adults  - Process - 1","The number in the denominator who have treatment with curative intent.","The number of adults with non-small-cell lung cancer stage I or II and good performance status."]
[null,"QS17","Lung cancer in adults ",5,null,"Adults with non-small-cell lung cancer stage I or II and good performance status have treatment with curative intent","Proportion of adults with non-small-cell lung cancer stage I or II and good performance status who are satisfied that treatment options were explained to them.","Outcome","QS17 - Lung cancer in adults ","5 - QS17 - Lung cancer in adults ",1,"5 - QS17 - Lung cancer in adults  - Outcome - 1","The number in the denominator who are satisfied that treatment options were explained to them.","The number of adults with non-small-cell lung cancer stage I or II and good performance status."]
[null,"QS17","Lung cancer in adults ",5,null,"Adults with non-small-cell lung cancer stage I or II and good performance status have treatment with curative intent","1-year survival rate for adults with non-small-cell lung cancer stage I or II.","Outcome","QS17 - Lung cancer in adults ","5 - QS17 - Lung cancer in adults ",2,"5 - QS17 - Lung cancer in adults  - Outcome - 2"]
[null,"QS17","Lung cancer in adults ",5,null,"Adults with non-small-cell lung cancer stage I or II and good performance status have treatment with curative intent","5-year survival rate for adults with non-small-cell lung cancer stage I or II.","Outcome","QS17 - Lung cancer in adults ","5 - QS17 - Lung cancer in adults ",3,"5 - QS17 - Lung cancer in adults  - Outcome - 3"]
[null,"QS17","Lung cancer in adults ",6,null,"Adults with non-small-cell lung cancer stage III or IV who are having tissue sampling, have samples taken that are suitable for pathological diagnosis and assessment of predictive biomarkers.","Evidence of the availability of radiologists and respiratory specialists experienced in performing lung biopsies for adults with lung cancer.","Structure","QS17 - Lung cancer in adults ","6 - QS17 - Lung cancer in adults ",1,"6 - QS17 - Lung cancer in adults  - Structure - 1"]
[null,"QS17","Lung cancer in adults ",6,null,"Adults with non-small-cell lung cancer stage III or IV who are having tissue sampling, have samples taken that are suitable for pathological diagnosis and assessment of predictive biomarkers.","Evidence of local processes to ensure that adults with non-small-cell lung cancer stage III or IV who are having tissue sampling, have samples taken that are suitable for pathological diagnosis and assessment of predictive biomarkers.","Structure",{"$f":"CONCATENATE(B371, \" - \", C371)","v":"QS17 - Lung cancer in adults "},{"$f":"CONCATENATE(D371, \" - \", I371)","v":"6 - QS17 - Lung cancer in adults "},{"$f":"IF(AND(B371=B370, D371=D370, H371=H370)=TRUE, K370+1, 1)","v":2},{"$f":"CONCATENATE(J371, \" - \", H371, \" - \",K371)","v":"6 - QS17 - Lung cancer in adults  - Structure - 2"}]
[null,"QS17","Lung cancer in adults ",6,null,"Adults with non-small-cell lung cancer stage III or IV who are having tissue sampling, have samples taken that are suitable for pathological diagnosis and assessment of predictive biomarkers.","Evidence of audit of the local test performance of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for people with lung cancer.","Structure","QS17 - Lung cancer in adults ","6 - QS17 - Lung cancer in adults ",3,"6 - QS17 - Lung cancer in adults  - Structure - 3"]
[null,"QS17","Lung cancer in adults ",6,null,"Adults with non-small-cell lung cancer stage III or IV who are having tissue sampling, have samples taken that are suitable for pathological diagnosis and assessment of predictive biomarkers.","Proportion of adults with non-small-cell lung cancer stage III or IV who have a second diagnostic test in order to determine histological sub-type or predictive biomarkers.","Process","QS17 - Lung cancer in adults ","6 - QS17 - Lung cancer in adults ",1,"6 - QS17 - Lung cancer in adults  - Process - 1","The number in the denominator who have a second diagnostic test in order to determine histological sub-type or predictive biomarkers.","The number of adults with non-small-cell lung cancer stage III or IV."]
[null,"QS17","Lung cancer in adults ",6,null,"Adults with non-small-cell lung cancer stage III or IV who are having tissue sampling, have samples taken that are suitable for pathological diagnosis and assessment of predictive biomarkers.","Proportion of adults with non-small-cell lung cancer stage III or IV for whom the reported tumour sub-type is 'not otherwise specified'.","Process","QS17 - Lung cancer in adults ","6 - QS17 - Lung cancer in adults ",2,"6 - QS17 - Lung cancer in adults  - Process - 2","The number in the denominator for whom the reported tumour sub-type is 'not otherwise specified'.","The number of adults with non-small-cell lung cancer stage III or IV."]
[null,"QS17","Lung cancer in adults ",6,null,"Adults with non-small-cell lung cancer stage III or IV who are having tissue sampling, have samples taken that are suitable for pathological diagnosis and assessment of predictive biomarkers.","Proportion of adults with non-small-cell lung cancer stage III or IV and performance status 0 to 2 who are successfully tested for all relevant biomarkers..","Process","QS17 - Lung cancer in adults ","6 - QS17 - Lung cancer in adults ",3,"6 - QS17 - Lung cancer in adults  - Process - 3","The number in the denominator who are successfully tested for all relevant biomarkers.","The number of adults with non-small-cell lung cancer stage III or IV and performance status 0 to 2."]
[null,"QS17","Lung cancer in adults ",6,null,"Adults with non-small-cell lung cancer stage III or IV who are having tissue sampling, have samples taken that are suitable for pathological diagnosis and assessment of predictive biomarkers.","Proportion of adults with non-small-cell lung cancer stage III or IV and performance status 0 to 2 who have a pathological diagnosis.","Outcome","QS17 - Lung cancer in adults ","6 - QS17 - Lung cancer in adults ",1,"6 - QS17 - Lung cancer in adults  - Outcome - 1","The number in the denominator who have a pathological diagnosis.","The number of adults with non-small-cell lung cancer stage III or IV and performance status 0 to 2."]
[null,"QS17","Lung cancer in adults ",6,null,"Adults with non-small-cell lung cancer stage III or IV who are having tissue sampling, have samples taken that are suitable for pathological diagnosis and assessment of predictive biomarkers.","1-year survival rate for adults with non-small-cell lung cancer stage III or IV.","Outcome","QS17 - Lung cancer in adults ","6 - QS17 - Lung cancer in adults ",2,"6 - QS17 - Lung cancer in adults  - Outcome - 2"]
[null,"QS18","Ovarian cancer ",1,null,"Women aged 50 years or over reporting one or more symptoms occurring persistently or frequently that suggest ovarian cancer are offered a CA125 test.","Evidence of local arrangements to ensure all women aged 50 years and over reporting one or more symptoms occurring persistently or frequently that suggest ovarian cancer are offered a CA125 test.","Structure","QS18 - Ovarian cancer ",{"$f":"CONCATENATE(D378, \" - \", I378)","v":"1 - QS18 - Ovarian cancer "},{"$f":"IF(AND(B378=B377, D378=D377, H378=H377)=TRUE, K377+1, 1)","v":1},{"$f":"CONCATENATE(J378, \" - \", H378, \" - \",K378)","v":"1 - QS18 - Ovarian cancer  - Structure - 1"},"",""]
[null,"QS18","Ovarian cancer ",1,null,"Women aged 50 years or over reporting one or more symptoms occurring persistently or frequently that suggest ovarian cancer are offered a CA125 test.","Proportion of women aged 50 years and over reporting at least one symptom occurring persistently or frequently that suggests ovarian cancer who receive a CA125 test.","Process","QS18 - Ovarian cancer ","1 - QS18 - Ovarian cancer ",1,"1 - QS18 - Ovarian cancer  - Process - 1","The number of women in the denominator receiving a CA125 test.","The number of women aged 50 years and over reporting at least one symptom occurring persistently or frequently that suggests ovarian cancer."]
[null,"QS18","Ovarian cancer ",2,null,"Women with raised CA125 have an ultrasound of their abdomen and pelvis within 2 weeks of receiving the CA125 test results.","Evidence of local arrangements to ensure all women with raised CA125 have an ultrasound of their abdomen and pelvis within 2 weeks of receiving the CA125 test results.","Structure","QS18 - Ovarian cancer ",{"$f":"CONCATENATE(D380, \" - \", I380)","v":"2 - QS18 - Ovarian cancer "},{"$f":"IF(AND(B380=B379, D380=D379, H380=H379)=TRUE, K379+1, 1)","v":1},{"$f":"CONCATENATE(J380, \" - \", H380, \" - \",K380)","v":"2 - QS18 - Ovarian cancer  - Structure - 1"},"",""]
[null,"QS18","Ovarian cancer ",2,null,"Women with raised CA125 have an ultrasound of their abdomen and pelvis within 2 weeks of receiving the CA125 test results.","Proportion of women with raised CA125 who have an ultrasound of their abdomen and pelvis within 2 weeks of receiving the CA125 test results.","Process","QS18 - Ovarian cancer ","2 - QS18 - Ovarian cancer ",1,"2 - QS18 - Ovarian cancer  - Process - 1","The number of women in the denominator who have an ultrasound of their abdomen and pelvis within 2 weeks of receiving the CA125 test results.","The number of women with raised CA125."]
[null,"QS18","Ovarian cancer ",3,null,"Women with normal CA125, or raised CA125 but normal ultrasound, with no confirmed diagnosis but continuing symptoms, are reassessed by their GP within 1 month.","Evidence of local arrangements and written clinical protocols to ensure women with normal CA125, or raised CA125 but normal ultrasound, with no confirmed diagnosis but continuing symptoms, are reassessed by their GP within 1 month.","Structure","QS18 - Ovarian cancer ","3 - QS18 - Ovarian cancer ",1,"3 - QS18 - Ovarian cancer  - Structure - 1","",""]
[null,"QS18","Ovarian cancer ",3,null,"Women with normal CA125, or raised CA125 but normal ultrasound, with no confirmed diagnosis but continuing symptoms, are reassessed by their GP within 1 month.","Proportion of women with normal CA125 and no confirmed diagnosis but continuing symptoms, who are reassessed by their GP within 1 month.","Process",{"$f":"CONCATENATE(B383, \" - \", C383)","v":"QS18 - Ovarian cancer "},"3 - QS18 - Ovarian cancer ",1,"3 - QS18 - Ovarian cancer  - Process - 1","The number of women in the denominator who are reassessed by their GP within 1 month.","The number of women with normal CA125 and no confirmed diagnosis but continuing symptoms."]
[null,"QS18","Ovarian cancer ",3,null,"Women with normal CA125, or raised CA125 but normal ultrasound, with no confirmed diagnosis but continuing symptoms, are reassessed by their GP within 1 month.","Proportion of women with raised CA125 but normal ultrasound and no confirmed diagnosis but continuing symptoms, who are reassessed by their GP within 1 month.","Process","QS18 - Ovarian cancer ","3 - QS18 - Ovarian cancer ",2,"3 - QS18 - Ovarian cancer  - Process - 2","The number of women in the denominator who are reassessed by their GP within 1 month.","The number of women with raised CA125 but normal ultrasound, and no confirmed diagnosis but continuing symptoms."]
[null,"QS18","Ovarian cancer ",4,null,"Women with a risk of malignancy index (RMI I) score of 250 or greater are referred to a specialist gynaecological cancer multidisciplinary team.","Evidence of local arrangements to ensure women with an RMI I score of 250 or greater are referred to a specialist gynaecological cancer multidisciplinary team.","Structure","QS18 - Ovarian cancer ","4 - QS18 - Ovarian cancer ",1,"4 - QS18 - Ovarian cancer  - Structure - 1","",""]
[null,"QS18","Ovarian cancer ",4,null,"Women with a risk of malignancy index (RMI I) score of 250 or greater are referred to a specialist gynaecological cancer multidisciplinary team.","Proportion of women with an RMI I score of 250 or greater referred to a specialist gynaecological cancer multidisciplinary team.","Process","QS18 - Ovarian cancer ","4 - QS18 - Ovarian cancer ",1,"4 - QS18 - Ovarian cancer  - Process - 1","The number of women in the denominator referred to a specialist gynaecological cancer multidisciplinary team.","The number of women with an RMI I score of 250 or greater."]
[null,"QS18","Ovarian cancer ",5,null,"Women who are offered staging for ovarian cancer, following ultrasound, are offered computed tomography (CT) of the abdomen and pelvis as the initial staging investigation.","Evidence of local arrangements and written clinical protocols to ensure women who are offered staging for ovarian cancer, following ultrasound, are offered CT of the abdomen and pelvis as the initial staging investigation.","Structure","QS18 - Ovarian cancer ","5 - QS18 - Ovarian cancer ",1,"5 - QS18 - Ovarian cancer  - Structure - 1","",""]
[null,"QS18","Ovarian cancer ",5,null,"Women who are offered staging for ovarian cancer, following ultrasound, are offered computed tomography (CT) of the abdomen and pelvis as the initial staging investigation.","Proportion of women who are offered staging for ovarian cancer, following ultrasound, who receive CT of the abdomen and pelvis as the initial staging investigation","Process","QS18 - Ovarian cancer ","5 - QS18 - Ovarian cancer ",1,"5 - QS18 - Ovarian cancer  - Process - 1","The number of women in the denominator receiving CT of the abdomen and pelvis as the initial staging investigation.","The number of women who are offered staging for ovarian cancer, following ultrasound."]
[null,"QS18","Ovarian cancer ",6,null,"Women who have computed tomography (CT) for staging of ovarian cancer have the results reported by a radiologist who is a core member of the specialist gynaecological cancer multidisciplinary team.","Evidence of local arrangements and written clinical protocols to ensure that women who have CT for staging of ovarian cancer have the results reported by a radiologist who is a core member of the specialist gynaecological cancer multidisciplinary team.","Structure","QS18 - Ovarian cancer ","6 - QS18 - Ovarian cancer ",1,"6 - QS18 - Ovarian cancer  - Structure - 1","",""]
[null,"QS18","Ovarian cancer ",6,null,"Women who have computed tomography (CT) for staging of ovarian cancer have the results reported by a radiologist who is a core member of the specialist gynaecological cancer multidisciplinary team.","Proportion of women who have CT for staging ovarian cancer that have the results reported by a radiologist who is a core member of the specialist gynaecological cancer multidisciplinary team.","Process","QS18 - Ovarian cancer ","6 - QS18 - Ovarian cancer ",1,"6 - QS18 - Ovarian cancer  - Process - 1","The number of women in the denominator having their CT staging results reported by a radiologist who is a core member of the specialist gynaecological cancer multidisciplinary team.","The number of women who have CT for staging of ovarian cancer."]
[null,"QS18","Ovarian cancer ",7,null,"Women with an indeterminate adnexal mass on ultrasound are offered magnetic resonance imaging (MRI) for further characterisation.","Evidence of local arrangements to ensure women with an indeterminate adnexal mass on ultrasound have MRI for further characterisation.","Structure","QS18 - Ovarian cancer ","7 - QS18 - Ovarian cancer ",1,"7 - QS18 - Ovarian cancer  - Structure - 1","",""]
[null,"QS18","Ovarian cancer ",7,null,"Women with an indeterminate adnexal mass on ultrasound are offered magnetic resonance imaging (MRI) for further characterisation.","Proportion of women with an indeterminate adnexal mass on ultrasound who have MRI for further characterisation.","Process","QS18 - Ovarian cancer ","7 - QS18 - Ovarian cancer ",1,"7 - QS18 - Ovarian cancer  - Process - 1","The number of women in the denominator who have MRI for further characterisation.","The number of women with an indeterminate adnexal mass on ultrasound."]
[null,"QS18","Ovarian cancer ",8,null,"Women with suspected stage I ovarian cancer have optimal surgical staging","Evidence of local arrangements and written clinical protocols to ensure women with suspected stage I ovarian cancer have optimal surgical staging","Structure","QS18 - Ovarian cancer ","8 - QS18 - Ovarian cancer ",1,"8 - QS18 - Ovarian cancer  - Structure - 1","",""]
[null,"QS18","Ovarian cancer ",8,null,"Women with suspected stage I ovarian cancer have optimal surgical staging","Proportion of women with stage I ovarian cancer that had optimal surgical staging.","Process","QS18 - Ovarian cancer ","8 - QS18 - Ovarian cancer ",1,"8 - QS18 - Ovarian cancer  - Process - 1","The number of women in the denominator who had optimal surgical staging.","The number of women with stage I ovarian cancer."]
[null,"QS18","Ovarian cancer ",8,null,"Women with suspected stage I ovarian cancer have optimal surgical staging","Proportion of women with stage I ovarian cancer that had up-front systematic retroperitoneal lymphadenectomy","Process","QS18 - Ovarian cancer ","8 - QS18 - Ovarian cancer ",2,"8 - QS18 - Ovarian cancer  - Process - 2","The number of women in the denominator who had up-front systematic retroperitoneal lymphadenectomy.","The number of women with stage I ovarian cancer."]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,null,"Parents and carers of children and young people presenting with non-specific symptoms and signs are given 'safety netting' information that includes information on bacterial meningitis and meningococcal septicaemia.","Evidence of local arrangements for parents and carers of children and young people presenting with non-specific symptoms and signs to be given 'safety netting' information that includes information on bacterial meningitis and meningococcal septicaemia.","Structure","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","1 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"1 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Structure - 1","",""]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,null,"Parents and carers of children and young people presenting with non-specific symptoms and signs are given 'safety netting' information that includes information on bacterial meningitis and meningococcal septicaemia.","Proportion of parents or carers of children and young people presenting with non-specific symptoms and signs who are given 'safety netting' information that includes information on bacterial meningitis and meningococcal septicaemia.","Process","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","1 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"1 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Process - 1","The number of people in the denominator who are given 'safety netting' information that includes information on bacterial meningitis and meningococcal septicaemia.","The number of parents or carers of children and young people presenting with non-specific symptoms and signs."]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,null,"Parents and carers of children and young people presenting with non-specific symptoms and signs are given 'safety netting' information that includes information on bacterial meningitis and meningococcal septicaemia.","Parent/carer satisfaction with information received.","Outcome","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","1 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"1 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Outcome - 1"]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",2,null,"Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia have their temperature, respiratory rate, pulse, blood pressure, urine output, oxygen saturation and neurological condition monitored at least hourly until stable.","Evidence of local arrangements for children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia to have their temperature, respiratory rate, pulse, blood pressure, urine output, oxygen saturation and neurological condition monitored at least hourly until stable.","Structure","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","2 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"2 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Structure - 1",""]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",2,null,"Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia have their temperature, respiratory rate, pulse, blood pressure, urine output, oxygen saturation and neurological condition monitored at least hourly until stable.","Proportion of children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia who have their temperature, respiratory rate, pulse, blood pressure, urine output, oxygen saturation and neurological condition monitored at least hourly until stable.","Process","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","2 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"2 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Process - 1","The number of people in the denominator who have their temperature, respiratory rate, pulse, blood pressure, urine output, oxygen saturation and neurological condition monitored at least hourly until stable.","The number of children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia."]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",3,null,"Children and young people presenting with a petechial rash receive antibiotics in accordance with NICE guidance.","Evidence of local arrangements for children and young people presenting with a petechial rash to receive antibiotics in accordance with NICE guidance.","Structure","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","3 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"3 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Structure - 1","",""]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",3,null,"Children and young people presenting with a petechial rash receive antibiotics in accordance with NICE guidance.","Proportion of children and young people presenting with a petechial rash who receive antibiotics in accordance with NICE guidance.","Process","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","3 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"3 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Process - 1","The number of people in the denominator who receive antibiotics in accordance with NICE guidance.","The number of children and young people presenting with a petechial rash."]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",4,null,"Children and young people with suspected bacterial meningitis or meningococcal septicaemia receive intravenous or intraosseous antibiotics within an hour of arrival at hospital.","Evidence of local arrangements for children and young people with suspected bacterial meningitis or meningococcal septicaemia to receive intravenous or intraosseous antibiotics within an hour of arrival at hospital.","Structure","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","4 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"4 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Structure - 1","",""]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",4,null,"Children and young people with suspected bacterial meningitis or meningococcal septicaemia receive intravenous or intraosseous antibiotics within an hour of arrival at hospital.","Proportion of children and young people with suspected bacterial meningitis or meningococcal septicaemia who receive intravenous or intraosseous antibiotics within an hour of arrival at hospital.","Process","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","4 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"4 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Process - 1","The number of people in the denominator who receive intravenous or intraosseous antibiotics within an hour of arrival at hospital.","The number of children and young people with suspected bacterial meningitis or meningococcal septicaemia arriving in hospital."]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",5,null,"Children and young people with suspected bacterial meningitis have a lumbar puncture.","Evidence of local arrangements for children and young people with suspected bacterial meningitis to have a lumbar puncture.","Structure","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","5 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"5 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Structure - 1","",""]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",5,null,"Children and young people with suspected bacterial meningitis have a lumbar puncture.","Proportion of children and young people with suspected bacterial meningitis who have a lumbar puncture.","Process","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","5 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"5 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Process - 1","The number of people in the denominator who have a lumbar puncture.","The number of children and young people with suspected bacterial meningitis."]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",6,null,"Children and young people with suspected bacterial meningitis have their cerebrospinal fluid (CSF) microsocpy result available within 4 hours of lumbar puncture.","Evidence of local arrangements for children and young people with suspected bacterial meningitis to have their CSF microscopy result available within 4 hours of lumbar puncture.","Structure","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","6 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"6 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Structure - 1",""]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",6,null,"Children and young people with suspected bacterial meningitis have their cerebrospinal fluid (CSF) microsocpy result available within 4 hours of lumbar puncture.","Proportion of children and young people with suspected bacterial meningitis who have their CSF microscopy result available within 4 hours of lumbar puncture.","Process","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","6 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"6 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Process - 1","The number of people in the denominator who have their CSF microscopy result available within 4 hours of lumbar puncture.","The number of children and young people with suspected bacterial meningitis who have had a lumbar puncture."]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",7,null,"Children and young people with suspected bacterial meningitis or meningococcal septicaemia have whole blood meningococcal polymerase chain reaction (PCR) testing.","Evidence of local arrangements for children and young people with suspected bacterial meningitis or meningococcal septicaemia to have whole blood meningococcal PCR testing.","Structure","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","7 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"7 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Structure - 1","",""]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",7,null,"Children and young people with suspected bacterial meningitis or meningococcal septicaemia have whole blood meningococcal polymerase chain reaction (PCR) testing.","Proportion of children and young people with suspected bacterial meningitis or meningococcal septicaemia who have whole blood meningococcal PCR testing.","Process","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","7 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"7 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Process - 1","The number of people in the denominator who have whole blood meningococcal PCR testing.","The number of children and young people with suspected bacterial meningitis or meningococcal septicaemia."]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",8,null,"Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia, who have signs of shock or raised intracranial pressure, are assessed by a consultant paediatrician.","Evidence of local arrangements for children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia who have signs of shock or raised intracranial pressure to be assessed by a consultant paediatrician.","Structure","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","8 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"8 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Structure - 1","",""]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",8,null,"Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia, who have signs of shock or raised intracranial pressure, are assessed by a consultant paediatrician.","Proportion of children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia who have signs of shock or raised intracranial pressure that are assessed by a consultant paediatrician.","Process","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","8 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"8 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Process - 1","The number of people in the denominator who are assessed by a consultant paediatrician.","The number of children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia who have signs of shock or raised intracranial pressure."]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",9,null,"Children and young people with meningococcal septicaemia undergoing tracheal intubation and mechanical ventilation have the procedure undertaken by an anaesthetist experienced in paediatric airway management.","Evidence of local arrangements for children and young people with meningococcal septicaemia undergoing tracheal intubation and mechanical ventilation to have the procedure undertaken by an anaesthetist experienced in paediatric airway management.","Structure","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","9 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"9 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Structure - 1","",""]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",9,null,"Children and young people with meningococcal septicaemia undergoing tracheal intubation and mechanical ventilation have the procedure undertaken by an anaesthetist experienced in paediatric airway management.","Proportion of children and young people with meningococcal septicaemia undergoing tracheal intubation and mechanical ventilation who have the procedure undertaken by an anaesthetist experienced in paediatric airway management.","Process","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","9 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"9 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Process - 1","The number of people in the denominator who have the tracheal intubation and mechanical ventilation procedure undertaken by an anaesthetist experienced in paediatric airway management.","The number of children and young people with meningococcal septicaemia undergoing tracheal intubation and mechanical ventilation."]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",10,null,"Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia being transferred within or between hospitals are escorted by a healthcare professional trained in advanced paediatric life support.","Evidence of local arrangements for children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia being transferred within or between hosptials to be escorted by a healthcare professional trained in advanced paediatric life support.","Structure","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","10 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"10 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Structure - 1","",""]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",10,null,"Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia being transferred within or between hospitals are escorted by a healthcare professional trained in advanced paediatric life support.","Proportion of children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia being transferred within or between hospitals who are escorted by a healthcare professional trained in advanced paediatric life support.","Process","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","10 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"10 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Process - 1","The number of people in the denominator who are escorted by a healthcare professional trained in advanced paediatric life support.","The number of children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia being transferred within or between hospitals."]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",11,null,"Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia requiring transfer to a paediatric intensive care unit or high dependency unit in another hospital are transferred by a specialist paediatric retrieval team.","Evidence of local arrangements for children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia requiring transfer to a paediatric intensive care unit or high dependency unit in another hospital are transferred by a specialist paediatric retrieval team.","Structure","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","11 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"11 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Structure - 1","",""]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",11,null,"Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia requiring transfer to a paediatric intensive care unit or high dependency unit in another hospital are transferred by a specialist paediatric retrieval team.","Proportion of children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia requiring transfer to a paediatric intensive care unit or high dependency unit in another hospital who are transferred by a specialist paediatric retrieval team.","Process","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","11 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"11 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Process - 1","The number of people in the denominator who are transferred by a specialist paediatric retrieval team.","The number of children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia requiring transfer to a paediatric intensive care unit or high dependency unit in another hospital."]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",12,null,"Children and young people who have had bacterial meningitis or meningococcal septicaemia, and/or their parents and carers, are given information before discharge about the disease, its potential long-term effects and how to access further support.","Evidence of local arrangements for children and young people who have had bacterial meningitis or meningococcal septicaemia, or their parents and carers, to be given information before discharge about the disease, its potential long-term effects and how to access further support.","Structure","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","12 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"12 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Structure - 1","",""]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",12,null,"Children and young people who have had bacterial meningitis or meningococcal septicaemia, and/or their parents and carers, are given information before discharge about the disease, its potential long-term effects and how to access further support.","Proportion of children and young people who have had bacterial meningitis or meningococcal septicaemia, or their parents or carers, who receive information before discharge about the disease, its potential long-term effects and how to access further support.","Process","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","12 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"12 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Process - 1","The number of people in the denominator or their parents or carers who receive information before discharge about the disease, its potential long-term effects and how to access further support.","The number of children and young people who have had bacterial meningitis or meningococcal septicaemia."]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",12,null,"Children and young people who have had bacterial meningitis or meningococcal septicaemia, and/or their parents and carers, are given information before discharge about the disease, its potential long-term effects and how to access further support.","Patient and/or parent or carer satisfaction with information recieved before discharge.","Outcome","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","12 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"12 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Outcome - 1"]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",13,null,"Children and young people who have had bacterial meningitis or meningococcal septicaemia have an audiological assessment before discharge.","Evidence of local arrangements for children and young people who have had bacterial meningitis or meningococcal septicaemia to have an audiological assessment before discharge.","Structure","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","13 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"13 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Structure - 1","",""]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",13,null,"Children and young people who have had bacterial meningitis or meningococcal septicaemia have an audiological assessment before discharge.","Proportion of children and young people who have had bacterial meningitis or meningococcal septicaemia who have an audiological assessment before discharge.","Process","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","13 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"13 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Process - 1","The number of people in the denominator who have an audiological assessment before discharge.","The number of children and young people who have had bacterial meningitis or meningococcal septicaemia."]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",14,null,"Children and young people who have had bacterial meningitis or meningococcal septicaemia have a follow-up appointment with a consultant paediatrician within 6 weeks of discharge.","Evidence of local arrangements for children and young people who have had bacterial meningitis or meningococcal septicaemia to have a follow-up appointment with a consultant paediatrician within 6 weeks of discharge.","Structure","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","14 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"14 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Structure - 1","",""]
[null,"QS19","Meningitis (bacterial) and meningococcal septicaemia in children and young people ",14,null,"Children and young people who have had bacterial meningitis or meningococcal septicaemia have a follow-up appointment with a consultant paediatrician within 6 weeks of discharge.","Proportion of children and young people who have had bacterial meningitis or meningococcal septicaemia who have a follow-up appointment with a consultant paediatrician within 6 weeks of discharge.","Process","QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ","14 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people ",1,"14 - QS19 - Meningitis (bacterial) and meningococcal septicaemia in children and young people  - Process - 1","The number of people in the denominator who have a follow-up appointment with a consultant paediatrician within 6 weeks of discharge.","The number of children and young people who are discharged after having had bacterial meningitis or meningococcal septicaemia."]
[null,"QS20","Colorectal cancer ",1,null,"Adults with a new diagnosis of colorectal cancer have testing for Lynch syndrome.","Evidence of local arrangements to ensure that there is a clinical lead responsible for implementing the testing pathway for Lynch syndrome.","Structure","QS20 - Colorectal cancer ","1 - QS20 - Colorectal cancer ",1,"1 - QS20 - Colorectal cancer  - Structure - 1",""]
[null,"QS20","Colorectal cancer ",1,null,"Adults with a new diagnosis of colorectal cancer have testing for Lynch syndrome.","Proportion of adults with a new diagnosis of colorectal cancer who had IHC for mismatch repair proteins or microsatellite instability testing on the tumour.","Process","QS20 - Colorectal cancer ","1 - QS20 - Colorectal cancer ",1,"1 - QS20 - Colorectal cancer  - Process - 1","The number in the denominator who had IHC for mismatch repair proteins or microsatellite instability testing on the tumour.","The number of adults with a new diagnosis of colorectal cancer."]
[null,"QS20","Colorectal cancer ",1,null,"Adults with a new diagnosis of colorectal cancer have testing for Lynch syndrome.","Proportion of adults with a new diagnosis of colorectal cancer and a tumour that shows abnormal MLH1 expression by IHC, or microsatellite instability, who had BRAF V600E mutation testing.","Process","QS20 - Colorectal cancer ","1 - QS20 - Colorectal cancer ",2,"1 - QS20 - Colorectal cancer  - Process - 2","The number in the denominator who had BRAF V600E mutation testing.","The number of adults with a new diagnosis of colorectal cancer and a tumour that shows abnormal MLH1 expression by IHC, or microsatellite instability."]
[null,"QS20","Colorectal cancer ",1,null,"Adults with a new diagnosis of colorectal cancer have testing for Lynch syndrome.","Proportion of adults with a new diagnosis of colorectal cancer and a tumour that shows abnormal MLH1 expression by IHC, or microsatellite instability, and a negative BRAF V600E test who had MLH1 promoter hypermethylation testing.","Process","QS20 - Colorectal cancer ","1 - QS20 - Colorectal cancer ",3,"1 - QS20 - Colorectal cancer  - Process - 3","The number in the denominator who had MLH1 promoter hypermethylation testing.","The number of adults with a new diagnosis of colorectal cancer and a tumour that shows abnormal MLH1 expression by IHC, or microsatellite instability, and a negative BRAF V600E test."]
[null,"QS20","Colorectal cancer ",1,null,"Adults with a new diagnosis of colorectal cancer have testing for Lynch syndrome.","Proportion of adults with a new diagnosis of colorectal cancer and test results suggestive of Lynch syndrome-associated colorectal cancer who had genetic testing of germline DNA to confirm Lynch syndrome.","Process","QS20 - Colorectal cancer ","1 - QS20 - Colorectal cancer ",{"$f":"IF(AND(B430=B429, D430=D429, H430=H429)=TRUE, K429+1, 1)","v":4},"1 - QS20 - Colorectal cancer  - Process - 4","The number in the denominator who had genetic testing of germline DNA to confirm Lynch syndrome.","The number of adults with a new diagnosis of colorectal cancer and test results suggestive of Lynch syndrome-associated colorectal cancer."]
[null,"QS20","Colorectal cancer ",1,null,"Adults with a new diagnosis of colorectal cancer have testing for Lynch syndrome.","Rate of diagnosis of Lynch syndrome in adults with a new diagnosis of colorectal cancer.","Outcome","QS20 - Colorectal cancer ","1 - QS20 - Colorectal cancer ",1,"1 - QS20 - Colorectal cancer  - Outcome - 1"]
[null,"QS20","Colorectal cancer ",2,null,"Adults with early rectal cancer discuss the implications of all potential treatment options with their healthcare professional.","Evidence of availability of information to support discussions about all potential treatment options for adults with early rectal cancer.","Structure","QS20 - Colorectal cancer ","2 - QS20 - Colorectal cancer ",1,"2 - QS20 - Colorectal cancer  - Structure - 1","",""]
[null,"QS20","Colorectal cancer ",2,null,"Adults with early rectal cancer discuss the implications of all potential treatment options with their healthcare professional.","Proportion of adults with early rectal cancer who had a discussion about all potential treatment options with their healthcare professional.","Process","QS20 - Colorectal cancer ","2 - QS20 - Colorectal cancer ",1,"2 - QS20 - Colorectal cancer  - Process - 1","The number in the denominator who had a discussion about all potential treatment options with their healthcare professional.","The number of adults with early rectal cancer."]
[null,"QS20","Colorectal cancer ",3,null,"Adults with metastatic colorectal cancer suitable for systemic anti-cancer treatment have testing to identify tumours with RAS and BRAF V600E mutations.","Evidence of local arrangements and clinical protocols to ensure that adults with metastatic colorectal cancer suitable for systemic anti-cancer treatment have testing to identify tumours with RAS and BRAF V600E mutations.","Structure","QS20 - Colorectal cancer ","3 - QS20 - Colorectal cancer ",1,"3 - QS20 - Colorectal cancer  - Structure - 1"]
[null,"QS20","Colorectal cancer ",3,null,"Adults with metastatic colorectal cancer suitable for systemic anti-cancer treatment have testing to identify tumours with RAS and BRAF V600E mutations.","Proportion of adults with metastatic colorectal cancer suitable for systemic anti-cancer treatment who had testing to identify tumours with RAS and BRAF V600E mutations.","Process","QS20 - Colorectal cancer ","3 - QS20 - Colorectal cancer ",1,"3 - QS20 - Colorectal cancer  - Process - 1","The number in the denominator who had testing to identify tumours with RAS and BRAF V600E mutations.","The number of adults with metastatic colorectal cancer suitable for systemic anti-cancer treatment."]
[null,"QS20","Colorectal cancer ",3,null,"Adults with metastatic colorectal cancer suitable for systemic anti-cancer treatment have testing to identify tumours with RAS and BRAF V600E mutations.","Progression-free survival for adults with metastatic colorectal cancer suitable for systemic anti-cancer treatment.","Outcome","QS20 - Colorectal cancer ","3 - QS20 - Colorectal cancer ",1,"3 - QS20 - Colorectal cancer  - Outcome - 1"]
[null,"QS20","Colorectal cancer ",4,null,"Adults who have had potentially curative surgical treatment for non-metastatic colorectal cancer have follow-up for the first 3 years to detect local recurrence and distant metastases. ","Evidence of local arrangements and written clinical protocols to ensure that adults who have had potentially curative surgery for non-metastatic colorectal cancer have follow-up tests for the first 3 years after treatment.","Structure","QS20 - Colorectal cancer ","4 - QS20 - Colorectal cancer ",1,"4 - QS20 - Colorectal cancer  - Structure - 1"]
[null,"QS20","Colorectal cancer ",4,null,"Adults who have had potentially curative surgical treatment for non-metastatic colorectal cancer have follow-up for the first 3 years to detect local recurrence and distant metastases. ","Proportion of adults who had potentially curative surgery for non-metastatic colorectal cancer who had 6-monthly serum carcinoembryonic antigen (CEA) measurement in the 3 years after potentially curative surgery.","Process","QS20 - Colorectal cancer ","4 - QS20 - Colorectal cancer ",1,"4 - QS20 - Colorectal cancer  - Process - 1","The number in the denominator who had 6-monthly serum CEA measurement in the 3 years after potentially curative surgery.","The number of adults who had potentially curative surgery for non-metastatic colorectal cancer."]
[null,"QS20","Colorectal cancer ",4,null,"Adults who have had potentially curative surgical treatment for non-metastatic colorectal cancer have follow-up for the first 3 years to detect local recurrence and distant metastases. ","Proportion of adults who had potentially curative surgery for non-metastatic colorectal cancer who had at least 2 CT scans of the chest, abdomen and pelvis in the 3 years after potentially curative surgery.","Process","QS20 - Colorectal cancer ","4 - QS20 - Colorectal cancer ",2,"4 - QS20 - Colorectal cancer  - Process - 2","The number in the denominator who had at least 2 CT scans of the chest, abdomen and pelvis in the 3 years after potentially curative surgery.","The number of adults who had potentially curative surgery for non-metastatic colorectal cancer."]
[null,"QS20","Colorectal cancer ",4,null,"Adults who have had potentially curative surgical treatment for non-metastatic colorectal cancer have follow-up for the first 3 years to detect local recurrence and distant metastases. ","Proportion of adults who had potentially curative surgery for non-metastatic colorectal cancer who had a clearance colonoscopy within 1 year of their diagnosis.","Process","QS20 - Colorectal cancer ","4 - QS20 - Colorectal cancer ",3,"4 - QS20 - Colorectal cancer  - Process - 3","The number in the denominator who had a clearance colonoscopy within 1 year of their diagnosis.","The number of adults who had potentially curative surgery for non-metastatic colorectal cancer."]
[null,"QS20","Colorectal cancer ",4,null,"Adults who have had potentially curative surgical treatment for non-metastatic colorectal cancer have follow-up for the first 3 years to detect local recurrence and distant metastases. ","Proportion of adults with newly diagnosed locally recurrent colorectal cancer after potentially curative surgery for non-metastatic colorectal cancer whose recurrent cancer was resectable at diagnosis.","Outcome","QS20 - Colorectal cancer ","4 - QS20 - Colorectal cancer ",1,"4 - QS20 - Colorectal cancer  - Outcome - 1","The number in the denominator whose recurrent cancer was resectable at diagnosis.","The number of adults with newly diagnosed locally recurrent colorectal cancer after potentially curative surgery for non-metastatic colorectal cancer."]
[null,"QS20","Colorectal cancer ",null,null,null,null,null,"QS20 - Colorectal cancer ",{"$f":"CONCATENATE(D442, \" - \", I442)","v":" - QS20 - Colorectal cancer "},{"$f":"IF(AND(B442=B441, D442=D441, H442=H441)=TRUE, K441+1, 1)","v":1},{"$f":"CONCATENATE(J442, \" - \", H442, \" - \",K442)","v":" - QS20 - Colorectal cancer  -  - 1"}]
[null,"QS20","Colorectal cancer ",null,null,null,null,null,"QS20 - Colorectal cancer "," - QS20 - Colorectal cancer ",2," - QS20 - Colorectal cancer  -  - 2"]
[null,"QS20","Colorectal cancer ",null,null,null,null,null,"QS20 - Colorectal cancer "," - QS20 - Colorectal cancer ",3," - QS20 - Colorectal cancer  -  - 3"]
[null,"QS20","Colorectal cancer ",null,null,null,null,null,"QS20 - Colorectal cancer "," - QS20 - Colorectal cancer ",4," - QS20 - Colorectal cancer  -  - 4"]
[null,"QS20","Colorectal cancer ",null,null,null,null,null,"QS20 - Colorectal cancer "," - QS20 - Colorectal cancer ",5," - QS20 - Colorectal cancer  -  - 5"]
[null,"QS20","Colorectal cancer ",null,null,null,null,null,{"$f":"CONCATENATE(B447, \" - \", C447)","v":"QS20 - Colorectal cancer "}," - QS20 - Colorectal cancer ",6," - QS20 - Colorectal cancer  -  - 6"]
[null,"QS20","Colorectal cancer ",null,null,null,null,null,"QS20 - Colorectal cancer "," - QS20 - Colorectal cancer ",7," - QS20 - Colorectal cancer  -  - 7"]
[null,"QS20","Colorectal cancer ",null,null,null,null,null,"QS20 - Colorectal cancer "," - QS20 - Colorectal cancer ",8," - QS20 - Colorectal cancer  -  - 8"]
[null,"QS21","Stable angina ",1,null,"People with features of typical or atypical angina are offered 64-slice (or above) CT coronary angiography.","Evidence of local arrangements to ensure that people with features of typical or atypical angina are offered 64-slice (or above) CT coronary angiography.","Structure","QS21 - Stable angina ","1 - QS21 - Stable angina ",1,"1 - QS21 - Stable angina  - Structure - 1","",""]
[null,"QS21","Stable angina ",1,null,"People with features of typical or atypical angina are offered 64-slice (or above) CT coronary angiography.","Proportion of people with features of typical or atypical angina who receive 64-slice (or above) CT coronary angiography.","Process","QS21 - Stable angina ","1 - QS21 - Stable angina ",1,"1 - QS21 - Stable angina  - Process - 1","The number of people in the denominator who receive 64-slice (or above) CT coronary angiography.","The number of people with features of typical or atypical angina."]
[null,"QS21","Stable angina ",2,null,"People with stable angina are offered a short-acting nitrate and either a beta-blocker or calcium-channel blocker as first-line treatment.","Evidence of local arrangements to ensure that people with stable angina are offered a short-acting nitrate and either a beta-blocker or calcium-channel blocker as first-line treatment.","Structure","QS21 - Stable angina ","2 - QS21 - Stable angina ",1,"2 - QS21 - Stable angina  - Structure - 1","",""]
[null,"QS21","Stable angina ",2,null,"People with stable angina are offered a short-acting nitrate and either a beta-blocker or calcium-channel blocker as first-line treatment.","Proportion of people newly diagnosed with stable angina who are prescribed a short-acting nitrate and either a beta-blocker or calcium-channel blocker as first-line treatment.","Process","QS21 - Stable angina ","2 - QS21 - Stable angina ",1,"2 - QS21 - Stable angina  - Process - 1","The number of people in the denominator prescribed a short-acting nitrate and either a beta-blocker or calcium-channel blocker as first-line treatment.","The number of people newly diagnosed with stable angina."]
[null,"QS21","Stable angina ",3,null,"People with stable angina are prescribed a short-acting nitrate and 1 or 2 anti-anginal drugs as necessary, before revascularisation is considered.","Evidence of local arrangements to ensure that people with stable angina are prescribed a short-acting nitrate and 1 or 2 anti-anginal drugs as necessary before revascularisation is considered. ","Structure","QS21 - Stable angina ","3 - QS21 - Stable angina ",1,"3 - QS21 - Stable angina  - Structure - 1","",""]
[null,"QS21","Stable angina ",3,null,"People with stable angina are prescribed a short-acting nitrate and 1 or 2 anti-anginal drugs as necessary, before revascularisation is considered.","Proportion of people with stable angina who are prescribed a short-acting nitrate and 1 or 2 anti-anginal drugs as necessary before revascularisation is considered","Process","QS21 - Stable angina ","3 - QS21 - Stable angina ",1,"3 - QS21 - Stable angina  - Process - 1","The number of people in the denominator prescribed a short-acting nitrate and 1 or 2 anti-anginal drugs as necessary before revascularisation is considered.","The number of people with stable angina considered for revascularisation."]
[null,"QS21","Stable angina ",4,null,"People with stable angina who have had coronary angiography, have their treatment options discussed by a multidisciplinary team if there is left main stem disease, anatomically complex three-vessel disease or doubt about the best method of revascularisation.","Evidence of local arrangements to provide a multidisciplinary team to discuss the risks and benefits of continuing drug treatment or revascularisation strategy for people with stable angina.","Structure","QS21 - Stable angina ","4 - QS21 - Stable angina ",1,"4 - QS21 - Stable angina  - Structure - 1",""]
[null,"QS21","Stable angina ",4,null,"People with stable angina who have had coronary angiography, have their treatment options discussed by a multidisciplinary team if there is left main stem disease, anatomically complex three-vessel disease or doubt about the best method of revascularisation.","Proportion of people with stable angina who have had coronary angiography who have their treatment options discussed by a multidisciplinary team if there is left main stem disease, anatomically complex three-vessel disease or doubt about the best method of revascularisation.","Process","QS21 - Stable angina ","4 - QS21 - Stable angina ",1,"4 - QS21 - Stable angina  - Process - 1","The number of people in the denominator who have their treatment options discussed by a multidisciplinary team.","The number of people with stable angina who have had coronary angiography who have left main stem disease or anatomically complex three-vessel disease, or if there is doubt about the best method of revascularisation."]
[null,"QS21","Stable angina ",5,null,"People with stable angina whose symptoms have not responded to treatment are offered a re-evaluation of their diagnosis and treatment.","Evidence of local arrangements to ensure that people with stable angina whose symptoms have not responded to treatment are offered a re-evaluation of their diagnosis and treatment.","Structure","QS21 - Stable angina ","5 - QS21 - Stable angina ",1,"5 - QS21 - Stable angina  - Structure - 1","",""]
[null,"QS21","Stable angina ",5,null,"People with stable angina whose symptoms have not responded to treatment are offered a re-evaluation of their diagnosis and treatment.","Proportion of people with stable angina whose symptoms have not responded to treatment who have their diagnosis and treatment re-evaluated.","Process","QS21 - Stable angina ","5 - QS21 - Stable angina ",1,"5 - QS21 - Stable angina  - Process - 1","The number of people in the denominator who have their diagnosis and treatment re-evaluated.","The number of people with stable angina whose symptoms have not responded to treatment."]
[null,"QS22","Antenatal care ",1,null,"Pregnant women are supported to access antenatal care by 10 weeks of pregnancy. [2012, updated 2023]","The proportion of booking appointments held by 10 weeks of pregnancy.","Process","QS22 - Antenatal care ","1 - QS22 - Antenatal care ",1,"1 - QS22 - Antenatal care  - Process - 1","The number in the denominator held by 10 weeks of pregnancy.","The number of booking appointments."]
[null,"QS22","Antenatal care ",1,null,"Pregnant women are supported to access antenatal care by 10 weeks of pregnancy. [2012, updated 2023]","The proportion of booking appointments which included a risk assessment.","Outcome","QS22 - Antenatal care ","1 - QS22 - Antenatal care ",1,"1 - QS22 - Antenatal care  - Outcome - 1","",""]
[null,"QS22","Antenatal care ",1,null,"Pregnant women are supported to access antenatal care by 10 weeks of pregnancy. [2012, updated 2023]","Perinatal mortality rates.","Outcome","QS22 - Antenatal care ","1 - QS22 - Antenatal care ",2,"1 - QS22 - Antenatal care  - Outcome - 2"]
[null,"QS22","Antenatal care ",2,null,"Pregnant women have a risk assessment at routine antenatal appointments. [2012, updated 2023]","The proportion of booking appointments which included a risk assessment.","Process","QS22 - Antenatal care ","2 - QS22 - Antenatal care ",1,"2 - QS22 - Antenatal care  - Process - 1","The number in the denominator which included a risk assessment.","The number of booking appointments."]
[null,"QS22","Antenatal care ",2,null,"Pregnant women have a risk assessment at routine antenatal appointments. [2012, updated 2023]","The proportion of routine antenatal appointments (excluding the booking appointment) which included a risk assessment.","Process","QS22 - Antenatal care ","2 - QS22 - Antenatal care ",2,"2 - QS22 - Antenatal care  - Process - 2","The number in The denominator which included a risk assessment.","The number of routine antenatal appointments (excluding The booking appointment)."]
[null,"QS22","Antenatal care ",2,null,"Pregnant women have a risk assessment at routine antenatal appointments. [2012, updated 2023]","Rates of maternal mortality.","Outcome","QS22 - Antenatal care ","2 - QS22 - Antenatal care ",1,"2 - QS22 - Antenatal care  - Outcome - 1"]
[null,"QS22","Antenatal care ",2,null,"Pregnant women have a risk assessment at routine antenatal appointments. [2012, updated 2023]","Stillbirth rates.","Outcome","QS22 - Antenatal care ","2 - QS22 - Antenatal care ",2,"2 - QS22 - Antenatal care  - Outcome - 2"]
[null,"QS22","Antenatal care ",2,null,"Pregnant women have a risk assessment at routine antenatal appointments. [2012, updated 2023]","Neonatal mortality rates.","Outcome","QS22 - Antenatal care ","2 - QS22 - Antenatal care ",3,"2 - QS22 - Antenatal care  - Outcome - 3"]
[null,"QS22","Antenatal care ",3,null,"Pregnant women have coordinated care from a small team of midwives. [2012, updated 2023]","The proportion of pregnant women who received care from a small team of midwives throughout their pregnancy.","Process","QS22 - Antenatal care ","3 - QS22 - Antenatal care ",1,"3 - QS22 - Antenatal care  - Process - 1","The number in The denominator who received care from a small team of midwives throughout Their pregnancy.","The number of pregnant women."]
[null,"QS22","Antenatal care ",3,null,"Pregnant women have coordinated care from a small team of midwives. [2012, updated 2023]","The proportion of women who gave birth who said they saw or spoke to members of the same team of midwives at antenatal appointments.","Outcome","QS22 - Antenatal care ","3 - QS22 - Antenatal care ",1,"3 - QS22 - Antenatal care  - Outcome - 1","The number in the denominator who said They saw or spoke to members of The same team of midwives every time at antenatal appointments.","The number of women who gave birth."]
[null,"QS22","Antenatal care ",4,null,"Pregnant women are offered vaccinations at routine antenatal appointments. [new 2023]","Evidence of local arrangements to ensure that healthcare professionals receive training to discuss and offer vaccinations to pregnant women.","Structure","QS22 - Antenatal care ","4 - QS22 - Antenatal care ",1,"4 - QS22 - Antenatal care  - Structure - 1"]
[null,"QS22","Antenatal care ",4,null,"Pregnant women are offered vaccinations at routine antenatal appointments. [new 2023]","Proportion of eligible women who had the seasonal flu vaccination during pregnancy.","Process","QS22 - Antenatal care ","4 - QS22 - Antenatal care ",1,"4 - QS22 - Antenatal care  - Process - 1","The number in the denominator who had The seasonal flu vaccination during pregnancy.","The number of pregnant women eligible for seasonal flu vaccination."]
[null,"QS22","Antenatal care ",4,null,"Pregnant women are offered vaccinations at routine antenatal appointments. [new 2023]","Proportion of eligible women who had a pertussis vaccination during pregnancy.","Process","QS22 - Antenatal care ","4 - QS22 - Antenatal care ",2,"4 - QS22 - Antenatal care  - Process - 2","The number in the denominator who had a pertussis vaccination during pregnancy.","The number of pregnant women eligible for pertussis vaccination."]
[null,"QS22","Antenatal care ",4,null,"Pregnant women are offered vaccinations at routine antenatal appointments. [new 2023]","The proportion of eligible women who had a COVID-19 vaccine during pregnancy.","Process","QS22 - Antenatal care ","4 - QS22 - Antenatal care ",3,"4 - QS22 - Antenatal care  - Process - 3","The number in the denominator who had a COVID-19 vaccine during pregnancy.","The number of pregnant women eligible for a COVID-19 vaccine."]
[null,"QS22","Antenatal care ",4,null,"Pregnant women are offered vaccinations at routine antenatal appointments. [new 2023]","Rates of hospitalisation and intensive care unit admission in pregnant women because of flu.","Outcome","QS22 - Antenatal care ","4 - QS22 - Antenatal care ",1,"4 - QS22 - Antenatal care  - Outcome - 1"]
[null,"QS22","Antenatal care ",4,null,"Pregnant women are offered vaccinations at routine antenatal appointments. [new 2023]","Incidence of pertussis.","Outcome","QS22 - Antenatal care ","4 - QS22 - Antenatal care ",2,"4 - QS22 - Antenatal care  - Outcome - 2"]
[null,"QS22","Antenatal care ",4,null,"Pregnant women are offered vaccinations at routine antenatal appointments. [new 2023]","Rates of hospital admission in pregnant women because of COVID-19.","Outcome","QS22 - Antenatal care ","4 - QS22 - Antenatal care ",3,"4 - QS22 - Antenatal care  - Outcome - 3"]
[null,"QS22","Antenatal care ",5,null,"Pregnant women and partners who smoke are referred for stop-smoking support and treatment at routine antenatal appointments. [2012, updated 2023]","Proportion of booking appointments that included a carbon monoxide (CO) test.","Process","QS22 - Antenatal care ","5 - QS22 - Antenatal care ",1,"5 - QS22 - Antenatal care  - Process - 1","The number in the denominator that included a CO test.","The number of booking appointments."]
[null,"QS22","Antenatal care ",5,null,"Pregnant women and partners who smoke are referred for stop-smoking support and treatment at routine antenatal appointments. [2012, updated 2023]","Proportion of pregnant women who smoke who were given an opt-out referral for stop-smoking support and treatment at the booking appointment.","Process","QS22 - Antenatal care ","5 - QS22 - Antenatal care ",2,"5 - QS22 - Antenatal care  - Process - 2","The number in the denominator who were given an opt-out referral for stop-smoking support and treatment.","The number of pregnant women recorded as current smokers at The booking appointment."]
[null,"QS22","Antenatal care ",5,null,"Pregnant women and partners who smoke are referred for stop-smoking support and treatment at routine antenatal appointments. [2012, updated 2023]","Proportion of pregnant women whose partner was recorded as a current smoker and was given a referral for stop-smoking support and treatment at the booking appointment.","Process","QS22 - Antenatal care ","5 - QS22 - Antenatal care ",3,"5 - QS22 - Antenatal care  - Process - 3","The number in the denominator whose partner was given a referral for stop-smoking support and treatment.","The number of pregnant women whose partner was recorded as a current smoker at The booking appointment."]
[null,"QS22","Antenatal care ",5,null,"Pregnant women and partners who smoke are referred for stop-smoking support and treatment at routine antenatal appointments. [2012, updated 2023]","Proportion of 36-week routine antenatal appointments that included a CO test.","Process","QS22 - Antenatal care ","5 - QS22 - Antenatal care ",4,"5 - QS22 - Antenatal care  - Process - 4","The number in the denominator that included a CO test.","The number of 36-week routine antenatal appointments."]
[null,"QS22","Antenatal care ",5,null,"Pregnant women and partners who smoke are referred for stop-smoking support and treatment at routine antenatal appointments. [2012, updated 2023]","Proportion of pregnant women who smoke who were given an opt-out referral for stop-smoking support and treatment at the 36-week routine antenatal appointment.","Process","QS22 - Antenatal care ","5 - QS22 - Antenatal care ",5,"5 - QS22 - Antenatal care  - Process - 5","The number in the denominator who were given an opt-out referral for stop-smoking support and treatment at The 36-week routine antenatal appointment.","The number of pregnant women recorded as current smokers at The 36-week routine antenatal appointment who have not already engaged with stop-smoking support and treatment."]
[null,"QS22","Antenatal care ",5,null,"Pregnant women and partners who smoke are referred for stop-smoking support and treatment at routine antenatal appointments. [2012, updated 2023]","Proportion of pregnant women whose partner was recorded as a current smoker and was given a referral for stop-smoking support and treatment at the 36-week routine antenatal appointment.","Process","QS22 - Antenatal care ","5 - QS22 - Antenatal care ",6,"5 - QS22 - Antenatal care  - Process - 6","The number in the denominator whose partner was given a referral for stop-smoking support and treatment.","The number of pregnant women whose partner was recorded as a current smoker at The 36-week routine antenatal appointment."]
[null,"QS22","Antenatal care ",5,null,"Pregnant women and partners who smoke are referred for stop-smoking support and treatment at routine antenatal appointments. [2012, updated 2023]","The proportion of women who were current smokers at delivery.","Outcome","QS22 - Antenatal care ","5 - QS22 - Antenatal care ",1,"5 - QS22 - Antenatal care  - Outcome - 1","The number in the denominator who were current smokers at delivery.","The number of women who gave birth."]
[null,"QS22","Antenatal care ",5,null,"Pregnant women and partners who smoke are referred for stop-smoking support and treatment at routine antenatal appointments. [2012, updated 2023]","The proportion of pregnant women with a partner who was a current smoker at delivery.","Outcome","QS22 - Antenatal care ","5 - QS22 - Antenatal care ",2,"5 - QS22 - Antenatal care  - Outcome - 2","The number in the denominator whose partner was a current smoker at delivery.","The number of pregnant women who gave birth who have a partner."]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",1," - QS22 - Antenatal care  -  - 1"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",2," - QS22 - Antenatal care  -  - 2"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",3," - QS22 - Antenatal care  -  - 3"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",4," - QS22 - Antenatal care  -  - 4"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",5," - QS22 - Antenatal care  -  - 5"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",6," - QS22 - Antenatal care  -  - 6"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",7," - QS22 - Antenatal care  -  - 7"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",8," - QS22 - Antenatal care  -  - 8"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",9," - QS22 - Antenatal care  -  - 9"]
[null,"QS22","Antenatal care ",null,null,null,null,null,{"$f":"CONCATENATE(B494, \" - \", C494)","v":"QS22 - Antenatal care "},{"$f":"CONCATENATE(D494, \" - \", I494)","v":" - QS22 - Antenatal care "},{"$f":"IF(AND(B494=B493, D494=D493, H494=H493)=TRUE, K493+1, 1)","v":10},{"$f":"CONCATENATE(J494, \" - \", H494, \" - \",K494)","v":" - QS22 - Antenatal care  -  - 10"}]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",11," - QS22 - Antenatal care  -  - 11"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",12," - QS22 - Antenatal care  -  - 12"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",13," - QS22 - Antenatal care  -  - 13"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",14," - QS22 - Antenatal care  -  - 14"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",15," - QS22 - Antenatal care  -  - 15"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",16," - QS22 - Antenatal care  -  - 16"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",{"$f":"IF(AND(B501=B500, D501=D500, H501=H500)=TRUE, K500+1, 1)","v":17},{"$f":"CONCATENATE(J501, \" - \", H501, \" - \",K501)","v":" - QS22 - Antenatal care  -  - 17"}]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",18," - QS22 - Antenatal care  -  - 18"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care ",{"$f":"CONCATENATE(D503, \" - \", I503)","v":" - QS22 - Antenatal care "},{"$f":"IF(AND(B503=B502, D503=D502, H503=H502)=TRUE, K502+1, 1)","v":19},{"$f":"CONCATENATE(J503, \" - \", H503, \" - \",K503)","v":" - QS22 - Antenatal care  -  - 19"}]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",20," - QS22 - Antenatal care  -  - 20"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",21," - QS22 - Antenatal care  -  - 21"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",22," - QS22 - Antenatal care  -  - 22"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",23," - QS22 - Antenatal care  -  - 23"]
[null,"QS22","Antenatal care ",null,null,null,null,null,{"$f":"CONCATENATE(B508, \" - \", C508)","v":"QS22 - Antenatal care "}," - QS22 - Antenatal care ",24," - QS22 - Antenatal care  -  - 24"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",25," - QS22 - Antenatal care  -  - 25"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",26," - QS22 - Antenatal care  -  - 26"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",27," - QS22 - Antenatal care  -  - 27"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",28," - QS22 - Antenatal care  -  - 28"]
[null,"QS22","Antenatal care ",null,null,null,null,null,"QS22 - Antenatal care "," - QS22 - Antenatal care ",29," - QS22 - Antenatal care  -  - 29"]
[null,"QS23","Drug use disorders in adults",1,null,"People who inject drugs have access to needle and syringe programmes in accordance with NICE guidance.","Evidence of local arrangements to ensure people who inject drugs have access to needle and syringe programmes in accordance with NICE’s guideline on needle and syringe programmes. ","Structure","QS23 - Drug use disorders in adults",{"$f":"CONCATENATE(D514, \" - \", I514)","v":"1 - QS23 - Drug use disorders in adults"},{"$f":"IF(AND(B514=B513, D514=D513, H514=H513)=TRUE, K513+1, 1)","v":1},{"$f":"CONCATENATE(J514, \" - \", H514, \" - \",K514)","v":"1 - QS23 - Drug use disorders in adults - Structure - 1"},"",""]
[null,"QS23","Drug use disorders in adults",1,null,"People who inject drugs have access to needle and syringe programmes in accordance with NICE guidance.","Proportion of people who inject drugs who access needle and syringe programmes.","Outcome","QS23 - Drug use disorders in adults","1 - QS23 - Drug use disorders in adults",1,"1 - QS23 - Drug use disorders in adults - Outcome - 1","The number of people who access needle and syringe programmes.","The estimated prevalence of injecting drug users."]
[null,"QS23","Drug use disorders in adults",1,null,"People who inject drugs have access to needle and syringe programmes in accordance with NICE guidance.","Incidence of blood-borne viruses among people who inject drugs","Outcome","QS23 - Drug use disorders in adults","1 - QS23 - Drug use disorders in adults",2,"1 - QS23 - Drug use disorders in adults - Outcome - 2"]
[null,"QS23","Drug use disorders in adults",2,null,"People in drug treatment are offered a comprehensive assessment. ","Evidence of local arrangements to ensure people in drug treatment are offered a comprehensive assessment.","Structure","QS23 - Drug use disorders in adults","2 - QS23 - Drug use disorders in adults",1,"2 - QS23 - Drug use disorders in adults - Structure - 1","",""]
[null,"QS23","Drug use disorders in adults",2,null,"People in drug treatment are offered a comprehensive assessment. ","Proportion of people in drug treatment who receive a comprehensive assessment.","Process","QS23 - Drug use disorders in adults","2 - QS23 - Drug use disorders in adults",1,"2 - QS23 - Drug use disorders in adults - Process - 1","The number of people in the denominator receiving a comprehensive assessment.","The number of people in drug treatment."]
[null,"QS23","Drug use disorders in adults",3,null,"Families and carers of people with drug use disorders are offered an assessment of their needs.","Evidence of local arrangements to ensure families and carers of people with drug use disorders are offered an assessment of their needs. ","Structure","QS23 - Drug use disorders in adults","3 - QS23 - Drug use disorders in adults",1,"3 - QS23 - Drug use disorders in adults - Structure - 1","",""]
[null,"QS23","Drug use disorders in adults",3,null,"Families and carers of people with drug use disorders are offered an assessment of their needs.","Proportion of identified family members and carers of people with drug use disorders who are offered an assessment of their needs","Process","QS23 - Drug use disorders in adults","3 - QS23 - Drug use disorders in adults",1,"3 - QS23 - Drug use disorders in adults - Process - 1","The number of people in the denominator offered an assessment of their needs.","The number of identified family members and carers of people with drug use disorders."]
[null,"QS23","Drug use disorders in adults",4,null,"People accessing drug treatment services are offered testing and referral for treatment for hepatitis B, hepatitis C and HIV and vaccination for hepatitis B. ","Evidence of local arrangements to ensure people accessing drug treatment services are offered testing for hepatitis B, hepatitis C and HIV, and referral for treatment if positive.","Structure","QS23 - Drug use disorders in adults","4 - QS23 - Drug use disorders in adults",1,"4 - QS23 - Drug use disorders in adults - Structure - 1","",""]
[null,"QS23","Drug use disorders in adults",4,null,"People accessing drug treatment services are offered testing and referral for treatment for hepatitis B, hepatitis C and HIV and vaccination for hepatitis B. ","Evidence of local arrangements to ensure people accessing drug treatment services are offered vaccination for hepatitis B.","Structure","QS23 - Drug use disorders in adults","4 - QS23 - Drug use disorders in adults",2,"4 - QS23 - Drug use disorders in adults - Structure - 2","",""]
[null,"QS23","Drug use disorders in adults",4,null,"People accessing drug treatment services are offered testing and referral for treatment for hepatitis B, hepatitis C and HIV and vaccination for hepatitis B. ","Proportion of people accessing drug treatment services, not known to have hepatitis B, who receive testing for hepatitis B.","Process","QS23 - Drug use disorders in adults","4 - QS23 - Drug use disorders in adults",1,"4 - QS23 - Drug use disorders in adults - Process - 1","The number of people in the denominator receiving testing for hepatitis B.","The number of people accessing drug treatment services not known to have hepatitis B."]
[null,"QS23","Drug use disorders in adults",4,null,"People accessing drug treatment services are offered testing and referral for treatment for hepatitis B, hepatitis C and HIV and vaccination for hepatitis B. ","Proportion of people accessing drug treatment services who test positive for hepatitis B and are referred for treatment.","Process","QS23 - Drug use disorders in adults","4 - QS23 - Drug use disorders in adults",2,"4 - QS23 - Drug use disorders in adults - Process - 2","The number of people in the denominator referred for treatment for hepatitis B.","The number of people accessing drug treatment services who test positive for hepatitis B."]
[null,"QS23","Drug use disorders in adults",4,null,"People accessing drug treatment services are offered testing and referral for treatment for hepatitis B, hepatitis C and HIV and vaccination for hepatitis B. ","Proportion of people accessing drug treatment services, not known to have hepatitis C, who receive testing for hepatitis C. ","Process","QS23 - Drug use disorders in adults","4 - QS23 - Drug use disorders in adults",3,"4 - QS23 - Drug use disorders in adults - Process - 3","The number of people in the denominator receiving testing for hepatitis C.","The number of people accessing drug treatment services not known to have hepatitis C."]
[null,"QS23","Drug use disorders in adults",4,null,"People accessing drug treatment services are offered testing and referral for treatment for hepatitis B, hepatitis C and HIV and vaccination for hepatitis B. ","Proportion of people accessing drug treatment services who test positive for hepatitis C and are referred for treatment.","Process","QS23 - Drug use disorders in adults","4 - QS23 - Drug use disorders in adults",4,"4 - QS23 - Drug use disorders in adults - Process - 4","The number of people in the denominator referred for treatment for hepatitis C.","The number of people accessing drug treatment services who test positive for hepatitis C."]
[null,"QS23","Drug use disorders in adults",4,null,"People accessing drug treatment services are offered testing and referral for treatment for hepatitis B, hepatitis C and HIV and vaccination for hepatitis B. ","Proportion of people accessing drug treatment services, not known to have HIV, who receive testing for HIV.","Process","QS23 - Drug use disorders in adults","4 - QS23 - Drug use disorders in adults",5,"4 - QS23 - Drug use disorders in adults - Process - 5","The number of people in the denominator receiving testing for HIV.","The number of people accessing drug treatment services not known to have HIV."]
[null,"QS23","Drug use disorders in adults",4,null,"People accessing drug treatment services are offered testing and referral for treatment for hepatitis B, hepatitis C and HIV and vaccination for hepatitis B. ","Proportion of people accessing drug treatment services who test positive for HIV and are referred for treatment.","Process","QS23 - Drug use disorders in adults","4 - QS23 - Drug use disorders in adults",6,"4 - QS23 - Drug use disorders in adults - Process - 6","The number of people in the denominator referred for treatment for HIV.","The number of people accessing drug treatment services who test positive for HIV."]
[null,"QS23","Drug use disorders in adults",4,null,"People accessing drug treatment services are offered testing and referral for treatment for hepatitis B, hepatitis C and HIV and vaccination for hepatitis B. ","Proportion of people accessing drug treatment services who are vaccinated against hepatitis B (either by the service or previously).","Process","QS23 - Drug use disorders in adults","4 - QS23 - Drug use disorders in adults",7,"4 - QS23 - Drug use disorders in adults - Process - 7","The number of people in the denominator who are vaccinated against hepatitis B.","The number of people accessing drug treatment services who are not known to have hepatitis B."]
[null,"QS23","Drug use disorders in adults",4,null,"People accessing drug treatment services are offered testing and referral for treatment for hepatitis B, hepatitis C and HIV and vaccination for hepatitis B. ","Rate of hepatitis B infection in people with drug use disorders","Outcome","QS23 - Drug use disorders in adults","4 - QS23 - Drug use disorders in adults",1,"4 - QS23 - Drug use disorders in adults - Outcome - 1"]
[null,"QS23","Drug use disorders in adults",4,null,"People accessing drug treatment services are offered testing and referral for treatment for hepatitis B, hepatitis C and HIV and vaccination for hepatitis B. ","Rate of hepatitis C infection in people with drug use disorders.","Outcome","QS23 - Drug use disorders in adults","4 - QS23 - Drug use disorders in adults",2,"4 - QS23 - Drug use disorders in adults - Outcome - 2"]
[null,"QS23","Drug use disorders in adults",5,null,"People in drug treatment are given information and advice about the following treatment options: harm reduction, maintenance, detoxification and abstinence.","Evidence of local arrangements for provision of all treatment options by local services.","Structure","QS23 - Drug use disorders in adults","5 - QS23 - Drug use disorders in adults",1,"5 - QS23 - Drug use disorders in adults - Structure - 1","",""]
[null,"QS23","Drug use disorders in adults",5,null,"People in drug treatment are given information and advice about the following treatment options: harm reduction, maintenance, detoxification and abstinence.","Evidence of local arrangements to ensure people in drug treatment are given information and advice about the following treatment options: harm reduction, maintenance, detoxification and abstinence.","Structure","QS23 - Drug use disorders in adults","5 - QS23 - Drug use disorders in adults",2,"5 - QS23 - Drug use disorders in adults - Structure - 2","",""]
[null,"QS23","Drug use disorders in adults",5,null,"People in drug treatment are given information and advice about the following treatment options: harm reduction, maintenance, detoxification and abstinence.","Proportion of people in drug treatment receiving information and advice about the following treatment options: harm reduction, maintenance, detoxification and abstinence.","Process","QS23 - Drug use disorders in adults","5 - QS23 - Drug use disorders in adults",1,"5 - QS23 - Drug use disorders in adults - Process - 1","The number of people in the denominator receiving information and advice about the following treatment options: harm reduction, maintenance, detoxification and abstinence.","The number of people in drug treatment."]
[null,"QS23","Drug use disorders in adults",6,null,"People in drug treatment are offered appropriate psychosocial interventions by their keyworker.","Evidence of local arrangements to ensure people in drug treatment are offered appropriate psychosocial interventions by their keyworker.","Structure","QS23 - Drug use disorders in adults","6 - QS23 - Drug use disorders in adults",1,"6 - QS23 - Drug use disorders in adults - Structure - 1","",""]
[null,"QS23","Drug use disorders in adults",6,null,"People in drug treatment are offered appropriate psychosocial interventions by their keyworker.","Proportion of people in drug treatment who receive appropriate psychosocial interventions from their keyworker.","Process","QS23 - Drug use disorders in adults","6 - QS23 - Drug use disorders in adults",1,"6 - QS23 - Drug use disorders in adults - Process - 1","The number of people in the denominator receiving appropriate psychosocial interventions from their keyworker.","The number of people in drug treatment."]
[null,"QS23","Drug use disorders in adults",7,null,"People in drug treatment are offered support to access services that promote recovery and reintegration including housing, education, employment, personal finance, healthcare and mutual aid.","Evidence of local arrangements to ensure people in drug treatment are offered support to access services that promote recovery and reintegration, including housing, education, employment, personal finance, healthcare and mutual aid.","Structure","QS23 - Drug use disorders in adults","7 - QS23 - Drug use disorders in adults",1,"7 - QS23 - Drug use disorders in adults - Structure - 1","",""]
[null,"QS23","Drug use disorders in adults",7,null,"People in drug treatment are offered support to access services that promote recovery and reintegration including housing, education, employment, personal finance, healthcare and mutual aid.","Proportion of people in drug treatment who receive support to access services that promote recovery and reintegration.","Process","QS23 - Drug use disorders in adults","7 - QS23 - Drug use disorders in adults",1,"7 - QS23 - Drug use disorders in adults - Process - 1","The number of people in the denominator receiving support to access services that promote recovery and reintegration.","The number of people in drug treatment."]
[null,"QS23","Drug use disorders in adults",8,null,"People in drug treatment are offered appropriate formal psychosocial interventions and/or psychological treatments.","Evidence of local arrangements to ensure people in drug treatment are offered appropriate formal psychosocial interventions and/or psychological treatments.","Structure","QS23 - Drug use disorders in adults","8 - QS23 - Drug use disorders in adults",1,"8 - QS23 - Drug use disorders in adults - Structure - 1","",""]
[null,"QS23","Drug use disorders in adults",8,null,"People in drug treatment are offered appropriate formal psychosocial interventions and/or psychological treatments.","Proportion of people in drug treatment who receive appropriate formal psychosocial interventions.","Process","QS23 - Drug use disorders in adults","8 - QS23 - Drug use disorders in adults",1,"8 - QS23 - Drug use disorders in adults - Process - 1","The number of people in the denominator receiving appropriate formal psychosocial interventions.","The number of people in drug treatment."]
[null,"QS23","Drug use disorders in adults",8,null,"People in drug treatment are offered appropriate formal psychosocial interventions and/or psychological treatments.","Proportion of people in drug treatment who have comorbid depression or anxiety disorders who receive psychological treatments for those disorders.","Process","QS23 - Drug use disorders in adults","8 - QS23 - Drug use disorders in adults",2,"8 - QS23 - Drug use disorders in adults - Process - 2","The number of people in the denominator receiving psychological treatments for those disorders.","The number of people in drug treatment who have comorbid depression or anxiety disorders."]
[null,"QS23","Drug use disorders in adults",9,null,"People who have achieved abstinence are offered continued treatment or support for at least 6 months.","Evidence of local arrangements to ensure people who have achieved abstinence are offered continued treatment and support for at least 6 months.","Structure","QS23 - Drug use disorders in adults","9 - QS23 - Drug use disorders in adults",1,"9 - QS23 - Drug use disorders in adults - Structure - 1","",""]
[null,"QS23","Drug use disorders in adults",9,null,"People who have achieved abstinence are offered continued treatment or support for at least 6 months.","Proportion of people who have achieved abstinence who receive continued treatment and support for at least 6 months.","Process","QS23 - Drug use disorders in adults","9 - QS23 - Drug use disorders in adults",1,"9 - QS23 - Drug use disorders in adults - Process - 1","The number of people in the denominator who receive continued treatment and support for at least 6 months after being identified as drug free.","The number of people who have achieved abstinence."]
[null,"QS23","Drug use disorders in adults",9,null,"People who have achieved abstinence are offered continued treatment or support for at least 6 months.","Proportion of people who have achieved abstinence who are still abstinent at 6 months.","Outcome","QS23 - Drug use disorders in adults","9 - QS23 - Drug use disorders in adults",1,"9 - QS23 - Drug use disorders in adults - Outcome - 1"]
[null,"QS23","Drug use disorders in adults",10,null,"People in drug treatment are given information and advice on the NICE eligibility criteria for residential rehabilitative treatment.","Evidence of local arrangements to ensure that people in drug treatment are given information and advice on the NICE eligibility criteria for residential rehabilitative treatment.","Structure","QS23 - Drug use disorders in adults","10 - QS23 - Drug use disorders in adults",1,"10 - QS23 - Drug use disorders in adults - Structure - 1","",""]
[null,"QS23","Drug use disorders in adults",10,null,"People in drug treatment are given information and advice on the NICE eligibility criteria for residential rehabilitative treatment.","Proportion of people in drug treatment who receive information and advice on the NICE eligibility criteria for residential rehabilitative treatment.","Process","QS23 - Drug use disorders in adults","10 - QS23 - Drug use disorders in adults",1,"10 - QS23 - Drug use disorders in adults - Process - 1","The number of people in the denominator receiving information and advice on the NICE eligibility criteria for residential rehabilitative treatment.","The number of people in drug treatment."]
[null,"QS24","Nutrition support in adults ",1,null,"People in care settings are screened for the risk of malnutrition using a validated screening tool","Evidence of local arrangements to ensure that care settings have access to suitably calibrated equipment to enable accurate screening to be conducted","Structure","QS24 - Nutrition support in adults ","1 - QS24 - Nutrition support in adults ",1,"1 - QS24 - Nutrition support in adults  - Structure - 1"]
[null,"QS24","Nutrition support in adults ",1,null,"People in care settings are screened for the risk of malnutrition using a validated screening tool","Evidence of local arrangements to ensure that people in care settings are screened for the risk of malnutrition using a validated screening tool","Structure","QS24 - Nutrition support in adults ","1 - QS24 - Nutrition support in adults ",2,"1 - QS24 - Nutrition support in adults  - Structure - 2","",""]
[null,"QS24","Nutrition support in adults ",1,null,"People in care settings are screened for the risk of malnutrition using a validated screening tool","Evidence of local arrangements to ensure that screening for the risk of malnutrition is carried out by health and social care professionals who have undertaken training to use a validated screening tool","Structure","QS24 - Nutrition support in adults ","1 - QS24 - Nutrition support in adults ",3,"1 - QS24 - Nutrition support in adults  - Structure - 3","",""]
[null,"QS24","Nutrition support in adults ",1,null,"People in care settings are screened for the risk of malnutrition using a validated screening tool","The proportion of people in care settings who are screened for the risk of malnutrition using a validated screening tool.","Process","QS24 - Nutrition support in adults ","1 - QS24 - Nutrition support in adults ",1,"1 - QS24 - Nutrition support in adults  - Process - 1","The number of people in the denominator who are screened for the risk of malnutrition using a validated screening tool.","The number of people in a care setting."]
[null,"QS24","Nutrition support in adults ",1,null,"People in care settings are screened for the risk of malnutrition using a validated screening tool","The proportion of people admitted to hospital who are re-screened weekly for the risk of malnutrition","Process","QS24 - Nutrition support in adults ","1 - QS24 - Nutrition support in adults ",2,"1 - QS24 - Nutrition support in adults  - Process - 2","The number of people in the denominator who are re-screened weekly for the risk of malnutrition.","The number of people admitted to hospital."]
[null,"QS24","Nutrition support in adults ",1,null,"People in care settings are screened for the risk of malnutrition using a validated screening tool","The proportion of people in care home settings who are screened monthly for the risk of malnutrition.","Process","QS24 - Nutrition support in adults ","1 - QS24 - Nutrition support in adults ",3,"1 - QS24 - Nutrition support in adults  - Process - 3","The number of people in the denominator who are screened monthly for the risk of malnutrition.","The number of people in community care settings."]
[null,"QS24","Nutrition support in adults ",1,null,"People in care settings are screened for the risk of malnutrition using a validated screening tool","Incidence of people at risk of malnutrition","Outcome","QS24 - Nutrition support in adults ","1 - QS24 - Nutrition support in adults ",1,"1 - QS24 - Nutrition support in adults  - Outcome - 1"]
[null,"QS24","Nutrition support in adults ",1,null,"People in care settings are screened for the risk of malnutrition using a validated screening tool","Prevalence of malnutrition.","Outcome","QS24 - Nutrition support in adults ","1 - QS24 - Nutrition support in adults ",2,"1 - QS24 - Nutrition support in adults  - Outcome - 2"]
[null,"QS24","Nutrition support in adults ",2,null,"People who are malnourished or at risk of malnutrition have a management care plan that aims to meet their complete nutritional requirements","Evidence of a local written protocol that all management care plans aim to provide complete nutritional requirements","Structure","QS24 - Nutrition support in adults ","2 - QS24 - Nutrition support in adults ",1,"2 - QS24 - Nutrition support in adults  - Structure - 1","",""]
[null,"QS24","Nutrition support in adults ",2,null,"People who are malnourished or at risk of malnutrition have a management care plan that aims to meet their complete nutritional requirements","Evidence of local arrangements to ensure that care settings are able to provide appropriate nutrition support including artificial feeding when needed. ","Structure","QS24 - Nutrition support in adults ","2 - QS24 - Nutrition support in adults ",2,"2 - QS24 - Nutrition support in adults  - Structure - 2","",""]
[null,"QS24","Nutrition support in adults ",2,null,"People who are malnourished or at risk of malnutrition have a management care plan that aims to meet their complete nutritional requirements","Evidence of local arrangements to ensure that people who are malnourished or at risk of malnutrition are offered a management care plan that aims to meet their complete nutritional requirements including underlying conditions, specific circumstances and associated needs.","Structure","QS24 - Nutrition support in adults ","2 - QS24 - Nutrition support in adults ",3,"2 - QS24 - Nutrition support in adults  - Structure - 3","",""]
[null,"QS24","Nutrition support in adults ",2,null,"People who are malnourished or at risk of malnutrition have a management care plan that aims to meet their complete nutritional requirements","The proportion of people who are malnourished or at risk of malnutrition who receive a management care plan that aims to meet their complete nutritional requirements.","Process","QS24 - Nutrition support in adults ","2 - QS24 - Nutrition support in adults ",1,"2 - QS24 - Nutrition support in adults  - Process - 1","The number of people in the denominator who receive a management care plan that aims to meet their complete nutritional requirements.","The number of people who are malnourished or at risk of malnutrition."]
[null,"QS24","Nutrition support in adults ",3,null,"All people who are screened for the risk of malnutrition have their screening results and nutrition support goals (if applicable), documented and communicated in writing within and between settings","Evidence of local arrangements to ensure that a person’s screening results and nutrition support goals (if applicable) are documented and communicated in writing when a person transfers within and between settings","Structure","QS24 - Nutrition support in adults ","3 - QS24 - Nutrition support in adults ",1,"3 - QS24 - Nutrition support in adults  - Structure - 1","",""]
[null,"QS24","Nutrition support in adults ",3,null,"All people who are screened for the risk of malnutrition have their screening results and nutrition support goals (if applicable), documented and communicated in writing within and between settings","The proportion of people screened for the risk of malnutrition whose screening results and nutritional support goals (if applicable) are documented in their care plan","Process","QS24 - Nutrition support in adults ","3 - QS24 - Nutrition support in adults ",1,"3 - QS24 - Nutrition support in adults  - Process - 1","The number of people in the denominator whose screening results and nutritional support goals (if applicable) are documented in their care plan.","The number of people in a care setting who meet the criteria for screening (see statement 1)."]
[null,"QS24","Nutrition support in adults ",3,null,"All people who are screened for the risk of malnutrition have their screening results and nutrition support goals (if applicable), documented and communicated in writing within and between settings","The proportion of people screened for the risk of malnutrition whose screening results and nutritional support goals (if applicable) are communicated in writing within and between settings.","Process","QS24 - Nutrition support in adults ",{"$f":"CONCATENATE(D561, \" - \", I561)","v":"3 - QS24 - Nutrition support in adults "},{"$f":"IF(AND(B561=B560, D561=D560, H561=H560)=TRUE, K560+1, 1)","v":2},{"$f":"CONCATENATE(J561, \" - \", H561, \" - \",K561)","v":"3 - QS24 - Nutrition support in adults  - Process - 2"},"The number of people in the denominator whose screening results and nutritional support goals (if applicable) are communicated in writing.","The number of people transferred within or between settings and who have been screened for the risk of malnutrition."]
[null,"QS24","Nutrition support in adults ",4,null,"People managing their own artificial nutrition support and/or their carers are trained to manage their nutrition delivery system and monitor their wellbeing","Evidence of local arrangements to ensure that systems are in place for people managing their own artificial nutrition support and/or their carers to be trained to manage their nutrition delivery system and monitor their wellbeing","Structure","QS24 - Nutrition support in adults ","4 - QS24 - Nutrition support in adults ",1,"4 - QS24 - Nutrition support in adults  - Structure - 1"]
[null,"QS24","Nutrition support in adults ",4,null,"People managing their own artificial nutrition support and/or their carers are trained to manage their nutrition delivery system and monitor their wellbeing","Evidence of local arrangements to ensure that systems are in place for people managing their own artificial nutrition support and/or their carers to be able to contact a specialist urgently for advice if they identify any adverse changes in their wellbeing and in the management of their nutrition delivery system","Structure","QS24 - Nutrition support in adults ","4 - QS24 - Nutrition support in adults ",2,"4 - QS24 - Nutrition support in adults  - Structure - 2"]
[null,"QS24","Nutrition support in adults ",4,null,"People managing their own artificial nutrition support and/or their carers are trained to manage their nutrition delivery system and monitor their wellbeing","The proportion of people managing their own artificial nutrition support and/or their carers who are trained to manage their nutrition delivery system and monitor their wellbeing.","Process","QS24 - Nutrition support in adults ","4 - QS24 - Nutrition support in adults ",1,"4 - QS24 - Nutrition support in adults  - Process - 1","The number of people in the denominator who have received training to manage their nutrition delivery system and monitor their wellbeing.","The number of people or the carers of people managing their own artificial nutrition support."]
[null,"QS24","Nutrition support in adults ",4,null,"People managing their own artificial nutrition support and/or their carers are trained to manage their nutrition delivery system and monitor their wellbeing","The proportion of people managing their own artificial nutrition support, and/or their carers, who are provided with contact details of a specialist in nutrition support who can provide urgent advice.","Process","QS24 - Nutrition support in adults ","4 - QS24 - Nutrition support in adults ",2,"4 - QS24 - Nutrition support in adults  - Process - 2","The number of people in the denominator who are provided with contact details of a specialist in nutrition support who can provide urgent advice.","The number of people and or the carers of people managing their own artificial nutrition support."]
[null,"QS24","Nutrition support in adults ",4,null,"People managing their own artificial nutrition support and/or their carers are trained to manage their nutrition delivery system and monitor their wellbeing","People’s confidence and competence to manage their own or others artificial nutrition support","Outcome",{"$f":"CONCATENATE(B566, \" - \", C566)","v":"QS24 - Nutrition support in adults "},"4 - QS24 - Nutrition support in adults ",1,"4 - QS24 - Nutrition support in adults  - Outcome - 1"]
[null,"QS24","Nutrition support in adults ",4,null,"People managing their own artificial nutrition support and/or their carers are trained to manage their nutrition delivery system and monitor their wellbeing","Rates of adverse events and complications in people managing their own or others artificial nutrition support","Outcome","QS24 - Nutrition support in adults ","4 - QS24 - Nutrition support in adults ",2,"4 - QS24 - Nutrition support in adults  - Outcome - 2"]
[null,"QS24","Nutrition support in adults ",5,null,"People receiving nutrition support are offered a review of the indications, route, risks, benefits and goals of nutrition support at planned intervals","Evidence of local arrangements to ensure that people receiving nutrition support are offered a review of the indications, route, risks, benefits and goals of nutrition support at planned intervals","Structure","QS24 - Nutrition support in adults ","5 - QS24 - Nutrition support in adults ",1,"5 - QS24 - Nutrition support in adults  - Structure - 1","",""]
[null,"QS24","Nutrition support in adults ",5,null,"People receiving nutrition support are offered a review of the indications, route, risks, benefits and goals of nutrition support at planned intervals","The proportion of people receiving nutrition support who have the indications, route, risks, benefits and goals of their nutrition support reviewed at planned intervals","Process","QS24 - Nutrition support in adults ","5 - QS24 - Nutrition support in adults ",1,"5 - QS24 - Nutrition support in adults  - Process - 1","The number of people in the denominator whose most recent review (subject to decision) is no later than planned after their last review.","The number of people receiving nutrition support."]
[null,"QS25","Asthma ",1,null,"People aged 5 years and over with suspected asthma have objective tests to support diagnosis.","Evidence of local arrangements or referral pathways to asthma diagnostic hubs to ensure that people aged 5 years and over with suspected asthma have objective tests to support diagnosis.","Structure","QS25 - Asthma ","1 - QS25 - Asthma ",1,"1 - QS25 - Asthma  - Structure - 1"]
[null,"QS25","Asthma ",1,null,"People aged 5 years and over with suspected asthma have objective tests to support diagnosis.","Evidence of local arrangements to ensure that healthcare professionals are trained and competent to carry out and interpret objective tests to support diagnosis of asthma.","Structure","QS25 - Asthma ","1 - QS25 - Asthma ",2,"1 - QS25 - Asthma  - Structure - 2"]
[null,"QS25","Asthma ",1,null,"People aged 5 years and over with suspected asthma have objective tests to support diagnosis.","Evidence of local processes to ensure that the basis for a diagnosis of asthma is documented.","Structure","QS25 - Asthma ","1 - QS25 - Asthma ",3,"1 - QS25 - Asthma  - Structure - 3"]
[null,"QS25","Asthma ",1,null,"People aged 5 years and over with suspected asthma have objective tests to support diagnosis.","Proportion of adults aged 17 years and over with newly diagnosed asthma who have a record of a fractional exhaled nitric oxide (FeNO) test to support diagnosis.","Process","QS25 - Asthma ","1 - QS25 - Asthma ",1,"1 - QS25 - Asthma  - Process - 1","The number in the denominator who have a record of a FeNO test to support diagnosis.","The number of adults aged 17 years and over with newly diagnosed asthma."]
[null,"QS25","Asthma ",1,null,"People aged 5 years and over with suspected asthma have objective tests to support diagnosis.","Proportion of people aged 5 years and over with newly diagnosed asthma who have a record of a spirometry test to support diagnosis.","Process","QS25 - Asthma ","1 - QS25 - Asthma ",2,"1 - QS25 - Asthma  - Process - 2","The number in the denominator who have a record of a spirometry test to support diagnosis.","The number of people aged 5 years and over with newly diagnosed asthma."]
[null,"QS25","Asthma ",1,null,"People aged 5 years and over with suspected asthma have objective tests to support diagnosis.","Proportion of people aged 5 years and over with newly diagnosed asthma who have a record of the objective tests used to support diagnosis.","Process","QS25 - Asthma ","1 - QS25 - Asthma ",3,"1 - QS25 - Asthma  - Process - 3","The number in the denominator who have a record of the objective tests used to support diagnosis.","The number of people aged 5 years and over with newly diagnosed asthma."]
[null,"QS25","Asthma ",1,null,"People aged 5 years and over with suspected asthma have objective tests to support diagnosis.","Prevalence of asthma.","Outcome","QS25 - Asthma ","1 - QS25 - Asthma ",1,"1 - QS25 - Asthma  - Outcome - 1"]
[null,"QS25","Asthma ",2,null,"People aged 5 years and over with asthma discuss and agree a written personalised action plan.","Evidence of a local framework and guidance for healthcare professionals on providing asthma education and developing a written personalised action plan for people aged 5 years and over with asthma.","Structure","QS25 - Asthma ","2 - QS25 - Asthma ",1,"2 - QS25 - Asthma  - Structure - 1"]
[null,"QS25","Asthma ",2,null,"People aged 5 years and over with asthma discuss and agree a written personalised action plan.","Evidence of local arrangements to ensure that people aged 5 years and over with asthma discuss and agree a written personalised action plan with their healthcare professional.","Structure","QS25 - Asthma ","2 - QS25 - Asthma ",2,"2 - QS25 - Asthma  - Structure - 2"]
[null,"QS25","Asthma ",2,null,"People aged 5 years and over with asthma discuss and agree a written personalised action plan.","Proportion of people aged 5 years and over with asthma who have a record of a discussion to agree a written personalised action plan.","Process","QS25 - Asthma ","2 - QS25 - Asthma ",1,"2 - QS25 - Asthma  - Process - 1","The number of people in the denominator who have a record of a discussion to agree a written personalised action plan.","The number of people aged 5 years and over with asthma."]
[null,"QS25","Asthma ",2,null,"People aged 5 years and over with asthma discuss and agree a written personalised action plan.","Proportion of people aged 5 years and over with asthma who have a documented written personalised action plan.","Process","QS25 - Asthma ","2 - QS25 - Asthma ",2,"2 - QS25 - Asthma  - Process - 2","The number of people in the denominator who have a documented written personalised action plan.","The number of people aged 5 years and over with asthma."]
[null,"QS25","Asthma ",2,null,"People aged 5 years and over with asthma discuss and agree a written personalised action plan.","Proportion of written personalised action plans for people aged 5 years and over with asthma that include approaches to minimising exposure to indoor and outdoor air pollution.","Process",{"$f":"CONCATENATE(B581, \" - \", C581)","v":"QS25 - Asthma "},{"$f":"CONCATENATE(D581, \" - \", I581)","v":"2 - QS25 - Asthma "},{"$f":"IF(AND(B581=B580, D581=D580, H581=H580)=TRUE, K580+1, 1)","v":3},{"$f":"CONCATENATE(J581, \" - \", H581, \" - \",K581)","v":"2 - QS25 - Asthma  - Process - 3"},"The number in the denominator that include approaches to minimising exposure to indoor and outdoor air pollution.","The number of written personalised action plans for people aged 5 years and over with asthma."]
[null,"QS25","Asthma ",2,null,"People aged 5 years and over with asthma discuss and agree a written personalised action plan.","Rate of hospital attendance or admission for an asthma attack.","Outcome","QS25 - Asthma ","2 - QS25 - Asthma ",1,"2 - QS25 - Asthma  - Outcome - 1"]
[null,"QS25","Asthma ",2,null,"People aged 5 years and over with asthma discuss and agree a written personalised action plan.","Satisfaction of people with asthma aged 5 years and over and their family and carers (as appropriate) that they are able to self-manage their condition and their asthma is well controlled.","Outcome","QS25 - Asthma ","2 - QS25 - Asthma ",2,"2 - QS25 - Asthma  - Outcome - 2"]
[null,"QS25","Asthma ",3,null,"People with asthma have their asthma control monitored at every asthma review.","Evidence that tools, such as a validated questionnaire, are used locally for monitoring asthma control in adults.","Structure","QS25 - Asthma ","3 - QS25 - Asthma ",1,"3 - QS25 - Asthma  - Structure - 1"]
[null,"QS25","Asthma ",3,null,"People with asthma have their asthma control monitored at every asthma review.","Evidence that spirometry or peak flow variability testing are used locally for monitoring asthma control in people aged 5 and over.","Structure","QS25 - Asthma ","3 - QS25 - Asthma ",2,"3 - QS25 - Asthma  - Structure - 2"]
[null,"QS25","Asthma ",3,null,"People with asthma have their asthma control monitored at every asthma review.","Evidence of local arrangements to ensure that people with asthma have their asthma control monitored at every asthma review.","Structure","QS25 - Asthma ","3 - QS25 - Asthma ",3,"3 - QS25 - Asthma  - Structure - 3"]
[null,"QS25","Asthma ",3,null,"People with asthma have their asthma control monitored at every asthma review.","Proportion of people with asthma who had an asthma review within the past 12 months.","Process","QS25 - Asthma ","3 - QS25 - Asthma ",1,"3 - QS25 - Asthma  - Process - 1","The number in the denominator who had an asthma review within the past 12 months.","The number of people with asthma."]
[null,"QS25","Asthma ",3,null,"People with asthma have their asthma control monitored at every asthma review.","Proportion of asthma reviews that include monitoring of asthma control.","Process","QS25 - Asthma ","3 - QS25 - Asthma ",2,"3 - QS25 - Asthma  - Process - 2","The number in the denominator that include monitoring of asthma control.","The number of asthma reviews."]
[null,"QS25","Asthma ",3,null,"People with asthma have their asthma control monitored at every asthma review.","Proportion of people with asthma prescribed more than 12 short-acting beta agonist (SABA) reliever inhalers within the past 12 months.","Outcome","QS25 - Asthma ","3 - QS25 - Asthma ",1,"3 - QS25 - Asthma  - Outcome - 1"]
[null,"QS25","Asthma ",3,null,"People with asthma have their asthma control monitored at every asthma review.","Rate of hospital attendance or admission for asthma attack.","Outcome","QS25 - Asthma ","3 - QS25 - Asthma ",2,"3 - QS25 - Asthma  - Outcome - 2"]
[null,"QS25","Asthma ",4,null,"People who receive treatment in an emergency care setting for an asthma attack are followed up by their general practice within 2 working days of discharge.","Evidence of local arrangements to ensure that emergency care settings notify the person's general practice following treatment for an asthma attack.","Structure","QS25 - Asthma ","4 - QS25 - Asthma ",1,"4 - QS25 - Asthma  - Structure - 1"]
[null,"QS25","Asthma ",4,null,"People who receive treatment in an emergency care setting for an asthma attack are followed up by their general practice within 2 working days of discharge.","Evidence of local arrangements to ensure that general practices follow‑up people treated in an emergency care setting for an asthma attack within 2 working days of discharge.","Structure","QS25 - Asthma ","4 - QS25 - Asthma ",2,"4 - QS25 - Asthma  - Structure - 2"]
[null,"QS25","Asthma ",4,null,"People who receive treatment in an emergency care setting for an asthma attack are followed up by their general practice within 2 working days of discharge.","Proportion of cases of asthma attack treated in an emergency care setting notified to the person's general practice.","Process","QS25 - Asthma ","4 - QS25 - Asthma ",1,{"$f":"CONCATENATE(J593, \" - \", H593, \" - \",K593)","v":"4 - QS25 - Asthma  - Process - 1"},"The number in the denominator notified to the person's general practice.","The number of cases asthma attack treated in an emergency care setting."]
[null,"QS25","Asthma ",4,null,"People who receive treatment in an emergency care setting for an asthma attack are followed up by their general practice within 2 working days of discharge.","Proportion of notifications of asthma attack treated in an emergency care setting followed up by a general practice within 2 working days of discharge.","Process","QS25 - Asthma ","4 - QS25 - Asthma ",2,{"$f":"CONCATENATE(J594, \" - \", H594, \" - \",K594)","v":"4 - QS25 - Asthma  - Process - 2"},"The number in the denominator that are followed up by a general practice within 2 working days of discharge.","The number of notifications of asthma attack treated in an emergency care setting."]
[null,"QS25","Asthma ",4,null,"People who receive treatment in an emergency care setting for an asthma attack are followed up by their general practice within 2 working days of discharge.","Rate of re-attendance within 7 days of a previous attendance in emergency care for asthma.","Outcome","QS25 - Asthma ","4 - QS25 - Asthma ",1,"4 - QS25 - Asthma  - Outcome - 1"]
[null,"QS25","Asthma ",4,null,"People who receive treatment in an emergency care setting for an asthma attack are followed up by their general practice within 2 working days of discharge.","Rate of hospital attendance or admission for asthma attack.","Outcome","QS25 - Asthma ","4 - QS25 - Asthma ",2,"4 - QS25 - Asthma  - Outcome - 2"]
[null,"QS25","Asthma ",4,null,"People who receive treatment in an emergency care setting for an asthma attack are followed up by their general practice within 2 working days of discharge.","Mortality rate for people with asthma.","Outcome","QS25 - Asthma ","4 - QS25 - Asthma ",3,"4 - QS25 - Asthma  - Outcome - 3"]
[null,"QS25","Asthma ",5,null,"People with suspected severe asthma are referred to a specialist multidisciplinary severe asthma service.","Evidence that specialist multidisciplinary severe asthma services are available for people with suspected severe asthma.","Structure","QS25 - Asthma ","5 - QS25 - Asthma ",1,"5 - QS25 - Asthma  - Structure - 1"]
[null,"QS25","Asthma ",5,null,"People with suspected severe asthma are referred to a specialist multidisciplinary severe asthma service. ","Evidence of local arrangements to ensure that people with suspected severe asthma are referred to a specialist multidisciplinary severe asthma service.","Structure","QS25 - Asthma ","5 - QS25 - Asthma ",2,"5 - QS25 - Asthma  - Structure - 2"]
[null,"QS25","Asthma ",5,null,"People with suspected severe asthma are referred to a specialist multidisciplinary severe asthma service. ","Proportion of people with suspected severe asthma who are referred to a specialist multidisciplinary severe asthma service.","Process","QS25 - Asthma ","5 - QS25 - Asthma ",1,"5 - QS25 - Asthma  - Process - 1","The number in the denominator who are referred to a specialist multidisciplinary severe asthma service.","The number of people with suspected severe asthma."]
[null,"QS25","Asthma ",5,null,"People with suspected severe asthma are referred to a specialist multidisciplinary severe asthma service. ","Rate of hospital attendance or admission for an asthma attack.","Outcome","QS25 - Asthma ","5 - QS25 - Asthma ",1,"5 - QS25 - Asthma  - Outcome - 1"]
[null,"QS25","Asthma ",5,null,"People with suspected severe asthma are referred to a specialist multidisciplinary severe asthma service. ","Proportion of people with asthma who have 2 or more courses of high-dose oral corticosteroids per year.","Outcome","QS25 - Asthma ","5 - QS25 - Asthma ",2,"5 - QS25 - Asthma  - Outcome - 2"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",1," - QS26 - Replaced by QS211 -  - 1"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",2," - QS26 - Replaced by QS211 -  - 2"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",3," - QS26 - Replaced by QS211 -  - 3"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",4," - QS26 - Replaced by QS211 -  - 4"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",5," - QS26 - Replaced by QS211 -  - 5"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",6," - QS26 - Replaced by QS211 -  - 6"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",7," - QS26 - Replaced by QS211 -  - 7"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",8," - QS26 - Replaced by QS211 -  - 8"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",9," - QS26 - Replaced by QS211 -  - 9"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",10," - QS26 - Replaced by QS211 -  - 10"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",11," - QS26 - Replaced by QS211 -  - 11"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",12," - QS26 - Replaced by QS211 -  - 12"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",13," - QS26 - Replaced by QS211 -  - 13"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",14," - QS26 - Replaced by QS211 -  - 14"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",15," - QS26 - Replaced by QS211 -  - 15"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",16," - QS26 - Replaced by QS211 -  - 16"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",17," - QS26 - Replaced by QS211 -  - 17"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",18," - QS26 - Replaced by QS211 -  - 18"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",19," - QS26 - Replaced by QS211 -  - 19"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",20," - QS26 - Replaced by QS211 -  - 20"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",21," - QS26 - Replaced by QS211 -  - 21"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",22," - QS26 - Replaced by QS211 -  - 22"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",23," - QS26 - Replaced by QS211 -  - 23"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",24," - QS26 - Replaced by QS211 -  - 24"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",25," - QS26 - Replaced by QS211 -  - 25"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",26," - QS26 - Replaced by QS211 -  - 26"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",27," - QS26 - Replaced by QS211 -  - 27"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",28," - QS26 - Replaced by QS211 -  - 28"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",29," - QS26 - Replaced by QS211 -  - 29"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",30," - QS26 - Replaced by QS211 -  - 30"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211",{"$f":"CONCATENATE(D633, \" - \", I633)","v":" - QS26 - Replaced by QS211"},{"$f":"IF(AND(B633=B632, D633=D632, H633=H632)=TRUE, K632+1, 1)","v":31},{"$f":"CONCATENATE(J633, \" - \", H633, \" - \",K633)","v":" - QS26 - Replaced by QS211 -  - 31"}]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",32," - QS26 - Replaced by QS211 -  - 32"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",33," - QS26 - Replaced by QS211 -  - 33"]
[null,"QS26","Replaced by QS211",null,null,null,null,null,"QS26 - Replaced by QS211"," - QS26 - Replaced by QS211",34," - QS26 - Replaced by QS211 -  - 34"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",1," - QS27 - Replaced by QS211 -  - 1"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,{"$f":"CONCATENATE(B638, \" - \", C638)","v":"QS27 - Replaced by QS211"}," - QS27 - Replaced by QS211",2," - QS27 - Replaced by QS211 -  - 2"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",3," - QS27 - Replaced by QS211 -  - 3"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",4," - QS27 - Replaced by QS211 -  - 4"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",5," - QS27 - Replaced by QS211 -  - 5"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",6," - QS27 - Replaced by QS211 -  - 6"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",7," - QS27 - Replaced by QS211 -  - 7"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",8," - QS27 - Replaced by QS211 -  - 8"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",9," - QS27 - Replaced by QS211 -  - 9"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",10," - QS27 - Replaced by QS211 -  - 10"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",11," - QS27 - Replaced by QS211 -  - 11"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",12," - QS27 - Replaced by QS211 -  - 12"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",13," - QS27 - Replaced by QS211 -  - 13"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",14," - QS27 - Replaced by QS211 -  - 14"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",15," - QS27 - Replaced by QS211 -  - 15"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",16," - QS27 - Replaced by QS211 -  - 16"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",17," - QS27 - Replaced by QS211 -  - 17"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",18," - QS27 - Replaced by QS211 -  - 18"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",19," - QS27 - Replaced by QS211 -  - 19"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",20," - QS27 - Replaced by QS211 -  - 20"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",21," - QS27 - Replaced by QS211 -  - 21"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",22," - QS27 - Replaced by QS211 -  - 22"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",23," - QS27 - Replaced by QS211 -  - 23"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",24," - QS27 - Replaced by QS211 -  - 24"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",25," - QS27 - Replaced by QS211 -  - 25"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",26," - QS27 - Replaced by QS211 -  - 26"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",27," - QS27 - Replaced by QS211 -  - 27"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",28," - QS27 - Replaced by QS211 -  - 28"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",29," - QS27 - Replaced by QS211 -  - 29"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",30," - QS27 - Replaced by QS211 -  - 30"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",31," - QS27 - Replaced by QS211 -  - 31"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",32," - QS27 - Replaced by QS211 -  - 32"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",33," - QS27 - Replaced by QS211 -  - 33"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",34," - QS27 - Replaced by QS211 -  - 34"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",35," - QS27 - Replaced by QS211 -  - 35"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",36," - QS27 - Replaced by QS211 -  - 36"]
[null,"QS27","Replaced by QS211",null,null,null,null,null,"QS27 - Replaced by QS211"," - QS27 - Replaced by QS211",37," - QS27 - Replaced by QS211 -  - 37"]
[null,"QS28","Hypertension in adults",1,null,"People with suspected hypertension are offered ambulatory blood pressure monitoring (ABPM) to confirm a diagnosis of hypertension.","Evidence of local arrangements to ensure people with suspected hypertension are offered ABPM to confirm a diagnosis of hypertension.","Structure","QS28 - Hypertension in adults","1 - QS28 - Hypertension in adults",1,"1 - QS28 - Hypertension in adults - Structure - 1","",""]
[null,"QS28","Hypertension in adults",1,null,"People with suspected hypertension are offered ambulatory blood pressure monitoring (ABPM) to confirm a diagnosis of hypertension.","Proportion of people with suspected hypertension who receive ABPM to confirm a diagnosis of hypertension.","Process","QS28 - Hypertension in adults","1 - QS28 - Hypertension in adults",1,"1 - QS28 - Hypertension in adults - Process - 1","The number of people in the denominator who receive ABPM to confirm a diagnosis of hypertension.","The number of people with suspected hypertension."]
[null,"QS28","Hypertension in adults",2,null,"People with newly diagnosed hypertension receive investigations for target organ damage within 1 month of diagnosis. ","Evidence of local arrangements for people with newly diagnosed hypertension to receive all investigations for target organ damage within 1 month of diagnosis. ","Structure","QS28 - Hypertension in adults","2 - QS28 - Hypertension in adults",1,"2 - QS28 - Hypertension in adults - Structure - 1","",""]
[null,"QS28","Hypertension in adults",2,null,"People with newly diagnosed hypertension receive investigations for target organ damage within 1 month of diagnosis. ","Proportion of people with newly diagnosed hypertension who receive all investigations for target organ damage within 1 month of diagnosis. ","Process","QS28 - Hypertension in adults","2 - QS28 - Hypertension in adults",1,"2 - QS28 - Hypertension in adults - Process - 1","The number of people in the denominator who receive all investigations for target organ damage within 1 month of diagnosis.","The number of people with newly diagnosed hypertension."]
[null,"QS28","Hypertension in adults",4,null,"People with treated hypertension have a clinic blood pressure target set to below 140/90 mmHg if aged under 80 years, or below 150/90 mmHg if aged 80 years and over. ","Evidence of local arrangements to ensure people aged 80 years and over with treated hypertension have a clinic blood pressure target set to below 150/90 mmHg.","Structure","QS28 - Hypertension in adults","4 - QS28 - Hypertension in adults",1,"4 - QS28 - Hypertension in adults - Structure - 1","",""]
[null,"QS28","Hypertension in adults",4,null,"People with treated hypertension have a clinic blood pressure target set to below 140/90 mmHg if aged under 80 years, or below 150/90 mmHg if aged 80 years and over. ","Evidence of local arrangements to ensure people aged under 80 years with treated hypertension have a clinic blood pressure target set to below 140/90 mmHg.","Structure","QS28 - Hypertension in adults","4 - QS28 - Hypertension in adults",2,"4 - QS28 - Hypertension in adults - Structure - 2","",""]
[null,"QS28","Hypertension in adults",4,null,"People with treated hypertension have a clinic blood pressure target set to below 140/90 mmHg if aged under 80 years, or below 150/90 mmHg if aged 80 years and over. ","People with treated hypertension whose target blood pressure is achieved.","Outcome","QS28 - Hypertension in adults","4 - QS28 - Hypertension in adults",1,"4 - QS28 - Hypertension in adults - Outcome - 1"]
[null,"QS28","Hypertension in adults",5,null,"People with hypertension are offered a review of risk factors for cardiovascular disease annually.\n","Evidence of local arrangements to ensure people with hypertension are offered a review of risk factors for cardiovascular disease annually.","Structure","QS28 - Hypertension in adults","5 - QS28 - Hypertension in adults",1,"5 - QS28 - Hypertension in adults - Structure - 1","",""]
[null,"QS28","Hypertension in adults",5,null,"People with hypertension are offered a review of risk factors for cardiovascular disease annually.\n","Proportion of people who have had hypertension for 12 months or longer who have had a review of risk factors for cardiovascular disease within the past 12 months.","Process","QS28 - Hypertension in adults","5 - QS28 - Hypertension in adults",1,"5 - QS28 - Hypertension in adults - Process - 1","The number of people in the denominator who have had a review of risk factors for cardiovascular disease within the past 12 months.","The number of people who have had hypertension for 12 months or longer who do not have established cardiovascular disease."]
[null,"QS28","Hypertension in adults",6,null,"People with resistant hypertension who are receiving 4 antihypertensive drugs and whose blood pressure remains uncontrolled are referred for specialist assessment."," Evidence of local arrangements for people with resistant hypertension who are receiving 4 antihypertensive drugs and whose blood pressure remains uncontrolled to be referred for specialist assessment.","Structure","QS28 - Hypertension in adults","6 - QS28 - Hypertension in adults",1,"6 - QS28 - Hypertension in adults - Structure - 1","",""]
[null,"QS28","Hypertension in adults",6,null,"People with resistant hypertension who are receiving 4 antihypertensive drugs and whose blood pressure remains uncontrolled are referred for specialist assessment.","Proportion of people with resistant hypertension who are receiving 4 antihypertensive drugs and whose blood pressure remains uncontrolled who are referred for specialist assessment.","Process","QS28 - Hypertension in adults","6 - QS28 - Hypertension in adults",1,"6 - QS28 - Hypertension in adults - Process - 1","The number of people in the denominator who are referred for specialist assessment.","The number of people with resistant hypertension who are receiving 4 antihypertensive drugs and whose blood pressure remains uncontrolled."]
[null,"QS31","Looked-after children and young people",1,null,"Looked-after children and young people experience warm, nurturing care.","Evidence of local arrangements for all carers of looked-after children and young people to receive ongoing high-quality core training and support packages that equip them to provide warm, nurturing care. \n","Structure",{"$f":"CONCATENATE(B685, \" - \", C685)","v":"QS31 - Looked-after children and young people"},{"$f":"CONCATENATE(D685, \" - \", I685)","v":"1 - QS31 - Looked-after children and young people"},{"$f":"IF(AND(B685=B684, D685=D684, H685=H684)=TRUE, K684+1, 1)","v":1},{"$f":"CONCATENATE(J685, \" - \", H685, \" - \",K685)","v":"1 - QS31 - Looked-after children and young people - Structure - 1"},"",""]
[null,"QS31","Looked-after children and young people",1,null,"Looked-after children and young people experience warm, nurturing care.","Evidence of local arrangements to ensure that all carers of babies and young children receive specialist training and support that helps them to develop positive attachments with children in their care. ","Structure","QS31 - Looked-after children and young people","1 - QS31 - Looked-after children and young people",2,"1 - QS31 - Looked-after children and young people - Structure - 2","",""]
[null,"QS31","Looked-after children and young people",1,null,"Looked-after children and young people experience warm, nurturing care.","Carer satisfaction with provision of training and support.","Outcome","QS31 - Looked-after children and young people",{"$f":"CONCATENATE(D687, \" - \", I687)","v":"1 - QS31 - Looked-after children and young people"},{"$f":"IF(AND(B687=B686, D687=D686, H687=H686)=TRUE, K686+1, 1)","v":1},{"$f":"CONCATENATE(J687, \" - \", H687, \" - \",K687)","v":"1 - QS31 - Looked-after children and young people - Outcome - 1"}]
[null,"QS31","Looked-after children and young people",1,null,"Looked-after children and young people experience warm, nurturing care.","Feedback from looked-after children and young people that they feel they receive warm, nurturing care.","Outcome","QS31 - Looked-after children and young people","1 - QS31 - Looked-after children and young people",2,"1 - QS31 - Looked-after children and young people - Outcome - 2"]
[null,"QS31","Looked-after children and young people",1,null,"Looked-after children and young people experience warm, nurturing care.","Looked-after children and young people's self-reported wellbeing and self-esteem.","Outcome","QS31 - Looked-after children and young people","1 - QS31 - Looked-after children and young people",3,"1 - QS31 - Looked-after children and young people - Outcome - 3"]
[null,"QS31","Looked-after children and young people",2,null,"Looked-after children and young people receive care from services and professionals that work collaboratively.\n","Evidence of effective local information-sharing protocols between health, social care and educational services. ","Structure","QS31 - Looked-after children and young people","2 - QS31 - Looked-after children and young people",1,"2 - QS31 - Looked-after children and young people - Structure - 1","",""]
[null,"QS31","Looked-after children and young people",2,null,"Looked-after children and young people receive care from services and professionals that work collaboratively.\n","Evidence of local arrangements for the team working with the child or young person to work collaboratively to manage the multidisciplinary care plan, with the named lead social worker taking a lead professional role.","Structure","QS31 - Looked-after children and young people","2 - QS31 - Looked-after children and young people",2,"2 - QS31 - Looked-after children and young people - Structure - 2","",""]
[null,"QS31","Looked-after children and young people",2,null,"Looked-after children and young people receive care from services and professionals that work collaboratively.\n","Evidence of local arrangements to ensure the team working with the child or young person has access to a consultancy service to support collaboration on complex casework.","Structure","QS31 - Looked-after children and young people","2 - QS31 - Looked-after children and young people",3,"2 - QS31 - Looked-after children and young people - Structure - 3","",""]
[null,"QS31","Looked-after children and young people",2,null,"Looked-after children and young people receive care from services and professionals that work collaboratively.\n","Evidence of local arrangements to include the carer as part of the team working with the child or young person.","Structure","QS31 - Looked-after children and young people","2 - QS31 - Looked-after children and young people",4,"2 - QS31 - Looked-after children and young people - Structure - 4","",""]
[null,"QS31","Looked-after children and young people",2,null,"Looked-after children and young people receive care from services and professionals that work collaboratively.\n","Feedback from carers that they feel involved as part of the team working with the child or young person.","Outcome","QS31 - Looked-after children and young people","2 - QS31 - Looked-after children and young people",1,"2 - QS31 - Looked-after children and young people - Outcome - 1"]
[null,"QS31","Looked-after children and young people",2,null,"Looked-after children and young people receive care from services and professionals that work collaboratively.\n","Feedback from looked-after children and young people that they do not have to re-tell their life and medical history when using services.","Outcome","QS31 - Looked-after children and young people","2 - QS31 - Looked-after children and young people",2,"2 - QS31 - Looked-after children and young people - Outcome - 2"]
[null,"QS31","Looked-after children and young people",2,null,"Looked-after children and young people receive care from services and professionals that work collaboratively.\n","Feedback from looked-after children and young people that they feel information about them is shared appropriately between people working with them, and caring for them.","Outcome","QS31 - Looked-after children and young people","2 - QS31 - Looked-after children and young people",3,"2 - QS31 - Looked-after children and young people - Outcome - 3"]
[null,"QS31","Looked-after children and young people",2,null,"Looked-after children and young people receive care from services and professionals that work collaboratively.\n","Feedback from the team working with the child or young person that they have all of the information they need to work effectively.","Outcome","QS31 - Looked-after children and young people","2 - QS31 - Looked-after children and young people",4,"2 - QS31 - Looked-after children and young people - Outcome - 4"]
[null,"QS31","Looked-after children and young people",3,null,"Looked-after children and young people live in stable placements that take account of their needs and preferences.\n","Evidence of a strategy to commission a diverse range of placements for looked-after children and young people, which includes arrangements for considering sibling co-placement.","Structure","QS31 - Looked-after children and young people","3 - QS31 - Looked-after children and young people",1,"3 - QS31 - Looked-after children and young people - Structure - 1","",""]
[null,"QS31","Looked-after children and young people",3,null,"Looked-after children and young people live in stable placements that take account of their needs and preferences.\n","Evidence of local arrangements for identifying potential carers among extended family and friends and assessing them for suitability at the start of the care planning process. ","Structure","QS31 - Looked-after children and young people","3 - QS31 - Looked-after children and young people",2,"3 - QS31 - Looked-after children and young people - Structure - 2","",""]
[null,"QS31","Looked-after children and young people",3,null,"Looked-after children and young people live in stable placements that take account of their needs and preferences.\n","Evidence of local arrangements to ensure that the child or young person gets to know their new carers and placement through visits and, where possible, overnight stays before they move to the placement.","Structure","QS31 - Looked-after children and young people",{"$f":"CONCATENATE(D700, \" - \", I700)","v":"3 - QS31 - Looked-after children and young people"},{"$f":"IF(AND(B700=B699, D700=D699, H700=H699)=TRUE, K699+1, 1)","v":3},{"$f":"CONCATENATE(J700, \" - \", H700, \" - \",K700)","v":"3 - QS31 - Looked-after children and young people - Structure - 3"},"",""]
[null,"QS31","Looked-after children and young people",3,null,"Looked-after children and young people live in stable placements that take account of their needs and preferences.\n","Evidence of local arrangements to involve looked-after children and young people in choices and discussions about placement changes.","Structure","QS31 - Looked-after children and young people","3 - QS31 - Looked-after children and young people",4,"3 - QS31 - Looked-after children and young people - Structure - 4","",""]
[null,"QS31","Looked-after children and young people",3,null,"Looked-after children and young people live in stable placements that take account of their needs and preferences.\n","Carer satisfaction with decisions made to place children or young people in their care.","Outcome","QS31 - Looked-after children and young people","3 - QS31 - Looked-after children and young people",1,"3 - QS31 - Looked-after children and young people - Outcome - 1"]
[null,"QS31","Looked-after children and young people",3,null,"Looked-after children and young people live in stable placements that take account of their needs and preferences.\n","Feedback from looked-after children and young people that they were involved in decisions about placement changes.","Outcome","QS31 - Looked-after children and young people","3 - QS31 - Looked-after children and young people",2,"3 - QS31 - Looked-after children and young people - Outcome - 2"]
[null,"QS31","Looked-after children and young people",3,null,"Looked-after children and young people live in stable placements that take account of their needs and preferences.\n","Looked-after children and young people's satisfaction with their placement.","Outcome","QS31 - Looked-after children and young people","3 - QS31 - Looked-after children and young people",3,"3 - QS31 - Looked-after children and young people - Outcome - 3"]
[null,"QS31","Looked-after children and young people",3,null,"Looked-after children and young people live in stable placements that take account of their needs and preferences.\n","Placement stability.","Outcome",{"$f":"CONCATENATE(B705, \" - \", C705)","v":"QS31 - Looked-after children and young people"},"3 - QS31 - Looked-after children and young people",4,"3 - QS31 - Looked-after children and young people - Outcome - 4"]
[null,"QS31","Looked-after children and young people",3,null,"Looked-after children and young people live in stable placements that take account of their needs and preferences.\n","Proportion of all placements that are emergency placements.","Outcome","QS31 - Looked-after children and young people","3 - QS31 - Looked-after children and young people",5,"3 - QS31 - Looked-after children and young people - Outcome - 5"]
[null,"QS31","Looked-after children and young people",4,null,"Looked-after children and young people have ongoing opportunities to explore and make sense of their identity and relationships.","Evidence of local arrangements to coordinate ongoing contact with people that looked-after children and young people value, including former carers, siblings, other family members, friends or professionals, if this is desired and in their best interests.","Structure","QS31 - Looked-after children and young people","4 - QS31 - Looked-after children and young people",1,"4 - QS31 - Looked-after children and young people - Structure - 1","",""]
[null,"QS31","Looked-after children and young people",4,null,"Looked-after children and young people have ongoing opportunities to explore and make sense of their identity and relationships.","Evidence of local arrangements to offer ongoing activities to looked-after children and young people to explore and make sense of their identity, including their life history and appropriate health history.","Structure","QS31 - Looked-after children and young people","4 - QS31 - Looked-after children and young people",2,"4 - QS31 - Looked-after children and young people - Structure - 2","",""]
[null,"QS31","Looked-after children and young people",4,null,"Looked-after children and young people have ongoing opportunities to explore and make sense of their identity and relationships.","Feedback from looked-after children and young people that they feel supported to explore and make sense of their identity and life history, including their health history.","Outcome","QS31 - Looked-after children and young people","4 - QS31 - Looked-after children and young people",1,"4 - QS31 - Looked-after children and young people - Outcome - 1"]
[null,"QS31","Looked-after children and young people",4,null,"Looked-after children and young people have ongoing opportunities to explore and make sense of their identity and relationships.","Feedback from looked-after children and young people that they feel supported to have continued contact with people they value.","Outcome","QS31 - Looked-after children and young people","4 - QS31 - Looked-after children and young people",2,"4 - QS31 - Looked-after children and young people - Outcome - 2"]
[null,"QS31","Looked-after children and young people",4,null,"Looked-after children and young people have ongoing opportunities to explore and make sense of their identity and relationships.","Feedback from looked-after children and young people that they have a supportive peer network.","Outcome","QS31 - Looked-after children and young people","4 - QS31 - Looked-after children and young people",3,"4 - QS31 - Looked-after children and young people - Outcome - 3"]
[null,"QS31","Looked-after children and young people",5,null,"Looked-after children and young people receive specialist and dedicated services within agreed timescales.","Evidence of local arrangements for case management and treatment to continue for looked-after young people moving from child to adult mental health services, until a handover with an assessment and completed care plan has been developed with the adult service.","Structure","QS31 - Looked-after children and young people","5 - QS31 - Looked-after children and young people",1,"5 - QS31 - Looked-after children and young people - Structure - 1","",""]
[null,"QS31","Looked-after children and young people",5,null,"Looked-after children and young people receive specialist and dedicated services within agreed timescales.","Evidence of local arrangements for health plans to be monitored and updated by independent reviewing officers, social workers and the lead health professional to ensure that the child or young person's continuing needs are being met.","Structure","QS31 - Looked-after children and young people","5 - QS31 - Looked-after children and young people",2,"5 - QS31 - Looked-after children and young people - Structure - 2","",""]
[null,"QS31","Looked-after children and young people",5,null,"Looked-after children and young people receive specialist and dedicated services within agreed timescales.","Evidence of local arrangements to ensure that looked-after children and young people receive specialist and dedicated services to meet their needs. These services should be delivered on a continuing basis within agreed timescales. ","Structure","QS31 - Looked-after children and young people","5 - QS31 - Looked-after children and young people",3,"5 - QS31 - Looked-after children and young people - Structure - 3","",""]
[null,"QS31","Looked-after children and young people",5,null,"Looked-after children and young people receive specialist and dedicated services within agreed timescales.","Proportion of looked-after young people who are moving from child to adult mental health services, whose case management and treatment continues until a handover is completed with the adult service.","Process","QS31 - Looked-after children and young people","5 - QS31 - Looked-after children and young people",1,"5 - QS31 - Looked-after children and young people - Process - 1","The number of people in the denominator who have their case management and treatment continued until handover with the adult service.","The number of looked-after young people who are moving from child to adult mental health services."]
[null,"QS31","Looked-after children and young people",5,null,"Looked-after children and young people receive specialist and dedicated services within agreed timescales.","Feedback from carers that they feel the needs of children and young people that they look after are being met through access to specialist and dedicated services when needed.","Outcome","QS31 - Looked-after children and young people","5 - QS31 - Looked-after children and young people",1,"5 - QS31 - Looked-after children and young people - Outcome - 1"]
[null,"QS31","Looked-after children and young people",5,null,"Looked-after children and young people receive specialist and dedicated services within agreed timescales.","Feedback from looked-after children and young people that they have access to the services they need.","Outcome","QS31 - Looked-after children and young people","5 - QS31 - Looked-after children and young people",2,"5 - QS31 - Looked-after children and young people - Outcome - 2"]
[null,"QS31","Looked-after children and young people",5,null,"Looked-after children and young people receive specialist and dedicated services within agreed timescales.","Feedback from recognised assessment tools that the child, young person or care leaver's needs are being met through access to specialist and dedicated services when needed.","Outcome","QS31 - Looked-after children and young people","5 - QS31 - Looked-after children and young people",3,"5 - QS31 - Looked-after children and young people - Outcome - 3"]
[null,"QS31","Looked-after children and young people",6,null,"Looked-after children and young people who move across local authority or health boundaries continue to receive the services they need.","Evidence of local arrangements to ensure that an assessment of health needs has been carried out before a child or young person is placed across a local authority or health boundary.","Structure","QS31 - Looked-after children and young people","6 - QS31 - Looked-after children and young people",1,"6 - QS31 - Looked-after children and young people - Structure - 1","",""]
[null,"QS31","Looked-after children and young people",6,null,"Looked-after children and young people who move across local authority or health boundaries continue to receive the services they need.","Evidence of local arrangements to ensure that looked-after children and young people have continued contact with key professionals when they are placed across a local authority or health boundary.","Structure","QS31 - Looked-after children and young people","6 - QS31 - Looked-after children and young people",2,"6 - QS31 - Looked-after children and young people - Structure - 2","",""]
[null,"QS31","Looked-after children and young people",6,null,"Looked-after children and young people who move across local authority or health boundaries continue to receive the services they need.","Evidence of local arrangements to ensure the placing authority shares relevant information before a child or young person is placed across a local authority or health boundary.","Structure","QS31 - Looked-after children and young people","6 - QS31 - Looked-after children and young people",3,"6 - QS31 - Looked-after children and young people - Structure - 3","",""]
[null,"QS31","Looked-after children and young people",6,null,"Looked-after children and young people who move across local authority or health boundaries continue to receive the services they need.","Evidence of local arrangements to ensure there is agreement between placing and receiving teams about schooling and healthcare arrangements before a child or young person is placed across a local authority or health boundary.","Structure","QS31 - Looked-after children and young people","6 - QS31 - Looked-after children and young people",4,"6 - QS31 - Looked-after children and young people - Structure - 4","",""]
[null,"QS31","Looked-after children and young people",6,null,"Looked-after children and young people who move across local authority or health boundaries continue to receive the services they need.","Proportion of looked-after children and young people placed across a local authority or health boundary for whom relevant information was shared before the placement took place.","Process","QS31 - Looked-after children and young people","6 - QS31 - Looked-after children and young people",1,"6 - QS31 - Looked-after children and young people - Process - 1","The number of people in the denominator for whom all relevant information was shared before the placement took place.","The number of looked-after children and young people placed across a local authority or health boundary."]
[null,"QS31","Looked-after children and young people",6,null,"Looked-after children and young people who move across local authority or health boundaries continue to receive the services they need.","Proportion of looked-after children and young people for whom an assessment of health needs was carried out before they were placed across a local authority or health boundary.","Process","QS31 - Looked-after children and young people","6 - QS31 - Looked-after children and young people",2,"6 - QS31 - Looked-after children and young people - Process - 2","The number of people in the denominator who received an assessment of health needs before they were placed across a local authority or health boundary.","The number of looked-after children and young people placed across a local authority or health boundary."]
[null,"QS31","Looked-after children and young people",6,null,"Looked-after children and young people who move across local authority or health boundaries continue to receive the services they need.","Carer satisfaction with the arrangements made for children and young people placed with them from a different area.","Outcome","QS31 - Looked-after children and young people","6 - QS31 - Looked-after children and young people",1,"6 - QS31 - Looked-after children and young people - Outcome - 1"]
[null,"QS31","Looked-after children and young people",6,null,"Looked-after children and young people who move across local authority or health boundaries continue to receive the services they need.","Feedback from looked-after children and young people that they remain in contact with key professionals when they move across a local authority or health boundary. ","Outcome","QS31 - Looked-after children and young people","6 - QS31 - Looked-after children and young people",2,"6 - QS31 - Looked-after children and young people - Outcome - 2"]
[null,"QS31","Looked-after children and young people",7,null,"Looked-after children and young people are supported to fulfil their potential.","Evidence of local arrangements for the designated teacher to engage with the child or young person's social worker and carer in developing and monitoring their education plans.","Structure","QS31 - Looked-after children and young people","7 - QS31 - Looked-after children and young people",1,"7 - QS31 - Looked-after children and young people - Structure - 1","",""]
[null,"QS31","Looked-after children and young people",7,null,"Looked-after children and young people are supported to fulfil their potential.","Evidence of supportive pathways into creative arts, physical activities and other hobbies and interests that support wellbeing and build self-esteem.","Structure","QS31 - Looked-after children and young people","7 - QS31 - Looked-after children and young people",2,"7 - QS31 - Looked-after children and young people - Structure - 2","",""]
[null,"QS31","Looked-after children and young people",7,null,"Looked-after children and young people are supported to fulfil their potential.","Evidence of supportive pathways into further and higher education and training. ","Structure","QS31 - Looked-after children and young people","7 - QS31 - Looked-after children and young people",3,"7 - QS31 - Looked-after children and young people - Structure - 3","",""]
[null,"QS31","Looked-after children and young people",7,null,"Looked-after children and young people are supported to fulfil their potential.","Education, employment or training status among looked-after children and young people.","Outcome","QS31 - Looked-after children and young people","7 - QS31 - Looked-after children and young people",1,"7 - QS31 - Looked-after children and young people - Outcome - 1"]
[null,"QS31","Looked-after children and young people",7,null,"Looked-after children and young people are supported to fulfil their potential.","Educational attainment among looked-after children and young people.","Outcome","QS31 - Looked-after children and young people","7 - QS31 - Looked-after children and young people",2,"7 - QS31 - Looked-after children and young people - Outcome - 2"]
[null,"QS31","Looked-after children and young people",7,null,"Looked-after children and young people are supported to fulfil their potential.","Feedback from looked-after children and young people that they feel supported to access education, training or employment that is right for them.","Outcome","QS31 - Looked-after children and young people","7 - QS31 - Looked-after children and young people",3,"7 - QS31 - Looked-after children and young people - Outcome - 3"]
[null,"QS31","Looked-after children and young people",8,null,"Care leavers move to independence at their own pace.","Evidence of local arrangements to ensure pathway planning is responsive to the needs of young people preparing to leave care and equips them with the skills they need to live independently. ","Structure","QS31 - Looked-after children and young people","8 - QS31 - Looked-after children and young people",1,"8 - QS31 - Looked-after children and young people - Structure - 1","",""]
[null,"QS31","Looked-after children and young people",8,null,"Care leavers move to independence at their own pace.","Evidence of local arrangements to ensure that care leavers are given the option to remain in a stable foster home or residential home beyond the age of 18, and to return to the care of the local authority, including their previous placement (if possible), if they experience difficulty in moving to live independently. ","Structure","QS31 - Looked-after children and young people","8 - QS31 - Looked-after children and young people",2,"8 - QS31 - Looked-after children and young people - Structure - 2","",""]
[null,"QS31","Looked-after children and young people",8,null,"Care leavers move to independence at their own pace.","Evidence that a range of accommodation and support is available for care leavers.","Structure","QS31 - Looked-after children and young people","8 - QS31 - Looked-after children and young people",3,"8 - QS31 - Looked-after children and young people - Structure - 3","",""]
[null,"QS31","Looked-after children and young people",8,null,"Care leavers move to independence at their own pace.","Accommodation status of young people leaving care.","Outcome","QS31 - Looked-after children and young people","8 - QS31 - Looked-after children and young people",1,"8 - QS31 - Looked-after children and young people - Outcome - 1"]
[null,"QS31","Looked-after children and young people",8,null,"Care leavers move to independence at their own pace.","Care leaver satisfaction with their accommodation.","Outcome","QS31 - Looked-after children and young people","8 - QS31 - Looked-after children and young people",2,"8 - QS31 - Looked-after children and young people - Outcome - 2"]
[null,"QS31","Looked-after children and young people",8,null,"Care leavers move to independence at their own pace.","Feedback from care leavers that they felt supported to move to live independently at their own pace.","Outcome","QS31 - Looked-after children and young people","8 - QS31 - Looked-after children and young people",3,"8 - QS31 - Looked-after children and young people - Outcome - 3"]
[null,"QS32","Caesarean section ",1,null,"Pregnant women who have had 1 or more previous caesarean sections have a documented discussion of the option to plan a vaginal birth. ","Evidence of local arrangements to ensure that pregnant women who have had 1 or more previous caesarean births have a documented discussion of the option to plan a vaginal birth. ","Structure","QS32 - Caesarean section ","1 - QS32 - Caesarean section ",1,"1 - QS32 - Caesarean section  - Structure - 1","",""]
[null,"QS32","Caesarean section ",1,null,"Pregnant women who have had 1 or more previous caesarean sections have a documented discussion of the option to plan a vaginal birth. ","The proportion of pregnant women who have had 1 or more previous caesarean births who have a documented discussion of the option to plan a vaginal birth.","Process","QS32 - Caesarean section ","1 - QS32 - Caesarean section ",1,"1 - QS32 - Caesarean section  - Process - 1","The number of women in the denominator who have a documented discussion of the option to plan a vaginal birth.","The number of pregnant women who have had 1 or more previous caesarean births."]
[null,"QS32","Caesarean section ",1,null,"Pregnant women who have had 1 or more previous caesarean sections have a documented discussion of the option to plan a vaginal birth. ","Women's satisfaction that they were supported in their choice for planned birthing option.","Outcome","QS32 - Caesarean section ","1 - QS32 - Caesarean section ",1,"1 - QS32 - Caesarean section  - Outcome - 1"]
[null,"QS32","Caesarean section ",1,null,"Pregnant women who have had 1 or more previous caesarean sections have a documented discussion of the option to plan a vaginal birth. ","Rates of delivery modes for women who have had previous caesarean births. ","Outcome","QS32 - Caesarean section ","1 - QS32 - Caesarean section ",2,"1 - QS32 - Caesarean section  - Outcome - 2"]
[null,"QS32","Caesarean section ",2,null,"Pregnant women who request a caesarean birth (when there is no medical indication) have a documented discussion with members of the maternity team about the overall benefits and risks of a caesarean birth compared with vaginal birth.","Evidence of local arrangements to ensure that pregnant women who request a caesarean birth (when there is no medical indication) have a documented discussion with members of the maternity team about the overall benefits and risks of a caesarean birth compared with vaginal birth.","Structure","QS32 - Caesarean section ","2 - QS32 - Caesarean section ",1,"2 - QS32 - Caesarean section  - Structure - 1","",""]
[null,"QS32","Caesarean section ",2,null,"Pregnant women who request a caesarean birth (when there is no medical indication) have a documented discussion with members of the maternity team about the overall benefits and risks of a caesarean birth compared with vaginal birth.","The proportion of pregnant women who request a caesarean birth (when there is no medical indication) who have a documented discussion with members of the maternity team about the overall benefits and risks of a caesarean birth compared with vaginal birth.","Process","QS32 - Caesarean section ","2 - QS32 - Caesarean section ",1,"2 - QS32 - Caesarean section  - Process - 1","The number of women in the denominator who have a documented discussion with at least 1 member of the maternity team about the overall risks and benefits of a caesarean birth compared with vaginal birth.","The number of pregnant women who request a caesarean birth when there is no clinical indication."]
[null,"QS32","Caesarean section ",2,null,"Pregnant women who request a caesarean birth (when there is no medical indication) have a documented discussion with members of the maternity team about the overall benefits and risks of a caesarean birth compared with vaginal birth.","Women’s satisfaction with the process of discussing options with the maternity team.","Outcome","QS32 - Caesarean section ","2 - QS32 - Caesarean section ",1,"2 - QS32 - Caesarean section  - Outcome - 1"]
[null,"QS32","Caesarean section ",3,null,"Pregnant women who request a caesarean birth because of anxiety about childbirth are offered a referral to a healthcare professional with expertise in perinatal mental health support.","Evidence of local arrangements to ensure that pregnant women who request a caesarean birth because of anxiety about childbirth are offered a referral to a healthcare professional with expertise in perinatal mental health support.","Structure","QS32 - Caesarean section ","3 - QS32 - Caesarean section ",1,"3 - QS32 - Caesarean section  - Structure - 1","",""]
[null,"QS32","Caesarean section ",3,null,"Pregnant women who request a caesarean birth because of anxiety about childbirth are offered a referral to a healthcare professional with expertise in perinatal mental health support.","The proportion of pregnant women who request a caesarean birth because of anxiety about childbirth who are referred to a healthcare professional with expertise in perinatal mental health support.","Process","QS32 - Caesarean section ","3 - QS32 - Caesarean section ",1,"3 - QS32 - Caesarean section  - Process - 1","The number of women in the denominator who are referred to a healthcare professional with expertise in perinatal mental health support.","The number of pregnant women who request a caesarean birth because of anxiety about childbirth."]
[null,"QS32","Caesarean section ",3,null,"Pregnant women who request a caesarean birth because of anxiety about childbirth are offered a referral to a healthcare professional with expertise in perinatal mental health support.","Women's satisfaction with the support provided for anxiety about childbirth.","Outcome","QS32 - Caesarean section ","3 - QS32 - Caesarean section ",1,"3 - QS32 - Caesarean section  - Outcome - 1"]
[null,"QS32","Caesarean section ",4,null,"Pregnant women who may require a planned caesarean birth have consultant involvement in decision-making.","Evidence of local arrangements to ensure that pregnant women who may require a planned caesarean birth have consultant involvement in decision-making.","Structure","QS32 - Caesarean section ","4 - QS32 - Caesarean section ",1,"4 - QS32 - Caesarean section  - Structure - 1","",""]
[null,"QS32","Caesarean section ",4,null,"Pregnant women who may require a planned caesarean birth have consultant involvement in decision-making.","The proportion of pregnant women who may require a planned caesarean birth who have consultant involvement in decision-making.","Process","QS32 - Caesarean section ","4 - QS32 - Caesarean section ",1,"4 - QS32 - Caesarean section  - Process - 1","The number of women in the denominator who have a consultant involved in decision-making.","The number of pregnant women who may require a planned caesarean birth."]
[null,"QS32","Caesarean section ",4,null,"Pregnant women who may require a planned caesarean birth have consultant involvement in decision-making.","Women’s satisfaction with the decision-making process.","Outcome","QS32 - Caesarean section ","4 - QS32 - Caesarean section ",1,"4 - QS32 - Caesarean section  - Outcome - 1"]
[null,"QS32","Caesarean section ",5,null,"Pregnant women having a planned caesarean birth have the procedure carried out at or after 39 weeks 0 days, unless an earlier delivery is necessary because of maternal or fetal indications.","Evidence of local arrangements to ensure that pregnant women having a planned caesarean birth have the procedure at or after 39 weeks 0 days, unless an earlier delivery is necessary because of maternal or fetal indications.","Structure","QS32 - Caesarean section ","5 - QS32 - Caesarean section ",1,"5 - QS32 - Caesarean section  - Structure - 1","",""]
[null,"QS32","Caesarean section ",5,null,"Pregnant women having a planned caesarean birth have the procedure carried out at or after 39 weeks 0 days, unless an earlier delivery is necessary because of maternal or fetal indications.","The proportion of pregnant women having a planned caesarean birth and not needing an earlier delivery because of maternal and fetal inidications who have the procedure carried out at or after 39 weeks 0 days. ","Process","QS32 - Caesarean section ","5 - QS32 - Caesarean section ",1,"5 - QS32 - Caesarean section  - Process - 1","The number of women in the denominator who have the caesarean birth carried out at or after 39 weeks 0 days.","The number of pregnant women having a planned caesarean birth who do not need an earlier delivery because of maternal or fetal indications."]
[null,"QS32","Caesarean section ",6,null,"Women being considered for an unplanned caesarean birth have a consultant obstetrician involved in the decision.","Women being considered for an unplanned caesarean birth have a consultant obstetrician involved in the decision.","Structure","QS32 - Caesarean section ","6 - QS32 - Caesarean section ",1,"6 - QS32 - Caesarean section  - Structure - 1","",""]
[null,"QS32","Caesarean section ",6,null,"Women being considered for an unplanned caesarean birth have a consultant obstetrician involved in the decision.","The proportion of women being considered for an unplanned caesarean birth who have a consultant obstetrician involved in the decision.","Process","QS32 - Caesarean section ","6 - QS32 - Caesarean section ",1,"6 - QS32 - Caesarean section  - Process - 1","The number of women in the denominator who have a consultant obstetrician involved in the decision.","The number of women being considered for an unplanned caesarean birth."]
[null,"QS32","Caesarean section ",6,null,"Women being considered for an unplanned caesarean birth have a consultant obstetrician involved in the decision.","Unplanned caesarean birth rates.","Outcome","QS32 - Caesarean section ","6 - QS32 - Caesarean section ",1,"6 - QS32 - Caesarean section  - Outcome - 1"]
[null,"QS32","Caesarean section ",6,null,"Women being considered for an unplanned caesarean birth have a consultant obstetrician involved in the decision.","Women’s satisfaction with the decision-making process.","Outcome","QS32 - Caesarean section ","6 - QS32 - Caesarean section ",2,"6 - QS32 - Caesarean section  - Outcome - 2"]
[null,"QS32","Caesarean section ",7,null,"This statement has been removed.",null,null,"QS32 - Caesarean section ","7 - QS32 - Caesarean section ",1,"7 - QS32 - Caesarean section  -  - 1","",""]
[null,"QS32","Caesarean section ",7,null,"This statement has been removed.",null,null,"QS32 - Caesarean section ","7 - QS32 - Caesarean section ",2,"7 - QS32 - Caesarean section  -  - 2","",""]
[null,"QS32","Caesarean section ",7,null,"This statement has been removed.",null,null,"QS32 - Caesarean section ","7 - QS32 - Caesarean section ",3,"7 - QS32 - Caesarean section  -  - 3"]
[null,"QS32","Caesarean section ",7,null,"This statement has been removed.",null,null,"QS32 - Caesarean section ","7 - QS32 - Caesarean section ",4,"7 - QS32 - Caesarean section  -  - 4"]
[null,"QS32","Caesarean section ",7,null,"This statement has been removed.",null,null,"QS32 - Caesarean section ","7 - QS32 - Caesarean section ",5,"7 - QS32 - Caesarean section  -  - 5"]
[null,"QS32","Caesarean section ",8,null,"Women who have had an emergency or unplanned caesarean birth are offered a discussion and are given written information about the reasons for their caesarean birth and birth options for future pregnancies.","Evidence of local arrangements to ensure that women who have had an emergency or unplanned caesarean birth are offered a discussion and are given written information about the reasons for their caesarean birth and birth options for future pregnancies.","Structure","QS32 - Caesarean section ","8 - QS32 - Caesarean section ",1,"8 - QS32 - Caesarean section  - Structure - 1","",""]
[null,"QS32","Caesarean section ",8,null,"Women who have had an emergency or unplanned caesarean birth are offered a discussion and are given written information about the reasons for their caesarean birth and birth options for future pregnancies.","The proportion of women who have had an emergency or unplanned caesarean birth who have had a discussion and were given written information about the reasons for their caesarean birth and birth options for future pregnancies.","Process","QS32 - Caesarean section ",{"$f":"CONCATENATE(D764, \" - \", I764)","v":"8 - QS32 - Caesarean section "},{"$f":"IF(AND(B764=B763, D764=D763, H764=H763)=TRUE, K763+1, 1)","v":1},{"$f":"CONCATENATE(J764, \" - \", H764, \" - \",K764)","v":"8 - QS32 - Caesarean section  - Process - 1"},"The number of women in the denominator who have had a discussion and were given written information about the reasons for their caesarean birth and birth options for future pregnancies.","The number of women who have had an emergency or unplanned caesarean birth."]
[null,"QS32","Caesarean section ",8,null,"Women who have had an emergency or unplanned caesarean birth are offered a discussion and are given written information about the reasons for their caesarean birth and birth options for future pregnancies.","Women's satisfaction with post-caesarean birth discussion and information.","Outcome","QS32 - Caesarean section ","8 - QS32 - Caesarean section ",1,"8 - QS32 - Caesarean section  - Outcome - 1"]
[null,"QS32","Caesarean section ",9,null,"Women who have had a caesarean birth are monitored for postoperative complications.","Evidence of local arrangements to ensure that women who have had a caesarean birth are monitored for immediate postoperative complications.","Structure","QS32 - Caesarean section ","9 - QS32 - Caesarean section ",1,"9 - QS32 - Caesarean section  - Structure - 1","",""]
[null,"QS32","Caesarean section ",9,null,"Women who have had a caesarean birth are monitored for postoperative complications.","The proportion of women who have had a caesarean birth who were monitored for immediate postoperative complications.","Process","QS32 - Caesarean section ","9 - QS32 - Caesarean section ",1,"9 - QS32 - Caesarean section  - Process - 1","The number of women in the denominator who are monitored for immediate postoperative complications.","The number of women who have a caesarean birth."]
[null,"QS32","Caesarean section ",9,null,"Women who have had a caesarean birth are monitored for postoperative complications.","Rates of complications in women who have had a caesarean birth.","Outcome","QS32 - Caesarean section ","9 - QS32 - Caesarean section ",1,"9 - QS32 - Caesarean section  - Outcome - 1"]
[null,"QS33","Rheumatoid arthritis in over 16s",1,null,"Adults with suspected persistent synovitis affecting more than 1 joint, or the small joints of the hands and feet, are referred to rheumatology services within 3 working days of presenting in primary care.","Evidence that healthcare professionals in primary care can recognise persistent synovitis.","Structure",{"$f":"CONCATENATE(B769, \" - \", C769)","v":"QS33 - Rheumatoid arthritis in over 16s"},"1 - QS33 - Rheumatoid arthritis in over 16s",1,"1 - QS33 - Rheumatoid arthritis in over 16s - Structure - 1","",""]
[null,"QS33","Rheumatoid arthritis in over 16s",1,null,"Adults with suspected persistent synovitis affecting more than 1 joint, or the small joints of the hands and feet, are referred to rheumatology services within 3 working days of presenting in primary care.","Evidence that systems are in place for adults with suspected persistent synovitis to be referred to rheumatology services within 3 working days of presentation.","Structure",{"$f":"CONCATENATE(B770, \" - \", C770)","v":"QS33 - Rheumatoid arthritis in over 16s"},{"$f":"CONCATENATE(D770, \" - \", I770)","v":"1 - QS33 - Rheumatoid arthritis in over 16s"},{"$f":"IF(AND(B770=B769, D770=D769, H770=H769)=TRUE, K769+1, 1)","v":2},{"$f":"CONCATENATE(J770, \" - \", H770, \" - \",K770)","v":"1 - QS33 - Rheumatoid arthritis in over 16s - Structure - 2"}]
[null,"QS33","Rheumatoid arthritis in over 16s",1,null,"Adults with suspected persistent synovitis affecting more than 1 joint, or the small joints of the hands and feet, are referred to rheumatology services within 3 working days of presenting in primary care.","Proportion of adults presenting in primary care with suspected persistent synovitis affecting more than 1 joint, or the small joints of the hands and feet, who are referred to rheumatology services within 3 working days.","Process","QS33 - Rheumatoid arthritis in over 16s","1 - QS33 - Rheumatoid arthritis in over 16s",1,"1 - QS33 - Rheumatoid arthritis in over 16s - Process - 1","The number in the denominator who are referred to rheumatology services within 3 working days of presenting in primary care.","The number of adults presenting in primary care with suspected persistent synovitis affecting more than 1 joint, or the small joints of the hands and feet."]
[null,"QS33","Rheumatoid arthritis in over 16s",1,null,"Adults with suspected persistent synovitis affecting more than 1 joint, or the small joints of the hands and feet, are referred to rheumatology services within 3 working days of presenting in primary care.","Time from presentation in primary care to diagnosis for adults with rheumatoid arthritis.","Outcome",{"$f":"CONCATENATE(B772, \" - \", C772)","v":"QS33 - Rheumatoid arthritis in over 16s"},{"$f":"CONCATENATE(D772, \" - \", I772)","v":"1 - QS33 - Rheumatoid arthritis in over 16s"},{"$f":"IF(AND(B772=B771, D772=D771, H772=H771)=TRUE, K771+1, 1)","v":1},"1 - QS33 - Rheumatoid arthritis in over 16s - Outcome - 1"]
[null,"QS33","Rheumatoid arthritis in over 16s",2,null,"Adults with active rheumatoid arthritis start conventional disease-modifying anti-rheumatic drug (cDMARD) monotherapy within 6 weeks of referral, with monthly monitoring until their treatment target is met.","Evidence of local arrangements to start treatment with cDMARD monotherapy for adults with active rheumatoid arthritis within 6 weeks of referral from primary care.","Structure","QS33 - Rheumatoid arthritis in over 16s","2 - QS33 - Rheumatoid arthritis in over 16s",1,"2 - QS33 - Rheumatoid arthritis in over 16s - Structure - 1","",""]
[null,"QS33","Rheumatoid arthritis in over 16s",2,null,"Adults with active rheumatoid arthritis start conventional disease-modifying anti-rheumatic drug (cDMARD) monotherapy within 6 weeks of referral, with monthly monitoring until their treatment target is met.","Evidence of local arrangements to measure CRP and disease activity monthly in adults with active rheumatoid arthritis until they are in remission or have low disease activity if remission cannot be achieved.","Structure","QS33 - Rheumatoid arthritis in over 16s","2 - QS33 - Rheumatoid arthritis in over 16s",2,"2 - QS33 - Rheumatoid arthritis in over 16s - Structure - 2"]
[null,"QS33","Rheumatoid arthritis in over 16s",2,null,"Adults with active rheumatoid arthritis start conventional disease-modifying anti-rheumatic drug (cDMARD) monotherapy within 6 weeks of referral, with monthly monitoring until their treatment target is met.","Proportion of adults with suspected persistent synovitis who have specialist assessment within 3 weeks of referral from primary care.","Process","QS33 - Rheumatoid arthritis in over 16s","2 - QS33 - Rheumatoid arthritis in over 16s",1,{"$f":"CONCATENATE(J775, \" - \", H775, \" - \",K775)","v":"2 - QS33 - Rheumatoid arthritis in over 16s - Process - 1"},"The number in the denominator who have specialist assessment within 3 weeks of referral.","The number of adults with suspected persistent synovitis referred to rheumatology services."]
[null,"QS33","Rheumatoid arthritis in over 16s",2,null,"Adults with active rheumatoid arthritis start conventional disease-modifying anti-rheumatic drug (cDMARD) monotherapy within 6 weeks of referral, with monthly monitoring until their treatment target is met.","Proportion of adults with active rheumatoid arthritis starting cDMARD monotherapy within 6 weeks of referral from primary care.","Process","QS33 - Rheumatoid arthritis in over 16s","2 - QS33 - Rheumatoid arthritis in over 16s",2,"2 - QS33 - Rheumatoid arthritis in over 16s - Process - 2","The number in the denominator who start cDMARD monotherapy within 6 weeks of referral.","The number of adults with active rheumatoid arthritis referred to rheumatology services."]
[null,"QS33","Rheumatoid arthritis in over 16s",2,null,"Adults with active rheumatoid arthritis start conventional disease-modifying anti-rheumatic drug (cDMARD) monotherapy within 6 weeks of referral, with monthly monitoring until their treatment target is met.","Proportion of adults with active rheumatoid arthritis who have their CRP and disease activity score measured monthly.","Process","QS33 - Rheumatoid arthritis in over 16s","2 - QS33 - Rheumatoid arthritis in over 16s",3,"2 - QS33 - Rheumatoid arthritis in over 16s - Process - 3","The number in the denominator who had their CRP and disease activity score measured within the past month.","The number of adults with active rheumatoid arthritis."]
[null,"QS33","Rheumatoid arthritis in over 16s",2,null,"Adults with active rheumatoid arthritis start conventional disease-modifying anti-rheumatic drug (cDMARD) monotherapy within 6 weeks of referral, with monthly monitoring until their treatment target is met.","Disease activity for adults with rheumatoid arthritis.","Outcome","QS33 - Rheumatoid arthritis in over 16s","2 - QS33 - Rheumatoid arthritis in over 16s",1,"2 - QS33 - Rheumatoid arthritis in over 16s - Outcome - 1"]
[null,"QS33","Rheumatoid arthritis in over 16s",2,null,"Adults with active rheumatoid arthritis start conventional disease-modifying anti-rheumatic drug (cDMARD) monotherapy within 6 weeks of referral, with monthly monitoring until their treatment target is met.","Health-related quality of life for adults with rheumatoid arthritis.","Outcome","QS33 - Rheumatoid arthritis in over 16s","2 - QS33 - Rheumatoid arthritis in over 16s",2,"2 - QS33 - Rheumatoid arthritis in over 16s - Outcome - 2"]
[null,"QS33","Rheumatoid arthritis in over 16s",3,null,"Adults with rheumatoid arthritis are given opportunities throughout the course of their disease to take part in educational activities that support self-management.","Evidence of availability of educational activities for people with rheumatoid arthritis throughout the course of their disease.","Structure",{"$f":"CONCATENATE(B780, \" - \", C780)","v":"QS33 - Rheumatoid arthritis in over 16s"},{"$f":"CONCATENATE(D780, \" - \", I780)","v":"3 - QS33 - Rheumatoid arthritis in over 16s"},{"$f":"IF(AND(B780=B779, D780=D779, H780=H779)=TRUE, K779+1, 1)","v":1},{"$f":"CONCATENATE(J780, \" - \", H780, \" - \",K780)","v":"3 - QS33 - Rheumatoid arthritis in over 16s - Structure - 1"},"",""]
[null,"QS33","Rheumatoid arthritis in over 16s",3,null,"Adults with rheumatoid arthritis are given opportunities throughout the course of their disease to take part in educational activities that support self-management.","Proportion of adults with rheumatoid arthritis who are offered educational activities within 1 month of diagnosis.","Process","QS33 - Rheumatoid arthritis in over 16s","3 - QS33 - Rheumatoid arthritis in over 16s",1,"3 - QS33 - Rheumatoid arthritis in over 16s - Process - 1","The number in the denominator who are offered educational activities within 1 month of diagnosis.","The number of adults with rheumatoid arthritis."]
[null,"QS33","Rheumatoid arthritis in over 16s",3,null,"Adults with rheumatoid arthritis are given opportunities throughout the course of their disease to take part in educational activities that support self-management.","Proportion of adults with rheumatoid arthritis who report at annual review that they have been given as much information as they want about their condition and its management.","Process","QS33 - Rheumatoid arthritis in over 16s","3 - QS33 - Rheumatoid arthritis in over 16s",2,"3 - QS33 - Rheumatoid arthritis in over 16s - Process - 2","The number in the denominator who report that they have been given as much information as they want about their condition and its management.","The number of adults with rheumatoid arthritis having an annual review."]
[null,"QS33","Rheumatoid arthritis in over 16s",3,null,"Adults with rheumatoid arthritis are given opportunities throughout the course of their disease to take part in educational activities that support self-management.","Proportion of adults with rheumatoid arthritis who are satisfied with their ability to self-manage their condition.","Outcome","QS33 - Rheumatoid arthritis in over 16s","3 - QS33 - Rheumatoid arthritis in over 16s",1,"3 - QS33 - Rheumatoid arthritis in over 16s - Outcome - 1","The number in the denominator who are satisfied with their ability to self-manage their condition.","The number of adults with rheumatoid arthritis."]
[null,"QS33","Rheumatoid arthritis in over 16s",4,null,"Adults with rheumatoid arthritis and disease flares or possible treatment-related side effects receive advice within 1-working-day of contacting rheumatology services.","Evidence of local arrangements for adults with rheumatoid arthritis to contact rheumatology services.","Structure",{"$f":"CONCATENATE(B784, \" - \", C784)","v":"QS33 - Rheumatoid arthritis in over 16s"},{"$f":"CONCATENATE(D784, \" - \", I784)","v":"4 - QS33 - Rheumatoid arthritis in over 16s"},{"$f":"IF(AND(B784=B783, D784=D783, H784=H783)=TRUE, K783+1, 1)","v":1},{"$f":"CONCATENATE(J784, \" - \", H784, \" - \",K784)","v":"4 - QS33 - Rheumatoid arthritis in over 16s - Structure - 1"},"",""]
[null,"QS33","Rheumatoid arthritis in over 16s",4,null,"Adults with rheumatoid arthritis and disease flares or possible treatment-related side effects receive advice within 1-working-day of contacting rheumatology services.","Evidence of availability of staff to give advice to adults with rheumatoid arthritis when they contact rheumatology services.","Structure","QS33 - Rheumatoid arthritis in over 16s","4 - QS33 - Rheumatoid arthritis in over 16s",2,"4 - QS33 - Rheumatoid arthritis in over 16s - Structure - 2"]
[null,"QS33","Rheumatoid arthritis in over 16s",4,null,"Adults with rheumatoid arthritis and disease flares or possible treatment-related side effects receive advice within 1-working-day of contacting rheumatology services.","Proportion of adults with rheumatoid arthritis who receive advice from rheumatology services within 1 working day when experiencing a disease flare or possible treatment-related side effects.","Process","QS33 - Rheumatoid arthritis in over 16s","4 - QS33 - Rheumatoid arthritis in over 16s",1,"4 - QS33 - Rheumatoid arthritis in over 16s - Process - 1","The number in the denominator who receive advice from rheumatology services within 1 working day.","The number of adults with rheumatoid arthritis and a disease flare or possible treatment-related side effects who contact rheumatology services."]
[null,"QS33","Rheumatoid arthritis in over 16s",4,null,"Adults with rheumatoid arthritis and disease flares or possible treatment-related side effects receive advice within 1-working-day of contacting rheumatology services.","Disease activity for adults with rheumatoid arthritis.","Outcome","QS33 - Rheumatoid arthritis in over 16s","4 - QS33 - Rheumatoid arthritis in over 16s",1,"4 - QS33 - Rheumatoid arthritis in over 16s - Outcome - 1"]
[null,"QS33","Rheumatoid arthritis in over 16s",4,null,"Adults with rheumatoid arthritis and disease flares or possible treatment-related side effects receive advice within 1-working-day of contacting rheumatology services.","Functional ability of adults with rheumatoid arthritis.","Outcome","QS33 - Rheumatoid arthritis in over 16s","4 - QS33 - Rheumatoid arthritis in over 16s",2,"4 - QS33 - Rheumatoid arthritis in over 16s - Outcome - 2"]
[null,"QS33","Rheumatoid arthritis in over 16s",5,null,"Adults with rheumatoid arthritis have a comprehensive annual review that is coordinated by rheumatology services.","Evidence of arrangements to ensure that adults with rheumatoid arthritis have a comprehensive annual review coordinated by rheumatology services.","Structure","QS33 - Rheumatoid arthritis in over 16s","5 - QS33 - Rheumatoid arthritis in over 16s",1,"5 - QS33 - Rheumatoid arthritis in over 16s - Structure - 1","",""]
[null,"QS33","Rheumatoid arthritis in over 16s",5,null,"Adults with rheumatoid arthritis have a comprehensive annual review that is coordinated by rheumatology services.","Proportion of adults with rheumatoid arthritis diagnosed more than 12 months ago who had a comprehensive review within the past 12 months.","Process","QS33 - Rheumatoid arthritis in over 16s","5 - QS33 - Rheumatoid arthritis in over 16s",1,"5 - QS33 - Rheumatoid arthritis in over 16s - Process - 1","The number in the denominator who had a comprehensive review within the past 12 months.","The number of adults with rheumatoid arthritis diagnosed more than 12 months ago."]
[null,"QS33","Rheumatoid arthritis in over 16s",5,null,"Adults with rheumatoid arthritis have a comprehensive annual review that is coordinated by rheumatology services.","Health-related quality of life for adults with rheumatoid arthritis.","Outcome","QS33 - Rheumatoid arthritis in over 16s","5 - QS33 - Rheumatoid arthritis in over 16s",1,"5 - QS33 - Rheumatoid arthritis in over 16s - Outcome - 1"]
[null,"QS34","Self-harm ",1,null,"People who have self‑harmed are cared for with compassion and the same respect and dignity as any service user.","Evidence of local arrangements to provide staff training on treating people with compassion, respect and dignity that includes specific reference to people who self‑harm.","Structure","QS34 - Self-harm ",{"$f":"CONCATENATE(D792, \" - \", I792)","v":"1 - QS34 - Self-harm "},{"$f":"IF(AND(B792=B791, D792=D791, H792=H791)=TRUE, K791+1, 1)","v":1},{"$f":"CONCATENATE(J792, \" - \", H792, \" - \",K792)","v":"1 - QS34 - Self-harm  - Structure - 1"},"",""]
[null,"QS34","Self-harm ",1,null,"People who have self‑harmed are cared for with compassion and the same respect and dignity as any service user.","Proportion of staff in contact with people who have self‑harmed who have received training on treating people with compassion, respect and dignity that includes specific reference to people who self‑harm.","Process","QS34 - Self-harm ","1 - QS34 - Self-harm ",1,"1 - QS34 - Self-harm  - Process - 1","The number of staff in the denominator who have received training on treating people with compassion, respect and dignity that includes specific reference to people who self‑harm.","The number of staff in contact with people who have self‑harmed."]
[null,"QS34","Self-harm ",1,null,"People who have self‑harmed are cared for with compassion and the same respect and dignity as any service user.","Evidence from feedback that people who have self‑harmed feel treated with compassion and the same respect and dignity as any service user.","Outcome","QS34 - Self-harm ","1 - QS34 - Self-harm ",1,"1 - QS34 - Self-harm  - Outcome - 1"]
[null,"QS34","Self-harm ",2,null,"People who have self‑harmed have an initial assessment of physical health, mental state, safeguarding concerns, social circumstances and immediate concerns about their safety.","Evidence of local arrangements to ensure that initial assessments of people who have self‑harmed include physical health, mental state, safeguarding concerns, social circumstances and immediate concerns about their Evidence of local arrangements to ensure that initial assessments of people who have self‑harmed include physical health, mental state, safeguarding concerns, social circumstances and immediate concerns about their safety.","Structure","QS34 - Self-harm ","2 - QS34 - Self-harm ",1,"2 - QS34 - Self-harm  - Structure - 1","",""]
[null,"QS34","Self-harm ",2,null,"People who have self‑harmed have an initial assessment of physical health, mental state, safeguarding concerns, social circumstances and immediate concerns about their safety.","Proportion of people who have self‑harmed who have an initial assessment of physical health, mental state, safeguarding concerns, social circumstances and immediate concerns about their safety.","Process","QS34 - Self-harm ","2 - QS34 - Self-harm ",1,"2 - QS34 - Self-harm  - Process - 1","The number of people in the denominator who have an initial assessment of physical health, mental state, safeguarding concerns, social circumstances and immediate concerns about their safety.","The number of people with a new episode of self‑harm."]
[null,"QS34","Self-harm ",3,null,"People who have self‑harmed receive a psychosocial assessment.","Evidence of local arrangements to ensure that mental health professionals undertake psychosocial assessments with people who have self‑harmed.","Structure","QS34 - Self-harm ","3 - QS34 - Self-harm ",1,"3 - QS34 - Self-harm  - Structure - 1","",""]
[null,"QS34","Self-harm ",3,null,"People who have self‑harmed receive a psychosocial assessment.","Proportion of people who have self‑harmed who receive a psychosocial assessment.","Process","QS34 - Self-harm ","3 - QS34 - Self-harm ",1,"3 - QS34 - Self-harm  - Process - 1","The number of people in the denominator receiving a comprehensive psychosocial assessment or referred to a specialist mental health professional for the assessment.","The number of people with a new episode of self‑harm."]
[null,null,null,null,null,null,null,null," - "," -  - ",1," -  -  -  - 1","The number of people in the denominator who receive a psychosocial assessment.","The number of people with a new episode of self‑harm."]
[null,"QS34","Self-harm ",4,null,"People who have self‑harmed receive the observation they need while in the healthcare setting.","Evidence of local arrangements to ensure that people who have self‑harmed receive the observation they need while in the healthcare setting.","Structure","QS34 - Self-harm ","4 - QS34 - Self-harm ",1,"4 - QS34 - Self-harm  - Structure - 1","",""]
[null,"QS34","Self-harm ",4,null,"People who have self‑harmed receive the observation they need while in the healthcare setting.","Proportion of people who have self‑harmed who have a record of observation arrangements while in the healthcare setting.","Process","QS34 - Self-harm ","4 - QS34 - Self-harm ",1,"4 - QS34 - Self-harm  - Process - 1","The number of people in the denominator with a record of observation arrangements while in the healthcare setting.","The number of people with a new episode of self‑harm."]
[null,"QS34","Self-harm ",4,null,"People who have self‑harmed receive the observation they need while in the healthcare setting.","Number of episodes of self‑harm occurring in healthcare settings.","Outcome","QS34 - Self-harm ","4 - QS34 - Self-harm ",1,"4 - QS34 - Self-harm  - Outcome - 1"]
[null,"QS34","Self-harm ",5,null,"People who have self‑harmed are cared for in a safe physical environment while in the healthcare setting.","Evidence of local arrangements to undertake assessments of the safety of the environment in healthcare settings.","Structure","QS34 - Self-harm ","5 - QS34 - Self-harm ",1,"5 - QS34 - Self-harm  - Structure - 1","",""]
[null,"QS34","Self-harm ",5,null,"People who have self‑harmed are cared for in a safe physical environment while in the healthcare setting.","Number of episodes of self‑harm occurring in healthcare settings.","Outcome","QS34 - Self-harm ","5 - QS34 - Self-harm ",1,"5 - QS34 - Self-harm  - Outcome - 1"]
[null,"QS34","Self-harm ",6,null,"People receiving continuing support for self‑harm have a collaboratively developed care plan.","Evidence of local arrangements to ensure that people receiving continuing support for self‑harm have a collaboratively developed care plan.","Structure","QS34 - Self-harm ","6 - QS34 - Self-harm ",1,"6 - QS34 - Self-harm  - Structure - 1","",""]
[null,"QS34","Self-harm ",6,null,"People receiving continuing support for self‑harm have a collaboratively developed care plan.","Proportion of people receiving continuing support for self‑harm who have a collaboratively developed care plan.","Process","QS34 - Self-harm ","6 - QS34 - Self-harm ",1,"6 - QS34 - Self-harm  - Process - 1","The number of people in the denominator who have a collaboratively developed care plan.","The number of people receiving continuing support for self‑harm."]
[null,"QS34","Self-harm ",7,null,"People receiving continuing support for self‑harm have a discussion with their healthcare professional about the potential benefits of psychological interventions specifically structured for people who self‑harm.","Evidence of local arrangements to provide psychological interventions specifically structured for people who self‑harm.","Structure","QS34 - Self-harm ","7 - QS34 - Self-harm ",1,"7 - QS34 - Self-harm  - Structure - 1","",""]
[null,"QS34","Self-harm ",7,null,"People receiving continuing support for self‑harm have a discussion with their healthcare professional about the potential benefits of psychological interventions specifically structured for people who self‑harm.","Proportion of people receiving continuing support for self‑harm who have a record of a discussion with their healthcare professional about the potential benefits of psychological interventions specifically structured for people who self‑harm.","Process","QS34 - Self-harm ","7 - QS34 - Self-harm ",1,"7 - QS34 - Self-harm  - Process - 1","The number of people in the denominator who have a record of a discussion with their healthcare professional about the potential benefits of psychological interventions specifically structured for people who self‑harm.","The number of people receiving continuing support for self‑harm."]
[null,"QS34","Self-harm ",7,null,"People receiving continuing support for self‑harm have a discussion with their healthcare professional about the potential benefits of psychological interventions specifically structured for people who self‑harm.","Proportion of adults who self‑harm who accept referral for structured, person-centred cognitive behavioural therapy that is specifically tailored for adults who self-harm and receive at least 4 sessions.","Process","QS34 - Self-harm ","7 - QS34 - Self-harm ",2,"7 - QS34 - Self-harm  - Process - 2","The number of people in the denominator who accept referral for structured, person-centred cognitive behavioural therapy that is specifically tailored for adults who self-harm and receive at least 4 sessions.","The number of adults who self‑harm."]
[null,"QS34","Self-harm ",7,null,"People receiving continuing support for self‑harm have a discussion with their healthcare professional about the potential benefits of psychological interventions specifically structured for people who self‑harm.","Proportion of children and young people with significant emotional dysregulation difficulties and frequent episodes of self‑harm who discuss referral for dialectical behaviour therapy adapted for adolescents with a healthcare professional.","Process","QS34 - Self-harm ","7 - QS34 - Self-harm ",3,"7 - QS34 - Self-harm  - Process - 3","The number of people in the denominator who discuss referral for dialectical behaviour therapy adapted for adolescents with a healthcare professional.","The number of children and young people with significant emotional dysregulation difficulties and frequent episodes of self‑harm."]
[null,"QS34","Self-harm ",8,null,"People receiving continuing support for self‑harm and moving between mental health services have a collaboratively developed plan describing how support will be provided during the transition.","Evidence of local arrangements to ensure that providers collaboratively plan in advance and coordinate effectively when people who have self‑harmed move between mental health services.","Structure","QS34 - Self-harm ","8 - QS34 - Self-harm ",{"$f":"IF(AND(B811=B809, D811=D809, H811=H809)=TRUE, K809+1, 1)","v":1},"8 - QS34 - Self-harm  - Structure - 1","",""]
[null,"QS34","Self-harm ",8,null,"People receiving continuing support for self‑harm and moving between mental health services have a collaboratively developed plan describing how support will be provided during the transition.","Proportion of people receiving continuing support for self‑harm and moving between mental health services who have a collaboratively developed plan describing how support will be provided during the transition.","Process","QS34 - Self-harm ","8 - QS34 - Self-harm ",1,"8 - QS34 - Self-harm  - Process - 1","The number of people in the denominator with a collaboratively developed plan describing how support will be provided during the transition.","The number of people receiving continuing support for self‑harm and moving between mental health services."]
[null,"QS35","Hypertension in pregnancy ",1,null,"Women of childbearing potential with treated hypertension are given information annually about safe antihypertensive treatment during pregnancy. ","Evidence of local arrangements to ensure that women of childbearing potential with treated hypertension are given information annually about safe antihypertensive treatment during pregnancy.","Structure","QS35 - Hypertension in pregnancy ","1 - QS35 - Hypertension in pregnancy ",1,"1 - QS35 - Hypertension in pregnancy  - Structure - 1","",""]
[null,"QS35","Hypertension in pregnancy ",1,null,"Women of childbearing potential with treated hypertension are given information annually about safe antihypertensive treatment during pregnancy. ","Proportion of women who have had treated hypertension for 12 months or longer who received information about safe antihypertensive treatment during pregnancy in the past 12 months.","Process","QS35 - Hypertension in pregnancy ","1 - QS35 - Hypertension in pregnancy ",1,"1 - QS35 - Hypertension in pregnancy  - Process - 1","The number of women in the denominator who received information about safe antihypertensive treatment during pregnancy in the past 12 months.","The number of women of childbearing potential who have had treated hypertension for 12 months or longer."]
[null,"QS35","Hypertension in pregnancy ",2,null,"Pregnant women at increased risk of pre-eclampsia at the booking appointment are offered a prescription of 75–150 mg of aspirin to take daily from 12 weeks until birth.","Evidence of local arrangements to ensure that pregnant women have their risk factors for pre-eclampsia identified and recorded at the booking appointment.","Structure","QS35 - Hypertension in pregnancy ","2 - QS35 - Hypertension in pregnancy ",1,"2 - QS35 - Hypertension in pregnancy  - Structure - 1"]
[null,"QS35","Hypertension in pregnancy ",2,null,"Pregnant women at increased risk of pre-eclampsia at the booking appointment are offered a prescription of 75–150 mg of aspirin to take daily from 12 weeks until birth.","Evidence of local arrangements to ensure that pregnant women at increased risk of pre-eclampsia at the booking appointment are offered a prescription of 75–150 mg of aspirin (unless contraindicated) to take daily from 12 weeks until birth.","Structure","QS35 - Hypertension in pregnancy ","2 - QS35 - Hypertension in pregnancy ",2,"2 - QS35 - Hypertension in pregnancy  - Structure - 2"]
[null,"QS35","Hypertension in pregnancy ",2,null,"Pregnant women at increased risk of pre-eclampsia at the booking appointment are offered a prescription of 75–150 mg of aspirin to take daily from 12 weeks until birth.","Proportion of pregnant women who have their risk factors for pre-eclampsia identified and recorded at the booking appointment.","Process","QS35 - Hypertension in pregnancy ","2 - QS35 - Hypertension in pregnancy ",1,"2 - QS35 - Hypertension in pregnancy  - Process - 1","The number of women in the denominator whose risk factors for pre-eclampsia are identified and recorded.","The number of pregnant women attending a booking appointment."]
[null,"QS35","Hypertension in pregnancy ",2,null,"Pregnant women at increased risk of pre-eclampsia at the booking appointment are offered a prescription of 75–150 mg of aspirin to take daily from 12 weeks until birth.","Proportion of pregnant women at increased risk of pre-eclampsia at the booking appointment who are offered a prescription of 75–150 mg of aspirin (unless contraindicated) to take daily from 12 weeks until birth.","Process","QS35 - Hypertension in pregnancy ","2 - QS35 - Hypertension in pregnancy ",2,"2 - QS35 - Hypertension in pregnancy  - Process - 2","The number of women in the denominator offered a prescription of 75–150 mg of aspirin to take daily from 12 weeks until birth.","The number of pregnant women at increased risk of pre-eclampsia and without contraindications to aspirin at the booking appointment."]
[null,"QS35","Hypertension in pregnancy ",2,null,"Pregnant women at increased risk of pre-eclampsia at the booking appointment are offered a prescription of 75–150 mg of aspirin to take daily from 12 weeks until birth.","Incidence of pre-eclampsia in women at increased risk of developing pre-eclampsia.","Outcome","QS35 - Hypertension in pregnancy ","2 - QS35 - Hypertension in pregnancy ",1,"2 - QS35 - Hypertension in pregnancy  - Outcome - 1"]
[null,"QS35","Hypertension in pregnancy ",3,null,"Pregnant women taking antihypertensive medication have a blood pressure target of 135/85 mmHg or less.","Evidence of local arrangements to ensure that pregnant women taking antihypertensive medication have a blood pressure target of 135/85 mmHg or less.","Structure","QS35 - Hypertension in pregnancy ","3 - QS35 - Hypertension in pregnancy ",1,"3 - QS35 - Hypertension in pregnancy  - Structure - 1"]
[null,"QS35","Hypertension in pregnancy ",3,null,null,null,null,"QS35 - Hypertension in pregnancy ","3 - QS35 - Hypertension in pregnancy ",1,"3 - QS35 - Hypertension in pregnancy  -  - 1"]
[null,"QS35","Hypertension in pregnancy ",3,null,"Pregnant women taking antihypertensive medication have a blood pressure target of 135/85 mmHg or less.","Rate of pregnant women with hypertension who maintain their target blood pressure throughout their pregnancy.","Outcome","QS35 - Hypertension in pregnancy ","3 - QS35 - Hypertension in pregnancy ",1,"3 - QS35 - Hypertension in pregnancy  - Outcome - 1"]
[null,"QS35","Hypertension in pregnancy ",4,null,"Pregnant women with severe hypertension are admitted for a full assessment, carried out by a healthcare professional trained in managing hypertension in pregnancy. ","Evidence of local arrangements for pregnant women with severe hypertension to be admitted for a full assessment, carried out by a healthcare professional trained in managing hypertensive disorders in pregnancy. ","Structure","QS35 - Hypertension in pregnancy ","4 - QS35 - Hypertension in pregnancy ",1,"4 - QS35 - Hypertension in pregnancy  - Structure - 1","",""]
[null,"QS35","Hypertension in pregnancy ",4,null,"Pregnant women with severe hypertension are admitted for a full assessment, carried out by a healthcare professional trained in managing hypertension in pregnancy. ","Proportion of women with severe hypertension who are admitted for a full assessment, carried out by a healthcare professional trained in managing hypertensive disorders in pregnancy. ","Process","QS35 - Hypertension in pregnancy ","4 - QS35 - Hypertension in pregnancy ",1,"4 - QS35 - Hypertension in pregnancy  - Process - 1","The number of women in the denominator who are admitted for a full assessment, carried out by a healthcare professional trained in managing hypertensive disorders in pregnancy.","The number of pregnant women with severe hypertension."]
[null,"QS35","Hypertension in pregnancy ",4,null,"Pregnant women with severe hypertension are admitted for a full assessment, carried out by a healthcare professional trained in managing hypertension in pregnancy. ","Number of women with severe hypertension in pregnancy who have a stroke.","Outcome","QS35 - Hypertension in pregnancy ","4 - QS35 - Hypertension in pregnancy ",1,"4 - QS35 - Hypertension in pregnancy  - Outcome - 1"]
[null,"QS35","Hypertension in pregnancy ",5,null,"Women with pre-eclampsia who have severe hypertension or are at a high risk of adverse events, or if there are any clinical concerns, are admitted to hospital and monitored.","Evidence of local arrangements to ensure that women with pre-eclampsia who have severe hypertension or are at a high risk of adverse events, or if there are any clinical concerns, are admitted to hospital.","Structure","QS35 - Hypertension in pregnancy ","5 - QS35 - Hypertension in pregnancy ",1,"5 - QS35 - Hypertension in pregnancy  - Structure - 1","",""]
[null,"QS35","Hypertension in pregnancy ",5,null,"Women with pre-eclampsia who have severe hypertension or are at a high risk of adverse events, or if there are any clinical concerns, are admitted to hospital and monitored.","Evidence of local arrangements for women with pre-eclampsia who have severe hypertension or are at a high risk of adverse events or if there are any clinical concerns, to receive an integrated package of care that includes monitoring of their condition.","Structure","QS35 - Hypertension in pregnancy ","5 - QS35 - Hypertension in pregnancy ",2,"5 - QS35 - Hypertension in pregnancy  - Structure - 2","",""]
[null,"QS35","Hypertension in pregnancy ",5,null,"Women with pre-eclampsia who have severe hypertension or are at a high risk of adverse events, or if there are any clinical concerns, are admitted to hospital and monitored.","The proportion of women with pre-eclampsia who have severe hypertension or are at a high risk of adverse events, or if there are any clinical concerns, who are admitted to hospital and monitored.","Process","QS35 - Hypertension in pregnancy ","5 - QS35 - Hypertension in pregnancy ",1,"5 - QS35 - Hypertension in pregnancy  - Process - 1","The number of women in the denominator who are admitted to hospital and monitored.","The number of women with pre-eclampsia who have severe hypertension or are at a high risk of adverse events, or if there are any clinical concerns."]
[null,"QS35","Hypertension in pregnancy ",null,null,null,null,null,"QS35 - Hypertension in pregnancy "," - QS35 - Hypertension in pregnancy ",1," - QS35 - Hypertension in pregnancy  -  - 1"]
[null,"QS35","Hypertension in pregnancy ",6,null,"Women with pre-eclampsia have a senior obstetrician involved in any decisions about the timing of birth.","Evidence of local arrangements to ensure that women with pre-eclampsia have a senior obstetrician involved in decisions about the timing of birth.","Structure","QS35 - Hypertension in pregnancy ","6 - QS35 - Hypertension in pregnancy ",1,"6 - QS35 - Hypertension in pregnancy  - Structure - 1","",""]
[null,"QS35","Hypertension in pregnancy ",6,null,"Women with pre-eclampsia have a senior obstetrician involved in any decisions about the timing of birth.","Proportion of women with pre-eclampsia who have given birth who had a senior obstetrician involved in decisions about the timing of birth.","Process","QS35 - Hypertension in pregnancy ","6 - QS35 - Hypertension in pregnancy ",1,"6 - QS35 - Hypertension in pregnancy  - Process - 1","The number of women in the denominator who had a senior obstetrician involved in decisions about the timing of birth.","The number of women who have given birth who had pre-eclampsia."]
[null,"QS35","Hypertension in pregnancy ",6,null,"Women with pre-eclampsia have a senior obstetrician involved in any decisions about the timing of birth.","Number of maternal deaths of women with pre-eclampsia.","Outcome","QS35 - Hypertension in pregnancy ","6 - QS35 - Hypertension in pregnancy ",1,"6 - QS35 - Hypertension in pregnancy  - Outcome - 1"]
[null,"QS35","Hypertension in pregnancy ",6,null,"Women with pre-eclampsia have a senior obstetrician involved in any decisions about the timing of birth.","Number of fetal deaths for women with pre-eclampsia.","Outcome","QS35 - Hypertension in pregnancy ",{"$f":"CONCATENATE(D833, \" - \", I833)","v":"6 - QS35 - Hypertension in pregnancy "},{"$f":"IF(AND(B833=B832, D833=D832, H833=H832)=TRUE, K832+1, 1)","v":2},{"$f":"CONCATENATE(J833, \" - \", H833, \" - \",K833)","v":"6 - QS35 - Hypertension in pregnancy  - Outcome - 2"}]
[null,"QS35","Hypertension in pregnancy ",6,null,"Women with pre-eclampsia have a senior obstetrician involved in any decisions about the timing of birth.","Number of admissions of women with pre-eclampsia to intensive care units (ICU).","Outcome","QS35 - Hypertension in pregnancy ","6 - QS35 - Hypertension in pregnancy ",3,"6 - QS35 - Hypertension in pregnancy  - Outcome - 3"]
[null,"QS35","Hypertension in pregnancy ",6,null,"Women with pre-eclampsia have a senior obstetrician involved in any decisions about the timing of birth.","Number of admissions of babies born to women with pre-eclampsia to neonatal intensive care units (NICU).","Outcome","QS35 - Hypertension in pregnancy ","6 - QS35 - Hypertension in pregnancy ",4,"6 - QS35 - Hypertension in pregnancy  - Outcome - 4"]
[null,"QS35","Hypertension in pregnancy ",6,null,null,null,null,"QS35 - Hypertension in pregnancy ","6 - QS35 - Hypertension in pregnancy ",1,"6 - QS35 - Hypertension in pregnancy  -  - 1"]
[null,"QS35","Hypertension in pregnancy ",7,null,"Women who have had hypertension in pregnancy have a plan for ongoing antihypertensive management included in their postnatal care plan, which is communicated to their GP when they are transferred to community care after the birth.","Evidence of local arrangements to communicate a plan for ongoing antihypertensive management for women who had hypertension in pregnancy to their GP when they are transferred to community care after the birth.","Structure","QS35 - Hypertension in pregnancy ","7 - QS35 - Hypertension in pregnancy ",1,"7 - QS35 - Hypertension in pregnancy  - Structure - 1","",""]
[null,"QS35","Hypertension in pregnancy ",7,null,"Women who have had hypertension in pregnancy have a plan for ongoing antihypertensive management included in their postnatal care plan, which is communicated to their GP when they are transferred to community care after the birth.","The proportion of women with hypertension in pregnancy for whom a plan for ongoing antihypertensive management is communicated to their GP when they are transferred to community care after the birth.","Process",{"$f":"CONCATENATE(B838, \" - \", C838)","v":"QS35 - Hypertension in pregnancy "},"7 - QS35 - Hypertension in pregnancy ",1,"7 - QS35 - Hypertension in pregnancy  - Process - 1","The number of women in the denominator for whom a plan for ongoing antihypertensive management is communicated to their GP when they are transferred to community care after the birth.","The number of women who have given birth who had hypertension in pregnancy."]
[null,"QS35","Hypertension in pregnancy ",8,null,"Women who have had gestational hypertension or pre-eclampsia discuss future pregnancy and lifetime cardiovascular risks during a medical review at their 6–8 week postnatal medical check.","Evidence of local arrangements for women who have had gestational hypertension or pre-eclampsia to have a discussion about future related risks during the medical review at their 6–8 week postnatal medical check.\n","Structure","QS35 - Hypertension in pregnancy ","8 - QS35 - Hypertension in pregnancy ",1,"8 - QS35 - Hypertension in pregnancy  - Structure - 1","",""]
[null,"QS35","Hypertension in pregnancy ",8,null,"Women who have had gestational hypertension or pre-eclampsia discuss future pregnancy and lifetime cardiovascular risks during a medical review at their 6–8 week postnatal medical check.","The proportion of women who have had gestational hypertension or pre-eclampsia who have a discussion about future related risks during the medical review at their 6–8 week postnatal medical check.","Process","QS35 - Hypertension in pregnancy ","8 - QS35 - Hypertension in pregnancy ",1,"8 - QS35 - Hypertension in pregnancy  - Process - 1","The number of women in the denominator who have a discussion about future related risks.","The number of women who have had gestational hypertension or pre-eclampsia who have a medical review at their 6–8 week postnatal check."]
[null,"QS36","Urinary tract infection in children and young people",1,null,"This statement has been removed. ",null,"Structure","QS36 - Urinary tract infection in children and young people","1 - QS36 - Urinary tract infection in children and young people",1,"1 - QS36 - Urinary tract infection in children and young people - Structure - 1","",""]
[null,"QS36","Urinary tract infection in children and young people",1,null,"This statement has been removed. ",null,"Process","QS36 - Urinary tract infection in children and young people","1 - QS36 - Urinary tract infection in children and young people",1,"1 - QS36 - Urinary tract infection in children and young people - Process - 1"]
[null,"QS36","Urinary tract infection in children and young people",2,null,"Infants, children and young people with a urinary tract infection have risk factors for urinary tract infection and serious underlying pathology recorded as part of their history and examination.","Evidence of local arrangements to ensure that infants, children and young people (under 16 years) with a urinary tract infection have risk factors for urinary tract infection and serious underlying pathology recorded as part of their history and examination.","Structure","QS36 - Urinary tract infection in children and young people","2 - QS36 - Urinary tract infection in children and young people",1,"2 - QS36 - Urinary tract infection in children and young people - Structure - 1","",""]
[null,"QS36","Urinary tract infection in children and young people",2,null,"Infants, children and young people with a urinary tract infection have risk factors for urinary tract infection and serious underlying pathology recorded as part of their history and examination.","Proportion of infants, children and young people with a urinary tract infection who have risk factors for urinary tract infection and serious underlying pathology recorded as part of their history and examination.","Process","QS36 - Urinary tract infection in children and young people","2 - QS36 - Urinary tract infection in children and young people",1,"2 - QS36 - Urinary tract infection in children and young people - Process - 1","The number of people in the denominator who have risk factors for urinary tract infection and serious underlying pathology recorded as part of their history and examination.","The number of infants, children and young people (under 16 years) with a urinary tract infection."]
[null,"QS36","Urinary tract infection in children and young people",3,null,"Infants, children and young people with a urinary tract infection caused by coliform bacteria have results of microbiology laboratory testing differentiated by Escherichia coli (E. coli) or non-E. coli organisms.","Evidence of local arrangements to ensure that microbiology laboratories detecting coliform bacteria as a cause of a urinary tract infection report results differentiated by E. coli or non-E. coli organisms.","Structure","QS36 - Urinary tract infection in children and young people","3 - QS36 - Urinary tract infection in children and young people",1,"3 - QS36 - Urinary tract infection in children and young people - Structure - 1","",""]
[null,"QS36","Urinary tract infection in children and young people",3,null,"Infants, children and young people with a urinary tract infection caused by coliform bacteria have results of microbiology laboratory testing differentiated by Escherichia coli (E. coli) or non-E. coli organisms.","Proportion of infants, children and young people with a urinary tract infection caused by coliform bacteria who have results of microbiology laboratory testing differentiated by E. coli or non-E. coli organisms.","Process","QS36 - Urinary tract infection in children and young people","3 - QS36 - Urinary tract infection in children and young people",1,"3 - QS36 - Urinary tract infection in children and young people - Process - 1","The number of people in the denominator who have results of microbiology laboratory testing differentiated by E. coli or non-E. coli organisms.","The number of infants, children and young people (under 16 years) with a urinary tract infection caused by coliform bacteria."]
[null,"QS36","Urinary tract infection in children and young people",4,null,"Children and young people who have had a urinary tract infection are given information about how to recognise re-infection and to seek medical advice straight away.","Evidence of local arrangements to ensure that children and young people (under 16 years) who have had a urinary tract infection are given information about how to recognise re-infection and to seek medical advice straight away.","Structure","QS36 - Urinary tract infection in children and young people","4 - QS36 - Urinary tract infection in children and young people",1,"4 - QS36 - Urinary tract infection in children and young people - Structure - 1","",""]
[null,"QS36","Urinary tract infection in children and young people",4,null,"Children and young people who have had a urinary tract infection are given information about how to recognise re-infection and to seek medical advice straight away.","Proportion of children and young people who have had a urinary tract infection who receive information about how to recognise re-infection and to seek medical advice straight away.","Process","QS36 - Urinary tract infection in children and young people","4 - QS36 - Urinary tract infection in children and young people",1,"4 - QS36 - Urinary tract infection in children and young people - Process - 1","The number of people in the denominator who receive information about how to recognise re-infection and to seek medical advice straight away.","The number of children and young people (under 16 years) who have had a urinary tract infection."]
[null,"QS36","Urinary tract infection in children and young people",4,null,"Children and young people who have had a urinary tract infection are given information about how to recognise re-infection and to seek medical advice straight away.","Patient satisfaction with information received about how to recognise re-infection and to seek medical advice straight away.","Outcome","QS36 - Urinary tract infection in children and young people","4 - QS36 - Urinary tract infection in children and young people",1,"4 - QS36 - Urinary tract infection in children and young people - Outcome - 1"]
[null,"QS37","Postnatal care",1,null,"Women who are transferring between services in the postnatal period have relevant information shared between healthcare professionals to support their care. [new 2022]","Proportion of transfers of women into a service in the postnatal period where a notification of transfer has taken place to relevant healthcare professionals and the woman or the parents.","Process","QS37 - Postnatal care","1 - QS37 - Postnatal care",1,"1 - QS37 - Postnatal care - Process - 1","The number in the denominator where a notification of transfer has taken place to relevant healthcare professionals and the woman or the parents.","The number of transfers of women into a service in the postnatal period."]
[null,"QS37","Postnatal care",1,null,"Women who are transferring between services in the postnatal period have relevant information shared between healthcare professionals to support their care. [new 2022]","Proportion of women transferring into a service in the postnatal period with a record of complete relevant information provided by the transferring service.","Process",{"$f":"CONCATENATE(B851, \" - \", C851)","v":"QS37 - Postnatal care"},{"$f":"CONCATENATE(D851, \" - \", I851)","v":"1 - QS37 - Postnatal care"},{"$f":"IF(AND(B851=B850, D851=D850, H851=H850)=TRUE, K850+1, 1)","v":2},{"$f":"CONCATENATE(J851, \" - \", H851, \" - \",K851)","v":"1 - QS37 - Postnatal care - Process - 2"},"The number in the denominator with a record of complete relevant information provided by the transferring service.","The number of women transferring into a service in the postnatal period."]
[null,"QS37","Postnatal care",1,null,"Women who are transferring between services in the postnatal period have relevant information shared between healthcare professionals to support their care. [new 2022]","Proportion of women who agreed that their healthcare professionals in the postnatal period always appeared to be aware of the relevant history for them and their baby.","Outcome",{"$f":"CONCATENATE(B852, \" - \", C852)","v":"QS37 - Postnatal care"},{"$f":"CONCATENATE(D852, \" - \", I852)","v":"1 - QS37 - Postnatal care"},{"$f":"IF(AND(B852=B851, D852=D851, H852=H851)=TRUE, K851+1, 1)","v":1},{"$f":"CONCATENATE(J852, \" - \", H852, \" - \",K852)","v":"1 - QS37 - Postnatal care - Outcome - 1"},"The number in the denominator who agreed that their healthcare professionals in the postnatal period always appeared to be aware of the relevant history for them and their baby.","The number of women who had a live birth."]
[null,"QS37","Postnatal care",2,null,"Parents are given personalised information and advice about feeding their baby before transfer to community care or before the midwife leaves after a home birth. [2013, updated 2022]","Proportion of women who had a live birth who received personalised information and advice about feeding their baby before transfer to community care or before the midwife left after a home birth.","Process","QS37 - Postnatal care","2 - QS37 - Postnatal care",1,"2 - QS37 - Postnatal care - Process - 1","The number in the denominator who received personalised information and advice about feeding their baby before transfer to community care or before the midwife left after a home birth.","The number of women who had a live birth."]
[null,"QS37","Postnatal care",2,null,"Parents are given personalised information and advice about feeding their baby before transfer to community care or before the midwife leaves after a home birth. [2013, updated 2022]","Rates of new-born hospital attendances and admissions for feeding-related conditions.","Outcome","QS37 - Postnatal care","2 - QS37 - Postnatal care",1,"2 - QS37 - Postnatal care - Outcome - 1"]
[null,"QS37","Postnatal care",2,null,"Parents are given personalised information and advice about feeding their baby before transfer to community care or before the midwife leaves after a home birth. [2013, updated 2022]","Proportion of parents who were satisfied with information and advice about feeding their baby given before transfer to community care or before the midwife left after a home birth.","Outcome","QS37 - Postnatal care","2 - QS37 - Postnatal care",2,"2 - QS37 - Postnatal care - Outcome - 2","The number in the denominator who were satisfied with information and advice about feeding their baby given before transfer to community care or before the midwife left after a home birth.","The number of parents of babies."]
[null,"QS37","Postnatal care",3,null,"Parents are given information and advice, before transfer to community care or before the midwife leaves after a home birth, about symptoms and signs of serious illness in the baby that require them to contact emergency services. [2013, updated 2022]","Proportion of women who had a live birth who received information and advice, before transfer to community care or before the midwife left after a home birth, about symptoms and signs of serious illness in the baby that require them to contact emergency services.","Process","QS37 - Postnatal care","3 - QS37 - Postnatal care",1,"3 - QS37 - Postnatal care - Process - 1","The number in The denominator who received information and advice, before transfer to community care or before The midwife left after a home birth, about symptoms and signs of serious illness in The baby that require Them to contact emergency services.","The number of women who had a live birth."]
[null,"QS37","Postnatal care",3,null,"Parents are given information and advice, before transfer to community care or before the midwife leaves after a home birth, about symptoms and signs of serious illness in the baby that require them to contact emergency services. [2013, updated 2022]","Incidence of infant mortality within the first 8 weeks after birth.","Outcome","QS37 - Postnatal care","3 - QS37 - Postnatal care",1,"3 - QS37 - Postnatal care - Outcome - 1","",""]
[null,"QS37","Postnatal care",3,null,"Parents are given information and advice, before transfer to community care or before the midwife leaves after a home birth, about symptoms and signs of serious illness in the baby that require them to contact emergency services. [2013, updated 2022]","Proportion of parents who feel informed about symptoms and signs of serious illness in the baby.","Outcome","QS37 - Postnatal care","3 - QS37 - Postnatal care",2,"3 - QS37 - Postnatal care - Outcome - 2","The number in The denominator who feel informed about symptoms and signs of serious illness in The baby.","The number of parents of babies."]
[null,"QS37","Postnatal care",4,null,"Parents receive face-to-face feeding support at each routine postnatal contact. [new 2022]","Evidence that healthcare professionals have the knowledge and skills they need to provide face-to-face feeding support.","Structure","QS37 - Postnatal care","4 - QS37 - Postnatal care",1,"4 - QS37 - Postnatal care - Structure - 1"]
[null,"QS37","Postnatal care",4,null,"Parents receive face-to-face feeding support at each routine postnatal contact. [new 2022]","Proportion of women who had a live birth who had an observation of a feed within 24 hours of the birth.","Process","QS37 - Postnatal care","4 - QS37 - Postnatal care",1,"4 - QS37 - Postnatal care - Process - 1","The number in the denominator who had an observation of a feed within 24 hours of The birth.","The number of women who had a live birth."]
[null,"QS37","Postnatal care",4,null,"Parents receive face-to-face feeding support at each routine postnatal contact. [new 2022]","Proportion of women who breastfeed who had an observation of a feed between 2 and 7 days after the birth.","Process","QS37 - Postnatal care","4 - QS37 - Postnatal care",2,"4 - QS37 - Postnatal care - Process - 2","The number in the denominator who had an observation of a feed between 2 and 7 days after The birth.","The number of women who breastfeed (exclusively or partially)."]
[null,"QS37","Postnatal care",4,null,"Parents receive face-to-face feeding support at each routine postnatal contact. [new 2022]","Proportion of routine postnatal contacts that include face-to-face feeding support.","Process","QS37 - Postnatal care","4 - QS37 - Postnatal care",3,"4 - QS37 - Postnatal care - Process - 3","The number in the denominator that include face-to-face feeding support.","The number of routine postnatal contacts."]
[null,"QS37","Postnatal care",4,null,"Parents receive face-to-face feeding support at each routine postnatal contact. [new 2022]","Rates of exclusive or partial breastfeeding at 6 to 8 weeks after the birth.","Outcome","QS37 - Postnatal care","4 - QS37 - Postnatal care",1,"4 - QS37 - Postnatal care - Outcome - 1"]
[null,"QS37","Postnatal care",4,null,"Parents receive face-to-face feeding support at each routine postnatal contact. [new 2022]","Proportion of parents who are satisfied with postnatal support with feeding.","Outcome","QS37 - Postnatal care","4 - QS37 - Postnatal care",2,"4 - QS37 - Postnatal care - Outcome - 2","The number in the denominator who are satisfied with postnatal support with feeding.","The number of parents of babies."]
[null,"QS37","Postnatal care",5,null,"Parents are given advice about safer practices for bed sharing at each routine postnatal contact. [2013, updated 2022]","Proportion of routine postnatal contacts that include advice about safer practices for bed sharing.","Process","QS37 - Postnatal care","5 - QS37 - Postnatal care",1,"5 - QS37 - Postnatal care - Process - 1","The number in the denominator that include advice about safer practices for bed sharing.","The number of routine postnatal contacts."]
[null,"QS37","Postnatal care",5,null,"Parents are given advice about safer practices for bed sharing at each routine postnatal contact. [2013, updated 2022]","Incidence of sudden infant death syndrome (SIDS).","Outcome","QS37 - Postnatal care","5 - QS37 - Postnatal care",1,"5 - QS37 - Postnatal care - Outcome - 1"]
[null,"QS37","Postnatal care",5,null,"Parents are given advice about safer practices for bed sharing at each routine postnatal contact. [2013, updated 2022]","Proportion of parents who know about safer practices for bed sharing.","Outcome","QS37 - Postnatal care","5 - QS37 - Postnatal care",2,"5 - QS37 - Postnatal care - Outcome - 2","The number in the denominator who know about safer practices for bed sharing.","The number of parents of babies."]
[null,"QS37","Postnatal care",6,null,"Women have a GP assessment 6 to 8 weeks after giving birth. [new 2022]","Proportion of women who had a GP assessment 6 to 8 weeks after giving birth.","Process","QS37 - Postnatal care","6 - QS37 - Postnatal care",1,"6 - QS37 - Postnatal care - Process - 1","The number in the denominator who had a GP assessment 6 to 8 weeks after giving birth.","The number of women who gave birth."]
[null,"QS37","Postnatal care",6,null,"Women have a GP assessment 6 to 8 weeks after giving birth. [new 2022]","Proportion of women who had a GP assessment 6 to 8 weeks after giving birth who are satisfied that the GP spent enough time talking to them about their physical and mental health.","Outcome","QS37 - Postnatal care","6 - QS37 - Postnatal care",1,"6 - QS37 - Postnatal care - Outcome - 1","The number in the denominator who are satisfied that The GP spent enough time talking to Them about Their physical and mental health.","The number of women who had a GP assessment 6 to 8 weeks after giving birth."]
[null,"QS37","Postnatal care",6,null,"Women have a GP assessment 6 to 8 weeks after giving birth. [new 2022]","Rates of unplanned hospital attendance for women within 3 months of giving birth.","Outcome","QS37 - Postnatal care","6 - QS37 - Postnatal care",2,"6 - QS37 - Postnatal care - Outcome - 2"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",1," - QS37 - Postnatal care -  - 1"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",2," - QS37 - Postnatal care -  - 2"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",3," - QS37 - Postnatal care -  - 3"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",4," - QS37 - Postnatal care -  - 4"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",5," - QS37 - Postnatal care -  - 5"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",6," - QS37 - Postnatal care -  - 6"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",7," - QS37 - Postnatal care -  - 7"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",8," - QS37 - Postnatal care -  - 8"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",9," - QS37 - Postnatal care -  - 9"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",10," - QS37 - Postnatal care -  - 10"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",11," - QS37 - Postnatal care -  - 11"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",12," - QS37 - Postnatal care -  - 12"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",13," - QS37 - Postnatal care -  - 13"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",14," - QS37 - Postnatal care -  - 14"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",15," - QS37 - Postnatal care -  - 15"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",16," - QS37 - Postnatal care -  - 16"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",17," - QS37 - Postnatal care -  - 17"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",18," - QS37 - Postnatal care -  - 18"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",19," - QS37 - Postnatal care -  - 19"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care",{"$f":"CONCATENATE(D890, \" - \", I890)","v":" - QS37 - Postnatal care"},20,{"$f":"CONCATENATE(J890, \" - \", H890, \" - \",K890)","v":" - QS37 - Postnatal care -  - 20"}]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",21," - QS37 - Postnatal care -  - 21"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",{"$f":"IF(AND(B892=B891, D892=D891, H892=H891)=TRUE, K891+1, 1)","v":22}," - QS37 - Postnatal care -  - 22"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",23," - QS37 - Postnatal care -  - 23"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",24," - QS37 - Postnatal care -  - 24"]
[null,"QS37","Postnatal care",null,null,null,null,null,{"$f":"CONCATENATE(B895, \" - \", C895)","v":"QS37 - Postnatal care"}," - QS37 - Postnatal care",25," - QS37 - Postnatal care -  - 25"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",26," - QS37 - Postnatal care -  - 26"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",27," - QS37 - Postnatal care -  - 27"]
[null,"QS37","Postnatal care",null,null,null,null,null,"QS37 - Postnatal care"," - QS37 - Postnatal care",28," - QS37 - Postnatal care -  - 28"]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",1,null,"People with acute upper gastrointestinal bleeding receive a risk assessment using a validated risk score. ","Evidence of local arrangements to ensure that people with acute upper gastrointestinal bleeding receive a risk assessment using a validated risk score.","Structure","QS38 - Acute upper gastrointestinal bleeding in adults","1 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"1 - QS38 - Acute upper gastrointestinal bleeding in adults - Structure - 1","",""]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",1,null,"People with acute upper gastrointestinal bleeding receive a risk assessment using a validated risk score. ","Proportion of people with acute upper gastrointestinal bleeding who receive a risk assessment using a validated risk score.","Process","QS38 - Acute upper gastrointestinal bleeding in adults","1 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"1 - QS38 - Acute upper gastrointestinal bleeding in adults - Process - 1","The number of people in the denominator who receive a risk assessment using a validated risk score.","The number of people with acute upper gastrointestinal bleeding."]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",2,null,"People with severe acute upper gastrointestinal bleeding who are haemodynamically unstable are given an endoscopy within 2 hours of optimal resuscitation.","Evidence of local arrangements to ensure that people with severe acute upper gastrointestinal bleeding who are haemodynamically unstable are given an endoscopy within 2 hours of optimal resuscitation.","Structure","QS38 - Acute upper gastrointestinal bleeding in adults","2 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"2 - QS38 - Acute upper gastrointestinal bleeding in adults - Structure - 1","",""]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",2,null,"People with severe acute upper gastrointestinal bleeding who are haemodynamically unstable are given an endoscopy within 2 hours of optimal resuscitation.","Proportion of people with severe acute upper gastrointestinal bleeding who are haemodynamically unstable who receive endoscopy within 2 hours of optimal resuscitation.","Process","QS38 - Acute upper gastrointestinal bleeding in adults","2 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"2 - QS38 - Acute upper gastrointestinal bleeding in adults - Process - 1","The number of people in the denominator who receive endoscopy within 2 hours of optimal resuscitation.","The number of people with severe acute upper gastrointestinal bleeding who are haemodynamically unstable."]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",3,null,"People admitted to hospital with acute upper gastrointestinal bleeding who are haemodynamically stable are given an endoscopy within 24 hours of admission.","Evidence of local arrangements to ensure that people admitted to hospital with acute upper gastrointestinal bleeding who are haemodynamically stable are given an endoscopy within 24 hours of admission.","Structure","QS38 - Acute upper gastrointestinal bleeding in adults","3 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"3 - QS38 - Acute upper gastrointestinal bleeding in adults - Structure - 1","",""]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",3,null,"People admitted to hospital with acute upper gastrointestinal bleeding who are haemodynamically stable are given an endoscopy within 24 hours of admission.","Proportion of people admitted to hospital with acute upper gastrointestinal bleeding who are haemodynamically stable who receive endoscopy within 24 hours of admission.","Process","QS38 - Acute upper gastrointestinal bleeding in adults","3 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"3 - QS38 - Acute upper gastrointestinal bleeding in adults - Process - 1","The number of people in the denominator who receive endoscopy within 24 hours of admission.","The number of people admitted to hospital with acute upper gastrointestinal bleeding who are haemodynamically stable."]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",3,null,"People admitted to hospital with acute upper gastrointestinal bleeding who are haemodynamically stable are given an endoscopy within 24 hours of admission.","Length of hospital stay for people with acute upper gastrointestinal bleeding who are haemodynamically stable.","Outcome","QS38 - Acute upper gastrointestinal bleeding in adults","3 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"3 - QS38 - Acute upper gastrointestinal bleeding in adults - Outcome - 1"]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",4,null,"People with non-variceal acute upper gastrointestinal bleeding and stigmata of recent haemorrhage are offered endoscopic treatments (combination or a mechanical method).  ","Evidence of local arrangements to ensure that people with non-variceal acute upper gastrointestinal bleeding and stigmata of recent haemorrhage are offered endoscopic treatments (combination or a mechanical method).","Structure","QS38 - Acute upper gastrointestinal bleeding in adults","4 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"4 - QS38 - Acute upper gastrointestinal bleeding in adults - Structure - 1","",""]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",4,null,"People with non-variceal acute upper gastrointestinal bleeding and stigmata of recent haemorrhage are offered endoscopic treatments (combination or a mechanical method).  ","Proportion of people with non-variceal acute upper gastrointestinal bleeding and stigmata of recent haemorrhage who receive endoscopic treatments (combination or a mechanical method).","Process","QS38 - Acute upper gastrointestinal bleeding in adults","4 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"4 - QS38 - Acute upper gastrointestinal bleeding in adults - Process - 1","The number of people in the denominator who receive endoscopic treatments (combination or a mechanical method).","The number of people with non-variceal acute upper gastrointestinal bleeding and stigmata of recent haemorrhage."]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",4,null,"People with non-variceal acute upper gastrointestinal bleeding and stigmata of recent haemorrhage are offered endoscopic treatments (combination or a mechanical method).  ","Proportion of people with non-variceal acute upper gastrointestinal bleeding and stigmata of recent haemorrhage who have uncontrolled bleeding or re-bleeding within 48 hours. ","Outcome","QS38 - Acute upper gastrointestinal bleeding in adults","4 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"4 - QS38 - Acute upper gastrointestinal bleeding in adults - Outcome - 1"]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",4,null,"People with non-variceal acute upper gastrointestinal bleeding and stigmata of recent haemorrhage are offered endoscopic treatments (combination or a mechanical method).  ","Proportion of people with non-variceal acute upper gastrointestinal bleeding and stigmata of recent haemorrhage who need rescue therapies.","Outcome","QS38 - Acute upper gastrointestinal bleeding in adults","4 - QS38 - Acute upper gastrointestinal bleeding in adults",2,"4 - QS38 - Acute upper gastrointestinal bleeding in adults - Outcome - 2"]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",5,null,"People with non-variceal acute upper gastrointestinal bleeding who continue to bleed or re-bleed after endoscopic treatment and who are haemodynamically unstable are given interventional radiology treatment.","Evidence of local arrangements to ensure that people with non-variceal acute upper gastrointestinal bleeding who continue to bleed or re-bleed after endoscopic treatment and who are haemodynamically unstable are given interventional radiology treatment (embolisation).","Structure","QS38 - Acute upper gastrointestinal bleeding in adults","5 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"5 - QS38 - Acute upper gastrointestinal bleeding in adults - Structure - 1","",""]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",5,null,"People with non-variceal acute upper gastrointestinal bleeding who continue to bleed or re-bleed after endoscopic treatment and who are haemodynamically unstable are given interventional radiology treatment.","Proportion of people with non-variceal acute upper gastrointestinal bleeding who continue to bleed or re-bleed after endoscopic treatment and who are haemodynamically unstable who receive interventional radiology treatment (embolisation).  ","Process","QS38 - Acute upper gastrointestinal bleeding in adults","5 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"5 - QS38 - Acute upper gastrointestinal bleeding in adults - Process - 1","The number of people in the denominator who receive interventional radiology treatment (embolisation).","The number of people with non-variceal acute upper gastrointestinal bleeding who continue to bleed or re-bleed after endoscopic treatment and who are haemodynamically unstable."]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",6,null,"People with suspected or confirmed variceal acute upper gastrointestinal bleeding are given antibiotic therapy at presentation.","Evidence of local arrangements to ensure that people with suspected or confirmed variceal acute upper gastrointestinal bleeding are given antibiotic therapy at presentation.","Structure","QS38 - Acute upper gastrointestinal bleeding in adults","6 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"6 - QS38 - Acute upper gastrointestinal bleeding in adults - Structure - 1","",""]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",6,null,"People with suspected or confirmed variceal acute upper gastrointestinal bleeding are given antibiotic therapy at presentation.","Proportion of people with suspected or confirmed variceal acute upper gastrointestinal bleeding who receive antibiotic therapy at presentation.","Process","QS38 - Acute upper gastrointestinal bleeding in adults","6 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"6 - QS38 - Acute upper gastrointestinal bleeding in adults - Process - 1","The number of people in the denominator who receive antibiotic therapy at presentation.","The number of people with suspected or confirmed variceal acute upper gastrointestinal bleeding at presentation."]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",6,null,"People with suspected or confirmed variceal acute upper gastrointestinal bleeding are given antibiotic therapy at presentation.","Rates of sepsis in people with suspected or confirmed variceal acute upper gastrointestinal bleeding.","Outcome","QS38 - Acute upper gastrointestinal bleeding in adults","6 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"6 - QS38 - Acute upper gastrointestinal bleeding in adults - Outcome - 1"]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",7,null,"People with acute upper gastrointestinal bleeding from oesophageal varices are given band ligation.","Evidence of local arrangements to ensure that people with acute upper gastrointestinal bleeding from oesophageal varices are given band ligation.","Structure","QS38 - Acute upper gastrointestinal bleeding in adults","7 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"7 - QS38 - Acute upper gastrointestinal bleeding in adults - Structure - 1","",""]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",7,null,"People with acute upper gastrointestinal bleeding from oesophageal varices are given band ligation.","Proportion of people with acute upper gastrointestinal bleeding from oesophageal varices who receive band ligation.","Process","QS38 - Acute upper gastrointestinal bleeding in adults","7 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"7 - QS38 - Acute upper gastrointestinal bleeding in adults - Process - 1","The number of people in the denominator who receive band ligation.","The number of people with acute upper gastrointestinal bleeding from oesophageal varices."]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",7,null,"People with acute upper gastrointestinal bleeding from oesophageal varices are given band ligation.","Rates of uncontrolled bleeding in people with upper gastrointestinal bleeding from oesophageal varices.","Outcome","QS38 - Acute upper gastrointestinal bleeding in adults","7 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"7 - QS38 - Acute upper gastrointestinal bleeding in adults - Outcome - 1"]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",8,null,"People with acute upper gastrointestinal bleeding from gastric varices are given an endoscopic injection of N-butyl-2-cyanoacrylate.","Evidence of local arrangements to ensure that people with acute upper gastrointestinal bleeding from gastric varices are given an endoscopic injection of N-butyl-2-cyanoacrylate.","Structure","QS38 - Acute upper gastrointestinal bleeding in adults","8 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"8 - QS38 - Acute upper gastrointestinal bleeding in adults - Structure - 1","",""]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",8,null,"People with acute upper gastrointestinal bleeding from gastric varices are given an endoscopic injection of N-butyl-2-cyanoacrylate.","Proportion of people with acute upper gastrointestinal bleeding from gastric varices who receive endoscopic injection of N-butyl-2-cyanoacrylate.","Process","QS38 - Acute upper gastrointestinal bleeding in adults","8 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"8 - QS38 - Acute upper gastrointestinal bleeding in adults - Process - 1","The number of people in the denominator who receive endoscopic injection of N‑butyl‑2‑cyanoacrylate.","The number of people with acute upper gastrointestinal bleeding from gastric varices."]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",8,null,"People with acute upper gastrointestinal bleeding from gastric varices are given an endoscopic injection of N-butyl-2-cyanoacrylate.","Rates of uncontrolled bleeding in people with acute upper gastrointestinal bleeding from gastric varices.","Outcome","QS38 - Acute upper gastrointestinal bleeding in adults","8 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"8 - QS38 - Acute upper gastrointestinal bleeding in adults - Outcome - 1"]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",9,null,"People with uncontrolled acute upper gastrointestinal bleeding from varices are given transjugular intrahepatic portosystemic shunts (TIPS).","Evidence of local arrangements to ensure that people with uncontrolled acute upper gastrointestinal bleeding from varices are given TIPS.","Structure","QS38 - Acute upper gastrointestinal bleeding in adults","9 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"9 - QS38 - Acute upper gastrointestinal bleeding in adults - Structure - 1","",""]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",9,null,"People with uncontrolled acute upper gastrointestinal bleeding from varices are given transjugular intrahepatic portosystemic shunts (TIPS).","The proportion of people with uncontrolled acute upper gastrointestinal bleeding from varices who receive TIPS","Process","QS38 - Acute upper gastrointestinal bleeding in adults","9 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"9 - QS38 - Acute upper gastrointestinal bleeding in adults - Process - 1","The number of people in the denominator who receive TIPS.","The number of people with uncontrolled acute upper gastrointestinal bleeding from varices."]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",10,null,"People with acute upper gastrointestinal bleeding who take aspirin for secondary prevention of vascular events and in whom haemostasis has been achieved are advised to continue on low-dose aspirin.","Evidence of local arrangements to ensure that people with acute upper gastrointestinal bleeding who take aspirin for secondary prevention of vascular events and in whom haemostasis has been achieved are advised to continue on low-dose aspirin. ","Structure","QS38 - Acute upper gastrointestinal bleeding in adults","10 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"10 - QS38 - Acute upper gastrointestinal bleeding in adults - Structure - 1","",""]
[null,"QS38","Acute upper gastrointestinal bleeding in adults",10,null,"People with acute upper gastrointestinal bleeding who take aspirin for secondary prevention of vascular events and in whom haemostasis has been achieved are advised to continue on low-dose aspirin.","Proportion of people with acute upper gastrointestinal bleeding who take aspirin for secondary prevention of vascular events and in whom haemostasis has been achieved who are advised to continue on low-dose aspirin.","Process","QS38 - Acute upper gastrointestinal bleeding in adults","10 - QS38 - Acute upper gastrointestinal bleeding in adults",1,"10 - QS38 - Acute upper gastrointestinal bleeding in adults - Process - 1","The number of people in the denominator who are advised to continue on low-dose aspirin.","The number of people with acute upper gastrointestinal bleeding who take aspirin for secondary prevention of vascular events and in whom haemostasis has been achieved."]
[null,"QS39","Attention deficit hyperactivity disorder ",1,null,"Children and young people with symptoms of attention deficit hyperactivity disorder (ADHD) are referred to an ADHD specialist for assessment.","Evidence of local arrangements to ensure that children and young people with symptoms of ADHD are referred to an ADHD specialist for assessment","Structure","QS39 - Attention deficit hyperactivity disorder ","1 - QS39 - Attention deficit hyperactivity disorder ",1,"1 - QS39 - Attention deficit hyperactivity disorder  - Structure - 1","",""]
[null,"QS39","Attention deficit hyperactivity disorder ",1,null,"Children and young people with symptoms of attention deficit hyperactivity disorder (ADHD) are referred to an ADHD specialist for assessment.","Proportion of children and young people with symptoms of ADHD who are referred to an ADHD specialist for assessment","Process","QS39 - Attention deficit hyperactivity disorder ","1 - QS39 - Attention deficit hyperactivity disorder ",1,"1 - QS39 - Attention deficit hyperactivity disorder  - Process - 1","The number of children and young people in the denominator referred to an ADHD specialist for assessment.","The number of children and young people aged 3 to 18 years with symptoms of ADHD."]
[null,"QS39","Attention deficit hyperactivity disorder ",1,null,"Children and young people with symptoms of attention deficit hyperactivity disorder (ADHD) are referred to an ADHD specialist for assessment.","Rates of new diagnosis of ADHD in children and young people.","Outcome","QS39 - Attention deficit hyperactivity disorder ","1 - QS39 - Attention deficit hyperactivity disorder ",1,"1 - QS39 - Attention deficit hyperactivity disorder  - Outcome - 1"]
[null,"QS39","Attention deficit hyperactivity disorder ",2,null,"Adults who present with symptoms of attention deficit hyperactivity disorder (ADHD) who do not have a childhood diagnosis of ADHD are referred to an ADHD specialist for assessment.","Evidence of local arrangements to ensure that adults who present with symptoms of ADHD who do not have a childhood diagnosis of ADHD are referred to an ADHD specialist for assessment.","Structure","QS39 - Attention deficit hyperactivity disorder ","2 - QS39 - Attention deficit hyperactivity disorder ",1,"2 - QS39 - Attention deficit hyperactivity disorder  - Structure - 1","",""]
[null,"QS39","Attention deficit hyperactivity disorder ",2,null,"Adults who present with symptoms of attention deficit hyperactivity disorder (ADHD) who do not have a childhood diagnosis of ADHD are referred to an ADHD specialist for assessment.","Proportion of adults who present with symptoms of ADHD without a childhood diagnosis of ADHD who are referred to an ADHD specialist for assessment.","Process","QS39 - Attention deficit hyperactivity disorder ","2 - QS39 - Attention deficit hyperactivity disorder ",1,"2 - QS39 - Attention deficit hyperactivity disorder  - Process - 1","The number of people in the denominator who are referred to an ADHD specialist for assessment.","The number of adults aged 18 years and over who present with symptoms of ADHD without a childhood diagnosis of ADHD."]
[null,"QS39","Attention deficit hyperactivity disorder ",2,null,"Adults who present with symptoms of attention deficit hyperactivity disorder (ADHD) who do not have a childhood diagnosis of ADHD are referred to an ADHD specialist for assessment.","Rates of new diagnosis of ADHD in adults.","Outcome","QS39 - Attention deficit hyperactivity disorder ","2 - QS39 - Attention deficit hyperactivity disorder ",1,"2 - QS39 - Attention deficit hyperactivity disorder  - Outcome - 1"]
[null,"QS39","Attention deficit hyperactivity disorder ",3,null,"Adults who were diagnosed with and treated for attention deficit hyperactivity disorder (ADHD) as children or young people and present with symptoms of continuing ADHD are referred to general adult psychiatric services.","Evidence of local arrangements to ensure that adults who present with symptoms of continuing ADHD are referred to general adult psychiatric services.","Structure","QS39 - Attention deficit hyperactivity disorder ","3 - QS39 - Attention deficit hyperactivity disorder ",1,"3 - QS39 - Attention deficit hyperactivity disorder  - Structure - 1","",""]
[null,"QS39","Attention deficit hyperactivity disorder ",3,null,"Adults who were diagnosed with and treated for attention deficit hyperactivity disorder (ADHD) as children or young people and present with symptoms of continuing ADHD are referred to general adult psychiatric services.","Proportion of adults with ADHD who present with symptoms of continuing ADHD who are referred to general adult psychiatric services.","Process","QS39 - Attention deficit hyperactivity disorder ","3 - QS39 - Attention deficit hyperactivity disorder ",1,"3 - QS39 - Attention deficit hyperactivity disorder  - Process - 1","The number of people in the denominator who are referred to general adult psychiatric services.","The number of adults aged 18 years and over with ADHD who present with symptoms of continuing ADHD."]
[null,"QS39","Attention deficit hyperactivity disorder ",3,null,"Adults who were diagnosed with and treated for attention deficit hyperactivity disorder (ADHD) as children or young people and present with symptoms of continuing ADHD are referred to general adult psychiatric services.","Adults feel supported to manage their ADHD.","Outcome","QS39 - Attention deficit hyperactivity disorder ","3 - QS39 - Attention deficit hyperactivity disorder ",1,"3 - QS39 - Attention deficit hyperactivity disorder  - Outcome - 1"]
[null,"QS39","Attention deficit hyperactivity disorder ",4,null,"Parents or carers of children and young people with symptoms of attention deficit hyperactivity disorder (ADHD) who meet the NICE eligibility criteria are offered a referral to a parent training programme.","Evidence of local arrangements to ensure that parents or carers of children and young people with symptoms of ADHD who meet NICE eligibility criteria are offered a referral to a parent training programme. ","Structure","QS39 - Attention deficit hyperactivity disorder ","4 - QS39 - Attention deficit hyperactivity disorder ",1,"4 - QS39 - Attention deficit hyperactivity disorder  - Structure - 1","",""]
[null,"QS39","Attention deficit hyperactivity disorder ",4,null,"Parents or carers of children and young people with symptoms of attention deficit hyperactivity disorder (ADHD) who meet the NICE eligibility criteria are offered a referral to a parent training programme.","Evidence of local arrangements for provision of parent training programmes.","Structure","QS39 - Attention deficit hyperactivity disorder ","4 - QS39 - Attention deficit hyperactivity disorder ",2,"4 - QS39 - Attention deficit hyperactivity disorder  - Structure - 2","",""]
[null,"QS39","Attention deficit hyperactivity disorder ",4,null,"Parents or carers of children and young people with symptoms of attention deficit hyperactivity disorder (ADHD) who meet the NICE eligibility criteria are offered a referral to a parent training programme.","Proportion of parents or carers of children and young people with symptoms of ADHD who meet NICE eligibility criteria who are referred to a parent training programme.","Process","QS39 - Attention deficit hyperactivity disorder ","4 - QS39 - Attention deficit hyperactivity disorder ",1,"4 - QS39 - Attention deficit hyperactivity disorder  - Process - 1","The number of people in the denominator referred to a parent training programme ","The number of parents or carers of children and young people with symptoms of ADHD who meet NICE eligibility criteria."]
[null,"QS39","Attention deficit hyperactivity disorder ",4,null,"Parents or carers of children and young people with symptoms of attention deficit hyperactivity disorder (ADHD) who meet the NICE eligibility criteria are offered a referral to a parent training programme.","Proportion of parents or carers of children and young people with symptoms of ADHD who meet NICE eligibility criteria who attend a parent training programme.","Process","QS39 - Attention deficit hyperactivity disorder ","4 - QS39 - Attention deficit hyperactivity disorder ",2,"4 - QS39 - Attention deficit hyperactivity disorder  - Process - 2","The number of people in the denominator attending a parent training programme.","The number of parents or carers of children and young people with symptoms of ADHD who are referred to a parent training programme."]
[null,"QS39","Attention deficit hyperactivity disorder ",4,null,"Parents or carers of children and young people with symptoms of attention deficit hyperactivity disorder (ADHD) who meet the NICE eligibility criteria are offered a referral to a parent training programme.","Proportion of parents and carers of children and young people with symptoms of ADHD who meet NICE eligibility criteria who complete a parent training programme.","Process","QS39 - Attention deficit hyperactivity disorder ","4 - QS39 - Attention deficit hyperactivity disorder ",3,"4 - QS39 - Attention deficit hyperactivity disorder  - Process - 3","The number of people in the denominator completing a parent training programme.","The number of parents or carers of children and young people with symptoms of ADHD who attend a parent training programme."]
[null,"QS39","Attention deficit hyperactivity disorder ",4,null,"Parents or carers of children and young people with symptoms of attention deficit hyperactivity disorder (ADHD) who meet the NICE eligibility criteria are offered a referral to a parent training programme.","Parent or carer satisfaction with the provision of parent training programmes.","Outcome","QS39 - Attention deficit hyperactivity disorder ","4 - QS39 - Attention deficit hyperactivity disorder ",1,"4 - QS39 - Attention deficit hyperactivity disorder  - Outcome - 1"]
[null,"QS39","Attention deficit hyperactivity disorder ",4,null,"Parents or carers of children and young people with symptoms of attention deficit hyperactivity disorder (ADHD) who meet the NICE eligibility criteria are offered a referral to a parent training programme.","Parents or carers feel supported to manage their child's condition. ","Outcome","QS39 - Attention deficit hyperactivity disorder ","4 - QS39 - Attention deficit hyperactivity disorder ",2,"4 - QS39 - Attention deficit hyperactivity disorder  - Outcome - 2"]
[null,"QS39","Attention deficit hyperactivity disorder ",6,null,"People with attention deficit hyperactivity disorder (ADHD) who are starting drug treatment have their initial drug dose adjusted and response assessed by an ADHD specialist.","Evidence of local arrangements to ensure that people with ADHD who are starting drug treatment have their initial drug dose adjusted and response assessed by an ADHD specialist.","Structure","QS39 - Attention deficit hyperactivity disorder ","6 - QS39 - Attention deficit hyperactivity disorder ",{"$f":"IF(AND(B941=B940, D941=D940, H941=H940)=TRUE, K940+1, 1)","v":1},{"$f":"CONCATENATE(J941, \" - \", H941, \" - \",K941)","v":"6 - QS39 - Attention deficit hyperactivity disorder  - Structure - 1"},"",""]
[null,"QS39","Attention deficit hyperactivity disorder ",6,null,"People with attention deficit hyperactivity disorder (ADHD) who are starting drug treatment have their initial drug dose adjusted and response assessed by an ADHD specialist.","Proportion of people with ADHD who are starting drug treatment who have their initial drug dose adjusted and response assessed by an ADHD specialist.","Process","QS39 - Attention deficit hyperactivity disorder ","6 - QS39 - Attention deficit hyperactivity disorder ",1,"6 - QS39 - Attention deficit hyperactivity disorder  - Process - 1","The number of people in the denominator who have their initial drug dose adjusted and response assessed by an ADHD specialist.","The number of people with ADHD who are starting drug treatment."]
[null,"QS39","Attention deficit hyperactivity disorder ",6,null,"People with attention deficit hyperactivity disorder (ADHD) who are starting drug treatment have their initial drug dose adjusted and response assessed by an ADHD specialist.","Rates of drug-related side effects in people starting drug treatment for ADHD","Outcome","QS39 - Attention deficit hyperactivity disorder ","6 - QS39 - Attention deficit hyperactivity disorder ",1,"6 - QS39 - Attention deficit hyperactivity disorder  - Outcome - 1"]
[null,"QS39","Attention deficit hyperactivity disorder ",7,null,"People with attention deficit hyperactivity disorder (ADHD) who are taking drug treatment have a specialist review at least annually to assess their need for continued treatment.","Evidence of local arrangements to ensure that people with ADHD who are taking drug treatment have a specialist review at least annually.","Structure","QS39 - Attention deficit hyperactivity disorder ","7 - QS39 - Attention deficit hyperactivity disorder ",1,"7 - QS39 - Attention deficit hyperactivity disorder  - Structure - 1","",""]
[null,"QS39","Attention deficit hyperactivity disorder ",7,null,"People with attention deficit hyperactivity disorder (ADHD) who are taking drug treatment have a specialist review at least annually to assess their need for continued treatment.","Proportion of people with ADHD who are taking drug treatment who receive a specialist review at least annually.","Process","QS39 - Attention deficit hyperactivity disorder ","7 - QS39 - Attention deficit hyperactivity disorder ",1,"7 - QS39 - Attention deficit hyperactivity disorder  - Process - 1","The number of people in the denominator receiving a specialist review with the last review date no more than 1 year after the previous review.","The number of people with ADHD who are taking drug treatment."]
[null,"QS39","Attention deficit hyperactivity disorder ",7,null,"People with attention deficit hyperactivity disorder (ADHD) who are taking drug treatment have a specialist review at least annually to assess their need for continued treatment.","People with ADHD feel supported to manage their condition.","Outcome","QS39 - Attention deficit hyperactivity disorder ","7 - QS39 - Attention deficit hyperactivity disorder ",1,"7 - QS39 - Attention deficit hyperactivity disorder  - Outcome - 1"]
[null,"QS40","Psoriasis ",1,null,"People with psoriasis are offered an assessment of disease severity at diagnosis and when response to treatment is assessed.","Evidence of local arrangements for people with psoriasis to receive an assessment of disease severity at diagnosis and when response to treatment is assessed.","Structure","QS40 - Psoriasis ","1 - QS40 - Psoriasis ",1,"1 - QS40 - Psoriasis  - Structure - 1","",""]
[null,"QS40","Psoriasis ",1,null,"People with psoriasis are offered an assessment of disease severity at diagnosis and when response to treatment is assessed.","Proportion of people with psoriasis who receive an assessment of disease severity at diagnosis.","Process","QS40 - Psoriasis ","1 - QS40 - Psoriasis ",1,"1 - QS40 - Psoriasis  - Process - 1","The number of people in the denominator who receive an assessment of disease severity at diagnosis.","The number of people with psoriasis."]
[null,"QS40","Psoriasis ",1,null,"People with psoriasis are offered an assessment of disease severity at diagnosis and when response to treatment is assessed.","Proportion of people with psoriasis who receive an assessment of disease severity when response to treatment is assessed.","Process","QS40 - Psoriasis ","1 - QS40 - Psoriasis ",2,"1 - QS40 - Psoriasis  - Process - 2","The number of people in the denominator who receive an assessment of disease severity when response to treatment is assessed.","The number of people with psoriasis receiving treatment."]
[null,"QS40","Psoriasis ",2,null,"People with psoriasis are offered an assessment of the impact of the disease on physical, psychological and social wellbeing at diagnosis and when response to treatment is assessed.","Evidence of local arrangements for people with psoriasis to have an assessment of the impact of the disease on physical, psychological and social wellbeing at diagnosis and when response to treatment is assessed.","Structure","QS40 - Psoriasis ",{"$f":"CONCATENATE(D950, \" - \", I950)","v":"2 - QS40 - Psoriasis "},{"$f":"IF(AND(B950=B949, D950=D949, H950=H949)=TRUE, K949+1, 1)","v":1},{"$f":"CONCATENATE(J950, \" - \", H950, \" - \",K950)","v":"2 - QS40 - Psoriasis  - Structure - 1"},"",""]
[null,"QS40","Psoriasis ",2,null,"People with psoriasis are offered an assessment of the impact of the disease on physical, psychological and social wellbeing at diagnosis and when response to treatment is assessed.","Proportion of people with psoriasis who receive an assessment of the impact of the disease on physical, psychological and social wellbeing at diagnosis.","Process","QS40 - Psoriasis ","2 - QS40 - Psoriasis ",1,"2 - QS40 - Psoriasis  - Process - 1","The number of people in the denominator who receive an assessment of the impact of the disease on physical, psychological and social wellbeing at diagnosis.","The number of people with psoriasis."]
[null,"QS40","Psoriasis ",2,null,"People with psoriasis are offered an assessment of the impact of the disease on physical, psychological and social wellbeing at diagnosis and when response to treatment is assessed.","Proportion of people with psoriasis who receive an assessment of the impact of the disease on physical, psychological and social wellbeing when response to treatment is assessed.","Process","QS40 - Psoriasis ","2 - QS40 - Psoriasis ",2,"2 - QS40 - Psoriasis  - Process - 2","The number of people in the denominator who receive an assessment of the impact of the disease on physical, psychological and social wellbeing when response to treatment is assessed.","The number of people with psoriasis receiving treatment."]
[null,"QS40","Psoriasis ",3,null,"People with psoriasis are referred for assessment by a dermatology specialist if indicated.","Evidence of local arrangements for people with psoriasis to be referred for assessment by a dermatology specialist if indicated.","Structure","QS40 - Psoriasis ","3 - QS40 - Psoriasis ",1,"3 - QS40 - Psoriasis  - Structure - 1","",""]
[null,"QS40","Psoriasis ",3,null,"People with psoriasis are referred for assessment by a dermatology specialist if indicated.","Proportion of people with psoriasis who are referred for assessment by a dermatology specialist if indicated.","Process","QS40 - Psoriasis ","3 - QS40 - Psoriasis ",1,"3 - QS40 - Psoriasis  - Process - 1","The number of people in the denominator who are referred for assessment by a dermatology specialist.","The number of people with psoriasis who have an indication for referral for assessment by a dermatology specialist."]
[null,"QS40","Psoriasis ",3,null,"People with psoriasis are referred for assessment by a dermatology specialist if indicated.","Patient experience.","Outcome",{"$f":"CONCATENATE(B955, \" - \", C955)","v":"QS40 - Psoriasis "},"3 - QS40 - Psoriasis ",1,"3 - QS40 - Psoriasis  - Outcome - 1"]
[null,"QS40","Psoriasis ",4,null,"Adults with severe psoriasis are offered a cardiovascular risk assessment at diagnosis and at least once every 5 years.","Evidence of local arrangements for adults with severe psoriasis to receive a cardiovascular risk assessment at diagnosis and at least once every 5 years.","Structure","QS40 - Psoriasis ","4 - QS40 - Psoriasis ",1,"4 - QS40 - Psoriasis  - Structure - 1","",""]
[null,"QS40","Psoriasis ",4,null,"Adults with severe psoriasis are offered a cardiovascular risk assessment at diagnosis and at least once every 5 years.","Proportion of adults with severe psoriasis who receive a cardiovascular risk assessment at diagnosis.","Process","QS40 - Psoriasis ","4 - QS40 - Psoriasis ",1,"4 - QS40 - Psoriasis  - Process - 1","The number of people in the denominator who receive a cardiovascular risk assessment at diagnosis.","The number of adults diagnosed with severe psoriasis."]
[null,"QS40","Psoriasis ",4,null,"Adults with severe psoriasis are offered a cardiovascular risk assessment at diagnosis and at least once every 5 years.","Proportion of adults with severe psoriasis diagnosed more than 5 years ago whose most recent cardiovascular risk assessment was within 5 years of diagnosis or the previous assessment.","Process","QS40 - Psoriasis ","4 - QS40 - Psoriasis ",2,"4 - QS40 - Psoriasis  - Process - 2","The number of people in the denominator whose most recent cardiovascular risk assessment was within 5 years of diagnosis or the previous cardiovascular risk assessment.","The number of adults with severe psoriasis diagnosed more than 5 years ago."]
[null,"QS40","Psoriasis ",5,null,"People with psoriasis having treatment are offered an annual assessment for psoriatic arthritis.","Evidence of local arrangements for people with psoriasis having treatment to receive an annual assessment for psoriatic arthritis. ","Structure","QS40 - Psoriasis ","5 - QS40 - Psoriasis ",1,"5 - QS40 - Psoriasis  - Structure - 1","",""]
[null,"QS40","Psoriasis ",5,null,"People with psoriasis having treatment are offered an annual assessment for psoriatic arthritis.","Proportion of people with psoriasis having treatment who receive an annual assessment for psoriatic arthritis.","Process","QS40 - Psoriasis ","5 - QS40 - Psoriasis ",1,"5 - QS40 - Psoriasis  - Process - 1","The number of people in the denominator who receive an annual assessment for psoriatic arthritis.","The number of people with psoriasis having treatment."]
[null,"QS40","Psoriasis ",6,null,"People with psoriasis receiving systemic therapy are monitored in accordance with locally agreed protocols.","Evidence of local arrangements for people with psoriasis receiving systemic therapy to be monitored in accordance with locally agreed protocols.","Structure","QS40 - Psoriasis ","6 - QS40 - Psoriasis ",1,"6 - QS40 - Psoriasis  - Structure - 1","",""]
[null,"QS41","Familial hypercholesterolaemia ",1,null,"Adults with a baseline total cholesterol above 7.5 mmol/l are assessed for a clinical diagnosis of familial hypercholesterolaemia (FH).","Evidence of local arrangements to ensure that adults with a baseline total cholesterol above 7.5 mmol/l are assessed for a clinical diagnosis of FH.","Structure","QS41 - Familial hypercholesterolaemia ","1 - QS41 - Familial hypercholesterolaemia ",1,"1 - QS41 - Familial hypercholesterolaemia  - Structure - 1","",""]
[null,"QS41","Familial hypercholesterolaemia ",1,null,"Adults with a baseline total cholesterol above 7.5 mmol/l are assessed for a clinical diagnosis of familial hypercholesterolaemia (FH).","Proportion of adults with a baseline total cholesterol above 7.5 mmol/l who are assessed for a clinical diagnosis of FH.","Process","QS41 - Familial hypercholesterolaemia ","1 - QS41 - Familial hypercholesterolaemia ",1,"1 - QS41 - Familial hypercholesterolaemia  - Process - 1","The number of people in the denominator assessed for a clinical diagnosis of FH.","The number of adults with a baseline total cholesterol above 7.5 mmol/l."]
[null,"QS41","Familial hypercholesterolaemia ",2,null,"People with a clinical diagnosis of familial hypercholesterolaemia (FH) are referred for specialist assessment.","Evidence of local arrangements to ensure that a protocol for referral for a specialist assessment is agreed between primary and secondary care.","Structure","QS41 - Familial hypercholesterolaemia ","2 - QS41 - Familial hypercholesterolaemia ",1,"2 - QS41 - Familial hypercholesterolaemia  - Structure - 1","",""]
[null,"QS41","Familial hypercholesterolaemia ",2,null,"People with a clinical diagnosis of familial hypercholesterolaemia (FH) are referred for specialist assessment.","Evidence of local arrangements to ensure that people with a clinical diagnosis of FH are referred for specialist assessment.","Structure","QS41 - Familial hypercholesterolaemia ","2 - QS41 - Familial hypercholesterolaemia ",2,"2 - QS41 - Familial hypercholesterolaemia  - Structure - 2","",""]
[null,"QS41","Familial hypercholesterolaemia ",2,null,"People with a clinical diagnosis of familial hypercholesterolaemia (FH) are referred for specialist assessment.","Proportion of people with a clinical diagnosis of FH referred for specialist assessment.","Process","QS41 - Familial hypercholesterolaemia ","2 - QS41 - Familial hypercholesterolaemia ",1,"2 - QS41 - Familial hypercholesterolaemia  - Process - 1","The number of people in the denominator referred for specialist assessment.","The number of people with a clinical diagnosis of FH."]
[null,"QS41","Familial hypercholesterolaemia ",2,null,"People with a clinical diagnosis of familial hypercholesterolaemia (FH) are referred for specialist assessment.","Ratio of observed to estimated numbers of people with FH, using an estimate based on the area’s estimated prevalence of FH (based on 1 in 500) and population size.","Outcome","QS41 - Familial hypercholesterolaemia ","2 - QS41 - Familial hypercholesterolaemia ",1,"2 - QS41 - Familial hypercholesterolaemia  - Outcome - 1"]
[null,"QS41","Familial hypercholesterolaemia ",3,null,"People with a clinical diagnosis of familial hypercholesterolaemia (FH) are offered DNA testing as part of a specialist assessment.","Evidence of local arrangements to ensure that people with a clinical diagnosis of FH are offered DNA testing as part of a specialist assessment.","Structure","QS41 - Familial hypercholesterolaemia ","3 - QS41 - Familial hypercholesterolaemia ",1,"3 - QS41 - Familial hypercholesterolaemia  - Structure - 1","",""]
[null,"QS41","Familial hypercholesterolaemia ",3,null,"People with a clinical diagnosis of familial hypercholesterolaemia (FH) are offered DNA testing as part of a specialist assessment.","Proportion of people with a clinical diagnosis of FH who receive DNA testing as part of a specialist assessment.","Process","QS41 - Familial hypercholesterolaemia ","3 - QS41 - Familial hypercholesterolaemia ",1,"3 - QS41 - Familial hypercholesterolaemia  - Process - 1","The number of people in the denominator receiving DNA testing as part of a specialist assessment.","The number of people with a clinical diagnosis of FH."]
[null,"QS41","Familial hypercholesterolaemia ",3,null,"People with a clinical diagnosis of familial hypercholesterolaemia (FH) are offered DNA testing as part of a specialist assessment.","Proportion of people with a clinical diagnosis of FH receiving DNA testing as part of a specialist assessment who give informed consent for the test.","Process","QS41 - Familial hypercholesterolaemia ","3 - QS41 - Familial hypercholesterolaemia ",2,"3 - QS41 - Familial hypercholesterolaemia  - Process - 2","The number of people in the denominator who give informed consent for the test.","The number of people with a clinical diagnosis of FH receiving DNA testing as part of a specialist assessment."]
[null,"QS41","Familial hypercholesterolaemia ",3,null,"People with a clinical diagnosis of familial hypercholesterolaemia (FH) are offered DNA testing as part of a specialist assessment.","Patient satisfaction with process of informed consent.","Outcome","QS41 - Familial hypercholesterolaemia ","3 - QS41 - Familial hypercholesterolaemia ",1,"3 - QS41 - Familial hypercholesterolaemia  - Outcome - 1"]
[null,"QS41","Familial hypercholesterolaemia ",4,null,"Children at risk of familial hypercholesterolaemia (FH) are offered diagnostic tests by the age of 10 years.","Evidence of local arrangements to ensure that children at risk of FH are offered diagnostic tests by the age of 10 years.","Structure","QS41 - Familial hypercholesterolaemia ","4 - QS41 - Familial hypercholesterolaemia ",1,"4 - QS41 - Familial hypercholesterolaemia  - Structure - 1","",""]
[null,"QS41","Familial hypercholesterolaemia ",4,null,"Children at risk of familial hypercholesterolaemia (FH) are offered diagnostic tests by the age of 10 years.","Proportion of children at risk of FH who receive a specified diagnostic test by the age of 10 years.","Process","QS41 - Familial hypercholesterolaemia ","4 - QS41 - Familial hypercholesterolaemia ",1,"4 - QS41 - Familial hypercholesterolaemia  - Process - 1","The number of people in the denominator who had received a specified diagnostic test.","The number of children aged 10 years at risk of FH."]
[null,"QS41","Familial hypercholesterolaemia ",4,null,"Children at risk of familial hypercholesterolaemia (FH) are offered diagnostic tests by the age of 10 years.","Ratio of observed to estimated numbers of children at risk of FH, using an estimate based on the area’s estimated prevalence of FH (based on 1 in 500) and population size.","Outcome","QS41 - Familial hypercholesterolaemia ","4 - QS41 - Familial hypercholesterolaemia ",1,"4 - QS41 - Familial hypercholesterolaemia  - Outcome - 1"]
[null,"QS41","Familial hypercholesterolaemia ",5,null,"Relatives of people with a confirmed diagnosis of monogenic familial hypercholesterolaemia (FH) are offered DNA testing through a nationwide, systematic cascade process.","Evidence of local arrangements to ensure that relatives of people with a confirmed diagnosis of monogenic FH are offered DNA testing through a nationwide systematic cascade processes.","Structure","QS41 - Familial hypercholesterolaemia ","5 - QS41 - Familial hypercholesterolaemia ",1,"5 - QS41 - Familial hypercholesterolaemia  - Structure - 1","",""]
[null,"QS41","Familial hypercholesterolaemia ",5,null,"Relatives of people with a confirmed diagnosis of monogenic familial hypercholesterolaemia (FH) are offered DNA testing through a nationwide, systematic cascade process.","Proportion of untested first‑degree relatives of people with a confirmed diagnosis of monogenic FH who are offered cascade testing.","Process","QS41 - Familial hypercholesterolaemia ","5 - QS41 - Familial hypercholesterolaemia ",1,"5 - QS41 - Familial hypercholesterolaemia  - Process - 1","The number of people in the denominator offered cascade testing.","The number of untested first‑degree relatives of people with a confirmed diagnosis of monogenic FH."]
[null,"QS41","Familial hypercholesterolaemia ",5,null,"Relatives of people with a confirmed diagnosis of monogenic familial hypercholesterolaemia (FH) are offered DNA testing through a nationwide, systematic cascade process.","Proportion of at‑risk, untested, second‑ and third‑degree relatives of people with a confirmed diagnosis of monogenic FH who are offered cascade testing.","Process","QS41 - Familial hypercholesterolaemia ","5 - QS41 - Familial hypercholesterolaemia ",2,"5 - QS41 - Familial hypercholesterolaemia  - Process - 2","The number of people in the denominator offered cascade testing.","The number of at‑risk, untested second‑ and third‑degree relatives of people with a confirmed diagnosis of monogenic FH."]
[null,"QS41","Familial hypercholesterolaemia ",5,null,"Relatives of people with a confirmed diagnosis of monogenic familial hypercholesterolaemia (FH) are offered DNA testing through a nationwide, systematic cascade process.","Proportion of untested first‑degree relatives of people with a confirmed diagnosis of monogenic FH who receive cascade testing.","Process","QS41 - Familial hypercholesterolaemia ","5 - QS41 - Familial hypercholesterolaemia ",3,"5 - QS41 - Familial hypercholesterolaemia  - Process - 3","The number of people in the denominator receiving cascade testing.","The number of untested first‑degree relatives of people with a confirmed diagnosis of monogenic FH."]
[null,"QS41","Familial hypercholesterolaemia ",5,null,"Relatives of people with a confirmed diagnosis of monogenic familial hypercholesterolaemia (FH) are offered DNA testing through a nationwide, systematic cascade process.","Proportion of at‑risk, untested, second‑ and third‑degree relatives of people with a confirmed diagnosis of monogenic FH who receive cascade testing.","Process","QS41 - Familial hypercholesterolaemia ","5 - QS41 - Familial hypercholesterolaemia ",4,"5 - QS41 - Familial hypercholesterolaemia  - Process - 4","The number of people in the denominator receiving cascade testing.","The number of at‑risk, untested second‑ and third‑degree relatives of people with a confirmed diagnosis of monogenic FH."]
[null,"QS41","Familial hypercholesterolaemia ",5,null,"Relatives of people with a confirmed diagnosis of monogenic familial hypercholesterolaemia (FH) are offered DNA testing through a nationwide, systematic cascade process.","Prevalence of FH.","Outcome","QS41 - Familial hypercholesterolaemia ","5 - QS41 - Familial hypercholesterolaemia ",1,"5 - QS41 - Familial hypercholesterolaemia  - Outcome - 1"]
[null,"QS41","Familial hypercholesterolaemia ",6,null,"Adults with familial hypercholesterolaemia (FH) receive lipid‑modifying drug treatment to reduce LDL‑C concentration by more than 50% from baseline.","Evidence of local arrangements to ensure that adults with FH receive lipid‑modifying drug treatment to reduce LDL‑C concentration by more than 50% from baseline.","Structure","QS41 - Familial hypercholesterolaemia ","6 - QS41 - Familial hypercholesterolaemia ",1,"6 - QS41 - Familial hypercholesterolaemia  - Structure - 1","",""]
[null,"QS41","Familial hypercholesterolaemia ",6,null,"Adults with familial hypercholesterolaemia (FH) receive lipid‑modifying drug treatment to reduce LDL‑C concentration by more than 50% from baseline.","Proportion of adults with FH who receive appropriate lipid‑modifying drug treatment.","Process","QS41 - Familial hypercholesterolaemia ","6 - QS41 - Familial hypercholesterolaemia ",1,"6 - QS41 - Familial hypercholesterolaemia  - Process - 1","The number of people in the denominator receiving appropriate lipid‑modifying drug treatment.","The number of adults with FH."]
[null,"QS41","Familial hypercholesterolaemia ",6,null,"Adults with familial hypercholesterolaemia (FH) receive lipid‑modifying drug treatment to reduce LDL‑C concentration by more than 50% from baseline.","Number of adults with FH whose LDL‑C concentration is reduced by more than 50% from baseline within 1 year.","Outcome","QS41 - Familial hypercholesterolaemia ","6 - QS41 - Familial hypercholesterolaemia ",1,"6 - QS41 - Familial hypercholesterolaemia  - Outcome - 1"]
[null,"QS41","Familial hypercholesterolaemia ",7,null,"Children with familial hypercholesterolaemia (FH) are assessed for lipid‑modifying drug treatment by a specialist with expertise in FH in a child‑focused setting by the age of 10 years.","Evidence of local arrangements to ensure that children with FH are assessed for lipid‑modifying drug treatment by a specialist with expertise in FH in a child-focused setting by the age of 10 years.","Structure","QS41 - Familial hypercholesterolaemia ","7 - QS41 - Familial hypercholesterolaemia ",1,"7 - QS41 - Familial hypercholesterolaemia  - Structure - 1","",""]
[null,"QS41","Familial hypercholesterolaemia ",7,null,"Children with familial hypercholesterolaemia (FH) are assessed for lipid‑modifying drug treatment by a specialist with expertise in FH in a child‑focused setting by the age of 10 years.","Proportion of children with FH who are assessed for lipid‑modifying drug treatment by a specialist with expertise in FH in a child-focused setting by the age of 10 years.","Process","QS41 - Familial hypercholesterolaemia ","7 - QS41 - Familial hypercholesterolaemia ",1,"7 - QS41 - Familial hypercholesterolaemia  - Process - 1","The number of people in the denominator assessed for lipid‑modifying drug treatment by a specialist with expertise in FH in a child‑focused setting.","The number of children with FH aged 10 years."]
[null,"QS41","Familial hypercholesterolaemia ",8,null,"People with familial hypercholesterolaemia (FH) are offered a structured review at least annually.","Evidence of local arrangements to ensure that people with FH are offered a structured review at least annually.","Structure","QS41 - Familial hypercholesterolaemia ","8 - QS41 - Familial hypercholesterolaemia ",1,"8 - QS41 - Familial hypercholesterolaemia  - Structure - 1","",""]
[null,"QS41","Familial hypercholesterolaemia ",8,null,"People with familial hypercholesterolaemia (FH) are offered a structured review at least annually.","Proportion of people with FH who receive a structured review at least annually.","Process","QS41 - Familial hypercholesterolaemia ","8 - QS41 - Familial hypercholesterolaemia ",1,"8 - QS41 - Familial hypercholesterolaemia  - Process - 1","The number of people in the denominator who had a structured review within 12 months of the last review or diagnosis.","The number of people with FH."]
[null,"QS42","Headaches in over 12s",1,null,"People diagnosed with a primary headache disorder have their headache type classified as part of the diagnosis.","Evidence of local arrangements to ensure that people diagnosed with a primary headache disorder have their headache type classified as part of the diagnosis.","Structure","QS42 - Headaches in over 12s","1 - QS42 - Headaches in over 12s",1,"1 - QS42 - Headaches in over 12s - Structure - 1","",""]
[null,"QS42","Headaches in over 12s",1,null,"People diagnosed with a primary headache disorder have their headache type classified as part of the diagnosis.","Proportion of people diagnosed with a primary headache disorder who have their headache type classified as part of the diagnosis.","Process","QS42 - Headaches in over 12s","1 - QS42 - Headaches in over 12s",1,"1 - QS42 - Headaches in over 12s - Process - 1","The number of people in the denominator who have their headache type classified as part of the diagnosis.","The number of people diagnosed with a primary headache disorder."]
[null,"QS42","Headaches in over 12s",2,null,"People with a primary headache disorder are given information on the risk of medication overuse headache.","Evidence of local arrangements to ensure that people with a primary headache disorder are given information on the risk of medication overuse headache.","Structure","QS42 - Headaches in over 12s","2 - QS42 - Headaches in over 12s",1,"2 - QS42 - Headaches in over 12s - Structure - 1","",""]
[null,"QS42","Headaches in over 12s",2,null,"People with a primary headache disorder are given information on the risk of medication overuse headache.","Proportion of people with a primary headache disorder who are given information on the risk of medication overuse headache.","Process","QS42 - Headaches in over 12s","2 - QS42 - Headaches in over 12s",1,"2 - QS42 - Headaches in over 12s - Process - 1","The number of people in the denominator who are given information on the risk of medication overuse headache.","The number of people with a primary headache disorder."]
[null,"QS42","Headaches in over 12s",2,null,"People with a primary headache disorder are given information on the risk of medication overuse headache.","Incidence of medication overuse headache.","Outcome","QS42 - Headaches in over 12s","2 - QS42 - Headaches in over 12s",1,"2 - QS42 - Headaches in over 12s - Outcome - 1"]
[null,"QS42","Headaches in over 12s",3,null,"People with tension-type headache or migraine are not referred for imaging if they do not have signs or symptoms of secondary headache.","Evidence of local arrangements to ensure that people with tension-type headache or migraine are not referred for imaging if they do not have signs or symptoms of secondary headache.","Structure","QS42 - Headaches in over 12s","3 - QS42 - Headaches in over 12s",1,"3 - QS42 - Headaches in over 12s - Structure - 1","",""]
[null,"QS42","Headaches in over 12s",3,null,"People with tension-type headache or migraine are not referred for imaging if they do not have signs or symptoms of secondary headache.","Proportion of people with a tension-type headache or migraine who are referred for imaging.","Process","QS42 - Headaches in over 12s","3 - QS42 - Headaches in over 12s",1,"3 - QS42 - Headaches in over 12s - Process - 1","The number of people in the denominator referred for imaging.","The number of people with tension-type headache or migraine."]
[null,"QS42","Headaches in over 12s",3,null,"People with tension-type headache or migraine are not referred for imaging if they do not have signs or symptoms of secondary headache.","Rate of positive findings of cause of headache on imaging.","Outcome","QS42 - Headaches in over 12s","3 - QS42 - Headaches in over 12s",1,"3 - QS42 - Headaches in over 12s - Outcome - 1"]
[null,"QS42","Headaches in over 12s",4,null,"People with migraine are advised to take combination therapy with a triptan and either a non-steroidal anti-inflammatory drug (NSAID) or paracetamol.","Evidence of local arrangements to ensure that people with migraine are advised to take combination therapy with a triptan and either an NSAID or paracetamol.","Structure","QS42 - Headaches in over 12s","4 - QS42 - Headaches in over 12s",1,"4 - QS42 - Headaches in over 12s - Structure - 1","",""]
[null,"QS42","Headaches in over 12s",4,null,"People with migraine are advised to take combination therapy with a triptan and either a non-steroidal anti-inflammatory drug (NSAID) or paracetamol.","Proportion of people with migraine who are advised to take combination therapy with a triptan and either an NSAID or paracetamol.","Process","QS42 - Headaches in over 12s","4 - QS42 - Headaches in over 12s",1,"4 - QS42 - Headaches in over 12s - Process - 1","The number of people in the denominator who are advised to take combination therapy with a triptan and either an NSAID or paracetamol.","The number of people with migraine."]
[null,"QS43","Smoking: supporting people to stop",1,null,"People are asked if they smoke by their healthcare practitioner, and those who smoke are offered advice on how to stop.","Evidence of local arrangements to ensure that people are asked if they smoke by their healthcare practitioner, and those who smoke are offered advice on how to stop.","Structure","QS43 - Smoking: supporting people to stop","1 - QS43 - Smoking: supporting people to stop",1,"1 - QS43 - Smoking: supporting people to stop - Structure - 1","",""]
[null,"QS43","Smoking: supporting people to stop",1,null,"People are asked if they smoke by their healthcare practitioner, and those who smoke are offered advice on how to stop.","Proportion of people who are asked if they smoke by their healthcare practitioner. ","Process","QS43 - Smoking: supporting people to stop","1 - QS43 - Smoking: supporting people to stop",1,"1 - QS43 - Smoking: supporting people to stop - Process - 1","The number of people in the denominator who are asked if they smoke by their healthcare practitioner.","The number of people who have face-to-face contact with a healthcare practitioner."]
[null,"QS43","Smoking: supporting people to stop",1,null,"People are asked if they smoke by their healthcare practitioner, and those who smoke are offered advice on how to stop.","Proportion of people who smoke who receive advice on how to stop. ","Process","QS43 - Smoking: supporting people to stop","1 - QS43 - Smoking: supporting people to stop",2,"1 - QS43 - Smoking: supporting people to stop - Process - 2","The number of people in the denominator who receive advice on how to stop.","The number of people who report that they smoke during face-to-face contact with a healthcare practitioner."]
[null,"QS43","Smoking: supporting people to stop",2,null,"Statement removed",null,null,"QS43 - Smoking: supporting people to stop","2 - QS43 - Smoking: supporting people to stop",1,"2 - QS43 - Smoking: supporting people to stop -  - 1","",""]
[null,"QS43","Smoking: supporting people to stop",2,null,"Statement removed",null,null,"QS43 - Smoking: supporting people to stop","2 - QS43 - Smoking: supporting people to stop",2,"2 - QS43 - Smoking: supporting people to stop -  - 2"]
[null,"QS43","Smoking: supporting people to stop",3,null,"People in contact with healthcare practitioners who provide stop-smoking support are offered stop-smoking advice and interventions.","Evidence of local arrangements to ensure that people in contact with healthcare practitioners who provide stop-smoking support are offered stop-smoking advice and interventions.","Structure","QS43 - Smoking: supporting people to stop","3 - QS43 - Smoking: supporting people to stop",1,"3 - QS43 - Smoking: supporting people to stop - Structure - 1","",""]
[null,"QS43","Smoking: supporting people to stop",3,null,"People in contact with healthcare practitioners who provide stop-smoking support are offered stop-smoking advice and interventions.","Proportion of people in contact with healthcare practitioners who provide stop-smoking support who are offered stop-smoking advice and interventions.","Process","QS43 - Smoking: supporting people to stop","3 - QS43 - Smoking: supporting people to stop",1,"3 - QS43 - Smoking: supporting people to stop - Process - 1","The number of people in the denominator who are offered stop-smoking advice and interventions.","The number of people in contact with healthcare practitioners who provide stop-smoking support."]
[null,"QS43","Smoking: supporting people to stop",4,null,"People who seek support to stop smoking and who choose to take pharmacotherapy are offered a full course.","Evidence of local arrangements to ensure that people who seek support to stop smoking and who choose to take pharmacotherapy are offered a full course.","Structure","QS43 - Smoking: supporting people to stop","4 - QS43 - Smoking: supporting people to stop",1,"4 - QS43 - Smoking: supporting people to stop - Structure - 1","",""]
[null,"QS43","Smoking: supporting people to stop",4,null,"People who seek support to stop smoking and who choose to take pharmacotherapy are offered a full course.","Proportion of people who seek support to stop smoking and who choose to take pharmacotherapy who receive a full course.","Process","QS43 - Smoking: supporting people to stop","4 - QS43 - Smoking: supporting people to stop",1,"4 - QS43 - Smoking: supporting people to stop - Process - 1","The number of people in the denominator who receive a full course of pharmacotherapy.","The number of people who seek support to stop smoking and who choose to take pharmacotherapy."]
[null,"QS43","Smoking: supporting people to stop",5,null,"People who smoke who have set a quit date have a carbon monoxide test 4 weeks after the quit date.","Evidence of local arrangements to ensure that people who smoke who have set a quit date have a carbon monoxide test 4 weeks after the quit date.","Structure","QS43 - Smoking: supporting people to stop","5 - QS43 - Smoking: supporting people to stop",1,"5 - QS43 - Smoking: supporting people to stop - Structure - 1","",""]
[null,"QS43","Smoking: supporting people to stop",5,null,"People who smoke who have set a quit date have a carbon monoxide test 4 weeks after the quit date.","Proportion of people who smoke who have set a quit date who had a carbon monoxide test 4 weeks after the quit date.","Process","QS43 - Smoking: supporting people to stop","5 - QS43 - Smoking: supporting people to stop",1,"5 - QS43 - Smoking: supporting people to stop - Process - 1","The number of people in the denominator who had a carbon monoxide test 4 weeks after the quit date.","The number of people who smoke who have set a quit date."]
[null,"QS43","Smoking: supporting people to stop",5,null,"People who smoke who have set a quit date have a carbon monoxide test 4 weeks after the quit date.","4‑week quit rates.","Outcome","QS43 - Smoking: supporting people to stop","5 - QS43 - Smoking: supporting people to stop",1,"5 - QS43 - Smoking: supporting people to stop - Outcome - 1"]
[null,"QS44","Atopic eczema in under 12s",1,null,"Children with atopic eczema are offered, at diagnosis, an assessment that includes recording of their detailed clinical and treatment histories and identification of potential trigger factors.","Evidence of local arrangements to ensure that children with atopic eczema are offered, at diagnosis, an assessment that includes recording of their detailed clinical and treatment histories and identification of potential trigger factors.","Structure","QS44 - Atopic eczema in under 12s","1 - QS44 - Atopic eczema in under 12s",1,"1 - QS44 - Atopic eczema in under 12s - Structure - 1","",""]
[null,"QS44","Atopic eczema in under 12s",1,null,"Children with atopic eczema are offered, at diagnosis, an assessment that includes recording of their detailed clinical and treatment histories and identification of potential trigger factors.","The proportion of children with atopic eczema who receive, at diagnosis, an assessment that includes recording of their detailed clinical and treatment histories and identification of potential trigger factors.","Process","QS44 - Atopic eczema in under 12s","1 - QS44 - Atopic eczema in under 12s",1,"1 - QS44 - Atopic eczema in under 12s - Process - 1","The number of children in the denominator who receive, at diagnosis, an assessment that includes recording of their detailed clinical and treatment histories and identification of potential trigger factors.","The number of children with newly diagnosed atopic eczema."]
[null,"QS44","Atopic eczema in under 12s",2,null,"Children with atopic eczema are offered treatment based on recorded eczema severity using the stepped-care plan, supported by education.","Evidence of local arrangements to ensure that children with atopic eczema are offered treatment based on recorded eczema severity using the stepped-care plan, supported by education.","Structure","QS44 - Atopic eczema in under 12s","2 - QS44 - Atopic eczema in under 12s",1,"2 - QS44 - Atopic eczema in under 12s - Structure - 1","",""]
[null,"QS44","Atopic eczema in under 12s",2,null,"Children with atopic eczema are offered treatment based on recorded eczema severity using the stepped-care plan, supported by education.","The proportion of children with atopic eczema who have their eczema severity recorded at each eczema consultation.","Process","QS44 - Atopic eczema in under 12s","2 - QS44 - Atopic eczema in under 12s",1,"2 - QS44 - Atopic eczema in under 12s - Process - 1","The number of children in the denominator who have their eczema severity recorded at each eczema consultation.","The number of eczema consultations with children with atopic eczema."]
[null,"QS44","Atopic eczema in under 12s",2,null,"Children with atopic eczema are offered treatment based on recorded eczema severity using the stepped-care plan, supported by education.","The proportion of children with atopic eczema who receive treatment based on recorded eczema severity using the stepped-care plan, supported by education.","Process","QS44 - Atopic eczema in under 12s",{"$f":"CONCATENATE(D1014, \" - \", I1014)","v":"2 - QS44 - Atopic eczema in under 12s"},{"$f":"IF(AND(B1014=B1013, D1014=D1013, H1014=H1013)=TRUE, K1013+1, 1)","v":2},{"$f":"CONCATENATE(J1014, \" - \", H1014, \" - \",K1014)","v":"2 - QS44 - Atopic eczema in under 12s - Process - 2"},"The number of children in the denominator who receive treatment based on recorded eczema severity using the stepped-care plan, supported by education.","The number of children with atopic eczema."]
[null,"QS44","Atopic eczema in under 12s",3,null,"Children with atopic eczema have their (and their families') psychological wellbeing and quality of life discussed and recorded at each eczema consultation.","Evidence of local arrangements to ensure that children with atopic eczema have their (and their families') psychological wellbeing and quality of life discussed and recorded at each eczema consultation.","Structure","QS44 - Atopic eczema in under 12s","3 - QS44 - Atopic eczema in under 12s",1,"3 - QS44 - Atopic eczema in under 12s - Structure - 1","",""]
[null,"QS44","Atopic eczema in under 12s",3,null,"Children with atopic eczema have their (and their families') psychological wellbeing and quality of life discussed and recorded at each eczema consultation.","The proportion of eczema consultations with children with atopic eczema at which their (and their families') psychological wellbeing and quality of life is discussed and recorded.","Process","QS44 - Atopic eczema in under 12s","3 - QS44 - Atopic eczema in under 12s",1,"3 - QS44 - Atopic eczema in under 12s - Process - 1","The number of consultations in the denominator at which children's (and their families') psychological wellbeing and quality of life is discussed and recorded.","The number of eczema consultations with children with atopic eczema."]
[null,"QS44","Atopic eczema in under 12s",4,null,"Children with atopic eczema are prescribed sufficient quantities (250–500 g weekly) from a choice of unperfumed emollients for daily use.","Evidence of local arrangements to prescribe children with atopic eczema sufficient quantities (250–500 g weekly) from a choice of unperfumed emollients for daily use.","Structure","QS44 - Atopic eczema in under 12s","4 - QS44 - Atopic eczema in under 12s",1,"4 - QS44 - Atopic eczema in under 12s - Structure - 1","",""]
[null,"QS44","Atopic eczema in under 12s",4,null,"Children with atopic eczema are prescribed sufficient quantities (250–500 g weekly) from a choice of unperfumed emollients for daily use.","The proportion of children with atopic eczema who are prescribed sufficient quantities (250–500 g weekly) of unperfumed emollients for daily use.","Process","QS44 - Atopic eczema in under 12s","4 - QS44 - Atopic eczema in under 12s",1,"4 - QS44 - Atopic eczema in under 12s - Process - 1","The number of children in the denominator who are prescribed sufficient quantities (250–500 g weekly) of unperfumed emollients for daily use.","The number of children with atopic eczema."]
[null,"QS44","Atopic eczema in under 12s",5,null,"Children with uncontrolled or unresponsive atopic eczema, including recurring infections, or psychosocial problems related to the atopic eczema are referred for specialist dermatological advice.","Evidence of local arrangements for children with uncontrolled or unresponsive atopic eczema, including recurring infections, or psychosocial problems related to the atopic eczema to be referred for specialist dermatological advice.","Structure",{"$f":"CONCATENATE(B1019, \" - \", C1019)","v":"QS44 - Atopic eczema in under 12s"},"5 - QS44 - Atopic eczema in under 12s",1,"5 - QS44 - Atopic eczema in under 12s - Structure - 1","",""]
[null,"QS44","Atopic eczema in under 12s",5,null,"Children with uncontrolled or unresponsive atopic eczema, including recurring infections, or psychosocial problems related to the atopic eczema are referred for specialist dermatological advice.","The proportion of children with uncontrolled or unresponsive atopic eczema, including recurring infections, or psychosocial problems related to the atopic eczema who are referred for specialist dermatological advice.","Process","QS44 - Atopic eczema in under 12s","5 - QS44 - Atopic eczema in under 12s",1,"5 - QS44 - Atopic eczema in under 12s - Process - 1","The number of children in the denominator who are referred for specialist dermatological advice.","The number of children with uncontrolled or unresponsive atopic eczema, including recurring infections, or psychosocial problems related to the atopic eczema."]
[null,"QS44","Atopic eczema in under 12s",6,null,"Infants and young children with moderate or severe atopic eczema that has not been controlled by optimal treatment are referred for specialist investigation to identify possible food and other allergies.","Evidence of local arrangements for infants and young children with moderate or severe atopic eczema that has not been controlled by optimal treatment to be referred for specialist investigation to identify possible food and other allergies.","Structure","QS44 - Atopic eczema in under 12s","6 - QS44 - Atopic eczema in under 12s",1,"6 - QS44 - Atopic eczema in under 12s - Structure - 1","",""]
[null,"QS44","Atopic eczema in under 12s",6,null,"Infants and young children with moderate or severe atopic eczema that has not been controlled by optimal treatment are referred for specialist investigation to identify possible food and other allergies.","The proportion of infants and young children with moderate or severe atopic eczema that has not been controlled by optimal treatment who are referred for specialist investigation to identify possible food and other allergies.","Process","QS44 - Atopic eczema in under 12s","6 - QS44 - Atopic eczema in under 12s",1,"6 - QS44 - Atopic eczema in under 12s - Process - 1","The number of infants and young children in the denominator who are referred for specialist investigation to identify possible food and other allergies.","The number of infants and young children with moderate or severe atopic eczema that has not been controlled by optimal treatment."]
[null,"QS44","Atopic eczema in under 12s",7,null,"Children with atopic eczema who have suspected eczema herpeticum receive immediate treatment with systemic aciclovir and are referred for same-day specialist dermatological advice.","Evidence of local arrangements to ensure that children with atopic eczema who have suspected eczema herpeticum receive immediate treatment with systemic aciclovir and are referred for same-day specialist dermatological advice.","Structure","QS44 - Atopic eczema in under 12s","7 - QS44 - Atopic eczema in under 12s",1,"7 - QS44 - Atopic eczema in under 12s - Structure - 1","",""]
[null,"QS44","Atopic eczema in under 12s",7,null,"Children with atopic eczema who have suspected eczema herpeticum receive immediate treatment with systemic aciclovir and are referred for same-day specialist dermatological advice.","The proportion of children with atopic eczema who have suspected eczema herpeticum who receive immediate treatment with systemic aciclovir and are referred for same-day specialist dermatological advice.","Process","QS44 - Atopic eczema in under 12s","7 - QS44 - Atopic eczema in under 12s",1,"7 - QS44 - Atopic eczema in under 12s - Process - 1","The number of children in the denominator who receive immediate treatment with systemic aciclovir and are referred for same-day specialist dermatological advice.","The number of children with atopic eczema who have suspected eczema herpeticum."]
[null,"QS45","Lower urinary tract symptoms in men",1,null,"Men with lower urinary tract symptoms (LUTS) are offered a full physical examination, including a digital rectal examination, as part of their initial assessment","Evidence of local arrangements to ensure that men with LUTS are offered a full physical examination, including a digital rectal examination, as part of their initial assessment.","Structure","QS45 - Lower urinary tract symptoms in men","1 - QS45 - Lower urinary tract symptoms in men",1,"1 - QS45 - Lower urinary tract symptoms in men - Structure - 1","",""]
[null,"QS45","Lower urinary tract symptoms in men",1,null,"Men with lower urinary tract symptoms (LUTS) are offered a full physical examination, including a digital rectal examination, as part of their initial assessment","Proportion of men with LUTS who receive a full physical examination, including a digital rectal examination, as part of their initial assessment.","Process","QS45 - Lower urinary tract symptoms in men","1 - QS45 - Lower urinary tract symptoms in men",1,"1 - QS45 - Lower urinary tract symptoms in men - Process - 1","The number of men in the denominator who receive a full physical examination, including a digital rectal examination, as part of their initial assessment.","The number of men who present with LUTS."]
[null,"QS45","Lower urinary tract symptoms in men",2,null,"Men with bothersome lower urinary tract symptoms (LUTS) are asked to complete a urinary frequency and volume chart, as part of their initial assessment.","Evidence of local arrangements to ensure that men with bothersome LUTS are asked to complete a urinary frequency and volume chart, as part of their initial assessment.","Structure","QS45 - Lower urinary tract symptoms in men","2 - QS45 - Lower urinary tract symptoms in men",1,"2 - QS45 - Lower urinary tract symptoms in men - Structure - 1","",""]
[null,"QS45","Lower urinary tract symptoms in men",2,null,"Men with bothersome lower urinary tract symptoms (LUTS) are asked to complete a urinary frequency and volume chart, as part of their initial assessment.","Proportion of men with bothersome LUTS who complete a urinary frequency and volume chart, as part of their initial assessment.","Process","QS45 - Lower urinary tract symptoms in men","2 - QS45 - Lower urinary tract symptoms in men",1,"2 - QS45 - Lower urinary tract symptoms in men - Process - 1","The number of men in the denominator who complete a urinary frequency and volume chart, as part of their initial assessment.","The number of men who present with bothersome LUTS."]
[null,"QS45","Lower urinary tract symptoms in men",3,null,"Men with lower urinary tract symptoms (LUTS) whose symptoms are not bothersome or complicated are given written advice on lifestyle interventions, as part of their initial assessment.","Evidence of local arrangements to ensure that men with LUTS whose symptoms are not bothersome or complicated are given written advice on lifestyle interventions, as part of their initial assessment.","Structure","QS45 - Lower urinary tract symptoms in men","3 - QS45 - Lower urinary tract symptoms in men",1,"3 - QS45 - Lower urinary tract symptoms in men - Structure - 1","",""]
[null,"QS45","Lower urinary tract symptoms in men",3,null,"Men with lower urinary tract symptoms (LUTS) whose symptoms are not bothersome or complicated are given written advice on lifestyle interventions, as part of their initial assessment.","Proportion of men with LUTS whose symptoms are not bothersome or complicated who are given written advice on lifestyle interventions, as part of their initial assessment.","Process","QS45 - Lower urinary tract symptoms in men","3 - QS45 - Lower urinary tract symptoms in men",1,"3 - QS45 - Lower urinary tract symptoms in men - Process - 1","The number of men in the denominator who are given written advice on lifestyle interventions, as part of their initial assessment.","The number of men who present with LUTS whose symptoms are not bothersome or complicated."]
[null,"QS45","Lower urinary tract symptoms in men",3,null,"Men with lower urinary tract symptoms (LUTS) whose symptoms are not bothersome or complicated are given written advice on lifestyle interventions, as part of their initial assessment.","Men with LUTS whose symptoms are not bothersome or complicated feel informed about lifestyle options that might help to manage their condition.","Outcome","QS45 - Lower urinary tract symptoms in men","3 - QS45 - Lower urinary tract symptoms in men",1,"3 - QS45 - Lower urinary tract symptoms in men - Outcome - 1"]
[null,"QS45","Lower urinary tract symptoms in men",4,null,"Men with lower urinary tract symptoms (LUTS) who have urinary incontinence are offered a choice of temporary containment products, as part of their initial assessment.","Evidence of local arrangements to ensure that men with LUTS who have urinary incontinence are offered a choice of temporary containment products, as part of their initial assessment","Structure","QS45 - Lower urinary tract symptoms in men","4 - QS45 - Lower urinary tract symptoms in men",1,"4 - QS45 - Lower urinary tract symptoms in men - Structure - 1","",""]
[null,"QS45","Lower urinary tract symptoms in men",4,null,"Men with lower urinary tract symptoms (LUTS) who have urinary incontinence are offered a choice of temporary containment products, as part of their initial assessment.","Proportion of men with LUTS who have urinary incontinence who receive temporary containment products, as part of their initial assessment.","Process","QS45 - Lower urinary tract symptoms in men","4 - QS45 - Lower urinary tract symptoms in men",1,"4 - QS45 - Lower urinary tract symptoms in men - Process - 1","The number of men in the denominator who receive a temporary containment product, as part of their initial assessment.","The number of men who present with LUTS and urinary incontinence."]
[null,"QS45","Lower urinary tract symptoms in men",5,null,"Men with lower urinary tract symptoms (LUTS) who have post-micturition dribble are given information about how to perform urethral milking.","Evidence of local arrangements to ensure that men with LUTS who have post-micturition dribble are given information about how to perform urethral milking.","Structure","QS45 - Lower urinary tract symptoms in men","5 - QS45 - Lower urinary tract symptoms in men",1,"5 - QS45 - Lower urinary tract symptoms in men - Structure - 1","",""]
[null,"QS45","Lower urinary tract symptoms in men",5,null,"Men with lower urinary tract symptoms (LUTS) who have post-micturition dribble are given information about how to perform urethral milking.","Proportion of men with LUTS and post-micturition dribble who are given information about how to perform urethral milking.","Process","QS45 - Lower urinary tract symptoms in men","5 - QS45 - Lower urinary tract symptoms in men",1,"5 - QS45 - Lower urinary tract symptoms in men - Process - 1","The number of men in the denominator who are given information about how to perform urethral milking.","The number of men with LUTS who have post-micturition dribble."]
[null,"QS45","Lower urinary tract symptoms in men",5,null,"Men with lower urinary tract symptoms (LUTS) who have post-micturition dribble are given information about how to perform urethral milking.","Men with LUTS and post-micturition dribble feel informed about how to perform urethral milking to help them to manage their condition.","Outcome","QS45 - Lower urinary tract symptoms in men","5 - QS45 - Lower urinary tract symptoms in men",1,"5 - QS45 - Lower urinary tract symptoms in men - Outcome - 1"]
[null,"QS45","Lower urinary tract symptoms in men",6,null,"Men with lower urinary tract symptoms (LUTS) who are prescribed drug treatments to manage symptoms receive a timely medication review.","Evidence of local arrangements to ensure that men with LUTS receive a timely medication review.","Structure","QS45 - Lower urinary tract symptoms in men","6 - QS45 - Lower urinary tract symptoms in men",1,"6 - QS45 - Lower urinary tract symptoms in men - Structure - 1","",""]
[null,"QS45","Lower urinary tract symptoms in men",6,null,"Men with lower urinary tract symptoms (LUTS) who are prescribed drug treatments to manage symptoms receive a timely medication review.","Proportion of men with LUTS prescribed alpha-blockers who receive an initial medication review at 4–6 weeks.","Process","QS45 - Lower urinary tract symptoms in men","6 - QS45 - Lower urinary tract symptoms in men",1,"6 - QS45 - Lower urinary tract symptoms in men - Process - 1","The number of men in the denominator who receive an initial medication review at 4–6 weeks.","The number of men with LUTS prescribed alpha-blockers."]
[null,"QS45","Lower urinary tract symptoms in men",6,null,"Men with lower urinary tract symptoms (LUTS) who are prescribed drug treatments to manage symptoms receive a timely medication review.","Proportion of men with LUTS prescribed 5‑alpha reductase inhibitors who receive an initial medication review at 3–6 months.","Process","QS45 - Lower urinary tract symptoms in men","6 - QS45 - Lower urinary tract symptoms in men",2,"6 - QS45 - Lower urinary tract symptoms in men - Process - 2","The number of men in the denominator who receive an initial medication review at 3–6 months.","The number of men with LUTS prescribed 5‑alpha reductase inhibitors."]
[null,"QS45","Lower urinary tract symptoms in men",6,null,"Men with lower urinary tract symptoms (LUTS) who are prescribed drug treatments to manage symptoms receive a timely medication review.","Proportion of men with LUTS prescribed anticholinergics who receive an initial medication review every 4–6 weeks until symptoms are stable.","Process","QS45 - Lower urinary tract symptoms in men","6 - QS45 - Lower urinary tract symptoms in men",3,"6 - QS45 - Lower urinary tract symptoms in men - Process - 3","The number of men in the denominator who receive an initial medication review every 4–6 weeks until symptoms are stable.","The number of men with LUTS prescribed anticholinergics."]
[null,"QS45","Lower urinary tract symptoms in men",7,null,"Men with lower urinary tract symptoms (LUTS) are offered a measurement of flow rate and post-void residual volume, as part of their specialist assessment.","Evidence of local arrangements to ensure that men with LUTS are offered a measurement of flow rate and post-void residual volume, as part of their specialist assessment.","Structure","QS45 - Lower urinary tract symptoms in men","7 - QS45 - Lower urinary tract symptoms in men",1,"7 - QS45 - Lower urinary tract symptoms in men - Structure - 1","",""]
[null,"QS45","Lower urinary tract symptoms in men",7,null,"Men with lower urinary tract symptoms (LUTS) are offered a measurement of flow rate and post-void residual volume, as part of their specialist assessment.","Proportion of men with LUTS who have flow rate and post-void residual volume measured, as part of their specialist assessment.","Process","QS45 - Lower urinary tract symptoms in men","7 - QS45 - Lower urinary tract symptoms in men",1,"7 - QS45 - Lower urinary tract symptoms in men - Process - 1","The number of men in the denominator who have flow rate and post-void residual volume measured at the time of specialist assessment.","The number of men with LUTS undergoing specialist assessment."]
[null,"QS45","Lower urinary tract symptoms in men",8,null,"Men with voiding symptoms are offered surgery only if voiding symptoms are severe or if drug treatment and conservative management have been unsuccessful or are not appropriate.","Evidence of local arrangements to ensure that men with voiding symptoms are offered surgery only if voiding symptoms are severe or if drug treatment and conservative management have been unsuccessful or are not appropriate.","Structure","QS45 - Lower urinary tract symptoms in men","8 - QS45 - Lower urinary tract symptoms in men",1,"8 - QS45 - Lower urinary tract symptoms in men - Structure - 1","",""]
[null,"QS45","Lower urinary tract symptoms in men",8,null,"Men with voiding symptoms are offered surgery only if voiding symptoms are severe or if drug treatment and conservative management have been unsuccessful or are not appropriate.","Proportion of men with voiding symptoms offered surgery whose symptoms are severe or in whom drug treatment and conservative management have been unsuccessful or are not appropriate.","Process","QS45 - Lower urinary tract symptoms in men","8 - QS45 - Lower urinary tract symptoms in men",1,"8 - QS45 - Lower urinary tract symptoms in men - Process - 1","The number of men in the denominator who are offered surgery.","The number of men with voiding symptoms whose symptoms are severe or in whom drug treatment and conservative management have been unsuccessful or are not appropriate."]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",1,null,"Women with a multiple pregnancy have the chorionicity and amnionicity of their pregnancy determined using ultrasound and recorded between 11+2 weeks and 14+1 weeks.","Evidence of local arrangements to ensure that women with a multiple pregnancy have an ultrasound scan between 11+2 weeks and 14+1 weeks to determine and record the chorionicity and amnionicity of their pregnancy.","Structure","QS46 - Multiple pregnancy: twin and triplet pregnancies","1 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"1 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Structure - 1","",""]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",1,null,"Women with a multiple pregnancy have the chorionicity and amnionicity of their pregnancy determined using ultrasound and recorded between 11+2 weeks and 14+1 weeks.","The proportion of women with a multiple pregnancy who receive an ultrasound scan between 11+2 weeks and 14+1 weeks to determine and record the chorionicity and amnionicity of their pregnancy.","Process","QS46 - Multiple pregnancy: twin and triplet pregnancies","1 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"1 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Process - 1","The number of women in the denominator who received an ultrasound scan between 11+2 weeks and 14+1 weeks to determine and record the chorionicity and amnionicity of their pregnancy.","The number of women with a multiple pregnancy of greater than 14+1 weeks' gestation."]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",1,null,"Women with a multiple pregnancy have the chorionicity and amnionicity of their pregnancy determined using ultrasound and recorded between 11+2 weeks and 14+1 weeks.","Determination of chorionicity and amnionicity.","Outcome","QS46 - Multiple pregnancy: twin and triplet pregnancies","1 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"1 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Outcome - 1"]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",2,null,"Women with a multiple pregnancy have their fetuses labelled using ultrasound and recorded between 11+2 weeks and 14+1 weeks.","Evidence of local arrangements to ensure that women with a multiple pregnancy have their fetuses labelled using an ultrasound scan and recorded between 11+2 weeks and 14+1 weeks.","Structure","QS46 - Multiple pregnancy: twin and triplet pregnancies","2 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"2 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Structure - 1","",""]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",2,null,"Women with a multiple pregnancy have their fetuses labelled using ultrasound and recorded between 11+2 weeks and 14+1 weeks.","The proportion of women with a multiple pregnancy who have their fetuses labelled using an ultrasound scan and recorded between 11+2 weeks and 14+1 weeks.","Process","QS46 - Multiple pregnancy: twin and triplet pregnancies","2 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"2 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Process - 1","The number of women in the denominator who have had their fetuses labelled using an ultrasound scan and recorded between 11+2 weeks and 14+1 weeks.","The number of women with a multiple pregnancy of greater than 14+1 weeks' gestation."]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",2,null,"Women with a multiple pregnancy have their fetuses labelled using ultrasound and recorded between 11+2 weeks and 14+1 weeks.","Consistent identification of fetuses in multiple pregnancies.","Outcome","QS46 - Multiple pregnancy: twin and triplet pregnancies","2 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"2 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Outcome - 1"]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",3,null,"Women with a multiple pregnancy are cared for by a multidisciplinary core team.","Evidence of local arrangements to ensure that women with a multiple pregnancy are cared for by a multidisciplinary core team.","Structure","QS46 - Multiple pregnancy: twin and triplet pregnancies","3 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"3 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Structure - 1","",""]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",4,null,"Women with a multiple pregnancy have a care plan that specifies the timing of appointments with the multidisciplinary core team appropriate for the chorionicity and amnionicity of their pregnancy.","Evidence of local arrangements to ensure that women with a multiple pregnancy have a care plan that specifies the timing of antenatal care appointments with the multidisciplinary core team appropriate for the chorionicity and amnionicity of their pregnancy.","Structure","QS46 - Multiple pregnancy: twin and triplet pregnancies","4 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"4 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Structure - 1","",""]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",4,null,"Women with a multiple pregnancy have a care plan that specifies the timing of appointments with the multidisciplinary core team appropriate for the chorionicity and amnionicity of their pregnancy.","Evidence of local audit to monitor the completeness and accuracy of the antenatal care plan for women with a multiple pregnancy.","Structure","QS46 - Multiple pregnancy: twin and triplet pregnancies","4 - QS46 - Multiple pregnancy: twin and triplet pregnancies",2,"4 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Structure - 2","",""]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",4,null,"Women with a multiple pregnancy have a care plan that specifies the timing of appointments with the multidisciplinary core team appropriate for the chorionicity and amnionicity of their pregnancy.","The proportion of women with a multiple pregnancy who have a care plan that specifies the timing of antenatal care appointments with the multidisciplinary core team appropriate for the chorionicity and amnionicity of their pregnancy.","Process","QS46 - Multiple pregnancy: twin and triplet pregnancies","4 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"4 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Process - 1","The number of women in the denominator who have a care plan that specifies the timing of antenatal care appointments with the multidisciplinary core team appropriate for the chorionicity and amnionicity of their pregnancy.","The number of women with a multiple pregnancy."]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",4,null,"Women with a multiple pregnancy have a care plan that specifies the timing of appointments with the multidisciplinary core team appropriate for the chorionicity and amnionicity of their pregnancy.","Women feel informed about their care and know which healthcare professionals they should see and when.","Outcome","QS46 - Multiple pregnancy: twin and triplet pregnancies","4 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"4 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Outcome - 1"]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",5,null,"Women with a multiple pregnancy are monitored for fetal complications according to the chorionicity and amnionicity of their pregnancy.","Evidence of local arrangements to ensure that women with a multiple pregnancy are monitored for fetal complications according to the chorionicity and amnionicity of their pregnancy.","Structure","QS46 - Multiple pregnancy: twin and triplet pregnancies","5 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"5 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Structure - 1","",""]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",5,null,"Women with a multiple pregnancy are monitored for fetal complications according to the chorionicity and amnionicity of their pregnancy.","The proportion of women with a monochorionic multiple pregnancy who receive diagnostic monitoring for feto-fetal transfusion syndrome using ultrasound from 16 weeks and every 14 days until birth.","Process","QS46 - Multiple pregnancy: twin and triplet pregnancies","5 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"5 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Process - 1","The number of women in the denominator who received diagnostic monitoring for feto-fetal transfusion syndrome using ultrasound from 16 weeks and every 14 days until birth.","The number of women who had a monochorionic multiple pregnancy and a gestational age greater than 16 weeks."]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",5,null,"Women with a multiple pregnancy are monitored for fetal complications according to the chorionicity and amnionicity of their pregnancy.","The proportion of women with a monochorionic multiple pregnancy who receive diagnostic monitoring for fetal weight discordance using 2 or more biometric parameters and amniotic fluid level assessment at each ultrasound scan from 16 weeks.","Process","QS46 - Multiple pregnancy: twin and triplet pregnancies","5 - QS46 - Multiple pregnancy: twin and triplet pregnancies",2,"5 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Process - 2","The number of women in the denominator who received diagnostic monitoring for fetal weight discordance using 2 or more biometric parameters and amniotic fluid level assessment at each ultrasound scan from 16 weeks.","The number of women with a monochorionic multiple pregnancy and a gestational age greater than 16 weeks."]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",5,null,"Women with a multiple pregnancy are monitored for fetal complications according to the chorionicity and amnionicity of their pregnancy.","The proportion of women with a dichorionic twin or trichorionic triplet pregnancy who receive diagnostic monitoring for fetal weight discordance using 2 or more biometric parameters and amniotic fluid levels at each ultrasound scan from 24 weeks.","Process","QS46 - Multiple pregnancy: twin and triplet pregnancies","5 - QS46 - Multiple pregnancy: twin and triplet pregnancies",3,"5 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Process - 3","The number of women in the denominator who received diagnostic monitoring for fetal weight discordance using 2 or more biometric parameters and amniotic fluid levels at each ultrasound scan from 24 weeks.","The number of women with a dichorionic twin or trichorionic triplet pregnancy and a gestational age greater than 24 weeks."]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",6,null,"Women with a higher-risk or complicated multiple pregnancy have a consultant from a tertiary level fetal medicine centre involved in their care.","Evidence of local arrangements to ensure that women with a higher-risk or complicated multiple pregnancy have a consultant from a tertiary level fetal medicine centre involved in their care.","Structure","QS46 - Multiple pregnancy: twin and triplet pregnancies","6 - QS46 - Multiple pregnancy: twin and triplet pregnancies",{"$f":"IF(AND(B1060=B1058, D1060=D1058, H1060=H1058)=TRUE, K1058+1, 1)","v":1},"6 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Structure - 1","",""]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",6,null,"Women with a higher-risk or complicated multiple pregnancy have a consultant from a tertiary level fetal medicine centre involved in their care.","The proportion of women with a higher-risk multiple pregnancy who have a consultant from a tertiary level fetal medicine centre involved in their care.","Process","QS46 - Multiple pregnancy: twin and triplet pregnancies","6 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"6 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Process - 1","The number of women in the denominator who have a consultant from a tertiary level fetal medicine centre involved in their care.","The number of women with a higher-risk multiple pregnancy."]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",6,null,"Women with a higher-risk or complicated multiple pregnancy have a consultant from a tertiary level fetal medicine centre involved in their care.","The proportion of women with a complicated multiple pregnancy who have a consultant from a tertiary level fetal medicine centre involved in their care.","Process","QS46 - Multiple pregnancy: twin and triplet pregnancies","6 - QS46 - Multiple pregnancy: twin and triplet pregnancies",2,"6 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Process - 2","The number of women in the denominator who have a consultant from a tertiary level fetal medicine centre involved in their care.","The number of women with a complicated multiple pregnancy."]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",6,null,"Women with a higher-risk or complicated multiple pregnancy have a consultant from a tertiary level fetal medicine centre involved in their care.","Infant and maternal mortality and morbidity.","Outcome","QS46 - Multiple pregnancy: twin and triplet pregnancies","6 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"6 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Outcome - 1"]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",7,null,"Women with a multiple pregnancy have a discussion by 24 weeks with one or more members of the multidisciplinary core team about the risks, signs and symptoms of preterm labour and possible outcomes of preterm birth.","Evidence of local arrangements to ensure that women with a multiple pregnancy have a discussion by 24 weeks with one or more members of the multidisciplinary core team about the risks, signs and symptoms of preterm labour and possible outcomes of preterm birth.","Structure","QS46 - Multiple pregnancy: twin and triplet pregnancies","7 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"7 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Structure - 1","",""]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",7,null,"Women with a multiple pregnancy have a discussion by 24 weeks with one or more members of the multidisciplinary core team about the risks, signs and symptoms of preterm labour and possible outcomes of preterm birth.","The proportion of women with a multiple pregnancy who have a discussion by 24 weeks with one or more members of the multidisciplinary core team about the risks, signs and symptoms of preterm labour and possible outcomes of preterm birth.","Process","QS46 - Multiple pregnancy: twin and triplet pregnancies","7 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"7 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Process - 1","The number of women in the denominator who have had a discussion by 24 weeks with one or more members of the multidisciplinary core team about the risks, signs and symptoms of preterm labour and possible outcomes of preterm birth.","The number of women with a multiple pregnancy that is greater than 24 weeks' gestation."]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",7,null,"Women with a multiple pregnancy have a discussion by 24 weeks with one or more members of the multidisciplinary core team about the risks, signs and symptoms of preterm labour and possible outcomes of preterm birth.","Levels of satisfaction with support and confidence to recognise the signs and symptoms of preterm labour.","Outcome","QS46 - Multiple pregnancy: twin and triplet pregnancies","7 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"7 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Outcome - 1"]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",8,null,"Women with a multiple pregnancy have a discussion by 28 weeks with one or more members of the multidisciplinary core team about the timing of birth and possible modes of delivery so that a birth plan can be agreed.","Evidence of local arrangements to ensure that women with a multiple pregnancy have a discussion with one or more members of the multidisciplinary core team by 28 weeks about the timing of birth and possible modes of delivery so that a birth plan can be agreed.","Structure","QS46 - Multiple pregnancy: twin and triplet pregnancies","8 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"8 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Structure - 1","",""]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",8,null,"Women with a multiple pregnancy have a discussion by 28 weeks with one or more members of the multidisciplinary core team about the timing of birth and possible modes of delivery so that a birth plan can be agreed.","The proportion of women with a multiple pregnancy who have a discussion with one or more members of the multidisciplinary core team by 28 weeks about the timing of birth and possible modes of delivery.","Process","QS46 - Multiple pregnancy: twin and triplet pregnancies","8 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"8 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Process - 1","The number of women in the denominator who have had a discussion with one or more members of the multidisciplinary core team by 28 weeks about the timing of birth and possible modes of delivery.","The number of women with a multiple pregnancy of 28 weeks or more."]
[null,"QS46","Multiple pregnancy: twin and triplet pregnancies",8,null,"Women with a multiple pregnancy have a discussion by 28 weeks with one or more members of the multidisciplinary core team about the timing of birth and possible modes of delivery so that a birth plan can be agreed.","Women feel well informed and able to make decisions that reflect what is important to them about the options for delivery.","Outcome","QS46 - Multiple pregnancy: twin and triplet pregnancies","8 - QS46 - Multiple pregnancy: twin and triplet pregnancies",1,"8 - QS46 - Multiple pregnancy: twin and triplet pregnancies - Outcome - 1"]
[null,"QS47","Heavy menstrual bleeding ",1,null,"People presenting with symptoms related to heavy menstrual bleeding have a focused history taken that includes the impact on their quality of life.","Evidence that healthcare professionals are aware of and recognise symptoms related to heavy menstrual bleeding that might suggest uterine cavity abnormality, histological abnormality, adenomyosis or fibroids.","Structure","QS47 - Heavy menstrual bleeding ","1 - QS47 - Heavy menstrual bleeding ",1,"1 - QS47 - Heavy menstrual bleeding  - Structure - 1","",""]
[null,"QS47","Heavy menstrual bleeding ",1,null,"People presenting with symptoms related to heavy menstrual bleeding have a focused history taken that includes the impact on their quality of life.","Evidence of local clinical protocols for a focused history that includes the impact on quality of life based on symptoms related to heavy menstrual bleeding.","Structure","QS47 - Heavy menstrual bleeding ","1 - QS47 - Heavy menstrual bleeding ",2,"1 - QS47 - Heavy menstrual bleeding  - Structure - 2"]
[null,"QS47","Heavy menstrual bleeding ",1,null,"People presenting with symptoms related to heavy menstrual bleeding have a focused history taken that includes the impact on their quality of life.","Proportion of people presenting with symptoms related to heavy menstrual bleeding who have a focused history taken that includes the impact on their quality of life.","Process","QS47 - Heavy menstrual bleeding ","1 - QS47 - Heavy menstrual bleeding ",1,"1 - QS47 - Heavy menstrual bleeding  - Process - 1","The number in the denominator who have a focused history taken that includes the impact on their quality of life.","The number of people who present with symptoms of heavy menstrual bleeding."]
[null,"QS47","Heavy menstrual bleeding ",1,null,"People presenting with symptoms related to heavy menstrual bleeding have a focused history taken that includes the impact on their quality of life.","People who report they were satisfied that the impact of their heavy menstrual bleeding on quality of life was recognised.","Outcome","QS47 - Heavy menstrual bleeding ","1 - QS47 - Heavy menstrual bleeding ",1,"1 - QS47 - Heavy menstrual bleeding  - Outcome - 1"]
[null,"QS47","Heavy menstrual bleeding ",2,null,"People with heavy menstrual bleeding and suspected submucosal fibroids, polyps or endometrial pathology are offered outpatient hysteroscopy.","Evidence of local arrangements to ensure that outpatient hysteroscopy services are organised according to the Royal College of Obstetricians and Gynaecologists' green-top guideline no.59 on hysteroscopy, best practice in outpatient, for example facilities are adequately sized, equipped and staffed.","Structure","QS47 - Heavy menstrual bleeding ","2 - QS47 - Heavy menstrual bleeding ",1,"2 - QS47 - Heavy menstrual bleeding  - Structure - 1","",""]
[null,"QS47","Heavy menstrual bleeding ",2,null,"People with heavy menstrual bleeding and suspected submucosal fibroids, polyps or endometrial pathology are offered outpatient hysteroscopy.","Evidence that healthcare professionals are trained to perform outpatient hysteroscopy procedures according to the Royal College of Obstetricians and Gynaecologists' green-top guideline no.59 on hysteroscopy, best practice in outpatient, using techniques and equipment that minimise discomfort and pain.","Structure","QS47 - Heavy menstrual bleeding ","2 - QS47 - Heavy menstrual bleeding ",2,"2 - QS47 - Heavy menstrual bleeding  - Structure - 2"]
[null,"QS47","Heavy menstrual bleeding ",2,null,"People with heavy menstrual bleeding and suspected submucosal fibroids, polyps or endometrial pathology are offered outpatient hysteroscopy.","Proportion of people with heavy menstrual bleeding and suspected submucosal fibroids, polyps or endometrial pathology who were offered outpatient hysteroscopy.","Process","QS47 - Heavy menstrual bleeding ","2 - QS47 - Heavy menstrual bleeding ",1,"2 - QS47 - Heavy menstrual bleeding  - Process - 1","The number in the denominator who were offered outpatient hysteroscopy.","The number of people with heavy menstrual bleeding and suspected submucosal fibroids, polyps or endometrial pathology."]
[null,"QS47","Heavy menstrual bleeding ",2,null,"People with heavy menstrual bleeding and suspected submucosal fibroids, polyps or endometrial pathology are offered outpatient hysteroscopy.","Proportion of people with heavy menstrual bleeding and suspected submucosal fibroids, polyps or endometrial pathology who report satisfaction with outpatient hysteroscopy.","Outcome","QS47 - Heavy menstrual bleeding ",{"$f":"CONCATENATE(D1077, \" - \", I1077)","v":"2 - QS47 - Heavy menstrual bleeding "},{"$f":"IF(AND(B1077=B1076, D1077=D1076, H1077=H1076)=TRUE, K1076+1, 1)","v":1},{"$f":"CONCATENATE(J1077, \" - \", H1077, \" - \",K1077)","v":"2 - QS47 - Heavy menstrual bleeding  - Outcome - 1"},"The number in the denominator who report satisfaction with outpatient hysteroscopy.","The number of people with heavy menstrual bleeding and suspected submucosal fibroids, polyps or endometrial pathology having outpatient hysteroscopy."]
[null,"QS47","Heavy menstrual bleeding ",3,null,"People with heavy menstrual bleeding have a discussion with their healthcare professional about all their treatment options.","Evidence of local arrangements to ensure that people with heavy menstrual bleeding have a documented discussion with their healthcare professional about all their treatment options.","Structure","QS47 - Heavy menstrual bleeding ","3 - QS47 - Heavy menstrual bleeding ",{"$f":"IF(AND(B1078=B1077, D1078=D1077, H1078=H1077)=TRUE, K1077+1, 1)","v":1},{"$f":"CONCATENATE(J1078, \" - \", H1078, \" - \",K1078)","v":"3 - QS47 - Heavy menstrual bleeding  - Structure - 1"}]
[null,"QS47","Heavy menstrual bleeding ",3,null,"People with heavy menstrual bleeding have a discussion with their healthcare professional about all their treatment options.","Proportion of people with heavy menstrual bleeding who have a documented discussion with their healthcare professional about all their treatment options.","Process",{"$f":"CONCATENATE(B1079, \" - \", C1079)","v":"QS47 - Heavy menstrual bleeding "},"3 - QS47 - Heavy menstrual bleeding ",1,"3 - QS47 - Heavy menstrual bleeding  - Process - 1","The number in the denominator who have a documented discussion with their healthcare professional about all their treatment options.","The number of people with heavy menstrual bleeding."]
[null,"QS47","Heavy menstrual bleeding ",3,null,"People with heavy menstrual bleeding have a discussion with their healthcare professional about all their treatment options.","Proportion of people with heavy menstrual bleeding who report satisfaction with the decision‑making process when choosing treatment.","Outcome","QS47 - Heavy menstrual bleeding ","3 - QS47 - Heavy menstrual bleeding ",1,"3 - QS47 - Heavy menstrual bleeding  - Outcome - 1","The number in the denominator who report satisfaction with the decision‑making process when choosing treatment.","The number of people with heavy menstrual bleeding."]
[null,"QS48","Depression in children and young people",1,null,"Children and young people with suspected depression have a diagnosis confirmed and recorded in their medical records.","Evidence of local arrangements to ensure that children and young people with suspected depression have a diagnosis confirmed and recorded in their medical records.","Structure","QS48 - Depression in children and young people",{"$f":"CONCATENATE(D1081, \" - \", I1081)","v":"1 - QS48 - Depression in children and young people"},{"$f":"IF(AND(B1081=B1080, D1081=D1080, H1081=H1080)=TRUE, K1080+1, 1)","v":1},{"$f":"CONCATENATE(J1081, \" - \", H1081, \" - \",K1081)","v":"1 - QS48 - Depression in children and young people - Structure - 1"},"",""]
[null,"QS48","Depression in children and young people",1,null,"Children and young people with suspected depression have a diagnosis confirmed and recorded in their medical records.","Proportion of children and young people with suspected depression who have a diagnosis confirmed and recorded in their medical records","Process","QS48 - Depression in children and young people","1 - QS48 - Depression in children and young people",1,"1 - QS48 - Depression in children and young people - Process - 1","The number of people in the denominator who have a diagnosis confirmed and recorded in their medical records.","The number of children and young people who presented with suspected depression."]
[null,"QS48","Depression in children and young people",2,null,"Children and young people with depression are given information appropriate to their age about the diagnosis and their treatment options.","Evidence of local arrangements to ensure that children and young people with depression are given information appropriate to their age about the diagnosis and their treatment options.","Structure","QS48 - Depression in children and young people","2 - QS48 - Depression in children and young people",1,"2 - QS48 - Depression in children and young people - Structure - 1","",""]
[null,"QS48","Depression in children and young people",2,null,"Children and young people with depression are given information appropriate to their age about the diagnosis and their treatment options.","Proportion of children and young people with depression who are given information appropriate to their age about the diagnosis and their treatment options","Process","QS48 - Depression in children and young people","2 - QS48 - Depression in children and young people",1,"2 - QS48 - Depression in children and young people - Process - 1","The number of people in the denominator given information appropriate to their age about the diagnosis and their treatment options.","The number of children and young people diagnosed with depression."]
[null,"QS48","Depression in children and young people",2,null,"Children and young people with depression are given information appropriate to their age about the diagnosis and their treatment options.","Evidence from experience surveys and feedback that children and young people with depression understand the diagnosis and their treatment options","Outcome","QS48 - Depression in children and young people","2 - QS48 - Depression in children and young people",1,"2 - QS48 - Depression in children and young people - Outcome - 1"]
[null,"QS48","Depression in children and young people",3,null,"Children and young people with suspected severe depression and at high risk of suicide are assessed by CAMHS (Child and Adolescent Mental Health Services) professionals within a maximum of 24 hours of referral. If necessary, children and young people are provided with a safe place while waiting for the assessment.","Evidence of local arrangements to ensure that CAMHS professionals assess all children and young people with suspected severe depression and at high risk of suicide within a maximum of 24 hours of referral.","Structure","QS48 - Depression in children and young people","3 - QS48 - Depression in children and young people",1,"3 - QS48 - Depression in children and young people - Structure - 1","",""]
[null,"QS48","Depression in children and young people",3,null,"Children and young people with suspected severe depression and at high risk of suicide are assessed by CAMHS (Child and Adolescent Mental Health Services) professionals within a maximum of 24 hours of referral. If necessary, children and young people are provided with a safe place while waiting for the assessment.","Evidence of local arrangements to ensure that children and young people with suspected severe depression and at high risk of suicide who are referred to CAMHS are provided with a safe place if necessary while waiting for an assessment.","Structure","QS48 - Depression in children and young people","3 - QS48 - Depression in children and young people",2,"3 - QS48 - Depression in children and young people - Structure - 2","",""]
[null,"QS48","Depression in children and young people",3,null,"Children and young people with suspected severe depression and at high risk of suicide are assessed by CAMHS (Child and Adolescent Mental Health Services) professionals within a maximum of 24 hours of referral. If necessary, children and young people are provided with a safe place while waiting for the assessment.","Proportion of children and young people with suspected severe depression and at high risk of suicide who are assessed by CAMHS professionals within 24 hours of referral.","Process","QS48 - Depression in children and young people","3 - QS48 - Depression in children and young people",1,"3 - QS48 - Depression in children and young people - Process - 1","The number of people in the denominator assessed by CAMHS professionals within 24 hours of referral.","The number of children and young people referred to CAMHS with suspected severe depression and at high risk of suicide."]
[null,"QS48","Depression in children and young people",4,null,"Children and young people with suspected severe depression but not at high risk of suicide are assessed by CAMHS (Child and Adolescent Mental Health Services) professionals within a maximum of 2 weeks of referral.","Evidence of local arrangements to ensure that CAMHS professionals assess children and young people with suspected severe depression but not at high risk of suicide within a maximum of 2 weeks of referral","Structure","QS48 - Depression in children and young people","4 - QS48 - Depression in children and young people",1,"4 - QS48 - Depression in children and young people - Structure - 1","",""]
[null,"QS48","Depression in children and young people",4,null,"Children and young people with suspected severe depression but not at high risk of suicide are assessed by CAMHS (Child and Adolescent Mental Health Services) professionals within a maximum of 2 weeks of referral.","Proportion of children and young people with suspected severe depression but not at high risk of suicide who are assessed by CAMHS professionals within 2 weeks of referral","Process","QS48 - Depression in children and young people","4 - QS48 - Depression in children and young people",1,"4 - QS48 - Depression in children and young people - Process - 1","The number of people in the denominator assessed by CAMHS professionals within 2 weeks of referral.","The number of children and young people referred to CAMHS with suspected severe depression but not at high risk of suicide."]
[null,"QS48","Depression in children and young people",5,null,"Children and young people receiving treatment for depression have their health outcomes recorded at the beginning and end of each step in treatment.","Evidence of local arrangements to ensure that the health outcomes of children and young people receiving treatment for depression are recorded at the beginning and end of each step in treatment.","Structure","QS48 - Depression in children and young people","5 - QS48 - Depression in children and young people",1,"5 - QS48 - Depression in children and young people - Structure - 1","",""]
[null,"QS48","Depression in children and young people",5,null,"Children and young people receiving treatment for depression have their health outcomes recorded at the beginning and end of each step in treatment.","Proportion of children and young people receiving treatment for depression who have their health outcomes recorded at the beginning and end of each step in treatment.","Process","QS48 - Depression in children and young people","5 - QS48 - Depression in children and young people",1,"5 - QS48 - Depression in children and young people - Process - 1","The number of people in the denominator who have their health outcomes recorded at the beginning and end of each step in treatment.","The number of children and young people receiving treatment for depression."]
[null,"QS49","Surgical site infection",1,null,"People having surgery are advised not to remove hair from the surgical site and are advised to have (or are helped to have) a shower, bath or bed bath the day before or on the day of surgery. ","Evidence of local arrangements to ensure that people having surgery are advised not to remove hair from the surgical site.","Structure","QS49 - Surgical site infection","1 - QS49 - Surgical site infection",1,"1 - QS49 - Surgical site infection - Structure - 1","",""]
[null,"QS49","Surgical site infection",1,null,"People having surgery are advised not to remove hair from the surgical site and are advised to have (or are helped to have) a shower, bath or bed bath the day before or on the day of surgery. ","Evidence of local arrangements to ensure that people having surgery are advised to have (or are helped to have) a shower, bath or bed bath the day before or on the day of surgery.","Structure","QS49 - Surgical site infection","1 - QS49 - Surgical site infection",2,"1 - QS49 - Surgical site infection - Structure - 2","",""]
[null,"QS49","Surgical site infection",1,null,"People having surgery are advised not to remove hair from the surgical site and are advised to have (or are helped to have) a shower, bath or bed bath the day before or on the day of surgery. ","Proportion of surgical procedures for which the person having surgery is advised to have (or is helped to have) a shower, bath or bed bath the day before or on the day of surgery.","Process","QS49 - Surgical site infection","1 - QS49 - Surgical site infection",1,"1 - QS49 - Surgical site infection - Process - 1","The number in the denominator for which the person having surgery is advised to have (or is helped to have) a shower, bath or bed bath the day before or on the day of surgery.","The number of surgical procedures."]
[null,"QS49","Surgical site infection",1,null,"People having surgery are advised not to remove hair from the surgical site and are advised to have (or are helped to have) a shower, bath or bed bath the day before or on the day of surgery. ","Proportion of surgical procedures for which the person having surgery is advised not to remove hair from the surgical site.","Process","QS49 - Surgical site infection","1 - QS49 - Surgical site infection",2,"1 - QS49 - Surgical site infection - Process - 2","The number in the denominator for which the person having surgery is advised not to remove hair from the surgical site.","The number of surgical procedures."]
[null,"QS49","Surgical site infection",1,null,"People having surgery are advised not to remove hair from the surgical site and are advised to have (or are helped to have) a shower, bath or bed bath the day before or on the day of surgery. ","Feedback from people having surgery on whether they received the help they needed to have a shower, bath or bed bath the day before or on the day of surgery. ","Outcome","QS49 - Surgical site infection","1 - QS49 - Surgical site infection",1,"1 - QS49 - Surgical site infection - Outcome - 1"]
[null,"QS49","Surgical site infection",2,null,"People having surgery for which antibiotic prophylaxis is indicated receive this in accordance with the local antibiotic formulary. ","Evidence of local arrangements to ensure that people having surgery for which antibiotic prophylaxis is indicated receive this in accordance with the local antibiotic formulary and that this is recorded.","Structure","QS49 - Surgical site infection","2 - QS49 - Surgical site infection",1,"2 - QS49 - Surgical site infection - Structure - 1","",""]
[null,"QS49","Surgical site infection",2,null,"People having surgery for which antibiotic prophylaxis is indicated receive this in accordance with the local antibiotic formulary. ","Proportion of surgical procedures for which antibiotic prophylaxis is indicated for which the person having surgery receives antibiotic prophylaxis in accordance with the local antibiotic formulary and that this is recorded.","Process","QS49 - Surgical site infection","2 - QS49 - Surgical site infection",1,"2 - QS49 - Surgical site infection - Process - 1","The number in the denominator for which the person having surgery receives antibiotic prophylaxis in accordance with the local antibiotic formulary and that this is recorded.","The number of surgical procedures for which antibiotic prophylaxis is indicated."]
[null,"QS49","Surgical site infection",3,null,"Adults having surgery under general or regional anaesthesia have normothermia maintained before, during (unless active cooling is part of the procedure) and after surgery. ","Evidence of local arrangements to ensure that adults having surgery under general or regional anaesthesia have normothermia maintained before, during (unless active cooling is part of the procedure) and after surgery.","Structure","QS49 - Surgical site infection","3 - QS49 - Surgical site infection",1,"3 - QS49 - Surgical site infection - Structure - 1","",""]
[null,"QS49","Surgical site infection",3,null,"Adults having surgery under general or regional anaesthesia have normothermia maintained before, during (unless active cooling is part of the procedure) and after surgery. ","Proportion of surgical procedures on adults under general or regional anaesthesia in which the person having surgery has their core temperature measured and documented in accordance with Inadvertent perioperative hypothermia (NICE clinical guideline 65).","Process","QS49 - Surgical site infection","3 - QS49 - Surgical site infection",1,"3 - QS49 - Surgical site infection - Process - 1","The number in the denominator in which the person having surgery has their core temperature measured and documented in accordance with Inadvertent perioperative hypothermia (NICE clinical guideline 65).","The number of surgical procedures on adults under general or regional anaesthesia."]
[null,"QS49","Surgical site infection",3,null,"Adults having surgery under general or regional anaesthesia have normothermia maintained before, during (unless active cooling is part of the procedure) and after surgery. ","Proportion of surgical procedures on adults under general or regional anaesthesia in which the person having surgery is normothermic before, during (unless active cooling is part of the procedure) and after surgery.","Outcome","QS49 - Surgical site infection","3 - QS49 - Surgical site infection",1,"3 - QS49 - Surgical site infection - Outcome - 1","The number in the denominator in which the person having surgery is normothermic before, during (unless active cooling is part of the procedure) and after surgery.","The number of surgical procedures on adults under general or regional anaesthesia."]
[null,"QS49","Surgical site infection",4,null,"People having surgery are cared for by an operating team that minimises the transfer of microorganisms during the procedure by following best practice in hand hygiene and theatre wear, and by not moving in and out of the operating area unnecessarily.","Evidence of local arrangements to ensure that operating teams follow practices for surgical hand decontamination in accordance with Surgical site infection (NICE clinical guideline 74) recommendations 1.3.1 and 1.3.2.","Structure","QS49 - Surgical site infection","4 - QS49 - Surgical site infection",1,"4 - QS49 - Surgical site infection - Structure - 1","",""]
[null,"QS49","Surgical site infection",4,null,"People having surgery are cared for by an operating team that minimises the transfer of microorganisms during the procedure by following best practice in hand hygiene and theatre wear, and by not moving in and out of the operating area unnecessarily.","Evidence of local arrangements to ensure that operating teams minimise any staff movements in and out of the operating area. ","Structure","QS49 - Surgical site infection","4 - QS49 - Surgical site infection",2,"4 - QS49 - Surgical site infection - Structure - 2","",""]
[null,"QS49","Surgical site infection",4,null,"People having surgery are cared for by an operating team that minimises the transfer of microorganisms during the procedure by following best practice in hand hygiene and theatre wear, and by not moving in and out of the operating area unnecessarily.","Evidence of local arrangements to ensure that operating teams remove any hand jewellery, artificial nails and nail polish before starting surgical hand decontamination. ","Structure","QS49 - Surgical site infection","4 - QS49 - Surgical site infection",3,"4 - QS49 - Surgical site infection - Structure - 3","",""]
[null,"QS49","Surgical site infection",4,null,"People having surgery are cared for by an operating team that minimises the transfer of microorganisms during the procedure by following best practice in hand hygiene and theatre wear, and by not moving in and out of the operating area unnecessarily.","Evidence of local arrangements to ensure that spot checks are carried out in relation to the other structure measures.","Structure","QS49 - Surgical site infection","4 - QS49 - Surgical site infection",4,"4 - QS49 - Surgical site infection - Structure - 4","",""]
[null,"QS49","Surgical site infection",4,null,"People having surgery are cared for by an operating team that minimises the transfer of microorganisms during the procedure by following best practice in hand hygiene and theatre wear, and by not moving in and out of the operating area unnecessarily.","Evidence of local arrangements to ensure that staff wear specific non-sterile theatre wear in all areas where operations are undertaken.","Structure","QS49 - Surgical site infection","4 - QS49 - Surgical site infection",5,"4 - QS49 - Surgical site infection - Structure - 5","",""]
[null,"QS49","Surgical site infection",5,null,"People having surgery and their carers receive information and advice on wound and dressing care, including how to recognise problems with the wound and who to contact if they are concerned. ","Evidence of local arrangements to ensure that people having surgery and their carers receive information and advice on wound and dressing care, including how to recognise problems with the wound and who to contact if they are concerned.","Structure","QS49 - Surgical site infection","5 - QS49 - Surgical site infection",1,"5 - QS49 - Surgical site infection - Structure - 1","",""]
[null,"QS49","Surgical site infection",5,null,"People having surgery and their carers receive information and advice on wound and dressing care, including how to recognise problems with the wound and who to contact if they are concerned. ","Proportion of surgical procedures for which the person having surgery and their carers receive information and advice on wound and dressing care, including how to recognise problems with the wound and who to contact if they are concerned.","Process","QS49 - Surgical site infection","5 - QS49 - Surgical site infection",1,"5 - QS49 - Surgical site infection - Process - 1","The number in the denominator for which the person having surgery and their carers receive information and advice on wound and dressing care, including how to recognise problems with the wound and who to contact if they are concerned.","The number of surgical procedures."]
[null,"QS49","Surgical site infection",6,null,"People with a surgical site infection are offered treatment with an antibiotic that covers the likely causative organisms and is selected based on local resistance patterns and the results of microbiological tests. ","Proportion of surgical site infections for which the person with the infection receives treatment with an antibiotic that covers the likely causative organisms and is selected based on local resistance patterns and the results of microbiological tests.","Process","QS49 - Surgical site infection","6 - QS49 - Surgical site infection",1,"6 - QS49 - Surgical site infection - Process - 1","The number in the denominator for which the person with the infection receives treatment with an antibiotic that covers the likely causative organisms and is selected based on local resistance patterns and the results of microbiological tests.","The number of surgical site infections. "]
[null,"QS49","Surgical site infection",6,null,"People with a surgical site infection are offered treatment with an antibiotic that covers the likely causative organisms and is selected based on local resistance patterns and the results of microbiological tests. ","Evidence of local arrangements to ensure that people with a surgical site infection are offered treatment with an antibiotic that covers the likely causative organisms and is selected based on local resistance patterns and the results of microbiological tests. ","Structure","QS49 - Surgical site infection","6 - QS49 - Surgical site infection",1,"6 - QS49 - Surgical site infection - Structure - 1","",""]
[null,"QS49","Surgical site infection",7,null,"People having surgery are cared for by healthcare providers that monitor surgical site infection rates (including post-discharge infections) and provide feedback to relevant staff and stakeholders for continuous improvement through adjustment of clinical practice. ","Evidence of local arrangements to ensure surveillance data on surgical site infection rates (including post-discharge infections) are fed back to relevant staff and stakeholders.","Structure","QS49 - Surgical site infection","7 - QS49 - Surgical site infection",1,"7 - QS49 - Surgical site infection - Structure - 1","",""]
[null,"QS49","Surgical site infection",7,null,"People having surgery are cared for by healthcare providers that monitor surgical site infection rates (including post-discharge infections) and provide feedback to relevant staff and stakeholders for continuous improvement through adjustment of clinical practice. ","Evidence of local arrangements to ensure that surveillance data on surgical site infection rates (including post-discharge infections) are used for continuous improvement through adjustment of clinical practice.","Structure","QS49 - Surgical site infection","7 - QS49 - Surgical site infection",2,"7 - QS49 - Surgical site infection - Structure - 2","",""]
[null,"QS49","Surgical site infection",7,null,"People having surgery are cared for by healthcare providers that monitor surgical site infection rates (including post-discharge infections) and provide feedback to relevant staff and stakeholders for continuous improvement through adjustment of clinical practice. ","Evidence of local arrangements to ensure the existence of surveillance systems that capture inpatient and post-discharge surgical site infections.","Structure","QS49 - Surgical site infection","7 - QS49 - Surgical site infection",3,"7 - QS49 - Surgical site infection - Structure - 3","",""]
[null,"QS49","Surgical site infection",7,null,"People having surgery are cared for by healthcare providers that monitor surgical site infection rates (including post-discharge infections) and provide feedback to relevant staff and stakeholders for continuous improvement through adjustment of clinical practice. ","Readmissions for surgical site infection.","Outcome","QS49 - Surgical site infection","7 - QS49 - Surgical site infection",1,"7 - QS49 - Surgical site infection - Outcome - 1"]
[null,"QS50","Mental wellbeing of older people in care homes",1,null,"Older people in care homes are offered opportunities during their day to participate in meaningful activity that promotes their health and mental wellbeing.","Evidence of local arrangements to ensure that older people in care homes are offered opportunities during their day to participate in meaningful activity that promotes their health and mental wellbeing.","Structure","QS50 - Mental wellbeing of older people in care homes","1 - QS50 - Mental wellbeing of older people in care homes",1,"1 - QS50 - Mental wellbeing of older people in care homes - Structure - 1","",""]
[null,"QS50","Mental wellbeing of older people in care homes",1,null,"Older people in care homes are offered opportunities during their day to participate in meaningful activity that promotes their health and mental wellbeing.","Feedback from older people in care homes that they are offered opportunities to take part in activity during their day.  ","Outcome","QS50 - Mental wellbeing of older people in care homes","1 - QS50 - Mental wellbeing of older people in care homes",1,"1 - QS50 - Mental wellbeing of older people in care homes - Outcome - 1"]
[null,"QS50","Mental wellbeing of older people in care homes",1,null,"Older people in care homes are offered opportunities during their day to participate in meaningful activity that promotes their health and mental wellbeing.","Feedback from older people in care homes that they have taken part in activity during their day that is meaningful to them.","Outcome","QS50 - Mental wellbeing of older people in care homes","1 - QS50 - Mental wellbeing of older people in care homes",2,"1 - QS50 - Mental wellbeing of older people in care homes - Outcome - 2"]
[null,"QS50","Mental wellbeing of older people in care homes",2,null,"Older people in care homes are enabled to maintain and develop their personal identity.","Evidence of local arrangements to ensure that older people in care homes are enabled to maintain and develop their personal identity.","Structure","QS50 - Mental wellbeing of older people in care homes","2 - QS50 - Mental wellbeing of older people in care homes",1,"2 - QS50 - Mental wellbeing of older people in care homes - Structure - 1","",""]
[null,"QS50","Mental wellbeing of older people in care homes",2,null,"Older people in care homes are enabled to maintain and develop their personal identity.","Feedback from older people in care homes that their personal identity is respected.","Outcome","QS50 - Mental wellbeing of older people in care homes","2 - QS50 - Mental wellbeing of older people in care homes",1,"2 - QS50 - Mental wellbeing of older people in care homes - Outcome - 1"]
[null,"QS50","Mental wellbeing of older people in care homes",3,null,"Older people in care homes have the symptoms and signs of mental health conditions recognised and recorded as part of their care plan. ","Evidence of protocols to ensure that staff are trained to recognise the symptoms and signs of mental health conditions in older people, and record them in their care plan.","Structure","QS50 - Mental wellbeing of older people in care homes","3 - QS50 - Mental wellbeing of older people in care homes",1,"3 - QS50 - Mental wellbeing of older people in care homes - Structure - 1","",""]
[null,"QS50","Mental wellbeing of older people in care homes",4,null,"Older people in care homes who have specific needs arising from sensory impairment have these recognised and recorded as part of their care plan.","Evidence of protocols to ensure that staff are trained to recognise specific needs arising from sensory impairment in older people, and record these needs as part of their care plan.","Structure","QS50 - Mental wellbeing of older people in care homes","4 - QS50 - Mental wellbeing of older people in care homes",1,"4 - QS50 - Mental wellbeing of older people in care homes - Structure - 1","",""]
[null,"QS50","Mental wellbeing of older people in care homes",4,null,"Older people in care homes who have specific needs arising from sensory impairment have these recognised and recorded as part of their care plan.","Proportion of older people in care homes who have regular sight tests.","Process","QS50 - Mental wellbeing of older people in care homes","4 - QS50 - Mental wellbeing of older people in care homes",1,"4 - QS50 - Mental wellbeing of older people in care homes - Process - 1","The number of people in the denominator who have had a sight test within the past 2 years.","The number of older people in care homes."]
[null,"QS50","Mental wellbeing of older people in care homes",5,null,"Older people in care homes have the symptoms and signs of physical problems recognised and recorded as part of their care plan. ","Evidence of protocols to ensure that staff are trained to recognise the symptoms and signs of physical problems in older people in care homes, and record them as part of their care plan.","Structure","QS50 - Mental wellbeing of older people in care homes","5 - QS50 - Mental wellbeing of older people in care homes",1,"5 - QS50 - Mental wellbeing of older people in care homes - Structure - 1","",""]
[null,"QS50","Mental wellbeing of older people in care homes",6,null,"Older people in care homes have access to the full range of healthcare services when they need them.","Evidence of referral arrangements to ensure that older people in care homes are given access to the full range of healthcare services when they need them.","Structure","QS50 - Mental wellbeing of older people in care homes","6 - QS50 - Mental wellbeing of older people in care homes",1,"6 - QS50 - Mental wellbeing of older people in care homes - Structure - 1","",""]
[null,"QS50","Mental wellbeing of older people in care homes",6,null,"Older people in care homes have access to the full range of healthcare services when they need them.","Feedback from older people in care homes and from their family, friends and/or carers that they are satisfied with the care they have received.","Outcome","QS50 - Mental wellbeing of older people in care homes","6 - QS50 - Mental wellbeing of older people in care homes",1,"6 - QS50 - Mental wellbeing of older people in care homes - Outcome - 1"]
[null,"QS51","Autism",1,null,"People with possible autism who are referred to an autism team for a diagnostic assessment have the diagnostic assessment started within 3 months of their referral.","Evidence of local arrangements to ensure that people with possible autism referred for a diagnostic assessment by an autism team have the assessment started within 3 months of their referral.","Structure","QS51 - Autism","1 - QS51 - Autism",1,"1 - QS51 - Autism - Structure - 1","",""]
[null,"QS51","Autism",1,null,"People with possible autism who are referred to an autism team for a diagnostic assessment have the diagnostic assessment started within 3 months of their referral.","Proportion of people with possible autism referred to an autism team for a diagnostic assessment who have the assessment started within 3 months of their referral","Process","QS51 - Autism","1 - QS51 - Autism",1,"1 - QS51 - Autism - Process - 1","The number of people in the denominator who have a diagnostic assessment started within 3 months of referral to the autism team.","The number of people with possible autism referred to an autism team for a diagnostic assessment."]
[null,"QS51","Autism",2,null,"People having a diagnostic assessment for autism are also assessed for coexisting physical health conditions and mental health problems.","Evidence of local arrangements to ensure that people having a diagnostic assessment for autism are also assessed for coexisting physical health conditions and mental health problems.","Structure","QS51 - Autism",{"$f":"CONCATENATE(D1129, \" - \", I1129)","v":"2 - QS51 - Autism"},{"$f":"IF(AND(B1129=B1128, D1129=D1128, H1129=H1128)=TRUE, K1128+1, 1)","v":1},{"$f":"CONCATENATE(J1129, \" - \", H1129, \" - \",K1129)","v":"2 - QS51 - Autism - Structure - 1"},"",""]
[null,"QS51","Autism",2,null,"People having a diagnostic assessment for autism are also assessed for coexisting physical health conditions and mental health problems.","The proportion of people having a diagnostic assessment for autism who are also assessed for coexisting physical health conditions and mental health problems.","Process","QS51 - Autism","2 - QS51 - Autism",1,"2 - QS51 - Autism - Process - 1","The number of people in the denominator who have an assessment for coexisting physical health conditions and mental health problems.","The number of people having a diagnostic assessment for autism."]
[null,"QS51","Autism",2,null,"People having a diagnostic assessment for autism are also assessed for coexisting physical health conditions and mental health problems.","Reduced morbidity from unidentified physical health conditions and mental health problems that affect the psychosocial functioning of the person with autism","Outcome","QS51 - Autism","2 - QS51 - Autism",1,"2 - QS51 - Autism - Outcome - 1"]
[null,"QS51","Autism",3,null,"People with autism have a personalised plan that is developed and implemented in a partnership between them and their family and carers (if appropriate) and the autism team","Evidence of local arrangements to ensure that people with autism have a personalised plan that is developed and implemented in a partnership between them and their family and carers (if appropriate) and the autism team.","Structure","QS51 - Autism","3 - QS51 - Autism",1,"3 - QS51 - Autism - Structure - 1","",""]
[null,"QS51","Autism",3,null,"People with autism have a personalised plan that is developed and implemented in a partnership between them and their family and carers (if appropriate) and the autism team","The proportion of people with autism who have a personalised plan that is developed in a partnership between them and their family and carers (if appropriate) and the autism team","Process","QS51 - Autism","3 - QS51 - Autism",1,"3 - QS51 - Autism - Process - 1","The number of people in the denominator who have a personalised plan that is developed in a partnership between them and their family and carers (if appropriate) and the autism team.","The number of people diagnosed with autism."]
[null,"QS51","Autism",3,null,"People with autism have a personalised plan that is developed and implemented in a partnership between them and their family and carers (if appropriate) and the autism team","The proportion of people with autism who have their personalised plan implemented in a partnership between them and their family and carers (if appropriate) and the autism team.","Process",{"$f":"CONCATENATE(B1134, \" - \", C1134)","v":"QS51 - Autism"},"3 - QS51 - Autism",2,"3 - QS51 - Autism - Process - 2","The number of people in the denominator who have their personalised plan implemented in a partnership between them and their family and carers (if appropriate) and the autism team.","The number of people with autism who have a personalised plan developed."]
[null,"QS51","Autism",4,null,"People with autism are offered a named key worker to coordinate the care and support detailed in their personalised plan.","Evidence of local arrangements for people with autism to be offered a named key worker to coordinate the care and support detailed in their personalised plan","Structure","QS51 - Autism","4 - QS51 - Autism",1,"4 - QS51 - Autism - Structure - 1","",""]
[null,"QS51","Autism",4,null,"People with autism are offered a named key worker to coordinate the care and support detailed in their personalised plan.","The proportion of people with autism who are having the care and support detailed in their personalised plan coordinated by a named key worker.","Process","QS51 - Autism","4 - QS51 - Autism",1,"4 - QS51 - Autism - Process - 1","The number of people in the denominator who are having their care and support coordinated by a named key worker.","The number of people with autism with an agreed personalised plan."]
[null,"QS51","Autism",5,null,"People with autism have a documented discussion with a member of the autism team about opportunities to take part in age-appropriate psychosocial interventions to help address the core features of autism.","Evidence of local arrangements to ensure that all people with autism have a documented discussion with a member of the autism team about opportunities to take part in age-appropriate psychosocial interventions to help address the core features of autism","Structure","QS51 - Autism","5 - QS51 - Autism",1,"5 - QS51 - Autism - Structure - 1","",""]
[null,"QS51","Autism",5,null,"People with autism have a documented discussion with a member of the autism team about opportunities to take part in age-appropriate psychosocial interventions to help address the core features of autism.","The proportion of people with autism who have a documented discussion with a member of the autism team about opportunities to take part in age-appropriate psychosocial interventions to help address the core features of autism.","Process","QS51 - Autism","5 - QS51 - Autism",1,"5 - QS51 - Autism - Process - 1","The number of people in the denominator who have a documented discussion with a member of the autism team about opportunities to take part in age-appropriate psychosocial interventions to help address the core features of autism.","The number of people with autism."]
[null,"QS51","Autism",6,null,"People with autism are not prescribed medication to address the core features of autism","Evidence of local arrangements to ensure that people with autism are not prescribed medication to address the core features of autism.","Structure","QS51 - Autism","6 - QS51 - Autism",1,"6 - QS51 - Autism - Structure - 1","",""]
[null,"QS51","Autism",6,null,"People with autism are not prescribed medication to address the core features of autism","The proportion of people with autism who are prescribed medication to address the core features of autism.","Process","QS51 - Autism","6 - QS51 - Autism",1,"6 - QS51 - Autism - Process - 1","The number of people in the denominator who are prescribed medication to address the core features of their autism.","The number of people with autism."]
[null,"QS51","Autism",7,null,"People with autism who develop behaviour that challenges are assessed for possible triggers, including physical health conditions, mental health problems and environmental factors.","Evidence of local arrangements to ensure that people with autism who develop behaviour that challenges are assessed for possible triggers, including physical health conditions, mental health problems and environmental factors","Structure","QS51 - Autism","7 - QS51 - Autism",1,"7 - QS51 - Autism - Structure - 1","",""]
[null,"QS51","Autism",7,null,"People with autism who develop behaviour that challenges are assessed for possible triggers, including physical health conditions, mental health problems and environmental factors.","The proportion of people with autism who develop behaviour that challenges who are assessed for possible triggers, including physical health conditions, mental health problems and environmental factors.","Process","QS51 - Autism","7 - QS51 - Autism",1,"7 - QS51 - Autism - Process - 1","The number of people in the denominator who are assessed for possible triggers, including physical health conditions, mental health problems and environmental factors","The number of people with autism who develop behaviour that challenges."]
[null,"QS51","Autism",8,null,"People with autism and behaviour that challenges are not offered antipsychotic medication for the behaviour unless it is being considered because psychosocial or other interventions are insufficient or cannot be delivered because of the severity of the behaviour.","Evidence of local arrangements to monitor the use of antipsychotic medication in people with autism and behaviour that challenges.","Structure","QS51 - Autism","8 - QS51 - Autism",1,"8 - QS51 - Autism - Structure - 1","",""]
[null,"QS51","Autism",8,null,"People with autism and behaviour that challenges are not offered antipsychotic medication for the behaviour unless it is being considered because psychosocial or other interventions are insufficient or cannot be delivered because of the severity of the behaviour.","The proportion of people with autism and behaviour that challenges having antipsychotic medication for the treatment of their behaviour that challenges in whom psychosocial interventions are insufficient or cannot be delivered because of the severity of the behaviour.","Process","QS51 - Autism","8 - QS51 - Autism",1,"8 - QS51 - Autism - Process - 1","The number of people in the denominator for whom psychosocial interventions are insufficient or cannot be delivered because of the severity of the behaviour.","The number of people with autism and behaviour that challenges currently receiving antipsychotic medication to manage their behaviour that challenges."]
[null,"QS52","Peripheral arterial disease",1,null,"People who have symptoms of, or who are at risk of developing, peripheral arterial disease (PAD) are offered a clinical assessment and ankle brachial pressure index (ABPI) measurement.","Evidence of local arrangements to ensure that all healthcare practitioners undertaking hand-held doppler ultrasound assessment of ABPI are appropriately trained.","Structure","QS52 - Peripheral arterial disease","1 - QS52 - Peripheral arterial disease",1,"1 - QS52 - Peripheral arterial disease - Structure - 1","",""]
[null,"QS52","Peripheral arterial disease",1,null,"People who have symptoms of, or who are at risk of developing, peripheral arterial disease (PAD) are offered a clinical assessment and ankle brachial pressure index (ABPI) measurement.","Evidence of local arrangements to ensure that health and social care practitioners receive training to recognise the symptoms of PAD.","Structure","QS52 - Peripheral arterial disease","1 - QS52 - Peripheral arterial disease",2,"1 - QS52 - Peripheral arterial disease - Structure - 2","",""]
[null,"QS52","Peripheral arterial disease",1,null,"People who have symptoms of, or who are at risk of developing, peripheral arterial disease (PAD) are offered a clinical assessment and ankle brachial pressure index (ABPI) measurement.","Evidence of local arrangements to ensure that people who have symptoms of, or who are at risk of developing, PAD are offered a clinical assessment and ABPI measurement.","Structure","QS52 - Peripheral arterial disease","1 - QS52 - Peripheral arterial disease",3,"1 - QS52 - Peripheral arterial disease - Structure - 3","",""]
[null,"QS52","Peripheral arterial disease",1,null,"People who have symptoms of, or who are at risk of developing, peripheral arterial disease (PAD) are offered a clinical assessment and ankle brachial pressure index (ABPI) measurement.","Proportion of people who have symptoms of PAD who receive a clinical assessment and ABPI measurement.","Process","QS52 - Peripheral arterial disease","1 - QS52 - Peripheral arterial disease",1,"1 - QS52 - Peripheral arterial disease - Process - 1","The number of people in the denominator receiving a clinical assessment and ABPI measurement.","The number of people who have symptoms of PAD."]
[null,"QS52","Peripheral arterial disease",1,null,"People who have symptoms of, or who are at risk of developing, peripheral arterial disease (PAD) are offered a clinical assessment and ankle brachial pressure index (ABPI) measurement.","Proportion of people who are at risk of developing PAD who receive a clinical assessment and ABPI measurement.","Process","QS52 - Peripheral arterial disease","1 - QS52 - Peripheral arterial disease",2,"1 - QS52 - Peripheral arterial disease - Process - 2","The number of people in the denominator receiving a clinical assessment and ABPI measurement.","The number of people at risk of developing PAD."]
[null,"QS52","Peripheral arterial disease",1,null,"People who have symptoms of, or who are at risk of developing, peripheral arterial disease (PAD) are offered a clinical assessment and ankle brachial pressure index (ABPI) measurement.","Disease severity at diagnosis","Outcome","QS52 - Peripheral arterial disease","1 - QS52 - Peripheral arterial disease",1,"1 - QS52 - Peripheral arterial disease - Outcome - 1"]
[null,"QS52","Peripheral arterial disease",2,null,"People with peripheral arterial disease (PAD) are offered an assessment for cardiovascular comorbidities and modifiable risk factors.","Evidence of local arrangements to ensure that people with PAD are offered an assessment of cardiovascular comorbidities and modifiable risk factors.","Structure","QS52 - Peripheral arterial disease","2 - QS52 - Peripheral arterial disease",1,"2 - QS52 - Peripheral arterial disease - Structure - 1","",""]
[null,"QS52","Peripheral arterial disease",2,null,"People with peripheral arterial disease (PAD) are offered an assessment for cardiovascular comorbidities and modifiable risk factors.","Proportion of people with PAD who receive an assessment of cardiovascular comorbidities and modifiable risk factors.","Process","QS52 - Peripheral arterial disease","2 - QS52 - Peripheral arterial disease",1,"2 - QS52 - Peripheral arterial disease - Process - 1","The number of people in the denominator receiving an assessment of cardiovascular comorbidities and modifiable risk factors.","The number of people with PAD."]
[null,"QS52","Peripheral arterial disease",3,null,"People with intermittent claudication are offered a supervised exercise programme.","Evidence of local arrangements to ensure the availability of supervised exercise programmes.","Structure","QS52 - Peripheral arterial disease","3 - QS52 - Peripheral arterial disease",1,"3 - QS52 - Peripheral arterial disease - Structure - 1","",""]
[null,"QS52","Peripheral arterial disease",3,null,"People with intermittent claudication are offered a supervised exercise programme.","Proportion of people with intermittent claudication who are offered a supervised exercise programme.","Process","QS52 - Peripheral arterial disease","3 - QS52 - Peripheral arterial disease",1,"3 - QS52 - Peripheral arterial disease - Process - 1","The number of people in the denominator offered a supervised exercise programme.","The number of people with intermittent claudication."]
[null,"QS52","Peripheral arterial disease",3,null,"People with intermittent claudication are offered a supervised exercise programme.","Proportion of people with intermittent claudication who start a supervised exercise programme.","Process","QS52 - Peripheral arterial disease","3 - QS52 - Peripheral arterial disease",2,"3 - QS52 - Peripheral arterial disease - Process - 2","The number of people in the denominator starting a supervised exercise programme.","The number of people with intermittent claudication offered a supervised exercise programme."]
[null,"QS52","Peripheral arterial disease",3,null,"People with intermittent claudication are offered a supervised exercise programme.","Proportion of people with intermittent claudication who complete a supervised exercise programme.","Process","QS52 - Peripheral arterial disease","3 - QS52 - Peripheral arterial disease",3,"3 - QS52 - Peripheral arterial disease - Process - 3","The number of people in the denominator completing a supervised exercise programme.","The number of people with intermittent claudication who start a supervised exercise programme."]
[null,"QS52","Peripheral arterial disease",3,null,"People with intermittent claudication are offered a supervised exercise programme.","Improvement in health-related quality of life.","Outcome","QS52 - Peripheral arterial disease","3 - QS52 - Peripheral arterial disease",1,"3 - QS52 - Peripheral arterial disease - Outcome - 1"]
[null,"QS52","Peripheral arterial disease",3,null,"People with intermittent claudication are offered a supervised exercise programme.","Improvement in pain-free walking distance.","Outcome","QS52 - Peripheral arterial disease","3 - QS52 - Peripheral arterial disease",2,"3 - QS52 - Peripheral arterial disease - Outcome - 2"]
[null,"QS52","Peripheral arterial disease",4,null,"People with peripheral arterial disease (PAD) being considered for revascularisation who need further imaging after a duplex ultrasound are offered magnetic resonance angiography (MRA).","Evidence of local arrangements to ensure that healthcare practitioners undertaking imaging are appropriately trained in the use of duplex ultrasound and MRA for PAD.","Structure","QS52 - Peripheral arterial disease","4 - QS52 - Peripheral arterial disease",1,"4 - QS52 - Peripheral arterial disease - Structure - 1","",""]
[null,"QS52","Peripheral arterial disease",4,null,"People with peripheral arterial disease (PAD) being considered for revascularisation who need further imaging after a duplex ultrasound are offered magnetic resonance angiography (MRA).","Evidence of local arrangements to ensure that people with PAD being considered for revascularisation who need further imaging after a duplex ultrasound are offered MRA.","Structure","QS52 - Peripheral arterial disease","4 - QS52 - Peripheral arterial disease",2,"4 - QS52 - Peripheral arterial disease - Structure - 2","",""]
[null,"QS52","Peripheral arterial disease",4,null,"People with peripheral arterial disease (PAD) being considered for revascularisation who need further imaging after a duplex ultrasound are offered magnetic resonance angiography (MRA).","Proportion of people with PAD being considered for revascularisation needing further imaging after a duplex ultrasound who receive MRA.","Process","QS52 - Peripheral arterial disease","4 - QS52 - Peripheral arterial disease",1,"4 - QS52 - Peripheral arterial disease - Process - 1","The number of people in the denominator receiving MRA.","The number of people with PAD being considered for revascularisation who need further imaging after a duplex ultrasound."]
[null,"QS52","Peripheral arterial disease",5,null,"People with intermittent claudication are offered angioplasty only when imaging has confirmed it is appropriate, after advice on the benefits of modifying risk factors has been given, and after a supervised exercise programme has not improved symptoms.","Evidence of local arrangements to ensure that people with intermittent claudication are offered angioplasty only when imaging has confirmed it is appropriate, advice on the benefits of modifying risk factors has been given and a supervised exercise programme has not improved symptoms.","Structure","QS52 - Peripheral arterial disease","5 - QS52 - Peripheral arterial disease",1,"5 - QS52 - Peripheral arterial disease - Structure - 1","",""]
[null,"QS52","Peripheral arterial disease",5,null,"People with intermittent claudication are offered angioplasty only when imaging has confirmed it is appropriate, after advice on the benefits of modifying risk factors has been given, and after a supervised exercise programme has not improved symptoms.","Proportion of people with intermittent claudication receiving angioplasty who have had imaging to confirm angioplasty is appropriate, received advice on the benefits of modifying risk factors and undergone a supervised exercise programme that did not improve symptoms.","Process","QS52 - Peripheral arterial disease","5 - QS52 - Peripheral arterial disease",1,"5 - QS52 - Peripheral arterial disease - Process - 1","The number of people in the denominator who have had imaging to confirm angioplasty is appropriate, received advice on the benefits of modifying risk factors and undergone supervised exercise programme that did not improve symptoms.","The number of people with intermittent claudication who receive angioplasty."]
[null,"QS53","Anxiety disorders",1,null,"People with a suspected anxiety disorder receive an assessment that identifies whether they have a specific anxiety disorder, the severity of symptoms and associated functional impairment.","Evidence of local arrangements for people with a suspected anxiety disorder to receive an assessment that identifies whether they have a specific anxiety disorder, the severity of symptoms and associated functional impairment.","Structure","QS53 - Anxiety disorders","1 - QS53 - Anxiety disorders",1,"1 - QS53 - Anxiety disorders - Structure - 1","",""]
[null,"QS53","Anxiety disorders",1,null,"People with a suspected anxiety disorder receive an assessment that identifies whether they have a specific anxiety disorder, the severity of symptoms and associated functional impairment.","Evidence of local arrangements to ensure that healthcare professionals receive training to perform assessments of anxiety disorders.","Structure","QS53 - Anxiety disorders","1 - QS53 - Anxiety disorders",2,"1 - QS53 - Anxiety disorders - Structure - 2","",""]
[null,"QS53","Anxiety disorders",1,null,"People with a suspected anxiety disorder receive an assessment that identifies whether they have a specific anxiety disorder, the severity of symptoms and associated functional impairment.","Proportion of people with a suspected anxiety disorder who receive an assessment that identifies whether they have a specific anxiety disorder, the severity of symptoms and associated functional impairment.","Process","QS53 - Anxiety disorders","1 - QS53 - Anxiety disorders",1,"1 - QS53 - Anxiety disorders - Process - 1","The number of people in the denominator who receive an assessment that identifies whether they have a specific anxiety disorder, the severity of symptoms and associated functional impairment.","The number of people with a suspected anxiety disorder."]
[null,"QS53","Anxiety disorders",2,null,"People with an anxiety disorder are offered evidence-based psychological interventions.","Evidence of local arrangements to ensure that people with an anxiety disorder are offered evidence-based psychological interventions.","Structure","QS53 - Anxiety disorders","2 - QS53 - Anxiety disorders",1,"2 - QS53 - Anxiety disorders - Structure - 1","",""]
[null,"QS53","Anxiety disorders",2,null,"People with an anxiety disorder are offered evidence-based psychological interventions.","Proportion of people with an anxiety disorder who receive evidence-based psychological interventions.","Process","QS53 - Anxiety disorders","2 - QS53 - Anxiety disorders",1,"2 - QS53 - Anxiety disorders - Process - 1","The number of people in the denominator who receive evidence-based psychological interventions.","The number of people with an anxiety disorder."]
[null,"QS53","Anxiety disorders",3,null,"People with an anxiety disorder are not prescribed benzodiazepines or antipsychotics unless specifically indicated.","Evidence of local monitoring arrangements to ensure that people with an anxiety disorder are not prescribed a benzodiazepine or an antipsychotic to treat their disorder unless specifically indicated.","Structure","QS53 - Anxiety disorders","3 - QS53 - Anxiety disorders",1,"3 - QS53 - Anxiety disorders - Structure - 1","",""]
[null,"QS53","Anxiety disorders",3,null,"People with an anxiety disorder are not prescribed benzodiazepines or antipsychotics unless specifically indicated.","Proportion of people who have an anxiety disorder and are prescribed a benzodiazepine that is not specifically indicated.","Process","QS53 - Anxiety disorders","3 - QS53 - Anxiety disorders",1,"3 - QS53 - Anxiety disorders - Process - 1","The number of people in the denominator for whom a benzodiazepine is not specifically indicated.","The number of people with an anxiety disorder who are prescribed a benzodiazepine."]
[null,"QS53","Anxiety disorders",3,null,"People with an anxiety disorder are not prescribed benzodiazepines or antipsychotics unless specifically indicated.","Proportion of people who have an anxiety disorder and are prescribed an antipsychotic that is not specifically indicated.","Process","QS53 - Anxiety disorders","3 - QS53 - Anxiety disorders",2,"3 - QS53 - Anxiety disorders - Process - 2","The number of people in the denominator for whom an antipsychotic is not specifically indicated.","The number of people with an anxiety disorder who are prescribed an antipsychotic."]
[null,"QS53","Anxiety disorders",3,null,"People with an anxiety disorder are not prescribed benzodiazepines or antipsychotics unless specifically indicated.","Rates of prescribing benzodiazepines.","Outcome","QS53 - Anxiety disorders","3 - QS53 - Anxiety disorders",1,"3 - QS53 - Anxiety disorders - Outcome - 1"]
[null,"QS53","Anxiety disorders",3,null,"People with an anxiety disorder are not prescribed benzodiazepines or antipsychotics unless specifically indicated.","Rates of prescribing antipsychotics.","Outcome","QS53 - Anxiety disorders","3 - QS53 - Anxiety disorders",2,"3 - QS53 - Anxiety disorders - Outcome - 2"]
[null,"QS53","Anxiety disorders",4,null,"People receiving treatment for an anxiety disorder have their response to treatment recorded at each treatment session.","Evidence of local arrangements to monitor response to treatment for people being treated for an anxiety disorder at each treatment session and use the findings to adjust delivery of interventions.","Structure","QS53 - Anxiety disorders","4 - QS53 - Anxiety disorders",1,"4 - QS53 - Anxiety disorders - Structure - 1","",""]
[null,"QS53","Anxiety disorders",4,null,"People receiving treatment for an anxiety disorder have their response to treatment recorded at each treatment session.","Proportion of people receiving treatment for an anxiety disorder who have their response to treatment recorded at initial contact and each subsequent treatment session.","Process","QS53 - Anxiety disorders","4 - QS53 - Anxiety disorders",1,"4 - QS53 - Anxiety disorders - Process - 1","The number of people in the denominator whose response to treatment is recorded at initial contact and each subsequent treatment session.","The number of people receiving treatment for an anxiety disorder."]
[null,"QS53","Anxiety disorders",4,null,"People receiving treatment for an anxiety disorder have their response to treatment recorded at each treatment session.","Evidence from feedback that people receiving treatment for an anxiety disorder are aware of their progress.","Outcome","QS53 - Anxiety disorders","4 - QS53 - Anxiety disorders",1,"4 - QS53 - Anxiety disorders - Outcome - 1"]
[null,"QS54","Faecal Incontinence in adults",1,null,"Adults in high-risk groups for faecal incontinence are asked in a sensitive way, at the time the risk factor is identified and then at times according to local care pathways, whether they have bowel control problems.","Evidence of identification of locally relevant groups at high risk of faecal incontinence from those listed in NICE clinical guideline 49 recommendation 1.1.2.","Structure","QS54 - Faecal Incontinence in adults","1 - QS54 - Faecal Incontinence in adults",1,"1 - QS54 - Faecal Incontinence in adults - Structure - 1","",""]
[null,"QS54","Faecal Incontinence in adults",1,null,"Adults in high-risk groups for faecal incontinence are asked in a sensitive way, at the time the risk factor is identified and then at times according to local care pathways, whether they have bowel control problems.","Evidence of local initiatives for raising awareness of faecal incontinence among staff working with groups at high risk, including training in talking openly and sensitively about the condition.","Structure","QS54 - Faecal Incontinence in adults","1 - QS54 - Faecal Incontinence in adults",2,"1 - QS54 - Faecal Incontinence in adults - Structure - 2","",""]
[null,"QS54","Faecal Incontinence in adults",1,null,"Adults in high-risk groups for faecal incontinence are asked in a sensitive way, at the time the risk factor is identified and then at times according to local care pathways, whether they have bowel control problems.","Evidence of local arrangements to ensure that when the risk factor for faecal incontinence is identified, staff ask adults in high-risk groups whether they have bowel control problems.","Structure","QS54 - Faecal Incontinence in adults","1 - QS54 - Faecal Incontinence in adults",3,"1 - QS54 - Faecal Incontinence in adults - Structure - 3","",""]
[null,"QS54","Faecal Incontinence in adults",1,null,"Adults in high-risk groups for faecal incontinence are asked in a sensitive way, at the time the risk factor is identified and then at times according to local care pathways, whether they have bowel control problems.","Evidence that local care pathways relevant to the groups at high risk of faecal incontinence include prompts to ask about bowel control problems (for example, at annual review).","Structure","QS54 - Faecal Incontinence in adults","1 - QS54 - Faecal Incontinence in adults",4,"1 - QS54 - Faecal Incontinence in adults - Structure - 4","",""]
[null,"QS54","Faecal Incontinence in adults",1,null,"Adults in high-risk groups for faecal incontinence are asked in a sensitive way, at the time the risk factor is identified and then at times according to local care pathways, whether they have bowel control problems.","Proportion of adults in locally relevant groups at high risk of faecal incontinence (from those listed in NICE clinical guideline 49 recommendation 1.1.2) who have been asked whether they have bowel control problems.","Process","QS54 - Faecal Incontinence in adults","1 - QS54 - Faecal Incontinence in adults",1,"1 - QS54 - Faecal Incontinence in adults - Process - 1","The number of people in the denominator who have been asked whether they have bowel control problems.","The number of adults in identified locally relevant groups at high risk of faecal incontinence (from those listed in NICE clinical guideline 49 recommendation 1.1.2). "]
[null,"QS54","Faecal Incontinence in adults",1,null,"Adults in high-risk groups for faecal incontinence are asked in a sensitive way, at the time the risk factor is identified and then at times according to local care pathways, whether they have bowel control problems.","Feedback from adults who have been asked about whether they have bowel control problems, on whether this was done in a sensitive way.","Outcome","QS54 - Faecal Incontinence in adults","1 - QS54 - Faecal Incontinence in adults",1,"1 - QS54 - Faecal Incontinence in adults - Outcome - 1"]
[null,"QS54","Faecal Incontinence in adults",1,null,"Adults in high-risk groups for faecal incontinence are asked in a sensitive way, at the time the risk factor is identified and then at times according to local care pathways, whether they have bowel control problems.","Incidence of faecal incontinence.","Outcome","QS54 - Faecal Incontinence in adults","1 - QS54 - Faecal Incontinence in adults",2,"1 - QS54 - Faecal Incontinence in adults - Outcome - 2"]
[null,"QS54","Faecal Incontinence in adults",2,null,"Adults reporting bowel control problems are offered a full baseline assessment, which is carried out by healthcare professionals who do not assume that symptoms are caused by any existing conditions or disabilities.","Evidence of local pathways for accessing full baseline assessments when adults report bowel control problems","Structure","QS54 - Faecal Incontinence in adults","2 - QS54 - Faecal Incontinence in adults",1,"2 - QS54 - Faecal Incontinence in adults - Structure - 1","",""]
[null,"QS54","Faecal Incontinence in adults",2,null,"Adults reporting bowel control problems are offered a full baseline assessment, which is carried out by healthcare professionals who do not assume that symptoms are caused by any existing conditions or disabilities.","Evidence of local initiatives to raise awareness of factors contributing to faecal incontinence so that healthcare professionals carrying out full baseline assessments do not assume that symptoms are caused by existing conditions or disabilities.","Structure","QS54 - Faecal Incontinence in adults","2 - QS54 - Faecal Incontinence in adults",2,"2 - QS54 - Faecal Incontinence in adults - Structure - 2","",""]
[null,"QS54","Faecal Incontinence in adults",2,null,"Adults reporting bowel control problems are offered a full baseline assessment, which is carried out by healthcare professionals who do not assume that symptoms are caused by any existing conditions or disabilities.","Proportion of adults reporting bowel control problems who receive a full baseline assessment.","Process","QS54 - Faecal Incontinence in adults","2 - QS54 - Faecal Incontinence in adults",1,"2 - QS54 - Faecal Incontinence in adults - Process - 1","The number of people in the denominator receiving a full baseline assessment.","The number of adults reporting bowel control problems."]
[null,"QS54","Faecal Incontinence in adults",2,null,"Adults reporting bowel control problems are offered a full baseline assessment, which is carried out by healthcare professionals who do not assume that symptoms are caused by any existing conditions or disabilities.","Feedback from adults with faecal incontinence (or their carers) that symptoms were properly assessed and not assumed to be caused by any pre-existing conditions or disabilities.","Outcome","QS54 - Faecal Incontinence in adults","2 - QS54 - Faecal Incontinence in adults",1,"2 - QS54 - Faecal Incontinence in adults - Outcome - 1"]
[null,"QS54","Faecal Incontinence in adults",3,null,"Adults with faecal incontinence and their carers are offered practical support, advice and a choice of appropriate products for coping with symptoms during the period of assessment and for as long as they experience episodes of faecal incontinence.","Evidence of local provision of ongoing practical support and advice on coping with symptoms of faecal incontinence.","Structure","QS54 - Faecal Incontinence in adults","3 - QS54 - Faecal Incontinence in adults",1,"3 - QS54 - Faecal Incontinence in adults - Structure - 1","",""]
[null,"QS54","Faecal Incontinence in adults",3,null,"Adults with faecal incontinence and their carers are offered practical support, advice and a choice of appropriate products for coping with symptoms during the period of assessment and for as long as they experience episodes of faecal incontinence.","Evidence of local pathways (which are known to healthcare professionals carrying out baseline assessments for adults reporting bowel control problems) for accessing practical support and advice on coping with symptoms of faecal incontinence","Structure","QS54 - Faecal Incontinence in adults","3 - QS54 - Faecal Incontinence in adults",2,"3 - QS54 - Faecal Incontinence in adults - Structure - 2","",""]
[null,"QS54","Faecal Incontinence in adults",3,null,"Adults with faecal incontinence and their carers are offered practical support, advice and a choice of appropriate products for coping with symptoms during the period of assessment and for as long as they experience episodes of faecal incontinence.","Evidence that a choice of appropriate products for faecal incontinence is available locally.","Structure","QS54 - Faecal Incontinence in adults","3 - QS54 - Faecal Incontinence in adults",3,"3 - QS54 - Faecal Incontinence in adults - Structure - 3","",""]
[null,"QS54","Faecal Incontinence in adults",3,null,"Adults with faecal incontinence and their carers are offered practical support, advice and a choice of appropriate products for coping with symptoms during the period of assessment and for as long as they experience episodes of faecal incontinence.","Proportion of adults reporting bowel control problems and their carers who receive support and advice at the time of baseline assessment for coping with symptoms.","Process","QS54 - Faecal Incontinence in adults","3 - QS54 - Faecal Incontinence in adults",1,"3 - QS54 - Faecal Incontinence in adults - Process - 1","The number of people in the denominator for whom they and their carers receive support and advice at the time of baseline assessment for coping with symptoms.","The number of adults with faecal incontinence."]
[null,"QS54","Faecal Incontinence in adults",3,null,"Adults with faecal incontinence and their carers are offered practical support, advice and a choice of appropriate products for coping with symptoms during the period of assessment and for as long as they experience episodes of faecal incontinence.","Proportion of adults reporting bowel control problems who are given a choice of appropriate products at the time of baseline assessment for coping with symptoms.","Process","QS54 - Faecal Incontinence in adults","3 - QS54 - Faecal Incontinence in adults",2,"3 - QS54 - Faecal Incontinence in adults - Process - 2","The number of people in the denominator who are given a choice of appropriate products at the time of baseline assessment for coping with symptoms.","The number of adults with faecal incontinence."]
[null,"QS54","Faecal Incontinence in adults",3,null,"Adults with faecal incontinence and their carers are offered practical support, advice and a choice of appropriate products for coping with symptoms during the period of assessment and for as long as they experience episodes of faecal incontinence.","Feedback from adults with faecal incontinence that they receive ongoing support and advice and a choice of appropriate products for coping with symptoms.","Outcome","QS54 - Faecal Incontinence in adults",{"$f":"CONCATENATE(D1193, \" - \", I1193)","v":"3 - QS54 - Faecal Incontinence in adults"},{"$f":"IF(AND(B1193=B1192, D1193=D1192, H1193=H1192)=TRUE, K1192+1, 1)","v":1},{"$f":"CONCATENATE(J1193, \" - \", H1193, \" - \",K1193)","v":"3 - QS54 - Faecal Incontinence in adults - Outcome - 1"}]
[null,"QS54","Faecal Incontinence in adults",4,null,"Adults with faecal incontinence have an initial management plan that covers any specific conditions causing the incontinence, and diet, bowel habit, toilet access and medication.","Evidence of local capability to provide interventions for initial management of faecal incontinence.","Structure","QS54 - Faecal Incontinence in adults","4 - QS54 - Faecal Incontinence in adults",1,"4 - QS54 - Faecal Incontinence in adults - Structure - 1","",""]
[null,"QS54","Faecal Incontinence in adults",4,null,"Adults with faecal incontinence have an initial management plan that covers any specific conditions causing the incontinence, and diet, bowel habit, toilet access and medication.","Evidence of local pathways (which are known to healthcare professionals carrying out baseline assessments for adults reporting bowel control problems) for accessing interventions for initial management of faecal incontinence.","Structure","QS54 - Faecal Incontinence in adults","4 - QS54 - Faecal Incontinence in adults",2,"4 - QS54 - Faecal Incontinence in adults - Structure - 2","",""]
[null,"QS54","Faecal Incontinence in adults",4,null,"Adults with faecal incontinence have an initial management plan that covers any specific conditions causing the incontinence, and diet, bowel habit, toilet access and medication.","Proportion of adults with faecal incontinence who have had a baseline assessment and have an initial management plan that covers any specific conditions causing symptoms, and diet, bowel habit, toilet access and medication.","Process","QS54 - Faecal Incontinence in adults","4 - QS54 - Faecal Incontinence in adults",1,"4 - QS54 - Faecal Incontinence in adults - Process - 1","The number of people in the denominator with an initial management plan that covers specific conditions that are causing symptoms, and diet, bowel habit, toilet access and medication.","The number of adults with faecal incontinence who have had a baseline assessment."]
[null,"QS54","Faecal Incontinence in adults",5,null,"Adults who continue to experience episodes of faecal incontinence after initial management are offered referral for specialised management.","Evidence of local referral pathways for all options for specialised management of faecal incontinence.","Structure","QS54 - Faecal Incontinence in adults","5 - QS54 - Faecal Incontinence in adults",1,"5 - QS54 - Faecal Incontinence in adults - Structure - 1","",""]
[null,"QS54","Faecal Incontinence in adults",5,null,"Adults who continue to experience episodes of faecal incontinence after initial management are offered referral for specialised management.","Proportion of adults continuing to experience episodes of faecal incontinence after initial management who are offered referral for specialised management.","Process",{"$f":"CONCATENATE(B1198, \" - \", C1198)","v":"QS54 - Faecal Incontinence in adults"},"5 - QS54 - Faecal Incontinence in adults",1,"5 - QS54 - Faecal Incontinence in adults - Process - 1","The number of people in the denominator who are offered referral for specialised management.","The number of adults continuing to experience episodes of faecal incontinence after initial management."]
[null,"QS55","Cancer services for children and young people",1,null,"Young people (aged 16–24 years) with cancer have their diagnosis, treatment and support agreed and delivered by a cancer-site-specific multidisciplinary team and a teenage and young adult multidisciplinary team.","Evidence of local arrangements for all young people (aged 16–24 years) with cancer to have their diagnosis, treatment and support agreed and delivered by a cancer-site-specific multidisciplinary team and a teenage and young adult multidisciplinary team","Structure","QS55 - Cancer services for children and young people","1 - QS55 - Cancer services for children and young people",1,"1 - QS55 - Cancer services for children and young people - Structure - 1","",""]
[null,"QS55","Cancer services for children and young people",1,null,"Young people (aged 16–24 years) with cancer have their diagnosis, treatment and support agreed and delivered by a cancer-site-specific multidisciplinary team and a teenage and young adult multidisciplinary team.","The proportion of young people (aged 16–24 years) diagnosed with cancer who have their diagnosis, treatment and support agreed by a cancer-site-specific multidisciplinary team and a teenage and young adult multidisciplinary team","Process","QS55 - Cancer services for children and young people","1 - QS55 - Cancer services for children and young people",1,"1 - QS55 - Cancer services for children and young people - Process - 1","The number of people in the denominator who have their diagnosis,  treatment and support agreed by a cancer-site-specific multidisciplinary team and a teenage and young adult multidisciplinary team.","The number of young people (aged 16–24 years) diagnosed with cancer."]
[null,"QS55","Cancer services for children and young people",1,null,"Young people (aged 16–24 years) with cancer have their diagnosis, treatment and support agreed and delivered by a cancer-site-specific multidisciplinary team and a teenage and young adult multidisciplinary team.","The proportion of young people (aged 16–24 years) with cancer who have their treatment and support delivered by a cancer-site-specific multidisciplinary team and a teenage and young adult multidisciplinary team.","Process","QS55 - Cancer services for children and young people","1 - QS55 - Cancer services for children and young people",2,"1 - QS55 - Cancer services for children and young people - Process - 2","The number of people in the denominator who have their treatment and support delivered by a cancer-site-specific multidisciplinary team and a teenage and young adult multidisciplinary team.","The number of young people (aged 16–24 years) with cancer."]
[null,"QS55","Cancer services for children and young people",2,null,"Children and young people (aged 0–24 years) with cancer should be offered the opportunity to take part in clinical trials if they are eligible.","Evidence of local arrangements to ensure that children and young people (aged 0–24 years) are assessed for eligibility for relevant clinical trials and offered the opportunity to take part.","Structure","QS55 - Cancer services for children and young people","2 - QS55 - Cancer services for children and young people",1,"2 - QS55 - Cancer services for children and young people - Structure - 1","",""]
[null,"QS55","Cancer services for children and young people",2,null,"Children and young people (aged 0–24 years) with cancer should be offered the opportunity to take part in clinical trials if they are eligible.","The proportion of children and young people (aged 0–24 years) with cancer and eligible for a clinical trial who are offered the opportunity to take part.","Process","QS55 - Cancer services for children and young people","2 - QS55 - Cancer services for children and young people",1,"2 - QS55 - Cancer services for children and young people - Process - 1","The number of people in the denominator offered the opportunity to take part.","Children and young people (aged 0–24 years) with cancer and eligible for a clinical trial."]
[null,"QS55","Cancer services for children and young people",2,null,"Children and young people (aged 0–24 years) with cancer should be offered the opportunity to take part in clinical trials if they are eligible.","The proportion of children and young people (aged 0–24 years) with cancer who are recruited into a clinical trial for which they are eligible.","Process","QS55 - Cancer services for children and young people","2 - QS55 - Cancer services for children and young people",2,"2 - QS55 - Cancer services for children and young people - Process - 2","The number of people in the denominator recruited into the clinical trial.","The number of children and young people (aged 0–24 years) with cancer and eligible for a clinical trial."]
[null,"QS55","Cancer services for children and young people",3,null,"Children and young people (aged 0–24 years) receiving chemotherapy have it prescribed using an electronic prescribing system.","Evidence of local arrangements to ensure that all children and young people (aged 0–24 years) receiving chemotherapy have it prescribed using an electronic prescribing system.","Structure","QS55 - Cancer services for children and young people","3 - QS55 - Cancer services for children and young people",1,"3 - QS55 - Cancer services for children and young people - Structure - 1","",""]
[null,"QS55","Cancer services for children and young people",3,null,"Children and young people (aged 0–24 years) receiving chemotherapy have it prescribed using an electronic prescribing system.","The number of patient safety incidents in children and young people (aged 0–24 years) related to chemotherapy prescriptions","Outcome","QS55 - Cancer services for children and young people","3 - QS55 - Cancer services for children and young people",1,"3 - QS55 - Cancer services for children and young people - Outcome - 1"]
[null,"QS55","Cancer services for children and young people",4,null,"Children and young people (aged 0–24 years) with cancer, and their families and carers, have their psychological and social needs assessed at key points in their care pathway and receive support based on their identified needs","Evidence of local arrangements to ensure that children and young people (aged 0–24 years) with cancer, and their families and carers, have their psychological and social needs assessed at key points on their care pathway.","Structure","QS55 - Cancer services for children and young people","4 - QS55 - Cancer services for children and young people",1,"4 - QS55 - Cancer services for children and young people - Structure - 1","",""]
[null,"QS55","Cancer services for children and young people",4,null,"Children and young people (aged 0–24 years) with cancer, and their families and carers, have their psychological and social needs assessed at key points in their care pathway and receive support based on their identified needs","Evidence of local arrangements to ensure that children and young people (aged 0–24 years) with cancer, and their families and carers, can access services delivering psychological and social support","Structure","QS55 - Cancer services for children and young people","4 - QS55 - Cancer services for children and young people",2,"4 - QS55 - Cancer services for children and young people - Structure - 2","",""]
[null,"QS55","Cancer services for children and young people",4,null,"Children and young people (aged 0–24 years) with cancer, and their families and carers, have their psychological and social needs assessed at key points in their care pathway and receive support based on their identified needs","The proportion of children and young people (aged 0–24 years) with cancer reaching a key point in their care pathway who have their psychological and social needs assessed.","Process","QS55 - Cancer services for children and young people","4 - QS55 - Cancer services for children and young people",1,"4 - QS55 - Cancer services for children and young people - Process - 1","The number of people in the denominator who have their psychological and social needs assessed.","The number of children and young people (aged 0–24 years) with cancer reaching a key point in their care pathway."]
[null,"QS55","Cancer services for children and young people",4,null,"Children and young people (aged 0–24 years) with cancer, and their families and carers, have their psychological and social needs assessed at key points in their care pathway and receive support based on their identified needs","The proportion of children and young people (aged 0–24 years) with cancer reaching a key point in their care pathway whose family and carers have their psychological and social needs assessed.","Process","QS55 - Cancer services for children and young people","4 - QS55 - Cancer services for children and young people",2,"4 - QS55 - Cancer services for children and young people - Process - 2","The number of people in the denominator whose family and carers have their psychological and social needs assessed.","The number of children and young people (aged 0–24 years) with cancer reaching a key point in their care pathway."]
[null,"QS55","Cancer services for children and young people",4,null,"Children and young people (aged 0–24 years) with cancer, and their families and carers, have their psychological and social needs assessed at key points in their care pathway and receive support based on their identified needs","The proportion of children and young people (aged 0–24 years) with cancer reaching a key point in their care pathway who receive support with identified psychological or social needs.","Process","QS55 - Cancer services for children and young people","4 - QS55 - Cancer services for children and young people",3,"4 - QS55 - Cancer services for children and young people - Process - 3","The number of people in the denominator receiving psychological or social support.","The number of children and young people (aged 0–24 years) with cancer reaching a key point in their care pathway with identified psychological or social needs."]
[null,"QS55","Cancer services for children and young people",4,null,"Children and young people (aged 0–24 years) with cancer, and their families and carers, have their psychological and social needs assessed at key points in their care pathway and receive support based on their identified needs","The proportion of children and young people (aged 0–24 years) with cancer reaching a key point in their care pathway whose family and carers receive support with identified psychological and social needs.","Process","QS55 - Cancer services for children and young people","4 - QS55 - Cancer services for children and young people",4,"4 - QS55 - Cancer services for children and young people - Process - 4","The number of people in the denominator receiving psychological or social support.","The number of children and young people (aged 0–24 years) with cancer reaching a key point in their care pathway whose family and carers have identified psychological or social needs."]
[null,"QS55","Cancer services for children and young people",4,null,"Children and young people (aged 0–24 years) with cancer, and their families and carers, have their psychological and social needs assessed at key points in their care pathway and receive support based on their identified needs","Children and young people with cancer, and their families and carers, feel supported during their care.","Outcome","QS55 - Cancer services for children and young people","4 - QS55 - Cancer services for children and young people",1,"4 - QS55 - Cancer services for children and young people - Outcome - 1"]
[null,"QS55","Cancer services for children and young people",5,null,"Children and young people (aged 0–24 years) who have had a central nervous system malignancy receive a specialist neuro-rehabilitation care package.","Evidence of local arrangements to ensure that all children and young people (aged 0–24 years) who have had a central nervous system malignancy receive a specialist neuro-rehabilitation care package.","Structure","QS55 - Cancer services for children and young people","5 - QS55 - Cancer services for children and young people",1,"5 - QS55 - Cancer services for children and young people - Structure - 1","",""]
[null,"QS55","Cancer services for children and young people",5,null,"Children and young people (aged 0–24 years) who have had a central nervous system malignancy receive a specialist neuro-rehabilitation care package.","The proportion of children and young people (aged 0–24 years) who have had treatment for a central nervous system malignancy who receive a specialist neuro-rehabilitation care package","Process","QS55 - Cancer services for children and young people","5 - QS55 - Cancer services for children and young people",1,"5 - QS55 - Cancer services for children and young people - Process - 1","The number of people in the denominator receiving a specialist neuro-rehabilitation care package.","The number of children and young people (aged 0–24 years) who have had treatment for a central nervous system malignancy."]
[null,"QS55","Cancer services for children and young people",6,null,"Children and young people (aged 0–24 years) who have been treated for cancer have an end-of-treatment summary and care plan that includes agreed follow-up and monitoring arrangements","Evidence of local arrangements to ensure that children and young people (aged 0–24 years) who have been treated for cancer have an end-of-treatment summary and care plan that includes agreed follow-up and monitoring arrangements.","Structure","QS55 - Cancer services for children and young people","6 - QS55 - Cancer services for children and young people",1,"6 - QS55 - Cancer services for children and young people - Structure - 1","",""]
[null,"QS55","Cancer services for children and young people",6,null,"Children and young people (aged 0–24 years) who have been treated for cancer have an end-of-treatment summary and care plan that includes agreed follow-up and monitoring arrangements","The proportion of children and young people (aged 0–24 years) completing treatment for cancer who have an end-of-treatment summary and care plan.","Process","QS55 - Cancer services for children and young people","6 - QS55 - Cancer services for children and young people",1,"6 - QS55 - Cancer services for children and young people - Process - 1","The number of people in the denominator who have an end-of-treatment summary and care plan.","The number of children and young people (aged 0–24 years) completing treatment for cancer."]
[null,"QS55","Cancer services for children and young people",6,null,"Children and young people (aged 0–24 years) who have been treated for cancer have an end-of-treatment summary and care plan that includes agreed follow-up and monitoring arrangements","The proportion of children and young people (aged 0–24 years) treated for cancer who have their end-of-treatment summary and care plan reviewed 5 years after the end of their initial treatment.","Process","QS55 - Cancer services for children and young people","6 - QS55 - Cancer services for children and young people",2,"6 - QS55 - Cancer services for children and young people - Process - 2","The number of people in the denominator who have their end-of-treatment summary and care plan reviewed 5 years after the end of their initial treatment.","The number of children and young people (aged 0–24 years) treated for cancer with an end-of-treatment summary and care plan."]
[null,"QS55","Cancer services for children and young people",7,null,"Children and young people (aged 0–24 years) with cancer are assessed for potential future fertility problems and advised about their options for fertility preservation before treatment is started.","Evidence of local arrangements to ensure that children and young people (0–24 years) with cancer are assessed for potential future fertility problems and advised about their options for fertility preservation before treatment is started.","Structure","QS55 - Cancer services for children and young people","7 - QS55 - Cancer services for children and young people",1,"7 - QS55 - Cancer services for children and young people - Structure - 1","",""]
[null,"QS55","Cancer services for children and young people",7,null,"Children and young people (aged 0–24 years) with cancer are assessed for potential future fertility problems and advised about their options for fertility preservation before treatment is started.","The proportion of children and young people (aged 0–24 years) with cancer who are assessed for potential future fertility problems and advised about their options for fertility preservation before treatment is started.","Process","QS55 - Cancer services for children and young people","7 - QS55 - Cancer services for children and young people",1,"7 - QS55 - Cancer services for children and young people - Process - 1","The number of people in the denominator who are assessed for potential future fertility problems before treatment and are advised about their options for fertility preservation.","The number of children and young people (aged 0–24 years) diagnosed with cancer."]
[]
[]
[]
[null,"QS56","Spinal metastases and metastatic spinal cord compression",2,null,"Adults with spinal pain suggestive of spinal metastases, but with no neurological symptoms or signs, have an MRI of the whole spine and any necessary treatment plan agreed within 1 week of the suspected diagnosis.","Proportion of adults with spinal pain suggestive of spinal metastases, but with no neurological symptoms or signs, who receive an MRI of the whole spine within 1 week of the suspected diagnosis.","Process","QS56 - Spinal metastases and metastatic spinal cord compression","2 - QS56 - Spinal metastases and metastatic spinal cord compression",1,"2 - QS56 - Spinal metastases and metastatic spinal cord compression - Process - 1","The number of adults in the denominator who receive an MRI of the whole spine within 1 week of presenting with spinal pain suggestive of spinal metastases, but with no neurological symptoms or signs.","The number of adults who present with spinal pain suggestive of spinal metastases, but with no neurological symptoms or signs."]
[null,"QS56","Spinal metastases and metastatic spinal cord compression",2,null,"Adults with spinal pain suggestive of spinal metastases, but with no neurological symptoms or signs, have an MRI of the whole spine and any necessary treatment plan agreed within 1 week of the suspected diagnosis.","Proportion of adults with spinal metastases confirmed by MRI of the whole spine, but with no neurological symptoms or signs, who have a treatment plan agreed within 1 week of the suspected diagnosis.","Process","QS56 - Spinal metastases and metastatic spinal cord compression","2 - QS56 - Spinal metastases and metastatic spinal cord compression",2,"2 - QS56 - Spinal metastases and metastatic spinal cord compression - Process - 2","The number of adults in the denominator who have a treatment plan agreed within 1 week of presenting with spinal pain suggestive of spinal metastases, but with no neurological symptoms or signs.","The number of adults with spinal metastases confirmed by MRI of the whole spine, but with no neurological symptoms or signs."]
[null,"QS56","Spinal metastases and metastatic spinal cord compression",3,null,"Adults with suspected metastatic spinal cord compression (MSCC) who present with neurological symptoms or signs have an MRI of the whole spine within 24 hours of the suspected diagnosis.","Proportion of adults with suspected MSCC who present with neurological symptoms or signs who receive an MRI of the whole spine within 24 hours of the suspected diagnosis.","Process","QS56 - Spinal metastases and metastatic spinal cord compression","3 - QS56 - Spinal metastases and metastatic spinal cord compression",{"$f":"IF(AND(B1226=B1225, D1226=D1225, H1226=H1225)=TRUE, K1225+1, 1)","v":1},{"$f":"CONCATENATE(J1226, \" - \", H1226, \" - \",K1226)","v":"3 - QS56 - Spinal metastases and metastatic spinal cord compression - Process - 1"},"The number of adults in the denominator who receive an MRI of the whole spine within 24 hours of presenting with suspected MSCC and neurological symptoms or signs.","The number of adults with suspected MSCC who present with neurological symptoms or signs."]
[null,"QS56","Spinal metastases and metastatic spinal cord compression",4,null,"Adults with suspected metastatic spinal cord compression (MSCC) who present with neurological symptoms or signs have their diagnostic investigations coordinated by an MSCC coordinator.","Proportion of adults with suspected MSCC who present with neurological symptoms or signs who have an assessment of their requirement for, and urgency of investigations, undertaken by an MSCC coordinator.","Process","QS56 - Spinal metastases and metastatic spinal cord compression","4 - QS56 - Spinal metastases and metastatic spinal cord compression",{"$f":"IF(AND(B1227=B1226, D1227=D1226, H1227=H1226)=TRUE, K1226+1, 1)","v":1},{"$f":"CONCATENATE(J1227, \" - \", H1227, \" - \",K1227)","v":"4 - QS56 - Spinal metastases and metastatic spinal cord compression - Process - 1"},"The number of adults in the denominator who have an assessment of their requirement for, and urgency of, investigations undertaken by an MSCC coordinator.","The number of adults with suspected MSCC who present with neurological symptoms or signs."]
[null,"QS56","Spinal metastases and metastatic spinal cord compression",5,null,"Adults with metastatic spinal cord compression (MSCC) have their ongoing care coordinated by an MSCC coordinator.","Proportion of adults with MSCC whose ongoing care is coordinated by an MSCC coordinator.","Process","QS56 - Spinal metastases and metastatic spinal cord compression","5 - QS56 - Spinal metastases and metastatic spinal cord compression",1,"5 - QS56 - Spinal metastases and metastatic spinal cord compression - Process - 1","The number of adults in the denominator whose ongoing care is coordinated by an MSCC coordinator.","The number of adults with MSCC."]
[null,"QS56","Spinal metastases and metastatic spinal cord compression",6,null,"Adults with MSCC that is not suitable for surgery start radiotherapy within 24 hours of the decision to treat (if appropriate).","Proportion of adults with MSCC that is not suitable for surgery who start radiotherapy within 24 hours of the decision to treat (if appropriate).","Process","QS56 - Spinal metastases and metastatic spinal cord compression","6 - QS56 - Spinal metastases and metastatic spinal cord compression",{"$f":"IF(AND(B1229=B1228, D1229=D1228, H1229=H1228)=TRUE, K1228+1, 1)","v":1},{"$f":"CONCATENATE(J1229, \" - \", H1229, \" - \",K1229)","v":"6 - QS56 - Spinal metastases and metastatic spinal cord compression - Process - 1"},"The number of adults in the denominator who start radiotherapy within 24 hours of the decision to treat.","The number of adults with MSCC that is not suitable for surgery for whom radiotherapy is appropriate."]
[null,"QS56","Spinal metastases and metastatic spinal cord compression",7,null,"Adults with metastatic spinal cord compression (MSCC) have a management plan that includes an assessment of ongoing care and rehabilitation needs.","Proportion of adults with MSCC who are discharged from hospital with a management plan that includes an assessment of ongoing care and rehabilitation needs.","Process","QS56 - Spinal metastases and metastatic spinal cord compression","7 - QS56 - Spinal metastases and metastatic spinal cord compression",{"$f":"IF(AND(B1230=B1229, D1230=D1229, H1230=H1229)=TRUE, K1229+1, 1)","v":1},{"$f":"CONCATENATE(J1230, \" - \", H1230, \" - \",K1230)","v":"7 - QS56 - Spinal metastases and metastatic spinal cord compression - Process - 1"},"The number of adults in the denominator who have a management plan on discharge.","The number of adults with MSCC who are discharged from hospital."]
[null,"QS57","Jaundice in newborn babies under 28 days",1,null,"Parents or carers of newborn babies have a discussion with healthcare professionals and are given written information about neonatal jaundice within 24 hours of the birth, including what to look for and who to contact if they are concerned.","Evidence of local availability of written information about neonatal jaundice for parents or carers of newborn babies.","Structure","QS57 - Jaundice in newborn babies under 28 days","1 - QS57 - Jaundice in newborn babies under 28 days",1,"1 - QS57 - Jaundice in newborn babies under 28 days - Structure - 1","",""]
[null,"QS57","Jaundice in newborn babies under 28 days",1,null,"Parents or carers of newborn babies have a discussion with healthcare professionals and are given written information about neonatal jaundice within 24 hours of the birth, including what to look for and who to contact if they are concerned.","Evidence of local arrangements to ensure telephone access to a relevant healthcare professional for parents or carers who are concerned about neonatal jaundice.","Structure","QS57 - Jaundice in newborn babies under 28 days","1 - QS57 - Jaundice in newborn babies under 28 days",2,"1 - QS57 - Jaundice in newborn babies under 28 days - Structure - 2","",""]
[null,"QS57","Jaundice in newborn babies under 28 days",1,null,"Parents or carers of newborn babies have a discussion with healthcare professionals and are given written information about neonatal jaundice within 24 hours of the birth, including what to look for and who to contact if they are concerned.","Proportion of newborn babies whose parents or carers have a discussion with healthcare professionals and receive written information about neonatal jaundice within 24 hours of the birth, including what to look for and who to contact if they are concerned.","Process","QS57 - Jaundice in newborn babies under 28 days","1 - QS57 - Jaundice in newborn babies under 28 days",1,"1 - QS57 - Jaundice in newborn babies under 28 days - Process - 1","The number of babies in the denominator whose parents or carers have a discussion with healthcare professionals and receive written information about neonatal jaundice within 24 hours of the birth, including what to look for and who to contact if they are concerned.","The number of newborn babies."]
[null,"QS57","Jaundice in newborn babies under 28 days",2,null,"Babies with suspected jaundice who are more than 24 hours old have their bilirubin level measured within 6 hours of a healthcare professional suspecting jaundice or a parent or carer reporting possible jaundice.","Evidence of local protocols and adequate access to bilirubin measurement, to ensure that babies with suspected jaundice who are more than 24 hours old have their bilirubin level measured within 6 hours of a healthcare professional suspecting jaundice or a parent or carer reporting possible jaundice.","Structure","QS57 - Jaundice in newborn babies under 28 days","2 - QS57 - Jaundice in newborn babies under 28 days",1,"2 - QS57 - Jaundice in newborn babies under 28 days - Structure - 1","",""]
[null,"QS57","Jaundice in newborn babies under 28 days",2,null,"Babies with suspected jaundice who are more than 24 hours old have their bilirubin level measured within 6 hours of a healthcare professional suspecting jaundice or a parent or carer reporting possible jaundice.","Proportion of babies with suspected jaundice who are more than 24 hours old who have their bilirubin level measured.","Process","QS57 - Jaundice in newborn babies under 28 days","2 - QS57 - Jaundice in newborn babies under 28 days",1,"2 - QS57 - Jaundice in newborn babies under 28 days - Process - 1","The number of babies in the denominator having their bilirubin level measured.","The number of babies with suspected jaundice who are more than 24 hours old."]
[null,"QS57","Jaundice in newborn babies under 28 days",2,null,"Babies with suspected jaundice who are more than 24 hours old have their bilirubin level measured within 6 hours of a healthcare professional suspecting jaundice or a parent or carer reporting possible jaundice.","Proportion of babies with suspected jaundice who are more than 24 hours old who have their bilirubin level measured within 6 hours of a healthcare professional suspecting jaundice or a parent or carer reporting possible jaundice.","Process","QS57 - Jaundice in newborn babies under 28 days","2 - QS57 - Jaundice in newborn babies under 28 days",2,"2 - QS57 - Jaundice in newborn babies under 28 days - Process - 2","The number of babies in the denominator having their bilirubin level measured within 6 hours of a healthcare professional suspecting jaundice or a parent or carer reporting possible jaundice.","The number of babies with suspected jaundice who are more than 24 hours old who have had their bilirubin measured."]
[null,"QS57","Jaundice in newborn babies under 28 days",3,null,"Babies with hyperbilirubinaemia are started on treatment in accordance with standardised threshold tables or charts.","Evidence of local arrangements to ensure the use of standardised treatment threshold tables or charts when starting treatment for babies with hyperbilirubinaemia.","Structure","QS57 - Jaundice in newborn babies under 28 days","3 - QS57 - Jaundice in newborn babies under 28 days",1,"3 - QS57 - Jaundice in newborn babies under 28 days - Structure - 1","",""]
[null,"QS57","Jaundice in newborn babies under 28 days",3,null,"Babies with hyperbilirubinaemia are started on treatment in accordance with standardised threshold tables or charts.","Proportion of babies identified with hyperbilirubinaemia who are started on treatment in accordance with standardised threshold tables or charts.","Process","QS57 - Jaundice in newborn babies under 28 days","3 - QS57 - Jaundice in newborn babies under 28 days",1,"3 - QS57 - Jaundice in newborn babies under 28 days - Process - 1","The number of babies in the denominator who are started on treatment in accordance with standardised threshold tables or charts.","The number of babies identified with hyperbilirubinaemia."]
[null,"QS57","Jaundice in newborn babies under 28 days",3,null,"Babies with hyperbilirubinaemia are started on treatment in accordance with standardised threshold tables or charts.","Incidence of kernicterus.","Outcome","QS57 - Jaundice in newborn babies under 28 days","3 - QS57 - Jaundice in newborn babies under 28 days",1,"3 - QS57 - Jaundice in newborn babies under 28 days - Outcome - 1"]
[null,"QS58","Sickle cell disease",1,null,"People who present at hospital with an acute painful sickle cell episode have a pain assessment, a clinical assessment and appropriate analgesia within 30 minutes of presentation.","Evidence of local arrangements to ensure that people who present at hospital with an acute painful sickle cell episode have a pain assessment, a clinical assessment and appropriate analgesia within 30 minutes of presentation.","Structure","QS58 - Sickle cell disease","1 - QS58 - Sickle cell disease",1,"1 - QS58 - Sickle cell disease - Structure - 1","",""]
[null,"QS58","Sickle cell disease",1,null,"People who present at hospital with an acute painful sickle cell episode have a pain assessment, a clinical assessment and appropriate analgesia within 30 minutes of presentation.","Proportion of people who present at hospital with an acute painful sickle cell episode and have a pain assessment, a clinical assessment and appropriate analgesia within 30 minutes of presentation.","Process","QS58 - Sickle cell disease",{"$f":"CONCATENATE(D1241, \" - \", I1241)","v":"1 - QS58 - Sickle cell disease"},{"$f":"IF(AND(B1241=B1240, D1241=D1240, H1241=H1240)=TRUE, K1240+1, 1)","v":1},{"$f":"CONCATENATE(J1241, \" - \", H1241, \" - \",K1241)","v":"1 - QS58 - Sickle cell disease - Process - 1"},"The number of people in the denominator who have a pain assessment, a clinical assessment and appropriate analgesia within 30 minutes of presentation.","The number of people who present at hospital with an acute painful sickle cell episode."]
[null,"QS58","Sickle cell disease",1,null,"People who present at hospital with an acute painful sickle cell episode have a pain assessment, a clinical assessment and appropriate analgesia within 30 minutes of presentation.","Proportion of people who present at hospital with an acute painful sickle cell episode who have their pain assessed using an age-appropriate pain scoring tool.","Process","QS58 - Sickle cell disease","1 - QS58 - Sickle cell disease",2,"1 - QS58 - Sickle cell disease - Process - 2","The number of people in the denominator who have their pain assessed using an age-appropriate pain scoring tool.","The number of people who present at hospital with an acute painful sickle cell episode."]
[null,"QS58","Sickle cell disease",2,null,"People with an acute painful sickle cell episode have an assessment of pain relief every 30 minutes until satisfactory pain relief has been achieved and then at least every 4 hours.","Evidence of local arrangements to ensure that people with an acute painful sickle cell episode have their pain relief reassessed every 30 minutes until satisfactory pain relief has been achieved and then at least every 4 hours.","Structure","QS58 - Sickle cell disease","2 - QS58 - Sickle cell disease",1,"2 - QS58 - Sickle cell disease - Structure - 1","",""]
[null,"QS58","Sickle cell disease",2,null,"People with an acute painful sickle cell episode have an assessment of pain relief every 30 minutes until satisfactory pain relief has been achieved and then at least every 4 hours.","Proportion of people with an acute painful sickle cell episode who have their pain relief reassessed every 30 minutes after pain relief is started until satisfactory pain relief has been achieved.","Process","QS58 - Sickle cell disease","2 - QS58 - Sickle cell disease",1,"2 - QS58 - Sickle cell disease - Process - 1","The number of people in the denominator who have their pain relief reassessed every 30 minutes after pain relief is started until satisfactory pain relief has been achieved.","The number of people with an acute painful sickle cell episode."]
[null,"QS58","Sickle cell disease",2,null,"People with an acute painful sickle cell episode have an assessment of pain relief every 30 minutes until satisfactory pain relief has been achieved and then at least every 4 hours.","Proportion of people with an acute painful sickle cell episode who have achieved satisfactory pain relief who have their pain relief assessed at least every 4 hours until discharge or the end of the episode.","Process","QS58 - Sickle cell disease","2 - QS58 - Sickle cell disease",2,"2 - QS58 - Sickle cell disease - Process - 2","The number of people in the denominator who have their pain relief assessed at least every 4 hours until discharge or the end of the episode.","The number of people with an acute painful sickle cell episode who have achieved satisfactory pain relief."]
[null,"QS58","Sickle cell disease",2,null,"People with an acute painful sickle cell episode have an assessment of pain relief every 30 minutes until satisfactory pain relief has been achieved and then at least every 4 hours.","Proportion of people with an acute painful sickle cell episode who have their pain relief reassessed using an age-appropriate pain scoring tool.","Process",{"$f":"CONCATENATE(B1246, \" - \", C1246)","v":"QS58 - Sickle cell disease"},"2 - QS58 - Sickle cell disease",3,"2 - QS58 - Sickle cell disease - Process - 3","The number of people in the denominator who have their pain relief reassessed using an age-appropriate pain scoring tool.","The number of people with an acute painful sickle cell episode."]
[null,"QS58","Sickle cell disease",3,null,"People with an acute painful sickle cell episode who are taking strong opioids are monitored for adverse events every hour for the first 6 hours after first administration or step up of pain relief and then at least every 4 hours.","Evidence of local arrangements to ensure that people with an acute painful sickle cell episode who are taking strong opioids have monitoring for adverse events every hour for the first 6 hours after first administration or step up of pain relief and then at least every 4 hours.","Structure","QS58 - Sickle cell disease","3 - QS58 - Sickle cell disease",1,"3 - QS58 - Sickle cell disease - Structure - 1","",""]
[null,"QS58","Sickle cell disease",3,null,"People with an acute painful sickle cell episode who are taking strong opioids are monitored for adverse events every hour for the first 6 hours after first administration or step up of pain relief and then at least every 4 hours.","Proportion of people with an acute painful sickle cell episode taking strong opioids who are monitored for adverse events every hour for the first 6 hours after first administration or step up of pain relief.","Process","QS58 - Sickle cell disease","3 - QS58 - Sickle cell disease",1,"3 - QS58 - Sickle cell disease - Process - 1","The number of people in the denominator who are monitored for adverse events every hour for the first 6 hours after first administration or step up of pain relief.","The number of people with an acute painful sickle cell episode taking strong opioids."]
[null,"QS58","Sickle cell disease",3,null,"People with an acute painful sickle cell episode who are taking strong opioids are monitored for adverse events every hour for the first 6 hours after first administration or step up of pain relief and then at least every 4 hours.","Proportion of people with an acute painful sickle cell episode taking strong opioids who have had hourly monitoring for adverse events for the first 6 hours after first administration or step up of pain relief and who are then monitored for adverse events at least every 4 hours until discharge or the end of the episode.","Process","QS58 - Sickle cell disease","3 - QS58 - Sickle cell disease",2,"3 - QS58 - Sickle cell disease - Process - 2","The number of people in the denominator who are monitored for adverse events at least every 4 hours until discharge or the end of the episode.","The number of people with an acute painful sickle cell episode taking strong opioids who have had hourly monitoring for adverse events for 6 hours following first administration or step up of pain relief."]
[null,"QS58","Sickle cell disease",4,null,"People with an acute painful sickle cell episode are assessed for acute chest syndrome if they have 1 or more of the following: abnormal respiratory signs or symptoms, chest pain, fever, or signs and symptoms of hypoxia.","Evidence of local arrangements to ensure that healthcare professionals caring for people with an acute painful sickle cell episode are aware of acute chest syndrome as a potential complication","Structure","QS58 - Sickle cell disease","4 - QS58 - Sickle cell disease",1,"4 - QS58 - Sickle cell disease - Structure - 1","",""]
[null,"QS58","Sickle cell disease",4,null,"People with an acute painful sickle cell episode are assessed for acute chest syndrome if they have 1 or more of the following: abnormal respiratory signs or symptoms, chest pain, fever, or signs and symptoms of hypoxia.","Evidence of local arrangements to ensure that people with an acute painful sickle cell episode are assessed for acute chest syndrome if they have 1 or more of the following: abnormal respiratory signs or symptoms, chest pain, fever, or signs and symptoms of hypoxia.","Structure","QS58 - Sickle cell disease","4 - QS58 - Sickle cell disease",2,"4 - QS58 - Sickle cell disease - Structure - 2","",""]
[null,"QS58","Sickle cell disease",4,null,"People with an acute painful sickle cell episode are assessed for acute chest syndrome if they have 1 or more of the following: abnormal respiratory signs or symptoms, chest pain, fever, or signs and symptoms of hypoxia.","Proportion of people with an acute painful sickle cell episode with 1 or more of the following: abnormal respiratory signs or symptoms, chest pain, fever, or signs and symptoms of hypoxia who are assessed for acute chest syndrome.","Process","QS58 - Sickle cell disease","4 - QS58 - Sickle cell disease",1,"4 - QS58 - Sickle cell disease - Process - 1","The number of people in the denominator who are assessed for acute chest syndrome.","The number of people with an acute painful sickle cell episode who have 1 or more of the following: abnormal respiratory signs or symptoms, chest pain, fever, or signs and symptoms of hypoxia."]
[null,"QS58","Sickle cell disease",5,null,"Healthcare professionals who care for people with an acute painful sickle cell episode have access to locally agreed protocols on treatment and management and specialist support from designated centres.","Evidence of local arrangements to ensure that all healthcare professionals who care for people with an acute painful sickle cell episode have access to specialist support from designated centres.","Structure","QS58 - Sickle cell disease","5 - QS58 - Sickle cell disease",1,"5 - QS58 - Sickle cell disease - Structure - 1","",""]
[null,"QS58","Sickle cell disease",5,null,"Healthcare professionals who care for people with an acute painful sickle cell episode have access to locally agreed protocols on treatment and management and specialist support from designated centres.","Evidence of local arrangements to ensure that locally agreed protocols on how to treat and manage acute painful sickle cell episodes are available and reviewed regularly.","Structure","QS58 - Sickle cell disease","5 - QS58 - Sickle cell disease",2,"5 - QS58 - Sickle cell disease - Structure - 2","",""]
[null,"QS58","Sickle cell disease",5,null,"Healthcare professionals who care for people with an acute painful sickle cell episode have access to locally agreed protocols on treatment and management and specialist support from designated centres.","Staff awareness of how to access locally agreed protocols for treatment and management of acute painful sickle cell episodes.","Outcome","QS58 - Sickle cell disease","5 - QS58 - Sickle cell disease",1,"5 - QS58 - Sickle cell disease - Outcome - 1"]
[null,"QS58","Sickle cell disease",5,null,"Healthcare professionals who care for people with an acute painful sickle cell episode have access to locally agreed protocols on treatment and management and specialist support from designated centres.","Staff awareness of how to access specialist support from their designated specialist centre.","Outcome","QS58 - Sickle cell disease","5 - QS58 - Sickle cell disease",2,"5 - QS58 - Sickle cell disease - Outcome - 2"]
[null,"QS58","Sickle cell disease",6,null,"People with an acute painful sickle cell episode are given information before discharge on how to continue to manage their current episode.","Evidence of local arrangements to ensure that people with an acute painful sickle cell episode are given information before discharge on how to continue to manage their current episode.","Structure","QS58 - Sickle cell disease","6 - QS58 - Sickle cell disease",1,"6 - QS58 - Sickle cell disease - Structure - 1","",""]
[null,"QS58","Sickle cell disease",6,null,"People with an acute painful sickle cell episode are given information before discharge on how to continue to manage their current episode.","Proportion of people with an acute painful sickle cell episode (or their parents or carers if appropriate) who are given information before discharge on how to continue to manage their current episode.","Process","QS58 - Sickle cell disease","6 - QS58 - Sickle cell disease",1,"6 - QS58 - Sickle cell disease - Process - 1","The number of people in the denominator (or parents or carers if appropriate) who are given information on how to continue to manage their current episode.","The number of people with an acute painful sickle cell episode who are discharged from hospital."]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",1,null,"Children aged 3 to 7 years attending school classes where a high proportion of children are identified as at risk of developing a conduct disorder take part in a classroom-based emotional learning and problem-solving programme.","Evidence of local arrangements for health and social care practitioners, managers and commissioners to work with colleagues in the education sector to design local pathways that include provision of classroom-based interventions for children at risk of developing a conduct disorder.","Structure","QS59 - Antisocial behaviour and conduct disorders in children and young people ","1 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",1,"1 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Structure - 1","",""]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",1,null,"Children aged 3 to 7 years attending school classes where a high proportion of children are identified as at risk of developing a conduct disorder take part in a classroom-based emotional learning and problem-solving programme.","Evidence of local arrangements to ensure that children aged 3 to 7 years in classroom populations that have a high proportion of children identified to be at risk of developing a conduct disorder are offered a classroom-based emotional learning and problem-solving programme.","Structure","QS59 - Antisocial behaviour and conduct disorders in children and young people ","1 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",2,"1 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Structure - 2","",""]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",1,null,"Children aged 3 to 7 years attending school classes where a high proportion of children are identified as at risk of developing a conduct disorder take part in a classroom-based emotional learning and problem-solving programme.","Evidence of locally agreed protocols for the identification of school classes where a high proportion of children are at risk of developing a conduct disorder, by individuals or groups with relevant expertise in antisocial behaviour and conduct disorders in children.","Structure","QS59 - Antisocial behaviour and conduct disorders in children and young people ","1 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",3,"1 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Structure - 3","",""]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",1,null,"Children aged 3 to 7 years attending school classes where a high proportion of children are identified as at risk of developing a conduct disorder take part in a classroom-based emotional learning and problem-solving programme.","Proportion of school classes (for children aged 3 to 7 years) where a high proportion of children are identified to be at risk of developing a conduct disorder that receive a classroom-based emotional learning and problem-solving programme.","Process","QS59 - Antisocial behaviour and conduct disorders in children and young people ","1 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",1,"1 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Process - 1","The number of school classes in the denominator that receive a classroom-based emotional learning and problem-solving programme.","The number of school classes (for children aged 3 to 7 years) that have a high proportion of children identified as at risk of developing a conduct disorder."]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",1,null,"Children aged 3 to 7 years attending school classes where a high proportion of children are identified as at risk of developing a conduct disorder take part in a classroom-based emotional learning and problem-solving programme.","Rates of antisocial behaviour within a classroom population.","Outcome","QS59 - Antisocial behaviour and conduct disorders in children and young people ","1 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",1,"1 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Outcome - 1"]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",2,null,"Children and young people with a suspected conduct disorder and any significant complicating factors have a comprehensive assessment, including an assessment of the child or young person's parents or carers.","Evidence of local arrangements to ensure that children and young people with a suspected conduct disorder and any significant complicating factors have a comprehensive assessment, including an assessment of their parents or carers.","Structure","QS59 - Antisocial behaviour and conduct disorders in children and young people ","2 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",1,"2 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Structure - 1","",""]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",2,null,"Children and young people with a suspected conduct disorder and any significant complicating factors have a comprehensive assessment, including an assessment of the child or young person's parents or carers.","The proportion of children and young people with a suspected conduct disorder and any significant complicating factors who have a comprehensive assessment.","Process","QS59 - Antisocial behaviour and conduct disorders in children and young people ","2 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",1,"2 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Process - 1","The number of children and young people in the denominator who have a comprehensive assessment.","The number of children and young people with a suspected conduct disorder and any significant complicating factors."]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",2,null,"Children and young people with a suspected conduct disorder and any significant complicating factors have a comprehensive assessment, including an assessment of the child or young person's parents or carers.","The proportion of parents or carers of children and young people with a suspected conduct disorder and any significant complicating factors who have a comprehensive assessment.","Process","QS59 - Antisocial behaviour and conduct disorders in children and young people ","2 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",2,"2 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Process - 2","The number of parents or carers in the denominator who have a comprehensive assessment.","The number of parents or carers of children and young people with a suspected conduct disorder and any significant complicating factors."]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",3,null,"Children and young people with a conduct disorder who have been referred for treatment and support have a key worker to oversee their care and facilitate engagement with services.","Evidence of local arrangements to ensure that children and young people with a conduct disorder who have been referred for treatment and support have a key worker to oversee their care and facilitate engagement with services.","Structure","QS59 - Antisocial behaviour and conduct disorders in children and young people ","3 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",1,"3 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Structure - 1","",""]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",3,null,"Children and young people with a conduct disorder who have been referred for treatment and support have a key worker to oversee their care and facilitate engagement with services.","Proportion of children and young people with a conduct disorder referred for treatment and support who have a key worker.","Process","QS59 - Antisocial behaviour and conduct disorders in children and young people ","3 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",1,"3 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Process - 1","The number of children and young people in the denominator who have a key worker.","The number of children and young people with a conduct disorder who have been referred for treatment and support."]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",3,null,"Children and young people with a conduct disorder who have been referred for treatment and support have a key worker to oversee their care and facilitate engagement with services.","'Did not attend' rates for children and young people with conduct disorders and their families","Outcome","QS59 - Antisocial behaviour and conduct disorders in children and young people ","3 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",1,"3 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Outcome - 1"]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",3,null,"Children and young people with a conduct disorder who have been referred for treatment and support have a key worker to oversee their care and facilitate engagement with services.","Treatment completion rates.","Outcome","QS59 - Antisocial behaviour and conduct disorders in children and young people ","3 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",2,"3 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Outcome - 2"]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",3,null,"Children and young people with a conduct disorder who have been referred for treatment and support have a key worker to oversee their care and facilitate engagement with services.","Treatment uptake rates.","Outcome","QS59 - Antisocial behaviour and conduct disorders in children and young people ","3 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",3,"3 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Outcome - 3"]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",4,null,"Parents or carers of children with a conduct disorder aged 3 to 11 years are offered a referral for group or individual parent or carer training programmes.","Evidence of local arrangements to ensure that parents or carers of children with a conduct disorder aged 3 to 11 years are offered a referral for group or individual parent or carer training programmes.","Structure","QS59 - Antisocial behaviour and conduct disorders in children and young people ","4 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",1,"4 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Structure - 1","",""]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",4,null,"Parents or carers of children with a conduct disorder aged 3 to 11 years are offered a referral for group or individual parent or carer training programmes.","Proportion of parents or carers of children with a conduct disorder aged 3 to 11 years who are offered a referral for a group or individual parent or carer training programme.","Process","QS59 - Antisocial behaviour and conduct disorders in children and young people ","4 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",1,"4 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Process - 1","The number of parents or carers in the denominator who are offered a referral for a group or individual parent or carer training programme.","The number of parents or carers of children with a conduct disorder aged 3 to 11 years."]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",4,null,"Parents or carers of children with a conduct disorder aged 3 to 11 years are offered a referral for group or individual parent or carer training programmes.","Proportion of parents or carers of children with a conduct disorder aged 3 to 11 years who attend a group or individual parent or carer training programme.","Process","QS59 - Antisocial behaviour and conduct disorders in children and young people ","4 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",2,"4 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Process - 2","The number of parents or carers in the denominator who attend a group or individual parent or carer training programme.","The number of parents or carers of children with a conduct disorder aged 3 to 11 years."]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",4,null,"Parents or carers of children with a conduct disorder aged 3 to 11 years are offered a referral for group or individual parent or carer training programmes.","Proportion of parents or carers of children with a conduct disorder aged 3 to 11 years who complete a group or individual parent or carer training programme.","Process","QS59 - Antisocial behaviour and conduct disorders in children and young people ","4 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",3,"4 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Process - 3","The number of parents or carers in the denominator who complete a group or individual parent or carer training programme.","The number of parents or carers of children with a conduct disorder aged 3 to 11 years."]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",5,null,"Children and young people aged 11 to 17 years who have a conduct disorder are offered a referral for multimodal interventions, with the involvement of their parents or carers.","Evidence of local arrangements to ensure that children and young people aged 11 to 17 years who have a conduct disorder are referred for multimodal interventions, which involve their parents or carers.","Structure","QS59 - Antisocial behaviour and conduct disorders in children and young people ","5 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",1,"5 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Structure - 1","",""]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",5,null,"Children and young people aged 11 to 17 years who have a conduct disorder are offered a referral for multimodal interventions, with the involvement of their parents or carers.","Proportion of children and young people aged 11 to 17 years who have a conduct disorder who take part in multimodal interventions.","Process","QS59 - Antisocial behaviour and conduct disorders in children and young people ","5 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",1,"5 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Process - 1","The number of children and young people in the denominator who take part in multimodal interventions.","The number of children and young people aged 11 to 17 years who have a conduct disorder."]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",5,null,"Children and young people aged 11 to 17 years who have a conduct disorder are offered a referral for multimodal interventions, with the involvement of their parents or carers.","Proportion of parents or carers of children and young people aged 11 to 17 years who have a conduct disorder who are involved in multimodal interventions.","Process","QS59 - Antisocial behaviour and conduct disorders in children and young people ","5 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",2,"5 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Process - 2","The number of parents or carers in the denominator who are involved in multimodal interventions.","The number of parents or carers of children and young people aged 11 to 17 years who have a conduct disorder."]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",6,null,"Children and young people with a conduct disorder and severely aggressive behaviour who have been prescribed risperidone have a baseline physical and metabolic investigation and are monitored for efficacy and adverse effects at regular intervals.","Evidence of local arrangements to ensure that children and young people with a conduct disorder and severely aggressive behaviour who have been prescribed risperidone have a baseline physical and metabolic investigation and are monitored for efficacy and adverse effects at regular intervals","Structure","QS59 - Antisocial behaviour and conduct disorders in children and young people ","6 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",1,"6 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Structure - 1","",""]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",6,null,"Children and young people with a conduct disorder and severely aggressive behaviour who have been prescribed risperidone have a baseline physical and metabolic investigation and are monitored for efficacy and adverse effects at regular intervals.","The proportion of children and young people with a conduct disorder and severely aggressive behaviour who have been prescribed risperidone who have a baseline physical and metabolic investigation carried out and recorded before the start of treatment.","Process","QS59 - Antisocial behaviour and conduct disorders in children and young people ","6 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",1,"6 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Process - 1","The number of children and young people in the denominator who have a baseline physical and metabolic investigation carried out and recorded before the start of treatment.","The number of children and young people with a conduct disorder and severely aggressive behaviour who have been prescribed risperidone."]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",6,null,"Children and young people with a conduct disorder and severely aggressive behaviour who have been prescribed risperidone have a baseline physical and metabolic investigation and are monitored for efficacy and adverse effects at regular intervals.","The proportion of children and young people with a conduct disorder and severely aggressive behaviour who are taking risperidone who have physical and metabolic investigations repeated and recorded at regular intervals.","Process","QS59 - Antisocial behaviour and conduct disorders in children and young people ","6 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",2,"6 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Process - 2","The number of children and young people in the denominator who have physical and metabolic investigations repeated and recorded at regular intervals.","The number of children and young people with a conduct disorder and severely aggressive behaviour who are taking risperidone."]
[null,"QS59","Antisocial behaviour and conduct disorders in children and young people ",6,null,"Children and young people with a conduct disorder and severely aggressive behaviour who have been prescribed risperidone have a baseline physical and metabolic investigation and are monitored for efficacy and adverse effects at regular intervals.","The proportion of children and young people with a conduct disorder and severely aggressive behaviour who are taking risperidone who have changes in their symptoms and behaviour monitored and recorded at regular intervals.","Process","QS59 - Antisocial behaviour and conduct disorders in children and young people ","6 - QS59 - Antisocial behaviour and conduct disorders in children and young people ",3,"6 - QS59 - Antisocial behaviour and conduct disorders in children and young people  - Process - 3","The number of children and young people in the denominator who have changes in their symptoms and behaviour monitored and recorded at regular intervals.","The number of children and young people with a conduct disorder and severely aggressive behaviour who are taking risperidone."]
[null,"QS60","Inducing labour ",1,null,"Women who are being offered induction of labour are given personalised information about the benefits and risks for them and their babies, and the alternatives to induction.","Evidence of local arrangements to ensure that women who are offered induction of labour are provided with personalised information about the benefits and risks for them and their babies, and the alternatives to induction.","Structure","QS60 - Inducing labour ","1 - QS60 - Inducing labour ",1,"1 - QS60 - Inducing labour  - Structure - 1","",""]
[null,"QS60","Inducing labour ",1,null,"Women who are being offered induction of labour are given personalised information about the benefits and risks for them and their babies, and the alternatives to induction.","Proportion of women who are offered induction of labour who receive personalised information about the benefits and risks for them and their babies, and the alternatives to induction.","Process","QS60 - Inducing labour ","1 - QS60 - Inducing labour ",1,"1 - QS60 - Inducing labour  - Process - 1","The number of women in the denominator who received personalised information about the benefits and risks for them and their babies, and the alternatives to induction.","The number of women who are offered induction of labour."]
[null,"QS60","Inducing labour ",1,null,"Women who are being offered induction of labour are given personalised information about the benefits and risks for them and their babies, and the alternatives to induction.","Women who are offered induction of labour feel that they were given sufficient information to enable them to choose to have their labour induced.","Outcome","QS60 - Inducing labour ","1 - QS60 - Inducing labour ",1,"1 - QS60 - Inducing labour  - Outcome - 1"]
[null,"QS60","Inducing labour ",2,null,"Women only have their labour induced as outpatients if safety and support procedures are in place.","Evidence of local arrangements to ensure that women who have their labour induced as outpatients are induced with safety and support procedures in place.","Structure","QS60 - Inducing labour ","2 - QS60 - Inducing labour ",1,"2 - QS60 - Inducing labour  - Structure - 1","",""]
[null,"QS60","Inducing labour ",2,null,"Women only have their labour induced as outpatients if safety and support procedures are in place.","Proportion of women who are induced as outpatients who are monitored for a period of time before they go home.","Process","QS60 - Inducing labour ","2 - QS60 - Inducing labour ",1,"2 - QS60 - Inducing labour  - Process - 1","The number of women in the denominator who are monitored for a period of time before they go home.","The number of women who are induced as outpatients."]
[null,"QS60","Inducing labour ",2,null,"Women only have their labour induced as outpatients if safety and support procedures are in place.","Proportion of women who are induced as outpatients who are given information on when to contact their midwife, maternity unit or obstetrician.","Process","QS60 - Inducing labour ","2 - QS60 - Inducing labour ",2,"2 - QS60 - Inducing labour  - Process - 2","The number in the denominator who are given information on when to contact their midwife, maternity unit or obstetrician.","The number of women who are induced as outpatients."]
[null,"QS60","Inducing labour ",2,null,"Women only have their labour induced as outpatients if safety and support procedures are in place.","Maternal safety.","Outcome","QS60 - Inducing labour ","2 - QS60 - Inducing labour ",1,"2 - QS60 - Inducing labour  - Outcome - 1"]
[null,"QS60","Inducing labour ",2,null,"Women only have their labour induced as outpatients if safety and support procedures are in place.","Newborn safety.","Outcome","QS60 - Inducing labour ","2 - QS60 - Inducing labour ",2,"2 - QS60 - Inducing labour  - Outcome - 2"]
[null,"QS60","Inducing labour ",3,null,"Women who have their labour induced have access to pain relief that is appropriate to their level of pain and to the type of pain relief they request.","Evidence of local arrangements for women who have their labour induced to have access to pain relief that is appropriate to their level of pain and to the type of pain relief they request.","Structure","QS60 - Inducing labour ","3 - QS60 - Inducing labour ",1,"3 - QS60 - Inducing labour  - Structure - 1","",""]
[null,"QS60","Inducing labour ",3,null,"Women who have their labour induced have access to pain relief that is appropriate to their level of pain and to the type of pain relief they request.","Women who had induction of labour are satisfied that the pain relief they received was appropriate to their level of pain and to the type of pain relief they requested.","Outcome","QS60 - Inducing labour ","3 - QS60 - Inducing labour ",1,"3 - QS60 - Inducing labour  - Outcome - 1"]
[null,"QS60","Inducing labour ",4,null,"Pregnant women discuss the option of vaginal examination for membrane sweeping at their antenatal appointments after 39 weeks of pregnancy.","Evidence of local arrangements to ensure that pregnant women discuss the option of vaginal examination for membrane sweeping at their antenatal appointments after 39 weeks of pregnancy.","Structure",{"$f":"CONCATENATE(B1293, \" - \", C1293)","v":"QS60 - Inducing labour "},{"$f":"CONCATENATE(D1293, \" - \", I1293)","v":"4 - QS60 - Inducing labour "},{"$f":"IF(AND(B1293=B1292, D1293=D1292, H1293=H1292)=TRUE, K1292+1, 1)","v":1},{"$f":"CONCATENATE(J1293, \" - \", H1293, \" - \",K1293)","v":"4 - QS60 - Inducing labour  - Structure - 1"}]
[null,"QS60","Inducing labour ",4,null,"Pregnant women discuss the option of vaginal examination for membrane sweeping at their antenatal appointments after 39 weeks of pregnancy.","Proportion of pregnant women attending an antenatal appointment after 39 weeks of pregnancy who discuss the option of vaginal examination for membrane sweeping.","Process","QS60 - Inducing labour ","4 - QS60 - Inducing labour ",1,"4 - QS60 - Inducing labour  - Process - 1","The number in the denominator who discuss the option of vaginal examination for membrane sweeping.","The number of pregnant women attending an antenatal appointment after 39 weeks of pregnancy."]
[null,"QS60","Inducing labour ",4,null,"Pregnant women discuss the option of vaginal examination for membrane sweeping at their antenatal appointments after 39 weeks of pregnancy.","Rates of induction of labour for women with prolonged pregnancy.","Outcome","QS60 - Inducing labour ","4 - QS60 - Inducing labour ",1,"4 - QS60 - Inducing labour  - Outcome - 1"]
[null,"QS60","Inducing labour ",4,null,"Pregnant women discuss the option of vaginal examination for membrane sweeping at their antenatal appointments after 39 weeks of pregnancy.","Mode of delivery for women with prolonged pregnancy including: spontaneous vaginal birth, instrumental vaginal birth, elective or emergency caesarean section.","Outcome","QS60 - Inducing labour ","4 - QS60 - Inducing labour ",2,"4 - QS60 - Inducing labour  - Outcome - 2"]
[null,"QS60","Inducing labour ",4,null,"Pregnant women discuss the option of vaginal examination for membrane sweeping at their antenatal appointments after 39 weeks of pregnancy.","Rates of stillbirth beyond 40 weeks' gestation (where there is no underlying medical cause).","Outcome","QS60 - Inducing labour ","4 - QS60 - Inducing labour ",3,"4 - QS60 - Inducing labour  - Outcome - 3"]
[null,"QS61","Infection prevention and control ",1,null,"People are prescribed antibiotics in accordance with local antibiotic formularies as part of antimicrobial stewardship.","Evidence of local antibiotic formularies governing the use of antibiotics to ensure that people are prescribed antibiotics appropriately.","Structure","QS61 - Infection prevention and control ","1 - QS61 - Infection prevention and control ",1,"1 - QS61 - Infection prevention and control  - Structure - 1","",""]
[null,"QS61","Infection prevention and control ",1,null,"People are prescribed antibiotics in accordance with local antibiotic formularies as part of antimicrobial stewardship.","Evidence of local audits of the appropriateness of antibiotic prescribing.","Structure","QS61 - Infection prevention and control ","1 - QS61 - Infection prevention and control ",2,"1 - QS61 - Infection prevention and control  - Structure - 2","",""]
[null,"QS61","Infection prevention and control ",1,null,"People are prescribed antibiotics in accordance with local antibiotic formularies as part of antimicrobial stewardship.","Evidence that local antibiotic formularies are reviewed regularly.","Structure","QS61 - Infection prevention and control ","1 - QS61 - Infection prevention and control ",3,"1 - QS61 - Infection prevention and control  - Structure - 3","",""]
[null,"QS61","Infection prevention and control ",1,null,"People are prescribed antibiotics in accordance with local antibiotic formularies as part of antimicrobial stewardship.","Antibiotic prescribing rates (primary and secondary care).","Outcome","QS61 - Infection prevention and control ","1 - QS61 - Infection prevention and control ",1,"1 - QS61 - Infection prevention and control  - Outcome - 1"]
[null,"QS61","Infection prevention and control ",2,null,"Organisations that provide healthcare have a strategy for continuous improvement in infection prevention and control, including accountable leadership, multi-agency working and the use of surveillance systems.","Evidence of an adequately resourced surveillance system with specific, locally defined objectives and priorities for preventing and managing healthcare-associated infections","Structure","QS61 - Infection prevention and control ","2 - QS61 - Infection prevention and control ",1,"2 - QS61 - Infection prevention and control  - Structure - 1","",""]
[null,"QS61","Infection prevention and control ",2,null,"Organisations that provide healthcare have a strategy for continuous improvement in infection prevention and control, including accountable leadership, multi-agency working and the use of surveillance systems.","Evidence of support for, and participation in, joint working initiatives beyond mandatory or contractual requirements, to reduce healthcare-associated infections locally.","Structure","QS61 - Infection prevention and control ","2 - QS61 - Infection prevention and control ",2,"2 - QS61 - Infection prevention and control  - Structure - 2","",""]
[null,"QS61","Infection prevention and control ",2,null,"Organisations that provide healthcare have a strategy for continuous improvement in infection prevention and control, including accountable leadership, multi-agency working and the use of surveillance systems.","Evidence that a lead for infection prevention and control has been assigned and is taking an active role.","Structure","QS61 - Infection prevention and control ","2 - QS61 - Infection prevention and control ",3,"2 - QS61 - Infection prevention and control  - Structure - 3","",""]
[null,"QS61","Infection prevention and control ",2,null,"Organisations that provide healthcare have a strategy for continuous improvement in infection prevention and control, including accountable leadership, multi-agency working and the use of surveillance systems.","Evidence that the organisation includes infection prevention and control within its overall strategy.","Structure","QS61 - Infection prevention and control ","2 - QS61 - Infection prevention and control ",4,"2 - QS61 - Infection prevention and control  - Structure - 4","",""]
[null,"QS61","Infection prevention and control ",2,null,"Organisations that provide healthcare have a strategy for continuous improvement in infection prevention and control, including accountable leadership, multi-agency working and the use of surveillance systems.","Evidence that the organisation’s board is up to date with, and has a working knowledge and understanding of, infection prevention and control.","Structure","QS61 - Infection prevention and control ","2 - QS61 - Infection prevention and control ",5,"2 - QS61 - Infection prevention and control  - Structure - 5","",""]
[null,"QS61","Infection prevention and control ",2,null,"Organisations that provide healthcare have a strategy for continuous improvement in infection prevention and control, including accountable leadership, multi-agency working and the use of surveillance systems.","Incidence of healthcare-associated infection.","Outcome","QS61 - Infection prevention and control ","2 - QS61 - Infection prevention and control ",1,"2 - QS61 - Infection prevention and control  - Outcome - 1"]
[null,"QS61","Infection prevention and control ",3,null,"People receive healthcare from healthcare workers who decontaminate their hands immediately before and after every episode of direct contact or care.","Evidence of local arrangements to ensure that all healthcare workers receive training in hand decontamination.","Structure","QS61 - Infection prevention and control ","3 - QS61 - Infection prevention and control ",1,"3 - QS61 - Infection prevention and control  - Structure - 1","",""]
[null,"QS61","Infection prevention and control ",3,null,"People receive healthcare from healthcare workers who decontaminate their hands immediately before and after every episode of direct contact or care.","Evidence of local arrangements to ensure that regular local hand hygiene observation audits are undertaken.","Structure","QS61 - Infection prevention and control ",{"$f":"CONCATENATE(D1309, \" - \", I1309)","v":"3 - QS61 - Infection prevention and control "},{"$f":"IF(AND(B1309=B1308, D1309=D1308, H1309=H1308)=TRUE, K1308+1, 1)","v":2},{"$f":"CONCATENATE(J1309, \" - \", H1309, \" - \",K1309)","v":"3 - QS61 - Infection prevention and control  - Structure - 2"},"",""]
[null,"QS61","Infection prevention and control ",3,null,"People receive healthcare from healthcare workers who decontaminate their hands immediately before and after every episode of direct contact or care.","Evidence of local arrangements to ensure the availability of facilities for hand decontamination.","Structure","QS61 - Infection prevention and control ","3 - QS61 - Infection prevention and control ",3,"3 - QS61 - Infection prevention and control  - Structure - 3","",""]
[null,"QS61","Infection prevention and control ",3,null,"People receive healthcare from healthcare workers who decontaminate their hands immediately before and after every episode of direct contact or care.","Incidence of healthcare-associated infection.","Outcome","QS61 - Infection prevention and control ","3 - QS61 - Infection prevention and control ",1,"3 - QS61 - Infection prevention and control  - Outcome - 1"]
[null,"QS61","Infection prevention and control ",4,null,"People who need a urinary catheter have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the catheter and its removal as soon as it is no longer needed.","Evidence of a written protocol to ensure that people who need a urinary catheter have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the catheter and its removal as soon as it is no longer needed.","Structure","QS61 - Infection prevention and control ","4 - QS61 - Infection prevention and control ",1,"4 - QS61 - Infection prevention and control  - Structure - 1","",""]
[null,"QS61","Infection prevention and control ",4,null,"People who need a urinary catheter have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the catheter and its removal as soon as it is no longer needed.","Proportion of people with a short-term urinary catheter who had their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the catheter and its removal as soon as it is no longer needed.","Process","QS61 - Infection prevention and control ","4 - QS61 - Infection prevention and control ",1,"4 - QS61 - Infection prevention and control  - Process - 1","The number of people in the denominator for whom all of the specified procedures were completed for the safe insertion and maintenance of the catheter and its removal as soon as it is no longer needed.","The number of people who have had a short-term urinary catheter."]
[null,"QS61","Infection prevention and control ",4,null,"People who need a urinary catheter have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the catheter and its removal as soon as it is no longer needed.","Proportion of people with a long-term urinary catheter who had their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the catheter and its removal as soon as it is no longer needed.","Process",{"$f":"CONCATENATE(B1314, \" - \", C1314)","v":"QS61 - Infection prevention and control "},"4 - QS61 - Infection prevention and control ",2,"4 - QS61 - Infection prevention and control  - Process - 2","The number of people in the denominator for whom all of the specified procedures were completed for the safe insertion and maintenance of the catheter and its removal as soon as it is no longer needed were completed.","The number of people who have had a long-term urinary catheter."]
[null,"QS61","Infection prevention and control ",4,null,"People who need a urinary catheter have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the catheter and its removal as soon as it is no longer needed.","Incidence of catheter-associated urinary tract infection.","Outcome","QS61 - Infection prevention and control ","4 - QS61 - Infection prevention and control ",1,"4 - QS61 - Infection prevention and control  - Outcome - 1"]
[null,"QS61","Infection prevention and control ",4,null,"People who need a urinary catheter have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the catheter and its removal as soon as it is no longer needed.","Incidence of healthcare-associated infection.","Outcome","QS61 - Infection prevention and control ","4 - QS61 - Infection prevention and control ",2,"4 - QS61 - Infection prevention and control  - Outcome - 2"]
[null,"QS61","Infection prevention and control ",5,null,"People who need a vascular access device have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the device and its removal as soon as it is no longer needed.","Evidence of a written protocol to ensure that people who need a vascular access device have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the device and its removal as soon as it is no longer needed.","Structure","QS61 - Infection prevention and control ","5 - QS61 - Infection prevention and control ",1,"5 - QS61 - Infection prevention and control  - Structure - 1","",""]
[null,"QS61","Infection prevention and control ",5,null,"People who need a vascular access device have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the device and its removal as soon as it is no longer needed.","Proportion of people with a vascular access device who had their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the device and its removal as soon as it is no longer needed.","Process","QS61 - Infection prevention and control ","5 - QS61 - Infection prevention and control ",1,"5 - QS61 - Infection prevention and control  - Process - 1","The number of people in the denominator for whom all of the specified procedures were completed for the safe insertion and maintenance of the device and its removal as soon as it is no longer needed.","The number of people who have had a vascular access device."]
[null,"QS61","Infection prevention and control ",5,null,"People who need a vascular access device have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the device and its removal as soon as it is no longer needed.","Incidence of vascular access device-related bloodstream infection.","Outcome","QS61 - Infection prevention and control ","5 - QS61 - Infection prevention and control ",1,"5 - QS61 - Infection prevention and control  - Outcome - 1"]
[null,"QS61","Infection prevention and control ",6,null,"People with a urinary catheter, vascular access device or enteral feeding tube, and their family members or carers (as appropriate), are educated about the safe management of the device or equipment, including techniques to prevent infection. ","Evidence of local arrangements for people with a urinary catheter, vascular access device or enteral feeding tube, and their family members or carers (as appropriate), to be educated about the safe management of their device or equipment, including techniques to prevent infection.","Structure","QS61 - Infection prevention and control ","6 - QS61 - Infection prevention and control ",1,"6 - QS61 - Infection prevention and control  - Structure - 1","",""]
[null,"QS61","Infection prevention and control ",6,null,"People with a urinary catheter, vascular access device or enteral feeding tube, and their family members or carers (as appropriate), are educated about the safe management of the device or equipment, including techniques to prevent infection. ","Proportion of people with a urinary catheter, vascular access device or enteral feeding tube, and their family members or carers (as appropriate), who are educated about the safe management of their device or equipment, including techniques to prevent infection.","Process","QS61 - Infection prevention and control ","6 - QS61 - Infection prevention and control ",1,"6 - QS61 - Infection prevention and control  - Process - 1","The number of people in the denominator who are educated about the safe management of their device or equipment, including techniques to prevent infection.","The number of people with a urinary catheter, vascular access device or enteral feeding tube, and their family members or carers (as appropriate)."]
[null,"QS61","Infection prevention and control ",6,null,"People with a urinary catheter, vascular access device or enteral feeding tube, and their family members or carers (as appropriate), are educated about the safe management of the device or equipment, including techniques to prevent infection. ","Incidence of healthcare-associated infection.","Outcome","QS61 - Infection prevention and control ","6 - QS61 - Infection prevention and control ",1,"6 - QS61 - Infection prevention and control  - Outcome - 1"]
[null,"QS61","Infection prevention and control ",6,null,"People with a urinary catheter, vascular access device or enteral feeding tube, and their family members or carers (as appropriate), are educated about the safe management of the device or equipment, including techniques to prevent infection. ","People with a urinary catheter, vascular access device or enteral feeding tube, and their family members or carers (as appropriate), feel able to manage their device or equipment.","Outcome","QS61 - Infection prevention and control ","6 - QS61 - Infection prevention and control ",2,"6 - QS61 - Infection prevention and control  - Outcome - 2"]
[null,"QS62","Constipation in children and young people ",1,null,"Children and young people with constipation receive a full assessment before a diagnosis of idiopathic constipation is made.","Evidence of local arrangements to ensure that children and young people with constipation receive a full assessment before a diagnosis of idiopathic constipation is made. ","Structure","QS62 - Constipation in children and young people ","1 - QS62 - Constipation in children and young people ",1,"1 - QS62 - Constipation in children and young people  - Structure - 1","",""]
[null,"QS62","Constipation in children and young people ",1,null,"Children and young people with constipation receive a full assessment before a diagnosis of idiopathic constipation is made.","Proportion of children and young people with constipation who receive a full assessment.","Process","QS62 - Constipation in children and young people ","1 - QS62 - Constipation in children and young people ",1,"1 - QS62 - Constipation in children and young people  - Process - 1","The number in the denominator who receive a full assessment.","The number of children and young people with constipation."]
[null,"QS62","Constipation in children and young people ",2,null,"Children and young people with idiopathic constipation receive oral macrogols as first-line treatment.","Evidence of local arrangements to ensure that children and young people with idiopathic constipation receive oral macrogols as first-line treatment. ","Structure","QS62 - Constipation in children and young people ","2 - QS62 - Constipation in children and young people ",1,"2 - QS62 - Constipation in children and young people  - Structure - 1","",""]
[null,"QS62","Constipation in children and young people ",2,null,"Children and young people with idiopathic constipation receive oral macrogols as first-line treatment.","Proportion of diagnosed cases of idiopathic constipation in children and young people for which oral macrogols are prescribed as first‑line treatment. ","Process","QS62 - Constipation in children and young people ","2 - QS62 - Constipation in children and young people ",1,"2 - QS62 - Constipation in children and young people  - Process - 1","The number in the denominator for which oral macrogols are prescribed as first‑line treatment.","The number of diagnosed cases of idiopathic constipation in children and young people."]
[null,"QS62","Constipation in children and young people ",2,null,"Children and young people with idiopathic constipation receive oral macrogols as first-line treatment.","Rates of unplanned hospital attendance for idiopathic constipation.","Outcome","QS62 - Constipation in children and young people ","2 - QS62 - Constipation in children and young people ",1,"2 - QS62 - Constipation in children and young people  - Outcome - 1"]
[null,"QS62","Constipation in children and young people ",3,null,"Children and young people with idiopathic constipation starting disimpaction therapy have their treatment reviewed by a healthcare professional within 1 week.","Evidence of local arrangements to ensure that children and young people with idiopathic constipation starting faecal disimpaction therapy have their treatment reviewed by a healthcare professional within 1 week.","Structure","QS62 - Constipation in children and young people ","3 - QS62 - Constipation in children and young people ",1,"3 - QS62 - Constipation in children and young people  - Structure - 1","",""]
[null,"QS62","Constipation in children and young people ",3,null,"Children and young people with idiopathic constipation starting disimpaction therapy have their treatment reviewed by a healthcare professional within 1 week.","Proportion of children and young people with idiopathic constipation starting disimpaction therapy who receive a review of their treatment from a healthcare professional within 1 week.","Process","QS62 - Constipation in children and young people ","3 - QS62 - Constipation in children and young people ",1,"3 - QS62 - Constipation in children and young people  - Process - 1","The number in the denominator who receive a review of their treatment from a healthcare professional within 1 week.","The number of children and young people with idiopathic constipation starting disimpaction therapy."]
[null,"QS62","Constipation in children and young people ",3,null,"Children and young people with idiopathic constipation starting disimpaction therapy have their treatment reviewed by a healthcare professional within 1 week.","Production of regular soft stools","Outcome","QS62 - Constipation in children and young people ","3 - QS62 - Constipation in children and young people ",1,"3 - QS62 - Constipation in children and young people  - Outcome - 1"]
[null,"QS62","Constipation in children and young people ",3,null,"Children and young people with idiopathic constipation starting disimpaction therapy have their treatment reviewed by a healthcare professional within 1 week.","Rates of reimpaction","Outcome","QS62 - Constipation in children and young people ","3 - QS62 - Constipation in children and young people ",2,"3 - QS62 - Constipation in children and young people  - Outcome - 2"]
[null,"QS62","Constipation in children and young people ",3,null,"Children and young people with idiopathic constipation starting disimpaction therapy have their treatment reviewed by a healthcare professional within 1 week.","Rates of unplanned hospital attendance for constipation","Outcome","QS62 - Constipation in children and young people ","3 - QS62 - Constipation in children and young people ",3,"3 - QS62 - Constipation in children and young people  - Outcome - 3"]
[null,"QS62","Constipation in children and young people ",4,null,"Children and young people with idiopathic constipation starting maintenance therapy have their first treatment review by a healthcare professional within 6 weeks.","Evidence of local arrangements to ensure that children and young people with idiopathic constipation starting maintenance therapy receive their first treatment review from a healthcare professional within 6 weeks.","Structure","QS62 - Constipation in children and young people ","4 - QS62 - Constipation in children and young people ",1,"4 - QS62 - Constipation in children and young people  - Structure - 1","",""]
[null,"QS62","Constipation in children and young people ",4,null,"Children and young people with idiopathic constipation starting maintenance therapy have their first treatment review by a healthcare professional within 6 weeks.","Proportion of children and young people with idiopathic constipation starting maintenance therapy who receive a review of their treatment from a healthcare professional within 6 weeks.","Process","QS62 - Constipation in children and young people ","4 - QS62 - Constipation in children and young people ",1,"4 - QS62 - Constipation in children and young people  - Process - 1","The number in the denominator who receive their first treatment review from a healthcare professional within 6 weeks.","The number of children and young people with idiopathic constipation starting maintenance therapy."]
[null,"QS62","Constipation in children and young people ",4,null,"Children and young people with idiopathic constipation starting maintenance therapy have their first treatment review by a healthcare professional within 6 weeks.","Production of regular soft stools","Outcome","QS62 - Constipation in children and young people ","4 - QS62 - Constipation in children and young people ",1,"4 - QS62 - Constipation in children and young people  - Outcome - 1"]
[null,"QS62","Constipation in children and young people ",4,null,"Children and young people with idiopathic constipation starting maintenance therapy have their first treatment review by a healthcare professional within 6 weeks.","Rates of reimpaction","Outcome","QS62 - Constipation in children and young people ","4 - QS62 - Constipation in children and young people ",2,"4 - QS62 - Constipation in children and young people  - Outcome - 2"]
[null,"QS62","Constipation in children and young people ",4,null,"Children and young people with idiopathic constipation starting maintenance therapy have their first treatment review by a healthcare professional within 6 weeks.","Rates of unplanned hospital attendance for constipation","Outcome","QS62 - Constipation in children and young people ","4 - QS62 - Constipation in children and young people ",3,"4 - QS62 - Constipation in children and young people  - Outcome - 3"]
[null,"QS62","Constipation in children and young people ",5,null,"Children and young people with idiopathic constipation starting laxative treatment, or their parents or carers, receive written information about laxatives.","Evidence of local arrangements for children and young people with idiopathic constipation starting laxative treatment, or their parents or carers, to receive written information about laxatives.","Structure","QS62 - Constipation in children and young people ","5 - QS62 - Constipation in children and young people ",1,"5 - QS62 - Constipation in children and young people  - Structure - 1","",""]
[null,"QS62","Constipation in children and young people ",5,null,"Children and young people with idiopathic constipation starting laxative treatment, or their parents or carers, receive written information about laxatives.","Proportion of children and young people with idiopathic constipation starting laxative treatment, or their parents or carers, who receive written information about laxatives.","Process","QS62 - Constipation in children and young people ","5 - QS62 - Constipation in children and young people ",1,"5 - QS62 - Constipation in children and young people  - Process - 1","The number in the denominator receiving written information about laxatives at the start of treatment.","The number of children and young people with idiopathic constipation starting laxative treatment, or their parents or carers."]
[null,"QS62","Constipation in children and young people ",5,null,"Children and young people with idiopathic constipation starting laxative treatment, or their parents or carers, receive written information about laxatives.","Satisfaction of children and young people, or their parents or carers, with the provision of information on laxatives to help them to manage the condition.","Outcome","QS62 - Constipation in children and young people ","5 - QS62 - Constipation in children and young people ",1,"5 - QS62 - Constipation in children and young people  - Outcome - 1"]
[null,"QS62","Constipation in children and young people ",6,null,"Children and young people with idiopathic constipation that does not respond to initial treatment within 3 months are referred to a healthcare professional with expertise in the problem.","Evidence of local arrangements and written clinical protocols to ensure that children and young people with idiopathic constipation that does not respond to initial treatment within 3 months are referred to a healthcare professional with expertise in the problem.","Structure","QS62 - Constipation in children and young people ","6 - QS62 - Constipation in children and young people ",1,"6 - QS62 - Constipation in children and young people  - Structure - 1","",""]
[null,"QS62","Constipation in children and young people ",6,null,"Children and young people with idiopathic constipation that does not respond to initial treatment within 3 months are referred to a healthcare professional with expertise in the problem.","Proportion of children and young people with idiopathic constipation that does not respond to initial treatment within 3 months who are referred to a healthcare professional with expertise in the problem.","Process","QS62 - Constipation in children and young people ","6 - QS62 - Constipation in children and young people ",1,"6 - QS62 - Constipation in children and young people  - Process - 1","The number in the denominator who are referred to a healthcare professional with expertise in the problem.","The number of children and young people with idiopathic constipation that does not respond to initial treatment within 3 months."]
[null,"QS62","Constipation in children and young people ",6,null,"Children and young people with idiopathic constipation that does not respond to initial treatment within 3 months are referred to a healthcare professional with expertise in the problem.","Rates of recurrent presentation to general practice.","Outcome","QS62 - Constipation in children and young people ","6 - QS62 - Constipation in children and young people ",1,"6 - QS62 - Constipation in children and young people  - Outcome - 1"]
[null,"QS63","Delirium in adults",1,null,"Adults newly admitted to hospital or long-term care who are at risk of delirium are assessed for recent changes that affect cognition, perception, physical function or social behaviour.","Evidence of local arrangements to ensure that adults newly admitted to hospital or long-term care who are at risk of delirium are assessed for recent changes that affect cognition, perception, physical function or social behaviour.","Structure","QS63 - Delirium in adults","1 - QS63 - Delirium in adults",1,"1 - QS63 - Delirium in adults - Structure - 1","",""]
[null,"QS63","Delirium in adults",1,null,"Adults newly admitted to hospital or long-term care who are at risk of delirium are assessed for recent changes that affect cognition, perception, physical function or social behaviour.","Proportion of adults newly admitted to hospital or long-term care who are at risk of delirium who are assessed for recent changes that affect cognition, perception, physical function or social behaviour.","Process","QS63 - Delirium in adults","1 - QS63 - Delirium in adults",1,"1 - QS63 - Delirium in adults - Process - 1","The number in the denominator who are assessed for recent changes in behaviour, including cognition, perception, physical function or social behaviour.","The number of adults newly admitted to hospital or long-term care who are at risk of delirium."]
[null,"QS63","Delirium in adults",1,null,"Adults newly admitted to hospital or long-term care who are at risk of delirium are assessed for recent changes that affect cognition, perception, physical function or social behaviour.","Detection of delirium","Outcome","QS63 - Delirium in adults","1 - QS63 - Delirium in adults",1,"1 - QS63 - Delirium in adults - Outcome - 1"]
[null,"QS63","Delirium in adults",2,null,"Adults newly admitted to hospital or long-term care who are at risk of delirium receive a range of tailored interventions to prevent delirium.","Evidence of local arrangements to ensure that adults newly admitted to hospital or long-term care who are at risk of delirium receive a range of tailored interventions to prevent delirium","Structure","QS63 - Delirium in adults","2 - QS63 - Delirium in adults",1,"2 - QS63 - Delirium in adults - Structure - 1","",""]
[null,"QS63","Delirium in adults",2,null,"Adults newly admitted to hospital or long-term care who are at risk of delirium receive a range of tailored interventions to prevent delirium.","Proportion of adults newly admitted to hospital or long-term care who are at risk of delirium who are assessed for clinical factors that may contribute to the development of delirium within 24 hours of their admission","Process","QS63 - Delirium in adults","2 - QS63 - Delirium in adults",1,"2 - QS63 - Delirium in adults - Process - 1","The number in the denominator who are assessed for clinical factors that may contribute to the development of delirium within 24 hours of their admission.","The number of adults newly admitted to hospital or long-term care who are at risk of delirium."]
[null,"QS63","Delirium in adults",2,null,"Adults newly admitted to hospital or long-term care who are at risk of delirium receive a range of tailored interventions to prevent delirium.","Proportion of adults newly admitted to hospital or long-term care who are at risk of delirium who receive a range of tailored interventions to prevent delirium","Process","QS63 - Delirium in adults","2 - QS63 - Delirium in adults",2,"2 - QS63 - Delirium in adults - Process - 2","The number in the denominator who receive a range of tailored interventions to prevent delirium.","The number of adults newly admitted to hospital or long-term care who are at risk of delirium who have an assessment for clinical factors that may contribute to the development of delirium."]
[null,"QS63","Delirium in adults",2,null,"Adults newly admitted to hospital or long-term care who are at risk of delirium receive a range of tailored interventions to prevent delirium.","Incidence of delirium","Outcome","QS63 - Delirium in adults","2 - QS63 - Delirium in adults",1,"2 - QS63 - Delirium in adults - Outcome - 1"]
[null,"QS63","Delirium in adults",3,null,"Adults with delirium in hospital or long-term care who are distressed or are a risk to themselves or others are not prescribed antipsychotic medication unless de-escalation techniques are ineffective or inappropriate. ","Evidence of local arrangements to ensure that adults with delirium in hospital or long-term care who are distressed or are a risk to themselves or others are not prescribed antipsychotic medication unless de-escalation techniques are ineffective or inappropriate.","Structure","QS63 - Delirium in adults","3 - QS63 - Delirium in adults",1,"3 - QS63 - Delirium in adults - Structure - 1","",""]
[null,"QS63","Delirium in adults",3,null,"Adults with delirium in hospital or long-term care who are distressed or are a risk to themselves or others are not prescribed antipsychotic medication unless de-escalation techniques are ineffective or inappropriate. ","Proportion of adults with delirium in hospital or long-term care who have been prescribed antipsychotic medication who were distressed or a risk to themselves or others and for whom de-escalation techniques were ineffective or inappropriate","Process","QS63 - Delirium in adults","3 - QS63 - Delirium in adults",1,"3 - QS63 - Delirium in adults - Process - 1","The number in the denominator who were distressed or a risk to themselves or others and for whom de-escalation techniques were ineffective or inappropriate.","The number of adults with delirium in hospital or long-term care who have been prescribed antipsychotic medication."]
[null,"QS63","Delirium in adults",3,null,"Adults with delirium in hospital or long-term care who are distressed or are a risk to themselves or others are not prescribed antipsychotic medication unless de-escalation techniques are ineffective or inappropriate. ","Antipsychotic medication prescribing rates","Outcome","QS63 - Delirium in adults","3 - QS63 - Delirium in adults",1,"3 - QS63 - Delirium in adults - Outcome - 1"]
[null,"QS63","Delirium in adults",4,null,"Adults with delirium in hospital or long-term care, and their family members and carers, are given information that explains the condition and describes other people’s experiences of delirium.","Evidence of local arrangements to ensure that adults with delirium in hospital or long-term care, and their family members and carers, are given information that explains the condition and describes other people’s experiences of delirium.","Structure","QS63 - Delirium in adults","4 - QS63 - Delirium in adults",1,"4 - QS63 - Delirium in adults - Structure - 1","",""]
[null,"QS63","Delirium in adults",4,null,"Adults with delirium in hospital or long-term care, and their family members and carers, are given information that explains the condition and describes other people’s experiences of delirium.","Proportion of adults with delirium in hospital or long-term care who are given information that explains the condition and describes other people’s experiences of delirium.","Process","QS63 - Delirium in adults","4 - QS63 - Delirium in adults",1,"4 - QS63 - Delirium in adults - Process - 1","The number in the denominator who are given information that explains the condition and describes other people's experiences of delirium.","The number of adults with delirium in hospital or long-term care."]
[null,"QS63","Delirium in adults",4,null,"Adults with delirium in hospital or long-term care, and their family members and carers, are given information that explains the condition and describes other people’s experiences of delirium.","Proportion of family members or carers of adults with delirium in hospital or long-term care who are given information that explains the condition and describes other people’s experiences of delirium","Process","QS63 - Delirium in adults","4 - QS63 - Delirium in adults",2,"4 - QS63 - Delirium in adults - Process - 2","The number in the denominator whose family members or carers are given information that explains the condition and describes other people's experiences of delirium.","The number of adults with delirium in hospital or long-term care."]
[null,"QS63","Delirium in adults",4,null,"Adults with delirium in hospital or long-term care, and their family members and carers, are given information that explains the condition and describes other people’s experiences of delirium.","Patient and carer experience","Outcome","QS63 - Delirium in adults","4 - QS63 - Delirium in adults",1,"4 - QS63 - Delirium in adults - Outcome - 1"]
[null,"QS63","Delirium in adults",5,null,"Adults with current or resolved delirium who are discharged from hospital have their diagnosis of delirium communicated to their GP.","Evidence of local arrangements to ensure that adults with current or resolved delirium who are discharged from hospital have their diagnosis of delirium communicated to their GP.","Structure","QS63 - Delirium in adults","5 - QS63 - Delirium in adults",1,"5 - QS63 - Delirium in adults - Structure - 1","",""]
[null,"QS63","Delirium in adults",5,null,"Adults with current or resolved delirium who are discharged from hospital have their diagnosis of delirium communicated to their GP.","Proportion of adults with current or resolved delirium who are discharged from hospital who have their diagnosis of delirium communicated to their GP.","Process","QS63 - Delirium in adults","5 - QS63 - Delirium in adults",1,"5 - QS63 - Delirium in adults - Process - 1","The number in the denominator who have their diagnosis of delirium communicated to their GP.","The number of adults with current or resolved delirium who are discharged from hospital."]
[null,"QS63","Delirium in adults",5,null,"Adults with current or resolved delirium who are discharged from hospital have their diagnosis of delirium communicated to their GP.","Continuity of care from hospital to home","Outcome","QS63 - Delirium in adults","5 - QS63 - Delirium in adults",1,"5 - QS63 - Delirium in adults - Outcome - 1"]
[null,"QS64","Fever in under 5s",1,null,"Infants and children under 5 years with unexplained fever have their risk of serious illness assessed and recorded using the traffic light system","Proportion of infants and children under 5 years with unexplained fever who have their risk of serious illness assessed and recorded using the traffic light system","Process","QS64 - Fever in under 5s","1 - QS64 - Fever in under 5s",1,"1 - QS64 - Fever in under 5s - Process - 1","The number in the denominator who have their risk of serious illness assessed and recorded using the traffic light system.","The number of infants and children under 5 years with unexplained fever."]
[null,"QS64","Fever in under 5s",1,null,"Infants and children under 5 years with unexplained fever have their risk of serious illness assessed and recorded using the traffic light system","Early identification of serious illness in infants and children under 5 years.","Outcome","QS64 - Fever in under 5s","1 - QS64 - Fever in under 5s",1,"1 - QS64 - Fever in under 5s - Outcome - 1"]
[null,"QS64","Fever in under 5s",1,null,"Infants and children under 5 years with unexplained fever have their risk of serious illness assessed and recorded using the traffic light system","Evidence of local arrangements to ensure that healthcare professionals are using the traffic light system to assess and record the risk of serious illness in infants and children under 5 years presenting with unexplained fever.","Structure","QS64 - Fever in under 5s","1 - QS64 - Fever in under 5s",1,"1 - QS64 - Fever in under 5s - Structure - 1","",""]
[null,"QS64","Fever in under 5s",2,null,"Infants and children under 5 years who are seen in person by a healthcare professional have their temperature, heart rate, respiratory rate and capillary refill time measured and recorded if fever is suspected","Proportion of infants and children under 5 years seen by a healthcare professional and suspected of having a fever who have their temperature, heart rate, respiratory rate and capillary refill time measured and recorded","Process","QS64 - Fever in under 5s","2 - QS64 - Fever in under 5s",1,"2 - QS64 - Fever in under 5s - Process - 1","The number in the denominator who have their temperature, heart rate, respiratory rate and capillary refill time measured and recorded.","The number of infants and children under 5 years seen by a healthcare professional and suspected of having a fever."]
[null,"QS64","Fever in under 5s",2,null,"Infants and children under 5 years who are seen in person by a healthcare professional have their temperature, heart rate, respiratory rate and capillary refill time measured and recorded if fever is suspected","Early identification of serious illness in infants and children under 5 years","Outcome","QS64 - Fever in under 5s","2 - QS64 - Fever in under 5s",1,"2 - QS64 - Fever in under 5s - Outcome - 1"]
[null,"QS64","Fever in under 5s",2,null,"Infants and children under 5 years who are seen in person by a healthcare professional have their temperature, heart rate, respiratory rate and capillary refill time measured and recorded if fever is suspected","Evidence of local arrangements to ensure that temperature, heart rate, respiratory rate and capillary refill time of infants and children under 5 years with suspected fever can be measured using the correct equipment and recorded","Structure","QS64 - Fever in under 5s","2 - QS64 - Fever in under 5s",1,"2 - QS64 - Fever in under 5s - Structure - 1","",""]
[null,"QS64","Fever in under 5s",3,null,"This statement has been removed. ",null,"Process","QS64 - Fever in under 5s","3 - QS64 - Fever in under 5s",1,"3 - QS64 - Fever in under 5s - Process - 1"]
[null,"QS64","Fever in under 5s",3,null,"This statement has been removed. ",null,"Structure","QS64 - Fever in under 5s","3 - QS64 - Fever in under 5s",1,"3 - QS64 - Fever in under 5s - Structure - 1","",""]
[null,"QS64","Fever in under 5s",4,null,"Parents and carers who are advised that they can care for an infant or child under 5 years with unexplained fever at home are given safety net advice, including information on when to seek further help.","Proportion of infants and children under 5 years with unexplained fever who are being cared for at home after assessment by a healthcare professional, whose parents and carers are given safety net advice, including information on when to seek further help","Process","QS64 - Fever in under 5s","4 - QS64 - Fever in under 5s",1,"4 - QS64 - Fever in under 5s - Process - 1","The number of infants and children in the denominator whose parents and carers receive safety net advice that includes information on when to seek further help.","The number of infants and children under 5 years with unexplained fever who are being cared for at home after assessment by a healthcare professional."]
[null,"QS64","Fever in under 5s",4,null,"Parents and carers who are advised that they can care for an infant or child under 5 years with unexplained fever at home are given safety net advice, including information on when to seek further help.","Parent and carer experience of services","Outcome","QS64 - Fever in under 5s","4 - QS64 - Fever in under 5s",1,"4 - QS64 - Fever in under 5s - Outcome - 1"]
[null,"QS64","Fever in under 5s",4,null,"Parents and carers who are advised that they can care for an infant or child under 5 years with unexplained fever at home are given safety net advice, including information on when to seek further help.","Evidence of local arrangements to ensure that safety net advice, which includes information on when to seek further help, is available for parents and carers who are advised they can care for an infant or child under 5 years with unexplained fever at home","Structure","QS64 - Fever in under 5s","4 - QS64 - Fever in under 5s",1,"4 - QS64 - Fever in under 5s - Structure - 1","",""]
[null,"QS65","Hepatitis B ",1,null,"People who are at increased risk of hepatitis B infection are offered testing and vaccination.","Evidence of local arrangements to ensure that people who are at increased risk of hepatitis B infection are offered testing and vaccination.","Structure","QS65 - Hepatitis B ",{"$f":"CONCATENATE(D1373, \" - \", I1373)","v":"1 - QS65 - Hepatitis B "},{"$f":"IF(AND(B1373=B1372, D1373=D1372, H1373=H1372)=TRUE, K1372+1, 1)","v":1},{"$f":"CONCATENATE(J1373, \" - \", H1373, \" - \",K1373)","v":"1 - QS65 - Hepatitis B  - Structure - 1"},"",""]
[null,"QS65","Hepatitis B ",1,null,"People who are at increased risk of hepatitis B infection are offered testing and vaccination.","Proportion of new GP registrants who belong to a group at increased risk of infection who are offered testing for hepatitis B.","Process","QS65 - Hepatitis B ","1 - QS65 - Hepatitis B ",1,"1 - QS65 - Hepatitis B  - Process - 1","The number in the denominator offered testing for hepatitis B.","The number of new GP registrants who belong to a group at increased risk of infection."]
[null,"QS65","Hepatitis B ",1,null,"People who are at increased risk of hepatitis B infection are offered testing and vaccination.","Proportion of new GP registrants who test negative for hepatitis B but remain at increased risk of infection who are offered vaccination for hepatitis B","Process","QS65 - Hepatitis B ","1 - QS65 - Hepatitis B ",2,"1 - QS65 - Hepatitis B  - Process - 2","The number in the denominator offered vaccination for hepatitis B.","The number of new GP registrants who test negative for hepatitis B but remain at increased risk of infection."]
[null,"QS65","Hepatitis B ",1,null,"People who are at increased risk of hepatitis B infection are offered testing and vaccination.","Proportion of prisoners/immigration detainees who are offered vaccination for hepatitis B when entering prison or an immigration removal centre.","Process","QS65 - Hepatitis B ","1 - QS65 - Hepatitis B ",3,"1 - QS65 - Hepatitis B  - Process - 3","The number in the denominator offered vaccination for hepatitis B.","The number of prisoners/immigration detainees entering prison or an immigration removal centre."]
[null,"QS65","Hepatitis B ",1,null,"People who are at increased risk of hepatitis B infection are offered testing and vaccination.","Proportion of prisoners/immigration detainees who are offered testing for hepatitis B when entering prison or an immigration removal centre.","Process","QS65 - Hepatitis B ","1 - QS65 - Hepatitis B ",4,"1 - QS65 - Hepatitis B  - Process - 4","The number in the denominator offered testing for hepatitis B.","The number of prisoners/immigration detainees entering a prison or an immigration removal centre."]
[null,"QS65","Hepatitis B ",1,null,"People who are at increased risk of hepatitis B infection are offered testing and vaccination.","Proportion of prisoners/immigration detainees who are offered testing for hepatitis B during their detention in prison or an immigration removal centre.","Process",{"$f":"CONCATENATE(B1378, \" - \", C1378)","v":"QS65 - Hepatitis B "},"1 - QS65 - Hepatitis B ",5,"1 - QS65 - Hepatitis B  - Process - 5","The number in the denominator offered testing for hepatitis B.","The number of prisoners/immigration detainees detained in a prison or an immigration removal centre."]
[null,"QS65","Hepatitis B ",1,null,"People who are at increased risk of hepatitis B infection are offered testing and vaccination.","Proportion of people using drug services who are offered vaccination for hepatitis B.","Process","QS65 - Hepatitis B ","1 - QS65 - Hepatitis B ",6,"1 - QS65 - Hepatitis B  - Process - 6","The number in the denominator offered vaccination for hepatitis B.","The number of people using drug services."]
[null,"QS65","Hepatitis B ",1,null,"People who are at increased risk of hepatitis B infection are offered testing and vaccination.","Proportion of people using drug services who are offered testing for hepatitis B.","Process","QS65 - Hepatitis B ","1 - QS65 - Hepatitis B ",7,"1 - QS65 - Hepatitis B  - Process - 7","The number in the denominator offered testing for hepatitis B.","The number of people using drug services."]
[null,"QS65","Hepatitis B ",1,null,"People who are at increased risk of hepatitis B infection are offered testing and vaccination.","Proportion of people at increased risk of infection using sexual health and genitourinary medicine clinics who are offered vaccination for hepatitis B.","Process","QS65 - Hepatitis B ","1 - QS65 - Hepatitis B ",8,"1 - QS65 - Hepatitis B  - Process - 8","The number in the denominator offered vaccination for hepatitis B.","The number of people at increased risk of infection using sexual health and genitourinary medicine clinics."]
[null,"QS65","Hepatitis B ",1,null,"People who are at increased risk of hepatitis B infection are offered testing and vaccination.","Proportion of people at increased risk of infection using sexual health and genitourinary medicine clinics who are offered testing for hepatitis B.","Process","QS65 - Hepatitis B ","1 - QS65 - Hepatitis B ",9,"1 - QS65 - Hepatitis B  - Process - 9","The number in the denominator offered testing for hepatitis B.","The number of people at increased risk of infection using sexual health and genitourinary medicine clinics."]
[null,"QS65","Hepatitis B ",2,null,"People who test positive for hepatitis B surface antigen (HBsAg) are referred to specialist care for further assessment. ","Evidence of local arrangements to ensure that people who test positive for HBsAg are referred to specialist care for further assessment.","Structure","QS65 - Hepatitis B ","2 - QS65 - Hepatitis B ",1,"2 - QS65 - Hepatitis B  - Structure - 1","",""]
[null,"QS65","Hepatitis B ",2,null,"People who test positive for hepatitis B surface antigen (HBsAg) are referred to specialist care for further assessment. ","Proportion of adults (aged 18 years and over) who test HBsAg‑positive who are referred to specialist care for further assessment.","Process","QS65 - Hepatitis B ","2 - QS65 - Hepatitis B ",1,"2 - QS65 - Hepatitis B  - Process - 1","The number in the denominator who are referred to specialist care for further assessment.","The number of adults (aged 18 years and over) who test HBsAg‑positive."]
[null,"QS65","Hepatitis B ",2,null,"People who test positive for hepatitis B surface antigen (HBsAg) are referred to specialist care for further assessment. ","Proportion of children and young people (under 18 years) who test HBsAg‑positive who are referred to specialist care for further assessment.","Process","QS65 - Hepatitis B ","2 - QS65 - Hepatitis B ",2,"2 - QS65 - Hepatitis B  - Process - 2","The number in the denominator who are referred to specialist care for further assessment.","The number of children and young people (under 18 years) who test HBsAg‑positive."]
[null,"QS65","Hepatitis B ",3,null,"Pregnant women who are identified as hepatitis B surface antigen (HBsAg)-positive at antenatal screening are assessed by a specialist within 6 weeks of receiving the screening test result.","Evidence of local arrangements to ensure that pregnant women who are identified as being HBsAg-positive at antenatal screening are assessed by a specialist within 6 weeks of receiving the screening test result.","Structure","QS65 - Hepatitis B ","3 - QS65 - Hepatitis B ",1,"3 - QS65 - Hepatitis B  - Structure - 1",null,""]
[null,"QS65","Hepatitis B ",3,null,"Pregnant women who are identified as hepatitis B surface antigen (HBsAg)-positive at antenatal screening are assessed by a specialist within 6 weeks of receiving the screening test result.","Proportion of pregnant women who are identified as being HBsAg-positive at antenatal screening who are assessed by a specialist within 6 weeks of receiving the screening test result.","Process","QS65 - Hepatitis B ","3 - QS65 - Hepatitis B ",1,"3 - QS65 - Hepatitis B  - Process - 1","The number in the denominator who are assessed by a specialist within 6 weeks of receiving the antenatal screening test result.","The number of pregnant women who are identified as being HBsAg-positive at antenatal screening."]
[null,"QS65","Hepatitis B ",3,null,"Pregnant women who are identified as hepatitis B surface antigen (HBsAg)-positive at antenatal screening are assessed by a specialist within 6 weeks of receiving the screening test result.","Vertical transmission rates from mother to child","Outcome","QS65 - Hepatitis B ","3 - QS65 - Hepatitis B ",1,"3 - QS65 - Hepatitis B  - Outcome - 1"]
[null,"QS65","Hepatitis B ",4,null,"Babies born to hepatitis B surface antigen (HBsAg)-positive mothers receive a complete course of hepatitis B vaccination and, at age 12 months, receive a blood test for hepatitis B infection.","Evidence of local arrangements to ensure that there is an identified person responsible for coordinating the local hepatitis B vaccination programme for babies at risk of infection. This person should also be responsible for scheduling vaccinations and follow-up to ensure that babies at risk are vaccinated at the right time.","Structure","QS65 - Hepatitis B ","4 - QS65 - Hepatitis B ",1,"4 - QS65 - Hepatitis B  - Structure - 1","",""]
[null,"QS65","Hepatitis B ",4,null,"Babies born to hepatitis B surface antigen (HBsAg)-positive mothers receive a complete course of hepatitis B vaccination and, at age 12 months, receive a blood test for hepatitis B infection.","Evidence of local commissioning arrangements to ensure that babies born to HBsAg‑positive mothers are given a complete course of hepatitis B vaccination.","Structure","QS65 - Hepatitis B ","4 - QS65 - Hepatitis B ",2,"4 - QS65 - Hepatitis B  - Structure - 2","",""]
[null,"QS65","Hepatitis B ",4,null,"Babies born to hepatitis B surface antigen (HBsAg)-positive mothers receive a complete course of hepatitis B vaccination and, at age 12 months, receive a blood test for hepatitis B infection.","Proportion of babies born to HBsAg-positive mothers who receive a blood test for hepatitis B infection at age 12 months.","Process","QS65 - Hepatitis B ","4 - QS65 - Hepatitis B ",1,"4 - QS65 - Hepatitis B  - Process - 1","The number in the denominator who receive a blood test for hepatitis B infection.","The number of babies at age 12 months born to HBsAg-positive mothers."]
[null,"QS65","Hepatitis B ",4,null,"Babies born to hepatitis B surface antigen (HBsAg)-positive mothers receive a complete course of hepatitis B vaccination and, at age 12 months, receive a blood test for hepatitis B infection.","Proportion of babies born to HBsAg-positive mothers who receive the complete course of hepatitis B vaccination.","Process","QS65 - Hepatitis B ","4 - QS65 - Hepatitis B ",2,"4 - QS65 - Hepatitis B  - Process - 2","The number in the denominator who receive a complete course of hepatitis B vaccination.","The number of babies born to HBsAg-positive mothers."]
[null,"QS65","Hepatitis B ",4,null,"Babies born to hepatitis B surface antigen (HBsAg)-positive mothers receive a complete course of hepatitis B vaccination and, at age 12 months, receive a blood test for hepatitis B infection.","Vertical transmission rates from mother to child.","Outcome","QS65 - Hepatitis B ","4 - QS65 - Hepatitis B ",1,"4 - QS65 - Hepatitis B  - Outcome - 1"]
[null,"QS65","Hepatitis B ",5,null,"People with chronic hepatitis B infection, and their family members or carers (if appropriate), are offered a personalised care plan outlining the proposed treatment and long-term management of their infection.","Evidence of local arrangements to ensure that people with chronic hepatitis B infection, and their family members or carers (if appropriate), are given a personalised care plan outlining the proposed treatment and long-term management of their infection.","Structure","QS65 - Hepatitis B ","5 - QS65 - Hepatitis B ",1,"5 - QS65 - Hepatitis B  - Structure - 1",""]
[null,"QS65","Hepatitis B ",5,null,"People with chronic hepatitis B infection, and their family members or carers (if appropriate), are offered a personalised care plan outlining the proposed treatment and long-term management of their infection.","Proportion of people with chronic hepatitis B infection, and their family members or carers (if appropriate), who are given a personalised care plan outlining the proposed treatment and long-term management of their infection.","Process","QS65 - Hepatitis B ","5 - QS65 - Hepatitis B ",1,"5 - QS65 - Hepatitis B  - Process - 1","The number in the denominator who receive (or whose family members or carers receive) a personalised care plan outlining the proposed treatment and long-term management of their infection.","The number of people with chronic hepatitis B infection."]
[null,"QS65","Hepatitis B ",5,null,"People with chronic hepatitis B infection, and their family members or carers (if appropriate), are offered a personalised care plan outlining the proposed treatment and long-term management of their infection.","People with chronic hepatitis B infection, and their family members and carers (if appropriate) feel informed about their proposed treatment and long-term management plan of their infection.","Outcome","QS65 - Hepatitis B ","5 - QS65 - Hepatitis B ",1,"5 - QS65 - Hepatitis B  - Outcome - 1"]
[null,"QS65","Hepatitis B ",6,null,"People with chronic hepatitis B infection who do not meet the criteria for antiviral treatment are monitored regularly at intervals determined by their infection status and age.","Evidence of local arrangements to ensure that people with chronic hepatitis B infection who do not meet the criteria for antiviral treatment are monitored regularly at intervals determined by their infection status and age.","Structure","QS65 - Hepatitis B ","6 - QS65 - Hepatitis B ",1,"6 - QS65 - Hepatitis B  - Structure - 1","",""]
[null,"QS65","Hepatitis B ",6,null,"People with chronic hepatitis B infection who do not meet the criteria for antiviral treatment are monitored regularly at intervals determined by their infection status and age.","Proportion of people with chronic hepatitis B infection who do not meet the criteria for antiviral treatment who are monitored regularly at intervals determined by their infection status and age.","Process","QS65 - Hepatitis B ","6 - QS65 - Hepatitis B ",1,"6 - QS65 - Hepatitis B  - Process - 1","The number of people in the denominator who are monitored regularly at intervals determined by their infection status and age.","The number of people with chronic hepatitis B infection who do not meet the criteria for antiviral treatment."]
[null,"QS65","Hepatitis B ",7,null,"Adults with chronic hepatitis B infection who have significant liver fibrosis or cirrhosis are offered 6‑monthly surveillance testing for hepatocellular carcinoma.","Evidence of local arrangements to ensure that adults with chronic hepatitis B infection with significant liver fibrosis or cirrhosis are offered 6‑monthly surveillance testing for hepatocellular carcinoma. ","Structure","QS65 - Hepatitis B ","7 - QS65 - Hepatitis B ",1,"7 - QS65 - Hepatitis B  - Structure - 1","",""]
[null,"QS65","Hepatitis B ",7,null,"Adults with chronic hepatitis B infection who have significant liver fibrosis or cirrhosis are offered 6‑monthly surveillance testing for hepatocellular carcinoma.","Proportion of adults with chronic hepatitis B infection with significant liver fibrosis or cirrhosis who receive 6‑monthly surveillance testing for hepatocellular carcinoma.","Process","QS65 - Hepatitis B ","7 - QS65 - Hepatitis B ",1,"7 - QS65 - Hepatitis B  - Process - 1","The number in the denominator who received their most recent hepatocellular carcinoma surveillance testing within 6 months of their previous test or within 6 months of having significant liver fibrosis or cirrhosis identified.","The number of adults with chronic hepatitis B infection with significant liver fibrosis or cirrhosis."]
[null,"QS65","Hepatitis B ",7,null,"Adults with chronic hepatitis B infection who have significant liver fibrosis or cirrhosis are offered 6‑monthly surveillance testing for hepatocellular carcinoma.","Stage of hepatocellular carcinoma at diagnosis for adults with chronic hepatitis B infection.","Outcome","QS65 - Hepatitis B ","7 - QS65 - Hepatitis B ",1,"7 - QS65 - Hepatitis B  - Outcome - 1"]
[null,"QS66","Intravenous fluid therapy in adults in hospital",1,null,"Hospitals have an intravenous (IV) fluids lead who has overall responsibility for training, clinical governance, audit and review of IV fluid prescribing, and patient outcomes.","Evidence that hospitals have an IV fluids lead who has overall responsibility for ensuring adequate training, clinical governance, audit and review of IV fluid prescribing, and patient outcomes.","Structure","QS66 - Intravenous fluid therapy in adults in hospital","1 - QS66 - Intravenous fluid therapy in adults in hospital",1,"1 - QS66 - Intravenous fluid therapy in adults in hospital - Structure - 1","",""]
[null,"QS66","Intravenous fluid therapy in adults in hospital",2,null,"Adults receiving intravenous (IV) fluid therapy in hospital are cared for by healthcare professionals competent in assessing patients' fluid and electrolyte needs, prescribing and administering IV fluids, and monitoring patient response.","Evidence of local arrangements to ensure that adults receiving IV fluid therapy in hospital are cared for by healthcare professionals who are competent in assessing patients' fluid and electrolyte needs, prescribing and administering IV fluids, and monitoring patient response.","Structure","QS66 - Intravenous fluid therapy in adults in hospital","2 - QS66 - Intravenous fluid therapy in adults in hospital",1,"2 - QS66 - Intravenous fluid therapy in adults in hospital - Structure - 1","",""]
[null,"QS66","Intravenous fluid therapy in adults in hospital",2,null,"Adults receiving intravenous (IV) fluid therapy in hospital are cared for by healthcare professionals competent in assessing patients' fluid and electrolyte needs, prescribing and administering IV fluids, and monitoring patient response.","Proportion of healthcare professionals who are responsible for prescribing IV fluid therapy in hospital who are able to demonstrate competency in prescribing IV fluids.","Process","QS66 - Intravenous fluid therapy in adults in hospital","2 - QS66 - Intravenous fluid therapy in adults in hospital",1,"2 - QS66 - Intravenous fluid therapy in adults in hospital - Process - 1","The number of healthcare professionals in the denominator who are able to demonstrate competency in prescribing IV fluids.","The number of healthcare professionals who are responsible for prescribing IV fluid therapy in hospital."]
[null,"QS66","Intravenous fluid therapy in adults in hospital",2,null,"Adults receiving intravenous (IV) fluid therapy in hospital are cared for by healthcare professionals competent in assessing patients' fluid and electrolyte needs, prescribing and administering IV fluids, and monitoring patient response.","Proportion of healthcare professionals who are responsible for administering IV fluid therapy in hospital who are able to demonstrate competency in administering IV fluids.","Process","QS66 - Intravenous fluid therapy in adults in hospital","2 - QS66 - Intravenous fluid therapy in adults in hospital",2,"2 - QS66 - Intravenous fluid therapy in adults in hospital - Process - 2","The number of healthcare professionals in the denominator who are able to demonstrate competency in administering IV fluids.","The number of healthcare professionals who are responsible for administering IV fluid therapy in hospital."]
[null,"QS66","Intravenous fluid therapy in adults in hospital",2,null,"Adults receiving intravenous (IV) fluid therapy in hospital are cared for by healthcare professionals competent in assessing patients' fluid and electrolyte needs, prescribing and administering IV fluids, and monitoring patient response.","Proportion of healthcare professionals who are caring for adults on IV fluid therapy who are able to demonstrate competency in monitoring patience response.","Process","QS66 - Intravenous fluid therapy in adults in hospital","2 - QS66 - Intravenous fluid therapy in adults in hospital",3,"2 - QS66 - Intravenous fluid therapy in adults in hospital - Process - 3","The number of healthcare professionals in the denominator who are able to demonstrate competency in monitoring patient response.","The number of healthcare professionals who are monitoring adults on IV fluid therapy."]
[null,"QS66","Intravenous fluid therapy in adults in hospital",3,null,"Adults receiving intravenous (IV) fluid therapy in hospital have an IV fluid management plan, determined by and reviewed by an expert, which includes the fluid and electrolyte prescription over the next 24 hours and arrangements for assessing patients and monitoring their plan.","Evidence of local arrangements to ensure that adults receiving IV fluid therapy in hospital have an IV fluid management plan, determined by and reviewed by an expert, which includes the fluid and electrolyte prescription for the next 24 hours and arrangements for assessing patients and monitoring their plan.","Structure","QS66 - Intravenous fluid therapy in adults in hospital","3 - QS66 - Intravenous fluid therapy in adults in hospital",1,"3 - QS66 - Intravenous fluid therapy in adults in hospital - Structure - 1","",""]
[null,"QS66","Intravenous fluid therapy in adults in hospital",3,null,"Adults receiving intravenous (IV) fluid therapy in hospital have an IV fluid management plan, determined by and reviewed by an expert, which includes the fluid and electrolyte prescription over the next 24 hours and arrangements for assessing patients and monitoring their plan.","Proportion of adults receiving IV fluid therapy in hospital who had an IV fluid management plan, determined by and reviewed by an expert, which included daily review of the fluid and electrolyte prescription and arrangements for assessing the patient and monitoring their plan.","Process","QS66 - Intravenous fluid therapy in adults in hospital","3 - QS66 - Intravenous fluid therapy in adults in hospital",1,"3 - QS66 - Intravenous fluid therapy in adults in hospital - Process - 1","The number of adults in the denominator who had an IV fluid management plan determined by and reviewed by an expert, which included daily review of the fluid and electrolyte prescription and arrangements for assessing the patient and monitoring their plan.","The number of adults receiving IV fluid therapy in hospital."]
[null,"QS66","Intravenous fluid therapy in adults in hospital",4,null,"For adults who receive intravenous (IV) fluid therapy in hospital, clear incidents of fluid mismanagement are reported as critical incidents","Evidence of local arrangements to ensure that clear incidents of fluid mismanagements are reported as critical incidents for adults receiving IV fluid therapy in hospital.","Structure","QS66 - Intravenous fluid therapy in adults in hospital","4 - QS66 - Intravenous fluid therapy in adults in hospital",1,"4 - QS66 - Intravenous fluid therapy in adults in hospital - Structure - 1","",""]
[null,"QS66","Intravenous fluid therapy in adults in hospital",4,null,"For adults who receive intravenous (IV) fluid therapy in hospital, clear incidents of fluid mismanagement are reported as critical incidents","Proportion of clear incidents of fluid mismanagement recorded for adults receiving IV fluid therapy in hospital that are reported as critical incidents.","Process","QS66 - Intravenous fluid therapy in adults in hospital","4 - QS66 - Intravenous fluid therapy in adults in hospital",1,"4 - QS66 - Intravenous fluid therapy in adults in hospital - Process - 1","The number of clear incidents of fluid mismanagement in the denominator for which a critical incident is reported.","The number of clear incidents of fluid mismanagement recorded for adults receiving IV fluid therapy in hospital."]
[null,"QS67","Varicose veins in the legs",1,null,"People with varicose veins that are causing symptoms or complications (including ulceration) are referred to a vascular service.","Evidence of local arrangements and written referral criteria to ensure that people with varicose veins that are causing symptoms or complications (including ulceration) are referred to a vascular service.","Structure","QS67 - Varicose veins in the legs","1 - QS67 - Varicose veins in the legs",1,"1 - QS67 - Varicose veins in the legs - Structure - 1","",""]
[null,"QS67","Varicose veins in the legs",1,null,"People with varicose veins that are causing symptoms or complications (including ulceration) are referred to a vascular service.","Proportion of people with varicose veins that are causing symptoms or complications (including ulceration) who are referred to a vascular service.\n\n\n\n","Process","QS67 - Varicose veins in the legs","1 - QS67 - Varicose veins in the legs",1,"1 - QS67 - Varicose veins in the legs - Process - 1","The number in the denominator who are referred to a vascular service.","The number of people who present with varicose veins that are causing symptoms or complications (including ulceration)."]
[null,"QS67","Varicose veins in the legs",1,null,"People with varicose veins that are causing symptoms or complications (including ulceration) are referred to a vascular service.","Progression of venous leg disease.","Outcome","QS67 - Varicose veins in the legs","1 - QS67 - Varicose veins in the legs",1,"1 - QS67 - Varicose veins in the legs - Outcome - 1"]
[null,"QS67","Varicose veins in the legs",2,null,"People with varicose veins who are seen by a vascular service are assessed with duplex ultrasound.","Evidence of local arrangements to ensure that people with varicose veins seen by a vascular service are assessed with duplex ultrasound.","Structure","QS67 - Varicose veins in the legs","2 - QS67 - Varicose veins in the legs",1,"2 - QS67 - Varicose veins in the legs - Structure - 1","",""]
[null,"QS67","Varicose veins in the legs",2,null,"People with varicose veins who are seen by a vascular service are assessed with duplex ultrasound.","Proportion of people with varicose veins seen by a vascular service who are assessed with duplex ultrasound.","Process","QS67 - Varicose veins in the legs","2 - QS67 - Varicose veins in the legs",1,"2 - QS67 - Varicose veins in the legs - Process - 1","The number in the denominator who are assessed with duplex ultrasound.","The number of people with varicose veins seen by a vascular service."]
[null,"QS67","Varicose veins in the legs",3,null,"People with confirmed varicose veins and truncal reflux are offered a suitable treatment in this order: endothermal ablation, ultrasound-guided foam sclerotherapy, surgery, compression hosiery.","Evidence of local arrangements that the full range of treatments for varicose veins is commissioned in accordance with NICE clinical guideline 168","Structure","QS67 - Varicose veins in the legs","3 - QS67 - Varicose veins in the legs",1,"3 - QS67 - Varicose veins in the legs - Structure - 1","",""]
[null,"QS67","Varicose veins in the legs",3,null,"People with confirmed varicose veins and truncal reflux are offered a suitable treatment in this order: endothermal ablation, ultrasound-guided foam sclerotherapy, surgery, compression hosiery.","Proportion of people with confirmed varicose veins and truncal reflux suitable for endothermal ablation who are offered endothermal ablation.","Process","QS67 - Varicose veins in the legs","3 - QS67 - Varicose veins in the legs",1,"3 - QS67 - Varicose veins in the legs - Process - 1","Number in the denominator offered endothermal ablation.","Number of people with confirmed varicose veins and truncal reflux suitable for endothermal ablation."]
[null,"QS67","Varicose veins in the legs",3,null,"People with confirmed varicose veins and truncal reflux are offered a suitable treatment in this order: endothermal ablation, ultrasound-guided foam sclerotherapy, surgery, compression hosiery.","Proportion of people with confirmed varicose veins and truncal reflux unsuitable for endothermal ablation who are offered ultrasound-guided foam sclerotherapy.","Process","QS67 - Varicose veins in the legs","3 - QS67 - Varicose veins in the legs",2,"3 - QS67 - Varicose veins in the legs - Process - 2","Number in the denominator offered ultrasound-guided foam sclerotherapy.","Number of people with confirmed varicose veins and truncal reflux unsuitable for endothermal ablation, but suitable for ultrasound-guided foam sclerotherapy."]
[null,"QS67","Varicose veins in the legs",3,null,"People with confirmed varicose veins and truncal reflux are offered a suitable treatment in this order: endothermal ablation, ultrasound-guided foam sclerotherapy, surgery, compression hosiery.","Proportion of people with confirmed varicose veins and truncal reflux unsuitable for endothermal ablation and ultrasound-guided foam sclerotherapy who are offered surgery.","Process","QS67 - Varicose veins in the legs","3 - QS67 - Varicose veins in the legs",3,"3 - QS67 - Varicose veins in the legs - Process - 3","Number in the denominator offered surgery.","Number of people with confirmed varicose veins and truncal reflux unsuitable for endothermal ablation and ultrasound-guided foam sclerotherapy, but suitable for surgery."]
[null,"QS67","Varicose veins in the legs",3,null,"People with confirmed varicose veins and truncal reflux are offered a suitable treatment in this order: endothermal ablation, ultrasound-guided foam sclerotherapy, surgery, compression hosiery.","Proportion of people with confirmed varicose veins and truncal reflux unsuitable for endothermal ablation, ultrasound-guided foam sclerotherapy and surgery who are offered compression hosiery.","Process","QS67 - Varicose veins in the legs","3 - QS67 - Varicose veins in the legs",4,"3 - QS67 - Varicose veins in the legs - Process - 4","Number in the denominator offered compression hosiery.","Number of people with confirmed varicose veins and truncal reflux unsuitable for endothermal ablation, ultrasound-guided foam sclerotherapy and surgery."]
[null,"QS68","Acute coronary syndromes in adults",1,null,"Adults with a suspected acute coronary syndrome are assessed for acute myocardial infarction using the criteria in the universal definition of myocardial infarction.","Evidence of local arrangements to ensure that adults with a suspected acute coronary syndrome are assessed for the presence of acute myocardial infarction using the criteria in the universal definition of myocardial infarction.","Structure","QS68 - Acute coronary syndromes in adults","1 - QS68 - Acute coronary syndromes in adults",1,"1 - QS68 - Acute coronary syndromes in adults - Structure - 1","",""]
[null,"QS68","Acute coronary syndromes in adults",1,null,"Adults with a suspected acute coronary syndrome are assessed for acute myocardial infarction using the criteria in the universal definition of myocardial infarction.","Proportion of adults with a diagnosis of acute myocardial infarction who had their diagnosis made using the criteria in the universal definition of myocardial infarction.","Process","QS68 - Acute coronary syndromes in adults","1 - QS68 - Acute coronary syndromes in adults",1,"1 - QS68 - Acute coronary syndromes in adults - Process - 1","The number in the denominator who had their diagnosis made using the criteria in the universal definition of myocardial infarction.","The number of adults with a diagnosis of acute myocardial infarction."]
[null,"QS68","Acute coronary syndromes in adults",2,null,"Adults with non-ST-segment-elevation myocardial infarction (NSTEMI) or unstable angina are assessed for their risk of future adverse cardiovascular events using an established risk scoring system that predicts 6-month mortality to guide clinical management.","Evidence of local arrangements to ensure that adults with NSTEMI or unstable angina are assessed for their risk of future adverse cardiovascular events using an established risk scoring system that predicts 6-month mortality to guide clinical management.","Structure","QS68 - Acute coronary syndromes in adults","2 - QS68 - Acute coronary syndromes in adults",1,"2 - QS68 - Acute coronary syndromes in adults - Structure - 1","",""]
[null,"QS68","Acute coronary syndromes in adults",2,null,"Adults with non-ST-segment-elevation myocardial infarction (NSTEMI) or unstable angina are assessed for their risk of future adverse cardiovascular events using an established risk scoring system that predicts 6-month mortality to guide clinical management.","Proportion of presentations for NSTEMI or unstable angina that had an assessment of the risk of future adverse cardiovascular events using an established risk scoring system that predicts 6-month mortality.","Process","QS68 - Acute coronary syndromes in adults","2 - QS68 - Acute coronary syndromes in adults",1,"2 - QS68 - Acute coronary syndromes in adults - Process - 1","The number in the denominator that had an assessment of the risk of future adverse cardiovascular events using an established risk scoring system that predicts 6-month mortality.","The number of presentations because of NSTEMI or unstable angina."]
[null,"QS68","Acute coronary syndromes in adults",3,null,"Adults with non-ST-segment-elevation myocardial infarction (NSTEMI) or unstable angina who have an intermediate or higher risk of future adverse cardiovascular events who are having coronary angiography (with follow-on percutaneous coronary intervention [PCI] if indicated), have it within 72 hours of first admission to hospital.","Evidence of local arrangements to ensure that adults with NSTEMI or unstable angina who have an intermediate or higher risk of future adverse cardiovascular events who are having coronary angiography (with follow-on PCI if indicated), have it within 72 hours of first admission to hospital.","Structure","QS68 - Acute coronary syndromes in adults","3 - QS68 - Acute coronary syndromes in adults",1,"3 - QS68 - Acute coronary syndromes in adults - Structure - 1","",""]
[null,"QS68","Acute coronary syndromes in adults",3,null,"Adults with non-ST-segment-elevation myocardial infarction (NSTEMI) or unstable angina who have an intermediate or higher risk of future adverse cardiovascular events who are having coronary angiography (with follow-on percutaneous coronary intervention [PCI] if indicated), have it within 72 hours of first admission to hospital.","Proportion of adults with NSTEMI or unstable angina who have an intermediate or higher risk of future adverse cardiovascular events who receive coronary angiography (with follow-on PCI if indicated) within 72 hours of first admission to hospital.","Process","QS68 - Acute coronary syndromes in adults","3 - QS68 - Acute coronary syndromes in adults",1,"3 - QS68 - Acute coronary syndromes in adults - Process - 1","The number of people in the denominator receiving coronary angiography (with follow-on PCI if indicated) within 72 hours of admission to hospital.","The number of adults with NSTEMI or unstable angina with an intermediate or higher risk of future adverse cardiovascular events having coronary angiography (with follow-on PCI if indicated)."]
[null,"QS68","Acute coronary syndromes in adults",3,null,"Adults with non-ST-segment-elevation myocardial infarction (NSTEMI) or unstable angina who have an intermediate or higher risk of future adverse cardiovascular events who are having coronary angiography (with follow-on percutaneous coronary intervention [PCI] if indicated), have it within 72 hours of first admission to hospital.","Incidence of cardiovascular events.","Outcome","QS68 - Acute coronary syndromes in adults","3 - QS68 - Acute coronary syndromes in adults",{"$f":"IF(AND(B1427=B1426, D1427=D1426, H1427=H1426)=TRUE, K1426+1, 1)","v":1},{"$f":"CONCATENATE(J1427, \" - \", H1427, \" - \",K1427)","v":"3 - QS68 - Acute coronary syndromes in adults - Outcome - 1"}]
[null,"QS68","Acute coronary syndromes in adults",4,null,"Adults with non-ST-segment-elevation myocardial infarction (NSTEMI) or unstable angina who are clinically unstable have coronary angiography (with follow-on percutaneous coronary intervention [PCI] if indicated) as soon as possible, but within 24 hours of becoming clinically unstable.  ","Evidence of local arrangements to ensure that adults with NSTEMI or unstable angina who are clinically unstable have coronary angiography (with follow-on PCI if indicated) as soon as possible, but within 24 hours of becoming clinically unstable.","Structure","QS68 - Acute coronary syndromes in adults","4 - QS68 - Acute coronary syndromes in adults",1,"4 - QS68 - Acute coronary syndromes in adults - Structure - 1",""]
[null,"QS68","Acute coronary syndromes in adults",4,null,"Adults with non-ST-segment-elevation myocardial infarction (NSTEMI) or unstable angina who are clinically unstable have coronary angiography (with follow-on percutaneous coronary intervention [PCI] if indicated) as soon as possible, but within 24 hours of becoming clinically unstable.  ","Length of time taken for adults with NSTEMI or unstable angina who are clinically unstable (on admission or during their hospital stay) to receive coronary angiography (with follow-on PCI if indicated).\n(Local areas should collaborate with healthcare professionals to determine if the timeframe was appropriate for the patient.)","Process","QS68 - Acute coronary syndromes in adults","4 - QS68 - Acute coronary syndromes in adults",1,"4 - QS68 - Acute coronary syndromes in adults - Process - 1","To be determined locally for each patient.","To be determined locally for each patient."]
[null,"QS68","Acute coronary syndromes in adults",4,null,"Adults with non-ST-segment-elevation myocardial infarction (NSTEMI) or unstable angina who are clinically unstable have coronary angiography (with follow-on percutaneous coronary intervention [PCI] if indicated) as soon as possible, but within 24 hours of becoming clinically unstable.  ","Proportion of adults with NSTEMI or unstable angina who are clinically unstable who receive coronary angiography (with follow-on PCI if indicated) within 24 hours of becoming clinically unstable.","Process","QS68 - Acute coronary syndromes in adults","4 - QS68 - Acute coronary syndromes in adults",2,"4 - QS68 - Acute coronary syndromes in adults - Process - 2","The number in the denominator receiving coronary angiography (with follow-on PCI if indicated) within 24 hours of becoming clinically unstable.","The number of adults with NSTEMI or unstable angina who are clinically unstable."]
[null,"QS68","Acute coronary syndromes in adults",4,null,"Adults with non-ST-segment-elevation myocardial infarction (NSTEMI) or unstable angina who are clinically unstable have coronary angiography (with follow-on percutaneous coronary intervention [PCI] if indicated) as soon as possible, but within 24 hours of becoming clinically unstable.  ","Incidence of cardiovascular events.","Outcome","QS68 - Acute coronary syndromes in adults","4 - QS68 - Acute coronary syndromes in adults",1,"4 - QS68 - Acute coronary syndromes in adults - Outcome - 1"]
[null,"QS68","Acute coronary syndromes in adults",5,null,"Adults who are unconscious after cardiac arrest caused by suspected acute ST-segment-elevation myocardial infarction (STEMI) are not excluded from having coronary angiography (with follow–on primary percutaneous coronary intervention [PCI] if indicated).","Evidence of local arrangements to ensure that adults who are unconscious after cardiac arrest caused by suspected acute STEMI are not excluded from having coronary angiography (with follow–on primary PCI if indicated) because they are unconscious.","Structure","QS68 - Acute coronary syndromes in adults","5 - QS68 - Acute coronary syndromes in adults",1,"5 - QS68 - Acute coronary syndromes in adults - Structure - 1","",""]
[null,"QS68","Acute coronary syndromes in adults",5,null,"Adults who are unconscious after cardiac arrest caused by suspected acute ST-segment-elevation myocardial infarction (STEMI) are not excluded from having coronary angiography (with follow–on primary percutaneous coronary intervention [PCI] if indicated).","Proportion of adults who were unconscious after cardiac arrest caused by suspected acute STEMI who receive coronary angiography (with follow-on primary PCI if indicated).","Process","QS68 - Acute coronary syndromes in adults","5 - QS68 - Acute coronary syndromes in adults",1,"5 - QS68 - Acute coronary syndromes in adults - Process - 1","The number in the denominator receiving coronary angiography (with follow-on primary PCI if indicated).","The number of adults who were unconscious after cardiac arrest caused by suspected acute STEMI."]
[null,"QS68","Acute coronary syndromes in adults",6,null,"Adults with acute ST-segment-elevation myocardial infarction (STEMI) who present within 12 hours of onset of symptoms have primary percutaneous coronary intervention (PCI), as the preferred coronary reperfusion strategy, as soon as possible but within 120 minutes of the time when fibrinolysis could have been given.","Evidence of local arrangements to ensure that adults with acute STEMI have access to primary PCI 24 hours a day.","Structure","QS68 - Acute coronary syndromes in adults","6 - QS68 - Acute coronary syndromes in adults",1,"6 - QS68 - Acute coronary syndromes in adults - Structure - 1","",""]
[null,"QS68","Acute coronary syndromes in adults",6,null,"Adults with acute ST-segment-elevation myocardial infarction (STEMI) who present within 12 hours of onset of symptoms have primary percutaneous coronary intervention (PCI), as the preferred coronary reperfusion strategy, as soon as possible but within 120 minutes of the time when fibrinolysis could have been given.","Evidence of local arrangements to ensure that adults with acute STEMI who present within 12 hours of onset of symptoms have primary PCI, as the preferred coronary reperfusion strategy, within 120 minutes of the time when fibrinolysis could have been given.","Structure","QS68 - Acute coronary syndromes in adults","6 - QS68 - Acute coronary syndromes in adults",2,"6 - QS68 - Acute coronary syndromes in adults - Structure - 2","",""]
[null,"QS68","Acute coronary syndromes in adults",6,null,"Adults with acute ST-segment-elevation myocardial infarction (STEMI) who present within 12 hours of onset of symptoms have primary percutaneous coronary intervention (PCI), as the preferred coronary reperfusion strategy, as soon as possible but within 120 minutes of the time when fibrinolysis could have been given.","Evidence that commissioners with their services providers have developed a single care pathway for coronary reperfusion.","Structure","QS68 - Acute coronary syndromes in adults",{"$f":"CONCATENATE(D1436, \" - \", I1436)","v":"6 - QS68 - Acute coronary syndromes in adults"},{"$f":"IF(AND(B1436=B1435, D1436=D1435, H1436=H1435)=TRUE, K1435+1, 1)","v":3},{"$f":"CONCATENATE(J1436, \" - \", H1436, \" - \",K1436)","v":"6 - QS68 - Acute coronary syndromes in adults - Structure - 3"},"",""]
[null,"QS68","Acute coronary syndromes in adults",6,null,"Adults with acute ST-segment-elevation myocardial infarction (STEMI) who present within 12 hours of onset of symptoms have primary percutaneous coronary intervention (PCI), as the preferred coronary reperfusion strategy, as soon as possible but within 120 minutes of the time when fibrinolysis could have been given.","Proportion of adults with acute STEMI who present within 12 hours of onset of symptoms who receive primary PCI within 120 minutes of when fibrinolysis could have been given.","Process","QS68 - Acute coronary syndromes in adults","6 - QS68 - Acute coronary syndromes in adults",1,"6 - QS68 - Acute coronary syndromes in adults - Process - 1","The number in the denominator receiving primary PCI within 120 minutes of when fibrinolysis could have been given.","The number of adults with acute STEMI who present within 12 hours of onset of symptoms."]
[null,"QS68","Acute coronary syndromes in adults",6,null,"Adults with acute ST-segment-elevation myocardial infarction (STEMI) who present within 12 hours of onset of symptoms have primary percutaneous coronary intervention (PCI), as the preferred coronary reperfusion strategy, as soon as possible but within 120 minutes of the time when fibrinolysis could have been given.","Proportion of adults with acute STEMI who present within 12 hours of onset of symptoms who receive primary PCI within 150 minutes of the call for professional help.","Process","QS68 - Acute coronary syndromes in adults","6 - QS68 - Acute coronary syndromes in adults",2,"6 - QS68 - Acute coronary syndromes in adults - Process - 2","The number of people in the denominator receiving primary PCI within 150 minutes of the call for professional help.","The number of adults with acute STEMI who present within 12 hours of onset of symptoms."]
[null,"QS68","Acute coronary syndromes in adults",6,null,"Adults with acute ST-segment-elevation myocardial infarction (STEMI) who present within 12 hours of onset of symptoms have primary percutaneous coronary intervention (PCI), as the preferred coronary reperfusion strategy, as soon as possible but within 120 minutes of the time when fibrinolysis could have been given.","Incidence of cardiovascular events.","Outcome","QS68 - Acute coronary syndromes in adults","6 - QS68 - Acute coronary syndromes in adults",1,"6 - QS68 - Acute coronary syndromes in adults - Outcome - 1"]
[null,"QS69","Ectopic pregnancy and miscarriage",1,null,"Women referred to early pregnancy assessment services are seen by the service at least within 24 hours of referral.","Evidence of local arrangements to ensure that women referred to early pregnancy assessment services are seen by the service at least within 24 hours of referral.","Structure","QS69 - Ectopic pregnancy and miscarriage","1 - QS69 - Ectopic pregnancy and miscarriage",1,"1 - QS69 - Ectopic pregnancy and miscarriage - Structure - 1","",""]
[null,"QS69","Ectopic pregnancy and miscarriage",1,null,"Women referred to early pregnancy assessment services are seen by the service at least within 24 hours of referral.","Proportion of women referred to early pregnancy assessment services who are seen by the service at least within 24 hours of referral.","Process",{"$f":"CONCATENATE(B1441, \" - \", C1441)","v":"QS69 - Ectopic pregnancy and miscarriage"},"1 - QS69 - Ectopic pregnancy and miscarriage",1,"1 - QS69 - Ectopic pregnancy and miscarriage - Process - 1","The number in the denominator who are seen in early pregnancy assessment services at least within 24 hours of referral.","The number of women referred to early pregnancy assessment."]
[null,"QS69","Ectopic pregnancy and miscarriage",2,null,"Women who are referred with suspected ectopic pregnancy or miscarriage are offered a transvaginal ultrasound scan to identify the location and viability of the pregnancy.","Evidence of local arrangements to ensure that women who are referred with suspected ectopic pregnancy or miscarriage are offered a transvaginal ultrasound scan to identify the location and viability of the pregnancy.","Structure","QS69 - Ectopic pregnancy and miscarriage","2 - QS69 - Ectopic pregnancy and miscarriage",1,"2 - QS69 - Ectopic pregnancy and miscarriage - Structure - 1",""]
[null,"QS69","Ectopic pregnancy and miscarriage",2,null,"Women who are referred with suspected ectopic pregnancy or miscarriage are offered a transvaginal ultrasound scan to identify the location and viability of the pregnancy.","Proportion of women who are referred with a suspected ectopic pregnancy and who receive a transvaginal ultrasound scan to identify the location and viability of the pregnancy.","Process","QS69 - Ectopic pregnancy and miscarriage","2 - QS69 - Ectopic pregnancy and miscarriage",1,"2 - QS69 - Ectopic pregnancy and miscarriage - Process - 1","The number in the denominator who receive a transvaginal ultrasound scan to identify the location and viability of the pregnancy.","The number of women who are referred with a suspected ectopic pregnancy."]
[null,"QS69","Ectopic pregnancy and miscarriage",2,null,"Women who are referred with suspected ectopic pregnancy or miscarriage are offered a transvaginal ultrasound scan to identify the location and viability of the pregnancy.","Proportion of women who are referred with a suspected miscarriage and who receive a transvaginal ultrasound scan to identify the location and viability of the pregnancy.","Process","QS69 - Ectopic pregnancy and miscarriage","2 - QS69 - Ectopic pregnancy and miscarriage",2,"2 - QS69 - Ectopic pregnancy and miscarriage - Process - 2","The number in the denominator who receive a transvaginal ultrasound scan to identify the location and viability of the pregnancy.","The number of women who are referred with a suspected miscarriage."]
[null,"QS69","Ectopic pregnancy and miscarriage",3,null,"Women with a suspected miscarriage who have had an initial transvaginal ultrasound scan are offered a second assessment to confirm the diagnosis.","Evidence of local arrangements to ensure that women with a suspected miscarriage who have had an initial transvaginal ultrasound scan are offered a second assessment to confirm the diagnosis.","Structure","QS69 - Ectopic pregnancy and miscarriage","3 - QS69 - Ectopic pregnancy and miscarriage",1,"3 - QS69 - Ectopic pregnancy and miscarriage - Structure - 1","",""]
[null,"QS69","Ectopic pregnancy and miscarriage",3,null,"Women with a suspected miscarriage who have had an initial transvaginal ultrasound scan are offered a second assessment to confirm the diagnosis.","Proportion of women with a suspected miscarriage who have had an initial transvaginal ultrasound scan and are offered a second assessment to confirm the diagnosis.","Process","QS69 - Ectopic pregnancy and miscarriage","3 - QS69 - Ectopic pregnancy and miscarriage",1,"3 - QS69 - Ectopic pregnancy and miscarriage - Process - 1","The number in the denominator who receive a second assessment to confirm the diagnosis.","The number of women with a suspected miscarriage who have had an initial transvaginal ultrasound scan."]
[null,"QS70","Bedwetting in children and young people",1,null,"Children and young people who are bedwetting have a comprehensive initial assessment.","Evidence of local arrangements to ensure that children and young people who are bedwetting have a comprehensive initial assessment.","Structure","QS70 - Bedwetting in children and young people","1 - QS70 - Bedwetting in children and young people",1,"1 - QS70 - Bedwetting in children and young people - Structure - 1","",""]
[null,"QS70","Bedwetting in children and young people",1,null,"Children and young people who are bedwetting have a comprehensive initial assessment.","Proportion of children and young people who are bedwetting who have a comprehensive initial assessment.","Process","QS70 - Bedwetting in children and young people","1 - QS70 - Bedwetting in children and young people",1,"1 - QS70 - Bedwetting in children and young people - Process - 1","The number in the denominator who have a comprehensive initial assessment.","The number of children and young people presenting with a new episode of bedwetting."]
[null,"QS70","Bedwetting in children and young people",2,null,"Children and young people have an agreed review date if they, or their parents or carers, are given advice about changing their daily routine to help with bedwetting.","Evidence of local arrangements to ensure that a review date is agreed for children and young people if they, or their parents or carers, are given advice about changing their daily routine to help with bedwetting.","Structure","QS70 - Bedwetting in children and young people","2 - QS70 - Bedwetting in children and young people",1,"2 - QS70 - Bedwetting in children and young people - Structure - 1","",""]
[null,"QS70","Bedwetting in children and young people",2,null,"Children and young people have an agreed review date if they, or their parents or carers, are given advice about changing their daily routine to help with bedwetting.","Proportion of children and young people who have an agreed review date if they, or their parents or carers, are given advice about changing their daily routine to help with bedwetting.","Process","QS70 - Bedwetting in children and young people","2 - QS70 - Bedwetting in children and young people",1,"2 - QS70 - Bedwetting in children and young people - Process - 1","The number in the denominator who have an agreed review date.","The number of children or young people who are given advice about changing their daily routine to help with bedwetting."]
[null,"QS70","Bedwetting in children and young people",2,null,"Children and young people have an agreed review date if they, or their parents or carers, are given advice about changing their daily routine to help with bedwetting.","Detection of unresolved bedwetting in children and young people who are given initial advice.","Outcome","QS70 - Bedwetting in children and young people","2 - QS70 - Bedwetting in children and young people",1,"2 - QS70 - Bedwetting in children and young people - Outcome - 1"]
[null,"QS70","Bedwetting in children and young people",3,null,"Children and young people, and their parents or carers if appropriate, have a discussion about initial treatment if bedwetting has not improved after changing their daily routine.","Evidence of local arrangements to ensure that children and young people, and their parents or carers if appropriate, have a discussion about initial treatment if bedwetting has not improved after changing their daily routine.","Structure","QS70 - Bedwetting in children and young people","3 - QS70 - Bedwetting in children and young people",1,"3 - QS70 - Bedwetting in children and young people - Structure - 1","",""]
[null,"QS70","Bedwetting in children and young people",3,null,"Children and young people, and their parents or carers if appropriate, have a discussion about initial treatment if bedwetting has not improved after changing their daily routine.","Proportion of children and young people whose bedwetting has not improved after changing their daily routine who have a recorded discussion (including their parents or carers if appropriate) about initial treatment.","Process","QS70 - Bedwetting in children and young people","3 - QS70 - Bedwetting in children and young people",1,"3 - QS70 - Bedwetting in children and young people - Process - 1","The number in the denominator who have a recorded discussion (including their parents or carers if appropriate) about initial treatment.","The number of children and young people whose bedwetting has not improved after changing their daily routine."]
[null,"QS70","Bedwetting in children and young people",3,null,"Children and young people, and their parents or carers if appropriate, have a discussion about initial treatment if bedwetting has not improved after changing their daily routine.","Children, young people and their parents or carers are actively involved in decisions about their care.","Outcome","QS70 - Bedwetting in children and young people","3 - QS70 - Bedwetting in children and young people",1,"3 - QS70 - Bedwetting in children and young people - Outcome - 1"]
[null,"QS70","Bedwetting in children and young people",4,null,"Children and young people who are bedwetting receive the treatment agreed in their initial treatment plan.","Evidence of local arrangements to ensure that children and young people who are bedwetting receive the treatment agreed in their initial treatment plan.","Structure","QS70 - Bedwetting in children and young people","4 - QS70 - Bedwetting in children and young people",1,"4 - QS70 - Bedwetting in children and young people - Structure - 1","",""]
[null,"QS70","Bedwetting in children and young people",4,null,"Children and young people who are bedwetting receive the treatment agreed in their initial treatment plan.","Proportion of children and young people who are bedwetting who receive the treatment agreed in their initial treatment plan.","Process","QS70 - Bedwetting in children and young people","4 - QS70 - Bedwetting in children and young people",1,"4 - QS70 - Bedwetting in children and young people - Process - 1","The number in the denominator who receive the treatment agreed in their initial treatment plan.","The number of children and young people who are bedwetting who have an initial treatment plan."]
[null,"QS70","Bedwetting in children and young people",4,null,"Children and young people who are bedwetting receive the treatment agreed in their initial treatment plan.","Waiting times to receive initial treatment for bedwetting.","Process","QS70 - Bedwetting in children and young people","4 - QS70 - Bedwetting in children and young people",2,"4 - QS70 - Bedwetting in children and young people - Process - 2","To be determined by local data collection","To be determined by local data collection"]
[null,"QS70","Bedwetting in children and young people",4,null,"Children and young people who are bedwetting receive the treatment agreed in their initial treatment plan.","Patient satisfaction with the availability of initial treatment for bedwetting.","Outcome","QS70 - Bedwetting in children and young people","4 - QS70 - Bedwetting in children and young people",1,"4 - QS70 - Bedwetting in children and young people - Outcome - 1"]
[null,"QS70","Bedwetting in children and young people",5,null,"Children and young people whose bedwetting has not responded to courses of initial treatments are referred for a specialist review.","Evidence of local arrangements to ensure that children and young people whose bedwetting has not responded to courses of initial treatments can access a specialist review. ","Structure","QS70 - Bedwetting in children and young people","5 - QS70 - Bedwetting in children and young people",1,"5 - QS70 - Bedwetting in children and young people - Structure - 1","",""]
[null,"QS70","Bedwetting in children and young people",5,null,"Children and young people whose bedwetting has not responded to courses of initial treatments are referred for a specialist review.","Proportion of children and young people whose bedwetting has not responded to courses of initial treatments who are referred for a specialist review.","Process","QS70 - Bedwetting in children and young people","5 - QS70 - Bedwetting in children and young people",1,"5 - QS70 - Bedwetting in children and young people - Process - 1","The number in the denominator referred for a specialist review.","The number of children and young people whose bedwetting has not responded to courses of initial treatments."]
[null,"QS70","Bedwetting in children and young people",5,null,"Children and young people whose bedwetting has not responded to courses of initial treatments are referred for a specialist review.","Reduction in inappropriate hospital referrals.","Outcome","QS70 - Bedwetting in children and young people","5 - QS70 - Bedwetting in children and young people",1,"5 - QS70 - Bedwetting in children and young people - Outcome - 1"]
[null,"QS71","Transient loss of consciousness",1,null,"People who have had a suspected transient loss of consciousness have an initial assessment to record details of the event, clinical history and physical examination.","Evidence of local arrangements to ensure that people who have had a suspected transient loss of consciousness have an initial assessment to record details of the event, clinical history and physical examination.","Structure","QS71 - Transient loss of consciousness","1 - QS71 - Transient loss of consciousness",1,"1 - QS71 - Transient loss of consciousness - Structure - 1","",""]
[null,"QS71","Transient loss of consciousness",1,null,"People who have had a suspected transient loss of consciousness have an initial assessment to record details of the event, clinical history and physical examination.","Proportion of people with a suspected transient loss of consciousness who have the details of the event recorded.","Process","QS71 - Transient loss of consciousness","1 - QS71 - Transient loss of consciousness",1,"1 - QS71 - Transient loss of consciousness - Process - 1","The number in the denominator who have the details of the event recorded.","The number of people with a suspected transient loss of consciousness."]
[null,"QS71","Transient loss of consciousness",1,null,"People who have had a suspected transient loss of consciousness have an initial assessment to record details of the event, clinical history and physical examination.","Proportion of people with a suspected transient loss of consciousness who have the details of the clinical history and physical examination assessment recorded.","Process","QS71 - Transient loss of consciousness","1 - QS71 - Transient loss of consciousness",2,"1 - QS71 - Transient loss of consciousness - Process - 2","The number in the denominator who have the details of the clinical history and physical examination assessment recorded.","The number of people with a suspected transient loss of consciousness."]
[null,"QS71","Transient loss of consciousness",2,null,"People who have had a transient loss of consciousness have a 12‑lead electrocardiogram (ECG) during the initial assessment.","Evidence of local arrangements to ensure that people who have had a transient loss of consciousness have a 12‑lead ECG during initial assessment.","Structure","QS71 - Transient loss of consciousness","2 - QS71 - Transient loss of consciousness",1,"2 - QS71 - Transient loss of consciousness - Structure - 1","",""]
[null,"QS71","Transient loss of consciousness",2,null,"People who have had a transient loss of consciousness have a 12‑lead electrocardiogram (ECG) during the initial assessment.","Proportion of people who have had a transient loss of consciousness who have a 12‑lead ECG during initial assessment.","Process","QS71 - Transient loss of consciousness","2 - QS71 - Transient loss of consciousness",1,"2 - QS71 - Transient loss of consciousness - Process - 1","The number in the denominator who have a 12‑lead ECG during initial assessment.","The number of people who have had a transient loss of consciousness."]
[null,"QS71","Transient loss of consciousness",3,null,"People who have had a transient loss of consciousness and 1 or more 'red flag' signs or symptoms identified have an urgent specialist cardiovascular assessment within 24 hours of the initial assessment.","Evidence of local arrangements to ensure that people who have had a transient loss of consciousness and 1 or more 'red flag' signs or symptoms identified have an urgent specialist cardiovascular assessment within 24 hours of the initial assessment.","Structure","QS71 - Transient loss of consciousness","3 - QS71 - Transient loss of consciousness",1,"3 - QS71 - Transient loss of consciousness - Structure - 1","",""]
[null,"QS71","Transient loss of consciousness",3,null,"People who have had a transient loss of consciousness and 1 or more 'red flag' signs or symptoms identified have an urgent specialist cardiovascular assessment within 24 hours of the initial assessment.","Proportion of people who have had transient loss of consciousness and 1 or more 'red flag' signs or symptoms identified who have an urgent specialist cardiovascular assessment within 24 hours of the initial assessment.","Process","QS71 - Transient loss of consciousness","3 - QS71 - Transient loss of consciousness",1,"3 - QS71 - Transient loss of consciousness - Process - 1","The number in the denominator who have an urgent specialist cardiovascular assessment within 24 hours.","The number of people who have had transient loss of consciousness and 1 or more 'red flag' signs or symptoms identified at initial assessment."]
[null,"QS71","Transient loss of consciousness",4,null,"People who have had a transient loss of consciousness are not routinely offered an electroencephalogram (EEG) to investigate the event.","Evidence of local arrangements to ensure that people who have had a transient loss of consciousness are not routinely offered an EEG to investigate the event.","Structure","QS71 - Transient loss of consciousness","4 - QS71 - Transient loss of consciousness",1,"4 - QS71 - Transient loss of consciousness - Structure - 1","",""]
[null,"QS71","Transient loss of consciousness",4,null,"People who have had a transient loss of consciousness are not routinely offered an electroencephalogram (EEG) to investigate the event.","Proportion of people who have had a transient loss of consciousness who have an EEG recorded to investigate the event.","Process","QS71 - Transient loss of consciousness","4 - QS71 - Transient loss of consciousness",1,"4 - QS71 - Transient loss of consciousness - Process - 1","The number in the denominator who have an EEG recorded to investigate the event.","The number of people who have had a transient loss of consciousness."]
[null,"QS71","Transient loss of consciousness",5,null,"People who have had a transient loss of consciousness are advised not to drive while they are awaiting specialist assessment.","Evidence of local arrangements to ensure that people who have had a transient loss of consciousness are advised not to drive while they are awaiting specialist assessment.","Structure","QS71 - Transient loss of consciousness","5 - QS71 - Transient loss of consciousness",1,"5 - QS71 - Transient loss of consciousness - Structure - 1","",""]
[null,"QS71","Transient loss of consciousness",5,null,"People who have had a transient loss of consciousness are advised not to drive while they are awaiting specialist assessment.","Proportion of people who have had transient loss of consciousness who are advised not to drive while awaiting specialist assessment.","Process","QS71 - Transient loss of consciousness","5 - QS71 - Transient loss of consciousness",1,"5 - QS71 - Transient loss of consciousness - Process - 1","The number in the denominator who are advised not to drive.","The number of people who have had transient loss of consciousness and are awaiting specialist assessment."]
[null,"QS71","Transient loss of consciousness",6,null,"People with a suspected cardiac arrhythmic cause of syncope are offered an ambulatory electrocardiogram (ECG) as a first line specialist cardiovascular investigation.","Evidence of local arrangements to ensure that people with a suspected cardiac arrhythmic cause of syncope are offered an ambulatory ECG as a first line specialist investigation, with the type of ambulatory ECG chosen according to the person's history and frequency of transient loss of consciousness.","Structure","QS71 - Transient loss of consciousness","6 - QS71 - Transient loss of consciousness",1,"6 - QS71 - Transient loss of consciousness - Structure - 1","",""]
[null,"QS71","Transient loss of consciousness",6,null,"People with a suspected cardiac arrhythmic cause of syncope are offered an ambulatory electrocardiogram (ECG) as a first line specialist cardiovascular investigation.","Proportion of people with a suspected cardiac arrhythmic cause of syncope who are offered an ambulatory ECG as a first‑line specialist investigation.","Process","QS71 - Transient loss of consciousness","6 - QS71 - Transient loss of consciousness",1,"6 - QS71 - Transient loss of consciousness - Process - 1","The number in the denominator who receive an ambulatory ECG as a first‑line specialist investigation, with the type of ambulatory ECG chosen according to the person's history and frequency of transient loss of consciousness.","The number of people with a suspected cardiac arrhythmic cause of syncope."]
[null,"QS72","Renal replacement therapy services for adults",1,null,"Adults preparing for or receiving renal replacement therapy, and their family members or carers, undertake individualised education programmes at specialist renal centres.","Evidence that adults preparing for or receiving renal replacement therapy, and their family members or carers, undertake individualised education programmes at specialist renal centres.","Structure","QS72 - Renal replacement therapy services for adults","1 - QS72 - Renal replacement therapy services for adults",1,"1 - QS72 - Renal replacement therapy services for adults - Structure - 1","",""]
[null,"QS72","Renal replacement therapy services for adults",1,null,"Adults preparing for or receiving renal replacement therapy, and their family members or carers, undertake individualised education programmes at specialist renal centres.","Proportion of adults preparing for renal replacement therapy who undertake individualised education programmes at specialist renal centres.","Process","QS72 - Renal replacement therapy services for adults","1 - QS72 - Renal replacement therapy services for adults",1,"1 - QS72 - Renal replacement therapy services for adults - Process - 1","The number in the denominator who undertake individualised education programmes at specialist renal centres.","The number of adults preparing for renal replacement therapy."]
[null,"QS72","Renal replacement therapy services for adults",1,null,"Adults preparing for or receiving renal replacement therapy, and their family members or carers, undertake individualised education programmes at specialist renal centres.","Proportion of adults receiving renal replacement therapy who undertake individualised education programmes at specialist renal centres.","Process","QS72 - Renal replacement therapy services for adults","1 - QS72 - Renal replacement therapy services for adults",2,"1 - QS72 - Renal replacement therapy services for adults - Process - 2","The number in the denominator who undertake individualised education programmes at specialist renal centres.","The number of adults receiving renal replacement therapy."]
[null,"QS72","Renal replacement therapy services for adults",1,null,"Adults preparing for or receiving renal replacement therapy, and their family members or carers, undertake individualised education programmes at specialist renal centres.","Proportion of family members or carers of adults preparing for renal replacement therapy who undertake individualised education programmes at specialist renal centres.","Process","QS72 - Renal replacement therapy services for adults","1 - QS72 - Renal replacement therapy services for adults",3,"1 - QS72 - Renal replacement therapy services for adults - Process - 3","The number in the denominator who undertake individualised education programmes at specialist renal centres.","The number of family members or carers of adults preparing for renal replacement therapy."]
[null,"QS72","Renal replacement therapy services for adults",1,null,"Adults preparing for or receiving renal replacement therapy, and their family members or carers, undertake individualised education programmes at specialist renal centres.","Proportion of family members or carers of adults receiving renal replacement therapy who undertake individualised education programmes at specialist renal centres.","Process","QS72 - Renal replacement therapy services for adults","1 - QS72 - Renal replacement therapy services for adults",4,"1 - QS72 - Renal replacement therapy services for adults - Process - 4","The number in the denominator who undertake individualised education programmes at specialist renal centres.","The number of family members or carers of adults receiving renal replacement therapy."]
[null,"QS72","Renal replacement therapy services for adults",1,null,"Adults preparing for or receiving renal replacement therapy, and their family members or carers, undertake individualised education programmes at specialist renal centres.","Patient satisfaction feedback from adults preparing for or receiving renal replacement therapy (and their family members and carers) about their individualised education programmes on renal replacement therapy at specialist renal centres.","Outcome","QS72 - Renal replacement therapy services for adults","1 - QS72 - Renal replacement therapy services for adults",1,"1 - QS72 - Renal replacement therapy services for adults - Outcome - 1"]
[null,"QS72","Renal replacement therapy services for adults",2,null,"Adults who will need renal replacement therapy are offered a pre‑emptive kidney transplant, if they are medically suitable.","Evidence of local arrangements to ensure that adults who will need renal replacement therapy have their suitability for kidney transplantation assessed at the earliest opportunity.","Structure","QS72 - Renal replacement therapy services for adults","2 - QS72 - Renal replacement therapy services for adults",1,"2 - QS72 - Renal replacement therapy services for adults - Structure - 1","",""]
[null,"QS72","Renal replacement therapy services for adults",2,null,"Adults who will need renal replacement therapy are offered a pre‑emptive kidney transplant, if they are medically suitable.","Evidence of local arrangements to ensure that adults who will need renal replacement therapy receive a pre‑emptive kidney transplant, if they are medically suitable.","Structure","QS72 - Renal replacement therapy services for adults","2 - QS72 - Renal replacement therapy services for adults",2,"2 - QS72 - Renal replacement therapy services for adults - Structure - 2","",""]
[null,"QS72","Renal replacement therapy services for adults",2,null,"Adults who will need renal replacement therapy are offered a pre‑emptive kidney transplant, if they are medically suitable.","Proportion of adults who will need renal replacement therapy who are assessed for transplant suitability.","Process","QS72 - Renal replacement therapy services for adults","2 - QS72 - Renal replacement therapy services for adults",1,"2 - QS72 - Renal replacement therapy services for adults - Process - 1","The number in the denominator who are assessed for transplant suitability.","The number of adults who will need renal replacement therapy."]
[null,"QS72","Renal replacement therapy services for adults",2,null,"Adults who will need renal replacement therapy are offered a pre‑emptive kidney transplant, if they are medically suitable.","Proportion of adults who will need renal replacement therapy and are medically suitable for pre‑emptive kidney transplantation, who receive a pre‑emptive kidney transplant.","Process","QS72 - Renal replacement therapy services for adults","2 - QS72 - Renal replacement therapy services for adults",2,"2 - QS72 - Renal replacement therapy services for adults - Process - 2","The number in the denominator receiving a pre‑emptive kidney transplant.","The number of adults who will need renal replacement therapy and are medically suitable for pre‑emptive kidney transplantation."]
[null,"QS72","Renal replacement therapy services for adults",3,null,"Adults on dialysis are offered a kidney transplant, if they are medically suitable.","Evidence of local arrangements to ensure that adults on dialysis have their suitability for kidney transplantation assessed at the earliest opportunity.","Structure","QS72 - Renal replacement therapy services for adults","3 - QS72 - Renal replacement therapy services for adults",1,"3 - QS72 - Renal replacement therapy services for adults - Structure - 1","",""]
[null,"QS72","Renal replacement therapy services for adults",3,null,"Adults on dialysis are offered a kidney transplant, if they are medically suitable.","Evidence of local arrangements to ensure that adults on dialysis receive a kidney transplant, if they are medically suitable.","Structure","QS72 - Renal replacement therapy services for adults","3 - QS72 - Renal replacement therapy services for adults",2,"3 - QS72 - Renal replacement therapy services for adults - Structure - 2","",""]
[null,"QS72","Renal replacement therapy services for adults",3,null,"Adults on dialysis are offered a kidney transplant, if they are medically suitable.","Proportion of adults receiving dialysis that was started in a planned way (excluding those presenting late in advanced chronic kidney disease) who are medically suitable and active on the kidney transplant waiting list within 6 months of starting dialysis.","Process","QS72 - Renal replacement therapy services for adults","3 - QS72 - Renal replacement therapy services for adults",1,"3 - QS72 - Renal replacement therapy services for adults - Process - 1","The number in the denominator active on the kidney transplant waiting list within 6 months of starting dialysis.","The number of adults receiving dialysis that was started in a planned way who are medically suitable for kidney transplantation."]
[null,"QS72","Renal replacement therapy services for adults",3,null,"Adults on dialysis are offered a kidney transplant, if they are medically suitable.","Proportion of adults receiving dialysis that was started in an unplanned way who are medically suitable and active on the kidney transplant waiting list within 12 months of starting dialysis.","Process","QS72 - Renal replacement therapy services for adults","3 - QS72 - Renal replacement therapy services for adults",2,"3 - QS72 - Renal replacement therapy services for adults - Process - 2","The number in the denominator active on the kidney transplant waiting list within 12 months of starting dialysis.","The number of adults receiving dialysis that was started in an unplanned way who are medically suitable for kidney transplantation."]
[null,"QS72","Renal replacement therapy services for adults",3,null,"Adults on dialysis are offered a kidney transplant, if they are medically suitable.","Proportion of adults previously or currently on dialysis who are medically suitable for, and who receive, a kidney transplant.","Process","QS72 - Renal replacement therapy services for adults","3 - QS72 - Renal replacement therapy services for adults",3,"3 - QS72 - Renal replacement therapy services for adults - Process - 3","The number in the denominator who receive a kidney transplant.","The number of adults previously or currently on dialysis, who are medically suitable for a kidney transplant."]
[null,"QS72","Renal replacement therapy services for adults",4,null,"This statement has been removed","This statement has been removed",null,"QS72 - Renal replacement therapy services for adults","4 - QS72 - Renal replacement therapy services for adults",1,"4 - QS72 - Renal replacement therapy services for adults -  - 1","",""]
[null,"QS72","Renal replacement therapy services for adults",5,null,"Adults who need long‑term dialysis are offered home‑based dialysis.","Evidence of local arrangements to ensure that adults on long‑term dialysis are offered the option of home‑based dialysis.","Structure","QS72 - Renal replacement therapy services for adults","5 - QS72 - Renal replacement therapy services for adults",1,"5 - QS72 - Renal replacement therapy services for adults - Structure - 1","",""]
[null,"QS72","Renal replacement therapy services for adults",5,null,"Adults who need long‑term dialysis are offered home‑based dialysis.","Proportion of adults on long‑term dialysis have a recorded discussion about the option of home‑based dialysis.","Process","QS72 - Renal replacement therapy services for adults","5 - QS72 - Renal replacement therapy services for adults",1,"5 - QS72 - Renal replacement therapy services for adults - Process - 1","The number in the denominator who have a recorded discussion about the option of home-based dialysis.","The number of adults on long‑term dialysis."]
[null,"QS72","Renal replacement therapy services for adults",6,null,"This statement has been removed.","This statement has been removed.",null,"QS72 - Renal replacement therapy services for adults","6 - QS72 - Renal replacement therapy services for adults",1,"6 - QS72 - Renal replacement therapy services for adults -  - 1"]
[null,"QS72","Renal replacement therapy services for adults",7,null,"Adults who have a suspected acute rejection episode have a transplant kidney biopsy carried out and reported on within 24 hours.","Evidence of local arrangements to ensure that adults who have a suspected acute rejection episode have a transplant kidney biopsy carried out and reported on within 24 hours.","Structure","QS72 - Renal replacement therapy services for adults",{"$f":"CONCATENATE(D1494, \" - \", I1494)","v":"7 - QS72 - Renal replacement therapy services for adults"},1,{"$f":"CONCATENATE(J1494, \" - \", H1494, \" - \",K1494)","v":"7 - QS72 - Renal replacement therapy services for adults - Structure - 1"},"",""]
[null,"QS72","Renal replacement therapy services for adults",7,null,"Adults who have a suspected acute rejection episode have a transplant kidney biopsy carried out and reported on within 24 hours.","Proportion of adults with a suspected acute rejection episode who have a transplant kidney biopsy carried out and reported on within 24 hours.","Process","QS72 - Renal replacement therapy services for adults","7 - QS72 - Renal replacement therapy services for adults",{"$f":"IF(AND(B1495=B1494, D1495=D1494, H1495=H1494)=TRUE, K1494+1, 1)","v":1},"7 - QS72 - Renal replacement therapy services for adults - Process - 1","The number in the denominator who have a transplant kidney biopsy carried out and reported on within 24 hours. ","The number of adults with a suspected acute rejection episode."]
[null,"QS72","Renal replacement therapy services for adults",8,null,"Adults receiving haemodialysis have their vascular access monitored and maintained using systematic assessment. ","Evidence of local arrangements to ensure that adults receiving haemodialysis have their vascular access monitored and maintained using systematic assessment.","Structure",{"$f":"CONCATENATE(B1496, \" - \", C1496)","v":"QS72 - Renal replacement therapy services for adults"},"8 - QS72 - Renal replacement therapy services for adults",1,"8 - QS72 - Renal replacement therapy services for adults - Structure - 1"]
[null,"QS72","Renal replacement therapy services for adults",8,null,"Adults receiving haemodialysis have their vascular access monitored and maintained using systematic assessment. ","Proportion of adults receiving haemodialysis who have an assessment of their vascular access before each access attempt.","Process","QS72 - Renal replacement therapy services for adults","8 - QS72 - Renal replacement therapy services for adults",{"$f":"IF(AND(B1497=B1496, D1497=D1496, H1497=H1496)=TRUE, K1496+1, 1)","v":1},{"$f":"CONCATENATE(J1497, \" - \", H1497, \" - \",K1497)","v":"8 - QS72 - Renal replacement therapy services for adults - Process - 1"},"The number in the denominator who have an assessment of their vascular access before each access attempt.","The number of adults receiving haemodialysis."]
[null,"QS72","Renal replacement therapy services for adults",8,null,"Adults receiving haemodialysis have their vascular access monitored and maintained using systematic assessment. ","Proportion of adults receiving haemodialysis in whom an assessment has identified signs of developing complications with vascular access who have a plan to address their vascular access.","Process","QS72 - Renal replacement therapy services for adults","8 - QS72 - Renal replacement therapy services for adults",2,"8 - QS72 - Renal replacement therapy services for adults - Process - 2","The number in the denominator who have a plan to address their vascular access.","The number of adults receiving haemodialysis in whom an assessment has identified signs of developing complications with vascular access."]
[null,"QS72","Renal replacement therapy services for adults",8,null,"Adults receiving haemodialysis have their vascular access monitored and maintained using systematic assessment. ","Infection rates.","Outcome","QS72 - Renal replacement therapy services for adults","8 - QS72 - Renal replacement therapy services for adults",1,"8 - QS72 - Renal replacement therapy services for adults - Outcome - 1"]
[null,"QS72","Renal replacement therapy services for adults",8,null,"Adults receiving haemodialysis have their vascular access monitored and maintained using systematic assessment. ","Proportion of adults receiving haemodialysis who had rupture of vascular access (fistula and graft).","Outcome","QS72 - Renal replacement therapy services for adults","8 - QS72 - Renal replacement therapy services for adults",2,"8 - QS72 - Renal replacement therapy services for adults - Outcome - 2","The number in the denominator who had rupture of vascular access (fistula and graft).","The number of adults receiving haemodialysis."]
[null,"QS72","Renal replacement therapy services for adults",8,null,"Adults receiving haemodialysis have their vascular access monitored and maintained using systematic assessment. ","Proportion of adults receiving haemodialysis who had an intervention for non-functioning or inadequately functioning access.","Outcome","QS72 - Renal replacement therapy services for adults","8 - QS72 - Renal replacement therapy services for adults",3,"8 - QS72 - Renal replacement therapy services for adults - Outcome - 3","The number in the denominator who had an intervention for non-functioning or inadequately functioning access.","The number of adults receiving haemodialysis."]
[null,"QS73","Fertility problems",1,null,"People who are concerned that it is taking longer than expected to conceive are given advice on the impact that lifestyle can have on their chances of getting pregnant.","Evidence of local arrangements to ensure that people who are concerned that it is taking longer than expected to conceive are given written and verbal advice on the impact that lifestyle (including body weight, smoking, alcohol and recreational drug use) can have on their chances of getting pregnant. ","Structure","QS73 - Fertility problems","1 - QS73 - Fertility problems",1,"1 - QS73 - Fertility problems - Structure - 1","",""]
[null,"QS73","Fertility problems",1,null,"People who are concerned that it is taking longer than expected to conceive are given advice on the impact that lifestyle can have on their chances of getting pregnant.","Proportion of people who are concerned that it is taking longer than expected to conceive who are given written and verbal advice on the impact that lifestyle (including body weight, smoking, alcohol and recreational drug use) can have on their chances of getting pregnant.","Process","QS73 - Fertility problems","1 - QS73 - Fertility problems",1,"1 - QS73 - Fertility problems - Process - 1","The number in the denominator given written and verbal advice on the impact that lifestyle (including body weight, smoking, alcohol and recreational drug use) can have on their chances of getting pregnant.","The number of people who are concerned that it is taking longer than expected to conceive."]
[null,"QS73","Fertility problems",1,null,"People who are concerned that it is taking longer than expected to conceive feel informed about the impact that lifestyle can have on their chances of getting pregnant.","People who are concerned that it is taking longer than expected to conceive feel informed about the impact that lifestyle can have on their chances of getting pregnant. ","Outcome","QS73 - Fertility problems","1 - QS73 - Fertility problems",1,"1 - QS73 - Fertility problems - Outcome - 1"]
[null,"QS73","Fertility problems",2,null,"People are referred for specialist consultation if the woman has not conceived after 1 year of intercourse or after 6 cycles of artificial insemination, or earlier in certain circumstances.","Evidence of local arrangements to ensure that referral pathways are in place for specialist consultation when women have not conceived after 1 year of intercourse or after 6 cycles of artificial insemination, or earlier in certain circumstances.","Structure","QS73 - Fertility problems","2 - QS73 - Fertility problems",1,"2 - QS73 - Fertility problems - Structure - 1","",""]
[null,"QS73","Fertility problems",2,null,"People are referred for specialist consultation if the woman has not conceived after 1 year of intercourse or after 6 cycles of artificial insemination, or earlier in certain circumstances.","Proportion of people (women aged 35 years or under and men) who are referred for specialist consultation if the woman has not conceived after 1 year of intercourse or after 6 cycles of artificial insemination, when there is no known clinical cause or history of predisposing factors for infertility in the woman or man.","Process","QS73 - Fertility problems","2 - QS73 - Fertility problems",1,"2 - QS73 - Fertility problems - Process - 1","The number in the denominator who are referred for specialist consultation.","The number of people (women aged 35 years or under and men) who have not conceived after 1 year of intercourse or after 6 cycles of artificial insemination and there is no known clinical cause or history of predisposing factors for infertility in the woman or man."]
[null,"QS73","Fertility problems",2,null,"People are referred for specialist consultation if the woman has not conceived after 1 year of intercourse or after 6 cycles of artificial insemination, or earlier in certain circumstances.","Proportion of people who are referred for specialist consultation within 1 year of identification of fertility problems when there is a known clinical cause in the woman or man, a history of predisposing factors for infertility or the woman is aged 36 years or older. ","Process","QS73 - Fertility problems","2 - QS73 - Fertility problems",2,"2 - QS73 - Fertility problems - Process - 2","The number in the denominator who are referred for specialist consultation within 1 year of identification of fertility problems.","The number of people who have not conceived and have a known clinical cause, a history of predisposing factors for infertility or the woman is aged 36 years or older."]
[null,"QS73","Fertility problems",3,null,"People who are having problems conceiving are offered counselling before, during and after investigation and treatment for their fertility problems.","Evidence of local arrangements to ensure that people who are having problems conceiving are offered counselling before, during and after investigation and treatment for their fertility problems in secondary or tertiary care.","Structure","QS73 - Fertility problems","3 - QS73 - Fertility problems",1,"3 - QS73 - Fertility problems - Structure - 1","",""]
[null,"QS73","Fertility problems",3,null,"People who are having problems conceiving are offered counselling before, during and after investigation and treatment for their fertility problems.","Proportion of people who are having problems conceiving and who are having investigations for fertility problems in secondary or tertiary care who receive counselling.","Process","QS73 - Fertility problems","3 - QS73 - Fertility problems",1,"3 - QS73 - Fertility problems - Process - 1","The number in the denominator who receive counselling.","The number of people who are having problems conceiving and who are having investigations for their fertility problems in secondary or tertiary care."]
[null,"QS73","Fertility problems",3,null,"People who are having problems conceiving are offered counselling before, during and after investigation and treatment for their fertility problems.","Proportion of people who are having problems conceiving and who are having treatment for fertility problems in secondary or tertiary care who receive counselling.","Process","QS73 - Fertility problems","3 - QS73 - Fertility problems",2,"3 - QS73 - Fertility problems - Process - 2","The number in the denominator who receive counselling.","The number of people who are having problems conceiving and who are having treatment for their fertility problems in secondary or tertiary care."]
[null,"QS73","Fertility problems",3,null,"People who are having problems conceiving are offered counselling before, during and after investigation and treatment for their fertility problems.","Proportion of people who are having problems conceiving and who have received treatment for fertility problems in secondary and tertiary care who receive counselling.","Process","QS73 - Fertility problems","3 - QS73 - Fertility problems",3,"3 - QS73 - Fertility problems - Process - 3","The number in the denominator who receive counselling.","The number of people who are having problems conceiving and who have received treatment for fertility problems in secondary or tertiary care."]
[null,"QS73","Fertility problems",3,null,"People who are having problems conceiving are offered counselling before, during and after investigation and treatment for their fertility problems.","People who are having problems conceiving feel supported throughout and after investigation and treatment for their fertility problems.","Outcome","QS73 - Fertility problems","3 - QS73 - Fertility problems",1,"3 - QS73 - Fertility problems - Outcome - 1"]
[null,"QS73","Fertility problems",4,null,"Services analysing semen samples use methods and reference values in accordance with the most recent World Health Organization laboratory manual.","Evidence of a quality assurance programme to ensure that services analysing semen samples use methods and reference values in accordance with the most recent World Health Organization laboratory manual.","Structure","QS73 - Fertility problems","4 - QS73 - Fertility problems",1,"4 - QS73 - Fertility problems - Structure - 1","",""]
[null,"QS73","Fertility problems",5,null,"Women aged under 40 years who meet the criteria for in vitro fertilisation (IVF) are offered 3 full cycles of IVF.","Evidence of local arrangements to provide 3 full cycles of IVF for women aged under 40 years who meet the criteria for IVF.","Structure","QS73 - Fertility problems","5 - QS73 - Fertility problems",1,"5 - QS73 - Fertility problems - Structure - 1","",""]
[null,"QS73","Fertility problems",5,null,"Women aged under 40 years who meet the criteria for in vitro fertilisation (IVF) are offered 3 full cycles of IVF.","Proportion of women aged under 40 years who meet the criteria for IVF who are offered 3 full cycles of IVF.","Process","QS73 - Fertility problems","5 - QS73 - Fertility problems",1,"5 - QS73 - Fertility problems - Process - 1","The number in the denominator who receive 3 full cycles of IVF.","The number of women aged under 40 years who meet the criteria for IVF."]
[null,"QS73","Fertility problems",6,null,"Women aged 40–42 years who meet the criteria for in vitro fertilisation (IVF) are offered 1 full cycle of IVF.","Evidence of a locally agreed policy on provision of 1 full cycle of IVF for women aged 40–42 years who meet the criteria for IVF.","Structure","QS73 - Fertility problems","6 - QS73 - Fertility problems",1,"6 - QS73 - Fertility problems - Structure - 1","",""]
[null,"QS73","Fertility problems",6,null,"Women aged 40–42 years who meet the criteria for in vitro fertilisation (IVF) are offered 1 full cycle of IVF.","Proportion of women aged 40–42 years who meet the criteria for IVF who are offered 1 full cycle of IVF.","Process","QS73 - Fertility problems","6 - QS73 - Fertility problems",1,"6 - QS73 - Fertility problems - Process - 1","The number in the denominator who receive 1 full cycle of IVF.","The number of women aged 40–42 years who meet the criteria for IVF."]
[null,"QS73","Fertility problems",7,null,"Women having in vitro fertilisation (IVF) are offered intracytoplasmic sperm injection (ICSI) only if there are severe deficits in semen quality, obstructive azoospermia, non-obstructive azoospermia or if previous IVF treatment resulted in failed or very poor fertilisation.","Evidence of local arrangements to ensure that ICSI is offered only if there are severe deficits in semen quality, obstructive azoospermia, non-obstructive azoospermia or if previous IVF treatment resulted in failed or very poor fertilisation.","Structure","QS73 - Fertility problems","7 - QS73 - Fertility problems",1,"7 - QS73 - Fertility problems - Structure - 1","",""]
[null,"QS73","Fertility problems",7,null,"Women having in vitro fertilisation (IVF) are offered intracytoplasmic sperm injection (ICSI) only if there are severe deficits in semen quality, obstructive azoospermia, non-obstructive azoospermia or if previous IVF treatment resulted in failed or very poor fertilisation.","Proportion of women having IVF with ICSI because of severe deficits in semen quality, obstructive azoospermia, non-obstructive azoospermia or because previous IVF treatment resulted in failed or very poor fertilisation.","Process","QS73 - Fertility problems","7 - QS73 - Fertility problems",1,"7 - QS73 - Fertility problems - Process - 1","The number in the denominator having ICSI because of severe deficits in semen quality, obstructive azoospermia, non‑obstructive azoospermia or because previous IVF treatment resulted in failed or very poor fertilisation.","The number of women having IVF with ICSI."]
[null,"QS73","Fertility problems",8,null,"Women having in vitro fertilisation (IVF) have 1 or 2 embryos transferred according to the woman’s or donor’s age, the cycle number and the quality of the embryos.","Evidence of local arrangements to implement an agreed embryo transfer strategy in which 1 or 2 embryos are transferred according to the woman’s or donor’s age, the cycle number and the quality of the embryos. ","Structure","QS73 - Fertility problems","8 - QS73 - Fertility problems",1,"8 - QS73 - Fertility problems - Structure - 1","",""]
[null,"QS73","Fertility problems",8,null,"Women having in vitro fertilisation (IVF) have 1 or 2 embryos transferred according to the woman’s or donor’s age, the cycle number and the quality of the embryos.","Proportion of IVF cycles in which embryo transfers are carried out in line with Fertility (NICE guideline CG156) (see also the definitions section below). ","Process","QS73 - Fertility problems","8 - QS73 - Fertility problems",1,"8 - QS73 - Fertility problems - Process - 1","The number in the denominator carried out in line with Fertility (NICE guideline CG156).","The number of embryo transfers in IVF cycles."]
[null,"QS73","Fertility problems",8,null,"Women having in vitro fertilisation (IVF) have 1 or 2 embryos transferred according to the woman’s or donor’s age, the cycle number and the quality of the embryos.","Number of IVF treatments resulting in multiple pregnancy.","Outcome","QS73 - Fertility problems","8 - QS73 - Fertility problems",1,"8 - QS73 - Fertility problems - Outcome - 1"]
[null,"QS73","Fertility problems",8,null,"Women having in vitro fertilisation (IVF) have 1 or 2 embryos transferred according to the woman’s or donor’s age, the cycle number and the quality of the embryos.","Proportion of embryo transfers that are elective single embryo transfers. ","Outcome","QS73 - Fertility problems","8 - QS73 - Fertility problems",2,"8 - QS73 - Fertility problems - Outcome - 2"]
[null,"QS73","Fertility problems",9,null,"People preparing to have treatment for cancer that is likely to result in fertility problems are offered cryopreservation.","Evidence of local arrangements to ensure that people preparing to have treatment for cancer that is likely to result in fertility problems are offered cryopreservation. ","Structure","QS73 - Fertility problems","9 - QS73 - Fertility problems",1,"9 - QS73 - Fertility problems - Structure - 1","",""]
[null,"QS73","Fertility problems",9,null,"People preparing to have treatment for cancer that is likely to result in fertility problems are offered cryopreservation.","Proportion of males having treatment for cancer that is likely to result in fertility problems who receive sperm cryopreservation.","Process","QS73 - Fertility problems","9 - QS73 - Fertility problems",1,"9 - QS73 - Fertility problems - Process - 1","The number in the denominator who receive sperm cryopreservation.","The number of males having treatment for cancer that is likely to result in fertility problems."]
[null,"QS73","Fertility problems",9,null,"People preparing to have treatment for cancer that is likely to result in fertility problems are offered cryopreservation.","Proportion of females having treatment for cancer that is likely to result in fertility problems who receive oocyte or embryo cryopreservation. ","Process","QS73 - Fertility problems","9 - QS73 - Fertility problems",2,"9 - QS73 - Fertility problems - Process - 2","The number in the denominator who receive oocyte or embryo cryopreservation.","The number of females having treatment for cancer that is likely to result in fertility problems and:\n\nwho are well enough to undergo ovarian stimulation and egg collection\n\nwhose condition will not worsen with cryopreservation\n\nwho have enough time before the start of their cancer treatment."]
[null,"QS74","Head Injury",1,null,"People attending an emergency department with a head injury have a CT head scan within 1 hour of a risk factor for brain injury being identified.","Evidence of local arrangements to ensure that CT head scans can be performed within 1 hour of a risk factor for brain injury being identified in people attending emergency departments with a head injury.","Structure","QS74 - Head Injury","1 - QS74 - Head Injury",1,"1 - QS74 - Head Injury - Structure - 1","",""]
[null,"QS74","Head Injury",1,null,"People attending an emergency department with a head injury have a CT head scan within 1 hour of a risk factor for brain injury being identified.","Proportion of emergency department attendances of people with a head injury for which a CT head scan is performed within 1 hour of a risk factor for brain injury being identified. ","Process","QS74 - Head Injury","1 - QS74 - Head Injury",1,"1 - QS74 - Head Injury - Process - 1","The number in the denominator having a CT head scan within 1 hour of a risk factor for brain injury being identified.","The number of emergency department attendances of people with a head injury and a risk factor for brain injury indicating the need for a CT head scan."]
[null,"QS74","Head Injury",1,null,"People attending an emergency department with a head injury have a CT head scan within 1 hour of a risk factor for brain injury being identified.","Mortality from skull fracture and intracranial injury","Outcome","QS74 - Head Injury","1 - QS74 - Head Injury",1,"1 - QS74 - Head Injury - Outcome - 1"]
[null,"QS74","Head Injury",2,null,"This statement has been removed. ",null,null,"QS74 - Head Injury","2 - QS74 - Head Injury",1,"2 - QS74 - Head Injury -  - 1","",""]
[null,"QS74","Head Injury",2,null,"This statement has been removed. ",null,null,"QS74 - Head Injury","2 - QS74 - Head Injury",2,"2 - QS74 - Head Injury -  - 2"]
[null,"QS74","Head Injury",2,null,"This statement has been removed. ",null,null,"QS74 - Head Injury","2 - QS74 - Head Injury",3,"2 - QS74 - Head Injury -  - 3"]
[null,"QS74","Head Injury",3,null,"People attending an emergency department with a head injury have a CT cervical spine scan within 1 hour of a risk factor for spinal injury being identified.","Evidence of local arrangements to ensure that CT cervical spine scans can be performed within 1 hour of a risk factor for spinal injury being identified in people attending emergency departments with head injury.","Structure","QS74 - Head Injury","3 - QS74 - Head Injury",1,"3 - QS74 - Head Injury - Structure - 1","",""]
[null,"QS74","Head Injury",3,null,"People attending an emergency department with a head injury have a CT cervical spine scan within 1 hour of a risk factor for spinal injury being identified.","Proportion of emergency department attendances of people with a head injury for which a CT cervical spine scan is performed within 1 hour of a risk factor for spinal injury being identified. ","Process","QS74 - Head Injury","3 - QS74 - Head Injury",1,"3 - QS74 - Head Injury - Process - 1","The number in the denominator having a CT cervical spine scan within 1 hour of a risk factor for spinal injury being identified.","The number of emergency department attendances of people with a head injury and a risk factor for spinal injury indicating the need for a cervical spine scan."]
[null,"QS74","Head Injury",4,null,"People attending an emergency department with a head injury have a provisional written radiology report within 1 hour if a CT head or cervical spine scan is performed","Evidence of local arrangements to ensure provisional written radiology reports are available within 1 hour of CT head and cervical spine scans","Structure","QS74 - Head Injury","4 - QS74 - Head Injury",1,"4 - QS74 - Head Injury - Structure - 1","",""]
[null,"QS74","Head Injury",4,null,"People attending an emergency department with a head injury have a provisional written radiology report within 1 hour if a CT head or cervical spine scan is performed","Proportion of emergency department attendances for head injury for which a provisional written radiology report is available within 1 hour of any CT head or cervical spine scan. ","Process","QS74 - Head Injury","4 - QS74 - Head Injury",1,"4 - QS74 - Head Injury - Process - 1","The number in the denominator with a provisional written radiology report available within 1 hour.","The number of emergency department attendances for head injury having a CT head or cervical spine scan."]
[null,"QS74","Head Injury",5,null,"People with a head injury who have a Glasgow Coma Scale (GCS) score of 8 or lower at any time have access to specialist treatment from a neuroscience unit.","Evidence of locally agreed transfer protocols between the ambulance service, emergency department, district general hospital and designated neuroscience unit. ","Structure","QS74 - Head Injury","5 - QS74 - Head Injury",1,"5 - QS74 - Head Injury - Structure - 1","",""]
[null,"QS74","Head Injury",5,null,"People with a head injury who have a Glasgow Coma Scale (GCS) score of 8 or lower at any time have access to specialist treatment from a neuroscience unit.","Proportion of emergency department attendances of people with a head injury and a GCS score of 8 or lower at any time for which there is a documented record of ongoing liaison with or transfer to a neuroscience unit. ","Process","QS74 - Head Injury","5 - QS74 - Head Injury",1,"5 - QS74 - Head Injury - Process - 1","The number in the denominator for which there is a documented record of ongoing liaison with or transfer to a neuroscience unit.","The number of emergency department attendances of people with a head injury and GCS score of 8 or lower at any time."]
[null,"QS74","Head Injury",5,null,"People with a head injury who have a Glasgow Coma Scale (GCS) score of 8 or lower at any time have access to specialist treatment from a neuroscience unit.","Mortality from skull fracture and intracranial injury: directly standardised rate, all ages, 3 year average. ","Outcome","QS74 - Head Injury","5 - QS74 - Head Injury",1,"5 - QS74 - Head Injury - Outcome - 1"]
[null,"QS74","Head Injury",6,null,"People who are in hospital with new cognitive, communicative, emotional, behavioural or physical difficulties that continue 72 hours after a traumatic brain injury have an assessment for inpatient rehabilitation.","Evidence of local arrangements to ensure that inpatient rehabilitation assessments can be carried out for people who are in hospital with new cognitive, communicative, emotional, behavioural or physical difficulties continuing 72 hours after a traumatic brain injury have an assessment of inpatient rehabilitation needs. ","Structure","QS74 - Head Injury","6 - QS74 - Head Injury",1,"6 - QS74 - Head Injury - Structure - 1","",""]
[null,"QS74","Head Injury",6,null,"People who are in hospital with new cognitive, communicative, emotional, behavioural or physical difficulties that continue 72 hours after a traumatic brain injury have an assessment for inpatient rehabilitation.","Proportion of people in hospital with new cognitive, communicative, emotional, behavioural or physical difficulties continuing 72 hours after a traumatic brain injury who have an assessment for inpatient rehabilitation. ","Process","QS74 - Head Injury","6 - QS74 - Head Injury",1,"6 - QS74 - Head Injury - Process - 1","The number in the denominator who have an assessment for inpatient rehabilitation.","The number of people who are in hospital with new cognitive, communicative, emotional, behavioural or physical difficulties continuing 72 hours after a traumatic brain injury."]
[null,"QS74","Head Injury",7,null,"Community-based neuro-rehabilitation services provide a range of interventions to help support people (aged 16 and over) with continuing cognitive, communicative, emotional, behavioural or physical difficulties as a result of a traumatic brain injury. ","Evidence of local arrangements to provide community-based neuro-rehabilitation services supplying a range of interventions to support people (aged 16 and over) with continuing cognitive, communicative, emotional, behavioural or physical difficulties as a result of a traumatic brain injury. ","Structure","QS74 - Head Injury","7 - QS74 - Head Injury",1,"7 - QS74 - Head Injury - Structure - 1","",""]
[null,"QS75","Neonatal infection",1,"Intrapartum antibiotics","Pregnant women and pregnant people whose babies are at risk of early-onset neonatal infection are offered intrapartum antibiotics and given the first dose within 1 hour of the decision to treat.","Proportion of pregnant women and pregnant people whose babies are at risk of early-onset neonatal infection who receive intrapartum antibiotics.","Process","QS75 - Neonatal infection","1 - QS75 - Neonatal infection",1,"1 - QS75 - Neonatal infection - Process - 1","The number in the denominator who receive intrapartum antibiotics.","The number of pregnant women and pregnant people whose babies are at risk of early-onset neonatal infection."]
[null,"QS75","Neonatal infection",1,"Intrapartum antibiotics","Pregnant women and pregnant people whose babies are at risk of early-onset neonatal infection are offered intrapartum antibiotics and given the first dose within 1 hour of the decision to treat.","Proportion of pregnant women and pregnant people receiving intrapartum antibiotics who are given them within 1 hour of the decision to treat.","Process","QS75 - Neonatal infection","1 - QS75 - Neonatal infection",2,"1 - QS75 - Neonatal infection - Process - 2","The number in the denominator whose intrapartum antibiotics are given within 1 hour of the decision to treat.","The number of pregnant women and pregnant people who receive intrapartum antibiotics."]
[null,"QS75","Neonatal infection",1,"Intrapartum antibiotics","Pregnant women and pregnant people whose babies are at risk of early-onset neonatal infection are offered intrapartum antibiotics and given the first dose within 1 hour of the decision to treat.","Rates of early-onset neonatal infection.","Outcome","QS75 - Neonatal infection","1 - QS75 - Neonatal infection",1,"1 - QS75 - Neonatal infection - Outcome - 1"]
[null,"QS75","Neonatal infection",2,null,"Newborn babies are assessed for the risk factors and clinical indicators of early-onset neonatal infection.","Proportion of newborn babies who are assessed for the risk factors and clinical indicators of early-onset neonatal infection.","Process","QS75 - Neonatal infection","2 - QS75 - Neonatal infection",{"$f":"IF(AND(B1546=B1545, D1546=D1545, H1546=H1545)=TRUE, K1545+1, 1)","v":1},{"$f":"CONCATENATE(J1546, \" - \", H1546, \" - \",K1546)","v":"2 - QS75 - Neonatal infection - Process - 1"},"The number in the denominator who are assessed for the risk factors and clinical indicators of early-onset neonatal infection.","The number of newborn babies."]
[null,"QS75","Neonatal infection",3,null,"Neonates who need intravenous antibiotic treatment for suspected neonatal infection receive it within 1 hour of the decision to treat.","Proportion of neonates who need IV antibiotic treatment for suspected neonatal infection who receive it within 1 hour of the decision to treat.","Process","QS75 - Neonatal infection","3 - QS75 - Neonatal infection",{"$f":"IF(AND(B1547=B1546, D1547=D1546, H1547=H1546)=TRUE, K1546+1, 1)","v":1},{"$f":"CONCATENATE(J1547, \" - \", H1547, \" - \",K1547)","v":"3 - QS75 - Neonatal infection - Process - 1"},"The number in the denominator who receive IV antibiotic treatment for suspected neonatal infection within 1 hour of the decision to treat.","The number of neonates where a decision to treat with IV antibiotic treatment for suspected neonatal infection has been made."]
[null,"QS75","Neonatal infection",3,null,"Neonates who need intravenous antibiotic treatment for suspected neonatal infection receive it within 1 hour of the decision to treat.","Neonatal mortality due to neonatal infection.","Outcome","QS75 - Neonatal infection","3 - QS75 - Neonatal infection",1,"3 - QS75 - Neonatal infection - Outcome - 1"]
[null,"QS75","Neonatal infection",4,null,"Neonates who start intravenous antibiotic treatment for suspected neonatal infection have their need for it reassessed at 36 hours for early-onset or at 48 hours for late-onset.","Evidence that hospitals and laboratories have systems in place to return blood culture results within 36 hours of bloods being taken for early-onset neonatal infection, and within 48 hours of bloods being taken for late-onset neonatal infection.","Structure","QS75 - Neonatal infection","4 - QS75 - Neonatal infection",1,"4 - QS75 - Neonatal infection - Structure - 1","",""]
[null,"QS75","Neonatal infection",4,null,"Neonates who start intravenous antibiotic treatment for suspected neonatal infection have their need for it reassessed at 36 hours for early-onset or at 48 hours for late-onset.","Proportion of neonates who start IV antibiotic treatment for suspected early-onset neonatal infection who have their need for it reassessed at 36 hours.","Process","QS75 - Neonatal infection",{"$f":"CONCATENATE(D1550, \" - \", I1550)","v":"4 - QS75 - Neonatal infection"},{"$f":"IF(AND(B1550=B1549, D1550=D1549, H1550=H1549)=TRUE, K1549+1, 1)","v":1},{"$f":"CONCATENATE(J1550, \" - \", H1550, \" - \",K1550)","v":"4 - QS75 - Neonatal infection - Process - 1"},"The number in the denominator who have their need for antibiotic treatment reassessed at 36 hours.","The number of neonates who start IV antibiotic treatment for suspected early-onset neonatal infection."]
[null,"QS75","Neonatal infection",4,null,"Neonates who start intravenous antibiotic treatment for suspected neonatal infection have their need for it reassessed at 36 hours for early-onset or at 48 hours for late-onset.","Proportion of neonates who start IV antibiotic treatment for suspected late-onset neonatal infection who have their need for it reassessed at 48 hours.","Process",{"$f":"CONCATENATE(B1551, \" - \", C1551)","v":"QS75 - Neonatal infection"},{"$f":"CONCATENATE(D1551, \" - \", I1551)","v":"4 - QS75 - Neonatal infection"},{"$f":"IF(AND(B1551=B1550, D1551=D1550, H1551=H1550)=TRUE, K1550+1, 1)","v":2},{"$f":"CONCATENATE(J1551, \" - \", H1551, \" - \",K1551)","v":"4 - QS75 - Neonatal infection - Process - 2"},"The number in the denominator who have their need for antibiotic treatment reassessed at 48 hours.","The number of neonates who start IV antibiotic treatment for suspected late-onset neonatal infection."]
[null,"QS75","Neonatal infection",5,null,"Parents or carers of babies that have or have had risk factors for neonatal infection, or whose baby has received intravenous antibiotics, are given verbal and written information about neonatal infection before transfer to community care, before the midwife leaves after a home birth or before discharge.","Proportion of parents or carers of babies that have or have had risk factors for neonatal infection, or where their baby has received intravenous (IV) antibiotics, who are given verbal and written information about neonatal infection before transfer to community care, before the midwife leaves after a home birth or before discharge.","Process","QS75 - Neonatal infection","5 - QS75 - Neonatal infection",{"$f":"IF(AND(B1552=B1550, D1552=D1550, H1552=H1550)=TRUE, K1550+1, 1)","v":1},"5 - QS75 - Neonatal infection - Process - 1","The number in the denominator whose parents or carers receive verbal and written information about neonatal infection before transfer to community care, before the midwife leaves after a home birth or before discharge.","The number of babies that have or have had risk factors for neonatal infection, or who have received IV antibiotics."]
[null,"QS76","Acute kidney injury",1,null,"Children, young people and adults who are at risk of acute kidney injury are given advice on maintaining kidney health. [2014, updated 2023]","Proportion of people with chronic kidney disease (estimated glomerular filtration rate [eGFR] less than 60 ml/min/1.73 m2), diabetes, heart failure, dementia, a learning disability or a previous episode of acute kidney injury who were given advice on maintaining kidney health at their most recent annual health review.","Process","QS76 - Acute kidney injury",{"$f":"CONCATENATE(D1553, \" - \", I1553)","v":"1 - QS76 - Acute kidney injury"},{"$f":"IF(AND(B1553=B1551, D1553=D1551, H1553=H1551)=TRUE, K1551+1, 1)","v":1},{"$f":"CONCATENATE(J1553, \" - \", H1553, \" - \",K1553)","v":"1 - QS76 - Acute kidney injury - Process - 1"},"The number in the denominator who were given advice on maintaining kidney health at their most recent annual health review.","The number of people with chronic kidney disease (eGFR less than 60 ml/min/1.73 m2), diabetes, heart failure, dementia, a learning disability or a previous episode of acute kidney injury."]
[null,"QS76","Acute kidney injury",2,null,"Children, young people and adults at risk of acute kidney injury who are admitted to hospital have their serum creatinine level monitored. [2014, updated 2023]","Proportion of hospital stays for children, young people and adults at risk of acute kidney injury in which serum creatinine level is measured on admission.","Process","QS76 - Acute kidney injury","2 - QS76 - Acute kidney injury",1,"2 - QS76 - Acute kidney injury - Process - 1","The number in the denominator in which serum creatinine level is measured on admission.","The number of hospital stays for children, young people and adults at risk of acute kidney injury."]
[null,"QS76","Acute kidney injury",2,null,"Children, young people and adults at risk of acute kidney injury who are admitted to hospital have their serum creatinine level monitored. [2014, updated 2023]","Proportion of hospital stays for children, young people and adults at risk of acute kidney injury in which serum creatinine level is rechecked following admission.","Process",{"$f":"CONCATENATE(B1555, \" - \", C1555)","v":"QS76 - Acute kidney injury"},"2 - QS76 - Acute kidney injury",2,"2 - QS76 - Acute kidney injury - Process - 2","The number in the denominator in which serum creatinine level is rechecked following admission.","The number of hospital stays for children, young people and adults at risk of acute kidney injury."]
[null,"QS76","Acute kidney injury",2,null,"Children, young people and adults at risk of acute kidney injury who are admitted to hospital have their serum creatinine level monitored. [2014, updated 2023]","Length of hospital stay with an episode of acute kidney injury.","Outcome","QS76 - Acute kidney injury","2 - QS76 - Acute kidney injury",1,"2 - QS76 - Acute kidney injury - Outcome - 1"]
[null,"QS76","Acute kidney injury",3,null,"Adults with an acute kidney injury warning stage 2 test result have a clinical review within 6 hours if they are acutely ill or admitted to hospital, or within 24 hours if they are clinically stable.[new 2023]","Evidence of processes for pathology providers to communicate acute kidney injury warning stage test results urgently to primary and secondary care clinicians.","Structure","QS76 - Acute kidney injury","3 - QS76 - Acute kidney injury",1,"3 - QS76 - Acute kidney injury - Structure - 1"]
[null,"QS76","Acute kidney injury",3,null,"Adults with an acute kidney injury warning stage 2 test result have a clinical review within 6 hours if they are acutely ill or admitted to hospital, or within 24 hours if they are clinically stable.[new 2023]","Proportion of acute kidney injury warning stage 2 test results for adults admitted to hospital that are followed up by a clinical review within 6 hours of the reported result.","Process","QS76 - Acute kidney injury","3 - QS76 - Acute kidney injury",1,"3 - QS76 - Acute kidney injury - Process - 1","The number in the denominator that are followed up by a clinical review within 6 hours of the reported result.","The number of acute kidney injury warning stage 2 test results for adults admitted to hospital."]
[null,"QS76","Acute kidney injury",3,null,"Adults with an acute kidney injury warning stage 2 test result have a clinical review within 6 hours if they are acutely ill or admitted to hospital, or within 24 hours if they are clinically stable.[new 2023]","Proportion of acute kidney injury warning stage 2 test results for adults who are acutely ill in the community that are followed up by a clinical review within 6 hours of the reported result.","Process","QS76 - Acute kidney injury","3 - QS76 - Acute kidney injury",2,"3 - QS76 - Acute kidney injury - Process - 2","The number in the denominator that are followed up by a clinical review within 6 hours of the reported result.","The number of acute kidney injury warning stage 2 test results for adults who are acutely ill in the community."]
[null,"QS76","Acute kidney injury",3,null,"Adults with an acute kidney injury warning stage 2 test result have a clinical review within 6 hours if they are acutely ill or admitted to hospital, or within 24 hours if they are clinically stable.[new 2023]","Proportion of acute kidney injury warning stage 2 test results for adults who are clinically stable in the community that are followed up by a clinical review within 24 hours of the reported result.","Process","QS76 - Acute kidney injury","3 - QS76 - Acute kidney injury",3,"3 - QS76 - Acute kidney injury - Process - 3","The number in the denominator that are followed up by a clinical review within 24 hours of the reported result.","The number of acute kidney injury warning stage 2 test results for adults who are clinically stable in the community."]
[null,"QS76","Acute kidney injury",3,null,"Adults with an acute kidney injury warning stage 2 test result have a clinical review within 6 hours if they are acutely ill or admitted to hospital, or within 24 hours if they are clinically stable.[new 2023]","Progression of acute kidney injury.","Outcome","QS76 - Acute kidney injury","3 - QS76 - Acute kidney injury",1,"3 - QS76 - Acute kidney injury - Outcome - 1"]
[null,"QS76","Acute kidney injury",3,null,"Adults with an acute kidney injury warning stage 2 test result have a clinical review within 6 hours if they are acutely ill or admitted to hospital, or within 24 hours if they are clinically stable.[new 2023]","30-day mortality associated with acute kidney injury.","Outcome","QS76 - Acute kidney injury","3 - QS76 - Acute kidney injury",2,"3 - QS76 - Acute kidney injury - Outcome - 2"]
[null,"QS76","Acute kidney injury",4,null,"Adults with an acute kidney injury warning stage 3 test result have a clinical review within 6 hours or, if they are acutely ill in the community, an immediate review to consider admission to hospital. [new 2023]","Evidence of processes for pathology providers to communicate acute kidney injury warning stage test results urgently to primary and secondary care clinicians.","Structure","QS76 - Acute kidney injury","4 - QS76 - Acute kidney injury",1,"4 - QS76 - Acute kidney injury - Structure - 1"]
[null,"QS76","Acute kidney injury",4,null,"Adults with an acute kidney injury warning stage 3 test result have a clinical review within 6 hours or, if they are acutely ill in the community, an immediate review to consider admission to hospital. [new 2023]","The time frames included in these measures are dependent on timely communication of acute kidney injury warning stage test results to clinicians responsible for follow-up.","Process","QS76 - Acute kidney injury","4 - QS76 - Acute kidney injury",1,"4 - QS76 - Acute kidney injury - Process - 1","The number in the denominator that are followed up by a clinical review within 6 hours of the reported result.","The number of acute kidney injury warning stage 3 test results for adults who are admitted to hospital or clinically stable in the community."]
[null,"QS76","Acute kidney injury",4,null,"Adults with an acute kidney injury warning stage 3 test result have a clinical review within 6 hours or, if they are acutely ill in the community, an immediate review to consider admission to hospital. [new 2023]","Proportion of acute kidney injury warning stage 3 test results for adults who are acutely ill in the community that are followed up by an immediate review to consider admission to hospital.","Process","QS76 - Acute kidney injury","4 - QS76 - Acute kidney injury",2,"4 - QS76 - Acute kidney injury - Process - 2","The number in the denominator that are followed up by an immediate review to consider admission to hospital.","The number of acute kidney injury warning stage 3 test results for adults who are acutely ill in the community."]
[null,"QS76","Acute kidney injury",4,null,"Adults with an acute kidney injury warning stage 3 test result have a clinical review within 6 hours or, if they are acutely ill in the community, an immediate review to consider admission to hospital. [new 2023]","30-day mortality associated with acute kidney injury.","Outcome","QS76 - Acute kidney injury","4 - QS76 - Acute kidney injury",1,"4 - QS76 - Acute kidney injury - Outcome - 1"]
[null,"QS76","Acute kidney injury",5,null,"Children, young people and adults with acute kidney injury who meet the criteria for renal replacement therapy are referred immediately to a nephrologist or, if appropriate, a critical care specialist. [2014, updated 2023]","Evidence that there is an agreed inter-hospital transfer standard in place to avoid delays in the transfer of people with acute kidney injury from referring hospitals to renal centres (where required).","Structure","QS76 - Acute kidney injury","5 - QS76 - Acute kidney injury",1,"5 - QS76 - Acute kidney injury - Structure - 1"]
[null,"QS76","Acute kidney injury",5,null,"Children, young people and adults with acute kidney injury who meet the criteria for renal replacement therapy are referred immediately to a nephrologist or, if appropriate, a critical care specialist. [2014, updated 2023]","Proportion of children, young people and adults with acute kidney injury who meet the criteria for renal replacement therapy who are referred immediately to a nephrologist or critical care specialist.","Process","QS76 - Acute kidney injury","5 - QS76 - Acute kidney injury",1,"5 - QS76 - Acute kidney injury - Process - 1","The number in the denominator who are referred immediately to a nephrologist or critical care specialist.","The number of children, young people and adults with acute kidney injury who meet the criteria for renal replacement therapy."]
[null,"QS76","Acute kidney injury",5,null,"Children, young people and adults with acute kidney injury who meet the criteria for renal replacement therapy are referred immediately to a nephrologist or, if appropriate, a critical care specialist. [2014, updated 2023]","Time from referral of children, young people and adults with acute kidney injury who meet the criteria for renal replacement therapy to be seen by a nephrologist or critical care specialist.","Outcome","QS76 - Acute kidney injury","5 - QS76 - Acute kidney injury",1,"5 - QS76 - Acute kidney injury - Outcome - 1"]
[null,"QS76","Acute kidney injury",5,null,"Children, young people and adults with acute kidney injury who meet the criteria for renal replacement therapy are referred immediately to a nephrologist or, if appropriate, a critical care specialist. [2014, updated 2023]","30-day mortality associated with acute kidney injury.","Outcome","QS76 - Acute kidney injury","5 - QS76 - Acute kidney injury",2,"5 - QS76 - Acute kidney injury - Outcome - 2"]
[null,"QS76","Acute kidney injury",6,null,"Adults discharged from hospital after acute kidney injury have a clinical review within 3 months, or sooner if they are at higher risk of poor outcomes. [new 2023]","Evidence that hospital discharge plans clearly identify an episode of acute kidney injury and include recommendations on timing and responsibility for follow-up clinical review.","Structure","QS76 - Acute kidney injury","6 - QS76 - Acute kidney injury",1,"6 - QS76 - Acute kidney injury - Structure - 1"]
[null,"QS76","Acute kidney injury",6,null,"Adults discharged from hospital after acute kidney injury have a clinical review within 3 months, or sooner if they are at higher risk of poor outcomes. [new 2023]","Proportion of people discharged from hospital after acute kidney injury who have a clinical review within 3 months of discharge.","Process","QS76 - Acute kidney injury","6 - QS76 - Acute kidney injury",1,"6 - QS76 - Acute kidney injury - Process - 1","The number in the denominator who have a clinical review within 3 months of discharge.","The number of people discharged from hospital after acute kidney injury."]
[null,"QS76","Acute kidney injury",6,null,"Adults discharged from hospital after acute kidney injury have a clinical review within 3 months, or sooner if they are at higher risk of poor outcomes. [new 2023]","Emergency readmissions to hospital within 30 days of discharge after acute kidney injury.","Outcome","QS76 - Acute kidney injury","6 - QS76 - Acute kidney injury",1,"6 - QS76 - Acute kidney injury - Outcome - 1"]
[null,"QS76","Acute kidney injury",6,null,"Adults discharged from hospital after acute kidney injury have a clinical review within 3 months, or sooner if they are at higher risk of poor outcomes. [new 2023]","Emergency readmissions to hospital within 90 days of discharge after acute kidney injury.","Outcome","QS76 - Acute kidney injury","6 - QS76 - Acute kidney injury",2,"6 - QS76 - Acute kidney injury - Outcome - 2"]
[null,"QS77","Urinary incontinence in women",1,null,"Women first presenting with urinary incontinence have a physical examination, recording of the type and duration of symptoms, and categorisation of the urinary incontinence.  ","Evidence of local arrangements to ensure that women first presenting with urinary incontinence have a physical examination, recording of the type and duration of symptoms, and categorisation of urinary incontinence. ","Structure","QS77 - Urinary incontinence in women","1 - QS77 - Urinary incontinence in women",1,"1 - QS77 - Urinary incontinence in women - Structure - 1","",""]
[null,"QS77","Urinary incontinence in women",1,null,"Women first presenting with urinary incontinence have a physical examination, recording of the type and duration of symptoms, and categorisation of the urinary incontinence.  ","Proportion of women first presenting with urinary incontinence who receive a physical examination, recording of the type and duration of symptoms, and categorisation of urinary incontinence. ","Process","QS77 - Urinary incontinence in women","1 - QS77 - Urinary incontinence in women",1,"1 - QS77 - Urinary incontinence in women - Process - 1","The number in the denominator who receive a physical examination, recording of type and duration of symptoms, and categorisation of urinary incontinence.","The number of women first presenting with urinary incontinence."]
[null,"QS77","Urinary incontinence in women",2,null,"Women first presenting with urinary incontinence are asked to complete a bladder diary for a minimum of 3 days and given advice about the impact that lifestyle changes can have. ","Evidence of local arrangements to ensure that women first presenting with symptoms of urinary incontinence are asked to complete a bladder diary for a minimum of 3 days.","Structure","QS77 - Urinary incontinence in women","2 - QS77 - Urinary incontinence in women",1,"2 - QS77 - Urinary incontinence in women - Structure - 1","",""]
[null,"QS77","Urinary incontinence in women",2,null,"Women first presenting with urinary incontinence are asked to complete a bladder diary for a minimum of 3 days and given advice about the impact that lifestyle changes can have. ","Evidence of local arrangements to ensure that women first presenting with urinary incontinence are given lifestyle advice. ","Structure","QS77 - Urinary incontinence in women","2 - QS77 - Urinary incontinence in women",2,"2 - QS77 - Urinary incontinence in women - Structure - 2","",""]
[null,"QS77","Urinary incontinence in women",2,null,"Women first presenting with urinary incontinence are asked to complete a bladder diary for a minimum of 3 days and given advice about the impact that lifestyle changes can have. ","Proportion of women first presenting with urinary incontinence who are asked to complete a bladder diary for a minimum of 3 days.","Process","QS77 - Urinary incontinence in women","2 - QS77 - Urinary incontinence in women",1,"2 - QS77 - Urinary incontinence in women - Process - 1","The number in the denominator who are asked to complete a bladder diary for a minimum of 3 days.","The number of women first presenting with urinary incontinence."]
[null,"QS77","Urinary incontinence in women",2,null,"Women first presenting with urinary incontinence are asked to complete a bladder diary for a minimum of 3 days and given advice about the impact that lifestyle changes can have. ","Proportion of women first presenting with urinary incontinence who are given advice about lifestyle changes.","Process","QS77 - Urinary incontinence in women","2 - QS77 - Urinary incontinence in women",2,"2 - QS77 - Urinary incontinence in women - Process - 2","The number in the denominator who are given advice about lifestyle changes.","The number of women first presenting with urinary incontinence."]
[null,"QS77","Urinary incontinence in women",3,null,"Women with urinary incontinence are only offered containment products as a temporary coping strategy, or as long-term management if treatment is unsuccessful. ","Evidence of local arrangements to ensure that containment products are offered only as a temporary coping strategy for urinary incontinence in women or as long-term management if treatment is unsuccessful. ","Structure","QS77 - Urinary incontinence in women","3 - QS77 - Urinary incontinence in women",1,"3 - QS77 - Urinary incontinence in women - Structure - 1","",""]
[null,"QS77","Urinary incontinence in women",3,null,"Women with urinary incontinence are only offered containment products as a temporary coping strategy, or as long-term management if treatment is unsuccessful. ","Proportion of women with urinary incontinence who are offered containment products as a temporary coping strategy or as long-term management if treatment is unsuccessful. ","Process","QS77 - Urinary incontinence in women","3 - QS77 - Urinary incontinence in women",1,"3 - QS77 - Urinary incontinence in women - Process - 1","The number in the denominator offered containment products as a temporary coping strategy or as long‑term management if treatment is unsuccessful.","The number of women with urinary incontinence who are offered containment products."]
[null,"QS77","Urinary incontinence in women",4,null,"Women with stress or mixed urinary incontinence are offered a supervised pelvic floor muscle training programme of at least 3 months' duration as first-line treatment.","Evidence of local arrangements to ensure that a supervised pelvic floor muscle training programme of at least 3 months' duration is available as first-line treatment for women with stress or mixed urinary incontinence.","Structure",{"$f":"CONCATENATE(B1583, \" - \", C1583)","v":"QS77 - Urinary incontinence in women"},{"$f":"CONCATENATE(D1583, \" - \", I1583)","v":"4 - QS77 - Urinary incontinence in women"},{"$f":"IF(AND(B1583=B1582, D1583=D1582, H1583=H1582)=TRUE, K1582+1, 1)","v":1},{"$f":"CONCATENATE(J1583, \" - \", H1583, \" - \",K1583)","v":"4 - QS77 - Urinary incontinence in women - Structure - 1"}]
[null,"QS77","Urinary incontinence in women",4,null,"Women with stress or mixed urinary incontinence are offered a supervised pelvic floor muscle training programme of at least 3 months' duration as first-line treatment.","Proportion of women with stress or mixed urinary incontinence who have a supervised pelvic floor muscle training programme of at least 3 months' duration as first-line treatment.","Process","QS77 - Urinary incontinence in women","4 - QS77 - Urinary incontinence in women",1,"4 - QS77 - Urinary incontinence in women - Process - 1","The number in the denominator who have a supervised pelvic floor muscle training programme of at least 3 months' duration as first-line treatment.","The number of women with stress or mixed urinary incontinence."]
[null,"QS77","Urinary incontinence in women",5,null,"Women with symptoms of urgency or mixed urinary incontinence are offered bladder training for a minimum of 6 weeks as first-line treatment.","Evidence of local arrangements to ensure that women with symptoms of urgency or mixed urinary incontinence are offered bladder training for a minimum of 6 weeks as first-line treatment.  ","Structure","QS77 - Urinary incontinence in women","5 - QS77 - Urinary incontinence in women",{"$f":"IF(AND(B1585=B1584, D1585=D1584, H1585=H1584)=TRUE, K1584+1, 1)","v":1},{"$f":"CONCATENATE(J1585, \" - \", H1585, \" - \",K1585)","v":"5 - QS77 - Urinary incontinence in women - Structure - 1"},"",""]
[null,"QS77","Urinary incontinence in women",5,null,"Women with symptoms of urgency or mixed urinary incontinence are offered bladder training for a minimum of 6 weeks as first-line treatment.","Proportion of women with symptoms of urgency or mixed urinary incontinence who have bladder training for a minimum of 6 weeks as first-line treatment. ","Process","QS77 - Urinary incontinence in women","5 - QS77 - Urinary incontinence in women",1,"5 - QS77 - Urinary incontinence in women - Process - 1","The number in the denominator who have bladder training for a minimum of 6 weeks as first‑line treatment.","The number of women having first‑line treatment for urgency or mixed urinary incontinence."]
[null,"QS77","Urinary incontinence in women",6,null,"Women with urinary incontinence have indwelling urethral catheters for long-term treatment only if they have an assessment and discussion of the practicalities and potential urological complications.","Evidence of local arrangements to ensure that healthcare professionals offer women with urinary incontinence long-term treatment with indwelling urethral catheters only if they have had assessment and discussion about the practicalities and potential urological complications.  ","Structure","QS77 - Urinary incontinence in women","6 - QS77 - Urinary incontinence in women",1,"6 - QS77 - Urinary incontinence in women - Structure - 1","",""]
[null,"QS77","Urinary incontinence in women",6,null,"Women with urinary incontinence have indwelling urethral catheters for long-term treatment only if they have an assessment and discussion of the practicalities and potential urological complications.","Proportion of women with urinary incontinence who had assessment and discussion of the practicalities and potential urological complications of the long-term use of indwelling urethral catheters. ","Process","QS77 - Urinary incontinence in women","6 - QS77 - Urinary incontinence in women",1,"6 - QS77 - Urinary incontinence in women - Process - 1","The number in the denominator who had assessment and discussion of the practicalities and potential urological complications of long‑term use of indwelling urethral catheters before the fitting of the indwelling urethral catheter.","The number of women with urinary incontinence who have indwelling urethral catheters for long‑term use."]
[null,"QS77","Urinary incontinence in women",7,null,"Women with overactive bladder or stress urinary incontinence symptoms have a multidisciplinary team review before they are offered surgery or other invasive treatment.","Evidence of local arrangements to ensure that a multidisciplinary team reviews the treatment options before surgery or other invasive treatment are offered to women with overactive bladder or stress urinary incontinence.","Structure","QS77 - Urinary incontinence in women","7 - QS77 - Urinary incontinence in women",1,"7 - QS77 - Urinary incontinence in women - Structure - 1","",""]
[null,"QS77","Urinary incontinence in women",7,null,"Women with overactive bladder or stress urinary incontinence symptoms have a multidisciplinary team review before they are offered surgery or other invasive treatment.","Proportion of women with overactive bladder or stress urinary incontinence who have a multidisciplinary team review before they are offered surgery or other invasive treatment.","Process","QS77 - Urinary incontinence in women","7 - QS77 - Urinary incontinence in women",1,"7 - QS77 - Urinary incontinence in women - Process - 1","The number in the denominator who had a multidisciplinary team review before they are offered surgery or other invasive treatment.","The number of women with overactive bladder or stress urinary incontinence who have surgery or other invasive treatment."]
[null,"QS78","Sarcoma",1,null,"Sarcoma advisory groups and sarcoma multidisciplinary teams (MDTs) have pathways for referral and diagnosis in place for people with suspected sarcoma","Evidence that sarcoma advisory groups and sarcoma MDTs have pathways for referral and diagnosis in place for people with suspected sarcoma","Structure","QS78 - Sarcoma","1 - QS78 - Sarcoma",1,"1 - QS78 - Sarcoma - Structure - 1","",""]
[null,"QS78","Sarcoma",1,null,"Sarcoma advisory groups and sarcoma multidisciplinary teams (MDTs) have pathways for referral and diagnosis in place for people with suspected sarcoma","Evidence of local arrangements to agree and communicate diagnostic pathways with primary and secondary care providers.","Structure","QS78 - Sarcoma","1 - QS78 - Sarcoma",2,"1 - QS78 - Sarcoma - Structure - 2","",""]
[null,"QS78","Sarcoma",1,null,"Sarcoma advisory groups and sarcoma multidisciplinary teams (MDTs) have pathways for referral and diagnosis in place for people with suspected sarcoma","Stage of sarcoma at diagnosis.","Outcome","QS78 - Sarcoma","1 - QS78 - Sarcoma",1,"1 - QS78 - Sarcoma - Outcome - 1"]
[null,"QS78","Sarcoma",2,null,"Adults, children and young people with bone sarcoma and adults with soft tissue sarcoma have their care plan confirmed by a sarcoma multidisciplinary team (MDT) and treatment delivered by services designated by the sarcoma advisory group.","Evidence of written protocols and local arrangements for adults, children and young people with bone sarcoma and adults with soft tissue sarcoma to have their care plan confirmed by a sarcoma MDT and treatment delivered by services designated by the sarcoma advisory group.","Structure","QS78 - Sarcoma","2 - QS78 - Sarcoma",1,"2 - QS78 - Sarcoma - Structure - 1","",""]
[null,"QS78","Sarcoma",2,null,"Adults, children and young people with bone sarcoma and adults with soft tissue sarcoma have their care plan confirmed by a sarcoma multidisciplinary team (MDT) and treatment delivered by services designated by the sarcoma advisory group.","Evidence of written protocols and pathways agreed between sarcoma MDTs and site‑specific cancer MDTs clarifying the circumstances in which patient care should be transferred from one team to the other","Structure","QS78 - Sarcoma","2 - QS78 - Sarcoma",2,"2 - QS78 - Sarcoma - Structure - 2","",""]
[null,"QS78","Sarcoma",2,null,"Adults, children and young people with bone sarcoma and adults with soft tissue sarcoma have their care plan confirmed by a sarcoma multidisciplinary team (MDT) and treatment delivered by services designated by the sarcoma advisory group.","Proportion of adults, children and young people with bone sarcomas who have their care plan confirmed by a sarcoma MDT and treatment delivered by services designated by the sarcoma advisory group.","Process","QS78 - Sarcoma","2 - QS78 - Sarcoma",1,"2 - QS78 - Sarcoma - Process - 1","The number in the denominator who have their care plan confirmed by a sarcoma MDT and treatment delivered by services designated by the sarcoma advisory group.","The number of adults, children and young people with bone sarcomas."]
[null,"QS78","Sarcoma",2,null,"Adults, children and young people with bone sarcoma and adults with soft tissue sarcoma have their care plan confirmed by a sarcoma multidisciplinary team (MDT) and treatment delivered by services designated by the sarcoma advisory group.","Proportion of adults with soft tissue sarcomas who have their care plan confirmed by a sarcoma MDT and treatment delivered by services designated by the sarcoma advisory group.","Process","QS78 - Sarcoma","2 - QS78 - Sarcoma",2,"2 - QS78 - Sarcoma - Process - 2","The number in the denominator who have their care plan confirmed by a sarcoma MDT and treatment delivered by services designated by the sarcoma advisory group.","The number of adults with soft tissue sarcomas."]
[null,"QS78","Sarcoma",3,null,"Sarcoma multidisciplinary teams (MDTs) publish information about their shared pathways, activity and patient outcomes, including information on site‑specific sarcomas.","Evidence of local arrangements for sarcoma MDTs to publish information about shared pathways, activity and patient outcomes, including information on site‑specific sarcomas. ","Structure","QS78 - Sarcoma","3 - QS78 - Sarcoma",1,"3 - QS78 - Sarcoma - Structure - 1","",""]
[null,"QS78","Sarcoma",4,null,"People with a retroperitoneal sarcoma are referred before having any treatment to a sarcoma treatment centre with special expertise in managing this type of tumour.","Evidence of local arrangements and protocols to ensure that people with a retroperitoneal sarcoma are referred before having any treatment to a sarcoma treatment centre with special expertise in managing this type of tumour.","Structure","QS78 - Sarcoma","4 - QS78 - Sarcoma",1,"4 - QS78 - Sarcoma - Structure - 1","",""]
[null,"QS78","Sarcoma",4,null,"People with a retroperitoneal sarcoma are referred before having any treatment to a sarcoma treatment centre with special expertise in managing this type of tumour.","Proportion of people with a retroperitoneal sarcoma who are referred before having any treatment to a sarcoma treatment centre with special expertise in managing this type of tumour.","Process","QS78 - Sarcoma","4 - QS78 - Sarcoma",1,"4 - QS78 - Sarcoma - Process - 1","The number in the denominator who are referred before having any treatment to a sarcoma treatment centre with special expertise in managing this type of tumour.","The number of people with a retroperitoneal sarcoma."]
[null,"QS78","Sarcoma",4,null,"People with a retroperitoneal sarcoma are referred before having any treatment to a sarcoma treatment centre with special expertise in managing this type of tumour.","Retroperitoneal sarcoma survival rate.","Outcome","QS78 - Sarcoma","4 - QS78 - Sarcoma",1,"4 - QS78 - Sarcoma - Outcome - 1"]
[null,"QS78","Sarcoma",5,null,"Surgeons performing planned resections of sarcomas are core or extended members of a sarcoma multidisciplinary team (MDT).","Evidence of local arrangements and protocols to ensure that people who have planned resection of their sarcoma have it performed by a surgeon who is a core or extended member of a sarcoma MDT.","Structure","QS78 - Sarcoma","5 - QS78 - Sarcoma",1,"5 - QS78 - Sarcoma - Structure - 1","",""]
[null,"QS78","Sarcoma",5,null,"Surgeons performing planned resections of sarcomas are core or extended members of a sarcoma multidisciplinary team (MDT).","Proportion of planned sarcoma resections that are performed by a surgeon who is a core or extended member of a sarcoma MDT.","Process","QS78 - Sarcoma","5 - QS78 - Sarcoma",1,"5 - QS78 - Sarcoma - Process - 1","The number in the denominator that are performed by a surgeon who is a core or extended member of a sarcoma MDT.","The number of planned sarcoma resections."]
[null,"QS78","Sarcoma",5,null,"Surgeons performing planned resections of sarcomas are core or extended members of a sarcoma multidisciplinary team (MDT).","30‑day mortality rate post‑sarcoma resection.","Outcome","QS78 - Sarcoma","5 - QS78 - Sarcoma",1,"5 - QS78 - Sarcoma - Outcome - 1"]
[null,"QS78","Sarcoma",5,null,"Surgeons performing planned resections of sarcomas are core or extended members of a sarcoma multidisciplinary team (MDT).","Recurrence within 2 years of initial surgery.","Outcome","QS78 - Sarcoma","5 - QS78 - Sarcoma",2,"5 - QS78 - Sarcoma - Outcome - 2"]
[null,"QS78","Sarcoma",6,null,"People with sarcoma are supported by an allocated key worker with specialist knowledge of sarcomas and their treatment.","Evidence of local arrangements to provide a designated key worker with specialist knowledge of sarcomas and their treatment for all people with sarcoma. ","Structure","QS78 - Sarcoma","6 - QS78 - Sarcoma",1,"6 - QS78 - Sarcoma - Structure - 1","",""]
[null,"QS78","Sarcoma",6,null,"People with sarcoma are supported by an allocated key worker with specialist knowledge of sarcomas and their treatment.","Proportion of people with sarcoma who have an allocated key worker with specialist knowledge of sarcomas and their treatment. ","Process","QS78 - Sarcoma","6 - QS78 - Sarcoma",1,"6 - QS78 - Sarcoma - Process - 1","The number in the denominator who are allocated a key worker with specialist knowledge of sarcomas and their treatment.","The number of people with sarcoma."]
[null,"QS78","Sarcoma",6,null,"People with sarcoma are supported by an allocated key worker with specialist knowledge of sarcomas and their treatment.","Coordination of care.","Outcome","QS78 - Sarcoma","6 - QS78 - Sarcoma",1,"6 - QS78 - Sarcoma - Outcome - 1"]
[null,"QS78","Sarcoma",6,null,"People with sarcoma are supported by an allocated key worker with specialist knowledge of sarcomas and their treatment.","Patient satisfaction and availability of key worker.","Outcome","QS78 - Sarcoma","6 - QS78 - Sarcoma",2,"6 - QS78 - Sarcoma - Outcome - 2"]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",1,null,"People are diagnosed with idiopathic pulmonary fibrosis only with the consensus of a multidisciplinary team with expertise in interstitial lung disease.","Evidence of local arrangements to ensure the availability of a multidisciplinary team with expertise in interstitial lung disease to diagnose idiopathic pulmonary fibrosis.","Structure","QS79 - Idiopathic pulmonary fibrosis in adults","1 - QS79 - Idiopathic pulmonary fibrosis in adults",1,"1 - QS79 - Idiopathic pulmonary fibrosis in adults - Structure - 1","",""]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",1,null,"People are diagnosed with idiopathic pulmonary fibrosis only with the consensus of a multidisciplinary team with expertise in interstitial lung disease.","Proportion of people diagnosed with idiopathic pulmonary fibrosis by a multidisciplinary team with expertise in interstitial lung disease.","Process","QS79 - Idiopathic pulmonary fibrosis in adults","1 - QS79 - Idiopathic pulmonary fibrosis in adults",1,"1 - QS79 - Idiopathic pulmonary fibrosis in adults - Process - 1","The number in the denominator whose condition was diagnosed with the consensus of a multidisciplinary team with expertise in interstitial lung disease.","The number of people diagnosed with idiopathic pulmonary fibrosis."]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",2,null,"People with idiopathic pulmonary fibrosis have an interstitial lung disease specialist nurse available to them.","Evidence of local arrangements to ensure that an interstitial lung disease specialist nurse is available to people with idiopathic pulmonary fibrosis at all stages of the care pathway.","Structure","QS79 - Idiopathic pulmonary fibrosis in adults","2 - QS79 - Idiopathic pulmonary fibrosis in adults",1,"2 - QS79 - Idiopathic pulmonary fibrosis in adults - Structure - 1","",""]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",2,null,"People with idiopathic pulmonary fibrosis have an interstitial lung disease specialist nurse available to them.","Proportion of people with idiopathic pulmonary fibrosis with an allocated interstitial lung disease specialist nurse.","Process","QS79 - Idiopathic pulmonary fibrosis in adults","2 - QS79 - Idiopathic pulmonary fibrosis in adults",1,"2 - QS79 - Idiopathic pulmonary fibrosis in adults - Process - 1","The number in the denominator with an allocated interstitial lung disease specialist nurse.","The number of people with idiopathic pulmonary fibrosis."]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",2,null,"People with idiopathic pulmonary fibrosis have an interstitial lung disease specialist nurse available to them.","Satisfaction of people with idiopathic pulmonary fibrosis, and their families and carers, with the support they receive.","Outcome","QS79 - Idiopathic pulmonary fibrosis in adults","2 - QS79 - Idiopathic pulmonary fibrosis in adults",1,"2 - QS79 - Idiopathic pulmonary fibrosis in adults - Outcome - 1"]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",3,null,"People with idiopathic pulmonary fibrosis have an assessment for home and ambulatory oxygen therapy at each follow-up appointment and before they leave hospital following an exacerbation of the disease.","Evidence of local arrangements to ensure that people with idiopathic pulmonary fibrosis have an assessment for home and ambulatory oxygen therapy considered at each follow-up appointment.","Structure","QS79 - Idiopathic pulmonary fibrosis in adults",{"$f":"CONCATENATE(D1615, \" - \", I1615)","v":"3 - QS79 - Idiopathic pulmonary fibrosis in adults"},{"$f":"IF(AND(B1615=B1614, D1615=D1614, H1615=H1614)=TRUE, K1614+1, 1)","v":1},{"$f":"CONCATENATE(J1615, \" - \", H1615, \" - \",K1615)","v":"3 - QS79 - Idiopathic pulmonary fibrosis in adults - Structure - 1"},"",""]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",3,null,"People with idiopathic pulmonary fibrosis have an assessment for home and ambulatory oxygen therapy at each follow-up appointment and before they leave hospital following an exacerbation of the disease.","Evidence of local arrangements to ensure that people with idiopathic pulmonary fibrosis are assessed for home and ambulatory oxygen therapy before discharge if they have been admitted to hospital because of an exacerbation of the disease.","Structure","QS79 - Idiopathic pulmonary fibrosis in adults","3 - QS79 - Idiopathic pulmonary fibrosis in adults",2,"3 - QS79 - Idiopathic pulmonary fibrosis in adults - Structure - 2","",""]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",3,null,"People with idiopathic pulmonary fibrosis have an assessment for home and ambulatory oxygen therapy at each follow-up appointment and before they leave hospital following an exacerbation of the disease.","Proportion of idiopathic pulmonary fibrosis follow-up appointments at which an assessment for home and ambulatory oxygen therapy was made.","Process","QS79 - Idiopathic pulmonary fibrosis in adults","3 - QS79 - Idiopathic pulmonary fibrosis in adults",1,"3 - QS79 - Idiopathic pulmonary fibrosis in adults - Process - 1","The number in the denominator at which assessment for home and ambulatory oxygen therapy was carried out.","The number of follow‑up appointments for people with idiopathic pulmonary fibrosis."]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",3,null,"People with idiopathic pulmonary fibrosis have an assessment for home and ambulatory oxygen therapy at each follow-up appointment and before they leave hospital following an exacerbation of the disease.","Proportion of hospital stays because of an exacerbation of idiopathic pulmonary fibrosis during which an assessment for home and ambulatory oxygen therapy was made.","Process","QS79 - Idiopathic pulmonary fibrosis in adults","3 - QS79 - Idiopathic pulmonary fibrosis in adults",2,"3 - QS79 - Idiopathic pulmonary fibrosis in adults - Process - 2","The number in the denominator during which an assessment for home and ambulatory oxygen therapy was carried out before discharge.","The number of hospital stays because of an exacerbation of idiopathic pulmonary fibrosis."]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",3,null,"People with idiopathic pulmonary fibrosis have an assessment for home and ambulatory oxygen therapy at each follow-up appointment and before they leave hospital following an exacerbation of the disease.","Quality of life and wellbeing of people with idiopathic pulmonary fibrosis.","Outcome","QS79 - Idiopathic pulmonary fibrosis in adults","3 - QS79 - Idiopathic pulmonary fibrosis in adults",1,"3 - QS79 - Idiopathic pulmonary fibrosis in adults - Outcome - 1"]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",4,null,"Pulmonary rehabilitation programmes provide services that are designed specifically for idiopathic pulmonary fibrosis.","Evidence of local arrangements to ensure that pulmonary rehabilitation programmes are tailored to the needs of people with idiopathic pulmonary fibrosis.","Structure",{"$f":"CONCATENATE(B1620, \" - \", C1620)","v":"QS79 - Idiopathic pulmonary fibrosis in adults"},"4 - QS79 - Idiopathic pulmonary fibrosis in adults",1,"4 - QS79 - Idiopathic pulmonary fibrosis in adults - Structure - 1","",""]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",4,null,"Pulmonary rehabilitation programmes provide services that are designed specifically for idiopathic pulmonary fibrosis.","Proportion of people with idiopathic pulmonary fibrosis who are offered pulmonary rehabilitation tailored to idiopathic pulmonary fibrosis.","Process","QS79 - Idiopathic pulmonary fibrosis in adults","4 - QS79 - Idiopathic pulmonary fibrosis in adults",1,"4 - QS79 - Idiopathic pulmonary fibrosis in adults - Process - 1","The number in the denominator whose pulmonary rehabilitation is tailored to idiopathic pulmonary fibrosis.","The number of people with idiopathic pulmonary fibrosis who start pulmonary rehabilitation."]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",4,null,"Pulmonary rehabilitation programmes provide services that are designed specifically for idiopathic pulmonary fibrosis.","Quality of life and wellbeing of people with idiopathic pulmonary fibrosis.","Outcome","QS79 - Idiopathic pulmonary fibrosis in adults","4 - QS79 - Idiopathic pulmonary fibrosis in adults",1,"4 - QS79 - Idiopathic pulmonary fibrosis in adults - Outcome - 1"]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",4,null,"Pulmonary rehabilitation programmes provide services that are designed specifically for idiopathic pulmonary fibrosis.","Hospital admissions, inpatient hospital days and readmissions for people with idiopathic pulmonary fibrosis.","Outcome","QS79 - Idiopathic pulmonary fibrosis in adults","4 - QS79 - Idiopathic pulmonary fibrosis in adults",2,"4 - QS79 - Idiopathic pulmonary fibrosis in adults - Outcome - 2"]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",5,null,"People with idiopathic pulmonary fibrosis and their families and carers have access to services that meet their palliative care needs.","Evidence of local arrangements to ensure that people with idiopathic pulmonary fibrosis and their families and carers have access to services that meet their palliative care needs.","Structure","QS79 - Idiopathic pulmonary fibrosis in adults","5 - QS79 - Idiopathic pulmonary fibrosis in adults",1,"5 - QS79 - Idiopathic pulmonary fibrosis in adults - Structure - 1","",""]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",5,null,"People with idiopathic pulmonary fibrosis and their families and carers have access to services that meet their palliative care needs.","Proportion of follow-up appointments for people with idiopathic pulmonary fibrosis with a recorded assessment of their current palliative care needs (including the needs of families and carers, if appropriate).","Process","QS79 - Idiopathic pulmonary fibrosis in adults","5 - QS79 - Idiopathic pulmonary fibrosis in adults",1,"5 - QS79 - Idiopathic pulmonary fibrosis in adults - Process - 1","The number in the denominator at which the current palliative care needs (including the needs of families and carers, if appropriate) have been assessed.","The number of follow‑up appointments for people with idiopathic pulmonary fibrosis."]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",5,null,"People with idiopathic pulmonary fibrosis and their families and carers have access to services that meet their palliative care needs.","Proportion of people with idiopathic pulmonary fibrosis whose current recorded palliative care needs (including the needs of families and carers, if appropriate) are met.","Process","QS79 - Idiopathic pulmonary fibrosis in adults","5 - QS79 - Idiopathic pulmonary fibrosis in adults",2,"5 - QS79 - Idiopathic pulmonary fibrosis in adults - Process - 2","The number in the denominator whose current palliative care needs (including the needs of families and carers, if appropriate) are met.","The number of people with idiopathic pulmonary fibrosis whose palliative care needs have been assessed."]
[null,"QS79","Idiopathic pulmonary fibrosis in adults",5,null,"People with idiopathic pulmonary fibrosis and their families and carers have access to services that meet their palliative care needs.","Satisfaction of people with idiopathic pulmonary fibrosis, and their families and carers, with the support they receive to manage their condition.","Outcome","QS79 - Idiopathic pulmonary fibrosis in adults","5 - QS79 - Idiopathic pulmonary fibrosis in adults",1,"5 - QS79 - Idiopathic pulmonary fibrosis in adults - Outcome - 1"]
[null,"QS80","Psychosis and schizophrenia in adults",1,null,"Adults with a first episode of psychosis start treatment in early intervention in psychosis services within 2 weeks of referral.","Evidence of local arrangements to ensure that early intervention in psychosis services are in place.","Structure","QS80 - Psychosis and schizophrenia in adults","1 - QS80 - Psychosis and schizophrenia in adults",1,"1 - QS80 - Psychosis and schizophrenia in adults - Structure - 1","",""]
[null,"QS80","Psychosis and schizophrenia in adults",1,null,"Adults with a first episode of psychosis start treatment in early intervention in psychosis services within 2 weeks of referral.","Evidence of local arrangements to ensure that local referral pathways are available for adults with a first episode of psychosis to start treatment in early intervention in psychosis services within 2 weeks of referral.","Structure","QS80 - Psychosis and schizophrenia in adults","1 - QS80 - Psychosis and schizophrenia in adults",2,"1 - QS80 - Psychosis and schizophrenia in adults - Structure - 2","",""]
[null,"QS80","Psychosis and schizophrenia in adults",1,null,"Adults with a first episode of psychosis start treatment in early intervention in psychosis services within 2 weeks of referral.","Proportion of adults referred with a first episode of psychosis who receive treatment from early intervention in psychosis services within 2 weeks of referral.","Process","QS80 - Psychosis and schizophrenia in adults","1 - QS80 - Psychosis and schizophrenia in adults",1,"1 - QS80 - Psychosis and schizophrenia in adults - Process - 1","The number in the denominator who receive treatment from early intervention in psychosis services within 2 weeks.","The number of adults referred with a first episode of psychosis."]
[null,"QS80","Psychosis and schizophrenia in adults",1,null,"Adults with a first episode of psychosis start treatment in early intervention in psychosis services within 2 weeks of referral.","Acute hospital admission rates.","Outcome","QS80 - Psychosis and schizophrenia in adults","1 - QS80 - Psychosis and schizophrenia in adults",1,"1 - QS80 - Psychosis and schizophrenia in adults - Outcome - 1"]
[null,"QS80","Psychosis and schizophrenia in adults",1,null,"Adults with a first episode of psychosis start treatment in early intervention in psychosis services within 2 weeks of referral.","Duration of untreated psychosis.","Outcome","QS80 - Psychosis and schizophrenia in adults","1 - QS80 - Psychosis and schizophrenia in adults",2,"1 - QS80 - Psychosis and schizophrenia in adults - Outcome - 2"]
[null,"QS80","Psychosis and schizophrenia in adults",2,null,"Adults with psychosis or schizophrenia are offered cognitive behavioural therapy for psychosis (CBTp).","Evidence of local arrangements to ensure that CBTp is available to adults with psychosis or schizophrenia.","Structure","QS80 - Psychosis and schizophrenia in adults","2 - QS80 - Psychosis and schizophrenia in adults",1,"2 - QS80 - Psychosis and schizophrenia in adults - Structure - 1","",""]
[null,"QS80","Psychosis and schizophrenia in adults",2,null,"Adults with psychosis or schizophrenia are offered cognitive behavioural therapy for psychosis (CBTp).","Proportion of adults with psychosis who receive CBTp.","Process","QS80 - Psychosis and schizophrenia in adults","2 - QS80 - Psychosis and schizophrenia in adults",1,"2 - QS80 - Psychosis and schizophrenia in adults - Process - 1","The number in the denominator who receive CBTp.","The number of adults with psychosis."]
[null,"QS80","Psychosis and schizophrenia in adults",2,null,"Adults with psychosis or schizophrenia are offered cognitive behavioural therapy for psychosis (CBTp).","Proportion of adults with schizophrenia who receive CBTp.","Process","QS80 - Psychosis and schizophrenia in adults","2 - QS80 - Psychosis and schizophrenia in adults",2,"2 - QS80 - Psychosis and schizophrenia in adults - Process - 2","The number in the denominator who receive CBTp.","The number of adults with schizophrenia."]
[null,"QS80","Psychosis and schizophrenia in adults",2,null,"Adults with psychosis or schizophrenia are offered cognitive behavioural therapy for psychosis (CBTp).","Relapse rates of psychosis and schizophrenia in adults.","Outcome","QS80 - Psychosis and schizophrenia in adults","2 - QS80 - Psychosis and schizophrenia in adults",1,"2 - QS80 - Psychosis and schizophrenia in adults - Outcome - 1"]
[null,"QS80","Psychosis and schizophrenia in adults",3,null,"Family members of adults with psychosis or schizophrenia are offered family intervention.","Evidence of local arrangements to ensure that family intervention is available to family members of adults with psychosis or schizophrenia.","Structure","QS80 - Psychosis and schizophrenia in adults","3 - QS80 - Psychosis and schizophrenia in adults",1,"3 - QS80 - Psychosis and schizophrenia in adults - Structure - 1","",""]
[null,"QS80","Psychosis and schizophrenia in adults",3,null,"Family members of adults with psychosis or schizophrenia are offered family intervention.","Proportion of adults with psychosis whose family members receive family intervention.","Process","QS80 - Psychosis and schizophrenia in adults","3 - QS80 - Psychosis and schizophrenia in adults",1,"3 - QS80 - Psychosis and schizophrenia in adults - Process - 1","The number in the denominator whose family members receive family intervention.","The number of adults with psychosis who live with or are in close contact with family members."]
[null,"QS80","Psychosis and schizophrenia in adults",3,null,"Family members of adults with psychosis or schizophrenia are offered family intervention.","Proportion of adults with schizophrenia whose family members receive family intervention.","Process","QS80 - Psychosis and schizophrenia in adults","3 - QS80 - Psychosis and schizophrenia in adults",2,"3 - QS80 - Psychosis and schizophrenia in adults - Process - 2","The number in the denominator whose family members receive family intervention.","The number of adults with schizophrenia who live with or are in close contact with family members."]
[null,"QS80","Psychosis and schizophrenia in adults",3,null,"Family members of adults with psychosis or schizophrenia are offered family intervention.","Relapse rates of psychosis and schizophrenia in adults.","Outcome","QS80 - Psychosis and schizophrenia in adults","3 - QS80 - Psychosis and schizophrenia in adults",1,"3 - QS80 - Psychosis and schizophrenia in adults - Outcome - 1"]
[null,"QS80","Psychosis and schizophrenia in adults",4,null,"Adults with schizophrenia that has not responded adequately to treatment with at least 2 antipsychotic drugs are offered clozapine.","Evidence of local arrangements to ensure that adults with schizophrenia that has not responded adequately to treatment with at least 2 antipsychotics drugs (at least 1 of which should be a non‑clozapine second‑generation antipsychotic) are offered clozapine.","Structure","QS80 - Psychosis and schizophrenia in adults","4 - QS80 - Psychosis and schizophrenia in adults",1,"4 - QS80 - Psychosis and schizophrenia in adults - Structure - 1","",""]
[null,"QS80","Psychosis and schizophrenia in adults",4,null,"Adults with schizophrenia that has not responded adequately to treatment with at least 2 antipsychotic drugs are offered clozapine.","Proportion of adults with schizophrenia that has not responded adequately to treatment with at least 2 antipsychotic drugs (at least 1 of which should be a non‑clozapine second‑generation antipsychotic) who receive clozapine.","Process","QS80 - Psychosis and schizophrenia in adults","4 - QS80 - Psychosis and schizophrenia in adults",1,"4 - QS80 - Psychosis and schizophrenia in adults - Process - 1","The number in the denominator who receive clozapine.","The number of adults with schizophrenia that has not responded adequately to treatment with at least 2 antipsychotic drugs (at least 1 of which should be a non‑clozapine second‑generation antipsychotic)."]
[null,"QS80","Psychosis and schizophrenia in adults",4,null,"Adults with schizophrenia that has not responded adequately to treatment with at least 2 antipsychotic drugs are offered clozapine.","Relapse rates of schizophrenia in adults.","Outcome","QS80 - Psychosis and schizophrenia in adults","4 - QS80 - Psychosis and schizophrenia in adults",1,"4 - QS80 - Psychosis and schizophrenia in adults - Outcome - 1"]
[null,"QS80","Psychosis and schizophrenia in adults",5,null,"Adults with psychosis or schizophrenia who wish to find or return to work are offered supported employment programmes.","Evidence of local arrangements to ensure that adults with psychosis or schizophrenia who wish to find or return to work are offered supported employment programmes.","Structure","QS80 - Psychosis and schizophrenia in adults","5 - QS80 - Psychosis and schizophrenia in adults",1,"5 - QS80 - Psychosis and schizophrenia in adults - Structure - 1","",""]
[null,"QS80","Psychosis and schizophrenia in adults",5,null,"Adults with psychosis or schizophrenia who wish to find or return to work are offered supported employment programmes.","Proportion of adults with psychosis or schizophrenia who wish to find or return to work who receive supported employment programmes.","Process","QS80 - Psychosis and schizophrenia in adults","5 - QS80 - Psychosis and schizophrenia in adults",1,"5 - QS80 - Psychosis and schizophrenia in adults - Process - 1","The number in the denominator who receive supported employment programmes.","The number of adults with psychosis or schizophrenia who wish to find or return to work."]
[null,"QS80","Psychosis and schizophrenia in adults",5,null,"Adults with psychosis or schizophrenia who wish to find or return to work are offered supported employment programmes.","Employment rates for adults with psychosis or schizophrenia.","Outcome","QS80 - Psychosis and schizophrenia in adults","5 - QS80 - Psychosis and schizophrenia in adults",1,"5 - QS80 - Psychosis and schizophrenia in adults - Outcome - 1"]
[null,"QS80","Psychosis and schizophrenia in adults",6,null,"Adults with psychosis or schizophrenia have specific comprehensive physical health assessments.","Evidence of local arrangements to ensure that adults with psychosis or schizophrenia receive comprehensive physical health assessments.","Structure","QS80 - Psychosis and schizophrenia in adults","6 - QS80 - Psychosis and schizophrenia in adults",1,"6 - QS80 - Psychosis and schizophrenia in adults - Structure - 1","",""]
[null,"QS80","Psychosis and schizophrenia in adults",6,null,"Adults with psychosis or schizophrenia have specific comprehensive physical health assessments.","Proportion of adults having treatment for first episode of psychosis who receive a comprehensive physical health assessment within 12 weeks.","Process","QS80 - Psychosis and schizophrenia in adults","6 - QS80 - Psychosis and schizophrenia in adults",1,"6 - QS80 - Psychosis and schizophrenia in adults - Process - 1","The number in the denominator who receive a comprehensive physical health assessment within 12 weeks.","The number of adults having treatment for a first episode of psychosis."]
[null,"QS80","Psychosis and schizophrenia in adults",6,null,"Adults with psychosis or schizophrenia have specific comprehensive physical health assessments.","Proportion of adults having treatment for first episode of psychosis who have a comprehensive physical health assessment 1 year after starting treatment.","Process","QS80 - Psychosis and schizophrenia in adults","6 - QS80 - Psychosis and schizophrenia in adults",2,"6 - QS80 - Psychosis and schizophrenia in adults - Process - 2","The number in the denominator who have a comprehensive physical health assessment 1 year after starting treatment.","The number of adults having treatment for a first episode of psychosis."]
[null,"QS80","Psychosis and schizophrenia in adults",6,null,"Adults with psychosis or schizophrenia have specific comprehensive physical health assessments.","Proportion of adults with psychosis and schizophrenia who have an annual comprehensive physical health assessment.","Process","QS80 - Psychosis and schizophrenia in adults","6 - QS80 - Psychosis and schizophrenia in adults",3,"6 - QS80 - Psychosis and schizophrenia in adults - Process - 3","The number in the denominator who have an annual comprehensive physical health assessment.","The number of adults with psychosis or schizophrenia."]
[null,"QS80","Psychosis and schizophrenia in adults",6,null,"Adults with psychosis or schizophrenia have specific comprehensive physical health assessments.","Premature mortality of adults with psychosis or schizophrenia.","Outcome","QS80 - Psychosis and schizophrenia in adults","6 - QS80 - Psychosis and schizophrenia in adults",1,"6 - QS80 - Psychosis and schizophrenia in adults - Outcome - 1"]
[null,"QS80","Psychosis and schizophrenia in adults",7,null,"Adults with psychosis or schizophrenia are offered combined healthy eating and physical activity programmes, and help to stop smoking.","Evidence of local arrangements to ensure that adults with psychosis or schizophrenia are offered combined healthy eating and physical activity programmes.","Structure","QS80 - Psychosis and schizophrenia in adults","7 - QS80 - Psychosis and schizophrenia in adults",1,"7 - QS80 - Psychosis and schizophrenia in adults - Structure - 1","",""]
[null,"QS80","Psychosis and schizophrenia in adults",7,null,"Adults with psychosis or schizophrenia are offered combined healthy eating and physical activity programmes, and help to stop smoking.","Evidence of local arrangements to ensure that adults with psychosis or schizophrenia who smoke are offered help to stop smoking.","Structure","QS80 - Psychosis and schizophrenia in adults","7 - QS80 - Psychosis and schizophrenia in adults",2,"7 - QS80 - Psychosis and schizophrenia in adults - Structure - 2","",""]
[null,"QS80","Psychosis and schizophrenia in adults",7,null,"Adults with psychosis or schizophrenia are offered combined healthy eating and physical activity programmes, and help to stop smoking.","Proportion of adults with psychosis or schizophrenia who received combined healthy eating and physical activity programmes within the past 12 months.","Process","QS80 - Psychosis and schizophrenia in adults","7 - QS80 - Psychosis and schizophrenia in adults",1,"7 - QS80 - Psychosis and schizophrenia in adults - Process - 1","The number in the denominator who received combined healthy eating and physical activity programmes within the past 12 months.","The number of adults with psychosis or schizophrenia."]
[null,"QS80","Psychosis and schizophrenia in adults",7,null,"Adults with psychosis or schizophrenia are offered combined healthy eating and physical activity programmes, and help to stop smoking.","Proportion of adults with psychosis or schizophrenia who smoke who received help to stop smoking within the past 12 months.","Process","QS80 - Psychosis and schizophrenia in adults","7 - QS80 - Psychosis and schizophrenia in adults",2,"7 - QS80 - Psychosis and schizophrenia in adults - Process - 2","The number in the denominator who received help to stop smoking within the past 12 months.","The number of adults with psychosis or schizophrenia who smoke."]
[null,"QS80","Psychosis and schizophrenia in adults",7,null,"Adults with psychosis or schizophrenia are offered combined healthy eating and physical activity programmes, and help to stop smoking.","Type 2 diabetes rates in adults with psychosis or schizophrenia.","Outcome","QS80 - Psychosis and schizophrenia in adults","7 - QS80 - Psychosis and schizophrenia in adults",1,"7 - QS80 - Psychosis and schizophrenia in adults - Outcome - 1"]
[null,"QS80","Psychosis and schizophrenia in adults",7,null,"Adults with psychosis or schizophrenia are offered combined healthy eating and physical activity programmes, and help to stop smoking.","Obesity rates in adults with psychosis or schizophrenia.","Outcome","QS80 - Psychosis and schizophrenia in adults","7 - QS80 - Psychosis and schizophrenia in adults",2,"7 - QS80 - Psychosis and schizophrenia in adults - Outcome - 2"]
[null,"QS80","Psychosis and schizophrenia in adults",7,null,"Adults with psychosis or schizophrenia are offered combined healthy eating and physical activity programmes, and help to stop smoking.","Smoking rates in adults with psychosis or schizophrenia.","Outcome","QS80 - Psychosis and schizophrenia in adults","7 - QS80 - Psychosis and schizophrenia in adults",3,"7 - QS80 - Psychosis and schizophrenia in adults - Outcome - 3"]
[null,"QS80","Psychosis and schizophrenia in adults",8,null,"Carers of adults with psychosis or schizophrenia are offered carer‑focused education and support programmes.","Evidence of local arrangements to ensure that carers of adults with psychosis or schizophrenia are offered a carer‑focused education and support programme.","Structure","QS80 - Psychosis and schizophrenia in adults","8 - QS80 - Psychosis and schizophrenia in adults",1,"8 - QS80 - Psychosis and schizophrenia in adults - Structure - 1","",""]
[null,"QS80","Psychosis and schizophrenia in adults",8,null,"Carers of adults with psychosis or schizophrenia are offered carer‑focused education and support programmes.","Proportion of adults with psychosis or schizophrenia whose carers receive a carer‑focused education and support programme.","Process","QS80 - Psychosis and schizophrenia in adults","8 - QS80 - Psychosis and schizophrenia in adults",1,"8 - QS80 - Psychosis and schizophrenia in adults - Process - 1","The number in the denominator whose carers receive a carer‑focused education and support programme.","The number of adults with psychosis or schizophrenia with an identified carer."]
[null,"QS80","Psychosis and schizophrenia in adults",8,null,"Carers of adults with psychosis or schizophrenia are offered carer‑focused education and support programmes.","Quality of life for carers of adults with psychosis or schizophrenia.","Outcome","QS80 - Psychosis and schizophrenia in adults","8 - QS80 - Psychosis and schizophrenia in adults",1,"8 - QS80 - Psychosis and schizophrenia in adults - Outcome - 1"]
[null,"QS81","Inflammatory bowel disease",1,null,"People with suspected inflammatory bowel disease have a specialist assessment within 4 weeks of referral.","Evidence of local referral pathways to ensure that people with suspected inflammatory bowel disease have a specialist assessment within 4 weeks of referral.","Structure","QS81 - Inflammatory bowel disease","1 - QS81 - Inflammatory bowel disease",1,"1 - QS81 - Inflammatory bowel disease - Structure - 1","",""]
[null,"QS81","Inflammatory bowel disease",1,null,"People with suspected inflammatory bowel disease have a specialist assessment within 4 weeks of referral.","Proportion of people with suspected inflammatory bowel disease who have a specialist assessment within 4 weeks of referral.","Process","QS81 - Inflammatory bowel disease","1 - QS81 - Inflammatory bowel disease",1,"1 - QS81 - Inflammatory bowel disease - Process - 1","The number in the denominator who have a specialist assessment within 4 weeks of referral.","The number of people with suspected inflammatory bowel disease who are referred for specialist assessment."]
[null,"QS81","Inflammatory bowel disease",1,null,"People with suspected inflammatory bowel disease have a specialist assessment within 4 weeks of referral.","Patient experience of the referral process.","Outcome","QS81 - Inflammatory bowel disease","1 - QS81 - Inflammatory bowel disease",1,"1 - QS81 - Inflammatory bowel disease - Outcome - 1"]
[null,"QS81","Inflammatory bowel disease",2,null,"Services provide age-appropriate support from a multidisciplinary team for people with inflammatory bowel disease, and their family members or carers.","Evidence that services provide age-appropriate support from a multidisciplinary team for people with inflammatory bowel disease, and their family members or carers.","Structure","QS81 - Inflammatory bowel disease","2 - QS81 - Inflammatory bowel disease",1,"2 - QS81 - Inflammatory bowel disease - Structure - 1","",""]
[null,"QS81","Inflammatory bowel disease",2,null,"Services provide age-appropriate support from a multidisciplinary team for people with inflammatory bowel disease, and their family members or carers.","Proportion of people with inflammatory bowel disease where there is a documented discussion about their needs, and the needs of their family members or carers (if appropriate), for age-appropriate support from a multidisciplinary team.","Process","QS81 - Inflammatory bowel disease","2 - QS81 - Inflammatory bowel disease",1,"2 - QS81 - Inflammatory bowel disease - Process - 1","The number in the denominator where there is a documented discussion about their needs, and the needs of their family members or carers (if appropriate), for age‑appropriate support from a multidisciplinary team.","The number of people with inflammatory bowel disease."]
[null,"QS81","Inflammatory bowel disease",2,null,"Services provide age-appropriate support from a multidisciplinary team for people with inflammatory bowel disease, and their family members or carers.","Proportion of people with inflammatory bowel disease whose needs, and the needs of their family members or carers (if appropriate), for age-appropriate support from a multidisciplinary team are met.","Process","QS81 - Inflammatory bowel disease","2 - QS81 - Inflammatory bowel disease",2,"2 - QS81 - Inflammatory bowel disease - Process - 2","The number in the denominator whose needs, and the needs of their family members or carers (if appropriate), for age‑appropriate support from a multidisciplinary team are met.","The number of people with inflammatory bowel disease whose needs for age‑appropriate support from a multidisciplinary team are recorded."]
[null,"QS81","Inflammatory bowel disease",2,null,"Services provide age-appropriate support from a multidisciplinary team for people with inflammatory bowel disease, and their family members or carers.","Satisfaction of people with inflammatory bowel disease with the support provided. ","Outcome","QS81 - Inflammatory bowel disease","2 - QS81 - Inflammatory bowel disease",1,"2 - QS81 - Inflammatory bowel disease - Outcome - 1"]
[null,"QS81","Inflammatory bowel disease",2,null,"Services provide age-appropriate support from a multidisciplinary team for people with inflammatory bowel disease, and their family members or carers.","Satisfaction of family members or carers of people with inflammatory bowel disease with the support provided. ","Outcome","QS81 - Inflammatory bowel disease","2 - QS81 - Inflammatory bowel disease",2,"2 - QS81 - Inflammatory bowel disease - Outcome - 2"]
[null,"QS81","Inflammatory bowel disease",3,null,"People having surgery for inflammatory bowel disease have it undertaken by a colorectal surgeon who is a core member of the inflammatory bowel disease multidisciplinary team.","Evidence of local arrangements to ensure that people having surgery for inflammatory bowel disease have it undertaken by a colorectal surgeon who is a core member of the inflammatory bowel disease multidisciplinary team.","Structure","QS81 - Inflammatory bowel disease","3 - QS81 - Inflammatory bowel disease",1,"3 - QS81 - Inflammatory bowel disease - Structure - 1","",""]
[null,"QS81","Inflammatory bowel disease",3,null,"People having surgery for inflammatory bowel disease have it undertaken by a colorectal surgeon who is a core member of the inflammatory bowel disease multidisciplinary team.","Proportion of surgical procedures for inflammatory bowel disease undertaken by a colorectal surgeon who is a core member of the inflammatory bowel disease multidisciplinary team.","Process","QS81 - Inflammatory bowel disease","3 - QS81 - Inflammatory bowel disease",1,"3 - QS81 - Inflammatory bowel disease - Process - 1","The number in the denominator undertaken by a colorectal surgeon who is a core member of the inflammatory bowel disease multidisciplinary team.","The number of surgical procedures for inflammatory bowel disease."]
[null,"QS81","Inflammatory bowel disease",3,null,"People having surgery for inflammatory bowel disease have it undertaken by a colorectal surgeon who is a core member of the inflammatory bowel disease multidisciplinary team.","Complications after surgery","Outcome","QS81 - Inflammatory bowel disease","3 - QS81 - Inflammatory bowel disease",1,"3 - QS81 - Inflammatory bowel disease - Outcome - 1"]
[null,"QS81","Inflammatory bowel disease",4,null,"People receiving drug treatment for inflammatory bowel disease are monitored for adverse effects.","Evidence of documented local safety policies and procedures to monitor for adverse effects in people receiving drug treatment for inflammatory bowel disease.","Structure","QS81 - Inflammatory bowel disease","4 - QS81 - Inflammatory bowel disease",1,"4 - QS81 - Inflammatory bowel disease - Structure - 1","",""]
[null,"QS81","Inflammatory bowel disease",4,null,"People receiving drug treatment for inflammatory bowel disease are monitored for adverse effects.","Proportion of people receiving drug treatment for inflammatory bowel disease who are monitored for adverse effects. ","Process","QS81 - Inflammatory bowel disease","4 - QS81 - Inflammatory bowel disease",1,"4 - QS81 - Inflammatory bowel disease - Process - 1","The number in the denominator for whom there is documented evidence that there is monitoring for adverse effects of drug treatment according to local safety policies and procedures.","The number of people receiving drug treatment for inflammatory bowel disease."]
[null,"QS81","Inflammatory bowel disease",4,null,"People receiving drug treatment for inflammatory bowel disease are monitored for adverse effects.","The number of adverse events reported because of drug treatment for inflammatory bowel disease.","Outcome","QS81 - Inflammatory bowel disease","4 - QS81 - Inflammatory bowel disease",1,"4 - QS81 - Inflammatory bowel disease - Outcome - 1"]
[null,"QS82","Smoking: reducing and preventing tobacco use",1,null,"Schools and colleges deliver combined interventions to stop children and young people taking up smoking by improving their social competence and awareness of social influences.","Evidence of arrangements within local schools and colleges to deliver combined interventions to stop children and young people taking up smoking by improving their social competence and awareness of social influences.","Structure","QS82 - Smoking: reducing and preventing tobacco use","1 - QS82 - Smoking: reducing and preventing tobacco use",1,"1 - QS82 - Smoking: reducing and preventing tobacco use - Structure - 1","",""]
[null,"QS82","Smoking: reducing and preventing tobacco use",1,null,"Schools and colleges deliver combined interventions to stop children and young people taking up smoking by improving their social competence and awareness of social influences.","Proportion of schools and colleges that deliver combined interventions to stop children and young people taking up smoking by improving their social competence and awareness of social influences.","Process","QS82 - Smoking: reducing and preventing tobacco use","1 - QS82 - Smoking: reducing and preventing tobacco use",1,"1 - QS82 - Smoking: reducing and preventing tobacco use - Process - 1","The number in the denominator that deliver combined interventions to stop children and young people taking up smoking by improving their social competence and awareness of social influences.","The number of schools and colleges in a specified geographic area."]
[null,"QS82","Smoking: reducing and preventing tobacco use",1,null,"Schools and colleges deliver combined interventions to stop children and young people taking up smoking by improving their social competence and awareness of social influences.","Proportion of children and young people who receive combined interventions to stop them taking up smoking by improving their social competence and awareness of social influences.","Process","QS82 - Smoking: reducing and preventing tobacco use","1 - QS82 - Smoking: reducing and preventing tobacco use",2,"1 - QS82 - Smoking: reducing and preventing tobacco use - Process - 2","The number in the denominator who receive combined interventions to stop them taking up smoking by improving their social competence and awareness of social influences.","The number of children and young people in schools and colleges in a specified geographic area."]
[null,"QS82","Smoking: reducing and preventing tobacco use",1,null,"Schools and colleges deliver combined interventions to stop children and young people taking up smoking by improving their social competence and awareness of social influences.","Proportion of children and young people who have tried smoking at least once.","Outcome","QS82 - Smoking: reducing and preventing tobacco use",{"$f":"CONCATENATE(D1679, \" - \", I1679)","v":"1 - QS82 - Smoking: reducing and preventing tobacco use"},{"$f":"IF(AND(B1679=B1678, D1679=D1678, H1679=H1678)=TRUE, K1678+1, 1)","v":1},{"$f":"CONCATENATE(J1679, \" - \", H1679, \" - \",K1679)","v":"1 - QS82 - Smoking: reducing and preventing tobacco use - Outcome - 1"}]
[null,"QS82","Smoking: reducing and preventing tobacco use",2,null,"Schools and colleges do not allow smoking anywhere in their grounds and remove any areas previously designated for smoking.","Evidence of arrangements in local schools and colleges to operate smokefree grounds and remove any areas designated for smoking.","Structure","QS82 - Smoking: reducing and preventing tobacco use","2 - QS82 - Smoking: reducing and preventing tobacco use",1,"2 - QS82 - Smoking: reducing and preventing tobacco use - Structure - 1","",""]
[null,"QS82","Smoking: reducing and preventing tobacco use",2,null,"Schools and colleges do not allow smoking anywhere in their grounds and remove any areas previously designated for smoking.","Proportion of schools and colleges that do not allow smoking anywhere in the grounds.","Process","QS82 - Smoking: reducing and preventing tobacco use","2 - QS82 - Smoking: reducing and preventing tobacco use",1,"2 - QS82 - Smoking: reducing and preventing tobacco use - Process - 1","The number in the denominator that do not allow smoking anywhere in the grounds.","The number of schools and colleges in the specified geographic area."]
[null,"QS82","Smoking: reducing and preventing tobacco use",2,null,"Schools and colleges do not allow smoking anywhere in their grounds and remove any areas previously designated for smoking.","Proportion of schools and colleges with no designated areas for smoking.","Process","QS82 - Smoking: reducing and preventing tobacco use","2 - QS82 - Smoking: reducing and preventing tobacco use",2,"2 - QS82 - Smoking: reducing and preventing tobacco use - Process - 2","The number in the denominator with no designated areas for smoking.","The number of schools and colleges in the specified geographic area."]
[null,"QS82","Smoking: reducing and preventing tobacco use",2,null,"Schools and colleges do not allow smoking anywhere in their grounds and remove any areas previously designated for smoking.","Schools and colleges with smokefree grounds and no areas designated for smoking.","Outcome","QS82 - Smoking: reducing and preventing tobacco use","2 - QS82 - Smoking: reducing and preventing tobacco use",1,"2 - QS82 - Smoking: reducing and preventing tobacco use - Outcome - 1"]
[null,"QS82","Smoking: reducing and preventing tobacco use",3,null,"Trading standards identify and take action against retailers that sell tobacco products to people under 18.","Evidence of local arrangements to obtain and interpret information to identify retailers that sell tobacco products to people under 18.","Structure",{"$f":"CONCATENATE(B1684, \" - \", C1684)","v":"QS82 - Smoking: reducing and preventing tobacco use"},"3 - QS82 - Smoking: reducing and preventing tobacco use",1,"3 - QS82 - Smoking: reducing and preventing tobacco use - Structure - 1","",""]
[null,"QS82","Smoking: reducing and preventing tobacco use",3,null,"Trading standards identify and take action against retailers that sell tobacco products to people under 18.","Evidence of local actions undertaken to prevent retailers from selling tobacco products to people under 18.","Structure","QS82 - Smoking: reducing and preventing tobacco use","3 - QS82 - Smoking: reducing and preventing tobacco use",2,"3 - QS82 - Smoking: reducing and preventing tobacco use - Structure - 2","",""]
[null,"QS82","Smoking: reducing and preventing tobacco use",3,null,"Trading standards identify and take action against retailers that sell tobacco products to people under 18.","Proportion of tobacco test purchases with a recorded underage sale.","Process","QS82 - Smoking: reducing and preventing tobacco use","3 - QS82 - Smoking: reducing and preventing tobacco use",1,"3 - QS82 - Smoking: reducing and preventing tobacco use - Process - 1","The number in the denominator with a recorded underage sale.","The number of tobacco test purchases carried out in a specified geographic area."]
[null,"QS82","Smoking: reducing and preventing tobacco use",3,null,"Trading standards identify and take action against retailers that sell tobacco products to people under 18.","Proportion of retailers with a recorded underage sale followed up with advice to the retailer.","Process","QS82 - Smoking: reducing and preventing tobacco use","3 - QS82 - Smoking: reducing and preventing tobacco use",2,"3 - QS82 - Smoking: reducing and preventing tobacco use - Process - 2","The number in the denominator followed up with advice to the retailer.","The number of test purchases with a recorded underage sale in a specified geographic area."]
[null,"QS82","Smoking: reducing and preventing tobacco use",3,null,"Trading standards identify and take action against retailers that sell tobacco products to people under 18.","Proportion of individuals sanctioned for persistently selling tobacco to people under 18. ","Process","QS82 - Smoking: reducing and preventing tobacco use","3 - QS82 - Smoking: reducing and preventing tobacco use",3,"3 - QS82 - Smoking: reducing and preventing tobacco use - Process - 3","The number in the denominator sanctioned for persistently selling tobacco to people under 18.","The number of individuals identified as persistently selling tobacco to people under 18 in a specified geographic area."]
[null,"QS82","Smoking: reducing and preventing tobacco use",3,null,"Trading standards identify and take action against retailers that sell tobacco products to people under 18.","Proportion of tobacco sales outlets sanctioned for persistently selling tobacco to people under 18.","Process","QS82 - Smoking: reducing and preventing tobacco use","3 - QS82 - Smoking: reducing and preventing tobacco use",4,"3 - QS82 - Smoking: reducing and preventing tobacco use - Process - 4","The number in the denominator sanctioned for persistently selling tobacco to people under 18.","The number of tobacco sales outlets identified as persistently selling tobacco to people under 18 in a specified geographic area."]
[null,"QS82","Smoking: reducing and preventing tobacco use",3,null,"Trading standards identify and take action against retailers that sell tobacco products to people under 18.","Incidence of underage tobacco sales. ","Outcome","QS82 - Smoking: reducing and preventing tobacco use","3 - QS82 - Smoking: reducing and preventing tobacco use",1,"3 - QS82 - Smoking: reducing and preventing tobacco use - Outcome - 1"]
[null,"QS82","Smoking: reducing and preventing tobacco use",4,null,"Employers allow employees to access evidence-based ‘stop smoking’ support during working hours without loss of pay.","Evidence of HR policies that allow employees to access ‘stop smoking’ support during working hours without loss of pay. ","Structure","QS82 - Smoking: reducing and preventing tobacco use","4 - QS82 - Smoking: reducing and preventing tobacco use",1,"4 - QS82 - Smoking: reducing and preventing tobacco use - Structure - 1","",""]
[null,"QS82","Smoking: reducing and preventing tobacco use",4,null,"Employers allow employees to access evidence-based ‘stop smoking’ support during working hours without loss of pay.","Proportion of employees who wanted to access ‘stop smoking’ support during working hours and did so.","Process","QS82 - Smoking: reducing and preventing tobacco use","4 - QS82 - Smoking: reducing and preventing tobacco use",1,"4 - QS82 - Smoking: reducing and preventing tobacco use - Process - 1","The number in the denominator who accessed 'stop smoking' support during working hours.","The number of employees who wanted to access 'stop smoking' support during working hours."]
[null,"QS82","Smoking: reducing and preventing tobacco use",4,null,"Employers allow employees to access evidence-based ‘stop smoking’ support during working hours without loss of pay.","Proportion of employees who accessed ‘stop smoking’ support during working hours without loss of pay.","Process","QS82 - Smoking: reducing and preventing tobacco use","4 - QS82 - Smoking: reducing and preventing tobacco use",2,"4 - QS82 - Smoking: reducing and preventing tobacco use - Process - 2","The number in the denominator who did not lose pay.","The number of employees who accessed 'stop smoking' support during working hours."]
[null,"QS82","Smoking: reducing and preventing tobacco use",5,null,"Healthcare services use contracts that do not allow employees to smoke during working hours or when recognisable as an employee. ","Evidence of arrangements within healthcare services to use employee contracts (including contractor and volunteer contracts) that do not allow smoking during working hours or when recognisable as an employee.","Structure","QS82 - Smoking: reducing and preventing tobacco use","5 - QS82 - Smoking: reducing and preventing tobacco use",1,"5 - QS82 - Smoking: reducing and preventing tobacco use - Structure - 1","",""]
[null,"QS82","Smoking: reducing and preventing tobacco use",5,null,"Healthcare services use contracts that do not allow employees to smoke during working hours or when recognisable as an employee. ","Proportion of healthcare services that use employee contracts (including contractor and volunteer contracts) that do not allow smoking during working hours or when recognisable as an employee.","Process","QS82 - Smoking: reducing and preventing tobacco use","5 - QS82 - Smoking: reducing and preventing tobacco use",1,"5 - QS82 - Smoking: reducing and preventing tobacco use - Process - 1","The number in the denominator that use employee contracts (including contractor and volunteer contracts) that do not allow smoking during working hours or when recognisable as an employee.","The number of healthcare services in the specified geographic area."]
[null,"QS82","Smoking: reducing and preventing tobacco use",5,null,"Healthcare services use contracts that do not allow employees to smoke during working hours or when recognisable as an employee. ","Staff, contractors and volunteers found smoking during working hours or when recognisable as an employee.","Outcome","QS82 - Smoking: reducing and preventing tobacco use","5 - QS82 - Smoking: reducing and preventing tobacco use",1,"5 - QS82 - Smoking: reducing and preventing tobacco use - Outcome - 1"]
[null,"QS82","Smoking: reducing and preventing tobacco use",6,null,"Healthcare settings do not allow smoking anywhere in their grounds and remove any areas previously designated for smoking.","Evidence of arrangements within healthcare settings to operate smokefree grounds and remove any areas previously designated for smoking.","Structure","QS82 - Smoking: reducing and preventing tobacco use","6 - QS82 - Smoking: reducing and preventing tobacco use",1,"6 - QS82 - Smoking: reducing and preventing tobacco use - Structure - 1","",""]
[null,"QS82","Smoking: reducing and preventing tobacco use",6,null,"Healthcare settings do not allow smoking anywhere in their grounds and remove any areas previously designated for smoking.","Proportion of healthcare settings that do not allow smoking anywhere in their grounds.","Process","QS82 - Smoking: reducing and preventing tobacco use","6 - QS82 - Smoking: reducing and preventing tobacco use",1,"6 - QS82 - Smoking: reducing and preventing tobacco use - Process - 1","The number in the denominator that do not allow smoking anywhere in their grounds.","The number of healthcare settings in the specified geographic area."]
[null,"QS82","Smoking: reducing and preventing tobacco use",6,null,"Healthcare settings do not allow smoking anywhere in their grounds and remove any areas previously designated for smoking.","Proportion of healthcare settings with no designated smoking areas.","Process","QS82 - Smoking: reducing and preventing tobacco use","6 - QS82 - Smoking: reducing and preventing tobacco use",2,"6 - QS82 - Smoking: reducing and preventing tobacco use - Process - 2","The number in the denominator with no designated smoking areas.","The number of healthcare settings in the specified geographic area."]
[null,"QS82","Smoking: reducing and preventing tobacco use",7,null,"Secondary healthcare settings ensure that a range of licensed nicotine-containing products and stop smoking pharmacotherapies is available on site for patients, visitors and employees.","Evidence of local arrangements to ensure that ‘stop smoking’ pharmacotherapies and licensed nicotine-containing products are stocked by pharmacies within secondary healthcare services.","Structure","QS82 - Smoking: reducing and preventing tobacco use","7 - QS82 - Smoking: reducing and preventing tobacco use",1,"7 - QS82 - Smoking: reducing and preventing tobacco use - Structure - 1","",""]
[null,"QS82","Smoking: reducing and preventing tobacco use",7,null,"Secondary healthcare settings ensure that a range of licensed nicotine-containing products and stop smoking pharmacotherapies is available on site for patients, visitors and employees.","Evidence of local arrangements to ensure that a range of licensed nicotine-containing products is available for sale within secondary healthcare services for visitors and employees. ","Structure","QS82 - Smoking: reducing and preventing tobacco use","7 - QS82 - Smoking: reducing and preventing tobacco use",2,"7 - QS82 - Smoking: reducing and preventing tobacco use - Structure - 2","",""]
[null,"QS82","Smoking: reducing and preventing tobacco use",7,null,"Secondary healthcare settings ensure that a range of licensed nicotine-containing products and stop smoking pharmacotherapies is available on site for patients, visitors and employees.","Proportion of secondary healthcare settings that stock pharmacotherapies and licensed nicotine-containing products.","Process","QS82 - Smoking: reducing and preventing tobacco use","7 - QS82 - Smoking: reducing and preventing tobacco use",1,"7 - QS82 - Smoking: reducing and preventing tobacco use - Process - 1","The number in the denominator that stock pharmacotherapies and licensed nicotine‑containing products.","The number of secondary healthcare settings in the specified geographic area."]
[null,"QS82","Smoking: reducing and preventing tobacco use",7,null,"Secondary healthcare settings ensure that a range of licensed nicotine-containing products and stop smoking pharmacotherapies is available on site for patients, visitors and employees.","Proportion of secondary healthcare settings that sell nicotine-containing products to visitors and employees.","Process","QS82 - Smoking: reducing and preventing tobacco use","7 - QS82 - Smoking: reducing and preventing tobacco use",2,"7 - QS82 - Smoking: reducing and preventing tobacco use - Process - 2","The number in the denominator that sell nicotine‑containing products to visitors and employees.","The number of secondary healthcare settings in the specified geographic area."]
[null,"QS82","Smoking: reducing and preventing tobacco use",8,null,"Local authorities use regional and local media channels to reinforce national tobacco reduction campaigns. ","Evidence of local authorities using regional or local media channels to reinforce messages from national tobacco reduction campaigns.","Structure","QS82 - Smoking: reducing and preventing tobacco use","8 - QS82 - Smoking: reducing and preventing tobacco use",1,"8 - QS82 - Smoking: reducing and preventing tobacco use - Structure - 1","",""]
[null,"QS82","Smoking: reducing and preventing tobacco use",8,null,"Local authorities use regional and local media channels to reinforce national tobacco reduction campaigns. ","Evidence of regional and local activities to reinforce national tobacco reduction campaigns.","Structure","QS82 - Smoking: reducing and preventing tobacco use","8 - QS82 - Smoking: reducing and preventing tobacco use",2,"8 - QS82 - Smoking: reducing and preventing tobacco use - Structure - 2","",""]
[null,"QS83","Alcohol: preventing harmful use in the community",1,null,"Local authorities use local crime and related trauma data to map the extent of alcohol-related problems, to inform the development or review of a statement of licensing policy.","Evidence that local crime and related trauma data are used to map the extent of alcohol-related problems to inform the development or review of a statement of licensing policy.","Structure","QS83 - Alcohol: preventing harmful use in the community","1 - QS83 - Alcohol: preventing harmful use in the community",1,"1 - QS83 - Alcohol: preventing harmful use in the community - Structure - 1","",""]
[null,"QS83","Alcohol: preventing harmful use in the community",2,null,"Trading standards and the police identify and take action against premises that sell alcohol to people under 18.","Evidence that trading standards and the police are identifying premises that sell alcohol to people under 18.","Structure","QS83 - Alcohol: preventing harmful use in the community","2 - QS83 - Alcohol: preventing harmful use in the community",1,"2 - QS83 - Alcohol: preventing harmful use in the community - Structure - 1","",""]
[null,"QS83","Alcohol: preventing harmful use in the community",2,null,"Trading standards and the police identify and take action against premises that sell alcohol to people under 18.","Evidence that trading standards and the police are taking action against premises that sell alcohol to people under 18.","Structure","QS83 - Alcohol: preventing harmful use in the community","2 - QS83 - Alcohol: preventing harmful use in the community",2,"2 - QS83 - Alcohol: preventing harmful use in the community - Structure - 2","",""]
[null,"QS83","Alcohol: preventing harmful use in the community",2,null,"Trading standards and the police identify and take action against premises that sell alcohol to people under 18.","Incidence of licensed premises found to sell alcohol to people under 18.","Outcome","QS83 - Alcohol: preventing harmful use in the community","2 - QS83 - Alcohol: preventing harmful use in the community",1,"2 - QS83 - Alcohol: preventing harmful use in the community - Outcome - 1"]
[null,"QS83","Alcohol: preventing harmful use in the community",3,null,"Schools and colleges include alcohol education in the curriculum. ","Evidence that schools and colleges include alcohol education in the curriculum.","Structure","QS83 - Alcohol: preventing harmful use in the community","3 - QS83 - Alcohol: preventing harmful use in the community",1,"3 - QS83 - Alcohol: preventing harmful use in the community - Structure - 1","",""]
[null,"QS83","Alcohol: preventing harmful use in the community",3,null,"Schools and colleges include alcohol education in the curriculum. ","Rates of absence from school or college related to alcohol.","Outcome","QS83 - Alcohol: preventing harmful use in the community","3 - QS83 - Alcohol: preventing harmful use in the community",1,"3 - QS83 - Alcohol: preventing harmful use in the community - Outcome - 1"]
[null,"QS83","Alcohol: preventing harmful use in the community",4,null,"Schools and colleges involve parents, carers, children and young people in initiatives to reduce alcohol use. ","Evidence that schools and colleges involve parents, carers, children and young people in initiatives to reduce alcohol use.","Structure","QS83 - Alcohol: preventing harmful use in the community","4 - QS83 - Alcohol: preventing harmful use in the community",1,"4 - QS83 - Alcohol: preventing harmful use in the community - Structure - 1","",""]
[null,"QS84","Physical activity: for NHS staff, patients and carers",1,null,"Adults having their NHS Health Check are given brief advice about how to be more physically active.","Evidence of local arrangements to ensure that adults who are having their NHS Health Check are given brief advice about how to be more physically active.","Structure","QS84 - Physical activity: for NHS staff, patients and carers","1 - QS84 - Physical activity: for NHS staff, patients and carers",1,"1 - QS84 - Physical activity: for NHS staff, patients and carers - Structure - 1","",""]
[null,"QS84","Physical activity: for NHS staff, patients and carers",1,null,"Adults having their NHS Health Check are given brief advice about how to be more physically active.","Proportion of adults having their NHS Health Check whose records state that they have been given brief advice about how to be more physically active. ","Process","QS84 - Physical activity: for NHS staff, patients and carers","1 - QS84 - Physical activity: for NHS staff, patients and carers",1,"1 - QS84 - Physical activity: for NHS staff, patients and carers - Process - 1","The number in the denominator whose records state that they have been given brief advice about how to be more physically active as part of their NHS Health Check.","The number of adults having their NHS Health Check."]
[null,"QS84","Physical activity: for NHS staff, patients and carers",1,null,"Adults having their NHS Health Check are given brief advice about how to be more physically active.","Proportion of adults having their NHS Health Check who are identified as needing to do more physical activity after receiving brief advice and whose records state that they have been signposted to physical activity services. ","Process","QS84 - Physical activity: for NHS staff, patients and carers","1 - QS84 - Physical activity: for NHS staff, patients and carers",2,"1 - QS84 - Physical activity: for NHS staff, patients and carers - Process - 2","The number in the denominator whose records state that they have been signposted to physical activity services as part of their NHS Health Check.","The number of adults having their NHS Health Check who are identified as needing to do more physical activity after receiving brief advice."]
[null,"QS84","Physical activity: for NHS staff, patients and carers",1,null,"Adults having their NHS Health Check are given brief advice about how to be more physically active.","Proportion of adults who have had an NHS Health Check and been signposted to physical activity services whose outcome is recorded. ","Process","QS84 - Physical activity: for NHS staff, patients and carers","1 - QS84 - Physical activity: for NHS staff, patients and carers",3,"1 - QS84 - Physical activity: for NHS staff, patients and carers - Process - 3","The number in the denominator whose outcome is recorded.","The number of adults who have had their NHS Health Check and been signposted to physical activity services."]
[null,"QS84","Physical activity: for NHS staff, patients and carers",1,null,"Adults having their NHS Health Check are given brief advice about how to be more physically active.","Proportion of adults meeting the recommendations in the UK physical activity guidelines. ","Outcome","QS84 - Physical activity: for NHS staff, patients and carers","1 - QS84 - Physical activity: for NHS staff, patients and carers",1,"1 - QS84 - Physical activity: for NHS staff, patients and carers - Outcome - 1"]
[null,"QS84","Physical activity: for NHS staff, patients and carers",2,null,"Parents or carers of children are given advice about physical activity during their child’s Healthy Child Programme 2-year review.","Evidence of local arrangements to ensure that parents or carers of children are given advice about physical activity as part of their child’s Healthy Child Programme 2-year review.","Structure","QS84 - Physical activity: for NHS staff, patients and carers","2 - QS84 - Physical activity: for NHS staff, patients and carers",1,"2 - QS84 - Physical activity: for NHS staff, patients and carers - Structure - 1","",""]
[null,"QS84","Physical activity: for NHS staff, patients and carers",2,null,"Parents or carers of children are given advice about physical activity during their child’s Healthy Child Programme 2-year review.","Proportion of Healthy Child Programme 2-year reviews in which parents or carers of children are given advice about physical activity.","Process","QS84 - Physical activity: for NHS staff, patients and carers","2 - QS84 - Physical activity: for NHS staff, patients and carers",1,"2 - QS84 - Physical activity: for NHS staff, patients and carers - Process - 1","The number in the denominator in which parents or carers of children are given advice about physical activity.","The number of Healthy Child Programme 2‑year reviews."]
[null,"QS84","Physical activity: for NHS staff, patients and carers",2,null,"Parents or carers of children are given advice about physical activity during their child’s Healthy Child Programme 2-year review.","Proportion of Healthy Child Programme 2-year reviews in which parents or carers of children are offered written information about local opportunities to be physically active.","Process","QS84 - Physical activity: for NHS staff, patients and carers","2 - QS84 - Physical activity: for NHS staff, patients and carers",2,"2 - QS84 - Physical activity: for NHS staff, patients and carers - Process - 2","The number in the denominator in which parents or carers of children are offered written information about local opportunities to be physically active.","The number of Healthy Child Programme 2‑year reviews."]
[null,"QS84","Physical activity: for NHS staff, patients and carers",2,null,"Parents or carers of children are given advice about physical activity during their child’s Healthy Child Programme 2-year review.","Proportion of children achieving the recommendations in the UK physical activity guidelines. ","Outcome","QS84 - Physical activity: for NHS staff, patients and carers","2 - QS84 - Physical activity: for NHS staff, patients and carers",1,"2 - QS84 - Physical activity: for NHS staff, patients and carers - Outcome - 1"]
[null,"QS84","Physical activity: for NHS staff, patients and carers",3,null,"Parents or carers of children are given advice about physical activity as part of the National Child Measurement Programme (NCMP).","Evidence of local arrangements to ensure that parents or carers of children are given advice about physical activity as part of the NCMP.","Structure","QS84 - Physical activity: for NHS staff, patients and carers","3 - QS84 - Physical activity: for NHS staff, patients and carers",1,"3 - QS84 - Physical activity: for NHS staff, patients and carers - Structure - 1","",""]
[null,"QS84","Physical activity: for NHS staff, patients and carers",3,null,"Parents or carers of children are given advice about physical activity as part of the National Child Measurement Programme (NCMP).","Proportion of children aged 4 to 5 years who are measured as part of the NCMP whose parents or carers are given advice about physical activity.","Process","QS84 - Physical activity: for NHS staff, patients and carers","3 - QS84 - Physical activity: for NHS staff, patients and carers",1,"3 - QS84 - Physical activity: for NHS staff, patients and carers - Process - 1","The number in the denominator whose parents or carers are given advice about physical activity.","The number of children aged 4 to 5 years who are measured as part of the NCMP."]
[null,"QS84","Physical activity: for NHS staff, patients and carers",3,null,"Parents or carers of children are given advice about physical activity as part of the National Child Measurement Programme (NCMP).","Proportion of children aged 10 to 11 years who are measured as part of the NCMP whose parents or carers are given advice about physical activity.","Process","QS84 - Physical activity: for NHS staff, patients and carers","3 - QS84 - Physical activity: for NHS staff, patients and carers",2,"3 - QS84 - Physical activity: for NHS staff, patients and carers - Process - 2","The number in the denominator whose parents or carers are given advice about physical activity.","The number of children aged 10 to 11 years who are measured as part of the NCMP."]
[null,"QS84","Physical activity: for NHS staff, patients and carers",3,null,"Parents or carers of children are given advice about physical activity as part of the National Child Measurement Programme (NCMP).","Proportion of children achieving the recommendations in the UK physical activity guidelines. ","Outcome","QS84 - Physical activity: for NHS staff, patients and carers","3 - QS84 - Physical activity: for NHS staff, patients and carers",1,"3 - QS84 - Physical activity: for NHS staff, patients and carers - Outcome - 1"]
[null,"QS84","Physical activity: for NHS staff, patients and carers",4,null,"NHS organisations have an organisation-wide, multi-component programme to encourage and support employees to be more physically active.","Evidence that NHS organisations have in place an organisation-wide, multi-component programme to encourage and support employees to be more physically active.","Structure","QS84 - Physical activity: for NHS staff, patients and carers","4 - QS84 - Physical activity: for NHS staff, patients and carers",1,"4 - QS84 - Physical activity: for NHS staff, patients and carers - Structure - 1","",""]
[null,"QS84","Physical activity: for NHS staff, patients and carers",4,null,"NHS organisations have an organisation-wide, multi-component programme to encourage and support employees to be more physically active.","Evidence that NHS organisations monitor their organisation-wide, multi-component physical activity programme.","Structure","QS84 - Physical activity: for NHS staff, patients and carers","4 - QS84 - Physical activity: for NHS staff, patients and carers",2,"4 - QS84 - Physical activity: for NHS staff, patients and carers - Structure - 2","",""]
[null,"QS84","Physical activity: for NHS staff, patients and carers",4,null,"NHS organisations have an organisation-wide, multi-component programme to encourage and support employees to be more physically active.","Evidence that NHS organisations encourage active travel through schemes that have been developed or promoted by an active travel champion.","Structure","QS84 - Physical activity: for NHS staff, patients and carers","4 - QS84 - Physical activity: for NHS staff, patients and carers",3,"4 - QS84 - Physical activity: for NHS staff, patients and carers - Structure - 3","",""]
[null,"QS84","Physical activity: for NHS staff, patients and carers",4,null,"NHS organisations have an organisation-wide, multi-component programme to encourage and support employees to be more physically active.","Proportion of NHS organisations with a multi-component physical activity programme that disseminate information (including written information) on at least an annual basis to their employees on how to be more physically active and on the health benefits of such activity.","Process","QS84 - Physical activity: for NHS staff, patients and carers","4 - QS84 - Physical activity: for NHS staff, patients and carers",1,"4 - QS84 - Physical activity: for NHS staff, patients and carers - Process - 1","The number in the denominator that disseminate information (including written information) on at least an annual basis on how to be more physically active and on the health benefits of such activity to their employees.","The number of NHS organisations with a multi‑component physical activity programme."]
[null,"QS84","Physical activity: for NHS staff, patients and carers",4,null,"NHS organisations have an organisation-wide, multi-component programme to encourage and support employees to be more physically active.","Proportion of organisation-wide, multi-component physical activity programmes in NHS organisations that include incentive schemes.","Process","QS84 - Physical activity: for NHS staff, patients and carers","4 - QS84 - Physical activity: for NHS staff, patients and carers",2,"4 - QS84 - Physical activity: for NHS staff, patients and carers - Process - 2","The number in the denominator that include incentive schemes.","The number of organisation-wide, multi‑component physical activity programmes in NHS organisations."]
[null,"QS84","Physical activity: for NHS staff, patients and carers",4,null,"NHS organisations have an organisation-wide, multi-component programme to encourage and support employees to be more physically active.","Proportion of employees in NHS organisations who take part in incentive schemes that are part of a multi-component physical activity programme.","Process","QS84 - Physical activity: for NHS staff, patients and carers","4 - QS84 - Physical activity: for NHS staff, patients and carers",3,"4 - QS84 - Physical activity: for NHS staff, patients and carers - Process - 3","The number in the denominator who take part in incentive schemes that are part of a multi‑component physical activity programme.","The number of people employed by an NHS organisation that has incentive schemes included within a multi‑component physical activity programme."]
[null,"QS84","Physical activity: for NHS staff, patients and carers",4,null,"NHS organisations have an organisation-wide, multi-component programme to encourage and support employees to be more physically active.","Proportion of NHS employees recorded as having taken part in active travel schemes that are led or promoted by their organisation within the last 12 months.","Process","QS84 - Physical activity: for NHS staff, patients and carers","4 - QS84 - Physical activity: for NHS staff, patients and carers",4,"4 - QS84 - Physical activity: for NHS staff, patients and carers - Process - 4","The number in the denominator recorded as having taken part in active travel schemes that are led or promoted by their organisation within the last 12 months.","The number of people employed by an NHS organisation with active travel schemes."]
[null,"QS84","Physical activity: for NHS staff, patients and carers",4,null,"NHS organisations have an organisation-wide, multi-component programme to encourage and support employees to be more physically active.","Proportion of employees in NHS organisations who feel supported to be more physically active.","Outcome","QS84 - Physical activity: for NHS staff, patients and carers","4 - QS84 - Physical activity: for NHS staff, patients and carers",1,"4 - QS84 - Physical activity: for NHS staff, patients and carers - Outcome - 1"]
[null,"QS84","Physical activity: for NHS staff, patients and carers",4,null,"NHS organisations have an organisation-wide, multi-component programme to encourage and support employees to be more physically active.","Proportion of NHS employees who use physically active modes of travel for commuting and while at work.","Outcome","QS84 - Physical activity: for NHS staff, patients and carers","4 - QS84 - Physical activity: for NHS staff, patients and carers",2,"4 - QS84 - Physical activity: for NHS staff, patients and carers - Outcome - 2"]
[null,"QS85","Medicines management in care homes",1,null,"People who transfer into a care home have their medicines listed by the care home on the day that they transfer.","Evidence of local arrangements to ensure that a list is made of a person's medicines on the day that they transfer into a care home.","Structure","QS85 - Medicines management in care homes","1 - QS85 - Medicines management in care homes",1,"1 - QS85 - Medicines management in care homes - Structure - 1","",""]
[null,"QS85","Medicines management in care homes",1,null,"People who transfer into a care home have their medicines listed by the care home on the day that they transfer.","Proportion of transfers of people into a care home where a list of the person's medicines is made by the care home on the day of transfer.","Process","QS85 - Medicines management in care homes","1 - QS85 - Medicines management in care homes",1,"1 - QS85 - Medicines management in care homes - Process - 1","The number in the denominator where a list of the person's medicines is made by the care home on the day of transfer.","The number of transfers of people into a care home."]
[null,"QS85","Medicines management in care homes",1,null,"People who transfer into a care home have their medicines listed by the care home on the day that they transfer.","Time between a person moving into a care home and completion of a list of their medicines.","Outcome","QS85 - Medicines management in care homes","1 - QS85 - Medicines management in care homes",1,"1 - QS85 - Medicines management in care homes - Outcome - 1"]
[null,"QS85","Medicines management in care homes",2,null,"Providers of health or social care services send a discharge summary, including details of the person's current medicines, with a person who transfers to or from a care home.","Evidence of local arrangements to ensure that a discharge summary, including details of a person's current medicines, is sent with a person when they transfer to or from a care home.","Structure","QS85 - Medicines management in care homes","2 - QS85 - Medicines management in care homes",1,"2 - QS85 - Medicines management in care homes - Structure - 1","",""]
[null,"QS85","Medicines management in care homes",2,null,"Providers of health or social care services send a discharge summary, including details of the person's current medicines, with a person who transfers to or from a care home.","Proportion of transfers of people to a care home in which a discharge summary, including details of a person's current medicines, is sent with the person.","Process","QS85 - Medicines management in care homes","2 - QS85 - Medicines management in care homes",1,"2 - QS85 - Medicines management in care homes - Process - 1","The number in the denominator in which a discharge summary, including details of a person's current medicines, is sent with the person.","The number of transfers of people to a care home."]
[null,"QS85","Medicines management in care homes",2,null,"Providers of health or social care services send a discharge summary, including details of the person's current medicines, with a person who transfers to or from a care home.","Proportion of transfers of people from a care home in which a discharge summary, including details of a person's current medicines, is sent with the person.","Process","QS85 - Medicines management in care homes","2 - QS85 - Medicines management in care homes",2,"2 - QS85 - Medicines management in care homes - Process - 2","The number in the denominator in which a discharge summary, including details of a person's current medicines, is sent with the person.","The number of transfers of people from a care home."]
[null,"QS85","Medicines management in care homes",3,null,"People who live in care homes are supported to self‑administer their medicines if they wish to and it does not put them or others at risk.","Evidence of local arrangements that care home staff provide support for residents to self‑administer their medicines unless a risk assessment has indicated otherwise.","Structure","QS85 - Medicines management in care homes","3 - QS85 - Medicines management in care homes",1,"3 - QS85 - Medicines management in care homes - Structure - 1","",""]
[null,"QS85","Medicines management in care homes",3,null,"People who live in care homes are supported to self‑administer their medicines if they wish to and it does not put them or others at risk.","Evidence of local arrangements to ensure that individual risk assessments are carried out that identify and document any support that a care home resident needs to self‑administer their medicines.","Structure","QS85 - Medicines management in care homes","3 - QS85 - Medicines management in care homes",2,"3 - QS85 - Medicines management in care homes - Structure - 2","",""]
[null,"QS85","Medicines management in care homes",3,null,"People who live in care homes are supported to self‑administer their medicines if they wish to and it does not put them or others at risk.","Proportion of people who live in a care home who have an individual risk assessment to identify any support they need to self‑administer their medicines.","Process","QS85 - Medicines management in care homes",{"$f":"CONCATENATE(D1743, \" - \", I1743)","v":"3 - QS85 - Medicines management in care homes"},{"$f":"IF(AND(B1743=B1742, D1743=D1742, H1743=H1742)=TRUE, K1742+1, 1)","v":1},{"$f":"CONCATENATE(J1743, \" - \", H1743, \" - \",K1743)","v":"3 - QS85 - Medicines management in care homes - Process - 1"},"The number in the denominator who have an individual risk assessment to identify any support they need to self‑administer their medicines.","The number of people who live in a care home."]
[null,"QS85","Medicines management in care homes",3,null,"People who live in care homes are supported to self‑administer their medicines if they wish to and it does not put them or others at risk.","Proportion of people who live in a care home who wish to self‑administer their medicines, and who have not had a risk assessment that indicates that this would put themselves or others at risk, who self‑administer their medicines.","Process","QS85 - Medicines management in care homes","3 - QS85 - Medicines management in care homes",2,"3 - QS85 - Medicines management in care homes - Process - 2","The number in the denominator who self‑administer their medicines.","The number of people who live in a care home who wish to self‑administer their medicines, and who have not had a risk assessment that indicates that this would put themselves or others at risk."]
[null,"QS85","Medicines management in care homes",3,null,"People who live in care homes are supported to self‑administer their medicines if they wish to and it does not put them or others at risk.","Feedback from care home residents that they feel supported to self‑administer their medicines, if they wish to and if they have not had a risk assessment that indicates that this would put themselves or others at risk.","Outcome","QS85 - Medicines management in care homes","3 - QS85 - Medicines management in care homes",1,"3 - QS85 - Medicines management in care homes - Outcome - 1"]
[null,"QS85","Medicines management in care homes",4,null,"Prescribers responsible for people who live in care homes provide comprehensive instructions for using and monitoring all newly prescribed medicines.","Evidence of local arrangements that prescribers responsible for people who live in care homes provide comprehensive instructions for using and monitoring all newly prescribed medicines.","Structure","QS85 - Medicines management in care homes","4 - QS85 - Medicines management in care homes",1,"4 - QS85 - Medicines management in care homes - Structure - 1","",""]
[null,"QS85","Medicines management in care homes",4,null,"Prescribers responsible for people who live in care homes provide comprehensive instructions for using and monitoring all newly prescribed medicines.","The proportion of newly prescribed medicines for people who live in care homes that are provided with comprehensive instructions for use and monitoring.","Process","QS85 - Medicines management in care homes","4 - QS85 - Medicines management in care homes",1,"4 - QS85 - Medicines management in care homes - Process - 1","The number in the denominator that are provided with comprehensive instructions for use and monitoring.","The number of newly prescribed medicines for people who live in care homes."]
[null,"QS85","Medicines management in care homes",4,null,"Prescribers responsible for people who live in care homes provide comprehensive instructions for using and monitoring all newly prescribed medicines.","Medicines‑related problems attributable to incomplete information provided with a prescription.","Outcome",{"$f":"CONCATENATE(B1748, \" - \", C1748)","v":"QS85 - Medicines management in care homes"},"4 - QS85 - Medicines management in care homes",1,"4 - QS85 - Medicines management in care homes - Outcome - 1"]
[null,"QS85","Medicines management in care homes",5,null,"People who live in care homes have medication reviews undertaken by a multidisciplinary team.","Evidence of local arrangements that medication reviews for people who live in care homes involve a multidisciplinary team who agree and document the roles and responsibilities of each member of the team and how they work together.","Structure","QS85 - Medicines management in care homes","5 - QS85 - Medicines management in care homes",1,"5 - QS85 - Medicines management in care homes - Structure - 1","",""]
[null,"QS85","Medicines management in care homes",5,null,"People who live in care homes have medication reviews undertaken by a multidisciplinary team.","Proportion of medication reviews carried out for people who live in care homes that involve a multidisciplinary team.","Process","QS85 - Medicines management in care homes","5 - QS85 - Medicines management in care homes",1,"5 - QS85 - Medicines management in care homes - Process - 1","The number in the denominator that involve a multidisciplinary team.","The number of medication reviews carried out for people who live in care homes."]
[null,"QS85","Medicines management in care homes",6,null,"Adults who live in care homes and have been assessed as lacking capacity are only administered medicine covertly if a management plan is agreed after a best interests meeting.","Evidence of local arrangements to agree a management plan after a best interests meeting in which a decision is made to covertly administer medicines to an adult care home resident.","Structure","QS85 - Medicines management in care homes","6 - QS85 - Medicines management in care homes",1,"6 - QS85 - Medicines management in care homes - Structure - 1","",""]
[null,"QS85","Medicines management in care homes",6,null,"Adults who live in care homes and have been assessed as lacking capacity are only administered medicine covertly if a management plan is agreed after a best interests meeting.","Proportion of adults in a care home being covertly administered medicine who have a record of a best interests meeting and management plan.","Process","QS85 - Medicines management in care homes","6 - QS85 - Medicines management in care homes",1,"6 - QS85 - Medicines management in care homes - Process - 1","The number in the denominator with a record of a best interests meeting and management plan.","The number of adults in a care home being covertly administered medicine."]
[null,"QS86","Falls in older people",1,null,"Older people are asked about falls when they have routine assessments and reviews with health and social care practitioners, and if they present at hospital.","Evidence of local arrangements to ensure that older people are asked about falls when they have routine assessments and reviews with primary care services.","Structure","QS86 - Falls in older people","1 - QS86 - Falls in older people",1,"1 - QS86 - Falls in older people - Structure - 1"]
[null,"QS86","Falls in older people",1,null,"Older people are asked about falls when they have routine assessments and reviews with health and social care practitioners, and if they present at hospital.","Evidence of local arrangements to ensure that older people are asked about falls when they have routine assessments and reviews with community health and social care practitioners.","Structure","QS86 - Falls in older people","1 - QS86 - Falls in older people",2,"1 - QS86 - Falls in older people - Structure - 2"]
[null,"QS86","Falls in older people",1,null,"Older people are asked about falls when they have routine assessments and reviews with health and social care practitioners, and if they present at hospital.","Evidence of local arrangements to ensure that older people are asked about falls when they present at hospital.","Structure","QS86 - Falls in older people","1 - QS86 - Falls in older people",3,"1 - QS86 - Falls in older people - Structure - 3"]
[null,"QS86","Falls in older people",1,null,"Older people are asked about falls when they have routine assessments and reviews with health and social care practitioners, and if they present at hospital.","Proportion of older people asked about falls during routine assessments and reviews with primary care services.","Process","QS86 - Falls in older people","1 - QS86 - Falls in older people",1,"1 - QS86 - Falls in older people - Process - 1","the number in the denominator where the person was asked about falls.","the number of older people who have had a routine assessment or review by a primary care service."]
[null,"QS86","Falls in older people",1,null,"Older people are asked about falls when they have routine assessments and reviews with health and social care practitioners, and if they present at hospital.","Proportion of older people asked about falls during routine assessments and reviews with community health and social care practitioners.","Process","QS86 - Falls in older people","1 - QS86 - Falls in older people",2,"1 - QS86 - Falls in older people - Process - 2","the number in the denominator where the person was asked about falls.","the number of older people who have had a routine assessment or review with a community health or social care practitioner."]
[null,"QS86","Falls in older people",1,null,"Older people are asked about falls when they have routine assessments and reviews with health and social care practitioners, and if they present at hospital.","Proportion of older people asked about falls when they present at hospital.","Process","QS86 - Falls in older people","1 - QS86 - Falls in older people",3,"1 - QS86 - Falls in older people - Process - 3","the number in the denominator where the person was asked about falls.","the number of older people who have presented at hospital."]
[null,"QS86","Falls in older people",1,null,"Older people are asked about falls when they have routine assessments and reviews with health and social care practitioners, and if they present at hospital.","Number of older people alerted to a risk of falling.","Outcome","QS86 - Falls in older people","1 - QS86 - Falls in older people",1,"1 - QS86 - Falls in older people - Outcome - 1"]
[null,"QS86","Falls in older people",2,null,"Older people at risk of falling are offered a multifactorial falls risk assessment. ","Evidence of local arrangements to ensure that older people at risk of falling are referred to healthcare professionals with skills and experience in carrying out multifactorial falls risk assessment.","Structure","QS86 - Falls in older people","2 - QS86 - Falls in older people",1,"2 - QS86 - Falls in older people - Structure - 1"]
[null,"QS86","Falls in older people",2,null,"Older people at risk of falling are offered a multifactorial falls risk assessment. ","Evidence of local arrangements to ensure that multifactorial assessment comprises multiple components to identify individual risks of falling.","Structure","QS86 - Falls in older people","2 - QS86 - Falls in older people",2,"2 - QS86 - Falls in older people - Structure - 2"]
[null,"QS86","Falls in older people",2,null,"Older people at risk of falling are offered a multifactorial falls risk assessment. ","Evidence of local arrangements for access to a specialist falls service comprising a multidisciplinary team with access to diagnostic, assessment and intervention facilities.","Structure","QS86 - Falls in older people","2 - QS86 - Falls in older people",3,"2 - QS86 - Falls in older people - Structure - 3"]
[null,"QS86","Falls in older people",2,null,"Older people at risk of falling are offered a multifactorial falls risk assessment. ","Proportion of older people at risk of falling presenting to a healthcare professional who are referred for multifactorial falls risk assessment.","Process","QS86 - Falls in older people","2 - QS86 - Falls in older people",1,"2 - QS86 - Falls in older people - Process - 1","the number in the denominator where the older person was referred for a multifactorial falls risk assessment.","the number of older people presenting to a healthcare professional who are considered to be at risk of falling."]
[null,"QS86","Falls in older people",2,null,"Older people at risk of falling are offered a multifactorial falls risk assessment. ","Proportion of older people at risk of falling who have a multifactorial falls risk assessment following referral by a healthcare professional.","Process","QS86 - Falls in older people","2 - QS86 - Falls in older people",2,"2 - QS86 - Falls in older people - Process - 2","the number in the denominator where the older person has had a multifactorial falls risk assessment.","the number of older people at risk of falling referred for a multifactorial falls risk assessment by a healthcare professional."]
[null,"QS86","Falls in older people",2,null,"Older people at risk of falling are offered a multifactorial falls risk assessment. ","Number of older people alerted to their specific risks of falling.","Outcome","QS86 - Falls in older people","2 - QS86 - Falls in older people",1,"2 - QS86 - Falls in older people - Outcome - 1"]
[null,"QS86","Falls in older people",2,null,"Older people at risk of falling are offered a multifactorial falls risk assessment. ","Proportion of older people with underlying health problems identified.","Outcome","QS86 - Falls in older people","2 - QS86 - Falls in older people",2,"2 - QS86 - Falls in older people - Outcome - 2"]
[null,"QS86","Falls in older people",2,null,"Older people at risk of falling are offered a multifactorial falls risk assessment. ","Rate of falls in older people.","Outcome","QS86 - Falls in older people","2 - QS86 - Falls in older people",3,"2 - QS86 - Falls in older people - Outcome - 3"]
[null,"QS86","Falls in older people",2,null,"Older people at risk of falling are offered a multifactorial falls risk assessment. ","Injuries due to falls in people aged 65 and over (age-sex standardised rate of emergency hospital admissions for injuries due to falls in people aged 65 and over per 100,000 population).","Outcome","QS86 - Falls in older people","2 - QS86 - Falls in older people",4,"2 - QS86 - Falls in older people - Outcome - 4"]
[null,"QS86","Falls in older people",3,null,"Older people assessed as being at increased risk of falling have an individualised multifactorial intervention. ","Evidence of local arrangements to ensure that older people assessed as being at increased risk of falling have an individualised multifactorial intervention.","Structure","QS86 - Falls in older people","3 - QS86 - Falls in older people",1,"3 - QS86 - Falls in older people - Structure - 1"]
[null,"QS86","Falls in older people",3,null,"Older people assessed as being at increased risk of falling have an individualised multifactorial intervention. ","Proportion of older people assessed as being at increased risk of falling who have an individualised multifactorial intervention.","Process","QS86 - Falls in older people","3 - QS86 - Falls in older people",1,"3 - QS86 - Falls in older people - Process - 1","the number in the denominator where the older person has received an individualised multifactorial intervention.","the number of older people assessed as being at increased risk of falling."]
[null,"QS86","Falls in older people",3,null,"Older people assessed as being at increased risk of falling have an individualised multifactorial intervention. ","Rates of falls in older people.","Outcome","QS86 - Falls in older people","3 - QS86 - Falls in older people",1,"3 - QS86 - Falls in older people - Outcome - 1"]
[null,"QS86","Falls in older people",3,null,"Older people assessed as being at increased risk of falling have an individualised multifactorial intervention. ","Injuries due to falls in people aged 65 and over (age-sex standardised rate of emergency hospital admissions for injuries due to falls in people aged 65 and over per 100,000 population).","Outcome","QS86 - Falls in older people","3 - QS86 - Falls in older people",2,"3 - QS86 - Falls in older people - Outcome - 2"]
[null,"QS86","Falls in older people",3,null,"Older people assessed as being at increased risk of falling have an individualised multifactorial intervention. ","Proportion of older people who have received a multifactorial intervention for falls who feel able to manage activities of daily living.","Outcome","QS86 - Falls in older people","3 - QS86 - Falls in older people",3,"3 - QS86 - Falls in older people - Outcome - 3"]
[null,"QS86","Falls in older people",4,null,"Older people who fall during a hospital stay are checked for signs or symptoms of fracture and potential for spinal injury before they are moved.","Evidence of local arrangements to ensure that hospitals have a post-fall protocol that includes checks for signs or symptoms of fracture and potential for spinal injury before the older person is moved.","Structure","QS86 - Falls in older people","4 - QS86 - Falls in older people",{"$f":"IF(AND(B1774=B1752, D1774=D1752, H1774=H1752)=TRUE, K1752+1, 1)","v":1},"4 - QS86 - Falls in older people - Structure - 1","",""]
[null,"QS86","Falls in older people",4,null,"Older people who fall during a hospital stay are checked for signs or symptoms of fracture and potential for spinal injury before they are moved.","Proportion of falls by older people during a hospital stay where the person is checked for signs or symptoms of fracture and potential for spinal injury before they are moved.","Process","QS86 - Falls in older people","4 - QS86 - Falls in older people",1,"4 - QS86 - Falls in older people - Process - 1","The number in the denominator where the person is checked for signs or symptoms of fracture and potential for spinal injury before they are moved.","The number of falls in older people during a hospital stay."]
[null,"QS86","Falls in older people",4,null,"Older people who fall during a hospital stay are checked for signs or symptoms of fracture and potential for spinal injury before they are moved.","Level of harm caused by falls in hospital in people aged 65 and over.","Outcome","QS86 - Falls in older people","4 - QS86 - Falls in older people",1,"4 - QS86 - Falls in older people - Outcome - 1"]
[null,"QS86","Falls in older people",4,null,"Older people who fall during a hospital stay are checked for signs or symptoms of fracture and potential for spinal injury before they are moved.","Injuries resulting from falls in hospital in people aged 65 and over.","Outcome","QS86 - Falls in older people","4 - QS86 - Falls in older people",2,"4 - QS86 - Falls in older people - Outcome - 2"]
[null,"QS86","Falls in older people",5,null,"Older people who fall during a hospital stay and have signs or symptoms of fracture or potential for spinal injury are moved using safe manual handling methods.","Evidence of local arrangements to ensure that hospitals have a post-fall protocol that includes using safe manual handling methods for moving older people with signs or symptoms of fracture or potential for spinal injury.","Structure","QS86 - Falls in older people","5 - QS86 - Falls in older people",1,"5 - QS86 - Falls in older people - Structure - 1","",""]
[null,"QS86","Falls in older people",5,null,"Older people who fall during a hospital stay and have signs or symptoms of fracture or potential for spinal injury are moved using safe manual handling methods.","Proportion of falls by older people during a hospital stay where the person has signs or symptoms of fracture or potential for spinal injury and is moved using safe manual handling methods.","Process","QS86 - Falls in older people","5 - QS86 - Falls in older people",1,"5 - QS86 - Falls in older people - Process - 1","The number in the denominator where the person is moved using safe manual handling methods.","The number of falls by older people during a hospital stay where the person has signs or symptoms of fracture or potential for spinal injury."]
[null,"QS86","Falls in older people",5,null,"Older people who fall during a hospital stay and have signs or symptoms of fracture or potential for spinal injury are moved using safe manual handling methods.","Level of harm caused by falls in hospital in people aged 65 and over.","Outcome","QS86 - Falls in older people","5 - QS86 - Falls in older people",1,"5 - QS86 - Falls in older people - Outcome - 1"]
[null,"QS86","Falls in older people",6,null,"Older people who fall during a hospital stay have a medical examination.","Evidence of local arrangements to ensure that NHS organisations with inpatient beds have a post-fall protocol that includes timescales for medical examination.","Structure","QS86 - Falls in older people","6 - QS86 - Falls in older people",1,"6 - QS86 - Falls in older people - Structure - 1","",""]
[null,"QS86","Falls in older people",6,null,"Older people who fall during a hospital stay have a medical examination.","Proportion of falls in older people during a hospital stay where the person has a medical examination completed within 12 hours.","Process","QS86 - Falls in older people","6 - QS86 - Falls in older people",1,"6 - QS86 - Falls in older people - Process - 1","The number in the denominator where the person has a medical examination completed within 12 hours.","The number of falls in older people during a hospital stay."]
[null,"QS86","Falls in older people",6,null,"Older people who fall during a hospital stay have a medical examination.","Proportion of falls in older people during a hospital stay where the person shows signs of serious injury, is highly vulnerable to injury or has been immobilised, where a fast-track medical examination is completed within 30 minutes.","Process","QS86 - Falls in older people","6 - QS86 - Falls in older people",2,"6 - QS86 - Falls in older people - Process - 2","The number in the denominator where the person has a fast‑track medical examination completed within 30 minutes.","The number of falls in older people during a hospital stay where the person shows signs of serious injury, is highly vulnerable to injury or has been immobilised."]
[null,"QS86","Falls in older people",6,null,"Older people who fall during a hospital stay have a medical examination.","Level of harm caused by falls during a hospital stay in people aged 65 and over.","Outcome","QS86 - Falls in older people","6 - QS86 - Falls in older people",1,"6 - QS86 - Falls in older people - Outcome - 1"]
[null,"QS86","Falls in older people",7,null,"Older people who present for medical attention because of a fall have a multifactorial falls risk assessment.","Evidence of local arrangements to ensure that older people who present for medical attention because of a fall have a multifactorial falls risk assessment.","Structure","QS86 - Falls in older people","7 - QS86 - Falls in older people",1,"7 - QS86 - Falls in older people - Structure - 1","",""]
[null,"QS86","Falls in older people",7,null,"Older people who present for medical attention because of a fall have a multifactorial falls risk assessment.","Proportion of older people who present for medical attention to their general practice because of a fall who have a multifactorial falls risk assessment.","Process","QS86 - Falls in older people","7 - QS86 - Falls in older people",1,"7 - QS86 - Falls in older people - Process - 1","The number in the denominator who have a multifactorial falls risk assessment.","The number of older people who present for medical attention to their general practice because of a fall."]
[null,"QS86","Falls in older people",7,null,"Older people who present for medical attention because of a fall have a multifactorial falls risk assessment.","Proportion of older people who present for medical attention at hospital because of a fall who have a multifactorial falls risk assessment.","Process","QS86 - Falls in older people","7 - QS86 - Falls in older people",2,"7 - QS86 - Falls in older people - Process - 2","The number in the denominator who have a multifactorial falls risk assessment.","The number of older people who present for medical attention at hospital because of a fall."]
[null,"QS86","Falls in older people",7,null,"Older people who present for medical attention because of a fall have a multifactorial falls risk assessment.","Proportion of older people who present for medical attention at walk-in health centres because of a fall who have a multifactorial falls risk assessment.","Process","QS86 - Falls in older people","7 - QS86 - Falls in older people",3,"7 - QS86 - Falls in older people - Process - 3","The number in the denominator who have a multifactorial falls risk assessment.","The number of older people who present for medical attention at walk‑in health centres because of a fall."]
[null,"QS86","Falls in older people",8,null,"Older people living in the community who have a known history of recurrent falls are referred for strength and balance training.","Evidence of local arrangements to ensure that older people living in the community who have a known history of recurrent falls are referred for strength and balance training.","Structure","QS86 - Falls in older people","8 - QS86 - Falls in older people",1,"8 - QS86 - Falls in older people - Structure - 1","",""]
[null,"QS86","Falls in older people",8,null,"Older people living in the community who have a known history of recurrent falls are referred for strength and balance training.","Proportion of older people living in the community with a known history of recurrent falls reporting to their GP who are referred for strength and balance training.","Process","QS86 - Falls in older people","8 - QS86 - Falls in older people",1,"8 - QS86 - Falls in older people - Process - 1","The number in the denominator referred for strength and balance training.","The number of older people living in the community with a known history of recurrent falls reporting to their GP."]
[null,"QS86","Falls in older people",8,null,"Older people living in the community who have a known history of recurrent falls are referred for strength and balance training.","Proportion of older people living in the community who report recurrent falls to a healthcare practitioner in hospital who are referred for strength and balance training.","Process","QS86 - Falls in older people","8 - QS86 - Falls in older people",2,"8 - QS86 - Falls in older people - Process - 2","The number in the denominator referred for strength and balance training.","The number of older people living in the community who report recurrent falls to a healthcare practitioner in hospital."]
[null,"QS86","Falls in older people",8,null,"Older people living in the community who have a known history of recurrent falls are referred for strength and balance training.","Rates of recurrent falls in older people.","Outcome","QS86 - Falls in older people","8 - QS86 - Falls in older people",1,"8 - QS86 - Falls in older people - Outcome - 1"]
[null,"QS86","Falls in older people",9,null,"Older people who are admitted to hospital after having a fall are offered a home hazard assessment and safety interventions.","Evidence of local arrangements to ensure that older people who are admitted to hospital after having a fall are offered a home hazard assessment.","Structure","QS86 - Falls in older people","9 - QS86 - Falls in older people",1,"9 - QS86 - Falls in older people - Structure - 1","",""]
[null,"QS86","Falls in older people",9,null,"Older people who are admitted to hospital after having a fall are offered a home hazard assessment and safety interventions.","Evidence of local arrangements to ensure that older people who are admitted to hospital after having a fall are offered safety interventions if these are identified by a home hazard assessment.","Structure","QS86 - Falls in older people","9 - QS86 - Falls in older people",2,"9 - QS86 - Falls in older people - Structure - 2","",""]
[null,"QS86","Falls in older people",9,null,"Older people who are admitted to hospital after having a fall are offered a home hazard assessment and safety interventions.","Proportion of older people admitted to hospital after a fall who are offered a home hazard assessment.","Process","QS86 - Falls in older people","9 - QS86 - Falls in older people",1,"9 - QS86 - Falls in older people - Process - 1","The number in the denominator offered a home hazard assessment.","The number of older people admitted to hospital after having a fall."]
[null,"QS86","Falls in older people",9,null,"Older people who are admitted to hospital after having a fall are offered a home hazard assessment and safety interventions.","Proportion of older people admitted to hospital after having a fall who have a home hazard assessment that is performed in their home.","Process","QS86 - Falls in older people","9 - QS86 - Falls in older people",2,"9 - QS86 - Falls in older people - Process - 2","The number in the denominator who have a home hazard assessment performed in their home.","The number of older people admitted to hospital after having a fall."]
[null,"QS86","Falls in older people",9,null,"Older people who are admitted to hospital after having a fall are offered a home hazard assessment and safety interventions.","Proportion of older people whose home hazard assessment identified a need for safety interventions who are offered those interventions.","Process","QS86 - Falls in older people","9 - QS86 - Falls in older people",3,"9 - QS86 - Falls in older people - Process - 3","The number in the denominator who are offered safety interventions.","The number of older people whose home hazard assessment identified a need for safety interventions."]
[null,"QS86","Falls in older people",9,null,"Older people who are admitted to hospital after having a fall are offered a home hazard assessment and safety interventions.","Proportion of older people who accepted the offer of safety interventions who received those interventions.","Process","QS86 - Falls in older people","9 - QS86 - Falls in older people",4,"9 - QS86 - Falls in older people - Process - 4","The number in the denominator who received safety interventions.","The number of older people who accepted the offer of safety interventions."]
[null,"QS86","Falls in older people",9,null,"Older people who are admitted to hospital after having a fall are offered a home hazard assessment and safety interventions.","Falls rates in the home for older people.","Outcome","QS86 - Falls in older people","9 - QS86 - Falls in older people",1,"9 - QS86 - Falls in older people - Outcome - 1"]
[null,"QS87","Osteoarthritis",1,null,"Adults aged 45 or over are diagnosed with osteoarthritis clinically without investigations if they have activity-related joint pain and any morning joint stiffness lasts no longer than 30 minutes.","Evidence of local arrangements to ensure that adults aged 45 or over are diagnosed with osteoarthritis clinically without investigations if they have activity-related joint pain and any morning joint stiffness lasts no longer than 30 minutes. ","Structure","QS87 - Osteoarthritis","1 - QS87 - Osteoarthritis",1,"1 - QS87 - Osteoarthritis - Structure - 1","",""]
[null,"QS87","Osteoarthritis",1,null,"Adults aged 45 or over are diagnosed with osteoarthritis clinically without investigations if they have activity-related joint pain and any morning joint stiffness lasts no longer than 30 minutes.","Proportion of adults aged 45 years or over who have activity-related joint pain and in whom any morning joint stiffness lasts no longer than 30 minutes who are diagnosed with osteoarthritis clinically without investigations.","Process","QS87 - Osteoarthritis","1 - QS87 - Osteoarthritis",1,"1 - QS87 - Osteoarthritis - Process - 1","The number in the denominator who are diagnosed with osteoarthritis clinically without investigations. ","The number of adults aged 45 years or over who have activity‑related joint pain and in whom any morning joint stiffness lasts no longer than 30 minutes who are diagnosed with osteoarthritis."]
[null,"QS87","Osteoarthritis",2,null,"This statement has been removed. ",null,null,"QS87 - Osteoarthritis","2 - QS87 - Osteoarthritis",1,"2 - QS87 - Osteoarthritis -  - 1","",""]
[null,"QS87","Osteoarthritis",2,null,"This statement has been removed. ",null,null,"QS87 - Osteoarthritis","2 - QS87 - Osteoarthritis",2,"2 - QS87 - Osteoarthritis -  - 2"]
[null,"QS87","Osteoarthritis",2,null,"This statement has been removed. ",null,null,"QS87 - Osteoarthritis","2 - QS87 - Osteoarthritis",3,"2 - QS87 - Osteoarthritis -  - 3"]
[null,"QS87","Osteoarthritis",3,null,"Adults with osteoarthritis are given information about their condition and its management at diagnosis and follow-up appointments.","Evidence of local arrangements to ensure that adults with osteoarthritis are given information on their condition and its management at diagnosis and follow-up appointments.","Structure","QS87 - Osteoarthritis","3 - QS87 - Osteoarthritis",1,"3 - QS87 - Osteoarthritis - Structure - 1","",""]
[null,"QS87","Osteoarthritis",3,null,"Adults with osteoarthritis are given information about their condition and its management at diagnosis and follow-up appointments.","Proportion of adults newly diagnosed with osteoarthritis with a record of having received information about their condition and its management.","Process","QS87 - Osteoarthritis","3 - QS87 - Osteoarthritis",1,"3 - QS87 - Osteoarthritis - Process - 1","The number in The denominator with a record of having received information about osteoarthritis and its management.","The number of adults newly diagnosed with osteoarthritis."]
[null,"QS87","Osteoarthritis",3,null,"Adults with osteoarthritis are given information about their condition and its management at diagnosis and follow-up appointments.","Proportion of adults with osteoarthritis with a record of having received information about their condition and its management at follow-up appointments.","Process","QS87 - Osteoarthritis","3 - QS87 - Osteoarthritis",2,"3 - QS87 - Osteoarthritis - Process - 2","The number in The denominator with a record of having received information about osteoarthritis and its management."," The number of adults with osteoarthritis who attended a follow-up appointment."]
[null,"QS87","Osteoarthritis",3,null,"Adults with osteoarthritis are given information about their condition and its management at diagnosis and follow-up appointments.","Adults with osteoarthritis are satisfied that they have the knowledge and confidence they need to self‑manage their condition.","Outcome"]
[null,"QS87","Osteoarthritis",3]
[null,"QS87","Osteoarthritis",4,null,"Adults with osteoarthritis are advised to do tailored therapeutic exercise.","Evidence of local arrangements to ensure that adults with osteoarthritis are advised to do tailored therapeutic exercise.","Structure","QS87 - Osteoarthritis","4 - QS87 - Osteoarthritis",1,"4 - QS87 - Osteoarthritis - Structure - 1","",""]
[null,"QS87","Osteoarthritis",4,null,"Adults with osteoarthritis are advised to do tailored therapeutic exercise.","Proportion of adults newly diagnosed with osteoarthritis who receive advice on tailored therapeutic exercise.","Process","QS87 - Osteoarthritis","4 - QS87 - Osteoarthritis",1,"4 - QS87 - Osteoarthritis - Process - 1","The number in the denominator who receive advice on tailored therapeutic exercise.the number in the denominator who receive advice on tailored therapeutic exercise.","The number of adults newly diagnosed with osteoarthritis."]
[null,"QS87","Osteoarthritis",4,null,"Adults with osteoarthritis are advised to do tailored therapeutic exercise.","Proportion of adults with osteoarthritis who receive advice to do tailored therapeutic exercise at their follow-up appointment.","Process","QS87 - Osteoarthritis","4 - QS87 - Osteoarthritis",2,"4 - QS87 - Osteoarthritis - Process - 2","The number in the denominator who receive advice to do tailored therapeutic exercise.","The number of adults with osteoarthritis attending a follow-up appointment."]
[null,"QS87","Osteoarthritis"]
[null,"QS87","Osteoarthritis",4,null,"Adults with osteoarthritis are advised to do tailored therapeutic exercise.","Physical activity in adults with osteoarthritis.","Outcome","QS87 - Osteoarthritis","4 - QS87 - Osteoarthritis",1,"4 - QS87 - Osteoarthritis - Outcome - 1"]
[null,"QS87","Osteoarthritis",4,null,"Adults with osteoarthritis are advised to do tailored therapeutic exercise.","Patient satisfaction with advice on exercise.","Outcome","QS87 - Osteoarthritis","4 - QS87 - Osteoarthritis",2,"4 - QS87 - Osteoarthritis - Outcome - 2"]
[null,"QS87","Osteoarthritis",5,null,"Adults with osteoarthritis who are living with overweight or obesity are offered support to lose weight.","Evidence of local arrangements to ensure that adults with osteoarthritis who are living with overweight or obesity are offered support to lose weight.","Structure","QS87 - Osteoarthritis","5 - QS87 - Osteoarthritis",1,"5 - QS87 - Osteoarthritis - Structure - 1","",""]
[null,"QS87","Osteoarthritis",5,null,"Adults with osteoarthritis who are living with overweight or obesity are offered support to lose weight.","Proportion of adults with osteoarthritis who are living with overweight or obesity who are offered support to lose weight.","Process","QS87 - Osteoarthritis","5 - QS87 - Osteoarthritis",1,"5 - QS87 - Osteoarthritis - Process - 1","The number in the denominator who are offered support to lose weight.","The number of adults with osteoarthritis who are living with overweight or obesity."]
[null,"QS87","Osteoarthritis",5,null,"Adults with osteoarthritis who are living with overweight or obesity are offered support to lose weight.","Weight loss in adults with osteoarthritis who are living with overweight or obesity.","Outcome","QS87 - Osteoarthritis","5 - QS87 - Osteoarthritis",1,"5 - QS87 - Osteoarthritis - Outcome - 1"]
[null,"QS87","Osteoarthritis",5,null,"Adults with osteoarthritis who are living with overweight or obesity are offered support to lose weight.","Patient satisfaction with support to lose weight.","Outcome","QS87 - Osteoarthritis","5 - QS87 - Osteoarthritis",2,"5 - QS87 - Osteoarthritis - Outcome - 2"]
[null,"QS87","Osteoarthritis",6,null,"Adults with osteoarthritis discuss and agree their follow-up with their primary healthcare team.","Evidence of local arrangements to ensure that adults with osteoarthritis discuss and agree their follow-up with their primary healthcare team.","Structure","QS87 - Osteoarthritis","6 - QS87 - Osteoarthritis",1,"6 - QS87 - Osteoarthritis - Structure - 1","",""]
[null,"QS87","Osteoarthritis",6,null,"Adults with osteoarthritis discuss and agree their follow-up with their primary healthcare team.","Proportion of adults with osteoarthritis with a documented discussion to agree their follow-up.","Process","QS87 - Osteoarthritis","6 - QS87 - Osteoarthritis",1,"6 - QS87 - Osteoarthritis - Process - 1","The number in The denominator with a documented discussion to agree Their follow-up.","The number of adults with osteoarthritis."]
[null,"QS87","Osteoarthritis",6,null,"Adults with osteoarthritis discuss and agree their follow-up with their primary healthcare team.","Levels of satisfaction with their current follow-up arrangements among adults with osteoarthritis.","Outcome","QS87 - Osteoarthritis","6 - QS87 - Osteoarthritis",1,"6 - QS87 - Osteoarthritis - Outcome - 1"]
[null,"QS87","Osteoarthritis",7,null,"Adults with osteoarthritis are supported with non-surgical core treatments for at least 3 months before any referral for consideration of joint surgery. ","Evidence of local arrangements to ensure that adults with osteoarthritis are supported with non-surgical core treatments for at least 3 months before any referral for consideration of joint surgery.","Structure","QS87 - Osteoarthritis","7 - QS87 - Osteoarthritis",1,"7 - QS87 - Osteoarthritis - Structure - 1","",""]
[null,"QS87","Osteoarthritis",7,null,"Adults with osteoarthritis are supported with non-surgical core treatments for at least 3 months before any referral for consideration of joint surgery. ","Proportion of adults with osteoarthritis referred for consideration of joint surgery who were supported with non-surgical core treatments for at least 3 months.","Process","QS87 - Osteoarthritis","7 - QS87 - Osteoarthritis",1,"7 - QS87 - Osteoarthritis - Process - 1","The number in the denominator who were supported with non‑surgical core treatments for at least 3 months.","The number of adults with osteoarthritis referred for consideration of joint surgery."]
[null,"QS87","Osteoarthritis",8,null,"Healthcare professionals do not use scoring tools to identify which adults with osteoarthritis are eligible for referral for consideration of joint surgery.","Evidence of local arrangements to ensure that healthcare professionals do not use scoring tools to identify which adults with osteoarthritis are eligible for referral for consideration of joint surgery.","Structure","QS87 - Osteoarthritis","8 - QS87 - Osteoarthritis",1,"8 - QS87 - Osteoarthritis - Structure - 1","",""]
[null,"QS87","Osteoarthritis",8,null,"Healthcare professionals do not use scoring tools to identify which adults with osteoarthritis are eligible for referral for consideration of joint surgery.","Proportion of adults with osteoarthritis referred for consideration of joint surgery whose referral is based on a scoring tool.","Process","QS87 - Osteoarthritis","8 - QS87 - Osteoarthritis",1,"8 - QS87 - Osteoarthritis - Process - 1","The number in the denominator for whom the referral decision is based on a scoring tool.","The number of adults with osteoarthritis referred for consideration of joint surgery."]
[null,"QS87","Osteoarthritis",8,null,"Healthcare professionals do not use scoring tools to identify which adults with osteoarthritis are eligible for referral for consideration of joint surgery.","Patient-reported health outcomes for adults with osteoarthritis","Outcome","QS87 - Osteoarthritis","8 - QS87 - Osteoarthritis",1,"8 - QS87 - Osteoarthritis - Outcome - 1"]
[null,"QS88","Personality disorders: borderline and antisocial",1,null,"Mental health professionals use a structured clinical assessment to diagnose borderline or antisocial personality disorder.","Evidence of local arrangements to ensure that mental health professionals use a structured clinical assessment to diagnose borderline or antisocial personality disorder.","Structure","QS88 - Personality disorders: borderline and antisocial",{"$f":"CONCATENATE(D1828, \" - \", I1828)","v":"1 - QS88 - Personality disorders: borderline and antisocial"},{"$f":"IF(AND(B1828=B1827, D1828=D1827, H1828=H1827)=TRUE, K1827+1, 1)","v":1},{"$f":"CONCATENATE(J1828, \" - \", H1828, \" - \",K1828)","v":"1 - QS88 - Personality disorders: borderline and antisocial - Structure - 1"},"",""]
[null,"QS88","Personality disorders: borderline and antisocial",1,null,"Mental health professionals use a structured clinical assessment to diagnose borderline or antisocial personality disorder.","Proportion of people with a diagnosis of borderline or antisocial personality disorder who had the diagnosis made by a mental health professional using a structured clinical assessment.","Process","QS88 - Personality disorders: borderline and antisocial","1 - QS88 - Personality disorders: borderline and antisocial",1,"1 - QS88 - Personality disorders: borderline and antisocial - Process - 1","The number in the denominator who had the diagnosis made by a mental health professional using a structured clinical assessment","The number of people with a diagnosis of borderline or antisocial personality disorder."]
[null,"QS88","Personality disorders: borderline and antisocial",2,null,"People with borderline personality disorder are offered psychological therapies and are involved in choosing the type, duration and intensity of therapy.","Evidence of local arrangements to ensure that people with borderline personality disorder are involved in choosing the type, duration and intensity of psychological therapies that they receive.","Structure","QS88 - Personality disorders: borderline and antisocial","2 - QS88 - Personality disorders: borderline and antisocial",1,"2 - QS88 - Personality disorders: borderline and antisocial - Structure - 1","",""]
[null,"QS88","Personality disorders: borderline and antisocial",2,null,"People with borderline personality disorder are offered psychological therapies and are involved in choosing the type, duration and intensity of therapy.","Evidence of local arrangements to ensure that psychological therapies are available to people with borderline personality disorder.","Structure","QS88 - Personality disorders: borderline and antisocial","2 - QS88 - Personality disorders: borderline and antisocial",2,"2 - QS88 - Personality disorders: borderline and antisocial - Structure - 2","",""]
[null,"QS88","Personality disorders: borderline and antisocial",2,null,"People with borderline personality disorder are offered psychological therapies and are involved in choosing the type, duration and intensity of therapy.","Proportion of people with borderline personality disorder who received psychological therapies.","Process","QS88 - Personality disorders: borderline and antisocial","2 - QS88 - Personality disorders: borderline and antisocial",1,"2 - QS88 - Personality disorders: borderline and antisocial - Process - 1","The number in the denominator who received psychological therapies.","The number of people with borderline personality disorder."]
[null,"QS88","Personality disorders: borderline and antisocial",2,null,"People with borderline personality disorder are offered psychological therapies and are involved in choosing the type, duration and intensity of therapy.","Proportion of people with borderline personality disorder who chose the type, duration and intensity of psychological therapy they received.","Process",{"$f":"CONCATENATE(B1833, \" - \", C1833)","v":"QS88 - Personality disorders: borderline and antisocial"},"2 - QS88 - Personality disorders: borderline and antisocial",2,"2 - QS88 - Personality disorders: borderline and antisocial - Process - 2","The number in the denominator who chose the type, duration and intensity of psychological therapy they received.","The number of people with borderline personality disorder who received psychological therapies."]
[null,"QS88","Personality disorders: borderline and antisocial",2,null,"People with borderline personality disorder are offered psychological therapies and are involved in choosing the type, duration and intensity of therapy.","Evidence from experience surveys and feedback that service users feel actively involved in shared decision-making.","Outcome","QS88 - Personality disorders: borderline and antisocial","2 - QS88 - Personality disorders: borderline and antisocial",1,"2 - QS88 - Personality disorders: borderline and antisocial - Outcome - 1"]
[null,"QS88","Personality disorders: borderline and antisocial",3,null,"People with antisocial personality disorder are offered group-based cognitive and behavioural therapies and are involved in choosing the duration and intensity of the therapy.","Evidence of local arrangements to ensure that group-based cognitive and behavioural therapies are available to people with antisocial personality disorder.","Structure","QS88 - Personality disorders: borderline and antisocial","3 - QS88 - Personality disorders: borderline and antisocial",1,"3 - QS88 - Personality disorders: borderline and antisocial - Structure - 1","",""]
[null,"QS88","Personality disorders: borderline and antisocial",3,null,"People with antisocial personality disorder are offered group-based cognitive and behavioural therapies and are involved in choosing the duration and intensity of the therapy.","Evidence of local arrangements to ensure that people with antisocial personality disorder are involved in choosing the duration and intensity of group-based cognitive and behavioural therapy that they receive.","Structure","QS88 - Personality disorders: borderline and antisocial","3 - QS88 - Personality disorders: borderline and antisocial",2,"3 - QS88 - Personality disorders: borderline and antisocial - Structure - 2","",""]
[null,"QS88","Personality disorders: borderline and antisocial",3,null,"People with antisocial personality disorder are offered group-based cognitive and behavioural therapies and are involved in choosing the duration and intensity of the therapy.","Proportion of people with antisocial personality disorder who received group-based cognitive and behavioural therapy. ","Process","QS88 - Personality disorders: borderline and antisocial","3 - QS88 - Personality disorders: borderline and antisocial",1,"3 - QS88 - Personality disorders: borderline and antisocial - Process - 1","The number in the denominator who received group‑based cognitive and behavioural therapy.","The number of people with antisocial personality disorder."]
[null,"QS88","Personality disorders: borderline and antisocial",3,null,"People with antisocial personality disorder are offered group-based cognitive and behavioural therapies and are involved in choosing the duration and intensity of the therapy.","Proportion of people with antisocial personality disorder who chose the duration and intensity of group-based cognitive and behavioural therapy they received. ","Process","QS88 - Personality disorders: borderline and antisocial","3 - QS88 - Personality disorders: borderline and antisocial",2,"3 - QS88 - Personality disorders: borderline and antisocial - Process - 2","The number in the denominator who chose the duration and intensity of the group‑based cognitive and behavioural therapy they received.","The number of people with antisocial personality disorder who received group‑based cognitive and behavioural therapy."]
[null,"QS88","Personality disorders: borderline and antisocial",3,null,"People with antisocial personality disorder are offered group-based cognitive and behavioural therapies and are involved in choosing the duration and intensity of the therapy.","Evidence from experience surveys and feedback that service users feel actively involved in shared decision-making.","Outcome","QS88 - Personality disorders: borderline and antisocial","3 - QS88 - Personality disorders: borderline and antisocial",1,"3 - QS88 - Personality disorders: borderline and antisocial - Outcome - 1"]
[null,"QS88","Personality disorders: borderline and antisocial",4,null,"People with borderline or antisocial personality disorders are prescribed antipsychotic or sedative medication only for short-term crisis management or treatment of comorbid conditions. ","Evidence of local arrangements to ensure that people with borderline or antisocial personality disorder are prescribed antipsychotic or sedative medication only for short-term crisis management or treatment of comorbid conditions.","Structure","QS88 - Personality disorders: borderline and antisocial","4 - QS88 - Personality disorders: borderline and antisocial",1,"4 - QS88 - Personality disorders: borderline and antisocial - Structure - 1","",""]
[null,"QS88","Personality disorders: borderline and antisocial",4,null,"People with borderline or antisocial personality disorders are prescribed antipsychotic or sedative medication only for short-term crisis management or treatment of comorbid conditions. ","Evidence of local arrangements to ensure that when people with borderline or antisocial personality disorder are prescribed antipsychotic or sedative medication, there is a record of the reason for prescribing the medication and the duration of the treatment.","Structure","QS88 - Personality disorders: borderline and antisocial","4 - QS88 - Personality disorders: borderline and antisocial",2,"4 - QS88 - Personality disorders: borderline and antisocial - Structure - 2","",""]
[null,"QS88","Personality disorders: borderline and antisocial",4,null,"People with borderline or antisocial personality disorders are prescribed antipsychotic or sedative medication only for short-term crisis management or treatment of comorbid conditions. ","Proportion of people with borderline or antisocial personality disorder prescribed antipsychotic or sedative medication in a crisis or to treat comorbid conditions.","Process","QS88 - Personality disorders: borderline and antisocial","4 - QS88 - Personality disorders: borderline and antisocial",1,"4 - QS88 - Personality disorders: borderline and antisocial - Process - 1","The number in the denominator who were prescribed the antipsychotic or sedative medication in a crisis or to treat comorbid conditions.","The number of people with borderline or antisocial personality disorder prescribed antipsychotic or sedative medication."]
[null,"QS88","Personality disorders: borderline and antisocial",4,null,"People with borderline or antisocial personality disorders are prescribed antipsychotic or sedative medication only for short-term crisis management or treatment of comorbid conditions. ","Proportion of people with borderline or antisocial personality disorder prescribed antipsychotic or sedative medication in a crisis and who had it prescribed for no longer than a week.","Process","QS88 - Personality disorders: borderline and antisocial","4 - QS88 - Personality disorders: borderline and antisocial",2,"4 - QS88 - Personality disorders: borderline and antisocial - Process - 2","The number in the denominator prescribed antipsychotic or sedative medication for no longer than a week.","The number of people with borderline or antisocial personality disorder prescribed antipsychotic or sedative medication in a crisis."]
[null,"QS88","Personality disorders: borderline and antisocial",4,null,"People with borderline or antisocial personality disorders are prescribed antipsychotic or sedative medication only for short-term crisis management or treatment of comorbid conditions. ","Antipsychotic and sedative medication prescribing rates.","Outcome","QS88 - Personality disorders: borderline and antisocial","4 - QS88 - Personality disorders: borderline and antisocial",1,"4 - QS88 - Personality disorders: borderline and antisocial - Outcome - 1"]
[null,"QS88","Personality disorders: borderline and antisocial",5,null,"People with borderline or antisocial personality disorder agree a structured and phased plan with their care provider before their services change or are withdrawn. ","Evidence of local arrangements that people with borderline or antisocial personality disorder agree with their care provider a structured and phased plan before their services change or are withdrawn.","Structure","QS88 - Personality disorders: borderline and antisocial","5 - QS88 - Personality disorders: borderline and antisocial",1,"5 - QS88 - Personality disorders: borderline and antisocial - Structure - 1","",""]
[null,"QS88","Personality disorders: borderline and antisocial",5,null,"People with borderline or antisocial personality disorder agree a structured and phased plan with their care provider before their services change or are withdrawn. ","Evidence of local arrangements to ensure that people with borderline or antisocial personality disorder can easily access services in time of crisis.","Structure","QS88 - Personality disorders: borderline and antisocial","5 - QS88 - Personality disorders: borderline and antisocial",2,"5 - QS88 - Personality disorders: borderline and antisocial - Structure - 2","",""]
[null,"QS88","Personality disorders: borderline and antisocial",5,null,"People with borderline or antisocial personality disorder agree a structured and phased plan with their care provider before their services change or are withdrawn. ","Proportion of changes to services or service withdrawals that have been planned and agreed beforehand by people with borderline or antisocial personality disorder and their care provider.","Process","QS88 - Personality disorders: borderline and antisocial","5 - QS88 - Personality disorders: borderline and antisocial",1,"5 - QS88 - Personality disorders: borderline and antisocial - Process - 1","Number in the denominator planned and agreed beforehand by people with borderline or antisocial personality disorder and their care provider.","Changes to services or service withdrawals for people with borderline or antisocial personality disorder."]
[null,"QS88","Personality disorders: borderline and antisocial",5,null,"People with borderline or antisocial personality disorder agree a structured and phased plan with their care provider before their services change or are withdrawn. ","Evidence from experience surveys and feedback that service users feel actively involved in shared decision-making.","Outcome","QS88 - Personality disorders: borderline and antisocial","5 - QS88 - Personality disorders: borderline and antisocial",1,"5 - QS88 - Personality disorders: borderline and antisocial - Outcome - 1"]
[null,"QS88","Personality disorders: borderline and antisocial",5,null,"People with borderline or antisocial personality disorder agree a structured and phased plan with their care provider before their services change or are withdrawn. ","Frequency of crisis situations linked to transitions.","Outcome","QS88 - Personality disorders: borderline and antisocial","5 - QS88 - Personality disorders: borderline and antisocial",2,"5 - QS88 - Personality disorders: borderline and antisocial - Outcome - 2"]
[null,"QS88","Personality disorders: borderline and antisocial",5,null,"People with borderline or antisocial personality disorder agree a structured and phased plan with their care provider before their services change or are withdrawn. ","Service user experience of integrated care.","Outcome","QS88 - Personality disorders: borderline and antisocial","5 - QS88 - Personality disorders: borderline and antisocial",3,"5 - QS88 - Personality disorders: borderline and antisocial - Outcome - 3"]
[null,"QS88","Personality disorders: borderline and antisocial",6,null,"People with borderline or antisocial personality disorder have their long-term goals for education and employment identified in their care plan.","Evidence of local arrangements to ensure that people with borderline or antisocial personality disorder have their long-term goals for education and employment identified in their care plan.","Structure","QS88 - Personality disorders: borderline and antisocial","6 - QS88 - Personality disorders: borderline and antisocial",1,"6 - QS88 - Personality disorders: borderline and antisocial - Structure - 1","",""]
[null,"QS88","Personality disorders: borderline and antisocial",6,null,"People with borderline or antisocial personality disorder have their long-term goals for education and employment identified in their care plan.","Proportion of people with borderline or antisocial personality disorder who have their long-term goals for education and employment identified in their care plan.","Process","QS88 - Personality disorders: borderline and antisocial","6 - QS88 - Personality disorders: borderline and antisocial",1,"6 - QS88 - Personality disorders: borderline and antisocial - Process - 1","Number in the denominator who have their long‑term goals for education and employment identified in their care plan.","Number of people with borderline or antisocial personality disorder."]
[null,"QS88","Personality disorders: borderline and antisocial",6,null,"People with borderline or antisocial personality disorder have their long-term goals for education and employment identified in their care plan.","Proportion of people in contact with secondary mental health services who are able and fit to work and are in paid employment.","Outcome","QS88 - Personality disorders: borderline and antisocial","6 - QS88 - Personality disorders: borderline and antisocial",1,"6 - QS88 - Personality disorders: borderline and antisocial - Outcome - 1"]
[null,"QS88","Personality disorders: borderline and antisocial",7,null,"Mental health professionals supporting people with borderline or antisocial personality disorder have an agreed level and frequency of supervision.","Evidence of local arrangements to ensure that mental health professionals supporting people with borderline or antisocial personality disorder have an agreed level and frequency of supervision.","Structure","QS88 - Personality disorders: borderline and antisocial","7 - QS88 - Personality disorders: borderline and antisocial",1,"7 - QS88 - Personality disorders: borderline and antisocial - Structure - 1","",""]
[null,"QS88","Personality disorders: borderline and antisocial",7,null,"Mental health professionals supporting people with borderline or antisocial personality disorder have an agreed level and frequency of supervision.","Evidence of local arrangements to ensure that the level and frequency of supervision of mental health professionals supporting people with borderline or antisocial personality disorder is monitored. ","Structure","QS88 - Personality disorders: borderline and antisocial","7 - QS88 - Personality disorders: borderline and antisocial",2,"7 - QS88 - Personality disorders: borderline and antisocial - Structure - 2","",""]
[null,"QS88","Personality disorders: borderline and antisocial",7,null,"Mental health professionals supporting people with borderline or antisocial personality disorder have an agreed level and frequency of supervision.","Proportion of mental health professionals supporting people with borderline or antisocial personality disorder who have an agreed level and frequency of supervision.","Process","QS88 - Personality disorders: borderline and antisocial","7 - QS88 - Personality disorders: borderline and antisocial",1,"7 - QS88 - Personality disorders: borderline and antisocial - Process - 1","Number in the denominator who have an agreed level and frequency of supervision.","Number of mental health professionals supporting people with borderline or antisocial personality disorder."]
[null,"QS88","Personality disorders: borderline and antisocial",7,null,"Mental health professionals supporting people with borderline or antisocial personality disorder have an agreed level and frequency of supervision.","Job satisfaction among mental health professionals.","Outcome","QS88 - Personality disorders: borderline and antisocial","7 - QS88 - Personality disorders: borderline and antisocial",1,"7 - QS88 - Personality disorders: borderline and antisocial - Outcome - 1"]
[null,"QS88","Personality disorders: borderline and antisocial",7,null,"Mental health professionals supporting people with borderline or antisocial personality disorder have an agreed level and frequency of supervision.","Staff retention among mental health professionals.","Outcome","QS88 - Personality disorders: borderline and antisocial","7 - QS88 - Personality disorders: borderline and antisocial",2,"7 - QS88 - Personality disorders: borderline and antisocial - Outcome - 2"]
[null,"QS89","Pressure ulcers",1,null,"People admitted to hospital or a care home with nursing have a pressure ulcer risk assessment within 6 hours of admission.","Evidence of local arrangements to ensure that healthcare professionals in hospitals and care homes with nursing know how to carry out pressure ulcer risk assessments","Structure","QS89 - Pressure ulcers","1 - QS89 - Pressure ulcers",1,"1 - QS89 - Pressure ulcers - Structure - 1","",""]
[null,"QS89","Pressure ulcers",1,null,"People admitted to hospital or a care home with nursing have a pressure ulcer risk assessment within 6 hours of admission.","Evidence of local arrangements to ensure that people admitted to hospital or a care home with nursing have a pressure ulcer risk assessment within 6 hours of admission.","Structure","QS89 - Pressure ulcers","1 - QS89 - Pressure ulcers",2,"1 - QS89 - Pressure ulcers - Structure - 2","",""]
[null,"QS89","Pressure ulcers",1,null,"People admitted to hospital or a care home with nursing have a pressure ulcer risk assessment within 6 hours of admission.","Proportion of new inpatient hospital admissions that have a pressure ulcer risk assessment carried out within 6 hours of admission.","Process","QS89 - Pressure ulcers","1 - QS89 - Pressure ulcers",1,"1 - QS89 - Pressure ulcers - Process - 1","The number in the denominator that have a pressure ulcer risk assessment carried out within 6 hours of admission.","The number of new inpatient hospital admissions."]
[null,"QS89","Pressure ulcers",1,null,"People admitted to hospital or a care home with nursing have a pressure ulcer risk assessment within 6 hours of admission.","Proportion of new residential admissions to care homes with nursing that have a pressure ulcer risk assessment carried out within 6 hours of admission.","Process","QS89 - Pressure ulcers","1 - QS89 - Pressure ulcers",2,"1 - QS89 - Pressure ulcers - Process - 2","The number in the denominator that have a pressure ulcer risk assessment carried out within 6 hours of admission.","The number of new residential admissions to care homes with nursing."]
[null,"QS89","Pressure ulcers",2,null,"People with a risk factor for developing pressure ulcers who are referred to community nursing services have a pressure ulcer risk assessment at the first face to face visit.","Evidence of local arrangements to ensure that healthcare professionals from community nursing services know how to perform pressure ulcer risk assessments.","Structure","QS89 - Pressure ulcers","2 - QS89 - Pressure ulcers",1,"2 - QS89 - Pressure ulcers - Structure - 1","",""]
[null,"QS89","Pressure ulcers",2,null,"People with a risk factor for developing pressure ulcers who are referred to community nursing services have a pressure ulcer risk assessment at the first face to face visit.","Evidence of local arrangements to ensure that people with 1 or more risk factors for pressure ulcers referred to community nursing services have a pressure ulcer risk assessment at the first face to face visit.","Structure","QS89 - Pressure ulcers","2 - QS89 - Pressure ulcers",2,"2 - QS89 - Pressure ulcers - Structure - 2","",""]
[null,"QS89","Pressure ulcers",2,null,"People with a risk factor for developing pressure ulcers who are referred to community nursing services have a pressure ulcer risk assessment at the first face to face visit.","Proportion of referrals to community nursing services for people with 1 or more risk factors for pressure ulcers in which a pressure ulcer risk assessment is carried out at the first face to face visit.","Process","QS89 - Pressure ulcers","2 - QS89 - Pressure ulcers",1,"2 - QS89 - Pressure ulcers - Process - 1","The number in the denominator in which a pressure ulcer risk assessment is carried out at the first face‑to‑face visit.","The number of referrals to community nursing services for people with 1 or more risk factors for pressure ulcers."]
[null,"QS89","Pressure ulcers",3,null,"People have their risk of developing pressure ulcers reassessed after a surgical or interventional procedure, or after a change in their care environment following a transfer.","Evidence of local arrangements to ensure that healthcare professionals know how to carry out a risk assessment to reassess the risk of developing pressure ulcers.","Structure","QS89 - Pressure ulcers","3 - QS89 - Pressure ulcers",1,"3 - QS89 - Pressure ulcers - Structure - 1","",""]
[null,"QS89","Pressure ulcers",3,null,"People have their risk of developing pressure ulcers reassessed after a surgical or interventional procedure, or after a change in their care environment following a transfer.","Evidence of local arrangements to ensure that people who have had a surgical or interventional procedure, or who have been transferred between care environments, have their pressure ulcer risk reassessed afterwards. ","Structure","QS89 - Pressure ulcers","3 - QS89 - Pressure ulcers",2,"3 - QS89 - Pressure ulcers - Structure - 2","",""]
[null,"QS89","Pressure ulcers",3,null,"People have their risk of developing pressure ulcers reassessed after a surgical or interventional procedure, or after a change in their care environment following a transfer.","Proportion of inpatient hospital interventional or surgical procedures that have a pressure ulcer risk reassessment carried out while the person is in hospital.","Process","QS89 - Pressure ulcers","3 - QS89 - Pressure ulcers",1,"3 - QS89 - Pressure ulcers - Process - 1","The number in the denominator that have a pressure ulcer risk reassessment carried out after the interventional or surgical procedure while the person is in hospital.","The number of inpatient hospital interventional or surgical procedures."]
[null,"QS89","Pressure ulcers",3,null,"People have their risk of developing pressure ulcers reassessed after a surgical or interventional procedure, or after a change in their care environment following a transfer.","Proportion of changes in care environment following a transfer that have a pressure ulcer risk reassessment carried out afterwards.","Process","QS89 - Pressure ulcers","3 - QS89 - Pressure ulcers",2,"3 - QS89 - Pressure ulcers - Process - 2","The number in the denominator that have a pressure ulcer risk reassessment carried out after the change in care environment.","The number of changes in care environment following a transfer."]
[null,"QS89","Pressure ulcers",4,null,"People have a skin assessment if they are identified as high risk of developing pressure ulcers. ","Evidence of local arrangements to ensure that people have a skin assessment if they are identified as high risk of developing pressure ulcers.","Structure","QS89 - Pressure ulcers","4 - QS89 - Pressure ulcers",1,"4 - QS89 - Pressure ulcers - Structure - 1","",""]
[null,"QS89","Pressure ulcers",4,null,"People have a skin assessment if they are identified as high risk of developing pressure ulcers. ","Proportion of pressure ulcer risk assessments with an identification of high risk that have a follow-up skin assessment.","Process","QS89 - Pressure ulcers","4 - QS89 - Pressure ulcers",1,"4 - QS89 - Pressure ulcers - Process - 1","The number in the denominator with a skin assessment carried out following the pressure ulcer risk assessment or reassessment.","The number of pressure ulcer risk assessments with an identification of high risk."]
[null,"QS89","Pressure ulcers",5,null,"People at risk of developing pressure ulcers receive advice on the benefits and frequency of repositioning. ","Evidence of local arrangements to ensure that people at risk of developing pressure ulcers are given advice on the benefits and frequency of repositioning.","Structure","QS89 - Pressure ulcers","5 - QS89 - Pressure ulcers",1,"5 - QS89 - Pressure ulcers - Structure - 1","",""]
[null,"QS89","Pressure ulcers",5,null,"People at risk of developing pressure ulcers receive advice on the benefits and frequency of repositioning. ","Proportion of adults newly identified as being at risk of developing pressure ulcers that are given advice to change position at least every 6 hours.","Process","QS89 - Pressure ulcers","5 - QS89 - Pressure ulcers",1,"5 - QS89 - Pressure ulcers - Process - 1","The number in the denominator, or their carers, who receive advice to change position at least every 6 hours.","The number of adults newly identified as being at risk, but not at high risk, of developing pressure ulcers."]
[null,"QS89","Pressure ulcers",5,null,"People at risk of developing pressure ulcers receive advice on the benefits and frequency of repositioning. ","Proportion of adults newly identified as being at high risk of developing pressure ulcers that are given advice to reposition at least every 4 hours.","Process","QS89 - Pressure ulcers","5 - QS89 - Pressure ulcers",2,"5 - QS89 - Pressure ulcers - Process - 2","The number in the denominator, or their carers, who receive advice to change position at least every 4 hours.","The number of adults newly identified as being at high risk of developing pressure ulcers."]
[null,"QS89","Pressure ulcers",5,null,"People at risk of developing pressure ulcers receive advice on the benefits and frequency of repositioning. ","Proportion of children and young people newly identified as being at risk or high risk of developing pressure ulcers that are given advice to change position at least every 4 hours.","Process","QS89 - Pressure ulcers","5 - QS89 - Pressure ulcers",3,"5 - QS89 - Pressure ulcers - Process - 3","The number in the denominator, or their carers, who receive advice to change position at least every 4 hours.","The number of children and young people newly identified as being at risk or high risk of developing pressure ulcers."]
[null,"QS89","Pressure ulcers",6,null,"People at risk of developing pressure ulcers, who are unable to reposition themselves, are helped to change their position.   ","Evidence of local arrangements to ensure that people who are unable to reposition themselves at the appropriate frequency are helped to do so.","Structure","QS89 - Pressure ulcers","6 - QS89 - Pressure ulcers",1,"6 - QS89 - Pressure ulcers - Structure - 1","",""]
[null,"QS89","Pressure ulcers",6,null,"People at risk of developing pressure ulcers, who are unable to reposition themselves, are helped to change their position.   ","Evidence of local arrangements to ensure that repositioning equipment is available to help with repositioning people who are unable to reposition themselves.","Structure","QS89 - Pressure ulcers","6 - QS89 - Pressure ulcers",2,"6 - QS89 - Pressure ulcers - Structure - 2","",""]
[null,"QS89","Pressure ulcers",6,null,"People at risk of developing pressure ulcers, who are unable to reposition themselves, are helped to change their position.   ","Proportion of adults at risk of developing pressure ulcers and needing help to change their position who have a plan for repositioning every 6 hours.","Process","QS89 - Pressure ulcers","6 - QS89 - Pressure ulcers",1,"6 - QS89 - Pressure ulcers - Process - 1","The number in the denominator who have a plan for repositioning every 6 hours.","The number of adults at risk, but not high risk, of developing pressure ulcers who need help to change their position."]
[null,"QS89","Pressure ulcers",6,null,"People at risk of developing pressure ulcers, who are unable to reposition themselves, are helped to change their position.   ","Proportion of adults at high risk of developing pressure ulcers and needing help to change their position who have a plan for repositioning every 4 hours.","Process","QS89 - Pressure ulcers","6 - QS89 - Pressure ulcers",2,"6 - QS89 - Pressure ulcers - Process - 2","The number in the denominator who have a plan for repositioning every 4 hours.","The number of adults at high risk of developing pressure ulcers who need help to change their position."]
[null,"QS89","Pressure ulcers",6,null,"People at risk of developing pressure ulcers, who are unable to reposition themselves, are helped to change their position.   ","Proportion of neonates, infants, children and young people at risk or high risk of developing pressure ulcers and needing help to change their position who have a plan for repositioning every 4 hours.","Process","QS89 - Pressure ulcers","6 - QS89 - Pressure ulcers",3,"6 - QS89 - Pressure ulcers - Process - 3","The number in the denominator who have a plan for repositioning every 4 hours.","The number of neonates, infants, children and young people at risk or high risk of developing pressure ulcers who need help to change their position."]
[null,"QS89","Pressure ulcers",7,null,"People at high risk of developing pressure ulcers, and their carers, receive information on how to prevent them. ","Evidence of local arrangements to ensure that people at high risk of developing pressure ulcers, and their carers, receive information on how to prevent them.","Structure","QS89 - Pressure ulcers","7 - QS89 - Pressure ulcers",1,"7 - QS89 - Pressure ulcers - Structure - 1","",""]
[null,"QS89","Pressure ulcers",7,null,"People at high risk of developing pressure ulcers, and their carers, receive information on how to prevent them. ","Proportion of people newly identified at high risk of developing pressure ulcers who receive information on how to prevent them.","Process","QS89 - Pressure ulcers","7 - QS89 - Pressure ulcers",1,"7 - QS89 - Pressure ulcers - Process - 1","The number in the denominator, or their carer, that receive information on how to prevent pressure ulcers.","The number of people newly identified at high risk of developing pressure ulcers."]
[null,"QS89","Pressure ulcers",8,null,"People at high risk of developing pressure ulcers are provided with pressure redistribution devices.","Evidence of local arrangements to provide pressure redistribution devices for people at high risk of developing pressure ulcers","Structure","QS89 - Pressure ulcers","8 - QS89 - Pressure ulcers",1,"8 - QS89 - Pressure ulcers - Structure - 1","",""]
[null,"QS89","Pressure ulcers",8,null,"People at high risk of developing pressure ulcers are provided with pressure redistribution devices.","Proportion of people newly identified as being at high risk of developing pressure ulcers who receive a pressure redistribution device.","Process","QS89 - Pressure ulcers","8 - QS89 - Pressure ulcers",1,"8 - QS89 - Pressure ulcers - Process - 1","The number in the denominator who receive a pressure redistribution device.","The number of people newly identified as being at high risk of developing pressure ulcers."]
[null,"QS89","Pressure ulcers",8,null,"People at high risk of developing pressure ulcers are provided with pressure redistribution devices.","Waiting times from the identified need for a pressure redistribution device to the time the device is requested.","Outcome","QS89 - Pressure ulcers","8 - QS89 - Pressure ulcers",1,"8 - QS89 - Pressure ulcers - Outcome - 1"]
[null,"QS89","Pressure ulcers",8,null,"People at high risk of developing pressure ulcers are provided with pressure redistribution devices.","Waiting times from the time the pressure redistribution device is requested to the time the device is received.","Outcome","QS89 - Pressure ulcers","8 - QS89 - Pressure ulcers",2,"8 - QS89 - Pressure ulcers - Outcome - 2"]
[null,"QS90","Urinary tract infections in adults",1,null,"Women aged under 65 years are diagnosed with a urinary tract infection (UTI) if they have 2 or more key urinary symptoms and no other excluding causes or warning signs. [new 2023]","Proportion of episodes of suspected UTI in women aged under 65 with signs and symptoms documented in the patient's records.","Process","QS90 - Urinary tract infections in adults","1 - QS90 - Urinary tract infections in adults",1,"1 - QS90 - Urinary tract infections in adults - Process - 1","The number in the denominator with signs and symptoms documented in the patient's records.","The number of episodes of suspected UTI in women aged under 65."]
[null,"QS90","Urinary tract infections in adults",1,null,"Women aged under 65 years are diagnosed with a urinary tract infection (UTI) if they have 2 or more key urinary symptoms and no other excluding causes or warning signs. [new 2023]","Proportion of women aged under 65 years diagnosed with a UTI who have 2 or more key urinary symptoms and no other excluding causes or warning signs.","Process","QS90 - Urinary tract infections in adults","1 - QS90 - Urinary tract infections in adults",2,"1 - QS90 - Urinary tract infections in adults - Process - 2","The number in the denominator who have 2 or more key urinary symptoms and no other excluding causes or warning signs.","The number of women aged under 65 diagnosed with a UTI."]
[null,"QS90","Urinary tract infections in adults",1,null,"Women aged under 65 years are diagnosed with a urinary tract infection (UTI) if they have 2 or more key urinary symptoms and no other excluding causes or warning signs. [new 2023]","Prescription rates for antibiotics used for lower UTIs (such as trimethoprim, nitrofurantoin, fosfomycin or pivmecillinam).","Outcome","QS90 - Urinary tract infections in adults","1 - QS90 - Urinary tract infections in adults",1,"1 - QS90 - Urinary tract infections in adults - Outcome - 1"]
[null,"QS90","Urinary tract infections in adults",2,null,"Adults with indwelling urinary catheters do not have dipstick testing to diagnose urinary tract infections (UTIs). [2015, updated 2023]","Evidence of a register of people with an indwelling urinary catheter in the community.","Structure","QS90 - Urinary tract infections in adults","2 - QS90 - Urinary tract infections in adults",1,"2 - QS90 - Urinary tract infections in adults - Structure - 1"]
[null,"QS90","Urinary tract infections in adults",2,null,"Adults with indwelling urinary catheters do not have dipstick testing to diagnose urinary tract infections (UTIs). [2015, updated 2023]","Proportion of episodes of suspected UTI in adults with indwelling urinary catheters that are investigated using dipstick testing.","Process","QS90 - Urinary tract infections in adults","2 - QS90 - Urinary tract infections in adults",1,"2 - QS90 - Urinary tract infections in adults - Process - 1","The number in the denominator investigated using dipstick testing.","The number of episodes of suspected UTI in adults with indwelling urinary catheters."]
[null,"QS90","Urinary tract infections in adults",2,null,"Adults with indwelling urinary catheters do not have dipstick testing to diagnose urinary tract infections (UTIs). [2015, updated 2023]","Proportion of episodes of suspected catheter-associated UTI in adults where a urine sample is sent to laboratories for culture and sensitivity testing.","Process","QS90 - Urinary tract infections in adults",{"$f":"CONCATENATE(D1892, \" - \", I1892)","v":"2 - QS90 - Urinary tract infections in adults"},{"$f":"IF(AND(B1892=B1891, D1892=D1891, H1892=H1891)=TRUE, K1891+1, 1)","v":2},{"$f":"CONCATENATE(J1892, \" - \", H1892, \" - \",K1892)","v":"2 - QS90 - Urinary tract infections in adults - Process - 2"},"The number in the denominator where a urine sample is sent to laboratories for culture and sensitivity testing.","The number of episodes of suspected catheter-associated UTI in adults."]
[null,"QS90","Urinary tract infections in adults",2,null,"Adults with indwelling urinary catheters do not have dipstick testing to diagnose urinary tract infections (UTIs). [2015, updated 2023]","Antibiotic prescription rates for adults with indwelling urinary catheters.","Outcome","QS90 - Urinary tract infections in adults","2 - QS90 - Urinary tract infections in adults",1,"2 - QS90 - Urinary tract infections in adults - Outcome - 1"]
[null,"QS90","Urinary tract infections in adults",3,null,"Men and non-pregnant women are not prescribed antibiotics to treat asymptomatic bacteriuria. [2015, updated 2023]","Proportion of episodes of suspected UTI in men and non-pregnant women with signs and symptoms documented in the patient's records.","Process","QS90 - Urinary tract infections in adults","3 - QS90 - Urinary tract infections in adults",1,"3 - QS90 - Urinary tract infections in adults - Process - 1","The number in the denominator with signs and symptoms documented in the patient's records.","The number of episodes of suspected UTI in men and non-pregnant women."]
[null,"QS90","Urinary tract infections in adults",3,null,"Men and non-pregnant women are not prescribed antibiotics to treat asymptomatic bacteriuria. [2015, updated 2023]","Proportion of episodes of asymptomatic bacteriuria in men and non-pregnant women treated with antibiotics.","Process","QS90 - Urinary tract infections in adults","3 - QS90 - Urinary tract infections in adults",2,"3 - QS90 - Urinary tract infections in adults - Process - 2","The number in the denominator treated with antibiotics.","The number of episodes of bacteriuria in men and non-pregnant women with no symptoms recorded."]
[null,"QS90","Urinary tract infections in adults",3,null,"Men and non-pregnant women are not prescribed antibiotics to treat asymptomatic bacteriuria. [2015, updated 2023]","Antimicrobial prescribing rates for men and non-pregnant women with asymptomatic bacteriuria.","Outcome","QS90 - Urinary tract infections in adults","3 - QS90 - Urinary tract infections in adults",1,"3 - QS90 - Urinary tract infections in adults - Outcome - 1"]
[null,"QS90","Urinary tract infections in adults",4,null,"Non-pregnant women with an uncomplicated lower urinary tract infection (UTI) are prescribed a 3-day course of antibiotics, and men and pregnant women with an uncomplicated lower UTI are prescribed a 7-day course of antibiotics. [new 2023]","Proportion of prescriptions for antimicrobials with the clinical indication, dose and duration of treatment documented in the patient's records.","Process",{"$f":"CONCATENATE(B1897, \" - \", C1897)","v":"QS90 - Urinary tract infections in adults"},"4 - QS90 - Urinary tract infections in adults",1,"4 - QS90 - Urinary tract infections in adults - Process - 1","The number in the denominator with the clinical indication, dose and duration of treatment documented in the patient's records.","The number of prescriptions for antimicrobials."]
[null,"QS90","Urinary tract infections in adults",4,null,"Non-pregnant women with an uncomplicated lower urinary tract infection (UTI) are prescribed a 3-day course of antibiotics, and men and pregnant women with an uncomplicated lower UTI are prescribed a 7-day course of antibiotics. [new 2023]","Proportion of antibiotic courses prescribed for a 3-day duration for episodes of uncomplicated lower UTI in non-pregnant women.","Process","QS90 - Urinary tract infections in adults","4 - QS90 - Urinary tract infections in adults",2,"4 - QS90 - Urinary tract infections in adults - Process - 2","The number in the denominator prescribed a 3-day course of antibiotics.","The number of antibiotic courses prescribed for episodes of uncomplicated lower UTI in non-pregnant women."]
[null,"QS90","Urinary tract infections in adults",4,null,"Non-pregnant women with an uncomplicated lower urinary tract infection (UTI) are prescribed a 3-day course of antibiotics, and men and pregnant women with an uncomplicated lower UTI are prescribed a 7-day course of antibiotics. [new 2023]","Proportion of antibiotic courses prescribed for a 7-day duration for episodes of uncomplicated lower UTI in men.","Process","QS90 - Urinary tract infections in adults","4 - QS90 - Urinary tract infections in adults",3,"4 - QS90 - Urinary tract infections in adults - Process - 3","The number in the denominator prescribed a 7-day course of antibiotics.","The number of antibiotic courses prescribed for episodes of uncomplicated lower UTI in men."]
[null,"QS90","Urinary tract infections in adults",4,null,"Non-pregnant women with an uncomplicated lower urinary tract infection (UTI) are prescribed a 3-day course of antibiotics, and men and pregnant women with an uncomplicated lower UTI are prescribed a 7-day course of antibiotics. [new 2023]","Proportion of antibiotic courses prescribed for a 7-day duration for episodes of uncomplicated lower UTI in pregnant women.","Process","QS90 - Urinary tract infections in adults","4 - QS90 - Urinary tract infections in adults",4,"4 - QS90 - Urinary tract infections in adults - Process - 4","The number in the denominator prescribed a 7-day course of antibiotics.","The number of antibiotic courses prescribed for episodes of uncomplicated lower UTI in pregnant women."]
[null,"QS90","Urinary tract infections in adults",4,null,"Non-pregnant women with an uncomplicated lower urinary tract infection (UTI) are prescribed a 3-day course of antibiotics, and men and pregnant women with an uncomplicated lower UTI are prescribed a 7-day course of antibiotics. [new 2023]","Average duration of antibiotic treatment for UTI.","Outcome","QS90 - Urinary tract infections in adults","4 - QS90 - Urinary tract infections in adults",1,"4 - QS90 - Urinary tract infections in adults - Outcome - 1"]
[null,"QS90","Urinary tract infections in adults",5,null,"Men with a recurrent urinary tract infection (UTI), and women with a recurrent lower UTI where the cause is unknown or a recurrent upper UTI, are referred for specialist advice. [new 2023]","Proportion of men with a recurrent UTI who are referred for specialist advice.","Process","QS90 - Urinary tract infections in adults","5 - QS90 - Urinary tract infections in adults",1,"5 - QS90 - Urinary tract infections in adults - Process - 1","The number in the denominator referred for specialist advice.","The number of men with a recurrent UTI."]
[null,"QS90","Urinary tract infections in adults",5,null,"Men with a recurrent urinary tract infection (UTI), and women with a recurrent lower UTI where the cause is unknown or a recurrent upper UTI, are referred for specialist advice. [new 2023]","Proportion of women with a recurrent lower UTI where the underlying cause is unknown following clinical assessment who are referred for specialist advice.","Process","QS90 - Urinary tract infections in adults","5 - QS90 - Urinary tract infections in adults",2,"5 - QS90 - Urinary tract infections in adults - Process - 2","The number in the denominator referred for specialist advice.","The number of women with a recurrent lower UTI where the underlying cause of recurrence is unknown following clinical assessment."]
[null,"QS90","Urinary tract infections in adults",5,null,"Men with a recurrent urinary tract infection (UTI), and women with a recurrent lower UTI where the cause is unknown or a recurrent upper UTI, are referred for specialist advice. [new 2023]","Proportion of women with a recurrent upper UTI referred for specialist advice.","Process","QS90 - Urinary tract infections in adults","5 - QS90 - Urinary tract infections in adults",3,"5 - QS90 - Urinary tract infections in adults - Process - 3","The number in the denominator referred for specialist advice.","The number of women with a recurrent upper UTI."]
[null,"QS90","Urinary tract infections in adults",5,null,"Men with a recurrent urinary tract infection (UTI), and women with a recurrent lower UTI where the cause is unknown or a recurrent upper UTI, are referred for specialist advice. [new 2023]","Number of recurrent UTIs in adults.","Outcome","QS90 - Urinary tract infections in adults","5 - QS90 - Urinary tract infections in adults",{"$f":"IF(AND(B1905=B1898, D1905=D1898, H1905=H1898)=TRUE, K1898+1, 1)","v":1},"5 - QS90 - Urinary tract infections in adults - Outcome - 1"]
[null,"QS91","Prostate cancer",1,null,"People with prostate cancer have a discussion about treatment options and adverse effects with a named nurse specialist.","Evidence of local arrangements to ensure that people with prostate cancer have a discussion about treatment options and adverse effects with a named nurse specialist.","Structure","QS91 - Prostate cancer","1 - QS91 - Prostate cancer",{"$f":"IF(AND(B1906=B1899, D1906=D1899, H1906=H1899)=TRUE, K1899+1, 1)","v":1},"1 - QS91 - Prostate cancer - Structure - 1","",""]
[null,"QS91","Prostate cancer",1,null,"People with prostate cancer have a discussion about treatment options and adverse effects with a named nurse specialist.","Proportion of people with prostate cancer who have a recorded discussion about treatment options and adverse effects with a named nurse specialist.","Process","QS91 - Prostate cancer","1 - QS91 - Prostate cancer",1,"1 - QS91 - Prostate cancer - Process - 1","The number in the denominator who have a recorded discussion about treatment options and adverse effects with a named nurse specialist.","The number of people with prostate cancer."]
[null,"QS91","Prostate cancer",1,null,"People with prostate cancer have a discussion about treatment options and adverse effects with a named nurse specialist.","Rates of people with prostate cancer satisfied with the discussion about treatment options and adverse effects.","Outcome","QS91 - Prostate cancer","1 - QS91 - Prostate cancer",1,"1 - QS91 - Prostate cancer - Outcome - 1"]
[null,"QS91","Prostate cancer",2,null,"People with Cambridge Prognostic Group (CPG) 1 localised prostate cancer for whom radical treatment is suitable are offered active surveillance.","Evidence of local arrangements to ensure that people with CPG 1 localised prostate cancer for whom radical treatment is suitable are offered active surveillance.","Structure","QS91 - Prostate cancer","2 - QS91 - Prostate cancer",1,"2 - QS91 - Prostate cancer - Structure - 1","",""]
[null,"QS91","Prostate cancer",2,null,"People with Cambridge Prognostic Group (CPG) 1 localised prostate cancer for whom radical treatment is suitable are offered active surveillance.","Proportion of people with CPG 1 localised prostate cancer for whom radical treatment is suitable on active surveillance.","Process","QS91 - Prostate cancer","2 - QS91 - Prostate cancer",1,"2 - QS91 - Prostate cancer - Process - 1","The number in the denominator who are on active surveillance.","The number of people with CPG 1 localised prostate cancer for whom radical treatment is suitable."]
[null,"QS91","Prostate cancer",2,null,"People with Cambridge Prognostic Group (CPG) 1 localised prostate cancer for whom radical treatment is suitable are offered active surveillance.","Rates of people with CPG 1 localised prostate cancer satisfied with their chosen treatment option.","Outcome","QS91 - Prostate cancer","2 - QS91 - Prostate cancer",1,"2 - QS91 - Prostate cancer - Outcome - 1"]
[]
[null,"QS91","Prostate cancer",3,null,"People with Cambridge Prognostic Group (CPG) 2, 3, 4 and 5 localised or locally advanced prostate cancer who are offered non‑surgical radical treatment are offered radical radiotherapy and androgen deprivation therapy in combination.","Evidence of local arrangements to ensure that people with CPG 2, 3, 4 and 5 localised or locally advanced prostate cancer who are offered non‑surgical radical treatment are offered radical radiotherapy and androgen deprivation therapy in combination.","Structure","QS91 - Prostate cancer","3 - QS91 - Prostate cancer",{"$f":"IF(AND(B1913=B1912, D1913=D1912, H1913=H1912)=TRUE, K1912+1, 1)","v":1},"3 - QS91 - Prostate cancer - Structure - 1","",""]
[null,"QS91","Prostate cancer",3,null,"People with Cambridge Prognostic Group (CPG) 2, 3, 4 and 5 localised or locally advanced prostate cancer who are offered non‑surgical radical treatment are offered radical radiotherapy and androgen deprivation therapy in combination.","Proportion of people with CPG 2, 3, 4 and 5 localised or locally advanced prostate cancer receiving non‑surgical radical treatment, who receive radical radiotherapy and androgen deprivation therapy in combination.","Process","QS91 - Prostate cancer","3 - QS91 - Prostate cancer",1,"3 - QS91 - Prostate cancer - Process - 1","The number in the denominator who received radical radiotherapy and androgen deprivation therapy in combination.","The number of people with CPG 2, 3, 4 and 5 localised or locally advanced prostate cancer receiving non‑surgical radical treatment."]
[null,"QS91","Prostate cancer",4,null,"People with adverse effects of prostate cancer treatment are referred to specialist services.","Evidence of local pathways that allow people with adverse effects of prostate cancer treatment to be referred to specialist services.","Structure","QS91 - Prostate cancer","4 - QS91 - Prostate cancer",1,"4 - QS91 - Prostate cancer - Structure - 1","",""]
[null,"QS91","Prostate cancer",4,null,"People with adverse effects of prostate cancer treatment are referred to specialist services.","Proportion of people with adverse effects of prostate cancer treatment referred to specialist services.","Process","QS91 - Prostate cancer","4 - QS91 - Prostate cancer",1,"4 - QS91 - Prostate cancer - Process - 1","The number in the denominator who use specialist services.","The number of people with adverse effects of prostate cancer treatment."]
[null,"QS91","Prostate cancer",5,null,"People with hormone‑relapsed metastatic prostate cancer have their treatment options discussed by the urological cancer multidisciplinary team (MDT).","Evidence of local arrangements to ensure that people with hormone‑relapsed metastatic disease have their treatment options discussed by the urological cancer MDT.","Structure","QS91 - Prostate cancer","5 - QS91 - Prostate cancer",1,"5 - QS91 - Prostate cancer - Structure - 1","",""]
[null,"QS91","Prostate cancer",5,null,"People with hormone‑relapsed metastatic prostate cancer have their treatment options discussed by the urological cancer multidisciplinary team (MDT).","Proportion of people with hormone‑relapsed metastatic disease who have their treatment options discussed by the urological cancer MDT.","Process","QS91 - Prostate cancer","5 - QS91 - Prostate cancer",1,"5 - QS91 - Prostate cancer - Process - 1","The number in the denominator who have their treatment options discussed by the urological cancer MDT.","The number of people with hormone‑relapsed metastatic prostate cancer."]
[null,"QS92","Smoking: harm reduction",1,null,"People who are unwilling or not ready to stop smoking are offered a harm‑reduction approach to smoking.","Evidence of local arrangements and written protocols to ensure that people who are unwilling or not ready to stop smoking are offered a harm‑reduction approach to smoking.","Structure","QS92 - Smoking: harm reduction","1 - QS92 - Smoking: harm reduction",1,"1 - QS92 - Smoking: harm reduction - Structure - 1","",""]
[null,"QS92","Smoking: harm reduction",1,null,"People who are unwilling or not ready to stop smoking are offered a harm‑reduction approach to smoking.","Proportion of people identified as being unwilling or not ready to stop smoking who are offered a harm‑reduction approach to smoking.","Process","QS92 - Smoking: harm reduction","1 - QS92 - Smoking: harm reduction",1,"1 - QS92 - Smoking: harm reduction - Process - 1","The number in the denominator who are offered a harm‑reduction approach to smoking.","The number of people identified as being unwilling or not ready to stop smoking."]
[null,"QS92","Smoking: harm reduction",1,null,"People who are unwilling or not ready to stop smoking are offered a harm‑reduction approach to smoking.","Proportion of people who decline a referral to a 'stop smoking' service, and who are unwilling or not ready to stop smoking, who are offered a harm‑reduction approach to smoking.","Process","QS92 - Smoking: harm reduction","1 - QS92 - Smoking: harm reduction",2,"1 - QS92 - Smoking: harm reduction - Process - 2","The number in the denominator who are offered a harm‑reduction approach to smoking.","The number of people who decline a referral to a 'stop smoking' service and who are unwilling or not ready to stop smoking."]
[null,"QS92","Smoking: harm reduction",1,null,"People who are unwilling or not ready to stop smoking are offered a harm‑reduction approach to smoking.","Uptake of smoking harm‑reduction approaches.","Outcome","QS92 - Smoking: harm reduction","1 - QS92 - Smoking: harm reduction",1,"1 - QS92 - Smoking: harm reduction - Outcome - 1"]
[null,"QS92","Smoking: harm reduction",2,null,"People who are unwilling or not ready to stop smoking are advised that health problems associated with smoking are caused primarily by components in tobacco smoke other than nicotine.","Evidence of local arrangements and protocols to ensure that people who are unwilling or not ready to stop smoking are advised that health problems associated with smoking are caused primarily by components in tobacco smoke other than nicotine.","Structure","QS92 - Smoking: harm reduction","2 - QS92 - Smoking: harm reduction",1,"2 - QS92 - Smoking: harm reduction - Structure - 1","",""]
[null,"QS92","Smoking: harm reduction",2,null,"People who are unwilling or not ready to stop smoking are advised that health problems associated with smoking are caused primarily by components in tobacco smoke other than nicotine.","Proportion of people identified as being unwilling or not ready to stop smoking who are advised that health problems associated with smoking are caused primarily by components in tobacco smoke other than nicotine.","Process","QS92 - Smoking: harm reduction","2 - QS92 - Smoking: harm reduction",1,"2 - QS92 - Smoking: harm reduction - Process - 1","The number in the denominator who are advised that health problems associated with smoking are caused primarily by components in tobacco smoke other than nicotine.","The number of people identified as being unwilling or not ready to stop smoking."]
[null,"QS92","Smoking: harm reduction",2,null,"People who are unwilling or not ready to stop smoking are advised that health problems associated with smoking are caused primarily by components in tobacco smoke other than nicotine.","Awareness of people who smoke that health problems associated with smoking are caused primarily by components in tobacco smoke other than nicotine.","Outcome","QS92 - Smoking: harm reduction","2 - QS92 - Smoking: harm reduction",1,"2 - QS92 - Smoking: harm reduction - Outcome - 1"]
[null,"QS92","Smoking: harm reduction",3,null,"People who are unwilling or not ready to stop smoking are advised about using nicotine‑containing products and supported to obtain licensed nicotine‑containing products.","Evidence of local arrangements that people who are unwilling or not ready to stop smoking are advised about using nicotine‑containing products and supported to obtain licensed nicotine‑containing products.","Structure","QS92 - Smoking: harm reduction","3 - QS92 - Smoking: harm reduction",1,"3 - QS92 - Smoking: harm reduction - Structure - 1","",""]
[null,"QS92","Smoking: harm reduction",3,null,"People who are unwilling or not ready to stop smoking are advised about using nicotine‑containing products and supported to obtain licensed nicotine‑containing products.","Proportion of people identified as being unwilling or not ready to stop smoking who are advised about using nicotine‑containing products.","Process","QS92 - Smoking: harm reduction","3 - QS92 - Smoking: harm reduction",1,"3 - QS92 - Smoking: harm reduction - Process - 1","The number in the denominator who are advised about using nicotine‑containing products.","The number of people identified as being unwilling or not ready to stop smoking."]
[null,"QS92","Smoking: harm reduction",3,null,"People who are unwilling or not ready to stop smoking are advised about using nicotine‑containing products and supported to obtain licensed nicotine‑containing products.","Proportion of people identified as being unwilling or not ready to stop smoking who are supported to obtain licensed nicotine‑containing products.","Process","QS92 - Smoking: harm reduction","3 - QS92 - Smoking: harm reduction",2,"3 - QS92 - Smoking: harm reduction - Process - 2","The number in the denominator who are supported to obtain licensed nicotine‑containing products.","The number of people identified as being unwilling or not ready to stop smoking."]
[null,"QS92","Smoking: harm reduction",3,null,"People who are unwilling or not ready to stop smoking are advised about using nicotine‑containing products and supported to obtain licensed nicotine‑containing products.","Uptake of licensed nicotine‑containing products.","Outcome","QS92 - Smoking: harm reduction","3 - QS92 - Smoking: harm reduction",1,"3 - QS92 - Smoking: harm reduction - Outcome - 1"]
[null,"QS92","Smoking: harm reduction",4,null,"Stop smoking' services offer harm‑reduction approaches alongside existing approaches to stopping smoking in one step.","Evidence of local arrangements that 'stop smoking' services offer harm‑reduction approaches to smoking alongside existing approaches to stopping smoking in one step.","Structure","QS92 - Smoking: harm reduction","4 - QS92 - Smoking: harm reduction",1,"4 - QS92 - Smoking: harm reduction - Structure - 1","",""]
[null,"QS93","Atrial fibrillation",1,null,"Adults with non-valvular atrial fibrillation and a CHA2DS2-VASC stroke risk score of 2 or above are offered anticoagulation.","Evidence of local arrangements and written clinical protocols to ensure that adults with non-valvular atrial fibrillation and a CHA2DS2-VASC stroke risk score of 2 or above are offered anticoagulation.","Structure","QS93 - Atrial fibrillation","1 - QS93 - Atrial fibrillation",1,"1 - QS93 - Atrial fibrillation - Structure - 1","",""]
[null,"QS93","Atrial fibrillation",1,null,"Adults with non-valvular atrial fibrillation and a CHA2DS2-VASC stroke risk score of 2 or above are offered anticoagulation.","Proportion of adults with non-valvular atrial fibrillation and a CHA2DS2-VASC stroke risk score of 2 or above who receive anticoagulation.","Process","QS93 - Atrial fibrillation","1 - QS93 - Atrial fibrillation",1,"1 - QS93 - Atrial fibrillation - Process - 1","The number in the denominator who receive anticoagulation.","The number of adults with non‑valvular atrial fibrillation and a CHA2DS2‑VASC stroke risk score of 2 or above."]
[null,"QS93","Atrial fibrillation",1,null,"Adults with non-valvular atrial fibrillation and a CHA2DS2-VASC stroke risk score of 2 or above are offered anticoagulation.","Stroke rates in adults with a primary diagnosis of non-valvular atrial fibrillation.","Outcome","QS93 - Atrial fibrillation","1 - QS93 - Atrial fibrillation",1,"1 - QS93 - Atrial fibrillation - Outcome - 1"]
[null,"QS93","Atrial fibrillation",2,null,"Adults with atrial fibrillation are not prescribed aspirin as monotherapy for stroke prevention.","Evidence of local monitoring arrangements to ensure that adults with atrial fibrillation are not prescribed aspirin as monotherapy for stroke prevention.","Structure","QS93 - Atrial fibrillation","2 - QS93 - Atrial fibrillation",1,"2 - QS93 - Atrial fibrillation - Structure - 1","",""]
[null,"QS93","Atrial fibrillation",2,null,"Adults with atrial fibrillation are not prescribed aspirin as monotherapy for stroke prevention.","Proportion of adults with atrial fibrillation who are prescribed aspirin as monotherapy for stroke prevention.","Process","QS93 - Atrial fibrillation","2 - QS93 - Atrial fibrillation",1,"2 - QS93 - Atrial fibrillation - Process - 1","The number in the denominator who are prescribed aspirin as monotherapy for stroke prevention.","The number of adults with atrial fibrillation."]
[null,"QS93","Atrial fibrillation",2,null,"Adults with atrial fibrillation are not prescribed aspirin as monotherapy for stroke prevention.","Rates of prescribing aspirin.","Outcome","QS93 - Atrial fibrillation","2 - QS93 - Atrial fibrillation",1,"2 - QS93 - Atrial fibrillation - Outcome - 1"]
[null,"QS93","Atrial fibrillation",3,null,"Adults with atrial fibrillation who are prescribed anticoagulation discuss the options with their healthcare professional at least once a year.","Evidence of local arrangements to ensure that adults with atrial fibrillation who are prescribed anticoagulation can discuss the options with their healthcare professional at least once a year.","Structure","QS93 - Atrial fibrillation","3 - QS93 - Atrial fibrillation",1,"3 - QS93 - Atrial fibrillation - Structure - 1","",""]
[null,"QS93","Atrial fibrillation",3,null,"Adults with atrial fibrillation who are prescribed anticoagulation discuss the options with their healthcare professional at least once a year.","Proportion of adults with atrial fibrillation who are prescribed anticoagulation who discuss the options with their healthcare professional at least once a year.","Process","QS93 - Atrial fibrillation","3 - QS93 - Atrial fibrillation",1,"3 - QS93 - Atrial fibrillation - Process - 1","The number in the denominator who discuss the options with their healthcare professional at least once a year.","The number of adults with atrial fibrillation who are prescribed anticoagulation."]
[null,"QS93","Atrial fibrillation",3,null,"Adults with atrial fibrillation who are prescribed anticoagulation discuss the options with their healthcare professional at least once a year.","Patient experience.","Outcome","QS93 - Atrial fibrillation","3 - QS93 - Atrial fibrillation",1,"3 - QS93 - Atrial fibrillation - Outcome - 1"]
[null,"QS93","Atrial fibrillation",3,null,"Adults with atrial fibrillation who are prescribed anticoagulation discuss the options with their healthcare professional at least once a year.","Rates of adherence to anticoagulation therapy for adults with atrial fibrillation.","Outcome","QS93 - Atrial fibrillation","3 - QS93 - Atrial fibrillation",2,"3 - QS93 - Atrial fibrillation - Outcome - 2"]
[null,"QS93","Atrial fibrillation",4,null,"Adults with atrial fibrillation taking a vitamin K antagonist who have poor anticoagulation control have their anticoagulation reassessed.","Evidence of local arrangements and written clinical protocols to ensure that adults with atrial fibrillation taking a vitamin K antagonist have their anticoagulation reassessed if their anticoagulation control is poor.","Structure","QS93 - Atrial fibrillation","4 - QS93 - Atrial fibrillation",1,"4 - QS93 - Atrial fibrillation - Structure - 1","",""]
[null,"QS93","Atrial fibrillation",4,null,"Adults with atrial fibrillation taking a vitamin K antagonist who have poor anticoagulation control have their anticoagulation reassessed.","Proportion of adults with atrial fibrillation taking a vitamin K antagonist who have their time in therapeutic range (TTR) recorded at each visit for INR assessment.","Process","QS93 - Atrial fibrillation","4 - QS93 - Atrial fibrillation",1,"4 - QS93 - Atrial fibrillation - Process - 1","The number in the denominator who have their TTR recorded at each visit for INR assessment.","The number of adults with atrial fibrillation taking a vitamin K antagonist."]
[null,"QS93","Atrial fibrillation",4,null,"Adults with atrial fibrillation taking a vitamin K antagonist who have poor anticoagulation control have their anticoagulation reassessed.","Proportion of adults with poor anticoagulation control who have it reassessed.","Process","QS93 - Atrial fibrillation","4 - QS93 - Atrial fibrillation",2,"4 - QS93 - Atrial fibrillation - Process - 2","The number in the denominator who have their anticoagulation reassessed.","The number of adults with poor anticoagulation control."]
[null,"QS93","Atrial fibrillation",4,null,"Adults with atrial fibrillation taking a vitamin K antagonist who have poor anticoagulation control have their anticoagulation reassessed.","Rates of thromboembolic complications.","Outcome","QS93 - Atrial fibrillation","4 - QS93 - Atrial fibrillation",1,"4 - QS93 - Atrial fibrillation - Outcome - 1"]
[null,"QS93","Atrial fibrillation",4,null,"Adults with atrial fibrillation taking a vitamin K antagonist who have poor anticoagulation control have their anticoagulation reassessed.","Patient experience.","Outcome","QS93 - Atrial fibrillation","4 - QS93 - Atrial fibrillation",2,"4 - QS93 - Atrial fibrillation - Outcome - 2"]
[null,"QS93","Atrial fibrillation",5,null,"Adults with atrial fibrillation whose treatment fails to control their symptoms are referred for specialised management within 4 weeks.","Evidence of local arrangements and referral pathways to ensure that adults with atrial fibrillation whose treatment fails to control their symptoms are referred for specialised management within 4 weeks.","Structure","QS93 - Atrial fibrillation","5 - QS93 - Atrial fibrillation",1,"5 - QS93 - Atrial fibrillation - Structure - 1","",""]
[null,"QS93","Atrial fibrillation",5,null,"Adults with atrial fibrillation whose treatment fails to control their symptoms are referred for specialised management within 4 weeks.","Proportion of adults with atrial fibrillation whose treatment fails to control their symptoms who are referred for specialised management within 4 weeks.","Process","QS93 - Atrial fibrillation","5 - QS93 - Atrial fibrillation",1,"5 - QS93 - Atrial fibrillation - Process - 1","The number in the denominator who are referred for specialised management within 4 weeks.","The number of adults with atrial fibrillation whose treatment fails to control their symptoms."]
[null,"QS93","Atrial fibrillation",5,null,"Adults with atrial fibrillation whose treatment fails to control their symptoms are referred for specialised management within 4 weeks.","Adults with atrial fibrillation symptom control.","Outcome","QS93 - Atrial fibrillation","5 - QS93 - Atrial fibrillation",1,"5 - QS93 - Atrial fibrillation - Outcome - 1"]
[null,"QS93","Atrial fibrillation",5,null,"Adults with atrial fibrillation whose treatment fails to control their symptoms are referred for specialised management within 4 weeks.","Rates of stroke and heart failure for adults with atrial fibrillation.","Outcome","QS93 - Atrial fibrillation","5 - QS93 - Atrial fibrillation",2,"5 - QS93 - Atrial fibrillation - Outcome - 2"]
[null,"QS93","Atrial fibrillation",6,null,"Adults with atrial fibrillation on long-term vitamin K antagonist therapy are supported to self-manage with a coagulometer.","Evidence of local arrangements for adults with atrial fibrillation on long-term vitamin K antagonist therapy to be supported to self-manage with a coagulometer.","Structure","QS93 - Atrial fibrillation","6 - QS93 - Atrial fibrillation",1,"6 - QS93 - Atrial fibrillation - Structure - 1","",""]
[null,"QS93","Atrial fibrillation",6,null,"Adults with atrial fibrillation on long-term vitamin K antagonist therapy are supported to self-manage with a coagulometer.","Proportion of adults with atrial fibrillation on long-term vitamin K antagonist therapy who are supported to self-manage with a coagulometer.","Process","QS93 - Atrial fibrillation","6 - QS93 - Atrial fibrillation",1,"6 - QS93 - Atrial fibrillation - Process - 1","The number in the denominator who are supported to self‑manage with a coagulometer.","The number of adults with atrial fibrillation on long‑term vitamin K antagonist therapy."]
[null,"QS93","Atrial fibrillation",6,null,"Adults with atrial fibrillation on long-term vitamin K antagonist therapy are supported to self-manage with a coagulometer.","Patient experience.","Outcome","QS93 - Atrial fibrillation","6 - QS93 - Atrial fibrillation",1,"6 - QS93 - Atrial fibrillation - Outcome - 1"]
[null,"QS93","Atrial fibrillation",6,null,"Adults with atrial fibrillation on long-term vitamin K antagonist therapy are supported to self-manage with a coagulometer.","Rates of adults on long-term vitamin K antagonist therapy who self-manage.","Outcome","QS93 - Atrial fibrillation","6 - QS93 - Atrial fibrillation",2,"6 - QS93 - Atrial fibrillation - Outcome - 2"]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",1,null,"Children and young people, and their parents or carers, using vending machines in local authority and NHS venues can buy healthy food and drink options.","Evidence that local authorities and NHS organisations provide, or make contractual arrangements for the provision of, healthy food and drink options in any vending machines in their venues that are used by children and young people.","Structure","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","1 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",1,"1 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Structure - 1","",""]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",1,null,"Children and young people, and their parents or carers, using vending machines in local authority and NHS venues can buy healthy food and drink options.","Proportion of local authority and NHS venues used by children and young people with vending machines that have vending machines that contain healthy food and drink options.","Process","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","1 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",1,"1 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Process - 1","The number in the denominator that have vending machines that contain healthy food and drink options.","The number of local authority and NHS venues used by children and young people with vending machines."]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",2,null,"Children and young people, and their parents or carers, see details of nutritional information on menus at local authority and NHS venues.","Evidence that local authorities and NHS organisations ensure that information on the nutritional content of meals is included on menus at venues that are used by children and young people.","Structure","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","2 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",1,"2 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Structure - 1","",""]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",3,null,"Children and young people, and their parents or carers, see healthy food and drink choices displayed prominently in local authority and NHS venues.","Evidence that local authority and NHS venues used by children and young people make arrangements to display healthy food and drink options in prominent positions.","Structure","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","3 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",1,"3 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Structure - 1","",""]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",3,null,"Children and young people, and their parents or carers, see healthy food and drink choices displayed prominently in local authority and NHS venues.","Sales of healthy food and drink options.","Outcome","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","3 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",1,"3 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Outcome - 1"]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",4,null,"Children and young people, and their parents or carers, have access to a publicly available up‑to‑date list of local lifestyle weight management programmes.","Evidence that an up‑to‑date list of local lifestyle weight management programmes for children and young people is made publically available by the local authority.","Structure","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","4 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",1,"4 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Structure - 1","",""]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",4,null,"Children and young people, and their parents or carers, have access to a publicly available up‑to‑date list of local lifestyle weight management programmes.","Number of referrals (including self‑referrals, by children and young people or their parents or carers) to lifestyle weight management programmes.","Outcome","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",{"$f":"CONCATENATE(D1960, \" - \", I1960)","v":"4 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes"},{"$f":"IF(AND(B1960=B1959, D1960=D1959, H1960=H1959)=TRUE, K1959+1, 1)","v":1},{"$f":"CONCATENATE(J1960, \" - \", H1960, \" - \",K1960)","v":"4 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Outcome - 1"}]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",5,null,"Children and young people identified as being overweight or obese, and their parents or carers as appropriate, are given information about local lifestyle weight management programmes.","Evidence of written protocols and local arrangements for healthcare professionals and other professionals to give information about local lifestyle weight management programmes to children and young people identified as being overweight or obese, and their parents or carers (as appropriate).","Structure","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","5 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",1,"5 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Structure - 1","",""]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",5,null,"Children and young people identified as being overweight or obese, and their parents or carers as appropriate, are given information about local lifestyle weight management programmes.","Proportion of children and young people identified as being overweight or obese, and their parents or carers as appropriate, who are given information about local lifestyle weight management programmes.","Process","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","5 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",1,"5 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Process - 1","The number in the denominator who are given information about local lifestyle weight management programmes.","The number of children and young people identified as being overweight or obese, and their parents or carers as appropriate."]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",5,null,"Children and young people identified as being overweight or obese, and their parents or carers as appropriate, are given information about local lifestyle weight management programmes.","Number of children and young people enrolling in lifestyle weight management programmes.","Outcome","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","5 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",1,"5 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Outcome - 1"]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",6,null,"Family members or carers of children and young people are invited to attend lifestyle weight management programmes, regardless of their weight.","Evidence that providers of lifestyle weight management programmes for children and young people invite family members or carers to attend, regardless of their weight.","Structure","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","6 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",1,"6 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Structure - 1","",""]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",6,null,"Family members or carers of children and young people are invited to attend lifestyle weight management programmes, regardless of their weight.","Proportion of children and young people who attend a lifestyle weight management programme whose family members or carers have been invited to attend.","Process",{"$f":"CONCATENATE(B1965, \" - \", C1965)","v":"QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes"},"6 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",1,"6 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Process - 1","The number in the denominator whose family members or carers have been invited to attend.","The number of children and young people who attend a lifestyle weight management programme."]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",6,null,"Family members or carers of children and young people are invited to attend lifestyle weight management programmes, regardless of their weight.","Family member attendance and involvement in lifestyle weight management programmes.","Outcome","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","6 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",1,"6 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Outcome - 1"]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",7,null,"Children and young people, and their parents or carers, can access data on attendance, outcomes and the views of participants and staff from lifestyle weight management programmes.","Evidence that commissioners and providers of lifestyle weight management programmes for children and young people jointly agree the key performance indicators to be collected for monitoring and evaluation.","Structure","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","7 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",1,"7 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Structure - 1","",""]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",7,null,"Children and young people, and their parents or carers, can access data on attendance, outcomes and the views of participants and staff from lifestyle weight management programmes.","Evidence that commissioners and providers of lifestyle weight management programmes for children and young people have used data from monitoring and evaluation to amend and improve programmes.","Structure","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","7 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",2,"7 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Structure - 2","",""]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",7,null,"Children and young people, and their parents or carers, can access data on attendance, outcomes and the views of participants and staff from lifestyle weight management programmes.","Proportion of children and young people recruited to a lifestyle weight management programme that has data on attendance, outcomes and the views of participants and staff collected at recruitment and completion.","Process","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","7 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",1,"7 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Process - 1","The number in the denominator that has data on attendance, outcomes and the views of participants and staff collected at recruitment and completion.","The number of children and young people recruited to a lifestyle weight management programme."]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",7,null,"Children and young people, and their parents or carers, can access data on attendance, outcomes and the views of participants and staff from lifestyle weight management programmes.","Proportion of children and young people who complete a lifestyle weight management programme that has data on outcomes collected at 6 months after completion of the programme.","Process","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","7 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",2,"7 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Process - 2","The number in the denominator that has data on outcomes collected at 6 months after completion of the programme.","The number of children and young people who complete a lifestyle weight management programme."]
[null,"QS94","Obesity in children and young people: prevention and lifestyle weight management programmes",7,null,"Children and young people, and their parents or carers, can access data on attendance, outcomes and the views of participants and staff from lifestyle weight management programmes.","Proportion of children and young people who complete a lifestyle weight management programme that has data on outcomes collected at 1 year after completion of the programme.","Process","QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes","7 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes",3,"7 - QS94 - Obesity in children and young people: prevention and lifestyle weight management programmes - Process - 3","The number in the denominator that has data on outcomes collected at 1 year after completion of the programme.","The number of children and young people who complete a lifestyle weight management programme."]
[null,"QS95","Bipolar disorder in adults",1,null,"Adults presenting in primary care with symptoms of depression are offered a referral for a specialist mental health assessment if they have experienced overactivity or disinhibited behaviour lasting 4 days or more.","Evidence of practice arrangements and written clinical protocols to ensure that adults presenting with symptoms of depression are referred for a specialist mental health assessment if they have experienced overactivity or disinhibited behaviour lasting 4 days or more. ","Structure","QS95 - Bipolar disorder in adults","1 - QS95 - Bipolar disorder in adults",1,"1 - QS95 - Bipolar disorder in adults - Structure - 1","",""]
[null,"QS95","Bipolar disorder in adults",1,null,"Adults presenting in primary care with symptoms of depression are offered a referral for a specialist mental health assessment if they have experienced overactivity or disinhibited behaviour lasting 4 days or more.","Proportion of adults presenting in primary care with symptoms of depression who are asked if they have experienced overactivity or disinhibited behaviour lasting 4 days or more.","Process","QS95 - Bipolar disorder in adults","1 - QS95 - Bipolar disorder in adults",1,"1 - QS95 - Bipolar disorder in adults - Process - 1","The number in the denominator asked if they have experienced overactivity or disinhibited behaviour lasting 4 days or more.","The number of adults presenting in primary care with symptoms of depression."]
[null,"QS95","Bipolar disorder in adults",1,null,"Adults presenting in primary care with symptoms of depression are offered a referral for a specialist mental health assessment if they have experienced overactivity or disinhibited behaviour lasting 4 days or more.","Proportion of adults presenting in primary care with symptoms of depression who have experienced overactivity or disinhibited behaviour lasting 4 days or more who were referred for a specialist mental health assessment.","Process","QS95 - Bipolar disorder in adults","1 - QS95 - Bipolar disorder in adults",2,"1 - QS95 - Bipolar disorder in adults - Process - 2","The number in the denominator referred for a specialist mental health assessment.","The number of adults presenting in primary care with symptoms of depression who have experienced overactivity or disinhibited behaviour lasting 4 days or more."]
[null,"QS95","Bipolar disorder in adults",1,null,"Adults presenting in primary care with symptoms of depression are offered a referral for a specialist mental health assessment if they have experienced overactivity or disinhibited behaviour lasting 4 days or more.","Referral rates for specialist mental health assessment.","Outcome","QS95 - Bipolar disorder in adults","1 - QS95 - Bipolar disorder in adults",1,"1 - QS95 - Bipolar disorder in adults - Outcome - 1"]
[null,"QS95","Bipolar disorder in adults",1,null,"Adults presenting in primary care with symptoms of depression are offered a referral for a specialist mental health assessment if they have experienced overactivity or disinhibited behaviour lasting 4 days or more.","Recognition of bipolar disorder within the community.","Outcome","QS95 - Bipolar disorder in adults","1 - QS95 - Bipolar disorder in adults",2,"1 - QS95 - Bipolar disorder in adults - Outcome - 2"]
[null,"QS95","Bipolar disorder in adults",2,null,"Adults with bipolar disorder have their early warning symptoms and triggers of relapse, preferred response during relapse and personal recovery goals specified in their care plan.","Evidence of practice arrangements and written clinical protocols to ensure that care plans specify early warning symptoms and triggers of mania and depression relapse, preferred response during relapse and personal recovery goals. ","Structure","QS95 - Bipolar disorder in adults","2 - QS95 - Bipolar disorder in adults",1,"2 - QS95 - Bipolar disorder in adults - Structure - 1","",""]
[null,"QS95","Bipolar disorder in adults",2,null,"Adults with bipolar disorder have their early warning symptoms and triggers of relapse, preferred response during relapse and personal recovery goals specified in their care plan.","Proportion of adults with bipolar disorder who have a care plan that specifies early warning symptoms of mania and depression relapse.","Process","QS95 - Bipolar disorder in adults","2 - QS95 - Bipolar disorder in adults",1,"2 - QS95 - Bipolar disorder in adults - Process - 1","The number in the denominator who have a care plan that specifies early warning symptoms of mania and depression relapse.","The number of adults with bipolar disorder who have a care plan."]
[null,"QS95","Bipolar disorder in adults",2,null,"Adults with bipolar disorder have their early warning symptoms and triggers of relapse, preferred response during relapse and personal recovery goals specified in their care plan.","Proportion of adults with bipolar disorder who have a care plan that specifies triggers of mania and depression relapse.","Process","QS95 - Bipolar disorder in adults","2 - QS95 - Bipolar disorder in adults",2,"2 - QS95 - Bipolar disorder in adults - Process - 2","The number in the denominator who have a care plan that specifies triggers of mania and depression relapse.","The number of adults with bipolar disorder who have a care plan."]
[null,"QS95","Bipolar disorder in adults",2,null,"Adults with bipolar disorder have their early warning symptoms and triggers of relapse, preferred response during relapse and personal recovery goals specified in their care plan.","Proportion of adults with bipolar disorder who have a care plan that specifies preferred response during mania and depression relapse.","Process","QS95 - Bipolar disorder in adults","2 - QS95 - Bipolar disorder in adults",3,"2 - QS95 - Bipolar disorder in adults - Process - 3","The number in the denominator who have a care plan that specifies preferred response during mania and depression relapse.","The number of adults with bipolar disorder who have a care plan."]
[null,"QS95","Bipolar disorder in adults",2,null,"Adults with bipolar disorder have their early warning symptoms and triggers of relapse, preferred response during relapse and personal recovery goals specified in their care plan.","Proportion of adults with bipolar disorder who have a care plan that specifies personal recovery goals. ","Process","QS95 - Bipolar disorder in adults","2 - QS95 - Bipolar disorder in adults",4,"2 - QS95 - Bipolar disorder in adults - Process - 4","The number in the denominator who have a care plan that specifies personal recovery goals.","The number of adults with bipolar disorder who have a care plan."]
[null,"QS95","Bipolar disorder in adults",2,null,"Adults with bipolar disorder have their early warning symptoms and triggers of relapse, preferred response during relapse and personal recovery goals specified in their care plan.","Adults with bipolar disorder who feel enabled to self-manage their condition.","Outcome","QS95 - Bipolar disorder in adults","2 - QS95 - Bipolar disorder in adults",1,"2 - QS95 - Bipolar disorder in adults - Outcome - 1"]
[null,"QS95","Bipolar disorder in adults",2,null,"Adults with bipolar disorder have their early warning symptoms and triggers of relapse, preferred response during relapse and personal recovery goals specified in their care plan.","Health-related quality of life for adults with a long-term mental health condition.","Outcome","QS95 - Bipolar disorder in adults","2 - QS95 - Bipolar disorder in adults",2,"2 - QS95 - Bipolar disorder in adults - Outcome - 2"]
[null,"QS95","Bipolar disorder in adults",2,null,"Adults with bipolar disorder have their early warning symptoms and triggers of relapse, preferred response during relapse and personal recovery goals specified in their care plan.","Frequency of relapse rates among adults with bipolar disorder.","Outcome","QS95 - Bipolar disorder in adults","2 - QS95 - Bipolar disorder in adults",3,"2 - QS95 - Bipolar disorder in adults - Outcome - 3"]
[null,"QS95","Bipolar disorder in adults",3,null,"Carers of adults with bipolar disorder are involved in care planning, decision-making and information sharing about the person as agreed in the care plan.   ","Evidence of local arrangements to ensure that carers are involved in care planning, decision-making and information sharing about the adult with bipolar disorder as agreed in the care plan.","Structure","QS95 - Bipolar disorder in adults","3 - QS95 - Bipolar disorder in adults",1,"3 - QS95 - Bipolar disorder in adults - Structure - 1","",""]
[null,"QS95","Bipolar disorder in adults",3,null,"Carers of adults with bipolar disorder are involved in care planning, decision-making and information sharing about the person as agreed in the care plan.   ","Proportion of adults with bipolar disorder whose care plan includes statements on information sharing with carers.","Process","QS95 - Bipolar disorder in adults","3 - QS95 - Bipolar disorder in adults",1,"3 - QS95 - Bipolar disorder in adults - Process - 1","The number in the denominator whose care plan includes statements on information sharing with carers.","The number of adults with bipolar disorder with an identified carer."]
[null,"QS95","Bipolar disorder in adults",3,null,"Carers of adults with bipolar disorder are involved in care planning, decision-making and information sharing about the person as agreed in the care plan.   ","Proportion of adults with bipolar disorder whose care plan includes statements on decision-making by carers.","Process","QS95 - Bipolar disorder in adults","3 - QS95 - Bipolar disorder in adults",2,"3 - QS95 - Bipolar disorder in adults - Process - 2","The number in the denominator whose care plan includes statements on decision‑making by carers.","The number of adults with bipolar disorder with an identified carer."]
[null,"QS95","Bipolar disorder in adults",3,null,"Carers of adults with bipolar disorder are involved in care planning, decision-making and information sharing about the person as agreed in the care plan.   ","Carers’ satisfaction with services.","Outcome","QS95 - Bipolar disorder in adults","3 - QS95 - Bipolar disorder in adults",1,"3 - QS95 - Bipolar disorder in adults - Outcome - 1"]
[null,"QS95","Bipolar disorder in adults",4,null,"Adults with bipolar disorder are offered psychological interventions.","Evidence of local arrangements for the provision of psychological intervention programmes.","Structure","QS95 - Bipolar disorder in adults","4 - QS95 - Bipolar disorder in adults",1,"4 - QS95 - Bipolar disorder in adults - Structure - 1","",""]
[null,"QS95","Bipolar disorder in adults",4,null,"Adults with bipolar disorder are offered psychological interventions.","Evidence of practice arrangements and written clinical protocols to ensure that adults with bipolar disorder are offered psychological interventions.","Structure","QS95 - Bipolar disorder in adults","4 - QS95 - Bipolar disorder in adults",2,"4 - QS95 - Bipolar disorder in adults - Structure - 2","",""]
[null,"QS95","Bipolar disorder in adults",4,null,"Adults with bipolar disorder are offered psychological interventions.","Proportion of adults with bipolar disorder who receive a psychological intervention. ","Process","QS95 - Bipolar disorder in adults","4 - QS95 - Bipolar disorder in adults",1,"4 - QS95 - Bipolar disorder in adults - Process - 1","The number in the denominator who receive a psychological intervention.","The number of adults with bipolar disorder."]
[null,"QS95","Bipolar disorder in adults",4,null,"Adults with bipolar disorder are offered psychological interventions.","Relapse rates for adults with bipolar disorder.","Outcome","QS95 - Bipolar disorder in adults","4 - QS95 - Bipolar disorder in adults",1,"4 - QS95 - Bipolar disorder in adults - Outcome - 1"]
[null,"QS95","Bipolar disorder in adults",4,null,"Adults with bipolar disorder are offered psychological interventions.","Hospital admission rates for adults with bipolar disorder.","Outcome","QS95 - Bipolar disorder in adults","4 - QS95 - Bipolar disorder in adults",2,"4 - QS95 - Bipolar disorder in adults - Outcome - 2"]
[null,"QS95","Bipolar disorder in adults",5,null,"Adults with bipolar disorder prescribed lithium have their dosage adjusted if their plasma lithium levels are outside the optimum range. ","Evidence of practice arrangements and written clinical protocols to ensure that adults with bipolar disorder who are prescribed lithium have their dosage adjusted if their plasma lithium levels are outside the optimum range.","Structure","QS95 - Bipolar disorder in adults","5 - QS95 - Bipolar disorder in adults",1,"5 - QS95 - Bipolar disorder in adults - Structure - 1","",""]
[null,"QS95","Bipolar disorder in adults",5,null,"Adults with bipolar disorder prescribed lithium have their dosage adjusted if their plasma lithium levels are outside the optimum range. ","Proportion of adults with bipolar disorder prescribed lithium who had their dosage adjusted if their plasma lithium levels were outside the optimum range.","Process","QS95 - Bipolar disorder in adults","5 - QS95 - Bipolar disorder in adults",1,"5 - QS95 - Bipolar disorder in adults - Process - 1","The number in the denominator who had their dosage adjusted if their plasma lithium levels were outside the optimum range.","The number of adults with bipolar disorder prescribed lithium."]
[null,"QS95","Bipolar disorder in adults",5,null,"Adults with bipolar disorder prescribed lithium have their dosage adjusted if their plasma lithium levels are outside the optimum range. ","Adults with bipolar disorder prescribed lithium who have their plasma lithium levels maintained within the optimum range.","Outcome","QS95 - Bipolar disorder in adults","5 - QS95 - Bipolar disorder in adults",1,"5 - QS95 - Bipolar disorder in adults - Outcome - 1"]
[null,"QS95","Bipolar disorder in adults",5,null,"Adults with bipolar disorder prescribed lithium have their dosage adjusted if their plasma lithium levels are outside the optimum range. ","Kidney function among adults with bipolar disorder prescribed lithium.","Outcome","QS95 - Bipolar disorder in adults","5 - QS95 - Bipolar disorder in adults",2,"5 - QS95 - Bipolar disorder in adults - Outcome - 2"]
[null,"QS95","Bipolar disorder in adults",5,null,"Adults with bipolar disorder prescribed lithium have their dosage adjusted if their plasma lithium levels are outside the optimum range. ","Thyroid function among adults with bipolar disorder prescribed lithium.","Outcome","QS95 - Bipolar disorder in adults","5 - QS95 - Bipolar disorder in adults",3,"5 - QS95 - Bipolar disorder in adults - Outcome - 3"]
[null,"QS95","Bipolar disorder in adults",6,null,"Women of childbearing potential are not offered valproate to treat bipolar disorder unless other treatments are ineffective or not tolerated. ","Evidence of practice arrangements and written clinical protocols to ensure that women of childbearing potential are not offered valproate to treat bipolar disorder unless other treatments are ineffective or not tolerated.","Structure","QS95 - Bipolar disorder in adults","6 - QS95 - Bipolar disorder in adults",1,"6 - QS95 - Bipolar disorder in adults - Structure - 1","",""]
[null,"QS95","Bipolar disorder in adults",6,null,"Women of childbearing potential are not offered valproate to treat bipolar disorder unless other treatments are ineffective or not tolerated. ","Evidence of practice arrangements and written clinical protocols to ensure that if women of childbearing potential are prescribed valproate, the reasons for that decision are recorded within the patient record.","Structure","QS95 - Bipolar disorder in adults","6 - QS95 - Bipolar disorder in adults",2,"6 - QS95 - Bipolar disorder in adults - Structure - 2","",""]
[null,"QS95","Bipolar disorder in adults",6,null,"Women of childbearing potential are not offered valproate to treat bipolar disorder unless other treatments are ineffective or not tolerated. ","Evidence of practice arrangements and written clinical protocols to ensure that if women of childbearing potential are prescribed valproate, they are informed of and understand:\n- the risks associated with taking valproate during pregnancy\n- the need to use effective, long-acting contraception\n- the need for regular treatment reviews\n- the need to rapidly consult if planning a pregnancy or on becoming pregnant\n- the need to prescribe folic acid if planning a pregnancy or on becoming pregnant.\n","Structure","QS95 - Bipolar disorder in adults","6 - QS95 - Bipolar disorder in adults",3,"6 - QS95 - Bipolar disorder in adults - Structure - 3","",""]
[null,"QS95","Bipolar disorder in adults",6,null,"Women of childbearing potential are not offered valproate to treat bipolar disorder unless other treatments are ineffective or not tolerated. ","Proportion of women of childbearing potential prescribed valproate to treat bipolar disorder.","Process","QS95 - Bipolar disorder in adults","6 - QS95 - Bipolar disorder in adults",1,"6 - QS95 - Bipolar disorder in adults - Process - 1","The number in the denominator prescribed valproate to treat bipolar disorder.","The number of women of childbearing potential with bipolar disorder."]
[null,"QS95","Bipolar disorder in adults",6,null,"Women of childbearing potential are not offered valproate to treat bipolar disorder unless other treatments are ineffective or not tolerated. ","Proportion of women of childbearing potential prescribed valproate to treat bipolar disorder because other treatments are ineffective or not tolerated.","Process","QS95 - Bipolar disorder in adults","6 - QS95 - Bipolar disorder in adults",2,"6 - QS95 - Bipolar disorder in adults - Process - 2","The number in the denominator prescribed valproate because other treatments are ineffective or not tolerated.","The number of women of childbearing potential prescribed valproate to treat bipolar disorder."]
[null,"QS95","Bipolar disorder in adults",6,null,"Women of childbearing potential are not offered valproate to treat bipolar disorder unless other treatments are ineffective or not tolerated. ","Proportion of women of childbearing potential prescribed valproate to treat bipolar disorder who had been informed and had understood the risks associated with taking valproate. ","Process","QS95 - Bipolar disorder in adults","6 - QS95 - Bipolar disorder in adults",3,"6 - QS95 - Bipolar disorder in adults - Process - 3","The number in the denominator who had been informed and had understood the risks associated with taking valproate.","The number of women of childbearing potential prescribed valproate to treat bipolar disorder."]
[null,"QS95","Bipolar disorder in adults",6,null,"Women of childbearing potential are not offered valproate to treat bipolar disorder unless other treatments are ineffective or not tolerated. ","Valproate prescribing rates among women of childbearing potential with bipolar disorder.","Outcome","QS95 - Bipolar disorder in adults","6 - QS95 - Bipolar disorder in adults",1,"6 - QS95 - Bipolar disorder in adults - Outcome - 1"]
[null,"QS95","Bipolar disorder in adults",6,null,"Women of childbearing potential are not offered valproate to treat bipolar disorder unless other treatments are ineffective or not tolerated. ","Children with serious developmental disorders and/or congenital malformations who were born to mothers having treatment with valproate for bipolar disorder.","Outcome","QS95 - Bipolar disorder in adults","6 - QS95 - Bipolar disorder in adults",2,"6 - QS95 - Bipolar disorder in adults - Outcome - 2"]
[null,"QS95","Bipolar disorder in adults",7,null,"Adults with bipolar disorder have a physical health assessment at least annually.","Evidence of local arrangements to ensure that adults with bipolar disorder receive a physical health assessment at least annually.","Structure","QS95 - Bipolar disorder in adults","7 - QS95 - Bipolar disorder in adults",1,"7 - QS95 - Bipolar disorder in adults - Structure - 1","",""]
[null,"QS95","Bipolar disorder in adults",7,null,"Adults with bipolar disorder have a physical health assessment at least annually.","Evidence of local arrangements to ensure that symptoms of poor physical health identified during the physical health assessment of adults with bipolar disorder are addressed.","Structure","QS95 - Bipolar disorder in adults","7 - QS95 - Bipolar disorder in adults",2,"7 - QS95 - Bipolar disorder in adults - Structure - 2","",""]
[null,"QS95","Bipolar disorder in adults",7,null,"Adults with bipolar disorder have a physical health assessment at least annually.","Proportion of adults with bipolar disorder who receive an annual physical health assessment.","Process","QS95 - Bipolar disorder in adults","7 - QS95 - Bipolar disorder in adults",1,"7 - QS95 - Bipolar disorder in adults - Process - 1","The number in the denominator who received an annual physical health assessment within the last 12 months.","The number of adults with bipolar disorder."]
[null,"QS95","Bipolar disorder in adults",7,null,"Adults with bipolar disorder have a physical health assessment at least annually.","Proportion of adults with bipolar disorder who receive treatment or intervention for symptoms of poor physical health identified during the physical health assessment.","Process","QS95 - Bipolar disorder in adults","7 - QS95 - Bipolar disorder in adults",2,"7 - QS95 - Bipolar disorder in adults - Process - 2","The number in the denominator who receive treatment or intervention for symptoms of poor physical health identified during the physical health assessment.","The number of adults with bipolar disorder who receive an annual physical health assessment that identified symptoms of poor physical health."]
[null,"QS95","Bipolar disorder in adults",7,null,"Adults with bipolar disorder have a physical health assessment at least annually.","Premature mortality among adults with bipolar disorder.","Outcome","QS95 - Bipolar disorder in adults","7 - QS95 - Bipolar disorder in adults",1,"7 - QS95 - Bipolar disorder in adults - Outcome - 1"]
[null,"QS95","Bipolar disorder in adults",8,null,"Adults with bipolar disorder who currently work, and those who wish to find or return to work, receive supported employment programmes.","Evidence of local arrangements to ensure that adults with bipolar disorder who currently work, and those who wish to find or return to work, receive supported employment programmes.","Structure","QS95 - Bipolar disorder in adults","8 - QS95 - Bipolar disorder in adults",1,"8 - QS95 - Bipolar disorder in adults - Structure - 1","",""]
[null,"QS95","Bipolar disorder in adults",8,null,"Adults with bipolar disorder who currently work, and those who wish to find or return to work, receive supported employment programmes.","Proportion of adults with bipolar disorder who currently work who receive supported employment programmes.","Process","QS95 - Bipolar disorder in adults","8 - QS95 - Bipolar disorder in adults",1,"8 - QS95 - Bipolar disorder in adults - Process - 1","The number in the denominator who receive a supported employment programme.","The number of adults with bipolar disorder who currently work."]
[null,"QS95","Bipolar disorder in adults",8,null,"Adults with bipolar disorder who currently work, and those who wish to find or return to work, receive supported employment programmes.","Proportion of adults with bipolar disorder who wish to find or return to work who receive supported employment programmes.","Process","QS95 - Bipolar disorder in adults","8 - QS95 - Bipolar disorder in adults",2,"8 - QS95 - Bipolar disorder in adults - Process - 2","The number in the denominator who receive a supported employment programme.","The number of adults with bipolar disorder who wish to find or return to work."]
[null,"QS95","Bipolar disorder in adults",8,null,"Adults with bipolar disorder who currently work, and those who wish to find or return to work, receive supported employment programmes.","Employment rates among adults with bipolar disorder.","Outcome","QS95 - Bipolar disorder in adults","8 - QS95 - Bipolar disorder in adults",1,"8 - QS95 - Bipolar disorder in adults - Outcome - 1"]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,null,"Adults with dyspepsia or reflux symptoms who present to community pharmacists are given advice about making lifestyle changes, using over-the-counter medicines and when to consult their GP.","Evidence of local arrangements to ensure that adults with dyspepsia or reflux symptoms who present to their community pharmacist are given advice about making lifestyle changes, using over-the-counter medicines and when to consult their GP.","Structure","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","1 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"1 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Structure - 1","",""]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,null,"Adults with dyspepsia or reflux symptoms who present to community pharmacists are given advice about making lifestyle changes, using over-the-counter medicines and when to consult their GP.","Proportion of presentations of adults with dyspepsia or reflux symptoms to community pharmacists in which advice is received about making lifestyle changes, using over-the-counter medicines and when to consult a GP.","Process","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","1 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"1 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Process - 1","The number in the denominator in which advice is received about making lifestyle changes, using over‑the‑counter medicines and when to consult a GP.","The number of presentations of adults with dyspepsia or reflux symptoms to community pharmacists."]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,null,"Adults with dyspepsia or reflux symptoms who present to community pharmacists are given advice about making lifestyle changes, using over-the-counter medicines and when to consult their GP.","Adults with dyspepsia or reflux symptoms are satisfied that they are able to self-manage their condition.","Outcome","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","1 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"1 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Outcome - 1"]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,null,"Adults with dyspepsia or reflux symptoms who present to community pharmacists are given advice about making lifestyle changes, using over-the-counter medicines and when to consult their GP.","Patient-reported health outcomes for adults with dyspepsia or gastro-oesophageal reflux disease.","Outcome","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","1 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",2,"1 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Outcome - 2"]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",2,null,"Adults presenting with dyspepsia or reflux symptoms are referred for urgent direct access endoscopy to take place within 2 weeks if they have dysphagia, or are aged 55 and over with weight loss. ","Evidence of local arrangements to ensure that adults presenting with dyspepsia or reflux symptoms are referred for urgent direct access endoscopy to take place within 2 weeks if they have dysphagia, or are aged 55 and over with weight loss. ","Structure","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Structure - 1","",""]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",2,null,"Adults presenting with dyspepsia or reflux symptoms are referred for urgent direct access endoscopy to take place within 2 weeks if they have dysphagia, or are aged 55 and over with weight loss. ","Proportion of adults presenting with dyspepsia or reflux symptoms and dysphagia who are referred for urgent direct access endoscopy.","Process","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Process - 1","The number in the denominator who are referred for urgent direct access endoscopy.","The number of adults presenting with dyspepsia or reflux symptoms and dysphagia."]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",2,null,"Adults presenting with dyspepsia or reflux symptoms are referred for urgent direct access endoscopy to take place within 2 weeks if they have dysphagia, or are aged 55 and over with weight loss. ","Proportion of referrals for adults presenting with dyspepsia or reflux symptoms and dysphagia who receive urgent direct access endoscopy within 2 weeks.","Process","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",2,"2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Process - 2","The number in the denominator who receive endoscopy within 2 weeks.","The number of referrals for urgent direct access endoscopy for adults presenting with dyspepsia or reflux symptoms and dysphagia."]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",2,null,"Adults presenting with dyspepsia or reflux symptoms are referred for urgent direct access endoscopy to take place within 2 weeks if they have dysphagia, or are aged 55 and over with weight loss. ","Proportion of adults aged 55 and over presenting with dyspepsia or reflux symptoms and weight loss who are referred for urgent direct access endoscopy.","Process","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",3,"2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Process - 3","The number in the denominator who are referred for urgent direct access endoscopy.","The number of adults aged 55 and over presenting with dyspepsia or reflux symptoms and weight loss."]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",2,null,"Adults presenting with dyspepsia or reflux symptoms are referred for urgent direct access endoscopy to take place within 2 weeks if they have dysphagia, or are aged 55 and over with weight loss. ","Proportion of referrals for adults aged 55 and over presenting with dyspepsia or reflux symptoms and weight loss who receive urgent direct access endoscopy within 2 weeks.","Process","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",{"$f":"CONCATENATE(D2024, \" - \", I2024)","v":"2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management"},{"$f":"IF(AND(B2024=B2023, D2024=D2023, H2024=H2023)=TRUE, K2023+1, 1)","v":4},{"$f":"CONCATENATE(J2024, \" - \", H2024, \" - \",K2024)","v":"2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Process - 4"},"The number in the denominator who receive endoscopy within 2 weeks.","The number of referrals for urgent direct access endoscopy for adults aged 55 and over presenting with dyspepsia or reflux symptoms and weight loss."]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",2,null,"Adults presenting with dyspepsia or reflux symptoms are referred for urgent direct access endoscopy to take place within 2 weeks if they have dysphagia, or are aged 55 and over with weight loss. ","Incidence of oesophagogastric cancer.","Outcome","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Outcome - 1"]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",2,null,"Adults presenting with dyspepsia or reflux symptoms are referred for urgent direct access endoscopy to take place within 2 weeks if they have dysphagia, or are aged 55 and over with weight loss. ","Oesophagogastric cancer survival rates.","Outcome","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",2,"2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Outcome - 2"]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",2,null,"Adults presenting with dyspepsia or reflux symptoms are referred for urgent direct access endoscopy to take place within 2 weeks if they have dysphagia, or are aged 55 and over with weight loss. ","Patient satisfaction with investigation of dyspepsia and reflux symptoms.","Outcome","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",3,"2 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Outcome - 3"]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",3,null,"Adults with dyspepsia or reflux symptoms have a 2‑week washout period before a test for Helicobacter pylori if they are receiving proton pump inhibitor therapy.","Evidence of local arrangements to ensure that adults with dyspepsia or reflux symptoms have a 2‑week washout period before a test for H pylori if they are receiving PPI therapy.","Structure","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","3 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"3 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Structure - 1","",""]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",3,null,"Adults with dyspepsia or reflux symptoms have a 2‑week washout period before a test for Helicobacter pylori if they are receiving proton pump inhibitor therapy.","Proportion of adults with dyspepsia or reflux symptoms receiving PPI therapy who are tested for H pylori who had a 2‑week washout period before the test.","Process",{"$f":"CONCATENATE(B2029, \" - \", C2029)","v":"QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management"},"3 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"3 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Process - 1","The number in the denominator who had a 2‑week washout period before the test.","The number of adults with dyspepsia or reflux symptoms receiving PPI therapy who are tested for H pylori."]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",3,null,"Adults with dyspepsia or reflux symptoms have a 2‑week washout period before a test for Helicobacter pylori if they are receiving proton pump inhibitor therapy.","H pylori antimicrobial resistance rate","Outcome","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","3 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"3 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Outcome - 1"]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",4,null,"Adults aged 55 and over with dyspepsia or reflux symptoms that have not responded to treatment have a discussion with their GP about referral for non-urgent direct access endoscopy.","Evidence of local arrangements to ensure that adults aged 55 and over with dyspepsia or reflux symptoms that have not responded to treatment have a discussion with their GP about referral for non-urgent direct access endoscopy.","Structure","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","4 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"4 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Structure - 1","",""]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",4,null,"Adults aged 55 and over with dyspepsia or reflux symptoms that have not responded to treatment have a discussion with their GP about referral for non-urgent direct access endoscopy.","Proportion of adults aged 55 and over with dyspepsia or reflux symptoms that have not responded to treatment who have a recorded discussion with their GP about referral for non-urgent direct access endoscopy.","Process","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","4 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"4 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Process - 1","The number in the denominator who have a recorded discussion with their GP about referral for non‑urgent direct access endoscopy.","The number of adults aged 55 and over with dyspepsia or reflux symptoms that have not responded to treatment."]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",4,null,"Adults aged 55 and over with dyspepsia or reflux symptoms that have not responded to treatment have a discussion with their GP about referral for non-urgent direct access endoscopy.","Incidence of oesophagogastric cancer.","Outcome","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","4 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"4 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Outcome - 1"]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",4,null,"Adults aged 55 and over with dyspepsia or reflux symptoms that have not responded to treatment have a discussion with their GP about referral for non-urgent direct access endoscopy.","Oesophagogastric cancer survival rate.","Outcome","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","4 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",2,"4 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Outcome - 2"]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",4,null,"Adults aged 55 and over with dyspepsia or reflux symptoms that have not responded to treatment have a discussion with their GP about referral for non-urgent direct access endoscopy.","Patient satisfaction with investigation of dyspepsia and reflux symptoms","Outcome","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","4 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",3,"4 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Outcome - 3"]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",5,null,"Adults with persistent, unexplained dyspepsia or reflux symptoms have a discussion with their GP about referral to a specialist service.","Evidence of local arrangements to ensure that adults with persistent, unexplained dyspepsia or reflux symptoms have a discussion with their GP about referral to a specialist service.","Structure","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","5 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"5 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Structure - 1","",""]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",5,null,"Adults with persistent, unexplained dyspepsia or reflux symptoms have a discussion with their GP about referral to a specialist service.","Proportion of adults presenting with persistent, unexplained dyspepsia or reflux symptoms with a recorded discussion with their GP about referral to a specialist service.","Process","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","5 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"5 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Process - 1","The number in the denominator with a recorded discussion with their GP about referral to a specialist service.","The number of adults presenting with persistent, unexplained dyspepsia or reflux symptoms."]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",5,null,"Adults with persistent, unexplained dyspepsia or reflux symptoms have a discussion with their GP about referral to a specialist service.","Incidence of Barrett’s oesophagus.","Outcome","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","5 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",1,"5 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Outcome - 1"]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",5,null,"Adults with persistent, unexplained dyspepsia or reflux symptoms have a discussion with their GP about referral to a specialist service.","Incidence of oesophageal stricture.","Outcome","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","5 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",2,"5 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Outcome - 2"]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",5,null,"Adults with persistent, unexplained dyspepsia or reflux symptoms have a discussion with their GP about referral to a specialist service.","Incidence of pyloric stenosis in adults.","Outcome","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","5 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",3,"5 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Outcome - 3"]
[null,"QS96","Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",5,null,"Adults with persistent, unexplained dyspepsia or reflux symptoms have a discussion with their GP about referral to a specialist service.","Patient-reported health outcomes for people with dyspepsia or reflux symptoms.","Outcome","QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management","5 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management",4,"5 - QS96 - Dyspepsia and gastro-oesophageal reflux disease in adults: investigation and management - Outcome - 4"]
[null,"QS97","Drug allergy",1,null,"People with suspected drug allergy have their drug reaction documented using the structured assessment guide.","Evidence of local arrangements to ensure that people with suspected drug allergy have their drug reaction documented using the structured assessment guide.","Structure","QS97 - Drug allergy","1 - QS97 - Drug allergy",1,"1 - QS97 - Drug allergy - Structure - 1","",""]
[null,"QS97","Drug allergy",1,null,"People with suspected drug allergy have their drug reaction documented using the structured assessment guide.","Proportion of people with suspected drug allergy who have their drug reaction documented using the structured assessment guide.","Process","QS97 - Drug allergy","1 - QS97 - Drug allergy",1,"1 - QS97 - Drug allergy - Process - 1","The number in the denominator who have their drug reaction documented using the structured assessment guide.","The number of people with suspected drug allergy."]
[null,"QS97","Drug allergy",1,null,"People with suspected drug allergy have their drug reaction documented using the structured assessment guide.","Medication errors (inappropriate prescribing or administration of drugs).","Outcome","QS97 - Drug allergy","1 - QS97 - Drug allergy",1,"1 - QS97 - Drug allergy - Outcome - 1"]
[null,"QS97","Drug allergy",1,null,"People with suspected drug allergy have their drug reaction documented using the structured assessment guide.","Number of repeat allergic drug reactions (including patient‑reported episodes).","Outcome","QS97 - Drug allergy","1 - QS97 - Drug allergy",2,"1 - QS97 - Drug allergy - Outcome - 2"]
[null,"QS97","Drug allergy",2,null,"People with a new diagnosis of drug allergy are advised to carry structured information about their drug reaction at all times.","Evidence of local arrangements to ensure that people with a new diagnosis of drug allergy are advised to carry structured information about their drug reaction at all times.","Structure","QS97 - Drug allergy","2 - QS97 - Drug allergy",1,"2 - QS97 - Drug allergy - Structure - 1","",""]
[null,"QS97","Drug allergy",2,null,"People with a new diagnosis of drug allergy are advised to carry structured information about their drug reaction at all times.","Self‑management of drug allergy.","Outcome","QS97 - Drug allergy","2 - QS97 - Drug allergy",1,"2 - QS97 - Drug allergy - Outcome - 1"]
[null,"QS97","Drug allergy",2,null,"People with a new diagnosis of drug allergy are advised to carry structured information about their drug reaction at all times.","Proportion of people with a new diagnosis of drug allergy who are advised to carry structured information about their drug reaction at all times.","Process","QS97 - Drug allergy","2 - QS97 - Drug allergy",1,"2 - QS97 - Drug allergy - Process - 1","The number in the denominator who are advised to carry structured information about their drug reaction at all times.","The number of people with a new diagnosis of drug allergy."]
[null,"QS97","Drug allergy",3,null,"People with a suspected or confirmed anaphylactic reaction, or severe non‑immediate cutaneous reaction to a drug, or reaction to a general anaesthetic are referred to a specialist drug allergy service.","Evidence of local arrangements to ensure that people with a suspected or confirmed anaphylactic reaction, or severe non‑immediate cutaneous reaction to a drug, or reaction to a general anaesthetic are referred to a specialist drug allergy service.","Structure","QS97 - Drug allergy","3 - QS97 - Drug allergy",1,"3 - QS97 - Drug allergy - Structure - 1","",""]
[null,"QS97","Drug allergy",3,null,"People with a suspected or confirmed anaphylactic reaction, or severe non‑immediate cutaneous reaction to a drug, or reaction to a general anaesthetic are referred to a specialist drug allergy service.","Proportion of people with a suspected or confirmed anaphylactic reaction to a drug who are referred to a specialist drug allergy service.","Process","QS97 - Drug allergy","3 - QS97 - Drug allergy",1,"3 - QS97 - Drug allergy - Process - 1","The number in the denominator who are referred to a specialist drug allergy service.","The number of people with a suspected or confirmed anaphylactic reaction to a drug."]
[null,"QS97","Drug allergy",3,null,"People with a suspected or confirmed anaphylactic reaction, or severe non‑immediate cutaneous reaction to a drug, or reaction to a general anaesthetic are referred to a specialist drug allergy service.","Proportion of people with a severe non‑immediate cutaneous reaction to a drug who are referred to a specialist drug allergy service.","Process","QS97 - Drug allergy","3 - QS97 - Drug allergy",2,"3 - QS97 - Drug allergy - Process - 2","The number in the denominator who are referred to a specialist drug allergy service.","The number of people with a severe non‑immediate cutaneous reaction to a drug."]
[null,"QS97","Drug allergy",3,null,"People with a suspected or confirmed anaphylactic reaction, or severe non‑immediate cutaneous reaction to a drug, or reaction to a general anaesthetic are referred to a specialist drug allergy service.","Proportion of people with a reaction to a general anaesthetic who are referred to a specialist drug allergy service.","Process","QS97 - Drug allergy","3 - QS97 - Drug allergy",3,"3 - QS97 - Drug allergy - Process - 3","The number in the denominator who are referred to a specialist drug allergy service.","The number of people with a reaction to a general anaesthetic."]
[null,"QS97","Drug allergy",3,null,"People with a suspected or confirmed anaphylactic reaction, or severe non‑immediate cutaneous reaction to a drug, or reaction to a general anaesthetic are referred to a specialist drug allergy service.","Mortality.","Outcome","QS97 - Drug allergy","3 - QS97 - Drug allergy",1,"3 - QS97 - Drug allergy - Outcome - 1"]
[null,"QS97","Drug allergy",3,null,"People with a suspected or confirmed anaphylactic reaction, or severe non‑immediate cutaneous reaction to a drug, or reaction to a general anaesthetic are referred to a specialist drug allergy service.","Number of repeat allergic drug reactions.","Outcome","QS97 - Drug allergy","3 - QS97 - Drug allergy",2,"3 - QS97 - Drug allergy - Outcome - 2"]
[null,"QS97","Drug allergy",3,null,"People with a suspected or confirmed anaphylactic reaction, or severe non‑immediate cutaneous reaction to a drug, or reaction to a general anaesthetic are referred to a specialist drug allergy service.","Length of hospital stay.","Outcome","QS97 - Drug allergy","3 - QS97 - Drug allergy",3,"3 - QS97 - Drug allergy - Outcome - 3"]
[null,"QS97","Drug allergy",3,null,"People with a suspected or confirmed anaphylactic reaction, or severe non‑immediate cutaneous reaction to a drug, or reaction to a general anaesthetic are referred to a specialist drug allergy service.","Inappropriate avoidance of drugs.","Outcome","QS97 - Drug allergy","3 - QS97 - Drug allergy",4,"3 - QS97 - Drug allergy - Outcome - 4"]
[null,"QS97","Drug allergy",3,null,"People with a suspected or confirmed anaphylactic reaction, or severe non‑immediate cutaneous reaction to a drug, or reaction to a general anaesthetic are referred to a specialist drug allergy service.","Further anaesthetics without problems.","Outcome","QS97 - Drug allergy","3 - QS97 - Drug allergy",5,"3 - QS97 - Drug allergy - Outcome - 5"]
[null,"QS97","Drug allergy",4,null,"People with drug allergy have their status documented in their electronic medical record using the recommended coding framework.","Evidence of local arrangements to ensure that people with drug allergy have their status documented in their electronic medical record using the recommended coding framework.","Structure","QS97 - Drug allergy","4 - QS97 - Drug allergy",1,"4 - QS97 - Drug allergy - Structure - 1","",""]
[null,"QS97","Drug allergy",4,null,"People with drug allergy have their status documented in their electronic medical record using the recommended coding framework.","Proportion of electronic medical records with a drug allergy status documented using the recommended coding framework.","Process","QS97 - Drug allergy","4 - QS97 - Drug allergy",1,"4 - QS97 - Drug allergy - Process - 1","The number in the denominator with a drug allergy status documented using the recommended coding framework.","The number of electronic medical records."]
[null,"QS97","Drug allergy",4,null,"People with drug allergy have their status documented in their electronic medical record using the recommended coding framework.","Mortality.","Outcome","QS97 - Drug allergy","4 - QS97 - Drug allergy",1,"4 - QS97 - Drug allergy - Outcome - 1"]
[null,"QS97","Drug allergy",4,null,"People with drug allergy have their status documented in their electronic medical record using the recommended coding framework.","Repeat allergic drug reactions.","Outcome","QS97 - Drug allergy","4 - QS97 - Drug allergy",2,"4 - QS97 - Drug allergy - Outcome - 2"]
[null,"QS97","Drug allergy",4,null,"People with drug allergy have their status documented in their electronic medical record using the recommended coding framework.","Length of hospital stay.","Outcome","QS97 - Drug allergy","4 - QS97 - Drug allergy",3,"4 - QS97 - Drug allergy - Outcome - 3"]
[null,"QS97","Drug allergy",4,null,"People with drug allergy have their status documented in their electronic medical record using the recommended coding framework.","Inappropriate avoidance of drugs.","Outcome","QS97 - Drug allergy","4 - QS97 - Drug allergy",4,"4 - QS97 - Drug allergy - Outcome - 4"]
[null,"QS97","Drug allergy",4,null,"People with drug allergy have their status documented in their electronic medical record using the recommended coding framework.","Anaphylaxis.","Outcome","QS97 - Drug allergy","4 - QS97 - Drug allergy",5,"4 - QS97 - Drug allergy - Outcome - 5"]
[null,"QS97","Drug allergy",5,null,"People with a new diagnosis of drug allergy who are being referred or discharged have their drug allergy status updated in all GP referral and hospital discharge letters.","Evidence of local arrangements to ensure that people with a new diagnosis of drug allergy who are being referred or discharged have their drug allergy status updated in all GP referral and hospital discharge letters.","Structure","QS97 - Drug allergy","5 - QS97 - Drug allergy",1,"5 - QS97 - Drug allergy - Structure - 1","",""]
[null,"QS97","Drug allergy",5,null,"People with a new diagnosis of drug allergy who are being referred or discharged have their drug allergy status updated in all GP referral and hospital discharge letters.","Proportion of GP referral letters for people with a new diagnosis of drug allergy with updated drug allergy status.","Process","QS97 - Drug allergy","5 - QS97 - Drug allergy",1,"5 - QS97 - Drug allergy - Process - 1","The number in the denominator with updated drug allergy status.","The number of GP referral letters for people with a new diagnosis of drug allergy."]
[null,"QS97","Drug allergy",5,null,"People with a new diagnosis of drug allergy who are being referred or discharged have their drug allergy status updated in all GP referral and hospital discharge letters.","Proportion of hospital discharge letters for people with a new diagnosis of drug allergy with updated drug allergy status.","Process","QS97 - Drug allergy","5 - QS97 - Drug allergy",2,"5 - QS97 - Drug allergy - Process - 2","The number in the denominator with updated drug allergy status.","The number of hospital discharge letters for people with a new diagnosis of drug allergy."]
[null,"QS97","Drug allergy",5,null,"People with a new diagnosis of drug allergy who are being referred or discharged have their drug allergy status updated in all GP referral and hospital discharge letters.","Mortality.","Outcome","QS97 - Drug allergy","5 - QS97 - Drug allergy",1,"5 - QS97 - Drug allergy - Outcome - 1"]
[null,"QS97","Drug allergy",5,null,"People with a new diagnosis of drug allergy who are being referred or discharged have their drug allergy status updated in all GP referral and hospital discharge letters.","Repeat allergic drug reactions.","Outcome","QS97 - Drug allergy","5 - QS97 - Drug allergy",2,"5 - QS97 - Drug allergy - Outcome - 2"]
[null,"QS97","Drug allergy",5,null,"People with a new diagnosis of drug allergy who are being referred or discharged have their drug allergy status updated in all GP referral and hospital discharge letters.","Length of hospital stay.","Outcome","QS97 - Drug allergy","5 - QS97 - Drug allergy",3,"5 - QS97 - Drug allergy - Outcome - 3"]
[null,"QS97","Drug allergy",5,null,"People with a new diagnosis of drug allergy who are being referred or discharged have their drug allergy status updated in all GP referral and hospital discharge letters.","Inappropriate avoidance of drugs.","Outcome","QS97 - Drug allergy","5 - QS97 - Drug allergy",4,"5 - QS97 - Drug allergy - Outcome - 4"]
[null,"QS97","Drug allergy",5,null,"People with a new diagnosis of drug allergy who are being referred or discharged have their drug allergy status updated in all GP referral and hospital discharge letters.","Anaphylaxis.","Outcome","QS97 - Drug allergy","5 - QS97 - Drug allergy",5,"5 - QS97 - Drug allergy - Outcome - 5"]
[null,"QS97","Drug allergy",6,null,"People with a drug allergy have information included on their prescriptions about which drugs or drug classes to avoid.","Evidence of local arrangements to ensure that prescriptions have drug allergy information included about which drugs or drug classes to avoid.","Structure","QS97 - Drug allergy","6 - QS97 - Drug allergy",1,"6 - QS97 - Drug allergy - Structure - 1","",""]
[null,"QS97","Drug allergy",6,null,"People with a drug allergy have information included on their prescriptions about which drugs or drug classes to avoid.","Proportion of paper prescriptions issued in any healthcare setting which have drug allergy information included about which drugs or drug classes to avoid.","Process","QS97 - Drug allergy","6 - QS97 - Drug allergy",1,"6 - QS97 - Drug allergy - Process - 1","The number in the denominator which have drug allergy information about which drugs or drug classes to avoid.","The number of paper prescriptions issued in any healthcare setting."]
[null,"QS97","Drug allergy",6,null,"People with a drug allergy have information included on their prescriptions about which drugs or drug classes to avoid.","Proportion of electronic prescriptions issued in any healthcare setting which have drug allergy information included about which drugs or drug classes to avoid.","Process","QS97 - Drug allergy","6 - QS97 - Drug allergy",2,"6 - QS97 - Drug allergy - Process - 2","The number in the denominator which have drug allergy information about which drugs or drug classes to avoid.","The number of electronic prescriptions issued in any healthcare setting."]
[null,"QS97","Drug allergy",6,null,"People with a drug allergy have information included on their prescriptions about which drugs or drug classes to avoid.","Mortality.","Outcome","QS97 - Drug allergy","6 - QS97 - Drug allergy",1,"6 - QS97 - Drug allergy - Outcome - 1"]
[null,"QS97","Drug allergy",6,null,"People with a drug allergy have information included on their prescriptions about which drugs or drug classes to avoid.","Repeat allergic drug reactions.","Outcome","QS97 - Drug allergy","6 - QS97 - Drug allergy",2,"6 - QS97 - Drug allergy - Outcome - 2"]
[null,"QS97","Drug allergy",6,null,"People with a drug allergy have information included on their prescriptions about which drugs or drug classes to avoid.","Inappropriate avoidance of drugs.","Outcome","QS97 - Drug allergy","6 - QS97 - Drug allergy",3,"6 - QS97 - Drug allergy - Outcome - 3"]
[null,"QS98","Maternal and child nutrition",1,null,"Pregnant women attending antenatal and health visitor appointments are given advice on how to eat healthily in pregnancy. ","Evidence of local arrangements for midwives and health visitors to advise pregnant women how to eat healthily in pregnancy. ","Structure","QS98 - Maternal and child nutrition","1 - QS98 - Maternal and child nutrition",1,"1 - QS98 - Maternal and child nutrition - Structure - 1","",""]
[null,"QS98","Maternal and child nutrition",1,null,"Pregnant women attending antenatal and health visitor appointments are given advice on how to eat healthily in pregnancy. ","Proportion of pregnant women attending their antenatal booking appointment who receive advice on how to eat healthily during pregnancy from a midwife. ","Process","QS98 - Maternal and child nutrition","1 - QS98 - Maternal and child nutrition",1,"1 - QS98 - Maternal and child nutrition - Process - 1","The number in the denominator who receive advice on how to eat healthily during pregnancy from a midwife.","The number of pregnant women attending their antenatal booking appointment."]
[null,"QS98","Maternal and child nutrition",1,null,"Pregnant women attending antenatal and health visitor appointments are given advice on how to eat healthily in pregnancy. ","Proportion of pregnant women attending their health visitor appointment who receive advice on how to eat healthily during pregnancy","Process","QS98 - Maternal and child nutrition","1 - QS98 - Maternal and child nutrition",2,"1 - QS98 - Maternal and child nutrition - Process - 2","The number in the denominator who receive advice on how to eat healthily during pregnancy from a health visitor.","The number of pregnant women attending their health visitor appointment."]
[null,"QS98","Maternal and child nutrition",1,null,"Pregnant women attending antenatal and health visitor appointments are given advice on how to eat healthily in pregnancy. ","Healthy eating in pregnancy.","Outcome","QS98 - Maternal and child nutrition","1 - QS98 - Maternal and child nutrition",1,"1 - QS98 - Maternal and child nutrition - Outcome - 1"]
[null,"QS98","Maternal and child nutrition",2,null,"Women with a BMI of 30 or more after childbirth are offered a structured weight-loss programme.","Evidence of local arrangements to ensure that women with a BMI of 30 or more after childbirth are offered a structured weight-loss programme.","Structure","QS98 - Maternal and child nutrition","2 - QS98 - Maternal and child nutrition",1,"2 - QS98 - Maternal and child nutrition - Structure - 1","",""]
[null,"QS98","Maternal and child nutrition",2,null,"Women with a BMI of 30 or more after childbirth are offered a structured weight-loss programme.","Proportion of women with a BMI of 30 or more after childbirth attending their baby’s 6–8 week health visitor appointment who receive a structured weight-loss programme. ","Process","QS98 - Maternal and child nutrition","2 - QS98 - Maternal and child nutrition",1,"2 - QS98 - Maternal and child nutrition - Process - 1","The number in the denominator who receive a structured weight‑loss programme.","The number of women with a BMI of 30 or more after childbirth attending their baby's 6–8 week health visitor appointment."]
[null,"QS98","Maternal and child nutrition",2,null,"Women with a BMI of 30 or more after childbirth are offered a structured weight-loss programme.","Obesity rates in pregnancy. ","Outcome","QS98 - Maternal and child nutrition","2 - QS98 - Maternal and child nutrition",1,"2 - QS98 - Maternal and child nutrition - Outcome - 1"]
[null,"QS98","Maternal and child nutrition",2,null,"Women with a BMI of 30 or more after childbirth are offered a structured weight-loss programme.","Attendance at a weight-loss programme.","Outcome","QS98 - Maternal and child nutrition","2 - QS98 - Maternal and child nutrition",2,"2 - QS98 - Maternal and child nutrition - Outcome - 2"]
[null,"QS98","Maternal and child nutrition",2,null,"Women with a BMI of 30 or more after childbirth are offered a structured weight-loss programme.","Pregnancy morbidity.","Outcome","QS98 - Maternal and child nutrition","2 - QS98 - Maternal and child nutrition",3,"2 - QS98 - Maternal and child nutrition - Outcome - 3"]
[null,"QS98","Maternal and child nutrition",2,null,"Women with a BMI of 30 or more after childbirth are offered a structured weight-loss programme.","Infant morbidity.","Outcome","QS98 - Maternal and child nutrition",{"$f":"CONCATENATE(D2088, \" - \", I2088)","v":"2 - QS98 - Maternal and child nutrition"},{"$f":"IF(AND(B2088=B2087, D2088=D2087, H2088=H2087)=TRUE, K2087+1, 1)","v":4},{"$f":"CONCATENATE(J2088, \" - \", H2088, \" - \",K2088)","v":"2 - QS98 - Maternal and child nutrition - Outcome - 4"}]
[null,"QS98","Maternal and child nutrition",3,null,"Pregnant women and the parents and carers of children under 4 years who may be eligible for the Healthy Start scheme are given information and support to apply.","Evidence of local arrangements to ensure that pregnant women and the parents and carers of children under 4 years who may be eligible for the Healthy Start scheme receive information and support to apply. ","Structure","QS98 - Maternal and child nutrition","3 - QS98 - Maternal and child nutrition",1,"3 - QS98 - Maternal and child nutrition - Structure - 1","",""]
[null,"QS98","Maternal and child nutrition",3,null,"Pregnant women and the parents and carers of children under 4 years who may be eligible for the Healthy Start scheme are given information and support to apply.","Proportion of pregnant women who may be eligible for the Healthy Start scheme receive information and support to apply when they attend their antenatal booking appointment.","Process","QS98 - Maternal and child nutrition","3 - QS98 - Maternal and child nutrition",1,"3 - QS98 - Maternal and child nutrition - Process - 1","The number in the denominator who receive advice and support to apply.","The number of pregnant women who may be eligible for the Healthy Start scheme attending their antenatal booking appointment."]
[null,"QS98","Maternal and child nutrition",3,null,"Pregnant women and the parents and carers of children under 4 years who may be eligible for the Healthy Start scheme are given information and support to apply.","Proportion of 6–8 week health visitor appointments where parents and carers who may be eligible for the Healthy Start scheme receive information and support to apply. ","Process","QS98 - Maternal and child nutrition","3 - QS98 - Maternal and child nutrition",2,"3 - QS98 - Maternal and child nutrition - Process - 2","The number in the denominator where advice and support to apply is given.","The number of 6–8 week health visitor appointments where parents and carers may be eligible for the Healthy Start scheme."]
[null,"QS98","Maternal and child nutrition",3,null,"Pregnant women and the parents and carers of children under 4 years who may be eligible for the Healthy Start scheme are given information and support to apply.","Proportion of 8–12 month developmental reviews where parents and carers who may be eligible for the Healthy Start scheme receive information and support to apply.","Process","QS98 - Maternal and child nutrition","3 - QS98 - Maternal and child nutrition",3,"3 - QS98 - Maternal and child nutrition - Process - 3","The number in the denominator where advice and support to apply is given.","The number of 8–12 month developmental reviews where parents and carers may be eligible for the Healthy Start scheme."]
[null,"QS98","Maternal and child nutrition",3,null,"Pregnant women and the parents and carers of children under 4 years who may be eligible for the Healthy Start scheme are given information and support to apply.","Proportion of 2- to 2-and-a-half year health reviews where parents and carers who may be eligible for the Healthy Start scheme receive information and support to apply.","Process",{"$f":"CONCATENATE(B2093, \" - \", C2093)","v":"QS98 - Maternal and child nutrition"},"3 - QS98 - Maternal and child nutrition",4,"3 - QS98 - Maternal and child nutrition - Process - 4","The number in the denominator where advice and support to apply is given.","The number of 2‑ to 2‑and‑a‑half‑year health reviews where parents and carers may be eligible for the Healthy Start scheme."]
[null,"QS98","Maternal and child nutrition",3,null,"Pregnant women and the parents and carers of children under 4 years who may be eligible for the Healthy Start scheme are given information and support to apply.","Proportion of vaccination appointments at age 3 years 5 months to 4 years where parents and carers who may be eligible for the Healthy Start scheme receive information and support to apply.","Process","QS98 - Maternal and child nutrition","3 - QS98 - Maternal and child nutrition",5,"3 - QS98 - Maternal and child nutrition - Process - 5","The number in the denominator where advice and support to apply is given.","The number of vaccination appointments at age 3 years 5 months to 4 years where parents and carers may be eligible for the Healthy Start scheme."]
[null,"QS98","Maternal and child nutrition",3,null,"Pregnant women and the parents and carers of children under 4 years who may be eligible for the Healthy Start scheme are given information and support to apply.","Vitamin D deficiency.","Outcome","QS98 - Maternal and child nutrition","3 - QS98 - Maternal and child nutrition",1,"3 - QS98 - Maternal and child nutrition - Outcome - 1"]
[null,"QS98","Maternal and child nutrition",3,null,"Pregnant women and the parents and carers of children under 4 years who may be eligible for the Healthy Start scheme are given information and support to apply.","Neural tube defects.","Outcome","QS98 - Maternal and child nutrition","3 - QS98 - Maternal and child nutrition",2,"3 - QS98 - Maternal and child nutrition - Outcome - 2"]
[null,"QS98","Maternal and child nutrition",3,null,"Pregnant women and the parents and carers of children under 4 years who may be eligible for the Healthy Start scheme are given information and support to apply.","Iron and calcium absorption.","Outcome","QS98 - Maternal and child nutrition","3 - QS98 - Maternal and child nutrition",3,"3 - QS98 - Maternal and child nutrition - Outcome - 3"]
[null,"QS98","Maternal and child nutrition",4,null,"Women receive breastfeeding support from a service that uses an evaluated, structured programme. (QS37 - statement 5)","Evidence of local arrangements for breastfeeding support to be provided through a service that uses an evaluated, structured programme.","Structure","QS98 - Maternal and child nutrition","4 - QS98 - Maternal and child nutrition",1,"4 - QS98 - Maternal and child nutrition - Structure - 1","",""]
[null,"QS98","Maternal and child nutrition",4,null,"Women receive breastfeeding support from a service that uses an evaluated, structured programme. (QS37 - statement 5)","Rates of breastfeeding initiation.","Outcome","QS98 - Maternal and child nutrition","4 - QS98 - Maternal and child nutrition",1,"4 - QS98 - Maternal and child nutrition - Outcome - 1"]
[null,"QS98","Maternal and child nutrition",4,null,"Women receive breastfeeding support from a service that uses an evaluated, structured programme. (QS37 - statement 5)","Rates of exclusive or partial breastfeeding on discharge from hospital and at 5–7 days, 10–15 days, 6–8 weeks and 16 weeks after the birth.","Outcome","QS98 - Maternal and child nutrition","4 - QS98 - Maternal and child nutrition",2,"4 - QS98 - Maternal and child nutrition - Outcome - 2"]
[null,"QS98","Maternal and child nutrition",4,null,"Women receive breastfeeding support from a service that uses an evaluated, structured programme. (QS37 - statement 5)","Women's satisfaction with breastfeeding support.","Outcome","QS98 - Maternal and child nutrition","4 - QS98 - Maternal and child nutrition",3,"4 - QS98 - Maternal and child nutrition - Outcome - 3"]
[null,"QS98","Maternal and child nutrition",4,null,"Women receive breastfeeding support from a service that uses an evaluated, structured programme. (QS37 - statement 5)","Proportion of women who receive breastfeeding support through a service that uses an evaluated, structured programme.","Process","QS98 - Maternal and child nutrition","4 - QS98 - Maternal and child nutrition",1,"4 - QS98 - Maternal and child nutrition - Process - 1","The number of women in the denominator who receive breastfeeding support through a service that uses an evaluated, structured programme.","The number of women who breastfeed (exclusively or partially)."]
[null,"QS98","Maternal and child nutrition",4,null,"Women receive breastfeeding support from a service that uses an evaluated, structured programme. (QS37 - statement 5)","Proportion of women who wanted to continue breastfeeding but stopped before they had planned to.","Process","QS98 - Maternal and child nutrition","4 - QS98 - Maternal and child nutrition",2,"4 - QS98 - Maternal and child nutrition - Process - 2","The number of women who wanted to continue breastfeeding but stopped before they had planned to.","The number of women who breastfed (exclusively or partially)."]
[null,"QS98","Maternal and child nutrition",5,null,"Parents and carers are given advice on introducing their baby to a variety of nutritious foods to complement breastmilk or formula milk.","Evidence of local arrangements to advise parents and carers how to introduce a variety of nutritious foods to their baby to complement breastmilk or formula milk.","Structure","QS98 - Maternal and child nutrition","5 - QS98 - Maternal and child nutrition",1,"5 - QS98 - Maternal and child nutrition - Structure - 1","",""]
[null,"QS98","Maternal and child nutrition",5,null,"Parents and carers are given advice on introducing their baby to a variety of nutritious foods to complement breastmilk or formula milk.","Evidence of local arrangements to advise parents and carers when to introduce a variety of nutritious foods to their baby to complement breastmilk or formula milk.","Structure","QS98 - Maternal and child nutrition","5 - QS98 - Maternal and child nutrition",2,"5 - QS98 - Maternal and child nutrition - Structure - 2","",""]
[null,"QS98","Maternal and child nutrition",5,null,"Parents and carers are given advice on introducing their baby to a variety of nutritious foods to complement breastmilk or formula milk.","Proportion of 6–8 week health visitor appointments where parents and carers receive advice on how to introduce their baby to a variety of nutritious foods to complement breastmilk or formula milk.","Process","QS98 - Maternal and child nutrition","5 - QS98 - Maternal and child nutrition",1,"5 - QS98 - Maternal and child nutrition - Process - 1","The number in the denominator where the parents and carers receive advice on how to introduce their baby to a variety of nutritious foods to complement breastmilk or formula milk.","The number of 6–8 week health visitor appointments."]
[null,"QS98","Maternal and child nutrition",5,null,"Parents and carers are given advice on introducing their baby to a variety of nutritious foods to complement breastmilk or formula milk.","Proportion of 6–8 week health visitor appointments where parents and carers receive advice on when to introduce their baby to a variety of nutritious foods to complement breastmilk or formula milk.","Process","QS98 - Maternal and child nutrition","5 - QS98 - Maternal and child nutrition",2,"5 - QS98 - Maternal and child nutrition - Process - 2","The number in the denominator where the parents and carers receive advice on when to introduce their baby to a variety of nutritious foods to complement breastmilk or formula milk.","The number of 6–8 week health visitor appointments."]
[null,"QS98","Maternal and child nutrition",5,null,"Parents and carers are given advice on introducing their baby to a variety of nutritious foods to complement breastmilk or formula milk.","Introduction of solid food at around 6 months. ","Outcome","QS98 - Maternal and child nutrition","5 - QS98 - Maternal and child nutrition",1,"5 - QS98 - Maternal and child nutrition - Outcome - 1"]
[null,"QS98","Maternal and child nutrition",5,null,"Parents and carers are given advice on introducing their baby to a variety of nutritious foods to complement breastmilk or formula milk.","Infant obesity rates.","Outcome","QS98 - Maternal and child nutrition","5 - QS98 - Maternal and child nutrition",2,"5 - QS98 - Maternal and child nutrition - Outcome - 2"]
[null,"QS98","Maternal and child nutrition",5,null,"Parents and carers are given advice on introducing their baby to a variety of nutritious foods to complement breastmilk or formula milk.","Faltering infant growth.","Outcome","QS98 - Maternal and child nutrition","5 - QS98 - Maternal and child nutrition",3,"5 - QS98 - Maternal and child nutrition - Outcome - 3"]
[null,"QS98","Maternal and child nutrition",6,null,"Parents and carers receiving Healthy Start food vouchers are offered advice on how to use them to increase the amount of fruit and vegetables in their family’s diet.","Evidence of local arrangements to offer parents and carers receiving Healthy Start food vouchers advice on how to use them to increase the amount of fruit and vegetables in their family’s diet.","Structure","QS98 - Maternal and child nutrition","6 - QS98 - Maternal and child nutrition",1,"6 - QS98 - Maternal and child nutrition - Structure - 1","",""]
[null,"QS98","Maternal and child nutrition",6,null,"Parents and carers receiving Healthy Start food vouchers are offered advice on how to use them to increase the amount of fruit and vegetables in their family’s diet.","Proportion of 6–8 week health visitor appointments where parents and carers receiving Healthy Start food vouchers receive advice on how to use them to increase the amount of fruit and vegetables in their family’s diet. ","Process","QS98 - Maternal and child nutrition","6 - QS98 - Maternal and child nutrition",1,"6 - QS98 - Maternal and child nutrition - Process - 1","The number in the denominator where advice is given on how to use the vouchers to increase the amount of fruit and vegetables in their family's diet.","The number of 6–8 week health visitor appointments where the parents and carers are receiving Healthy Start food vouchers."]
[null,"QS98","Maternal and child nutrition",6,null,"Parents and carers receiving Healthy Start food vouchers are offered advice on how to use them to increase the amount of fruit and vegetables in their family’s diet.","Proportion of 8–12 month developmental reviews where parents and carers receiving Healthy Start food vouchers receive advice on how to use them to increase the amount of fruit and vegetables in their family’s diet. ","Process","QS98 - Maternal and child nutrition","6 - QS98 - Maternal and child nutrition",2,"6 - QS98 - Maternal and child nutrition - Process - 2","The number in the denominator where advice is given on how to use the vouchers to increase the amount of fruit and vegetables in their family's diet.","The number of 8–12 month developmental reviews where the parents and carers are receiving Healthy Start food vouchers."]
[null,"QS98","Maternal and child nutrition",6,null,"Parents and carers receiving Healthy Start food vouchers are offered advice on how to use them to increase the amount of fruit and vegetables in their family’s diet.","Proportion of 2- to 2-and-a-half–year health reviews where parents and carers receiving Healthy Start food vouchers receive advice on how to use them to increase the amount of fruit and vegetables in their family’s diet. ","Process","QS98 - Maternal and child nutrition","6 - QS98 - Maternal and child nutrition",3,"6 - QS98 - Maternal and child nutrition - Process - 3","The number in the denominator where advice is given on how to use the vouchers to increase the amount of fruit and vegetables in their family's diet.","The number of 2‑ to 2‑and‑a‑half‑year health reviews where the parents and carers are receiving Healthy Start food vouchers."]
[null,"QS98","Maternal and child nutrition",6,null,"Parents and carers receiving Healthy Start food vouchers are offered advice on how to use them to increase the amount of fruit and vegetables in their family’s diet.","Proportion of vaccination appointments at age 3 years and 5 months to 4 years where parents and carers receiving Healthy Start food vouchers receive advice on how to use them to increase the amount of fruit and vegetables in their family’s diet. ","Process","QS98 - Maternal and child nutrition","6 - QS98 - Maternal and child nutrition",4,"6 - QS98 - Maternal and child nutrition - Process - 4","The number in the denominator where advice is given on how to use the vouchers to increase the amount of fruit and vegetables in their family's diet.","The number of vaccination appointments at age 3 years and 5 months to 4 years where the parents and carers are receiving Healthy Start food vouchers."]
[null,"QS98","Maternal and child nutrition",6,null,"Parents and carers receiving Healthy Start food vouchers are offered advice on how to use them to increase the amount of fruit and vegetables in their family’s diet.","Fruit and vegetable intake.","Outcome","QS98 - Maternal and child nutrition","6 - QS98 - Maternal and child nutrition",1,"6 - QS98 - Maternal and child nutrition - Outcome - 1"]
[null,"QS98","Maternal and child nutrition",6,null,"Parents and carers receiving Healthy Start food vouchers are offered advice on how to use them to increase the amount of fruit and vegetables in their family’s diet.","Obesity.","Outcome","QS98 - Maternal and child nutrition","6 - QS98 - Maternal and child nutrition",2,"6 - QS98 - Maternal and child nutrition - Outcome - 2"]
[null,"QS99","Secondary prevention after a myocardial infarction ",1,null,"Adults admitted to hospital with a myocardial infarction (MI) have an assessment of left ventricular function before discharge","Evidence of local arrangements to ensure that adults admitted to hospital with an MI have an assessment of left ventricular function before discharge","Structure","QS99 - Secondary prevention after a myocardial infarction ","1 - QS99 - Secondary prevention after a myocardial infarction ",1,"1 - QS99 - Secondary prevention after a myocardial infarction  - Structure - 1","",""]
[null,"QS99","Secondary prevention after a myocardial infarction ",1,null,"Adults admitted to hospital with a myocardial infarction (MI) have an assessment of left ventricular function before discharge","Proportion of discharges from hospital after an MI where the patient had an assessment of left ventricular function while in hospital.","Process","QS99 - Secondary prevention after a myocardial infarction ","1 - QS99 - Secondary prevention after a myocardial infarction ",1,"1 - QS99 - Secondary prevention after a myocardial infarction  - Process - 1","The number in the denominator where the patient had an assessment of left ventricular function while in hospital.","The number of discharges from hospital after an MI."]
[null,"QS99","Secondary prevention after a myocardial infarction ",2,null,"Adults admitted to hospital with a myocardial infarction (MI) are referred for cardiac rehabilitation before discharge","Evidence of local arrangements to ensure that adults admitted to hospital with an MI are referred for cardiac rehabilitation before discharge","Structure","QS99 - Secondary prevention after a myocardial infarction ","2 - QS99 - Secondary prevention after a myocardial infarction ",1,"2 - QS99 - Secondary prevention after a myocardial infarction  - Structure - 1","",""]
[null,"QS99","Secondary prevention after a myocardial infarction ",2,null,"Adults admitted to hospital with a myocardial infarction (MI) are referred for cardiac rehabilitation before discharge","Proportion of discharges from hospital after an MI where the patient was referred for cardiac rehabilitation while in hospital","Process","QS99 - Secondary prevention after a myocardial infarction ","2 - QS99 - Secondary prevention after a myocardial infarction ",1,"2 - QS99 - Secondary prevention after a myocardial infarction  - Process - 1","The number in the denominator where the patient was referred for cardiac rehabilitation while in hospital.","The number of discharges from hospital after an MI."]
[null,"QS99","Secondary prevention after a myocardial infarction ",2,null,"Adults admitted to hospital with a myocardial infarction (MI) are referred for cardiac rehabilitation before discharge","Uptake rates of cardiac rehabilitation programmes.","Outcome","QS99 - Secondary prevention after a myocardial infarction ","2 - QS99 - Secondary prevention after a myocardial infarction ",1,"2 - QS99 - Secondary prevention after a myocardial infarction  - Outcome - 1"]
[null,"QS99","Secondary prevention after a myocardial infarction ",3,null,"Adults admitted to hospital with a myocardial infarction (MI) have the results of investigations and a plan for future treatment and monitoring shared with their GP","Evidence of local arrangements to ensure that adults admitted to hospital with an MI have the results of investigations and a plan for future treatment and monitoring shared with their GP","Structure","QS99 - Secondary prevention after a myocardial infarction ","3 - QS99 - Secondary prevention after a myocardial infarction ",1,"3 - QS99 - Secondary prevention after a myocardial infarction  - Structure - 1","",""]
[null,"QS99","Secondary prevention after a myocardial infarction ",3,null,"Adults admitted to hospital with a myocardial infarction (MI) have the results of investigations and a plan for future treatment and monitoring shared with their GP","Proportion of discharges from hospital after an MI where the patient had the results of investigations shared with their GP","Process","QS99 - Secondary prevention after a myocardial infarction ","3 - QS99 - Secondary prevention after a myocardial infarction ",1,"3 - QS99 - Secondary prevention after a myocardial infarction  - Process - 1","The number in the denominator where the patient had the results of investigations shared with their GP.","The number of discharges from hospital after an MI."]
[null,"QS99","Secondary prevention after a myocardial infarction ",3,null,"Adults admitted to hospital with a myocardial infarction (MI) have the results of investigations and a plan for future treatment and monitoring shared with their GP","Proportion of discharges from hospital after an MI where the patient had plans for future treatment and monitoring shared with their GP","Process","QS99 - Secondary prevention after a myocardial infarction ","3 - QS99 - Secondary prevention after a myocardial infarction ",2,"3 - QS99 - Secondary prevention after a myocardial infarction  - Process - 2","The number in the denominator where the patient had plans for future treatment and monitoring shared with their GP.","The number of discharges from hospital after an MI."]
[null,"QS99","Secondary prevention after a myocardial infarction ",3,null,"Adults admitted to hospital with a myocardial infarction (MI) have the results of investigations and a plan for future treatment and monitoring shared with their GP","Readmission rates","Outcome","QS99 - Secondary prevention after a myocardial infarction ","3 - QS99 - Secondary prevention after a myocardial infarction ",1,"3 - QS99 - Secondary prevention after a myocardial infarction  - Outcome - 1"]
[null,"QS99","Secondary prevention after a myocardial infarction ",3,null,"Adults admitted to hospital with a myocardial infarction (MI) have the results of investigations and a plan for future treatment and monitoring shared with their GP","Rates of uptake and adherence to cardiac rehabilitation","Outcome","QS99 - Secondary prevention after a myocardial infarction ","3 - QS99 - Secondary prevention after a myocardial infarction ",2,"3 - QS99 - Secondary prevention after a myocardial infarction  - Outcome - 2"]
[null,"QS99","Secondary prevention after a myocardial infarction ",3,null,"Adults admitted to hospital with a myocardial infarction (MI) have the results of investigations and a plan for future treatment and monitoring shared with their GP","Patient experience of GP services","Outcome","QS99 - Secondary prevention after a myocardial infarction ","3 - QS99 - Secondary prevention after a myocardial infarction ",3,"3 - QS99 - Secondary prevention after a myocardial infarction  - Outcome - 3"]
[null,"QS99","Secondary prevention after a myocardial infarction ",4,null,"Adults referred to a cardiac rehabilitation programme after a myocardial infarction (MI) have an assessment appointment within 10 days of discharge from hospital","Evidence of local arrangements to ensure that adults referred to a cardiac rehabilitation programme after an MI have an assessment appointment within 10 days of discharge from hospital","Structure","QS99 - Secondary prevention after a myocardial infarction ","4 - QS99 - Secondary prevention after a myocardial infarction ",1,"4 - QS99 - Secondary prevention after a myocardial infarction  - Structure - 1","",""]
[null,"QS99","Secondary prevention after a myocardial infarction ",4,null,"Adults referred to a cardiac rehabilitation programme after a myocardial infarction (MI) have an assessment appointment within 10 days of discharge from hospital","Uptake rates of cardiac rehabilitation programmes","Outcome","QS99 - Secondary prevention after a myocardial infarction ","4 - QS99 - Secondary prevention after a myocardial infarction ",1,"4 - QS99 - Secondary prevention after a myocardial infarction  - Outcome - 1"]
[null,"QS99","Secondary prevention after a myocardial infarction ",4,null,"Adults referred to a cardiac rehabilitation programme after a myocardial infarction (MI) have an assessment appointment within 10 days of discharge from hospital","Proportion of referrals to a cardiac rehabilitation programme from hospital where the patient attends an assessment appointment within 10 days of discharge after an MI","Process","QS99 - Secondary prevention after a myocardial infarction ","4 - QS99 - Secondary prevention after a myocardial infarction ",1,"4 - QS99 - Secondary prevention after a myocardial infarction  - Process - 1","The number in the denominator where the patient attends an assessment appointment within 10 days of discharge.","The number of referrals to a cardiac rehabilitation programme from hospital after admission for an MI."]
[null,"QS99","Secondary prevention after a myocardial infarction ",5,null,"Adults referred to a cardiac rehabilitation programme after a myocardial infarction (MI) are offered sessions during and outside working hours and the choice of undertaking the programme at home, in the community or in a hospital setting","Evidence of local arrangements to provide cardiac rehabilitation programmes during and outside working hours and the choice of undertaking programmes at home, in the community or in a hospital setting.","Structure","QS99 - Secondary prevention after a myocardial infarction ","5 - QS99 - Secondary prevention after a myocardial infarction ",1,"5 - QS99 - Secondary prevention after a myocardial infarction  - Structure - 1","",""]
[null,"QS99","Secondary prevention after a myocardial infarction ",5,null,"Adults referred to a cardiac rehabilitation programme after a myocardial infarction (MI) are offered sessions during and outside working hours and the choice of undertaking the programme at home, in the community or in a hospital setting","Rates of uptake of and adherence to cardiac rehabilitation programmes","Outcome","QS99 - Secondary prevention after a myocardial infarction ","5 - QS99 - Secondary prevention after a myocardial infarction ",1,"5 - QS99 - Secondary prevention after a myocardial infarction  - Outcome - 1"]
[null,"QS99","Secondary prevention after a myocardial infarction ",5,null,"Adults referred to a cardiac rehabilitation programme after a myocardial infarction (MI) are offered sessions during and outside working hours and the choice of undertaking the programme at home, in the community or in a hospital setting","Patient experience of cardiac rehabilitation programmes","Outcome","QS99 - Secondary prevention after a myocardial infarction ","5 - QS99 - Secondary prevention after a myocardial infarction ",2,"5 - QS99 - Secondary prevention after a myocardial infarction  - Outcome - 2"]
[null,"QS99","Secondary prevention after a myocardial infarction ",5,null,"Adults referred to a cardiac rehabilitation programme after a myocardial infarction (MI) are offered sessions during and outside working hours and the choice of undertaking the programme at home, in the community or in a hospital setting","Proportion of people referred to a cardiac rehabilitation programme who are offered sessions during and outside working hours and the choice of undertaking the programme at home, in the community or in a hospital setting.","Process","QS99 - Secondary prevention after a myocardial infarction ","5 - QS99 - Secondary prevention after a myocardial infarction ",1,"5 - QS99 - Secondary prevention after a myocardial infarction  - Process - 1","The number in the denominator offered sessions during and outside working hours and the choice of undertaking the programme at home, in the community or in a hospital setting.","The number of people referred to a cardiac rehabilitation programme after an MI."]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",1,null,"Adults aged between 25 and 84 years with an estimated increased risk of cardiovascular disease (CVD) are offered a full formal risk assessment using the QRISK3 tool.","Evidence of local arrangements to ensure that the QRISK3 tool is used to formally risk assess adults between 25 and 84 years when an estimated increased risk of CVD is identified.","Structure","QS100 - Cardiovascular risk assessment and lipid modification ","1 - QS100 - Cardiovascular risk assessment and lipid modification ",1,"1 - QS100 - Cardiovascular risk assessment and lipid modification  - Structure - 1","",""]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",1,null,"Adults aged between 25 and 84 years with an estimated increased risk of cardiovascular disease (CVD) are offered a full formal risk assessment using the QRISK3 tool.","Proportion of adults between 25 and 84 years with an estimated increased risk of CVD who have a full formal risk assessment using the QRISK3 tool.","Process","QS100 - Cardiovascular risk assessment and lipid modification ","1 - QS100 - Cardiovascular risk assessment and lipid modification ",1,"1 - QS100 - Cardiovascular risk assessment and lipid modification  - Process - 1","The number in the denominator having a full formal risk assessment using the QRISK3 tool. ","The number of adults between 25 and 84 years with an estimated increased risk of CVD. "]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",2,null,"Adults with a 10‑year risk of cardiovascular disease (CVD) of 10% or more are assessed for secondary causes before any offer of statin therapy","Evidence of local arrangements to ensure that adults with a 10‑year risk of CVD of 10% or more are assessed for secondary causes before any offer of statin treatment.","Structure","QS100 - Cardiovascular risk assessment and lipid modification ","2 - QS100 - Cardiovascular risk assessment and lipid modification ",1,"2 - QS100 - Cardiovascular risk assessment and lipid modification  - Structure - 1","",""]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",2,null,"Adults with a 10‑year risk of cardiovascular disease (CVD) of 10% or more are assessed for secondary causes before any offer of statin therapy","Proportion of adults with a 10‑year risk of CVD of 10% or more who are assessed for secondary causes before any offer of statin treatment.","Process","QS100 - Cardiovascular risk assessment and lipid modification ","2 - QS100 - Cardiovascular risk assessment and lipid modification ",1,"2 - QS100 - Cardiovascular risk assessment and lipid modification  - Process - 1","The number in the denominator who are assessed for secondary causes before any offer of statin treatment.","The number of adults with a 10‑year risk of CVD of 10% or more."]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",3,null,"Adults with a 10‑year risk of cardiovascular disease (CVD) of 10% or more receive advice on lifestyle changes before any offer of statin therapy","Evidence of local arrangements to ensure that adults with a 10‑year risk of CVD of 10% or more receive advice on lifestyle changes before any offer of statin treatment.","Structure","QS100 - Cardiovascular risk assessment and lipid modification ","3 - QS100 - Cardiovascular risk assessment and lipid modification ",1,"3 - QS100 - Cardiovascular risk assessment and lipid modification  - Structure - 1","",""]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",3,null,"Adults with a 10‑year risk of cardiovascular disease (CVD) of 10% or more receive advice on lifestyle changes before any offer of statin therapy","Proportion of adults with a 10‑year risk of CVD of 10% or more who receive advice on lifestyle changes before any offer of statin treatment.","Process","QS100 - Cardiovascular risk assessment and lipid modification ","3 - QS100 - Cardiovascular risk assessment and lipid modification ",1,"3 - QS100 - Cardiovascular risk assessment and lipid modification  - Process - 1","The number in the denominator who receive advice on lifestyle changes before any offer of statin treatment","The number of adults with a 10‑year risk of 10% or more."]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",4,null,"Adults with a 10‑year risk of cardiovascular disease (CVD) of 10% or more for whom lifestyle changes are ineffective or inappropriate, discuss the risks and benefits of starting statin therapy with their healthcare professional","Evidence of local arrangements to ensure that adults with a 10‑year risk of CVD of 10% or more, for whom lifestyle changes are ineffective or inappropriate, discuss with their healthcare professional the risks and benefits of starting statin treatment.","Structure","QS100 - Cardiovascular risk assessment and lipid modification ","4 - QS100 - Cardiovascular risk assessment and lipid modification ",1,"4 - QS100 - Cardiovascular risk assessment and lipid modification  - Structure - 1","",""]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",4,null,"Adults with a 10‑year risk of cardiovascular disease (CVD) of 10% or more for whom lifestyle changes are ineffective or inappropriate, discuss the risks and benefits of starting statin therapy with their healthcare professional","Proportion of adults with a 10‑year risk of CVD of 10% or more, for whom lifestyle changes are ineffective or inappropriate, with a recorded discussion on the risks and benefits of starting statin treatment.","Process",{"$f":"CONCATENATE(B2143, \" - \", C2143)","v":"QS100 - Cardiovascular risk assessment and lipid modification "},{"$f":"CONCATENATE(D2143, \" - \", I2143)","v":"4 - QS100 - Cardiovascular risk assessment and lipid modification "},{"$f":"IF(AND(B2143=B2141, D2143=D2141, H2143=H2141)=TRUE, K2141+1, 1)","v":1},{"$f":"CONCATENATE(J2143, \" - \", H2143, \" - \",K2143)","v":"4 - QS100 - Cardiovascular risk assessment and lipid modification  - Process - 1"},"The number in the denominator who have a record of a discussion on the risks and benefits of starting statin treatment.","The number of adults with a 10‑year risk of CVD of 10% or more for whom lifestyle changes have been ineffective or are inappropriate."]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",4,null,"Adults with a 10‑year risk of cardiovascular disease (CVD) of 10% or more for whom lifestyle changes are ineffective or inappropriate, discuss the risks and benefits of starting statin therapy with their healthcare professional","Proportion of adults with a 10‑year risk of CVD of 10% or more on high-intensity statin.","Outcome","QS100 - Cardiovascular risk assessment and lipid modification ","4 - QS100 - Cardiovascular risk assessment and lipid modification ",{"$f":"IF(AND(B2144=B2142, D2144=D2142, H2144=H2142)=TRUE, K2142+1, 1)","v":1},"4 - QS100 - Cardiovascular risk assessment and lipid modification  - Outcome - 1","The number in the denominator who have a record of high-intensity statin.","The number of adults with a 10‑year risk of CVD of 10% or more."]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",5,null,"Adults choosing statin therapy for the primary prevention of cardiovascular disease (CVD) are offered atorvastatin 20 mg","Evidence of local arrangements to ensure that adults who choose statin therapy for primary prevention are offered atorvastatin 20 mg","Structure","QS100 - Cardiovascular risk assessment and lipid modification ","5 - QS100 - Cardiovascular risk assessment and lipid modification ",1,"5 - QS100 - Cardiovascular risk assessment and lipid modification  - Structure - 1","",""]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",5,null,"Adults choosing statin therapy for the primary prevention of cardiovascular disease (CVD) are offered atorvastatin 20 mg","Proportion of adults choosing statin therapy for primary prevention of CVD who are prescribed atorvastatin 20 mg","Process","QS100 - Cardiovascular risk assessment and lipid modification ","5 - QS100 - Cardiovascular risk assessment and lipid modification ",1,"5 - QS100 - Cardiovascular risk assessment and lipid modification  - Process - 1","The number in the denominator prescribed atorvastatin 20 mg.","The number of adults choosing statin therapy for primary prevention of CVD."]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",5,null,"Adults choosing statin therapy for the primary prevention of cardiovascular disease (CVD) are offered atorvastatin 20 mg","Proportion of adults choosing statin treatment for primary prevention of CVD who have a greater than 40% reduction in non-high-density lipoprotein (HDL) cholesterol at 3 months of treatment.","Outcome","QS100 - Cardiovascular risk assessment and lipid modification ","5 - QS100 - Cardiovascular risk assessment and lipid modification ",1,"5 - QS100 - Cardiovascular risk assessment and lipid modification  - Outcome - 1","The number in the denominator who have a greater than 40% reduction in non-HDL cholesterol at 3 months of treatment.","The number of adults choosing statin treatment for primary prevention of CVD."]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",6,null,"Adults with newly diagnosed cardiovascular disease (CVD) are offered atorvastatin 80 mg","Evidence of local arrangements to ensure that adults with newly diagnosed CVD are offered atorvastatin 80 mg.","Structure","QS100 - Cardiovascular risk assessment and lipid modification ","6 - QS100 - Cardiovascular risk assessment and lipid modification ",{"$f":"IF(AND(B2148=B2146, D2148=D2146, H2148=H2146)=TRUE, K2146+1, 1)","v":1},"6 - QS100 - Cardiovascular risk assessment and lipid modification  - Structure - 1","",""]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",6,null,"Adults with newly diagnosed cardiovascular disease (CVD) are offered atorvastatin 80 mg","Proportion of adults with newly diagnosed CVD who are prescribed atorvastatin 80 mg","Process","QS100 - Cardiovascular risk assessment and lipid modification ","6 - QS100 - Cardiovascular risk assessment and lipid modification ",1,"6 - QS100 - Cardiovascular risk assessment and lipid modification  - Process - 1","The number in the denominator prescribed atorvastatin 80 mg.","The number of adults with newly diagnosed CVD."]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",6,null,"Adults with newly diagnosed cardiovascular disease (CVD) are offered atorvastatin 80 mg","Proportion of adults with CVD choosing statin treatment who have a low-density lipoprotein (LDL) cholesterol level of 2.0 mmol per litre or less, or non-high-density lipoprotein (HDL) cholesterol level of 2.6 mmol per litre or less.","Outcome","QS100 - Cardiovascular risk assessment and lipid modification ","6 - QS100 - Cardiovascular risk assessment and lipid modification ",1,"6 - QS100 - Cardiovascular risk assessment and lipid modification  - Outcome - 1","The number in the denominator who have an LDL cholesterol level of 2.0 mmol per litre or less, or non-HDL cholesterol level of 2.6 mmol per litre or less.","The number of adults with CVD choosing statin treatment."]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",7,null,"Adults on a high‑intensity statin who have side effects are offered a lower dose or an alternative statin","Evidence of local arrangements to ensure that adults on a high‑intensity statin are monitored for side effects and offered a lower dose or an alternative statin if necessary.","Structure","QS100 - Cardiovascular risk assessment and lipid modification ","7 - QS100 - Cardiovascular risk assessment and lipid modification ",{"$f":"IF(AND(B2151=B2149, D2151=D2149, H2151=H2149)=TRUE, K2149+1, 1)","v":1},"7 - QS100 - Cardiovascular risk assessment and lipid modification  - Structure - 1","",""]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",7,null,"Adults on a high‑intensity statin who have side effects are offered a lower dose or an alternative statin","Proportion of adults reporting side effects from a high‑intensity statin who are given a lower dose or alternative statin","Process","QS100 - Cardiovascular risk assessment and lipid modification ","7 - QS100 - Cardiovascular risk assessment and lipid modification ",1,"7 - QS100 - Cardiovascular risk assessment and lipid modification  - Process - 1","The number in the denominator at which a lower dose or alternative statin is prescribed.","The number of presentations of adults reporting side effects from a high‑intensity statin."]
[null,null,null,null,null,null,null,null," - "," -  - ",1," -  -  -  - 1"]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",8,null,"Adults on lipid-lowering treatment have a repeat measurement of full lipid profile and liver transaminases at 2 to 3 months of treatment.","Evidence of local arrangements to ensure that adults on lipid-lowering treatment have a repeat measurement of full lipid profile and liver transaminases at 3 months of treatment.","Structure","QS100 - Cardiovascular risk assessment and lipid modification ","8 - QS100 - Cardiovascular risk assessment and lipid modification ",1,"8 - QS100 - Cardiovascular risk assessment and lipid modification  - Structure - 1","",""]
[null,"QS100","Cardiovascular risk assessment and lipid modification ",8,null,"Adults on lipid-lowering treatment have a repeat measurement of full lipid profile and liver transaminases at 2 to 3 months of treatment.","Proportion of adults on lipid-lowering treatment who have had a repeat measurement of lipids and liver transaminases at 3 months of treatment.","Process","QS100 - Cardiovascular risk assessment and lipid modification ",{"$f":"CONCATENATE(D2155, \" - \", I2155)","v":"8 - QS100 - Cardiovascular risk assessment and lipid modification "},{"$f":"IF(AND(B2155=B2154, D2155=D2154, H2155=H2154)=TRUE, K2154+1, 1)","v":1},{"$f":"CONCATENATE(J2155, \" - \", H2155, \" - \",K2155)","v":"8 - QS100 - Cardiovascular risk assessment and lipid modification  - Process - 1"},"The number in the denominator who have had a repeat measurement of lipids and liver transaminases at 3 months of treatment.","The number of adults prescribed  lipid-lowering treatment for at least 3 months."]
[null,"QS101","Learning disability: behaviour that challenges",1,null,"Local authorities and clinical commissioning groups jointly choose a lead person to oversee strategic commissioning of services for all people with a learning disability. [new 2019]","Evidence of local arrangements for local authorities and clinical commissioning groups to jointly choose a lead person to oversee strategic commissioning of services for all people with a learning disability.","Structure","QS101 - Learning disability: behaviour that challenges","1 - QS101 - Learning disability: behaviour that challenges",1,"1 - QS101 - Learning disability: behaviour that challenges - Structure - 1"]
[null,"QS101","Learning disability: behaviour that challenges",1,null,"Local authorities and clinical commissioning groups jointly choose a lead person to oversee strategic commissioning of services for all people with a learning disability. [new 2019]","Evidence that the lead commissioner role specifies that they have in‑depth knowledge and experience of working with children, young people and adults with a learning disability and behaviour that challenges, including knowledge of local services.","Structure","QS101 - Learning disability: behaviour that challenges","1 - QS101 - Learning disability: behaviour that challenges",2,"1 - QS101 - Learning disability: behaviour that challenges - Structure - 2"]
[null,"QS101","Learning disability: behaviour that challenges",2,null,"People with a learning disability have an annual health check from their GP. [2015, amended 2019]","Evidence of local arrangements to ensure that people with a learning disability have an annual health check from their GP.","Structure","QS101 - Learning disability: behaviour that challenges","2 - QS101 - Learning disability: behaviour that challenges",1,"2 - QS101 - Learning disability: behaviour that challenges - Structure - 1"]
[null,"QS101","Learning disability: behaviour that challenges",2,null,"People with a learning disability have an annual health check from their GP. [2015, amended 2019]","Proportion of people with a learning disability who have an annual health check from their GP.","Process","QS101 - Learning disability: behaviour that challenges","2 - QS101 - Learning disability: behaviour that challenges",1,"2 - QS101 - Learning disability: behaviour that challenges - Process - 1","The number in the denominator who had an annual health check from their GP in the past 12 months.","The number of people with a learning disability in contact with a GP service."]
[null,"QS101","Learning disability: behaviour that challenges",3,null,"People with a learning disability and behaviour that challenges have an initial assessment to identify possible triggers, environmental factors and function of the behaviour. [2015]","Evidence of local arrangements to ensure that people with a learning disability and behaviour that challenges have an initial assessment to identify possible triggers, environmental factors and function of the behaviour.","Structure",{"$f":"CONCATENATE(B2160, \" - \", C2160)","v":"QS101 - Learning disability: behaviour that challenges"},"3 - QS101 - Learning disability: behaviour that challenges",1,"3 - QS101 - Learning disability: behaviour that challenges - Structure - 1","The number in the denominator who have an initial assessment to identify possible triggers, environmental factors and function of the behaviour.","The number of people with a learning disability presenting with behaviour that challenges."]
[null,"QS101","Learning disability: behaviour that challenges",3,null,"People with a learning disability and behaviour that challenges have an initial assessment to identify possible triggers, environmental factors and function of the behaviour. [2015]","Proportion of people with a learning disability and behaviour that challenges who have an initial assessment to identify possible triggers, environmental factors and function of the behaviour.","Process","QS101 - Learning disability: behaviour that challenges","3 - QS101 - Learning disability: behaviour that challenges",1,"3 - QS101 - Learning disability: behaviour that challenges - Process - 1","The number in the denominator who have an initial assessment to identify possible triggers, environmental factors and function of the behaviour.","The number of people with a learning disability presenting with behaviour that challenges."]
[null,"QS101","Learning disability: behaviour that challenges",4,null,"People with a learning disability and behaviour that challenges have a named lead practitioner. [2015, updated 2019]","Evidence of local arrangements to ensure that named lead practitioners are responsible for coordinating care and support of people with a learning disability and behaviour that challenges.","Structure","QS101 - Learning disability: behaviour that challenges","4 - QS101 - Learning disability: behaviour that challenges",1,"4 - QS101 - Learning disability: behaviour that challenges - Structure - 1"]
[null,"QS101","Learning disability: behaviour that challenges",4,null,"People with a learning disability and behaviour that challenges have a named lead practitioner. [2015, updated 2019]","Evidence of local arrangements to ensure that lead practitioners have access to all agencies involved in supporting people with a learning disability and behaviour that challenges.","Structure","QS101 - Learning disability: behaviour that challenges","4 - QS101 - Learning disability: behaviour that challenges",2,"4 - QS101 - Learning disability: behaviour that challenges - Structure - 2"]
[null,"QS101","Learning disability: behaviour that challenges",4,null,"People with a learning disability and behaviour that challenges have a named lead practitioner. [2015, updated 2019]","Proportion of people with a learning disability and behaviour that challenges who have a named lead practitioner.","Process","QS101 - Learning disability: behaviour that challenges","4 - QS101 - Learning disability: behaviour that challenges",1,"4 - QS101 - Learning disability: behaviour that challenges - Process - 1","The number in the denominator who have a named lead practitioner.","The number of people with a learning disability and behaviour that challenges."]
[null,"QS101","Learning disability: behaviour that challenges",4,null,"People with a learning disability and behaviour that challenges have a named lead practitioner. [2015, updated 2019]","Proportion of people with a learning disability and behaviour that challenges who feel satisfied with services.","Outcome","QS101 - Learning disability: behaviour that challenges","4 - QS101 - Learning disability: behaviour that challenges",1,"4 - QS101 - Learning disability: behaviour that challenges - Outcome - 1","The number in the denominator who feel satisfied with services.","The number of people with a learning disability and behaviour that challenges."]
[null,"QS101","Learning disability: behaviour that challenges",4,null,"People with a learning disability and behaviour that challenges have a named lead practitioner. [2015, updated 2019]","Proportion of people with a learning disability and behaviour that challenges and their families and carers who feel satisfied with involvement in decision making.","Outcome","QS101 - Learning disability: behaviour that challenges","4 - QS101 - Learning disability: behaviour that challenges",2,"4 - QS101 - Learning disability: behaviour that challenges - Outcome - 2","The number in the denominator who feel satisfied with services.","The number of people with a learning disability and behaviour that challenges and their families and carers."]
[null,"QS101","Learning disability: behaviour that challenges",5,null,"Families and carers of people with a learning disability and behaviour that challenges are involved in developing the person's care and support plan, which includes how to prevent or respond to a crisis. [new 2019]","Evidence of local arrangements to ensure that community learning disability teams or relevant children's services (for example, disabled children's teams) and service providers work in partnership with the families and carers of people with a learning disability and behaviour that challenges to develop a care and support plan that includes how to prevent or respond to a crisis.","Structure","QS101 - Learning disability: behaviour that challenges","5 - QS101 - Learning disability: behaviour that challenges",1,"5 - QS101 - Learning disability: behaviour that challenges - Structure - 1"]
[null,"QS101","Learning disability: behaviour that challenges",5,null,"Families and carers of people with a learning disability and behaviour that challenges are involved in developing the person's care and support plan, which includes how to prevent or respond to a crisis. [new 2019]","Proportion of care and support plans for people with a learning disability and behaviour that challenges where families and carers were involved in developing them.","Process","QS101 - Learning disability: behaviour that challenges","5 - QS101 - Learning disability: behaviour that challenges",1,"5 - QS101 - Learning disability: behaviour that challenges - Process - 1","The number in the denominator where families and carers were involved in developing them.","The number of care and support plans for people with a learning disability and behaviour that challenges."]
[null,"QS101","Learning disability: behaviour that challenges",5,null,"Families and carers of people with a learning disability and behaviour that challenges are involved in developing the person's care and support plan, which includes how to prevent or respond to a crisis. [new 2019]","Proportion of adults with a learning disability who live in their own home or with their family.","Outcome","QS101 - Learning disability: behaviour that challenges","5 - QS101 - Learning disability: behaviour that challenges",1,"5 - QS101 - Learning disability: behaviour that challenges - Outcome - 1","The number in the denominator who live in their own home or with their family.","The number of adults with a learning disability."]
[null,"QS101","Learning disability: behaviour that challenges",5,null,"Families and carers of people with a learning disability and behaviour that challenges are involved in developing the person's care and support plan, which includes how to prevent or respond to a crisis. [new 2019]","Proportion of children and young people with a learning disability who live with their family.","Outcome","QS101 - Learning disability: behaviour that challenges","5 - QS101 - Learning disability: behaviour that challenges",2,"5 - QS101 - Learning disability: behaviour that challenges - Outcome - 2","The number in the denominator who live with their family.","The number of children and young people with a learning disability."]
[null,"QS101","Learning disability: behaviour that challenges",6,null,"Parents or carers of children aged under 12 years with a learning disability and behaviour that challenges are offered a parent‑training programme. [2015]","Evidence of local arrangements to ensure that parents or carers of children aged under 12 years with a learning disability and behaviour that challenges are offered a parent‑training programme for behaviour that challenges.","Structure","QS101 - Learning disability: behaviour that challenges","6 - QS101 - Learning disability: behaviour that challenges",1,"6 - QS101 - Learning disability: behaviour that challenges - Structure - 1"]
[null,"QS101","Learning disability: behaviour that challenges",6,null,"Parents or carers of children aged under 12 years with a learning disability and behaviour that challenges are offered a parent‑training programme. [2015]","Proportion of parents or carers of children aged under 12 years with a learning disability and behaviour that challenges who are offered a parent‑training programme for behaviour that challenges.","Process","QS101 - Learning disability: behaviour that challenges","6 - QS101 - Learning disability: behaviour that challenges",1,"6 - QS101 - Learning disability: behaviour that challenges - Process - 1","The number in the denominator whose parents or carers are offered a parent‑training programme for behaviour that challenges.","The number of children aged under 12 years with a learning disability and behaviour that challenges."]
[null,"QS101","Learning disability: behaviour that challenges",7,null,"People with a learning disability and behaviour that challenges take part in personalised daily activities. [2015]","Evidence of local arrangements to ensure that people with a learning disability and behaviour that challenges take part in personalised daily activities.","Structure","QS101 - Learning disability: behaviour that challenges","7 - QS101 - Learning disability: behaviour that challenges",1,"7 - QS101 - Learning disability: behaviour that challenges - Structure - 1"]
[null,"QS101","Learning disability: behaviour that challenges",7,null,"People with a learning disability and behaviour that challenges take part in personalised daily activities. [2015]","Proportion of people with a learning disability and behaviour that challenges with a personalised daily activity schedule.","Process","QS101 - Learning disability: behaviour that challenges","7 - QS101 - Learning disability: behaviour that challenges",1,"7 - QS101 - Learning disability: behaviour that challenges - Process - 1","The number in the denominator with a personalised daily activity schedule.","The number of people with a learning disability and behaviour that challenges."]
[null,"QS101","Learning disability: behaviour that challenges",7,null,"People with a learning disability and behaviour that challenges take part in personalised daily activities. [2015]","Proportion of people taking part in personalised daily activities.","Process","QS101 - Learning disability: behaviour that challenges","7 - QS101 - Learning disability: behaviour that challenges",2,"7 - QS101 - Learning disability: behaviour that challenges - Process - 2","The number in the denominator who take part in personalised daily activities.","The number of people with a learning disability and behaviour that challenges with a personalised daily activity schedule."]
[null,"QS101","Learning disability: behaviour that challenges",7,null,"People with a learning disability and behaviour that challenges take part in personalised daily activities. [2015]","Service user experience of personalised daily activities.","Outcome","QS101 - Learning disability: behaviour that challenges","7 - QS101 - Learning disability: behaviour that challenges",1,"7 - QS101 - Learning disability: behaviour that challenges - Outcome - 1"]
[null,"QS101","Learning disability: behaviour that challenges",8,null,"People with a learning disability and behaviour that challenges have access to specialist behavioural support in the community. [new 2019]","Evidence of local arrangements for specialist behavioural support to be available in the community for people with a learning disability and behaviour that challenges (including for people in contact with, or at risk of contact with, the criminal justice system).","Structure","QS101 - Learning disability: behaviour that challenges","8 - QS101 - Learning disability: behaviour that challenges",1,"8 - QS101 - Learning disability: behaviour that challenges - Structure - 1"]
[null,"QS101","Learning disability: behaviour that challenges",8,null,"People with a learning disability and behaviour that challenges have access to specialist behavioural support in the community. [new 2019]","Evidence that local maximum waiting times for initial assessment, and for urgent and routine access to treatment and support for people with a learning disability and behaviour that challenges, have been set.","Structure","QS101 - Learning disability: behaviour that challenges","8 - QS101 - Learning disability: behaviour that challenges",2,"8 - QS101 - Learning disability: behaviour that challenges - Structure - 2"]
[null,"QS101","Learning disability: behaviour that challenges",8,null,"People with a learning disability and behaviour that challenges have access to specialist behavioural support in the community. [new 2019]","Evidence that professionals working in specialist behavioural support are trained in helping people with a learning disability and their families and carers to understand and change behaviour that challenges.","Structure","QS101 - Learning disability: behaviour that challenges","8 - QS101 - Learning disability: behaviour that challenges",3,"8 - QS101 - Learning disability: behaviour that challenges - Structure - 3"]
[null,"QS101","Learning disability: behaviour that challenges",8,null,"People with a learning disability and behaviour that challenges have access to specialist behavioural support in the community. [new 2019]","Proportion of people with a learning disability and behaviour that challenges accessing specialist behavioural support who receive support in the community.","Process","QS101 - Learning disability: behaviour that challenges","8 - QS101 - Learning disability: behaviour that challenges",1,"8 - QS101 - Learning disability: behaviour that challenges - Process - 1","The number in the denominator who receive support in the community.","The number of people with a learning disability and behaviour that challenges accessing specialist behavioural support."]
[null,"QS101","Learning disability: behaviour that challenges",8,null,"People with a learning disability and behaviour that challenges have access to specialist behavioural support in the community. [new 2019]","Proportion of adults with a learning disability who live in their own home or with their family.","Outcome","QS101 - Learning disability: behaviour that challenges","8 - QS101 - Learning disability: behaviour that challenges",1,"8 - QS101 - Learning disability: behaviour that challenges - Outcome - 1","The number in the denominator who live in their own home or with their family.","The number of adults with a learning disability."]
[null,"QS101","Learning disability: behaviour that challenges",8,null,"People with a learning disability and behaviour that challenges have access to specialist behavioural support in the community. [new 2019]","Proportion of children and young people with a learning disability who live with their family.","Outcome","QS101 - Learning disability: behaviour that challenges","8 - QS101 - Learning disability: behaviour that challenges",2,"8 - QS101 - Learning disability: behaviour that challenges - Outcome - 2","The number in the denominator who live with their family.","The number of children and young people with a learning disability."]
[null,"QS101","Learning disability: behaviour that challenges",8,null,"People with a learning disability and behaviour that challenges have access to specialist behavioural support in the community. [new 2019]","Rates of inpatient admissions for people with a learning disability.","Outcome","QS101 - Learning disability: behaviour that challenges","8 - QS101 - Learning disability: behaviour that challenges",3,"8 - QS101 - Learning disability: behaviour that challenges - Outcome - 3"]
[null,"QS101","Learning disability: behaviour that challenges",8,null,"People with a learning disability and behaviour that challenges have access to specialist behavioural support in the community. [new 2019]","Rates of restrictive intervention use for people with a learning disability.","Outcome","QS101 - Learning disability: behaviour that challenges","8 - QS101 - Learning disability: behaviour that challenges",4,"8 - QS101 - Learning disability: behaviour that challenges - Outcome - 4"]
[null,"QS101","Learning disability: behaviour that challenges",9,null,"Adults with a learning disability and behaviour that challenges are supported to choose where and how they live.","Evidence that a range of different housing and care options are available that meet the needs of adults with a learning disability and behaviour that challenges.","Structure","QS101 - Learning disability: behaviour that challenges","9 - QS101 - Learning disability: behaviour that challenges",1,"9 - QS101 - Learning disability: behaviour that challenges - Structure - 1"]
[null,"QS101","Learning disability: behaviour that challenges",9,null,"Adults with a learning disability and behaviour that challenges are supported to choose where and how they live.","Proportion of adults with a learning disability and behaviour that challenges who are supported to communicate their housing preferences and any specific support needs or risks.","Process","QS101 - Learning disability: behaviour that challenges","9 - QS101 - Learning disability: behaviour that challenges",1,"9 - QS101 - Learning disability: behaviour that challenges - Process - 1","The number in the denominator who are supported to communicate their housing preferences and any specific support needs or risks.","The number of adults with a learning disability and behaviour that challenges."]
[null,"QS101","Learning disability: behaviour that challenges",9,null,"Adults with a learning disability and behaviour that challenges are supported to choose where and how they live.","Proportion of adults with a learning disability and behaviour that challenges who live somewhere that meets their needs.","Process","QS101 - Learning disability: behaviour that challenges","9 - QS101 - Learning disability: behaviour that challenges",2,"9 - QS101 - Learning disability: behaviour that challenges - Process - 2","The number in the denominator who live somewhere that meets their needs.","the number of adults with a learning disability and behaviour that challenges."]
[null,"QS101","Learning disability: behaviour that challenges",9,null,"Adults with a learning disability and behaviour that challenges are supported to choose where and how they live.","Proportion of adults with a learning disability and behaviour that challenges who feel satisfied with the level of involvement in decision making about housing.","Outcome","QS101 - Learning disability: behaviour that challenges","9 - QS101 - Learning disability: behaviour that challenges",1,"9 - QS101 - Learning disability: behaviour that challenges - Outcome - 1","The number in the denominator who feel satisfied with the level of involvement in decision making about housing.","The number of adults with a learning disability and behaviour that challenges."]
[null,"QS101","Learning disability: behaviour that challenges",10,null,"People with a learning disability and behaviour that challenges have a documented review every time a restrictive intervention is used. [2015]","Evidence of local arrangements and written protocols to ensure that people with a learning disability and behaviour that challenges have a documented review every time a restrictive intervention is used.","Structure","QS101 - Learning disability: behaviour that challenges","10 - QS101 - Learning disability: behaviour that challenges",1,"10 - QS101 - Learning disability: behaviour that challenges - Structure - 1"]
[null,"QS101","Learning disability: behaviour that challenges",10,null,"People with a learning disability and behaviour that challenges have a documented review every time a restrictive intervention is used. [2015]","Proportion of people with a learning disability and behaviour that challenges who receive a restrictive intervention.","Process","QS101 - Learning disability: behaviour that challenges","10 - QS101 - Learning disability: behaviour that challenges",1,"10 - QS101 - Learning disability: behaviour that challenges - Process - 1","The number in the denominator who receive a restrictive intervention.","The number of people with a learning disability and behaviour that challenges."]
[null,"QS101","Learning disability: behaviour that challenges",10,null,"People with a learning disability and behaviour that challenges have a documented review every time a restrictive intervention is used. [2015]","Proportion of people with a learning disability and behaviour that challenges who have a documented review every time a restrictive intervention is used.","Process","QS101 - Learning disability: behaviour that challenges","10 - QS101 - Learning disability: behaviour that challenges",2,"10 - QS101 - Learning disability: behaviour that challenges - Process - 2","The number in the denominator who have a documented review every time a restrictive intervention is used.","The number of people with a learning disability and behaviour that challenges who receive a restrictive intervention."]
[null,"QS101","Learning disability: behaviour that challenges",10,null,"People with a learning disability and behaviour that challenges have a documented review every time a restrictive intervention is used. [2015]","Rates of restrictive interventions.","Outcome","QS101 - Learning disability: behaviour that challenges","10 - QS101 - Learning disability: behaviour that challenges",1,"10 - QS101 - Learning disability: behaviour that challenges - Outcome - 1"]
[null,"QS101","Learning disability: behaviour that challenges",11,null,"People with a learning disability and behaviour that challenges only receive antipsychotic medication as part of treatment that includes psychosocial interventions. [2015]","Evidence of local arrangements to ensure that people with a learning disability and behaviour that challenges only receive antipsychotic medication as part of treatment that includes psychosocial interventions.","Structure","QS101 - Learning disability: behaviour that challenges","11 - QS101 - Learning disability: behaviour that challenges",1,"11 - QS101 - Learning disability: behaviour that challenges - Structure - 1"]
[null,"QS101","Learning disability: behaviour that challenges",11,null,"People with a learning disability and behaviour that challenges only receive antipsychotic medication as part of treatment that includes psychosocial interventions. [2015]","Proportion of people with a learning disability and behaviour that challenges prescribed antipsychotic medication as part of treatment that includes psychosocial interventions.","Process","QS101 - Learning disability: behaviour that challenges","11 - QS101 - Learning disability: behaviour that challenges",1,"11 - QS101 - Learning disability: behaviour that challenges - Process - 1","The number in the denominator who are receiving psychosocial interventions.","The number of people with a learning disability and behaviour that challenges prescribed antipsychotic medication within the past 12 months."]
[null,"QS101","Learning disability: behaviour that challenges",11,null,"People with a learning disability and behaviour that challenges only receive antipsychotic medication as part of treatment that includes psychosocial interventions. [2015]","Proportion of people with a learning disability and behaviour that challenges prescribed antipsychotic medication with a recorded rationale for the prescribing decision.","Process","QS101 - Learning disability: behaviour that challenges","11 - QS101 - Learning disability: behaviour that challenges",2,"11 - QS101 - Learning disability: behaviour that challenges - Process - 2","The number in the denominator with a recorded rationale for the prescribing decision.","The number of people with a learning disability and behaviour that challenges prescribed antipsychotic medication within the past 12 months."]
[null,"QS101","Learning disability: behaviour that challenges",11,null,"People with a learning disability and behaviour that challenges only receive antipsychotic medication as part of treatment that includes psychosocial interventions. [2015]","Prescribing rates of antipsychotics in people with a learning disability and behaviour that challenges.","Outcome","QS101 - Learning disability: behaviour that challenges","11 - QS101 - Learning disability: behaviour that challenges",1,"11 - QS101 - Learning disability: behaviour that challenges - Outcome - 1"]
[null,"QS101","Learning disability: behaviour that challenges",12,null,"People with a learning disability and behaviour that challenges have a multidisciplinary review of their antipsychotic medication 12 weeks after starting treatment and then at least every 6 months. [2015]","Evidence of local arrangements and written protocols to ensure that people with a learning disability and behaviour that challenges have a multidisciplinary review of their antipsychotic medication 12 weeks after starting treatment and then at least every 6 months.","Structure","QS101 - Learning disability: behaviour that challenges","12 - QS101 - Learning disability: behaviour that challenges",1,"12 - QS101 - Learning disability: behaviour that challenges - Structure - 1"]
[null,"QS101","Learning disability: behaviour that challenges",12,null,"People with a learning disability and behaviour that challenges have a multidisciplinary review of their antipsychotic medication 12 weeks after starting treatment and then at least every 6 months. [2015]","Proportion of people with a learning disability and behaviour that challenges who have a multidisciplinary review of their antipsychotic medication 12 weeks after starting treatment.","Process","QS101 - Learning disability: behaviour that challenges","12 - QS101 - Learning disability: behaviour that challenges",1,"12 - QS101 - Learning disability: behaviour that challenges - Process - 1","The number in the denominator who have a multidisciplinary review of their antipsychotic medication 12 weeks after starting treatment.","The number of people with a learning disability and behaviour that challenges prescribed antipsychotic medication within the past 12 months."]
[null,"QS101","Learning disability: behaviour that challenges",12,null,"People with a learning disability and behaviour that challenges have a multidisciplinary review of their antipsychotic medication 12 weeks after starting treatment and then at least every 6 months. [2015]","Proportion of people with a learning disability and behaviour that challenges who have a multidisciplinary review of their antipsychotic medication at least every 6 months after the first 12 weeks of treatment.","Process","QS101 - Learning disability: behaviour that challenges","12 - QS101 - Learning disability: behaviour that challenges",2,"12 - QS101 - Learning disability: behaviour that challenges - Process - 2","The number in the denominator who have a multidisciplinary review of their antipsychotic medication at least every 6 months after the first 12 weeks of treatment.","The number of people with a learning disability and behaviour that challenges prescribed antipsychotic medication within the last 12 months."]
[null,"QS101","Learning disability: behaviour that challenges",12,null,"People with a learning disability and behaviour that challenges have a multidisciplinary review of their antipsychotic medication 12 weeks after starting treatment and then at least every 6 months. [2015]","Prescribing rates of antipsychotics in people with a learning disability and behaviour that challenges.","Outcome","QS101 - Learning disability: behaviour that challenges","12 - QS101 - Learning disability: behaviour that challenges",{"$f":"IF(AND(B2200=B2180, D2200=D2180, H2200=H2180)=TRUE, K2180+1, 1)","v":1},"12 - QS101 - Learning disability: behaviour that challenges - Outcome - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",1,null,"Children and young people who are referred to a specialist mental health service with a first episode of psychosis start assessment within 2 weeks.","Evidence of local arrangements to ensure that systems are in place for children and young people who are referred to a specialist mental health service with a first episode of psychosis to start assessment within 2 weeks.","Structure","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","1 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"1 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Structure - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",1,null,"Children and young people who are referred to a specialist mental health service with a first episode of psychosis start assessment within 2 weeks.","Proportion of children and young people who are referred to a specialist mental health service with a first episode of psychosis who start assessment within 2 weeks.","Process","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","1 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"1 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Process - 1","The number in the denominator who start assessment within 2 weeks of referral.","The number of children and young people who are referred to a specialist mental health service with a first episode of psychosis."]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",1,null,"Children and young people who are referred to a specialist mental health service with a first episode of psychosis start assessment within 2 weeks.","Mental health admission rates for children and young people.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","1 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"1 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",1,null,"Children and young people who are referred to a specialist mental health service with a first episode of psychosis start assessment within 2 weeks.","Duration of untreated psychosis.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","1 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",2,"1 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 2"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",2,null,"Children and young people with a first episode of psychosis and their family members are offered family intervention. ","Evidence of local arrangements to ensure that family intervention is an available treatment option for children and young people with a first episode of psychosis and their family members.","Structure","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","2 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"2 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Structure - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",2,null,"Children and young people with a first episode of psychosis and their family members are offered family intervention. ","Proportion of children and young people with a first episode of psychosis whose family members receive family intervention.","Process","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","2 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"2 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Process - 1","The number in the denominator whose family members receive family intervention.","The number of children and young people with a first episode of psychosis."]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",2,null,"Children and young people with a first episode of psychosis and their family members are offered family intervention. ","Proportion of children and young people with a first episode of psychosis who receive family intervention.","Process","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","2 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",2,"2 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Process - 2","The number in the denominator who receive family intervention.","The number of children and young people with a first episode of psychosis."]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",2,null,"Children and young people with a first episode of psychosis and their family members are offered family intervention. ","Relapse rates for children and young people with psychosis","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","2 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"2 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",3,null,"Children and young people newly diagnosed with bipolar depression or a first episode of psychosis are offered a psychological intervention.","Evidence of local arrangements to ensure that children and young people newly diagnosed with bipolar depression or a first episode of psychosis are offered a psychological intervention.","Structure","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","3 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"3 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Structure - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",3,null,"Children and young people newly diagnosed with bipolar depression or a first episode of psychosis are offered a psychological intervention.","Proportion of children and young people newly diagnosed with bipolar depression who receive cognitive behavioural therapy or interpersonal therapy","Process","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","3 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"3 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Process - 1","The number in the denominator who receive cognitive behavioural therapy or interpersonal therapy.","The number of children and young people newly diagnosed with bipolar depression."]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",3,null,"Children and young people newly diagnosed with bipolar depression or a first episode of psychosis are offered a psychological intervention.","Proportion of children and young people newly diagnosed with a first episode of psychosis who receive cognitive behavioural therapy.","Process","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","3 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",2,"3 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Process - 2","The number in the denominator who receive cognitive behavioural therapy.","The number of children and young people newly diagnosed with a first episode of psychosis."]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",3,null,"Children and young people newly diagnosed with bipolar depression or a first episode of psychosis are offered a psychological intervention.","Relapse rates for children and young people with bipolar depression","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","3 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"3 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",3,null,"Children and young people newly diagnosed with bipolar depression or a first episode of psychosis are offered a psychological intervention.","Relapse rates for children and young people with psychosis","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","3 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",2,"3 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 2"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",4,null,"Parents and carers of children and young people newly diagnosed with bipolar disorder, psychosis or schizophrenia are given information about carer-focused education and support.","Evidence of local arrangements to ensure that parents and carers of children and young people newly diagnosed with bipolar disorder, psychosis or schizophrenia are given information about carer-focused education and support.","Structure","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","4 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"4 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Structure - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",4,null,"Parents and carers of children and young people newly diagnosed with bipolar disorder, psychosis or schizophrenia are given information about carer-focused education and support.","Proportion of children and young people newly diagnosed with bipolar disorder, psychosis or schizophrenia whose parents or carers receive information about carer-focused education and support","Process","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","4 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"4 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Process - 1","The number in the denominator whose parents or carers receive information about carer‑focused education and support.","The number of children and young people newly diagnosed with bipolar disorder, psychosis or schizophrenia."]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",4,null,"Parents and carers of children and young people newly diagnosed with bipolar disorder, psychosis or schizophrenia are given information about carer-focused education and support.","Satisfaction of parents and carers of children and young people newly diagnosed with bipolar disorder, psychosis or schizophrenia with the information and support provided to meet their own needs.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","4 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"4 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",4,null,"Parents and carers of children and young people newly diagnosed with bipolar disorder, psychosis or schizophrenia are given information about carer-focused education and support.","Quality of life for parents and carers of children and young people with bipolar disorder, psychosis or schizophrenia.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","4 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",2,"4 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 2"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",5,null,"Children and young people with bipolar disorder, psychosis or schizophrenia are given healthy lifestyle advice at diagnosis and at annual review.","Evidence of local arrangements to ensure that children and young people with bipolar disorder, psychosis or schizophrenia are given healthy lifestyle advice at diagnosis.","Structure","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Structure - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",5,null,"Children and young people with bipolar disorder, psychosis or schizophrenia are given healthy lifestyle advice at diagnosis and at annual review.","Evidence of local arrangements to ensure that children and young people with bipolar disorder, psychosis or schizophrenia being supported in primary care or specialist mental health services are given healthy lifestyle advice at their annual review.","Structure","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",2,"5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Structure - 2"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",5,null,"Children and young people with bipolar disorder, psychosis or schizophrenia are given healthy lifestyle advice at diagnosis and at annual review.","Proportion of children and young people with bipolar disorder, psychosis or schizophrenia who receive healthy lifestyle advice at diagnosis.","Process","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Process - 1","The number in the denominator who receive healthy lifestyle advice at diagnosis.","The number of children and young people with a new diagnosis of bipolar disorder, psychosis or schizophrenia."]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",5,null,"Children and young people with bipolar disorder, psychosis or schizophrenia are given healthy lifestyle advice at diagnosis and at annual review.","Proportion of children and young people with bipolar disorder, psychosis or schizophrenia who receive healthy lifestyle advice at their annual review.","Process","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",2,"5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Process - 2","The number in the denominator who receive healthy lifestyle advice at their annual review.","The number of children and young people with bipolar disorder, psychosis or schizophrenia who are supported in primary care or specialist mental health services."]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",5,null,"Children and young people with bipolar disorder, psychosis or schizophrenia are given healthy lifestyle advice at diagnosis and at annual review.","Obesity rates in children and young people with bipolar disorder, psychosis or schizophrenia.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",5,null,"Children and young people with bipolar disorder, psychosis or schizophrenia are given healthy lifestyle advice at diagnosis and at annual review.","Physical activity in children and young people with bipolar disorder, psychosis or schizophrenia","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",2,"5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 2"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",5,null,"Children and young people with bipolar disorder, psychosis or schizophrenia are given healthy lifestyle advice at diagnosis and at annual review.","Drug use in children and young people with bipolar disorder, psychosis or schizophrenia.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",3,"5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 3"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",5,null,"Children and young people with bipolar disorder, psychosis or schizophrenia are given healthy lifestyle advice at diagnosis and at annual review.","Alcohol consumption in children and young people with bipolar disorder, psychosis or schizophrenia.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",4,"5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 4"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",5,null,"Children and young people with bipolar disorder, psychosis or schizophrenia are given healthy lifestyle advice at diagnosis and at annual review.","Smoking rates in children and young people with bipolar disorder, psychosis or schizophrenia.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",5,"5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 5"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",5,null,"Children and young people with bipolar disorder, psychosis or schizophrenia are given healthy lifestyle advice at diagnosis and at annual review.","Infection rates for sexually transmitted diseases in children and young people with bipolar disorder, psychosis or schizophrenia.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",6,"5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 6"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",5,null,"Children and young people with bipolar disorder, psychosis or schizophrenia are given healthy lifestyle advice at diagnosis and at annual review.","Premature mortality of people with bipolar disorder, psychosis or schizophrenia","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",7,"5 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 7"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",6,null,"Children and young people with bipolar disorder, psychosis or schizophrenia prescribed antipsychotic medication have their treatment monitored for side effects.","Evidence of local arrangements to ensure that children and young people with bipolar disorder, psychosis or schizophrenia prescribed antipsychotic medication have their treatment monitored for side effects.","Structure","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","6 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"6 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Structure - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",6,null,"Children and young people with bipolar disorder, psychosis or schizophrenia prescribed antipsychotic medication have their treatment monitored for side effects.","Proportion of children and young people newly diagnosed with bipolar disorder, psychosis or schizophrenia prescribed antipsychotic medication who have a record of baseline physical health investigations.","Process","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","6 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"6 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Process - 1","The number in the denominator who have a record of baseline physical health investigations.","The number of children and young people newly diagnosed with bipolar disorder, psychosis or schizophrenia prescribed antipsychotic medication."]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",6,null,"Children and young people with bipolar disorder, psychosis or schizophrenia prescribed antipsychotic medication have their treatment monitored for side effects.","Proportion of children and young people with bipolar disorder, psychosis or schizophrenia newly prescribed antipsychotic medication who have a record of side-effect monitoring 12 weeks after starting treatment.","Process","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","6 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",2,"6 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Process - 2","The number in the denominator who have a record of side‑effect monitoring 12 weeks after starting treatment.","The number of children and young people with bipolar disorder, psychosis or schizophrenia newly prescribed antipsychotic medication."]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",6,null,"Children and young people with bipolar disorder, psychosis or schizophrenia prescribed antipsychotic medication have their treatment monitored for side effects.","Proportion of children and young people with bipolar disorder, psychosis or schizophrenia prescribed antipsychotic medication for more than a year with a record of side-effect monitoring within the last 6 months.","Process","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","6 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",3,"6 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Process - 3","The number in the denominator with a record of side‑effect monitoring within the last 6 months.","The number of children and young people with bipolar disorder, psychosis or schizophrenia prescribed antipsychotic medication for more than a year."]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",6,null,"Children and young people with bipolar disorder, psychosis or schizophrenia prescribed antipsychotic medication have their treatment monitored for side effects.","Obesity rates in children and young people with bipolar disorder, psychosis or schizophrenia.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","6 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"6 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",6,null,"Children and young people with bipolar disorder, psychosis or schizophrenia prescribed antipsychotic medication have their treatment monitored for side effects.","Incidence of cardiovascular disease in people with bipolar disorder, psychosis or schizophrenia.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","6 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",2,"6 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 2"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",6,null,"Children and young people with bipolar disorder, psychosis or schizophrenia prescribed antipsychotic medication have their treatment monitored for side effects.","Incidence of type 2 diabetes in people with bipolar disorder, psychosis or schizophrenia. ","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","6 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",3,"6 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 3"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",7,null,"Children and young people with bipolar disorder, psychosis or schizophrenia who are in crisis are offered home treatment if it is suitable.","Evidence of local arrangements to ensure that children and young people with bipolar disorder, psychosis or schizophrenia who are in crisis are offered home treatment if it is suitable.","Structure","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","7 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"7 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Structure - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",7,null,"Children and young people with bipolar disorder, psychosis or schizophrenia who are in crisis are offered home treatment if it is suitable.","Proportion of crisis episodes in children and young people with bipolar disorder, psychosis or schizophrenia that are assessed for the suitability of home treatment.","Process","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","7 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"7 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Process - 1","The number in the denominator that are assessed for the suitability of home treatment.","The number of crisis episodes in children and young people with bipolar disorder, psychosis or schizophrenia."]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",7,null,"Children and young people with bipolar disorder, psychosis or schizophrenia who are in crisis are offered home treatment if it is suitable.","Proportion of crisis episodes in children and young people with bipolar disorder, psychosis or schizophrenia that are assessed as suitable for home treatment and result in home treatment.","Process","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",{"$f":"CONCATENATE(D2238, \" - \", I2238)","v":"7 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people"},{"$f":"IF(AND(B2238=B2237, D2238=D2237, H2238=H2237)=TRUE, K2237+1, 1)","v":2},{"$f":"CONCATENATE(J2238, \" - \", H2238, \" - \",K2238)","v":"7 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Process - 2"},"The number in the denominator that result in home treatment.","The number of crisis episodes in children and young people with bipolar disorder, psychosis or schizophrenia that are assessed as suitable for home treatment."]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",7,null,"Children and young people with bipolar disorder, psychosis or schizophrenia who are in crisis are offered home treatment if it is suitable.","Mental health admission rates for children and young people.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","7 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"7 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",8,null,"Children and young people with bipolar disorder, psychosis and schizophrenia have arrangements for accessing education or employment-related training included in their care plan.","Evidence of local arrangements to ensure that children and young people with bipolar disorder, psychosis or schizophrenia have arrangements for accessing education or employment-related training included in their care plan","Structure","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","8 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"8 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Structure - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",8,null,"Children and young people with bipolar disorder, psychosis and schizophrenia have arrangements for accessing education or employment-related training included in their care plan.","Proportion of children and young people with bipolar disorder, psychosis or schizophrenia who have arrangements for accessing education or employment-related training included in their care plan.","Process","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","8 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"8 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Process - 1","The number in the denominator who have arrangements for accessing education or employment‑related training included in their care plan.","The number of children and young people with bipolar disorder, psychosis or schizophrenia."]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",8,null,"Children and young people with bipolar disorder, psychosis and schizophrenia have arrangements for accessing education or employment-related training included in their care plan.","Satisfaction of children and young people with bipolar disorder, psychosis or schizophrenia with the support they received to access education or employment-related training.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","8 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",1,"8 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 1"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",8,null,"Children and young people with bipolar disorder, psychosis and schizophrenia have arrangements for accessing education or employment-related training included in their care plan.","Educational attainment of young people with bipolar disorder, psychosis or schizophrenia at age 16 years.","Outcome",{"$f":"CONCATENATE(B2243, \" - \", C2243)","v":"QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people"},"8 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",2,"8 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 2"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",8,null,"Children and young people with bipolar disorder, psychosis and schizophrenia have arrangements for accessing education or employment-related training included in their care plan.","Educational attainment of young people with bipolar disorder, psychosis or schizophrenia at age 19 years.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","8 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",3,"8 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 3"]
[null,"QS102","Bipolar disorder, psychosis and schizophrenia in children and young people",8,null,"Children and young people with bipolar disorder, psychosis and schizophrenia have arrangements for accessing education or employment-related training included in their care plan.","Employment of people with bipolar disorder, psychosis or schizophrenia.","Outcome","QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people","8 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people",4,"8 - QS102 - Bipolar disorder, psychosis and schizophrenia in children and young people - Outcome - 4"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",1,null,"Adults presenting to hospital with new suspected acute heart failure have a single measurement of natriuretic peptide.","Evidence of local arrangements to ensure that adults presenting to hospital with new suspected acute heart failure have a single measurement of natriuretic peptide.","Structure","QS103 - Acute heart failure: diagnosis and management in adults","1 - QS103 - Acute heart failure: diagnosis and management in adults",1,"1 - QS103 - Acute heart failure: diagnosis and management in adults - Structure - 1"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",1,null,"Adults presenting to hospital with new suspected acute heart failure have a single measurement of natriuretic peptide.","Proportion of adults presenting to hospital with new suspected acute heart failure who have a single measurement of natriuretic peptide.","Process","QS103 - Acute heart failure: diagnosis and management in adults","1 - QS103 - Acute heart failure: diagnosis and management in adults",1,"1 - QS103 - Acute heart failure: diagnosis and management in adults - Process - 1","The number in the denominator who have a single measurement of natriuretic peptide.","The number of presentations of adults to hospital with new suspected acute heart failure."]
[null,"QS103","Acute heart failure: diagnosis and management in adults",1,null,"Adults presenting to hospital with new suspected acute heart failure have a single measurement of natriuretic peptide.","Proportion of hospitals that use appropriate assay thresholds of plasma BNP less than 100 ng/litre and plasma NT‑proBNP less than 300 ng/litre.","Process","QS103 - Acute heart failure: diagnosis and management in adults","1 - QS103 - Acute heart failure: diagnosis and management in adults",2,"1 - QS103 - Acute heart failure: diagnosis and management in adults - Process - 2","The number in the denominator that use appropriate assay thresholds of plasma BNP less than 100 ng/litre and plasma NT‑proBNP less than 300 ng/litre.","The number of hospitals in England to which people may present with suspected acute heart failure."]
[null,"QS103","Acute heart failure: diagnosis and management in adults",1,null,"Adults presenting to hospital with new suspected acute heart failure have a single measurement of natriuretic peptide.","Mortality rates.","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","1 - QS103 - Acute heart failure: diagnosis and management in adults",1,"1 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 1"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",1,null,"Adults presenting to hospital with new suspected acute heart failure have a single measurement of natriuretic peptide.","Length of stay.","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","1 - QS103 - Acute heart failure: diagnosis and management in adults",2,"1 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 2"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",1,null,"Adults presenting to hospital with new suspected acute heart failure have a single measurement of natriuretic peptide.","Readmission rates.","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","1 - QS103 - Acute heart failure: diagnosis and management in adults",3,"1 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 3"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",2,null,"Adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels have a transthoracic doppler 2D echocardiogram within 48 hours of admission.","Evidence of local arrangements to ensure that adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels have a transthoracic doppler 2D echocardiogram within 48 hours of admission.","Structure","QS103 - Acute heart failure: diagnosis and management in adults","2 - QS103 - Acute heart failure: diagnosis and management in adults",1,"2 - QS103 - Acute heart failure: diagnosis and management in adults - Structure - 1"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",2,null,"Adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels have a transthoracic doppler 2D echocardiogram within 48 hours of admission.","Proportion of adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels who have a transthoracic doppler 2D echocardiogram within 48 hours of admission.","Process","QS103 - Acute heart failure: diagnosis and management in adults","2 - QS103 - Acute heart failure: diagnosis and management in adults",1,"2 - QS103 - Acute heart failure: diagnosis and management in adults - Process - 1","The number in the denominator who have a transthoracic doppler 2D echocardiogram within 48 hours of admission.","The number of hospital episodes of adults with new suspected acute heart failure and raised natriuretic peptide levels."]
[null,"QS103","Acute heart failure: diagnosis and management in adults",2,null,"Adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels have a transthoracic doppler 2D echocardiogram within 48 hours of admission.","Mortality rates.","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","2 - QS103 - Acute heart failure: diagnosis and management in adults",1,"2 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 1"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",2,null,"Adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels have a transthoracic doppler 2D echocardiogram within 48 hours of admission.","Length of stay. ","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","2 - QS103 - Acute heart failure: diagnosis and management in adults",2,"2 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 2"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",2,null,"Adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels have a transthoracic doppler 2D echocardiogram within 48 hours of admission.","Incidence of adverse events (withdrawal of beta‑blockers and other disease‑modifying drugs).","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","2 - QS103 - Acute heart failure: diagnosis and management in adults",3,"2 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 3"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",2,null,"Adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels have a transthoracic doppler 2D echocardiogram within 48 hours of admission.","Readmission rates.","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","2 - QS103 - Acute heart failure: diagnosis and management in adults",4,"2 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 4"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",3,null,"Adults admitted to hospital with acute heart failure have input within 24 hours of admission from a dedicated specialist heart failure team.","Evidence of local arrangements to ensure that adults admitted to hospital with acute heart failure have input within 24 hours of admission from a dedicated specialist heart failure team.","Structure ","QS103 - Acute heart failure: diagnosis and management in adults","3 - QS103 - Acute heart failure: diagnosis and management in adults",1,"3 - QS103 - Acute heart failure: diagnosis and management in adults - Structure  - 1"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",3,null,"Adults admitted to hospital with acute heart failure have input within 24 hours of admission from a dedicated specialist heart failure team.","Proportion of adults admitted to hospital with acute heart failure who have input within 24 hours of admission from a dedicated specialist heart failure team.","Process","QS103 - Acute heart failure: diagnosis and management in adults","3 - QS103 - Acute heart failure: diagnosis and management in adults",1,"3 - QS103 - Acute heart failure: diagnosis and management in adults - Process - 1","The number in the denominator who receive input within 24 hours of admission from a dedicated specialist heart failure team.","The number of adults admitted to hospital with acute heart failure."]
[null,"QS103","Acute heart failure: diagnosis and management in adults",3,null,"Adults admitted to hospital with acute heart failure have input within 24 hours of admission from a dedicated specialist heart failure team.","Mortality rates.","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","3 - QS103 - Acute heart failure: diagnosis and management in adults",1,"3 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 1"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",3,null,"Adults admitted to hospital with acute heart failure have input within 24 hours of admission from a dedicated specialist heart failure team.","Readmission rates.","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","3 - QS103 - Acute heart failure: diagnosis and management in adults",2,"3 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 2"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",4,null,"Adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta‑blocker treatment during their hospital admission.","Evidence of local arrangements to ensure that adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta‑blocker treatment during their hospital admission.","Structure","QS103 - Acute heart failure: diagnosis and management in adults","4 - QS103 - Acute heart failure: diagnosis and management in adults",1,"4 - QS103 - Acute heart failure: diagnosis and management in adults - Structure - 1"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",4,null,"Adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta‑blocker treatment during their hospital admission.","Proportion of adults with acute heart failure due to left ventricular systolic dysfunction who are started on beta‑blocker treatment during their hospital admission.","Process","QS103 - Acute heart failure: diagnosis and management in adults","4 - QS103 - Acute heart failure: diagnosis and management in adults",1,"4 - QS103 - Acute heart failure: diagnosis and management in adults - Process - 1","The number in the denominator who are started on beta‑blocker treatment during their hospital admission.","The number of hospital admissions of adults with acute heart failure due to left ventricular systolic dysfunction in which the patient is not already taking a beta‑blocker."]
[null,"QS103","Acute heart failure: diagnosis and management in adults",4,null,"Adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta‑blocker treatment during their hospital admission.","Proportion of adults with acute heart failure due to left ventricular systolic dysfunction who continue with beta‑blocker treatment during their hospital admission.","Process","QS103 - Acute heart failure: diagnosis and management in adults","4 - QS103 - Acute heart failure: diagnosis and management in adults",2,"4 - QS103 - Acute heart failure: diagnosis and management in adults - Process - 2","The number in the denominator who continue beta‑blocker treatment during their hospital admission.","The number of hospital admissions of adults with acute heart failure due to left ventricular systolic dysfunction."]
[null,"QS103","Acute heart failure: diagnosis and management in adults",4,null,"Adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta‑blocker treatment during their hospital admission.","Mortality rates.","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","4 - QS103 - Acute heart failure: diagnosis and management in adults",1,"4 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 1"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",4,null,"Adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta‑blocker treatment during their hospital admission.","Readmission rates.","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","4 - QS103 - Acute heart failure: diagnosis and management in adults",2,"4 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 2"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",4,null,"Adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta‑blocker treatment during their hospital admission.","Incidence of adverse events (withdrawal of beta‑blockers and other disease‑modifying drugs).","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","4 - QS103 - Acute heart failure: diagnosis and management in adults",3,"4 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 3"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",4,null,"Adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta‑blocker treatment during their hospital admission.","Beta‑blocker use at follow‑up.","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","4 - QS103 - Acute heart failure: diagnosis and management in adults",4,"4 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 4"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",5,null,"Adults admitted to hospital with acute heart failure and reduced left ventricular ejection fraction are offered an angiotensin‑converting enzyme (ACE) inhibitor and an aldosterone antagonist.","Evidence of local arrangements to ensure that adults admitted to hospital with acute heart failure and reduced left ventricular ejection fraction are offered an ACE inhibitor and an aldosterone antagonist. ","Structure","QS103 - Acute heart failure: diagnosis and management in adults","5 - QS103 - Acute heart failure: diagnosis and management in adults",1,"5 - QS103 - Acute heart failure: diagnosis and management in adults - Structure - 1"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",5,null,"Adults admitted to hospital with acute heart failure and reduced left ventricular ejection fraction are offered an angiotensin‑converting enzyme (ACE) inhibitor and an aldosterone antagonist.","Proportion of new hospital admissions for adults with acute heart failure and reduced left ventricular ejection fraction when an ACE inhibitor and an aldosterone antagonist are offered.","Process","QS103 - Acute heart failure: diagnosis and management in adults","5 - QS103 - Acute heart failure: diagnosis and management in adults",1,"5 - QS103 - Acute heart failure: diagnosis and management in adults - Process - 1","The number in the denominator treated with an ACE inhibitor and an aldosterone antagonist. ","The number of new hospital admissions for adults with acute heart failure and reduced left ventricular ejection fraction."]
[null,"QS103","Acute heart failure: diagnosis and management in adults",5,null,"Adults admitted to hospital with acute heart failure and reduced left ventricular ejection fraction are offered an angiotensin‑converting enzyme (ACE) inhibitor and an aldosterone antagonist.","Mortality rates.","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","5 - QS103 - Acute heart failure: diagnosis and management in adults",1,"5 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 1"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",5,null,"Adults admitted to hospital with acute heart failure and reduced left ventricular ejection fraction are offered an angiotensin‑converting enzyme (ACE) inhibitor and an aldosterone antagonist.","Readmission rates.","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","5 - QS103 - Acute heart failure: diagnosis and management in adults",2,"5 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 2"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",6,null,"Adults with acute heart failure have a follow‑up clinical assessment by a member of the community- or hospital‑based specialist heart failure team within 2 weeks of hospital discharge.","Evidence of local arrangements to ensure that adults with acute heart failure have a follow‑up clinical assessment by a member of the community- or hospital‑based specialist heart failure team within 2 weeks of hospital discharge.","Structure","QS103 - Acute heart failure: diagnosis and management in adults","6 - QS103 - Acute heart failure: diagnosis and management in adults",1,"6 - QS103 - Acute heart failure: diagnosis and management in adults - Structure - 1"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",6,null,"Adults with acute heart failure have a follow‑up clinical assessment by a member of the community- or hospital‑based specialist heart failure team within 2 weeks of hospital discharge.","Proportion of adults with acute heart failure who have a follow‑up clinical assessment by a member of the community- or hospital‑based specialist heart failure team within 2 weeks of hospital discharge.","Process","QS103 - Acute heart failure: diagnosis and management in adults","6 - QS103 - Acute heart failure: diagnosis and management in adults",1,"6 - QS103 - Acute heart failure: diagnosis and management in adults - Process - 1","The number in the denominator who have a follow‑up clinical assessment by a member of the community- or hospital‑based specialist heart failure team within 2 weeks of hospital discharge.","The number of hospital discharges of adults with a diagnosis of acute heart failure."]
[null,"QS103","Acute heart failure: diagnosis and management in adults",6,null,"Adults with acute heart failure have a follow‑up clinical assessment by a member of the community- or hospital‑based specialist heart failure team within 2 weeks of hospital discharge.","Mortality rates.","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","6 - QS103 - Acute heart failure: diagnosis and management in adults",1,"6 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 1"]
[null,"QS103","Acute heart failure: diagnosis and management in adults",6,null,"Adults with acute heart failure have a follow‑up clinical assessment by a member of the community- or hospital‑based specialist heart failure team within 2 weeks of hospital discharge.","Readmission rates.","Outcome","QS103 - Acute heart failure: diagnosis and management in adults","6 - QS103 - Acute heart failure: diagnosis and management in adults",2,"6 - QS103 - Acute heart failure: diagnosis and management in adults - Outcome - 2"]
[null,"QS104","Gallstone disease",1,null,"Adults with acute cholecystitis have laparoscopic cholecystectomy within 1 week of diagnosis.","Evidence of local arrangements to ensure that adults with acute cholecystitis have laparoscopic cholecystectomy within 1 week of diagnosis.","Structure","QS104 - Gallstone disease","1 - QS104 - Gallstone disease",1,"1 - QS104 - Gallstone disease - Structure - 1"]
[null,"QS104","Gallstone disease",1,null,"Adults with acute cholecystitis have laparoscopic cholecystectomy within 1 week of diagnosis.","Evidence of local arrangements to ensure that secondary care services that offer laparoscopic cholecystectomy regularly perform the procedure.","Structure","QS104 - Gallstone disease","1 - QS104 - Gallstone disease",2,"1 - QS104 - Gallstone disease - Structure - 2"]
[null,"QS104","Gallstone disease",1,null,"Adults with acute cholecystitis have laparoscopic cholecystectomy within 1 week of diagnosis.","Proportion of adults with acute cholecystitis who have a laparoscopic cholecystectomy within 1 week of diagnosis.","Process","QS104 - Gallstone disease","1 - QS104 - Gallstone disease",1,"1 - QS104 - Gallstone disease - Process - 1","The number in the denominator who have a laparoscopic cholecystectomy within 1 week of diagnosis.","The number of adults with acute cholecystitis."]
[null,"QS104","Gallstone disease",1,null,"Adults with acute cholecystitis have laparoscopic cholecystectomy within 1 week of diagnosis.","Acute readmission rates for adults with acute cholecystitis.","Outcome","QS104 - Gallstone disease","1 - QS104 - Gallstone disease",1,"1 - QS104 - Gallstone disease - Outcome - 1"]
[null,"QS104","Gallstone disease",1,null,"Adults with acute cholecystitis have laparoscopic cholecystectomy within 1 week of diagnosis.","Length of stay for adults with acute cholecystitis.","Outcome","QS104 - Gallstone disease","1 - QS104 - Gallstone disease",2,"1 - QS104 - Gallstone disease - Outcome - 2"]
[null,"QS104","Gallstone disease",1,null,"Adults with acute cholecystitis have laparoscopic cholecystectomy within 1 week of diagnosis.","Quality of life for adults with acute cholecystitis.","Outcome","QS104 - Gallstone disease","1 - QS104 - Gallstone disease",3,"1 - QS104 - Gallstone disease - Outcome - 3"]
[null,"QS104","Gallstone disease",2,null,"Adults with common bile duct stones causing jaundice have endoscopic retrograde cholangiopancreatography within 72 hours of diagnosis.","Evidence of local arrangements to ensure that adults with common bile duct stones causing jaundice have endoscopic retrograde cholangiopancreatography within 72 hours of diagnosis.","Structure","QS104 - Gallstone disease","2 - QS104 - Gallstone disease",1,"2 - QS104 - Gallstone disease - Structure - 1"]
[null,"QS104","Gallstone disease",2,null,"Adults with common bile duct stones causing jaundice have endoscopic retrograde cholangiopancreatography within 72 hours of diagnosis.","Proportion of adults with common bile duct stones causing jaundice who have endoscopic retrograde cholangiopancreatography within 72 hours of diagnosis.","Process","QS104 - Gallstone disease","2 - QS104 - Gallstone disease",1,"2 - QS104 - Gallstone disease - Process - 1","The number in the denominator who have endoscopic retrograde cholangiopancreatography within 72 hours of diagnosis.","The number of adults with common bile duct stones causing jaundice."]
[null,"QS104","Gallstone disease",2,null,"Adults with common bile duct stones causing jaundice have endoscopic retrograde cholangiopancreatography within 72 hours of diagnosis.","Rates of cholangitis in adults with common bile duct stones.","Outcome","QS104 - Gallstone disease","2 - QS104 - Gallstone disease",1,"2 - QS104 - Gallstone disease - Outcome - 1"]
[null,"QS104","Gallstone disease",3,null,"Adults with common bile duct stones who need emergency endoscopic retrograde cholangiopancreatography have it within 24 hours.","Evidence of local arrangements to ensure that adults with common bile duct stones who need emergency endoscopic retrograde cholangiopancreatography have it within 24 hours.","Structure","QS104 - Gallstone disease","3 - QS104 - Gallstone disease",1,"3 - QS104 - Gallstone disease - Structure - 1"]
[null,"QS104","Gallstone disease",3,null,"Adults with common bile duct stones who need emergency endoscopic retrograde cholangiopancreatography have it within 24 hours.","Proportion of adults with common bile duct stones who need emergency endoscopic retrograde cholangiopancreatography who have it within 24 hours.","Process","QS104 - Gallstone disease","3 - QS104 - Gallstone disease",1,"3 - QS104 - Gallstone disease - Process - 1","The number in the denominator who have endoscopic retrograde cholangiopancreatography within 24 hours.","The number of adults with common bile duct stones who need emergency endoscopic retrograde cholangiopancreatography."]
[null,"QS104","Gallstone disease",3,null,"Adults with common bile duct stones who need emergency endoscopic retrograde cholangiopancreatography have it within 24 hours.","Rates of sepsis in adults with common bile duct stones.","Outcome","QS104 - Gallstone disease","3 - QS104 - Gallstone disease",1,"3 - QS104 - Gallstone disease - Outcome - 1"]
[null,"QS104","Gallstone disease",4,null,"Adults with symptomatic gallstone disease who have not had their gallbladder or gallstones removed are advised to avoid food and drink that triggers their symptoms.","Evidence of local arrangements and written clinical protocols to ensure that adults with symptomatic gallstone disease who have not had their gallbladder or gallstones removed are advised to avoid food and drink that triggers their symptoms.","Structure","QS104 - Gallstone disease","4 - QS104 - Gallstone disease",1,"4 - QS104 - Gallstone disease - Structure - 1"]
[null,"QS104","Gallstone disease",4,null,"Adults with symptomatic gallstone disease who have not had their gallbladder or gallstones removed are advised to avoid food and drink that triggers their symptoms.","Proportion of adults with symptomatic gallstone disease who have not had their gallbladder or gallstones removed who are advised to avoid food and drink that triggers their symptoms.","Process","QS104 - Gallstone disease","4 - QS104 - Gallstone disease",1,"4 - QS104 - Gallstone disease - Process - 1","The number in the denominator who are advised to avoid food and drink that triggers their symptoms.","The number of adults with symptomatic gallstone disease who have not had their gallbladder or gallstones removed."]
[null,"QS104","Gallstone disease",4,null,"Adults with symptomatic gallstone disease who have not had their gallbladder or gallstones removed are advised to avoid food and drink that triggers their symptoms.","Patient experience.","Outcome","QS104 - Gallstone disease","4 - QS104 - Gallstone disease",1,"4 - QS104 - Gallstone disease - Outcome - 1"]
[null,"QS104","Gallstone disease",4,null,"Adults with symptomatic gallstone disease who have not had their gallbladder or gallstones removed are advised to avoid food and drink that triggers their symptoms.","Quality of life for adults with gallstone disease.","Outcome","QS104 - Gallstone disease","4 - QS104 - Gallstone disease",2,"4 - QS104 - Gallstone disease - Outcome - 2"]
[null,"QS105","Intrapartum care",1,null,"Women at low risk of complications during labour are given the choice of all 4 birth settings and information about local birth outcomes.","Evidence of local arrangements to provide women at low risk of complications with a choice of all 4 birth settings.","Structure","QS105 - Intrapartum care","1 - QS105 - Intrapartum care",1,"1 - QS105 - Intrapartum care - Structure - 1"]
[null,"QS105","Intrapartum care",1,null,"Women at low risk of complications during labour are given the choice of all 4 birth settings and information about local birth outcomes.","Evidence of local arrangements to provide women at low risk of complications with local information about birth outcomes.","Structure","QS105 - Intrapartum care","1 - QS105 - Intrapartum care",2,"1 - QS105 - Intrapartum care - Structure - 2"]
[null,"QS105","Intrapartum care",1,null,"Women at low risk of complications during labour are given the choice of all 4 birth settings and information about local birth outcomes.","Proportion of women at low risk of complications with a recorded discussion at their antenatal booking appointment of their preferred choice of birth setting.","Process","QS105 - Intrapartum care","1 - QS105 - Intrapartum care",1,"1 - QS105 - Intrapartum care - Process - 1","The number in the denominator with a recorded discussion at their antenatal booking appointment of their preferred choice of birth setting.","The number of women at low risk of complications attending an antenatal booking appointment."]
[null,"QS105","Intrapartum care",1,null,"Women at low risk of complications during labour are given the choice of all 4 birth settings and information about local birth outcomes.","Proportion of women at low risk of complications with a recorded discussion at their antenatal booking appointment about local birth outcomes.","Process","QS105 - Intrapartum care","1 - QS105 - Intrapartum care",2,"1 - QS105 - Intrapartum care - Process - 2","The number in the denominator with a recorded discussion at their antenatal booking appointment about local birth outcomes.","The number of women at low risk of complications attending an antenatal booking appointment."]
[null,"QS105","Intrapartum care",1,null,"Women at low risk of complications during labour are given the choice of all 4 birth settings and information about local birth outcomes.","Maternal experience and satisfaction with place of birth.","Outcome","QS105 - Intrapartum care","1 - QS105 - Intrapartum care",1,"1 - QS105 - Intrapartum care - Outcome - 1"]
[null,"QS105","Intrapartum care",2,null,"Women in established labour have one-to-one care and support from an assigned midwife.","Evidence of midwifery staff available to provide one-to-one care to women in established labour in each birth setting.","Structure","QS105 - Intrapartum care","2 - QS105 - Intrapartum care",1,"2 - QS105 - Intrapartum care - Structure - 1"]
[null,"QS105","Intrapartum care",2,null,"Women in established labour have one-to-one care and support from an assigned midwife.","Midwifery staffing levels as in the NICE guideline on safe midwifery staffing for maternity settings.","Process","QS105 - Intrapartum care","2 - QS105 - Intrapartum care",1,"2 - QS105 - Intrapartum care - Process - 1","The number of women in the denominator who receive one-to-one care from an assigned midwife during established labour.","The number of women in established labour in a time period."]
[null,"QS105","Intrapartum care",2,null,"Women in established labour have one-to-one care and support from an assigned midwife.","Neonatal morbidity.","Outcome","QS105 - Intrapartum care","2 - QS105 - Intrapartum care",1,"2 - QS105 - Intrapartum care - Outcome - 1"]
[null,"QS105","Intrapartum care",2,null,"Women in established labour have one-to-one care and support from an assigned midwife.","Maternal morbidity.","Outcome","QS105 - Intrapartum care","2 - QS105 - Intrapartum care",2,"2 - QS105 - Intrapartum care - Outcome - 2"]
[null,"QS105","Intrapartum care",2,null,"Women in established labour have one-to-one care and support from an assigned midwife.","Maternal satisfaction and experience of care.","Outcome","QS105 - Intrapartum care",{"$f":"CONCATENATE(D2302, \" - \", I2302)","v":"2 - QS105 - Intrapartum care"},{"$f":"IF(AND(B2302=B2301, D2302=D2301, H2302=H2301)=TRUE, K2301+1, 1)","v":3},{"$f":"CONCATENATE(J2302, \" - \", H2302, \" - \",K2302)","v":"2 - QS105 - Intrapartum care - Outcome - 3"}]
[null,"QS105","Intrapartum care",3,null,"This statement has been removed.",null,null,"QS105 - Intrapartum care","3 - QS105 - Intrapartum care",1,"3 - QS105 - Intrapartum care -  - 1"]
[null,"QS105","Intrapartum care",3,null,"This statement has been removed.",null,null,"QS105 - Intrapartum care","3 - QS105 - Intrapartum care",2,"3 - QS105 - Intrapartum care -  - 2"]
[null,"QS105","Intrapartum care",3,null,"This statement has been removed.",null,null,"QS105 - Intrapartum care","3 - QS105 - Intrapartum care",3,"3 - QS105 - Intrapartum care -  - 3"]
[null,"QS105","Intrapartum care",4,null,"Women at low risk of complications who have cardiotocography because of concern arising from intermittent auscultation have the cardiotocograph removed if the trace is normal for 20 minutes.","Evidence of local arrangements to ensure that women at low risk of complications having cardiotocography because of concern arising from intermittent auscultation have the cardiotocograph removed if the trace is normal for 20 minutes.","Structure","QS105 - Intrapartum care","4 - QS105 - Intrapartum care",1,"4 - QS105 - Intrapartum care - Structure - 1"]
[null,"QS105","Intrapartum care",4,null,"Women at low risk of complications who have cardiotocography because of concern arising from intermittent auscultation have the cardiotocograph removed if the trace is normal for 20 minutes.","Proportion of women at low risk of complications who have cardiotocography because of concern arising from intermittent auscultation have the cardiotocograph removed if the trace is normal for 20 minutes.","Process",{"$f":"CONCATENATE(B2307, \" - \", C2307)","v":"QS105 - Intrapartum care"},"4 - QS105 - Intrapartum care",1,"4 - QS105 - Intrapartum care - Process - 1","The number in the denominator who have the cardiotocograph removed.","The number of women in labour at low risk of complications who have cardiotocography because of concern arising from intermittent auscultation and who have a normal trace for 20 minutes."]
[null,"QS105","Intrapartum care",4,null,"Women at low risk of complications who have cardiotocography because of concern arising from intermittent auscultation have the cardiotocograph removed if the trace is normal for 20 minutes.","Maternal satisfaction and experience of care.","Outcome","QS105 - Intrapartum care","4 - QS105 - Intrapartum care",1,"4 - QS105 - Intrapartum care - Outcome - 1"]
[null,"QS105","Intrapartum care",5,null,"Women at low risk of complications are not offered amniotomy or oxytocin if labour is progressing normally.","Evidence of local arrangements to ensure that women at low risk of complications who are in labour that is progressing normally do not have amniotomy or oxytocin.","Structure","QS105 - Intrapartum care","5 - QS105 - Intrapartum care",1,"5 - QS105 - Intrapartum care - Structure - 1"]
[null,"QS105","Intrapartum care",5,null,"Women at low risk of complications are not offered amniotomy or oxytocin if labour is progressing normally.","Proportion of women at low risk of complications whose labour is progressing normally who do not have amniotomy or oxytocin.","Process","QS105 - Intrapartum care","5 - QS105 - Intrapartum care",1,"5 - QS105 - Intrapartum care - Process - 1","The number in the denominator who do not have amniotomy or oxytocin.","The number of women at low risk of complications whose labour is progressing normally."]
[null,"QS105","Intrapartum care",5,null,"Women at low risk of complications are not offered amniotomy or oxytocin if labour is progressing normally.","The number of women in labour that is progressing normally having amniotomy or oxytocin.","Outcome","QS105 - Intrapartum care","5 - QS105 - Intrapartum care",1,"5 - QS105 - Intrapartum care - Outcome - 1"]
[null,"QS105","Intrapartum care",5,null,"Women at low risk of complications are not offered amniotomy or oxytocin if labour is progressing normally.","Maternal satisfaction and experience of care.","Outcome","QS105 - Intrapartum care","5 - QS105 - Intrapartum care",2,"5 - QS105 - Intrapartum care - Outcome - 2"]
[null,"QS105","Intrapartum care",6,null,"Women do not have the cord clamped earlier than 1 minute after the birth unless there is concern about cord integrity or the baby’s heartbeat.","Evidence of local arrangements to ensure that midwives and obstetricians do not clamp the cord earlier than 1 minute after the birth unless there is a concern about cord integrity or the baby’s heartbeat.","Structure","QS105 - Intrapartum care","6 - QS105 - Intrapartum care",1,"6 - QS105 - Intrapartum care - Structure - 1"]
[null,"QS105","Intrapartum care",6,null,"Women do not have the cord clamped earlier than 1 minute after the birth unless there is concern about cord integrity or the baby’s heartbeat.","Proportion of cords clamped earlier than 1 minute after the birth where there is not a concern about cord integrity or the baby’s heartbeat.","Process","QS105 - Intrapartum care","6 - QS105 - Intrapartum care",1,"6 - QS105 - Intrapartum care - Process - 1","The number in the denominator where the cord is clamped after 1 minute after the birth.","The number of babies born where there is no concern about cord integrity or the baby’s heartbeat."]
[null,"QS105","Intrapartum care",6,null,"Women do not have the cord clamped earlier than 1 minute after the birth unless there is concern about cord integrity or the baby’s heartbeat.","Proportion of cords clamped earlier than 1 minute where there is a concern about cord integrity or the baby’s heartbeat.","Process","QS105 - Intrapartum care","6 - QS105 - Intrapartum care",2,"6 - QS105 - Intrapartum care - Process - 2","The number in the denominator where the cord is clamped earlier than 1 minute after the birth.","The number of babies born where there is a concern about cord integrity or the baby’s heartbeat."]
[null,"QS105","Intrapartum care",6,null,"Women do not have the cord clamped earlier than 1 minute after the birth unless there is concern about cord integrity or the baby’s heartbeat.","Maternal satisfaction and experience of care.","Outcome","QS105 - Intrapartum care","6 - QS105 - Intrapartum care",1,"6 - QS105 - Intrapartum care - Outcome - 1"]
[null,"QS105","Intrapartum care",7,null,"Women have skin-to-skin contact with their babies after the birth.","Evidence of local arrangements to ensure that midwives and obstetricians encourage women to have skin-to-skin contact with their babies after the birth.","Structure","QS105 - Intrapartum care","7 - QS105 - Intrapartum care",1,"7 - QS105 - Intrapartum care - Structure - 1"]
[null,"QS105","Intrapartum care",7,null,"Women have skin-to-skin contact with their babies after the birth.","Proportion of women with a record of having skin-to-skin contact with their babies after the birth.","Process","QS105 - Intrapartum care","7 - QS105 - Intrapartum care",1,"7 - QS105 - Intrapartum care - Process - 1","The number in the denominator where there is a record of the woman having skin-to-skin contact with the baby.","The number of babies born."]
[null,"QS105","Intrapartum care",7,null,"Women have skin-to-skin contact with their babies after the birth.","Women’s satisfaction with the support received to have skin-to-skin contact with their babies after the birth.","Outcome","QS105 - Intrapartum care","7 - QS105 - Intrapartum care",1,"7 - QS105 - Intrapartum care - Outcome - 1"]
[null,"QS106","Bladder cancer",1,null,"Adults who are having transurethral resection of bladder tumour (TURBT) have detrusor muscle obtained during the procedure.","Evidence of local arrangements to ensure that adults having TURBT have detrusor muscle obtained during the procedure.","Structure","QS106 - Bladder cancer","1 - QS106 - Bladder cancer",1,"1 - QS106 - Bladder cancer - Structure - 1"]
[null,"QS106","Bladder cancer",1,null,"Adults who are having transurethral resection of bladder tumour (TURBT) have detrusor muscle obtained during the procedure.","Proportion of TURBT procedures during which detrusor muscle was obtained.","Process","QS106 - Bladder cancer","1 - QS106 - Bladder cancer",1,"1 - QS106 - Bladder cancer - Process - 1","The number in the denominator in which detrusor muscle was taken at the time of performing the TURBT.","The number of TURBT procedures performed."]
[null,"QS106","Bladder cancer",2,null,"Adults with suspected bladder cancer are offered a single dose of intravesical mitomycin C, given at the same time as the first transurethral resection of bladder tumour (TURBT).","Evidence of local arrangements and written clinical protocols to ensure that adults with suspected bladder cancer who are having a first TURBT are offered a single dose of intravesical mitomycin C, given at the same time as the TURBT.","Structure","QS106 - Bladder cancer","2 - QS106 - Bladder cancer",1,"2 - QS106 - Bladder cancer - Structure - 1"]
[null,"QS106","Bladder cancer",2,null,"Adults with suspected bladder cancer are offered a single dose of intravesical mitomycin C, given at the same time as the first transurethral resection of bladder tumour (TURBT).","Proportion of first TURBT procedures in which adults with suspected bladder cancer are given a single dose of intravesical mitomycin C.","Process","QS106 - Bladder cancer","2 - QS106 - Bladder cancer",1,"2 - QS106 - Bladder cancer - Process - 1","The number in the denominator in which a single dose of intravesical mitomycin C is given.","The number of first TURBTs performed for adults with suspected bladder cancer."]
[null,"QS106","Bladder cancer",3,null,"Adults with bladder cancer have access to a designated clinical nurse specialist.","Evidence of local arrangements and written clinical protocols to ensure that designated clinical nurse specialists are accessible to adults with bladder cancer.","Structure","QS106 - Bladder cancer","3 - QS106 - Bladder cancer",1,"3 - QS106 - Bladder cancer - Structure - 1"]
[null,"QS106","Bladder cancer",3,null,"Adults with bladder cancer have access to a designated clinical nurse specialist.","Proportion of adults with bladder cancer who have a designated clinical nurse specialist.","Process","QS106 - Bladder cancer","3 - QS106 - Bladder cancer",1,"3 - QS106 - Bladder cancer - Process - 1","The number in the denominator who have a designated clinical nurse specialist.","The number of adults with bladder cancer in secondary care."]
[null,"QS106","Bladder cancer",3,null,"Adults with bladder cancer have access to a designated clinical nurse specialist.","Satisfaction with support received from a clinical nurse specialist, reported by adults with bladder cancer.","Outcome","QS106 - Bladder cancer","3 - QS106 - Bladder cancer",1,"3 - QS106 - Bladder cancer - Outcome - 1"]
[null,"QS106","Bladder cancer",4,null,"Adults with newly diagnosed non‑muscle‑invasive bladder cancer have a risk classification of their cancer completed.","Evidence of local arrangements and written clinical protocols to ensure that adults with newly diagnosed non muscle invasive bladder cancer have a risk classification of their cancer completed.","Structure","QS106 - Bladder cancer","4 - QS106 - Bladder cancer",1,"4 - QS106 - Bladder cancer - Structure - 1"]
[null,"QS106","Bladder cancer",4,null,"Adults with newly diagnosed non‑muscle‑invasive bladder cancer have a risk classification of their cancer completed.","Proportion of adults with newly diagnosed non muscle invasive bladder cancer who have a risk classification of their cancer completed.","Process","QS106 - Bladder cancer","4 - QS106 - Bladder cancer",1,"4 - QS106 - Bladder cancer - Process - 1","The number in the denominator who have a risk classification of their cancer completed.","The number of adults with a new diagnosis of non‑muscle‑invasive bladder cancer."]
[null,"QS106","Bladder cancer",5,null,"Adults with high‑risk non‑muscle‑invasive bladder cancer discuss intravesical Bacille Calmette‑Guérin (BCG) and radical cystectomy with a urologist who performs both treatments and a clinical nurse specialist.","Evidence of local arrangements and written clinical protocols to ensure that adults with high risk non muscle invasive bladder cancer discuss intravesical BCG and radical cystectomy with a urologist who performs both treatments and a clinical nurse specialist before a treatment option is agreed.","Structure","QS106 - Bladder cancer","5 - QS106 - Bladder cancer",1,"5 - QS106 - Bladder cancer - Structure - 1"]
[null,"QS106","Bladder cancer",5,null,"Adults with high‑risk non‑muscle‑invasive bladder cancer discuss intravesical Bacille Calmette‑Guérin (BCG) and radical cystectomy with a urologist who performs both treatments and a clinical nurse specialist.","Proportion of adults with high risk non muscle invasive bladder cancer who discuss intravesical BCG and radical cystectomy with a urologist who performs both treatments and a clinical nurse specialist before agreeing a treatment option. ","Process","QS106 - Bladder cancer","5 - QS106 - Bladder cancer",1,"5 - QS106 - Bladder cancer - Process - 1","The number in the denominator who have a discussion about intravesical BCG and radical cystectomy with a urologist who performs both treatments and a clinical nurse specialist before agreeing a treatment option.","The number of adults with newly diagnosed high‑risk non‑muscle‑invasive bladder cancer."]
[null,"QS106","Bladder cancer",5,null,"Adults with high‑risk non‑muscle‑invasive bladder cancer discuss intravesical Bacille Calmette‑Guérin (BCG) and radical cystectomy with a urologist who performs both treatments and a clinical nurse specialist.","Satisfaction with explanation of treatment options reported by adults with high risk non muscle invasive bladder cancer. ","Outcome","QS106 - Bladder cancer","5 - QS106 - Bladder cancer",1,"5 - QS106 - Bladder cancer - Outcome - 1"]
[null,"QS106","Bladder cancer",6,null,"Adults with muscle‑invasive urothelial bladder cancer discuss neoadjuvant chemotherapy, radical cystectomy and radiotherapy using a radiosensitiser with a urologist who performs radical cystectomy, a clinical oncologist and a clinical nurse specialist.","Evidence of local arrangements and written clinical protocols to ensure that adults with muscle invasive urothelial bladder cancer discuss neoadjuvant chemotherapy, radical cystectomy and radiotherapy using a radiosensitiser with a urologist who performs radical cystectomy, a clinical oncologist and a clinical nurse specialist. ","Structure","QS106 - Bladder cancer","6 - QS106 - Bladder cancer",1,"6 - QS106 - Bladder cancer - Structure - 1"]
[null,"QS106","Bladder cancer",6,null,"Adults with muscle‑invasive urothelial bladder cancer discuss neoadjuvant chemotherapy, radical cystectomy and radiotherapy using a radiosensitiser with a urologist who performs radical cystectomy, a clinical oncologist and a clinical nurse specialist.","Proportion of adults with muscle invasive urothelial bladder cancer who discuss neoadjuvant chemotherapy, radical cystectomy and radiotherapy using a radiosensitiser with a urologist who performs radical cystectomy, a clinical oncologist and a clinical nurse specialist before agreeing a treatment option. ","Process","QS106 - Bladder cancer","6 - QS106 - Bladder cancer",1,"6 - QS106 - Bladder cancer - Process - 1","The number in the denominator who have a discussion about neoadjuvant chemotherapy, radical cystectomy and radiotherapy using a radiosensitiser with a urologist who performs radical cystectomy, a clinical oncologist and a clinical nurse specialist before agreeing a treatment option.","The number of adults with muscle‑invasive urothelial bladder cancer."]
[null,"QS106","Bladder cancer",6,null,"Adults with muscle‑invasive urothelial bladder cancer discuss neoadjuvant chemotherapy, radical cystectomy and radiotherapy using a radiosensitiser with a urologist who performs radical cystectomy, a clinical oncologist and a clinical nurse specialist.","Satisfaction with explanation of treatment options reported by adults with muscle invasive urothelial bladder cancer.","Outcome","QS106 - Bladder cancer","6 - QS106 - Bladder cancer",1,"6 - QS106 - Bladder cancer - Outcome - 1"]
[null,"QS106","Bladder cancer",7,null,"Adults who have had low‑risk non‑muscle‑invasive bladder cancer and who have no recurrence of the bladder cancer within 12 months of their initial transurethral resection of bladder tumour (TURBT) are discharged to primary care.","Evidence of local arrangements for adults who have had low risk non muscle invasive bladder cancer and who have no recurrence of the bladder cancer within 12 months of their initial TURBT to be discharged to primary care.","Structure","QS106 - Bladder cancer","7 - QS106 - Bladder cancer",1,"7 - QS106 - Bladder cancer - Structure - 1"]
[null,"QS106","Bladder cancer",7,null,"Adults who have had low‑risk non‑muscle‑invasive bladder cancer and who have no recurrence of the bladder cancer within 12 months of their initial transurethral resection of bladder tumour (TURBT) are discharged to primary care.","Proportion of adults who have had low risk non muscle invasive bladder cancer and who have no recurrence of the bladder cancer within 12 months of their initial TURBT who are discharged to primary care.","Process","QS106 - Bladder cancer","7 - QS106 - Bladder cancer",1,"7 - QS106 - Bladder cancer - Process - 1","The number in the denominator who are discharged to primary care.","The number of adults who have had low‑risk non‑muscle‑invasive bladder cancer who have no recurrence of the bladder cancer within 12 months of their initial TURBT."]
[null,"QS106","Bladder cancer",7,null,"Adults who have had low‑risk non‑muscle‑invasive bladder cancer and who have no recurrence of the bladder cancer within 12 months of their initial transurethral resection of bladder tumour (TURBT) are discharged to primary care.","Satisfaction with discharge to primary care reported by adults who have had low risk non muscle  invasive bladder cancer.","Outcome","QS106 - Bladder cancer","7 - QS106 - Bladder cancer",1,"7 - QS106 - Bladder cancer - Outcome - 1"]
[null,"QS107","Preventing unintentional injury in under 15s",1,null,"Local authority areas have a person responsible for coordinating action to prevent unintentional injuries in children and young people (under 15) in the home.","Evidence that there is a designated person responsible for coordinating action among local authority departments, local NHS organisations and other local agencies to prevent unintentional injuries in children and young people (under 15) in the home.","Structure","QS107 - Preventing unintentional injury in under 15s","1 - QS107 - Preventing unintentional injury in under 15s",1,"1 - QS107 - Preventing unintentional injury in under 15s - Structure - 1"]
[null,"QS107","Preventing unintentional injury in under 15s",1,null,"Local authority areas have a person responsible for coordinating action to prevent unintentional injuries in children and young people (under 15) in the home.","Evidence that local authority departments, local NHS organisations and other local agencies work in collaboration with a person responsible for coordinating local action to prevent unintentional injuries in children and young people (under 15) in the home.","Structure","QS107 - Preventing unintentional injury in under 15s","1 - QS107 - Preventing unintentional injury in under 15s",2,"1 - QS107 - Preventing unintentional injury in under 15s - Structure - 2"]
[null,"QS107","Preventing unintentional injury in under 15s",2,null,"Households in which children and young people (under 15) are at greater risk of unintentional injury in the home are identified through collaboration between local agencies for a structured home safety assessment.","Evidence of a local strategy to ensure that households in which children and young people (under 15) may be at greater risk of unintentional injury in the home are identified through collaboration between local agencies for a structured home safety assessment.","Structure","QS107 - Preventing unintentional injury in under 15s","2 - QS107 - Preventing unintentional injury in under 15s",1,"2 - QS107 - Preventing unintentional injury in under 15s - Structure - 1"]
[null,"QS107","Preventing unintentional injury in under 15s",2,null,"Households in which children and young people (under 15) are at greater risk of unintentional injury in the home are identified through collaboration between local agencies for a structured home safety assessment.","Evidence that local authority departments, local NHS organisations and other local agencies collaborate to implement a local strategy to ensure that households in which children and young people (under 15) may be at greater risk of unintentional injury in the home are identified for a structured home safety assessment.","Structure","QS107 - Preventing unintentional injury in under 15s","2 - QS107 - Preventing unintentional injury in under 15s",2,"2 - QS107 - Preventing unintentional injury in under 15s - Structure - 2"]
[null,"QS107","Preventing unintentional injury in under 15s",2,null,"Households in which children and young people (under 15) are at greater risk of unintentional injury in the home are identified through collaboration between local agencies for a structured home safety assessment.","Evidence that local authority departments, local NHS organisations and other local agencies collaborate to identify households in which children and young people (under 15) may be at greater risk of unintentional injury in the home.","Structure","QS107 - Preventing unintentional injury in under 15s","2 - QS107 - Preventing unintentional injury in under 15s",3,"2 - QS107 - Preventing unintentional injury in under 15s - Structure - 3"]
[null,"QS107","Preventing unintentional injury in under 15s",2,null,"Households in which children and young people (under 15) are at greater risk of unintentional injury in the home are identified through collaboration between local agencies for a structured home safety assessment.","Evidence that local authority departments, local NHS organisations and other local agencies collaborate to identify neighbourhoods and population groups in which children and young people (under 15) may be at greater risk of unintentional injury in the home.","Structure","QS107 - Preventing unintentional injury in under 15s","2 - QS107 - Preventing unintentional injury in under 15s",4,"2 - QS107 - Preventing unintentional injury in under 15s - Structure - 4"]
[null,"QS107","Preventing unintentional injury in under 15s",2,null,"Households in which children and young people (under 15) are at greater risk of unintentional injury in the home are identified through collaboration between local agencies for a structured home safety assessment.","Number of households identified in which children and young people (under 15) may be at greater risk of unintentional injury in the home.","Outcome","QS107 - Preventing unintentional injury in under 15s","2 - QS107 - Preventing unintentional injury in under 15s",1,"2 - QS107 - Preventing unintentional injury in under 15s - Outcome - 1"]
[null,"QS107","Preventing unintentional injury in under 15s",3,null,"Households in which children and young people (under 15) have been identified as being at greater risk of unintentional injury in the home have a structured home safety assessment.","Evidence of local arrangements for households in which children and young people (under 15) have been identified as being at greater risk of unintentional injury in the home to have a structured home safety assessment.","Structure","QS107 - Preventing unintentional injury in under 15s","3 - QS107 - Preventing unintentional injury in under 15s",1,"3 - QS107 - Preventing unintentional injury in under 15s - Structure - 1"]
[null,"QS107","Preventing unintentional injury in under 15s",3,null,"Households in which children and young people (under 15) have been identified as being at greater risk of unintentional injury in the home have a structured home safety assessment.","Proportion of households in which children and young people (under 15) have been identified as being at greater risk of unintentional injury in the home that have a structured home safety assessment.","Process","QS107 - Preventing unintentional injury in under 15s","3 - QS107 - Preventing unintentional injury in under 15s",1,"3 - QS107 - Preventing unintentional injury in under 15s - Process - 1","The number in the denominator that have a structured home safety assessment.","The number of households in which children and young people (under 15) have been identified as being at greater risk of unintentional injury in the home."]
[null,"QS107","Preventing unintentional injury in under 15s",4,null,"Households with children and young people (under 15) that have had a structured home safety assessment at which risks have been identified receive tailored advice or support to reduce the risks.","Evidence of local arrangements for households with children and young people (under 15) that have had a structured home safety assessment at which risks have been identified to receive tailored advice or support to reduce the risks.","Structure","QS107 - Preventing unintentional injury in under 15s","4 - QS107 - Preventing unintentional injury in under 15s",1,"4 - QS107 - Preventing unintentional injury in under 15s - Structure - 1"]
[null,"QS107","Preventing unintentional injury in under 15s",4,null,"Households with children and young people (under 15) that have had a structured home safety assessment at which risks have been identified receive tailored advice or support to reduce the risks.","Proportion of households having a structured home safety assessment of the risk of unintentional injuries to children and young people (under 15) in which risks are identified.","Process","QS107 - Preventing unintentional injury in under 15s","4 - QS107 - Preventing unintentional injury in under 15s",1,"4 - QS107 - Preventing unintentional injury in under 15s - Process - 1","The number in the denominator in which risks are identified.","The number of households having a structured home safety assessment of the risk of unintentional injuries to children and young people (under 15)."]
[null,"QS107","Preventing unintentional injury in under 15s",4,null,"Households with children and young people (under 15) that have had a structured home safety assessment at which risks have been identified receive tailored advice or support to reduce the risks.","Proportion of households in which risks of unintentional injuries to children and young people (under 15) are identified by a structured home safety assessment that receive tailored advice to reduce risks identified.","Process","QS107 - Preventing unintentional injury in under 15s","4 - QS107 - Preventing unintentional injury in under 15s",2,"4 - QS107 - Preventing unintentional injury in under 15s - Process - 2","The number in the denominator that receive tailored advice to reduce risks identified.","The number of households in which risks of unintentional injuries to children and young people (under 15) are identified by a structured home safety assessment."]
[null,"QS107","Preventing unintentional injury in under 15s",4,null,"Households with children and young people (under 15) that have had a structured home safety assessment at which risks have been identified receive tailored advice or support to reduce the risks.","Proportion of households in which risks of unintentional injuries to children and young people (under 15) are identified by a structured home safety assessment that receive follow‑up support to reduce risks identified.","Process","QS107 - Preventing unintentional injury in under 15s","4 - QS107 - Preventing unintentional injury in under 15s",3,"4 - QS107 - Preventing unintentional injury in under 15s - Process - 3","The number in the denominator that receive follow‑up support to reduce risks identified.","The number of households in which risks of unintentional injuries to children and young people (under 15) are identified by a structured home safety assessment."]
[null,"QS107","Preventing unintentional injury in under 15s",4,null,"Households with children and young people (under 15) that have had a structured home safety assessment at which risks have been identified receive tailored advice or support to reduce the risks.","Incidence of unintentional injuries in children and young people (under 15) occurring in the home.","Outcome","QS107 - Preventing unintentional injury in under 15s","4 - QS107 - Preventing unintentional injury in under 15s",1,"4 - QS107 - Preventing unintentional injury in under 15s - Outcome - 1"]
[null,"QS107","Preventing unintentional injury in under 15s",5,null,"Households with children and young people (under 15) receive advice on home safety or are referred for a structured home safety assessment by practitioners providing family support on home visits who identify risks of unintentional injury.","Evidence of local arrangements to ensure that households with children and young people (under 15) receive advice on home safety or are referred for a structured home safety assessment by practitioners providing family support on home visits who identify risks of unintentional injury.","Structure","QS107 - Preventing unintentional injury in under 15s","5 - QS107 - Preventing unintentional injury in under 15s",1,"5 - QS107 - Preventing unintentional injury in under 15s - Structure - 1"]
[null,"QS107","Preventing unintentional injury in under 15s",5,null,"Households with children and young people (under 15) receive advice on home safety or are referred for a structured home safety assessment by practitioners providing family support on home visits who identify risks of unintentional injury.","Proportion of households with children and young people (under 15) that receive advice on home safety from practitioners providing family support on home visits who identify risks of unintentional injury.","Process","QS107 - Preventing unintentional injury in under 15s","5 - QS107 - Preventing unintentional injury in under 15s",1,"5 - QS107 - Preventing unintentional injury in under 15s - Process - 1","The number in the denominator that receive advice on home safety.","The number of households with children and young people (under 15) in which risks of unintentional injury are identified by practitioners providing family support on home visits."]
[null,"QS107","Preventing unintentional injury in under 15s",5,null,"Households with children and young people (under 15) receive advice on home safety or are referred for a structured home safety assessment by practitioners providing family support on home visits who identify risks of unintentional injury.","Proportion of households with children and young people (under 15) that are referred for a structured home safety assessment by practitioners providing family support on home visits who identify risks of unintentional injury.","Process","QS107 - Preventing unintentional injury in under 15s","5 - QS107 - Preventing unintentional injury in under 15s",2,"5 - QS107 - Preventing unintentional injury in under 15s - Process - 2","The number in the denominator that are referred for a structured home safety assessment.","The number of households with children and young people (under 15) in which risks of unintentional injury are identified by practitioners providing family support on home visits."]
[null,"QS107","Preventing unintentional injury in under 15s",5,null,"Households with children and young people (under 15) receive advice on home safety or are referred for a structured home safety assessment by practitioners providing family support on home visits who identify risks of unintentional injury.","Number of referrals for structured home safety assessments in households with children and young people (under 15).","Outcome","QS107 - Preventing unintentional injury in under 15s","5 - QS107 - Preventing unintentional injury in under 15s",1,"5 - QS107 - Preventing unintentional injury in under 15s - Outcome - 1"]
[null,"QS108","Multiple sclerosis",1,null,"Adults with multiple sclerosis (MS) are given support at the time of diagnosis to understand the condition, its progression and the ways it can be managed, by the consultant neurologist making the diagnosis.","Evidence of local arrangements to ensure that adults with MS are supported at the time of diagnosis to understand the condition, its progression and the ways it can be managed, by the consultant neurologist making the diagnosis.","Structure","QS108 - Multiple sclerosis","1 - QS108 - Multiple sclerosis",1,"1 - QS108 - Multiple sclerosis - Structure - 1"]
[null,"QS108","Multiple sclerosis",1,null,"Adults with multiple sclerosis (MS) are given support at the time of diagnosis to understand the condition, its progression and the ways it can be managed, by the consultant neurologist making the diagnosis.","Proportion of adults with MS who are given information about MS, its progression and the ways it can be managed by the consultant neurologist at the time of diagnosis.","Process","QS108 - Multiple sclerosis","1 - QS108 - Multiple sclerosis",1,"1 - QS108 - Multiple sclerosis - Process - 1","The number in the denominator who are given information about the condition by the consultant neurologist at the time of diagnosis.","The number of adults receiving a new diagnosis of MS from a consultant neurologist."]
[null,"QS108","Multiple sclerosis",1,null,"Adults with multiple sclerosis (MS) are given support at the time of diagnosis to understand the condition, its progression and the ways it can be managed, by the consultant neurologist making the diagnosis.","Patient satisfaction with the support provided at diagnosis.","Outcome","QS108 - Multiple sclerosis","1 - QS108 - Multiple sclerosis",1,"1 - QS108 - Multiple sclerosis - Outcome - 1"]
[null,"QS108","Multiple sclerosis",2,null,"Adults with multiple sclerosis (MS) are offered a face‑to‑face follow‑up appointment with a healthcare professional with expertise in MS, to take place within 6 weeks of diagnosis.","Evidence of local arrangements to ensure that adults with MS have a face‑to‑face follow‑up appointment with a healthcare professional with expertise in MS within 6 weeks of diagnosis.","Structure","QS108 - Multiple sclerosis","2 - QS108 - Multiple sclerosis",1,"2 - QS108 - Multiple sclerosis - Structure - 1"]
[null,"QS108","Multiple sclerosis",2,null,"Adults with multiple sclerosis (MS) are offered a face‑to‑face follow‑up appointment with a healthcare professional with expertise in MS, to take place within 6 weeks of diagnosis.","Proportion of adults with MS who have a face‑to‑face follow‑up appointment with a healthcare professional with expertise in MS within 6 weeks of diagnosis.","Process","QS108 - Multiple sclerosis","2 - QS108 - Multiple sclerosis",1,"2 - QS108 - Multiple sclerosis - Process - 1","The number in the denominator who have a face‑to‑face follow‑up appointment with a healthcare professional with expertise in MS within 6 weeks of diagnosis.","The number of adults receiving a new diagnosis of MS."]
[null,"QS108","Multiple sclerosis",3,null,"Adults with multiple sclerosis (MS) have a single point of contact who coordinates access to care from a multidisciplinary team with expertise in MS.","Evidence of local arrangements to provide adults with MS with a single point of contact with knowledge of MS services who coordinates access to care from a multidisciplinary team with expertise in MS.","Structure","QS108 - Multiple sclerosis","3 - QS108 - Multiple sclerosis",1,"3 - QS108 - Multiple sclerosis - Structure - 1"]
[null,"QS108","Multiple sclerosis",3,null,"Adults with multiple sclerosis (MS) have a single point of contact who coordinates access to care from a multidisciplinary team with expertise in MS.","Evidence of local arrangements for a multidisciplinary team with expertise in MS to care for adults with MS.","Structure","QS108 - Multiple sclerosis","3 - QS108 - Multiple sclerosis",2,"3 - QS108 - Multiple sclerosis - Structure - 2"]
[null,"QS108","Multiple sclerosis",3,null,"Adults with multiple sclerosis (MS) have a single point of contact who coordinates access to care from a multidisciplinary team with expertise in MS.","Proportion of adults with MS with a single point of contact who coordinates access to care from a multidisciplinary team with expertise in MS.","Process","QS108 - Multiple sclerosis","3 - QS108 - Multiple sclerosis",1,"3 - QS108 - Multiple sclerosis - Process - 1","The number in the denominator with a single point of contact who coordinates access to care from a multidisciplinary team with expertise in MS.","The number of adults with MS."]
[null,"QS108","Multiple sclerosis",3,null,"Adults with multiple sclerosis (MS) have a single point of contact who coordinates access to care from a multidisciplinary team with expertise in MS.","Patient satisfaction with a single point of contact for coordination of access to care.","Outcome","QS108 - Multiple sclerosis","3 - QS108 - Multiple sclerosis",1,"3 - QS108 - Multiple sclerosis - Outcome - 1"]
[null,"QS108","Multiple sclerosis",3,null,"Adults with multiple sclerosis (MS) have a single point of contact who coordinates access to care from a multidisciplinary team with expertise in MS.","Patient satisfaction with timeliness of access to care from the multidisciplinary team with expertise in MS.","Outcome","QS108 - Multiple sclerosis","3 - QS108 - Multiple sclerosis",2,"3 - QS108 - Multiple sclerosis - Outcome - 2"]
[null,"QS108","Multiple sclerosis",4,null,"Adults with multiple sclerosis (MS) who have problems with mobility or fatigue are offered support to remain physically active.","Evidence of local arrangements to ensure that adults with MS who have problems with mobility or fatigue are supported to remain physically active.","Structure","QS108 - Multiple sclerosis",{"$f":"CONCATENATE(D2366, \" - \", I2366)","v":"4 - QS108 - Multiple sclerosis"},{"$f":"IF(AND(B2366=B2365, D2366=D2365, H2366=H2365)=TRUE, K2365+1, 1)","v":1},{"$f":"CONCATENATE(J2366, \" - \", H2366, \" - \",K2366)","v":"4 - QS108 - Multiple sclerosis - Structure - 1"}]
[null,"QS108","Multiple sclerosis",4,null,"Adults with multiple sclerosis (MS) who have problems with mobility or fatigue are offered support to remain physically active.","Proportion of adults with MS who are offered support to remain physically active.","Process","QS108 - Multiple sclerosis","4 - QS108 - Multiple sclerosis",1,"4 - QS108 - Multiple sclerosis - Process - 1","The number in the denominator who are offered support to remain physically active.","The number of adults with MS who have problems with mobility or fatigue."]
[null,"QS108","Multiple sclerosis",4,null,"Adults with multiple sclerosis (MS) who have problems with mobility or fatigue are offered support to remain physically active.","Adults with MS who have problems with mobility or fatigue feel supported by healthcare professionals to remain physically active.","Outcome","QS108 - Multiple sclerosis","4 - QS108 - Multiple sclerosis",1,"4 - QS108 - Multiple sclerosis - Outcome - 1"]
[null,"QS108","Multiple sclerosis",4,null,"Adults with multiple sclerosis (MS) who have problems with mobility or fatigue are offered support to remain physically active.","Levels of physical activity among adults with MS.","Outcome","QS108 - Multiple sclerosis","4 - QS108 - Multiple sclerosis",2,"4 - QS108 - Multiple sclerosis - Outcome - 2"]
[null,"QS108","Multiple sclerosis",5,null,"Adults with multiple sclerosis (MS) who have a relapse that would benefit from treatment are offered treatment as soon as possible and within 14 days of the onset of symptoms.","Evidence of local pathways to ensure that adults with MS who have a relapse that would benefit from treatment are offered treatment as soon as possible and within 14 days of the onset of symptoms.","Structure","QS108 - Multiple sclerosis","5 - QS108 - Multiple sclerosis",1,"5 - QS108 - Multiple sclerosis - Structure - 1"]
[null,"QS108","Multiple sclerosis",5,null,"Adults with multiple sclerosis (MS) who have a relapse that would benefit from treatment are offered treatment as soon as possible and within 14 days of the onset of symptoms.","Length of time between onset of symptoms of relapse and receiving treatment for adults with MS.","Process",{"$f":"CONCATENATE(B2371, \" - \", C2371)","v":"QS108 - Multiple sclerosis"},"5 - QS108 - Multiple sclerosis",1,"5 - QS108 - Multiple sclerosis - Process - 1","To be determined by local data collection","To be determined by local data collection"]
[null,"QS108","Multiple sclerosis",5,null,"Adults with multiple sclerosis (MS) who have a relapse that would benefit from treatment are offered treatment as soon as possible and within 14 days of the onset of symptoms.","Proportion of relapses in adults with MS that would benefit from treatment and are treated within 14 days of the onset of symptoms.","Process","QS108 - Multiple sclerosis","5 - QS108 - Multiple sclerosis",2,"5 - QS108 - Multiple sclerosis - Process - 2","The number in the denominator treated within 14 days of the onset of symptoms.","The number of relapses in adults with MS that would benefit from treatment."]
[null,"QS108","Multiple sclerosis",5,null,"Adults with multiple sclerosis (MS) who have a relapse that would benefit from treatment are offered treatment as soon as possible and within 14 days of the onset of symptoms.","Unplanned hospital admissions for MS.","Outcome","QS108 - Multiple sclerosis","5 - QS108 - Multiple sclerosis",1,"5 - QS108 - Multiple sclerosis - Outcome - 1"]
[null,"QS108","Multiple sclerosis",6,null,"Adults with multiple sclerosis (MS) are offered a comprehensive review at least once a year by healthcare professionals with expertise in MS.","Evidence of local arrangements to ensure that adults with MS are offered a comprehensive review at least once a year by healthcare professionals with expertise in MS.","Structure","QS108 - Multiple sclerosis","6 - QS108 - Multiple sclerosis",1,"6 - QS108 - Multiple sclerosis - Structure - 1"]
[null,"QS108","Multiple sclerosis",6,null,"Adults with multiple sclerosis (MS) are offered a comprehensive review at least once a year by healthcare professionals with expertise in MS.","Proportion of adults with MS who have a comprehensive review by healthcare professionals with expertise in MS within 12 months of the previous review or diagnosis.","Process","QS108 - Multiple sclerosis","6 - QS108 - Multiple sclerosis",1,"6 - QS108 - Multiple sclerosis - Process - 1","The number in the denominator who have a comprehensive review by healthcare professionals with expertise in MS within 12 months of the previous review or diagnosis.","The number of adults with MS."]
[null,"QS109","Diabetes in pregnancy",1,null,"Women with diabetes who are of childbearing potential are offered preconception planning advice at diabetes care reviews.","Proportion of women with diabetes who are of childbearing potential and attend a diabetes care review who are offered advice about preconception planning.","Process","QS109 - Diabetes in pregnancy","1 - QS109 - Diabetes in pregnancy",1,"1 - QS109 - Diabetes in pregnancy - Process - 1","The number in the denominator who are offered advice about preconception planning.","The number of women with diabetes who are of childbearing potential and attend a diabetes care review."]
[null,"QS109","Diabetes in pregnancy",1,null,"Women with diabetes who are of childbearing potential are offered preconception planning advice at diabetes care reviews.","Percentage of pregnancies in women with diabetes where 5 mg folic acid was taken at the time of the last menstrual period.","Outcome","QS109 - Diabetes in pregnancy","1 - QS109 - Diabetes in pregnancy",1,"1 - QS109 - Diabetes in pregnancy - Outcome - 1"]
[null,"QS109","Diabetes in pregnancy",1,null,"Women with diabetes who are of childbearing potential are offered preconception planning advice at diabetes care reviews.","Percentage of pregnancies in women with diabetes who had early pregnancy HbA1c less than 48 mmol/mol.","Outcome","QS109 - Diabetes in pregnancy","1 - QS109 - Diabetes in pregnancy",2,"1 - QS109 - Diabetes in pregnancy - Outcome - 2"]
[null,"QS109","Diabetes in pregnancy",1,null,"Women with diabetes who are of childbearing potential are offered preconception planning advice at diabetes care reviews.","Percentage of women with diabetes who were well-prepared for pregnancy.","Outcome","QS109 - Diabetes in pregnancy","1 - QS109 - Diabetes in pregnancy",3,"1 - QS109 - Diabetes in pregnancy - Outcome - 3"]
[null,"QS109","Diabetes in pregnancy",2,null,"Women with pre-existing diabetes are seen by members of the joint diabetes and antenatal care team as soon as possible after informing their healthcare professional that they are pregnant.","Proportion of women with pre-existing diabetes who are seen by members of the joint diabetes and antenatal care team by 10 weeks' gestation.","Process","QS109 - Diabetes in pregnancy","2 - QS109 - Diabetes in pregnancy",1,"2 - QS109 - Diabetes in pregnancy - Process - 1","The number in the denominator who are seen by members of the joint diabetes and antenatal care team by 10 weeks' gestation.","The number of pregnant women with pre-existing diabetes."]
[null,"QS109","Diabetes in pregnancy",2,null,"Women with pre-existing diabetes are seen by members of the joint diabetes and antenatal care team as soon as possible after informing their healthcare professional that they are pregnant.","Average wait time for pregnant women with pre-existing diabetes to be seen by members of the joint diabetes and antenatal care team following referral.","Process","QS109 - Diabetes in pregnancy","2 - QS109 - Diabetes in pregnancy",2,"2 - QS109 - Diabetes in pregnancy - Process - 2"]
[null,"QS109","Diabetes in pregnancy",2,null,"Women with pre-existing diabetes are seen by members of the joint diabetes and antenatal care team as soon as possible after informing their healthcare professional that they are pregnant.","Proportion of women with pre-existing diabetes who have had a review of their medication to ensure it is pregnancy appropriate by 10 weeks' gestation.","Outcome","QS109 - Diabetes in pregnancy","2 - QS109 - Diabetes in pregnancy",1,"2 - QS109 - Diabetes in pregnancy - Outcome - 1","The number in the denominator who have had a review of their medication to ensure it is pregnancy appropriate by 10 weeks' gestation.","The number of pregnant women with pre‑existing diabetes."]
[null,"QS109","Diabetes in pregnancy",2,null,"Women with pre-existing diabetes are seen by members of the joint diabetes and antenatal care team as soon as possible after informing their healthcare professional that they are pregnant.","Optimal diabetes care in pregnancy.","Outcome","QS109 - Diabetes in pregnancy","2 - QS109 - Diabetes in pregnancy",2,"2 - QS109 - Diabetes in pregnancy - Outcome - 2"]
[null,"QS109","Diabetes in pregnancy",3,null,"Pregnant women with type 1 diabetes are offered continuous glucose monitoring.","Proportion of pregnant women with type 1 diabetes who use CGM.","Process","QS109 - Diabetes in pregnancy","3 - QS109 - Diabetes in pregnancy",1,"3 - QS109 - Diabetes in pregnancy - Process - 1","The number in the denominator who use CGM.","The number of pregnant women with type 1 diabetes."]
[null,"QS109","Diabetes in pregnancy",3,null,"Pregnant women with type 1 diabetes are offered continuous glucose monitoring.","Adverse foetal and neonatal outcomes for babies of women with diabetes.","Outcome","QS109 - Diabetes in pregnancy","3 - QS109 - Diabetes in pregnancy",1,"3 - QS109 - Diabetes in pregnancy - Outcome - 1"]
[null,"QS109","Diabetes in pregnancy",3,null,"Pregnant women with type 1 diabetes are offered continuous glucose monitoring.","Time in range during pregnancy for women with diabetes.","Outcome","QS109 - Diabetes in pregnancy","3 - QS109 - Diabetes in pregnancy",2,"3 - QS109 - Diabetes in pregnancy - Outcome - 2"]
[null,"QS109","Diabetes in pregnancy",3,null,"Pregnant women with type 1 diabetes are offered continuous glucose monitoring.","Maternal diabetic complications.","Outcome","QS109 - Diabetes in pregnancy","3 - QS109 - Diabetes in pregnancy",3,"3 - QS109 - Diabetes in pregnancy - Outcome - 3"]
[null,"QS109","Diabetes in pregnancy",4,null,"Women diagnosed with gestational diabetes are offered postnatal testing of blood glucose levels and referred to the National Diabetes Prevention Programme if eligible.","Proportion of women who were diagnosed with gestational diabetes who had a blood test to exclude persisting hyperglycaemia after the birth, before they were transferred to community care.","Process","QS109 - Diabetes in pregnancy","4 - QS109 - Diabetes in pregnancy",1,"4 - QS109 - Diabetes in pregnancy - Process - 1","The number in the denominator who had a blood test to exclude persisting hyperglycaemia after the birth, before they were transferred to community care.","The number of women who were diagnosed with gestational diabetes."]
[null,"QS109","Diabetes in pregnancy",4,null,"Women diagnosed with gestational diabetes are offered postnatal testing of blood glucose levels and referred to the National Diabetes Prevention Programme if eligible.","Proportion of women who were diagnosed with gestational diabetes and whose blood glucose levels returned to normal after the birth who had a fasting plasma glucose test at 6 to 13 weeks after the birth.","Process","QS109 - Diabetes in pregnancy","4 - QS109 - Diabetes in pregnancy",2,"4 - QS109 - Diabetes in pregnancy - Process - 2","The number in the denominator who had a fasting plasma glucose test 6 to 13 weeks after the birth.","The number of women who were diagnosed with gestational diabetes whose blood glucose levels returned to normal after the birth."]
[null,"QS109","Diabetes in pregnancy",4,null,"Women diagnosed with gestational diabetes are offered postnatal testing of blood glucose levels and referred to the National Diabetes Prevention Programme if eligible.","Proportion of women with gestational diabetes who gave birth in the previous 12 months and whose blood glucose levels returned to normal after the birth who were referred into the National Diabetes Prevention Programme.","Process","QS109 - Diabetes in pregnancy","4 - QS109 - Diabetes in pregnancy",3,"4 - QS109 - Diabetes in pregnancy - Process - 3","The number in the denominator who were referred into the National Diabetes Prevention Programme.","The number of women who had gestational diabetes who gave birth in the previous 12 months and whose blood glucose levels returned to normal after the birth."]
[null,"QS109","Diabetes in pregnancy",4,null,"Women diagnosed with gestational diabetes are offered postnatal testing of blood glucose levels and referred to the National Diabetes Prevention Programme if eligible.","Early identification of pre-existing type 1 diabetes in women who were diagnosed with gestational diabetes.","Outcome","QS109 - Diabetes in pregnancy","4 - QS109 - Diabetes in pregnancy",1,"4 - QS109 - Diabetes in pregnancy - Outcome - 1"]
[null,"QS109","Diabetes in pregnancy",4,null,"Women diagnosed with gestational diabetes are offered postnatal testing of blood glucose levels and referred to the National Diabetes Prevention Programme if eligible.","Rates of type 2 diabetes in women diagnosed with gestational diabetes.","Outcome","QS109 - Diabetes in pregnancy","4 - QS109 - Diabetes in pregnancy",2,"4 - QS109 - Diabetes in pregnancy - Outcome - 2"]
[null,"QS109","Diabetes in pregnancy",5,null,"Women diagnosed with gestational diabetes who have negative postnatal testing for diabetes after the birth are offered annual HbA1c testing.","Proportion of women with a record of gestational diabetes and no subsequent diagnosis of diabetes who had a HbA1c test in the previous 12 months.","Process","QS109 - Diabetes in pregnancy","5 - QS109 - Diabetes in pregnancy",1,"5 - QS109 - Diabetes in pregnancy - Process - 1","The number in the denominator who had a HbA1c test in the previous 12 months.","The number of women who gave birth more than 12 months ago with a record of gestational diabetes and no subsequent diagnosis of diabetes."]
[null,null,null,null,null,null,null,null," - "," -  - ",1," -  -  -  - 1"]
[null,null,null,null,null,null,null,null," - "," -  - ",2," -  -  -  - 2"]
[null,null,null,null,null,null,null,null," - "," -  - ",3," -  -  -  - 3"]
[null,null,null,null,null,null,null,null," - "," -  - ",4," -  -  -  - 4"]
[null,null,null,null,null,null,null,null," - "," -  - ",5," -  -  -  - 5"]
[null,null,null,null,null,null,null,null," - "," -  - ",6," -  -  -  - 6"]
[null,null,null,null,null,null,null,null," - "," -  - ",7," -  -  -  - 7"]
[null,null,null,null,null,null,null,null," - "," -  - ",8," -  -  -  - 8"]
[null,null,null,null,null,null,null,null," - "," -  - ",9," -  -  -  - 9"]
[null,null,null,null,null,null,null,null," - "," -  - ",10," -  -  -  - 10"]
[null,null,null,null,null,null,null,null," - "," -  - ",11," -  -  -  - 11"]
[null,null,null,null,null,null,null,null," - "," -  - ",12," -  -  -  - 12"]
[null,null,null,null,null,null,null,null," - "," -  - ",13," -  -  -  - 13"]
[null,null,null,null,null,null,null,null," - "," -  - ",14," -  -  -  - 14"]
[null,null,null,null,null,null,null,null," - "," -  - ",15," -  -  -  - 15"]
[null,null,null,null,null,null,null,null," - "," -  - ",16," -  -  -  - 16"]
[null,null,null,null,null,null,null,null," - "," -  - ",17," -  -  -  - 17"]
[null,null,null,null,null,null,null,null," - "," -  - ",18," -  -  -  - 18"]
[null,null,null,null,null,null,null,null," - "," -  - ",19," -  -  -  - 19"]
[null,null,null,null,null,null,null,null," - "," -  - ",20," -  -  -  - 20"]
[null,"QS110","Pneumonia in adults",1,null,"Adults have a mortality risk assessment using the CRB65 score when they are diagnosed with community‑acquired pneumonia in primary care.","Evidence of local arrangements to ensure that adults have a mortality risk assessment using the CRB65 score when they are diagnosed with community‑acquired pneumonia in primary care.","Structure","QS110 - Pneumonia in adults","1 - QS110 - Pneumonia in adults",1,"1 - QS110 - Pneumonia in adults - Structure - 1"]
[null,"QS110","Pneumonia in adults",1,null,"Adults have a mortality risk assessment using the CRB65 score when they are diagnosed with community‑acquired pneumonia in primary care.","Proportion of community‑acquired pneumonia diagnoses of adults in primary care at which the adult has a mortality risk assessment using the CRB65 score.","Process","QS110 - Pneumonia in adults","1 - QS110 - Pneumonia in adults",1,"1 - QS110 - Pneumonia in adults - Process - 1","The number in the denominator at which the adult has a mortality risk assessment using the CRB65 score.","The number of diagnoses of community‑acquired pneumonia in adults in primary care."]
[null,"QS110","Pneumonia in adults",1,null,"Adults have a mortality risk assessment using the CRB65 score when they are diagnosed with community‑acquired pneumonia in primary care.","Mortality due to pneumonia.","Outcome","QS110 - Pneumonia in adults","1 - QS110 - Pneumonia in adults",1,"1 - QS110 - Pneumonia in adults - Outcome - 1"]
[null,"QS110","Pneumonia in adults",2,null,"Adults with low‑severity community‑acquired pneumonia are prescribed a 5‑day course of a single antibiotic.","Proportion of adults with low‑severity community‑acquired pneumonia who receive a 5‑day maximum course of a single antibiotic.","Process","QS110 - Pneumonia in adults","2 - QS110 - Pneumonia in adults",1,"2 - QS110 - Pneumonia in adults - Process - 1","The number in the denominator who are prescribed a 5‑day maximum course of a single antibiotic.","The number of adults with low‑severity community‑acquired pneumonia."]
[null,"QS110","Pneumonia in adults",3,null,"Adults with suspected community‑acquired pneumonia in hospital have a chest X‑ray and receive a diagnosis within 4 hours of presentation.","Evidence of local arrangements and processes to ensure that adults with suspected community‑acquired pneumonia in hospital have a chest X‑ray and receive a diagnosis within 4 hours of presentation at hospital.","Structure","QS110 - Pneumonia in adults","3 - QS110 - Pneumonia in adults",1,"3 - QS110 - Pneumonia in adults - Structure - 1"]
[null,"QS110","Pneumonia in adults",3,null,"Adults with suspected community‑acquired pneumonia in hospital have a chest X‑ray and receive a diagnosis within 4 hours of presentation.","Proportion of diagnoses of community‑acquired pneumonia in adults in hospital at which the adult has a chest X‑ray within 4 hours of presentation at hospital.","Process","QS110 - Pneumonia in adults","3 - QS110 - Pneumonia in adults",1,"3 - QS110 - Pneumonia in adults - Process - 1","The number in the denominator for which a chest X‑ray was carried out within 4 hours of presentation at hospital.","The number of diagnoses of community‑acquired pneumonia in adults."]
[null,"QS110","Pneumonia in adults",3,null,"Adults with suspected community‑acquired pneumonia in hospital have a chest X‑ray and receive a diagnosis within 4 hours of presentation.","Proportion of diagnoses of community‑acquired pneumonia in adults in hospital which are made within 4 hours of presentation at hospital.","Process","QS110 - Pneumonia in adults","3 - QS110 - Pneumonia in adults",2,"3 - QS110 - Pneumonia in adults - Process - 2","The number in the denominator for which a diagnosis was made within 4 hours of presentation at hospital.","The number of diagnoses of community‑acquired pneumonia in adults in hospital."]
[null,null,null,null,null,null,null,null," - "," -  - ",1," -  -  -  - 1"]
[null,"QS110","Pneumonia in adults",3,null,"Adults with suspected community‑acquired pneumonia in hospital have a chest X‑ray and receive a diagnosis within 4 hours of presentation.","Inappropriate antibiotic use.","Outcome","QS110 - Pneumonia in adults","3 - QS110 - Pneumonia in adults",1,"3 - QS110 - Pneumonia in adults - Outcome - 1"]
[null,"QS110","Pneumonia in adults",4,null,"Adults have a mortality risk assessment using the CURB65 score when they are diagnosed with community‑acquired pneumonia in hospital.","Evidence of local arrangements to ensure that adults have a mortality risk assessment using the CURB65 score when they are diagnosed with community‑acquired pneumonia in hospital.","Structure","QS110 - Pneumonia in adults","4 - QS110 - Pneumonia in adults",1,"4 - QS110 - Pneumonia in adults - Structure - 1"]
[null,"QS110","Pneumonia in adults",4,null,"Adults have a mortality risk assessment using the CURB65 score when they are diagnosed with community‑acquired pneumonia in hospital.","Proportion of diagnoses of community‑acquired pneumonia in adults in hospital at which the adult has a mortality risk assessment using the CURB65 score.","Process","QS110 - Pneumonia in adults","4 - QS110 - Pneumonia in adults",1,"4 - QS110 - Pneumonia in adults - Process - 1","The number in the denominator at which the adult has a mortality risk assessment using the CURB65 score.","The number of diagnoses of community‑acquired pneumonia in adults in hospital."]
[null,"QS110","Pneumonia in adults",5,null,"Adults with community‑acquired pneumonia who are admitted to hospital start antibiotic therapy within 4 hours of presentation.","Evidence of local arrangements to ensure that adults with community‑acquired pneumonia who are admitted to hospital start antibiotic therapy within 4 hours of presentation.","Structure","QS110 - Pneumonia in adults","5 - QS110 - Pneumonia in adults",1,"5 - QS110 - Pneumonia in adults - Structure - 1"]
[null,"QS110","Pneumonia in adults",5,null,"Adults with community‑acquired pneumonia who are admitted to hospital start antibiotic therapy within 4 hours of presentation.","Proportion of hospital admissions of community‑acquired pneumonia in adults at which antibiotic therapy is started within 4 hours of presentation.","Process","QS110 - Pneumonia in adults","5 - QS110 - Pneumonia in adults",1,"5 - QS110 - Pneumonia in adults - Process - 1","The number in the denominator at which antibiotic therapy is started within 4 hours of presentation.","The number of hospital admissions of community‑acquired pneumonia in adults."]
[null,"QS110","Pneumonia in adults",5,null,"Adults with community‑acquired pneumonia who are admitted to hospital start antibiotic therapy within 4 hours of presentation.","Mortality due to pneumonia.","Outcome","QS110 - Pneumonia in adults","5 - QS110 - Pneumonia in adults",1,"5 - QS110 - Pneumonia in adults - Outcome - 1"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",1,null,"Adults using vending machines in local authority and NHS venues can buy healthy food and drink options.","Evidence that local authorities and NHS organisations provide, or make contractual arrangements for the provision of, healthy food and drink options in any vending machines in their venues.","Structure","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","1 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"1 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Structure - 1"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",1,null,"Adults using vending machines in local authority and NHS venues can buy healthy food and drink options.","Proportion of local authority and NHS venues with vending machines that contain healthy food and drink options.","Process","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","1 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"1 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Process - 1","The number in the denominator that have vending machines that contain healthy food and drink options.","The number of local authority and NHS venues with vending machines."]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",2,null,"Adults see details of nutritional information on menus at local authority and NHS venues.","Evidence that local authorities and NHS organisations ensure that information on the nutritional content of meals is included on menus at venues.","Structure","QS111 - Obesity in adults: prevention and lifestyle weight management programmes",{"$f":"CONCATENATE(D2430, \" - \", I2430)","v":"2 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes"},{"$f":"IF(AND(B2430=B2429, D2430=D2429, H2430=H2429)=TRUE, K2429+1, 1)","v":1},{"$f":"CONCATENATE(J2430, \" - \", H2430, \" - \",K2430)","v":"2 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Structure - 1"}]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",3,null,"Adults see healthy food and drink choices displayed prominently in local authority and NHS venues.","Evidence that local authority and NHS venues make arrangements to display healthy food and drink options in prominent positions.","Structure","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","3 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"3 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Structure - 1"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",3,null,"Adults see healthy food and drink choices displayed prominently in local authority and NHS venues.","Sales of healthy food and drink options.","Outcome","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","3 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"3 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Outcome - 1"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",4,null,"Adults have access to a publicly available, up‑to‑date list of local lifestyle weight management programmes.","Evidence that an up‑to‑date list of local lifestyle weight management programmes for adults is publicly available.","Structure","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","4 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"4 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Structure - 1"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",4,null,"Adults have access to a publicly available, up‑to‑date list of local lifestyle weight management programmes.","Number of self‑referrals of overweight or obese adults to locally commissioned lifestyle weight management programmes.","Outcome","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","4 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"4 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Outcome - 1"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",5,null,"Adults can access data on attendance, outcomes and views of participants and staff from locally commissioned lifestyle weight management programmes.","Evidence that commissioners and providers of lifestyle weight management programmes jointly agree the key performance indicators to be collected for monitoring and evaluation.","Structure",{"$f":"CONCATENATE(B2435, \" - \", C2435)","v":"QS111 - Obesity in adults: prevention and lifestyle weight management programmes"},"5 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"5 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Structure - 1"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",5,null,"Adults can access data on attendance, outcomes and views of participants and staff from locally commissioned lifestyle weight management programmes.","Evidence that commissioners and providers of lifestyle weight management programmes have used data from monitoring and evaluation to amend and improve programmes.","Structure","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","5 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",2,"5 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Structure - 2"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",5,null,"Adults can access data on attendance, outcomes and views of participants and staff from locally commissioned lifestyle weight management programmes.","Proportion of adults recruited to a locally commissioned lifestyle weight management programme who have information on attendance, outcomes and views of participants and staff collected at recruitment and completion.","Process","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","5 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"5 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Process - 1","The number in the denominator who have information on attendance, outcomes and views of participants and staff collected at recruitment and completion.","The number of adults recruited to a locally commissioned lifestyle weight management programme."]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",5,null,"Adults can access data on attendance, outcomes and views of participants and staff from locally commissioned lifestyle weight management programmes.","Proportion of adults who complete a lifestyle weight management programme who have data on outcomes collected 6 months after completion of the programme.","Process","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","5 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",2,"5 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Process - 2","The number in the denominator who have data on outcomes collected 6 months after completion of the programme.","The number of adults who complete a lifestyle weight management programme."]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",5,null,"Adults can access data on attendance, outcomes and views of participants and staff from locally commissioned lifestyle weight management programmes.","Proportion of adults who complete a lifestyle weight management programme who have data on outcomes collected 1 year after completion of the programme.","Process","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","5 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",3,"5 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Process - 3","The number in the denominator who have data on outcomes collected 1 year after completion of the programme.","The number of adults who complete a lifestyle weight management programme."]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",5,null,"Adults can access data on attendance, outcomes and views of participants and staff from locally commissioned lifestyle weight management programmes.","Improved performance of local lifestyle weight management programmes.","Outcome","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","5 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"5 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Outcome - 1"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",6,null,"Adults identified as being overweight or obese are given information about local lifestyle weight management programmes.","Evidence of local arrangements to give adults who are identified as being overweight or obese information about local lifestyle weight management programmes.","Structure","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","6 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"6 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Structure - 1"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",6,null,"Adults identified as being overweight or obese are given information about local lifestyle weight management programmes.","Proportion of adults identified as being overweight or obese who are given information about local lifestyle weight management programmes.","Process","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","6 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"6 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Process - 1","The number in the denominator who are given information about local weight management programmes.","The number of adults identified as being overweight or obese."]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",6,null,"Adults identified as being overweight or obese are given information about local lifestyle weight management programmes.","Number of self‑referrals of overweight or obese adults to lifestyle weight management programmes.","Outcome","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","6 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"6 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Outcome - 1"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",6,null,"Adults identified as being overweight or obese are given information about local lifestyle weight management programmes.","Obesity prevalence.","Outcome","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","6 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",2,"6 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Outcome - 2"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",6,null,"Adults identified as being overweight or obese are given information about local lifestyle weight management programmes.","Prevalence of obesity‑related comorbidities.","Outcome","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","6 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",3,"6 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Outcome - 3"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",7,null,"Adults identified as overweight or obese with comorbidities are offered a referral to a lifestyle weight management programme.","Evidence of local arrangements to ensure that adults who are identified as overweight or obese with comorbidities are offered a referral to a lifestyle weight management programme.","Structure","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","7 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"7 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Structure - 1"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",7,null,"Adults identified as overweight or obese with comorbidities are offered a referral to a lifestyle weight management programme.","Proportion of adults who are identified as overweight or obese with comorbidities who are referred to a lifestyle weight management programme.","Process","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","7 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"7 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Process - 1","The number in the denominator who are referred to a lifestyle weight management programme.","The number of adults who are identified as overweight or obese with comorbidities."]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",7,null,"Adults identified as overweight or obese with comorbidities are offered a referral to a lifestyle weight management programme.","Number of adults who are identified as overweight or obese with comorbidities enrolling in lifestyle weight management services.","Outcome","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","7 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"7 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Outcome - 1"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",7,null,"Adults identified as overweight or obese with comorbidities are offered a referral to a lifestyle weight management programme.","Obesity prevalence among adults with comorbidities.","Outcome","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","7 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",2,"7 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Outcome - 2"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",7,null,"Adults identified as overweight or obese with comorbidities are offered a referral to a lifestyle weight management programme.","Obesity‑related comorbidities","Outcome","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","7 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",3,"7 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Outcome - 3"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",8,null,"Adults about to complete a lifestyle weight management programme agree a plan to prevent weight regain.","Evidence of local arrangements to ensure that adults about to complete a lifestyle weight management programme agree a plan to prevent weight regain.","Structure","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","8 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"8 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Structure - 1"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",8,null,"Adults about to complete a lifestyle weight management programme agree a plan to prevent weight regain.","Proportion of adults completing a lifestyle weight management programme who agree a plan to prevent weight regain.","Process","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","8 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"8 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Process - 1","The number in the denominator who agree a plan to prevent weight regain.","The number of adults about to complete a lifestyle weight management programme."]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",8,null,"Adults about to complete a lifestyle weight management programme agree a plan to prevent weight regain.","Obesity prevalence.","Outcome","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","8 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",1,"8 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Outcome - 1"]
[null,"QS111","Obesity in adults: prevention and lifestyle weight management programmes",8,null,"Adults about to complete a lifestyle weight management programme agree a plan to prevent weight regain.","Prevalence of obesity‑related comorbidities.","Outcome","QS111 - Obesity in adults: prevention and lifestyle weight management programmes","8 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes",2,"8 - QS111 - Obesity in adults: prevention and lifestyle weight management programmes - Outcome - 2"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",1,null,"Parents and carers attending postnatal appointments are given information about gastro‑oesophageal reflux (GOR) in infants. ","Evidence of local arrangements to ensure that parents and carers attending postnatal appointments are given information about GOR in infants.","Structure","QS112 - Gastro-oesophageal reflux in children and young people","1 - QS112 - Gastro-oesophageal reflux in children and young people",1,"1 - QS112 - Gastro-oesophageal reflux in children and young people - Structure - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",1,null,"Parents and carers attending postnatal appointments are given information about gastro‑oesophageal reflux (GOR) in infants. ","Proportion of infants aged 8 weeks and under whose parents or carers received information about GOR during 1 of the postnatal appointments.","Process","QS112 - Gastro-oesophageal reflux in children and young people","1 - QS112 - Gastro-oesophageal reflux in children and young people",1,"1 - QS112 - Gastro-oesophageal reflux in children and young people - Process - 1","The number in the denominator whose parents received information about GOR during 1 of the postnatal appointments.","The number of infants aged 8 weeks and under who had at least 1 postnatal appointment."]
[null,"QS112","Gastro-oesophageal reflux in children and young people",1,null,"Parents and carers attending postnatal appointments are given information about gastro‑oesophageal reflux (GOR) in infants. ","Parental anxiety around infant GOR.","Outcome","QS112 - Gastro-oesophageal reflux in children and young people","1 - QS112 - Gastro-oesophageal reflux in children and young people",1,"1 - QS112 - Gastro-oesophageal reflux in children and young people - Outcome - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",1,null,"Parents and carers attending postnatal appointments are given information about gastro‑oesophageal reflux (GOR) in infants. ","GP visits regarding GOR. ","Outcome","QS112 - Gastro-oesophageal reflux in children and young people","1 - QS112 - Gastro-oesophageal reflux in children and young people",2,"1 - QS112 - Gastro-oesophageal reflux in children and young people - Outcome - 2"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",2,null,"Breast‑fed infants with frequent regurgitation associated with marked distress have their feeding assessed. ","Evidence of local arrangements to ensure that breast-fed infants with frequent regurgitation associated with marked distress have their feeding assessed before other treatments are offered. ","Structure","QS112 - Gastro-oesophageal reflux in children and young people","2 - QS112 - Gastro-oesophageal reflux in children and young people",1,"2 - QS112 - Gastro-oesophageal reflux in children and young people - Structure - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",2,null,"Breast‑fed infants with frequent regurgitation associated with marked distress have their feeding assessed. ","Proportion of breast‑fed infants with frequent regurgitation associated with marked distress who have a breastfeeding assessment. ","Process","QS112 - Gastro-oesophageal reflux in children and young people","2 - QS112 - Gastro-oesophageal reflux in children and young people",1,"2 - QS112 - Gastro-oesophageal reflux in children and young people - Process - 1","Number in the denominator who have a breastfeeding assessment.","Number of breast‑fed infants presenting with frequent regurgitation associated with marked distress."]
[null,"QS112","Gastro-oesophageal reflux in children and young people",2,null,"Breast‑fed infants with frequent regurgitation associated with marked distress have their feeding assessed. ","Breast‑fed infants with frequent regurgitation associated with marked distress presenting in healthcare settings.","Outcome","QS112 - Gastro-oesophageal reflux in children and young people","2 - QS112 - Gastro-oesophageal reflux in children and young people",1,"2 - QS112 - Gastro-oesophageal reflux in children and young people - Outcome - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",3,null,"Formula‑fed infants with frequent regurgitation associated with marked distress have their symptoms managed using a stepped‑care approach. ","Evidence of local arrangements to ensure that formula‑fed infants with frequent regurgitation associated with marked distress have their symptoms managed using a stepped‑care approach.","Structure","QS112 - Gastro-oesophageal reflux in children and young people","3 - QS112 - Gastro-oesophageal reflux in children and young people",1,"3 - QS112 - Gastro-oesophageal reflux in children and young people - Structure - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",3,null,"Formula‑fed infants with frequent regurgitation associated with marked distress have their symptoms managed using a stepped‑care approach. ","Proportion of formula‑fed infants with frequent regurgitation associated with marked distress that have their feeding history reviewed.","Process","QS112 - Gastro-oesophageal reflux in children and young people","3 - QS112 - Gastro-oesophageal reflux in children and young people",1,"3 - QS112 - Gastro-oesophageal reflux in children and young people - Process - 1","Number in the denominator who have their feeding history reviewed.","Number of formula‑fed infants presenting with frequent regurgitation associated with marked distress."]
[null,"QS112","Gastro-oesophageal reflux in children and young people",3,null,"Formula‑fed infants with frequent regurgitation associated with marked distress have their symptoms managed using a stepped‑care approach. ","Proportion of formula‑fed infants with frequent regurgitation associated with marked distress that had excessive feed volumes reduced. ","Process","QS112 - Gastro-oesophageal reflux in children and young people","3 - QS112 - Gastro-oesophageal reflux in children and young people",2,"3 - QS112 - Gastro-oesophageal reflux in children and young people - Process - 2","Number in the denominator whose excessive feed volumes were reduced.","Number of formula‑fed infants presenting with frequent regurgitation associated with marked distress who receive excessive feed volumes."]
[null,"QS112","Gastro-oesophageal reflux in children and young people",3,null,"Formula‑fed infants with frequent regurgitation associated with marked distress have their symptoms managed using a stepped‑care approach. ","Proportion of formula‑fed infants with frequent regurgitation associated with marked distress who received a trial of smaller and more frequent feeds.","Process","QS112 - Gastro-oesophageal reflux in children and young people","3 - QS112 - Gastro-oesophageal reflux in children and young people",3,"3 - QS112 - Gastro-oesophageal reflux in children and young people - Process - 3","Number in the denominator who received a trial of smaller and more frequent feeds.","Number of formula‑fed infants presenting with frequent regurgitation associated with marked distress receiving appropriate total daily amount of milk."]
[null,"QS112","Gastro-oesophageal reflux in children and young people",3,null,"Formula‑fed infants with frequent regurgitation associated with marked distress have their symptoms managed using a stepped‑care approach. ","Proportion of formula‑fed infants with frequent regurgitation associated with marked distress given a trial of thickened formula.","Process","QS112 - Gastro-oesophageal reflux in children and young people","3 - QS112 - Gastro-oesophageal reflux in children and young people",4,"3 - QS112 - Gastro-oesophageal reflux in children and young people - Process - 4","Number in the denominator given a trial of thickened formula.","Number of formula‑fed infants with frequent regurgitation associated with marked distress receiving appropriate total daily amount of milk and receiving trial of small and frequent feeds."]
[null,"QS112","Gastro-oesophageal reflux in children and young people",3,null,"Formula‑fed infants with frequent regurgitation associated with marked distress have their symptoms managed using a stepped‑care approach. ","Infants with frequent regurgitation associated with marked distress presenting in healthcare settings.","Outcome","QS112 - Gastro-oesophageal reflux in children and young people","3 - QS112 - Gastro-oesophageal reflux in children and young people",1,"3 - QS112 - Gastro-oesophageal reflux in children and young people - Outcome - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",4,null,"Infants with frequent regurgitation associated with marked distress have a trial of alginate therapy if first‑line management is unsuccessful.","Evidence of local arrangements to ensure that infants with frequent regurgitation associated with marked distress have a trial of alginate therapy if first‑line management is unsuccessful. ","Structure","QS112 - Gastro-oesophageal reflux in children and young people","4 - QS112 - Gastro-oesophageal reflux in children and young people",1,"4 - QS112 - Gastro-oesophageal reflux in children and young people - Structure - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",4,null,"Infants with frequent regurgitation associated with marked distress have a trial of alginate therapy if first‑line management is unsuccessful.","Proportion of breast‑fed infants with frequent regurgitation associated with marked distress that continues despite a feeding assessment and advice who have a trial of alginate therapy","Process","QS112 - Gastro-oesophageal reflux in children and young people","4 - QS112 - Gastro-oesophageal reflux in children and young people",1,"4 - QS112 - Gastro-oesophageal reflux in children and young people - Process - 1","Number in the denominator who have a trial of alginate therapy.","Number of breast‑fed infants presenting with frequent regurgitation associated with marked distress that continues despite a feeding assessment and advice."]
[null,"QS112","Gastro-oesophageal reflux in children and young people",4,null,"Infants with frequent regurgitation associated with marked distress have a trial of alginate therapy if first‑line management is unsuccessful.","Proportion of formula‑fed infants with frequent regurgitation associated with marked distress that continues despite a feeding assessment and advice who have a trial of alginate therapy. ","Process","QS112 - Gastro-oesophageal reflux in children and young people","4 - QS112 - Gastro-oesophageal reflux in children and young people",2,"4 - QS112 - Gastro-oesophageal reflux in children and young people - Process - 2","Number in the denominator who have a trial of alginate therapy.","Number of formula‑fed infants with frequent regurgitation associated with marked distress that continues despite a stepped‑care approach."]
[null,"QS112","Gastro-oesophageal reflux in children and young people",4,null,"Infants with frequent regurgitation associated with marked distress have a trial of alginate therapy if first‑line management is unsuccessful.","Infants with frequent regurgitation associated with marked distress presenting in healthcare settings.","Outcome","QS112 - Gastro-oesophageal reflux in children and young people","4 - QS112 - Gastro-oesophageal reflux in children and young people",1,"4 - QS112 - Gastro-oesophageal reflux in children and young people - Outcome - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",5,null,"Infants and children are not investigated or treated for gastro‑oesophageal reflux disease (GORD) if they have no visible regurgitation and only 1 associated symptom.","Evidence of local arrangements to ensure that infants and children are not investigated or treated for GORD if they have no visible regurgitation and only 1 associated symptom.","Structure","QS112 - Gastro-oesophageal reflux in children and young people","5 - QS112 - Gastro-oesophageal reflux in children and young people",1,"5 - QS112 - Gastro-oesophageal reflux in children and young people - Structure - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",5,null,"Infants and children are not investigated or treated for gastro‑oesophageal reflux disease (GORD) if they have no visible regurgitation and only 1 associated symptom.","Proportion of infants and children with no visible regurgitation and only 1 associated symptom investigated or treated for GORD.","Process","QS112 - Gastro-oesophageal reflux in children and young people","5 - QS112 - Gastro-oesophageal reflux in children and young people",1,"5 - QS112 - Gastro-oesophageal reflux in children and young people - Process - 1","Number in the denominator who had no visible regurgitation and only 1 associated symptom.","Number of infants and children investigated or treated for GORD."]
[null,"QS112","Gastro-oesophageal reflux in children and young people",6,null,"Infants and children are not prescribed acid‑suppressing drugs if visible regurgitation is an isolated symptom. ","Evidence of local arrangements to ensure that infants and children with regurgitation as an isolated symptom are not prescribed acid‑suppressing drugs.","Structure","QS112 - Gastro-oesophageal reflux in children and young people","6 - QS112 - Gastro-oesophageal reflux in children and young people",1,"6 - QS112 - Gastro-oesophageal reflux in children and young people - Structure - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",6,null,"Infants and children are not prescribed acid‑suppressing drugs if visible regurgitation is an isolated symptom. ","Proportion of infants and children presenting with regurgitation as an isolated symptom prescribed acid‑suppressing drugs.","Process","QS112 - Gastro-oesophageal reflux in children and young people","6 - QS112 - Gastro-oesophageal reflux in children and young people",1,"6 - QS112 - Gastro-oesophageal reflux in children and young people - Process - 1","Number in the denominator prescribed acid‑suppressing drugs.","Number of infants and children presenting with regurgitation as an isolated symptom."]
[null,"QS112","Gastro-oesophageal reflux in children and young people",6,null,"Infants and children are not prescribed acid‑suppressing drugs if visible regurgitation is an isolated symptom. ","PPI and H2RA prescribing rates among infants and children.","Outcome","QS112 - Gastro-oesophageal reflux in children and young people","6 - QS112 - Gastro-oesophageal reflux in children and young people",1,"6 - QS112 - Gastro-oesophageal reflux in children and young people - Outcome - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",7,null,"Infants, children and young people do not have an upper gastrointestinal (GI) contrast study to diagnose or assess the severity of gastro‑oesophageal reflux disease (GORD).","Evidence of local arrangements to ensure that upper GI contrast studies are not used to diagnose or assess the severity of GORD in infants, children and young people","Structure","QS112 - Gastro-oesophageal reflux in children and young people","7 - QS112 - Gastro-oesophageal reflux in children and young people",1,"7 - QS112 - Gastro-oesophageal reflux in children and young people - Structure - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",7,null,"Infants, children and young people do not have an upper gastrointestinal (GI) contrast study to diagnose or assess the severity of gastro‑oesophageal reflux disease (GORD).","Proportion of infants, children and young people referred for upper GI contrast study to diagnose or assess the severity of GORD.","Process","QS112 - Gastro-oesophageal reflux in children and young people","7 - QS112 - Gastro-oesophageal reflux in children and young people",1,"7 - QS112 - Gastro-oesophageal reflux in children and young people - Process - 1","Number in the denominator referred to diagnose or assess the severity of GORD.","Number of infants, children and young people referred for upper GI contrast study."]
[null,"QS112","Gastro-oesophageal reflux in children and young people",8,null,"Infants, children and young people are not prescribed domperidone, metoclopramide or erythromycin to manage gastro‑oesophageal reflux (GOR) or gastro‑oesophageal reflux disease (GORD) without specialist paediatric advice.","Evidence of local arrangements to ensure that infants, children and young people are not prescribed domperidone, metoclopramide or erythromycin to manage GOR or GORD without specialist paediatric advice.","Structure","QS112 - Gastro-oesophageal reflux in children and young people","8 - QS112 - Gastro-oesophageal reflux in children and young people",1,"8 - QS112 - Gastro-oesophageal reflux in children and young people - Structure - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",8,null,"Infants, children and young people are not prescribed domperidone, metoclopramide or erythromycin to manage gastro‑oesophageal reflux (GOR) or gastro‑oesophageal reflux disease (GORD) without specialist paediatric advice.","Proportion of infants, children and young people prescribed domperidone, metoclopramide or erythromycin to manage GOR or GORD on the basis of specialist paediatric advice.","Process","QS112 - Gastro-oesophageal reflux in children and young people","8 - QS112 - Gastro-oesophageal reflux in children and young people",1,"8 - QS112 - Gastro-oesophageal reflux in children and young people - Process - 1","Number in the denominator who were prescribed domperidone, metoclopramide or erythromycin on the basis of specialist paediatric advice.","Number of infants, children and young people prescribed domperidone, metoclopramide or erythromycin to manage GOR or GORD."]
[null,"QS112","Gastro-oesophageal reflux in children and young people",8,null,"Infants, children and young people are not prescribed domperidone, metoclopramide or erythromycin to manage gastro‑oesophageal reflux (GOR) or gastro‑oesophageal reflux disease (GORD) without specialist paediatric advice.","Domperidone, metoclopramide and erythromycin prescribing among infants, children and young people.","Outcome","QS112 - Gastro-oesophageal reflux in children and young people","8 - QS112 - Gastro-oesophageal reflux in children and young people",1,"8 - QS112 - Gastro-oesophageal reflux in children and young people - Outcome - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",9,null,"Infants, children and young people with vomiting or regurgitation and any 'red flag' symptoms are referred to specialist care with investigations as appropriate.","Evidence of local arrangements to ensure that infants, children and young people with vomiting or regurgitation and any 'red flag' symptoms are further investigated or referred to specialist care with investigations as appropriate. ","Structure","QS112 - Gastro-oesophageal reflux in children and young people","9 - QS112 - Gastro-oesophageal reflux in children and young people",1,"9 - QS112 - Gastro-oesophageal reflux in children and young people - Structure - 1"]
[null,"QS112","Gastro-oesophageal reflux in children and young people",9,null,"Infants, children and young people with vomiting or regurgitation and any 'red flag' symptoms are referred to specialist care with investigations as appropriate.","Proportion of infants, children and young people with vomiting or regurgitation and any 'red flag' symptoms who had further investigations and specialist referral.","Process","QS112 - Gastro-oesophageal reflux in children and young people","9 - QS112 - Gastro-oesophageal reflux in children and young people",1,"9 - QS112 - Gastro-oesophageal reflux in children and young people - Process - 1","Number in the denominator who had further investigations and specialist referral.","Number of infants, children and young people presenting with vomiting or regurgitation and any 'red flag' symptoms."]
[null,"QS112","Gastro-oesophageal reflux in children and young people",9,null,"Infants, children and young people with vomiting or regurgitation and any 'red flag' symptoms are referred to specialist care with investigations as appropriate.","Proportion of infants, children and young people with vomiting or regurgitation and any 'red flag' symptoms who had appropriate investigations and specialist referral.","process","QS112 - Gastro-oesophageal reflux in children and young people","9 - QS112 - Gastro-oesophageal reflux in children and young people",2,"9 - QS112 - Gastro-oesophageal reflux in children and young people - process - 2","Number in the denominator who had appropriate investigations and specialist referral.","Number of infants, children and young people with vomiting or regurgitation and any 'red flag' symptoms who had further investigations and specialist referral."]
[null,"QS113","Healthcare-associated infections",1,null,"Hospitals monitor healthcare-associated infections and other infections of local relevance to drive continuous quality improvement","Evidence of local arrangements for hospitals to monitor healthcare-associated infections and other infections of local relevance.","Structure","QS113 - Healthcare-associated infections","1 - QS113 - Healthcare-associated infections",1,"1 - QS113 - Healthcare-associated infections - Structure - 1"]
[null,"QS113","Healthcare-associated infections",1,null,"Hospitals monitor healthcare-associated infections and other infections of local relevance to drive continuous quality improvement","Evidence of local arrangements for the results of monitoring healthcare-associated infections and other infections of local relevance to be used across the organisation to inform and review objectives for quality improvement.","Structure","QS113 - Healthcare-associated infections","1 - QS113 - Healthcare-associated infections",2,"1 - QS113 - Healthcare-associated infections - Structure - 2"]
[null,"QS113","Healthcare-associated infections",1,null,"Hospitals monitor healthcare-associated infections and other infections of local relevance to drive continuous quality improvement","Incidence of healthcare-associated infections","Outcome","QS113 - Healthcare-associated infections","1 - QS113 - Healthcare-associated infections",1,"1 - QS113 - Healthcare-associated infections - Outcome - 1"]
[null,"QS113","Healthcare-associated infections",2,null,"Hospitals work with local health and social care organisations to assess and manage the risk of infections in hospitals from community outbreaks and incidents","Evidence of local arrangements for hospitals to monitor the risk of healthcare-associated infections from incidents and outbreaks in the community","Structure","QS113 - Healthcare-associated infections","2 - QS113 - Healthcare-associated infections",1,"2 - QS113 - Healthcare-associated infections - Structure - 1"]
[null,"QS113","Healthcare-associated infections",2,null,"Hospitals work with local health and social care organisations to assess and manage the risk of infections in hospitals from community outbreaks and incidents","Evidence of local arrangements for collaborative working between hospitals and other local health and social care organisations to investigate and manage the risks of healthcare-associated infection from incidents and outbreaks in the community","Structure","QS113 - Healthcare-associated infections","2 - QS113 - Healthcare-associated infections",2,"2 - QS113 - Healthcare-associated infections - Structure - 2"]
[null,"QS113","Healthcare-associated infections",2,null,"Hospitals work with local health and social care organisations to assess and manage the risk of infections in hospitals from community outbreaks and incidents","Incidence of healthcare-associated infections","Outcome","QS113 - Healthcare-associated infections","2 - QS113 - Healthcare-associated infections",1,"2 - QS113 - Healthcare-associated infections - Outcome - 1"]
[null,"QS113","Healthcare-associated infections",3,null,"Hospital staff have individual objectives and appraisals on infection prevention and control linked to board-level objectives and strategies","Evidence of local arrangements to ensure all staff have clear objectives in relation to infection prevention and control that are linked to board-level objectives","Structure","QS113 - Healthcare-associated infections","3 - QS113 - Healthcare-associated infections",1,"3 - QS113 - Healthcare-associated infections - Structure - 1"]
[null,"QS113","Healthcare-associated infections",3,null,"Hospital staff have individual objectives and appraisals on infection prevention and control linked to board-level objectives and strategies","Evidence of local arrangements to ensure all staff have an appraisal and development plan that cover infection prevention and control","Structure","QS113 - Healthcare-associated infections","3 - QS113 - Healthcare-associated infections",2,"3 - QS113 - Healthcare-associated infections - Structure - 2"]
[null,"QS113","Healthcare-associated infections",3,null,"Hospital staff have individual objectives and appraisals on infection prevention and control linked to board-level objectives and strategies","Proportion of hospital staff who have individual infection prevention and control objectives that are linked to board-level objectives","Process","QS113 - Healthcare-associated infections","3 - QS113 - Healthcare-associated infections",1,"3 - QS113 - Healthcare-associated infections - Process - 1","The number in the denominator who have individual infection prevention and control objectives that are linked to board‑level objectives.","The number of hospital staff."]
[null,"QS113","Healthcare-associated infections",3,null,"Hospital staff have individual objectives and appraisals on infection prevention and control linked to board-level objectives and strategies","Proportion of hospital staff who have an appraisal of their infection prevention and control objectives","Process","QS113 - Healthcare-associated infections",{"$f":"CONCATENATE(D2494, \" - \", I2494)","v":"3 - QS113 - Healthcare-associated infections"},{"$f":"IF(AND(B2494=B2493, D2494=D2493, H2494=H2493)=TRUE, K2493+1, 1)","v":2},{"$f":"CONCATENATE(J2494, \" - \", H2494, \" - \",K2494)","v":"3 - QS113 - Healthcare-associated infections - Process - 2"},"The number in the denominator who have an appraisal of their infection prevention and control objectives.","The number of hospital staff."]
[null,"QS113","Healthcare-associated infections",3,null,"Hospital staff have individual objectives and appraisals on infection prevention and control linked to board-level objectives and strategies","Proportion of hospital staff who have a development plan that includes infection prevention and control","Process","QS113 - Healthcare-associated infections","3 - QS113 - Healthcare-associated infections",3,"3 - QS113 - Healthcare-associated infections - Process - 3","The number in the denominator who have a development plan that addresses individual needs for knowledge, abilities and skills in infection prevention and control.","The number of hospital staff."]
[null,"QS113","Healthcare-associated infections",4,null,"Hospitals involve infection prevention and control teams in the building, refurbishment and maintenance of hospital facilities","Evidence of local arrangements for involving infection prevention and control teams in the building and refurbishment of facilities in the hospital. Examples of evidence may include protocols covering infection prevention and control in the built environment; estate department procedures to engage infection prevention and control teams in new build and refurbishment projects; building and refurbishment project plans and schedules of work that show the involvement of infection prevention and control teams; and records of completed building and refurbishment works that show whether infection prevention and control requirements have been met","Structure","QS113 - Healthcare-associated infections","4 - QS113 - Healthcare-associated infections",1,"4 - QS113 - Healthcare-associated infections - Structure - 1"]
[null,"QS113","Healthcare-associated infections",4,null,"Hospitals involve infection prevention and control teams in the building, refurbishment and maintenance of hospital facilities","Evidence of local arrangements for involving infection prevention and control teams in the maintenance of facilities in the hospital. Examples of evidence may include protocols covering infection prevention and control in the built environment; estate department procedures to engage infection prevention and control teams in maintenance works; maintenance plans and schedules that show the involvement of infection prevention and control teams; and records of completed maintenance works that show whether infection prevention and control requirements have been met","Structure","QS113 - Healthcare-associated infections","4 - QS113 - Healthcare-associated infections",2,"4 - QS113 - Healthcare-associated infections - Structure - 2"]
[null,"QS113","Healthcare-associated infections",5,null,"People admitted to, discharged from, or transferred between or within hospitals, have information about any infections and associated treatments shared with health and social care staff to inform their care","Evidence of local arrangements to ensure information about any infections and associated treatments for people admitted to, discharged from, or transferred between or within hospitals, is shared with the health and social care staff responsible for the ongoing care","Structure","QS113 - Healthcare-associated infections","5 - QS113 - Healthcare-associated infections",1,"5 - QS113 - Healthcare-associated infections - Structure - 1"]
[null,"QS113","Healthcare-associated infections",5,null,"People admitted to, discharged from, or transferred between or within hospitals, have information about any infections and associated treatments shared with health and social care staff to inform their care","Proportion of admissions to hospital, including transfers of patients from other hospitals, where information on infections and associated treatments is received","Process",{"$f":"CONCATENATE(B2499, \" - \", C2499)","v":"QS113 - Healthcare-associated infections"},"5 - QS113 - Healthcare-associated infections",1,"5 - QS113 - Healthcare-associated infections - Process - 1","The number in the denominator where information on infections and associated treatments is received.","The number of admissions to hospital of people with infections."]
[null,"QS113","Healthcare-associated infections",5,null,"People admitted to, discharged from, or transferred between or within hospitals, have information about any infections and associated treatments shared with health and social care staff to inform their care","Proportion of discharges from hospital, including transfers of patients to other hospitals, where information on infections and associated treatments is provided to health and social care staff responsible for ongoing care","Process","QS113 - Healthcare-associated infections","5 - QS113 - Healthcare-associated infections",2,"5 - QS113 - Healthcare-associated infections - Process - 2","The number in the denominator where information on infections and associated treatments is provided.","The number of discharges from hospital of people with infections."]
[null,"QS113","Healthcare-associated infections",5,null,"People admitted to, discharged from, or transferred between or within hospitals, have information about any infections and associated treatments shared with health and social care staff to inform their care","Proportion of transfers of patients within a hospital where information on infections and associated treatments is provided to health care staff responsible for ongoing care","Process","QS113 - Healthcare-associated infections","5 - QS113 - Healthcare-associated infections",3,"5 - QS113 - Healthcare-associated infections - Process - 3","The number in the denominator where information on infections and associated treatments is provided to health care staff responsible for ongoing care.","The number of transfers of patients between wards within a hospital."]
[null,"QS114","Irritable bowel syndrome in adults",1,null,"Adults with symptoms of irritable bowel syndrome are offered tests for inflammatory markers as first-line investigation to exclude inflammatory causes.","Evidence of local arrangements to ensure that adults with symptoms of irritable bowel syndrome are offered tests for inflammatory markers as first-line investigation to exclude inflammatory causes.","Structure","QS114 - Irritable bowel syndrome in adults","1 - QS114 - Irritable bowel syndrome in adults",1,"1 - QS114 - Irritable bowel syndrome in adults - Structure - 1"]
[null,"QS114","Irritable bowel syndrome in adults",1,null,"Adults with symptoms of irritable bowel syndrome are offered tests for inflammatory markers as first-line investigation to exclude inflammatory causes.","Proportion of adults with symptoms of irritable bowel syndrome that have tests for inflammatory markers as first-line investigation to exclude inflammatory causes","Process","QS114 - Irritable bowel syndrome in adults","1 - QS114 - Irritable bowel syndrome in adults",1,"1 - QS114 - Irritable bowel syndrome in adults - Process - 1","The number in the denominator who have tests for inflammatory markers as first‑line investigation to exclude inflammatory causes.","The number of adults with symptoms of irritable bowel syndrome."]
[null,"QS114","Irritable bowel syndrome in adults",1,null,"Adults with symptoms of irritable bowel syndrome are offered tests for inflammatory markers as first-line investigation to exclude inflammatory causes.","Number of adults diagnosed with irritable bowel syndrome.","Outcome","QS114 - Irritable bowel syndrome in adults","1 - QS114 - Irritable bowel syndrome in adults",1,"1 - QS114 - Irritable bowel syndrome in adults - Outcome - 1"]
[null,"QS114","Irritable bowel syndrome in adults",2,null,"Adults with symptoms of irritable bowel syndrome are given a positive diagnosis if no red flag indicators are present and investigations identify no other cause of symptoms.","Evidence of local arrangements to ensure that adults with symptoms of irritable bowel syndrome are given a positive diagnosis if no red flag indicators are present and investigations identify no other cause of symptoms.","Structure","QS114 - Irritable bowel syndrome in adults","2 - QS114 - Irritable bowel syndrome in adults",1,"2 - QS114 - Irritable bowel syndrome in adults - Structure - 1"]
[null,"QS114","Irritable bowel syndrome in adults",2,null,"Adults with symptoms of irritable bowel syndrome are given a positive diagnosis if no red flag indicators are present and investigations identify no other cause of symptoms.","Proportion of adults with symptoms of irritable bowel syndrome who receive a positive diagnosis if no red flag indicators are present and investigations identify no other cause of symptoms.","Process","QS114 - Irritable bowel syndrome in adults","2 - QS114 - Irritable bowel syndrome in adults",1,"2 - QS114 - Irritable bowel syndrome in adults - Process - 1","The number in the denominator who receive a positive diagnosis of irritable bowel syndrome.","The number of adults with symptoms of irritable bowel syndrome who have no red flag indicators and investigations identify no other cause of symptoms."]
[null,"QS114","Irritable bowel syndrome in adults",2,null,"Adults with symptoms of irritable bowel syndrome are given a positive diagnosis if no red flag indicators are present and investigations identify no other cause of symptoms.","Incidence of irritable bowel syndrome.","Outcome","QS114 - Irritable bowel syndrome in adults","2 - QS114 - Irritable bowel syndrome in adults",1,"2 - QS114 - Irritable bowel syndrome in adults - Outcome - 1"]
[null,"QS114","Irritable bowel syndrome in adults",2,null,"Adults with symptoms of irritable bowel syndrome are given a positive diagnosis if no red flag indicators are present and investigations identify no other cause of symptoms.","Satisfaction with the irritable bowel syndrome diagnostic process. ","Outcome","QS114 - Irritable bowel syndrome in adults","2 - QS114 - Irritable bowel syndrome in adults",2,"2 - QS114 - Irritable bowel syndrome in adults - Outcome - 2"]
[null,"QS114","Irritable bowel syndrome in adults",3,null,"Adults with irritable bowel syndrome are offered advice on further dietary management if their symptoms persist after they have followed general lifestyle and dietary advice.","Evidence of local arrangements to ensure that adults with irritable bowel syndrome are offered advice on further dietary management if their symptoms persist after they have followed general lifestyle and dietary advice. ","Structure","QS114 - Irritable bowel syndrome in adults","3 - QS114 - Irritable bowel syndrome in adults",1,"3 - QS114 - Irritable bowel syndrome in adults - Structure - 1"]
[null,"QS114","Irritable bowel syndrome in adults",3,null,"Adults with irritable bowel syndrome are offered advice on further dietary management if their symptoms persist after they have followed general lifestyle and dietary advice.","Proportion of adults with irritable bowel syndrome who are offered advice on further dietary management if their symptoms persist after they have followed general lifestyle and dietary advice for an agreed time.","Process","QS114 - Irritable bowel syndrome in adults","3 - QS114 - Irritable bowel syndrome in adults",1,"3 - QS114 - Irritable bowel syndrome in adults - Process - 1","The number in the denominator who receive advice on further dietary management.","The number of adults with irritable bowel syndrome whose symptoms persist after they have followed general lifestyle and dietary advice for an agreed time."]
[null,"QS114","Irritable bowel syndrome in adults",3,null,"Adults with irritable bowel syndrome are offered advice on further dietary management if their symptoms persist after they have followed general lifestyle and dietary advice.","People with irritable bowel syndrome feel confident to manage their condition","Outcome","QS114 - Irritable bowel syndrome in adults","3 - QS114 - Irritable bowel syndrome in adults",1,"3 - QS114 - Irritable bowel syndrome in adults - Outcome - 1"]
[null,"QS114","Irritable bowel syndrome in adults",3,null,"Adults with irritable bowel syndrome are offered advice on further dietary management if their symptoms persist after they have followed general lifestyle and dietary advice.","Satisfaction with care received for irritable bowel syndrome","Outcome","QS114 - Irritable bowel syndrome in adults","3 - QS114 - Irritable bowel syndrome in adults",2,"3 - QS114 - Irritable bowel syndrome in adults - Outcome - 2"]
[null,"QS114","Irritable bowel syndrome in adults",4,null,"Adults with irritable bowel syndrome agree their follow-up with their healthcare professional. ","Evidence of local arrangements to ensure that adults with irritable bowel syndrome agree their follow-up with their healthcare professional. ","Structure","QS114 - Irritable bowel syndrome in adults","4 - QS114 - Irritable bowel syndrome in adults",1,"4 - QS114 - Irritable bowel syndrome in adults - Structure - 1"]
[null,"QS114","Irritable bowel syndrome in adults",4,null,"Adults with irritable bowel syndrome agree their follow-up with their healthcare professional. ","Evidence of local arrangements (for example through local protocols on appointment reminders) to ensure that adults with irritable bowel syndrome have follow-up as agreed with their healthcare professional.","Structure","QS114 - Irritable bowel syndrome in adults","4 - QS114 - Irritable bowel syndrome in adults",2,"4 - QS114 - Irritable bowel syndrome in adults - Structure - 2"]
[null,"QS114","Irritable bowel syndrome in adults",4,null,"Adults with irritable bowel syndrome agree their follow-up with their healthcare professional. ","Proportion of adults with irritable bowel syndrome who agree their follow-up arrangements with their healthcare professional. ","Process","QS114 - Irritable bowel syndrome in adults","4 - QS114 - Irritable bowel syndrome in adults",1,"4 - QS114 - Irritable bowel syndrome in adults - Process - 1","The number in the denominator who agree their follow‑up arrangements with their healthcare professional.","The number of adults with irritable bowel syndrome."]
[null,"QS114","Irritable bowel syndrome in adults",4,null,"Adults with irritable bowel syndrome agree their follow-up with their healthcare professional. ","Proportion of adults with irritable bowel syndrome whose follow-up takes place by the date agreed with their healthcare professional. ","Process","QS114 - Irritable bowel syndrome in adults","4 - QS114 - Irritable bowel syndrome in adults",2,"4 - QS114 - Irritable bowel syndrome in adults - Process - 2","The number in the denominator whose follow‑up takes place by the date agreed.","The number of adults with irritable bowel syndrome who have a follow‑up date agreed with their healthcare professional."]
[null,"QS114","Irritable bowel syndrome in adults",4,null,"Adults with irritable bowel syndrome agree their follow-up with their healthcare professional. ","People with irritable bowel syndrome feel confident to manage their condition.","Outcome","QS114 - Irritable bowel syndrome in adults","4 - QS114 - Irritable bowel syndrome in adults",1,"4 - QS114 - Irritable bowel syndrome in adults - Outcome - 1"]
[null,"QS114","Irritable bowel syndrome in adults",4,null,"Adults with irritable bowel syndrome agree their follow-up with their healthcare professional. ","Satisfaction with care received for irritable bowel syndrome. ","Outcome","QS114 - Irritable bowel syndrome in adults","4 - QS114 - Irritable bowel syndrome in adults",2,"4 - QS114 - Irritable bowel syndrome in adults - Outcome - 2"]
[null,"QS115","Antenatal and postnatal mental health ",1,null,"Women of childbearing potential are not prescribed valproate to treat a mental health problem.","Evidence of practice arrangements and written clinical protocols to ensure that women of childbearing potential are not prescribed valproate to treat a mental health problem.","Structure","QS115 - Antenatal and postnatal mental health ","1 - QS115 - Antenatal and postnatal mental health ",1,"1 - QS115 - Antenatal and postnatal mental health  - Structure - 1"]
[null,"QS115","Antenatal and postnatal mental health ",1,null,"Women of childbearing potential are not prescribed valproate to treat a mental health problem.","Proportion of women of childbearing potential prescribed valproate to treat a mental health problem.","Process","QS115 - Antenatal and postnatal mental health ","1 - QS115 - Antenatal and postnatal mental health ",1,"1 - QS115 - Antenatal and postnatal mental health  - Process - 1","The number in the denominator prescribed valproate to treat a mental health problem.","The number of women who are of childbearing potential."]
[null,"QS115","Antenatal and postnatal mental health ",1,null,"Women of childbearing potential are not prescribed valproate to treat a mental health problem.","Children with serious developmental disorders or congenital malformations born to mothers who took valproate in pregnancy for treatment of a mental health problem.","Outcome","QS115 - Antenatal and postnatal mental health ","1 - QS115 - Antenatal and postnatal mental health ",1,"1 - QS115 - Antenatal and postnatal mental health  - Outcome - 1"]
[null,"QS115","Antenatal and postnatal mental health ",2,null,"Women of childbearing potential with a severe mental health problem are given information at their annual review about how their mental health problem and its treatment might affect them or their baby if they become pregnant.","Evidence of local arrangements to ensure that women of childbearing potential with a severe mental health problem are given information at their annual review about how their mental health problem and its treatment might affect them or their baby if they become pregnant.","Structure","QS115 - Antenatal and postnatal mental health ","2 - QS115 - Antenatal and postnatal mental health ",1,"2 - QS115 - Antenatal and postnatal mental health  - Structure - 1"]
[null,"QS115","Antenatal and postnatal mental health ",2,null,"Women of childbearing potential with a severe mental health problem are given information at their annual review about how their mental health problem and its treatment might affect them or their baby if they become pregnant.","Proportion of women of childbearing potential with a severe mental health problem given information at their annual review about how their mental health problem and its treatment might affect them or their baby if they become pregnant.","Process","QS115 - Antenatal and postnatal mental health ","2 - QS115 - Antenatal and postnatal mental health ",1,"2 - QS115 - Antenatal and postnatal mental health  - Process - 1","The number in the denominator who have received information as part of their annual review about how their mental health problem and its treatment might affect them or their baby if they become pregnant.","The number of women of childbearing potential with a severe mental health problem having an annual review."]
[null,"QS115","Antenatal and postnatal mental health ",3,null,"Pregnant women with a previous severe mental health problem or any current mental health problem are given information at their booking appointment about how their mental health problem and its treatment might affect them or their baby.","Evidence of local arrangements to ensure that women with a previous severe mental health problem or any current mental health problem are given information at their booking appointment about how their mental health problem and its treatment might affect them or their baby.","Structure","QS115 - Antenatal and postnatal mental health ","3 - QS115 - Antenatal and postnatal mental health ",1,"3 - QS115 - Antenatal and postnatal mental health  - Structure - 1"]
[null,"QS115","Antenatal and postnatal mental health ",3,null,"Pregnant women with a previous severe mental health problem or any current mental health problem are given information at their booking appointment about how their mental health problem and its treatment might affect them or their baby.","Proportion of pregnant women with a previous severe mental health problem or any current mental health problem who are given information at their booking appointment about how their mental health problem and its treatment might affect them or their baby.","Process","QS115 - Antenatal and postnatal mental health ","3 - QS115 - Antenatal and postnatal mental health ",1,"3 - QS115 - Antenatal and postnatal mental health  - Process - 1","The number in the denominator who have received information about how their mental health problem and its treatment might affect them or their baby.","The number of pregnant women with a previous severe mental health problem or any current mental health problem attending their booking appointment."]
[null,"QS115","Antenatal and postnatal mental health ",4,null,"Women are asked about their emotional wellbeing at each routine antenatal and postnatal contact.","Evidence of arrangements for healthcare professionals to ask women about their emotional wellbeing at all routine antenatal and postnatal contacts.","Structure","QS115 - Antenatal and postnatal mental health ","4 - QS115 - Antenatal and postnatal mental health ",1,"4 - QS115 - Antenatal and postnatal mental health  - Structure - 1"]
[null,"QS115","Antenatal and postnatal mental health ",4,null,"Women are asked about their emotional wellbeing at each routine antenatal and postnatal contact.","The proportion of routine antenatal and postnatal contacts at which woman are asked about their emotional wellbeing by a healthcare professional.","Process","QS115 - Antenatal and postnatal mental health ","4 - QS115 - Antenatal and postnatal mental health ",1,"4 - QS115 - Antenatal and postnatal mental health  - Process - 1","The number in the denominator at which women were asked about their emotional wellbeing by a healthcare professional.","The number of routine antenatal and postnatal contacts."]
[null,"QS115","Antenatal and postnatal mental health ",4,null,"Women are asked about their emotional wellbeing at each routine antenatal and postnatal contact.","Women's satisfaction with being able to discuss any concerns or worries at routine appointments.","Outcome","QS115 - Antenatal and postnatal mental health ","4 - QS115 - Antenatal and postnatal mental health ",1,"4 - QS115 - Antenatal and postnatal mental health  - Outcome - 1"]
[null,"QS115","Antenatal and postnatal mental health ",4,null,"Women are asked about their emotional wellbeing at each routine antenatal and postnatal contact.","Identification of mental health problems.","Outcome","QS115 - Antenatal and postnatal mental health ","4 - QS115 - Antenatal and postnatal mental health ",2,"4 - QS115 - Antenatal and postnatal mental health  - Outcome - 2"]
[null,"QS115","Antenatal and postnatal mental health ",5,null,"Women with a suspected mental health problem in pregnancy or the postnatal period receive a comprehensive mental health assessment.","Evidence of local arrangements and written protocols to ensure that women with a suspected mental health problem in pregnancy or the postnatal period receive a comprehensive mental health assessment.","Structure","QS115 - Antenatal and postnatal mental health ","5 - QS115 - Antenatal and postnatal mental health ",1,"5 - QS115 - Antenatal and postnatal mental health  - Structure - 1"]
[null,"QS115","Antenatal and postnatal mental health ",5,null,"Women with a suspected mental health problem in pregnancy or the postnatal period receive a comprehensive mental health assessment.","Proportion of women with a suspected mental health problem in pregnancy or within 12 months of giving birth who receive a comprehensive mental health assessment.","Process","QS115 - Antenatal and postnatal mental health ","5 - QS115 - Antenatal and postnatal mental health ",1,"5 - QS115 - Antenatal and postnatal mental health  - Process - 1","The number in the denominator who receive a comprehensive mental health assessment.","The number of women with a suspected mental health problem who are pregnant or have given birth within the past 12 months."]
[null,"QS115","Antenatal and postnatal mental health ",6,null,"Women referred for psychological interventions in pregnancy or the postnatal period start treatment within 6 weeks of referral.","Evidence of local arrangements to ensure psychological interventions can be started within 6 weeks of referral for women with a mental health problem in pregnancy or who have a mental health problem in the postnatal period.","Structure","QS115 - Antenatal and postnatal mental health ","6 - QS115 - Antenatal and postnatal mental health ",1,"6 - QS115 - Antenatal and postnatal mental health  - Structure - 1"]
[null,"QS115","Antenatal and postnatal mental health ",6,null,"Women referred for psychological interventions in pregnancy or the postnatal period start treatment within 6 weeks of referral.","Proportion of women referred for psychological interventions in pregnancy or within 12 months of giving birth who are assessed for treatment within 2 weeks of referral.","Process","QS115 - Antenatal and postnatal mental health ","6 - QS115 - Antenatal and postnatal mental health ",1,"6 - QS115 - Antenatal and postnatal mental health  - Process - 1","Number of women in the denominator who are assessed for treatment within 2 weeks of referral.","The number of women referred for psychological interventions in pregnancy or within 12 months of giving birth."]
[null,"QS115","Antenatal and postnatal mental health ",6,null,"Women referred for psychological interventions in pregnancy or the postnatal period start treatment within 6 weeks of referral.","Proportion of women assessed as appropriate for psychological interventions in pregnancy or within 12 months of giving birth who start psychological interventions within 4 weeks of assessment.","Process","QS115 - Antenatal and postnatal mental health ","6 - QS115 - Antenatal and postnatal mental health ",2,"6 - QS115 - Antenatal and postnatal mental health  - Process - 2","Number of women in the denominator who start psychological interventions within 4 weeks of assessment.","Number of women assessed as appropriate for psychological interventions in pregnancy or within 12 months of giving birth."]
[null,"QS115","Antenatal and postnatal mental health ",7,null,"Specialist multidisciplinary perinatal community services and inpatient psychiatric mother and baby units are available to support women with a mental health problem in pregnancy or the postnatal period.","Evidence of local arrangements to provide specialist multidisciplinary perinatal community services.","Structure","QS115 - Antenatal and postnatal mental health ","7 - QS115 - Antenatal and postnatal mental health ",1,"7 - QS115 - Antenatal and postnatal mental health  - Structure - 1"]
[null,"QS115","Antenatal and postnatal mental health ",7,null,"Specialist multidisciplinary perinatal community services and inpatient psychiatric mother and baby units are available to support women with a mental health problem in pregnancy or the postnatal period.","Evidence of local arrangements to ensure that women needing inpatient care for a mental health problem within 12 months of childbirth can be admitted to an inpatient psychiatric mother and baby unit.","Structure","QS115 - Antenatal and postnatal mental health ","7 - QS115 - Antenatal and postnatal mental health ",2,"7 - QS115 - Antenatal and postnatal mental health  - Structure - 2"]
[null,"QS115","Antenatal and postnatal mental health ",7,null,"Specialist multidisciplinary perinatal community services and inpatient psychiatric mother and baby units are available to support women with a mental health problem in pregnancy or the postnatal period.","Evidence of referral arrangements for women with a severe mental health problem to be referred to specialist multidisciplinary perinatal community services and inpatient psychiatric mother and baby units.","Structure","QS115 - Antenatal and postnatal mental health ","7 - QS115 - Antenatal and postnatal mental health ",3,"7 - QS115 - Antenatal and postnatal mental health  - Structure - 3"]
[null,"QS116","Domestic violence and abuse",1,null,"People presenting to frontline staff with indicators of possible domestic violence or abuse are asked about their experiences in a private discussion.","Evidence of local arrangements to ensure that people presenting to frontline staff with indicators of possible domestic violence or abuse are asked about their experiences in a private discussion.","Structure","QS116 - Domestic violence and abuse","1 - QS116 - Domestic violence and abuse",1,"1 - QS116 - Domestic violence and abuse - Structure - 1"]
[null,"QS116","Domestic violence and abuse",1,null,"People presenting to frontline staff with indicators of possible domestic violence or abuse are asked about their experiences in a private discussion.","Proportion of people presenting to frontline staff with indicators of possible domestic violence or abuse who are asked about their experiences in a private discussion. ","Process","QS116 - Domestic violence and abuse","1 - QS116 - Domestic violence and abuse",1,"1 - QS116 - Domestic violence and abuse - Process - 1","The number in the denominator who are asked if they have experienced domestic violence or abuse in a private discussion.","The number of people presenting to frontline staff with indicators of domestic violence or abuse."]
[null,"QS116","Domestic violence and abuse",1,null,"People presenting to frontline staff with indicators of possible domestic violence or abuse are asked about their experiences in a private discussion.","Incidence of domestic violence and abuse. ","Outcome","QS116 - Domestic violence and abuse","1 - QS116 - Domestic violence and abuse",1,"1 - QS116 - Domestic violence and abuse - Outcome - 1"]
[null,"QS116","Domestic violence and abuse",2,null,"People experiencing domestic violence and abuse receive a response from level 1 or 2 trained staff.","Evidence of local arrangements to ensure that staff are trained to level 1 or 2 to respond to domestic violence and abuse.","Structure","QS116 - Domestic violence and abuse","2 - QS116 - Domestic violence and abuse",1,"2 - QS116 - Domestic violence and abuse - Structure - 1"]
[null,"QS116","Domestic violence and abuse",2,null,"People experiencing domestic violence and abuse receive a response from level 1 or 2 trained staff.","Proportion of people experiencing domestic violence or abuse who receive a response from level 1 or 2 trained staff.","Process","QS116 - Domestic violence and abuse","2 - QS116 - Domestic violence and abuse",1,"2 - QS116 - Domestic violence and abuse - Process - 1","The number in the denominator who receive a response from level 1 or 2 trained staff.","The number of people who disclose or are asked if they are experiencing domestic violence or abuse."]
[null,"QS116","Domestic violence and abuse",2,null,"People experiencing domestic violence and abuse receive a response from level 1 or 2 trained staff.","Safety of people experiencing domestic violence and abuse. ","Outcome","QS116 - Domestic violence and abuse","2 - QS116 - Domestic violence and abuse",1,"2 - QS116 - Domestic violence and abuse - Outcome - 1"]
[null,"QS116","Domestic violence and abuse",3,null,"People experiencing domestic violence or abuse are offered referral to specialist support services. ","Evidence of local referral pathways to ensure that people experiencing domestic violence or abuse are referred to specialist support services.","Structure","QS116 - Domestic violence and abuse","3 - QS116 - Domestic violence and abuse",1,"3 - QS116 - Domestic violence and abuse - Structure - 1"]
[null,"QS116","Domestic violence and abuse",3,null,"People experiencing domestic violence or abuse are offered referral to specialist support services. ","Evidence of local arrangements to ensure that specialist support services are available for people experiencing domestic violence or abuse.","Structure","QS116 - Domestic violence and abuse","3 - QS116 - Domestic violence and abuse",2,"3 - QS116 - Domestic violence and abuse - Structure - 2"]
[null,"QS116","Domestic violence and abuse",3,null,"People experiencing domestic violence or abuse are offered referral to specialist support services. ","Proportion of people who disclose that they are experiencing domestic violence or abuse who are referred to specialist support services.","Process","QS116 - Domestic violence and abuse","3 - QS116 - Domestic violence and abuse",1,"3 - QS116 - Domestic violence and abuse - Process - 1","The number in the denominator who are referred to specialist services.","The number of people who disclose that they are experiencing domestic violence or abuse."]
[null,"QS116","Domestic violence and abuse",3,null,"People experiencing domestic violence or abuse are offered referral to specialist support services. ","Satisfaction with specialist support services.","Outcome","QS116 - Domestic violence and abuse","3 - QS116 - Domestic violence and abuse",1,"3 - QS116 - Domestic violence and abuse - Outcome - 1"]
[null,"QS116","Domestic violence and abuse",4,null,"People who disclose that they are perpetrating domestic violence or abuse are offered referral to specialist services.","Evidence of local referral pathways to ensure that people who disclose that they are perpetrating domestic violence or abuse are referred to specialist services.","Structure","QS116 - Domestic violence and abuse","4 - QS116 - Domestic violence and abuse",1,"4 - QS116 - Domestic violence and abuse - Structure - 1"]
[null,"QS116","Domestic violence and abuse",4,null,"People who disclose that they are perpetrating domestic violence or abuse are offered referral to specialist services.","Evidence of local arrangements to ensure that specialist services are available to support people who disclose that they are perpetrating domestic violence or abuse.","Structure","QS116 - Domestic violence and abuse","4 - QS116 - Domestic violence and abuse",2,"4 - QS116 - Domestic violence and abuse - Structure - 2"]
[null,"QS116","Domestic violence and abuse",4,null,"People who disclose that they are perpetrating domestic violence or abuse are offered referral to specialist services.","Proportion of people who disclose that they are perpetrating domestic violence or abuse who are referred to specialist services.","Process","QS116 - Domestic violence and abuse","4 - QS116 - Domestic violence and abuse",1,"4 - QS116 - Domestic violence and abuse - Process - 1","The number in the denominator who are referred to specialist services.","The number of people who disclose that they are perpetrating domestic violence or abuse."]
[null,"QS116","Domestic violence and abuse",4,null,"People who disclose that they are perpetrating domestic violence or abuse are offered referral to specialist services.","Reduction in repeated domestic violence and abuse. ","Outcome","QS116 - Domestic violence and abuse","4 - QS116 - Domestic violence and abuse",1,"4 - QS116 - Domestic violence and abuse - Outcome - 1"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",1,null,"Local populations who are vulnerable to the health problems associated with a cold home are identified through year-round planning by local health and social care commissioners and providers.","Evidence of local arrangements for multi-stakeholder winter planning meetings for collaboration on year-round planning to identify local populations who are vulnerable to the health problems associated with a cold home.","Structure","QS117 - Preventing excess winter deaths and illness associated with cold homes","1 - QS117 - Preventing excess winter deaths and illness associated with cold homes",1,"1 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Structure - 1"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",1,null,"Local populations who are vulnerable to the health problems associated with a cold home are identified through year-round planning by local health and social care commissioners and providers.","Evidence of a local winter plan.","Structure","QS117 - Preventing excess winter deaths and illness associated with cold homes","1 - QS117 - Preventing excess winter deaths and illness associated with cold homes",2,"1 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Structure - 2"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",1,null,"Local populations who are vulnerable to the health problems associated with a cold home are identified through year-round planning by local health and social care commissioners and providers.","Evidence of local action to support Public Health England's Cold weather plan for England.","Structure","QS117 - Preventing excess winter deaths and illness associated with cold homes","1 - QS117 - Preventing excess winter deaths and illness associated with cold homes",3,"1 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Structure - 3"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",1,null,"Local populations who are vulnerable to the health problems associated with a cold home are identified through year-round planning by local health and social care commissioners and providers.","Identification of local populations vulnerable to the health problems associated with a cold home.","Outcome","QS117 - Preventing excess winter deaths and illness associated with cold homes","1 - QS117 - Preventing excess winter deaths and illness associated with cold homes",1,"1 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Outcome - 1"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",2,null,"Local health and social care commissioners and providers share data to identify people who are vulnerable to the health problems associated with a cold home.","Evidence of local arrangements for multi-stakeholder winter planning meetings for data sharing to identify people who are vulnerable to the health problems associated with a cold home.","Structure","QS117 - Preventing excess winter deaths and illness associated with cold homes","2 - QS117 - Preventing excess winter deaths and illness associated with cold homes",1,"2 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Structure - 1"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",2,null,"Local health and social care commissioners and providers share data to identify people who are vulnerable to the health problems associated with a cold home.","Evidence of local data-sharing arrangements and analysis to enable identification of people who are vulnerable to the health problems associated with a cold home.","Structure","QS117 - Preventing excess winter deaths and illness associated with cold homes","2 - QS117 - Preventing excess winter deaths and illness associated with cold homes",2,"2 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Structure - 2"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",2,null,"Local health and social care commissioners and providers share data to identify people who are vulnerable to the health problems associated with a cold home.","Identification of people who are vulnerable to the health problems associated with a cold home.","Outcome","QS117 - Preventing excess winter deaths and illness associated with cold homes",{"$f":"CONCATENATE(D2558, \" - \", I2558)","v":"2 - QS117 - Preventing excess winter deaths and illness associated with cold homes"},{"$f":"IF(AND(B2558=B2557, D2558=D2557, H2558=H2557)=TRUE, K2557+1, 1)","v":1},{"$f":"CONCATENATE(J2558, \" - \", H2558, \" - \",K2558)","v":"2 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Outcome - 1"}]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",3,null,"People who are vulnerable to the health problems associated with a cold home receive tailored support with help from a local single-point-of-contact health and housing referral service.","Evidence of local arrangements to ensure that people who are vulnerable to the health problems associated with a cold home receive tailored support with help from a local single-point-of-contact health and housing referral service.","Structure","QS117 - Preventing excess winter deaths and illness associated with cold homes","3 - QS117 - Preventing excess winter deaths and illness associated with cold homes",1,"3 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Structure - 1"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",3,null,"People who are vulnerable to the health problems associated with a cold home receive tailored support with help from a local single-point-of-contact health and housing referral service.","Proportion of people identified as being vulnerable to the health problems associated with a cold home who are referred to the local single-point-of-contact health and housing referral service.","Process","QS117 - Preventing excess winter deaths and illness associated with cold homes","3 - QS117 - Preventing excess winter deaths and illness associated with cold homes",1,"3 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Process - 1","The number in the denominator who are referred to the single‑point‑of‑contact health and housing referral service.","The number of people identified as being vulnerable to the health problems associated with a cold home."]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",3,null,"People who are vulnerable to the health problems associated with a cold home receive tailored support with help from a local single-point-of-contact health and housing referral service.","Proportion of people identified as being vulnerable to the health problems associated with a cold home and referred to the single-point-of-contact health and housing referral service whose tailored support needs are agreed.","Process","QS117 - Preventing excess winter deaths and illness associated with cold homes","3 - QS117 - Preventing excess winter deaths and illness associated with cold homes",2,"3 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Process - 2","The number in the denominator whose tailored support needs are agreed.","The number of people identified as being vulnerable to the health problems associated with a cold home and referred to the single‑point‑of‑contact health and housing referral service."]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",3,null,"People who are vulnerable to the health problems associated with a cold home receive tailored support with help from a local single-point-of-contact health and housing referral service.","Proportion of people identified as being vulnerable to the health problems associated with a cold home with tailored support needs agreed with the single-point-of-contact health and housing referral service whose needs were met.","Process","QS117 - Preventing excess winter deaths and illness associated with cold homes","3 - QS117 - Preventing excess winter deaths and illness associated with cold homes",3,"3 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Process - 3","The number in the denominator whose needs were met.","The number of people identified as being vulnerable to the health problems associated with a cold home whose tailored support needs were agreed with the single‑point‑of‑contact health and housing referral service."]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",3,null,"People who are vulnerable to the health problems associated with a cold home receive tailored support with help from a local single-point-of-contact health and housing referral service.","Proportion of people identified as being vulnerable to the health problems associated with a cold home and referred to the single-point-of-contact health and housing referral service who are no longer vulnerable to the health problems associated with a cold home.","Process",{"$f":"CONCATENATE(B2563, \" - \", C2563)","v":"QS117 - Preventing excess winter deaths and illness associated with cold homes"},"3 - QS117 - Preventing excess winter deaths and illness associated with cold homes",4,"3 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Process - 4","The number in the denominator no longer considered vulnerable to the health problems associated with a cold home.","The number of people identified as being vulnerable to the health problems associated with a cold home and referred to the single‑point‑of‑contact health and housing referral service."]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",3,null,"People who are vulnerable to the health problems associated with a cold home receive tailored support with help from a local single-point-of-contact health and housing referral service.","People who used the local single-point-of-contact health and housing referral service who feel able to manage their home heating needs.","Outcome","QS117 - Preventing excess winter deaths and illness associated with cold homes","3 - QS117 - Preventing excess winter deaths and illness associated with cold homes",1,"3 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Outcome - 1"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",3,null,"People who are vulnerable to the health problems associated with a cold home receive tailored support with help from a local single-point-of-contact health and housing referral service.","The number of people living in fuel poverty.","Outcome","QS117 - Preventing excess winter deaths and illness associated with cold homes","3 - QS117 - Preventing excess winter deaths and illness associated with cold homes",2,"3 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Outcome - 2"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",4,null,"People who are vulnerable to the health problems associated with a cold home are asked at least once a year whether they have difficulty keeping warm at home by their primary or community healthcare or home care practitioners.","Evidence of local protocols to define people who are vulnerable to the health problems associated with a cold home.","Structure","QS117 - Preventing excess winter deaths and illness associated with cold homes","4 - QS117 - Preventing excess winter deaths and illness associated with cold homes",1,"4 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Structure - 1"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",4,null,"People who are vulnerable to the health problems associated with a cold home are asked at least once a year whether they have difficulty keeping warm at home by their primary or community healthcare or home care practitioners.","Evidence of local protocols for primary healthcare professionals to ask people who are vulnerable to the health problems associated with a cold home at least once a year whether they have difficulty keeping warm at home.","Structure","QS117 - Preventing excess winter deaths and illness associated with cold homes","4 - QS117 - Preventing excess winter deaths and illness associated with cold homes",2,"4 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Structure - 2"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",4,null,"People who are vulnerable to the health problems associated with a cold home are asked at least once a year whether they have difficulty keeping warm at home by their primary or community healthcare or home care practitioners.","Evidence of local protocols for community healthcare practitioners to ask people who are vulnerable to the health problems associated with a cold home at least once a year whether they have difficulty keeping warm at home.","Structure","QS117 - Preventing excess winter deaths and illness associated with cold homes","4 - QS117 - Preventing excess winter deaths and illness associated with cold homes",3,"4 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Structure - 3"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",4,null,"People who are vulnerable to the health problems associated with a cold home are asked at least once a year whether they have difficulty keeping warm at home by their primary or community healthcare or home care practitioners.","Evidence of local protocols for home care practitioners to ask the people they visit at home who are vulnerable to the health problems associated with a cold home at least once a year whether they have difficulty keeping warm at home.","Structure","QS117 - Preventing excess winter deaths and illness associated with cold homes","4 - QS117 - Preventing excess winter deaths and illness associated with cold homes",4,"4 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Structure - 4"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",4,null,"People who are vulnerable to the health problems associated with a cold home are asked at least once a year whether they have difficulty keeping warm at home by their primary or community healthcare or home care practitioners.","Proportion of people who are identified as being vulnerable to the health problems associated with a cold home who are asked at least once a year whether they have difficulty keeping warm at home by primary healthcare practitioners.","Process","QS117 - Preventing excess winter deaths and illness associated with cold homes","4 - QS117 - Preventing excess winter deaths and illness associated with cold homes",1,"4 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Process - 1","The number in the denominator who are asked at least once a year whether they have difficulty keeping warm at home by primary healthcare practitioners.","The number of people who are identified as vulnerable to the health problems associated with a cold home."]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",4,null,"People who are vulnerable to the health problems associated with a cold home are asked at least once a year whether they have difficulty keeping warm at home by their primary or community healthcare or home care practitioners.","Proportion of people who are identified as being vulnerable to the health problems associated with a cold home who are asked at least once a year whether they have difficulty keeping warm at home by community healthcare practitioners.","Process","QS117 - Preventing excess winter deaths and illness associated with cold homes","4 - QS117 - Preventing excess winter deaths and illness associated with cold homes",2,"4 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Process - 2","The number in the denominator who are asked at least once a year whether they have difficulty keeping warm at home by community healthcare practitioners.","The number of people who are identified as vulnerable to the health problems associated with a cold home."]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",4,null,"People who are vulnerable to the health problems associated with a cold home are asked at least once a year whether they have difficulty keeping warm at home by their primary or community healthcare or home care practitioners.","Proportion of people who are identified as being vulnerable to the health problems associated with a cold home who receive home care who are asked at least once a year whether they have difficulty keeping warm at home by home care practitioners.","Process","QS117 - Preventing excess winter deaths and illness associated with cold homes","4 - QS117 - Preventing excess winter deaths and illness associated with cold homes",3,"4 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Process - 3","The number in the denominator who are asked at least once a year whether they have difficulty keeping warm at home by home care practitioners.","The number of people who are identified as being vulnerable to the health problems associated with a cold home who receive home care."]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",4,null,"People who are vulnerable to the health problems associated with a cold home are asked at least once a year whether they have difficulty keeping warm at home by their primary or community healthcare or home care practitioners.","Referral rates to a local single-point-of-contact health and housing referral service.","Outcome","QS117 - Preventing excess winter deaths and illness associated with cold homes","4 - QS117 - Preventing excess winter deaths and illness associated with cold homes",1,"4 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Outcome - 1"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",5,null,"Hospitals, mental health services and social care services identify people who are vulnerable to health problems associated with a cold home as part of the admission process.","Evidence that care settings (hospitals, mental health services and social care services) have arrangements to identify people who are vulnerable to the health problems associated with a cold home as part of the admission process.","Structure","QS117 - Preventing excess winter deaths and illness associated with cold homes","5 - QS117 - Preventing excess winter deaths and illness associated with cold homes",1,"5 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Structure - 1"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",5,null,"Hospitals, mental health services and social care services identify people who are vulnerable to health problems associated with a cold home as part of the admission process.","The number of people vulnerable to the health problems associated with a cold home who are identified on admission.","Outcome","QS117 - Preventing excess winter deaths and illness associated with cold homes","5 - QS117 - Preventing excess winter deaths and illness associated with cold homes",1,"5 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Outcome - 1"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",6,null,"People who are vulnerable to the health problems associated with a cold home who will be discharged to their own home from hospital, or a mental health or social care setting have a discharge plan that includes ensuring that their home is warm enough.","Evidence of arrangements for people who are vulnerable to the health problems associated with a cold home who will be discharged to their own home from a care setting to have a discharge plan that includes actions to ensure their home is warm enough.","Structure","QS117 - Preventing excess winter deaths and illness associated with cold homes","6 - QS117 - Preventing excess winter deaths and illness associated with cold homes",1,"6 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Structure - 1"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",6,null,"People who are vulnerable to the health problems associated with a cold home who will be discharged to their own home from hospital, or a mental health or social care setting have a discharge plan that includes ensuring that their home is warm enough.","Proportion of people identified as being vulnerable to the health problems associated with a cold home being discharged to their own home from a care setting who have a discharge plan that includes actions to ensure their home is warm enough.","Process","QS117 - Preventing excess winter deaths and illness associated with cold homes","6 - QS117 - Preventing excess winter deaths and illness associated with cold homes",1,"6 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Process - 1","The number in the denominator who have a discharge plan that includes actions to ensure their home is warm enough.","The number of people identified as being vulnerable to the health problems associated with a cold home being discharged to their own home from a care setting."]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",6,null,"People who are vulnerable to the health problems associated with a cold home who will be discharged to their own home from hospital, or a mental health or social care setting have a discharge plan that includes ensuring that their home is warm enough.","People who are discharged from a care setting who feel able to manage their home heating needs.","Outcome","QS117 - Preventing excess winter deaths and illness associated with cold homes","6 - QS117 - Preventing excess winter deaths and illness associated with cold homes",1,"6 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Outcome - 1"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",6,null,"People who are vulnerable to the health problems associated with a cold home who will be discharged to their own home from hospital, or a mental health or social care setting have a discharge plan that includes ensuring that their home is warm enough.","Delayed transfers of care.","Outcome","QS117 - Preventing excess winter deaths and illness associated with cold homes","6 - QS117 - Preventing excess winter deaths and illness associated with cold homes",2,"6 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Outcome - 2"]
[null,"QS117","Preventing excess winter deaths and illness associated with cold homes",6,null,"People who are vulnerable to the health problems associated with a cold home who will be discharged to their own home from hospital, or a mental health or social care setting have a discharge plan that includes ensuring that their home is warm enough.","Readmission rates.","Outcome","QS117 - Preventing excess winter deaths and illness associated with cold homes","6 - QS117 - Preventing excess winter deaths and illness associated with cold homes",3,"6 - QS117 - Preventing excess winter deaths and illness associated with cold homes - Outcome - 3"]
[null,"QS118","Food allergy",1,null,"Children and young people with suspected food allergy have an allergy-focused clinical history taken.","Evidence of local arrangements and written clinical protocols to ensure that children and young people who present with signs or symptoms of suspected food allergy have an allergy-focused clinical history taken.","Structure","QS118 - Food allergy","1 - QS118 - Food allergy",1,"1 - QS118 - Food allergy - Structure - 1"]
[null,"QS118","Food allergy",1,null,"Children and young people with suspected food allergy have an allergy-focused clinical history taken.","Proportion of children and young people presenting with suspected food allergy who have an allergy-focused clinical history taken.","Process",{"$f":"CONCATENATE(B2582, \" - \", C2582)","v":"QS118 - Food allergy"},{"$f":"CONCATENATE(D2582, \" - \", I2582)","v":"1 - QS118 - Food allergy"},1,"1 - QS118 - Food allergy - Process - 1","The number in the denominator who have an allergy‑focused clinical history taken.","The number of children and young people presenting with suspected food allergy."]
[null,"QS118","Food allergy",1,null,"Children and young people with suspected food allergy have an allergy-focused clinical history taken.","Identification of food allergy.","Outcome",{"$f":"CONCATENATE(B2583, \" - \", C2583)","v":"QS118 - Food allergy"},{"$f":"CONCATENATE(D2583, \" - \", I2583)","v":"1 - QS118 - Food allergy"},1,"1 - QS118 - Food allergy - Outcome - 1"]
[null,"QS118","Food allergy",2,null,"Children and young people whose allergy-focused clinical history suggests an IgE-mediated food allergy are offered skin prick or blood tests for IgE antibodies to the suspected food allergens and likely co-allergens. ","Evidence of local arrangements and written clinical protocols to ensure that children and young people whose allergy-focused clinical history suggests an IgE-mediated food allergy are offered skin prick or blood tests for IgE antibodies to the suspected food allergens and likely co-allergens.","Structure",{"$f":"CONCATENATE(B2584, \" - \", C2584)","v":"QS118 - Food allergy"},{"$f":"CONCATENATE(D2584, \" - \", I2584)","v":"2 - QS118 - Food allergy"},1,"2 - QS118 - Food allergy - Structure - 1"]
[null,"QS118","Food allergy",2,null,"Children and young people whose allergy-focused clinical history suggests an IgE-mediated food allergy are offered skin prick or blood tests for IgE antibodies to the suspected food allergens and likely co-allergens. ","Proportion of children and young people whose allergy-focused clinical history suggests an IgE-mediated food allergy who have skin prick or blood tests for IgE antibodies to the suspected food allergens and likely co-allergens.","Process","QS118 - Food allergy","2 - QS118 - Food allergy",1,"2 - QS118 - Food allergy - Process - 1","The number in the denominator who have skin prick or blood tests for IgE antibodies to the suspected food allergens and likely co‑allergens.","The number of children and young people whose allergy‑focused clinical history suggests an IgE‑mediated food allergy."]
[null,"QS118","Food allergy",2,null,"Children and young people whose allergy-focused clinical history suggests an IgE-mediated food allergy are offered skin prick or blood tests for IgE antibodies to the suspected food allergens and likely co-allergens. ","Incidence of IgE-mediated food allergy.","Outcome","QS118 - Food allergy","2 - QS118 - Food allergy",1,"2 - QS118 - Food allergy - Outcome - 1"]
[null,"QS118","Food allergy",2,null,"Children and young people whose allergy-focused clinical history suggests an IgE-mediated food allergy are offered skin prick or blood tests for IgE antibodies to the suspected food allergens and likely co-allergens. ","Children and young people with IgE-mediated food allergy who feel, or whose families feel, able to manage their condition.","Outcome","QS118 - Food allergy","2 - QS118 - Food allergy",2,"2 - QS118 - Food allergy - Outcome - 2"]
[null,"QS118","Food allergy",3,null,"Children and young people whose allergy-focused clinical history suggests a non-IgE-mediated food allergy, and who have not had a severe delayed reaction, are offered a trial elimination of the suspected allergen and subsequent reintroduction.","Evidence of local arrangements and written clinical protocols to ensure that children and young people whose allergy-focused clinical history suggests a non-IgE-mediated food allergy, and who have not had a severe delayed reaction, are offered a trial elimination of the suspected allergen and subsequent reintroduction.","Structure","QS118 - Food allergy","3 - QS118 - Food allergy",1,"3 - QS118 - Food allergy - Structure - 1"]
[null,"QS118","Food allergy",3,null,"Children and young people whose allergy-focused clinical history suggests a non-IgE-mediated food allergy, and who have not had a severe delayed reaction, are offered a trial elimination of the suspected allergen and subsequent reintroduction.","Proportion of children and young people whose allergy-focused clinical history suggests a non-IgE-mediated food allergy, and who have not had a severe delayed reaction, who are offered a trial elimination of the suspected allergen and subsequent reintroduction.","Process","QS118 - Food allergy","3 - QS118 - Food allergy",1,"3 - QS118 - Food allergy - Process - 1","The number in the denominator who are offered a trial elimination of the suspected allergen and subsequent reintroduction.","The number of children and young people whose allergy‑focused clinical history suggests a non‑IgE‑mediated food allergy, and who have not had a severe delayed reaction."]
[null,"QS118","Food allergy",3,null,"Children and young people whose allergy-focused clinical history suggests a non-IgE-mediated food allergy, and who have not had a severe delayed reaction, are offered a trial elimination of the suspected allergen and subsequent reintroduction.","Incidence of non-IgE-mediated food allergy.","Outcome","QS118 - Food allergy","3 - QS118 - Food allergy",1,"3 - QS118 - Food allergy - Outcome - 1"]
[null,"QS118","Food allergy",3,null,"Children and young people whose allergy-focused clinical history suggests a non-IgE-mediated food allergy, and who have not had a severe delayed reaction, are offered a trial elimination of the suspected allergen and subsequent reintroduction.","Children and young people with IgE-mediated food allergy who feel, or whose families feel, able to manage their condition.","Outcome","QS118 - Food allergy","3 - QS118 - Food allergy",2,"3 - QS118 - Food allergy - Outcome - 2"]
[null,"QS118","Food allergy",4,null,"Children and young people are referred to secondary or specialist allergy care when indicated by their allergy-focused clinical history or diagnostic testing.  ","Evidence of local arrangements and written clinical protocols to ensure that children and young people are referred to secondary or specialist allergy care if indicated by their allergy-focused clinical history or diagnostic testing. ","Structure","QS118 - Food allergy","4 - QS118 - Food allergy",1,"4 - QS118 - Food allergy - Structure - 1"]
[null,"QS118","Food allergy",4,null,"Children and young people are referred to secondary or specialist allergy care when indicated by their allergy-focused clinical history or diagnostic testing.  ","Proportion of children and young people who are referred to secondary or specialist allergy care if their allergy-focused clinical history or diagnostic testing indicates a need for a referral.","Process","QS118 - Food allergy","4 - QS118 - Food allergy",1,"4 - QS118 - Food allergy - Process - 1","The number in the denominator who are referred to secondary or specialist allergy care.","The number of children and young people who have an allergy‑focused clinical history or diagnostic testing that indicates a need for a referral to secondary or specialist allergy care."]
[null,"QS118","Food allergy",4,null,"Children and young people are referred to secondary or specialist allergy care when indicated by their allergy-focused clinical history or diagnostic testing.  ","Identification of food allergy.","Outcome","QS118 - Food allergy","4 - QS118 - Food allergy",1,"4 - QS118 - Food allergy - Outcome - 1"]
[null,"QS118","Food allergy",4,null,"Children and young people are referred to secondary or specialist allergy care when indicated by their allergy-focused clinical history or diagnostic testing.  ","Children and young people with food allergy who feel, or whose families feel, able to manage their condition.","Outcome","QS118 - Food allergy","4 - QS118 - Food allergy",2,"4 - QS118 - Food allergy - Outcome - 2"]
[null,"QS119","Anaphylaxis ",1,null,"People who have emergency treatment for suspected anaphylaxis are referred to a specialist allergy service. ","Evidence of local arrangements and written clinical protocols to ensure that people who have emergency treatment for suspected anaphylaxis are referred to a specialist allergy service.","Structure","QS119 - Anaphylaxis ","1 - QS119 - Anaphylaxis ",1,"1 - QS119 - Anaphylaxis  - Structure - 1"]
[null,"QS119","Anaphylaxis ",1,null,"People who have emergency treatment for suspected anaphylaxis are referred to a specialist allergy service. ","Proportion of cases of emergency treatment for suspected anaphylaxis that are followed by referral to a specialist allergy service.","Process","QS119 - Anaphylaxis ","1 - QS119 - Anaphylaxis ",1,"1 - QS119 - Anaphylaxis  - Process - 1","The number in the denominator that are followed by referral to a specialist allergy service.","The number of cases of emergency treatment for suspected anaphylaxis."]
[null,"QS119","Anaphylaxis ",1,null,"People who have emergency treatment for suspected anaphylaxis are referred to a specialist allergy service. ","People who are vulnerable to anaphylaxis feel able to manage their condition.","Outcome","QS119 - Anaphylaxis ","1 - QS119 - Anaphylaxis ",1,"1 - QS119 - Anaphylaxis  - Outcome - 1"]
[null,"QS119","Anaphylaxis ",2,null,"People who are prescribed an adrenaline auto-injector after emergency treatment for suspected anaphylaxis are given training in how and when to use it before being discharged.  ","Evidence of local arrangements and written protocols to ensure that people who are prescribed an adrenaline auto-injector after emergency treatment for suspected anaphylaxis are given training in how and when to use it before being discharged.","Structure","QS119 - Anaphylaxis ","2 - QS119 - Anaphylaxis ",1,"2 - QS119 - Anaphylaxis  - Structure - 1"]
[null,"QS119","Anaphylaxis ",2,null,"People who are prescribed an adrenaline auto-injector after emergency treatment for suspected anaphylaxis are given training in how and when to use it before being discharged.  ","Proportion of people who are prescribed an adrenaline auto-injector after emergency treatment for suspected anaphylaxis who are given training in how and when to use it before being discharged.","Process","QS119 - Anaphylaxis ","2 - QS119 - Anaphylaxis ",1,"2 - QS119 - Anaphylaxis  - Process - 1","The number in the denominator who are given training in how and when to use an adrenaline auto‑injector before being discharged.","The number of people who are prescribed an adrenaline auto‑injector after emergency treatment for suspected anaphylaxis."]
[null,"QS119","Anaphylaxis ",2,null,"People who are prescribed an adrenaline auto-injector after emergency treatment for suspected anaphylaxis are given training in how and when to use it before being discharged.  ","People who have had a suspected anaphylactic reaction feel able to manage their condition.","Outcome","QS119 - Anaphylaxis ","2 - QS119 - Anaphylaxis ",1,"2 - QS119 - Anaphylaxis  - Outcome - 1"]
[null,"QS119","Anaphylaxis ",2,null,"People who are prescribed an adrenaline auto-injector after emergency treatment for suspected anaphylaxis are given training in how and when to use it before being discharged.  ","Cases of emergency treatment for suspected anaphylaxis after an adrenaline auto-injector has been prescribed. ","Outcome","QS119 - Anaphylaxis ","2 - QS119 - Anaphylaxis ",2,"2 - QS119 - Anaphylaxis  - Outcome - 2"]
[null,"QS119","Anaphylaxis ",3,null,"People who have a systemic reaction to wasp or bee stings are referred to a specialist allergy service to assess whether venom immunotherapy would be suitable. ","Evidence of local arrangements and written protocols to ensure that people who have a systemic reaction to wasp or bee stings are referred to a specialist allergy service to assess whether venom immunotherapy would be suitable.","Structure","QS119 - Anaphylaxis ","3 - QS119 - Anaphylaxis ",1,"3 - QS119 - Anaphylaxis  - Structure - 1"]
[null,"QS119","Anaphylaxis ",3,null,"People who have a systemic reaction to wasp or bee stings are referred to a specialist allergy service to assess whether venom immunotherapy would be suitable. ","Proportion of people who have a systemic reaction to a wasp or bee sting who are referred to a specialist allergy service to assess whether venom immunotherapy would be suitable.","Process","QS119 - Anaphylaxis ","3 - QS119 - Anaphylaxis ",1,"3 - QS119 - Anaphylaxis  - Process - 1","The number in the denominator who are referred to a specialist allergy service to assess whether venom immunotherapy would be suitable.","The number of people presenting with a systemic reaction to a wasp or bee sting."]
[null,"QS119","Anaphylaxis ",3,null,"People who have a systemic reaction to wasp or bee stings are referred to a specialist allergy service to assess whether venom immunotherapy would be suitable. ","Prescriptions of venom immunotherapy. ","Outcome","QS119 - Anaphylaxis ","3 - QS119 - Anaphylaxis ",1,"3 - QS119 - Anaphylaxis  - Outcome - 1"]
[null,"QS119","Anaphylaxis ",3,null,"People who have a systemic reaction to wasp or bee stings are referred to a specialist allergy service to assess whether venom immunotherapy would be suitable. ","Incidence of venom-induced anaphylaxis.","Outcome","QS119 - Anaphylaxis ","3 - QS119 - Anaphylaxis ",2,"3 - QS119 - Anaphylaxis  - Outcome - 2"]
[null,"QS119","Anaphylaxis ",3,null,"People who have a systemic reaction to wasp or bee stings are referred to a specialist allergy service to assess whether venom immunotherapy would be suitable. ","People feel able to manage their condition after treatment for anaphylaxis caused by a wasp or bee sting.","Outcome","QS119 - Anaphylaxis ","3 - QS119 - Anaphylaxis ",3,"3 - QS119 - Anaphylaxis  - Outcome - 3"]
[null,"QS120","Medicines optimisation",1,null,"People are given the opportunity to be involved in making decisions about their medicines.","Evidence that prescribers give people information about the potential benefits and harms of using medicines.","Structure","QS120 - Medicines optimisation","1 - QS120 - Medicines optimisation",1,"1 - QS120 - Medicines optimisation - Structure - 1"]
[null,"QS120","Medicines optimisation",1,null,"People are given the opportunity to be involved in making decisions about their medicines.","Evidence that prescribers take into account people's preferences and values about treatment options that includes the use of medicines.","Structure","QS120 - Medicines optimisation","1 - QS120 - Medicines optimisation",2,"1 - QS120 - Medicines optimisation - Structure - 2"]
[null,"QS120","Medicines optimisation",1,null,"People are given the opportunity to be involved in making decisions about their medicines.","Evidence that prescribers offer people the opportunity to use available decision aids to make informed choices about the use of medicines that take account of the trade‑off between potential benefits and harms.","Structure","QS120 - Medicines optimisation","1 - QS120 - Medicines optimisation",3,"1 - QS120 - Medicines optimisation - Structure - 3"]
[null,"QS120","Medicines optimisation",1,null,"People are given the opportunity to be involved in making decisions about their medicines.","Medicines adherence.","Outcome","QS120 - Medicines optimisation","1 - QS120 - Medicines optimisation",1,"1 - QS120 - Medicines optimisation - Outcome - 1"]
[null,"QS120","Medicines optimisation",1,null,"People are given the opportunity to be involved in making decisions about their medicines.","Patient satisfaction with outcomes from the use of medicines.","Outcome","QS120 - Medicines optimisation","1 - QS120 - Medicines optimisation",2,"1 - QS120 - Medicines optimisation - Outcome - 2"]
[null,"QS120","Medicines optimisation",2,null,"People who are prescribed medicines are given an explanation on how to identify and report medicines‑related patient safety incidents.","Evidence of arrangements to ensure that people who are prescribed medicines have an explanation of how to identify medicines‑related patient safety incidents.","Structure","QS120 - Medicines optimisation","2 - QS120 - Medicines optimisation",1,"2 - QS120 - Medicines optimisation - Structure - 1"]
[null,"QS120","Medicines optimisation",2,null,"People who are prescribed medicines are given an explanation on how to identify and report medicines‑related patient safety incidents.","Evidence of arrangements to ensure that people who are prescribed medicines have an explanation of how to report medicines‑related patient safety incidents.","Structure","QS120 - Medicines optimisation","2 - QS120 - Medicines optimisation",2,"2 - QS120 - Medicines optimisation - Structure - 2"]
[null,"QS120","Medicines optimisation",2,null,"People who are prescribed medicines are given an explanation on how to identify and report medicines‑related patient safety incidents.","Proportion of new prescriptions of medicines for which patients are given an explanation on how to identify and report medicines‑related patient safety incidents.","Process","QS120 - Medicines optimisation","2 - QS120 - Medicines optimisation",1,"2 - QS120 - Medicines optimisation - Process - 1","The number in the denominator for which patients are given an explanation on how to identify and report medicines‑related patient safety incidents.","The number of new prescriptions of medicines."]
[null,"QS120","Medicines optimisation",2,null,"People who are prescribed medicines are given an explanation on how to identify and report medicines‑related patient safety incidents.","Harm attributable to errors in medication.","Outcome","QS120 - Medicines optimisation","2 - QS120 - Medicines optimisation",1,"2 - QS120 - Medicines optimisation - Outcome - 1"]
[null,"QS120","Medicines optimisation",3,null,"Local health and social care providers monitor medicines-related patient safety incidents to inform their learning in the use of medicines","Evidence of local arrangements to ensure that health and social care providers monitor medicines‑related patient safety incidents.","Structure","QS120 - Medicines optimisation","3 - QS120 - Medicines optimisation",1,"3 - QS120 - Medicines optimisation - Structure - 1"]
[null,"QS120","Medicines optimisation",3,null,"Local health and social care providers monitor medicines-related patient safety incidents to inform their learning in the use of medicines","Evidence of local arrangements to ensure that health and social care providers report medicines‑related patient safety incidents using national patient safety reporting systems.","Structure","QS120 - Medicines optimisation","3 - QS120 - Medicines optimisation",2,"3 - QS120 - Medicines optimisation - Structure - 2"]
[null,"QS120","Medicines optimisation",3,null,"Local health and social care providers monitor medicines-related patient safety incidents to inform their learning in the use of medicines","Evidence of local arrangements to ensure that health and social care providers learn from the monitoring and reporting of medicines‑related patient safety incidents.","Structure","QS120 - Medicines optimisation","3 - QS120 - Medicines optimisation",3,"3 - QS120 - Medicines optimisation - Structure - 3"]
[null,"QS120","Medicines optimisation",3,null,"Local health and social care providers monitor medicines-related patient safety incidents to inform their learning in the use of medicines","Evidence that local health and social care providers have arrangements to share learning about medicines‑related patient safety incidents. This can include feedback on trends or significant incidents to support continuing professional development","Structure","QS120 - Medicines optimisation","3 - QS120 - Medicines optimisation",4,"3 - QS120 - Medicines optimisation - Structure - 4"]
[null,"QS120","Medicines optimisation",3,null,"Local health and social care providers monitor medicines-related patient safety incidents to inform their learning in the use of medicines","Proportion of reported medicines‑related patient safety incidents that are investigated.","Process","QS120 - Medicines optimisation","3 - QS120 - Medicines optimisation",1,"3 - QS120 - Medicines optimisation - Process - 1","The number in the denominator that are investigated.","The number of reported medicines‑related patient safety incidents."]
[null,"QS120","Medicines optimisation",3,null,"Local health and social care providers monitor medicines-related patient safety incidents to inform their learning in the use of medicines","Harm attributable to errors in medication.","Outcome","QS120 - Medicines optimisation",{"$f":"CONCATENATE(D2622, \" - \", I2622)","v":"3 - QS120 - Medicines optimisation"},{"$f":"IF(AND(B2622=B2621, D2622=D2621, H2622=H2621)=TRUE, K2621+1, 1)","v":1},{"$f":"CONCATENATE(J2622, \" - \", H2622, \" - \",K2622)","v":"3 - QS120 - Medicines optimisation - Outcome - 1"}]
[null,"QS120","Medicines optimisation",4,null,"People who are inpatients in an acute setting have a reconciled list of their medicines within 24 hours of admission.","Evidence of local arrangements to ensure that people who are inpatients in an acute setting have a reconciled list of their medicines within 24 hours of admission.","Structure","QS120 - Medicines optimisation","4 - QS120 - Medicines optimisation",1,"4 - QS120 - Medicines optimisation - Structure - 1"]
[null,"QS120","Medicines optimisation",4,null,"People who are inpatients in an acute setting have a reconciled list of their medicines within 24 hours of admission.","Proportion of people who are inpatients in an acute setting who have a reconciled list of their medicines within 24 hours of admission.","Process","QS120 - Medicines optimisation","4 - QS120 - Medicines optimisation",1,"4 - QS120 - Medicines optimisation - Process - 1","The number in the denominator who have a reconciled list of their medicines within 24 hours of admission.","The number of people who are inpatients in an acute setting."]
[null,"QS120","Medicines optimisation",4,null,"People who are inpatients in an acute setting have a reconciled list of their medicines within 24 hours of admission.","Harm attributable to errors in medication following acute inpatient admission.","Outcome","QS120 - Medicines optimisation","4 - QS120 - Medicines optimisation",1,"4 - QS120 - Medicines optimisation - Outcome - 1"]
[null,"QS120","Medicines optimisation",4,null,"People who are inpatients in an acute setting have a reconciled list of their medicines within 24 hours of admission.","Patient satisfaction with outcomes from the use of medicines.","Outcome","QS120 - Medicines optimisation","4 - QS120 - Medicines optimisation",2,"4 - QS120 - Medicines optimisation - Outcome - 2"]
[null,"QS120","Medicines optimisation",4,null,"People who are inpatients in an acute setting have a reconciled list of their medicines within 24 hours of admission.","Number of patient complaints relating to medication issues.","Outcome",{"$f":"CONCATENATE(B2627, \" - \", C2627)","v":"QS120 - Medicines optimisation"},"4 - QS120 - Medicines optimisation",3,"4 - QS120 - Medicines optimisation - Outcome - 3"]
[null,"QS120","Medicines optimisation",5,null,"People discharged from a care setting have a reconciled list of their medicines in their GP record within 1 week of the GP practice receiving the information, and before a prescription or new supply of medicines is issued.","Evidence of local arrangements to ensure that people discharged from a care setting have a reconciled list of their medicines in their GP record within 1 week of the GP practice receiving the information.","Structure","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",1,"5 - QS120 - Medicines optimisation - Structure - 1"]
[null,"QS120","Medicines optimisation",5,null,"People discharged from a care setting have a reconciled list of their medicines in their GP record within 1 week of the GP practice receiving the information, and before a prescription or new supply of medicines is issued.","Evidence of local arrangements to ensure that people discharged from a care setting are not issued a prescription or new supply of medicines until they have a reconciled list of their medicines in their GP record.","Structure","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",2,"5 - QS120 - Medicines optimisation - Structure - 2"]
[null,"QS120","Medicines optimisation",5,null,"People discharged from a care setting have a reconciled list of their medicines in their GP record within 1 week of the GP practice receiving the information, and before a prescription or new supply of medicines is issued.","The proportion of people on medicines discharged from a care setting who have a reconciled list of their medicines within 1 week of the GP practice receiving the information.","Process","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",1,"5 - QS120 - Medicines optimisation - Process - 1","The number in the denominator who have a reconciled list of their medicines within 1 week of the GP practice receiving the information.","The number of people on medicines who are discharged from a care setting."]
[null,"QS120","Medicines optimisation",5,null,"People discharged from a care setting have a reconciled list of their medicines in their GP record within 1 week of the GP practice receiving the information, and before a prescription or new supply of medicines is issued.","Proportion of new prescriptions within 1 month of discharge from a care setting where there was a reconciled list of medicines in the patient's GP record.","Process","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",2,"5 - QS120 - Medicines optimisation - Process - 2","Number in the denominator where there was a reconciled list of medicines in the patient's GP record.","Number of new prescriptions within 1 month of discharge from a care setting."]
[null,"QS120","Medicines optimisation",5,null,"People discharged from a care setting have a reconciled list of their medicines in their GP record within 1 week of the GP practice receiving the information, and before a prescription or new supply of medicines is issued.","Harm attributable to errors in medication following discharge from a care setting.","Outcome","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",1,"5 - QS120 - Medicines optimisation - Outcome - 1"]
[null,"QS120","Medicines optimisation",5,null,"People discharged from a care setting have a reconciled list of their medicines in their GP record within 1 week of the GP practice receiving the information, and before a prescription or new supply of medicines is issued.","Patient satisfaction with outcomes from the use of medicines.","Outcome","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",2,"5 - QS120 - Medicines optimisation - Outcome - 2"]
[null,"QS120","Medicines optimisation",5,null,"People discharged from a care setting have a reconciled list of their medicines in their GP record within 1 week of the GP practice receiving the information, and before a prescription or new supply of medicines is issued.","Number of patient complaints relating to medication issues following discharge from a care setting.","Outcome","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",3,"5 - QS120 - Medicines optimisation - Outcome - 3"]
[null,"QS120","Medicines optimisation",5,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","Evidence that local healthcare providers have arrangements to identify people taking medicines who would benefit from a structured medication review.","Structure","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",1,"5 - QS120 - Medicines optimisation - Structure - 1"]
[null,"QS120","Medicines optimisation",5,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","Evidence that local healthcare providers have arrangements to offer structured medication reviews to people who are likely to benefit.","Structure","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",2,"5 - QS120 - Medicines optimisation - Structure - 2"]
[null,"QS120","Medicines optimisation",5,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","Proportion of people taking medicines for long‑term conditions who are identified as potentially benefiting from a structured medication review.","Process","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",1,"5 - QS120 - Medicines optimisation - Process - 1","The number in the denominator who are identified as potentially benefiting from a structured medication review.","The number of people taking medicines for long-term conditions."]
[null,"QS120","Medicines optimisation",5,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","Proportion of people taking multiple medicines who are identified as potentially benefiting from a structured medication review.","Process","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",2,"5 - QS120 - Medicines optimisation - Process - 2","The number in the denominator who are identified as potentially benefiting from a structured medication review.","The number of people taking multiple medicines."]
[null,"QS120","Medicines optimisation",5,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","The proportion of people identified as potentially benefiting from a structured medication review who have a structured medication review.","Process","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",3,"5 - QS120 - Medicines optimisation - Process - 3","The number in the denominator who have a structured medication review.","The number of people identified as potentially benefiting from a structured medication review. "]
[null,"QS120","Medicines optimisation",5,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","People with long‑term conditions gain optimum outcomes from use of medicines.","Outcome","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",1,"5 - QS120 - Medicines optimisation - Outcome - 1"]
[null,"QS120","Medicines optimisation",5,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","People using multiple medicines gain optimum outcomes from use of medicines.","Outcome","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",2,"5 - QS120 - Medicines optimisation - Outcome - 2"]
[null,"QS120","Medicines optimisation",5,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","Patient satisfaction with outcomes from the use of medicines.","Outcome","QS120 - Medicines optimisation","5 - QS120 - Medicines optimisation",3,"5 - QS120 - Medicines optimisation - Outcome - 3"]
[null,"QS120","Medicines optimisation",6,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","Evidence that local healthcare providers have arrangements to identify people taking medicines who would benefit from a structured medication review. ","Structure","QS120 - Medicines optimisation","6 - QS120 - Medicines optimisation",1,"6 - QS120 - Medicines optimisation - Structure - 1"]
[null,"QS120","Medicines optimisation",6,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","Evidence that local healthcare providers have arrangements to offer structured medication reviews to people who are likely to benefit. ","Structure","QS120 - Medicines optimisation","6 - QS120 - Medicines optimisation",2,"6 - QS120 - Medicines optimisation - Structure - 2"]
[null,"QS120","Medicines optimisation",6,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","Proportion of people taking medicines for long‑term conditions who are identified as potentially benefiting from a structured medication review.","Process","QS120 - Medicines optimisation","6 - QS120 - Medicines optimisation",1,"6 - QS120 - Medicines optimisation - Process - 1","The number in the denominator who are identified as potentially benefiting from a structured medication review.","The number of people taking medicines for long-term conditions."]
[null,"QS120","Medicines optimisation",6,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","Proportion of people taking multiple medicines who are identified as potentially benefiting from a structured medication review.","Process","QS120 - Medicines optimisation","6 - QS120 - Medicines optimisation",2,"6 - QS120 - Medicines optimisation - Process - 2","The number in the denominator who are identified as potentially benefiting from a structured medication review.","The number of people taking multiple medicines."]
[null,"QS120","Medicines optimisation",6,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","The proportion of people identified as potentially benefiting from a structured medication review who have a structured medication review.","Process","QS120 - Medicines optimisation","6 - QS120 - Medicines optimisation",3,"6 - QS120 - Medicines optimisation - Process - 3","The number in the denominator who have a structured medication review.","The number of people identified as potentially benefiting from a structured medication review."]
[null,"QS120","Medicines optimisation",6,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","People with long‑term conditions gain optimum outcomes from use of medicines.","Outcome","QS120 - Medicines optimisation","6 - QS120 - Medicines optimisation",1,"6 - QS120 - Medicines optimisation - Outcome - 1"]
[null,"QS120","Medicines optimisation",6,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","People using multiple medicines gain optimum outcomes from use of medicines.","Outcome","QS120 - Medicines optimisation","6 - QS120 - Medicines optimisation",2,"6 - QS120 - Medicines optimisation - Outcome - 2"]
[null,"QS120","Medicines optimisation",6,null,"Local healthcare providers identify people taking medicines who would benefit from a structured medication review.","Patient satisfaction with outcomes from the use of medicines.","Outcome","QS120 - Medicines optimisation","6 - QS120 - Medicines optimisation",3,"6 - QS120 - Medicines optimisation - Outcome - 3"]
[null,"QS121","Antimicrobial stewardship",1,null,"People with a self-limiting condition, as assessed by a primary care prescriber, receive advice about self‑management and adverse consequences of overusing antimicrobials","Evidence of local arrangements to ensure that people with a self‑limiting condition, as assessed by a primary care prescriber, receive advice about self-management and adverse consequences of overusing antimicrobials","Structure","QS121 - Antimicrobial stewardship","1 - QS121 - Antimicrobial stewardship",1,"1 - QS121 - Antimicrobial stewardship - Structure - 1"]
[null,"QS121","Antimicrobial stewardship",1,null,"People with a self-limiting condition, as assessed by a primary care prescriber, receive advice about self‑management and adverse consequences of overusing antimicrobials","Evidence of local arrangements to promote self-management of self‑limiting conditions and raise awareness of risks associated with overusing antimicrobials","Structure","QS121 - Antimicrobial stewardship","1 - QS121 - Antimicrobial stewardship",2,"1 - QS121 - Antimicrobial stewardship - Structure - 2"]
[null,"QS121","Antimicrobial stewardship",1,null,"People with a self-limiting condition, as assessed by a primary care prescriber, receive advice about self‑management and adverse consequences of overusing antimicrobials","Proportion of presentations in primary care assessed as a self‑limiting condition with a record stating that advice about self‑management was given","Process","QS121 - Antimicrobial stewardship","1 - QS121 - Antimicrobial stewardship",1,"1 - QS121 - Antimicrobial stewardship - Process - 1","The number in the denominator with a record stating that advice about self‑management was given.","The number of presentations in primary care assessed as a self‑limiting condition."]
[null,"QS121","Antimicrobial stewardship",1,null,"People with a self-limiting condition, as assessed by a primary care prescriber, receive advice about self‑management and adverse consequences of overusing antimicrobials","Proportion of presentations in primary care assessed as a self‑limiting condition with a record stating that advice about the adverse consequences of overusing antimicrobials was given","Process","QS121 - Antimicrobial stewardship","1 - QS121 - Antimicrobial stewardship",2,"1 - QS121 - Antimicrobial stewardship - Process - 2","The number in the denominator with a record stating that advice about the adverse consequences of overusing antimicrobials was given.","The number of presentations in primary care assessed as a self‑limiting condition."]
[null,"QS121","Antimicrobial stewardship",1,null,"People with a self-limiting condition, as assessed by a primary care prescriber, receive advice about self‑management and adverse consequences of overusing antimicrobials","Antimicrobial prescribing rates in primary care","Outcome","QS121 - Antimicrobial stewardship","1 - QS121 - Antimicrobial stewardship",1,"1 - QS121 - Antimicrobial stewardship - Outcome - 1"]
[null,"QS121","Antimicrobial stewardship",2,null,"Prescribers in primary care can use back‑up (delayed) antimicrobial prescribing when there is clinical uncertainty about whether a condition is self‑limiting or is likely to deteriorate","Evidence of local arrangements to ensure that prescribers in primary care can use back‑up (delayed) antimicrobial prescribing if there is uncertainty about whether a condition is self‑limiting or is likely to deteriorate","Structure","QS121 - Antimicrobial stewardship","2 - QS121 - Antimicrobial stewardship",1,"2 - QS121 - Antimicrobial stewardship - Structure - 1"]
[null,"QS121","Antimicrobial stewardship",2,null,"Prescribers in primary care can use back‑up (delayed) antimicrobial prescribing when there is clinical uncertainty about whether a condition is self‑limiting or is likely to deteriorate","Proportion of prescriptions for antimicrobials issued as a back‑up (delayed) prescription","Process","QS121 - Antimicrobial stewardship","2 - QS121 - Antimicrobial stewardship",1,"2 - QS121 - Antimicrobial stewardship - Process - 1","The number in the denominator issued as a back‑up (delayed) prescription.","The number of prescriptions for antimicrobials issued."]
[null,"QS121","Antimicrobial stewardship",2,null,"Prescribers in primary care can use back‑up (delayed) antimicrobial prescribing when there is clinical uncertainty about whether a condition is self‑limiting or is likely to deteriorate","Proportion of people issued a back‑up (delayed) prescription for antimicrobials who are advised when to use the prescription","Process","QS121 - Antimicrobial stewardship","2 - QS121 - Antimicrobial stewardship",2,"2 - QS121 - Antimicrobial stewardship - Process - 2","The number in the denominator who are told when to use the prescription.","The number of people issued a back‑up (delayed) prescription for antimicrobials."]
[null,"QS121","Antimicrobial stewardship",2,null,"Prescribers in primary care can use back‑up (delayed) antimicrobial prescribing when there is clinical uncertainty about whether a condition is self‑limiting or is likely to deteriorate","Back-up (delayed) prescriptions for antimicrobials that are dispensed","Outcome","QS121 - Antimicrobial stewardship","2 - QS121 - Antimicrobial stewardship",1,"2 - QS121 - Antimicrobial stewardship - Outcome - 1"]
[null,"QS121","Antimicrobial stewardship",2,null,"Prescribers in primary care can use back‑up (delayed) antimicrobial prescribing when there is clinical uncertainty about whether a condition is self‑limiting or is likely to deteriorate","Antimicrobial prescribing rates in primary care","Outcome","QS121 - Antimicrobial stewardship","2 - QS121 - Antimicrobial stewardship",2,"2 - QS121 - Antimicrobial stewardship - Outcome - 2"]
[null,"QS121","Antimicrobial stewardship",3,null,"People prescribed an antimicrobial have the clinical indication, dose and duration of treatment documented in their clinical record","Evidence of local arrangements and processes to ensure that all prescribers document the clinical indication, dose and duration of treatment in patients' records when prescribing an antimicrobial","Structure","QS121 - Antimicrobial stewardship","3 - QS121 - Antimicrobial stewardship",1,"3 - QS121 - Antimicrobial stewardship - Structure - 1"]
[null,"QS121","Antimicrobial stewardship",3,null,"People prescribed an antimicrobial have the clinical indication, dose and duration of treatment documented in their clinical record","Proportion of prescriptions for antimicrobials with the clinical indication, dose and duration of treatment documented","Process","QS121 - Antimicrobial stewardship","3 - QS121 - Antimicrobial stewardship",1,"3 - QS121 - Antimicrobial stewardship - Process - 1","The number in the denominator with the clinical indication, dose and duration of treatment documented.","The number of prescriptions for antimicrobials."]
[null,"QS121","Antimicrobial stewardship",3,null,"People prescribed an antimicrobial have the clinical indication, dose and duration of treatment documented in their clinical record","Antimicrobial prescribing rates","Outcome","QS121 - Antimicrobial stewardship","3 - QS121 - Antimicrobial stewardship",1,"3 - QS121 - Antimicrobial stewardship - Outcome - 1"]
[null,"QS121","Antimicrobial stewardship",4,null,"People in hospital who are prescribed an antimicrobial have a microbiological sample taken and their treatment reviewed when the results are available","Evidence of local arrangements and processes to ensure that people in hospital who are prescribed an antimicrobial have a microbiological sample taken and their treatment reviewed when the results are available","Structure","QS121 - Antimicrobial stewardship","4 - QS121 - Antimicrobial stewardship",1,"4 - QS121 - Antimicrobial stewardship - Structure - 1"]
[null,"QS121","Antimicrobial stewardship",4,null,"People in hospital who are prescribed an antimicrobial have a microbiological sample taken and their treatment reviewed when the results are available","Proportion of prescriptions for antimicrobials issued to people admitted to hospital with a record of a microbiological sample being taken","Process","QS121 - Antimicrobial stewardship","4 - QS121 - Antimicrobial stewardship",1,"4 - QS121 - Antimicrobial stewardship - Process - 1","The number in the denominator with a record of a microbiological sample being taken.","The number of prescriptions for antimicrobials issued to people admitted to hospital."]
[null,"QS121","Antimicrobial stewardship",4,null,"People in hospital who are prescribed an antimicrobial have a microbiological sample taken and their treatment reviewed when the results are available","Proportion of prescriptions for antimicrobials issued to people admitted to hospital and reviewed when microbiological results become available","Process","QS121 - Antimicrobial stewardship","4 - QS121 - Antimicrobial stewardship",2,"4 - QS121 - Antimicrobial stewardship - Process - 2","The number in the denominator reviewed when the microbiological results become available.","The number of prescriptions for antimicrobials issued to people admitted to hospital with a record of a microbiological sample being taken."]
[null,"QS121","Antimicrobial stewardship",4,null,"People in hospital who are prescribed an antimicrobial have a microbiological sample taken and their treatment reviewed when the results are available","Altered or withdrawn prescriptions for antimicrobials following microbiological results showing lack of effectiveness of initial antimicrobial treatment","Outcome","QS121 - Antimicrobial stewardship","4 - QS121 - Antimicrobial stewardship",1,"4 - QS121 - Antimicrobial stewardship - Outcome - 1"]
[null,"QS121","Antimicrobial stewardship",4,null,"People in hospital who are prescribed an antimicrobial have a microbiological sample taken and their treatment reviewed when the results are available","Antimicrobial prescribing rates in hospitals","Outcome","QS121 - Antimicrobial stewardship","4 - QS121 - Antimicrobial stewardship",2,"4 - QS121 - Antimicrobial stewardship - Outcome - 2"]
[null,"QS121","Antimicrobial stewardship",4,null,"People in hospital who are prescribed an antimicrobial have a microbiological sample taken and their treatment reviewed when the results are available","Length of hospital stay","Outcome","QS121 - Antimicrobial stewardship","4 - QS121 - Antimicrobial stewardship",3,"4 - QS121 - Antimicrobial stewardship - Outcome - 3"]
[null,"QS121","Antimicrobial stewardship",5,null,"Individuals and teams responsible for antimicrobial stewardship monitor data and provide feedback on prescribing practice at prescriber, team, organisation and commissioner level","Evidence of local arrangements to deliver an antimicrobial stewardship programme","Structure","QS121 - Antimicrobial stewardship","5 - QS121 - Antimicrobial stewardship",1,"5 - QS121 - Antimicrobial stewardship - Structure - 1"]
[null,"QS121","Antimicrobial stewardship",5,null,"Individuals and teams responsible for antimicrobial stewardship monitor data and provide feedback on prescribing practice at prescriber, team, organisation and commissioner level","Evidence of local arrangements and processes to ensure that individuals and teams responsible for antimicrobial stewardship monitor data and provide feedback on prescribing practice at prescriber, team, organisation and commissioner level","Structure","QS121 - Antimicrobial stewardship","5 - QS121 - Antimicrobial stewardship",2,"5 - QS121 - Antimicrobial stewardship - Structure - 2"]
[null,"QS121","Antimicrobial stewardship",5,null,"Individuals and teams responsible for antimicrobial stewardship monitor data and provide feedback on prescribing practice at prescriber, team, organisation and commissioner level","Proportion of prescribers who receive feedback on their antimicrobial prescribing practice","Process","QS121 - Antimicrobial stewardship","5 - QS121 - Antimicrobial stewardship",1,"5 - QS121 - Antimicrobial stewardship - Process - 1","The number in the denominator who receive feedback on their antimicrobial prescribing practice.","The number of prescribers."]
[null,"QS121","Antimicrobial stewardship",5,null,"Individuals and teams responsible for antimicrobial stewardship monitor data and provide feedback on prescribing practice at prescriber, team, organisation and commissioner level","Proportion of teams within an organisation that receive feedback on their antimicrobial prescribing practice","Process","QS121 - Antimicrobial stewardship","5 - QS121 - Antimicrobial stewardship",2,"5 - QS121 - Antimicrobial stewardship - Process - 2","The number in the denominator that receive feedback on their antimicrobial prescribing practice.","The number of teams prescribing antimicrobials within an organisation."]
[null,"QS121","Antimicrobial stewardship",5,null,"Individuals and teams responsible for antimicrobial stewardship monitor data and provide feedback on prescribing practice at prescriber, team, organisation and commissioner level","Proportion of organisations within a specified commissioning area that receive feedback on their antimicrobial prescribing practice","Process","QS121 - Antimicrobial stewardship","5 - QS121 - Antimicrobial stewardship",3,"5 - QS121 - Antimicrobial stewardship - Process - 3","The number in the denominator that receive feedback on their antimicrobial prescribing practice.","The number of organisations prescribing antimicrobials within a specified commissioning area."]
[null,"QS121","Antimicrobial stewardship",5,null,"Individuals and teams responsible for antimicrobial stewardship monitor data and provide feedback on prescribing practice at prescriber, team, organisation and commissioner level","Antimicrobial prescribing rates","Outcome","QS121 - Antimicrobial stewardship","5 - QS121 - Antimicrobial stewardship",1,"5 - QS121 - Antimicrobial stewardship - Outcome - 1"]
[null,"QS122","Bronchiolitis in children",1,null,"Children with bronchiolitis are not prescribed antibiotics to treat the infection.","Evidence of local prescribing protocols to direct antibiotic prescribing in children with bronchiolitis.","Structure","QS122 - Bronchiolitis in children","1 - QS122 - Bronchiolitis in children",{"$f":"IF(AND(B2676=B2675, D2676=D2675, H2676=H2675)=TRUE, K2675+1, 1)","v":1},{"$f":"CONCATENATE(J2676, \" - \", H2676, \" - \",K2676)","v":"1 - QS122 - Bronchiolitis in children - Structure - 1"}]
[null,"QS122","Bronchiolitis in children",1,null,"Children with bronchiolitis are not prescribed antibiotics to treat the infection.","Proportion of diagnoses of bronchiolitis with a prescription for antibiotics in primary care.","Process",{"$f":"CONCATENATE(B2677, \" - \", C2677)","v":"QS122 - Bronchiolitis in children"},{"$f":"CONCATENATE(D2677, \" - \", I2677)","v":"1 - QS122 - Bronchiolitis in children"},1,"1 - QS122 - Bronchiolitis in children - Process - 1","The number in the denominator with a prescription for antibiotics.","The number of diagnoses of acute bronchiolitis in primary care."]
[null,"QS122","Bronchiolitis in children",1,null,"Children with bronchiolitis are not prescribed antibiotics to treat the infection.","Proportion of diagnoses of bronchiolitis with a prescription for antibiotics in secondary care.","Process","QS122 - Bronchiolitis in children","1 - QS122 - Bronchiolitis in children",2,"1 - QS122 - Bronchiolitis in children - Process - 2","The number in the denominator with a prescription for antibiotics.","The number of diagnoses of bronchiolitis in secondary care."]
[null,"QS122","Bronchiolitis in children",2,null,"Parents and carers of children with bronchiolitis are informed that medication is not being used because the condition is usually self-limiting.","Evidence of local arrangements to help parents and carers of children with bronchiolitis understand that medication is not being used because the condition is usually self-limiting.","Structure",{"$f":"CONCATENATE(B2679, \" - \", C2679)","v":"QS122 - Bronchiolitis in children"},{"$f":"CONCATENATE(D2679, \" - \", I2679)","v":"2 - QS122 - Bronchiolitis in children"},{"$f":"IF(AND(B2679=B2678, D2679=D2678, H2679=H2678)=TRUE, K2678+1, 1)","v":1},{"$f":"CONCATENATE(J2679, \" - \", H2679, \" - \",K2679)","v":"2 - QS122 - Bronchiolitis in children - Structure - 1"}]
[null,"QS122","Bronchiolitis in children",2,null,"Parents and carers of children with bronchiolitis are informed that medication is not being used because the condition is usually self-limiting.","Proportion of diagnoses of bronchiolitis in primary care where the parents and carers are informed that medication is not being used because the condition is usually self-limiting.","Process","QS122 - Bronchiolitis in children","2 - QS122 - Bronchiolitis in children",1,"2 - QS122 - Bronchiolitis in children - Process - 1","The number in the denominator where the parents and carers are informed that medication is not being used because the condition is usually self-limiting.","The number of diagnoses of bronchiolitis in primary care."]
[null,"QS122","Bronchiolitis in children",2,null,"Parents and carers of children with bronchiolitis are informed that medication is not being used because the condition is usually self-limiting.","Proportion of diagnoses of bronchiolitis in secondary care where the parents and carers are informed that medication is not being used because the condition is usually self-limiting.","Process","QS122 - Bronchiolitis in children","2 - QS122 - Bronchiolitis in children",2,"2 - QS122 - Bronchiolitis in children - Process - 2","The number in the denominator where the parents and carers are informed that medication is not being used because the condition is usually self-limiting.","The number of diagnoses of bronchiolitis in secondary care."]
[null,"QS122","Bronchiolitis in children",2,null,"Parents and carers of children with bronchiolitis are informed that medication is not being used because the condition is usually self-limiting.","Parent- and carer-reported confidence in caring for children with bronchiolitis at home.","Outcome","QS122 - Bronchiolitis in children","2 - QS122 - Bronchiolitis in children",1,"2 - QS122 - Bronchiolitis in children - Outcome - 1"]
[null,"QS122","Bronchiolitis in children",2,null,"Parents and carers of children with bronchiolitis are informed that medication is not being used because the condition is usually self-limiting."," Antibiotic prescribing rates for bronchiolitis.","Outcome","QS122 - Bronchiolitis in children","2 - QS122 - Bronchiolitis in children",2,"2 - QS122 - Bronchiolitis in children - Outcome - 2"]
[null,"QS122","Bronchiolitis in children",3,null,"Parents and carers of children with bronchiolitis are given key safety information about what to expect and when to be concerned if caring for the child at home.","Evidence of local arrangements to ensure key safety information is provided to parents and carers of children with bronchiolitis being cared for at home.","Structure",{"$f":"CONCATENATE(B2684, \" - \", C2684)","v":"QS122 - Bronchiolitis in children"},{"$f":"CONCATENATE(D2684, \" - \", I2684)","v":"3 - QS122 - Bronchiolitis in children"},{"$f":"IF(AND(B2684=B2683, D2684=D2683, H2684=H2683)=TRUE, K2683+1, 1)","v":1},{"$f":"CONCATENATE(J2684, \" - \", H2684, \" - \",K2684)","v":"3 - QS122 - Bronchiolitis in children - Structure - 1"}]
[null,"QS122","Bronchiolitis in children",3,null,"Parents and carers of children with bronchiolitis are given key safety information about what to expect and when to be concerned if caring for the child at home.","Proportion of diagnoses of bronchiolitis in primary care where the parents and carers are given key safety information if the child is to be cared for at home.","Process","QS122 - Bronchiolitis in children","3 - QS122 - Bronchiolitis in children",1,"3 - QS122 - Bronchiolitis in children - Process - 1","The number in the denominator where the parents and carers are given key safety information.","The number of diagnoses of bronchiolitis in primary care where the child is to be cared for at home."]
[null,"QS122","Bronchiolitis in children",3,null,"Parents and carers of children with bronchiolitis are given key safety information about what to expect and when to be concerned if caring for the child at home.","Proportion of discharges from hospital or emergency care of children with bronchiolitis where the parents and carers are given key safety information.","Process","QS122 - Bronchiolitis in children","3 - QS122 - Bronchiolitis in children",2,"3 - QS122 - Bronchiolitis in children - Process - 2","The number in the denominator where the parents and carers are given key safety information.","The number of discharges from hospital or emergency care of children with bronchiolitis."]
[null,"QS122","Bronchiolitis in children",3,null,"Parents and carers of children with bronchiolitis are given key safety information about what to expect and when to be concerned if caring for the child at home.","Parent- and carer-reported confidence in caring for children with bronchiolitis at home.","Outcome","QS122 - Bronchiolitis in children","3 - QS122 - Bronchiolitis in children",1,"3 - QS122 - Bronchiolitis in children - Outcome - 1"]
[null,"QS123","Home care for older people",1,null,"Older people using home care services have a home care plan that identifies how their personal priorities and outcomes will be met.","Evidence of local processes to ensure that home care plans for older people identify how their personal priorities and outcomes will be met.","Structure",{"$f":"CONCATENATE(B2688, \" - \", C2688)","v":"QS123 - Home care for older people"},{"$f":"CONCATENATE(D2688, \" - \", I2688)","v":"1 - QS123 - Home care for older people"},{"$f":"IF(AND(B2688=B2687, D2688=D2687, H2688=H2687)=TRUE, K2687+1, 1)","v":1},{"$f":"CONCATENATE(J2688, \" - \", H2688, \" - \",K2688)","v":"1 - QS123 - Home care for older people - Structure - 1"}]
[null,"QS123","Home care for older people",1,null,"Older people using home care services have a home care plan that identifies how their personal priorities and outcomes will be met.","Proportion of older people using home care services whose home care plan includes their personal priorities and outcomes.","Process","QS123 - Home care for older people","1 - QS123 - Home care for older people",1,"1 - QS123 - Home care for older people - Process - 1","The number in the denominator whose home care plan includes their personal priorities and outcomes.","The number of older people using home care services."]
[null,"QS123","Home care for older people",1,null,"Older people using home care services have a home care plan that identifies how their personal priorities and outcomes will be met.","Proportion of older people using home care services whose home care plan identifies how their personal priorities and outcomes will be met.","Process","QS123 - Home care for older people","1 - QS123 - Home care for older people",2,"1 - QS123 - Home care for older people - Process - 2","The number in the denominator whose home care plan identifies how their personal priorities and outcomes will be met.","The number of older people using home care services."]
[null,"QS123","Home care for older people",1,null,"Older people using home care services have a home care plan that identifies how their personal priorities and outcomes will be met.","Older people's involvement in decision-making.","Outcome","QS123 - Home care for older people","1 - QS123 - Home care for older people",1,"1 - QS123 - Home care for older people - Outcome - 1"]
[null,"QS123","Home care for older people",1,null,"Older people using home care services have a home care plan that identifies how their personal priorities and outcomes will be met.","Health-related quality of life for older people using home care services.","Outcome","QS123 - Home care for older people","1 - QS123 - Home care for older people",2,"1 - QS123 - Home care for older people - Outcome - 2"]
[null,"QS123","Home care for older people",1,null,"Older people using home care services have a home care plan that identifies how their personal priorities and outcomes will be met.","Social care-related quality of life for older people using home care services.\n\n","Outcome","QS123 - Home care for older people","1 - QS123 - Home care for older people",3,"1 - QS123 - Home care for older people - Outcome - 3"]
[null,"QS123","Home care for older people",2,null,"Older people using home care services have a home care plan that identifies how their home care provider will respond to missed or late visits.","Evidence of local processes to ensure that older people using home care services have a home care plan that identifies how their home care provider will respond to missed or late visits.","Structure","QS123 - Home care for older people","2 - QS123 - Home care for older people",1,"2 - QS123 - Home care for older people - Structure - 1"]
[null,"QS123","Home care for older people",2,null,"Older people using home care services have a home care plan that identifies how their home care provider will respond to missed or late visits.","Proportion of older people using home care services who have a home care plan that identifies how their home care provider will respond to missed or late visits.","Process",{"$f":"CONCATENATE(B2695, \" - \", C2695)","v":"QS123 - Home care for older people"},{"$f":"CONCATENATE(D2695, \" - \", I2695)","v":"2 - QS123 - Home care for older people"},{"$f":"IF(AND(B2695=B2694, D2695=D2694, H2695=H2694)=TRUE, K2694+1, 1)","v":1},{"$f":"CONCATENATE(J2695, \" - \", H2695, \" - \",K2695)","v":"2 - QS123 - Home care for older people - Process - 1"},"The number in the denominator who have a home care plan that identifies how their home care provider will respond to missed or late visits.","The number of older people using home care services."]
[null,"QS123","Home care for older people",2,null,"Older people using home care services have a home care plan that identifies how their home care provider will respond to missed or late visits.","Proportion of planned home care visits for older people that are missed.","Process","QS123 - Home care for older people","2 - QS123 - Home care for older people",2,"2 - QS123 - Home care for older people - Process - 2","The number in the denominator that are missed.","The number of planned home care visits for older people."]
[null,"QS123","Home care for older people",2,null,"Older people using home care services have a home care plan that identifies how their home care provider will respond to missed or late visits.","Older people's satisfaction with the reliability of their home care service.","Outcome","QS123 - Home care for older people","2 - QS123 - Home care for older people",1,"2 - QS123 - Home care for older people - Outcome - 1"]
[null,"QS123","Home care for older people",2,null,"Older people using home care services have a home care plan that identifies how their home care provider will respond to missed or late visits.","Safety incidents among older people related to missed or late home care visits.","Outcome","QS123 - Home care for older people","2 - QS123 - Home care for older people",2,"2 - QS123 - Home care for older people - Outcome - 2"]
[null,"QS123","Home care for older people",3,null,"Older people using home care services receive care from a consistent team of home care workers who are familiar with their needs.","Evidence of local processes to ensure that older people using home care services receive care from a consistent team of home care workers who are familiar with their needs.","Structure",{"$f":"CONCATENATE(B2699, \" - \", C2699)","v":"QS123 - Home care for older people"},{"$f":"CONCATENATE(D2699, \" - \", I2699)","v":"3 - QS123 - Home care for older people"},{"$f":"IF(AND(B2699=B2698, D2699=D2698, H2699=H2698)=TRUE, K2698+1, 1)","v":1},{"$f":"CONCATENATE(J2699, \" - \", H2699, \" - \",K2699)","v":"3 - QS123 - Home care for older people - Structure - 1"}]
[null,"QS123","Home care for older people",3,null,"Older people using home care services receive care from a consistent team of home care workers who are familiar with their needs.","Total number of home care workers providing care to an older person using home care services.","Process","QS123 - Home care for older people","3 - QS123 - Home care for older people",1,"3 - QS123 - Home care for older people - Process - 1"]
[null,"QS123","Home care for older people",3,null,"Older people using home care services receive care from a consistent team of home care workers who are familiar with their needs.","The average number of home care visits each older person receives per home care worker.","Process","QS123 - Home care for older people","3 - QS123 - Home care for older people",2,"3 - QS123 - Home care for older people - Process - 2"]
[null,"QS123","Home care for older people",3,null,"Older people using home care services receive care from a consistent team of home care workers who are familiar with their needs.","Older people's satisfaction with the consistency of their home care team.","Outcome","QS123 - Home care for older people","3 - QS123 - Home care for older people",1,"3 - QS123 - Home care for older people - Outcome - 1"]
[null,"QS123","Home care for older people",4,null,"Older people using home care services have visits of at least 30 minutes except when short visits for specific tasks or checks have been agreed as part of a wider package of support.","Evidence of local processes to ensure that older people using home care services have visits of at least 30 minutes except when short visits for specific tasks or checks have been agreed as part of a wider package of support.","Structure","QS123 - Home care for older people","4 - QS123 - Home care for older people",1,"4 - QS123 - Home care for older people - Structure - 1"]
[null,"QS123","Home care for older people",4,null,"Older people using home care services have visits of at least 30 minutes except when short visits for specific tasks or checks have been agreed as part of a wider package of support.","Proportion of home care visits to older people lasting 30 minutes or longer.","Process","QS123 - Home care for older people","4 - QS123 - Home care for older people",1,"4 - QS123 - Home care for older people - Process - 1","The number in the denominator lasting 30 minutes or longer.","The number of home care visits to older people."]
[null,"QS123","Home care for older people",4,null,"Older people using home care services have visits of at least 30 minutes except when short visits for specific tasks or checks have been agreed as part of a wider package of support.","Proportion of home care visits to older people of less than 30 minutes with a prior agreement that a shorter visit is acceptable.","Process","QS123 - Home care for older people","4 - QS123 - Home care for older people",2,"4 - QS123 - Home care for older people - Process - 2","The number in the denominator with a prior agreement that a shorter visit of less than 30 minutes is acceptable.","The number of home care visits to older people that are less than 30 minutes."]
[null,"QS123","Home care for older people",4,null,"Older people using home care services have visits of at least 30 minutes except when short visits for specific tasks or checks have been agreed as part of a wider package of support.","Older people's satisfaction with the length of home care visits.","Outcome","QS123 - Home care for older people","4 - QS123 - Home care for older people",1,"4 - QS123 - Home care for older people - Outcome - 1"]
[null,"QS123","Home care for older people",4,null,"Older people using home care services have visits of at least 30 minutes except when short visits for specific tasks or checks have been agreed as part of a wider package of support.","Older people's perception of the way they are helped or treated.","Outcome","QS123 - Home care for older people","4 - QS123 - Home care for older people",2,"4 - QS123 - Home care for older people - Outcome - 2"]
[null,"QS123","Home care for older people",5,null,"Older people using home care services have a review of the outcomes of their home care plan within 6 weeks of starting to use the service and then at least annually.","Evidence of local processes to ensure that older people using home care services have a review of the outcomes of their home care plan within 6 weeks of starting to use the service.","Structure",{"$f":"CONCATENATE(B2708, \" - \", C2708)","v":"QS123 - Home care for older people"},{"$f":"CONCATENATE(D2708, \" - \", I2708)","v":"5 - QS123 - Home care for older people"},{"$f":"IF(AND(B2708=B2707, D2708=D2707, H2708=H2707)=TRUE, K2707+1, 1)","v":1},{"$f":"CONCATENATE(J2708, \" - \", H2708, \" - \",K2708)","v":"5 - QS123 - Home care for older people - Structure - 1"}]
[null,"QS123","Home care for older people",5,null,"Older people using home care services have a review of the outcomes of their home care plan within 6 weeks of starting to use the service and then at least annually.","Evidence of local processes to ensure that older people using home care services have a review of the outcomes of their home care plan at least annually.","Structure","QS123 - Home care for older people","5 - QS123 - Home care for older people",2,"5 - QS123 - Home care for older people - Structure - 2"]
[null,"QS123","Home care for older people",5,null,"Older people using home care services have a review of the outcomes of their home care plan within 6 weeks of starting to use the service and then at least annually.","Proportion of older people using home care services who have a review of the outcomes of their home care plan within 6 weeks of the service starting.","Process","QS123 - Home care for older people","5 - QS123 - Home care for older people",1,"5 - QS123 - Home care for older people - Process - 1","The number in the denominator who have a review of the outcomes of their home care plan within 6 weeks of the service starting.","The number of older people starting to use home care services."]
[null,"QS123","Home care for older people",5,null,"Older people using home care services have a review of the outcomes of their home care plan within 6 weeks of starting to use the service and then at least annually.","Proportion of older people using home care services who have a review of the outcomes of their home care plan within a year of their previous review.","Process","QS123 - Home care for older people","5 - QS123 - Home care for older people",2,"5 - QS123 - Home care for older people - Process - 2","The number in the denominator who have a review of the outcomes of their home care plan within a year of their previous review.","The number of older people using home care services for more than a year."]
[null,"QS123","Home care for older people",5,null,"Older people using home care services have a review of the outcomes of their home care plan within 6 weeks of starting to use the service and then at least annually.","Older people's satisfaction with the home care service.","Outcome","QS123 - Home care for older people","5 - QS123 - Home care for older people",1,"5 - QS123 - Home care for older people - Outcome - 1"]
[null,"QS123","Home care for older people",5,null,"Older people using home care services have a review of the outcomes of their home care plan within 6 weeks of starting to use the service and then at least annually.","Health-related quality of life.","Outcome","QS123 - Home care for older people","5 - QS123 - Home care for older people",2,"5 - QS123 - Home care for older people - Outcome - 2"]
[null,"QS123","Home care for older people",5,null,"Older people using home care services have a review of the outcomes of their home care plan within 6 weeks of starting to use the service and then at least annually.","Social care-related quality of life.","Outcome","QS123 - Home care for older people","5 - QS123 - Home care for older people",3,"5 - QS123 - Home care for older people - Outcome - 3"]
[null,"QS123","Home care for older people",6,null,"Home care providers have practice-based supervision discussions with home care workers at least every 3 months.","Evidence of local processes to ensure that home care providers have practice-based supervision discussions with home care workers at least every 3 months.\n\n","Structure",{"$f":"CONCATENATE(B2715, \" - \", C2715)","v":"QS123 - Home care for older people"},{"$f":"CONCATENATE(D2715, \" - \", I2715)","v":"6 - QS123 - Home care for older people"},{"$f":"IF(AND(B2715=B2714, D2715=D2714, H2715=H2714)=TRUE, K2714+1, 1)","v":1},{"$f":"CONCATENATE(J2715, \" - \", H2715, \" - \",K2715)","v":"6 - QS123 - Home care for older people - Structure - 1"}]
[null,"QS123","Home care for older people",6,null,"Home care providers have practice-based supervision discussions with home care workers at least every 3 months.","Proportion of home care workers supporting older people who had a practice-based supervision discussion within the past 3 months.","Process","QS123 - Home care for older people","6 - QS123 - Home care for older people",1,"6 - QS123 - Home care for older people - Process - 1","The number in the denominator who had a practice-based supervision discussion within the past 3 months.","The number of home care workers supporting older people."]
[null,"QS123","Home care for older people",6,null,"Home care providers have practice-based supervision discussions with home care workers at least every 3 months.","Older people's satisfaction with the home care service.","Outcome","QS123 - Home care for older people","6 - QS123 - Home care for older people",1,"6 - QS123 - Home care for older people - Outcome - 1"]
[null,"QS123","Home care for older people",6,null,"Home care providers have practice-based supervision discussions with home care workers at least every 3 months.","Staff retention among home care workers.","Outcome","QS123 - Home care for older people","6 - QS123 - Home care for older people",2,"6 - QS123 - Home care for older people - Outcome - 2"]
[null,"QS124","Suspected cancer\n",1,"Direct access to diagnostic tests","GPs have direct access to diagnostic endoscopy, ultrasound, MRI, X-ray and CT for people with suspected cancer.\n\n","Evidence of local arrangements to give GPs direct access to diagnostic endoscopy, ultrasound, MRI, X-ray and CT for people with suspected cancer.","Structure",{"$f":"CONCATENATE(B2719, \" - \", C2719)","v":"QS124 - Suspected cancer\n"},{"$f":"CONCATENATE(D2719, \" - \", I2719)","v":"1 - QS124 - Suspected cancer\n"},{"$f":"IF(AND(B2719=B2718, D2719=D2718, H2719=H2718)=TRUE, K2718+1, 1)","v":1},{"$f":"CONCATENATE(J2719, \" - \", H2719, \" - \",K2719)","v":"1 - QS124 - Suspected cancer\n - Structure - 1"}]
[null,"QS124","Suspected cancer\n",1,"Direct access to diagnostic tests","GPs have direct access to diagnostic endoscopy, ultrasound, MRI, X-ray and CT for people with suspected cancer.\n\n","Time to diagnostic test for suspected cancer.","Outcome","QS124 - Suspected cancer\n","1 - QS124 - Suspected cancer\n",1,"1 - QS124 - Suspected cancer\n - Outcome - 1"]
[null,"QS124","Suspected cancer\n",1,"Direct access to diagnostic tests","GPs have direct access to diagnostic endoscopy, ultrasound, MRI, X-ray and CT for people with suspected cancer.\n\n","Time from presentation at GP to cancer diagnosis.","Outcome","QS124 - Suspected cancer\n","1 - QS124 - Suspected cancer\n",2,"1 - QS124 - Suspected cancer\n - Outcome - 2"]
[null,"QS124","Suspected cancer\n",2,"Urgent direct access endoscopy for oesophageal or stomach cancer","People presenting in primary care with symptoms that suggest oesophageal or stomach cancer have an urgent direct access upper gastrointestinal endoscopy.\n\n","Evidence of local direct access pathways to ensure that people presenting in primary care with symptoms that suggest oesophageal or stomach cancer have an urgent direct access upper gastrointestinal endoscopy.","Structure","QS124 - Suspected cancer\n","2 - QS124 - Suspected cancer\n",{"$f":"IF(AND(B2722=B2719, D2722=D2719, H2722=H2719)=TRUE, K2719+1, 1)","v":1},"2 - QS124 - Suspected cancer\n - Structure - 1"]
[null,"QS124","Suspected cancer\n",2,"Urgent direct access endoscopy for oesophageal or stomach cancer","People presenting in primary care with symptoms that suggest oesophageal or stomach cancer have an urgent direct access upper gastrointestinal endoscopy.\n\n","Proportion of people with symptoms that suggest oesophageal or stomach cancer who have an urgent direct access upper gastrointestinal endoscopy.\n\n","Process","QS124 - Suspected cancer\n","2 - QS124 - Suspected cancer\n",1,"2 - QS124 - Suspected cancer\n - Process - 1","the number in the denominator who have an urgent direct access upper gastrointestinal endoscopy","the number of people with symptoms that suggest oesophageal or stomach cancer sent for an urgent direct access upper gastrointestinal endoscopy at the time of presentation at their GP"]
[null,"QS124","Suspected cancer\n",2,"Urgent direct access endoscopy for oesophageal or stomach cancer","People presenting in primary care with symptoms that suggest oesophageal or stomach cancer have an urgent direct access upper gastrointestinal endoscopy.\n\n","Time to oesophageal cancer diagnosis.","Outcome","QS124 - Suspected cancer\n","2 - QS124 - Suspected cancer\n",1,"2 - QS124 - Suspected cancer\n - Outcome - 1"]
[null,"QS124","Suspected cancer\n",2,"Urgent direct access endoscopy for oesophageal or stomach cancer","People presenting in primary care with symptoms that suggest oesophageal or stomach cancer have an urgent direct access upper gastrointestinal endoscopy.\n\n","Time to stomach cancer diagnosis.","Outcome","QS124 - Suspected cancer\n","2 - QS124 - Suspected cancer\n",2,"2 - QS124 - Suspected cancer\n - Outcome - 2"]
[null,"QS124","Suspected cancer\n",3,"Testing for blood in faeces","Adults presenting in primary care with symptoms that suggest colorectal cancer, who do not meet the referral pathway criteria, have a test for blood in their faeces.\n","Evidence of local arrangements and written clinical protocols to ensure that adults presenting in primary care with symptoms that suggest colorectal cancer who do not meet the referral pathway criteria, have a test for blood in faeces.","Structure","QS124 - Suspected cancer\n","3 - QS124 - Suspected cancer\n",1,"3 - QS124 - Suspected cancer\n - Structure - 1"]
[null,"QS124","Suspected cancer\n",3,"Testing for blood in faeces","Adults presenting in primary care with symptoms that suggest colorectal cancer, who do not meet the referral pathway criteria, have a test for blood in their faeces.\n","Proportion of presentations of adults with symptoms that suggest colorectal cancer, without visible rectal bleeding, in which the person has a test for blood in faeces.","Process","QS124 - Suspected cancer\n","3 - QS124 - Suspected cancer\n",1,"3 - QS124 - Suspected cancer\n - Process - 1","the number in the denominator resulting in a test for blood in faeces","the number of presentations of adults with symptoms that suggest colorectal cancer who do not meet the referral pathway criteria"]
[null,"QS124","Suspected cancer\n",3,"Testing for blood in faeces","Adults presenting in primary care with symptoms that suggest colorectal cancer, who do not meet the referral pathway criteria, have a test for blood in their faeces.\n","Stage of colorectal cancer at diagnosis.","Outcome","QS124 - Suspected cancer\n","3 - QS124 - Suspected cancer\n",1,"3 - QS124 - Suspected cancer\n - Outcome - 1"]
[null,"QS124","Suspected cancer\n",3,"Testing for blood in faeces","Adults presenting in primary care with symptoms that suggest colorectal cancer, who do not meet the referral pathway criteria, have a test for blood in their faeces.\n","Colorectal cancer-related mortality.","Outcome","QS124 - Suspected cancer\n","3 - QS124 - Suspected cancer\n",2,"3 - QS124 - Suspected cancer\n - Outcome - 2"]
[null,"QS124","Suspected cancer\n",4,"Encouraging attendance at cancer services","People with suspected cancer who are referred to a cancer service are given written information encouraging them to attend.","Evidence of local arrangements to ensure that people with suspected cancer who are referred to a cancer service are given written information to encourage them to attend.","Structure","QS124 - Suspected cancer\n","4 - QS124 - Suspected cancer\n",1,"4 - QS124 - Suspected cancer\n - Structure - 1"]
[null,"QS124","Suspected cancer\n",4,"Encouraging attendance at cancer services","People with suspected cancer who are referred to a cancer service are given written information encouraging them to attend.","Proportion of referrals of people with suspected cancer to a cancer service for which there is a recorded discussion when they are offered the referral about information to encourage attendance.\n\n","Process","QS124 - Suspected cancer\n","4 - QS124 - Suspected cancer\n",1,"4 - QS124 - Suspected cancer\n - Process - 1","the number in the denominator for which there is a record of a discussion when the referral was offered about information to encourage attendance","the number of referrals of people with suspected cancer to a cancer service"]
[null,"QS124","Suspected cancer\n",4,"Encouraging attendance at cancer services","People with suspected cancer who are referred to a cancer service are given written information encouraging them to attend.","Number of missed appointments.","Outcome","QS124 - Suspected cancer\n","4 - QS124 - Suspected cancer\n",1,"4 - QS124 - Suspected cancer\n - Outcome - 1"]
[null,"QS124","Suspected cancer\n",4,"Encouraging attendance at cancer services","People with suspected cancer who are referred to a cancer service are given written information encouraging them to attend.","Patient satisfaction with information provided.","Outcome","QS124 - Suspected cancer\n","4 - QS124 - Suspected cancer\n",2,"4 - QS124 - Suspected cancer\n - Outcome - 2"]
[null,"QS124","Suspected cancer\n",4,"Encouraging attendance at cancer services","People with suspected cancer who are referred to a cancer service are given written information encouraging them to attend.","Time to cancer diagnosis.","Outcome","QS124 - Suspected cancer\n","4 - QS124 - Suspected cancer\n",3,"4 - QS124 - Suspected cancer\n - Outcome - 3"]
[null,"QS125","Diabetes in children and young people",1,"Same-day referral and appointments","Children and young people presenting in primary care with suspected diabetes are referred to and seen by a multidisciplinary paediatric diabetes team on the same day. ","Evidence of local arrangements and written clinical protocols to ensure that children and young people presenting in primary care with suspected diabetes are referred to and seen by a multidisciplinary paediatric diabetes team on the same day. ","Structure","QS125 - Diabetes in children and young people","1 - QS125 - Diabetes in children and young people",1,"1 - QS125 - Diabetes in children and young people - Structure - 1"]
[null,"QS125","Diabetes in children and young people",1,"Same-day referral and appointments","Children and young people presenting in primary care with suspected diabetes are referred to and seen by a multidisciplinary paediatric diabetes team on the same day. ","Proportion of children and young people presenting in primary care with suspected diabetes who are referred to and seen by a multidisciplinary paediatric diabetes team on the same day. ","Process","QS125 - Diabetes in children and young people","1 - QS125 - Diabetes in children and young people",1,"1 - QS125 - Diabetes in children and young people - Process - 1","The number in the denominator who are referred to and seen by a multidisciplinary paediatric diabetes team on the same day.","The number of children and young people presenting in primary care with suspected diabetes."]
[null,"QS125","Diabetes in children and young people",1,"Same-day referral and appointments","Children and young people presenting in primary care with suspected diabetes are referred to and seen by a multidisciplinary paediatric diabetes team on the same day. ","Presentations of diabetic ketoacidosis.","Outcome","QS125 - Diabetes in children and young people","1 - QS125 - Diabetes in children and young people",1,"1 - QS125 - Diabetes in children and young people - Outcome - 1"]
[null,"QS125","Diabetes in children and young people",2,"Education and information","Children and young people with type 1 or type 2 diabetes are offered a programme of diabetes education from diagnosis that is updated at least annually.","Evidence of local arrangements and written protocols to ensure that children and young people with type 1 diabetes are offered a programme of diabetes education from diagnosis that is updated at least annually. ","Structure","QS125 - Diabetes in children and young people","2 - QS125 - Diabetes in children and young people",1,"2 - QS125 - Diabetes in children and young people - Structure - 1"]
[null,"QS125","Diabetes in children and young people",2,"Education and information","Children and young people with type 1 or type 2 diabetes are offered a programme of diabetes education from diagnosis that is updated at least annually.","Evidence of local arrangements and written protocols to ensure that children and young people with type 2 diabetes are offered a programme of diabetes education from diagnosis that is updated at least annually. ","Structure","QS125 - Diabetes in children and young people","2 - QS125 - Diabetes in children and young people",2,"2 - QS125 - Diabetes in children and young people - Structure - 2"]
[null,"QS125","Diabetes in children and young people",2,"Education and information","Children and young people with type 1 or type 2 diabetes are offered a programme of diabetes education from diagnosis that is updated at least annually.","Proportion of children and young people with type 1 diabetes who are offered a programme of diabetes education from diagnosis that is updated at least annually.","Process","QS125 - Diabetes in children and young people","2 - QS125 - Diabetes in children and young people",1,"2 - QS125 - Diabetes in children and young people - Process - 1","The number in the denominator who receive a programme of diabetes education from diagnosis that is updated at least annually. ","The number of children and young people with type 1 diabetes. "]
[null,"QS125","Diabetes in children and young people",2,"Education and information","Children and young people with type 1 or type 2 diabetes are offered a programme of diabetes education from diagnosis that is updated at least annually.","Proportion of children and young people with type 2 diabetes who are offered a programme of diabetes education from diagnosis that is updated at least annually. ","Process","QS125 - Diabetes in children and young people","2 - QS125 - Diabetes in children and young people",2,"2 - QS125 - Diabetes in children and young people - Process - 2","The number in the denominator who receive a programme of diabetes education from diagnosis that is updated at least annually.","The number of children and young people with type 2 diabetes. "]
[null,"QS125","Diabetes in children and young people",2,"Education and information","Children and young people with type 1 or type 2 diabetes are offered a programme of diabetes education from diagnosis that is updated at least annually.","Quality of life of children and young people with type 1 or type 2 diabetes.","Outcome","QS125 - Diabetes in children and young people","2 - QS125 - Diabetes in children and young people",1,"2 - QS125 - Diabetes in children and young people - Outcome - 1"]
[null,"QS125","Diabetes in children and young people",2,"Education and information","Children and young people with type 1 or type 2 diabetes are offered a programme of diabetes education from diagnosis that is updated at least annually.","HbA1c level of 48 mmol/mol or lower.","Outcome","QS125 - Diabetes in children and young people","2 - QS125 - Diabetes in children and young people",2,"2 - QS125 - Diabetes in children and young people - Outcome - 2"]
[null,"QS125","Diabetes in children and young people",2,"Education and information","Children and young people with type 1 or type 2 diabetes are offered a programme of diabetes education from diagnosis that is updated at least annually.","Satisfaction of children, young people and their family members or carers (as appropriate) with the education intervention. ","Outcome","QS125 - Diabetes in children and young people","2 - QS125 - Diabetes in children and young people",3,"2 - QS125 - Diabetes in children and young people - Outcome - 3"]
[null,"QS125","Diabetes in children and young people",3,"Intensive insulin therapy and level 3 carbohydrate counting education for type 1 diabetes","Children and young people with type 1 diabetes are offered intensive insulin therapy and level 3 carbohydrate counting education at diagnosis. ","Evidence of local arrangements and written clinical protocols to ensure that children and young people with type 1 diabetes are offered intensive insulin therapy and level 3 carbohydrate‑counting education at diagnosis.","Structure","QS125 - Diabetes in children and young people","3 - QS125 - Diabetes in children and young people",1,"3 - QS125 - Diabetes in children and young people - Structure - 1"]
[null,"QS125","Diabetes in children and young people",3,"Intensive insulin therapy and level 3 carbohydrate counting education for type 1 diabetes","Children and young people with type 1 diabetes are offered intensive insulin therapy and level 3 carbohydrate counting education at diagnosis. ","Proportion of children and young people with type 1 diabetes who are offered intensive insulin therapy and level 3 carbohydrate counting education at diagnosis.","Process","QS125 - Diabetes in children and young people","3 - QS125 - Diabetes in children and young people",1,"3 - QS125 - Diabetes in children and young people - Process - 1","The number in the denominator who receive intensive insulin therapy and level 3 carbohydrate‑counting education at diagnosis.","The number of children and young people with type 1 diabetes. "]
[null,"QS125","Diabetes in children and young people",3,"Intensive insulin therapy and level 3 carbohydrate counting education for type 1 diabetes","Children and young people with type 1 diabetes are offered intensive insulin therapy and level 3 carbohydrate counting education at diagnosis. ","HbA1c level of 48 mmol/mol or lower.","Outcome","QS125 - Diabetes in children and young people","3 - QS125 - Diabetes in children and young people",1,"3 - QS125 - Diabetes in children and young people - Outcome - 1"]
[null,"QS125","Diabetes in children and young people",3,"Intensive insulin therapy and level 3 carbohydrate counting education for type 1 diabetes","Children and young people with type 1 diabetes are offered intensive insulin therapy and level 3 carbohydrate counting education at diagnosis. ","Quality of life of children and young people with type 1 diabetes.","Outcome","QS125 - Diabetes in children and young people","3 - QS125 - Diabetes in children and young people",2,"3 - QS125 - Diabetes in children and young people - Outcome - 2"]
[null,"QS125","Diabetes in children and young people",4,"Continuous glucose monitoring in type 1 diabetes","Children and young people with type 1 diabetes are offered real-time continuous glucose monitoring (rtCGM).","Evidence of local arrangements to ensure that rtCGM is available to all children and young people with type 1 diabetes.","Structure","QS125 - Diabetes in children and young people","4 - QS125 - Diabetes in children and young people",1,"4 - QS125 - Diabetes in children and young people - Structure - 1"]
[null,"QS125","Diabetes in children and young people",4,"Continuous glucose monitoring in type 1 diabetes","Children and young people with type 1 diabetes are offered real-time continuous glucose monitoring (rtCGM).","Proportion of children and young people with type 1 diabetes who receive rtCGM.","Process","QS125 - Diabetes in children and young people","4 - QS125 - Diabetes in children and young people",1,"4 - QS125 - Diabetes in children and young people - Process - 1","The number in the denominator who receive rtCGM.","The number of children and young people with type 1 diabetes."]
[null,"QS125","Diabetes in children and young people",4,"Continuous glucose monitoring in type 1 diabetes","Children and young people with type 1 diabetes are offered real-time continuous glucose monitoring (rtCGM).","HbA1c level of 48 mmol/mol or lower.","Outcome","QS125 - Diabetes in children and young people","4 - QS125 - Diabetes in children and young people",1,"4 - QS125 - Diabetes in children and young people - Outcome - 1"]
[null,"QS125","Diabetes in children and young people",4,"Continuous glucose monitoring in type 1 diabetes","Children and young people with type 1 diabetes are offered real-time continuous glucose monitoring (rtCGM).","Time in range.","Outcome",{"$f":"CONCATENATE(B2752, \" - \", C2752)","v":"QS125 - Diabetes in children and young people"},{"$f":"CONCATENATE(D2752, \" - \", I2752)","v":"4 - QS125 - Diabetes in children and young people"},{"$f":"IF(AND(B2752=B2751, D2752=D2751, H2752=H2751)=TRUE, K2751+1, 1)","v":2},{"$f":"CONCATENATE(J2752, \" - \", H2752, \" - \",K2752)","v":"4 - QS125 - Diabetes in children and young people - Outcome - 2"}]
[null,"QS125","Diabetes in children and young people",4,"Continuous glucose monitoring in type 1 diabetes","Children and young people with type 1 diabetes are offered real-time continuous glucose monitoring (rtCGM).","Quality of life of children and young people with type 1 diabetes.","Outcome",{"$f":"CONCATENATE(B2753, \" - \", C2753)","v":"QS125 - Diabetes in children and young people"},{"$f":"CONCATENATE(D2753, \" - \", I2753)","v":"4 - QS125 - Diabetes in children and young people"},{"$f":"IF(AND(B2753=B2752, D2753=D2752, H2753=H2752)=TRUE, K2752+1, 1)","v":3},{"$f":"CONCATENATE(J2753, \" - \", H2753, \" - \",K2753)","v":"4 - QS125 - Diabetes in children and young people - Outcome - 3"}]
[null,"QS125","Diabetes in children and young people",5,"Blood ketone monitoring in type 1 diabetes","Children and young people with type 1 diabetes are offered blood ketone testing strips and a blood ketone meter.","Evidence of local arrangements to ensure that children and young people with type 1 diabetes are offered blood ketone testing strips and a blood ketone meter.","Structure","QS125 - Diabetes in children and young people","5 - QS125 - Diabetes in children and young people",{"$f":"IF(AND(B2754=B2753, D2754=D2753, H2754=H2753)=TRUE, K2753+1, 1)","v":1},"5 - QS125 - Diabetes in children and young people - Structure - 1"]
[null,"QS125","Diabetes in children and young people",5,"Blood ketone monitoring in type 1 diabetes","Children and young people with type 1 diabetes are offered blood ketone testing strips and a blood ketone meter.","Proportion of children and young people with type 1 diabetes who receive blood ketone testing strips and a blood ketone meter.","Process","QS125 - Diabetes in children and young people","5 - QS125 - Diabetes in children and young people",1,"5 - QS125 - Diabetes in children and young people - Process - 1","The number in the denominator who receive blood ketone testing strips and a blood ketone meter.","The number of children and young people with type 1 diabetes. "]
[null,"QS125","Diabetes in children and young people",5,"Blood ketone monitoring in type 1 diabetes","Children and young people with type 1 diabetes are offered blood ketone testing strips and a blood ketone meter.","Diabetic ketoacidosis.","Outcome","QS125 - Diabetes in children and young people","5 - QS125 - Diabetes in children and young people",1,"5 - QS125 - Diabetes in children and young people - Outcome - 1"]
[null,"QS125","Diabetes in children and young people",5,"Blood ketone monitoring in type 1 diabetes","Children and young people with type 1 diabetes are offered blood ketone testing strips and a blood ketone meter.","Hospital admission rates of children and young people with type 1 diabetes.","Outcome","QS125 - Diabetes in children and young people","5 - QS125 - Diabetes in children and young people",2,"5 - QS125 - Diabetes in children and young people - Outcome - 2"]
[null,"QS125","Diabetes in children and young people",5,"Blood ketone monitoring in type 1 diabetes","Children and young people with type 1 diabetes are offered blood ketone testing strips and a blood ketone meter.","Satisfaction of children and young people with type 1 diabetes and their family members or carers (as appropriate) with blood ketone testing strips and blood ketone meters. ","Outcome","QS125 - Diabetes in children and young people","5 - QS125 - Diabetes in children and young people",{"$f":"IF(AND(B2758=B2757, D2758=D2757, H2758=H2757)=TRUE, K2757+1, 1)","v":3},{"$f":"CONCATENATE(J2758, \" - \", H2758, \" - \",K2758)","v":"5 - QS125 - Diabetes in children and young people - Outcome - 3"}]
[null,"QS125","Diabetes in children and young people",6,"Access to mental health professionals with an understanding of type 1 or type 2 diabetes","Children and young people with type 1 or type 2 diabetes are offered access to mental health professionals with an understanding of diabetes. ","Evidence of local arrangements to ensure that children and young people with type 1 or type 2 diabetes are offered access to mental health professionals with an understanding of diabetes.","Structure","QS125 - Diabetes in children and young people","6 - QS125 - Diabetes in children and young people",1,"6 - QS125 - Diabetes in children and young people - Structure - 1"]
[null,"QS125","Diabetes in children and young people",6,"Access to mental health professionals with an understanding of type 1 or type 2 diabetes","Children and young people with type 1 or type 2 diabetes are offered access to mental health professionals with an understanding of diabetes. ","Proportion of children and young people with type 1 diabetes who are offered access to mental health professionals with an understanding of diabetes. ","Process","QS125 - Diabetes in children and young people","6 - QS125 - Diabetes in children and young people",1,"6 - QS125 - Diabetes in children and young people - Process - 1","The number in the denominator who have access to mental health professionals with an understanding of diabetes.","The number of children and young people with type 1 diabetes."]
[null,"QS125","Diabetes in children and young people",6,"Access to mental health professionals with an understanding of type 1 or type 2 diabetes","Children and young people with type 1 or type 2 diabetes are offered access to mental health professionals with an understanding of diabetes. ","Proportion of children and young people with type 2 diabetes who are offered access to mental health professionals with an understanding of diabetes.","Process",{"$f":"CONCATENATE(B2761, \" - \", C2761)","v":"QS125 - Diabetes in children and young people"},{"$f":"CONCATENATE(D2761, \" - \", I2761)","v":"6 - QS125 - Diabetes in children and young people"},{"$f":"IF(AND(B2761=B2760, D2761=D2760, H2761=H2760)=TRUE, K2760+1, 1)","v":2},{"$f":"CONCATENATE(J2761, \" - \", H2761, \" - \",K2761)","v":"6 - QS125 - Diabetes in children and young people - Process - 2"},"The number in the denominator who have access to mental health professionals with an understanding of diabetes.","The number of children and young people with type 2 diabetes."]
[null,"QS125","Diabetes in children and young people",6,"Access to mental health professionals with an understanding of type 1 or type 2 diabetes","Children and young people with type 1 or type 2 diabetes are offered access to mental health professionals with an understanding of diabetes. ","Self-management of type 1 and type 2 diabetes.","Outcome","QS125 - Diabetes in children and young people","6 - QS125 - Diabetes in children and young people",1,"6 - QS125 - Diabetes in children and young people - Outcome - 1"]
[null,"QS125","Diabetes in children and young people",6,"Access to mental health professionals with an understanding of type 1 or type 2 diabetes","Children and young people with type 1 or type 2 diabetes are offered access to mental health professionals with an understanding of diabetes. ","Adverse events (for example, severe hypoglycaemic episodes, diabetic ketoacidosis [DKA] or self harm). ","Outcome","QS125 - Diabetes in children and young people","6 - QS125 - Diabetes in children and young people",2,"6 - QS125 - Diabetes in children and young people - Outcome - 2"]
[null,"QS125","Diabetes in children and young people",6,"Access to mental health professionals with an understanding of type 1 or type 2 diabetes","Children and young people with type 1 or type 2 diabetes are offered access to mental health professionals with an understanding of diabetes. ","Quality of life of children and young people with type 1 or type 2 diabetes.","Outcome","QS125 - Diabetes in children and young people","6 - QS125 - Diabetes in children and young people",3,"6 - QS125 - Diabetes in children and young people - Outcome - 3"]
[null,"QS125","Diabetes in children and young people",6,"Access to mental health professionals with an understanding of type 1 or type 2 diabetes","Children and young people with type 1 or type 2 diabetes are offered access to mental health professionals with an understanding of diabetes. ","Satisfaction of children, young people and their family members or carers (as appropriate) with the intervention. ","Outcome","QS125 - Diabetes in children and young people","6 - QS125 - Diabetes in children and young people",4,"6 - QS125 - Diabetes in children and young people - Outcome - 4"]
[null,"QS125","Diabetes in children and young people",6,"Access to mental health professionals with an understanding of type 1 or type 2 diabetes","Children and young people with type 1 or type 2 diabetes are offered access to mental health professionals with an understanding of diabetes. ","Anxiety or depression in children and young people with type 1 or type 2 diabetes.","Outcome","QS125 - Diabetes in children and young people","6 - QS125 - Diabetes in children and young people",5,"6 - QS125 - Diabetes in children and young people - Outcome - 5"]
[null,"QS125","Diabetes in children and young people",6,"Access to mental health professionals with an understanding of type 1 or type 2 diabetes","Children and young people with type 1 or type 2 diabetes are offered access to mental health professionals with an understanding of diabetes. ","School performance or attendance of children and young people with type 1 or type 2 diabetes.","Outcome","QS125 - Diabetes in children and young people","6 - QS125 - Diabetes in children and young people",6,"6 - QS125 - Diabetes in children and young people - Outcome - 6"]
[" ","QS126","Motor neurone disease",1,"Information and support at diagnosis","Adults diagnosed with motor neurone disease (MND) are given information about the diagnosis, prognosis and management of MND by a consultant neurologist with expertise in treating people with MND","Evidence of local arrangements to ensure that people diagnosed with MND are given information about the diagnosis, prognosis and management of MND by a consultant neurologist with expertise in MND","Structure","QS126 - Motor neurone disease","1 - QS126 - Motor neurone disease",1,"1 - QS126 - Motor neurone disease - Structure - 1"]
[null,"QS126","Motor neurone disease",1,"Information and support at diagnosis","Adults diagnosed with motor neurone disease (MND) are given information about the diagnosis, prognosis and management of MND by a consultant neurologist with expertise in treating people with MND","Of adults with MND, the number who are given information at diagnosis about the diagnosis, prognosis and management of MND by a consultant neurologist with expertise in treating people with MND","Process","QS126 - Motor neurone disease","1 - QS126 - Motor neurone disease",1,"1 - QS126 - Motor neurone disease - Process - 1","The number in the denominator who are given information at diagnosis about the diagnosis, prognosis and management of MND by a consultant neurologist with expertise in treating people with MND.","The number of adults with MND"]
[null,"QS126","Motor neurone disease",1,"Information and support at diagnosis","Adults diagnosed with motor neurone disease (MND) are given information about the diagnosis, prognosis and management of MND by a consultant neurologist with expertise in treating people with MND","Adults diagnosed with MND understand how the condition is likely to affect them","Outcome","QS126 - Motor neurone disease","1 - QS126 - Motor neurone disease",1,"1 - QS126 - Motor neurone disease - Outcome - 1"]
[null,"QS126","Motor neurone disease",1,"Information and support at diagnosis","Adults diagnosed with motor neurone disease (MND) are given information about the diagnosis, prognosis and management of MND by a consultant neurologist with expertise in treating people with MND","Adults diagnosed with MND understand the type of care and support they can receive","Outcome","QS126 - Motor neurone disease","1 - QS126 - Motor neurone disease",2,"1 - QS126 - Motor neurone disease - Outcome - 2"]
[null,"QS126","Motor neurone disease",1,"Information and support at diagnosis","Adults diagnosed with motor neurone disease (MND) are given information about the diagnosis, prognosis and management of MND by a consultant neurologist with expertise in treating people with MND","Adults diagnosed with MND, and their families or carers, feel able to cope","Outcome","QS126 - Motor neurone disease","1 - QS126 - Motor neurone disease",3,"1 - QS126 - Motor neurone disease - Outcome - 3"]
[null,"QS126","Motor neurone disease",2,"Respiratory assessment and non‑invasive ventilation","Adults with motor neurone disease who have respiratory impairment are offered non‑invasive ventilation based on regular assessments of respiratory function and symptoms","Evidence that MND multidisciplinary teams include respiratory physiologists or healthcare professionals who can assess respiratory function","Structure","QS126 - Motor neurone disease","2 - QS126 - Motor neurone disease",1,"2 - QS126 - Motor neurone disease - Structure - 1"]
[null,"QS126","Motor neurone disease",2,"Respiratory assessment and non‑invasive ventilation","Adults with motor neurone disease who have respiratory impairment are offered non‑invasive ventilation based on regular assessments of respiratory function and symptoms","Evidence of local arrangements and written protocols to ensure that adults with MND have their respiratory function and symptoms assessed at diagnosis and then every 2–3 months","Structure","QS126 - Motor neurone disease","2 - QS126 - Motor neurone disease",2,"2 - QS126 - Motor neurone disease - Structure - 2"]
[null,"QS126","Motor neurone disease",2,"Respiratory assessment and non‑invasive ventilation","Adults with motor neurone disease who have respiratory impairment are offered non‑invasive ventilation based on regular assessments of respiratory function and symptoms","Evidence of established relationships and decision making arrangements between MND multidisciplinary teams and respiratory ventilation services","Structure","QS126 - Motor neurone disease","2 - QS126 - Motor neurone disease",3,"2 - QS126 - Motor neurone disease - Structure - 3"]
[null,"QS126","Motor neurone disease",2,"Respiratory assessment and non‑invasive ventilation","Adults with motor neurone disease who have respiratory impairment are offered non‑invasive ventilation based on regular assessments of respiratory function and symptoms","Evidence of local arrangements to provide NIV for adults with MND who have respiratory impairment","Structure","QS126 - Motor neurone disease","2 - QS126 - Motor neurone disease",4,"2 - QS126 - Motor neurone disease - Structure - 4"]
[null,"QS126","Motor neurone disease",2,"Respiratory assessment and non‑invasive ventilation","Adults with motor neurone disease who have respiratory impairment are offered non‑invasive ventilation based on regular assessments of respiratory function and symptoms","Of adults diagnosed with MND, the number of adults who had their respiratory function and symptoms assessed as part of the initial assessment to diagnose MND","Process","QS126 - Motor neurone disease","2 - QS126 - Motor neurone disease",1,"2 - QS126 - Motor neurone disease - Process - 1","The number in the denominator who had their respiratory function and symptoms assessed as part of the initial assessment to diagnose MND.","The number of adults diagnosed with MND"]
[null,"QS126","Motor neurone disease",2,"Respiratory assessment and non‑invasive ventilation","Adults with motor neurone disease who have respiratory impairment are offered non‑invasive ventilation based on regular assessments of respiratory function and symptoms","Of adults with MND, the number who have had their respiratory function and symptoms assessed within the past 3 months","Process","QS126 - Motor neurone disease","2 - QS126 - Motor neurone disease",2,"2 - QS126 - Motor neurone disease - Process - 2","The number in the denominator who have had their respiratory function and symptoms assessed within the past 3 months.","The number of adults with MND"]
[null,"QS126","Motor neurone disease",2,"Respiratory assessment and non‑invasive ventilation","Adults with motor neurone disease who have respiratory impairment are offered non‑invasive ventilation based on regular assessments of respiratory function and symptoms","Of adults with MND who have respiratory impairment, the number who are established on NIV","Process","QS126 - Motor neurone disease","2 - QS126 - Motor neurone disease",3,"2 - QS126 - Motor neurone disease - Process - 3","The number in the denominator who have respiratory impairment, the number who are established on NIV.","The number of adults with MND who have a respiratory impairment"]
[null,"QS126","Motor neurone disease",2,"Respiratory assessment and non‑invasive ventilation","Adults with motor neurone disease who have respiratory impairment are offered non‑invasive ventilation based on regular assessments of respiratory function and symptoms","Survival of adults with MND from diagnosis","Outcome","QS126 - Motor neurone disease","2 - QS126 - Motor neurone disease",1,"2 - QS126 - Motor neurone disease - Outcome - 1"]
[null,"QS126","Motor neurone disease",2,"Respiratory assessment and non‑invasive ventilation","Adults with motor neurone disease who have respiratory impairment are offered non‑invasive ventilation based on regular assessments of respiratory function and symptoms","Adults with MND able to maintain activities of daily living","Outcome","QS126 - Motor neurone disease","2 - QS126 - Motor neurone disease",2,"2 - QS126 - Motor neurone disease - Outcome - 2"]
[null,"QS126","Motor neurone disease",3,"Provision of equipment and adaptions based on multidisciplinary team assessment","Adults with motor neurone disease (MND) receive tailored equipment and adaptions without delay, based on regular multidisciplinary team assessments","Evidence of local arrangements to ensure that adults with MND have regular assessments from MND multidisciplinary teams","Structure","QS126 - Motor neurone disease","3 - QS126 - Motor neurone disease",1,"3 - QS126 - Motor neurone disease - Structure - 1"]
[null,"QS126","Motor neurone disease",3,"Provision of equipment and adaptions based on multidisciplinary team assessment","Adults with motor neurone disease (MND) receive tailored equipment and adaptions without delay, based on regular multidisciplinary team assessments","Evidence of local arrangements to ensure that equipment is provided, or adapted, in a timely way to meet the individual needs identified for adults with MND","Structure","QS126 - Motor neurone disease","3 - QS126 - Motor neurone disease",2,"3 - QS126 - Motor neurone disease - Structure - 2"]
[null,"QS126","Motor neurone disease",3,"Provision of equipment and adaptions based on multidisciplinary team assessment","Adults with motor neurone disease (MND) receive tailored equipment and adaptions without delay, based on regular multidisciplinary team assessments","Of adults with MND, the number who have had a comprehensive assessment by the MND multidisciplinary team in the past 3 months","Process","QS126 - Motor neurone disease","3 - QS126 - Motor neurone disease",1,"3 - QS126 - Motor neurone disease - Process - 1"]
[null,"QS126","Motor neurone disease",3,"Provision of equipment and adaptions based on multidisciplinary team assessment","Adults with motor neurone disease (MND) receive tailored equipment and adaptions without delay, based on regular multidisciplinary team assessments","The length of time in days between an equipment need or an adaption need being identified in a comprehensive multidisciplinary team assessment, and the equipment being provided or adaption made","Process","QS126 - Motor neurone disease","3 - QS126 - Motor neurone disease",2,"3 - QS126 - Motor neurone disease - Process - 2"]
[null,"QS126","Motor neurone disease",3,"Provision of equipment and adaptions based on multidisciplinary team assessment","Adults with motor neurone disease (MND) receive tailored equipment and adaptions without delay, based on regular multidisciplinary team assessments","Adults with MND able to maintain activities of daily living","Outcome","QS126 - Motor neurone disease","3 - QS126 - Motor neurone disease",1,"3 - QS126 - Motor neurone disease - Outcome - 1"]
[null,"QS126","Motor neurone disease",3,"Provision of equipment and adaptions based on multidisciplinary team assessment","Adults with motor neurone disease (MND) receive tailored equipment and adaptions without delay, based on regular multidisciplinary team assessments","Adults with MND feel they are able to maintain their quality of life","Outcome","QS126 - Motor neurone disease","3 - QS126 - Motor neurone disease",2,"3 - QS126 - Motor neurone disease - Outcome - 2"]
[null,"QS126","Motor neurone disease",3,"Provision of equipment and adaptions based on multidisciplinary team assessment","Adults with motor neurone disease (MND) receive tailored equipment and adaptions without delay, based on regular multidisciplinary team assessments","Number of injuries to adults in the home associated with functions impaired by MND","Outcome","QS126 - Motor neurone disease","3 - QS126 - Motor neurone disease",3,"3 - QS126 - Motor neurone disease - Outcome - 3"]
[null,"QS126","Motor neurone disease",4,"Continuity of care","Adults with motor neurone disease (MND) receive personal care and support from a consistent team of workers who are familiar with their needs","Evidence of local arrangements to ensure that adults with MND receive personal care and support from a consistent team of care workers who are familiar with their needs","Structure","QS126 - Motor neurone disease","4 - QS126 - Motor neurone disease",1,"4 - QS126 - Motor neurone disease - Structure - 1"]
[null,"QS126","Motor neurone disease",4,"Continuity of care","Adults with motor neurone disease (MND) receive personal care and support from a consistent team of workers who are familiar with their needs","Number of workers providing personal care and support for an adult with MND","Process","QS126 - Motor neurone disease","4 - QS126 - Motor neurone disease",1,"4 - QS126 - Motor neurone disease - Process - 1"]
[null,"QS126","Motor neurone disease",4,"Continuity of care","Adults with motor neurone disease (MND) receive personal care and support from a consistent team of workers who are familiar with their needs","Number of first visits of workers providing personal care and support for an adult with MND","Process","QS126 - Motor neurone disease","4 - QS126 - Motor neurone disease",2,"4 - QS126 - Motor neurone disease - Process - 2"]
[null,"QS126","Motor neurone disease",4,"Continuity of care","Adults with motor neurone disease (MND) receive personal care and support from a consistent team of workers who are familiar with their needs","Adults with MND feel they receive the personal care and support they need","Outcome","QS126 - Motor neurone disease","4 - QS126 - Motor neurone disease",1,"4 - QS126 - Motor neurone disease - Outcome - 1"]
[null,"QS126","Motor neurone disease",4,"Continuity of care","Adults with motor neurone disease (MND) receive personal care and support from a consistent team of workers who are familiar with their needs","Adults with MND feel they are treated with dignity and respect","Outcome","QS126 - Motor neurone disease","4 - QS126 - Motor neurone disease",2,"4 - QS126 - Motor neurone disease - Outcome - 2"]
[null,"QS126","Motor neurone disease",5,"Planning for end of life care","Adults with motor neurone disease (MND) are given opportunities to discuss their preferences and concerns about end of life care at diagnosis and key stages of disease progression","Evidence of local arrangements to ensure that adults with MND are given opportunities to discuss their preferences and concerns about end of life care at diagnosis and key stages of disease progression","Structure","QS126 - Motor neurone disease","5 - QS126 - Motor neurone disease",1,"5 - QS126 - Motor neurone disease - Structure - 1"]
[null,"QS126","Motor neurone disease",5,"Planning for end of life care","Adults with motor neurone disease (MND) are given opportunities to discuss their preferences and concerns about end of life care at diagnosis and key stages of disease progression","Of adults with MND, the number given opportunities to discuss their preferences and concerns about end of life care at diagnosis","Process","QS126 - Motor neurone disease","5 - QS126 - Motor neurone disease",1,"5 - QS126 - Motor neurone disease - Process - 1","The number in the denominator who were given opportunities to discuss their preferences and concerns about end of life care at diagnosis.","The number of adults with MND"]
[null,"QS126","Motor neurone disease",5,"Planning for end of life care","Adults with motor neurone disease (MND) are given opportunities to discuss their preferences and concerns about end of life care at diagnosis and key stages of disease progression","Of adults with MND, the number given opportunities to discuss their preferences and concerns about end of life care at key stages of disease progression","Process","QS126 - Motor neurone disease","5 - QS126 - Motor neurone disease",2,"5 - QS126 - Motor neurone disease - Process - 2","The number in the denominator who were given opportunities to discuss their preferences and concerns about end of life care ","The number of adults with MND at key stages of disease progression"]
[null,"QS126","Motor neurone disease",5,"Planning for end of life care","Adults with motor neurone disease (MND) are given opportunities to discuss their preferences and concerns about end of life care at diagnosis and key stages of disease progression","Adults with MND feel they have choice and control over their end of life care","Outcome","QS126 - Motor neurone disease","5 - QS126 - Motor neurone disease",1,"5 - QS126 - Motor neurone disease - Outcome - 1"]
[null,"QS126","Motor neurone disease",5,"Planning for end of life care","Adults with motor neurone disease (MND) are given opportunities to discuss their preferences and concerns about end of life care at diagnosis and key stages of disease progression","Adults with MND receive end of life care informed by their wishes and preferences if they lose the ability to communicate","Outcome","QS126 - Motor neurone disease","5 - QS126 - Motor neurone disease",2,"5 - QS126 - Motor neurone disease - Outcome - 2"]
[null,"QS127","Obesity: clinical assessment and management",1,"Informing people of their BMI","People are informed of their body mass index (BMI)  when it is calculated and advised about any associated health risks.","Evidence of local arrangements to ensure that people are informed of their BMI when it is calculated.","Structure",{"$f":"CONCATENATE(B2799, \" - \", C2799)","v":"QS127 - Obesity: clinical assessment and management"},{"$f":"CONCATENATE(D2799, \" - \", I2799)","v":"1 - QS127 - Obesity: clinical assessment and management"},{"$f":"IF(AND(B2799=B2798, D2799=D2798, H2799=H2798)=TRUE, K2798+1, 1)","v":1},{"$f":"CONCATENATE(J2799, \" - \", H2799, \" - \",K2799)","v":"1 - QS127 - Obesity: clinical assessment and management - Structure - 1"}]
[null,"QS127","Obesity: clinical assessment and management",1,"Informing people of their BMI","People are informed of their body mass index (BMI)  when it is calculated and advised about any associated health risks.","Evidence of local arrangements to ensure that people have a discussion with the healthcare professional about the associated health risks related to their BMI measurement.","Structure","QS127 - Obesity: clinical assessment and management","1 - QS127 - Obesity: clinical assessment and management",2,"1 - QS127 - Obesity: clinical assessment and management - Structure - 2"]
[null,"QS127","Obesity: clinical assessment and management",1,"Informing people of their BMI","People are informed of their body mass index (BMI)  when it is calculated and advised about any associated health risks.","Proportion of people who are informed of their BMI when it is calculated.","Process","QS127 - Obesity: clinical assessment and management","1 - QS127 - Obesity: clinical assessment and management",1,"1 - QS127 - Obesity: clinical assessment and management - Process - 1","The number in the denominator who are informed of their BMI.","The number of people who have had their BMI calculated."]
[null,"QS127","Obesity: clinical assessment and management",1,"Informing people of their BMI","People are informed of their body mass index (BMI)  when it is calculated and advised about any associated health risks.","Proportion of people who have a discussion with their healthcare professional about their associated health risks in relation to their BMI.","Process","QS127 - Obesity: clinical assessment and management","1 - QS127 - Obesity: clinical assessment and management",2,"1 - QS127 - Obesity: clinical assessment and management - Process - 2","The number in the denominator who had a discussion with their healthcare professional about their associated health risks in relation to their BMI.","The number of people informed of their BMI."]
[null,"QS127","Obesity: clinical assessment and management",1,"Informing people of their BMI","People are informed of their body mass index (BMI)  when it is calculated and advised about any associated health risks.","Patient awareness of their BMI measurement","Outcome","QS127 - Obesity: clinical assessment and management","1 - QS127 - Obesity: clinical assessment and management",1,"1 - QS127 - Obesity: clinical assessment and management - Outcome - 1"]
[null,"QS127","Obesity: clinical assessment and management",1,"Informing people of their BMI","People are informed of their body mass index (BMI)  when it is calculated and advised about any associated health risks.","Patient understanding of the health risks associated with their weight","Outcome","QS127 - Obesity: clinical assessment and management","1 - QS127 - Obesity: clinical assessment and management",2,"1 - QS127 - Obesity: clinical assessment and management - Outcome - 2"]
[null,"QS127","Obesity: clinical assessment and management",2,"Discussion on the choice of interventions","Adults with obesity for whom tier 2 interventions have been unsuccessful have a discussion about the choice of alternative interventions for weight management, including tier 3 services.","Evidence of local arrangements and written protocols to ensure that adults with obesity for whom tier 2 interventions have been unsuccessful have a discussion about the choice of alternative interventions for weight management, including tier 3 services.","Structure","QS127 - Obesity: clinical assessment and management","2 - QS127 - Obesity: clinical assessment and management",1,"2 - QS127 - Obesity: clinical assessment and management - Structure - 1"]
[null,"QS127","Obesity: clinical assessment and management",2,"Discussion on the choice of interventions","Adults with obesity for whom tier 2 interventions have been unsuccessful have a discussion about the choice of alternative interventions for weight management, including tier 3 services.","Proportion of adults with obesity for whom tier 2 interventions have been unsuccessful who have a discussion about the choice of alternative interventions for weight management, including tier 3 services.","Process","QS127 - Obesity: clinical assessment and management","2 - QS127 - Obesity: clinical assessment and management",1,"2 - QS127 - Obesity: clinical assessment and management - Process - 1","The number in the denominator who have a discussion about the choice of alternative interventions for weight management, including tier 3 services.","The number of adults with obesity for whom tier 2 interventions have been unsuccessful."]
[null,"QS127","Obesity: clinical assessment and management",2,"Discussion on the choice of interventions","Adults with obesity for whom tier 2 interventions have been unsuccessful have a discussion about the choice of alternative interventions for weight management, including tier 3 services.","Patient satisfaction with knowing the full range of choices on offer.","Outcome","QS127 - Obesity: clinical assessment and management","2 - QS127 - Obesity: clinical assessment and management",1,"2 - QS127 - Obesity: clinical assessment and management - Outcome - 1"]
[null,"QS127","Obesity: clinical assessment and management",3,"Referring children and young people for specialist care","Children and young people who are overweight or obese and have significant comorbidities or complex needs are referred to a paediatrician with a special interest in obesity.","Evidence of local arrangements and written protocols to ensure that children and young people who are overweight or obese and have significant comorbidities or complex needs are referred to a paediatrician with a special interest in obesity.","Structure","QS127 - Obesity: clinical assessment and management","3 - QS127 - Obesity: clinical assessment and management",1,"3 - QS127 - Obesity: clinical assessment and management - Structure - 1"]
[null,"QS127","Obesity: clinical assessment and management",3,"Referring children and young people for specialist care","Children and young people who are overweight or obese and have significant comorbidities or complex needs are referred to a paediatrician with a special interest in obesity.","Proportion of children and young people who are overweight or obese and have significant comorbidities who are referred to a paediatrician with a special interest in obesity.","Process","QS127 - Obesity: clinical assessment and management","3 - QS127 - Obesity: clinical assessment and management",1,"3 - QS127 - Obesity: clinical assessment and management - Process - 1","The number in the denominator who are referred to a paediatrician with a special interest in obesity.","The number of children and young people who are overweight or obese and have significant comorbidities."]
[null,"QS127","Obesity: clinical assessment and management",3,"Referring children and young people for specialist care","Children and young people who are overweight or obese and have significant comorbidities or complex needs are referred to a paediatrician with a special interest in obesity.","Proportion of children and young people who are overweight or obese and have complex needs who are referred to a paediatrician with a special interest in obesity.","Process","QS127 - Obesity: clinical assessment and management","3 - QS127 - Obesity: clinical assessment and management",2,"3 - QS127 - Obesity: clinical assessment and management - Process - 2","The number in the denominator who are referred to a paediatrician with a special interest in obesity.","The number of children and young people who are overweight or obese and have complex needs.\n\nData source: Local data collection."]
[null,"QS127","Obesity: clinical assessment and management",3,"Referring children and young people for specialist care","Children and young people who are overweight or obese and have significant comorbidities or complex needs are referred to a paediatrician with a special interest in obesity.","Access to tier 3 services for children and young people who are overweight or obese and have significant comorbidities or complex needs.","Outcome","QS127 - Obesity: clinical assessment and management","3 - QS127 - Obesity: clinical assessment and management",1,"3 - QS127 - Obesity: clinical assessment and management - Outcome - 1"]
[null,"QS127","Obesity: clinical assessment and management",3,"Referring children and young people for specialist care","Children and young people who are overweight or obese and have significant comorbidities or complex needs are referred to a paediatrician with a special interest in obesity.","Weight loss in children and young people who are overweight or obese and have significant comorbidities or complex needs.","Outcome","QS127 - Obesity: clinical assessment and management","3 - QS127 - Obesity: clinical assessment and management",2,"3 - QS127 - Obesity: clinical assessment and management - Outcome - 2"]
[null,"QS127","Obesity: clinical assessment and management",3,"Referring children and young people for specialist care","Children and young people who are overweight or obese and have significant comorbidities or complex needs are referred to a paediatrician with a special interest in obesity.","Exclusion of underlying medical causes of obesity in children and young people who are overweight or obese.","Outcome","QS127 - Obesity: clinical assessment and management","3 - QS127 - Obesity: clinical assessment and management",3,"3 - QS127 - Obesity: clinical assessment and management - Outcome - 3"]
[null,"QS127","Obesity: clinical assessment and management",3,"Referring children and young people for specialist care","Children and young people who are overweight or obese and have significant comorbidities or complex needs are referred to a paediatrician with a special interest in obesity.","Treatment of comorbidity in children and young people who are overweight or obese.","Outcome","QS127 - Obesity: clinical assessment and management","3 - QS127 - Obesity: clinical assessment and management",4,"3 - QS127 - Obesity: clinical assessment and management - Outcome - 4"]
[null,"QS127","Obesity: clinical assessment and management",4,"Referring adults with type 2 diabetes for bariatric surgery assessment","Adults with a body mass index (BMI) of 35 kg/m2 or more who have been diagnosed with type 2 diabetes within the past 10 years are offered an expedited referral for bariatric surgery assessment.","Evidence of local arrangements and written clinical protocols to ensure that adults with a BMI of 35 kg/m2 or more who have been diagnosed with type 2 diabetes within the past 10 years are offered an expedited referral for bariatric surgery assessment.","Structure","QS127 - Obesity: clinical assessment and management","4 - QS127 - Obesity: clinical assessment and management",1,"4 - QS127 - Obesity: clinical assessment and management - Structure - 1"]
[null,"QS127","Obesity: clinical assessment and management",4,"Referring adults with type 2 diabetes for bariatric surgery assessment","Adults with a body mass index (BMI) of 35 kg/m2 or more who have been diagnosed with type 2 diabetes within the past 10 years are offered an expedited referral for bariatric surgery assessment.","Proportion of adults with a BMI of 35 kg/m2 or more who have been diagnosed with type 2 diabetes within the past 10 years who have an expedited referral for bariatric surgery assessment.","Process","QS127 - Obesity: clinical assessment and management","4 - QS127 - Obesity: clinical assessment and management",1,"4 - QS127 - Obesity: clinical assessment and management - Process - 1","The number in the denominator who have an expedited referral for bariatric surgery assessment.","The number of adults with a BMI of 35 kg/m2 or more who have been diagnosed with type 2 diabetes within the past 10 years."]
[null,"QS127","Obesity: clinical assessment and management",4,"Referring adults with type 2 diabetes for bariatric surgery assessment","Adults with a body mass index (BMI) of 35 kg/m2 or more who have been diagnosed with type 2 diabetes within the past 10 years are offered an expedited referral for bariatric surgery assessment.","Bariatric surgery assessments for adults with a BMI of 35 kg/m2 or more diagnosed with type 2 diabetes within the past 10 years.","Outcome","QS127 - Obesity: clinical assessment and management","4 - QS127 - Obesity: clinical assessment and management",1,"4 - QS127 - Obesity: clinical assessment and management - Outcome - 1"]
[null,"QS127","Obesity: clinical assessment and management",5,"Referring adults for bariatric surgery assessment","Adults with a body mass index (BMI) above 50 kg/m2 are offered a referral for bariatric surgery assessment.","Evidence of local arrangements and written clinical protocols to ensure that adults with a BMI above 50 kg/m2 are offered a referral for bariatric surgery assessment.","Structure","QS127 - Obesity: clinical assessment and management","5 - QS127 - Obesity: clinical assessment and management",1,"5 - QS127 - Obesity: clinical assessment and management - Structure - 1"]
[null,"QS127","Obesity: clinical assessment and management",5,"Referring adults for bariatric surgery assessment","Adults with a body mass index (BMI) above 50 kg/m2 are offered a referral for bariatric surgery assessment.","Proportion of adults with a BMI above 50 kg/m2 who are referred for bariatric surgery assessment.","Process","QS127 - Obesity: clinical assessment and management","5 - QS127 - Obesity: clinical assessment and management",1,"5 - QS127 - Obesity: clinical assessment and management - Process - 1","The number in the denominator who are referred for bariatric surgery assessment.","The number of adults with a BMI above 50 kg/m2."]
[null,"QS127","Obesity: clinical assessment and management",5,"Referring adults for bariatric surgery assessment","Adults with a body mass index (BMI) above 50 kg/m2 are offered a referral for bariatric surgery assessment.","Bariatric surgery assessments for adults with a BMI above 50 kg/m2.","Outcome","QS127 - Obesity: clinical assessment and management","5 - QS127 - Obesity: clinical assessment and management",1,"5 - QS127 - Obesity: clinical assessment and management - Outcome - 1"]
[null,"QS127","Obesity: clinical assessment and management",6,"Follow-up care after bariatric surgery","People who have had bariatric surgery have a postoperative follow-up care package within the bariatric surgery service for a minimum of 2 years. ","Evidence of local arrangements to ensure that people who have had bariatric surgery are offered a follow-up care package within the bariatric service for a minimum of 2 years.","Structure","QS127 - Obesity: clinical assessment and management","6 - QS127 - Obesity: clinical assessment and management",1,"6 - QS127 - Obesity: clinical assessment and management - Structure - 1"]
[null,"QS127","Obesity: clinical assessment and management",6,"Follow-up care after bariatric surgery","People who have had bariatric surgery have a postoperative follow-up care package within the bariatric surgery service for a minimum of 2 years. ","Proportion of people who have had bariatric surgery who have a follow-up care package within the bariatric service for a minimum of 2 years after bariatric surgery.","Process","QS127 - Obesity: clinical assessment and management","6 - QS127 - Obesity: clinical assessment and management",1,"6 - QS127 - Obesity: clinical assessment and management - Process - 1","The number in the denominator who have a postoperative follow-up care package within the bariatric service.","The number of people who had bariatric surgery within the past 2 years."]
[null,"QS127","Obesity: clinical assessment and management",6,"Follow-up care after bariatric surgery","People who have had bariatric surgery have a postoperative follow-up care package within the bariatric surgery service for a minimum of 2 years. ","Nutritional status in the first 2 years following bariatric surgery.","Outcome","QS127 - Obesity: clinical assessment and management","6 - QS127 - Obesity: clinical assessment and management",1,"6 - QS127 - Obesity: clinical assessment and management - Outcome - 1"]
[null,"QS127","Obesity: clinical assessment and management",6,"Follow-up care after bariatric surgery","People who have had bariatric surgery have a postoperative follow-up care package within the bariatric surgery service for a minimum of 2 years. ","Patient satisfaction with bariatric surgery.","Outcome","QS127 - Obesity: clinical assessment and management","6 - QS127 - Obesity: clinical assessment and management",2,"6 - QS127 - Obesity: clinical assessment and management - Outcome - 2"]
[null,"QS127","Obesity: clinical assessment and management",7,"Nutritional monitoring after discharge from the bariatric surgery service","People discharged from bariatric surgery service follow-up are offered monitoring of nutritional status at least once a year as part of a shared-care model of management.","Evidence of local arrangements and written clinical protocols to ensure that people are offered at least annual monitoring of nutritional status and appropriate supplementation after discharge from bariatric surgery service follow-up as part of a shared-care model of management.","Structure","QS127 - Obesity: clinical assessment and management","7 - QS127 - Obesity: clinical assessment and management",1,"7 - QS127 - Obesity: clinical assessment and management - Structure - 1"]
[null,"QS127","Obesity: clinical assessment and management",7,"Nutritional monitoring after discharge from the bariatric surgery service","People discharged from bariatric surgery service follow-up are offered monitoring of nutritional status at least once a year as part of a shared-care model of management.","Evidence of a locally agreed shared-care model of management for people who are discharged from bariatric surgery service follow-up, developed by tier 3 specialists and primary care. ","Structure","QS127 - Obesity: clinical assessment and management","7 - QS127 - Obesity: clinical assessment and management",2,"7 - QS127 - Obesity: clinical assessment and management - Structure - 2"]
[null,"QS127","Obesity: clinical assessment and management",7,"Nutritional monitoring after discharge from the bariatric surgery service","People discharged from bariatric surgery service follow-up are offered monitoring of nutritional status at least once a year as part of a shared-care model of management.","Proportion of people discharged from bariatric surgery service follow-up who have at least annual monitoring of nutritional status and appropriate supplementation as part of a shared-care model of management.","process","QS127 - Obesity: clinical assessment and management","7 - QS127 - Obesity: clinical assessment and management",1,"7 - QS127 - Obesity: clinical assessment and management - process - 1","The number in the denominator who have had their nutritional status monitored within the past year as part of a shared-care model of management.","The number of people discharged from bariatric surgery service follow-up more than 1 year ago."]
[null,"QS127","Obesity: clinical assessment and management",7,"Nutritional monitoring after discharge from the bariatric surgery service","People discharged from bariatric surgery service follow-up are offered monitoring of nutritional status at least once a year as part of a shared-care model of management.","Nutritional status after discharge from bariatric surgery service follow-up.","outcome","QS127 - Obesity: clinical assessment and management","7 - QS127 - Obesity: clinical assessment and management",1,"7 - QS127 - Obesity: clinical assessment and management - outcome - 1"]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",1,"Identifying risk ","Parents and carers of children under 5 have a discussion during each of the 5 key contacts about factors that may pose a risk to their child’s social and emotional wellbeing.","Evidence of local arrangements to ensure that parents of children under 5 have a discussion during each of the 5 key contacts about factors that may pose a risk to their child’s social and emotional wellbeing","Structure","QS128 - Early years: promoting health and wellbeing in under-5s","1 - QS128 - Early years: promoting health and wellbeing in under-5s",1,"1 - QS128 - Early years: promoting health and wellbeing in under-5s - Structure - 1"]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",1,"Identifying risk ","Parents and carers of children under 5 have a discussion during each of the 5 key contacts about factors that may pose a risk to their child’s social and emotional wellbeing.","Proportion of parents and carers who have a discussion at the antenatal health visitor appointment about factors that may pose a risk to their child’s social and emotional wellbeing. ","Process","QS128 - Early years: promoting health and wellbeing in under-5s","1 - QS128 - Early years: promoting health and wellbeing in under-5s",1,"1 - QS128 - Early years: promoting health and wellbeing in under-5s - Process - 1","The number in the denominator who have a discussion about factors that may pose a risk to their child's social and emotional wellbeing.","The number of parents and carers who are eligible to attend the antenatal health visitor appointment."]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",1,"Identifying risk ","Parents and carers of children under 5 have a discussion during each of the 5 key contacts about factors that may pose a risk to their child’s social and emotional wellbeing.","Proportion of parents and carers who have a discussion at the new baby health visitor appointment about factors that may pose a risk to their child’s social and emotional wellbeing. ","Process","QS128 - Early years: promoting health and wellbeing in under-5s","1 - QS128 - Early years: promoting health and wellbeing in under-5s",2,"1 - QS128 - Early years: promoting health and wellbeing in under-5s - Process - 2","The number in the denominator who have a discussion about factors that may pose a risk to their child's social and emotional wellbeing.","The number of parents and carers who are eligible to attend the new baby health visitor appointment."]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",1,"Identifying risk ","Parents and carers of children under 5 have a discussion during each of the 5 key contacts about factors that may pose a risk to their child’s social and emotional wellbeing.","Proportion of parents and carers who have a discussion at the 6–8 week health visitor appointment about factors that may pose a risk to their child’s social and emotional wellbeing. ","Process","QS128 - Early years: promoting health and wellbeing in under-5s","1 - QS128 - Early years: promoting health and wellbeing in under-5s",3,"1 - QS128 - Early years: promoting health and wellbeing in under-5s - Process - 3","The number in the denominator who have a discussion about factors that may pose a risk to their child's social and emotional wellbeing.","The number of parents and carers who are eligible to attend the 6–8 week health visitor appointment."]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",1,"Identifying risk ","Parents and carers of children under 5 have a discussion during each of the 5 key contacts about factors that may pose a risk to their child’s social and emotional wellbeing.","Proportion of parents and carers who have a discussion at the 9–12 month developmental review about factors that may pose a risk to their child’s social and emotional wellbeing. ","Process","QS128 - Early years: promoting health and wellbeing in under-5s","1 - QS128 - Early years: promoting health and wellbeing in under-5s",4,"1 - QS128 - Early years: promoting health and wellbeing in under-5s - Process - 4","The number in the denominator who have a discussion about factors that may pose a risk to their child's social and emotional wellbeing.","The number of parents and carers who are eligible to attend the 9–12 month developmental review."]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",1,"Identifying risk ","Parents and carers of children under 5 have a discussion during each of the 5 key contacts about factors that may pose a risk to their child’s social and emotional wellbeing.","Proportion of parents and carers who have a discussion at the 2–2½ year integrated review about factors that may pose a risk to their child’s social and emotional wellbeing. ","Process","QS128 - Early years: promoting health and wellbeing in under-5s","1 - QS128 - Early years: promoting health and wellbeing in under-5s",5,{"$f":"CONCATENATE(J2834, \" - \", H2834, \" - \",K2834)","v":"1 - QS128 - Early years: promoting health and wellbeing in under-5s - Process - 5"},"The number in the denominator who have a discussion about factors that may pose a risk to their child's social and emotional wellbeing.","The number of parents and carers who are eligible to attend the 2–2½ year integrated review."]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",1,"Identifying risk ","Parents and carers of children under 5 have a discussion during each of the 5 key contacts about factors that may pose a risk to their child’s social and emotional wellbeing.","Behaviour and developmental difficulties.","Outcome","QS128 - Early years: promoting health and wellbeing in under-5s","1 - QS128 - Early years: promoting health and wellbeing in under-5s",1,"1 - QS128 - Early years: promoting health and wellbeing in under-5s - Outcome - 1"]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",1,"Identifying risk ","Parents and carers of children under 5 have a discussion during each of the 5 key contacts about factors that may pose a risk to their child’s social and emotional wellbeing.","Depression, anxiety, self-harm and other poor mental health outcomes later in childhood.","Outcome","QS128 - Early years: promoting health and wellbeing in under-5s","1 - QS128 - Early years: promoting health and wellbeing in under-5s",2,"1 - QS128 - Early years: promoting health and wellbeing in under-5s - Outcome - 2"]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",2,"Speech and language","Children have their speech and language skills assessed at their 2–2½ year integrated review.","Evidence of local arrangements to ensure that children’s speech and language skills are assessed at their 2–2½ year integrated review.","Structure","QS128 - Early years: promoting health and wellbeing in under-5s","2 - QS128 - Early years: promoting health and wellbeing in under-5s",1,"2 - QS128 - Early years: promoting health and wellbeing in under-5s - Structure - 1"]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",2,"Speech and language","Children have their speech and language skills assessed at their 2–2½ year integrated review.","Proportion of children who have the 2–2½ year integrated review","Process","QS128 - Early years: promoting health and wellbeing in under-5s","2 - QS128 - Early years: promoting health and wellbeing in under-5s",1,"2 - QS128 - Early years: promoting health and wellbeing in under-5s - Process - 1","The number in the denominator who have the 2–2½ year integrated review.","The number of children aged 2–2½."]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",2,"Speech and language","Children have their speech and language skills assessed at their 2–2½ year integrated review.","Proportion of children having the 2–2 ½ year integrated review who have their speech and language skills assessed. ","Process","QS128 - Early years: promoting health and wellbeing in under-5s","2 - QS128 - Early years: promoting health and wellbeing in under-5s",2,"2 - QS128 - Early years: promoting health and wellbeing in under-5s - Process - 2","The number in the denominator who have their speech and language skills assessed.","The number of children who have the 2–2 ½ year integrated review."]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",2,"Speech and language","Children have their speech and language skills assessed at their 2–2½ year integrated review.","Speech and language skills in children under 5.","Outcome","QS128 - Early years: promoting health and wellbeing in under-5s","2 - QS128 - Early years: promoting health and wellbeing in under-5s",1,"2 - QS128 - Early years: promoting health and wellbeing in under-5s - Outcome - 1"]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",2,"Speech and language","Children have their speech and language skills assessed at their 2–2½ year integrated review.","School readiness of children under 5.","Outcome","QS128 - Early years: promoting health and wellbeing in under-5s","2 - QS128 - Early years: promoting health and wellbeing in under-5s",2,"2 - QS128 - Early years: promoting health and wellbeing in under-5s - Outcome - 2"]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",2,"Speech and language","Children have their speech and language skills assessed at their 2–2½ year integrated review.","Social, emotional and behavioural difficulties.","Outcome",{"$f":"CONCATENATE(B2842, \" - \", C2842)","v":"QS128 - Early years: promoting health and wellbeing in under-5s"},{"$f":"CONCATENATE(D2842, \" - \", I2842)","v":"2 - QS128 - Early years: promoting health and wellbeing in under-5s"},{"$f":"IF(AND(B2842=B2841, D2842=D2841, H2842=H2841)=TRUE, K2841+1, 1)","v":3},{"$f":"CONCATENATE(J2842, \" - \", H2842, \" - \",K2842)","v":"2 - QS128 - Early years: promoting health and wellbeing in under-5s - Outcome - 3"}]
[null,"QS128","Early years: promoting health and wellbeing in under-5s",2,"Speech and language","Children have their speech and language skills assessed at their 2–2½ year integrated review.","Mental health difficulties.","Outcome","QS128 - Early years: promoting health and wellbeing in under-5s","2 - QS128 - Early years: promoting health and wellbeing in under-5s",4,"2 - QS128 - Early years: promoting health and wellbeing in under-5s - Outcome - 4"]
[null,"QS129","Contraception",1,"Contraceptive information and methods","Women asking for contraception from contraceptive services are given information about, and offered a choice of, all methods including long-acting reversible contraception","Evidence that accessible information is available about the full range of contraceptive methods, including long-acting reversible contraception, and the local services that provide them.","Structure","QS129 - Contraception","1 - QS129 - Contraception",1,"1 - QS129 - Contraception - Structure - 1"]
[null,"QS129","Contraception",1,"Contraceptive information and methods","Women asking for contraception from contraceptive services are given information about, and offered a choice of, all methods including long-acting reversible contraception","Evidence of local processes and referral pathways to ensure that women asking for contraception from contraceptive services are given information about, and offered a choice of, all methods including long-acting reversible contraception.","Structure","QS129 - Contraception","1 - QS129 - Contraception",2,"1 - QS129 - Contraception - Structure - 2"]
[null,"QS129","Contraception",1,"Contraceptive information and methods","Women asking for contraception from contraceptive services are given information about, and offered a choice of, all methods including long-acting reversible contraception","Proportion of women who ask for contraception from contraceptive services who are given information about all methods, including long-acting reversible contraception","Process","QS129 - Contraception","1 - QS129 - Contraception",1,"1 - QS129 - Contraception - Process - 1","The number in the denominator who are given information about all methods, including long-acting reversible contraception. ","The number of women who ask for contraception from contraceptive services. "]
[null,"QS129","Contraception",1,"Contraceptive information and methods","Women asking for contraception from contraceptive services are given information about, and offered a choice of, all methods including long-acting reversible contraception","Proportion of women who ask for contraception from contraceptive services who are offered a choice of all contraceptive methods, including long-acting reversible contraception.","Process","QS129 - Contraception","1 - QS129 - Contraception",2,"1 - QS129 - Contraception - Process - 2","The number in the denominator who are offered a choice of all contraceptive methods, including long-acting reversible contraception.","The number of women who ask for contraception from contraceptive services. "]
[null,"QS129","Contraception",1,"Contraceptive information and methods","Women asking for contraception from contraceptive services are given information about, and offered a choice of, all methods including long-acting reversible contraception","Contraceptive use in women","Outcome","QS129 - Contraception","1 - QS129 - Contraception",1,"1 - QS129 - Contraception - Outcome - 1"]
[null,"QS129","Contraception",1,"Contraceptive information and methods","Women asking for contraception from contraceptive services are given information about, and offered a choice of, all methods including long-acting reversible contraception","Uptake of long-acting reversible contraception","Outcome","QS129 - Contraception","1 - QS129 - Contraception",2,"1 - QS129 - Contraception - Outcome - 2"]
[null,"QS129","Contraception",1,"Contraceptive information and methods","Women asking for contraception from contraceptive services are given information about, and offered a choice of, all methods including long-acting reversible contraception","Women’s satisfaction with their choice of contraceptive method","Outcome","QS129 - Contraception","1 - QS129 - Contraception",3,"1 - QS129 - Contraception - Outcome - 3"]
[null,"QS129","Contraception",2,"Emergency contraception ","Women asking for emergency contraception are told that an intrauterine device is more effective than an oral method.","Evidence of local processes to ensure that women asking for emergency contraception are told that an intrauterine device is more effective than an oral method.","Structure","QS129 - Contraception","2 - QS129 - Contraception",1,"2 - QS129 - Contraception - Structure - 1"]
[null,"QS129","Contraception",2,"Emergency contraception ","Women asking for emergency contraception are told that an intrauterine device is more effective than an oral method.","Proportion of requests for emergency contraception where the woman is told that an intrauterine device is more effective than an oral method.","Process","QS129 - Contraception","2 - QS129 - Contraception",1,"2 - QS129 - Contraception - Process - 1","The number in the denominator where the woman is told that an intrauterine device is more effective than an oral method.","The number of requests for emergency contraception."]
[null,"QS129","Contraception",2,"Emergency contraception ","Women asking for emergency contraception are told that an intrauterine device is more effective than an oral method.","Intrauterine device use as an emergency contraceptive","Outcome","QS129 - Contraception","2 - QS129 - Contraception",1,"2 - QS129 - Contraception - Outcome - 1"]
[null,"QS129","Contraception",2,"Emergency contraception ","Women asking for emergency contraception are told that an intrauterine device is more effective than an oral method.","Abortion rate","Outcome","QS129 - Contraception","2 - QS129 - Contraception",2,"2 - QS129 - Contraception - Outcome - 2"]
[null,"QS129","Contraception",3,"Contraception after an abortion","Women who request an abortion discuss contraception with a healthcare practitioner and are offered a choice of all methods when they are assessed for abortion and before discharge","Evidence of local processes to ensure that women discuss contraception and all contraceptive methods with a healthcare practitioner when being assessed for an abortion. ","Structure","QS129 - Contraception","3 - QS129 - Contraception",1,"3 - QS129 - Contraception - Structure - 1"]
[null,"QS129","Contraception",3,"Contraception after an abortion","Women who request an abortion discuss contraception with a healthcare practitioner and are offered a choice of all methods when they are assessed for abortion and before discharge","Evidence of local processes to ensure that a healthcare practitioner offers women a choice of all contraceptive methods before discharge from an abortion service.","Structure","QS129 - Contraception","3 - QS129 - Contraception",2,"3 - QS129 - Contraception - Structure - 2"]
[null,"QS129","Contraception",3,"Contraception after an abortion","Women who request an abortion discuss contraception with a healthcare practitioner and are offered a choice of all methods when they are assessed for abortion and before discharge","Proportion of women who discuss contraception and all contraceptive methods with a healthcare practitioner at an assessment for abortion.","Process","QS129 - Contraception","3 - QS129 - Contraception",1,"3 - QS129 - Contraception - Process - 1","The number in the denominator who discuss contraception and all contraceptive methods with a healthcare practitioner. ","The number of women having an assessment for abortion. "]
[null,"QS129","Contraception",3,"Contraception after an abortion","Women who request an abortion discuss contraception with a healthcare practitioner and are offered a choice of all methods when they are assessed for abortion and before discharge","Proportion of women who are offered a choice of all contraceptive methods before discharge from an abortion service.","Process","QS129 - Contraception","3 - QS129 - Contraception",2,"3 - QS129 - Contraception - Process - 2","The number in the denominator who are offered a choice of all contraceptive methods before discharge. ","The number of women discharged from an abortion service. "]
[null,"QS129","Contraception",3,"Contraception after an abortion","Women who request an abortion discuss contraception with a healthcare practitioner and are offered a choice of all methods when they are assessed for abortion and before discharge","Uptake of long-acting reversible contraception at the time of abortion","Outcome","QS129 - Contraception","3 - QS129 - Contraception",1,"3 - QS129 - Contraception - Outcome - 1"]
[null,"QS129","Contraception",3,"Contraception after an abortion","Women who request an abortion discuss contraception with a healthcare practitioner and are offered a choice of all methods when they are assessed for abortion and before discharge","Contraception uptake rate after abortion","Outcome","QS129 - Contraception","3 - QS129 - Contraception",2,"3 - QS129 - Contraception - Outcome - 2"]
[null,"QS129","Contraception",3,"Contraception after an abortion","Women who request an abortion discuss contraception with a healthcare practitioner and are offered a choice of all methods when they are assessed for abortion and before discharge","Women who have more than 1 abortion","Outcome",{"$f":"CONCATENATE(B2861, \" - \", C2861)","v":"QS129 - Contraception"},{"$f":"CONCATENATE(D2861, \" - \", I2861)","v":"3 - QS129 - Contraception"},{"$f":"IF(AND(B2861=B2860, D2861=D2860, H2861=H2860)=TRUE, K2860+1, 1)","v":3},{"$f":"CONCATENATE(J2861, \" - \", H2861, \" - \",K2861)","v":"3 - QS129 - Contraception - Outcome - 3"}]
[null,"QS129","Contraception",4,"Contraception after childbirth ","Women who give birth are given information about, and offered a choice of, all contraceptive methods by their midwife within 7 days of delivery. ","Evidence of local processes to ensure that women who give birth are given information about all contraceptive methods by their midwife within 7 days of delivery. ","Structure","QS129 - Contraception","4 - QS129 - Contraception",1,"4 - QS129 - Contraception - Structure - 1"]
[null,"QS129","Contraception",4,"Contraception after childbirth ","Women who give birth are given information about, and offered a choice of, all contraceptive methods by their midwife within 7 days of delivery. ","Evidence of local processes and referral pathways to ensure that women who give birth are offered a choice of all contraceptive methods by their midwife within 7 days of delivery. ","Structure","QS129 - Contraception","4 - QS129 - Contraception",2,"4 - QS129 - Contraception - Structure - 2"]
[null,"QS129","Contraception",4,"Contraception after childbirth ","Women who give birth are given information about, and offered a choice of, all contraceptive methods by their midwife within 7 days of delivery. ","Proportion of women who give birth who are given information about all contraceptive methods by their midwife within 7 days of delivery.","Process","QS129 - Contraception","4 - QS129 - Contraception",1,"4 - QS129 - Contraception - Process - 1","The number in the denominator who are given information about all contraceptive methods by their midwife within 7 days of delivery.","The number of women who give birth."]
[null,"QS129","Contraception",4,"Contraception after childbirth ","Women who give birth are given information about, and offered a choice of, all contraceptive methods by their midwife within 7 days of delivery. ","Proportion of women who give birth who are offered a choice of all contraceptive methods by their midwife within 7 days of delivery.","Process","QS129 - Contraception","4 - QS129 - Contraception",2,"4 - QS129 - Contraception - Process - 2","The number in the denominator who are offered a choice of all contraceptive methods by their midwife within 7 days of delivery.","The number of women who give birth."]
[null,"QS129","Contraception",4,"Contraception after childbirth ","Women who give birth are given information about, and offered a choice of, all contraceptive methods by their midwife within 7 days of delivery. ","Satisfaction with advice about contraceptive methods after childbirth.","Outcome","QS129 - Contraception","4 - QS129 - Contraception",1,"4 - QS129 - Contraception - Outcome - 1"]
[null,"QS129","Contraception",4,"Contraception after childbirth ","Women who give birth are given information about, and offered a choice of, all contraceptive methods by their midwife within 7 days of delivery. ","Contraception uptake rates in women who have given birth","Outcome","QS129 - Contraception","4 - QS129 - Contraception",2,"4 - QS129 - Contraception - Outcome - 2"]
[null,"QS129","Contraception",4,"Contraception after childbirth ","Women who give birth are given information about, and offered a choice of, all contraceptive methods by their midwife within 7 days of delivery. ","Women who have a short interpregnancy interval","Outcome","QS129 - Contraception","4 - QS129 - Contraception",3,"4 - QS129 - Contraception - Outcome - 3"]
[null,"QS130","Skin cancer",1,"Local health promotion activities","Integrated care boards work with local partners to implement strategies to raise awareness of skin cancer and the risks of over-exposure to sunlight and exposure to artificial UV light, particularly for people in at-risk groups","Evidence that integrated care boards use joint strategic needs assessments to determine local needs related to skin cancer awareness.","Structure","QS130 - Skin cancer","1 - QS130 - Skin cancer",1,"1 - QS130 - Skin cancer - Structure - 1"]
[null,"QS130","Skin cancer",1,"Local health promotion activities","Integrated care boards work with local partners to implement strategies to raise awareness of skin cancer and the risks of over-exposure to sunlight and exposure to artificial UV light, particularly for people in at-risk groups","Evidence that integrated care boards have an action plan that identifies key strategies to raise awareness of skin cancer and the risks of over-exposure to sunlight and exposure to artificial UV light, particularly for people in at-risk groups.","Structure","QS130 - Skin cancer","1 - QS130 - Skin cancer",2,"1 - QS130 - Skin cancer - Structure - 2"]
[null,"QS130","Skin cancer",1,"Local health promotion activities","Integrated care boards work with local partners to implement strategies to raise awareness of skin cancer and the risks of over-exposure to sunlight and exposure to artificial UV light, particularly for people in at-risk groups","Evidence of local campaigns to raise awareness of skin cancer and the risks of over-exposure to sunlight and exposure to artificial UV light, particularly for people in at-risk groups.","Structure","QS130 - Skin cancer","1 - QS130 - Skin cancer",3,"1 - QS130 - Skin cancer - Structure - 3"]
[null,"QS130","Skin cancer",1,"Local health promotion activities","Integrated care boards work with local partners to implement strategies to raise awareness of skin cancer and the risks of over-exposure to sunlight and exposure to artificial UV light, particularly for people in at-risk groups","a) Proportion of non-melanoma skin cancer diagnosed at stage 1 or 2.","Outcome","QS130 - Skin cancer","1 - QS130 - Skin cancer",1,"1 - QS130 - Skin cancer - Outcome - 1","The number in the denominator diagnosed at stage 1 or 2.","The number of melanomas diagnosed."]
[null,"QS130","Skin cancer",1,"Local health promotion activities","Integrated care boards work with local partners to implement strategies to raise awareness of skin cancer and the risks of over-exposure to sunlight and exposure to artificial UV light, particularly for people in at-risk groups","b) Proportion of non-melanoma skin cancer diagnosed at stage 1 or 2.","Outcome",{"$f":"CONCATENATE(B2873, \" - \", C2873)","v":"QS130 - Skin cancer"},{"$f":"CONCATENATE(D2873, \" - \", I2873)","v":"1 - QS130 - Skin cancer"},{"$f":"IF(AND(B2873=B2872, D2873=D2872, H2873=H2872)=TRUE, K2872+1, 1)","v":2},{"$f":"CONCATENATE(J2873, \" - \", H2873, \" - \",K2873)","v":"1 - QS130 - Skin cancer - Outcome - 2"},"The number in the denominator diagnosed at stage 1 or 2.","The number of non-melanoma skin cancers diagnosed."]
[null,"QS130","Skin cancer",2,"Suspected cancer pathway referrals","People with suspected melanoma, squamous cell carcinoma or a rare skin cancer are referred for an assessment using a suspected cancer pathway to have a diagnosis confirmed or ruled out within 28 days of referral","Proportion of confirmed melanomas, squamous cell carcinomas and rare skin cancers that were referred for an assessment using a suspected cancer pathway.","Process","QS130 - Skin cancer","2 - QS130 - Skin cancer",{"$f":"IF(AND(B2874=B2871, D2874=D2871, H2874=H2871)=TRUE, K2871+1, 1)","v":1},"2 - QS130 - Skin cancer - Process - 1","The number in the denominator that were referred for an assessment using a suspected cancer pathway.","The number of confirmed melanomas, squamous cell carcinomas and rare skin cancers."]
[null,"QS130","Skin cancer",2,"Suspected cancer pathway referrals","People with suspected melanoma, squamous cell carcinoma or a rare skin cancer are referred for an assessment using a suspected cancer pathway to have a diagnosis confirmed or ruled out within 28 days of referral","Proportion of melanoma, squamous cell carcinoma and rare skin cancers in which the person had a diagnosis of cancer confirmed or ruled out within 28 days of referral.","Outcome","QS130 - Skin cancer","2 - QS130 - Skin cancer",1,"2 - QS130 - Skin cancer - Outcome - 1","The number in the denominator in which the person had a diagnosis of cancer confirmed or ruled out within 28 days of referral.","The number of suspected melanomas, squamous cell carcinomas and rare skin cancers."]
[null,"QS130","Skin cancer",2,"Suspected cancer pathway referrals","People with suspected melanoma, squamous cell carcinoma or a rare skin cancer are referred for an assessment using a suspected cancer pathway to have a diagnosis confirmed or ruled out within 28 days of referral","Proportion of melanoma, squamous cell carcinoma and rare skin cancers that were first treated within 31 days of the decision to treat.","Outcome","QS130 - Skin cancer","2 - QS130 - Skin cancer",2,"2 - QS130 - Skin cancer - Outcome - 2","The number in the denominator that were first treated within 31 days of the decision to treat.","The number of melanomas, squamous cell carcinomas and rare skin cancers."]
[null,"QS130","Skin cancer",2,"Suspected cancer pathway referrals","People with suspected melanoma, squamous cell carcinoma or a rare skin cancer are referred for an assessment using a suspected cancer pathway to have a diagnosis confirmed or ruled out within 28 days of referral","Proportion of melanoma, squamous cell carcinoma and rare skin cancers that were first treated within 62 days of referral.","Outcome","QS130 - Skin cancer","2 - QS130 - Skin cancer",3,"2 - QS130 - Skin cancer - Outcome - 3","The number in the denominator that were first treated within 62 days of referral.","The number of melanomas, squamous cell carcinomas and rare skin cancers."]
[null,"QS130","Skin cancer",3,"Dermoscopy","People with suspected melanoma undergoing a specialist assessment have the lesion examined using dermoscopy.","Proportion of people with suspected melanoma undergoing a specialist assessment who have the lesion examined using dermoscopy.","Process","QS130 - Skin cancer","3 - QS130 - Skin cancer",1,"3 - QS130 - Skin cancer - Process - 1","The number in the denominator who have the lesion examined using dermoscopy.","The number of people with suspected melanoma undergoing a specialist assessment."]
[null,"QS130","Skin cancer",3,"Dermoscopy","People with suspected melanoma undergoing a specialist assessment have the lesion examined using dermoscopy.","Proportion of suspected melanomas not selected for biopsy that are subsequently confirmed as melanoma.","Outcome","QS130 - Skin cancer","3 - QS130 - Skin cancer",1,"3 - QS130 - Skin cancer - Outcome - 1","The number in the denominator subsequently confirmed as melanoma.","The number of suspected melanomas not selected for biopsy."]
[null,"QS130","Skin cancer",3,"Dermoscopy","People with suspected melanoma undergoing a specialist assessment have the lesion examined using dermoscopy.","Proportion of melanomas diagnosed at stage 1 or 2.","Outcome","QS130 - Skin cancer","3 - QS130 - Skin cancer",2,"3 - QS130 - Skin cancer - Outcome - 2","The number in the denominator diagnosed at stage 1 or 2.","The number of melanomas diagnosed."]
[null,"QS130","Skin cancer",4,"Skin cancer clinical nurse specialist","People with melanoma, high-risk squamous cell carcinoma or a rare skin cancer have access to a skin cancer clinical nurse specialist. ","Proportion of people with melanoma, high-risk squamous cell carcinoma or a rare skin cancer who have access to a skin cancer clinical nurse specialist.","Process","QS130 - Skin cancer","4 - QS130 - Skin cancer",{"$f":"IF(AND(B2881=B2880, D2881=D2880, H2881=H2880)=TRUE, K2880+1, 1)","v":1},{"$f":"CONCATENATE(J2881, \" - \", H2881, \" - \",K2881)","v":"4 - QS130 - Skin cancer - Process - 1"},"The number in the denominator who have access to a skin cancer clinical nurse specialist.","The number of people with melanoma, high-risk squamous cell carcinoma or a rare skin cancer."]
[null,"QS130","Skin cancer",4,"Skin cancer clinical nurse specialist","People with melanoma, high-risk squamous cell carcinoma or a rare skin cancer have access to a skin cancer clinical nurse specialist. ","Quality of life among people with melanoma, high-risk squamous cell carcinoma or a rare skin cancer.","Outcome","QS130 - Skin cancer","4 - QS130 - Skin cancer",1,"4 - QS130 - Skin cancer - Outcome - 1"]
[null,"QS130","Skin cancer",4,"Skin cancer clinical nurse specialist","People with melanoma, high-risk squamous cell carcinoma or a rare skin cancer have access to a skin cancer clinical nurse specialist. ","Satisfaction with support received from skin cancer clinical nurse specialist, reported by people with melanoma, high-risk squamous cell carcinoma or a rare skin cancer.","Outcome","QS130 - Skin cancer","4 - QS130 - Skin cancer",2,"4 - QS130 - Skin cancer - Outcome - 2","The number in the denominator who were satisfied with the support received.","The number of people with melanoma, high-risk squamous cell carcinoma or a rare skin cancer supported by a skin cancer clinical nurse specialist."]
[null,"QS130","Skin cancer",5,"Genetic testing","People with stage IIB to IV primary melanoma have BRAF analysis of the tumour.","Proportion of people with stage IIB to IV primary melanoma who have BRAF analysis of the tumour.","Process","QS130 - Skin cancer","5 - QS130 - Skin cancer",{"$f":"IF(AND(B2884=B2883, D2884=D2883, H2884=H2883)=TRUE, K2883+1, 1)","v":1},{"$f":"CONCATENATE(J2884, \" - \", H2884, \" - \",K2884)","v":"5 - QS130 - Skin cancer - Process - 1"},"The number in the denominator who have BRAF analysis of the tumour.","The number of people with stage IIB to IV primary melanoma."]
[null,"QS130","Skin cancer",6,"Imaging","People with stage IIC to IV melanoma have a staging scan.","Proportion of adults 25 and over with stage IIC to IV melanoma who have staging with whole-body CE-CT and brain CE-CT or MRI.","Process","QS130 - Skin cancer","6 - QS130 - Skin cancer",{"$f":"IF(AND(B2885=B2884, D2885=D2884, H2885=H2884)=TRUE, K2884+1, 1)","v":1},{"$f":"CONCATENATE(J2885, \" - \", H2885, \" - \",K2885)","v":"6 - QS130 - Skin cancer - Process - 1"},"The number in the denominator who have staging with whole-body CE-CT and brain CE-CT or MRI.","The number of adults 25 and over with stage IIC to IV melanoma."]
[null,"QS130","Skin cancer",6,"Imaging","People with stage IIC to IV melanoma have a staging scan.","Proportion of under 25s, pregnant women and pregnant people with stage IIC to IV melanoma, who have staging with whole-body and brain MRI.","Process","QS130 - Skin cancer","6 - QS130 - Skin cancer",2,"6 - QS130 - Skin cancer - Process - 2","The number in the denominator who have staging with whole-body and brain MRI.","The number of under 25s, pregnant women and pregnant people with stage IIC to IV melanoma."]
[null,"QS131","IV fluid therapy in children and young people in hospital",1,"Measuring plasma electrolyte concentration and blood glucose ","Term neonates, children and young people receiving intravenous (IV) fluid therapy have their plasma electrolyte concentrations and blood glucose measured when starting IV fluids and then at least every 24 hours.","Evidence of local arrangements to ensure that term neonates, children and young people receiving IV fluid therapy have their plasma electrolyte concentrations and blood glucose measured when starting IV fluids and then at least every 24 hours.","Structure","QS131 - IV fluid therapy in children and young people in hospital","1 - QS131 - IV fluid therapy in children and young people in hospital",1,"1 - QS131 - IV fluid therapy in children and young people in hospital - Structure - 1"]
[null,"QS131","IV fluid therapy in children and young people in hospital",1,"Measuring plasma electrolyte concentration and blood glucose ","Term neonates, children and young people receiving intravenous (IV) fluid therapy have their plasma electrolyte concentrations and blood glucose measured when starting IV fluids and then at least every 24 hours.","Proportion of term neonates, children and young people starting IV fluid therapy who have their plasma electrolyte concentrations and blood glucose measured.","Process","QS131 - IV fluid therapy in children and young people in hospital","1 - QS131 - IV fluid therapy in children and young people in hospital",1,"1 - QS131 - IV fluid therapy in children and young people in hospital - Process - 1","The number in the denominator who have their plasma electrolyte concentrations and blood glucose measured.","The number of term neonates, children and young people starting IV fluid therapy."]
[null,"QS131","IV fluid therapy in children and young people in hospital",1,"Measuring plasma electrolyte concentration and blood glucose ","Term neonates, children and young people receiving intravenous (IV) fluid therapy have their plasma electrolyte concentrations and blood glucose measured when starting IV fluids and then at least every 24 hours.","Proportion of term neonates, children and young people receiving IV fluid therapy who have their plasma electrolyte concentrations and blood glucose measured every 24 hours or less from the start of IV fluids.","Process","QS131 - IV fluid therapy in children and young people in hospital","1 - QS131 - IV fluid therapy in children and young people in hospital",2,"1 - QS131 - IV fluid therapy in children and young people in hospital - Process - 2","The number in the denominator who have their plasma electrolyte concentrations and blood glucose measured every 24 hours or less from the start of IV fluids.","The number of term neonates, children and young people receiving IV fluid therapy."]
[null,"QS131","IV fluid therapy in children and young people in hospital",1,"Measuring plasma electrolyte concentration and blood glucose ","Term neonates, children and young people receiving intravenous (IV) fluid therapy have their plasma electrolyte concentrations and blood glucose measured when starting IV fluids and then at least every 24 hours.","Patient safety incidents resulting from errors in IV fluid therapy in term neonates, children and young people.","Outcome","QS131 - IV fluid therapy in children and young people in hospital","1 - QS131 - IV fluid therapy in children and young people in hospital",1,"1 - QS131 - IV fluid therapy in children and young people in hospital - Outcome - 1"]
[null,"QS131","IV fluid therapy in children and young people in hospital",2,"Assessment of fluid balance ","Term neonates, children and young people receiving intravenous (IV) fluid therapy have their fluid balance assessed when starting IV fluids and then at least every 12 hours.","Evidence of local arrangements to ensure that term neonates, children and young people receiving IV fluid therapy have their fluid balance assessed when starting IV fluids and then at least every 12 hours.","Structure","QS131 - IV fluid therapy in children and young people in hospital","2 - QS131 - IV fluid therapy in children and young people in hospital",1,"2 - QS131 - IV fluid therapy in children and young people in hospital - Structure - 1"]
[null,"QS131","IV fluid therapy in children and young people in hospital",2,"Assessment of fluid balance ","Term neonates, children and young people receiving intravenous (IV) fluid therapy have their fluid balance assessed when starting IV fluids and then at least every 12 hours.","Proportion of term neonates, children and young people starting IV fluid therapy who have their fluid balance assessed.","Process","QS131 - IV fluid therapy in children and young people in hospital","2 - QS131 - IV fluid therapy in children and young people in hospital",1,"2 - QS131 - IV fluid therapy in children and young people in hospital - Process - 1","The number in the denominator who have their fluid balance assessed.","The number of term neonates, children and young people starting IV fluid therapy."]
[null,"QS131","IV fluid therapy in children and young people in hospital",2,"Assessment of fluid balance ","Term neonates, children and young people receiving intravenous (IV) fluid therapy have their fluid balance assessed when starting IV fluids and then at least every 12 hours.","Proportion of term neonates, children and young people receiving IV fluid therapy who have their fluid balance assessed every 12 hours or less from starting IV fluids.","Process","QS131 - IV fluid therapy in children and young people in hospital","2 - QS131 - IV fluid therapy in children and young people in hospital",2,"2 - QS131 - IV fluid therapy in children and young people in hospital - Process - 2","The number in the denominator who have their fluid balance assessed every 12 hours or less from starting IV fluids.","The number of term neonates, children and young people receiving IV fluid therapy."]
[null,"QS131","IV fluid therapy in children and young people in hospital",2,"Assessment of fluid balance ","Term neonates, children and young people receiving intravenous (IV) fluid therapy have their fluid balance assessed when starting IV fluids and then at least every 12 hours.","Patient safety incidents resulting from errors in IV fluid therapy in term neonates, children and young people.","Outcome","QS131 - IV fluid therapy in children and young people in hospital","2 - QS131 - IV fluid therapy in children and young people in hospital",1,"2 - QS131 - IV fluid therapy in children and young people in hospital - Outcome - 1"]
[null,"QS131","IV fluid therapy in children and young people in hospital",3,"Fluid type for intravenous (IV) fluid resuscitation","Term neonates, children and young people are not given hypotonic fluids or glucose-containing fluids for intravenous (IV) fluid resuscitation.","Evidence of local arrangements to ensure that term neonates, children and young people are not given hypotonic fluids or glucose-containing fluids for IV fluid resuscitation.","Structure","QS131 - IV fluid therapy in children and young people in hospital","3 - QS131 - IV fluid therapy in children and young people in hospital",1,"3 - QS131 - IV fluid therapy in children and young people in hospital - Structure - 1"]
[null,"QS131","IV fluid therapy in children and young people in hospital",3,"Fluid type for intravenous (IV) fluid resuscitation","Term neonates, children and young people are not given hypotonic fluids or glucose-containing fluids for intravenous (IV) fluid resuscitation.","Proportion of term neonates, children and young people who are given hypotonic fluids or glucose-containing fluids for IV fluid resuscitation.","Process","QS131 - IV fluid therapy in children and young people in hospital","3 - QS131 - IV fluid therapy in children and young people in hospital",1,"3 - QS131 - IV fluid therapy in children and young people in hospital - Process - 1","The number in the denominator who are given hypotonic fluids or glucose-containing fluids for IV fluid resuscitation.","The number of term neonates, children and young people receiving IV fluid resuscitation."]
[null,"QS131","IV fluid therapy in children and young people in hospital",3,"Fluid type for intravenous (IV) fluid resuscitation","Term neonates, children and young people are not given hypotonic fluids or glucose-containing fluids for intravenous (IV) fluid resuscitation.","Incidence of hyponatraemia attributable to IV fluid therapy in term neonates, children and young people.","Outcome","QS131 - IV fluid therapy in children and young people in hospital","3 - QS131 - IV fluid therapy in children and young people in hospital",1,"3 - QS131 - IV fluid therapy in children and young people in hospital - Outcome - 1"]
[null,"QS131","IV fluid therapy in children and young people in hospital",4,"Fluid type for routine maintenance ","Term neonates, children and young people receiving intravenous (IV) fluids for routine maintenance are not given hypotonic fluids as the initial fluid.","Evidence of local arrangements to ensure that term neonates, children and young people receiving IV fluids for routine maintenance are not given hypotonic fluids as the initial fluid.","Structure","QS131 - IV fluid therapy in children and young people in hospital","4 - QS131 - IV fluid therapy in children and young people in hospital",1,"4 - QS131 - IV fluid therapy in children and young people in hospital - Structure - 1"]
[null,"QS131","IV fluid therapy in children and young people in hospital",4,"Fluid type for routine maintenance ","Term neonates, children and young people receiving intravenous (IV) fluids for routine maintenance are not given hypotonic fluids as the initial fluid.","Proportion of term neonates, children and young people receiving IV fluids for routine maintenance who are given hypotonic fluids as the initial fluid.","Process","QS131 - IV fluid therapy in children and young people in hospital","4 - QS131 - IV fluid therapy in children and young people in hospital",1,"4 - QS131 - IV fluid therapy in children and young people in hospital - Process - 1","The number in the denominator who are given hypotonic fluids as the initial fluid.","The number of term neonates, children and young people receiving IV fluids for routine maintenance."]
[null,"QS131","IV fluid therapy in children and young people in hospital",4,"Fluid type for routine maintenance ","Term neonates, children and young people receiving intravenous (IV) fluids for routine maintenance are not given hypotonic fluids as the initial fluid.","Incidence of hyponatraemia attributable to IV fluid therapy in term neonates, children and young people.","Outcome","QS131 - IV fluid therapy in children and young people in hospital","4 - QS131 - IV fluid therapy in children and young people in hospital",1,"4 - QS131 - IV fluid therapy in children and young people in hospital - Outcome - 1"]
[null,"QS131","IV fluid therapy in children and young people in hospital",5,"Intravenous (IV) fluids lead ","Hospitals have an intravenous (IV) fluids lead who has overall responsibility for training, clinical governance, audit and review of IV fluid prescribing, and patient outcomes.","Evidence that hospitals have an IV fluids lead who has overall responsibility for ensuring adequate training, clinical governance, audit and review of IV fluid prescribing, and patient outcomes.","Structure","QS131 - IV fluid therapy in children and young people in hospital","5 - QS131 - IV fluid therapy in children and young people in hospital",1,"5 - QS131 - IV fluid therapy in children and young people in hospital - Structure - 1"]
[null,"QS131","IV fluid therapy in children and young people in hospital",5,"Intravenous (IV) fluids lead ","Hospitals have an intravenous (IV) fluids lead who has overall responsibility for training, clinical governance, audit and review of IV fluid prescribing, and patient outcomes.","Patient safety incidents resulting from errors in IV fluid therapy in term neonates, children and young people.","Outcome","QS131 - IV fluid therapy in children and young people in hospital","5 - QS131 - IV fluid therapy in children and young people in hospital",1,"5 - QS131 - IV fluid therapy in children and young people in hospital - Outcome - 1"]
[null,"QS132","Social care for older people with multiple long-term conditions",1,"Including physical and mental health needs in a care and support needs assessment","Older people with multiple long-term conditions having a care and support needs assessment have their physical and mental health needs included.","Evidence of a locally coordinated approach to ensure that older people with multiple long-term conditions having a care and support needs assessment have their physical and mental health needs included.","Structure",{"$f":"CONCATENATE(B2903, \" - \", C2903)","v":"QS132 - Social care for older people with multiple long-term conditions"},{"$f":"CONCATENATE(D2903, \" - \", I2903)","v":"1 - QS132 - Social care for older people with multiple long-term conditions"},1,{"$f":"CONCATENATE(J2903, \" - \", H2903, \" - \",K2903)","v":"1 - QS132 - Social care for older people with multiple long-term conditions - Structure - 1"}]
[null,"QS132","Social care for older people with multiple long-term conditions",1,"Including physical and mental health needs in a care and support needs assessment","Older people with multiple long-term conditions having a care and support needs assessment have their physical and mental health needs included.","Proportion of care and support needs assessments for older people with multiple long-term conditions that include physical and mental health needs.","Process","QS132 - Social care for older people with multiple long-term conditions","1 - QS132 - Social care for older people with multiple long-term conditions",1,"1 - QS132 - Social care for older people with multiple long-term conditions - Process - 1","The number in the denominator that include physical and mental health needs.","The number of care and support needs assessments for older people with multiple long-term conditions."]
[null,"QS132","Social care for older people with multiple long-term conditions",1,"Including physical and mental health needs in a care and support needs assessment","Older people with multiple long-term conditions having a care and support needs assessment have their physical and mental health needs included.","Satisfaction among older people with multiple long-term conditions and social care needs that all their health and care needs are identified and understood.","Outcome","QS132 - Social care for older people with multiple long-term conditions","1 - QS132 - Social care for older people with multiple long-term conditions",1,"1 - QS132 - Social care for older people with multiple long-term conditions - Outcome - 1"]
[null,"QS132","Social care for older people with multiple long-term conditions",2,"Discussing services that could help at a care and support needs assessment","Older people with multiple long-term conditions having a care and support needs assessment discuss services that could help, any cost of these services and how they can be paid for.","Evidence that accessible information is available locally about services that could help older people with multiple long-term conditions and social care needs, any cost of these services and how they can be paid for.","Structure","QS132 - Social care for older people with multiple long-term conditions","2 - QS132 - Social care for older people with multiple long-term conditions",1,"2 - QS132 - Social care for older people with multiple long-term conditions - Structure - 1"]
[null,"QS132","Social care for older people with multiple long-term conditions",2,"Discussing services that could help at a care and support needs assessment","Older people with multiple long-term conditions having a care and support needs assessment discuss services that could help, any cost of these services and how they can be paid for.","Evidence of local processes to ensure that care and support needs assessments for older people with multiple long-term conditions include discussions about the services that could help, any cost of these services and how they can be paid for.","Structure","QS132 - Social care for older people with multiple long-term conditions","2 - QS132 - Social care for older people with multiple long-term conditions",2,"2 - QS132 - Social care for older people with multiple long-term conditions - Structure - 2"]
[null,"QS132","Social care for older people with multiple long-term conditions",2,"Discussing services that could help at a care and support needs assessment","Older people with multiple long-term conditions having a care and support needs assessment discuss services that could help, any cost of these services and how they can be paid for.","Proportion of care and support needs assessments for older people with multiple long-term conditions that include discussing services that could help, any cost of these services and how they can be paid for.","Process","QS132 - Social care for older people with multiple long-term conditions","2 - QS132 - Social care for older people with multiple long-term conditions",1,"2 - QS132 - Social care for older people with multiple long-term conditions - Process - 1","The number in the denominator that include discussing services that could help, any cost of these services and how they can be paid for. ","The number of care and support needs assessments for older people with multiple long-term conditions. "]
[null,"QS132","Social care for older people with multiple long-term conditions",2,"Discussing services that could help at a care and support needs assessment","Older people with multiple long-term conditions having a care and support needs assessment discuss services that could help, any cost of these services and how they can be paid for.","Satisfaction among older people with multiple long-term conditions and social care needs with information provided about support and services.","Outcome","QS132 - Social care for older people with multiple long-term conditions","2 - QS132 - Social care for older people with multiple long-term conditions",1,"2 - QS132 - Social care for older people with multiple long-term conditions - Outcome - 1"]
[null,"QS132","Social care for older people with multiple long-term conditions",3,"Named care coordinator","Older people with multiple long-term conditions and eligible social care needs have a named care coordinator.","Evidence of local arrangements to ensure that older people with multiple long-term conditions and eligible social care needs have a named care coordinator.","Structure","QS132 - Social care for older people with multiple long-term conditions","3 - QS132 - Social care for older people with multiple long-term conditions",1,"3 - QS132 - Social care for older people with multiple long-term conditions - Structure - 1"]
[null,"QS132","Social care for older people with multiple long-term conditions",3,"Named care coordinator","Older people with multiple long-term conditions and eligible social care needs have a named care coordinator.","Evidence of a locally agreed specification of the role and functions of the care coordinator.","Structure","QS132 - Social care for older people with multiple long-term conditions","3 - QS132 - Social care for older people with multiple long-term conditions",2,"3 - QS132 - Social care for older people with multiple long-term conditions - Structure - 2"]
[null,"QS132","Social care for older people with multiple long-term conditions",3,"Named care coordinator","Older people with multiple long-term conditions and eligible social care needs have a named care coordinator.","Proportion of older people with multiple long-term conditions and eligible social care needs who have a named care coordinator.","Process","QS132 - Social care for older people with multiple long-term conditions","3 - QS132 - Social care for older people with multiple long-term conditions",1,"3 - QS132 - Social care for older people with multiple long-term conditions - Process - 1","The number in the denominator who have a named care coordinator. ","The number of older people with multiple long-term conditions and eligible social care needs. "]
[null,"QS132","Social care for older people with multiple long-term conditions",3,"Named care coordinator","Older people with multiple long-term conditions and eligible social care needs have a named care coordinator.","Satisfaction among older people with multiple long term conditions and eligible social care needs with support to help them manage their long-term health conditions.","Outcome","QS132 - Social care for older people with multiple long-term conditions","3 - QS132 - Social care for older people with multiple long-term conditions",1,"3 - QS132 - Social care for older people with multiple long-term conditions - Outcome - 1"]
[null,"QS132","Social care for older people with multiple long-term conditions",4,"Care planning","Older people with multiple long-term conditions and eligible social care needs have an agreed health and social care plan that includes how their personal priorities and outcomes will be met.","Evidence of local processes to ensure that older people with multiple long-term conditions and eligible social care needs are involved in developing and agreeing their health and social care plan.","Structure","QS132 - Social care for older people with multiple long-term conditions","4 - QS132 - Social care for older people with multiple long-term conditions",1,"4 - QS132 - Social care for older people with multiple long-term conditions - Structure - 1"]
[null,"QS132","Social care for older people with multiple long-term conditions",4,"Care planning","Older people with multiple long-term conditions and eligible social care needs have an agreed health and social care plan that includes how their personal priorities and outcomes will be met.","Evidence of local processes to ensure that health and social care plans for older people with multiple long-term conditions and eligible social care needs include how personal priorities and outcomes will be met.","structure","QS132 - Social care for older people with multiple long-term conditions","4 - QS132 - Social care for older people with multiple long-term conditions",2,"4 - QS132 - Social care for older people with multiple long-term conditions - structure - 2"]
[null,"QS132","Social care for older people with multiple long-term conditions",4,"Care planning","Older people with multiple long-term conditions and eligible social care needs have an agreed health and social care plan that includes how their personal priorities and outcomes will be met.","Proportion of older people with multiple long-term conditions and eligible social care needs with a health and social care plan that includes how their personal priorities and outcomes will be met.","process","QS132 - Social care for older people with multiple long-term conditions","4 - QS132 - Social care for older people with multiple long-term conditions",1,"4 - QS132 - Social care for older people with multiple long-term conditions - process - 1","The number in the denominator with a health and social care plan that includes how their personal priorities and outcomes will be met.","The number of older people with multiple long-term conditions and eligible social care needs."]
[null,"QS132","Social care for older people with multiple long-term conditions",4,"Care planning","Older people with multiple long-term conditions and eligible social care needs have an agreed health and social care plan that includes how their personal priorities and outcomes will be met.","Proportion of older people with multiple long-term conditions and eligible social care needs who sign their health and social care plan.","process","QS132 - Social care for older people with multiple long-term conditions","4 - QS132 - Social care for older people with multiple long-term conditions",{"$f":"IF(AND(B2917=B2916, D2917=D2916, H2917=H2916)=TRUE, K2916+1, 1)","v":2},"4 - QS132 - Social care for older people with multiple long-term conditions - process - 2","The number in the denominator who sign their health and social care plan.","The number of older people with multiple long-term conditions and eligible social care needs."]
[null,"QS132","Social care for older people with multiple long-term conditions",4,"Care planning","Older people with multiple long-term conditions and eligible social care needs have an agreed health and social care plan that includes how their personal priorities and outcomes will be met.","Satisfaction among older people with multiple long-term conditions and eligible social care needs that their health and social care plan reflects their personal priorities and outcomes.","Outcome","QS132 - Social care for older people with multiple long-term conditions","4 - QS132 - Social care for older people with multiple long-term conditions",1,"4 - QS132 - Social care for older people with multiple long-term conditions - Outcome - 1"]
[null,"QS132","Social care for older people with multiple long-term conditions",4,"Care planning","Older people with multiple long-term conditions and eligible social care needs have an agreed health and social care plan that includes how their personal priorities and outcomes will be met.","Health-related quality of life for older people with multiple long-term conditions and eligible social care needs.","Outcome","QS132 - Social care for older people with multiple long-term conditions","4 - QS132 - Social care for older people with multiple long-term conditions",2,"4 - QS132 - Social care for older people with multiple long-term conditions - Outcome - 2"]
[null,"QS132","Social care for older people with multiple long-term conditions",4,"Care planning","Older people with multiple long-term conditions and eligible social care needs have an agreed health and social care plan that includes how their personal priorities and outcomes will be met.","Social care-related quality of life for older people with multiple long-term conditions and eligible social care needs.","Outcome","QS132 - Social care for older people with multiple long-term conditions","4 - QS132 - Social care for older people with multiple long-term conditions",3,"4 - QS132 - Social care for older people with multiple long-term conditions - Outcome - 3"]
[null,"QS132","Social care for older people with multiple long-term conditions",5,"Review of health and social care plan","Older people with multiple long-term conditions and eligible social care needs have a review of their health and social care plan at least once a year.","Evidence of local arrangements to ensure that health and social care plans for older people with multiple long-term conditions and eligible social care needs are reviewed at least once a year.","Structure","QS132 - Social care for older people with multiple long-term conditions","5 - QS132 - Social care for older people with multiple long-term conditions",1,"5 - QS132 - Social care for older people with multiple long-term conditions - Structure - 1"]
[null,"QS132","Social care for older people with multiple long-term conditions",5,"Review of health and social care plan","Older people with multiple long-term conditions and eligible social care needs have a review of their health and social care plan at least once a year.","Proportion of older people with multiple long-term conditions and eligible social care needs who had a review of their health and social care plan within the past 12 months.","Process","QS132 - Social care for older people with multiple long-term conditions","5 - QS132 - Social care for older people with multiple long-term conditions",1,"5 - QS132 - Social care for older people with multiple long-term conditions - Process - 1","The number in the denominator who had a review of their health and social care plan within the past 12 months. ","The number of older people with multiple long-term conditions and eligible social care needs with a health and social care plan for more than 12 months. "]
[null,"QS132","Social care for older people with multiple long-term conditions",5,"Review of health and social care plan","Older people with multiple long-term conditions and eligible social care needs have a review of their health and social care plan at least once a year.","Confidence among older people with multiple long-term conditions and eligible social care needs that they can self-manage their conditions.","Outcome","QS132 - Social care for older people with multiple long-term conditions","5 - QS132 - Social care for older people with multiple long-term conditions",1,"5 - QS132 - Social care for older people with multiple long-term conditions - Outcome - 1"]
[null,"QS132","Social care for older people with multiple long-term conditions",5,"Review of health and social care plan","Older people with multiple long-term conditions and eligible social care needs have a review of their health and social care plan at least once a year.","Health-related quality of life for older people with multiple long-term conditions and eligible social care needs.","Outcome","QS132 - Social care for older people with multiple long-term conditions","5 - QS132 - Social care for older people with multiple long-term conditions",2,"5 - QS132 - Social care for older people with multiple long-term conditions - Outcome - 2"]
[null,"QS132","Social care for older people with multiple long-term conditions",5,"Review of health and social care plan","Older people with multiple long-term conditions and eligible social care needs have a review of their health and social care plan at least once a year.","Social care-related quality of life for older people with multiple long-term conditions and eligible social care needs.","Outcome","QS132 - Social care for older people with multiple long-term conditions","5 - QS132 - Social care for older people with multiple long-term conditions",3,"5 - QS132 - Social care for older people with multiple long-term conditions - Outcome - 3"]
[null,"QS133","Childrens attachment",1,"Comprehensive assessment","Children and young people who may have attachment difficulties, and their parents or carers, have a comprehensive assessment before any intervention programme.","Evidence of local arrangements to undertake comprehensive assessment before any intervention programme for attachment difficulties.","Structure","QS133 - Childrens attachment","1 - QS133 - Childrens attachment",1,"1 - QS133 - Childrens attachment - Structure - 1"]
[null,"QS133","Childrens attachment",1,"Comprehensive assessment","Children and young people who may have attachment difficulties, and their parents or carers, have a comprehensive assessment before any intervention programme.","Proportion of intervention programmes commencing for attachment difficulties in children and young people that included a comprehensive assessment before the interventions began.","Process","QS133 - Childrens attachment","1 - QS133 - Childrens attachment",1,"1 - QS133 - Childrens attachment - Process - 1","The number in the denominator that included a comprehensive assessment before the interventions began.","The number of intervention programmes commencing for attachment difficulties in children and young people."]
[null,"QS133","Childrens attachment",1,"Comprehensive assessment","Children and young people who may have attachment difficulties, and their parents or carers, have a comprehensive assessment before any intervention programme.","Social and emotional development and behavioural functioning of children at risk of or with confirmed attachment difficulties.","Outcome","QS133 - Childrens attachment","1 - QS133 - Childrens attachment",1,"1 - QS133 - Childrens attachment - Outcome - 1"]
[null,"QS133","Childrens attachment",1,"Comprehensive assessment","Children and young people who may have attachment difficulties, and their parents or carers, have a comprehensive assessment before any intervention programme.","Sensitivity and responsiveness in parents of children with attachment difficulties on the edge of care.","Outcome","QS133 - Childrens attachment","1 - QS133 - Childrens attachment",2,"1 - QS133 - Childrens attachment - Outcome - 2"]
[null,"QS133","Childrens attachment",2,"Education plan","Children and young people with attachment difficulties have an education plan setting out how they will be supported in school.","Evidence of local arrangements to develop education plans for all children and young people with attachment difficulties that set out how they will be supported in school.","Structure","QS133 - Childrens attachment","2 - QS133 - Childrens attachment",1,"2 - QS133 - Childrens attachment - Structure - 1"]
[null,"QS133","Childrens attachment",2,"Education plan","Children and young people with attachment difficulties have an education plan setting out how they will be supported in school.","Proportion of children and young people with attachment difficulties who have an education plan setting out how they will be supported in school.","Process","QS133 - Childrens attachment","2 - QS133 - Childrens attachment",1,"2 - QS133 - Childrens attachment - Process - 1","The number in the denominator who have an education plan setting out how they will be supported in school.","The number of children and young people with attachment difficulties."]
[null,"QS133","Childrens attachment",2,"Education plan","Children and young people with attachment difficulties have an education plan setting out how they will be supported in school.","School attendance rates for children and young people with attachment difficulties.","Outcome","QS133 - Childrens attachment","2 - QS133 - Childrens attachment",1,"2 - QS133 - Childrens attachment - Outcome - 1"]
[null,"QS133","Childrens attachment",2,"Education plan","Children and young people with attachment difficulties have an education plan setting out how they will be supported in school.","School exclusions for children and young people with attachment difficulties.","Outcome","QS133 - Childrens attachment","2 - QS133 - Childrens attachment",2,"2 - QS133 - Childrens attachment - Outcome - 2"]
[null,"QS133","Childrens attachment",3,"Video feedback programmes","Parents and carers of preschool-age children with or at risk of attachment difficulties are offered a video feedback programme.","Evidence of local arrangements to ensure that parents and carers of preschool-age children identified to have or be at risk of attachment difficulties are offered a video feedback programme.","Structure","QS133 - Childrens attachment","3 - QS133 - Childrens attachment",1,"3 - QS133 - Childrens attachment - Structure - 1"]
[null,"QS133","Childrens attachment",3,"Video feedback programmes","Parents and carers of preschool-age children with or at risk of attachment difficulties are offered a video feedback programme.","Proportion of preschool-age children with or at risk of attachment difficulties whose parents or carers receive a video feedback programme.","Process","QS133 - Childrens attachment","3 - QS133 - Childrens attachment",1,"3 - QS133 - Childrens attachment - Process - 1","The number in the denominator whose parents or carers receive a video feedback programme.","The number of preschool-age children with or at risk of attachment difficulties."]
[null,"QS133","Childrens attachment",3,"Video feedback programmes","Parents and carers of preschool-age children with or at risk of attachment difficulties are offered a video feedback programme.","Sensitivity and responsiveness in parents of children with attachment difficulties on the edge of care.","Outcome","QS133 - Childrens attachment","3 - QS133 - Childrens attachment",1,"3 - QS133 - Childrens attachment - Outcome - 1"]
[null,"QS133","Childrens attachment",3,"Video feedback programmes","Parents and carers of preschool-age children with or at risk of attachment difficulties are offered a video feedback programme.","Breakdown in care placements for preschool aged children with or at risk of attachment difficulties.","Outcome","QS133 - Childrens attachment","3 - QS133 - Childrens attachment",2,"3 - QS133 - Childrens attachment - Outcome - 2"]
[null,"QS133","Childrens attachment",4,"Training and support for carers","Health and social care provider organisations provide training, education and support programmes for carers of school aged children and young people with attachment difficulties.","Evidence of local arrangements to provide training, education and support programmes for carers of children and young people with attachment difficulties.","Structure","QS133 - Childrens attachment","4 - QS133 - Childrens attachment",1,"4 - QS133 - Childrens attachment - Structure - 1"]
[null,"QS133","Childrens attachment",4,"Training and support for carers","Health and social care provider organisations provide training, education and support programmes for carers of school aged children and young people with attachment difficulties.","Evidence that training, education and support programmes for carers of children and young people with attachment difficulties are appropriate to the age of the child.","Structure","QS133 - Childrens attachment","4 - QS133 - Childrens attachment",2,"4 - QS133 - Childrens attachment - Structure - 2"]
[null,"QS133","Childrens attachment",4,"Training and support for carers","Health and social care provider organisations provide training, education and support programmes for carers of school aged children and young people with attachment difficulties.","Breakdown of placements for children and young people with attachment difficulties.","Outcome","QS133 - Childrens attachment","4 - QS133 - Childrens attachment",1,"4 - QS133 - Childrens attachment - Outcome - 1"]
[null,"QS133","Childrens attachment",4,"Training and support for carers","Health and social care provider organisations provide training, education and support programmes for carers of school aged children and young people with attachment difficulties.","School attendance rates for children and young people with attachment difficulties in care.","Outcome","QS133 - Childrens attachment","4 - QS133 - Childrens attachment",2,"4 - QS133 - Childrens attachment - Outcome - 2"]
[null,"QS133","Childrens attachment",4,"Training and support for carers","Health and social care provider organisations provide training, education and support programmes for carers of school aged children and young people with attachment difficulties.","School exclusions for children and young people with attachment difficulties in care.","Outcome","QS133 - Childrens attachment","4 - QS133 - Childrens attachment",3,"4 - QS133 - Childrens attachment - Outcome - 3"]
[null,"QS134","Coeliac disease",1,"Serological testing for coeliac disease","People at increased risk or with symptoms of coeliac disease are offered a serological test for coeliac disease.","Evidence of local arrangements to undertake serological testing for people identified with increased risk or symptoms of coeliac disease.","Structure",{"$f":"CONCATENATE(B2943, \" - \", C2943)","v":"QS134 - Coeliac disease"},{"$f":"CONCATENATE(D2943, \" - \", I2943)","v":"1 - QS134 - Coeliac disease"},1,{"$f":"CONCATENATE(J2943, \" - \", H2943, \" - \",K2943)","v":"1 - QS134 - Coeliac disease - Structure - 1"}]
[null,"QS134","Coeliac disease",1,"Serological testing for coeliac disease","People at increased risk or with symptoms of coeliac disease are offered a serological test for coeliac disease.","Proportion of people at increased risk of coeliac disease who receive a serological test for coeliac disease.","Process",{"$f":"CONCATENATE(B2944, \" - \", C2944)","v":"QS134 - Coeliac disease"},{"$f":"CONCATENATE(D2944, \" - \", I2944)","v":"1 - QS134 - Coeliac disease"},1,{"$f":"CONCATENATE(J2944, \" - \", H2944, \" - \",K2944)","v":"1 - QS134 - Coeliac disease - Process - 1"},"The number in the denominator who receive a serological test for coeliac disease.","The number of people at increased risk of coeliac disease (people with type 1 diabetes or autoimmune thyroid disease at diagnosis, and first-degree relatives of people newly diagnosed with coeliac disease)."]
[null,"QS134","Coeliac disease",1,"Serological testing for coeliac disease","People at increased risk or with symptoms of coeliac disease are offered a serological test for coeliac disease.","Proportion of people with symptoms of coeliac disease who receive a serological test for coeliac disease.","Process","QS134 - Coeliac disease","1 - QS134 - Coeliac disease",2,"1 - QS134 - Coeliac disease - Process - 2","The number in the denominator who receive a serological test for coeliac disease.","The number of people who have symptoms of coeliac disease."]
[null,"QS134","Coeliac disease",1,"Serological testing for coeliac disease","People at increased risk or with symptoms of coeliac disease are offered a serological test for coeliac disease.","Diagnosed prevalence of coeliac disease","Outcome","QS134 - Coeliac disease","1 - QS134 - Coeliac disease",1,"1 - QS134 - Coeliac disease - Outcome - 1"]
[null,"QS134","Coeliac disease",2,"Referral to a specialist","People with a positive serological test for coeliac disease are referred to a specialist and advised to continue with a gluten‑containing diet until diagnosis is confirmed.","Evidence of local arrangements to ensure that people with a positive serological test for coeliac disease are referred to a specialist.","Structure","QS134 - Coeliac disease","2 - QS134 - Coeliac disease",1,"2 - QS134 - Coeliac disease - Structure - 1"]
[null,"QS134","Coeliac disease",2,"Referral to a specialist","People with a positive serological test for coeliac disease are referred to a specialist and advised to continue with a gluten‑containing diet until diagnosis is confirmed.","Evidence of local arrangements to ensure that people referred to a specialist following a positive serological test for coeliac disease are advised to continue with a gluten‑containing diet until diagnosis is confirmed.","Structure","QS134 - Coeliac disease","2 - QS134 - Coeliac disease",2,"2 - QS134 - Coeliac disease - Structure - 2"]
[null,"QS134","Coeliac disease",2,"Referral to a specialist","People with a positive serological test for coeliac disease are referred to a specialist and advised to continue with a gluten‑containing diet until diagnosis is confirmed.","Proportion of people with a positive serological test for coeliac disease who are referred to a specialist.","Process","QS134 - Coeliac disease","2 - QS134 - Coeliac disease",1,"2 - QS134 - Coeliac disease - Process - 1","The number in the denominator who are referred to a specialist.","The number of people with a positive serological test for coeliac disease."]
[null,"QS134","Coeliac disease",2,"Referral to a specialist","People with a positive serological test for coeliac disease are referred to a specialist and advised to continue with a gluten‑containing diet until diagnosis is confirmed.","Proportion of people referred to a specialist following a positive serological test for coeliac disease who are advised to continue with a gluten‑containing diet until diagnosis is confirmed.","Process","QS134 - Coeliac disease","2 - QS134 - Coeliac disease",2,"2 - QS134 - Coeliac disease - Process - 2","The number in the denominator who are advised to continue with a gluten‑containing diet until diagnosis is confirmed.","The number of people referred to a specialist following a positive serological test for coeliac disease."]
[null,"QS134","Coeliac disease",2,"Referral to a specialist","People with a positive serological test for coeliac disease are referred to a specialist and advised to continue with a gluten‑containing diet until diagnosis is confirmed.","Diagnosed prevalence of coeliac disease","Outcome","QS134 - Coeliac disease","2 - QS134 - Coeliac disease",1,"2 - QS134 - Coeliac disease - Outcome - 1"]
[null,"QS134","Coeliac disease",3,"Endoscopic intestinal biopsy","People referred to a specialist who need an endoscopic intestinal biopsy to diagnose coeliac disease have it within 6 weeks of referral.","Evidence of local processes to ensure that people referred to a specialist who need an endoscopic intestinal biopsy to diagnose coeliac disease have it within 6 weeks of referral.","Structure","QS134 - Coeliac disease","3 - QS134 - Coeliac disease",1,"3 - QS134 - Coeliac disease - Structure - 1"]
[null,"QS134","Coeliac disease",3,"Endoscopic intestinal biopsy","People referred to a specialist who need an endoscopic intestinal biopsy to diagnose coeliac disease have it within 6 weeks of referral.","Proportion of people referred to a specialist who need an endoscopic intestinal biopsy to diagnose coeliac disease who have it within 6 weeks of referral.","Process","QS134 - Coeliac disease","3 - QS134 - Coeliac disease",1,"3 - QS134 - Coeliac disease - Process - 1","The number in the denominator who have an endoscopic intestinal biopsy within 6 weeks of referral.","The number of people referred to a specialist who need an endoscopic intestinal biopsy to diagnose coeliac disease."]
[null,"QS134","Coeliac disease",3,"Endoscopic intestinal biopsy","People referred to a specialist who need an endoscopic intestinal biopsy to diagnose coeliac disease have it within 6 weeks of referral.","Proportion of people with a positive serological test for coeliac disease who complete the diagnosis process.","Process","QS134 - Coeliac disease","3 - QS134 - Coeliac disease",2,"3 - QS134 - Coeliac disease - Process - 2","The number in the denominator who complete the diagnosis process.","The number of people with a positive serological test for coeliac disease."]
[null,"QS134","Coeliac disease",3,"Endoscopic intestinal biopsy","People referred to a specialist who need an endoscopic intestinal biopsy to diagnose coeliac disease have it within 6 weeks of referral.","Diagnosed prevalence of coeliac disease.","Outcome","QS134 - Coeliac disease","3 - QS134 - Coeliac disease",1,"3 - QS134 - Coeliac disease - Outcome - 1"]
[null,"QS134","Coeliac disease",4,"Advice about a gluten-free diet","People newly diagnosed with coeliac disease discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease.","Evidence of local arrangements to ensure that people newly diagnosed with coeliac disease discuss how to follow a gluten‑free diet with a healthcare professional with specialist knowledge of coeliac disease.","Structure","QS134 - Coeliac disease","4 - QS134 - Coeliac disease",1,"4 - QS134 - Coeliac disease - Structure - 1"]
[null,"QS134","Coeliac disease",4,"Advice about a gluten-free diet","People newly diagnosed with coeliac disease discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease.","Proportion of people newly diagnosed with coeliac disease who discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease.","Process","QS134 - Coeliac disease","4 - QS134 - Coeliac disease",1,"4 - QS134 - Coeliac disease - Process - 1","The number in the denominator who discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease.","The number of people newly diagnosed with coeliac disease."]
[null,"QS134","Coeliac disease",4,"Advice about a gluten-free diet","People newly diagnosed with coeliac disease discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease.","Satisfaction among people with coeliac disease that they are supported to manage their condition.","Outcome","QS134 - Coeliac disease","4 - QS134 - Coeliac disease",1,"4 - QS134 - Coeliac disease - Outcome - 1"]
[null,"QS134","Coeliac disease",4,"Advice about a gluten-free diet","People newly diagnosed with coeliac disease discuss how to follow a gluten-free diet with a healthcare professional with specialist knowledge of coeliac disease.","Health-related quality of life for people with coeliac disease.","Outcome","QS134 - Coeliac disease","4 - QS134 - Coeliac disease",2,"4 - QS134 - Coeliac disease - Outcome - 2"]
[null,"QS134","Coeliac disease",5,"Annual review","People with coeliac disease are offered an annual review.","Evidence of local arrangements to ensure that people with coeliac disease are offered an annual review.","Structure","QS134 - Coeliac disease","5 - QS134 - Coeliac disease",1,"5 - QS134 - Coeliac disease - Structure - 1"]
[null,"QS134","Coeliac disease",5,"Annual review","People with coeliac disease are offered an annual review.","Proportion of people diagnosed with coeliac disease for more than 12 months who received an annual review in the previous 12 months.","Process","QS134 - Coeliac disease","5 - QS134 - Coeliac disease",1,"5 - QS134 - Coeliac disease - Process - 1","The number in the denominator who received an annual review in the previous 12 months.","The number of people diagnosed with coeliac disease for more than 12 months."]
[null,"QS134","Coeliac disease",5,"Annual review","People with coeliac disease are offered an annual review.","Health-related quality of life for people with coeliac disease","Outcome","QS134 - Coeliac disease","5 - QS134 - Coeliac disease",1,"5 - QS134 - Coeliac disease - Outcome - 1"]
[null,"QS134","Coeliac disease",5,"Annual review","People with coeliac disease are offered an annual review.","Identification of complications associated with coeliac disease.","Outcome","QS134 - Coeliac disease","5 - QS134 - Coeliac disease",2,"5 - QS134 - Coeliac disease - Outcome - 2"]
[null,"QS135","Preterm labour and birth",1,"Providing information about potential signs and symptoms of preterm labour","Pregnant women at increased risk of preterm labour are given information about the potential signs and symptoms.","Evidence of local arrangements and clinical protocols to ensure that pregnant women at increased risk of preterm labour are given information about the potential signs and symptoms.","Structure",{"$f":"CONCATENATE(B2964, \" - \", C2964)","v":"QS135 - Preterm labour and birth"},{"$f":"CONCATENATE(D2964, \" - \", I2964)","v":"1 - QS135 - Preterm labour and birth"},1,{"$f":"CONCATENATE(J2964, \" - \", H2964, \" - \",K2964)","v":"1 - QS135 - Preterm labour and birth - Structure - 1"}]
[null,"QS135","Preterm labour and birth",1,"Providing information about potential signs and symptoms of preterm labour","Pregnant women at increased risk of preterm labour are given information about the potential signs and symptoms.","Proportion of pregnant women at increased risk of preterm labour who are given information about the potential signs and symptoms.","Process","QS135 - Preterm labour and birth","1 - QS135 - Preterm labour and birth",1,"1 - QS135 - Preterm labour and birth - Process - 1","The number in the denominator who are given information about the potential signs and symptoms.","The number of pregnant women at increased risk of preterm labour."]
[null,"QS135","Preterm labour and birth",1,"Providing information about potential signs and symptoms of preterm labour","Pregnant women at increased risk of preterm labour are given information about the potential signs and symptoms.","Pregnant women's satisfaction with the information provided.","Outcome","QS135 - Preterm labour and birth","1 - QS135 - Preterm labour and birth",1,"1 - QS135 - Preterm labour and birth - Outcome - 1"]
[null,"QS135","Preterm labour and birth",2,"Prophylactic vaginal progesterone and prophylactic cervical cerclage","Women who have had a previous preterm birth or mid-trimester loss and have a cervical length of 25 mm or less measured between 16+0 and 24+0 weeks of pregnancy are offered a choice of either prophylactic vaginal progesterone or prophylactic cervical cerclage.","Evidence of local arrangements and written clinical protocols to ensure that women who have had a previous preterm birth or mid-trimester loss and have a cervical length of 25 mm or less measured between 16+0 and 24+0 weeks of pregnancy are offered a choice of either prophylactic vaginal progesterone or prophylactic cervical cerclage.","Structure","QS135 - Preterm labour and birth","2 - QS135 - Preterm labour and birth",1,"2 - QS135 - Preterm labour and birth - Structure - 1"]
[null,"QS135","Preterm labour and birth",2,"Prophylactic vaginal progesterone and prophylactic cervical cerclage","Women who have had a previous preterm birth or mid-trimester loss and have a cervical length of 25 mm or less measured between 16+0 and 24+0 weeks of pregnancy are offered a choice of either prophylactic vaginal progesterone or prophylactic cervical cerclage.","Proportion of women who have had a previous preterm birth or mid-trimester loss and have a cervical length of 25 mm or less measured between 16+0 and 24+0 weeks of pregnancy who are offered a choice of either prophylactic vaginal progesterone or prophylactic cervical cerclage.","Process","QS135 - Preterm labour and birth","2 - QS135 - Preterm labour and birth",1,"2 - QS135 - Preterm labour and birth - Process - 1","The number in the denominator who are offered a choice of either prophylactic vaginal progesterone or prophylactic cervical cerclage.","The number of women who have had a previous preterm birth or mid-trimester loss and have a cervical length of less than 25 mm measured between 16+0 and 24+0 weeks of pregnancy."]
[null,"QS135","Preterm labour and birth",2,"Prophylactic vaginal progesterone and prophylactic cervical cerclage","Women who have had a previous preterm birth or mid-trimester loss and have a cervical length of 25 mm or less measured between 16+0 and 24+0 weeks of pregnancy are offered a choice of either prophylactic vaginal progesterone or prophylactic cervical cerclage.","Timing of labour and birth.","Outcome","QS135 - Preterm labour and birth","2 - QS135 - Preterm labour and birth",1,"2 - QS135 - Preterm labour and birth - Outcome - 1"]
[null,"QS135","Preterm labour and birth",3,"Information for women having a planned preterm birth","Women having a planned preterm birth are given information about the risks and potential outcomes.","Evidence of local arrangements and clinical protocols to ensure that women having a planned preterm birth are given information about the risks and potential outcomes.","Structure","QS135 - Preterm labour and birth","3 - QS135 - Preterm labour and birth",1,"3 - QS135 - Preterm labour and birth - Structure - 1"]
[null,"QS135","Preterm labour and birth",3,"Information for women having a planned preterm birth","Women having a planned preterm birth are given information about the risks and potential outcomes.","Proportion of women having a planned preterm birth who are given information about the risks and potential outcomes.","Process","QS135 - Preterm labour and birth","3 - QS135 - Preterm labour and birth",1,"3 - QS135 - Preterm labour and birth - Process - 1","The number in the denominator who are given information about the risks and potential outcomes.","The number of women having a planned preterm birth."]
[null,"QS135","Preterm labour and birth",3,"Information for women having a planned preterm birth","Women having a planned preterm birth are given information about the risks and potential outcomes.","\nWomen's awareness of the risks and potential outcomes of having a planned preterm birth.","Outcome","QS135 - Preterm labour and birth","3 - QS135 - Preterm labour and birth",1,"3 - QS135 - Preterm labour and birth - Outcome - 1"]
[null,"QS135","Preterm labour and birth",4,"Tocolysis and corticosteroids for women in suspected preterm labour between 26+0 and 29+6 weeks of pregnancy","Women between 26+0 and 33+6 weeks of pregnancy who have intact membranes and are in suspected or diagnosed preterm labour are offered tocolysis.","Evidence of local arrangements and written clinical protocols to ensure that women between 26+0 and 33+6 weeks of pregnancy who have intact membranes and are in suspected or diagnosed preterm labour are offered tocolysis.","Structure","QS135 - Preterm labour and birth","4 - QS135 - Preterm labour and birth",1,"4 - QS135 - Preterm labour and birth - Structure - 1"]
[null,"QS135","Preterm labour and birth",4,"Tocolysis and corticosteroids for women in suspected preterm labour between 26+0 and 29+6 weeks of pregnancy","Women between 26+0 and 33+6 weeks of pregnancy who have intact membranes and are in suspected or diagnosed preterm labour are offered tocolysis.","Proportion of women between 26+0 and 33+6 weeks of pregnancy who have intact membranes and are in suspected or diagnosed preterm labour who receive tocolysis.","Process","QS135 - Preterm labour and birth","4 - QS135 - Preterm labour and birth",1,"4 - QS135 - Preterm labour and birth - Process - 1","The number in the denominator who receive tocolysis.","The number of women between 26+0 and 33+6 weeks of pregnancy who have intact membranes and are in suspected or diagnosed preterm labour."]
[null,"QS135","Preterm labour and birth",4,"Tocolysis and corticosteroids for women in suspected preterm labour between 26+0 and 29+6 weeks of pregnancy","Women between 26+0 and 33+6 weeks of pregnancy who have intact membranes and are in suspected or diagnosed preterm labour are offered tocolysis.","Neonatal death.","Outcome","QS135 - Preterm labour and birth","4 - QS135 - Preterm labour and birth",{"$f":"IF(AND(B2975=#REF!, D2975=#REF!, H2975=#REF!)=TRUE,#REF!+ 1, 1)","v":{"$error":"#REF!"}},{"$error":"#REF!"}]
[null,"QS135","Preterm labour and birth",4,"Tocolysis and corticosteroids for women in suspected preterm labour between 26+0 and 29+6 weeks of pregnancy","Women between 26+0 and 33+6 weeks of pregnancy who have intact membranes and are in suspected or diagnosed preterm labour are offered tocolysis.","Intraventricular haemorrhage.","Outcome","QS135 - Preterm labour and birth","4 - QS135 - Preterm labour and birth",{"$error":"#REF!"},{"$error":"#REF!"}]
[null,"QS135","Preterm labour and birth",4,"Tocolysis and corticosteroids for women in suspected preterm labour between 26+0 and 29+6 weeks of pregnancy","Women between 26+0 and 33+6 weeks of pregnancy who have intact membranes and are in suspected or diagnosed preterm labour are offered tocolysis.","Incidence of neonatal sepsis.","Outcome","QS135 - Preterm labour and birth","4 - QS135 - Preterm labour and birth",{"$error":"#REF!"},{"$error":"#REF!"}]
[null,"QS135","Preterm labour and birth",4,"Tocolysis and corticosteroids for women in suspected preterm labour between 26+0 and 29+6 weeks of pregnancy","Women between 26+0 and 33+6 weeks of pregnancy who have intact membranes and are in suspected or diagnosed preterm labour are offered tocolysis.","Use of antibiotics.","Outcome","QS135 - Preterm labour and birth","4 - QS135 - Preterm labour and birth",{"$error":"#REF!"},{"$error":"#REF!"}]
[null,"QS135","Preterm labour and birth",4,"Tocolysis and corticosteroids for women in suspected preterm labour between 26+0 and 29+6 weeks of pregnancy","Women between 26+0 and 33+6 weeks of pregnancy who have intact membranes and are in suspected or diagnosed preterm labour are offered tocolysis.","Ventilation.","Outcome","QS135 - Preterm labour and birth","4 - QS135 - Preterm labour and birth",{"$error":"#REF!"},{"$error":"#REF!"}]
[null,"QS135","Preterm labour and birth",5,"Corticosteroids for women between 30+0 and 33+6 weeks of pregnancy","Women between 24+0 and 33+6 weeks of pregnancy who are in suspected, diagnosed or established preterm labour, are having a planned preterm birth or have preterm prelabour rupture of membranes (P-PROM) are offered maternal corticosteroids.","Evidence of local arrangements and written clinical protocols to ensure that women between 24+0 and 33+6 weeks of pregnancy who are in suspected, diagnosed or established preterm labour, are having a planned preterm birth or have P-PROM are offered maternal corticosteroids.","Structure","QS135 - Preterm labour and birth","5 - QS135 - Preterm labour and birth",{"$f":"IF(AND(B2980=B2979, D2980=D2979, H2980=H2979)=TRUE, K2979+1, 1)","v":1},"5 - QS135 - Preterm labour and birth - Structure - 1"]
[null,"QS135","Preterm labour and birth",5,"Corticosteroids for women between 30+0 and 33+6 weeks of pregnancy","Women between 24+0 and 33+6 weeks of pregnancy who are in suspected, diagnosed or established preterm labour, are having a planned preterm birth or have preterm prelabour rupture of membranes (P-PROM) are offered maternal corticosteroids.","Proportion of women between 24+0 and 33+6 weeks of pregnancy in suspected, diagnosed or established preterm labour who receive maternal corticosteroids.","Process","QS135 - Preterm labour and birth","5 - QS135 - Preterm labour and birth",1,"5 - QS135 - Preterm labour and birth - Process - 1","The number in the denominator who receive maternal corticosteroids.","The number of women between 24+0 and 33+6 weeks of pregnancy in suspected, diagnosed or established preterm labour."]
[null,"QS135","Preterm labour and birth",5,"Corticosteroids for women between 30+0 and 33+6 weeks of pregnancy","Women between 24+0 and 33+6 weeks of pregnancy who are in suspected, diagnosed or established preterm labour, are having a planned preterm birth or have preterm prelabour rupture of membranes (P-PROM) are offered maternal corticosteroids.","Proportion of women between 24+0 and 33+6 weeks of pregnancy having a planned preterm birth who receive maternal corticosteroids.","Process","QS135 - Preterm labour and birth","5 - QS135 - Preterm labour and birth",2,"5 - QS135 - Preterm labour and birth - Process - 2","The number in the denominator who receive maternal corticosteroids.","The number of women between 24+0 and 33+6 weeks of pregnancy who are having a planned preterm birth."]
[null,"QS135","Preterm labour and birth",5,"Corticosteroids for women between 30+0 and 33+6 weeks of pregnancy","Women between 24+0 and 33+6 weeks of pregnancy who are in suspected, diagnosed or established preterm labour, are having a planned preterm birth or have preterm prelabour rupture of membranes (P-PROM) are offered maternal corticosteroids.","Proportion of women between 24+0 and 33+6 weeks of pregnancy with P-PROM who receive maternal corticosteroids.","Process","QS135 - Preterm labour and birth","5 - QS135 - Preterm labour and birth",3,"5 - QS135 - Preterm labour and birth - Process - 3","The number in the denominator who receive maternal corticosteroids.","The number of women between 24+0 and 33+6 weeks of pregnancy with P-PROM."]
[null,"QS135","Preterm labour and birth",5,"Corticosteroids for women between 30+0 and 33+6 weeks of pregnancy","Women between 24+0 and 33+6 weeks of pregnancy who are in suspected, diagnosed or established preterm labour, are having a planned preterm birth or have preterm prelabour rupture of membranes (P-PROM) are offered maternal corticosteroids."," Ventilation.","Outcome","QS135 - Preterm labour and birth","5 - QS135 - Preterm labour and birth",1,"5 - QS135 - Preterm labour and birth - Outcome - 1"]
[null,"QS135","Preterm labour and birth",5,"Corticosteroids for women between 30+0 and 33+6 weeks of pregnancy","Women between 24+0 and 33+6 weeks of pregnancy who are in suspected, diagnosed or established preterm labour, are having a planned preterm birth or have preterm prelabour rupture of membranes (P-PROM) are offered maternal corticosteroids.","Incidence of neonatal sepsis.","Outcome","QS135 - Preterm labour and birth","5 - QS135 - Preterm labour and birth",2,"5 - QS135 - Preterm labour and birth - Outcome - 2"]
[null,"QS135","Preterm labour and birth",5,"Corticosteroids for women between 30+0 and 33+6 weeks of pregnancy","Women between 24+0 and 33+6 weeks of pregnancy who are in suspected, diagnosed or established preterm labour, are having a planned preterm birth or have preterm prelabour rupture of membranes (P-PROM) are offered maternal corticosteroids.","Use of antibiotics.","Outcome","QS135 - Preterm labour and birth","5 - QS135 - Preterm labour and birth",3,"5 - QS135 - Preterm labour and birth - Outcome - 3",null," "]
[null,"QS135","Preterm labour and birth",6,"Magnesium sulfate for women between 24+0 and 29+6 weeks of pregnancy","Women between 24+0 and 29+6 weeks of pregnancy who are in established preterm labour or having a planned preterm birth within 24 hours are offered magnesium sulfate.","Evidence of local arrangements and written clinical protocols to ensure that women between 24+0 and 29+6 weeks of pregnancy who are in established preterm labour or having a planned preterm birth within 24 hours are offered magnesium sulfate.","Structure","QS135 - Preterm labour and birth","6 - QS135 - Preterm labour and birth",1,"6 - QS135 - Preterm labour and birth - Structure - 1"]
[null,"QS135","Preterm labour and birth",6,"Magnesium sulfate for women between 24+0 and 29+6 weeks of pregnancy","Women between 24+0 and 29+6 weeks of pregnancy who are in established preterm labour or having a planned preterm birth within 24 hours are offered magnesium sulfate.","Proportion of women between 24+0 and 29+6 weeks of pregnancy in established preterm labour who receive magnesium sulfate.","Process","QS135 - Preterm labour and birth","6 - QS135 - Preterm labour and birth",1,"6 - QS135 - Preterm labour and birth - Process - 1","The number in the denominator who receive magnesium sulfate.","The number of women between 24+0 and 29+6 weeks of pregnancy in established preterm labour."]
[null,"QS135","Preterm labour and birth",6,"Magnesium sulfate for women between 24+0 and 29+6 weeks of pregnancy","Women between 24+0 and 29+6 weeks of pregnancy who are in established preterm labour or having a planned preterm birth within 24 hours are offered magnesium sulfate.","Proportion of women between 24+0 and 29+6 weeks of pregnancy who are having a planned preterm birth within 24 hours who receive magnesium sulfate.","Process","QS135 - Preterm labour and birth","6 - QS135 - Preterm labour and birth",2,"6 - QS135 - Preterm labour and birth - Process - 2","The number in the denominator who receive magnesium sulfate in the 24 hours before the birth.","The number of women between 24+0 and 29+6 weeks of pregnancy who have a planned preterm birth."]
[null,"QS135","Preterm labour and birth",6,"Magnesium sulfate for women between 24+0 and 29+6 weeks of pregnancy","Women between 24+0 and 29+6 weeks of pregnancy who are in established preterm labour or having a planned preterm birth within 24 hours are offered magnesium sulfate.","Incidence of cerebral palsy.","Outcome","QS135 - Preterm labour and birth","6 - QS135 - Preterm labour and birth",1,"6 - QS135 - Preterm labour and birth - Outcome - 1"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"Information sharing on admission","Adults with social care needs who are admitted to hospital have existing care plans shared with the admitting team.","Evidence of local arrangements to ensure that existing care plans for adults with social care needs are shared with the admitting team when they are admitted to hospital.","Structure",{"$f":"CONCATENATE(B2991, \" - \", C2991)","v":"QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs"},{"$f":"CONCATENATE(D2991, \" - \", I2991)","v":"1 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs"},1,{"$f":"CONCATENATE(J2991, \" - \", H2991, \" - \",K2991)","v":"1 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Structure - 1"}]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"Information sharing on admission","Adults with social care needs who are admitted to hospital have existing care plans shared with the admitting team.","The proportion of adults with social care needs who have existing care plans shared with the admitting team when they are admitted to hospital.","Process","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","1 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"1 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Process - 1","The number in the denominator where the person's existing care plans are shared with the admitting team.","The number of hospital admissions of adults with social care needs."]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"Information sharing on admission","Adults with social care needs who are admitted to hospital have existing care plans shared with the admitting team.","People's experience of hospital admission.","Outcome","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","1 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"1 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Outcome - 1"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",2,"Comprehensive geriatric assessment","Older people with complex needs have a comprehensive geriatric assessment started on admission to hospital.","Evidence of local arrangements to ensure that older people with complex needs have a comprehensive geriatric assessment started on admission to hospital.","Structure","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","2 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"2 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Structure - 1"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",2,"Comprehensive geriatric assessment","Older people with complex needs have a comprehensive geriatric assessment started on admission to hospital.","Proportion of older people with complex needs who have a comprehensive geriatric assessment started on admission to hospital.","Process","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","2 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"2 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Process - 1","The number in the denominator where a comprehensive geriatric assessment is started on admission to hospital.","The number of hospital admissions of older people with complex needs."]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",2,"Comprehensive geriatric assessment","Older people with complex needs have a comprehensive geriatric assessment started on admission to hospital.","Length of hospital stay for older people with complex needs.","Outcome","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","2 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"2 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Outcome - 1"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",2,"Comprehensive geriatric assessment","Older people with complex needs have a comprehensive geriatric assessment started on admission to hospital.","Delayed transfers of care for older people with complex needs.","Outcome","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","2 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",2,"2 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Outcome - 2"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",2,"Comprehensive geriatric assessment","Older people with complex needs have a comprehensive geriatric assessment started on admission to hospital.","Permanent admissions to residential and nursing care homes in the 12 months after hospital admission.","Outcome","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","2 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",3,"2 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Outcome - 3"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",3,"Coordinated discharge","Adults with social care needs who are in hospital have a named discharge coordinator.","Evidence of local arrangements to ensure that adults with social care needs who are in hospital have a named discharge coordinator.","Structure","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","3 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"3 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Structure - 1"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",3,"Coordinated discharge","Adults with social care needs who are in hospital have a named discharge coordinator.","Proportion of discharges from hospital of adults with social care needs where there is a named discharge coordinator.","Process","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","3 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"3 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Process - 1","The number in the denominator where there is a named discharge coordinator.","The number of discharges from hospital of adults with social care needs."]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",3,"Coordinated discharge","Adults with social care needs who are in hospital have a named discharge coordinator.","Delayed transfers of care for adults with social care needs. ","Outcome","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","3 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"3 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Outcome - 1"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",3,"Coordinated discharge","Adults with social care needs who are in hospital have a named discharge coordinator.","Experience of the discharge process for adults with social care needs.","Outcome","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","3 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",2,"3 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Outcome - 2"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",3,"Coordinated discharge","Adults with social care needs who are in hospital have a named discharge coordinator.","Readmission rates for adults with social care needs.","Outcome","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","3 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",3,"3 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Outcome - 3"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",4,"Discharge plans","Adults with social care needs are given a copy of their agreed discharge plan before leaving hospital.","Evidence of local arrangements to ensure that adults with social care needs are given a copy of their agreed discharge plan before being leaving hospital. ","Structure","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","4 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"4 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Structure - 1"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",4,"Discharge plans","Adults with social care needs are given a copy of their agreed discharge plan before leaving hospital.","Proportion of discharges from hospital of adults with social care needs that include the person being given a copy of their agreed discharge plan before leaving hospital.","Process","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","4 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"4 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Process - 1","The number in the denominator where the person is given a copy of their agreed discharge plan before leaving hospital.","The number of discharges from hospital of adults with social care needs."]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",4,"Discharge plans","Adults with social care needs are given a copy of their agreed discharge plan before leaving hospital.","Readmission rates for adults with social care needs.","Outcome","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","4 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"4 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Outcome - 1"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",4,"Discharge plans","Adults with social care needs are given a copy of their agreed discharge plan before leaving hospital.","The experience of discharge from hospital for adults with social care needs.","Outcome","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","4 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",2,"4 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Outcome - 2"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",5,"Involving carers in discharge planning","Adults with social care needs have family or carers involved in discharge planning if they are providing support after discharge. ","Evidence of local arrangements to ensure that adults with social care needs have family or carers involved in discharge planning if they are providing support after discharge.","Structure","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","5 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"5 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Structure - 1"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",5,"Involving carers in discharge planning","Adults with social care needs have family or carers involved in discharge planning if they are providing support after discharge. ","Proportion of discharges from hospital of adults with social care needs where family or carers are involved in discharge planning if they are providing support after discharge.","Process","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","5 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"5 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Process - 1","The number in the denominator where family and carers are involved in discharge planning.","The number of discharges from hospital of adults with social care needs where family or carers are providing support after discharge."]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",5,"Involving carers in discharge planning","Adults with social care needs have family or carers involved in discharge planning if they are providing support after discharge. ","Delayed transfers of care for adults with social care needs. ","Outcome","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","5 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",1,"5 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Outcome - 1"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",5,"Involving carers in discharge planning","Adults with social care needs have family or carers involved in discharge planning if they are providing support after discharge. ","Readmission rates for adults with social care needs.","Outcome","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","5 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",2,"5 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Outcome - 2"]
[null,"QS136","Transition between inpatient hospital settings and community or care home settings for adults with social care needs",5,"Involving carers in discharge planning","Adults with social care needs have family or carers involved in discharge planning if they are providing support after discharge. ","Family and carer satisfaction with involvement in discharge planning for adults with social care needs.","Outcome","QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs","5 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs",3,"5 - QS136 - Transition between inpatient hospital settings and community or care home settings for adults with social care needs - Outcome - 3"]
[null,"QS137","Mental wellbeing and independence for older people",1,"Identifying those at risk of a decline ","Older people who are at risk of a decline in their independence and mental wellbeing are identified by service providers.","Evidence of local arrangements that ensure older people who are at risk of a decline in their independence and mental wellbeing are being identified by service providers","Structure",{"$f":"CONCATENATE(B3013, \" - \", C3013)","v":"QS137 - Mental wellbeing and independence for older people"},{"$f":"CONCATENATE(D3013, \" - \", I3013)","v":"1 - QS137 - Mental wellbeing and independence for older people"},1,{"$f":"CONCATENATE(J3013, \" - \", H3013, \" - \",K3013)","v":"1 - QS137 - Mental wellbeing and independence for older people - Structure - 1"}]
[null,"QS137","Mental wellbeing and independence for older people",1,"Identifying those at risk of a decline ","Older people who are at risk of a decline in their independence and mental wellbeing are identified by service providers.","Number of older people identified as at risk of a decline in their independence and mental wellbeing.","Outcome","QS137 - Mental wellbeing and independence for older people","1 - QS137 - Mental wellbeing and independence for older people",1,"1 - QS137 - Mental wellbeing and independence for older people - Outcome - 1"]
[null,"QS137","Mental wellbeing and independence for older people",1,"Identifying those at risk of a decline ","Older people who are at risk of a decline in their independence and mental wellbeing are identified by service providers.","Incidence of mental health conditions among older people identified as being at risk of decline.","Outcome","QS137 - Mental wellbeing and independence for older people","1 - QS137 - Mental wellbeing and independence for older people",2,"1 - QS137 - Mental wellbeing and independence for older people - Outcome - 2"]
[null,"QS137","Mental wellbeing and independence for older people",1,"Identifying those at risk of a decline ","Older people who are at risk of a decline in their independence and mental wellbeing are identified by service providers.","Incidence of admission to supported care facilities among older people identified as being at risk of decline. ","Outcome","QS137 - Mental wellbeing and independence for older people","1 - QS137 - Mental wellbeing and independence for older people",3,"1 - QS137 - Mental wellbeing and independence for older people - Outcome - 3"]
[null,"QS137","Mental wellbeing and independence for older people",2,"Physical activity for older people ","Older people most at risk of a decline in their independence and mental wellbeing are offered tailored, community-based physical activity programmes.","Evidence of local arrangements to ensure tailored, community-based physical activity programmes are in place for older people most at risk of a decline in their independence and mental wellbeing","Structure","QS137 - Mental wellbeing and independence for older people","2 - QS137 - Mental wellbeing and independence for older people",1,"2 - QS137 - Mental wellbeing and independence for older people - Structure - 1"]
[null,"QS137","Mental wellbeing and independence for older people",2,"Physical activity for older people ","Older people most at risk of a decline in their independence and mental wellbeing are offered tailored, community-based physical activity programmes.","Proportion of older people most at risk of a decline in their independence and mental wellbeing who take part in tailored, community-based physical activity programmes.","Process","QS137 - Mental wellbeing and independence for older people","2 - QS137 - Mental wellbeing and independence for older people",1,"2 - QS137 - Mental wellbeing and independence for older people - Process - 1","The number in the denominator who take part in tailored, community-based physical activity programmes.","The number of older people most at risk of a decline in their independence and mental wellbeing."]
[null,"QS137","Mental wellbeing and independence for older people",2,"Physical activity for older people ","Older people most at risk of a decline in their independence and mental wellbeing are offered tailored, community-based physical activity programmes.","Change in physical activity among older people","Outcome","QS137 - Mental wellbeing and independence for older people","2 - QS137 - Mental wellbeing and independence for older people",1,"2 - QS137 - Mental wellbeing and independence for older people - Outcome - 1"]
[null,"QS137","Mental wellbeing and independence for older people",2,"Physical activity for older people ","Older people most at risk of a decline in their independence and mental wellbeing are offered tailored, community-based physical activity programmes.","Incidence of mental health conditions among older people identified as being at risk of decline","Outcome","QS137 - Mental wellbeing and independence for older people","2 - QS137 - Mental wellbeing and independence for older people",2,"2 - QS137 - Mental wellbeing and independence for older people - Outcome - 2"]
[null,"QS137","Mental wellbeing and independence for older people",2,"Physical activity for older people ","Older people most at risk of a decline in their independence and mental wellbeing are offered tailored, community-based physical activity programmes.","Incidence of admission to supported care facilities among older people identified as being at risk of decline","Outcome","QS137 - Mental wellbeing and independence for older people","2 - QS137 - Mental wellbeing and independence for older people",3,"2 - QS137 - Mental wellbeing and independence for older people - Outcome - 3"]
[null,"QS137","Mental wellbeing and independence for older people",3,"Social participation ","Older people most at risk of a decline in their independence and mental wellbeing are offered a range of activities to build or maintain social participation","Evidence of local arrangements to ensure a range of activities are in place to build or maintain social participation in older people most at risk of a decline in their independence and mental wellbeing","Structure","QS137 - Mental wellbeing and independence for older people","3 - QS137 - Mental wellbeing and independence for older people",1,"3 - QS137 - Mental wellbeing and independence for older people - Structure - 1"]
[null,"QS137","Mental wellbeing and independence for older people",3,"Social participation ","Older people most at risk of a decline in their independence and mental wellbeing are offered a range of activities to build or maintain social participation","Proportion of older people most at risk of a decline in their independence and mental wellbeing who take part in activities to build or maintain social participation","Process","QS137 - Mental wellbeing and independence for older people","3 - QS137 - Mental wellbeing and independence for older people",1,"3 - QS137 - Mental wellbeing and independence for older people - Process - 1","The number in the denominator who take part in activities to build or maintain social participation.","The number of older people most at risk of a decline in their independence and mental wellbeing."]
[null,"QS137","Mental wellbeing and independence for older people",3,"Social participation ","Older people most at risk of a decline in their independence and mental wellbeing are offered a range of activities to build or maintain social participation","Proportion of older people and their carers who use services and report that they have as much social contact as they would like","Outcome","QS137 - Mental wellbeing and independence for older people","3 - QS137 - Mental wellbeing and independence for older people",1,"3 - QS137 - Mental wellbeing and independence for older people - Outcome - 1"]
[null,"QS137","Mental wellbeing and independence for older people",3,"Social participation ","Older people most at risk of a decline in their independence and mental wellbeing are offered a range of activities to build or maintain social participation","Incidence of mental health conditions among older people identified as being at risk of decline","Outcome","QS137 - Mental wellbeing and independence for older people","3 - QS137 - Mental wellbeing and independence for older people",2,"3 - QS137 - Mental wellbeing and independence for older people - Outcome - 2"]
[null,"QS137","Mental wellbeing and independence for older people",3,"Social participation ","Older people most at risk of a decline in their independence and mental wellbeing are offered a range of activities to build or maintain social participation","Incidence of admission to supported care facilities among older people identified as being at risk of decline. ","Outcome","QS137 - Mental wellbeing and independence for older people","3 - QS137 - Mental wellbeing and independence for older people",3,"3 - QS137 - Mental wellbeing and independence for older people - Outcome - 3"]
[null,"QS138","Blood transfusion",1,"Iron supplementation","People with iron-deficiency anaemia who are having surgery are offered iron supplementation before and after surgery.","Evidence of local arrangements to ensure that people with iron-deficiency anaemia who are having surgery are offered iron supplementation before surgery.","Structure",{"$f":"CONCATENATE(B3027, \" - \", C3027)","v":"QS138 - Blood transfusion"},{"$f":"CONCATENATE(D3027, \" - \", I3027)","v":"1 - QS138 - Blood transfusion"},1,{"$f":"CONCATENATE(J3027, \" - \", H3027, \" - \",K3027)","v":"1 - QS138 - Blood transfusion - Structure - 1"}]
[null,"QS138","Blood transfusion",1,"Iron supplementation","People with iron-deficiency anaemia who are having surgery are offered iron supplementation before and after surgery.","Evidence of local arrangements to ensure that people with iron-deficiency anaemia are offered iron supplementation after surgery.","Structure","QS138 - Blood transfusion","1 - QS138 - Blood transfusion",2,"1 - QS138 - Blood transfusion - Structure - 2"]
[null,"QS138","Blood transfusion",1,"Iron supplementation","People with iron-deficiency anaemia who are having surgery are offered iron supplementation before and after surgery.","Proportion of people with iron-deficiency anaemia who are having surgery and receive iron supplementation before surgery.","Process","QS138 - Blood transfusion","1 - QS138 - Blood transfusion",1,"1 - QS138 - Blood transfusion - Process - 1","The number in the denominator who receive iron supplementation before surgery.","The number of people with iron-deficiency anaemia who are having surgery."]
[null,"QS138","Blood transfusion",1,"Iron supplementation","People with iron-deficiency anaemia who are having surgery are offered iron supplementation before and after surgery.","Proportion of people with iron-deficiency anaemia who receive iron supplementation after surgery.","Process","QS138 - Blood transfusion","1 - QS138 - Blood transfusion",2,"1 - QS138 - Blood transfusion - Process - 2","The number in the denominator who receive iron supplementation.","The number of people with iron-deficiency anaemia who have had surgery."]
[null,"QS138","Blood transfusion",1,"Iron supplementation","People with iron-deficiency anaemia who are having surgery are offered iron supplementation before and after surgery.","Blood transfusion rates associated with surgery.","Outcome","QS138 - Blood transfusion","1 - QS138 - Blood transfusion",1,"1 - QS138 - Blood transfusion - Outcome - 1"]
[null,"QS138","Blood transfusion",2,"Tranexamic acid for adults","Adults who are having surgery and are expected to have moderate blood loss are offered tranexamic acid","Evidence of local arrangements to ensure that adults who are having surgery and are expected to have moderate blood loss are offered tranexamic acid.","Structure","QS138 - Blood transfusion","2 - QS138 - Blood transfusion",1,"2 - QS138 - Blood transfusion - Structure - 1"]
[null,"QS138","Blood transfusion",2,"Tranexamic acid for adults","Adults who are having surgery and are expected to have moderate blood loss are offered tranexamic acid","Proportion of adults who are having surgery and are expected to have moderate blood loss who receive tranexamic acid.","Process","QS138 - Blood transfusion","2 - QS138 - Blood transfusion",1,"2 - QS138 - Blood transfusion - Process - 1","The number of adults in the denominator who receive tranexamic acid.","The number of adults who are having surgery and are expected to have moderate blood loss."]
[null,"QS138","Blood transfusion",2,"Tranexamic acid for adults","Adults who are having surgery and are expected to have moderate blood loss are offered tranexamic acid","Blood transfusion rates associated with surgery.","Outcome","QS138 - Blood transfusion","2 - QS138 - Blood transfusion",1,"2 - QS138 - Blood transfusion - Outcome - 1"]
[null,"QS138","Blood transfusion",3,"Reassessment after red blood cell transfusions","People are clinically reassessed and have their haemoglobin levels checked after each unit of red blood cells they receive, unless they are bleeding or are on a chronic transfusion programme.","Evidence of local arrangements to ensure that people are clinically reassessed after each unit of red blood cells they receive, unless they are bleeding or are on a chronic transfusion programme.","Structure","QS138 - Blood transfusion","3 - QS138 - Blood transfusion",1,"3 - QS138 - Blood transfusion - Structure - 1"]
[null,"QS138","Blood transfusion",3,"Reassessment after red blood cell transfusions","People are clinically reassessed and have their haemoglobin levels checked after each unit of red blood cells they receive, unless they are bleeding or are on a chronic transfusion programme.","Evidence of local arrangements to ensure that people have their haemoglobin levels checked after each unit of red blood cells they receive, unless they are bleeding or are on a chronic transfusion programme.","Structure","QS138 - Blood transfusion","3 - QS138 - Blood transfusion",2,"3 - QS138 - Blood transfusion - Structure - 2"]
[null,"QS138","Blood transfusion",3,"Reassessment after red blood cell transfusions","People are clinically reassessed and have their haemoglobin levels checked after each unit of red blood cells they receive, unless they are bleeding or are on a chronic transfusion programme.","Proportion of red blood cell transfusions where a clinical reassessment of the person is carried out after each unit of blood transfused, unless they are bleeding or on a chronic transfusion programme.","Process","QS138 - Blood transfusion","3 - QS138 - Blood transfusion",1,"3 - QS138 - Blood transfusion - Process - 1","The number in the denominator where a clinical reassessment is carried out after each unit of blood transfused.","The number of red blood cell transfusions in people who are not bleeding or on a chronic transfusion programme."]
[null,"QS138","Blood transfusion",3,"Reassessment after red blood cell transfusions","People are clinically reassessed and have their haemoglobin levels checked after each unit of red blood cells they receive, unless they are bleeding or are on a chronic transfusion programme.","Proportion of red blood cell transfusions where the haemoglobin level of the person is checked after each unit of blood transfused, unless they are bleeding or on a chronic transfusion programme.","Process","QS138 - Blood transfusion","3 - QS138 - Blood transfusion",2,"3 - QS138 - Blood transfusion - Process - 2","The number in the denominator where the haemoglobin level of the person is checked after each unit of blood transfused.","The number of red blood cell transfusions in people who are not bleeding or on a chronic transfusion programme."]
[null,"QS138","Blood transfusion",3,"Reassessment after red blood cell transfusions","People are clinically reassessed and have their haemoglobin levels checked after each unit of red blood cells they receive, unless they are bleeding or are on a chronic transfusion programme.","Incidence of serious adverse events after red blood cell transfusion.","Outcome","QS138 - Blood transfusion","3 - QS138 - Blood transfusion",1,"3 - QS138 - Blood transfusion - Outcome - 1"]
[null,"QS138","Blood transfusion",4,"Patient information","People who may need or who have had a blood transfusion are given verbal and written information about blood transfusion.","Evidence of local arrangements to ensure that people who may need or who have had a blood transfusion are given verbal and written information about blood transfusion.","Structure","QS138 - Blood transfusion","4 - QS138 - Blood transfusion",1,"4 - QS138 - Blood transfusion - Structure - 1"]
[null,"QS138","Blood transfusion",4,"Patient information","People who may need or who have had a blood transfusion are given verbal and written information about blood transfusion.","Proportion of people who may need a blood transfusion who are given verbal and written information about blood transfusion.","Process","QS138 - Blood transfusion","4 - QS138 - Blood transfusion",1,"4 - QS138 - Blood transfusion - Process - 1","The number in the denominator who are given verbal and written information about blood transfusion.","The number of people who may need a blood transfusion."]
[null,"QS138","Blood transfusion",4,"Patient information","People who may need or who have had a blood transfusion are given verbal and written information about blood transfusion.","Proportion of people who have had a blood transfusion who are given verbal and written information about blood transfusion.","Process","QS138 - Blood transfusion","4 - QS138 - Blood transfusion",2,"4 - QS138 - Blood transfusion - Process - 2","The number in the denominator who are given verbal and written information about blood transfusion.","The number of people who have had a blood transfusion."]
[null,"QS138","Blood transfusion",4,"Patient information","People who may need or who have had a blood transfusion are given verbal and written information about blood transfusion.","Patient satisfaction with information they are given about blood transfusion.","Outcome","QS138 - Blood transfusion","4 - QS138 - Blood transfusion",1,"4 - QS138 - Blood transfusion - Outcome - 1"]
[null,"QS139","Oral health promotion in the community",1,null,"Local authorities carry out oral health needs assessments to identify groups at high risk of poor oral health as part of joint strategic needs assessments.","Evidence that oral health needs assessments are part of joint strategic needs assessments.","Structure",{"$f":"CONCATENATE(B3044, \" - \", C3044)","v":"QS139 - Oral health promotion in the community"},{"$f":"CONCATENATE(D3044, \" - \", I3044)","v":"1 - QS139 - Oral health promotion in the community"},{"$f":"IF(AND(B3044=B3043, D3044=D3043, H3044=H3043)=TRUE, K3043+1, 1)","v":1},{"$f":"CONCATENATE(J3044, \" - \", H3044, \" - \",K3044)","v":"1 - QS139 - Oral health promotion in the community - Structure - 1"}]
[null,"QS139","Oral health promotion in the community",1,null,"Local authorities carry out oral health needs assessments to identify groups at high risk of poor oral health as part of joint strategic needs assessments.","Identification of local groups of people at high risk of poor oral health.","Outcome","QS139 - Oral health promotion in the community","1 - QS139 - Oral health promotion in the community",1,"1 - QS139 - Oral health promotion in the community - Outcome - 1"]
[null,"QS139","Oral health promotion in the community",1,null,"Local authorities carry out oral health needs assessments to identify groups at high risk of poor oral health as part of joint strategic needs assessments.","Development of an oral health strategy.","Outcome","QS139 - Oral health promotion in the community","1 - QS139 - Oral health promotion in the community",2,"1 - QS139 - Oral health promotion in the community - Outcome - 2"]
[null,"QS139","Oral health promotion in the community",2,null,"Local authorities provide oral health improvement programmes in early years services and schools in areas where children and young people are at high risk of poor oral health.","Evidence of local arrangements to ensure that oral health improvement programmes are provided in early years services and schools in areas where children and young people are at high risk of poor oral health.","Structure","QS139 - Oral health promotion in the community","2 - QS139 - Oral health promotion in the community",1,"2 - QS139 - Oral health promotion in the community - Structure - 1"]
[null,"QS139","Oral health promotion in the community",2,null,"Local authorities provide oral health improvement programmes in early years services and schools in areas where children and young people are at high risk of poor oral health.","Proportion of early years services in areas where children are at high risk of poor oral health where oral health improvement programmes are provided.","Process","QS139 - Oral health promotion in the community","2 - QS139 - Oral health promotion in the community",1,"2 - QS139 - Oral health promotion in the community - Process - 1","The number in the denominator where oral health improvement programmes are provided.","The number of early years services in areas where children are at high risk of poor oral health."]
[null,"QS139","Oral health promotion in the community",2,null,"Local authorities provide oral health improvement programmes in early years services and schools in areas where children and young people are at high risk of poor oral health.","Proportion of schools in areas where children and young people are at high risk of poor oral health where oral health improvement programmes are provided.","Process","QS139 - Oral health promotion in the community","2 - QS139 - Oral health promotion in the community",2,"2 - QS139 - Oral health promotion in the community - Process - 2","The number in the denominator where oral health improvement programmes are provided.","The number of schools in areas where children and young people are at high risk of poor oral health."]
[null,"QS139","Oral health promotion in the community",2,null,"Local authorities provide oral health improvement programmes in early years services and schools in areas where children and young people are at high risk of poor oral health.","Plaque on teeth of children.","Outcome","QS139 - Oral health promotion in the community","2 - QS139 - Oral health promotion in the community",1,"2 - QS139 - Oral health promotion in the community - Outcome - 1"]
[null,"QS139","Oral health promotion in the community",2,null,"Local authorities provide oral health improvement programmes in early years services and schools in areas where children and young people are at high risk of poor oral health.","Tooth decay in children and young people.","Outcome","QS139 - Oral health promotion in the community","2 - QS139 - Oral health promotion in the community",2,"2 - QS139 - Oral health promotion in the community - Outcome - 2"]
[null,"QS139","Oral health promotion in the community",2,null,"Local authorities provide oral health improvement programmes in early years services and schools in areas where children and young people are at high risk of poor oral health.","Tooth extractions in secondary care for children and young people.","Outcome","QS139 - Oral health promotion in the community","2 - QS139 - Oral health promotion in the community",3,"2 - QS139 - Oral health promotion in the community - Outcome - 3"]
[null,"QS139","Oral health promotion in the community",3,null,"Health and social care services include oral health in care plans of people who are receiving health or social care support and at high risk of poor oral health.","Evidence of local arrangements to include oral health in the care plans of people receiving health or social care support and at high risk of poor oral health.","Structure",{"$f":"CONCATENATE(B3053, \" - \", C3053)","v":"QS139 - Oral health promotion in the community"},{"$f":"CONCATENATE(D3053, \" - \", I3053)","v":"3 - QS139 - Oral health promotion in the community"},1,{"$f":"CONCATENATE(J3053, \" - \", H3053, \" - \",K3053)","v":"3 - QS139 - Oral health promotion in the community - Structure - 1"}]
[null,"QS139","Oral health promotion in the community",3,null,"Health and social care services include oral health in care plans of people who are receiving health or social care support and at high risk of poor oral health.","Proportion of care plans that include oral health for people receiving health or social care support and at high risk of poor oral health.","Process","QS139 - Oral health promotion in the community","3 - QS139 - Oral health promotion in the community",1,"3 - QS139 - Oral health promotion in the community - Process - 1","The number in the denominator that include oral health.","The number of care plans for people receiving health or social care support and at high risk of poor oral health."]
[null,"QS139","Oral health promotion in the community",3,null,"Health and social care services include oral health in care plans of people who are receiving health or social care support and at high risk of poor oral health.","Tooth decay in people who are receiving health and social care support.","Outcome","QS139 - Oral health promotion in the community","3 - QS139 - Oral health promotion in the community",1,"3 - QS139 - Oral health promotion in the community - Outcome - 1"]
[null,"QS139","Oral health promotion in the community",4,null,"Dental practices providing emergency care to people who do not have a regular dentist give information about the benefits of attending for routine care and how a local dentist can be found.","Evidence of local arrangements to ensure that dental practices providing emergency care give information to people who do not have a regular dentist about the benefits of attending for routine care and how they can find a local dentist.","Structure",{"$f":"CONCATENATE(B3056, \" - \", C3056)","v":"QS139 - Oral health promotion in the community"},{"$f":"CONCATENATE(D3056, \" - \", I3056)","v":"4 - QS139 - Oral health promotion in the community"},1,{"$f":"CONCATENATE(J3056, \" - \", H3056, \" - \",K3056)","v":"4 - QS139 - Oral health promotion in the community - Structure - 1"}]
[null,"QS139","Oral health promotion in the community",4,null,"Dental practices providing emergency care to people who do not have a regular dentist give information about the benefits of attending for routine care and how a local dentist can be found.","Proportion of emergency attendances at dental practices of people who do not have a regular dentist where information about the benefits of attending for routine care and how to find a local dentist was given.","Process","QS139 - Oral health promotion in the community","4 - QS139 - Oral health promotion in the community",1,"4 - QS139 - Oral health promotion in the community - Process - 1","The number in the denominator where people were given information about the benefits of attending for routine care and how they can find a local dentist.","The number of emergency attendances at general dental practices of people who do not have a regular dentist."]
[null,"QS139","Oral health promotion in the community",4,null,"Dental practices providing emergency care to people who do not have a regular dentist give information about the benefits of attending for routine care and how a local dentist can be found.","Adults who were seen by an NHS dentist in the previous 24 months.","Outcome",{"$f":"CONCATENATE(B3058, \" - \", C3058)","v":"QS139 - Oral health promotion in the community"},{"$f":"CONCATENATE(D3058, \" - \", I3058)","v":"4 - QS139 - Oral health promotion in the community"},1,{"$f":"CONCATENATE(J3058, \" - \", H3058, \" - \",K3058)","v":"4 - QS139 - Oral health promotion in the community - Outcome - 1"}]
[null,"QS139","Oral health promotion in the community",4,null,"Dental practices providing emergency care to people who do not have a regular dentist give information about the benefits of attending for routine care and how a local dentist can be found.","Children who were seen by an NHS dentist in the previous 12 months.","Outcome","QS139 - Oral health promotion in the community","4 - QS139 - Oral health promotion in the community",2,"4 - QS139 - Oral health promotion in the community - Outcome - 2"]
[null,"QS140","Transition from childrens to adults services",1,null,"Young people who will move from children's to adults' services start planning their transition with health and social care practitioners by school year 9 (aged 13 to 14 years), or immediately if they enter children's services after school year 9. [2016]","Proportion of young people in school year 9 (aged 13 to 14 years) who will move from children's to adults' services who have started planning their transition.","Process",{"$f":"CONCATENATE(B3060, \" - \", C3060)","v":"QS140 - Transition from childrens to adults services"},{"$f":"CONCATENATE(D3060, \" - \", I3060)","v":"1 - QS140 - Transition from childrens to adults services"},1,{"$f":"CONCATENATE(J3060, \" - \", H3060, \" - \",K3060)","v":"1 - QS140 - Transition from childrens to adults services - Process - 1"},"The number in the denominator who have started planning their transition.","The number of young people in school year 9 (aged 13 to 14 years) who will move from children's to adults' services."]
[null,"QS140","Transition from childrens to adults services",1,null,"Young people who will move from children's to adults' services start planning their transition with health and social care practitioners by school year 9 (aged 13 to 14 years), or immediately if they enter children's services after school year 9. [2016]","Proportion of young people entering children's services after school year 9 and who will move to adults' services who started planning their transition immediately.","Process","QS140 - Transition from childrens to adults services","1 - QS140 - Transition from childrens to adults services",2,"1 - QS140 - Transition from childrens to adults services - Process - 2","The number in the denominator who started planning their transition immediately.","The number of young people entering children's services after school year 9 and who will move to adults' services."]
[null,"QS140","Transition from childrens to adults services",1,null,"Young people who will move from children's to adults' services start planning their transition with health and social care practitioners by school year 9 (aged 13 to 14 years), or immediately if they enter children's services after school year 9. [2016]","Proportion of young people (and their families and carers), who have transferred from children's to adults' services, who were satisfied with planning for transition and transfer (including their involvement).","Outcome","QS140 - Transition from childrens to adults services","1 - QS140 - Transition from childrens to adults services",1,"1 - QS140 - Transition from childrens to adults services - Outcome - 1","The number in the denominator who were satisfied with planning for transition and transfer (including their involvement).","The number of young people (and their families and carers) who have transferred from children's to adults' services."]
[null,"QS140","Transition from childrens to adults services",1,null,"Young people who will move from children's to adults' services start planning their transition with health and social care practitioners by school year 9 (aged 13 to 14 years), or immediately if they enter children's services after school year 9. [2016]","Rate of non-attendance at meetings or appointments in adults' services for young people who were expected to transfer from children's to adults' services.","Outcome","QS140 - Transition from childrens to adults services","1 - QS140 - Transition from childrens to adults services",2,"1 - QS140 - Transition from childrens to adults services - Outcome - 2"]
[null,"QS140","Transition from childrens to adults services",1,null,"Young people who will move from children's to adults' services start planning their transition with health and social care practitioners by school year 9 (aged 13 to 14 years), or immediately if they enter children's services after school year 9. [2016]","Proportion of young people attending adults' services after transfer from children's services who continue to engage with services.","Outcome","QS140 - Transition from childrens to adults services","1 - QS140 - Transition from childrens to adults services",3,"1 - QS140 - Transition from childrens to adults services - Outcome - 3","The number in the denominator who continue to engage with services.","The number of young people attending adults' services after transfer from children's services."]
[null,null,null,null,null,null,null,null," - "," -  - ",1," -  -  -  - 1"]
[null,"QS140","Transition from childrens to adults services",2,null,"Young people who will move from children's to adults' services have a coordinated transition plan. [new 2023]","Proportion of young people from school year 9 (aged 13 to 14 years) and above, who will move from children's to adults' services, who have a coordinated transition plan.","Process","QS140 - Transition from childrens to adults services","2 - QS140 - Transition from childrens to adults services",1,"2 - QS140 - Transition from childrens to adults services - Process - 1","The number in the denominator who have a coordinated transition plan.","The number of young people from school year 9 (aged 13 to 14 years) and above, who will move from children's to adults' services."]
[null,"QS140","Transition from childrens to adults services",2,null,"Young people who will move from children's to adults' services have a coordinated transition plan. [new 2023]","Proportion of young people (and their families and carers) who have transferred from children's to adults' services, who were satisfied with planning for transition and transfer (including their involvement).","Outcome","QS140 - Transition from childrens to adults services","2 - QS140 - Transition from childrens to adults services",1,"2 - QS140 - Transition from childrens to adults services - Outcome - 1","The number in the denominator who were satisfied with planning for transition and transfer (including their involvement).","The number of young people (and their families and carers) who have transferred from children's to adults' services."]
[null,"QS140","Transition from childrens to adults services",2,null,"Young people who will move from children's to adults' services have a coordinated transition plan. [new 2023]","Rate of non-attendance at meetings or appointments in adults' services for young people who were expected to transfer from children's to adults' services.","Outcome","QS140 - Transition from childrens to adults services","2 - QS140 - Transition from childrens to adults services",2,"2 - QS140 - Transition from childrens to adults services - Outcome - 2"]
[null,"QS140","Transition from childrens to adults services",2,null,"Young people who will move from children's to adults' services have a coordinated transition plan. [new 2023]","Proportion of young people attending adults' services after transfer from children's services who continue to engage with services.","Outcome","QS140 - Transition from childrens to adults services","2 - QS140 - Transition from childrens to adults services",3,"2 - QS140 - Transition from childrens to adults services - Outcome - 3","The number in the denominator who continue to engage with services.","The number of young people attending adults' services after transfer from children's services."]
[null,"QS140","Transition from childrens to adults services",3,null,"Young people who will move from children's to adults' services have an annual meeting to review transition planning. [2016]","Proportion of young people older than school year 9 (aged 13 to 14 years), who will move from children's to adults' services, who have had a meeting in the previous 12 months to review transition planning.","Process","QS140 - Transition from childrens to adults services","3 - QS140 - Transition from childrens to adults services",1,"3 - QS140 - Transition from childrens to adults services - Process - 1","The number in the denominator who have had a meeting in the previous 12 months to review transition planning.","The number of young people older than school year 9 (aged 13 to 14 years) who will move from children's to adults' services."]
[null,"QS140","Transition from childrens to adults services",3,null,"Young people who will move from children's to adults' services have an annual meeting to review transition planning. [2016]","Proportion of young people (and their families and carers) who have transferred from children's to adults' services, who were satisfied with planning for transition and transfer (including their involvement).","Outcome",{"$f":"CONCATENATE(B3071, \" - \", C3071)","v":"QS140 - Transition from childrens to adults services"},{"$f":"CONCATENATE(D3071, \" - \", I3071)","v":"3 - QS140 - Transition from childrens to adults services"},1,{"$f":"CONCATENATE(J3071, \" - \", H3071, \" - \",K3071)","v":"3 - QS140 - Transition from childrens to adults services - Outcome - 1"},"The number in the denominator who were satisfied with planning for transition and transfer (including their involvement).","The number of young people (and their families and carers) who have transferred from children's to adults' services."]
[null,"QS140","Transition from childrens to adults services",3,null,"Young people who will move from children's to adults' services have an annual meeting to review transition planning. [2016]","Rate of non-attendance at meetings or appointments in adults' services for young people who were expected to transfer from children's to adults' services.","Outcome","QS140 - Transition from childrens to adults services","3 - QS140 - Transition from childrens to adults services",2,"3 - QS140 - Transition from childrens to adults services - Outcome - 2"]
[null,"QS140","Transition from childrens to adults services",3,null,"Young people who will move from children's to adults' services have an annual meeting to review transition planning. [2016]","Proportion of young people attending adults' services after transfer from children's services who continue to engage with services.","Outcome","QS140 - Transition from childrens to adults services","3 - QS140 - Transition from childrens to adults services",3,"3 - QS140 - Transition from childrens to adults services - Outcome - 3","The number in the denominator who continue to engage with services.","The number of young people attending adults' services after transfer from children's services."]
[null,"QS140","Transition from childrens to adults services",4,null,"Young people who are moving from children's to adults' services have a named worker to coordinate care and support before, during and after transfer. [2016]","Proportion of young people who are moving from children's to adults' services who have a named worker to coordinate care and support before, during and after transfer.","Process","QS140 - Transition from childrens to adults services","4 - QS140 - Transition from childrens to adults services",1,"4 - QS140 - Transition from childrens to adults services - Process - 1","The number in the denominator who have a named worker to coordinate care and support before, during and after transfer.","The number of young people who are moving from children's to adults' services."]
[null,"QS140","Transition from childrens to adults services",4,null,"Young people who are moving from children's to adults' services have a named worker to coordinate care and support before, during and after transfer. [2016]","Proportion of young people (and their families and carers) who have transferred from children's to adults' services, who were satisfied with planning for transition and transfer (including their involvement).","Outcome","QS140 - Transition from childrens to adults services","4 - QS140 - Transition from childrens to adults services",1,"4 - QS140 - Transition from childrens to adults services - Outcome - 1","The number in the denominator who were satisfied with planning for transition and transfer (including their involvement).","The number of young people (and their families and carers) who have transferred from children's to adults' services."]
[null,"QS140","Transition from childrens to adults services",4,null,"Young people who are moving from children's to adults' services have a named worker to coordinate care and support before, during and after transfer. [2016]","Rate of non-attendance at meetings or appointments in adults' services for young people who were expected to transfer from children's to adults' services.","Outcome","QS140 - Transition from childrens to adults services","4 - QS140 - Transition from childrens to adults services",2,"4 - QS140 - Transition from childrens to adults services - Outcome - 2"]
[null,"QS140","Transition from childrens to adults services",4,null,"Young people who are moving from children's to adults' services have a named worker to coordinate care and support before, during and after transfer. [2016]","Proportion of young people attending adults' services after transfer from children's services who continue to engage with services.","Outcome","QS140 - Transition from childrens to adults services","4 - QS140 - Transition from childrens to adults services",3,"4 - QS140 - Transition from childrens to adults services - Outcome - 3","The number in the denominator who continue to engage with services.","The number of young people attending adults' services after transfer from children's services."]
[null,"QS140","Transition from childrens to adults services",5,null,"Young people who are moving from children's to adults' services meet a practitioner from each adults' service they will move to before they transfer. [2016, updated 2023]","Proportion of young people who moved from children's to adults' services who met a practitioner from each adults' service they moved to before they transferred.","Process","QS140 - Transition from childrens to adults services","5 - QS140 - Transition from childrens to adults services",1,"5 - QS140 - Transition from childrens to adults services - Process - 1","The number in the denominator who met a practitioner from each adults' service they moved to before they transferred.","The number of young people who moved from children's to adults' services."]
[null,"QS140","Transition from childrens to adults services",5,null,"Young people who are moving from children's to adults' services meet a practitioner from each adults' service they will move to before they transfer. [2016, updated 2023]","Proportion of young people (and their families and carers) who have transferred from children's to adults' services, who were satisfied with planning for transition and transfer (including their involvement).","Outcome","QS140 - Transition from childrens to adults services","5 - QS140 - Transition from childrens to adults services",1,"5 - QS140 - Transition from childrens to adults services - Outcome - 1","The number in the denominator who were satisfied with planning for transition and transfer (including their involvement).","The number of young people (and their families and carers) who have transferred from children's to adults' services."]
[null,"QS140","Transition from childrens to adults services",5,null,"Young people who are moving from children's to adults' services meet a practitioner from each adults' service they will move to before they transfer. [2016, updated 2023]","Rate of non-attendance at meetings or appointments in adults' services for young people who were expected to transfer from children's to adults' services.","Outcome","QS140 - Transition from childrens to adults services","5 - QS140 - Transition from childrens to adults services",2,"5 - QS140 - Transition from childrens to adults services - Outcome - 2"]
[null,"QS140","Transition from childrens to adults services",5,null,"Young people who are moving from children's to adults' services meet a practitioner from each adults' service they will move to before they transfer. [2016, updated 2023]","Proportion of young people attending adults' services after transfer from children's services who continue to engage with services.","Outcome","QS140 - Transition from childrens to adults services","5 - QS140 - Transition from childrens to adults services",3,"5 - QS140 - Transition from childrens to adults services - Outcome - 3","The number in the denominator who continue to engage with services.","The number of young people attending adults' services after transfer from children's services."]
[null,"QS140","Transition from childrens to adults services",6,null,"Young people who have moved from children's to adults' services but do not attend their initial meetings or appointments are contacted by adults' services and given further opportunities to engage. [2016, updated 2023]","Evidence of local arrangements to monitor and assure transitions from children's to adults' services.","Structure","QS140 - Transition from childrens to adults services","6 - QS140 - Transition from childrens to adults services",1,"6 - QS140 - Transition from childrens to adults services - Structure - 1"]
[null,"QS140","Transition from childrens to adults services",6,null,"Young people who have moved from children's to adults' services but do not attend their initial meetings or appointments are contacted by adults' services and given further opportunities to engage. [2016, updated 2023]","Evidence of local processes in adults' services for follow-up arrangements for young people who have moved from children's to adults' services but do not attend their initial meetings or appointments.","Structure","QS140 - Transition from childrens to adults services","6 - QS140 - Transition from childrens to adults services",2,"6 - QS140 - Transition from childrens to adults services - Structure - 2"]
[null,"QS140","Transition from childrens to adults services",6,null,"Young people who have moved from children's to adults' services but do not attend their initial meetings or appointments are contacted by adults' services and given further opportunities to engage. [2016, updated 2023]","Proportion of young people who have moved from children's to adults' services but did not attend their initial meetings or appointments who were contacted by adults' services and given further opportunities to engage.","Process","QS140 - Transition from childrens to adults services","6 - QS140 - Transition from childrens to adults services",1,"6 - QS140 - Transition from childrens to adults services - Process - 1","The number in the denominator who were contacted by adults' services and given further opportunities to engage.\n","The number of young people who have moved from children's to adults' services but did not attend their initial meetings or appointments."]
[null,"QS140","Transition from childrens to adults services",6,null,"Young people who have moved from children's to adults' services but do not attend their initial meetings or appointments are contacted by adults' services and given further opportunities to engage. [2016, updated 2023]","Proportion of young people who transferred from children's to adults' services who are discharged from each adults' service without attending a meeting or appointment.","Outcome","QS140 - Transition from childrens to adults services","6 - QS140 - Transition from childrens to adults services",1,"6 - QS140 - Transition from childrens to adults services - Outcome - 1","The number in the denominator who are discharged from each adults' service without attending a meeting or appointment.","The number of young people who transferred from children's to adults' services."]
[null,"QS140","Transition from childrens to adults services",6,null,"Young people who have moved from children's to adults' services but do not attend their initial meetings or appointments are contacted by adults' services and given further opportunities to engage. [2016, updated 2023]","Proportion of young people attending adults' services after transfer from children's services who continue to engage with services.","Outcome","QS140 - Transition from childrens to adults services","6 - QS140 - Transition from childrens to adults services",2,"6 - QS140 - Transition from childrens to adults services - Outcome - 2","The number in the denominator who continue to engage with services.","The number of young people attending adults' services after transfer from children's services."]
[null,null,null,null,null,null,null,null," - "," -  - ",{"$f":"IF(AND(B3087=B3082, D3087=D3082, H3087=H3082)=TRUE, K3082+1, 1)","v":1}," -  -  -  - 1"]
[null,"QS141","Tuberculosis",1,"Latent tuberculosis testing for people from high incidence countries","People aged 16 to 35 years who have arrived in the country within the past 5 years, from countries with a high incidence of tuberculosis (TB), are tested for latent TB infection when they register with a GP.","Evidence of local arrangements to identify people aged 16 to 35 years who have arrived in the country within the past 5 years, from countries with a high incidence of TB, when they register with a GP.","Structure",{"$f":"CONCATENATE(B3088, \" - \", C3088)","v":"QS141 - Tuberculosis"},{"$f":"CONCATENATE(D3088, \" - \", I3088)","v":"1 - QS141 - Tuberculosis"},1,{"$f":"CONCATENATE(J3088, \" - \", H3088, \" - \",K3088)","v":"1 - QS141 - Tuberculosis - Structure - 1"}]
[null,"QS141","Tuberculosis",1,"Latent tuberculosis testing for people from high incidence countries","People aged 16 to 35 years who have arrived in the country within the past 5 years, from countries with a high incidence of tuberculosis (TB), are tested for latent TB infection when they register with a GP.","Evidence of local arrangements to ensure that people aged 16 to 35 years who have arrived in the country within the past 5 years, from countries with a high incidence of TB, are tested or referred for testing for latent TB infection when they register with a GP.","Structure","QS141 - Tuberculosis","1 - QS141 - Tuberculosis",2,"1 - QS141 - Tuberculosis - Structure - 2"]
[null,"QS141","Tuberculosis",1,"Latent tuberculosis testing for people from high incidence countries","People aged 16 to 35 years who have arrived in the country within the past 5 years, from countries with a high incidence of tuberculosis (TB), are tested for latent TB infection when they register with a GP.","Proportion of people aged 16 to 35 years who have arrived in the country within the past 5 years, from countries with a high incidence of TB, who are tested for latent TB infection when they register with a GP.","Process","QS141 - Tuberculosis","1 - QS141 - Tuberculosis",1,"1 - QS141 - Tuberculosis - Process - 1","The number in the denominator who are tested for latent TB infection.","The number of people aged 16 to 35 years who have arrived in the country within the past 5 years, from countries with a high incidence of TB, registering with a GP."]
[null,"QS141","Tuberculosis",1,"Latent tuberculosis testing for people from high incidence countries","People aged 16 to 35 years who have arrived in the country within the past 5 years, from countries with a high incidence of tuberculosis (TB), are tested for latent TB infection when they register with a GP.","TB incidence.","Outcome","QS141 - Tuberculosis","1 - QS141 - Tuberculosis",1,"1 - QS141 - Tuberculosis - Outcome - 1"]
[null,"QS141","Tuberculosis",2,"Latent tuberculosis testing for adults with HIV","Adults aged under 65 years who are diagnosed with HIV, are tested for latent tuberculosis (TB) infection.","Evidence of local arrangements to ensure that adults aged under 65 years who are diagnosed with HIV, are referred for testing for latent TB infection.","Structure","QS141 - Tuberculosis","2 - QS141 - Tuberculosis",1,"2 - QS141 - Tuberculosis - Structure - 1"]
[null,"QS141","Tuberculosis",2,"Latent tuberculosis testing for adults with HIV","Adults aged under 65 years who are diagnosed with HIV, are tested for latent tuberculosis (TB) infection.","Proportion of adults aged under 65 years diagnosed with HIV, who are tested for latent TB infection.","Process","QS141 - Tuberculosis","2 - QS141 - Tuberculosis",1,"2 - QS141 - Tuberculosis - Process - 1","The number in the denominator who are tested for latent TB infection.","The number of adults aged under 65 years diagnosed with HIV."]
[null,"QS141","Tuberculosis",2,"Latent tuberculosis testing for adults with HIV","Adults aged under 65 years who are diagnosed with HIV, are tested for latent tuberculosis (TB) infection.","TB incidence.","Outcome","QS141 - Tuberculosis","2 - QS141 - Tuberculosis",1,"2 - QS141 - Tuberculosis - Outcome - 1"]
[null,"QS141","Tuberculosis",3,"Rapid diagnosis of pulmonary tuberculosis","People who are referred to a tuberculosis (TB) service, who meet specific criteria, have rapid diagnostic nucleic acid amplification tests (NAATs).","Evidence of local arrangements to ensure that people who are referred to a TB service, who meet specific criteria, have rapid diagnostic NAATs.","Structure","QS141 - Tuberculosis","3 - QS141 - Tuberculosis",1,"3 - QS141 - Tuberculosis - Structure - 1"]
[null,"QS141","Tuberculosis",3,"Rapid diagnosis of pulmonary tuberculosis","People who are referred to a tuberculosis (TB) service, who meet specific criteria, have rapid diagnostic nucleic acid amplification tests (NAATs).","Proportion of people referred to TB services, who are aged 15 years or younger, who have rapid diagnostic NAATs to detect M. tuberculosis complex in primary respiratory specimens.","Process","QS141 - Tuberculosis","3 - QS141 - Tuberculosis",1,"3 - QS141 - Tuberculosis - Process - 1","The number in the denominator who have rapid diagnostic NAATs to detect M. tuberculosis complex in primary respiratory specimens.","The number of people who are referred to TB services who are aged 15 years or younger."]
[null,"QS141","Tuberculosis",3,"Rapid diagnosis of pulmonary tuberculosis","People who are referred to a tuberculosis (TB) service, who meet specific criteria, have rapid diagnostic nucleic acid amplification tests (NAATs).","Proportion of people with HIV referred to TB services, who have rapid diagnostic NAATs to detect M. tuberculosis complex in primary respiratory specimens.","Process","QS141 - Tuberculosis","3 - QS141 - Tuberculosis",2,"3 - QS141 - Tuberculosis - Process - 2","The number in the denominator who have rapid diagnostic NAATs to detect M. tuberculosis complex in primary respiratory specimens.","The number of people with HIV who are referred to TB services."]
[null,"QS141","Tuberculosis",3,"Rapid diagnosis of pulmonary tuberculosis","People who are referred to a tuberculosis (TB) service, who meet specific criteria, have rapid diagnostic nucleic acid amplification tests (NAATs).","Proportion of people referred to TB services, who are identified as having risk factors for multidrug resistance, who have rapid diagnostic NAATs to detect rifampicin drug resistance in primary respiratory specimens.","Process","QS141 - Tuberculosis","3 - QS141 - Tuberculosis",3,"3 - QS141 - Tuberculosis - Process - 3","The number in the denominator who have rapid diagnostic NAATs to detect rifampicin drug resistance on primary respiratory specimens.","The number of people who are referred to TB services who are identified as having risk factors for multidrug resistance."]
[null,"QS141","Tuberculosis",3,"Rapid diagnosis of pulmonary tuberculosis","People who are referred to a tuberculosis (TB) service, who meet specific criteria, have rapid diagnostic nucleic acid amplification tests (NAATs).","Proportion of people with pulmonary TB starting treatment within 2 months of symptom onset.","Outcome","QS141 - Tuberculosis","3 - QS141 - Tuberculosis",1,"3 - QS141 - Tuberculosis - Outcome - 1"]
[null,"QS141","Tuberculosis",4,"Assessment","People who have imaging features suggestive of active pulmonary tuberculosis (TB) are assessed by the next working day.","Evidence of TB services having local arrangements in place to ensure that people who have imaging features suggestive of active pulmonary TB are assessed by the next working day.","Structure","QS141 - Tuberculosis","4 - QS141 - Tuberculosis",1,"4 - QS141 - Tuberculosis - Structure - 1"]
[null,"QS141","Tuberculosis",4,"Assessment","People who have imaging features suggestive of active pulmonary tuberculosis (TB) are assessed by the next working day.","Proportion of people with imaging features suggestive of active pulmonary TB who are assessed by the next working day after their results are received.","Process","QS141 - Tuberculosis","4 - QS141 - Tuberculosis",1,"4 - QS141 - Tuberculosis - Process - 1","The number in the denominator who are assessed by the next working day after their results are received.","The number of people with imaging features suggestive of active pulmonary TB."]
[null,"QS141","Tuberculosis",4,"Assessment","People who have imaging features suggestive of active pulmonary tuberculosis (TB) are assessed by the next working day.","Proportion of people with active pulmonary TB starting treatment within 2 months of symptom onset.","Outcome","QS141 - Tuberculosis","4 - QS141 - Tuberculosis",1,"4 - QS141 - Tuberculosis - Outcome - 1"]
[null,"QS141","Tuberculosis",4,"Assessment","People who have imaging features suggestive of active pulmonary tuberculosis (TB) are assessed by the next working day.","Active pulmonary TB incidence.","Outcome","QS141 - Tuberculosis","4 - QS141 - Tuberculosis",2,"4 - QS141 - Tuberculosis - Outcome - 2"]
[null,"QS141","Tuberculosis",5,"Directly observed therapy","People with active tuberculosis (TB) from under-served groups are offered directly observed therapy.","Evidence of local arrangements to ensure that people with active TB from under-served groups are offered directly observed therapy.","Structure","QS141 - Tuberculosis","5 - QS141 - Tuberculosis",1,"5 - QS141 - Tuberculosis - Structure - 1"]
[null,"QS141","Tuberculosis",5,"Directly observed therapy","People with active tuberculosis (TB) from under-served groups are offered directly observed therapy.","Proportion of people with active TB who are homeless who have directly observed therapy.","Process","QS141 - Tuberculosis","5 - QS141 - Tuberculosis",1,"5 - QS141 - Tuberculosis - Process - 1","The number in the denominator who have directly observed therapy.","The number of people with active TB who are homeless."]
[null,"QS141","Tuberculosis",5,"Directly observed therapy","People with active tuberculosis (TB) from under-served groups are offered directly observed therapy.","Proportion of people with active TB who misuse substances who have directly observed therapy.","Process","QS141 - Tuberculosis","5 - QS141 - Tuberculosis",2,"5 - QS141 - Tuberculosis - Process - 2","The number in the denominator who have directly observed therapy.","The number of people with active TB who misuse substances."]
[null,"QS141","Tuberculosis",5,"Directly observed therapy","People with active tuberculosis (TB) from under-served groups are offered directly observed therapy.","Proportion of people with active TB who have been in prison who have directly observed therapy.","Process","QS141 - Tuberculosis","5 - QS141 - Tuberculosis",3,"5 - QS141 - Tuberculosis - Process - 3","The number in the denominator who have directly observed therapy.","The number of people with active TB who have been in prison."]
[null,"QS141","Tuberculosis",5,"Directly observed therapy","People with active tuberculosis (TB) from under-served groups are offered directly observed therapy.","Proportion of people with active TB who are vulnerable migrants who have directly observed therapy.","Process","QS141 - Tuberculosis","5 - QS141 - Tuberculosis",4,"5 - QS141 - Tuberculosis - Process - 4","The number in the denominator who have directly observed therapy.","The number of people with active TB who are vulnerable migrants."]
[null,"QS141","Tuberculosis",5,"Directly observed therapy","People with active tuberculosis (TB) from under-served groups are offered directly observed therapy.","Proportion of people from underserved groups with active TB lost to follow-up.","Outcome","QS141 - Tuberculosis","5 - QS141 - Tuberculosis",1,"5 - QS141 - Tuberculosis - Outcome - 1"]
[null,"QS141","Tuberculosis",5,"Directly observed therapy","People with active tuberculosis (TB) from under-served groups are offered directly observed therapy.","TB treatment completion rates for people from under-served groups.","Outcome","QS141 - Tuberculosis","5 - QS141 - Tuberculosis",2,"5 - QS141 - Tuberculosis - Outcome - 2"]
[null,"QS141","Tuberculosis",5,"Directly observed therapy","People with active tuberculosis (TB) from under-served groups are offered directly observed therapy.","TB treatment completion rates for people from underserved groups with multidrug-resistant TB.","Outcome","QS141 - Tuberculosis","5 - QS141 - Tuberculosis",3,"5 - QS141 - Tuberculosis - Outcome - 3"]
[null,"QS141","Tuberculosis",6,"Accommodation","People with active pulmonary tuberculosis (TB) who are homeless are offered accommodation for the duration of their treatment.","Evidence of local arrangements to ensure that people diagnosed with active pulmonary TB who are homeless are identified.","Structure","QS141 - Tuberculosis","6 - QS141 - Tuberculosis",{"$f":"IF(AND(B3112=B3111, D3112=D3111, H3112=H3111)=TRUE, K3111+1, 1)","v":1},"6 - QS141 - Tuberculosis - Structure - 1"]
[null,"QS141","Tuberculosis",6,"Accommodation","People with active pulmonary tuberculosis (TB) who are homeless are offered accommodation for the duration of their treatment.","Evidence of local arrangements to ensure that people diagnosed with active pulmonary TB who are homeless are offered accommodation for the duration of their treatment.","Structure","QS141 - Tuberculosis","6 - QS141 - Tuberculosis",2,"6 - QS141 - Tuberculosis - Structure - 2"]
[null,"QS141","Tuberculosis",6,"Accommodation","People with active pulmonary tuberculosis (TB) who are homeless are offered accommodation for the duration of their treatment.","Proportion of people with active pulmonary TB who are homeless who are provided with accommodation for the duration of their treatment.","Process","QS141 - Tuberculosis","6 - QS141 - Tuberculosis",1,"6 - QS141 - Tuberculosis - Process - 1","The number in the denominator who are provided with accommodation for the duration of their treatment.","The number of people with active pulmonary TB who are homeless."]
[null,"QS141","Tuberculosis",6,"Accommodation","People with active pulmonary tuberculosis (TB) who are homeless are offered accommodation for the duration of their treatment.","TB treatment completion rates for people with active pulmonary TB who are homeless at the time of diagnosis.","Outcome","QS141 - Tuberculosis","6 - QS141 - Tuberculosis",1,"6 - QS141 - Tuberculosis - Outcome - 1"]
[null,"QS141","Tuberculosis",6,"Accommodation","People with active pulmonary tuberculosis (TB) who are homeless are offered accommodation for the duration of their treatment.","TB prevalence rates.","Outcome","QS141 - Tuberculosis","6 - QS141 - Tuberculosis",2,"6 - QS141 - Tuberculosis - Outcome - 2"]
[null,"QS141","Tuberculosis",6,"Accommodation","People with active pulmonary tuberculosis (TB) who are homeless are offered accommodation for the duration of their treatment.","TB incidence in homeless people.","Outcome","QS141 - Tuberculosis","6 - QS141 - Tuberculosis",3,"6 - QS141 - Tuberculosis - Outcome - 3"]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",1,"Annual health check","Young people and adults with learning disabilities have an annual health check that includes a review of mental health problems.","Evidence of local arrangements to ensure that young people and adults with learning disabilities have an annual health check that includes a review of mental health problems.","Structure","QS142 - Learning disabilities: identifying and managing mental health problems","1 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"1 - QS142 - Learning disabilities: identifying and managing mental health problems - Structure - 1"]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",1,"Annual health check","Young people and adults with learning disabilities have an annual health check that includes a review of mental health problems.","Proportion of young people with learning disabilities who have an annual health check that includes a review of mental health problems.","Process","QS142 - Learning disabilities: identifying and managing mental health problems","1 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"1 - QS142 - Learning disabilities: identifying and managing mental health problems - Process - 1","The number in the denominator who have had an annual health check that includes a review of mental health problems.","The number of young people with learning disabilities."]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",1,"Annual health check","Young people and adults with learning disabilities have an annual health check that includes a review of mental health problems.","Proportion of adults with learning disabilities who have an annual health check that includes a review of mental health problems.","Process","QS142 - Learning disabilities: identifying and managing mental health problems","1 - QS142 - Learning disabilities: identifying and managing mental health problems",2,"1 - QS142 - Learning disabilities: identifying and managing mental health problems - Process - 2","The number in the denominator who have had an annual health check that includes a review of mental health problems.","The number of adults with learning disabilities."]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",1,"Annual health check","Young people and adults with learning disabilities have an annual health check that includes a review of mental health problems.","Identification of mental health needs in young people and adults with learning disabilities.","Outcome","QS142 - Learning disabilities: identifying and managing mental health problems","1 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"1 - QS142 - Learning disabilities: identifying and managing mental health problems - Outcome - 1"]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",1,"Annual health check","Young people and adults with learning disabilities have an annual health check that includes a review of mental health problems.","Identification of physical health needs in young people and adults with learning disabilities.","Outcome","QS142 - Learning disabilities: identifying and managing mental health problems","1 - QS142 - Learning disabilities: identifying and managing mental health problems",2,"1 - QS142 - Learning disabilities: identifying and managing mental health problems - Outcome - 2"]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",2,"Assessment by a professional with relevant expertise","People with learning disabilities who need a mental health assessment are referred to a professional with expertise in mental health problems in people with learning disabilities.","Evidence of local arrangements to ensure that people with learning disabilities who need a mental health assessment are referred to a professional with expertise in mental health problems in people with learning disabilities.","Structure","QS142 - Learning disabilities: identifying and managing mental health problems","2 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"2 - QS142 - Learning disabilities: identifying and managing mental health problems - Structure - 1"]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",2,"Assessment by a professional with relevant expertise","People with learning disabilities who need a mental health assessment are referred to a professional with expertise in mental health problems in people with learning disabilities.","Proportion of people with learning disabilities who need a mental health assessment and are referred to a professional with expertise in mental health problems in people with learning disabilities.","Process","QS142 - Learning disabilities: identifying and managing mental health problems","2 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"2 - QS142 - Learning disabilities: identifying and managing mental health problems - Process - 1","The number in the denominator who are referred to a professional with expertise in mental health problems in people with learning disabilities.","The number of people with learning disabilities who need a mental health assessment."]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",2,"Assessment by a professional with relevant expertise","People with learning disabilities who need a mental health assessment are referred to a professional with expertise in mental health problems in people with learning disabilities.","Proportion of people with learning disabilities who are referred for a mental health assessment and are assessed by a professional with expertise in mental health problems in people with learning disabilities.","Process","QS142 - Learning disabilities: identifying and managing mental health problems","2 - QS142 - Learning disabilities: identifying and managing mental health problems",2,"2 - QS142 - Learning disabilities: identifying and managing mental health problems - Process - 2","The number in the denominator who are assessed by a professional with expertise in mental health problems in people with learning disabilities.","The number of people with learning disabilities who are referred for a mental health assessment."]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",2,"Assessment by a professional with relevant expertise","People with learning disabilities who need a mental health assessment are referred to a professional with expertise in mental health problems in people with learning disabilities.","Identification of mental health problems in people with learning disabilities.","Outcome","QS142 - Learning disabilities: identifying and managing mental health problems","2 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"2 - QS142 - Learning disabilities: identifying and managing mental health problems - Outcome - 1"]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",3,"Key worker","People with learning disabilities and a serious mental illness have a key worker to coordinate their care.","Evidence of local arrangements and written protocols to ensure that people with learning disabilities and a serious mental illness have a key worker to coordinate their care.","Structure","QS142 - Learning disabilities: identifying and managing mental health problems","3 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"3 - QS142 - Learning disabilities: identifying and managing mental health problems - Structure - 1"]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",3,"Key worker","People with learning disabilities and a serious mental illness have a key worker to coordinate their care.","Proportion of people with learning disabilities and a serious mental illness who have a key worker to coordinate their care.","Process","QS142 - Learning disabilities: identifying and managing mental health problems","3 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"3 - QS142 - Learning disabilities: identifying and managing mental health problems - Process - 1","The number in the denominator who have a key worker to coordinate their care.","The number of people with learning disabilities and a serious mental illness."]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",3,"Key worker","People with learning disabilities and a serious mental illness have a key worker to coordinate their care.","Patient and carer satisfaction with their key worker’s coordination of care.","Outcome","QS142 - Learning disabilities: identifying and managing mental health problems","3 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"3 - QS142 - Learning disabilities: identifying and managing mental health problems - Outcome - 1"]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",4,"Tailoring psychological interventions","People with learning disabilities and mental health problems who are receiving psychological interventions have them tailored to their preferences, level of understanding, and strengths and needs.","Evidence of local arrangements to ensure that people with learning disabilities and mental health problems who are receiving psychological interventions have them tailored to their preferences, level of understanding, and strengths and needs.","Structure","QS142 - Learning disabilities: identifying and managing mental health problems","4 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"4 - QS142 - Learning disabilities: identifying and managing mental health problems - Structure - 1"]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",4,"Tailoring psychological interventions","People with learning disabilities and mental health problems who are receiving psychological interventions have them tailored to their preferences, level of understanding, and strengths and needs.","Proportion of people with learning disabilities and mental health problems who are receiving psychological interventions that are tailored to their preferences, level of understanding, and strengths and needs.","Process","QS142 - Learning disabilities: identifying and managing mental health problems","4 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"4 - QS142 - Learning disabilities: identifying and managing mental health problems - Process - 1","The number in the denominator who receive psychological interventions that are tailored to their preferences, level of understanding, and strengths and needs.","The number of people with learning disabilities and mental health problems who are receiving psychological interventions."]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",4,"Tailoring psychological interventions","People with learning disabilities and mental health problems who are receiving psychological interventions have them tailored to their preferences, level of understanding, and strengths and needs.","Quality of life of people with learning disabilities and mental health problems and their family members and carers.","Outcome","QS142 - Learning disabilities: identifying and managing mental health problems","4 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"4 - QS142 - Learning disabilities: identifying and managing mental health problems - Outcome - 1"]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",5,"Annually documenting the reasons for continuing antipsychotic drugs","People with learning disabilities who are taking antipsychotic drugs that are not reduced or stopped have annual documentation on reasons for continuing this prescription.","Evidence of local arrangements to ensure that people with learning disabilities who are taking antipsychotic drugs that are not reduced or stopped have annual documentation on reasons for continuing this prescription.","Structure","QS142 - Learning disabilities: identifying and managing mental health problems","5 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"5 - QS142 - Learning disabilities: identifying and managing mental health problems - Structure - 1"]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",5,"Annually documenting the reasons for continuing antipsychotic drugs","People with learning disabilities who are taking antipsychotic drugs that are not reduced or stopped have annual documentation on reasons for continuing this prescription.","Proportion of people with learning disabilities who are taking antipsychotic drugs that are not reduced or stopped and who have annual documentation on reasons for continuing this prescription.","Process","QS142 - Learning disabilities: identifying and managing mental health problems","5 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"5 - QS142 - Learning disabilities: identifying and managing mental health problems - Process - 1","The number in the denominator who have annual documentation on reasons for continuing this prescription.","The number of people with learning disabilities who are taking antipsychotic drugs that are not reduced or stopped."]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",5,"Annually documenting the reasons for continuing antipsychotic drugs","People with learning disabilities who are taking antipsychotic drugs that are not reduced or stopped have annual documentation on reasons for continuing this prescription.","Antipsychotic medication prescribing rates for people with learning disabilities.","Outcome","QS142 - Learning disabilities: identifying and managing mental health problems","5 - QS142 - Learning disabilities: identifying and managing mental health problems",1,"5 - QS142 - Learning disabilities: identifying and managing mental health problems - Outcome - 1"]
[null,"QS142","Learning disabilities: identifying and managing mental health problems",5,"Annually documenting the reasons for continuing antipsychotic drugs","People with learning disabilities who are taking antipsychotic drugs that are not reduced or stopped have annual documentation on reasons for continuing this prescription.","Quality of life of people with learning disabilities and their family members and carers.","Outcome","QS142 - Learning disabilities: identifying and managing mental health problems","5 - QS142 - Learning disabilities: identifying and managing mental health problems",2,"5 - QS142 - Learning disabilities: identifying and managing mental health problems - Outcome - 2"]
[null,"QS143","Menopause",1,"Diagnosing and managing menopause in women","Women over 45 years presenting with menopausal symptoms are diagnosed with perimenopause or menopause based on their symptoms alone, without confirmatory laboratory tests.","Evidence of local arrangements to ensure that women over 45 years presenting with menopausal symptoms are diagnosed with perimenopause or menopause based on their symptoms alone, without confirmatory laboratory tests.","Structure","QS143 - Menopause","1 - QS143 - Menopause",1,"1 - QS143 - Menopause - Structure - 1"]
[null,"QS143","Menopause",1,"Diagnosing and managing menopause in women","Women over 45 years presenting with menopausal symptoms are diagnosed with perimenopause or menopause based on their symptoms alone, without confirmatory laboratory tests.","Proportion of women over 45 years diagnosed with perimenopause and menopause whose diagnosis is based on their symptoms alone, without confirmatory laboratory tests.","Process","QS143 - Menopause","1 - QS143 - Menopause",1,"1 - QS143 - Menopause - Process - 1","the number in the denominator whose diagnosis is based on their symptoms alone, without confirmatory laboratory tests.","the number of women over 45 years diagnosed with perimenopause or menopause."]
[null,"QS143","Menopause",1,"Diagnosing and managing menopause in women","Women over 45 years presenting with menopausal symptoms are diagnosed with perimenopause or menopause based on their symptoms alone, without confirmatory laboratory tests.","Proportion of women over 45 years with menopause who felt reassured by their healthcare professional about their diagnosis.","Outcome","QS143 - Menopause","1 - QS143 - Menopause",1,"1 - QS143 - Menopause - Outcome - 1"]
[null,"QS143","Menopause",1,"Diagnosing and managing menopause in women","Women over 45 years presenting with menopausal symptoms are diagnosed with perimenopause or menopause based on their symptoms alone, without confirmatory laboratory tests.","Number of laboratory tests to confirm a diagnosis of menopause in women over 45 years.","Outcome","QS143 - Menopause","1 - QS143 - Menopause",2,"1 - QS143 - Menopause - Outcome - 2"]
[null,"QS143","Menopause",2,"Diagnosing and managing menopause in women","Women under 40 years presenting with menopausal symptoms have their levels of follicle-stimulating hormone (FSH) measured.","Evidence of local arrangements to ensure that women under 40 years presenting with menopausal symptoms have their FSH levels measured.","Structure","QS143 - Menopause","2 - QS143 - Menopause",1,"2 - QS143 - Menopause - Structure - 1"]
[null,"QS143","Menopause",2,"Diagnosing and managing menopause in women","Women under 40 years presenting with menopausal symptoms have their levels of follicle-stimulating hormone (FSH) measured.","Proportion of women under 40 years presenting with menopausal symptoms who have their FSH levels measured.","Process","QS143 - Menopause","2 - QS143 - Menopause",1,"2 - QS143 - Menopause - Process - 1"," the number in the denominator who have their FSH levels measured.","the number of women under 40 years presenting with menopausal symptoms."]
[null,"QS143","Menopause",2,"Diagnosing and managing menopause in women","Women under 40 years presenting with menopausal symptoms have their levels of follicle-stimulating hormone (FSH) measured.","Proportion of women with premature ovarian insufficiency who had a positive experience of the diagnostic process.","Outcome","QS143 - Menopause","2 - QS143 - Menopause",1,"2 - QS143 - Menopause - Outcome - 1"]
[null,"QS143","Menopause",2,"Diagnosing and managing menopause in women","Women under 40 years presenting with menopausal symptoms have their levels of follicle-stimulating hormone (FSH) measured.","Average time to diagnosis of premature ovarian insufficiency from first presenting with menopausal symptoms for women under 40 years.","Outcome","QS143 - Menopause","2 - QS143 - Menopause",2,"2 - QS143 - Menopause - Outcome - 2"]
[null,"QS143","Menopause",2,"Diagnosing and managing menopause in women","Women under 40 years presenting with menopausal symptoms have their levels of follicle-stimulating hormone (FSH) measured.","Incidence of premature ovarian insufficiency.","Outcome","QS143 - Menopause","2 - QS143 - Menopause",3,"2 - QS143 - Menopause - Outcome - 3"]
[null,"QS143","Menopause",3,"Diagnosing and managing menopause in women","Women with premature ovarian insufficiency are offered hormone replacement therapy (HRT) or a combined hormonal contraceptive.","Evidence of local arrangements to ensure that women with premature ovarian insufficiency are offered HRT or a combined hormonal contraceptive.","Structure","QS143 - Menopause","3 - QS143 - Menopause",1,"3 - QS143 - Menopause - Structure - 1"]
[null,"QS143","Menopause",3,"Diagnosing and managing menopause in women","Women with premature ovarian insufficiency are offered hormone replacement therapy (HRT) or a combined hormonal contraceptive.","Proportion of women with premature ovarian insufficiency who receive HRT or a combined hormonal contraceptive.","Process","QS143 - Menopause","3 - QS143 - Menopause",1,"3 - QS143 - Menopause - Process - 1","the number in the denominator receiving HRT or a combined hormonal contraceptive.","the number of women with premature ovarian insufficiency."]
[null,"QS143","Menopause",3,"Diagnosing and managing menopause in women","Women with premature ovarian insufficiency are offered hormone replacement therapy (HRT) or a combined hormonal contraceptive.","Health-related quality of life for women with premature ovarian insufficiency.","Outcome","QS143 - Menopause","3 - QS143 - Menopause",1,"3 - QS143 - Menopause - Outcome - 1"]
[null,"QS143","Menopause",3,"Diagnosing and managing menopause in women","Women with premature ovarian insufficiency are offered hormone replacement therapy (HRT) or a combined hormonal contraceptive.","Long-term health effects (for example, osteoporosis or cardiovascular disease) in women with premature ovarian insufficiency.","Outcome","QS143 - Menopause","3 - QS143 - Menopause",2,"3 - QS143 - Menopause - Outcome - 2"]
[null,"QS143","Menopause",4,"Diagnosing and managing menopause in women","Women having treatment for menopausal symptoms have a review 3 months after starting each treatment and then at least annually.","Evidence of local arrangements to ensure that women having treatment for menopausal symptoms have a review 3 months after starting each treatment and then at least annually.","Structure","QS143 - Menopause","4 - QS143 - Menopause",1,"4 - QS143 - Menopause - Structure - 1"]
[null,"QS143","Menopause",4,"Diagnosing and managing menopause in women","Women having treatment for menopausal symptoms have a review 3 months after starting each treatment and then at least annually.","Proportion of women having treatment for menopausal symptoms who have a review 3 months after starting treatment.","Process","QS143 - Menopause","4 - QS143 - Menopause",1,"4 - QS143 - Menopause - Process - 1","the number in the denominator who have a review 3 months after starting treatment.","the number of women having treatment for menopausal symptoms."]
[null,"QS143","Menopause",4,"Diagnosing and managing menopause in women","Women having treatment for menopausal symptoms have a review 3 months after starting each treatment and then at least annually.","Proportion of women receiving treatment for menopausal symptoms who have an annual review within 12 months of the 3-month review or last annual review.","Process",{"$f":"CONCATENATE(B3152, \" - \", C3152)","v":"QS143 - Menopause"},{"$f":"CONCATENATE(D3152, \" - \", I3152)","v":"4 - QS143 - Menopause"},2,{"$f":"CONCATENATE(J3152, \" - \", H3152, \" - \",K3152)","v":"4 - QS143 - Menopause - Process - 2"},"the number in the denominator who have an annual review within 12 months of the 3-month review or last annual review.","the number of women receiving treatment for menopausal symptoms."]
[null,"QS143","Menopause",5,"Diagnosing and managing menopause in women","Women who are likely to go through menopause as a result of medical or surgical treatment are given information about menopause and fertility before they have their treatment.","Evidence of local arrangements to ensure that women who are likely to go through menopause as a result of medical or surgical treatment are given information about menopause and fertility before they have their treatment.","Structure","QS143 - Menopause","5 - QS143 - Menopause",1,"5 - QS143 - Menopause - Structure - 1"]
[null,"QS143","Menopause",5,"Diagnosing and managing menopause in women","Women who are likely to go through menopause as a result of medical or surgical treatment are given information about menopause and fertility before they have their treatment.","Proportion of women having medical or surgical treatment that is likely to cause the menopause who are given information about menopause and fertility before they have their treatment.","Process","QS143 - Menopause","5 - QS143 - Menopause",1,"5 - QS143 - Menopause - Process - 1","the number in the denominator who are given information about menopause and fertility before they have their treatment.","the number of women who have medical or surgical treatment that is likely to cause the menopause."]
[null,"QS143","Menopause",5,"Diagnosing and managing menopause in women","Women who are likely to go through menopause as a result of medical or surgical treatment are given information about menopause and fertility before they have their treatment.","Women having medical or surgical treatment that is likely to cause the menopause are aware of the symptoms of menopause.","Outcome","QS143 - Menopause","5 - QS143 - Menopause",1,"5 - QS143 - Menopause - Outcome - 1"]
[null,"QS144","Care of dying adults in the last days of life",1,null,"Adults who have signs and symptoms that suggest they may be in the last days of life are monitored for further changes to help determine if they are nearing death, stabilising or recovering.","Evidence of local arrangements and systems to ensure that it is recognised when an adult may be entering the last days of life.","Structure",{"$f":"CONCATENATE(B3156, \" - \", C3156)","v":"QS144 - Care of dying adults in the last days of life"},{"$f":"CONCATENATE(D3156, \" - \", I3156)","v":"1 - QS144 - Care of dying adults in the last days of life"},1,{"$f":"CONCATENATE(J3156, \" - \", H3156, \" - \",K3156)","v":"1 - QS144 - Care of dying adults in the last days of life - Structure - 1"}]
[null,"QS144","Care of dying adults in the last days of life",1,null,"Adults who have signs and symptoms that suggest they may be in the last days of life are monitored for further changes to help determine if they are nearing death, stabilising or recovering.","Evidence of local arrangements and systems to monitor signs and symptoms of adults thought to be in the last days of life, and to review changes in a person's condition to help determine if they are nearing death, stabilising or recovering.","Structure","QS144 - Care of dying adults in the last days of life","1 - QS144 - Care of dying adults in the last days of life",2,"1 - QS144 - Care of dying adults in the last days of life - Structure - 2"]
[null,"QS144","Care of dying adults in the last days of life",1,null,"Adults who have signs and symptoms that suggest they may be in the last days of life are monitored for further changes to help determine if they are nearing death, stabilising or recovering.","Proportion of adult deaths with documented evidence that it was recognised that the person was in the last days of life.","Process","QS144 - Care of dying adults in the last days of life","1 - QS144 - Care of dying adults in the last days of life",1,"1 - QS144 - Care of dying adults in the last days of life - Process - 1","The number in the denominator in which the care records show it was recognised that the adult was in the last days of life.","The number of adult deaths."]
[null,"QS144","Care of dying adults in the last days of life",1,null,"Adults who have signs and symptoms that suggest they may be in the last days of life are monitored for further changes to help determine if they are nearing death, stabilising or recovering.","Proportion of adults recognised as being in the last days of life with documented evidence that their signs and symptoms were monitored at least daily.","Process","QS144 - Care of dying adults in the last days of life","1 - QS144 - Care of dying adults in the last days of life",2,"1 - QS144 - Care of dying adults in the last days of life - Process - 2","The number in the denominator in which the care records show evidence of monitoring of signs and symptoms at least daily.","The number of adults recognised as being in the last days of life."]
[null,"QS144","Care of dying adults in the last days of life",1,null,"Adults who have signs and symptoms that suggest they may be in the last days of life are monitored for further changes to help determine if they are nearing death, stabilising or recovering.","Proportion of adults thought to be in the last days of life given care appropriate to whether they were nearing death, stabilising or recovering.","Outcome","QS144 - Care of dying adults in the last days of life","1 - QS144 - Care of dying adults in the last days of life",1,"1 - QS144 - Care of dying adults in the last days of life - Outcome - 1"]
[null,"QS144","Care of dying adults in the last days of life",2,null,"Adults in the last days of life, and the people important to them, are given opportunities to discuss, develop and review an individualised care plan.","Evidence of local arrangements to ensure that adults in the last days of life, and the people important to them, are given opportunities to discuss and develop individualised care plans.","Structure","QS144 - Care of dying adults in the last days of life","2 - QS144 - Care of dying adults in the last days of life",1,"2 - QS144 - Care of dying adults in the last days of life - Structure - 1"]
[null,"QS144","Care of dying adults in the last days of life",2,null,"Adults in the last days of life, and the people important to them, are given opportunities to discuss, develop and review an individualised care plan.","Evidence of local arrangements to ensure that adults in the last days of life have their individualised care plans reviewed.","Structure","QS144 - Care of dying adults in the last days of life","2 - QS144 - Care of dying adults in the last days of life",2,"2 - QS144 - Care of dying adults in the last days of life - Structure - 2"]
[null,"QS144","Care of dying adults in the last days of life",2,null,"Adults in the last days of life, and the people important to them, are given opportunities to discuss, develop and review an individualised care plan.","Proportion of adults recognised as being in the last days of life, and the people important to them, who are given opportunities to discuss and develop an individualised care plan.","Process","QS144 - Care of dying adults in the last days of life","2 - QS144 - Care of dying adults in the last days of life",1,"2 - QS144 - Care of dying adults in the last days of life - Process - 1","The number in the denominator with care records that show the person who was in the last days of life, and the people important to them, were given opportunities to discuss and develop an individualised care plan.","The number of adults recognised as being in the last days of life."]
[null,"QS144","Care of dying adults in the last days of life",2,null,"Adults in the last days of life, and the people important to them, are given opportunities to discuss, develop and review an individualised care plan.","Proportion of adults recognised as being in the last days of life who have an individualised care plan.","Process","QS144 - Care of dying adults in the last days of life","2 - QS144 - Care of dying adults in the last days of life",2,"2 - QS144 - Care of dying adults in the last days of life - Process - 2","The number in the denominator with an individualised care plan.","Number of adults recognised as being in the last days of life."]
[null,"QS144","Care of dying adults in the last days of life",2,null,"Adults in the last days of life, and the people important to them, are given opportunities to discuss, develop and review an individualised care plan.","Proportion of adults recognised as being in the last days of life whose individualised care plan was followed.","Process","QS144 - Care of dying adults in the last days of life","2 - QS144 - Care of dying adults in the last days of life",3,"2 - QS144 - Care of dying adults in the last days of life - Process - 3","The number in the denominator whose individualised care plan was followed.","The number of adults recognised as being in the last days of life."]
[null,"QS144","Care of dying adults in the last days of life",2,null,"Adults in the last days of life, and the people important to them, are given opportunities to discuss, develop and review an individualised care plan.","Proportion of adults who feel they have choice and control over their care in the last days of life.","Outcome","QS144 - Care of dying adults in the last days of life","2 - QS144 - Care of dying adults in the last days of life",1,"2 - QS144 - Care of dying adults in the last days of life - Outcome - 1"]
[null,"QS144","Care of dying adults in the last days of life",3,null,"Adults in the last days of life who are likely to need symptom control are prescribed anticipatory medicines with individualised indications for use, dosage and route of administration.","Evidence of local arrangements to ensure that adults in the last days of life are assessed for likely symptoms and are prescribed anticipatory medicines.","Structure",{"$f":"CONCATENATE(B3167, \" - \", C3167)","v":"QS144 - Care of dying adults in the last days of life"},{"$f":"CONCATENATE(D3167, \" - \", I3167)","v":"3 - QS144 - Care of dying adults in the last days of life"},{"$f":"IF(AND(B3167=B3165, D3167=D3165, H3167=H3165)=TRUE, K3165+1, 1)","v":1},{"$f":"CONCATENATE(J3167, \" - \", H3167, \" - \",K3167)","v":"3 - QS144 - Care of dying adults in the last days of life - Structure - 1"}]
[null,"QS144","Care of dying adults in the last days of life",3,null,"Adults in the last days of life who are likely to need symptom control are prescribed anticipatory medicines with individualised indications for use, dosage and route of administration.","Proportion of adults recognised as being in the last days of life who have their prescribing needs assessed for symptoms likely to occur in their last days of life.","Process","QS144 - Care of dying adults in the last days of life","3 - QS144 - Care of dying adults in the last days of life",1,"3 - QS144 - Care of dying adults in the last days of life - Process - 1","The number in the denominator whose prescribing needs have been assessed for symptoms likely to occur in the last days of life.","Number of adults recognised as being in the last days of life."]
[null,"QS144","Care of dying adults in the last days of life",3,null,"Adults in the last days of life who are likely to need symptom control are prescribed anticipatory medicines with individualised indications for use, dosage and route of administration.","Proportion of adults recognised as being in the last days of life prescribed anticipatory medicines with individualised indications for use, dosage and route of administration.","Process","QS144 - Care of dying adults in the last days of life","3 - QS144 - Care of dying adults in the last days of life",2,"3 - QS144 - Care of dying adults in the last days of life - Process - 2","The number in the denominator with care records that show anticipatory medicines have been prescribed with individualised indications for use, dosage and route of administration.","Number of adults recognised as being in the last days of life."]
[null,"QS144","Care of dying adults in the last days of life",3,null,"Adults in the last days of life who are likely to need symptom control are prescribed anticipatory medicines with individualised indications for use, dosage and route of administration.","Proportion of adults who had their key symptoms controlled in the last days of life.","Outcome","QS144 - Care of dying adults in the last days of life","3 - QS144 - Care of dying adults in the last days of life",1,"3 - QS144 - Care of dying adults in the last days of life - Outcome - 1"]
[null,"QS144","Care of dying adults in the last days of life",4,null,"Adults in the last days of life have their hydration status assessed daily, and have a discussion about the risks and benefits of hydration options.","Evidence of local arrangements to ensure that adults in the last days of life have their hydration status assessed daily.","Structure","QS144 - Care of dying adults in the last days of life","4 - QS144 - Care of dying adults in the last days of life",1,"4 - QS144 - Care of dying adults in the last days of life - Structure - 1"]
[null,"QS144","Care of dying adults in the last days of life",4,null,"Adults in the last days of life have their hydration status assessed daily, and have a discussion about the risks and benefits of hydration options.","Evidence of local arrangements to ensure that adults in the last days of life, and the people important to them, have discussions about the risks and benefits of hydration options.","Structure","QS144 - Care of dying adults in the last days of life","4 - QS144 - Care of dying adults in the last days of life",2,"4 - QS144 - Care of dying adults in the last days of life - Structure - 2"]
[null,"QS144","Care of dying adults in the last days of life",4,null,"Adults in the last days of life have their hydration status assessed daily, and have a discussion about the risks and benefits of hydration options.","Proportion of adults recognised as being in the last days of life who have their hydration status assessed daily.","Process","QS144 - Care of dying adults in the last days of life","4 - QS144 - Care of dying adults in the last days of life",1,"4 - QS144 - Care of dying adults in the last days of life - Process - 1","The number in the denominator who have their hydration status assessed daily.","The number of adults recognised as being in the last days of life."]
[null,"QS144","Care of dying adults in the last days of life",4,null,"Adults in the last days of life have their hydration status assessed daily, and have a discussion about the risks and benefits of hydration options.","Proportion of adults recognised as being in the last days of life who have a discussion about the risks and benefits of hydration options.","Process","QS144 - Care of dying adults in the last days of life","4 - QS144 - Care of dying adults in the last days of life",2,"4 - QS144 - Care of dying adults in the last days of life - Process - 2","The number in the denominator whose individual care plan shows that there has been a discussion about the risks and benefits of hydration options.","The number of adults recognised as being in the last days of life."]
[null,"QS144","Care of dying adults in the last days of life",4,null,"Adults in the last days of life have their hydration status assessed daily, and have a discussion about the risks and benefits of hydration options.","Proportion of adults who felt comfortable in the last days of life.","Outcome","QS144 - Care of dying adults in the last days of life","4 - QS144 - Care of dying adults in the last days of life",1,"4 - QS144 - Care of dying adults in the last days of life - Outcome - 1"]
[null,"QS144","Care of dying adults in the last days of life",4,null,"Adults in the last days of life have their hydration status assessed daily, and have a discussion about the risks and benefits of hydration options.","Proportion of bereaved people who feel satisfied that the person who has died was supported to drink or receive fluids if they wished.","Outcome","QS144 - Care of dying adults in the last days of life","4 - QS144 - Care of dying adults in the last days of life",2,"4 - QS144 - Care of dying adults in the last days of life - Outcome - 2"]
[null,"QS145","Vaccine uptake in under 19s",1,null,"Children and young people who do not attend their vaccination appointment are followed up using the preferred method of contact specified in their record.","Proportion of children and young people who have up-to-date medical records that include preferred methods of contact.","Process",{"$f":"CONCATENATE(B3177, \" - \", C3177)","v":"QS145 - Vaccine uptake in under 19s"},{"$f":"CONCATENATE(D3177, \" - \", I3177)","v":"1 - QS145 - Vaccine uptake in under 19s"},1,{"$f":"CONCATENATE(J3177, \" - \", H3177, \" - \",K3177)","v":"1 - QS145 - Vaccine uptake in under 19s - Process - 1"},"The number in the denominator who have up-to-date medical records that include preferred method of contact.","the number of children and young people."]
[null,"QS145","Vaccine uptake in under 19s",1,null,"Children and young people who do not attend their vaccination appointment are followed up using the preferred method of contact specified in their record.","Proportion of children and young people who do not attend their vaccination appointment who are followed up.","Process","QS145 - Vaccine uptake in under 19s","1 - QS145 - Vaccine uptake in under 19s",{"$f":"IF(AND(B3178=B3177, D3178=D3177, H3178=H3177)=TRUE, K3177+1, 1)","v":2},"1 - QS145 - Vaccine uptake in under 19s - Process - 2","The number in the denominator who are followed up.","The number of children and young people who do not attend their vaccination appointment."]
[null,"QS145","Vaccine uptake in under 19s",1,null,"Children and young people who do not attend their vaccination appointment are followed up using the preferred method of contact specified in their record.","Vaccination coverage in under 19s.","Outcome","QS145 - Vaccine uptake in under 19s","1 - QS145 - Vaccine uptake in under 19s",{"$f":"IF(AND(B3179=B3178, D3179=D3178, H3179=H3178)=TRUE, K3178+1, 1)","v":1},"1 - QS145 - Vaccine uptake in under 19s - Outcome - 1"]
[null,"QS145","Vaccine uptake in under 19s",2,null,"Children and young people identified as having missed childhood vaccinations are offered the outstanding vaccinations.","Evidence of local arrangements to ensure that children and young people identified as having missed childhood vaccinations are offered the outstanding vaccinations.","Structure","QS145 - Vaccine uptake in under 19s","2 - QS145 - Vaccine uptake in under 19s",1,"2 - QS145 - Vaccine uptake in under 19s - Structure - 1"]
[null,"QS145","Vaccine uptake in under 19s",2,null,"Children and young people identified as having missed childhood vaccinations are offered the outstanding vaccinations.","Proportion of children and young people identified as having missed childhood vaccinations who are offered the outstanding vaccinations.","Process","QS145 - Vaccine uptake in under 19s","2 - QS145 - Vaccine uptake in under 19s",1,"2 - QS145 - Vaccine uptake in under 19s - Process - 1","The number in the denominator who are offered the outstanding vaccinations.","The number of children and young people identified as having missed childhood vaccinations."]
[null,"QS145","Vaccine uptake in under 19s",2,null,"Children and young people identified as having missed childhood vaccinations are offered the outstanding vaccinations.","Proportion of children and young people identified as having missed childhood vaccinations who are offered a referral to a service where they can receive outstanding vaccinations.","Process","QS145 - Vaccine uptake in under 19s","2 - QS145 - Vaccine uptake in under 19s",2,"2 - QS145 - Vaccine uptake in under 19s - Process - 2","The number in the denominator who are offered a referral to a service where they can receive outstanding vaccinations.","The number of children and young people identified as having missed childhood vaccinations."]
[null,"QS145","Vaccine uptake in under 19s",2,null,"Children and young people identified as having missed childhood vaccinations are offered the outstanding vaccinations.","Vaccination coverage in under 19s.","Outcome","QS145 - Vaccine uptake in under 19s","2 - QS145 - Vaccine uptake in under 19s",1,"2 - QS145 - Vaccine uptake in under 19s - Outcome - 1"]
[null,"QS145","Vaccine uptake in under 19s",3,null,"Children and young people receiving a vaccination have it recorded in their GP record, the child health information system (CHIS) and in their personal child health record.","Evidence of local arrangements to ensure that children and young people receiving a vaccination have it recorded electronically in their GP record.","Structure","QS145 - Vaccine uptake in under 19s","3 - QS145 - Vaccine uptake in under 19s",1,"3 - QS145 - Vaccine uptake in under 19s - Structure - 1"]
[null,"QS145","Vaccine uptake in under 19s",3,null,"Children and young people receiving a vaccination have it recorded in their GP record, the child health information system (CHIS) and in their personal child health record.","Evidence of local arrangements to ensure that children and young people receiving a vaccination have it recorded on the CHIS.","Structure","QS145 - Vaccine uptake in under 19s","3 - QS145 - Vaccine uptake in under 19s",2,"3 - QS145 - Vaccine uptake in under 19s - Structure - 2"]
[null,"QS145","Vaccine uptake in under 19s",3,null,"Children and young people receiving a vaccination have it recorded in their GP record, the child health information system (CHIS) and in their personal child health record.","Evidence of local arrangements to ensure that children and young people receiving a vaccination have it recorded in their personal child health record.","Structure","QS145 - Vaccine uptake in under 19s","3 - QS145 - Vaccine uptake in under 19s",3,"3 - QS145 - Vaccine uptake in under 19s - Structure - 3"]
[null,"QS145","Vaccine uptake in under 19s",3,null,"Children and young people receiving a vaccination have it recorded in their GP record, the child health information system (CHIS) and in their personal child health record.","Proportion of children and young people receiving a vaccination who have it recorded on their GP record and personal child health record.","Process","QS145 - Vaccine uptake in under 19s","3 - QS145 - Vaccine uptake in under 19s",1,"3 - QS145 - Vaccine uptake in under 19s - Process - 1","The number in the denominator who have their vaccination recorded on their GP record and personal child health record.","The number of children and young people receiving a vaccination identified as receiving one by CHIS."]
[null,"QS145","Vaccine uptake in under 19s",3,null,"Children and young people receiving a vaccination have it recorded in their GP record, the child health information system (CHIS) and in their personal child health record.","Accurate planning for future population immunisation programmes and appointment requirements.","Outcome","QS145 - Vaccine uptake in under 19s","3 - QS145 - Vaccine uptake in under 19s",1,"3 - QS145 - Vaccine uptake in under 19s - Outcome - 1"]
[null,"QS145","Vaccine uptake in under 19s",3,null,"Children and young people receiving a vaccination have it recorded in their GP record, the child health information system (CHIS) and in their personal child health record.","Timely administration of vaccines to children and young people.","Outcome","QS145 - Vaccine uptake in under 19s","3 - QS145 - Vaccine uptake in under 19s",2,"3 - QS145 - Vaccine uptake in under 19s - Outcome - 2"]
[null,"QS145","Vaccine uptake in under 19s",4,null,"Children and young people have their immunisation status checked at specific educational stages.","Evidence of local arrangements to ensure that children and young people have their immunisation status checked at specific educational stages.","Structure",{"$f":"CONCATENATE(B3190, \" - \", C3190)","v":"QS145 - Vaccine uptake in under 19s"},{"$f":"CONCATENATE(D3190, \" - \", I3190)","v":"4 - QS145 - Vaccine uptake in under 19s"},1,{"$f":"CONCATENATE(J3190, \" - \", H3190, \" - \",K3190)","v":"4 - QS145 - Vaccine uptake in under 19s - Structure - 1"}]
[null,"QS145","Vaccine uptake in under 19s",4,null,"Children and young people have their immunisation status checked at specific educational stages.","Proportion of children aged under 5 years who have their immunisation status checked at preschool entry by a health visitor.","Process","QS145 - Vaccine uptake in under 19s","4 - QS145 - Vaccine uptake in under 19s",{"$f":"IF(AND(B3191=B3190, D3191=D3190, H3191=H3190)=TRUE, K3190+1, 1)","v":1},"4 - QS145 - Vaccine uptake in under 19s - Process - 1","the number in the denominator who have their immunisation status checked at preschool entry by the Healthy Child Programme team.","the number of children aged under 5 years."]
[null,"QS145","Vaccine uptake in under 19s",4,null,"Children and young people have their immunisation status checked at specific educational stages.","Proportion of children aged 4 to 5 years who have their immunisation status checked at school entry.","Process","QS145 - Vaccine uptake in under 19s","4 - QS145 - Vaccine uptake in under 19s",2,"4 - QS145 - Vaccine uptake in under 19s - Process - 2","the number in the denominator who have their immunisation status checked at school entry.","The number of children aged under 5 years."]
[null,"QS145","Vaccine uptake in under 19s",4,null,"Children and young people have their immunisation status checked at specific educational stages.","Proportion of children and young people aged 4 to 19 years who have their immunisation status checked when they transfer to a new school.","Process","QS145 - Vaccine uptake in under 19s","4 - QS145 - Vaccine uptake in under 19s",3,"4 - QS145 - Vaccine uptake in under 19s - Process - 3","the number in the denominator who have their immunisation status checked when they transfer to a new school.","the number of children and young people aged 5 to 19 years transferring to a new school."]
[null,"QS145","Vaccine uptake in under 19s",4,null,"Children and young people have their immunisation status checked at specific educational stages.","Proportion of young people aged under 19 years who have their immunisation status checked at further educational setting entry.","Process","QS145 - Vaccine uptake in under 19s","4 - QS145 - Vaccine uptake in under 19s",4,"4 - QS145 - Vaccine uptake in under 19s - Process - 4","the number in the denominator who have their immunisation status checked at further educational setting entry.","The number of young people aged under 19 years entering a further educational setting."]
[null,"QS145","Vaccine uptake in under 19s",4,null,"Children and young people have their immunisation status checked at specific educational stages.","Identified children and young people in education with gaps in vaccination history.","Outcome","QS145 - Vaccine uptake in under 19s","4 - QS145 - Vaccine uptake in under 19s",1,"4 - QS145 - Vaccine uptake in under 19s - Outcome - 1"]
[null,"QS145","Vaccine uptake in under 19s",4,null,"Children and young people have their immunisation status checked at specific educational stages.","Vaccine uptake in children and young people.","Outcome","QS145 - Vaccine uptake in under 19s","4 - QS145 - Vaccine uptake in under 19s",2,"4 - QS145 - Vaccine uptake in under 19s - Outcome - 2"]
[null,"QS145","Vaccine uptake in under 19s",5,null,"Young offenders have their immunisation status checked within 7 days of arrival into a secure setting and are offered any outstanding vaccinations.","Evidence of local arrangements to ensure that young offenders have their immunisation status checked within 7 days of arrival into a secure setting.","Structure",{"$f":"CONCATENATE(B3197, \" - \", C3197)","v":"QS145 - Vaccine uptake in under 19s"},{"$f":"CONCATENATE(D3197, \" - \", I3197)","v":"5 - QS145 - Vaccine uptake in under 19s"},1,{"$f":"CONCATENATE(J3197, \" - \", H3197, \" - \",K3197)","v":"5 - QS145 - Vaccine uptake in under 19s - Structure - 1"}]
[null,"QS145","Vaccine uptake in under 19s",5,null,"Young offenders have their immunisation status checked within 7 days of arrival into a secure setting and are offered any outstanding vaccinations.","Evidence of local arrangements to ensure that young offenders in secure settings are offered outstanding vaccinations.","Structure","QS145 - Vaccine uptake in under 19s","5 - QS145 - Vaccine uptake in under 19s",2,"5 - QS145 - Vaccine uptake in under 19s - Structure - 2"]
[null,"QS145","Vaccine uptake in under 19s",5,null,"Young offenders have their immunisation status checked within 7 days of arrival into a secure setting and are offered any outstanding vaccinations.","Proportion of young offenders in secure settings who have their immunisation status checked within 7 days of arrival into a secure setting.","Process","QS145 - Vaccine uptake in under 19s","5 - QS145 - Vaccine uptake in under 19s",{"$f":"IF(AND(B3199=B3197, D3199=D3197, H3199=H3197)=TRUE, K3197+1, 1)","v":1},"5 - QS145 - Vaccine uptake in under 19s - Process - 1","The number in the denominator who have their immunisation status checked within 7 days of arrival into a secure setting.","The number of young people entering secure settings."]
[null,"QS145","Vaccine uptake in under 19s",5,null,"Young offenders have their immunisation status checked within 7 days of arrival into a secure setting and are offered any outstanding vaccinations.","Proportion of young offenders in secure settings identified as having gaps in their immunisation history who are offered outstanding vaccinations.","Process","QS145 - Vaccine uptake in under 19s","5 - QS145 - Vaccine uptake in under 19s",2,"5 - QS145 - Vaccine uptake in under 19s - Process - 2","The number in the denominator who are offered outstanding vaccinations.","The number of young people entering secure settings identified as having gaps in their immunisation history."]
[null,"QS145","Vaccine uptake in under 19s",5,null,"Young offenders have their immunisation status checked within 7 days of arrival into a secure setting and are offered any outstanding vaccinations.","Immunisation coverage in young offenders.","Outcome","QS145 - Vaccine uptake in under 19s","5 - QS145 - Vaccine uptake in under 19s",1,"5 - QS145 - Vaccine uptake in under 19s - Outcome - 1"]
[null,"QS146","Head and neck cancer",1,"Nutritional status","People with cancer of the upper aerodigestive tract have their nutritional status, including the need for a prophylactic tube, assessed at diagnosis.  ","Evidence of local arrangements and written clinical protocols to ensure that people with cancer of the upper aerodigestive tract have their nutritional status, including the need for a prophylactic tube, assessed at diagnosis.","Structure",{"$f":"CONCATENATE(B3202, \" - \", C3202)","v":"QS146 - Head and neck cancer"},{"$f":"CONCATENATE(D3202, \" - \", I3202)","v":"1 - QS146 - Head and neck cancer"},1,{"$f":"CONCATENATE(J3202, \" - \", H3202, \" - \",K3202)","v":"1 - QS146 - Head and neck cancer - Structure - 1"}]
[null,"QS146","Head and neck cancer",1,"Nutritional status","People with cancer of the upper aerodigestive tract have their nutritional status, including the need for a prophylactic tube, assessed at diagnosis.  ","Proportion of people with cancer of the upper aerodigestive tract who have their nutritional status, including the need for a prophylactic tube, assessed at diagnosis.","Process","QS146 - Head and neck cancer","1 - QS146 - Head and neck cancer",1,"1 - QS146 - Head and neck cancer - Process - 1","The number in the denominator who have their nutritional status, including the need for a prophylactic tube, assessed at diagnosis.","The number of people diagnosed with cancer of the upper aerodigestive tract."]
[null,"QS146","Head and neck cancer",1,"Nutritional status","People with cancer of the upper aerodigestive tract have their nutritional status, including the need for a prophylactic tube, assessed at diagnosis.  ","Nutritional status of people with cancer of the upper aerodigestive tract.","Outcome","QS146 - Head and neck cancer","1 - QS146 - Head and neck cancer",1,"1 - QS146 - Head and neck cancer - Outcome - 1"]
[null,"QS146","Head and neck cancer",2,"Clinical staging","People with specific advanced stage cancers of the upper aerodigestive tract are offered systemic staging using fluorodeoxyglucose positron emission tomography (FDG PET)-CT.","Evidence of local arrangements and written clinical protocols to ensure that people with N3 upper aerodigestive tract cancer are offered systemic staging using FDG PET-CT.","Structure","QS146 - Head and neck cancer","2 - QS146 - Head and neck cancer",1,"2 - QS146 - Head and neck cancer - Structure - 1"]
[null,"QS146","Head and neck cancer",2,"Clinical staging","People with specific advanced stage cancers of the upper aerodigestive tract are offered systemic staging using fluorodeoxyglucose positron emission tomography (FDG PET)-CT.","Evidence of local arrangements and written clinical protocols to ensure that people with T4 cancers of the hypopharynx and nasopharynx are offered systemic staging using FDG PET-CT.","Structure","QS146 - Head and neck cancer","2 - QS146 - Head and neck cancer",2,"2 - QS146 - Head and neck cancer - Structure - 2"]
[null,"QS146","Head and neck cancer",2,"Clinical staging","People with specific advanced stage cancers of the upper aerodigestive tract are offered systemic staging using fluorodeoxyglucose positron emission tomography (FDG PET)-CT.","Proportion of people with N3 upper aerodigestive tract cancer who have systemic staging using FDG PET-CT.","Process","QS146 - Head and neck cancer","2 - QS146 - Head and neck cancer",1,"2 - QS146 - Head and neck cancer - Process - 1","The number in the denominator who have systemic staging using FDG PET-CT.","The number of people with N3 upper aerodigestive tract cancer."]
[null,"QS146","Head and neck cancer",2,"Clinical staging","People with specific advanced stage cancers of the upper aerodigestive tract are offered systemic staging using fluorodeoxyglucose positron emission tomography (FDG PET)-CT.","Proportion of people with T4 cancers of the hypopharynx and nasopharynx who have systemic staging using FDG PET-CT.","Process","QS146 - Head and neck cancer","2 - QS146 - Head and neck cancer",2,"2 - QS146 - Head and neck cancer - Process - 2","the number in the denominator who have systemic staging using FDG PET-CT.","the number of people with T4 cancers of the hypopharynx and nasopharynx."]
[null,"QS146","Head and neck cancer",2,"Clinical staging","People with specific advanced stage cancers of the upper aerodigestive tract are offered systemic staging using fluorodeoxyglucose positron emission tomography (FDG PET)-CT.","Rates of surgery or radiotherapy in people with advanced stage cancer of the upper aerodigestive tract.","Outcome","QS146 - Head and neck cancer","2 - QS146 - Head and neck cancer",1,"2 - QS146 - Head and neck cancer - Outcome - 1"]
[null,"QS146","Head and neck cancer",2,"Clinical staging","People with specific advanced stage cancers of the upper aerodigestive tract are offered systemic staging using fluorodeoxyglucose positron emission tomography (FDG PET)-CT.","Evidence of local arrangements and written clinical protocols to ensure that people with T4 cancers of the hypopharynx and nasopharynx are offered systemic staging using FDG PET-CT.","Structure","QS146 - Head and neck cancer","2 - QS146 - Head and neck cancer",1,"2 - QS146 - Head and neck cancer - Structure - 1"]
[null,"QS146","Head and neck cancer",2,"Clinical staging","People with specific advanced stage cancers of the upper aerodigestive tract are offered systemic staging using fluorodeoxyglucose positron emission tomography (FDG PET)-CT.","Proportion of people with T4 cancers of the hypopharynx and nasopharynx who have systemic staging using FDG PET-CT.","Process","QS146 - Head and neck cancer","2 - QS146 - Head and neck cancer",1,"2 - QS146 - Head and neck cancer - Process - 1","The number in the denominator who have systemic staging using FDG PET-CT.","The number of people with T4 cancers of the hypopharynx and nasopharynx."]
[null,"QS146","Head and neck cancer",3,"Sentinel lymph node biopsy","People with early stage oral cavity cancer who do not need cervical access as part of surgical management are offered sentinel lymph node biopsy as an alternative to elective neck dissection.","Evidence of local arrangements and written clinical protocols to ensure that people with early stage oral cavity cancer who do not need cervical access as part of surgical management are offered sentinel lymph node biopsy as an alternative to elective neck dissection. ","Structure","QS146 - Head and neck cancer","3 - QS146 - Head and neck cancer",1,"3 - QS146 - Head and neck cancer - Structure - 1"]
[null,"QS146","Head and neck cancer",3,"Sentinel lymph node biopsy","People with early stage oral cavity cancer who do not need cervical access as part of surgical management are offered sentinel lymph node biopsy as an alternative to elective neck dissection.","Proportion of people with early stage oral cavity cancer who do not need cervical access as part of surgical management who have sentinel lymph node biopsy as an alternative to elective neck dissection.","Process","QS146 - Head and neck cancer","3 - QS146 - Head and neck cancer",1,"3 - QS146 - Head and neck cancer - Process - 1","The number in the denominator who do not need cervical access as part of surgical management who have sentinel lymph node biopsy as an alternative to elective neck dissection.","The number of people with early stage oral cavity cancer."]
[null,"QS146","Head and neck cancer",3,"Sentinel lymph node biopsy","People with early stage oral cavity cancer who do not need cervical access as part of surgical management are offered sentinel lymph node biopsy as an alternative to elective neck dissection.","Surgery-related morbidity for people with early stage oral cavity cancer.","Outcome","QS146 - Head and neck cancer","3 - QS146 - Head and neck cancer",1,"3 - QS146 - Head and neck cancer - Outcome - 1"]
[null,"QS146","Head and neck cancer",3,"Sentinel lymph node biopsy","People with early stage oral cavity cancer who do not need cervical access as part of surgical management are offered sentinel lymph node biopsy as an alternative to elective neck dissection.","Length of hospital stay for people with early stage oral cavity cancer.","Outcome","QS146 - Head and neck cancer","3 - QS146 - Head and neck cancer",2,"3 - QS146 - Head and neck cancer - Outcome - 2"]
[null,"QS146","Head and neck cancer",4,"Choice of treatment","People with cancer of the upper aerodigestive tract are given the choice of either radiotherapy or surgery if both are suitable options for their type of cancer.","Evidence of local arrangements and written clinical protocols to ensure that people with cancer of the upper aerodigestive tract are given a choice of either radiotherapy or surgery if both are suitable options for their type of cancer.","Structure","QS146 - Head and neck cancer","4 - QS146 - Head and neck cancer",1,"4 - QS146 - Head and neck cancer - Structure - 1"]
[null,"QS146","Head and neck cancer",4,"Choice of treatment","People with cancer of the upper aerodigestive tract are given the choice of either radiotherapy or surgery if both are suitable options for their type of cancer.","Proportion of people with newly diagnosed T1b–T2 squamous cell carcinoma of the glottic larynx who are given a choice of surgery or radiotherapy.","Process","QS146 - Head and neck cancer","4 - QS146 - Head and neck cancer",1,"4 - QS146 - Head and neck cancer - Process - 1","The number in the denominator who are given a choice of surgery or radiotherapy.","The number of people with newly diagnosed T1b–T2 squamous cell carcinoma of the glottic larynx."]
[null,"QS146","Head and neck cancer",4,"Choice of treatment","People with cancer of the upper aerodigestive tract are given the choice of either radiotherapy or surgery if both are suitable options for their type of cancer.","Proportion of people with newly diagnosed T1–T2 squamous cell carcinoma of the supraglottic larynx who are given a choice of surgery or radiotherapy.","Process","QS146 - Head and neck cancer","4 - QS146 - Head and neck cancer",2,"4 - QS146 - Head and neck cancer - Process - 2","The number in the denominator who are given a choice of surgery or radiotherapy.","The number of people with newly diagnosed T1–T2 squamous cell carcinoma of the supraglottic larynx."]
[null,"QS146","Head and neck cancer",4,"Choice of treatment","People with cancer of the upper aerodigestive tract are given the choice of either radiotherapy or surgery if both are suitable options for their type of cancer.","Proportion of people with T1–2 N0 tumours of the oropharynx who are given a choice of surgery or radiotherapy.","Process","QS146 - Head and neck cancer","4 - QS146 - Head and neck cancer",3,"4 - QS146 - Head and neck cancer - Process - 3","The number in the denominator who are given a choice of surgery or radiotherapy.","The number of people with T1–2 N0 tumours of the oropharynx."]
[null,"QS146","Head and neck cancer",4,"Choice of treatment","People with cancer of the upper aerodigestive tract are given the choice of either radiotherapy or surgery if both are suitable options for their type of cancer.","Proportion of people with T3 squamous cell carcinoma of the larynx who are given a choice of either radiotherapy with concomitant chemotherapy or surgery with adjuvant radiotherapy, with or without concomitant chemotherapy.","Process","QS146 - Head and neck cancer","4 - QS146 - Head and neck cancer",4,"4 - QS146 - Head and neck cancer - Process - 4","The number in the denominator who are given a choice of either radiotherapy with concomitant chemotherapy or surgery with adjuvant radiotherapy, with or without concomitant chemotherapy.","The number of people with T3 squamous cell carcinoma of the larynx."]
[null,"QS146","Head and neck cancer",4,"Choice of treatment","People with cancer of the upper aerodigestive tract are given the choice of either radiotherapy or surgery if both are suitable options for their type of cancer.","Satisfaction with treatment for people with cancers of the upper aerodigestive tract that have similar outcomes from radiotherapy and surgery.","Outcome","QS146 - Head and neck cancer","4 - QS146 - Head and neck cancer",1,"4 - QS146 - Head and neck cancer - Outcome - 1"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",1,"Making health and wellbeing an organisational priority ","Employees work in organisations that have a named senior manager who makes employee health and wellbeing a core priority.","Evidence of arrangements for a named senior manager to have responsibility for making employee health and wellbeing a core organisational priority. ","Structure",{"$f":"CONCATENATE(B3222, \" - \", C3222)","v":"QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing"},{"$f":"CONCATENATE(D3222, \" - \", I3222)","v":"1 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing"},{"$f":"IF(AND(B3222=B3221, D3222=D3221, H3222=H3221)=TRUE, K3221+1, 1)","v":1},{"$f":"CONCATENATE(J3222, \" - \", H3222, \" - \",K3222)","v":"1 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Structure - 1"}]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",1,"Making health and wellbeing an organisational priority ","Employees work in organisations that have a named senior manager who makes employee health and wellbeing a core priority.","Evidence of arrangements for implementing an employee health and wellbeing strategy. ","Structure","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","1 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",2,"1 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Structure - 2"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",1,"Making health and wellbeing an organisational priority ","Employees work in organisations that have a named senior manager who makes employee health and wellbeing a core priority.","Evidence of arrangements to incorporate health and wellbeing in all relevant policies and communications. ","Structure","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","1 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",3,"1 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Structure - 3"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",1,"Making health and wellbeing an organisational priority ","Employees work in organisations that have a named senior manager who makes employee health and wellbeing a core priority.","Employee sickness absence rates.","Outcome","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","1 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",1,"1 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Outcome - 1"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",1,"Making health and wellbeing an organisational priority ","Employees work in organisations that have a named senior manager who makes employee health and wellbeing a core priority.","Employee retention rates.","Outcome","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","1 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",2,"1 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Outcome - 2"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",1,"Making health and wellbeing an organisational priority ","Employees work in organisations that have a named senior manager who makes employee health and wellbeing a core priority.","Employee satisfaction rates.","Outcome","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","1 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",3,"1 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Outcome - 3"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",2,"Role of line managers","Employees are managed by people who support their health and wellbeing.","Evidence that supporting employee health and wellbeing is included in any documents outlining the skills and knowledge that line managers need.","Structure","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","2 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",1,"2 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Structure - 1"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",2,"Role of line managers","Employees are managed by people who support their health and wellbeing.","Proportion of line managers whose job descriptions include supporting employee health and wellbeing.","Process","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","2 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",1,"2 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Process - 1","The number in the denominator whose job description includes supporting employee health and wellbeing.","The number of line managers in the organisation."]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",2,"Role of line managers","Employees are managed by people who support their health and wellbeing.","Proportion of line managers whose performance reviews include an evaluation of how they support employee health and wellbeing.","Process","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","2 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",2,"2 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Process - 2","The number in the denominator whose performance reviews include an evaluation of how they support employee health and wellbeing.","The number of line managers in the organisation."]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",2,"Role of line managers","Employees are managed by people who support their health and wellbeing.","Employee sickness absence rates.","Outcome","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","2 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",1,"2 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Outcome - 1"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",2,"Role of line managers","Employees are managed by people who support their health and wellbeing.","Employee retention rates.","Outcome","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","2 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",2,"2 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Outcome - 2"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",3,"Identifying and managing stress ","Employees are managed by people who are trained to recognise and support them when they are experiencing stress.","Evidence of arrangements to ensure that line managers are given training in how to recognise and support employees when they are experiencing stress.","Structure","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","3 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",1,"3 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Structure - 1"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",3,"Identifying and managing stress ","Employees are managed by people who are trained to recognise and support them when they are experiencing stress.","Proportion of line managers who are trained to use a stress risk assessment to identify and respond to sources of stress. ","Process","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","3 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",1,"3 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Process - 1","The number in the denominator who are trained to use a stress risk assessment to identify and respond to sources of stress.","The number of line managers in the organisation."]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",3,"Identifying and managing stress ","Employees are managed by people who are trained to recognise and support them when they are experiencing stress.","Proportion of line managers who are trained to recognise the causes of stress.","Process","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","3 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",2,"3 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Process - 2","The number in the denominator who are trained to recognise the causes of stress.","The number of line managers in the organisation."]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",3,"Identifying and managing stress ","Employees are managed by people who are trained to recognise and support them when they are experiencing stress.","Proportion of line managers who receive information on sources of support for stress both inside and outside the workplace. ","Process","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","3 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",3,"3 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Process - 3","The number in the denominator who receive information on sources of support for stress both inside and outside the workplace.","The number of line managers in the organisation."]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",3,"Identifying and managing stress ","Employees are managed by people who are trained to recognise and support them when they are experiencing stress.","Identification of stress in employees.","Outcome","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","3 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",1,"3 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Outcome - 1"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",3,"Identifying and managing stress ","Employees are managed by people who are trained to recognise and support them when they are experiencing stress.","Support for employees experiencing stress.","Outcome","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","3 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",2,"3 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Outcome - 2"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",4,"Employee involvement in decision-making","Employees have the opportunity to contribute to decision-making through staff engagement forums.","Evidence of arrangements for staff engagement forums that enable employees to contribute to decision-making.","Structure","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","4 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",1,"4 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Structure - 1"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",4,"Employee involvement in decision-making","Employees have the opportunity to contribute to decision-making through staff engagement forums.","Evidence of arrangements for feedback to employees on actions taken as a result of their contribution.","Structure","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","4 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",2,"4 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Structure - 2"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",4,"Employee involvement in decision-making","Employees have the opportunity to contribute to decision-making through staff engagement forums.","Employee satisfaction rates.","Outcome","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","4 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",1,"4 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Outcome - 1"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",4,"Employee involvement in decision-making","Employees have the opportunity to contribute to decision-making through staff engagement forums.","Employee engagement.","Outcome","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","4 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",2,"4 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Outcome - 2"]
[null,"QS147","Healthy workplaces: improving employee mental and physical health and wellbeing",4,"Employee involvement in decision-making","Employees have the opportunity to contribute to decision-making through staff engagement forums.","Employee retention rates.","Outcome","QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing","4 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing",3,"4 - QS147 - Healthy workplaces: improving employee mental and physical health and wellbeing - Outcome - 3"]
[null,"QS148","Community engagement: improving health and wellbeing ",1,"Identifying local priorities","Members of the local community are involved in setting priorities for health and wellbeing initiatives.","Evidence of local arrangements for involving members of the local community in setting priorities for health and wellbeing initiatives.","Structure",{"$f":"CONCATENATE(B3244, \" - \", C3244)","v":"QS148 - Community engagement: improving health and wellbeing "},{"$f":"CONCATENATE(D3244, \" - \", I3244)","v":"1 - QS148 - Community engagement: improving health and wellbeing "},{"$f":"IF(AND(B3244=B3238, D3244=D3238, H3244=H3238)=TRUE, K3238+1, 1)","v":1},{"$f":"CONCATENATE(J3244, \" - \", H3244, \" - \",K3244)","v":"1 - QS148 - Community engagement: improving health and wellbeing  - Structure - 1"}]
[null,"QS148","Community engagement: improving health and wellbeing ",1,"Identifying local priorities","Members of the local community are involved in setting priorities for health and wellbeing initiatives.","Priorities for health and wellbeing initiatives reflect what is important to members of the local communities.","Outcome","QS148 - Community engagement: improving health and wellbeing ","1 - QS148 - Community engagement: improving health and wellbeing ",{"$f":"IF(AND(B3245=B3244, D3245=D3244, H3245=H3244)=TRUE, K3244+1, 1)","v":1},"1 - QS148 - Community engagement: improving health and wellbeing  - Outcome - 1"]
[null,"QS148","Community engagement: improving health and wellbeing ",1,"Identifying local priorities","Members of the local community are involved in setting priorities for health and wellbeing initiatives.","Community ownership of health and wellbeing initiatives, such as levels of participation, and breadth of local community representation on committees, boards and other groups. ","Outcome","QS148 - Community engagement: improving health and wellbeing ","1 - QS148 - Community engagement: improving health and wellbeing ",2,"1 - QS148 - Community engagement: improving health and wellbeing  - Outcome - 2"]
[null,"QS148","Community engagement: improving health and wellbeing ",2,"Evaluation","Members of the local community are involved in monitoring and evaluating health and wellbeing initiatives as soon as the priorities are agreed.","Evidence of local arrangements for involving members of the local community in monitoring and evaluating local health and wellbeing initiatives as soon as the priorities are agreed.","Structure","QS148 - Community engagement: improving health and wellbeing ","2 - QS148 - Community engagement: improving health and wellbeing ",1,"2 - QS148 - Community engagement: improving health and wellbeing  - Structure - 1"]
[null,"QS148","Community engagement: improving health and wellbeing ",2,"Evaluation","Members of the local community are involved in monitoring and evaluating health and wellbeing initiatives as soon as the priorities are agreed.","Evidence of local arrangements for involving members of the local community in agreeing what to measure to illustrate the impact of the initiative once the priorities are agreed. ","Structure","QS148 - Community engagement: improving health and wellbeing ","2 - QS148 - Community engagement: improving health and wellbeing ",2,"2 - QS148 - Community engagement: improving health and wellbeing  - Structure - 2"]
[null,"QS148","Community engagement: improving health and wellbeing ",2,"Evaluation","Members of the local community are involved in monitoring and evaluating health and wellbeing initiatives as soon as the priorities are agreed.","Proportion of local health and wellbeing initiatives monitored against measures agreed within the evaluation plan.","Process","QS148 - Community engagement: improving health and wellbeing ","2 - QS148 - Community engagement: improving health and wellbeing ",1,"2 - QS148 - Community engagement: improving health and wellbeing  - Process - 1","Number in the denominator monitored against measures agreed within the plan.","Number of local health and wellbeing initiatives with an evaluation plan."]
[null,"QS148","Community engagement: improving health and wellbeing ",2,"Evaluation","Members of the local community are involved in monitoring and evaluating health and wellbeing initiatives as soon as the priorities are agreed.","Proportion of local health and wellbeing initiatives with an evaluation plan that provide feedback to the engaged members of the local communities.","Process","QS148 - Community engagement: improving health and wellbeing ","2 - QS148 - Community engagement: improving health and wellbeing ",2,"2 - QS148 - Community engagement: improving health and wellbeing  - Process - 2","Number in the denominator that provide feedback to the engaged members of the local communities.","Number of local health and wellbeing initiatives with an evaluation plan."]
[null,"QS148","Community engagement: improving health and wellbeing ",2,"Evaluation","Members of the local community are involved in monitoring and evaluating health and wellbeing initiatives as soon as the priorities are agreed.","Evaluation providing information as identified within the evaluation plan.","Outcome","QS148 - Community engagement: improving health and wellbeing ","2 - QS148 - Community engagement: improving health and wellbeing ",1,"2 - QS148 - Community engagement: improving health and wellbeing  - Outcome - 1"]
[null,"QS148","Community engagement: improving health and wellbeing ",2,"Evaluation","Members of the local community are involved in monitoring and evaluating health and wellbeing initiatives as soon as the priorities are agreed.","Increased social engagement within local communities","Outcome","QS148 - Community engagement: improving health and wellbeing ","2 - QS148 - Community engagement: improving health and wellbeing ",2,"2 - QS148 - Community engagement: improving health and wellbeing  - Outcome - 2"]
[null,"QS148","Community engagement: improving health and wellbeing ",2,"Evaluation","Members of the local community are involved in monitoring and evaluating health and wellbeing initiatives as soon as the priorities are agreed.","Empowered members of local communities that understand the impact of the initiatives they are involved in.","Outcome","QS148 - Community engagement: improving health and wellbeing ","2 - QS148 - Community engagement: improving health and wellbeing ",3,"2 - QS148 - Community engagement: improving health and wellbeing  - Outcome - 3"]
[null,"QS148","Community engagement: improving health and wellbeing ",3,"Identifying community assets","Members of the local community are involved in identifying the skills, knowledge, networks, relationships and facilities available to health and wellbeing initiatives.","Evidence of local arrangements to ensure that members of the local community are involved in identifying skills within the community as part of health and wellbeing initiatives. ","Structure","QS148 - Community engagement: improving health and wellbeing ","3 - QS148 - Community engagement: improving health and wellbeing ",1,"3 - QS148 - Community engagement: improving health and wellbeing  - Structure - 1"]
[null,"QS148","Community engagement: improving health and wellbeing ",3,"Identifying community assets","Members of the local community are involved in identifying the skills, knowledge, networks, relationships and facilities available to health and wellbeing initiatives.","Evidence of local arrangements to ensure that members of the local community are involved in identifying knowledge within the community as part of health and wellbeing initiatives. ","Structure","QS148 - Community engagement: improving health and wellbeing ","3 - QS148 - Community engagement: improving health and wellbeing ",2,"3 - QS148 - Community engagement: improving health and wellbeing  - Structure - 2"]
[null,"QS148","Community engagement: improving health and wellbeing ",3,"Identifying community assets","Members of the local community are involved in identifying the skills, knowledge, networks, relationships and facilities available to health and wellbeing initiatives.","Evidence of local arrangements to ensure that members of the local community are involved in identifying networks within the community as part of health and wellbeing initiatives. ","Structure","QS148 - Community engagement: improving health and wellbeing ","3 - QS148 - Community engagement: improving health and wellbeing ",3,"3 - QS148 - Community engagement: improving health and wellbeing  - Structure - 3"]
[null,"QS148","Community engagement: improving health and wellbeing ",3,"Identifying community assets","Members of the local community are involved in identifying the skills, knowledge, networks, relationships and facilities available to health and wellbeing initiatives.","Evidence of local arrangements to ensure that members of the local community are involved in identifying relationships within the community as part of health and wellbeing initiatives. ","Structure","QS148 - Community engagement: improving health and wellbeing ","3 - QS148 - Community engagement: improving health and wellbeing ",4,"3 - QS148 - Community engagement: improving health and wellbeing  - Structure - 4"]
[null,"QS148","Community engagement: improving health and wellbeing ",3,"Identifying community assets","Members of the local community are involved in identifying the skills, knowledge, networks, relationships and facilities available to health and wellbeing initiatives.","Evidence of local arrangements to ensure that members of the local community are involved in identifying facilities within the community as part of health and wellbeing initiatives. ","Structure","QS148 - Community engagement: improving health and wellbeing ","3 - QS148 - Community engagement: improving health and wellbeing ",5,"3 - QS148 - Community engagement: improving health and wellbeing  - Structure - 5"]
[null,"QS148","Community engagement: improving health and wellbeing ",3,"Identifying community assets","Members of the local community are involved in identifying the skills, knowledge, networks, relationships and facilities available to health and wellbeing initiatives.","Evidence of local arrangements to ensure that the joint strategic needs assessment includes the identification of community assets.","Structure","QS148 - Community engagement: improving health and wellbeing ","3 - QS148 - Community engagement: improving health and wellbeing ",6,"3 - QS148 - Community engagement: improving health and wellbeing  - Structure - 6"]
[null,"QS148","Community engagement: improving health and wellbeing ",3,"Identifying community assets","Members of the local community are involved in identifying the skills, knowledge, networks, relationships and facilities available to health and wellbeing initiatives.","Community members are recognised as assets and feel valued by the commissioners.","Outcome","QS148 - Community engagement: improving health and wellbeing ","3 - QS148 - Community engagement: improving health and wellbeing ",1,"3 - QS148 - Community engagement: improving health and wellbeing  - Outcome - 1"]
[null,"QS148","Community engagement: improving health and wellbeing ",3,"Identifying community assets","Members of the local community are involved in identifying the skills, knowledge, networks, relationships and facilities available to health and wellbeing initiatives.","Local communities and commissioners work together to recognise existing assets that health and wellbeing initiatives can be built on.","Outcome","QS148 - Community engagement: improving health and wellbeing ","3 - QS148 - Community engagement: improving health and wellbeing ",2,"3 - QS148 - Community engagement: improving health and wellbeing  - Outcome - 2"]
[null,"QS148","Community engagement: improving health and wellbeing ",4,"Peer and lay roles","Members of the local community are actively recruited to take on peer and lay roles for health and wellbeing initiatives.","Evidence of local arrangements to actively recruit members of the community to take on peer and lay roles for local health and wellbeing initiatives.","Structure","QS148 - Community engagement: improving health and wellbeing ","4 - QS148 - Community engagement: improving health and wellbeing ",1,"4 - QS148 - Community engagement: improving health and wellbeing  - Structure - 1"]
[null,"QS148","Community engagement: improving health and wellbeing ",4,"Peer and lay roles","Members of the local community are actively recruited to take on peer and lay roles for health and wellbeing initiatives.","Evidence of local specification of the roles and responsibilities of members of the community taking on peer and lay roles.","Structure","QS148 - Community engagement: improving health and wellbeing ","4 - QS148 - Community engagement: improving health and wellbeing ",2,"4 - QS148 - Community engagement: improving health and wellbeing  - Structure - 2"]
[null,"QS148","Community engagement: improving health and wellbeing ",4,"Peer and lay roles","Members of the local community are actively recruited to take on peer and lay roles for health and wellbeing initiatives.","Evidence of local arrangements to support members of the community taking on peer and lay roles to fulfil these roles.","Structure","QS148 - Community engagement: improving health and wellbeing ","4 - QS148 - Community engagement: improving health and wellbeing ",3,"4 - QS148 - Community engagement: improving health and wellbeing  - Structure - 3"]
[null,"QS148","Community engagement: improving health and wellbeing ",4,"Peer and lay roles","Members of the local community are actively recruited to take on peer and lay roles for health and wellbeing initiatives.","Community members are provided with information and support to improve their health and wellbeing by members of the same community or from people with similar backgrounds.","Outcome","QS148 - Community engagement: improving health and wellbeing ","4 - QS148 - Community engagement: improving health and wellbeing ",1,"4 - QS148 - Community engagement: improving health and wellbeing  - Outcome - 1"]
[null,"QS148","Community engagement: improving health and wellbeing ",4,"Peer and lay roles","Members of the local community are actively recruited to take on peer and lay roles for health and wellbeing initiatives.","Effective communication between statutory, community and voluntary organisations and members of the local community.","Outcome","QS148 - Community engagement: improving health and wellbeing ","4 - QS148 - Community engagement: improving health and wellbeing ",2,"4 - QS148 - Community engagement: improving health and wellbeing  - Outcome - 2"]
[null,"QS148","Community engagement: improving health and wellbeing ",4,"Peer and lay roles","Members of the local community are actively recruited to take on peer and lay roles for health and wellbeing initiatives.","Community members in peer and lay roles are actively involved in organising and delivering health and wellbeing initiatives.","Outcome","QS148 - Community engagement: improving health and wellbeing ","4 - QS148 - Community engagement: improving health and wellbeing ",3,"4 - QS148 - Community engagement: improving health and wellbeing  - Outcome - 3"]
[null,"QS149","Osteoporosis",1,"Assessment of fragility fracture risk","Adults who have had a fragility fracture or use systemic glucocorticoids or have a history of falls have an assessment of their fracture risk.","Evidence of local arrangements to ensure that adults who have had a fragility fracture, use systemic glucocorticoids or have a history of falls, have an assessment of their fracture risk.","Structure","QS149 - Osteoporosis","1 - QS149 - Osteoporosis",1,"1 - QS149 - Osteoporosis - Structure - 1"]
[null,"QS149","Osteoporosis",1,"Assessment of fragility fracture risk","Adults who have had a fragility fracture or use systemic glucocorticoids or have a history of falls have an assessment of their fracture risk.","Proportion of adults who have had a fragility fracture who have an assessment of their fracture risk.","Process","QS149 - Osteoporosis","1 - QS149 - Osteoporosis",1,"1 - QS149 - Osteoporosis - Process - 1","the number in the denominator who have an assessment of their fracture risk.","the number of adults who have had a fragility fracture."]
[null,"QS149","Osteoporosis",1,"Assessment of fragility fracture risk","Adults who have had a fragility fracture or use systemic glucocorticoids or have a history of falls have an assessment of their fracture risk.","Proportion of adults who use systemic glucocorticoids who have an assessment of their fracture risk.","Process","QS149 - Osteoporosis","1 - QS149 - Osteoporosis",2,"1 - QS149 - Osteoporosis - Process - 2","the number in the denominator who have an assessment of their fracture risk.","the number of adults who use systemic glucocorticoids."]
[null,"QS149","Osteoporosis",1,"Assessment of fragility fracture risk","Adults who have had a fragility fracture or use systemic glucocorticoids or have a history of falls have an assessment of their fracture risk.","Proportion of adults aged 50 and over who have a history of falls who have an assessment of their fracture risk.","Process","QS149 - Osteoporosis","1 - QS149 - Osteoporosis",3,"1 - QS149 - Osteoporosis - Process - 3","the number in the denominator who have an assessment of their fracture risk.","the number of adults aged 50 and over who have a history of falls."]
[null,"QS149","Osteoporosis",1,"Assessment of fragility fracture risk","Adults who have had a fragility fracture or use systemic glucocorticoids or have a history of falls have an assessment of their fracture risk.","Incidence of fragility fractures.","Outcome","QS149 - Osteoporosis","1 - QS149 - Osteoporosis",1,"1 - QS149 - Osteoporosis - Outcome - 1"]
[null,"QS149","Osteoporosis",2,"Starting drug treatment","Adults at high risk of fragility fracture are offered drug treatment to reduce fracture risk.","Evidence of local arrangements to ensure that adults at high risk of fragility fracture are offered drug treatment to reduce fracture risk.","Structure","QS149 - Osteoporosis","2 - QS149 - Osteoporosis",1,"2 - QS149 - Osteoporosis - Structure - 1"]
[null,"QS149","Osteoporosis",2,"Starting drug treatment","Adults at high risk of fragility fracture are offered drug treatment to reduce fracture risk.","Proportion of adults at high risk of fragility fracture receiving drug treatment to reduce fracture risk.","Process","QS149 - Osteoporosis","2 - QS149 - Osteoporosis",1,"2 - QS149 - Osteoporosis - Process - 1","the number in the denominator who receive drug treatment to reduce fracture risk.","the number of adults at high risk of fragility fracture."]
[null,"QS149","Osteoporosis",2,"Starting drug treatment","Adults at high risk of fragility fracture are offered drug treatment to reduce fracture risk.","Incidence of fragility fractures.","Outcome","QS149 - Osteoporosis","2 - QS149 - Osteoporosis",1,"2 - QS149 - Osteoporosis - Outcome - 1"]
[null,"QS149","Osteoporosis",2,"Starting drug treatment","Adults at high risk of fragility fracture are offered drug treatment to reduce fracture risk.","Hospital admission rates for fragility fractures.","Outcome","QS149 - Osteoporosis","2 - QS149 - Osteoporosis",2,"2 - QS149 - Osteoporosis - Outcome - 2"]
[null,"QS149","Osteoporosis",3,"Adverse effects and adherence to treatment","Adults prescribed drug treatment to reduce fracture risk are asked about adverse effects and adherence to treatment at each medication review.","Evidence of local arrangements to ensure that adults prescribed drug treatment to reduce fracture risk are asked about adverse effects and adherence to treatment at each medication review.","Structure","QS149 - Osteoporosis","3 - QS149 - Osteoporosis",1,"3 - QS149 - Osteoporosis - Structure - 1"]
[null,"QS149","Osteoporosis",3,"Adverse effects and adherence to treatment","Adults prescribed drug treatment to reduce fracture risk are asked about adverse effects and adherence to treatment at each medication review.","Proportion of medication reviews for adults prescribed drug treatment to reduce fracture risk that include a record of adverse effects and adherence to treatment.","Process","QS149 - Osteoporosis","3 - QS149 - Osteoporosis",1,"3 - QS149 - Osteoporosis - Process - 1","the number in the denominator that include a record of adverse effects and adherence to treatment.","the number of medication reviews for adults prescribed drug treatment to reduce fracture risk."]
[null,"QS149","Osteoporosis",3,"Adverse effects and adherence to treatment","Adults prescribed drug treatment to reduce fracture risk are asked about adverse effects and adherence to treatment at each medication review.","Adults adhering to drug treatment to reduce fracture risk.","Outcome","QS149 - Osteoporosis","3 - QS149 - Osteoporosis",1,"3 - QS149 - Osteoporosis - Outcome - 1"]
[null,"QS149","Osteoporosis",3,"Adverse effects and adherence to treatment","Adults prescribed drug treatment to reduce fracture risk are asked about adverse effects and adherence to treatment at each medication review.","Incidence of fragility fracture.","Outcome","QS149 - Osteoporosis","3 - QS149 - Osteoporosis",2,"3 - QS149 - Osteoporosis - Outcome - 2"]
[null,"QS149","Osteoporosis",4,"Long-term follow-up","Adults having long-term bisphosphonate therapy have a review of the need for continuing treatment.","Evidence of local arrangements to ensure that adults taking zoledronic acid for 3 years have a review of the need for continuing treatment.","Structure","QS149 - Osteoporosis","4 - QS149 - Osteoporosis",1,"4 - QS149 - Osteoporosis - Structure - 1"]
[null,"QS149","Osteoporosis",4,"Long-term follow-up","Adults having long-term bisphosphonate therapy have a review of the need for continuing treatment.","Evidence of local arrangements to ensure that adults taking alendronate, ibandronate or risedronate for 5 years have a review of the need for continuing treatment.","Structure","QS149 - Osteoporosis","4 - QS149 - Osteoporosis",2,"4 - QS149 - Osteoporosis - Structure - 2"]
[null,"QS149","Osteoporosis",4,"Long-term follow-up","Adults having long-term bisphosphonate therapy have a review of the need for continuing treatment.","Proportion of adults taking zoledronic acid for 3 years who have a review of the need for continuing treatment.","Process","QS149 - Osteoporosis","4 - QS149 - Osteoporosis",1,"4 - QS149 - Osteoporosis - Process - 1","the number in the denominator who have a review of the need for continuing treatment.","the number of adults taking zoledronic acid for 3 years."]
[null,"QS149","Osteoporosis",4,"Long-term follow-up","Adults having long-term bisphosphonate therapy have a review of the need for continuing treatment.","Proportion of adults taking alendronate, ibandronate or risedronate for 5 years who have a review of the need for continuing treatment.","Process","QS149 - Osteoporosis","4 - QS149 - Osteoporosis",2,"4 - QS149 - Osteoporosis - Process - 2","the number in the denominator who have a review of the need for continuing treatment.","the number of adults taking alendronate, ibandronate or risedronate for 5 years."]
[null,"QS149","Osteoporosis",4,"Long-term follow-up","Adults having long-term bisphosphonate therapy have a review of the need for continuing treatment.","Patient satisfaction with long-term bisphosphonate therapy.","Outcome","QS149 - Osteoporosis","4 - QS149 - Osteoporosis",1,"4 - QS149 - Osteoporosis - Outcome - 1"]
[null,"QS149","Osteoporosis",4,"Long-term follow-up","Adults having long-term bisphosphonate therapy have a review of the need for continuing treatment.","Health-related quality of life for adults having long-term bisphosphonate therapy.","Outcome","QS149 - Osteoporosis","4 - QS149 - Osteoporosis",2,"4 - QS149 - Osteoporosis - Outcome - 2"]
[null,"QS150","Haematological cancers",1,null,"People with haematological cancer have an integrated report produced by a specialist integrated haematological malignancy diagnostic service (SIHMDS) that is shared with the haemato-oncology multidisciplinary team (MDT).","Evidence of local arrangements to ensure that people with haematological cancer have an integrated report produced by a SIHMDS, containing all clinical information relevant to management, that is shared with the haemato-oncology MDT.","Structure","QS150 - Haematological cancers","1 - QS150 - Haematological cancers",1,"1 - QS150 - Haematological cancers - Structure - 1"]
[null,"QS150","Haematological cancers",1,null,"People with haematological cancer have an integrated report produced by a specialist integrated haematological malignancy diagnostic service (SIHMDS) that is shared with the haemato-oncology multidisciplinary team (MDT).","Proportion of people with haematological cancer who have an integrated report produced by a SIHMDS.","Process","QS150 - Haematological cancers","1 - QS150 - Haematological cancers",1,"1 - QS150 - Haematological cancers - Process - 1","The number in the denominator who have an integrated report produced by a SIHMDS.","The number of people with haematological cancer."]
[null,"QS150","Haematological cancers",1,null,"People with haematological cancer have an integrated report produced by a specialist integrated haematological malignancy diagnostic service (SIHMDS) that is shared with the haemato-oncology multidisciplinary team (MDT).","Number of integrated reports produced by a SIHMDS that are shared with the haemato-oncology MDT.","Process","QS150 - Haematological cancers","1 - QS150 - Haematological cancers",2,"1 - QS150 - Haematological cancers - Process - 2","The number in the denominator that are shared with the haemato-oncology MDT.","The number of SIHMDS integrated reports."]
[null,"QS150","Haematological cancers",1,null,"People with haematological cancer have an integrated report produced by a specialist integrated haematological malignancy diagnostic service (SIHMDS) that is shared with the haemato-oncology multidisciplinary team (MDT).","Discontinuation of treatment.","Outcome","QS150 - Haematological cancers","1 - QS150 - Haematological cancers",1,"1 - QS150 - Haematological cancers - Outcome - 1"]
[null,"QS150","Haematological cancers",2,null,"Young people and adults with specific subtypes of non-Hodgkin's lymphoma have staging using fluorodeoxyglucose-positron emission tomography-CT (FDG-PET-CT).","Evidence of local arrangements to ensure that young people and adults with specific subtypes of non-Hodgkin's lymphoma have staging using FDG-PET-CT.","Structure","QS150 - Haematological cancers","2 - QS150 - Haematological cancers",1,"2 - QS150 - Haematological cancers - Structure - 1"]
[null,"QS150","Haematological cancers",2,null,"Young people and adults with specific subtypes of non-Hodgkin's lymphoma have staging using fluorodeoxyglucose-positron emission tomography-CT (FDG-PET-CT).","Proportion of young people and adults with stage I diffuse large B-cell lymphoma who have staging using FDG-PET-CT.","Process","QS150 - Haematological cancers","2 - QS150 - Haematological cancers",1,"2 - QS150 - Haematological cancers - Process - 1","The number in the denominator who have staging using FDG-PET-CT.","The number of young people and adults with stage I diffuse large B-cell lymphoma."]
[null,"QS150","Haematological cancers",2,null,"Young people and adults with specific subtypes of non-Hodgkin's lymphoma have staging using fluorodeoxyglucose-positron emission tomography-CT (FDG-PET-CT).","Proportion of young people and adults with stage I or localised stage II follicular lymphoma for whom radiotherapy would be technically possible who have staging using FDG-PET-CT.","Process","QS150 - Haematological cancers","2 - QS150 - Haematological cancers",2,"2 - QS150 - Haematological cancers - Process - 2","The number in the denominator who have staging using FDG-PET-CT.","The number of young people and adults with stage I or localised stage II follicular lymphoma for whom radiotherapy would be technically possible."]
[null,"QS150","Haematological cancers",2,null,"Young people and adults with specific subtypes of non-Hodgkin's lymphoma have staging using fluorodeoxyglucose-positron emission tomography-CT (FDG-PET-CT).","Proportion of young people and adults with stage I or II Burkitt lymphoma with other low-risk features who have staging using FDG-PET-CT.","Process","QS150 - Haematological cancers","2 - QS150 - Haematological cancers",3,"2 - QS150 - Haematological cancers - Process - 3","The number in the denominator who have staging using FDG-PET-CT.","The number of young people and adults with stage I or II Burkitt lymphoma with other low-risk features."]
[null,"QS150","Haematological cancers",2,null,"Young people and adults with specific subtypes of non-Hodgkin's lymphoma have staging using fluorodeoxyglucose-positron emission tomography-CT (FDG-PET-CT).","Number of young people and adults with specific subtypes of non-Hodgkin's lymphoma who have accurate staging.","Outcome","QS150 - Haematological cancers","2 - QS150 - Haematological cancers",1,"2 - QS150 - Haematological cancers - Outcome - 1"]
[null,"QS150","Haematological cancers",2,null,"Young people and adults with specific subtypes of non-Hodgkin's lymphoma have staging using fluorodeoxyglucose-positron emission tomography-CT (FDG-PET-CT).","Treatment appropriate to the subtype of non-Hodgkin's lymphoma.","Outcome","QS150 - Haematological cancers","2 - QS150 - Haematological cancers",2,"2 - QS150 - Haematological cancers - Outcome - 2"]
[null,"QS150","Haematological cancers",3,null,"Young people and adults with localised stage IIA follicular lymphoma have local radiotherapy as first-line treatment.","Evidence of local arrangements to ensure that young people and adults with localised stage IIA follicular lymphoma have local radiotherapy as first-line treatment.","Structure","QS150 - Haematological cancers","3 - QS150 - Haematological cancers",1,"3 - QS150 - Haematological cancers - Structure - 1"]
[null,"QS150","Haematological cancers",3,null,"Young people and adults with localised stage IIA follicular lymphoma have local radiotherapy as first-line treatment.","Proportion of young people and adults with localised stage IIA follicular lymphoma who receive local radiotherapy as first-line treatment.","Process","QS150 - Haematological cancers","3 - QS150 - Haematological cancers",1,"3 - QS150 - Haematological cancers - Process - 1","The number in the denominator who receive local radiotherapy as first-line treatment.","The number of young people and adults with localised stage IIA follicular lymphoma."]
[null,"QS150","Haematological cancers",3,null,"Young people and adults with localised stage IIA follicular lymphoma have local radiotherapy as first-line treatment.","Survival rates for young people and adults with localised stage IIA follicular lymphoma.","Outcome","QS150 - Haematological cancers","3 - QS150 - Haematological cancers",1,"3 - QS150 - Haematological cancers - Outcome - 1"]
[null,"QS150","Haematological cancers",4,null,"Young people and adults who have completed their treatment for non-Hodgkin's lymphoma or myeloma have a discussion about their end-of-treatment summary plan.","Evidence of local arrangements to ensure that young people and adults who have had treatment for non-Hodgkin's lymphoma or myeloma have a discussion about their end-of-treatment summary plan when they complete their treatment.","Structure","QS150 - Haematological cancers","4 - QS150 - Haematological cancers",1,"4 - QS150 - Haematological cancers - Structure - 1"]
[null,"QS150","Haematological cancers",4,null,"Young people and adults who have completed their treatment for non-Hodgkin's lymphoma or myeloma have a discussion about their end-of-treatment summary plan.","Proportion of young people and adults who have completed their treatment for non-Hodgkin's lymphoma and who have a discussion about their end-of-treatment summary plan.","Process","QS150 - Haematological cancers","4 - QS150 - Haematological cancers",1,"4 - QS150 - Haematological cancers - Process - 1","The number in the denominator who have a discussion about their end-of-treatment summary plan.","The number of young people and adults who have completed their treatment for non-Hodgkin's lymphoma."]
[null,"QS150","Haematological cancers",4,null,"Young people and adults who have completed their treatment for non-Hodgkin's lymphoma or myeloma have a discussion about their end-of-treatment summary plan.","Proportion of young people and adults who have completed their treatment for myeloma and who have a discussion about their end-of-treatment summary plan.","Process","QS150 - Haematological cancers","4 - QS150 - Haematological cancers",2,"4 - QS150 - Haematological cancers - Process - 2","The number in the denominator who have a discussion about their end-of-treatment summary plan.","The number of young people and adults who have completed their treatment for myeloma."]
[null,"QS150","Haematological cancers",4,null,"Young people and adults who have completed their treatment for non-Hodgkin's lymphoma or myeloma have a discussion about their end-of-treatment summary plan.","Young people and adults with non-Hodgkin's lymphoma or myeloma feel supported to self-manage their condition.","Outcome","QS150 - Haematological cancers","4 - QS150 - Haematological cancers",1,"4 - QS150 - Haematological cancers - Outcome - 1"]
[null,"QS150","Haematological cancers",4,null,"Young people and adults who have completed their treatment for non-Hodgkin's lymphoma or myeloma have a discussion about their end-of-treatment summary plan.","Early identification of treatment-related morbidity in young people and adults with non-Hodgkin's lymphoma or myeloma.","Outcome","QS150 - Haematological cancers","4 - QS150 - Haematological cancers",2,"4 - QS150 - Haematological cancers - Outcome - 2"]
[null,"QS151","Oral health in care homes",1,null,"Adults who move into a care home have their mouth care needs assessed on admission.","Evidence of local arrangements to ensure that adults have their mouth care needs assessed on admission.","Structure","QS151 - Oral health in care homes","1 - QS151 - Oral health in care homes",1,"1 - QS151 - Oral health in care homes - Structure - 1"]
[null,"QS151","Oral health in care homes",1,null,"Adults who move into a care home have their mouth care needs assessed on admission.","Proportion of adults living in a care home who had their mouth care needs assessed on admission.","Process","QS151 - Oral health in care homes","1 - QS151 - Oral health in care homes",1,"1 - QS151 - Oral health in care homes - Process - 1","The number in the denominator who had their mouth care needs assessed on admission.","The number of adults living in a care home."]
[null,"QS151","Oral health in care homes",1,null,"Adults who move into a care home have their mouth care needs assessed on admission.","Satisfaction of resident or carer with the care home admission process.","Outcome","QS151 - Oral health in care homes","1 - QS151 - Oral health in care homes",1,"1 - QS151 - Oral health in care homes - Outcome - 1"]
[null,"QS151","Oral health in care homes",1,null,"Adults who move into a care home have their mouth care needs assessed on admission.","Satisfaction of resident or carer with the mouth care they receive.","Outcome",{"$f":"CONCATENATE(B3308, \" - \", C3308)","v":"QS151 - Oral health in care homes"},{"$f":"CONCATENATE(D3308, \" - \", I3308)","v":"1 - QS151 - Oral health in care homes"},2,{"$f":"CONCATENATE(J3308, \" - \", H3308, \" - \",K3308)","v":"1 - QS151 - Oral health in care homes - Outcome - 2"}]
[null,"QS151","Oral health in care homes",2,null,"Adults living in care homes have their mouth care needs recorded in their personal care plan.","Evidence of local arrangements for adults living in care homes to have their mouth care needs recorded in their personal care plan.","Structure","QS151 - Oral health in care homes","2 - QS151 - Oral health in care homes",{"$f":"IF(AND(B3309=B3308, D3309=D3308, H3309=H3308)=TRUE, K3308+1, 1)","v":1},"2 - QS151 - Oral health in care homes - Structure - 1"]
[null,"QS151","Oral health in care homes",2,null,"Adults living in care homes have their mouth care needs recorded in their personal care plan.","Proportion of adults living in a care home who have their mouth care needs recorded in their personal care plan.","Process","QS151 - Oral health in care homes","2 - QS151 - Oral health in care homes",1,"2 - QS151 - Oral health in care homes - Process - 1","The number in the denominator who have their mouth care needs recorded in their personal care plan.","The number of adults living in a care home."]
[null,"QS151","Oral health in care homes",2,null,"Adults living in care homes have their mouth care needs recorded in their personal care plan.","Care staff awareness of individual residents' mouth care needs.","Outcome","QS151 - Oral health in care homes","2 - QS151 - Oral health in care homes",1,"2 - QS151 - Oral health in care homes - Outcome - 1"]
[null,"QS151","Oral health in care homes",3,null,"Adults living in care homes are supported to clean their teeth twice a day and to carry out daily care for their dentures.","Evidence of local arrangements for adults living in care homes to be supported to clean their teeth twice a day and carry out daily care for dentures.","Structure","QS151 - Oral health in care homes","3 - QS151 - Oral health in care homes",1,"3 - QS151 - Oral health in care homes - Structure - 1"]
[null,"QS151","Oral health in care homes",3,null,"Adults living in care homes are supported to clean their teeth twice a day and to carry out daily care for their dentures.","Proportion of adults in a care home who are supported with daily mouth care.","Process","QS151 - Oral health in care homes","3 - QS151 - Oral health in care homes",1,"3 - QS151 - Oral health in care homes - Process - 1","The number in the denominator who are supported with daily mouth care.","The number of adults living in a care home."]
[null,"QS151","Oral health in care homes",3,null,"Adults living in care homes are supported to clean their teeth twice a day and to carry out daily care for their dentures.","Oral health-related quality of life for adults living in care homes.","Outcome","QS151 - Oral health in care homes","3 - QS151 - Oral health in care homes",1,"3 - QS151 - Oral health in care homes - Outcome - 1"]
[null,"QS152","Liver disease",1,null,"People with non‑alcoholic fatty liver disease are given advice on physical activity, diet and alcohol.","Evidence of local arrangements to provide advice on physical activity, diet and alcohol to people with NAFLD.","Structure","QS152 - Liver disease","1 - QS152 - Liver disease",1,"1 - QS152 - Liver disease - Structure - 1"]
[null,"QS152","Liver disease",1,null,"People with non‑alcoholic fatty liver disease are given advice on physical activity, diet and alcohol.","Proportion of people with NAFLD who are given advice on physical activity.","Process","QS152 - Liver disease","1 - QS152 - Liver disease",1,"1 - QS152 - Liver disease - Process - 1","The number in the denominator who are given advice on physical activity.","The number of people with NAFLD."]
[null,"QS152","Liver disease",1,null,"People with non‑alcoholic fatty liver disease are given advice on physical activity, diet and alcohol.","Proportion of people with NAFLD who are overweight or obese who are given advice on diet.","Process","QS152 - Liver disease","1 - QS152 - Liver disease",2,"1 - QS152 - Liver disease - Process - 2","The number in the denominator who are given advice on diet.","The number of people with NAFLD who are overweight or obese."]
[null,"QS152","Liver disease",1,null,"People with non‑alcoholic fatty liver disease are given advice on physical activity, diet and alcohol.","Proportion of people with NAFLD who drink alcohol who are given advice on alcohol.","Process","QS152 - Liver disease","1 - QS152 - Liver disease",3,"1 - QS152 - Liver disease - Process - 3","The number in the denominator who are given advice on alcohol.","The number of people with NAFLD who drink alcohol."]
[null,"QS152","Liver disease",1,null,"People with non‑alcoholic fatty liver disease are given advice on physical activity, diet and alcohol.","Awareness of people with NAFLD that lifestyle changes may help them to avoid more serious liver disease.","Outcome","QS152 - Liver disease","1 - QS152 - Liver disease",1,"1 - QS152 - Liver disease - Outcome - 1"]
[null,"QS152","Liver disease",1,null,"People with non‑alcoholic fatty liver disease are given advice on physical activity, diet and alcohol.","Rate of disease progression among people with NAFLD.","Outcome","QS152 - Liver disease","1 - QS152 - Liver disease",2,"1 - QS152 - Liver disease - Outcome - 2"]
[null,"QS152","Liver disease",2,null,"People with non‑alcoholic fatty liver disease are offered regular testing for advanced liver fibrosis.","Evidence of local referral pathways to ensure that people with NAFLD are offered regular testing for advanced liver fibrosis.","Structure","QS152 - Liver disease","2 - QS152 - Liver disease",1,"2 - QS152 - Liver disease - Structure - 1"]
[null,"QS152","Liver disease",2,null,"People with non‑alcoholic fatty liver disease are offered regular testing for advanced liver fibrosis.","Evidence that GP practices and paediatric hepatology services have arrangements to offer regular testing for advanced liver fibrosis to people with NAFLD.","Structure","QS152 - Liver disease","2 - QS152 - Liver disease",2,"2 - QS152 - Liver disease - Structure - 2"]
[null,"QS152","Liver disease",2,null,"People with non‑alcoholic fatty liver disease are offered regular testing for advanced liver fibrosis.","Proportion of people newly diagnosed with NAFLD who are tested for advanced liver fibrosis.","Process","QS152 - Liver disease","2 - QS152 - Liver disease",1,"2 - QS152 - Liver disease - Process - 1","The number in the denominator who are tested for advanced liver fibrosis.","The number of people newly diagnosed with NAFLD."]
[null,"QS152","Liver disease",2,null,"People with non‑alcoholic fatty liver disease are offered regular testing for advanced liver fibrosis.","Proportion of adults with NAFLD identified as having a low risk of advanced liver fibrosis (such as an enhanced liver fibrosis [ELF] score below 10.51) who were tested for advanced liver fibrosis within the past 3 years.","Process","QS152 - Liver disease","2 - QS152 - Liver disease",2,"2 - QS152 - Liver disease - Process - 2","The number in the denominator who were tested for advanced liver fibrosis within the past 3 years.","The number of adults with NAFLD identified as having a low risk of advanced liver fibrosis (such as an ELF score below 10.51)."]
[null,"QS152","Liver disease",2,null,"People with non‑alcoholic fatty liver disease are offered regular testing for advanced liver fibrosis.","Proportion of children and young people with NAFLD identified as having a low risk of advanced liver fibrosis (such as an ELF score below 10.51) who were tested for advanced liver fibrosis within the past 2 years.","Process","QS152 - Liver disease","2 - QS152 - Liver disease",3,"2 - QS152 - Liver disease - Process - 3","The number in the denominator who were tested for advanced liver fibrosis within the past 2 years.","The number of children and young people with NAFLD identified as having a low risk of advanced liver fibrosis (such as an ELF score below 10.51)."]
[null,"QS152","Liver disease",2,null,"People with non‑alcoholic fatty liver disease are offered regular testing for advanced liver fibrosis.","Inappropriate referrals to a specialist for young people and adults with NAFLD.","Outcome","QS152 - Liver disease","2 - QS152 - Liver disease",1,"2 - QS152 - Liver disease - Outcome - 1"]
[null,"QS152","Liver disease",2,null,"People with non‑alcoholic fatty liver disease are offered regular testing for advanced liver fibrosis.","Incidence of advanced liver fibrosis in people with NAFLD.","Outcome","QS152 - Liver disease","2 - QS152 - Liver disease",2,"2 - QS152 - Liver disease - Outcome - 2"]
[null,"QS152","Liver disease",3,null,"Young people and adults with risk factors for cirrhosis are offered non‑invasive testing for cirrhosis.","Evidence of local availability of non-invasive testing for cirrhosis.","Structure","QS152 - Liver disease","3 - QS152 - Liver disease",1,"3 - QS152 - Liver disease - Structure - 1"]
[null,"QS152","Liver disease",3,null,"Young people and adults with risk factors for cirrhosis are offered non‑invasive testing for cirrhosis.","Evidence of local arrangements to ensure that young people and adults with risk factors for cirrhosis are offered non‑invasive testing for cirrhosis.","Structure","QS152 - Liver disease","3 - QS152 - Liver disease",2,"3 - QS152 - Liver disease - Structure - 2"]
[null,"QS152","Liver disease",3,null,"Young people and adults with risk factors for cirrhosis are offered non‑invasive testing for cirrhosis.","Proportion of young people and adults who have been drinking alcohol in a harmful way for several months (for measurement purposes this could be at least 3 months) who receive non‑invasive testing for cirrhosis.","Process","QS152 - Liver disease","3 - QS152 - Liver disease",1,"3 - QS152 - Liver disease - Process - 1","The number in the denominator who receive non‑invasive testing for cirrhosis.","The number of young people and adults who have been drinking alcohol in a harmful way for several months (for measurement purposes this could be at least 3 months)."]
[null,"QS152","Liver disease",3,null,"Young people and adults with risk factors for cirrhosis are offered non‑invasive testing for cirrhosis.","Proportion of young people and adults diagnosed with hepatitis C virus infection who receive non‑invasive testing for cirrhosis.","Process","QS152 - Liver disease","3 - QS152 - Liver disease",2,"3 - QS152 - Liver disease - Process - 2","The number in the denominator who receive non‑invasive testing for cirrhosis.","The number of young people and adults diagnosed with hepatitis C virus infection."]
[null,"QS152","Liver disease",3,null,"Young people and adults with risk factors for cirrhosis are offered non‑invasive testing for cirrhosis.","Proportion of adults newly referred for assessment for hepatitis B virus infection who receive non‑invasive testing for cirrhosis.","Process","QS152 - Liver disease","3 - QS152 - Liver disease",3,"3 - QS152 - Liver disease - Process - 3","The number in the denominator who receive non‑invasive testing for cirrhosis.","The number of adults newly referred for assessment for hepatitis B virus infection."]
[null,"QS152","Liver disease",3,null,"Young people and adults with risk factors for cirrhosis are offered non‑invasive testing for cirrhosis.","Proportion of young people and adults diagnosed with alcohol‑related liver disease who receive non‑invasive testing for cirrhosis.","Process","QS152 - Liver disease","3 - QS152 - Liver disease",4,"3 - QS152 - Liver disease - Process - 4","The number in the denominator who receive non‑invasive testing for cirrhosis.","The number of young people and adults diagnosed with alcohol‑related liver disease."]
[null,"QS152","Liver disease",3,null,"Young people and adults with risk factors for cirrhosis are offered non‑invasive testing for cirrhosis.","Proportion of young people and adults diagnosed with non‑alcoholic fatty liver disease with advanced liver fibrosis who receive non‑invasive testing for cirrhosis.","Process","QS152 - Liver disease","3 - QS152 - Liver disease",5,"3 - QS152 - Liver disease - Process - 5","The number in the denominator who receive non‑invasive testing for cirrhosis.","The number of young people and adults diagnosed with non‑alcoholic fatty liver disease with advanced liver fibrosis."]
[null,"QS152","Liver disease",3,null,"Young people and adults with risk factors for cirrhosis are offered non‑invasive testing for cirrhosis.","Incidence of Cirrhosis","Outcome","QS152 - Liver disease","3 - QS152 - Liver disease",1,"3 - QS152 - Liver disease - Outcome - 1"]
[null,"QS152","Liver disease",4,null,"Adults with cirrhosis are offered 6-monthly surveillance for hepatocellular carcinoma.","Evidence of local arrangements to ensure that adults with cirrhosis are offered 6‑monthly surveillance for hepatocellular carcinoma.","Structure","QS152 - Liver disease","4 - QS152 - Liver disease",1,"4 - QS152 - Liver disease - Structure - 1"]
[null,"QS152","Liver disease",4,null,"Adults with cirrhosis are offered 6-monthly surveillance for hepatocellular carcinoma.","Proportion of adults with cirrhosis who received ultrasound surveillance for hepatocellular carcinoma within the past 6 months.","Process","QS152 - Liver disease","4 - QS152 - Liver disease",1,"4 - QS152 - Liver disease - Process - 1","The number in the denominator who received ultrasound surveillance for hepatocellular carcinoma within the past 6 months.","The number of adults with cirrhosis."]
[null,"QS152","Liver disease",4,null,"Adults with cirrhosis are offered 6-monthly surveillance for hepatocellular carcinoma.","Proportion of adults with cirrhosis who are diagnosed with hepatocellular carcinoma at an early stage.","Outcome","QS152 - Liver disease","4 - QS152 - Liver disease",1,"4 - QS152 - Liver disease - Outcome - 1","The number in the denominator who are diagnosed with hepatocellular carcinoma at an early stage.","The number of adults with cirrhosis who are diagnosed with hepatocellular carcinoma."]
[null,"QS152","Liver disease",4,null,"Adults with cirrhosis are offered 6-monthly surveillance for hepatocellular carcinoma.","Hepatocellular carcinoma survival rates.","Outcome","QS152 - Liver disease","4 - QS152 - Liver disease",2,"4 - QS152 - Liver disease - Outcome - 2"]
[null,"QS152","Liver disease",5,null,"Young people and adults with cirrhosis and upper gastrointestinal bleeding are given prophylactic intravenous antibiotics at presentation.","Evidence of local arrangements to ensure that young people and adults with cirrhosis and upper gastrointestinal bleeding are given prophylactic intravenous antibiotics at presentation.","Structure","QS152 - Liver disease","5 - QS152 - Liver disease",1,"5 - QS152 - Liver disease - Structure - 1"]
[null,"QS152","Liver disease",5,null,"Young people and adults with cirrhosis and upper gastrointestinal bleeding are given prophylactic intravenous antibiotics at presentation.","Proportion of presentations of young people and adults with cirrhosis and upper gastrointestinal bleeding in which the person receives prophylactic intravenous antibiotics at presentation.","Process","QS152 - Liver disease","5 - QS152 - Liver disease",1,"5 - QS152 - Liver disease - Process - 1","The number in the denominator in which the person receives prophylactic intravenous antibiotics at presentation.","The number of presentations of young people and adults with cirrhosis and upper gastrointestinal bleeding."]
[null,"QS152","Liver disease",5,null,"Young people and adults with cirrhosis and upper gastrointestinal bleeding are given prophylactic intravenous antibiotics at presentation.","Rate of bacterial infection in young people and adults with cirrhosis and upper gastrointestinal bleeding.","Outcome","QS152 - Liver disease","5 - QS152 - Liver disease",1,"5 - QS152 - Liver disease - Outcome - 1"]
[null,"QS152","Liver disease",5,null,"Young people and adults with cirrhosis and upper gastrointestinal bleeding are given prophylactic intravenous antibiotics at presentation.","Length of hospital stay for young people and adults with cirrhosis and upper gastrointestinal bleeding.","Outcome","QS152 - Liver disease","5 - QS152 - Liver disease",2,"5 - QS152 - Liver disease - Outcome - 2"]
[null,"QS152","Liver disease",5,null,"Young people and adults with cirrhosis and upper gastrointestinal bleeding are given prophylactic intravenous antibiotics at presentation.","Hospital re-admission rate for young people and adults with cirrhosis and upper gastrointestinal bleeding.","Outcome","QS152 - Liver disease","5 - QS152 - Liver disease",3,"5 - QS152 - Liver disease - Outcome - 3"]
[null,"QS152","Liver disease",5,null,"Young people and adults with cirrhosis and upper gastrointestinal bleeding are given prophylactic intravenous antibiotics at presentation.","Mortality rate in young people and adults with cirrhosis and upper gastrointestinal bleeding.","Outcome","QS152 - Liver disease","5 - QS152 - Liver disease",4,"5 - QS152 - Liver disease - Outcome - 4"]
[null,"QS153","Multimorbidity",1,null,"Adults with multimorbidity are identified by their GP practice.","Evidence that GP practices identify all adults with multimorbidity.","Structure","QS153 - Multimorbidity","1 - QS153 - Multimorbidity",1,"1 - QS153 - Multimorbidity - Structure - 1"]
[null,"QS153","Multimorbidity",1,null,"Adults with multimorbidity are identified by their GP practice.","Proportion of adults with multimorbidity identified by the GP practice.","Process","QS153 - Multimorbidity","1 - QS153 - Multimorbidity",1,"1 - QS153 - Multimorbidity - Process - 1","The number in the denominator identified as having multimorbidity by the GP practice.","The number of adults registered with the GP practice."]
[null,"QS153","Multimorbidity",1,null,"Adults with multimorbidity are identified by their GP practice.","Number of adults with multimorbidity identified by the GP practice who may benefit from an approach to care that takes account of multimorbidity.","Outcome","QS153 - Multimorbidity","1 - QS153 - Multimorbidity",1,"1 - QS153 - Multimorbidity - Outcome - 1"]
[null,"QS153","Multimorbidity",2,null,"Adults with an individualised management plan for multimorbidity are given opportunities to discuss their values, priorities and goals.","Evidence of local arrangements to ensure that adults with an individualised management plan for multimorbidity are given opportunities to discuss their values, priorities and goals.","Structure","QS153 - Multimorbidity","2 - QS153 - Multimorbidity",1,"2 - QS153 - Multimorbidity - Structure - 1"]
[null,"QS153","Multimorbidity",2,null,"Adults with an individualised management plan for multimorbidity are given opportunities to discuss their values, priorities and goals.","Proportion of adults with an individualised management plan for multimorbidity whose plan has a record of values, priorities and goals.","Process","QS153 - Multimorbidity","2 - QS153 - Multimorbidity",1,"2 - QS153 - Multimorbidity - Process - 1","The number in the denominator whose individualised management plan has a record of values, priorities and goals.","The number of adults with an individualised management plan for multimorbidity."]
[null,"QS153","Multimorbidity",2,null,"Adults with an individualised management plan for multimorbidity are given opportunities to discuss their values, priorities and goals.","Adults with an individualised management plan for multimorbidity feel that the decisions about their treatment have taken into account their values, priorities and goals.","Outcome","QS153 - Multimorbidity","2 - QS153 - Multimorbidity",1,"2 - QS153 - Multimorbidity - Outcome - 1"]
[null,"QS153","Multimorbidity",3,null,"Adults with an individualised management plan for multimorbidity know who is responsible for coordinating their care.","Evidence of local arrangements to ensure that adults with an individualised management plan for multimorbidity know who is responsible for coordinating their care.","Structure","QS153 - Multimorbidity","3 - QS153 - Multimorbidity",1,"3 - QS153 - Multimorbidity - Structure - 1"]
[null,"QS153","Multimorbidity",3,null,"Adults with an individualised management plan for multimorbidity know who is responsible for coordinating their care.","Proportion of adults with an individualised management plan for multimorbidity whose plan states who is responsible for coordinating their care.","Process","QS153 - Multimorbidity","3 - QS153 - Multimorbidity",1,"3 - QS153 - Multimorbidity - Process - 1","The number in the denominator whose individualised management plan states who is responsible for coordinating their care.","The number of adults with an individualised management plan for multimorbidity."]
[null,"QS153","Multimorbidity",3,null,"Adults with an individualised management plan for multimorbidity know who is responsible for coordinating their care.","Number of adults with an individualised management plan for multimorbidity who feel they were involved in the discussion about who is responsible for coordinating their care.","Outcome","QS153 - Multimorbidity","3 - QS153 - Multimorbidity",1,"3 - QS153 - Multimorbidity - Outcome - 1"]
[null,"QS153","Multimorbidity",3,null,"Adults with an individualised management plan for multimorbidity know who is responsible for coordinating their care.","Number of adults with an individualised management plan for multimorbidity who know which healthcare professional is coordinating their care.","Outcome","QS153 - Multimorbidity","3 - QS153 - Multimorbidity",2,"3 - QS153 - Multimorbidity - Outcome - 2"]
[null,"QS153","Multimorbidity",4,null,"Adults having a review of their medicines and other treatments for multimorbidity discuss whether any can be stopped or changed.","Evidence of local arrangements to ensure that adults having a review of their medicines and other treatments for multimorbidity discuss whether any can be stopped or changed.","Structure","QS153 - Multimorbidity","4 - QS153 - Multimorbidity",1,"4 - QS153 - Multimorbidity - Structure - 1"]
[null,"QS153","Multimorbidity",4,null,"Adults having a review of their medicines and other treatments for multimorbidity discuss whether any can be stopped or changed.","Proportion of adults having a review of their medicines and other treatments for multimorbidity who discussed whether any could be stopped or changed.","Process","QS153 - Multimorbidity","4 - QS153 - Multimorbidity",1,"4 - QS153 - Multimorbidity - Process - 1","The number in the denominator who discussed whether any treatments could be stopped or changed.","The number of adults having a review of their medicines and other treatments for multimorbidity."]
[null,"QS153","Multimorbidity",4,null,"Adults having a review of their medicines and other treatments for multimorbidity discuss whether any can be stopped or changed.","Number of adverse events from medicines in adults with multimorbidity.","Outcome","QS153 - Multimorbidity","4 - QS153 - Multimorbidity",1,"4 - QS153 - Multimorbidity - Outcome - 1"]
[null,"QS153","Multimorbidity",4,null,"Adults having a review of their medicines and other treatments for multimorbidity discuss whether any can be stopped or changed.","Adults having a review of their medicines and other treatments for multimorbidity feel that the decisions about their treatments have taken into account the outcomes they felt were important.","Outcome","QS153 - Multimorbidity","4 - QS153 - Multimorbidity",2,"4 - QS153 - Multimorbidity - Outcome - 2"]
[null,"QS153","Multimorbidity",4,null,"Adults having a review of their medicines and other treatments for multimorbidity discuss whether any can be stopped or changed.","Adults having a review of their medicines and other treatments for multimorbidity feel that their treatment burden is reduced.","Outcome","QS153 - Multimorbidity","4 - QS153 - Multimorbidity",3,"4 - QS153 - Multimorbidity - Outcome - 3"]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",1,null,"People in contact with mental health services who have been violent or aggressive are supported to identify triggers and early warning signs for these behaviours.","Evidence of local arrangements to ensure that people in contact with mental health services who have been violent or aggressive while receiving support in mental health, health or community settings have identified triggers and early warning signs for these behaviours included in their care plan.","Structure","QS154 - Violent and aggressive behaviours in people with mental health problems","1 - QS154 - Violent and aggressive behaviours in people with mental health problems",1,"1 - QS154 - Violent and aggressive behaviours in people with mental health problems - Structure - 1"]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",1,null,"People in contact with mental health services who have been violent or aggressive are supported to identify triggers and early warning signs for these behaviours.","Proportion of people in contact with mental health services who have been violent or aggressive while receiving support in mental health, health or community settings whose care plan includes identified triggers and early warning signs for these behaviours.","Process","QS154 - Violent and aggressive behaviours in people with mental health problems","1 - QS154 - Violent and aggressive behaviours in people with mental health problems",1,"1 - QS154 - Violent and aggressive behaviours in people with mental health problems - Process - 1","The number in the denominator with a care plan that includes any identified triggers and early warning signs.","The number of people in contact with mental health services who have been violent or aggressive while receiving support in mental health, health or community settings."]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",1,null,"People in contact with mental health services who have been violent or aggressive are supported to identify triggers and early warning signs for these behaviours.","Service user experience of involvement in managing violent and aggressive behaviours.","Outcome","QS154 - Violent and aggressive behaviours in people with mental health problems","1 - QS154 - Violent and aggressive behaviours in people with mental health problems",1,"1 - QS154 - Violent and aggressive behaviours in people with mental health problems - Outcome - 1"]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",1,null,"People in contact with mental health services who have been violent or aggressive are supported to identify triggers and early warning signs for these behaviours.","Number of incidents needing restrictive interventions including observation, seclusion, manual restraint, mechanical restraint and rapid tranquillisation.","Outcome","QS154 - Violent and aggressive behaviours in people with mental health problems","1 - QS154 - Violent and aggressive behaviours in people with mental health problems",2,"1 - QS154 - Violent and aggressive behaviours in people with mental health problems - Outcome - 2"]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",2,null,"People in contact with mental health services who have been violent or aggressive are supported to identify successful de-escalation techniques and make advance statements about the use of restrictive interventions.","Evidence of local arrangements to ensure that people in contact with mental health services who have been violent or aggressive while receiving support in mental health, health or community settings have any identified de‑escalation techniques that have been successful and advance statements about the use of restrictive interventions included in their care plan.","Structure","QS154 - Violent and aggressive behaviours in people with mental health problems","2 - QS154 - Violent and aggressive behaviours in people with mental health problems",1,"2 - QS154 - Violent and aggressive behaviours in people with mental health problems - Structure - 1"]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",2,null,"People in contact with mental health services who have been violent or aggressive are supported to identify successful de-escalation techniques and make advance statements about the use of restrictive interventions.","Proportion of people in contact with mental health services who have been violent or aggressive while receiving support in mental health, health or community settings whose care plan identifies de-escalation techniques that have been successful.","Process","QS154 - Violent and aggressive behaviours in people with mental health problems","2 - QS154 - Violent and aggressive behaviours in people with mental health problems",1,"2 - QS154 - Violent and aggressive behaviours in people with mental health problems - Process - 1","The number in the denominator with a care plan that includes any identified de-escalation techniques that have been successful.","The number of people in contact with mental health services who have been violent or aggressive while receiving support in mental health, health or community settings."]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",2,null,"People in contact with mental health services who have been violent or aggressive are supported to identify successful de-escalation techniques and make advance statements about the use of restrictive interventions.","Proportion of people in contact with mental health services who have been violent or aggressive while receiving support in mental health, health or community settings whose care plan includes advance statements about the use of restrictive interventions.","Process","QS154 - Violent and aggressive behaviours in people with mental health problems","2 - QS154 - Violent and aggressive behaviours in people with mental health problems",2,"2 - QS154 - Violent and aggressive behaviours in people with mental health problems - Process - 2","The number in the denominator with a care plan that includes advance statements about the use of restrictive interventions.","The number of people in contact with mental health services who have been violent or aggressive while receiving support in mental health, health or community settings."]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",2,null,"People in contact with mental health services who have been violent or aggressive are supported to identify successful de-escalation techniques and make advance statements about the use of restrictive interventions.","Service user experience of managing violent and aggressive behaviours.","Outcome","QS154 - Violent and aggressive behaviours in people with mental health problems","2 - QS154 - Violent and aggressive behaviours in people with mental health problems",1,"2 - QS154 - Violent and aggressive behaviours in people with mental health problems - Outcome - 1"]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",2,null,"People in contact with mental health services who have been violent or aggressive are supported to identify successful de-escalation techniques and make advance statements about the use of restrictive interventions.","Number of incidents requiring restrictive interventions including observation, seclusion, manual restraint, mechanical restraint and rapid tranquillisation.","Outcome","QS154 - Violent and aggressive behaviours in people with mental health problems","2 - QS154 - Violent and aggressive behaviours in people with mental health problems",2,"2 - QS154 - Violent and aggressive behaviours in people with mental health problems - Outcome - 2"]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",3,null,"People with a mental health problem who are manually restrained have their physical health monitored during and after restraint.","Evidence of local arrangements to ensure that people with a mental health problem who are manually restrained have their physical health monitored during and after manual restraint.","Structure","QS154 - Violent and aggressive behaviours in people with mental health problems","3 - QS154 - Violent and aggressive behaviours in people with mental health problems",1,"3 - QS154 - Violent and aggressive behaviours in people with mental health problems - Structure - 1"]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",3,null,"People with a mental health problem who are manually restrained have their physical health monitored during and after restraint.","Proportion of incidents involving manual restraint of a person with a mental health problem in which physical health was monitored during the restraint.","Process","QS154 - Violent and aggressive behaviours in people with mental health problems","3 - QS154 - Violent and aggressive behaviours in people with mental health problems",1,"3 - QS154 - Violent and aggressive behaviours in people with mental health problems - Process - 1","The number in the denominator in which physical health was monitored during the restraint.","The number of incidents involving manual restraint of a person with a mental health problem."]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",3,null,"People with a mental health problem who are manually restrained have their physical health monitored during and after restraint.","Proportion of incidents involving manual restraint of a person with a mental health problem in which physical health was monitored after manual restraint.","Process",{"$f":"CONCATENATE(B3372, \" - \", C3372)","v":"QS154 - Violent and aggressive behaviours in people with mental health problems"},{"$f":"CONCATENATE(D3372, \" - \", I3372)","v":"3 - QS154 - Violent and aggressive behaviours in people with mental health problems"},2,{"$f":"CONCATENATE(J3372, \" - \", H3372, \" - \",K3372)","v":"3 - QS154 - Violent and aggressive behaviours in people with mental health problems - Process - 2"},"The number in the denominator in which physical health was monitored after manual restraint.","The number of incidents involving manual restraint of a person with a mental health problem."]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",3,null,"People with a mental health problem who are manually restrained have their physical health monitored during and after restraint.","Proportion of incidents involving manual restraint of a person with a mental health problem where harm to the person occurred.","Outcome","QS154 - Violent and aggressive behaviours in people with mental health problems","3 - QS154 - Violent and aggressive behaviours in people with mental health problems",{"$f":"IF(AND(B3373=B3372, D3373=D3372, H3373=H3372)=TRUE, K3372+1, 1)","v":1},"3 - QS154 - Violent and aggressive behaviours in people with mental health problems - Outcome - 1"]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",4,null,"People with a mental health problem who are given rapid tranquillisation have side effects, vital signs, hydration level and consciousness monitored after the intervention.","Evidence of local arrangements to ensure that people with a mental health problem who are given rapid tranquillisation have side effects, vital signs, hydration level and consciousness monitored.","Structure","QS154 - Violent and aggressive behaviours in people with mental health problems","4 - QS154 - Violent and aggressive behaviours in people with mental health problems",1,"4 - QS154 - Violent and aggressive behaviours in people with mental health problems - Structure - 1"]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",4,null,"People with a mental health problem who are given rapid tranquillisation have side effects, vital signs, hydration level and consciousness monitored after the intervention.","Proportion of incidents involving rapid tranquillisation of people with a mental health problem in which side effects, vital signs, hydration level and consciousness were monitored after the intervention.","Process","QS154 - Violent and aggressive behaviours in people with mental health problems","4 - QS154 - Violent and aggressive behaviours in people with mental health problems",1,"4 - QS154 - Violent and aggressive behaviours in people with mental health problems - Process - 1","The number in the denominator in which side effects, vital signs, hydration level and consciousness were monitored after the intervention.","The number of incidents involving rapid tranquillisation of people with a mental health problem."]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",4,null,"People with a mental health problem who are given rapid tranquillisation have side effects, vital signs, hydration level and consciousness monitored after the intervention.","Proportion of incidents involving rapid tranquillisation of a person with a mental health problem where harm to the person occurred.","Outcome","QS154 - Violent and aggressive behaviours in people with mental health problems","4 - QS154 - Violent and aggressive behaviours in people with mental health problems",1,"4 - QS154 - Violent and aggressive behaviours in people with mental health problems - Outcome - 1"]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",5,null,"People with a mental health problem who experience restraint, rapid tranquillisation or seclusion are involved in an immediate post-incident debrief.","Evidence of local arrangements to ensure that the service carries out an immediate post-incident debrief after each incident when restraint, rapid tranquillisation or seclusion was used.","Structure","QS154 - Violent and aggressive behaviours in people with mental health problems","5 - QS154 - Violent and aggressive behaviours in people with mental health problems",1,"5 - QS154 - Violent and aggressive behaviours in people with mental health problems - Structure - 1"]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",5,null,"People with a mental health problem who experience restraint, rapid tranquillisation or seclusion are involved in an immediate post-incident debrief.","Evidence of local arrangements to ensure that people with a mental health problem who experience restraint, rapid tranquillisation or seclusion are involved in an immediate post-incident debrief.","Structure","QS154 - Violent and aggressive behaviours in people with mental health problems","5 - QS154 - Violent and aggressive behaviours in people with mental health problems",2,"5 - QS154 - Violent and aggressive behaviours in people with mental health problems - Structure - 2"]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",5,null,"People with a mental health problem who experience restraint, rapid tranquillisation or seclusion are involved in an immediate post-incident debrief.","Proportion of incidents involving a person with a mental health problem where the person was involved in the immediate post-incident debrief.","Process","QS154 - Violent and aggressive behaviours in people with mental health problems","5 - QS154 - Violent and aggressive behaviours in people with mental health problems",1,"5 - QS154 - Violent and aggressive behaviours in people with mental health problems - Process - 1","The number in the denominator where the person was involved in the immediate post-incident debrief.","The number of incidents involving a person with a mental health problem."]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",5,null,"People with a mental health problem who experience restraint, rapid tranquillisation or seclusion are involved in an immediate post-incident debrief.","Service user experience of post-incident debriefs.","Outcome","QS154 - Violent and aggressive behaviours in people with mental health problems","5 - QS154 - Violent and aggressive behaviours in people with mental health problems",1,"5 - QS154 - Violent and aggressive behaviours in people with mental health problems - Outcome - 1"]
[null,"QS154","Violent and aggressive behaviours in people with mental health problems",5,null,"People with a mental health problem who experience restraint, rapid tranquillisation or seclusion are involved in an immediate post-incident debrief.","Reduced number of incidents.","Outcome","QS154 - Violent and aggressive behaviours in people with mental health problems","5 - QS154 - Violent and aggressive behaviours in people with mental health problems",2,"5 - QS154 - Violent and aggressive behaviours in people with mental health problems - Outcome - 2"]
[null,"QS155","Low back pain and sciatica in over 16s",1,null,"Primary care services have an approach to risk stratification for young people and adults presenting with a new episode of low back pain with or without sciatica.","Evidence of a locally defined approach to risk stratification and of systems in place to make staff aware of the approach.","Structure","QS155 - Low back pain and sciatica in over 16s","1 - QS155 - Low back pain and sciatica in over 16s",1,"1 - QS155 - Low back pain and sciatica in over 16s - Structure - 1"]
[null,"QS155","Low back pain and sciatica in over 16s",2,null,"Young people and adults with low back pain with or without sciatica do not have imaging requested by a non-specialist service unless serious underlying pathology is suspected.","Evidence of local arrangements for young people and adults with low back pain with or without sciatica to be referred for specialist opinion.","Structure","QS155 - Low back pain and sciatica in over 16s","2 - QS155 - Low back pain and sciatica in over 16s",1,"2 - QS155 - Low back pain and sciatica in over 16s - Structure - 1"]
[null,"QS155","Low back pain and sciatica in over 16s",2,null,"Young people and adults with low back pain with or without sciatica do not have imaging requested by a non-specialist service unless serious underlying pathology is suspected.","Evidence of local protocols outlining serious underlying pathology in relation to presentations of low back pain with or without sciatica.","Structure","QS155 - Low back pain and sciatica in over 16s","2 - QS155 - Low back pain and sciatica in over 16s",2,"2 - QS155 - Low back pain and sciatica in over 16s - Structure - 2"]
[null,"QS155","Low back pain and sciatica in over 16s",2,null,"Young people and adults with low back pain with or without sciatica do not have imaging requested by a non-specialist service unless serious underlying pathology is suspected.","Proportion of young people and adults with low back pain with or without sciatica who have imaging requested by a non-specialist service when no serious underlying pathology is suspected.","Process","QS155 - Low back pain and sciatica in over 16s","2 - QS155 - Low back pain and sciatica in over 16s",1,"2 - QS155 - Low back pain and sciatica in over 16s - Process - 1","The number in the denominator who have imaging requested by a non-specialist service.","The number of young people and adults with low back pain with or without sciatica for whom there is no suspicion of serious underlying pathology."]
[null,"QS155","Low back pain and sciatica in over 16s",3,null,"Young people and adults with low back pain with or without sciatica are given advice and information to self-manage their condition.","Evidence of local arrangements to ensure that staff have access to information and the knowledge needed to signpost to other services for young people and adults with low back pain with or without sciatica.","Structure","QS155 - Low back pain and sciatica in over 16s","3 - QS155 - Low back pain and sciatica in over 16s",1,"3 - QS155 - Low back pain and sciatica in over 16s - Structure - 1"]
[null,"QS155","Low back pain and sciatica in over 16s",3,null,"Young people and adults with low back pain with or without sciatica are given advice and information to self-manage their condition.","Proportion of young people and adults with low back pain with or without sciatica who are given advice and information to self-manage their condition.","Process","QS155 - Low back pain and sciatica in over 16s","3 - QS155 - Low back pain and sciatica in over 16s",1,"3 - QS155 - Low back pain and sciatica in over 16s - Process - 1","The number in the denominator who are given advice and information to self-manage their condition.","The number of young people and adults with low back pain with or without sciatica."]
[null,"QS155","Low back pain and sciatica in over 16s",3,null,"Young people and adults with low back pain with or without sciatica are given advice and information to self-manage their condition.","Number of repeat GP appointments for young people and adults with low back pain with or without sciatica.","Outcome","QS155 - Low back pain and sciatica in over 16s","3 - QS155 - Low back pain and sciatica in over 16s",1,"3 - QS155 - Low back pain and sciatica in over 16s - Outcome - 1"]
[null,"QS155","Low back pain and sciatica in over 16s",3,null,"Young people and adults with low back pain with or without sciatica are given advice and information to self-manage their condition.","Levels of satisfaction amongst young people and adults with the management of their low back pain with or without sciatica.","Outcome","QS155 - Low back pain and sciatica in over 16s","3 - QS155 - Low back pain and sciatica in over 16s",2,"3 - QS155 - Low back pain and sciatica in over 16s - Outcome - 2"]
[null,"QS155","Low back pain and sciatica in over 16s",4,null,"Young people and adults are not given paracetamol alone, anticonvulsants or antidepressants to treat low back pain without sciatica.","Evidence of local arrangements to ensure that no GP prescriptions include paracetamol alone, anticonvulsants or antidepressants to treat young people and adults with low back pain without sciatica unless the young person or adult has other indications for those medicines.","Structure","QS155 - Low back pain and sciatica in over 16s","4 - QS155 - Low back pain and sciatica in over 16s",1,"4 - QS155 - Low back pain and sciatica in over 16s - Structure - 1"]
[null,"QS155","Low back pain and sciatica in over 16s",4,null,"Young people and adults are not given paracetamol alone, anticonvulsants or antidepressants to treat low back pain without sciatica.","Proportion of young people and adults with low back pain without sciatica, who are given anticonvulsants and have no other indications for them.","Process","QS155 - Low back pain and sciatica in over 16s","4 - QS155 - Low back pain and sciatica in over 16s",1,"4 - QS155 - Low back pain and sciatica in over 16s - Process - 1","The number in the denominator who are given anticonvulsants.","The number of young people and adults with low back pain without sciatica and no other indications for anticonvulsants."]
[null,"QS155","Low back pain and sciatica in over 16s",4,null,"Young people and adults are not given paracetamol alone, anticonvulsants or antidepressants to treat low back pain without sciatica.","Proportion of young people and adults with low back pain without sciatica, who are given antidepressants and have no other indications for them.","Process","QS155 - Low back pain and sciatica in over 16s","4 - QS155 - Low back pain and sciatica in over 16s",2,"4 - QS155 - Low back pain and sciatica in over 16s - Process - 2","The number in the denominator who are given antidepressants.","The number of young people and adults with low back pain without sciatica and no other indications for antidepressants."]
[null,"QS155","Low back pain and sciatica in over 16s",4,null,"Young people and adults are not given paracetamol alone, anticonvulsants or antidepressants to treat low back pain without sciatica.","Proportion of young people and adults with low back pain without sciatica, who are given paracetamol alone and have no other indications for it.","Process","QS155 - Low back pain and sciatica in over 16s","4 - QS155 - Low back pain and sciatica in over 16s",3,"4 - QS155 - Low back pain and sciatica in over 16s - Process - 3","The number in the denominator who are given paracetamol alone.","The number of young people and adults with low back pain without sciatica and no other indications for paracetamol."]
[null,"QS155","Low back pain and sciatica in over 16s",4,null,"Young people and adults are not given paracetamol alone, anticonvulsants or antidepressants to treat low back pain without sciatica.","Number of medicines-related adverse events for young people and adults with low back pain without sciatica.","Outcome",{"$f":"CONCATENATE(B3394, \" - \", C3394)","v":"QS155 - Low back pain and sciatica in over 16s"},{"$f":"CONCATENATE(D3394, \" - \", I3394)","v":"4 - QS155 - Low back pain and sciatica in over 16s"},{"$f":"IF(AND(B3394=B3393, D3394=D3393, H3394=H3393)=TRUE, K3393+1, 1)","v":1},{"$f":"CONCATENATE(J3394, \" - \", H3394, \" - \",K3394)","v":"4 - QS155 - Low back pain and sciatica in over 16s - Outcome - 1"}]
[null,"QS155","Low back pain and sciatica in over 16s",5,null,"Young people and adults are not given opioids to treat chronic low back pain without sciatica.","Evidence of local arrangements to ensure that no GP prescriptions include opioids to treat young people and adults with chronic low back pain without sciatica unless they have other indications for those medicines.","Structure","QS155 - Low back pain and sciatica in over 16s","5 - QS155 - Low back pain and sciatica in over 16s",1,"5 - QS155 - Low back pain and sciatica in over 16s - Structure - 1"]
[null,"QS155","Low back pain and sciatica in over 16s",5,null,"Young people and adults are not given opioids to treat chronic low back pain without sciatica.","Proportion of young people and adults who are given opioids to treat chronic low back pain without sciatica and have no other indications for them.","Process","QS155 - Low back pain and sciatica in over 16s","5 - QS155 - Low back pain and sciatica in over 16s",1,"5 - QS155 - Low back pain and sciatica in over 16s - Process - 1","The number in the denominator who are given opioids.","The number of young people and adults with chronic low back pain without sciatica and no other indications for opioids."]
[null,"QS155","Low back pain and sciatica in over 16s",5,null,"Young people and adults are not given opioids to treat chronic low back pain without sciatica.","Number of opioids-related adverse events for young people and adults with chronic low back pain without sciatica.","Outcome","QS155 - Low back pain and sciatica in over 16s","5 - QS155 - Low back pain and sciatica in over 16s",1,"5 - QS155 - Low back pain and sciatica in over 16s - Outcome - 1"]
[null,"QS155","Low back pain and sciatica in over 16s",6,null,"Young people and adults do not have spinal injections for low back pain without sciatica with the exception of radiofrequency denervation for people who meet the criteria.","Evidence of local arrangements to ensure that spinal injections are not given to young people and adults to treat low back pain without sciatica, with the exception of radiofrequency denervation for people who meet the criteria.","Structure","QS155 - Low back pain and sciatica in over 16s","6 - QS155 - Low back pain and sciatica in over 16s",1,"6 - QS155 - Low back pain and sciatica in over 16s - Structure - 1"]
[null,"QS155","Low back pain and sciatica in over 16s",6,null,"Young people and adults do not have spinal injections for low back pain without sciatica with the exception of radiofrequency denervation for people who meet the criteria.","Proportion of young people and adults who have spinal injections for low back pain without sciatica who meet the criteria for radiofrequency denervation.","Process","QS155 - Low back pain and sciatica in over 16s","6 - QS155 - Low back pain and sciatica in over 16s",1,"6 - QS155 - Low back pain and sciatica in over 16s - Process - 1","The number in the denominator who meet the criteria for radiofrequency denervation.","The number of young people and adults who have spinal injections for low back pain without sciatica."]
[null,"QS156","Physical health of people in prisons",1,null,"People entering or transferring between prisons have a medicines reconciliation carried out before their second-stage health assessment.","Evidence of local arrangements to ensure that an accurate list of a person's current medicines is obtained from the person's GP, other healthcare professionals and, where appropriate, the transferring prison healthcare team.","Structure","QS156 - Physical health of people in prisons","1 - QS156 - Physical health of people in prisons",1,"1 - QS156 - Physical health of people in prisons - Structure - 1"]
[null,"QS156","Physical health of people in prisons",1,null,"People entering or transferring between prisons have a medicines reconciliation carried out before their second-stage health assessment.","Evidence of local arrangements to ensure that a list of the medicines currently being taken by a person is obtained from them.","Structure","QS156 - Physical health of people in prisons","1 - QS156 - Physical health of people in prisons",2,"1 - QS156 - Physical health of people in prisons - Structure - 2"]
[null,"QS156","Physical health of people in prisons",1,null,"People entering or transferring between prisons have a medicines reconciliation carried out before their second-stage health assessment.","Evidence of local arrangements to ensure that medicines reconciliation is carried out before the second-stage health assessment.","Structure","QS156 - Physical health of people in prisons","1 - QS156 - Physical health of people in prisons",3,"1 - QS156 - Physical health of people in prisons - Structure - 3"]
[null,"QS156","Physical health of people in prisons",1,null,"People entering or transferring between prisons have a medicines reconciliation carried out before their second-stage health assessment.","Proportion of second-stage health assessments for people entering or transferring between prisons where medicines reconciliation has already been carried out.","Process","QS156 - Physical health of people in prisons","1 - QS156 - Physical health of people in prisons",1,"1 - QS156 - Physical health of people in prisons - Process - 1","The number in the denominator where a medicines reconciliation was carried out before the second-stage health assessment.","The number of second-stage health assessments for people entering or transferring between prisons."]
[null,"QS156","Physical health of people in prisons",1,null,"People entering or transferring between prisons have a medicines reconciliation carried out before their second-stage health assessment.","Number of adverse medication events in prison.","Outcome","QS156 - Physical health of people in prisons","1 - QS156 - Physical health of people in prisons",1,"1 - QS156 - Physical health of people in prisons - Outcome - 1"]
[null,"QS156","Physical health of people in prisons",1,null,"People entering or transferring between prisons have a medicines reconciliation carried out before their second-stage health assessment.","Number of hospital admissions of people in prison because of adverse medication events.","Outcome","QS156 - Physical health of people in prisons","1 - QS156 - Physical health of people in prisons",2,"1 - QS156 - Physical health of people in prisons - Outcome - 2"]
[null,"QS156","Physical health of people in prisons",2,null,"People entering or transferring between prisons have a second-stage health assessment within 7 days.","Evidence of local arrangements to ensure that prison healthcare services are available to carry out a second-stage health assessment within 7 days of people entering or transferring between prisons.","Structure","QS156 - Physical health of people in prisons","2 - QS156 - Physical health of people in prisons",1,"2 - QS156 - Physical health of people in prisons - Structure - 1"]
[null,"QS156","Physical health of people in prisons",2,null,"People entering or transferring between prisons have a second-stage health assessment within 7 days.","Proportion of prison stays where a second-stage health assessment takes place within 7 days of arrival in prison.","Process","QS156 - Physical health of people in prisons","2 - QS156 - Physical health of people in prisons",1,"2 - QS156 - Physical health of people in prisons - Process - 1","The number in the denominator where a second-stage health assessment takes place within 7 days.","The number of prison stays which last for more than 7 days."]
[null,"QS156","Physical health of people in prisons",2,null,"People entering or transferring between prisons have a second-stage health assessment within 7 days.","Uptake rates of national screening programmes in prison (for example retinal screening, breast, cervical and bowel cancer screening).","Outcome","QS156 - Physical health of people in prisons","2 - QS156 - Physical health of people in prisons",1,"2 - QS156 - Physical health of people in prisons - Outcome - 1"]
[null,"QS156","Physical health of people in prisons",2,null,"People entering or transferring between prisons have a second-stage health assessment within 7 days.","Number of deaths in prisons.","Outcome","QS156 - Physical health of people in prisons","2 - QS156 - Physical health of people in prisons",2,"2 - QS156 - Physical health of people in prisons - Outcome - 2"]
[null,"QS156","Physical health of people in prisons",2,null,"People entering or transferring between prisons have a second-stage health assessment within 7 days.","Number of people in prison engaging with healthcare services.","Outcome","QS156 - Physical health of people in prisons","2 - QS156 - Physical health of people in prisons",3,"2 - QS156 - Physical health of people in prisons - Outcome - 3"]
[null,"QS156","Physical health of people in prisons",3,null,"People entering or transferring between prisons are tested for blood-borne viruses and assessed for risk of sexually transmitted infections.","Evidence of local arrangements to test for blood-borne viruses when people enter or are transferred between prisons.","Structure","QS156 - Physical health of people in prisons","3 - QS156 - Physical health of people in prisons",1,"3 - QS156 - Physical health of people in prisons - Structure - 1"]
[null,"QS156","Physical health of people in prisons",3,null,"People entering or transferring between prisons are tested for blood-borne viruses and assessed for risk of sexually transmitted infections.","Evidence of local arrangements to ensure that people entering or transferring between prisons are assessed for the risk of sexually transmitted infections.","Structure","QS156 - Physical health of people in prisons","3 - QS156 - Physical health of people in prisons",2,"3 - QS156 - Physical health of people in prisons - Structure - 2"]
[null,"QS156","Physical health of people in prisons",3,null,"People entering or transferring between prisons are tested for blood-borne viruses and assessed for risk of sexually transmitted infections.","Proportion of second-stage health assessments for people entering or transferring between prisons where testing for blood-borne viruses takes place or has already been completed.","Process","QS156 - Physical health of people in prisons","3 - QS156 - Physical health of people in prisons",1,"3 - QS156 - Physical health of people in prisons - Process - 1","The number in the denominator where testing for blood-borne viruses take place or has already been completed.","The number of second-stage health assessments for people entering or transferring between prisons."]
[null,"QS156","Physical health of people in prisons",3,null,"People entering or transferring between prisons are tested for blood-borne viruses and assessed for risk of sexually transmitted infections.","Proportion of second-stage health assessments for people entering or transferring between prisons where assessment for the risk of sexually transmitted infections takes place or has already been completed.","Process","QS156 - Physical health of people in prisons","3 - QS156 - Physical health of people in prisons",2,"3 - QS156 - Physical health of people in prisons - Process - 2","The number in the denominator where assessment for the risk of sexually transmitted infections takes place or has already been completed.","The number of second-stage health assessments for people entering or transferring between prisons."]
[null,"QS156","Physical health of people in prisons",3,null,"People entering or transferring between prisons are tested for blood-borne viruses and assessed for risk of sexually transmitted infections.","The number of people diagnosed and treated for blood-borne viruses in prisons.","Outcome","QS156 - Physical health of people in prisons","3 - QS156 - Physical health of people in prisons",1,"3 - QS156 - Physical health of people in prisons - Outcome - 1"]
[null,"QS156","Physical health of people in prisons",3,null,"People entering or transferring between prisons are tested for blood-borne viruses and assessed for risk of sexually transmitted infections.","The number of people diagnosed and treated for sexually transmitted infections in prisons.","Outcome","QS156 - Physical health of people in prisons","3 - QS156 - Physical health of people in prisons",2,"3 - QS156 - Physical health of people in prisons - Outcome - 2"]
[null,"QS156","Physical health of people in prisons",4,null,"People in prison who have complex health and social care needs have a lead care coordinator.","Evidence of local arrangements to ensure that a lead care coordinator is available for people in prison who are being cared for by different prison teams.","Structure","QS156 - Physical health of people in prisons","4 - QS156 - Physical health of people in prisons",1,"4 - QS156 - Physical health of people in prisons - Structure - 1"]
[null,"QS156","Physical health of people in prisons",4,null,"People in prison who have complex health and social care needs have a lead care coordinator.","Proportion of people in prison who have complex health and social care needs who have a lead care coordinator.","Process","QS156 - Physical health of people in prisons","4 - QS156 - Physical health of people in prisons",1,"4 - QS156 - Physical health of people in prisons - Process - 1","The number in the denominator who have a lead care coordinator.","The number of people in prison with complex health and social care needs."]
[null,"QS156","Physical health of people in prisons",4,null,"People in prison who have complex health and social care needs have a lead care coordinator.","Number of unplanned hospital admissions of people in prison.","Outcome","QS156 - Physical health of people in prisons","4 - QS156 - Physical health of people in prisons",1,"4 - QS156 - Physical health of people in prisons - Outcome - 1"]
[null,"QS156","Physical health of people in prisons",4,null,"People in prison who have complex health and social care needs have a lead care coordinator.","Number of care plans jointly developed and shared on transfer between prisons or release from prison.","Outcome","QS156 - Physical health of people in prisons","4 - QS156 - Physical health of people in prisons",2,"4 - QS156 - Physical health of people in prisons - Outcome - 2"]
[null,"QS156","Physical health of people in prisons",5,null,"People being transferred or discharged from prison are given a minimum of 7 days' prescribed medicines or an FP10 prescription.","Evidence of local arrangements to ensure that a minimum of 7 days' prescribed medicines is transferred with the property of people moving to another prison.","Structure","QS156 - Physical health of people in prisons","5 - QS156 - Physical health of people in prisons",1,"5 - QS156 - Physical health of people in prisons - Structure - 1"]
[null,"QS156","Physical health of people in prisons",5,null,"People being transferred or discharged from prison are given a minimum of 7 days' prescribed medicines or an FP10 prescription.","Evidence of local arrangements to ensure that, based on a risk assessment, a minimum of 7 days' prescribed medicines or an FP10 prescription is provided to people leaving prison.","Structure","QS156 - Physical health of people in prisons","5 - QS156 - Physical health of people in prisons",2,"5 - QS156 - Physical health of people in prisons - Structure - 2"]
[null,"QS156","Physical health of people in prisons",5,null,"People being transferred or discharged from prison are given a minimum of 7 days' prescribed medicines or an FP10 prescription.","Proportion of transfers between prison settings where a minimum of 7 days' prescribed medicines is provided.","Process","QS156 - Physical health of people in prisons","5 - QS156 - Physical health of people in prisons",1,"5 - QS156 - Physical health of people in prisons - Process - 1","The number in the denominator where a minimum of 7 days' prescribed medicines is provided.","The number of transfers between prison settings where the person is currently receiving prescribed medicines."]
[null,"QS156","Physical health of people in prisons",5,null,"People being transferred or discharged from prison are given a minimum of 7 days' prescribed medicines or an FP10 prescription.","Proportion of prison discharges where a minimum of 7 days' prescribed medicines or an FP10 prescription are provided.","Process","QS156 - Physical health of people in prisons","5 - QS156 - Physical health of people in prisons",2,"5 - QS156 - Physical health of people in prisons - Process - 2","The number in the denominator who receive a minimum of 7 days' prescribed medicines or an fp10 prescription.","The number of discharges from prison where the person is receiving prescribed medicines."]
[null,"QS156","Physical health of people in prisons",5,null,"People being transferred or discharged from prison are given a minimum of 7 days' prescribed medicines or an FP10 prescription.","Rates of medication continuity when people are transferred between prisons.","Outcome","QS156 - Physical health of people in prisons","5 - QS156 - Physical health of people in prisons",1,"5 - QS156 - Physical health of people in prisons - Outcome - 1"]
[null,"QS156","Physical health of people in prisons",5,null,"People being transferred or discharged from prison are given a minimum of 7 days' prescribed medicines or an FP10 prescription.","Rates of medication continuity when people are discharged from prison.","Outcome","QS156 - Physical health of people in prisons","5 - QS156 - Physical health of people in prisons",2,"5 - QS156 - Physical health of people in prisons - Outcome - 2"]
[null,"QS157","HIV testing: encouraging uptake",1,null,"Young people and adults are offered an HIV test when admitted to hospital or attending an emergency department in areas of extremely high HIV prevalence, or when having a blood test when admitted to hospital or attending an emergency department in areas of high HIV prevalence.","Evidence of local processes to offer an HIV test to all young people and adults who are admitted to hospital or attend an emergency department in areas of extremely high HIV prevalence.","Structure","QS157 - HIV testing: encouraging uptake","1 - QS157 - HIV testing: encouraging uptake",1,"1 - QS157 - HIV testing: encouraging uptake - Structure - 1"]
[null,"QS157","HIV testing: encouraging uptake",1,null,"Young people and adults are offered an HIV test when admitted to hospital or attending an emergency department in areas of extremely high HIV prevalence, or when having a blood test when admitted to hospital or attending an emergency department in areas of high HIV prevalence.","Evidence of local processes to offer an HIV test to all young people and adults having a blood test when admitted to hospital or attending an emergency department in areas of high HIV prevalence.","Structure","QS157 - HIV testing: encouraging uptake","1 - QS157 - HIV testing: encouraging uptake",2,"1 - QS157 - HIV testing: encouraging uptake - Structure - 2"]
[null,"QS157","HIV testing: encouraging uptake",1,null,"Young people and adults are offered an HIV test when admitted to hospital or attending an emergency department in areas of extremely high HIV prevalence, or when having a blood test when admitted to hospital or attending an emergency department in areas of high HIV prevalence.","Proportion of young people and adults admitted to hospital or attending an emergency department, in an area of extremely high HIV prevalence, who receive an HIV test.","Process","QS157 - HIV testing: encouraging uptake","1 - QS157 - HIV testing: encouraging uptake",1,"1 - QS157 - HIV testing: encouraging uptake - Process - 1","The number in the denominator who receive an hiv test.","The number of young people and adults admitted to hospital or attending an emergency department in an area of extremely high hiv prevalence."]
[null,"QS157","HIV testing: encouraging uptake",1,null,"Young people and adults are offered an HIV test when admitted to hospital or attending an emergency department in areas of extremely high HIV prevalence, or when having a blood test when admitted to hospital or attending an emergency department in areas of high HIV prevalence.","Proportion of young people and adults having a blood test when admitted to hospital or attending an emergency department in an area of high HIV prevalence who receive an HIV test.","Process","QS157 - HIV testing: encouraging uptake","1 - QS157 - HIV testing: encouraging uptake",2,"1 - QS157 - HIV testing: encouraging uptake - Process - 2","The number in the denominator who receive an hiv test.","The number of young people and adults having a blood test when admitted to hospital or attending an emergency department in an area of high hiv prevalence."]
[null,"QS157","HIV testing: encouraging uptake",1,null,"Young people and adults are offered an HIV test when admitted to hospital or attending an emergency department in areas of extremely high HIV prevalence, or when having a blood test when admitted to hospital or attending an emergency department in areas of high HIV prevalence.","Number of new HIV diagnoses in areas of high and extremely high prevalence.","Outcome","QS157 - HIV testing: encouraging uptake","1 - QS157 - HIV testing: encouraging uptake",1,"1 - QS157 - HIV testing: encouraging uptake - Outcome - 1"]
[null,"QS157","HIV testing: encouraging uptake",1,null,"Young people and adults are offered an HIV test when admitted to hospital or attending an emergency department in areas of extremely high HIV prevalence, or when having a blood test when admitted to hospital or attending an emergency department in areas of high HIV prevalence.","Number of new HIV diagnoses made at a late stage of infection in areas of high and extremely high prevalence.","Outcome","QS157 - HIV testing: encouraging uptake","1 - QS157 - HIV testing: encouraging uptake",2,"1 - QS157 - HIV testing: encouraging uptake - Outcome - 2"]
[null,"QS157","HIV testing: encouraging uptake",2,null,"Young people and adults in areas of high or extremely high HIV prevalence are offered an HIV test by their GP practice when registering or when having a blood test if they have not had an HIV test in the past 12 months.","Evidence of local processes to offer an HIV test to young people and adults registering with a GP in areas of high or extremely high HIV prevalence.","Structure","QS157 - HIV testing: encouraging uptake","2 - QS157 - HIV testing: encouraging uptake",1,"2 - QS157 - HIV testing: encouraging uptake - Structure - 1"]
[null,"QS157","HIV testing: encouraging uptake",2,null,"Young people and adults in areas of high or extremely high HIV prevalence are offered an HIV test by their GP practice when registering or when having a blood test if they have not had an HIV test in the past 12 months.","Evidence of local processes to offer an HIV test to young people and adults having a blood test at their GP practice in areas of high or extremely high HIV prevalence if they have not had an HIV test in the past 12 months.","Structure","QS157 - HIV testing: encouraging uptake","2 - QS157 - HIV testing: encouraging uptake",2,"2 - QS157 - HIV testing: encouraging uptake - Structure - 2"]
[null,"QS157","HIV testing: encouraging uptake",2,null,"Young people and adults in areas of high or extremely high HIV prevalence are offered an HIV test by their GP practice when registering or when having a blood test if they have not had an HIV test in the past 12 months.","Proportion of young people and adults newly registered with a GP in an area of high or extremely high HIV prevalence who receive an HIV test within 3 months of registration.","Process","QS157 - HIV testing: encouraging uptake","2 - QS157 - HIV testing: encouraging uptake",1,"2 - QS157 - HIV testing: encouraging uptake - Process - 1","The number in the denominator who receive an hiv test within 3 months of registration.","The number of young people and adults newly registered with a gp in an area of high or extremely high hiv prevalence."]
[null,"QS157","HIV testing: encouraging uptake",2,null,"Young people and adults in areas of high or extremely high HIV prevalence are offered an HIV test by their GP practice when registering or when having a blood test if they have not had an HIV test in the past 12 months.","Proportion of young people and adults who have not had an HIV test in the past 12 months having a blood test at their GP practice in an area of high or extremely high HIV prevalence who receive an HIV test.","Process","QS157 - HIV testing: encouraging uptake","2 - QS157 - HIV testing: encouraging uptake",2,"2 - QS157 - HIV testing: encouraging uptake - Process - 2","The number in the denominator who receive an hiv test.","The number of young people and adults who have not had an hiv test in the past 12 months having a blood test at their gp practice in an area of high or extremely high hiv prevalence."]
[null,"QS157","HIV testing: encouraging uptake",2,null,"Young people and adults in areas of high or extremely high HIV prevalence are offered an HIV test by their GP practice when registering or when having a blood test if they have not had an HIV test in the past 12 months.","HIV testing rate per 1,000 registered patients in GP practices in areas of high and extremely high HIV prevalence.","Outcome","QS157 - HIV testing: encouraging uptake","2 - QS157 - HIV testing: encouraging uptake",1,"2 - QS157 - HIV testing: encouraging uptake - Outcome - 1"]
[null,"QS157","HIV testing: encouraging uptake",2,null,"Young people and adults in areas of high or extremely high HIV prevalence are offered an HIV test by their GP practice when registering or when having a blood test if they have not had an HIV test in the past 12 months.","Number of new HIV diagnoses in areas of high and extremely high HIV prevalence.","Outcome","QS157 - HIV testing: encouraging uptake","2 - QS157 - HIV testing: encouraging uptake",2,"2 - QS157 - HIV testing: encouraging uptake - Outcome - 2"]
[null,"QS157","HIV testing: encouraging uptake",2,null,"Young people and adults in areas of high or extremely high HIV prevalence are offered an HIV test by their GP practice when registering or when having a blood test if they have not had an HIV test in the past 12 months.","Number of new HIV diagnoses made at a late stage of infection in areas of high and extremely high HIV prevalence.","Outcome","QS157 - HIV testing: encouraging uptake","2 - QS157 - HIV testing: encouraging uptake",3,"2 - QS157 - HIV testing: encouraging uptake - Outcome - 3"]
[null,"QS157","HIV testing: encouraging uptake",3,null,"Young people and adults newly diagnosed with an HIV indicator condition are offered an HIV test.","Evidence of local systems that alert healthcare professionals to the need to offer an HIV test when an indicator condition is diagnosed.","Structure","QS157 - HIV testing: encouraging uptake","3 - QS157 - HIV testing: encouraging uptake",1,"3 - QS157 - HIV testing: encouraging uptake - Structure - 1"]
[null,"QS157","HIV testing: encouraging uptake",3,null,"Young people and adults newly diagnosed with an HIV indicator condition are offered an HIV test.","Evidence of local processes to offer an HIV test to young people and adults newly diagnosed with an indicator condition.","Structure","QS157 - HIV testing: encouraging uptake","3 - QS157 - HIV testing: encouraging uptake",2,"3 - QS157 - HIV testing: encouraging uptake - Structure - 2"]
[null,"QS157","HIV testing: encouraging uptake",3,null,"Young people and adults newly diagnosed with an HIV indicator condition are offered an HIV test.","Proportion of young people and adults newly diagnosed with an indicator condition who receive an HIV test.","Process","QS157 - HIV testing: encouraging uptake","3 - QS157 - HIV testing: encouraging uptake",1,"3 - QS157 - HIV testing: encouraging uptake - Process - 1","The number in the denominator who receive an hiv test.","The number of young people and adults newly diagnosed with an indicator condition."]
[null,"QS157","HIV testing: encouraging uptake",3,null,"Young people and adults newly diagnosed with an HIV indicator condition are offered an HIV test.","Number of new HIV diagnoses.","Outcome","QS157 - HIV testing: encouraging uptake","3 - QS157 - HIV testing: encouraging uptake",1,"3 - QS157 - HIV testing: encouraging uptake - Outcome - 1"]
[null,"QS157","HIV testing: encouraging uptake",3,null,"Young people and adults newly diagnosed with an HIV indicator condition are offered an HIV test.","Number of new HIV diagnoses made at a late stage of infection.","Outcome","QS157 - HIV testing: encouraging uptake","3 - QS157 - HIV testing: encouraging uptake",2,"3 - QS157 - HIV testing: encouraging uptake - Outcome - 2"]
[null,"QS157","HIV testing: encouraging uptake",4,null,"Young people and adults in at-risk groups who test negative for HIV are advised that the test should be repeated at least annually.","Evidence of local processes to identify if young people and adults who test negative for HIV are in at-risk groups.","Structure","QS157 - HIV testing: encouraging uptake","4 - QS157 - HIV testing: encouraging uptake",1,"4 - QS157 - HIV testing: encouraging uptake - Structure - 1"]
[null,"QS157","HIV testing: encouraging uptake",4,null,"Young people and adults in at-risk groups who test negative for HIV are advised that the test should be repeated at least annually.","Evidence of local processes to advise young people and adults in at-risk groups who test negative for HIV that the test should be repeated at least annually.","Structure","QS157 - HIV testing: encouraging uptake","4 - QS157 - HIV testing: encouraging uptake",2,"4 - QS157 - HIV testing: encouraging uptake - Structure - 2"]
[null,"QS157","HIV testing: encouraging uptake",4,null,"Young people and adults in at-risk groups who test negative for HIV are advised that the test should be repeated at least annually.","Proportion of young people and adults in at-risk groups who test negative for HIV who are advised that the test should be repeated at least annually.","Process","QS157 - HIV testing: encouraging uptake","4 - QS157 - HIV testing: encouraging uptake",1,"4 - QS157 - HIV testing: encouraging uptake - Process - 1","The number in the denominator who are advised that the test should be repeated at least annually.","The number of young people and adults in at-risk groups who test negative for hiv."]
[null,"QS157","HIV testing: encouraging uptake",4,null,"Young people and adults in at-risk groups who test negative for HIV are advised that the test should be repeated at least annually.","Proportion of young people and adults in at-risk groups who had an HIV test in the past 12 months.","Outcome","QS157 - HIV testing: encouraging uptake","4 - QS157 - HIV testing: encouraging uptake",1,"4 - QS157 - HIV testing: encouraging uptake - Outcome - 1","The number in the denominator who had an hiv test in the past 12 months.","The number of young people and adults in at-risk groups."]
[null,"QS157","HIV testing: encouraging uptake",4,null,"Young people and adults in at-risk groups who test negative for HIV are advised that the test should be repeated at least annually.","Number of new HIV diagnoses in at-risk groups.","Outcome","QS157 - HIV testing: encouraging uptake","4 - QS157 - HIV testing: encouraging uptake",2,"4 - QS157 - HIV testing: encouraging uptake - Outcome - 2"]
[null,"QS157","HIV testing: encouraging uptake",4,null,"Young people and adults in at-risk groups who test negative for HIV are advised that the test should be repeated at least annually.","Number of new HIV diagnoses made at a late stage of infection in at-risk groups.","Outcome","QS157 - HIV testing: encouraging uptake","4 - QS157 - HIV testing: encouraging uptake",3,"4 - QS157 - HIV testing: encouraging uptake - Outcome - 3"]
[null,"QS157","HIV testing: encouraging uptake",5,null,"People who may have been exposed to HIV by a person newly diagnosed with HIV are offered an HIV test.","Evidence of local arrangements to ensure that notification procedures are in place to identify people who may have been exposed to HIV by a person newly diagnosed with HIV. These arrangements may include referral pathways to specialist sexual health services.","Structure","QS157 - HIV testing: encouraging uptake","5 - QS157 - HIV testing: encouraging uptake",1,"5 - QS157 - HIV testing: encouraging uptake - Structure - 1"]
[null,"QS157","HIV testing: encouraging uptake",5,null,"People who may have been exposed to HIV by a person newly diagnosed with HIV are offered an HIV test.","Proportion of contactable people who may have been exposed to HIV by a person newly diagnosed with HIV who are tested within 3 months.","Process","QS157 - HIV testing: encouraging uptake","5 - QS157 - HIV testing: encouraging uptake",1,"5 - QS157 - HIV testing: encouraging uptake - Process - 1"," the number in the denominator who are tested for hiv within 3 months.","The number of contactable people who may have been exposed to hiv by a person newly diagnosed with hiv."]
[null,"QS157","HIV testing: encouraging uptake",5,null,"People who may have been exposed to HIV by a person newly diagnosed with HIV are offered an HIV test."," Number of people tested per total number of index cases.","Outcome","QS157 - HIV testing: encouraging uptake","5 - QS157 - HIV testing: encouraging uptake",1,"5 - QS157 - HIV testing: encouraging uptake - Outcome - 1"]
[null,"QS157","HIV testing: encouraging uptake",5,null,"People who may have been exposed to HIV by a person newly diagnosed with HIV are offered an HIV test.","Number of new HIV diagnoses.","Outcome","QS157 - HIV testing: encouraging uptake","5 - QS157 - HIV testing: encouraging uptake",2,"5 - QS157 - HIV testing: encouraging uptake - Outcome - 2"]
[null,"QS157","HIV testing: encouraging uptake",5,null,"People who may have been exposed to HIV by a person newly diagnosed with HIV are offered an HIV test.","Number of new HIV diagnoses made at a late stage of infection.","Outcome","QS157 - HIV testing: encouraging uptake","5 - QS157 - HIV testing: encouraging uptake",3,"5 - QS157 - HIV testing: encouraging uptake - Outcome - 3"]
[null,"QS158","Rehabilitation after critical illness in adults",1,null,"Adults in critical care at risk of morbidity have their rehabilitation goals agreed within 4 days of admission to critical care or before discharge from critical care, whichever is sooner.","Evidence of local systems to flag when adults in critical care are at risk of morbidity.","Structure","QS158 - Rehabilitation after critical illness in adults","1 - QS158 - Rehabilitation after critical illness in adults",1,"1 - QS158 - Rehabilitation after critical illness in adults - Structure - 1"]
[null,"QS158","Rehabilitation after critical illness in adults",1,null,"Adults in critical care at risk of morbidity have their rehabilitation goals agreed within 4 days of admission to critical care or before discharge from critical care, whichever is sooner.","Evidence of local arrangements to ensure that adults in critical care at risk of morbidity have rehabilitation goals agreed and documented.","Structure","QS158 - Rehabilitation after critical illness in adults","1 - QS158 - Rehabilitation after critical illness in adults",2,"1 - QS158 - Rehabilitation after critical illness in adults - Structure - 2"]
[null,"QS158","Rehabilitation after critical illness in adults",1,null,"Adults in critical care at risk of morbidity have their rehabilitation goals agreed within 4 days of admission to critical care or before discharge from critical care, whichever is sooner.","Proportion of adults in critical care at risk of morbidity who have their rehabilitation goals agreed within 4 days of being admitted to critical care or before discharge from critical care, whichever is sooner.","Process",{"$f":"CONCATENATE(B3458, \" - \", C3458)","v":"QS158 - Rehabilitation after critical illness in adults"},{"$f":"CONCATENATE(D3458, \" - \", I3458)","v":"1 - QS158 - Rehabilitation after critical illness in adults"},{"$f":"IF(AND(B3458=B3457, D3458=D3457, H3458=H3457)=TRUE, K3457+1, 1)","v":1},{"$f":"CONCATENATE(J3458, \" - \", H3458, \" - \",K3458)","v":"1 - QS158 - Rehabilitation after critical illness in adults - Process - 1"},"The number in the denominator who have their rehabilitation goals agreed within 4 days of being admitted to critical care or before discharge from critical care, whichever is sooner.","The number of adults in critical care who are at risk of morbidity."]
[null,"QS158","Rehabilitation after critical illness in adults",1,null,"Adults in critical care at risk of morbidity have their rehabilitation goals agreed within 4 days of admission to critical care or before discharge from critical care, whichever is sooner.","Levels of satisfaction with involvement in their own care among adults in critical care.","Outcome","QS158 - Rehabilitation after critical illness in adults","1 - QS158 - Rehabilitation after critical illness in adults",1,"1 - QS158 - Rehabilitation after critical illness in adults - Outcome - 1"]
[null,"QS158","Rehabilitation after critical illness in adults",2,null,"Adults at risk of morbidity have a formal handover of care, including their agreed individualised structured rehabilitation programme, when they transfer from critical care to a general ward.","Evidence of formal handover processes between team discharging adults at risk of morbidity from critical care and team admitting them to a general ward.","Structure","QS158 - Rehabilitation after critical illness in adults","2 - QS158 - Rehabilitation after critical illness in adults",1,"2 - QS158 - Rehabilitation after critical illness in adults - Structure - 1"]
[null,"QS158","Rehabilitation after critical illness in adults",2,null,"Adults at risk of morbidity have a formal handover of care, including their agreed individualised structured rehabilitation programme, when they transfer from critical care to a general ward.","Evidence of local arrangements to ensure that the structured rehabilitation programme is included in the formal handover between the critical care team and the team admitting adults to a general ward.","Structure","QS158 - Rehabilitation after critical illness in adults","2 - QS158 - Rehabilitation after critical illness in adults",2,"2 - QS158 - Rehabilitation after critical illness in adults - Structure - 2"]
[null,"QS158","Rehabilitation after critical illness in adults",2,null,"Adults at risk of morbidity have a formal handover of care, including their agreed individualised structured rehabilitation programme, when they transfer from critical care to a general ward.","Proportion of adults at risk of morbidity who have a formal handover of care when transferring from critical care to a general ward.","Process","QS158 - Rehabilitation after critical illness in adults","2 - QS158 - Rehabilitation after critical illness in adults",1,"2 - QS158 - Rehabilitation after critical illness in adults - Process - 1","The number in the denominator who have a formal handover of care.","The number of adults at risk of morbidity transferring from critical care to a general ward."]
[null,"QS158","Rehabilitation after critical illness in adults",2,null,"Adults at risk of morbidity have a formal handover of care, including their agreed individualised structured rehabilitation programme, when they transfer from critical care to a general ward.","Proportion of adults at risk of morbidity transferring from critical care to a general ward whose formal handover of care includes their individualised, structured rehabilitation programme.","Process","QS158 - Rehabilitation after critical illness in adults","2 - QS158 - Rehabilitation after critical illness in adults",2,"2 - QS158 - Rehabilitation after critical illness in adults - Process - 2","The number in the denominator whose handover of care includes their individualised, structured rehabilitation programme.","The number of adults at risk of morbidity transferring from critical care to a general ward who have a formal handover of care."]
[null,"QS158","Rehabilitation after critical illness in adults",2,null,"Adults at risk of morbidity have a formal handover of care, including their agreed individualised structured rehabilitation programme, when they transfer from critical care to a general ward.","Level of satisfaction with continuity of care for adults who are discharged from critical care to a general ward.","Outcome","QS158 - Rehabilitation after critical illness in adults","2 - QS158 - Rehabilitation after critical illness in adults",1,"2 - QS158 - Rehabilitation after critical illness in adults - Outcome - 1"]
[null,"QS158","Rehabilitation after critical illness in adults",3,null,"Adults who were in critical care and at risk of morbidity are given information based on their rehabilitation goals before they are discharged from hospital.","Evidence of local arrangements to provide adults who are discharged from hospital after a critical care stay with information relevant to their individual needs and rehabilitation goals.","Structure","QS158 - Rehabilitation after critical illness in adults","3 - QS158 - Rehabilitation after critical illness in adults",1,"3 - QS158 - Rehabilitation after critical illness in adults - Structure - 1"]
[null,"QS158","Rehabilitation after critical illness in adults",3,null,"Adults who were in critical care and at risk of morbidity are given information based on their rehabilitation goals before they are discharged from hospital.","Proportion of adults who were in critical care and at risk of morbidity who are given information on hospital discharge based on the rehabilitation goals agreed during their hospital stay.","Process","QS158 - Rehabilitation after critical illness in adults","3 - QS158 - Rehabilitation after critical illness in adults",1,"3 - QS158 - Rehabilitation after critical illness in adults - Process - 1","The number in the denominator who are given information based on the rehabilitation goals agreed during their hospital stay.","The number of adults who were in critical care and at risk of morbidity discharged from hospital."]
[null,"QS158","Rehabilitation after critical illness in adults",3,null,"Adults who were in critical care and at risk of morbidity are given information based on their rehabilitation goals before they are discharged from hospital.","Levels of satisfaction with information that was relevant to recovery at home among adults who were discharged from hospital following a critical care stay.","Outcome","QS158 - Rehabilitation after critical illness in adults","3 - QS158 - Rehabilitation after critical illness in adults",1,"3 - QS158 - Rehabilitation after critical illness in adults - Outcome - 1"]
[null,"QS158","Rehabilitation after critical illness in adults",4,null,"Adults who stayed in critical care for more than 4 days and were at risk of morbidity have a review 2 to 3 months after discharge from critical care.","Evidence of local follow-up arrangements for adults who had a critical care stay of more than 4 days and were at risk of morbidity.","Structure","QS158 - Rehabilitation after critical illness in adults","4 - QS158 - Rehabilitation after critical illness in adults",1,"4 - QS158 - Rehabilitation after critical illness in adults - Structure - 1"]
[null,"QS158","Rehabilitation after critical illness in adults",4,null,"Adults who stayed in critical care for more than 4 days and were at risk of morbidity have a review 2 to 3 months after discharge from critical care.","Proportion of adults who were in critical care for more than 4 days and at risk of morbidity, who have a review between 2 and 3 months after discharge from critical care.","Process","QS158 - Rehabilitation after critical illness in adults","4 - QS158 - Rehabilitation after critical illness in adults",1,"4 - QS158 - Rehabilitation after critical illness in adults - Process - 1","The number in the denominator who have a review between 2 and 3 months after discharge from critical care.","The number of adults who were in critical care for more than 4 days and at risk of morbidity, who have been discharged from critical care."]
[null,"QS158","Rehabilitation after critical illness in adults",4,null,"Adults who stayed in critical care for more than 4 days and were at risk of morbidity have a review 2 to 3 months after discharge from critical care.","Number of physical problems identified within 3 months of discharge from critical care.","Outcome","QS158 - Rehabilitation after critical illness in adults","4 - QS158 - Rehabilitation after critical illness in adults",1,"4 - QS158 - Rehabilitation after critical illness in adults - Outcome - 1"]
[null,"QS158","Rehabilitation after critical illness in adults",4,null,"Adults who stayed in critical care for more than 4 days and were at risk of morbidity have a review 2 to 3 months after discharge from critical care.","Number of non-physical problems identified within 3 months of discharge from critical care.","Outcome","QS158 - Rehabilitation after critical illness in adults","4 - QS158 - Rehabilitation after critical illness in adults",2,"4 - QS158 - Rehabilitation after critical illness in adults - Outcome - 2"]
[null,"QS158","Rehabilitation after critical illness in adults",4,null,"Adults who stayed in critical care for more than 4 days and were at risk of morbidity have a review 2 to 3 months after discharge from critical care.","Levels of satisfaction with support received to manage rehabilitation needs among adults discharged from critical care.","Outcome","QS158 - Rehabilitation after critical illness in adults","4 - QS158 - Rehabilitation after critical illness in adults",3,"4 - QS158 - Rehabilitation after critical illness in adults - Outcome - 3"]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",1,null,"People admitted to an inpatient mental health setting have access to independent advocacy services.","Evidence of local arrangements to provide independent advocacy services for people admitted to an inpatient mental health setting.","Structure","QS159 - Transition between inpatient mental health settings and community or care home settings","1 - QS159 - Transition between inpatient mental health settings and community or care home settings",1,"1 - QS159 - Transition between inpatient mental health settings and community or care home settings - Structure - 1"]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",1,null,"People admitted to an inpatient mental health setting have access to independent advocacy services.","Evidence of local arrangements to promote independent advocacy services to people admitted to an inpatient mental health setting.","Structure","QS159 - Transition between inpatient mental health settings and community or care home settings","1 - QS159 - Transition between inpatient mental health settings and community or care home settings",2,"1 - QS159 - Transition between inpatient mental health settings and community or care home settings - Structure - 2"]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",1,null,"People admitted to an inpatient mental health setting have access to independent advocacy services.","Proportion of admissions to an inpatient mental health setting for which information is provided on admission about support available from independent advocacy services.","Process","QS159 - Transition between inpatient mental health settings and community or care home settings","1 - QS159 - Transition between inpatient mental health settings and community or care home settings",1,"1 - QS159 - Transition between inpatient mental health settings and community or care home settings - Process - 1","The number in the denominator for which information is provided on admission about support available from independent advocacy services.","The number of admissions to an inpatient mental health setting."]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",1,null,"People admitted to an inpatient mental health setting have access to independent advocacy services.","Level of satisfaction with access to independent advocacy services for people using inpatient mental health settings.","Outcome","QS159 - Transition between inpatient mental health settings and community or care home settings","1 - QS159 - Transition between inpatient mental health settings and community or care home settings",1,"1 - QS159 - Transition between inpatient mental health settings and community or care home settings - Outcome - 1"]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",2,null,"People admitted to specialist inpatient mental health settings outside the area in which they live have a review of their placement at least every 3 months.","Evidence of local arrangements to monitor the length of placements of people admitted to a specialist inpatient mental health setting outside the area in which they live.","Structure","QS159 - Transition between inpatient mental health settings and community or care home settings","2 - QS159 - Transition between inpatient mental health settings and community or care home settings",1,"2 - QS159 - Transition between inpatient mental health settings and community or care home settings - Structure - 1"]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",2,null,"People admitted to specialist inpatient mental health settings outside the area in which they live have a review of their placement at least every 3 months.","Evidence of local arrangements to review placements at least every 3 months for people in an out-of-area placement in a specialist inpatient mental health setting.","Structure","QS159 - Transition between inpatient mental health settings and community or care home settings","2 - QS159 - Transition between inpatient mental health settings and community or care home settings",2,"2 - QS159 - Transition between inpatient mental health settings and community or care home settings - Structure - 2"]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",2,null,"People admitted to specialist inpatient mental health settings outside the area in which they live have a review of their placement at least every 3 months.","Proportion of out-of-area placements in specialist inpatient mental health settings for which there is a review of the placement at least every 3 months.","Process","QS159 - Transition between inpatient mental health settings and community or care home settings","2 - QS159 - Transition between inpatient mental health settings and community or care home settings",1,"2 - QS159 - Transition between inpatient mental health settings and community or care home settings - Process - 1","The number in the denominator for which there is a review of the placement at least every 3 months.","The number of out-of-area placements in specialist inpatient mental health settings lasting longer than 3 months."]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",2,null,"People admitted to specialist inpatient mental health settings outside the area in which they live have a review of their placement at least every 3 months.","Number of active out-of-area placements in specialist inpatient mental health settings.","Outcome","QS159 - Transition between inpatient mental health settings and community or care home settings","2 - QS159 - Transition between inpatient mental health settings and community or care home settings",1,"2 - QS159 - Transition between inpatient mental health settings and community or care home settings - Outcome - 1"]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",2,null,"People admitted to specialist inpatient mental health settings outside the area in which they live have a review of their placement at least every 3 months.","Length of stay in out-of-area placements in specialist inpatient mental health settings.","Outcome","QS159 - Transition between inpatient mental health settings and community or care home settings","2 - QS159 - Transition between inpatient mental health settings and community or care home settings",2,"2 - QS159 - Transition between inpatient mental health settings and community or care home settings - Outcome - 2"]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",3,null,"People discharged from an inpatient mental health setting have their care plan sent within 24 hours to everyone identified in the plan as involved in their ongoing care."," Evidence of local arrangements to develop care plans that detail who will be involved in providing ongoing care to people discharged from an inpatient mental health setting.","Structure","QS159 - Transition between inpatient mental health settings and community or care home settings","3 - QS159 - Transition between inpatient mental health settings and community or care home settings",1,"3 - QS159 - Transition between inpatient mental health settings and community or care home settings - Structure - 1"]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",3,null,"People discharged from an inpatient mental health setting have their care plan sent within 24 hours to everyone identified in the plan as involved in their ongoing care.","Evidence of local arrangements to send within 24 hours, the care plans of people discharged from an inpatient mental health setting to everyone identified in it as involved in their ongoing care.","Structure","QS159 - Transition between inpatient mental health settings and community or care home settings","3 - QS159 - Transition between inpatient mental health settings and community or care home settings",2,"3 - QS159 - Transition between inpatient mental health settings and community or care home settings - Structure - 2"]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",3,null,"People discharged from an inpatient mental health setting have their care plan sent within 24 hours to everyone identified in the plan as involved in their ongoing care.","Proportion of discharges from an inpatient mental health setting where the person's care plan is sent within 24 hours to everyone identified in it as involved in their ongoing care.","Process","QS159 - Transition between inpatient mental health settings and community or care home settings","3 - QS159 - Transition between inpatient mental health settings and community or care home settings",1,"3 - QS159 - Transition between inpatient mental health settings and community or care home settings - Process - 1","The number in the denominator in which the person's care plan is sent within 24 hours to everyone identified in it as involved in their ongoing care.","The number of discharges from an inpatient mental health setting."]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",3,null,"People discharged from an inpatient mental health setting have their care plan sent within 24 hours to everyone identified in the plan as involved in their ongoing care.","Level of satisfaction with support following discharge from inpatient mental health settings.","Outcome","QS159 - Transition between inpatient mental health settings and community or care home settings","3 - QS159 - Transition between inpatient mental health settings and community or care home settings",1,"3 - QS159 - Transition between inpatient mental health settings and community or care home settings - Outcome - 1"]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",3,null,"People discharged from an inpatient mental health setting have their care plan sent within 24 hours to everyone identified in the plan as involved in their ongoing care.","Readmissions to inpatient mental health services within 30 days of discharge.","Outcome","QS159 - Transition between inpatient mental health settings and community or care home settings","3 - QS159 - Transition between inpatient mental health settings and community or care home settings",2,"3 - QS159 - Transition between inpatient mental health settings and community or care home settings - Outcome - 2"]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",4,null,"People who have a risk of suicide identified at preparation for discharge from an inpatient mental health setting are followed up within 48 hours of being discharged.","Evidence of local arrangements to identify people at risk of suicide at preparation for discharge from an inpatient mental health setting and to record the risk for 48-hour follow-up.","Structure","QS159 - Transition between inpatient mental health settings and community or care home settings","4 - QS159 - Transition between inpatient mental health settings and community or care home settings",1,"4 - QS159 - Transition between inpatient mental health settings and community or care home settings - Structure - 1"]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",4,null,"People who have a risk of suicide identified at preparation for discharge from an inpatient mental health setting are followed up within 48 hours of being discharged.","Evidence of local arrangements to follow-up within 48 hours of discharge people who are identified as being at risk of suicide.","Structure","QS159 - Transition between inpatient mental health settings and community or care home settings","4 - QS159 - Transition between inpatient mental health settings and community or care home settings",2,"4 - QS159 - Transition between inpatient mental health settings and community or care home settings - Structure - 2"]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",4,null,"People who have a risk of suicide identified at preparation for discharge from an inpatient mental health setting are followed up within 48 hours of being discharged.","Proportion of discharges from an inpatient mental health setting in which people are followed up within 48 hours of discharge if they are identified as being at risk of suicide.","Process","QS159 - Transition between inpatient mental health settings and community or care home settings","4 - QS159 - Transition between inpatient mental health settings and community or care home settings",1,"4 - QS159 - Transition between inpatient mental health settings and community or care home settings - Process - 1","The number in the denominator followed up within 48 hours of discharge.","The number of discharges from an inpatient mental health setting of people identified as being at risk of suicide."]
[null,"QS159","Transition between inpatient mental health settings and community or care home settings",4,null,"People who have a risk of suicide identified at preparation for discharge from an inpatient mental health setting are followed up within 48 hours of being discharged.","Number of suicides of people recently discharged from inpatient mental health settings.","Outcome","QS159 - Transition between inpatient mental health settings and community or care home settings","4 - QS159 - Transition between inpatient mental health settings and community or care home settings",1,"4 - QS159 - Transition between inpatient mental health settings and community or care home settings - Outcome - 1"]
[null,"QS160","End of life care for infants, children and young people",1,null,"Infants, children and young people with a life-limiting condition and their parents or carers are involved in developing an advance care plan.","Evidence of local arrangements to ensure that parents of babies diagnosed with a life-limiting condition during pregnancy are involved in developing an advance care plan before the birth.","Structure","QS160 - End of life care for infants, children and young people","1 - QS160 - End of life care for infants, children and young people",1,"1 - QS160 - End of life care for infants, children and young people - Structure - 1"]
[null,"QS160","End of life care for infants, children and young people",1,null,"Infants, children and young people with a life-limiting condition and their parents or carers are involved in developing an advance care plan.","Evidence of local arrangements to ensure that the parents or carers of infants with a life-limiting condition are involved in developing an advance care plan.","Structure","QS160 - End of life care for infants, children and young people","1 - QS160 - End of life care for infants, children and young people",2,"1 - QS160 - End of life care for infants, children and young people - Structure - 2"]
[null,"QS160","End of life care for infants, children and young people",1,null,"Infants, children and young people with a life-limiting condition and their parents or carers are involved in developing an advance care plan.","Evidence of local arrangements to ensure that children and young people with life-limiting conditions and their parents or carers are involved in developing an advance care plan.","Structure","QS160 - End of life care for infants, children and young people","1 - QS160 - End of life care for infants, children and young people",3,"1 - QS160 - End of life care for infants, children and young people - Structure - 3"]
[null,"QS160","End of life care for infants, children and young people",1,null,"Infants, children and young people with a life-limiting condition and their parents or carers are involved in developing an advance care plan.","Proportion of pregnancies with a diagnosis of a life-limiting condition in the baby in which the parents are involved in developing an advance care plan before birth.","Process","QS160 - End of life care for infants, children and young people","1 - QS160 - End of life care for infants, children and young people",1,"1 - QS160 - End of life care for infants, children and young people - Process - 1","The number in the denominator in which parents are involved in developing an advance care plan before birth.","The number of pregnancies with a diagnosis of a life-limiting condition in the baby."]
[null,"QS160","End of life care for infants, children and young people",1,null,"Infants, children and young people with a life-limiting condition and their parents or carers are involved in developing an advance care plan.","Proportion of parents or carers of infants with a life-limiting condition who are involved in developing an advance care plan.","Process","QS160 - End of life care for infants, children and young people","1 - QS160 - End of life care for infants, children and young people",2,"1 - QS160 - End of life care for infants, children and young people - Process - 2","The number in the denominator who are involved in developing an advance care plan.","The number of parents or carers of infants with a life-limiting condition."]
[null,"QS160","End of life care for infants, children and young people",1,null,"Infants, children and young people with a life-limiting condition and their parents or carers are involved in developing an advance care plan.","Proportion of children and young people with a life-limiting condition who are involved in developing their advance care plan.","Process","QS160 - End of life care for infants, children and young people","1 - QS160 - End of life care for infants, children and young people",3,"1 - QS160 - End of life care for infants, children and young people - Process - 3","The number in the denominator who are involved in developing their advance care plan.","The number of children and young people with a life-limiting condition."]
[null,"QS160","End of life care for infants, children and young people",1,null,"Infants, children and young people with a life-limiting condition and their parents or carers are involved in developing an advance care plan.","Level of satisfaction with care in infants, children and young people with a life-limiting condition and their parents and carers.","Outcome","QS160 - End of life care for infants, children and young people","1 - QS160 - End of life care for infants, children and young people",1,"1 - QS160 - End of life care for infants, children and young people - Outcome - 1"]
[null,"QS160","End of life care for infants, children and young people",2,null,"Infants, children and young people with a life-limiting condition have a named medical specialist who leads and coordinates their care.","Evidence of local arrangements to ensure that named medical specialists are assigned to infants, children and young people with a life-limiting condition to lead and coordinate their care.","Structure","QS160 - End of life care for infants, children and young people","2 - QS160 - End of life care for infants, children and young people",1,"2 - QS160 - End of life care for infants, children and young people - Structure - 1"]
[null,"QS160","End of life care for infants, children and young people",2,null,"Infants, children and young people with a life-limiting condition have a named medical specialist who leads and coordinates their care.","Proportion of infants, children and young people with a life-limiting condition who have a named medical specialist.","Process","QS160 - End of life care for infants, children and young people","2 - QS160 - End of life care for infants, children and young people",1,"2 - QS160 - End of life care for infants, children and young people - Process - 1","The number in the denominator who have a named medical specialist.","The number of infants, children and young people with a life-limiting condition."]
[null,"QS160","End of life care for infants, children and young people",2,null,"Infants, children and young people with a life-limiting condition have a named medical specialist who leads and coordinates their care.","Level of satisfaction with end of life care in children and young people with a life-limiting condition.","Outcome","QS160 - End of life care for infants, children and young people","2 - QS160 - End of life care for infants, children and young people",1,"2 - QS160 - End of life care for infants, children and young people - Outcome - 1"]
[null,"QS160","End of life care for infants, children and young people",3,null,"Infants, children and young people with a life-limiting condition and their parents or carers are given information about emotional and psychological support, including how to access it.","Evidence of local arrangements to ensure that information about emotional and psychological support for infants, children and young people, including how to access it, is available for infants, children and young people with a life-limiting condition and their parents or carers.","Structure","QS160 - End of life care for infants, children and young people","3 - QS160 - End of life care for infants, children and young people",1,"3 - QS160 - End of life care for infants, children and young people - Structure - 1"]
[null,"QS160","End of life care for infants, children and young people",3,null,"Infants, children and young people with a life-limiting condition and their parents or carers are given information about emotional and psychological support, including how to access it.","Proportion of children and young people with a life-limiting condition and their parents or carers who are given information about emotional and psychological support, including how to access it.","Process","QS160 - End of life care for infants, children and young people","3 - QS160 - End of life care for infants, children and young people",1,"3 - QS160 - End of life care for infants, children and young people - Process - 1","The number in the denominator who are given information about emotional and psychological support, including how to access it.","The number of children and young people with a life-limiting condition and their parents or carers."]
[null,"QS160","End of life care for infants, children and young people",3,null,"Infants, children and young people with a life-limiting condition and their parents or carers are given information about emotional and psychological support, including how to access it.","Level of satisfaction of infants, children and young people with a life-limiting condition, and their parents or carers, with information they are given about emotional and psychological support.","Outcome","QS160 - End of life care for infants, children and young people","3 - QS160 - End of life care for infants, children and young people",1,"3 - QS160 - End of life care for infants, children and young people - Outcome - 1"]
[null,"QS160","End of life care for infants, children and young people",4,null,"Infants, children and young people with a life-limiting condition are cared for by a multidisciplinary team that includes members of the specialist paediatric palliative care team.","Evidence of local arrangements to ensure multidisciplinary teams involved in the care of infants, children and young people with life-limiting conditions include input from the specialist paediatric palliative care team.","Structure","QS160 - End of life care for infants, children and young people","4 - QS160 - End of life care for infants, children and young people",1,"4 - QS160 - End of life care for infants, children and young people - Structure - 1"]
[null,"QS160","End of life care for infants, children and young people",4,null,"Infants, children and young people with a life-limiting condition are cared for by a multidisciplinary team that includes members of the specialist paediatric palliative care team.","Proportion of infants, children and young people with life-limiting conditions cared for by a multidisciplinary team that includes input from a specialist paediatric palliative care team.","Process","QS160 - End of life care for infants, children and young people","4 - QS160 - End of life care for infants, children and young people",1,"4 - QS160 - End of life care for infants, children and young people - Process - 1","The number in the denominator cared for by a multidisciplinary team that includes input from a specialist paediatric palliative care team.","The number of infants, children and young people with life-limiting conditions."]
[null,"QS160","End of life care for infants, children and young people",4,null,"Infants, children and young people with a life-limiting condition are cared for by a multidisciplinary team that includes members of the specialist paediatric palliative care team.","Level of satisfaction with end of life care in infants, children and young people with life-limiting conditions, and their parents or carers.","Outcome","QS160 - End of life care for infants, children and young people","4 - QS160 - End of life care for infants, children and young people",1,"4 - QS160 - End of life care for infants, children and young people - Outcome - 1"]
[null,"QS160","End of life care for infants, children and young people",5,null,"Parents or carers of infants, children and young people approaching the end of life are offered support for grief and loss when their child is nearing the end of their life and after their death.","Evidence of local arrangements to provide support for grief and loss to parents or carers when infants, children and young people are approaching the end of life and after their death.","Structure","QS160 - End of life care for infants, children and young people","5 - QS160 - End of life care for infants, children and young people",1,"5 - QS160 - End of life care for infants, children and young people - Structure - 1"]
[null,"QS160","End of life care for infants, children and young people",5,null,"Parents or carers of infants, children and young people approaching the end of life are offered support for grief and loss when their child is nearing the end of their life and after their death.","Proportion of parents or carers of infants, children and young people with a life-limiting condition, who had a plan for support with grief and loss before the death of the infant, child or young person.","Process","QS160 - End of life care for infants, children and young people","5 - QS160 - End of life care for infants, children and young people",1,"5 - QS160 - End of life care for infants, children and young people - Process - 1","The number in the denominator whose parents and carers had a plan for support with grief and loss before the death of the infant, child or young person.","The number of infants, children and young people with a life-limiting condition who have died."]
[null,"QS160","End of life care for infants, children and young people",5,null,"Parents or carers of infants, children and young people approaching the end of life are offered support for grief and loss when their child is nearing the end of their life and after their death.","Proportion of parents or carers of infants, children and young people with a life-limiting condition who have a plan for support with grief and loss after the death of the infant, child or young person.","Process","QS160 - End of life care for infants, children and young people","5 - QS160 - End of life care for infants, children and young people",2,"5 - QS160 - End of life care for infants, children and young people - Process - 2","The number in the denominator who have a plan for support with grief and loss after the death of the infant, child or young person.","The number of parents or carers of infants, children and young people with a life-limiting condition who have died."]
[null,"QS160","End of life care for infants, children and young people",5,null,"Parents or carers of infants, children and young people approaching the end of life are offered support for grief and loss when their child is nearing the end of their life and after their death.","Level of satisfaction with grief and loss support in parents or carers of infants, children and young people receiving end of life care.","Outcome","QS160 - End of life care for infants, children and young people","5 - QS160 - End of life care for infants, children and young people",1,"5 - QS160 - End of life care for infants, children and young people - Outcome - 1"]
[null,"QS160","End of life care for infants, children and young people",6,null,"Infants, children and young people approaching the end of life and being cared for at home have 24-hour access to both children's nursing care and advice from a consultant in paediatric palliative care.","Evidence of local arrangements to ensure that children's nursing care is available 24 hours a day for infants, children and young people approaching the end of life who are being cared for at home.","Structure","QS160 - End of life care for infants, children and young people","6 - QS160 - End of life care for infants, children and young people",1,"6 - QS160 - End of life care for infants, children and young people - Structure - 1"]
[null,"QS160","End of life care for infants, children and young people",6,null,"Infants, children and young people approaching the end of life and being cared for at home have 24-hour access to both children's nursing care and advice from a consultant in paediatric palliative care.","Evidence of local arrangements to ensure that advice from a consultant in paediatric palliative care is available 24 hours a day for infants, children and young people approaching the end of life who are being cared for at home.","Structure","QS160 - End of life care for infants, children and young people","6 - QS160 - End of life care for infants, children and young people",2,"6 - QS160 - End of life care for infants, children and young people - Structure - 2"]
[null,"QS160","End of life care for infants, children and young people",6,null,"Infants, children and young people approaching the end of life and being cared for at home have 24-hour access to both children's nursing care and advice from a consultant in paediatric palliative care.","Proportion of infants, children and young people approaching the end of life and being cared for at home who have 24-hour access to children's nursing care.","Process","QS160 - End of life care for infants, children and young people","6 - QS160 - End of life care for infants, children and young people",1,"6 - QS160 - End of life care for infants, children and young people - Process - 1","The number in the denominator who have 24-hour access to children's nursing care before their death.","The number of infants, children and young people approaching the end of life and being cared for at home."]
[null,"QS160","End of life care for infants, children and young people",6,null,"Infants, children and young people approaching the end of life and being cared for at home have 24-hour access to both children's nursing care and advice from a consultant in paediatric palliative care.","Proportion of infants, children and young people approaching the end of life and being cared for at home who have 24-hour access to advice from a consultant in paediatric palliative care.","Process","QS160 - End of life care for infants, children and young people","6 - QS160 - End of life care for infants, children and young people",2,"6 - QS160 - End of life care for infants, children and young people - Process - 2","The number in the denominator who have 24-hour access to advice from a consultant in paediatric palliative care before their death.","The number of infants, children and young people approaching the end of life and being cared for at home."]
[null,"QS160","End of life care for infants, children and young people",6,null,"Infants, children and young people approaching the end of life and being cared for at home have 24-hour access to both children's nursing care and advice from a consultant in paediatric palliative care.","Proportion of infants, children and young people who had the option of being cared for at home when approaching the end of life.","Outcome","QS160 - End of life care for infants, children and young people","6 - QS160 - End of life care for infants, children and young people",1,"6 - QS160 - End of life care for infants, children and young people - Outcome - 1"]
[null,"QS161","Sepsis",1,null,"People with suspected sepsis are assessed using a structured set of observations to stratify risk of severe illness or death.","Evidence of local arrangements to ensure that a structured set of observations are used to stratify risk of severe illness or death from sepsis.","Structure","QS161 - Sepsis","1 - QS161 - Sepsis",1,"1 - QS161 - Sepsis - Structure - 1"]
[null,"QS161","Sepsis",1,null,"People with suspected sepsis are assessed using a structured set of observations to stratify risk of severe illness or death.","Proportion of people with sepsis in acute hospital settings who were assessed using a structured set of observations to stratify risk of severe illness or death from sepsis.","Process","QS161 - Sepsis","1 - QS161 - Sepsis",1,"1 - QS161 - Sepsis - Process - 1","The number in the denominator who were assessed using a structured set of observations to stratify risk of severe illness or death from sepsis.","The number of people diagnosed with sepsis in acute hospital settings."]
[null,"QS161","Sepsis",1,null,"People with suspected sepsis are assessed using a structured set of observations to stratify risk of severe illness or death.","Proportion of people with sepsis who were referred to an acute hospital setting from primary or ambulatory care settings who were assessed using a structured set of observations to stratify risk of severe illness or death from sepsis.","Process","QS161 - Sepsis","1 - QS161 - Sepsis",2,"1 - QS161 - Sepsis - Process - 2","The number in the denominator who were assessed using a structured set of observations to stratify risk of severe illness or death from sepsis.","The number of people with sepsis referred to an acute hospital setting from primary or ambulatory care settings."]
[null,"QS161","Sepsis",1,null,"People with suspected sepsis are assessed using a structured set of observations to stratify risk of severe illness or death.","Rates of admission to critical care for people with sepsis.","Outcome","QS161 - Sepsis","1 - QS161 - Sepsis",1,"1 - QS161 - Sepsis - Outcome - 1"]
[null,"QS161","Sepsis",1,null,"People with suspected sepsis are assessed using a structured set of observations to stratify risk of severe illness or death.","Rates of in-hospital mortality for people with sepsis.","Outcome","QS161 - Sepsis","1 - QS161 - Sepsis",2,"1 - QS161 - Sepsis - Outcome - 2"]
[null,"QS161","Sepsis",2,null,"People with suspected sepsis in acute hospital settings and at least 1 of the criteria indicating high risk of severe illness or death have an immediate review by a senior clinical decision maker and antibiotics given within 1 hour if indicated.","Evidence of local arrangements for immediate review by a senior clinical decision-maker for people with suspected sepsis in acute hospital settings and at least 1 of the criteria indicating high risk of severe illness or death from sepsis.","Structure","QS161 - Sepsis","2 - QS161 - Sepsis",1,"2 - QS161 - Sepsis - Structure - 1"]
[null,"QS161","Sepsis",2,null,"People with suspected sepsis in acute hospital settings and at least 1 of the criteria indicating high risk of severe illness or death have an immediate review by a senior clinical decision maker and antibiotics given within 1 hour if indicated.","Evidence of local arrangements to ensure urgent assessment mechanisms are in place to deliver antibiotics to people with suspected sepsis in acute hospital settings within 1 hour of any high risk criteria of severe illness or death from sepsis being identified.","Structure",{"$f":"CONCATENATE(B3522, \" - \", C3522)","v":"QS161 - Sepsis"},{"$f":"CONCATENATE(D3522, \" - \", I3522)","v":"2 - QS161 - Sepsis"},{"$f":"IF(AND(B3522=B3521, D3522=D3521, H3522=H3521)=TRUE, K3521+1, 1)","v":2},{"$f":"CONCATENATE(J3522, \" - \", H3522, \" - \",K3522)","v":"2 - QS161 - Sepsis - Structure - 2"}]
[null,"QS161","Sepsis",2,null,"People with suspected sepsis in acute hospital settings and at least 1 of the criteria indicating high risk of severe illness or death have an immediate review by a senior clinical decision maker and antibiotics given within 1 hour if indicated.","Proportion of people with suspected sepsis in acute hospital settings and at least 1 of the criteria indicating high risk of severe illness or death from sepsis who have an immediate review by a senior clinical decision-maker.","Process","QS161 - Sepsis","2 - QS161 - Sepsis",1,"2 - QS161 - Sepsis - Process - 1","The number in the denominator who have an immediate review by a senior clinical decision-maker.","The number of people with suspected sepsis in acute hospital settings and at least 1 of the criteria indicating high risk of severe illness or death from sepsis."]
[null,"QS161","Sepsis",2,null,"People with suspected sepsis in acute hospital settings and at least 1 of the criteria indicating high risk of severe illness or death have an immediate review by a senior clinical decision maker and antibiotics given within 1 hour if indicated.","Proportion of people with suspected sepsis in acute hospital settings and at least 1 of the criteria indicating high risk of severe illness or death from sepsis who receive the first dose of intravenous antibiotics within 1 hour of risk being stratified.","Process","QS161 - Sepsis","2 - QS161 - Sepsis",2,"2 - QS161 - Sepsis - Process - 2","The number in the denominator who receive the first dose of intravenous antibiotics within 1 hour of risk being stratified.","The number of people with suspected sepsis in acute hospital settings and at least 1 of the criteria indicating high risk of severe illness or death from sepsis."]
[null,"QS161","Sepsis",2,null,"People with suspected sepsis in acute hospital settings and at least 1 of the criteria indicating high risk of severe illness or death have an immediate review by a senior clinical decision maker and antibiotics given within 1 hour if indicated.","Rates of in-hospital mortality for people with sepsis.","Outcome","QS161 - Sepsis","2 - QS161 - Sepsis",{"$f":"IF(AND(B3525=B3524, D3525=D3524, H3525=H3524)=TRUE, K3524+1, 1)","v":1},{"$f":"CONCATENATE(J3525, \" - \", H3525, \" - \",K3525)","v":"2 - QS161 - Sepsis - Outcome - 1"}]
[null,"QS161","Sepsis",3,null,"People with suspected sepsis in acute hospital settings who need treatment to restore cardiovascular stability have an intravenous fluid bolus within 1 hour of risk being stratified.","Evidence of local arrangements and written clinical protocols to ensure that people with suspected sepsis in acute hospital settings who need treatment to restore cardiovascular stability have an intravenous fluid bolus within 1 hour of risk being stratified.","Structure","QS161 - Sepsis","3 - QS161 - Sepsis",1,"3 - QS161 - Sepsis - Structure - 1"]
[null,"QS161","Sepsis",3,null,"People with suspected sepsis in acute hospital settings who need treatment to restore cardiovascular stability have an intravenous fluid bolus within 1 hour of risk being stratified.","Evidence of local arrangements and written clinical protocols to ensure that people with suspected sepsis in acute hospital settings have their lactate levels recorded.","Structure","QS161 - Sepsis","3 - QS161 - Sepsis",2,"3 - QS161 - Sepsis - Structure - 2"]
[null,"QS161","Sepsis",3,null,"People with suspected sepsis in acute hospital settings who need treatment to restore cardiovascular stability have an intravenous fluid bolus within 1 hour of risk being stratified.","Proportion of adults and young people age 12 years and over with suspected sepsis in acute hospital settings and systolic blood pressure less than 90 mmHg who receive an intravenous fluid bolus within 1 hour of blood pressure being measured as less than 90 mmHg.","Process","QS161 - Sepsis","3 - QS161 - Sepsis",1,"3 - QS161 - Sepsis - Process - 1","The number in the denominator who receive an intravenous fluid bolus within 1 hour of blood pressure being measured as less than 90 mmhg.","The number of adults and young people age 12 years and over with suspected sepsis in acute hospital settings and systolic blood pressure less than 90 mmhg."]
[null,"QS161","Sepsis",3,null,"People with suspected sepsis in acute hospital settings who need treatment to restore cardiovascular stability have an intravenous fluid bolus within 1 hour of risk being stratified.","Proportion of people with suspected sepsis in acute hospital settings, at least 1 criteria indicating high risk of severe illness or death from sepsis, and with lactate over 2 mmol/litre, who receive an intravenous fluid bolus within 1 hour of risk being stratified.","Process","QS161 - Sepsis","3 - QS161 - Sepsis",2,"3 - QS161 - Sepsis - Process - 2","The number in the denominator who receive an intravenous fluid bolus within 1 hour of risk being stratified.","The number of people with suspected sepsis in acute hospital settings, at least 1 criteria indicating high risk of severe illness or death from sepsis, and with lactate over 2 mmol/litre."]
[null,"QS161","Sepsis",3,null,"People with suspected sepsis in acute hospital settings who need treatment to restore cardiovascular stability have an intravenous fluid bolus within 1 hour of risk being stratified.","Rates of cardiovascular stability in people with suspected sepsis.","Outcome","QS161 - Sepsis","3 - QS161 - Sepsis",1,"3 - QS161 - Sepsis - Outcome - 1"]
[null,"QS161","Sepsis",3,null,"People with suspected sepsis in acute hospital settings who need treatment to restore cardiovascular stability have an intravenous fluid bolus within 1 hour of risk being stratified.","Rates of 28-day all-cause mortality in people with sepsis.","Outcome","QS161 - Sepsis","3 - QS161 - Sepsis",2,"3 - QS161 - Sepsis - Outcome - 2"]
[null,"QS161","Sepsis",4,null,"People with suspected sepsis in acute hospital settings who receive intravenous antibiotics or fluid bolus are seen by a consultant if their condition fails to respond within 1 hour of initial treatment.","Evidence of acute hospital settings having arrangements in place which ensure that people with suspected sepsis are seen by a consultant if their condition fails to respond within 1 hour of initial intravenous antibiotics or fluid bolus. This includes ensuring a consultant is available to attend promptly.","Structure","QS161 - Sepsis","4 - QS161 - Sepsis",1,"4 - QS161 - Sepsis - Structure - 1"]
[null,"QS161","Sepsis",4,null,"People with suspected sepsis in acute hospital settings who receive intravenous antibiotics or fluid bolus are seen by a consultant if their condition fails to respond within 1 hour of initial treatment.","Proportion of people with suspected sepsis in acute hospital settings who are seen by a consultant if their condition fails to respond within 1 hour of initial intravenous antibiotics or fluid bolus.","Process","QS161 - Sepsis","4 - QS161 - Sepsis",1,"4 - QS161 - Sepsis - Process - 1","The number in the denominator who are seen by a consultant.","The number of people with suspected sepsis in acute hospital settings whose condition fails to respond within 1 hour of initial intravenous antibiotics or fluid bolus."]
[null,"QS161","Sepsis",4,null,"People with suspected sepsis in acute hospital settings who receive intravenous antibiotics or fluid bolus are seen by a consultant if their condition fails to respond within 1 hour of initial treatment.","Rates of 28-day all-cause mortality in people with sepsis.","Outcome","QS161 - Sepsis","4 - QS161 - Sepsis",1,"4 - QS161 - Sepsis - Outcome - 1"]
[null,"QS161","Sepsis",5,null,"People with suspected sepsis who have been stratified as at low risk of severe illness or death are given information about symptoms to monitor and how to access medical care.","Evidence of local arrangements to ensure that information about symptoms to monitor and how to access medical care if needed is available to people with suspected sepsis who have been stratified as being at low risk of severe illness or death.","Structure","QS161 - Sepsis","5 - QS161 - Sepsis",1,"5 - QS161 - Sepsis - Structure - 1"]
[null,"QS161","Sepsis",5,null,"People with suspected sepsis who have been stratified as at low risk of severe illness or death are given information about symptoms to monitor and how to access medical care.","Proportion of people with suspected sepsis who have been stratified as being at low risk of severe illness or death who are given information about symptoms to monitor and how to access medical care.","Process","QS161 - Sepsis","5 - QS161 - Sepsis",1,"5 - QS161 - Sepsis - Process - 1","The number in the denominator who are given information about symptoms to monitor and how to access medical care.","The number of people with suspected sepsis who have been stratified as being at low risk of severe illness or death."]
[null,"QS161","Sepsis",5,null,"People with suspected sepsis who have been stratified as at low risk of severe illness or death are given information about symptoms to monitor and how to access medical care.","Levels of awareness of symptoms in people with suspected sepsis.","Outcome","QS161 - Sepsis","5 - QS161 - Sepsis",1,"5 - QS161 - Sepsis - Outcome - 1"]
[null,"QS162","Cerebral palsy in children and young people",1,null,"Children with any major risk factor for cerebral palsy have enhanced clinical and developmental follow-up from birth to 2 years.","Evidence of local arrangements to provide enhanced clinical and developmental follow-up from birth to 2 years for children with any major risk factor for cerebral palsy.","Structure","QS162 - Cerebral palsy in children and young people","1 - QS162 - Cerebral palsy in children and young people",1,"1 - QS162 - Cerebral palsy in children and young people - Structure - 1"]
[null,"QS162","Cerebral palsy in children and young people",1,null,"Children with any major risk factor for cerebral palsy have enhanced clinical and developmental follow-up from birth to 2 years.","Proportion of children with any major risk factor for cerebral palsy attending a routine appointment up to 3 months of age who had movement and development checked.","Process","QS162 - Cerebral palsy in children and young people","1 - QS162 - Cerebral palsy in children and young people",1,"1 - QS162 - Cerebral palsy in children and young people - Process - 1","The number in the denominator who had movement and development checked.","The number of children with any major risk factor for cerebral palsy attending a routine appointment up to 3 months of age."]
[null,"QS162","Cerebral palsy in children and young people",1,null,"Children with any major risk factor for cerebral palsy have enhanced clinical and developmental follow-up from birth to 2 years.","Proportion of children with any major risk factor for cerebral palsy and older than 3 months who have a planned schedule of developmental follow-ups.","Process","QS162 - Cerebral palsy in children and young people","1 - QS162 - Cerebral palsy in children and young people",2,"1 - QS162 - Cerebral palsy in children and young people - Process - 2","The number in the denominator who have a planned schedule of developmental follow-ups.","The number of children with any major risk factor for cerebral palsy and older than 3 months."]
[null,"QS162","Cerebral palsy in children and young people",1,null,"Children with any major risk factor for cerebral palsy have enhanced clinical and developmental follow-up from birth to 2 years.","Number of children and young people with cerebral palsy who were diagnosed by age 2 years.","Outcome","QS162 - Cerebral palsy in children and young people","1 - QS162 - Cerebral palsy in children and young people",1,"1 - QS162 - Cerebral palsy in children and young people - Outcome - 1"]
[null,"QS162","Cerebral palsy in children and young people",2,null,"Children with delayed motor milestones are referred to a child development service.","Evidence of local arrangements to provide child development services for children with delayed motor milestones.","Structure","QS162 - Cerebral palsy in children and young people","2 - QS162 - Cerebral palsy in children and young people",1,"2 - QS162 - Cerebral palsy in children and young people - Structure - 1"]
[null,"QS162","Cerebral palsy in children and young people",2,null,"Children with delayed motor milestones are referred to a child development service.","Proportion of children with delayed motor milestones who are referred to a child development service.","Process","QS162 - Cerebral palsy in children and young people","2 - QS162 - Cerebral palsy in children and young people",1,"2 - QS162 - Cerebral palsy in children and young people - Process - 1","The number in the denominator who are referred to a child development service.","The number of children with delayed motor milestones."]
[null,"QS162","Cerebral palsy in children and young people",2,null,"Children with delayed motor milestones are referred to a child development service.","Number of children and young people with cerebral palsy who were diagnosed by age 2 years.","Outcome","QS162 - Cerebral palsy in children and young people","2 - QS162 - Cerebral palsy in children and young people",1,"2 - QS162 - Cerebral palsy in children and young people - Outcome - 1"]
[null,"QS162","Cerebral palsy in children and young people",3,null,"Parents and carers of children and young people with cerebral palsy are given information about the diagnosis and management of cerebral palsy.","Evidence of local arrangements to ensure that parents and carers of children and young people with cerebral palsy are provided with up-to-date information on the diagnosis and management of cerebral palsy that is tailored to their needs.","Structure","QS162 - Cerebral palsy in children and young people","3 - QS162 - Cerebral palsy in children and young people",1,"3 - QS162 - Cerebral palsy in children and young people - Structure - 1"]
[null,"QS162","Cerebral palsy in children and young people",3,null,"Parents and carers of children and young people with cerebral palsy are given information about the diagnosis and management of cerebral palsy.","Proportion of parents and carers of children and young people with cerebral palsy who are given information about the diagnosis and management of cerebral palsy at the point of diagnosis.","Process","QS162 - Cerebral palsy in children and young people","3 - QS162 - Cerebral palsy in children and young people",1,"3 - QS162 - Cerebral palsy in children and young people - Process - 1","The number in the denominator whose parents or carers are given information about the diagnosis and management of cerebral palsy.","The number of children and young people with cerebral palsy."]
[null,"QS162","Cerebral palsy in children and young people",3,null,"Parents and carers of children and young people with cerebral palsy are given information about the diagnosis and management of cerebral palsy.","Level of parent and carer satisfaction with information they are given about the diagnosis and management of cerebral palsy.","Outcome","QS162 - Cerebral palsy in children and young people","3 - QS162 - Cerebral palsy in children and young people",1,"3 - QS162 - Cerebral palsy in children and young people - Outcome - 1"]
[null,"QS162","Cerebral palsy in children and young people",4,null,"Children and young people with cerebral palsy have a personal folder to help them make decisions about how their condition is managed.","Evidence of a locally defined approach to the development of personal folders for children and young people with cerebral palsy to help them make decisions about how their condition is managed, and systems in place to make staff aware of the approach.","Structure","QS162 - Cerebral palsy in children and young people","4 - QS162 - Cerebral palsy in children and young people",1,"4 - QS162 - Cerebral palsy in children and young people - Structure - 1"]
[null,"QS162","Cerebral palsy in children and young people",4,null,"Children and young people with cerebral palsy have a personal folder to help them make decisions about how their condition is managed.","Proportion of children and young people with cerebral palsy who have a personal folder to help them make decisions about how their condition is managed.","Process","QS162 - Cerebral palsy in children and young people","4 - QS162 - Cerebral palsy in children and young people",1,"4 - QS162 - Cerebral palsy in children and young people - Process - 1","The number in the denominator who have a personal folder to help them make decisions about how their condition is managed.","The number of children and young people with cerebral palsy."]
[null,"QS162","Cerebral palsy in children and young people",4,null,"Children and young people with cerebral palsy have a personal folder to help them make decisions about how their condition is managed.","Levels of satisfaction of children and young people with cerebral palsy with control over care and daily life.","Outcome","QS162 - Cerebral palsy in children and young people","4 - QS162 - Cerebral palsy in children and young people",1,"4 - QS162 - Cerebral palsy in children and young people - Outcome - 1"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",1,null,"Adults in contact with the police because of a suspected offence have any features of mental health problems responded to in a way that reduces the risk of anxiety, self-harm or aggression.","Evidence of arrangements to ensure that police officers are given induction training in responding to features of mental health problems.","Structure","QS163 - Mental health of adults in contact with the criminal justice system","1 - QS163 - Mental health of adults in contact with the criminal justice system",1,"1 - QS163 - Mental health of adults in contact with the criminal justice system - Structure - 1"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",1,null,"Adults in contact with the police because of a suspected offence have any features of mental health problems responded to in a way that reduces the risk of anxiety, self-harm or aggression.","Evidence of arrangements to ensure that police officers are given regular update training in responding to features of mental health problems.","Structure","QS163 - Mental health of adults in contact with the criminal justice system","1 - QS163 - Mental health of adults in contact with the criminal justice system",2,"1 - QS163 - Mental health of adults in contact with the criminal justice system - Structure - 2"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",1,null,"Adults in contact with the police because of a suspected offence have any features of mental health problems responded to in a way that reduces the risk of anxiety, self-harm or aggression.","Proportion of adults at risk of self-harm or suicide and in contact with the police because of a suspected offence for whom initial safety precautions are taken.","Process","QS163 - Mental health of adults in contact with the criminal justice system","1 - QS163 - Mental health of adults in contact with the criminal justice system",1,"1 - QS163 - Mental health of adults in contact with the criminal justice system - Process - 1","The number in the denominator for whom initial safety precautions are taken.","The number of adults at risk of self-harm or suicide and in contact with the police because of a suspected offence."]
[null,"QS163","Mental health of adults in contact with the criminal justice system",1,null,"Adults in contact with the police because of a suspected offence have any features of mental health problems responded to in a way that reduces the risk of anxiety, self-harm or aggression.","Proportion of adults behaving aggressively and in contact with the police because of a suspected offence who are calmed using de-escalation techniques.","Process","QS163 - Mental health of adults in contact with the criminal justice system","1 - QS163 - Mental health of adults in contact with the criminal justice system",2,"1 - QS163 - Mental health of adults in contact with the criminal justice system - Process - 2","The number in the denominator who are calmed using de-escalation techniques.","The number of adults behaving aggressively and in contact with the police because of a suspected offence."]
[null,"QS163","Mental health of adults in contact with the criminal justice system",1,null,"Adults in contact with the police because of a suspected offence have any features of mental health problems responded to in a way that reduces the risk of anxiety, self-harm or aggression.","Number of adults with mental health problems in contact with the police because of a suspected offence who are referred to liaison and diversion services.","Outcome","QS163 - Mental health of adults in contact with the criminal justice system","1 - QS163 - Mental health of adults in contact with the criminal justice system",1,"1 - QS163 - Mental health of adults in contact with the criminal justice system - Outcome - 1"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",1,null,"Adults in contact with the police because of a suspected offence have any features of mental health problems responded to in a way that reduces the risk of anxiety, self-harm or aggression.","Number of assaults on police officers by adults with mental health problems.","Outcome","QS163 - Mental health of adults in contact with the criminal justice system","1 - QS163 - Mental health of adults in contact with the criminal justice system",2,"1 - QS163 - Mental health of adults in contact with the criminal justice system - Outcome - 2"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",1,null,"Adults in contact with the police because of a suspected offence have any features of mental health problems responded to in a way that reduces the risk of anxiety, self-harm or aggression.","Number of assaults on other detainees by adults with mental health problems.","Outcome","QS163 - Mental health of adults in contact with the criminal justice system","1 - QS163 - Mental health of adults in contact with the criminal justice system",3,"1 - QS163 - Mental health of adults in contact with the criminal justice system - Outcome - 3"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",1,null,"Adults in contact with the police because of a suspected offence have any features of mental health problems responded to in a way that reduces the risk of anxiety, self-harm or aggression.","Number of self-harm and suicide attempts by adults in contact with the police because of a suspected offence.","Outcome","QS163 - Mental health of adults in contact with the criminal justice system","1 - QS163 - Mental health of adults in contact with the criminal justice system",4,"1 - QS163 - Mental health of adults in contact with the criminal justice system - Outcome - 4"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",2,null,"Adults in contact with the police because of a suspected offence who have suspected mental health problems are referred for a comprehensive mental health assessment.","Evidence of local arrangements of joint working between the police and mental health services to ensure adults with suspected mental health problems are referred for comprehensive mental health assessments.","Structure","QS163 - Mental health of adults in contact with the criminal justice system","2 - QS163 - Mental health of adults in contact with the criminal justice system",1,"2 - QS163 - Mental health of adults in contact with the criminal justice system - Structure - 1"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",2,null,"Adults in contact with the police because of a suspected offence who have suspected mental health problems are referred for a comprehensive mental health assessment.","Proportion of adults in contact with the police because of a suspected offence identified as having suspected mental health problems who are referred for a comprehensive mental health assessment.","Process","QS163 - Mental health of adults in contact with the criminal justice system","2 - QS163 - Mental health of adults in contact with the criminal justice system",1,"2 - QS163 - Mental health of adults in contact with the criminal justice system - Process - 1","The number in the denominator who are referred for a comprehensive mental health assessment.","The number of adults in contact with the police because of a suspected offence identified as having suspected mental health problems."]
[null,"QS163","Mental health of adults in contact with the criminal justice system",2,null,"Adults in contact with the police because of a suspected offence who have suspected mental health problems are referred for a comprehensive mental health assessment.","Number of adults with mental health problems in contact with the police referred to liaison and diversion services.","Outcome","QS163 - Mental health of adults in contact with the criminal justice system","2 - QS163 - Mental health of adults in contact with the criminal justice system",1,"2 - QS163 - Mental health of adults in contact with the criminal justice system - Outcome - 1"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",2,null,"Adults in contact with the police because of a suspected offence who have suspected mental health problems are referred for a comprehensive mental health assessment.","Number of mental health assessments undertaken following referral from police services.","Outcome","QS163 - Mental health of adults in contact with the criminal justice system","2 - QS163 - Mental health of adults in contact with the criminal justice system",2,"2 - QS163 - Mental health of adults in contact with the criminal justice system - Outcome - 2"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",3,null,"Adults with mental health problems who are in contact with the criminal justice system have a care plan that is shared with relevant services.","Evidence of local arrangements for mental health care plans to include an agreed process for the plan to be shared with relevant services both inside and outside the criminal justice system.","Structure","QS163 - Mental health of adults in contact with the criminal justice system","3 - QS163 - Mental health of adults in contact with the criminal justice system",1,"3 - QS163 - Mental health of adults in contact with the criminal justice system - Structure - 1"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",3,null,"Adults with mental health problems who are in contact with the criminal justice system have a care plan that is shared with relevant services.","Proportion of adults with mental health problems in contact with the criminal justice system whose care plan is shared with the services identified in the plan as involved in their ongoing care.","Process","QS163 - Mental health of adults in contact with the criminal justice system","3 - QS163 - Mental health of adults in contact with the criminal justice system",1,"3 - QS163 - Mental health of adults in contact with the criminal justice system - Process - 1","The number in the denominator whose mental health care plan is shared with the services identified in the plan as involved in their ongoing care.","The number of adults in contact with the criminal justice system with a mental health care plan."]
[null,"QS163","Mental health of adults in contact with the criminal justice system",3,null,"Adults with mental health problems who are in contact with the criminal justice system have a care plan that is shared with relevant services.","Continuity of care for adults with mental health problems in contact with the criminal justice system.","Outcome","QS163 - Mental health of adults in contact with the criminal justice system","3 - QS163 - Mental health of adults in contact with the criminal justice system",1,"3 - QS163 - Mental health of adults in contact with the criminal justice system - Outcome - 1"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",3,null,"Adults with mental health problems who are in contact with the criminal justice system have a care plan that is shared with relevant services.","Referral rates to mental health services, for example liaison and diversion to prison mental health services or prison mental health services to community mental health teams.","Outcome","QS163 - Mental health of adults in contact with the criminal justice system","3 - QS163 - Mental health of adults in contact with the criminal justice system",2,"3 - QS163 - Mental health of adults in contact with the criminal justice system - Outcome - 2"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",4,null,"Adults who have a mental health risk management plan and are transferring within the criminal justice system have their plan reviewed by the receiving service.","Evidence of local arrangements for mental health risk management plans to be reviewed by the receiving service when adults are transferred between services within the criminal justice system.","Structure","QS163 - Mental health of adults in contact with the criminal justice system","4 - QS163 - Mental health of adults in contact with the criminal justice system",1,"4 - QS163 - Mental health of adults in contact with the criminal justice system - Structure - 1"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",4,null,"Adults who have a mental health risk management plan and are transferring within the criminal justice system have their plan reviewed by the receiving service.","Evidence of local arrangements to implement mental health risk management plans.","Structure","QS163 - Mental health of adults in contact with the criminal justice system","4 - QS163 - Mental health of adults in contact with the criminal justice system",2,"4 - QS163 - Mental health of adults in contact with the criminal justice system - Structure - 2"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",4,null,"Adults who have a mental health risk management plan and are transferring within the criminal justice system have their plan reviewed by the receiving service.","Proportion of transfers between services within the criminal justice system in which mental health risk management plans were reviewed.","Process","QS163 - Mental health of adults in contact with the criminal justice system","4 - QS163 - Mental health of adults in contact with the criminal justice system",1,"4 - QS163 - Mental health of adults in contact with the criminal justice system - Process - 1","The number in the denominator in which mental health risk management plans were reviewed.","The number of transfers between services within the criminal justice system."]
[null,"QS163","Mental health of adults in contact with the criminal justice system",4,null,"Adults who have a mental health risk management plan and are transferring within the criminal justice system have their plan reviewed by the receiving service.","Number of assaults within the criminal justice system.","Outcome","QS163 - Mental health of adults in contact with the criminal justice system","4 - QS163 - Mental health of adults in contact with the criminal justice system",1,"4 - QS163 - Mental health of adults in contact with the criminal justice system - Outcome - 1"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",4,null,"Adults who have a mental health risk management plan and are transferring within the criminal justice system have their plan reviewed by the receiving service.","Number of self-harm incidents within the criminal justice system.","Outcome","QS163 - Mental health of adults in contact with the criminal justice system","4 - QS163 - Mental health of adults in contact with the criminal justice system",2,"4 - QS163 - Mental health of adults in contact with the criminal justice system - Outcome - 2"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",4,null,"Adults who have a mental health risk management plan and are transferring within the criminal justice system have their plan reviewed by the receiving service.","Number of assaults committed by adults under the care of probation services.","Outcome","QS163 - Mental health of adults in contact with the criminal justice system","4 - QS163 - Mental health of adults in contact with the criminal justice system",3,"4 - QS163 - Mental health of adults in contact with the criminal justice system - Outcome - 3"]
[null,"QS163","Mental health of adults in contact with the criminal justice system",4,null,"Adults who have a mental health risk management plan and are transferring within the criminal justice system have their plan reviewed by the receiving service.","Number of self-harm incidents involving adults under the care of probation services.","Outcome","QS163 - Mental health of adults in contact with the criminal justice system","4 - QS163 - Mental health of adults in contact with the criminal justice system",4,"4 - QS163 - Mental health of adults in contact with the criminal justice system - Outcome - 4"]
[null,"QS164","Parkinson's disease",1,null,"Adults with Parkinson's disease have a point of contact with specialist services. ","Evidence of local arrangements to ensure that specialist services can provide a point of contact for adults with Parkinson's disease.","Structure","QS164 - Parkinson's disease","1 - QS164 - Parkinson's disease",1,"1 - QS164 - Parkinson's disease - Structure - 1"]
[null,"QS164","Parkinson's disease",1,null,"Adults with Parkinson's disease have a point of contact with specialist services. ","Proportion of adults with Parkinson's disease who have a point of contact with specialist services.","Process","QS164 - Parkinson's disease","1 - QS164 - Parkinson's disease",1,"1 - QS164 - Parkinson's disease - Process - 1","The number in the denominator who have a point of contact with specialist services.","The number of adults with Parkinson's disease. "]
[null,"QS164","Parkinson's disease",1,null,"Adults with Parkinson's disease have a point of contact with specialist services. ","Satisfaction of adults with Parkinson's disease with ease of access to specialist services.","Outcome","QS164 - Parkinson's disease","1 - QS164 - Parkinson's disease",1,"1 - QS164 - Parkinson's disease - Outcome - 1"]
[null,"QS164","Parkinson's disease",1,null,"Adults with Parkinson's disease have a point of contact with specialist services. ","Satisfaction of adults with Parkinson's disease that they have the support and knowledge they need to self-manage their condition.","Outcome","QS164 - Parkinson's disease","1 - QS164 - Parkinson's disease",2,"1 - QS164 - Parkinson's disease - Outcome - 2"]
[null,"QS164","Parkinson's disease",2,null,"Adults with Parkinson's disease taking dopaminergic therapy are given information about the risk of developing impulse control disorders, when starting treatment and at least annually.","Evidence that written information about the risk of developing impulse control disorders with dopaminergic therapy is available.","Structure","QS164 - Parkinson's disease","2 - QS164 - Parkinson's disease",1,"2 - QS164 - Parkinson's disease - Structure - 1"]
[null,"QS164","Parkinson's disease",2,null,"Adults with Parkinson's disease taking dopaminergic therapy are given information about the risk of developing impulse control disorders, when starting treatment and at least annually.","Evidence of local processes to ensure that adults with Parkinson's disease taking dopaminergic therapy have a discussion with a healthcare professional about the risk of developing impulse control disorders when starting treatment and at least annually.","Structure","QS164 - Parkinson's disease","2 - QS164 - Parkinson's disease",2,"2 - QS164 - Parkinson's disease - Structure - 2"]
[null,"QS164","Parkinson's disease",2,null,"Adults with Parkinson's disease taking dopaminergic therapy are given information about the risk of developing impulse control disorders, when starting treatment and at least annually.","Proportion of adults with Parkinson's disease starting dopaminergic therapy who are given written information about the risk of developing impulse control disorders.","Process","QS164 - Parkinson's disease","2 - QS164 - Parkinson's disease",1,"2 - QS164 - Parkinson's disease - Process - 1","The number in the denominator who are given written information about the risk of developing impulse control disorders. ","The number of adults with Parkinson's disease starting dopaminergic therapy. "]
[null,"QS164","Parkinson's disease",2,null,"Adults with Parkinson's disease taking dopaminergic therapy are given information about the risk of developing impulse control disorders, when starting treatment and at least annually.","Proportion of adults with Parkinson's disease starting dopaminergic therapy who have a record of a discussion about the risk of developing impulse control disorders.","Process","QS164 - Parkinson's disease","2 - QS164 - Parkinson's disease",2,"2 - QS164 - Parkinson's disease - Process - 2","The number in the denominator who have a record of a discussion about the risk of developing impulse control disorders.","The number of adults with Parkinson's disease starting dopaminergic therapy. "]
[null,"QS164","Parkinson's disease",2,null,"Adults with Parkinson's disease taking dopaminergic therapy are given information about the risk of developing impulse control disorders, when starting treatment and at least annually.","Proportion of adults with Parkinson's disease taking dopaminergic therapy who have a record of a discussion within the past 12 months about the risk of developing impulse control disorders.","Process","QS164 - Parkinson's disease","2 - QS164 - Parkinson's disease",3,"2 - QS164 - Parkinson's disease - Process - 3","The number in the denominator who have a record of a discussion within the past 12 months about the risk of developing impulse control disorders. ","The number of adults with Parkinson's disease taking dopaminergic therapy. "]
[null,"QS164","Parkinson's disease",2,null,"Adults with Parkinson's disease taking dopaminergic therapy are given information about the risk of developing impulse control disorders, when starting treatment and at least annually.","Awareness of the risk of developing impulse control disorders among adults taking dopaminergic therapy for Parkinson's disease.","Outcome","QS164 - Parkinson's disease","2 - QS164 - Parkinson's disease",1,"2 - QS164 - Parkinson's disease - Outcome - 1"]
[null,"QS164","Parkinson's disease",2,null,"Adults with Parkinson's disease taking dopaminergic therapy are given information about the risk of developing impulse control disorders, when starting treatment and at least annually.","Awareness of the risk of developing impulse control disorders among family members and carers of adults taking dopaminergic therapy for Parkinson's disease.","Outcome","QS164 - Parkinson's disease","2 - QS164 - Parkinson's disease",2,"2 - QS164 - Parkinson's disease - Outcome - 2"]
[null,"QS164","Parkinson's disease",3,null,"Adults with Parkinson's disease are referred to physiotherapy, occupational therapy or speech and language therapy if they have problems with balance, motor function, activities of daily living, communication, swallowing or saliva.","Evidence that physiotherapy, occupational therapy, and speech and language therapy specific for Parkinson's disease are available locally.","Structure",{"$f":"CONCATENATE(B3585, \" - \", C3585)","v":"QS164 - Parkinson's disease"},{"$f":"CONCATENATE(D3585, \" - \", I3585)","v":"3 - QS164 - Parkinson's disease"},{"$f":"IF(AND(B3585=B3584, D3585=D3584, H3585=H3584)=TRUE, K3584+1, 1)","v":1},{"$f":"CONCATENATE(J3585, \" - \", H3585, \" - \",K3585)","v":"3 - QS164 - Parkinson's disease - Structure - 1"}]
[null,"QS164","Parkinson's disease",3,null,"Adults with Parkinson's disease are referred to physiotherapy, occupational therapy or speech and language therapy if they have problems with balance, motor function, activities of daily living, communication, swallowing or saliva.","Evidence of local processes to identify adults with Parkinson's disease and problems with balance, motor function, activities of daily living, communication, swallowing or saliva.","Structure","QS164 - Parkinson's disease","3 - QS164 - Parkinson's disease",2,"3 - QS164 - Parkinson's disease - Structure - 2"]
[null,"QS164","Parkinson's disease",3,null,"Adults with Parkinson's disease are referred to physiotherapy, occupational therapy or speech and language therapy if they have problems with balance, motor function, activities of daily living, communication, swallowing or saliva.","Proportion of adults with Parkinson's disease and balance or motor function problems identified within the past 12 months who are referred for physiotherapy specific for Parkinson's disease.","Process","QS164 - Parkinson's disease","3 - QS164 - Parkinson's disease",1,"3 - QS164 - Parkinson's disease - Process - 1","The number in the denominator who are referred for physiotherapy specific for Parkinson's disease.","The number of adults with Parkinson's disease and balance or motor function problems identified within the past 12 months. "]
[null,"QS164","Parkinson's disease",3,null,"Adults with Parkinson's disease are referred to physiotherapy, occupational therapy or speech and language therapy if they have problems with balance, motor function, activities of daily living, communication, swallowing or saliva.","Proportion of adults with Parkinson's disease and difficulties with activities of daily living identified within the past 12 months who are referred for occupational therapy specific for Parkinson's disease.","Process","QS164 - Parkinson's disease","3 - QS164 - Parkinson's disease",2,"3 - QS164 - Parkinson's disease - Process - 2","The number in the denominator who are referred for occupational therapy specific for Parkinson's disease.","The number of adults with Parkinson's disease and difficulties with activities of daily living identified within the past 12 months. "]
[null,"QS164","Parkinson's disease",3,null,"Adults with Parkinson's disease are referred to physiotherapy, occupational therapy or speech and language therapy if they have problems with balance, motor function, activities of daily living, communication, swallowing or saliva.","Proportion of adults with Parkinson's disease and problems with communication, swallowing or saliva identified within the past 12 months who are referred for speech and language therapy specific for Parkinson's disease.","Process","QS164 - Parkinson's disease","3 - QS164 - Parkinson's disease",3,"3 - QS164 - Parkinson's disease - Process - 3","The number in the denominator who are referred for speech and language therapy.","The number of adults with Parkinson's disease and problems with communication, swallowing or saliva identified within the past 12 months. "]
[null,"QS164","Parkinson's disease",3,null,"Adults with Parkinson's disease are referred to physiotherapy, occupational therapy or speech and language therapy if they have problems with balance, motor function, activities of daily living, communication, swallowing or saliva.","Health-related quality of life for adults with Parkinson's disease.","Outcome","QS164 - Parkinson's disease","3 - QS164 - Parkinson's disease",1,"3 - QS164 - Parkinson's disease - Outcome - 1"]
[null,"QS164","Parkinson's disease",3,null,"Adults with Parkinson's disease are referred to physiotherapy, occupational therapy or speech and language therapy if they have problems with balance, motor function, activities of daily living, communication, swallowing or saliva.","Hospital admission rate for falls among adults with Parkinson's disease.","Outcome","QS164 - Parkinson's disease","3 - QS164 - Parkinson's disease",2,"3 - QS164 - Parkinson's disease - Outcome - 2"]
[null,"QS164","Parkinson's disease",3,null,"Adults with Parkinson's disease are referred to physiotherapy, occupational therapy or speech and language therapy if they have problems with balance, motor function, activities of daily living, communication, swallowing or saliva.","Hospital admission rate for aspiration pneumonia among adults with Parkinson's disease.","Outcome","QS164 - Parkinson's disease","3 - QS164 - Parkinson's disease",3,"3 - QS164 - Parkinson's disease - Outcome - 3"]
[null,"QS164","Parkinson's disease",4,null,"Adults with Parkinson's disease who are in hospital or a care home take levodopa within 30 minutes of their individually prescribed administration time.","Evidence of local processes to accurately document administration times for levodopa for adults with Parkinson's disease on admission to hospital or a care home to reflect timings before admission. ","Structure",{"$f":"CONCATENATE(B3593, \" - \", C3593)","v":"QS164 - Parkinson's disease"},{"$f":"CONCATENATE(D3593, \" - \", I3593)","v":"4 - QS164 - Parkinson's disease"},{"$f":"IF(AND(B3593=B3592, D3593=D3592, H3593=H3592)=TRUE, K3592+1, 1)","v":1},{"$f":"CONCATENATE(J3593, \" - \", H3593, \" - \",K3593)","v":"4 - QS164 - Parkinson's disease - Structure - 1"}]
[null,"QS164","Parkinson's disease",4,null,"Adults with Parkinson's disease who are in hospital or a care home take levodopa within 30 minutes of their individually prescribed administration time.","Evidence of local processes to identify missed, early or late administration of levodopa for adults with Parkinson's disease in hospital or a care home. ","Structure","QS164 - Parkinson's disease","4 - QS164 - Parkinson's disease",2,"4 - QS164 - Parkinson's disease - Structure - 2"]
[null,"QS164","Parkinson's disease",4,null,"Adults with Parkinson's disease who are in hospital or a care home take levodopa within 30 minutes of their individually prescribed administration time.","Proportion of prescribed doses of levodopa for adults with Parkinson's disease in hospital or a care home that were missed.","Process","QS164 - Parkinson's disease","4 - QS164 - Parkinson's disease",1,"4 - QS164 - Parkinson's disease - Process - 1","The number in the denominator that were missed.","The number of prescribed doses of levodopa for adults with Parkinson's disease in hospital or a care home. "]
[null,"QS164","Parkinson's disease",4,null,"Adults with Parkinson's disease who are in hospital or a care home take levodopa within 30 minutes of their individually prescribed administration time.","Proportion of doses of levodopa for adults with Parkinson's disease in hospital or a care home that were given more than 30 minutes before the individually prescribed administration time.","Process","QS164 - Parkinson's disease","4 - QS164 - Parkinson's disease",2,"4 - QS164 - Parkinson's disease - Process - 2","The number in the denominator that were given more than 30 minutes before the individually prescribed administration time. ","The number of doses of levodopa for adults with Parkinson's disease in hospital or a care home. "]
[null,"QS164","Parkinson's disease",4,null,"Adults with Parkinson's disease who are in hospital or a care home take levodopa within 30 minutes of their individually prescribed administration time.","Proportion of doses of levodopa for adults with Parkinson's disease in hospital or a care home that were given more than 30 minutes after the individually prescribed administration time.","Process","QS164 - Parkinson's disease","4 - QS164 - Parkinson's disease",3,"4 - QS164 - Parkinson's disease - Process - 3","The number in the denominator that were given more than 30 minutes after the individually prescribed administration time. ","The number of doses of levodopa for adults with Parkinson's disease in hospital or a care home. "]
[null,"QS164","Parkinson's disease",4,null,"Adults with Parkinson's disease who are in hospital or a care home take levodopa within 30 minutes of their individually prescribed administration time.","Patient safety incidents related to medicines for adults with Parkinson's disease in hospital or a care home.","Outcome","QS164 - Parkinson's disease","4 - QS164 - Parkinson's disease",1,"4 - QS164 - Parkinson's disease - Outcome - 1"]
[null,"QS164","Parkinson's disease",4,null,"Adults with Parkinson's disease who are in hospital or a care home take levodopa within 30 minutes of their individually prescribed administration time.","Length of hospital stay for adults with Parkinson's disease.","Outcome","QS164 - Parkinson's disease","4 - QS164 - Parkinson's disease",2,"4 - QS164 - Parkinson's disease - Outcome - 2"]
[null,"QS164","Parkinson's disease",5,null,"Services for adults with Parkinson's disease provide access to clozapine and patient monitoring for treating hallucinations and delusions.","Evidence of local pathways to provide access to clozapine and patient monitoring for treating hallucinations and delusions in adults with Parkinson's disease. ","Structure","QS164 - Parkinson's disease","5 - QS164 - Parkinson's disease",1,"5 - QS164 - Parkinson's disease - Structure - 1"]
[null,"QS164","Parkinson's disease",5,null,"Services for adults with Parkinson's disease provide access to clozapine and patient monitoring for treating hallucinations and delusions.","Prescribing rates of lower dose clozapine for adults with Parkinson's.","Outcome","QS164 - Parkinson's disease","5 - QS164 - Parkinson's disease",1,"5 - QS164 - Parkinson's disease - Outcome - 1"]
[null,"QS164","Parkinson's disease",5,null,"Services for adults with Parkinson's disease provide access to clozapine and patient monitoring for treating hallucinations and delusions.","Satisfaction with the management of hallucinations and delusions among adults with Parkinson's disease.","Outcome","QS164 - Parkinson's disease","5 - QS164 - Parkinson's disease",2,"5 - QS164 - Parkinson's disease - Outcome - 2"]
[null,"QS164","Parkinson's disease",5,null,"Services for adults with Parkinson's disease provide access to clozapine and patient monitoring for treating hallucinations and delusions.","Permanent admissions to care homes for adults with Parkinson's disease and hallucinations or delusions. ","Outcome","QS164 - Parkinson's disease","5 - QS164 - Parkinson's disease",3,"5 - QS164 - Parkinson's disease - Outcome - 3"]
[null,"QS165","Drug misuse prevention",1,null,"Looked-after children and young people having their annual health plan review are assessed for vulnerability to drug misuse. ","Evidence of local arrangements for the use of an agreed brief and valid questionnaire to assess looked-after children and young people's vulnerability to drug misuse at their annual health plan review.","Structure","QS165 - Drug misuse prevention","1 - QS165 - Drug misuse prevention",1,"1 - QS165 - Drug misuse prevention - Structure - 1"]
[null,"QS165","Drug misuse prevention",1,null,"Looked-after children and young people having their annual health plan review are assessed for vulnerability to drug misuse. ","Evidence of local arrangements for staff to be trained by specialist services in how to assess looked-after children and young people's vulnerability to drug misuse.","Structure","QS165 - Drug misuse prevention","1 - QS165 - Drug misuse prevention",2,"1 - QS165 - Drug misuse prevention - Structure - 2"]
[null,"QS165","Drug misuse prevention",1,null,"Looked-after children and young people having their annual health plan review are assessed for vulnerability to drug misuse. ","Proportion of looked-after children and young people having their annual health plan review who have an assessment of vulnerability to drug misuse.","Process","QS165 - Drug misuse prevention","1 - QS165 - Drug misuse prevention",1,"1 - QS165 - Drug misuse prevention - Process - 1","The number in the denominator who have an assessment of vulnerability to drug misuse.","The number of looked-after children and young people who have had a health plan review in the previous 12 months."]
[null,"QS165","Drug misuse prevention",1,null,"Looked-after children and young people having their annual health plan review are assessed for vulnerability to drug misuse. ","Number of looked-after children and young people who misuse drugs.","Outcome","QS165 - Drug misuse prevention","1 - QS165 - Drug misuse prevention",1,"1 - QS165 - Drug misuse prevention - Outcome - 1"]
[null,"QS165","Drug misuse prevention",1,null,"Looked-after children and young people having their annual health plan review are assessed for vulnerability to drug misuse. ","Proportion of looked-after children and young people misusing drugs, who access support for drug misuse. ","Outcome","QS165 - Drug misuse prevention","1 - QS165 - Drug misuse prevention",2,"1 - QS165 - Drug misuse prevention - Outcome - 2"]
[null,"QS165","Drug misuse prevention",2,null,"Care leavers having a health assessment as part of planning to leave care are assessed for vulnerability to drug misuse. ","Evidence of local arrangements for the use of an agreed brief and valid questionnaire to assess care leavers' vulnerability to drug misuse at their health assessment.","Structure","QS165 - Drug misuse prevention","2 - QS165 - Drug misuse prevention",1,"2 - QS165 - Drug misuse prevention - Structure - 1"]
[null,"QS165","Drug misuse prevention",2,null,"Care leavers having a health assessment as part of planning to leave care are assessed for vulnerability to drug misuse. ","Evidence of local arrangements for staff to be trained by specialist services in how to assess care leavers' vulnerability to drug misuse.","Structure","QS165 - Drug misuse prevention","2 - QS165 - Drug misuse prevention",2,"2 - QS165 - Drug misuse prevention - Structure - 2"]
[null,"QS165","Drug misuse prevention",2,null,"Care leavers having a health assessment as part of planning to leave care are assessed for vulnerability to drug misuse. ","Proportion of care leavers having a health assessment as part of planning to leave care who have an assessment of vulnerability to drug misuse.","Process","QS165 - Drug misuse prevention","2 - QS165 - Drug misuse prevention",1,"2 - QS165 - Drug misuse prevention - Process - 1","The number in the denominator where there is an assessment of vulnerability to drug misuse.","The number of care leavers having a health assessment as part of planning to leave care."]
[null,"QS165","Drug misuse prevention",2,null,"Care leavers having a health assessment as part of planning to leave care are assessed for vulnerability to drug misuse. ","Number of care leavers who misuse drugs.","Outcome","QS165 - Drug misuse prevention","2 - QS165 - Drug misuse prevention",1,"2 - QS165 - Drug misuse prevention - Outcome - 1"]
[null,"QS165","Drug misuse prevention",2,null,"Care leavers having a health assessment as part of planning to leave care are assessed for vulnerability to drug misuse. ","Proportion of care leavers misusing drugs who access support for drug misuse.","Outcome","QS165 - Drug misuse prevention","2 - QS165 - Drug misuse prevention",2,"2 - QS165 - Drug misuse prevention - Outcome - 2"]
[null,"QS165","Drug misuse prevention",3,null,"Children and young people having a young offender assessment are assessed for vulnerability to drug misuse.","Evidence of local arrangements for the use of an agreed brief and valid questionnaire to assess children and young people's vulnerability to drug misuse at young offender assessments.","Structure","QS165 - Drug misuse prevention","3 - QS165 - Drug misuse prevention",1,"3 - QS165 - Drug misuse prevention - Structure - 1"]
[null,"QS165","Drug misuse prevention",3,null,"Children and young people having a young offender assessment are assessed for vulnerability to drug misuse.","Evidence of local arrangements for staff to be trained in how to assess children and young people's vulnerability to drug misuse.","Structure","QS165 - Drug misuse prevention","3 - QS165 - Drug misuse prevention",2,"3 - QS165 - Drug misuse prevention - Structure - 2"]
[null,"QS165","Drug misuse prevention",3,null,"Children and young people having a young offender assessment are assessed for vulnerability to drug misuse.","Proportion of young offender assessments which include an assessment of vulnerability to drug misuse.","Process","QS165 - Drug misuse prevention","3 - QS165 - Drug misuse prevention",1,"3 - QS165 - Drug misuse prevention - Process - 1","The number in the denominator which include an assessment of vulnerability to drug misuse.","The number of young offender assessments."]
[null,"QS165","Drug misuse prevention",3,null,"Children and young people having a young offender assessment are assessed for vulnerability to drug misuse.","Number of children and young people in contact with youth offending services who misuse drugs.","Outcome","QS165 - Drug misuse prevention","3 - QS165 - Drug misuse prevention",1,"3 - QS165 - Drug misuse prevention - Outcome - 1"]
[null,"QS165","Drug misuse prevention",3,null,"Children and young people having a young offender assessment are assessed for vulnerability to drug misuse.","Proportion of children and young people who are in contact with youth offending services, misusing drugs, who access support for drug misuse.","Outcome","QS165 - Drug misuse prevention","3 - QS165 - Drug misuse prevention",2,"3 - QS165 - Drug misuse prevention - Outcome - 2"]
[null,"QS165","Drug misuse prevention",4,null,"Adults assessed as vulnerable to drug misuse are given information about local services and where to find further advice and support. ","Evidence of local arrangements to provide written information about local services and where to find further advice and support.","Structure","QS165 - Drug misuse prevention","4 - QS165 - Drug misuse prevention",1,"4 - QS165 - Drug misuse prevention - Structure - 1"]
[null,"QS165","Drug misuse prevention",4,null,"Adults assessed as vulnerable to drug misuse are given information about local services and where to find further advice and support. ","Proportion of adults assessed as vulnerable to drug misuse who are given information about local services and where to find further advice and support.","Process","QS165 - Drug misuse prevention","4 - QS165 - Drug misuse prevention",1,"4 - QS165 - Drug misuse prevention - Process - 1","The number in the denominator who are given information about local services and where to find further advice and support.","The number of adults assessed as vulnerable to drug misuse."]
[null,"QS165","Drug misuse prevention",4,null,"Adults assessed as vulnerable to drug misuse are given information about local services and where to find further advice and support. ","Proportion of people aged 16 to 59 years who use drugs frequently.","Outcome","QS165 - Drug misuse prevention","4 - QS165 - Drug misuse prevention",1,"4 - QS165 - Drug misuse prevention - Outcome - 1"]
[null,"QS165","Drug misuse prevention",4,null,"Adults assessed as vulnerable to drug misuse are given information about local services and where to find further advice and support. ","Proportion of people aged 16 to 24 years who use drugs frequently.","Outcome","QS165 - Drug misuse prevention","4 - QS165 - Drug misuse prevention",2,"4 - QS165 - Drug misuse prevention - Outcome - 2"]
[null,"QS166","Trauma",1,null,"People with major trauma who cannot maintain their airway and/or ventilation have drug‑assisted rapid sequence induction (RSI) of anaesthesia and intubation within 45 minutes of the initial call to the emergency services.","Evidence of the availability of healthcare professionals trained to perform drug‑assisted RSI of anaesthesia and intubation at the scene, or of systems to transport people to the nearest emergency department where it can be performed.","Structure","QS166 - Trauma","1 - QS166 - Trauma",1,"1 - QS166 - Trauma - Structure - 1"]
[null,"QS166","Trauma",1,null,"People with major trauma who cannot maintain their airway and/or ventilation have drug‑assisted rapid sequence induction (RSI) of anaesthesia and intubation within 45 minutes of the initial call to the emergency services.","Evidence of local arrangements to support decision‑making about whether to dispatch trained healthcare professionals to the scene to deliver drug‑assisted RSI of anaesthesia and intubation, or transport the person to the nearest emergency department where it can be performed.","Structure","QS166 - Trauma","1 - QS166 - Trauma",2,"1 - QS166 - Trauma - Structure - 2"]
[null,"QS166","Trauma",1,null,"People with major trauma who cannot maintain their airway and/or ventilation have drug‑assisted rapid sequence induction (RSI) of anaesthesia and intubation within 45 minutes of the initial call to the emergency services.","Proportion of people with major trauma who cannot maintain their airway and/or ventilation who have drug‑assisted RSI of anaesthesia and intubation.","Process","QS166 - Trauma","1 - QS166 - Trauma",1,"1 - QS166 - Trauma - Process - 1","The number in the denominator who have drug‑assisted RSI of anaesthesia and intubation.","The number of people with major trauma who cannot maintain their airway and/or ventilation."]
[null,"QS166","Trauma",1,null,"People with major trauma who cannot maintain their airway and/or ventilation have drug‑assisted rapid sequence induction (RSI) of anaesthesia and intubation within 45 minutes of the initial call to the emergency services.","Proportion of people with major trauma who cannot maintain their airway and/or ventilation who have drug‑assisted RSI of anaesthesia and intubation within 45 minutes of the initial call to the emergency services.","Process","QS166 - Trauma","1 - QS166 - Trauma",2,"1 - QS166 - Trauma - Process - 2","The number in the denominator who have drug‑assisted RSI of anaesthesia and intubation within 45 minutes of the initial call to the emergency services.","The number of people with major trauma who cannot maintain their airway and/or ventilation and have drug‑assisted RSI of anaesthesia and intubation."]
[null,"QS166","Trauma",1,null,"People with major trauma who cannot maintain their airway and/or ventilation have drug‑assisted rapid sequence induction (RSI) of anaesthesia and intubation within 45 minutes of the initial call to the emergency services.","Mortality rates from major trauma.","Outcome","QS166 - Trauma","1 - QS166 - Trauma",1,"1 - QS166 - Trauma - Outcome - 1"]
[null,"QS166","Trauma",1,null,"People with major trauma who cannot maintain their airway and/or ventilation have drug‑assisted rapid sequence induction (RSI) of anaesthesia and intubation within 45 minutes of the initial call to the emergency services.","Rates of brain injury resulting from lack of oxygen caused by major trauma.","Outcome","QS166 - Trauma","1 - QS166 - Trauma",2,"1 - QS166 - Trauma - Outcome - 2"]
[null,"QS166","Trauma",2,null,"People who have had urgent 3D imaging for major trauma have a provisional written radiology report within 60 minutes of the scan.","Evidence of local arrangements to ensure that provisional written radiology reports of urgent 3D imaging for chest trauma, haemorrhage and spinal injury are available within 60 minutes of the scan.","Structure","QS166 - Trauma","2 - QS166 - Trauma",1,"2 - QS166 - Trauma - Structure - 1"]
[null,"QS166","Trauma",2,null,"People who have had urgent 3D imaging for major trauma have a provisional written radiology report within 60 minutes of the scan.","Proportion of urgent 3D images for chest trauma with a provisional written radiology report available within 60 minutes of the scan.","Process","QS166 - Trauma","2 - QS166 - Trauma",1,"2 - QS166 - Trauma - Process - 1","The number in the denominator with a provisional written radiology report available within 60 minutes of the scan.","The number of urgent 3D images for chest trauma."]
[null,"QS166","Trauma",2,null,"People who have had urgent 3D imaging for major trauma have a provisional written radiology report within 60 minutes of the scan.","Proportion of urgent 3D images for haemorrhage with a provisional written radiology report available within 60 minutes of the scan.","Process","QS166 - Trauma","2 - QS166 - Trauma",2,"2 - QS166 - Trauma - Process - 2","The number in the denominator with a provisional written radiology report available within 60 minutes of the scan.","The number of urgent 3D images for haemorrhage."]
[null,"QS166","Trauma",2,null,"People who have had urgent 3D imaging for major trauma have a provisional written radiology report within 60 minutes of the scan.","Proportion of urgent 3D images for spinal injury with a provisional written radiology report available within 60 minutes of the scan.","Process","QS166 - Trauma","2 - QS166 - Trauma",3,"2 - QS166 - Trauma - Process - 3","The number in the denominator with a provisional written radiology report available within 60 minutes of the scan.","The number of urgent 3D images for spinal injury."]
[null,"QS166","Trauma",2,null,"People who have had urgent 3D imaging for major trauma have a provisional written radiology report within 60 minutes of the scan.","Mortality rates from major trauma.","Outcome","QS166 - Trauma","2 - QS166 - Trauma",1,"2 - QS166 - Trauma - Outcome - 1"]
[null,"QS166","Trauma",2,null,"People who have had urgent 3D imaging for major trauma have a provisional written radiology report within 60 minutes of the scan.","Length of hospital stay for people with major trauma.","Outcome","QS166 - Trauma","2 - QS166 - Trauma",2,"2 - QS166 - Trauma - Outcome - 2"]
[null,"QS166","Trauma",2,null,"People who have had urgent 3D imaging for major trauma have a provisional written radiology report within 60 minutes of the scan.","Health-related quality of life for people who have experienced major trauma.","Outcome","QS166 - Trauma","2 - QS166 - Trauma",3,"2 - QS166 - Trauma - Outcome - 3"]
[null,"QS166","Trauma",3,null,"People with open fractures of long bones, the hindfoot or midfoot have fixation and definitive soft tissue cover within 72 hours of injury if this cannot be performed at the same time as debridement.","Evidence that orthopaedic and plastic surgery specialities have a joint orthoplastic surgery service that allows for fixation and definitive soft tissue cover of open fractures of long bones, the hindfoot or midfoot within 72 hours of injury if this cannot be performed at the same time as debridement.","Structure","QS166 - Trauma","3 - QS166 - Trauma",1,"3 - QS166 - Trauma - Structure - 1"]
[null,"QS166","Trauma",3,null,"People with open fractures of long bones, the hindfoot or midfoot have fixation and definitive soft tissue cover within 72 hours of injury if this cannot be performed at the same time as debridement.","Proportion of open fractures of long bones, the hindfoot or midfoot with fixation and definitive soft tissue cover performed within 72 hours of injury if this cannot be performed at the same time as debridement.","Process","QS166 - Trauma","3 - QS166 - Trauma",1,"3 - QS166 - Trauma - Process - 1","The number in the denominator with fixation and definitive soft tissue cover performed within 72 hours of injury.","The number of open fractures of long bones, the hindfoot or midfoot where fixation and soft tissue cover cannot be performed at the same time as debridement."]
[null,"QS166","Trauma",3,null,"People with open fractures of long bones, the hindfoot or midfoot have fixation and definitive soft tissue cover within 72 hours of injury if this cannot be performed at the same time as debridement.","Proportion of open fractures of long bones, the hindfoot or midfoot with fixation and definitive soft tissue cover performed within 72 hours of injury.","Process","QS166 - Trauma","3 - QS166 - Trauma",2,"3 - QS166 - Trauma - Process - 2","The number in the denominator with fixation and definitive soft tissue cover performed within 72 hours of injury.","The number of open fractures of long bones, the hindfoot or midfoot."]
[null,"QS166","Trauma",3,null,"People with open fractures of long bones, the hindfoot or midfoot have fixation and definitive soft tissue cover within 72 hours of injury if this cannot be performed at the same time as debridement.","Rates of unplanned surgery after surgery on open fractures.","Outcome","QS166 - Trauma","3 - QS166 - Trauma",1,"3 - QS166 - Trauma - Outcome - 1"]
[null,"QS166","Trauma",3,null,"People with open fractures of long bones, the hindfoot or midfoot have fixation and definitive soft tissue cover within 72 hours of injury if this cannot be performed at the same time as debridement.","Non-emergency amputation rates for people with open fractures.","Outcome",{"$f":"CONCATENATE(B3640, \" - \", C3640)","v":"QS166 - Trauma"},{"$f":"CONCATENATE(D3640, \" - \", I3640)","v":"3 - QS166 - Trauma"},{"$f":"IF(AND(B3640=B3639, D3640=D3639, H3640=H3639)=TRUE, K3639+1, 1)","v":2},{"$f":"CONCATENATE(J3640, \" - \", H3640, \" - \",K3640)","v":"3 - QS166 - Trauma - Outcome - 2"}]
[null,"QS166","Trauma",3,null,"People with open fractures of long bones, the hindfoot or midfoot have fixation and definitive soft tissue cover within 72 hours of injury if this cannot be performed at the same time as debridement.","Length of hospital stay for people with open fractures.","Outcome","QS166 - Trauma","3 - QS166 - Trauma",3,"3 - QS166 - Trauma - Outcome - 3"]
[null,"QS166","Trauma",3,null,"People with open fractures of long bones, the hindfoot or midfoot have fixation and definitive soft tissue cover within 72 hours of injury if this cannot be performed at the same time as debridement.","Time taken to return to normal activities for people with open fractures.","Outcome","QS166 - Trauma","3 - QS166 - Trauma",4,"3 - QS166 - Trauma - Outcome - 4"]
[null,"QS166","Trauma",4,null,"People with full in-line spinal immobilisation have their risk of cervical spine injury assessed using the Canadian C‑spine rule.","Evidence of the documented use of checklists to ensure that the Canadian C‑spine rule is used to assess people with full in‑line spinal immobilisation for their risk of cervical spine injury.","Structure","QS166 - Trauma","4 - QS166 - Trauma",1,"4 - QS166 - Trauma - Structure - 1"]
[null,"QS166","Trauma",4,null,"People with full in-line spinal immobilisation have their risk of cervical spine injury assessed using the Canadian C‑spine rule.","Proportion of people with full in‑line spinal immobilisation who have had their risk of cervical spine injury assessed using the Canadian C‑spine rule.","Process","QS166 - Trauma","4 - QS166 - Trauma",1,"4 - QS166 - Trauma - Process - 1","The number in the denominator who have had their risk of cervical spine injury assessed using the Canadian C‑spine rule.","The number of people with full in‑line spinal immobilisation."]
[null,"QS166","Trauma",4,null,"People with full in-line spinal immobilisation have their risk of cervical spine injury assessed using the Canadian C‑spine rule.","Rates of neurological deterioration caused by inappropriate removal of spinal immobilisation.","Outcome","QS166 - Trauma","4 - QS166 - Trauma",1,"4 - QS166 - Trauma - Outcome - 1"]
[null,"QS166","Trauma",4,null,"People with full in-line spinal immobilisation have their risk of cervical spine injury assessed using the Canadian C‑spine rule.","Rates of appropriate removal of full in-line spinal immobilisation.","Outcome","QS166 - Trauma","4 - QS166 - Trauma",2,"4 - QS166 - Trauma - Outcome - 2"]
[null,"QS166","Trauma",5,null,"Major trauma centres have a dedicated trauma ward for patients with multisystem injuries and a designated consultant available to contact 24 hours a day, 7 days a week.","Evidence of a dedicated trauma ward for patients with multisystem injuries.","Structure","QS166 - Trauma","5 - QS166 - Trauma",1,"5 - QS166 - Trauma - Structure - 1"]
[null,"QS166","Trauma",5,null,"Major trauma centres have a dedicated trauma ward for patients with multisystem injuries and a designated consultant available to contact 24 hours a day, 7 days a week.","Evidence of the availability of a designated consultant 24 hours a day, 7 days a week, who has responsibility and authority for the hospital trauma service and leads the multidisciplinary team care.","Structure","QS166 - Trauma","5 - QS166 - Trauma",2,"5 - QS166 - Trauma - Structure - 2"]
[null,"QS166","Trauma",5,null,"Major trauma centres have a dedicated trauma ward for patients with multisystem injuries and a designated consultant available to contact 24 hours a day, 7 days a week.","Mortality rates from major trauma.","Outcome","QS166 - Trauma","5 - QS166 - Trauma",1,"5 - QS166 - Trauma - Outcome - 1"]
[null,"QS166","Trauma",5,null,"Major trauma centres have a dedicated trauma ward for patients with multisystem injuries and a designated consultant available to contact 24 hours a day, 7 days a week.","Length of hospital stay for people who have had major trauma.","Outcome","QS166 - Trauma","5 - QS166 - Trauma",2,"5 - QS166 - Trauma - Outcome - 2"]
[null,"QS166","Trauma",5,null,"Major trauma centres have a dedicated trauma ward for patients with multisystem injuries and a designated consultant available to contact 24 hours a day, 7 days a week.","Patient experience of major trauma services.","Outcome","QS166 - Trauma","5 - QS166 - Trauma",3,"5 - QS166 - Trauma - Outcome - 3"]
[null,"QS166","Trauma",6,null,"Major trauma centres have acute specialist services for rehabilitation after major trauma, and for children and older people.","Evidence of the availability of acute specialist services for rehabilitation after major trauma.","Structure","QS166 - Trauma","6 - QS166 - Trauma",1,"6 - QS166 - Trauma - Structure - 1"]
[null,"QS166","Trauma",6,null,"Major trauma centres have acute specialist services for rehabilitation after major trauma, and for children and older people.","Evidence of the availability of acute specialist services for children.","Structure","QS166 - Trauma","6 - QS166 - Trauma",2,"6 - QS166 - Trauma - Structure - 2"]
[null,"QS166","Trauma",6,null,"Major trauma centres have acute specialist services for rehabilitation after major trauma, and for children and older people.","Evidence of the availability of acute specialist services for older people.","Structure","QS166 - Trauma","6 - QS166 - Trauma",3,"6 - QS166 - Trauma - Structure - 3"]
[null,"QS166","Trauma",6,null,"Major trauma centres have acute specialist services for rehabilitation after major trauma, and for children and older people.","Morbidity from major trauma.","Outcome","QS166 - Trauma","6 - QS166 - Trauma",1,"6 - QS166 - Trauma - Outcome - 1"]
[null,"QS166","Trauma",6,null,"Major trauma centres have acute specialist services for rehabilitation after major trauma, and for children and older people.","Length of hospital stay for people who have had major trauma.","Outcome","QS166 - Trauma","6 - QS166 - Trauma",2,"6 - QS166 - Trauma - Outcome - 2"]
[null,"QS166","Trauma",6,null,"Major trauma centres have acute specialist services for rehabilitation after major trauma, and for children and older people.","Patient experience of major trauma services.","Outcome","QS166 - Trauma","6 - QS166 - Trauma",3,"6 - QS166 - Trauma - Outcome - 3"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,null,"People from Black, Asian and other minority ethnic groups have their views represented in setting priorities and designing local health and wellbeing programmes.","Evidence of work carried out to gather intelligence about the ethnic diversity of the local population. ","Structure","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Structure - 1"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,null,"People from Black, Asian and other minority ethnic groups have their views represented in setting priorities and designing local health and wellbeing programmes.","Evidence of work carried out to gain understanding of the needs of Black, Asian and other minority ethnic groups living in the local area. ","Structure","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,"1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Structure - 2"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,null,"People from Black, Asian and other minority ethnic groups have their views represented in setting priorities and designing local health and wellbeing programmes.","Evidence of actions taken to gather views of local people from Black, Asian and other minority ethnic groups on priorities for and design of health and wellbeing programmes.","Structure","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,"1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Structure - 3"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,null,"People from Black, Asian and other minority ethnic groups have their views represented in setting priorities and designing local health and wellbeing programmes.","Evidence of how intelligence on ethnic diversity, the needs and views of the local population is used to inform commissioning. ","Structure","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",4,"1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Structure - 4"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,null,"People from Black, Asian and other minority ethnic groups have their views represented in setting priorities and designing local health and wellbeing programmes.","Proportion of local health and wellbeing programmes that gathered views of people from Black, Asian and other minority ethnic groups when setting priorities and designing the programmes.","Process","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Process - 1","The number in the denominator that gathered views of people from Black, Asian and other minority ethnic groups when setting priorities and designing the programmes.","The number of health and wellbeing programmes commissioned locally."]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,null,"People from Black, Asian and other minority ethnic groups have their views represented in setting priorities and designing local health and wellbeing programmes.","Proportion of people representing the views of Black, Asian and other minority ethnic groups involved in setting priorities and designing local health and wellbeing programmes who felt that their views were valued.","Process","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,"1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Process - 2","The number in the denominator that felt their views were valued.","The number of people representing the views of Black, Asian and other minority ethnic groups involved in setting priorities and designing local health and wellbeing programmes."]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,null,"People from Black, Asian and other minority ethnic groups have their views represented in setting priorities and designing local health and wellbeing programmes.","Uptake of local health and wellbeing services among people from Black, Asian and other minority ethnic groups.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 1"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,null,"People from Black, Asian and other minority ethnic groups have their views represented in setting priorities and designing local health and wellbeing programmes.","Proportion of people from Black, Asian and other minority ethnic groups referred to local health and wellbeing services who feel that the services meet their needs. ","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,"1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 2"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,null,"People from Black, Asian and other minority ethnic groups have their views represented in setting priorities and designing local health and wellbeing programmes.","Prevalence of obesity among local people from Black, Asian and other minority ethnic groups.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,"1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 3"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,null,"People from Black, Asian and other minority ethnic groups have their views represented in setting priorities and designing local health and wellbeing programmes.","Physical activity levels among local people from Black, Asian and other minority ethnic groups.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",4,"1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 4"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,null,"People from Black, Asian and other minority ethnic groups have their views represented in setting priorities and designing local health and wellbeing programmes.","Prevalence of tobacco use among local people from Black, Asian and other minority ethnic groups.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",5,"1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 5"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,null,"People from Black, Asian and other minority ethnic groups have their views represented in setting priorities and designing local health and wellbeing programmes.","Mental wellbeing among local people from Black, Asian and other minority ethnic groups. ","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",6,"1 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 6"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,null,"People from Black, Asian and other minority ethnic groups are represented in peer and lay roles within local health and wellbeing programmes.","Evidence of local arrangements to ensure that people from Black, Asian and other minority ethnic groups are represented in peer and lay roles for local health and wellbeing programmes.","Structure","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","2 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"2 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Structure - 1"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,null,"People from Black, Asian and other minority ethnic groups are represented in peer and lay roles within local health and wellbeing programmes.","Evidence of local arrangements to support people from Black, Asian and other minority ethnic groups taking on peer and lay roles in local health and wellbeing programmes.","Structure","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","2 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,"2 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Structure - 2"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,null,"People from Black, Asian and other minority ethnic groups are represented in peer and lay roles within local health and wellbeing programmes.","Proportion of local health and wellbeing programmes with people working in peer and lay roles who are representative of the local community.","Process","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","2 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"2 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Process - 1","The number in the denominator with people working in peer and lay roles who are representative of the local community.","The number of local health and wellbeing programmes."]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,null,"People from Black, Asian and other minority ethnic groups are represented in peer and lay roles within local health and wellbeing programmes.","The number of people from Black, Asian and other minority groups who access local health and wellbeing programmes.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","2 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"2 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 1"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,null,"People from Black, Asian and other minority ethnic groups are represented in peer and lay roles within local health and wellbeing programmes.","The number of people in peer and lay roles supporting Black, Asian and other minority ethnic groups to improve their health and wellbeing.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","2 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,"2 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 2"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,null,"People from Black, Asian and other minority ethnic groups are represented in peer and lay roles within local health and wellbeing programmes.","Experience of engaging with local health and wellbeing programmes among people from Black, Asian and other minority groups.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","2 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,"2 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 3"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,null,"People from Black, Asian and other minority ethnic groups are represented in peer and lay roles within local health and wellbeing programmes.","Long-term retention of people in peer and lay roles.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","2 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",4,"2 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 4"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,null,"People from Black, Asian and other minority ethnic groups at high risk of type 2 diabetes are referred to an intensive lifestyle change programme.","Evidence of local arrangements for identifying and referring people from Black, Asian and other minority ethnic groups at high risk of type 2 diabetes.","Structure","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Structure - 1"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,null,"People from Black, Asian and other minority ethnic groups at high risk of type 2 diabetes are referred to an intensive lifestyle change programme.","Proportion of people from Black, Asian and other minority ethnic groups identified as being at high risk of type 2 diabetes who are referred to an intensive lifestyle change programme. ","Process","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Process - 1","The number in the denominator who are referred to an intensive lifestyle change programme.","The number of people from Black, Asian and other minority ethnic groups who are identified as being at high risk of type 2 diabetes."]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,null,"People from Black, Asian and other minority ethnic groups at high risk of type 2 diabetes are referred to an intensive lifestyle change programme.","Proportion of people from Black, Asian and other minority ethnic groups referred to an intensive lifestyle change programme who attended the programme.","Process","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,"3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Process - 2","The number in the denominator who attended an intensive lifestyle change programme.","The number of people from Black, Asian and other minority ethnic groups who are at high risk of type 2 diabetes referred to an intensive lifestyle change programme."]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,null,"People from Black, Asian and other minority ethnic groups at high risk of type 2 diabetes are referred to an intensive lifestyle change programme.","Proportion of people from Black, Asian and other minority ethnic groups referred to an intensive lifestyle change programme who completed the programme.","Process","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,"3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Process - 3","The number in the denominator who completed an intensive lifestyle change programme.","The number of people from Black, Asian and other minority ethnic groups who are at high risk of type 2 diabetes referred to an intensive lifestyle change programme."]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,null,"People from Black, Asian and other minority ethnic groups at high risk of type 2 diabetes are referred to an intensive lifestyle change programme.","Change in BMI among people from Black, Asian and other minority ethnic groups completing intensive lifestyle change programmes.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 1"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,null,"People from Black, Asian and other minority ethnic groups at high risk of type 2 diabetes are referred to an intensive lifestyle change programme.","Change in blood pressure among people from Black, Asian and other minority ethnic groups completing intensive lifestyle change programmes.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,"3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 2"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,null,"People from Black, Asian and other minority ethnic groups at high risk of type 2 diabetes are referred to an intensive lifestyle change programme.","Change in HbA1c among people from Black, Asian and other minority ethnic groups completing intensive lifestyle change programmes.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,"3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 3"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,null,"People from Black, Asian and other minority ethnic groups at high risk of type 2 diabetes are referred to an intensive lifestyle change programme.","Prevalence of type 2 diabetes among people from Black, Asian and other minority groups.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",4,"3 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 4"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",4,null,"People from Black, Asian and other minority ethnic groups referred to a cardiac rehabilitation programme are given a choice of times and settings for the sessions and are followed up if they do not attend.","Evidence of local arrangements to discuss any factors that might stop people from Black, Asian or other minority ethnic groups from attending a cardiac rehabilitation programme, before they receive a referral. ","Structure","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Structure - 1"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",4,null,"People from Black, Asian and other minority ethnic groups referred to a cardiac rehabilitation programme are given a choice of times and settings for the sessions and are followed up if they do not attend.","Evidence of local arrangements to provide cardiac rehabilitation sessions for people from Black, Asian and other minority ethnic groups in a variety of settings including at home, in the community or in a hospital.","Structure","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,"4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Structure - 2"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",4,null,"People from Black, Asian and other minority ethnic groups referred to a cardiac rehabilitation programme are given a choice of times and settings for the sessions and are followed up if they do not attend.","Evidence of local arrangements to provide cardiac rehabilitation sessions for people from Black, Asian and other minority ethnic groups at a choice of times, for example, sessions outside working hours.","Structure","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,"4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Structure - 3"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",4,null,"People from Black, Asian and other minority ethnic groups referred to a cardiac rehabilitation programme are given a choice of times and settings for the sessions and are followed up if they do not attend.","Proportion of people from Black, Asian and other minority ethnic groups referred to a cardiac rehabilitation programme who are offered sessions in a variety of settings including home, the community or a hospital. ","Process","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Process - 1","The number in the denominator offered sessions in a variety of settings including home, the community or a hospital.","The number of people from Black, Asian and other minority ethnic groups referred to a cardiac rehabilitation programme."]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",4,null,"People from Black, Asian and other minority ethnic groups referred to a cardiac rehabilitation programme are given a choice of times and settings for the sessions and are followed up if they do not attend.","Proportion of people from Black, Asian and other minority ethnic groups referred to a cardiac rehabilitation programme who did not start the programme who were contacted with a reminder.","Process","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,"4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Process - 2","The number in the denominator who were contacted with a reminder.","The number of people from Black, Asian and other minority ethnic groups referred to a cardiac rehabilitation programme who did not start the programme."]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",4,null,"People from Black, Asian and other minority ethnic groups referred to a cardiac rehabilitation programme are given a choice of times and settings for the sessions and are followed up if they do not attend.","Proportion of people from Black, Asian and other minority ethnic groups who missed their cardiac rehabilitation appointment who were contacted with a reminder.","Process","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,"4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Process - 3","The number in the denominator who were contacted with a reminder.","The number of people from Black, Asian and other minority ethnic groups participating in a cardiac rehabilitation programme who missed their appointment."]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",4,null,"People from Black, Asian and other minority ethnic groups referred to a cardiac rehabilitation programme are given a choice of times and settings for the sessions and are followed up if they do not attend.","Rate of uptake of cardiac rehabilitation programmes among people from Black, Asian and other minority ethnic groups. ","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 1"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",4,null,"People from Black, Asian and other minority ethnic groups referred to a cardiac rehabilitation programme are given a choice of times and settings for the sessions and are followed up if they do not attend.","Rates of adherence to cardiac rehabilitation programmes among people from Black, Asian and other minority ethnic groups. ","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,"4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 2"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",4,null,"People from Black, Asian and other minority ethnic groups referred to a cardiac rehabilitation programme are given a choice of times and settings for the sessions and are followed up if they do not attend.","Service user experience among people from Black, Asian and other minority ethnic groups who accessed cardiac rehabilitation programmes.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,"4 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 3"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",5,null,"People from Black, Asian and other minority ethnic groups can access mental health services in a variety of community-based settings.","Evidence of local arrangements to improve access to mental health services for people from Black, Asian and other minority ethnic groups.","Structure","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","5 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"5 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Structure - 1"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",5,null,"People from Black, Asian and other minority ethnic groups can access mental health services in a variety of community-based settings.","Evidence of local arrangements to ensure that mental health services are provided in a variety of settings that people from Black, Asian and other minority ethnic groups can choose from.","Structure","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","5 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,"5 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Structure - 2"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",5,null,"People from Black, Asian and other minority ethnic groups can access mental health services in a variety of community-based settings.","Proportion of people from Black, Asian and other minority ethnic groups accessing mental health services who are offered support in community-based settings.","Process","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","5 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"5 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Process - 1","The number in the denominator offered support in community-based settings.","The number of people from Black, Asian and other minority ethnic groups accessing mental health services."]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",5,null,"People from Black, Asian and other minority ethnic groups can access mental health services in a variety of community-based settings.","Rates of uptake of mental health services among people from Black, Asian and other minority ethnic groups.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","5 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"5 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 1"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",5,null,"People from Black, Asian and other minority ethnic groups can access mental health services in a variety of community-based settings.","Proportion of people from Black, Asian and other minority ethnic groups who complete treatment from mental health services.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","5 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,"5 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 2"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",5,null,"People from Black, Asian and other minority ethnic groups can access mental health services in a variety of community-based settings.","Service user experience among people from Black, Asian and other minority ethnic groups who accessed mental health services.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","5 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",3,"5 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 3"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",6,null,"People from Black, Asian and other minority ethnic groups with a serious mental illness have a physical health assessment at least annually.","Evidence of local arrangements to ensure that people from Black, Asian and other minority ethnic groups with a serious mental illness have a physical health assessment at least annually. ","Structure",{"$f":"CONCATENATE(B3700, \" - \", C3700)","v":"QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups"},{"$f":"CONCATENATE(D3700, \" - \", I3700)","v":"6 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups"},{"$f":"IF(AND(B3700=B3699, D3700=D3699, H3700=H3699)=TRUE, K3699+1, 1)","v":1},{"$f":"CONCATENATE(J3700, \" - \", H3700, \" - \",K3700)","v":"6 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Structure - 1"}]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",6,null,"People from Black, Asian and other minority ethnic groups with a serious mental illness have a physical health assessment at least annually.","Evidence of local primary and secondary care services working together to monitor and address the physical health needs of people affected by serious mental illness as part of the Rethink Mental Health Integrated Physical Health Pathway.","Structure","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","6 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,"6 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Structure - 2"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",6,null,"People from Black, Asian and other minority ethnic groups with a serious mental illness have a physical health assessment at least annually.","Proportion of people from Black, Asian and other minority ethnic groups with a serious mental illness who have had a physical health assessment within the past 12 months.","Process","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","6 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"6 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Process - 1","The number in the denominator who have had a physical health assessment within the past 12 months.","The number of people from Black, Asian and other minority ethnic groups with a serious mental illness. "]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",6,null,"People from Black, Asian and other minority ethnic groups with a serious mental illness have a physical health assessment at least annually.","Premature mortality rates among people from Black, Asian and other minority ethnic groups with a serious mental illness.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","6 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",1,"6 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 1"]
[null,"QS167","Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",6,null,"People from black, Asian and other minority ethnic groups with a serious mental illness have a physical health assessment at least annually.","Prevalence of type 2 diabetes among people from Black, Asian and other minority ethnic groups with a serious mental illness.","Outcome","QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups","6 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups",2,"6 - QS167 - Promoting health and preventing premature mortality in Black, Asian and other minority ethnic groups - Outcome - 2"]
[null,"QS168","Cystic fibrosis",1,null,"People with cystic fibrosis have the results of all assessments they have had during the past year reviewed annually by a specialist multidisciplinary team.","Evidence that cystic fibrosis multidisciplinary teams have professionals with specialist expertise in the condition including a paediatrician or adult physician, nurse, physiotherapist, dietitian, pharmacist and a clinical psychologist.","Structure","QS168 - Cystic fibrosis","1 - QS168 - Cystic fibrosis",1,"1 - QS168 - Cystic fibrosis - Structure - 1"]
[null,"QS168","Cystic fibrosis",1,null,"People with cystic fibrosis have the results of all assessments they have had during the past year reviewed annually by a specialist multidisciplinary team.","Evidence of local systems to identify and invite people with cystic fibrosis to have comprehensive annual reviews.","Structure","QS168 - Cystic fibrosis","1 - QS168 - Cystic fibrosis",2,"1 - QS168 - Cystic fibrosis - Structure - 2"]
[null,"QS168","Cystic fibrosis",1,null,"People with cystic fibrosis have the results of all assessments they have had during the past year reviewed annually by a specialist multidisciplinary team.","Proportion of people with cystic fibrosis who have the results of all assessments they have had during the past year reviewed by a specialist multidisciplinary team.","Process","QS168 - Cystic fibrosis","1 - QS168 - Cystic fibrosis",1,"1 - QS168 - Cystic fibrosis - Process - 1","The number in the denominator who have had the results of all assessments they have had during the past year reviewed by a specialist multidisciplinary team.","The number of people with cystic fibrosis."]
[null,"QS168","Cystic fibrosis",1,null,"People with cystic fibrosis have the results of all assessments they have had during the past year reviewed annually by a specialist multidisciplinary team.","Lung function (forced expiratory volume in 1 second [FEV1]) of people with cystic fibrosis.","Outcome","QS168 - Cystic fibrosis","1 - QS168 - Cystic fibrosis",1,"1 - QS168 - Cystic fibrosis - Outcome - 1"]
[null,"QS168","Cystic fibrosis",1,null,"People with cystic fibrosis have the results of all assessments they have had during the past year reviewed annually by a specialist multidisciplinary team.","Health-related quality of life scores of people with cystic fibrosis.","Outcome","QS168 - Cystic fibrosis","1 - QS168 - Cystic fibrosis",2,"1 - QS168 - Cystic fibrosis - Outcome - 2"]
[null,"QS168","Cystic fibrosis",1,null,"People with cystic fibrosis have the results of all assessments they have had during the past year reviewed annually by a specialist multidisciplinary team.","Median BMI percentiles in children and young people with cystic fibrosis.","Outcome","QS168 - Cystic fibrosis","1 - QS168 - Cystic fibrosis",3,"1 - QS168 - Cystic fibrosis - Outcome - 3"]
[null,"QS168","Cystic fibrosis",1,null,"People with cystic fibrosis have the results of all assessments they have had during the past year reviewed annually by a specialist multidisciplinary team.","Median BMI in adults with cystic fibrosis.","Outcome","QS168 - Cystic fibrosis","1 - QS168 - Cystic fibrosis",4,"1 - QS168 - Cystic fibrosis - Outcome - 4"]
[null,"QS168","Cystic fibrosis",2,null,"People with cystic fibrosis have individual rooms with en‑suite facilities when admitted to hospital as inpatients.","Evidence of local infection control strategies that cover inpatient settings for people with cystic fibrosis.","Structure","QS168 - Cystic fibrosis","2 - QS168 - Cystic fibrosis",1,"2 - QS168 - Cystic fibrosis - Structure - 1"]
[null,"QS168","Cystic fibrosis",2,null,"People with cystic fibrosis have individual rooms with en‑suite facilities when admitted to hospital as inpatients.","Evidence of inpatient wards containing individual rooms with en‑suite facilities.","Structure","QS168 - Cystic fibrosis","2 - QS168 - Cystic fibrosis",2,"2 - QS168 - Cystic fibrosis - Structure - 2"]
[null,"QS168","Cystic fibrosis",2,null,"People with cystic fibrosis have individual rooms with en‑suite facilities when admitted to hospital as inpatients.","Proportion of inpatient admissions for people with cystic fibrosis where admission was to an individual room with en‑suite facilities.","Process","QS168 - Cystic fibrosis","2 - QS168 - Cystic fibrosis",1,"2 - QS168 - Cystic fibrosis - Process - 1","The number in the denominator where admission was to an individual room with en‑suite facilities.","The number of inpatient admissions for people with cystic fibrosis."]
[null,"QS168","Cystic fibrosis",2,null,"People with cystic fibrosis have individual rooms with en‑suite facilities when admitted to hospital as inpatients.","Incidence of cross‑infection in people with cystic fibrosis admitted as inpatients.","Outcome","QS168 - Cystic fibrosis","2 - QS168 - Cystic fibrosis",1,"2 - QS168 - Cystic fibrosis - Outcome - 1"]
[null,"QS168","Cystic fibrosis",2,null,"People with cystic fibrosis have individual rooms with en‑suite facilities when admitted to hospital as inpatients.","Health-related quality of life scores of people with cystic fibrosis.","Outcome","QS168 - Cystic fibrosis","2 - QS168 - Cystic fibrosis",2,"2 - QS168 - Cystic fibrosis - Outcome - 2"]
[null,"QS168","Cystic fibrosis",3,null,"People with cystic fibrosis who have chronic Pseudomonas aeruginosa infection have sustained treatment with an inhaled antibiotic.","Evidence of local arrangements to identify people with cystic fibrosis who have Pseudomonas aeruginosa infection.","Structure","QS168 - Cystic fibrosis","3 - QS168 - Cystic fibrosis",1,"3 - QS168 - Cystic fibrosis - Structure - 1"]
[null,"QS168","Cystic fibrosis",3,null,"People with cystic fibrosis who have chronic Pseudomonas aeruginosa infection have sustained treatment with an inhaled antibiotic.","Evidence of the availability of devices for people with cystic fibrosis to take inhaled antibiotics.","Structure","QS168 - Cystic fibrosis","3 - QS168 - Cystic fibrosis",2,"3 - QS168 - Cystic fibrosis - Structure - 2"]
[null,"QS168","Cystic fibrosis",3,null,"People with cystic fibrosis who have chronic Pseudomonas aeruginosa infection have sustained treatment with an inhaled antibiotic.","Proportion of people with cystic fibrosis who have chronic Pseudomonas aeruginosa infection prescribed an inhaled antibiotic.","Process","QS168 - Cystic fibrosis","3 - QS168 - Cystic fibrosis",1,"3 - QS168 - Cystic fibrosis - Process - 1","The number in the denominator who are prescribed an inhaled antibiotic.","The number of people with cystic fibrosis who have chronic Pseudomonas aeruginosa infection."]
[null,"QS168","Cystic fibrosis",3,null,"People with cystic fibrosis who have chronic Pseudomonas aeruginosa infection have sustained treatment with an inhaled antibiotic.","Lung function (forced expiratory volume in 1 second [FEV1]) of people with cystic fibrosis.","Outcome","QS168 - Cystic fibrosis","3 - QS168 - Cystic fibrosis",1,"3 - QS168 - Cystic fibrosis - Outcome - 1"]
[null,"QS168","Cystic fibrosis",4,null,"People with cystic fibrosis who have clinical evidence of lung disease are prescribed rhDNase as the first choice of mucoactive agent.","Evidence of the availability of devices for people with cystic fibrosis to take inhaled rhDNase.","Structure","QS168 - Cystic fibrosis","4 - QS168 - Cystic fibrosis",1,"4 - QS168 - Cystic fibrosis - Structure - 1"]
[null,"QS168","Cystic fibrosis",4,null,"People with cystic fibrosis who have clinical evidence of lung disease are prescribed rhDNase as the first choice of mucoactive agent.","Proportion of people with cystic fibrosis and clinical evidence of lung disease who are prescribed rhDNase as the first choice of mucoactive agent.","Process","QS168 - Cystic fibrosis","4 - QS168 - Cystic fibrosis",1,"4 - QS168 - Cystic fibrosis - Process - 1","The number in the denominator prescribed rhDNase as the first choice of mucoactive agent.","The number of people with cystic fibrosis and clinical evidence of lung disease."]
[null,"QS168","Cystic fibrosis",4,null,"People with cystic fibrosis who have clinical evidence of lung disease are prescribed rhDNase as the first choice of mucoactive agent.","Lung function (forced expiratory volume in 1 second [FEV1]) of people with cystic fibrosis.","Outcome","QS168 - Cystic fibrosis","4 - QS168 - Cystic fibrosis",1,"4 - QS168 - Cystic fibrosis - Outcome - 1"]
[null,"QS169","Developmental follow-up of children and young people born preterm",1,null,"Parents or carers of a preterm baby have an agreed discharge plan.","Evidence of local arrangements for healthcare professionals to agree a discharge plan with parents or carers of a preterm baby before the baby is discharged from hospital.","Structure","QS169 - Developmental follow-up of children and young people born preterm","1 - QS169 - Developmental follow-up of children and young people born preterm",1,"1 - QS169 - Developmental follow-up of children and young people born preterm - Structure - 1"]
[null,"QS169","Developmental follow-up of children and young people born preterm",1,null,"Parents or carers of a preterm baby have an agreed discharge plan.","Proportion of preterm babies discharged from hospital whose parents or carers have a discharge plan.","Process","QS169 - Developmental follow-up of children and young people born preterm","1 - QS169 - Developmental follow-up of children and young people born preterm",1,"1 - QS169 - Developmental follow-up of children and young people born preterm - Process - 1","The number in the denominator whose parents or carers have a discharge plan.","The number of preterm babies discharged from hospital."]
[null,"QS169","Developmental follow-up of children and young people born preterm",1,null,"Parents or carers of a preterm baby have an agreed discharge plan.","Proportion of parents or carers who felt prepared for their baby's discharge from hospital. ","Outcome","QS169 - Developmental follow-up of children and young people born preterm","1 - QS169 - Developmental follow-up of children and young people born preterm",1,"1 - QS169 - Developmental follow-up of children and young people born preterm - Outcome - 1"]
[null,"QS169","Developmental follow-up of children and young people born preterm",2,null,"Parents or carers of a preterm baby who is eligible for enhanced developmental support are provided with a single point of contact for outreach care within the neonatal service.","Evidence of local arrangements for a neonatal outreach team with expertise in the development of babies born preterm to be available through a single point of contact.","Structure","QS169 - Developmental follow-up of children and young people born preterm","2 - QS169 - Developmental follow-up of children and young people born preterm",1,"2 - QS169 - Developmental follow-up of children and young people born preterm - Structure - 1"]
[null,"QS169","Developmental follow-up of children and young people born preterm",2,null,"Parents or carers of a preterm baby who is eligible for enhanced developmental support are provided with a single point of contact for outreach care within the neonatal service.","Proportion of preterm babies who are eligible for enhanced developmental support whose parents or carers are provided with a single point of contact for outreach care within the neonatal service.","Process","QS169 - Developmental follow-up of children and young people born preterm","2 - QS169 - Developmental follow-up of children and young people born preterm",1,"2 - QS169 - Developmental follow-up of children and young people born preterm - Process - 1","The number in the denominator whose parents or carers are provided with a single point of contact for outreach care within the neonatal service.","The number of preterm babies who are eligible for enhanced developmental support."]
[null,"QS169","Developmental follow-up of children and young people born preterm",2,null,"Parents or carers of a preterm baby who is eligible for enhanced developmental support are provided with a single point of contact for outreach care within the neonatal service.","Proportion of parents or carers of a preterm baby who felt they could access support for dealing with non-acute issues following discharge from neonatal services.","Outcome","QS169 - Developmental follow-up of children and young people born preterm","2 - QS169 - Developmental follow-up of children and young people born preterm",1,"2 - QS169 - Developmental follow-up of children and young people born preterm - Outcome - 1"]
[null,"QS169","Developmental follow-up of children and young people born preterm",3,null,"Children born preterm who are eligible for enhanced developmental surveillance have at least 2 follow-up appointments in the first year and an assessment at 2 years that focus on development.","Evidence of local systems, such as BadgerNet, to record data on children born preterm and identify who needs enhanced developmental surveillance.","Structure","QS169 - Developmental follow-up of children and young people born preterm","3 - QS169 - Developmental follow-up of children and young people born preterm",1,"3 - QS169 - Developmental follow-up of children and young people born preterm - Structure - 1"]
[null,"QS169","Developmental follow-up of children and young people born preterm",3,null,"Children born preterm who are eligible for enhanced developmental surveillance have at least 2 follow-up appointments in the first year and an assessment at 2 years that focus on development.","Evidence of local systems to arrange 2 face-to-face follow-up appointments in the first year and an assessment at 2 years (corrected ages) that focus on development with children born preterm who are eligible for enhanced developmental surveillance.","Structure","QS169 - Developmental follow-up of children and young people born preterm","3 - QS169 - Developmental follow-up of children and young people born preterm",2,"3 - QS169 - Developmental follow-up of children and young people born preterm - Structure - 2"]
[null,"QS169","Developmental follow-up of children and young people born preterm",3,null,"Children born preterm who are eligible for enhanced developmental surveillance have at least 2 follow-up appointments in the first year and an assessment at 2 years that focus on development.","Proportion of children born preterm who are eligible for enhanced developmental surveillance who have a follow-up appointment between 3 and 5 months (corrected age) that focuses on development.","Process","QS169 - Developmental follow-up of children and young people born preterm","3 - QS169 - Developmental follow-up of children and young people born preterm",1,"3 - QS169 - Developmental follow-up of children and young people born preterm - Process - 1","The number in the denominator who have a follow-up appointment between 3 and 5 months (corrected age) that focuses on development.","The number of children born preterm who are eligible for enhanced developmental surveillance."]
[null,"QS169","Developmental follow-up of children and young people born preterm",3,null,"Children born preterm who are eligible for enhanced developmental surveillance have at least 2 follow-up appointments in the first year and an assessment at 2 years that focus on development.","Proportion of children born preterm who are eligible for enhanced developmental surveillance who have a further follow-up appointment by 12 months (corrected age) that focuses on development.","Process","QS169 - Developmental follow-up of children and young people born preterm","3 - QS169 - Developmental follow-up of children and young people born preterm",2,"3 - QS169 - Developmental follow-up of children and young people born preterm - Process - 2","The number in the denominator who have a further follow-up appointment by 12 months (corrected age) that focuses on development.","The number of children born preterm who are eligible for enhanced developmental surveillance. "]
[null,"QS169","Developmental follow-up of children and young people born preterm",3,null,"Children born preterm who are eligible for enhanced developmental surveillance have at least 2 follow-up appointments in the first year and an assessment at 2 years that focus on development.","Proportion of children born preterm who are eligible for enhanced developmental surveillance who have a face-to-face developmental assessment at 2 years (corrected age).","Process","QS169 - Developmental follow-up of children and young people born preterm","3 - QS169 - Developmental follow-up of children and young people born preterm",3,"3 - QS169 - Developmental follow-up of children and young people born preterm - Process - 3","The number in the denominator who have a face-to-face developmental assessment at 2 years (corrected age).","The number of children born preterm who are eligible for enhanced developmental surveillance."]
[null,"QS169","Developmental follow-up of children and young people born preterm",3,null,"Children born preterm who are eligible for enhanced developmental surveillance have at least 2 follow-up appointments in the first year and an assessment at 2 years that focus on development.","Proportion of children born preterm who are eligible for enhanced developmental surveillance who have a face-to-face developmental assessment at 2 years (corrected age) with a developmental outcome category recorded.","Outcome","QS169 - Developmental follow-up of children and young people born preterm","3 - QS169 - Developmental follow-up of children and young people born preterm",1,"3 - QS169 - Developmental follow-up of children and young people born preterm - Outcome - 1"]
[null,"QS169","Developmental follow-up of children and young people born preterm",3,null,"Children born preterm who are eligible for enhanced developmental surveillance have at least 2 follow-up appointments in the first year and an assessment at 2 years that focus on development.","Proportion of children born preterm with developmental problems and disorders identified at the appointments in the first 2 years (corrected ages) who have support provided.","Outcome","QS169 - Developmental follow-up of children and young people born preterm","3 - QS169 - Developmental follow-up of children and young people born preterm",2,"3 - QS169 - Developmental follow-up of children and young people born preterm - Outcome - 2"]
[null,"QS169","Developmental follow-up of children and young people born preterm",4,null,"Children born before 28+0 weeks' gestation have a developmental assessment at 4 years.","Evidence of local systems, such as BadgerNet, to record data on children born preterm and identify those born before 28+0 weeks' gestation.","Structure","QS169 - Developmental follow-up of children and young people born preterm","4 - QS169 - Developmental follow-up of children and young people born preterm",1,"4 - QS169 - Developmental follow-up of children and young people born preterm - Structure - 1"]
[null,"QS169","Developmental follow-up of children and young people born preterm",4,null,"Children born before 28+0 weeks' gestation have a developmental assessment at 4 years.","Evidence of local systems to arrange a developmental assessment at 4 years (uncorrected age) with children who are born before 28+0 weeks' gestation.","Structure","QS169 - Developmental follow-up of children and young people born preterm","4 - QS169 - Developmental follow-up of children and young people born preterm",2,"4 - QS169 - Developmental follow-up of children and young people born preterm - Structure - 2"]
[null,"QS169","Developmental follow-up of children and young people born preterm",4,null,"Children born before 28+0 weeks' gestation have a developmental assessment at 4 years.","Proportion of children born before 28+0 weeks' gestation who have a face-to-face developmental assessment at 4 years (uncorrected age).","Process","QS169 - Developmental follow-up of children and young people born preterm","4 - QS169 - Developmental follow-up of children and young people born preterm",1,"4 - QS169 - Developmental follow-up of children and young people born preterm - Process - 1","The number in the denominator who have a face-to-face developmental assessment at 4 years (uncorrected age).","The number of children born before 28+0 weeks' gestation."]
[null,"QS169","Developmental follow-up of children and young people born preterm",4,null,"Children born before 28+0 weeks' gestation have a developmental assessment at 4 years.","Proportion of children born before 28+0 weeks' gestation with developmental problems and disorders identified at the developmental assessment at 4 years (uncorrected age) who have support provided.","Outcome","QS169 - Developmental follow-up of children and young people born preterm","4 - QS169 - Developmental follow-up of children and young people born preterm",1,"4 - QS169 - Developmental follow-up of children and young people born preterm - Outcome - 1"]
[null,"QS170","Spondyloarthritis",1,null,"Adults with suspected axial or peripheral spondyloarthritis are referred to a rheumatologist.","Evidence of local arrangements to raise awareness of signs, symptoms and risk factors of axial and peripheral spondyloarthritis in primary care. ","Structure","QS170 - Spondyloarthritis","1 - QS170 - Spondyloarthritis",1,"1 - QS170 - Spondyloarthritis - Structure - 1"]
[null,"QS170","Spondyloarthritis",1,null,"Adults with suspected axial or peripheral spondyloarthritis are referred to a rheumatologist.","Evidence of local referral criteria and pathways to ensure that adults with suspected axial or peripheral spondyloarthritis are referred to a rheumatologist.","Structure","QS170 - Spondyloarthritis","1 - QS170 - Spondyloarthritis",2,"1 - QS170 - Spondyloarthritis - Structure - 2"]
[null,"QS170","Spondyloarthritis",1,null,"Adults with suspected axial or peripheral spondyloarthritis are referred to a rheumatologist.","Proportion of adults with suspected axial or peripheral spondyloarthritis referred to a rheumatologist.","Process","QS170 - Spondyloarthritis","1 - QS170 - Spondyloarthritis",1,"1 - QS170 - Spondyloarthritis - Process - 1","The number in the denominator referred to a rheumatologist.","The number of adults with suspected axial or peripheral spondyloarthritis."]
[null,"QS170","Spondyloarthritis",1,null,"Adults with suspected axial or peripheral spondyloarthritis are referred to a rheumatologist.","Time from first presentation of symptoms to diagnosis for adults with spondyloarthritis. ","Outcome","QS170 - Spondyloarthritis","1 - QS170 - Spondyloarthritis",1,"1 - QS170 - Spondyloarthritis - Outcome - 1"]
[null,"QS170","Spondyloarthritis",1,null,"Adults with suspected axial or peripheral spondyloarthritis are referred to a rheumatologist.","Health-related quality-of-life score of adults with spondyloarthritis. ","Outcome","QS170 - Spondyloarthritis","1 - QS170 - Spondyloarthritis",2,"1 - QS170 - Spondyloarthritis - Outcome - 2"]
[null,"QS170","Spondyloarthritis",1,null,"Adults with suspected axial or peripheral spondyloarthritis are referred to a rheumatologist.","Functional ability score of adults with axial spondyloarthritis. ","Outcome","QS170 - Spondyloarthritis","1 - QS170 - Spondyloarthritis",3,"1 - QS170 - Spondyloarthritis - Outcome - 3"]
[null,"QS170","Spondyloarthritis",1,null,"Adults with suspected axial or peripheral spondyloarthritis are referred to a rheumatologist.","Joint replacement surgery for adults with peripheral spondyloarthritis.","Outcome","QS170 - Spondyloarthritis","1 - QS170 - Spondyloarthritis",4,"1 - QS170 - Spondyloarthritis - Outcome - 4"]
[null,"QS170","Spondyloarthritis",2,null,"Adults with suspected axial spondyloarthritis and an X‑ray that does not show sacroiliitis have an MRI using an inflammatory back pain protocol.","Evidence of local arrangements to ensure that rheumatologists and musculoskeletal interface services can access X‑ray and MRI diagnostic services for people with suspected axial spondyloarthritis. ","Structure","QS170 - Spondyloarthritis","2 - QS170 - Spondyloarthritis",1,"2 - QS170 - Spondyloarthritis - Structure - 1"]
[null,"QS170","Spondyloarthritis",2,null,"Adults with suspected axial spondyloarthritis and an X‑ray that does not show sacroiliitis have an MRI using an inflammatory back pain protocol.","Evidence of local arrangements to ensure that a musculoskeletal radiologist interprets imaging for people with suspected axial spondyloarthritis when appropriate. ","Structure","QS170 - Spondyloarthritis","2 - QS170 - Spondyloarthritis",2,"2 - QS170 - Spondyloarthritis - Structure - 2"]
[null,"QS170","Spondyloarthritis",2,null,"Adults with suspected axial spondyloarthritis and an X‑ray that does not show sacroiliitis have an MRI using an inflammatory back pain protocol.","Evidence of an inflammatory back pain protocol outlining how to perform MRI on adults with suspected axial spondyloarthritis.","Structure","QS170 - Spondyloarthritis","2 - QS170 - Spondyloarthritis",3,"2 - QS170 - Spondyloarthritis - Structure - 3"]
[null,"QS170","Spondyloarthritis",2,null,"Adults with suspected axial spondyloarthritis and an X‑ray that does not show sacroiliitis have an MRI using an inflammatory back pain protocol.","Proportion of adults with suspected axial spondyloarthritis and an X‑ray that does not show sacroiliitis that have an MRl.","Process","QS170 - Spondyloarthritis","2 - QS170 - Spondyloarthritis",1,"2 - QS170 - Spondyloarthritis - Process - 1","The number in the denominator that have an MRI."," The number of adults with suspected axial spondyloarthritis who have had an X‑ray that does not show sacroiliitis."]
[null,"QS170","Spondyloarthritis",2,null,"Adults with suspected axial spondyloarthritis and an X‑ray that does not show sacroiliitis have an MRI using an inflammatory back pain protocol.","Proportion of MRIs for suspected axial spondyloarthritis in adults performed using an inflammatory back pain protocol.","Process","QS170 - Spondyloarthritis","2 - QS170 - Spondyloarthritis",2,"2 - QS170 - Spondyloarthritis - Process - 2","The number in the denominator performed using an inflammatory back pain protocol.","The number of MRIs performed to investigate suspected axial spondyloarthritis in adults."]
[null,"QS170","Spondyloarthritis",2,null,"Adults with suspected axial spondyloarthritis and an X‑ray that does not show sacroiliitis have an MRI using an inflammatory back pain protocol.","Time from first presentation of symptoms to diagnosis for adults with axial spondyloarthritis. ","Outcome","QS170 - Spondyloarthritis","2 - QS170 - Spondyloarthritis",1,"2 - QS170 - Spondyloarthritis - Outcome - 1"]
[null,"QS170","Spondyloarthritis",2,null,"Adults with suspected axial spondyloarthritis and an X‑ray that does not show sacroiliitis have an MRI using an inflammatory back pain protocol.","Health-related quality-of-life score of adults with axial spondyloarthritis. ","Outcome","QS170 - Spondyloarthritis","2 - QS170 - Spondyloarthritis",2,"2 - QS170 - Spondyloarthritis - Outcome - 2"]
[null,"QS170","Spondyloarthritis",2,null,"Adults with suspected axial spondyloarthritis and an X‑ray that does not show sacroiliitis have an MRI using an inflammatory back pain protocol.","Functional ability score of adults with axial spondyloarthritis. ","Outcome","QS170 - Spondyloarthritis","2 - QS170 - Spondyloarthritis",3,"2 - QS170 - Spondyloarthritis - Outcome - 3"]
[null,"QS170","Spondyloarthritis",3,null,"Adults with axial spondyloarthritis are referred to a specialist physiotherapist for a structured exercise programme.","Evidence of local referral pathways to specialist physiotherapists for adults with axial spondyloarthritis. ","Structure","QS170 - Spondyloarthritis","3 - QS170 - Spondyloarthritis",1,"3 - QS170 - Spondyloarthritis - Structure - 1"]
[null,"QS170","Spondyloarthritis",3,null,"Adults with axial spondyloarthritis are referred to a specialist physiotherapist for a structured exercise programme.","Proportion of adults with axial spondyloarthritis referred to a specialist physiotherapist for a structured exercise programme.","Process","QS170 - Spondyloarthritis","3 - QS170 - Spondyloarthritis",1,"3 - QS170 - Spondyloarthritis - Process - 1","The number in the denominator referred to a specialist physiotherapist for a structured exercise programme.","The number of adults with axial spondyloarthritis."]
[null,"QS170","Spondyloarthritis",3,null,"Adults with axial spondyloarthritis are referred to a specialist physiotherapist for a structured exercise programme.","Proportion of adults with axial spondyloarthritis referred to a specialist physiotherapist for a structured exercise programme who attended the programme.","Process","QS170 - Spondyloarthritis","3 - QS170 - Spondyloarthritis",2,"3 - QS170 - Spondyloarthritis - Process - 2","The number in the denominator who attended the programme.","The number of adults with axial spondyloarthritis referred to a specialist physiotherapist for a structured exercise programme."]
[null,"QS170","Spondyloarthritis",3,null,"Adults with axial spondyloarthritis are referred to a specialist physiotherapist for a structured exercise programme.","Functional ability score of adults with axial spondyloarthritis. ","Outcome","QS170 - Spondyloarthritis","3 - QS170 - Spondyloarthritis",1,"3 - QS170 - Spondyloarthritis - Outcome - 1"]
[null,"QS170","Spondyloarthritis",3,null,"Adults with axial spondyloarthritis are referred to a specialist physiotherapist for a structured exercise programme.","Self-reported pain score of adults with axial spondyloarthritis. ","Outcome","QS170 - Spondyloarthritis","3 - QS170 - Spondyloarthritis",2,"3 - QS170 - Spondyloarthritis - Outcome - 2"]
[null,"QS170","Spondyloarthritis",3,null,"Adults with axial spondyloarthritis are referred to a specialist physiotherapist for a structured exercise programme.","Self-reported fatigue score of adults with axial spondyloarthritis. ","Outcome","QS170 - Spondyloarthritis","3 - QS170 - Spondyloarthritis",3,"3 - QS170 - Spondyloarthritis - Outcome - 3"]
[null,"QS170","Spondyloarthritis",3,null,"Adults with axial spondyloarthritis are referred to a specialist physiotherapist for a structured exercise programme.","Spinal mobility score of adults with axial spondyloarthritis. ","Outcome","QS170 - Spondyloarthritis","3 - QS170 - Spondyloarthritis",4,"3 - QS170 - Spondyloarthritis - Outcome - 4"]
[null,"QS170","Spondyloarthritis",4,null,"Adults with spondyloarthritis are given information about their condition, which healthcare professionals will be involved with their care, and how and when to get in touch with them.","Evidence that written information is available for adults with spondyloarthritis about their condition, who will be involved with their care, and how and when to get in touch with them.","Structure","QS170 - Spondyloarthritis","4 - QS170 - Spondyloarthritis",1,"4 - QS170 - Spondyloarthritis - Structure - 1"]
[null,"QS170","Spondyloarthritis",4,null,"Adults with spondyloarthritis are given information about their condition, which healthcare professionals will be involved with their care, and how and when to get in touch with them.","Evidence of local processes to ensure that adults with spondyloarthritis have a discussion with a healthcare professional about their condition, who will be involved with their care, and how and when to get in touch with them.","Structure",{"$f":"CONCATENATE(B3764, \" - \", C3764)","v":"QS170 - Spondyloarthritis"},{"$f":"CONCATENATE(D3764, \" - \", I3764)","v":"4 - QS170 - Spondyloarthritis"},{"$f":"IF(AND(B3764=B3763, D3764=D3763, H3764=H3763)=TRUE, K3763+1, 1)","v":2},{"$f":"CONCATENATE(J3764, \" - \", H3764, \" - \",K3764)","v":"4 - QS170 - Spondyloarthritis - Structure - 2"}]
[null,"QS170","Spondyloarthritis",4,null,"Adults with spondyloarthritis are given information about their condition, which healthcare professionals will be involved with their care, and how and when to get in touch with them.","Proportion of adults with spondyloarthritis who are given written information about their condition, which healthcare professionals will be involved with their care, and how and when to get in touch with them.","Process","QS170 - Spondyloarthritis","4 - QS170 - Spondyloarthritis",1,"4 - QS170 - Spondyloarthritis - Process - 1","The number in the denominator who are given written information about their condition, which healthcare professionals will be involved with their care, and how and when to get in touch with them.","The number of adults with spondyloarthritis."]
[null,"QS170","Spondyloarthritis",4,null,"Adults with spondyloarthritis are given information about their condition, which healthcare professionals will be involved with their care, and how and when to get in touch with them.","Proportion of adults with spondyloarthritis who have a record of a discussion about their condition, which healthcare professionals will be involved with their care, and how and when to get in touch with them.","Process","QS170 - Spondyloarthritis","4 - QS170 - Spondyloarthritis",2,"4 - QS170 - Spondyloarthritis - Process - 2","The number in the denominator who have a record of a discussion about their condition, which healthcare professionals will be involved with their care, and how and when to get in touch with them.","The number of adults with spondyloarthritis."]
[null,"QS170","Spondyloarthritis",4,null,"Adults with spondyloarthritis are given information about their condition, which healthcare professionals will be involved with their care, and how and when to get in touch with them.","Adults with spondyloarthritis know how to self-manage their condition.","Outcome","QS170 - Spondyloarthritis","4 - QS170 - Spondyloarthritis",1,"4 - QS170 - Spondyloarthritis - Outcome - 1"]
[null,"QS170","Spondyloarthritis",4,null,"Adults with spondyloarthritis are given information about their condition, which healthcare professionals will be involved with their care, and how and when to get in touch with them.","Adults with spondyloarthritis know how to access care when they need additional support. ","Outcome","QS170 - Spondyloarthritis","4 - QS170 - Spondyloarthritis",2,"4 - QS170 - Spondyloarthritis - Outcome - 2"]
[null,"QS171","Medicines management for people receiving social care in the community",1,null,"Adults having an assessment for social care in the community have their medicines support needs included in the assessment.","Evidence that assessments of an adult's needs and preferences for social care in the community include assessment of their medicines support needs. ","Structure","QS171 - Medicines management for people receiving social care in the community","1 - QS171 - Medicines management for people receiving social care in the community",1,"1 - QS171 - Medicines management for people receiving social care in the community - Structure - 1"]
[null,"QS171","Medicines management for people receiving social care in the community",1,null,"Adults having an assessment for social care in the community have their medicines support needs included in the assessment.","Proportion of adults having an assessment for social care in the community who have their medicines support needs included in the assessment. ","Process","QS171 - Medicines management for people receiving social care in the community","1 - QS171 - Medicines management for people receiving social care in the community",1,"1 - QS171 - Medicines management for people receiving social care in the community - Process - 1","The number in the denominator who have their medicines support needs included in the assessment.","The number of adults having an assessment for social care in the community."]
[null,"QS171","Medicines management for people receiving social care in the community",1,null,"Adults having an assessment for social care in the community have their medicines support needs included in the assessment.","Satisfaction of people receiving social care in the community that their medicines support meets their needs and preferences.","Outcome","QS171 - Medicines management for people receiving social care in the community","1 - QS171 - Medicines management for people receiving social care in the community",1,"1 - QS171 - Medicines management for people receiving social care in the community - Outcome - 1"]
[null,"QS171","Medicines management for people receiving social care in the community",2,null,"Adults receiving medicines support in the community from a social care provider have their general practice and supplying pharmacy informed that support has started. ","Evidence of local arrangements for social care providers to notify a person's general practice and supplying pharmacy when they start to provide them with medicines support in the community.","Structure","QS171 - Medicines management for people receiving social care in the community","2 - QS171 - Medicines management for people receiving social care in the community",1,"2 - QS171 - Medicines management for people receiving social care in the community - Structure - 1"]
[null,"QS171","Medicines management for people receiving social care in the community",2,null,"Adults receiving medicines support in the community from a social care provider have their general practice and supplying pharmacy informed that support has started. ","Proportion of adults receiving medicines support in the community from a social care provider whose general practice is informed that medicines support has started.","Process","QS171 - Medicines management for people receiving social care in the community","2 - QS171 - Medicines management for people receiving social care in the community",1,"2 - QS171 - Medicines management for people receiving social care in the community - Process - 1","The number in the denominator whose general practice is informed that they have started to receive medicines support. ","The number of adults receiving medicines support in the community from a social care provider. "]
[null,"QS171","Medicines management for people receiving social care in the community",2,null,"Adults receiving medicines support in the community from a social care provider have their general practice and supplying pharmacy informed that support has started. ","Proportion of adults receiving medicines support in the community from a social care provider whose supplying pharmacy is informed that medicines support has started.","Process","QS171 - Medicines management for people receiving social care in the community","2 - QS171 - Medicines management for people receiving social care in the community",2,"2 - QS171 - Medicines management for people receiving social care in the community - Process - 2","The number in the denominator whose supplying pharmacy is informed that they have started to receive medicines support. ","The number of adults receiving medicines support in the community from a social care provider. "]
[null,"QS171","Medicines management for people receiving social care in the community",2,null,"Adults receiving medicines support in the community from a social care provider have their general practice and supplying pharmacy informed that support has started. ","Number of medicines-related incidents.","Outcome","QS171 - Medicines management for people receiving social care in the community","2 - QS171 - Medicines management for people receiving social care in the community",1,"2 - QS171 - Medicines management for people receiving social care in the community - Outcome - 1"]
[null,"QS171","Medicines management for people receiving social care in the community",3,null,"Adults receiving medicines support in the community from a social care provider have a record of the medicines support that they need in their care plan. ","Evidence of local processes for social care providers to ensure that care plans include a record of the medicines support a person needs. ","Structure","QS171 - Medicines management for people receiving social care in the community","3 - QS171 - Medicines management for people receiving social care in the community",1,"3 - QS171 - Medicines management for people receiving social care in the community - Structure - 1"]
[null,"QS171","Medicines management for people receiving social care in the community",3,null,"Adults receiving medicines support in the community from a social care provider have a record of the medicines support that they need in their care plan. ","Proportion of adults receiving medicines support in the community from a social care provider whose care plan includes a record of the medicines support they need.","Process","QS171 - Medicines management for people receiving social care in the community","3 - QS171 - Medicines management for people receiving social care in the community",1,"3 - QS171 - Medicines management for people receiving social care in the community - Process - 1","The number in the denominator that include a record of the medicines support they need.","The number of care plans for adults receiving medicines support in the community from a social care provider."]
[null,"QS171","Medicines management for people receiving social care in the community",3,null,"Adults receiving medicines support in the community from a social care provider have a record of the medicines support that they need in their care plan. ","Satisfaction of people providing medicines support with information recorded about the medicine support needed.","Outcome","QS171 - Medicines management for people receiving social care in the community","3 - QS171 - Medicines management for people receiving social care in the community",1,"3 - QS171 - Medicines management for people receiving social care in the community - Outcome - 1"]
[null,"QS171","Medicines management for people receiving social care in the community",3,null,"Adults receiving medicines support in the community from a social care provider have a record of the medicines support that they need in their care plan. ","Satisfaction of people receiving social care in the community with their medicines support.","Outcome","QS171 - Medicines management for people receiving social care in the community","3 - QS171 - Medicines management for people receiving social care in the community",2,"3 - QS171 - Medicines management for people receiving social care in the community - Outcome - 2"]
[null,"QS171","Medicines management for people receiving social care in the community",4,null,"Adults receiving medicines support in the community from a social care provider are given information on how to raise any medicines-related problems.","Evidence of local processes for service providers to actively encourage adults receiving medicines support in the community to raise any medicines-related problems.","Structure","QS171 - Medicines management for people receiving social care in the community","4 - QS171 - Medicines management for people receiving social care in the community",1,"4 - QS171 - Medicines management for people receiving social care in the community - Structure - 1"]
[null,"QS171","Medicines management for people receiving social care in the community",4,null,"Adults receiving medicines support in the community from a social care provider are given information on how to raise any medicines-related problems.","Evidence that care workers providing medicines support for adults receiving social care in the community give them information on how to raise any problems with their medicines.","Structure","QS171 - Medicines management for people receiving social care in the community","4 - QS171 - Medicines management for people receiving social care in the community",2,"4 - QS171 - Medicines management for people receiving social care in the community - Structure - 2"]
[null,"QS171","Medicines management for people receiving social care in the community",4,null,"Adults receiving medicines support in the community from a social care provider are given information on how to raise any medicines-related problems.","Proportion of adults receiving medicines support in the community from a social care provider who are given information on how to raise any medicines-related problems.","Process","QS171 - Medicines management for people receiving social care in the community","4 - QS171 - Medicines management for people receiving social care in the community",1,"4 - QS171 - Medicines management for people receiving social care in the community - Process - 1","The number in the denominator who are given information on how to raise any medicines-related problems.","The number of adults receiving medicines support in the community from a social care provider."]
[null,"QS171","Medicines management for people receiving social care in the community",4,null,"Adults receiving medicines support in the community from a social care provider are given information on how to raise any medicines-related problems.","People's satisfaction with being able to raise medicines-related problems.","Outcome","QS171 - Medicines management for people receiving social care in the community","4 - QS171 - Medicines management for people receiving social care in the community",1,"4 - QS171 - Medicines management for people receiving social care in the community - Outcome - 1"]
[null,"QS171","Medicines management for people receiving social care in the community",4,null,"Adults receiving medicines support in the community from a social care provider are given information on how to raise any medicines-related problems.","Number of medicines-related problems raised by adults receiving social care in the community.","Outcome","QS171 - Medicines management for people receiving social care in the community","4 - QS171 - Medicines management for people receiving social care in the community",2,"4 - QS171 - Medicines management for people receiving social care in the community - Outcome - 2"]
[null,"QS171","Medicines management for people receiving social care in the community",4,null,"Adults receiving medicines support in the community from a social care provider are given information on how to raise any medicines-related problems.","Number of medicines-related incidents involving adults receiving social care in the community.","Outcome","QS171 - Medicines management for people receiving social care in the community","4 - QS171 - Medicines management for people receiving social care in the community",3,"4 - QS171 - Medicines management for people receiving social care in the community - Outcome - 3"]
[null,"QS172","Endometriosis",1,null,"Women presenting with suspected endometriosis have an abdominal and, if appropriate, a pelvic examination.","Evidence of local arrangements to identify women with signs and symptoms of endometriosis.","Structure","QS172 - Endometriosis","1 - QS172 - Endometriosis",1,"1 - QS172 - Endometriosis - Structure - 1"]
[null,"QS172","Endometriosis",1,null,"Women presenting with suspected endometriosis have an abdominal and, if appropriate, a pelvic examination.","Evidence of protocols detailing symptoms of endometriosis and the need for abdominal and pelvic examination when this is suspected.","Structure","QS172 - Endometriosis","1 - QS172 - Endometriosis",2,"1 - QS172 - Endometriosis - Structure - 2"]
[null,"QS172","Endometriosis",1,null,"Women presenting with suspected endometriosis have an abdominal and, if appropriate, a pelvic examination.","Proportion of women who present to healthcare professionals with symptoms or signs suggesting endometriosis who have an abdominal and pelvic examination.","Process","QS172 - Endometriosis","1 - QS172 - Endometriosis",1,"1 - QS172 - Endometriosis - Process - 1","The number in the denominator who have an abdominal and a pelvic examination.","Number of women presenting with symptoms or signs suggesting endometriosis for whom a pelvic examination is appropriate."]
[null,"QS172","Endometriosis",1,null,"Women presenting with suspected endometriosis have an abdominal and, if appropriate, a pelvic examination.","Proportion of women who present to healthcare professionals with symptoms or signs suggesting endometriosis for whom a pelvic examination would not be appropriate who have an abdominal examination.","Process","QS172 - Endometriosis","1 - QS172 - Endometriosis",2,"1 - QS172 - Endometriosis - Process - 2","The number in the denominator who have an abdominal examination.","The number of women presenting with symptoms or signs suggesting endometriosis for whom a pelvic examination would not be appropriate."]
[null,"QS172","Endometriosis",1,null,"Women presenting with suspected endometriosis have an abdominal and, if appropriate, a pelvic examination.","Number of working diagnoses of endometriosis following initial presentation.","Outcome","QS172 - Endometriosis","1 - QS172 - Endometriosis",1,"1 - QS172 - Endometriosis - Outcome - 1"]
[null,"QS172","Endometriosis",1,null,"Women presenting with suspected endometriosis have an abdominal and, if appropriate, a pelvic examination.","Time from initial presentation with symptoms or signs of endometriosis to diagnosis.","Outcome","QS172 - Endometriosis","1 - QS172 - Endometriosis",2,"1 - QS172 - Endometriosis - Outcome - 2"]
[null,"QS172","Endometriosis",2,null,"Women are referred to a gynaecology service if initial hormonal treatment for endometriosis is not effective, not tolerated or contraindicated.","Evidence of local referral pathways to a gynaecology service for women in whom initial hormonal treatment for endometriosis is not effective, not tolerated or contraindicated.","Structure","QS172 - Endometriosis","2 - QS172 - Endometriosis",1,"2 - QS172 - Endometriosis - Structure - 1"]
[null,"QS172","Endometriosis",2,null,"Women are referred to a gynaecology service if initial hormonal treatment for endometriosis is not effective, not tolerated or contraindicated.","Proportion of women in whom initial hormonal treatment for endometriosis is not effective after 6 months, not tolerated or contraindicated who are referred to a gynaecology service.","Process","QS172 - Endometriosis","2 - QS172 - Endometriosis",1,"2 - QS172 - Endometriosis - Process - 1","The number in the denominator who are referred to a gynaecology service.","The number of women in whom initial hormonal treatment for endometriosis is not effective after 6 months, not tolerated or contraindicated."]
[null,"QS172","Endometriosis",2,null,"Women are referred to a gynaecology service if initial hormonal treatment for endometriosis is not effective, not tolerated or contraindicated.","Satisfaction of women with suspected or confirmed endometriosis with their treatment plan.","Outcome","QS172 - Endometriosis","2 - QS172 - Endometriosis",1,"2 - QS172 - Endometriosis - Outcome - 1"]
[null,"QS172","Endometriosis",3,null,"Women with suspected or confirmed deep endometriosis involving the bowel, bladder or ureter are referred to a specialist endometriosis service.","Evidence of local referral protocols for women with suspected or confirmed deep endometriosis involving the bowel, bladder or ureter.","Structure","QS172 - Endometriosis","3 - QS172 - Endometriosis",1,"3 - QS172 - Endometriosis - Structure - 1"]
[null,"QS172","Endometriosis",3,null,"Women with suspected or confirmed deep endometriosis involving the bowel, bladder or ureter are referred to a specialist endometriosis service.","Evidence of services working toward accreditation as specialist endometriosis services.","Structure","QS172 - Endometriosis","3 - QS172 - Endometriosis",2,"3 - QS172 - Endometriosis - Structure - 2"]
[null,"QS172","Endometriosis",3,null,"Women with suspected or confirmed deep endometriosis involving the bowel, bladder or ureter are referred to a specialist endometriosis service.","Proportion of women with suspected or confirmed deep endometriosis involving the bowel, bladder or ureter who are referred to a specialist endometriosis service.","Process","QS172 - Endometriosis","3 - QS172 - Endometriosis",1,"3 - QS172 - Endometriosis - Process - 1","The number in the denominator who are referred to a specialist endometriosis service.","The number of women with suspected or confirmed deep endometriosis involving the bowel, bladder or ureter."]
[null,"QS172","Endometriosis",3,null,"Women with suspected or confirmed deep endometriosis involving the bowel, bladder or ureter are referred to a specialist endometriosis service.","Diagnosis rates of deep endometriosis involving the bowel, bladder or ureter.","Outcome","QS172 - Endometriosis","3 - QS172 - Endometriosis",1,"3 - QS172 - Endometriosis - Outcome - 1"]
[null,"QS172","Endometriosis",3,null,"Women with suspected or confirmed deep endometriosis involving the bowel, bladder or ureter are referred to a specialist endometriosis service.","Rates of surgical treatment for deep endometriosis involving the bowel, bladder or ureter by specialist endometriosis services.","Outcome","QS172 - Endometriosis","3 - QS172 - Endometriosis",2,"3 - QS172 - Endometriosis - Outcome - 2"]
[null,"QS173","Intermediate care including reablement",1,null,"Adults being assessed for intermediate care have a discussion about the support the service will and will not provide.","Evidence that information about the support provided by the local intermediate care service is available.","Structure","QS173 - Intermediate care including reablement","1 - QS173 - Intermediate care including reablement",1,"1 - QS173 - Intermediate care including reablement - Structure - 1"]
[null,"QS173","Intermediate care including reablement",1,null,"Adults being assessed for intermediate care have a discussion about the support the service will and will not provide.","Evidence of local processes to ensure that adults being assessed for intermediate care have a discussion about the support the service will and will not provide.","Structure","QS173 - Intermediate care including reablement","1 - QS173 - Intermediate care including reablement",2,"1 - QS173 - Intermediate care including reablement - Structure - 2"]
[null,"QS173","Intermediate care including reablement",1,null,"Adults being assessed for intermediate care have a discussion about the support the service will and will not provide.","Proportion of adults being assessed for intermediate care who have a record of a discussion about the support the service will and will not provide.","Process","QS173 - Intermediate care including reablement","1 - QS173 - Intermediate care including reablement",1,"1 - QS173 - Intermediate care including reablement - Process - 1","The number in the denominator who have a record of a discussion about the support the service will and will not provide.","The number of adults being assessed for intermediate care."]
[null,"QS173","Intermediate care including reablement",1,null,"Adults being assessed for intermediate care have a discussion about the support the service will and will not provide.","Level of awareness of the support the service provides among adults assessed for intermediate care and their families and carers.","Outcome","QS173 - Intermediate care including reablement","1 - QS173 - Intermediate care including reablement",1,"1 - QS173 - Intermediate care including reablement - Outcome - 1"]
[null,"QS173","Intermediate care including reablement",2,null,"Adults accepted for bed-based intermediate care start the service within 2 days of referral.","Evidence of local arrangements to ensure that bed-based intermediate care can be started within 2 days of referral.","Structure","QS173 - Intermediate care including reablement","2 - QS173 - Intermediate care including reablement",1,"2 - QS173 - Intermediate care including reablement - Structure - 1"]
[null,"QS173","Intermediate care including reablement",2,null,"Adults accepted for bed-based intermediate care start the service within 2 days of referral.","Proportion of adults accepted for bed-based intermediate care from hospital who start the service within 2 days of referral.","Process","QS173 - Intermediate care including reablement","2 - QS173 - Intermediate care including reablement",1,"2 - QS173 - Intermediate care including reablement - Process - 1","The number in the denominator who start the service within 2 days of referral.","The number of adults accepted for bed-based intermediate care from hospital."]
[null,"QS173","Intermediate care including reablement",2,null,"Adults accepted for bed-based intermediate care start the service within 2 days of referral.","Proportion of adults accepted for bed-based intermediate care from the community who start the service within 2 days of referral.","Process","QS173 - Intermediate care including reablement","2 - QS173 - Intermediate care including reablement",2,"2 - QS173 - Intermediate care including reablement - Process - 2","The number in the denominator who start the service within 2 days of referral.","The number of adults accepted for bed-based intermediate care from the community."]
[null,"QS173","Intermediate care including reablement",2,null,"Adults accepted for bed-based intermediate care start the service within 2 days of referral.","Proportion of referrals for bed-based intermediate care that were not accepted due to insufficient capacity.","Process","QS173 - Intermediate care including reablement","2 - QS173 - Intermediate care including reablement",3,"2 - QS173 - Intermediate care including reablement - Process - 3","The number in the denominator that were not accepted due to insufficient capacity.","The number of referrals for bed-based intermediate care."]
[null,"QS173","Intermediate care including reablement",2,null,"Adults accepted for bed-based intermediate care start the service within 2 days of referral.","Rate of unplanned hospital admissions for chronic ambulatory care sensitive conditions.","Outcome","QS173 - Intermediate care including reablement","2 - QS173 - Intermediate care including reablement",1,"2 - QS173 - Intermediate care including reablement - Outcome - 1"]
[null,"QS173","Intermediate care including reablement",2,null,"Adults accepted for bed-based intermediate care start the service within 2 days of referral.","Rate of delayed transfer of care from hospital for adults.","Outcome","QS173 - Intermediate care including reablement","2 - QS173 - Intermediate care including reablement",2,"2 - QS173 - Intermediate care including reablement - Outcome - 2"]
[null,"QS173","Intermediate care including reablement",2,null,"Adults accepted for bed-based intermediate care start the service within 2 days of referral.","Proportion of discharges from bed-based intermediate care to acute hospital or residential care.","Outcome","QS173 - Intermediate care including reablement","2 - QS173 - Intermediate care including reablement",3,"2 - QS173 - Intermediate care including reablement - Outcome - 3"]
[null,"QS173","Intermediate care including reablement",2,null,"Adults accepted for bed-based intermediate care start the service within 2 days of referral.","Proportion of people who were still at home 91 days after discharge from hospital into reablement or rehabilitation services.","Outcome","QS173 - Intermediate care including reablement","2 - QS173 - Intermediate care including reablement",4,"2 - QS173 - Intermediate care including reablement - Outcome - 4"]
[null,"QS173","Intermediate care including reablement",3,null,"Adults starting intermediate care discuss and agree personalised goals.","Evidence of local arrangements to ensure that staff carrying out assessments for intermediate care are trained to discuss and agree personalised goals with adults starting the service.","Structure","QS173 - Intermediate care including reablement","3 - QS173 - Intermediate care including reablement",1,"3 - QS173 - Intermediate care including reablement - Structure - 1"]
[null,"QS173","Intermediate care including reablement",3,null,"Adults starting intermediate care discuss and agree personalised goals.","Evidence of local processes to ensure that personalised goals are documented and shared with the person starting intermediate care, their family and carers (as appropriate), and care staff.","Structure","QS173 - Intermediate care including reablement","3 - QS173 - Intermediate care including reablement",2,"3 - QS173 - Intermediate care including reablement - Structure - 2"]
[null,"QS173","Intermediate care including reablement",3,null,"Adults starting intermediate care discuss and agree personalised goals.","Proportion of adults starting intermediate care who have a record of a discussion to agree personalised goals.","Process","QS173 - Intermediate care including reablement","3 - QS173 - Intermediate care including reablement",1,"3 - QS173 - Intermediate care including reablement - Process - 1","The number in the denominator who have a record of a discussion to agree personalised goals.","The number of adults starting intermediate care."]
[null,"QS173","Intermediate care including reablement",3,null,"Adults starting intermediate care discuss and agree personalised goals.","Proportion of adults starting intermediate care who have documented personalised goals.","Process","QS173 - Intermediate care including reablement","3 - QS173 - Intermediate care including reablement",2,"3 - QS173 - Intermediate care including reablement - Process - 2","The number in the denominator who have documented personalised goals.","The number of adults starting intermediate care."]
[null,"QS173","Intermediate care including reablement",3,null,"Adults starting intermediate care discuss and agree personalised goals.","Satisfaction of adults discharged from intermediate care that the service supported them to achieve their personalised goals.","Outcome","QS173 - Intermediate care including reablement","3 - QS173 - Intermediate care including reablement",1,"3 - QS173 - Intermediate care including reablement - Outcome - 1"]
[null,"QS173","Intermediate care including reablement",3,null,"Adults starting intermediate care discuss and agree personalised goals.","Proportion of adults discharged from intermediate care with a level of independence improved from admission.","Outcome","QS173 - Intermediate care including reablement","3 - QS173 - Intermediate care including reablement",2,"3 - QS173 - Intermediate care including reablement - Outcome - 2"]
[null,"QS173","Intermediate care including reablement",4,null,"Adults using intermediate care services discuss and agree a transition plan for when their support ends.","Evidence of local referral pathways between intermediate care and statutory, independent and voluntary services.","Structure","QS173 - Intermediate care including reablement","4 - QS173 - Intermediate care including reablement",1,"4 - QS173 - Intermediate care including reablement - Structure - 1"]
[null,"QS173","Intermediate care including reablement",4,null,"Adults using intermediate care services discuss and agree a transition plan for when their support ends.","Evidence of local information about where adults leaving intermediate care can get support.","Structure","QS173 - Intermediate care including reablement","4 - QS173 - Intermediate care including reablement",2,"4 - QS173 - Intermediate care including reablement - Structure - 2"]
[null,"QS173","Intermediate care including reablement",4,null,"Adults using intermediate care services discuss and agree a transition plan for when their support ends.","Evidence of local processes to ensure that adults using intermediate care services discuss and agree a transition plan for when their support ends.","Structure","QS173 - Intermediate care including reablement","4 - QS173 - Intermediate care including reablement",3,"4 - QS173 - Intermediate care including reablement - Structure - 3"]
[null,"QS173","Intermediate care including reablement",4,null,"Adults using intermediate care services discuss and agree a transition plan for when their support ends.","Proportion of adults starting to use intermediate care services who have a record of a discussion to agree a transition plan for when their support ends.","Process","QS173 - Intermediate care including reablement","4 - QS173 - Intermediate care including reablement",1,"4 - QS173 - Intermediate care including reablement - Process - 1","The number in the denominator who have a record of a discussion to agree a transition plan for when their support ends.","The number of adults starting to use intermediate care services."]
[null,"QS173","Intermediate care including reablement",4,null,"Adults using intermediate care services discuss and agree a transition plan for when their support ends.","Proportion of adults starting to use intermediate care services who have a documented transition plan for when their support ends.","Process","QS173 - Intermediate care including reablement","4 - QS173 - Intermediate care including reablement",2,"4 - QS173 - Intermediate care including reablement - Process - 2","The number in the denominator who have a documented transition plan for when their support ends.","The number of adults starting to use intermediate care services."]
[null,"QS173","Intermediate care including reablement",4,null,"Adults using intermediate care services discuss and agree a transition plan for when their support ends.","Proportion of adults discharged from intermediate care whose transition plan for when their support ends was reviewed before discharge.","Process","QS173 - Intermediate care including reablement","4 - QS173 - Intermediate care including reablement",3,"4 - QS173 - Intermediate care including reablement - Process - 3","The number in the denominator whose transition plan for when their support ends was reviewed before discharge.","The number of adults discharged from intermediate care."]
[null,"QS173","Intermediate care including reablement",4,null,"Adults using intermediate care services discuss and agree a transition plan for when their support ends.","Rate of emergency readmissions to hospital within 30 days of discharge from hospital into reablement or rehabilitation services.","Outcome","QS173 - Intermediate care including reablement","4 - QS173 - Intermediate care including reablement",1,"4 - QS173 - Intermediate care including reablement - Outcome - 1"]
[null,"QS173","Intermediate care including reablement",4,null,"Adults using intermediate care services discuss and agree a transition plan for when their support ends.","Proportion of people who were still at home 91 days after discharge from hospital into reablement or rehabilitation services.","Outcome","QS173 - Intermediate care including reablement","4 - QS173 - Intermediate care including reablement",2,"4 - QS173 - Intermediate care including reablement - Outcome - 2"]
[null,"QS173","Intermediate care including reablement",4,null,"Adults using intermediate care services discuss and agree a transition plan for when their support ends.","Satisfaction of adults with their transition from intermediate care.","Outcome","QS173 - Intermediate care including reablement","4 - QS173 - Intermediate care including reablement",3,"4 - QS173 - Intermediate care including reablement - Outcome - 3"]
[null,"QS174","Emergency and acute medical care in over 16s",1,null,"Ambulance services have specialist and advanced paramedic practitioners.","Evidence of ambulance services supporting specialist and advanced paramedic training.","Structure","QS174 - Emergency and acute medical care in over 16s","1 - QS174 - Emergency and acute medical care in over 16s",1,"1 - QS174 - Emergency and acute medical care in over 16s - Structure - 1"]
[null,"QS174","Emergency and acute medical care in over 16s",1,null,"Ambulance services have specialist and advanced paramedic practitioners.","Evidence of ambulance services having specialist and advanced paramedic practitioners who can respond to 999 calls for suspected medical emergencies.","Structure",{"$f":"CONCATENATE(B3828, \" - \", C3828)","v":"QS174 - Emergency and acute medical care in over 16s"},{"$f":"CONCATENATE(D3828, \" - \", I3828)","v":"1 - QS174 - Emergency and acute medical care in over 16s"},{"$f":"IF(AND(B3828=B3827, D3828=D3827, H3828=H3827)=TRUE, K3827+1, 1)","v":2},{"$f":"CONCATENATE(J3828, \" - \", H3828, \" - \",K3828)","v":"1 - QS174 - Emergency and acute medical care in over 16s - Structure - 2"}]
[null,"QS174","Emergency and acute medical care in over 16s",1,null,"Ambulance services have specialist and advanced paramedic practitioners.","Proportion of incidents resolved without conveyance to an emergency department.","Outcome","QS174 - Emergency and acute medical care in over 16s","1 - QS174 - Emergency and acute medical care in over 16s",1,"1 - QS174 - Emergency and acute medical care in over 16s - Outcome - 1"]
[null,"QS174","Emergency and acute medical care in over 16s",2,null,"Adults with undifferentiated medical emergencies who need hospital admission are assessed and initially treated in an acute medical unit (AMU).","Evidence of local arrangements and written clinical protocols to ensure that adults with undifferentiated medical emergencies who need hospital admission have an assessment and initial treatment in an AMU.","Structure","QS174 - Emergency and acute medical care in over 16s","2 - QS174 - Emergency and acute medical care in over 16s",1,"2 - QS174 - Emergency and acute medical care in over 16s - Structure - 1"]
[null,"QS174","Emergency and acute medical care in over 16s",2,null,"Adults with undifferentiated medical emergencies who need hospital admission are assessed and initially treated in an acute medical unit (AMU).","Proportion of hospital admissions for undifferentiated medical emergencies who were admitted to an AMU.","Process","QS174 - Emergency and acute medical care in over 16s","2 - QS174 - Emergency and acute medical care in over 16s",1,"2 - QS174 - Emergency and acute medical care in over 16s - Process - 1","The number in the denominator who are admitted to an AMU.","The number of hospital admissions of adults for undifferentiated medical emergencies."]
[null,"QS174","Emergency and acute medical care in over 16s",2,null,"Adults with undifferentiated medical emergencies who need hospital admission are assessed and initially treated in an acute medical unit (AMU).","Hospital mortality rates for adults admitted to hospital for undifferentiated medical emergencies.","Outcome","QS174 - Emergency and acute medical care in over 16s","2 - QS174 - Emergency and acute medical care in over 16s",1,"2 - QS174 - Emergency and acute medical care in over 16s - Outcome - 1"]
[null,"QS174","Emergency and acute medical care in over 16s",2,null,"Adults with undifferentiated medical emergencies who need hospital admission are assessed and initially treated in an acute medical unit (AMU).","Length of hospital stay for adults admitted with undifferentiated medical emergencies.","Outcome","QS174 - Emergency and acute medical care in over 16s","2 - QS174 - Emergency and acute medical care in over 16s",2,"2 - QS174 - Emergency and acute medical care in over 16s - Outcome - 2"]
[null,"QS174","Emergency and acute medical care in over 16s",3,null,"Adults admitted with a medical emergency have a timely consultant assessment and review.","Evidence of consultant availability during daytime working hours to assess adults who have a medical emergency within 6 hours of the time of admission to hospital.","Structure","QS174 - Emergency and acute medical care in over 16s","3 - QS174 - Emergency and acute medical care in over 16s",1,"3 - QS174 - Emergency and acute medical care in over 16s - Structure - 1"]
[null,"QS174","Emergency and acute medical care in over 16s",3,null,"Adults admitted with a medical emergency have a timely consultant assessment and review.","Evidence of consultant availability to assess adults who have a medical emergency within 14 hours of the time of admission to hospital.","Structure","QS174 - Emergency and acute medical care in over 16s","3 - QS174 - Emergency and acute medical care in over 16s",2,"3 - QS174 - Emergency and acute medical care in over 16s - Structure - 2"]
[null,"QS174","Emergency and acute medical care in over 16s",3,null,"Adults admitted with a medical emergency have a timely consultant assessment and review.","Evidence of consultant availability to review adults daily who have a medical emergency after the initial consultant review is carried out.","Structure","QS174 - Emergency and acute medical care in over 16s","3 - QS174 - Emergency and acute medical care in over 16s",3,"3 - QS174 - Emergency and acute medical care in over 16s - Structure - 3"]
[null,"QS174","Emergency and acute medical care in over 16s",3,null,"Adults admitted with a medical emergency have a timely consultant assessment and review.","Proportion of hospital admissions for adults with a medical emergency during the daytime working hours in which a consultant assessment is carried out within 6 hours of the time of admission to hospital.","Process","QS174 - Emergency and acute medical care in over 16s","3 - QS174 - Emergency and acute medical care in over 16s",1,"3 - QS174 - Emergency and acute medical care in over 16s - Process - 1","The number in the denominator in which a consultant assessment is carried out within 6 hours of the time of admission to hospital.","The number of hospital admissions of adults with a medical emergency during the daytime working hours."]
[null,"QS174","Emergency and acute medical care in over 16s",3,null,"Adults admitted with a medical emergency have a timely consultant assessment and review.","Proportion of hospital admissions for adults with a medical emergency in which a consultant assessment is carried out within 14 hours of the time of admission to hospital.","Process","QS174 - Emergency and acute medical care in over 16s","3 - QS174 - Emergency and acute medical care in over 16s",2,"3 - QS174 - Emergency and acute medical care in over 16s - Process - 2","The number in the denominator in which a consultant assessment is carried out within 14 hours of the time of admission to hospital.","The number of hospital admissions for adults with a medical emergency."]
[null,"QS174","Emergency and acute medical care in over 16s",3,null,"Adults admitted with a medical emergency have a timely consultant assessment and review.","Proportion of hospital admissions for adults with a medical emergency in which a consultant review is carried out at least once every 24 hours after the initial consultant review.","Process","QS174 - Emergency and acute medical care in over 16s","3 - QS174 - Emergency and acute medical care in over 16s",3,"3 - QS174 - Emergency and acute medical care in over 16s - Process - 3","The number in the denominator in which a consultant review is carried out at least once every 24 hours.","The number of hospital admissions for adults with a medical emergency in which the person has had the initial consultant review."]
[null,"QS174","Emergency and acute medical care in over 16s",3,null,"Adults admitted with a medical emergency have a timely consultant assessment and review.","Length of hospital stay for adults admitted with a medical emergency.","Outcome","QS174 - Emergency and acute medical care in over 16s","3 - QS174 - Emergency and acute medical care in over 16s",1,"3 - QS174 - Emergency and acute medical care in over 16s - Outcome - 1"]
[null,"QS174","Emergency and acute medical care in over 16s",4,null,"Adults admitted with a medical emergency have a structured patient handover during transitions of care.","Evidence of structured (verbal and written or electronic) handover processes during transitions of care for adults who have been admitted with a medical emergency.","Structure","QS174 - Emergency and acute medical care in over 16s","4 - QS174 - Emergency and acute medical care in over 16s",1,"4 - QS174 - Emergency and acute medical care in over 16s - Structure - 1"]
[null,"QS174","Emergency and acute medical care in over 16s",4,null,"Adults admitted with a medical emergency have a structured patient handover during transitions of care.","Proportion of transitions of care for adults admitted with a medical emergency in which a structured handover of care is carried out.","Process","QS174 - Emergency and acute medical care in over 16s","4 - QS174 - Emergency and acute medical care in over 16s",1,"4 - QS174 - Emergency and acute medical care in over 16s - Process - 1","The number in the denominator who have a structured handover of care.","The number of transitions of care for adults admitted with a medical emergency."]
[null,"QS174","Emergency and acute medical care in over 16s",4,null,"Adults admitted with a medical emergency have a structured patient handover during transitions of care.","Patient experience of the structured care handover during transitions of care.","Outcome","QS174 - Emergency and acute medical care in over 16s","4 - QS174 - Emergency and acute medical care in over 16s",1,"4 - QS174 - Emergency and acute medical care in over 16s - Outcome - 1"]
[null,"QS175","Eating disorders",1,null,"People with suspected eating disorders who are referred to an eating disorder service start assessment and treatment within 4 weeks for children and young people or a locally agreed timeframe for adults.","Evidence that local referral pathways are in place for people with suspected eating disorders to start assessment and treatment within 4 weeks for children and young people or a locally agreed timeframe for adults.","Structure","QS175 - Eating disorders","1 - QS175 - Eating disorders",1,"1 - QS175 - Eating disorders - Structure - 1"]
[null,"QS175","Eating disorders",1,null,"People with suspected eating disorders who are referred to an eating disorder service start assessment and treatment within 4 weeks for children and young people or a locally agreed timeframe for adults.","Proportion of children and young people with suspected eating disorders who start assessment and treatment within a maximum of 4 weeks from first contact with a designated healthcare professional.","Process","QS175 - Eating disorders","1 - QS175 - Eating disorders",1,"1 - QS175 - Eating disorders - Process - 1"]
[null,"QS175","Eating disorders",1,null,"People with suspected eating disorders who are referred to an eating disorder service start assessment and treatment within 4 weeks for children and young people or a locally agreed timeframe for adults.","Proportion of adults with suspected eating disorders who are assessed and start treatment within locally agreed timeframes.","Process","QS175 - Eating disorders","1 - QS175 - Eating disorders",2,"1 - QS175 - Eating disorders - Process - 2"]
[null,"QS175","Eating disorders",1,null,"People with suspected eating disorders who are referred to an eating disorder service start assessment and treatment within 4 weeks for children and young people or a locally agreed timeframe for adults.","Length of time from referral to assessment and start of treatment at an eating disorder service for children and young people with suspected eating disorders.","Outcome","QS175 - Eating disorders","1 - QS175 - Eating disorders",1,"1 - QS175 - Eating disorders - Outcome - 1"]
[null,"QS175","Eating disorders",1,null,"People with suspected eating disorders who are referred to an eating disorder service start assessment and treatment within 4 weeks for children and young people or a locally agreed timeframe for adults.","Length of time from referral to assessment and start of treatment at an eating disorder service for adults with suspected eating disorders.","Outcome","QS175 - Eating disorders","1 - QS175 - Eating disorders",2,"1 - QS175 - Eating disorders - Outcome - 2"]
[null,"QS175","Eating disorders",1,null,"People with suspected eating disorders who are referred to an eating disorder service start assessment and treatment within 4 weeks for children and young people or a locally agreed timeframe for adults.","Rate of recovery for people with eating disorders.","Outcome","QS175 - Eating disorders","1 - QS175 - Eating disorders",3,"1 - QS175 - Eating disorders - Outcome - 3"]
[null,"QS175","Eating disorders",2,null,"People with eating disorders have a discussion with a healthcare professional about their options for psychological treatment.","Evidence of local arrangements to provide psychological treatments for people with eating disorders.","Structure","QS175 - Eating disorders","2 - QS175 - Eating disorders",1,"2 - QS175 - Eating disorders - Structure - 1"]
[null,"QS175","Eating disorders",2,null,"People with eating disorders have a discussion with a healthcare professional about their options for psychological treatment.","Proportion of people with eating disorders who have a documented discussion with a healthcare professional about their options for psychological treatment at diagnosis.","Process","QS175 - Eating disorders","2 - QS175 - Eating disorders",1,"2 - QS175 - Eating disorders - Process - 1","The number in the denominator who have a documented discussion with a healthcare professional about their options for psychological treatment at diagnosis.","The number in the denominator who have a documented discussion with a healthcare professional about their options for psychological treatment at diagnosis."]
[null,"QS175","Eating disorders",3,null,"People with binge eating disorder participate in a guided self-help programme as first-line psychological treatment.","Evidence of local arrangements to provide a guided self-help programme as first-line psychological treatment for people with binge eating disorder.","Structure","QS175 - Eating disorders","3 - QS175 - Eating disorders",1,"3 - QS175 - Eating disorders - Structure - 1"]
[null,"QS175","Eating disorders",3,null,"People with binge eating disorder participate in a guided self-help programme as first-line psychological treatment.","Proportion of people with binge eating disorder who participate in a guided self-help programme as first-line psychological treatment.","Process","QS175 - Eating disorders","3 - QS175 - Eating disorders",1,"3 - QS175 - Eating disorders - Process - 1","The number in the denominator who participate in a guided self-help programme as first-line psychological treatment.","The number of people diagnosed with binge eating disorder."]
[null,"QS175","Eating disorders",3,null,"People with binge eating disorder participate in a guided self-help programme as first-line psychological treatment.","Binge eating frequency for people with binge eating disorder.","Outcome","QS175 - Eating disorders","3 - QS175 - Eating disorders",1,"3 - QS175 - Eating disorders - Outcome - 1"]
[null,"QS175","Eating disorders",3,null,"People with binge eating disorder participate in a guided self-help programme as first-line psychological treatment.","Rate of relapse for people with binge eating disorder.","Outcome","QS175 - Eating disorders","3 - QS175 - Eating disorders",2,"3 - QS175 - Eating disorders - Outcome - 2"]
[null,"QS175","Eating disorders",4,null,"Children and young people with bulimia nervosa are offered bulimia-nervosa-focused family therapy (FT-BN).","Evidence of local arrangements to offer FT-BN to children and young people with bulimia nervosa.","Structure","QS175 - Eating disorders","4 - QS175 - Eating disorders",1,"4 - QS175 - Eating disorders - Structure - 1"]
[null,"QS175","Eating disorders",4,null,"Children and young people with bulimia nervosa are offered bulimia-nervosa-focused family therapy (FT-BN).","Proportion of children and young people with bulimia nervosa who are offered FT-BN.","Process","QS175 - Eating disorders","4 - QS175 - Eating disorders",1,"4 - QS175 - Eating disorders - Process - 1","The number in the denominator who are offered FT-BN.","The number of children and young people diagnosed with bulimia nervosa."]
[null,"QS175","Eating disorders",4,null,"Children and young people with bulimia nervosa are offered bulimia-nervosa-focused family therapy (FT-BN).","Binge eating frequency for children and young people with bulimia nervosa.","Outcome","QS175 - Eating disorders","4 - QS175 - Eating disorders",1,"4 - QS175 - Eating disorders - Outcome - 1"]
[null,"QS175","Eating disorders",4,null,"Children and young people with bulimia nervosa are offered bulimia-nervosa-focused family therapy (FT-BN).","Purging frequency for children and young people with bulimia nervosa.","Outcome","QS175 - Eating disorders","4 - QS175 - Eating disorders",2,"4 - QS175 - Eating disorders - Outcome - 2"]
[null,"QS175","Eating disorders",4,null,"Children and young people with bulimia nervosa are offered bulimia-nervosa-focused family therapy (FT-BN).","Rate of recovery for children and young people with bulimia nervosa.","Outcome","QS175 - Eating disorders","4 - QS175 - Eating disorders",3,"4 - QS175 - Eating disorders - Outcome - 3"]
[null,"QS175","Eating disorders",5,null,"People with eating disorders who are being supported by more than one service have a care plan that explains how the services will work together.","Evidence of joint working arrangements, including regular liaison and meetings to discuss care plans, between eating disorder services and other services, using formal processes of care planning, such as the Care Programme Approach (CPA).","Structure","QS175 - Eating disorders","5 - QS175 - Eating disorders",1,"5 - QS175 - Eating disorders - Structure - 1"]
[null,"QS175","Eating disorders",5,null,"People with eating disorders who are being supported by more than one service have a care plan that explains how the services will work together.","Proportion of people with eating disorders who are supported by more than one service who have a care plan that explains how the services will work together.","Process","QS175 - Eating disorders","5 - QS175 - Eating disorders",1,"5 - QS175 - Eating disorders - Process - 1","The number in the denominator who have a care plan that explains how the services will work together.","The number of people diagnosed with eating disorders who are supported by more than one service."]
[null,"QS175","Eating disorders",5,null,"People with eating disorders who are being supported by more than one service have a care plan that explains how the services will work together.","Proportion of people with eating disorders who are supported by more than one service and have CPA meetings to discuss their care plan.","Process","QS175 - Eating disorders","5 - QS175 - Eating disorders",2,"5 - QS175 - Eating disorders - Process - 2","The number in the denominator who have their care plan discussed in their last CPA meeting.","The number of people diagnosed with eating disorders who are supported by more than one service and have a care plan."]
[null,"QS175","Eating disorders",5,null,"People with eating disorders who are being supported by more than one service have a care plan that explains how the services will work together.","Rate of relapse for people with eating disorders who are supported by more than one service.","Outcome","QS175 - Eating disorders","5 - QS175 - Eating disorders",1,"5 - QS175 - Eating disorders - Outcome - 1"]
[null,"QS175","Eating disorders",5,null,"People with eating disorders who are being supported by more than one service have a care plan that explains how the services will work together.","Service user experience of eating disorder services.","Outcome","QS175 - Eating disorders","5 - QS175 - Eating disorders",2,"5 - QS175 - Eating disorders - Outcome - 2"]
[null,"QS175","Eating disorders",6,null,"People with eating disorders who are moving between services have their risks assessed.","Evidence of joint transition protocols between eating disorder services and other services, using formal processes of care planning such as the Care Programme Approach (CPA).","Structure","QS175 - Eating disorders","6 - QS175 - Eating disorders",1,"6 - QS175 - Eating disorders - Structure - 1"]
[null,"QS175","Eating disorders",6,null,"People with eating disorders who are moving between services have their risks assessed.","Evidence of joint working arrangements, including regular liaison and meetings, to discuss risk assessment and monitoring at transition between eating disorder services and other services providing care for people with eating disorders.","Structure","QS175 - Eating disorders","6 - QS175 - Eating disorders",2,"6 - QS175 - Eating disorders - Structure - 2"]
[null,"QS175","Eating disorders",6,null,"People with eating disorders who are moving between services have their risks assessed.","Proportion of people with eating disorders moving between services who have a care plan that includes a risk assessment before transfer.","Process","QS175 - Eating disorders","6 - QS175 - Eating disorders",1,"6 - QS175 - Eating disorders - Process - 1","The number in the denominator who have a care plan that includes a risk assessment before transfer.","The number of people with eating disorders who are moving between services."]
[null,"QS175","Eating disorders",6,null,"People with eating disorders who are moving between services have their risks assessed.","Proportion of people with eating disorders moving between services who have a care plan that includes a risk assessment after transfer.","Process","QS175 - Eating disorders","6 - QS175 - Eating disorders",2,"6 - QS175 - Eating disorders - Process - 2","The number in the denominator who have a care plan that includes a risk assessment after transfer.","The number of people with eating disorders who are moving between services."]
[null,"QS175","Eating disorders",6,null,"People with eating disorders who are moving between services have their risks assessed.","Proportion of people with eating disorders who have moved between services and did not attend their first meeting or appointment.","Outcome","QS175 - Eating disorders","6 - QS175 - Eating disorders",1,"6 - QS175 - Eating disorders - Outcome - 1"]
[null,"QS175","Eating disorders",6,null,"People with eating disorders who are moving between services have their risks assessed.","Relapse rate of people with eating disorders who move between services.","Outcome","QS175 - Eating disorders","6 - QS175 - Eating disorders",2,"6 - QS175 - Eating disorders - Outcome - 2"]
[null,"QS175","Eating disorders",6,null,"People with eating disorders who are moving between services have their risks assessed.","Service user experience of eating disorder services.","Outcome","QS175 - Eating disorders","6 - QS175 - Eating disorders",3,"6 - QS175 - Eating disorders - Outcome - 3"]
[null,"QS176","Oesophago-gastric cancer",1,null,"Adults with oesophago-gastric cancer have access to an oesophago-gastric clinical nurse specialist.","Evidence of the availability of clinical nurse specialists who specialise in the care and support of adults with oesophago-gastric cancer.","Structure","QS176 - Oesophago-gastric cancer","1 - QS176 - Oesophago-gastric cancer",1,"1 - QS176 - Oesophago-gastric cancer - Structure - 1"]
[null,"QS176","Oesophago-gastric cancer",1,null,"Adults with oesophago-gastric cancer have access to an oesophago-gastric clinical nurse specialist.","Proportion of adults with oesophago-gastric cancer who have contact details for an oesophago-gastric clinical nurse specialist.","Process","QS176 - Oesophago-gastric cancer","1 - QS176 - Oesophago-gastric cancer",1,"1 - QS176 - Oesophago-gastric cancer - Process - 1","the number in the denominator who have contact details for an oesophago-gastric clinical nurse specialist.","the number of adults with oesophago-gastric cancer."]
[null,"QS176","Oesophago-gastric cancer",1,null,"Adults with oesophago-gastric cancer have access to an oesophago-gastric clinical nurse specialist.","Patient satisfaction with the availability of a clinical nurse specialist, reported by adults with oesophago-gastric cancer.","Outcome","QS176 - Oesophago-gastric cancer","1 - QS176 - Oesophago-gastric cancer",1,"1 - QS176 - Oesophago-gastric cancer - Outcome - 1"]
[null,"QS176","Oesophago-gastric cancer",1,null,"Adults with oesophago-gastric cancer have access to an oesophago-gastric clinical nurse specialist.","Patient satisfaction with information provided by the clinical nurse specialist, reported by adults with oesophago-gastric cancer.","Outcome","QS176 - Oesophago-gastric cancer","1 - QS176 - Oesophago-gastric cancer",2,"1 - QS176 - Oesophago-gastric cancer - Outcome - 2"]
[null,"QS176","Oesophago-gastric cancer",2,null,"Adults with oesophago-gastric cancer have their treatment reviewed by a multidisciplinary team (MDT) that includes an oncologist and a specialist radiologist who both have an interest in oesophago-gastric cancer.","Evidence that an oncologist and a radiologist who both have a specialist interest in oesophago-gastric cancer take part in multidisciplinary team meetings.","Structure","QS176 - Oesophago-gastric cancer","2 - QS176 - Oesophago-gastric cancer",1,"2 - QS176 - Oesophago-gastric cancer - Structure - 1"]
[null,"QS176","Oesophago-gastric cancer",2,null,"Adults with oesophago-gastric cancer have their treatment reviewed by a multidisciplinary team (MDT) that includes an oncologist and a specialist radiologist who both have an interest in oesophago-gastric cancer.","Proportion of adults with newly diagnosed oesophago-gastric cancer whose treatment is reviewed at a multidisciplinary meeting that includes an oncologist and a radiologist who both have a specialist interest in oesophago-gastric cancer.","Process","QS176 - Oesophago-gastric cancer","2 - QS176 - Oesophago-gastric cancer",1,"2 - QS176 - Oesophago-gastric cancer - Process - 1","the number in the denominator whose treatment is reviewed at a multidisciplinary meeting that includes an oncologist and a radiologist who both have a specialist interest in oesophago-gastric cancer.","the number of adults with newly diagnosed oesophago-gastric cancer."]
[null,"QS176","Oesophago-gastric cancer",2,null,"Adults with oesophago-gastric cancer have their treatment reviewed by a multidisciplinary team (MDT) that includes an oncologist and a specialist radiologist who both have an interest in oesophago-gastric cancer.","Rates of referral from a local MDT to a specialist oesophago-gastric cancer MDT.","Outcome","QS176 - Oesophago-gastric cancer","2 - QS176 - Oesophago-gastric cancer",1,"2 - QS176 - Oesophago-gastric cancer - Outcome - 1"]
[null,"QS176","Oesophago-gastric cancer",2,null,"Adults with oesophago-gastric cancer have their treatment reviewed by a multidisciplinary team (MDT) that includes an oncologist and a specialist radiologist who both have an interest in oesophago-gastric cancer.","Average time from MDT to first treatment for oesophago-gastric cancer.","Outcome","QS176 - Oesophago-gastric cancer","2 - QS176 - Oesophago-gastric cancer",2,"2 - QS176 - Oesophago-gastric cancer - Outcome - 2"]
[null,"QS176","Oesophago-gastric cancer",3,null,"Adults with oesophageal or gastro-oesophageal junctional tumours (except T1a tumours) for whom radical treatment is suitable, have 18‑fluorodeoxyglucose positron emission tomography (F‑18 FDG PET‑CT) requested and reported within 1 week.","Evidence of the availability of equipment and systems to request and report the results of F‑18 FDG PET‑CT scans.","Structure","QS176 - Oesophago-gastric cancer","3 - QS176 - Oesophago-gastric cancer",1,"3 - QS176 - Oesophago-gastric cancer - Structure - 1"]
[null,"QS176","Oesophago-gastric cancer",3,null,"Adults with oesophageal or gastro-oesophageal junctional tumours (except T1a tumours) for whom radical treatment is suitable, have 18‑fluorodeoxyglucose positron emission tomography (F‑18 FDG PET‑CT) requested and reported within 1 week.","Evidence of local processes to identify F‑18 FDG PET‑CT scans reported more than 1 week after they have been requested.","Structure","QS176 - Oesophago-gastric cancer","3 - QS176 - Oesophago-gastric cancer",2,"3 - QS176 - Oesophago-gastric cancer - Structure - 2"]
[null,"QS176","Oesophago-gastric cancer",3,null,"Adults with oesophageal or gastro-oesophageal junctional tumours (except T1a tumours) for whom radical treatment is suitable, have 18‑fluorodeoxyglucose positron emission tomography (F‑18 FDG PET‑CT) requested and reported within 1 week.","Proportion of adults with oesophageal or gastro-oesophageal junctional cancer for whom radical treatment is suitable who have staging using F‑18 FDG PET‑CT with results reported within 1 week of the decision to request the scan.","Process","QS176 - Oesophago-gastric cancer","3 - QS176 - Oesophago-gastric cancer",1,"3 - QS176 - Oesophago-gastric cancer - Process - 1","the number of adults in the denominator who have the results of F‑18 FDG PET‑CT staging reported within 1 week of the decision to request the scan.","the number of adults with oesophageal or gastro-oesophageal junctional cancer for whom radical treatment is suitable."]
[null,"QS176","Oesophago-gastric cancer",3,null,"Adults with oesophageal or gastro-oesophageal junctional tumours (except T1a tumours) for whom radical treatment is suitable, have 18‑fluorodeoxyglucose positron emission tomography (F‑18 FDG PET‑CT) requested and reported within 1 week.","Proportion of adults with oesophageal or gastro-oesophageal junctional cancer who have accurate staging.","Outcome","QS176 - Oesophago-gastric cancer","3 - QS176 - Oesophago-gastric cancer",1,"3 - QS176 - Oesophago-gastric cancer - Outcome - 1"]
[null,"QS176","Oesophago-gastric cancer",3,null,"Adults with oesophageal or gastro-oesophageal junctional tumours (except T1a tumours) for whom radical treatment is suitable, have 18‑fluorodeoxyglucose positron emission tomography (F‑18 FDG PET‑CT) requested and reported within 1 week.","Proportion of adults with metastatic oesophageal or gastro-oesophageal junctional cancer who have endoscopic ultrasound.","Outcome","QS176 - Oesophago-gastric cancer","3 - QS176 - Oesophago-gastric cancer",2,"3 - QS176 - Oesophago-gastric cancer - Outcome - 2"]
[null,"QS176","Oesophago-gastric cancer",4,null,"Adults with oesophago-gastric cancer have tailored specialist dietetic support before and after radical treatment.","Evidence of the availability of tailored, specialist dietetic support for adults with oesophago-gastric cancer before and after radical treatment.","Structure","QS176 - Oesophago-gastric cancer","4 - QS176 - Oesophago-gastric cancer",1,"4 - QS176 - Oesophago-gastric cancer - Structure - 1"]
[null,"QS176","Oesophago-gastric cancer",4,null,"Adults with oesophago-gastric cancer have tailored specialist dietetic support before and after radical treatment.","Proportion of adults with oesophago-gastric cancer with radical treatment planned who have tailored, specialist dietetic support.","Process","QS176 - Oesophago-gastric cancer","4 - QS176 - Oesophago-gastric cancer",1,"4 - QS176 - Oesophago-gastric cancer - Process - 1","the number in the denominator who have tailored, specialist dietetic support before radical treatment.","the number of adults with oesophago-gastric cancer who have radical treatment planned."]
[null,"QS176","Oesophago-gastric cancer",4,null,"Adults with oesophago-gastric cancer have tailored specialist dietetic support before and after radical treatment.","Proportion of adults with oesophago-gastric cancer who have tailored specialist dietetic support after radical treatment.","Process","QS176 - Oesophago-gastric cancer","4 - QS176 - Oesophago-gastric cancer",2,"4 - QS176 - Oesophago-gastric cancer - Process - 2","the number in the denominator who have tailored specialist dietetic support after radical treatment.","the number of adults with oesophago-gastric cancer who have radical treatment."]
[null,"QS176","Oesophago-gastric cancer",4,null,"Adults with oesophago-gastric cancer have tailored specialist dietetic support before and after radical treatment.","Health-related quality of life for adults who have radical treatment for oesophago-gastric cancer.","Outcome","QS176 - Oesophago-gastric cancer","4 - QS176 - Oesophago-gastric cancer",1,"4 - QS176 - Oesophago-gastric cancer - Outcome - 1"]
[null,"QS177","Pancreatic cancer",1,null,"Adults with suspected pancreatic cancer have their diagnosis and care agreed by a specialist pancreatic cancer multidisciplinary team (MDT).","Evidence of specialist pancreatic cancer MDTs in the area.","Structure","QS177 - Pancreatic cancer","1 - QS177 - Pancreatic cancer",1,"1 - QS177 - Pancreatic cancer - Structure - 1"]
[null,"QS177","Pancreatic cancer",1,null,"Adults with suspected pancreatic cancer have their diagnosis and care agreed by a specialist pancreatic cancer multidisciplinary team (MDT).","Evidence of clear care pathways between local cancer units and specialist pancreatic cancer MDTs.","Structure","QS177 - Pancreatic cancer","1 - QS177 - Pancreatic cancer",2,"1 - QS177 - Pancreatic cancer - Structure - 2"]
[null,"QS177","Pancreatic cancer",1,null,"Adults with suspected pancreatic cancer have their diagnosis and care agreed by a specialist pancreatic cancer multidisciplinary team (MDT).","Proportion of adults with suspected pancreatic cancer who have their diagnosis and care agreed by a specialist pancreatic cancer MDT.","Process",{"$f":"CONCATENATE(B3892, \" - \", C3892)","v":"QS177 - Pancreatic cancer"},{"$f":"CONCATENATE(D3892, \" - \", I3892)","v":"1 - QS177 - Pancreatic cancer"},{"$f":"IF(AND(B3892=B3891, D3892=D3891, H3892=H3891)=TRUE, K3891+1, 1)","v":1},{"$f":"CONCATENATE(J3892, \" - \", H3892, \" - \",K3892)","v":"1 - QS177 - Pancreatic cancer - Process - 1"},"the number in the denominator who have their diagnosis and care agreed by a specialist pancreatic cancer MDT.","the number of adults with suspected pancreatic cancer."]
[null,"QS177","Pancreatic cancer",1,null,"Adults with suspected pancreatic cancer have their diagnosis and care agreed by a specialist pancreatic cancer multidisciplinary team (MDT).","Proportion of adults with a pancreatic cancer diagnosis confirmed by a specialist pancreatic cancer MDT.","Outcome","QS177 - Pancreatic cancer","1 - QS177 - Pancreatic cancer",1,"1 - QS177 - Pancreatic cancer - Outcome - 1"]
[null,"QS177","Pancreatic cancer",1,null,"Adults with suspected pancreatic cancer have their diagnosis and care agreed by a specialist pancreatic cancer multidisciplinary team (MDT).","Proportion of adults with pancreatic cancer receiving pancreatic cancer treatment.","Outcome","QS177 - Pancreatic cancer","1 - QS177 - Pancreatic cancer",2,"1 - QS177 - Pancreatic cancer - Outcome - 2"]
[null,"QS177","Pancreatic cancer",1,null,"Adults with suspected pancreatic cancer have their diagnosis and care agreed by a specialist pancreatic cancer multidisciplinary team (MDT).","Proportion of adults with pancreatic cancer who agree they were given enough care and support from healthcare services.","Outcome","QS177 - Pancreatic cancer","1 - QS177 - Pancreatic cancer",3,"1 - QS177 - Pancreatic cancer - Outcome - 3"]
[null,"QS177","Pancreatic cancer",2,null,"Adults with localised pancreatic cancer on CT have staging using fluorodeoxyglucose positron emission tomography/CT (FDG‑PET/CT) before they have surgery, radiotherapy or systemic therapy.","Evidence of local arrangements to ensure that FDG‑PET/CT is used for staging in adults with localised pancreatic cancer on CT before they have surgery, radiotherapy or systemic therapy.","Structure","QS177 - Pancreatic cancer","2 - QS177 - Pancreatic cancer",1,"2 - QS177 - Pancreatic cancer - Structure - 1"]
[null,"QS177","Pancreatic cancer",2,null,"Adults with localised pancreatic cancer on CT have staging using fluorodeoxyglucose positron emission tomography/CT (FDG‑PET/CT) before they have surgery, radiotherapy or systemic therapy.","Proportion of adults with localised pancreatic cancer on CT having surgery, radiotherapy or systemic therapy who had FDG‑PET/CT before receiving cancer treatment.","Process","QS177 - Pancreatic cancer","2 - QS177 - Pancreatic cancer",1,"2 - QS177 - Pancreatic cancer - Process - 1","the number in the denominator who had FDG‑PET/CT staging before receiving treatment.","the number of adults with localised pancreatic cancer on CT who had surgery, radiotherapy or systemic therapy."]
[null,"QS177","Pancreatic cancer",2,null,"Adults with localised pancreatic cancer on CT have staging using fluorodeoxyglucose positron emission tomography/CT (FDG‑PET/CT) before they have surgery, radiotherapy or systemic therapy.","Proportion of adults with pancreatic cancer who have staging recorded at diagnosis.","Outcome","QS177 - Pancreatic cancer","2 - QS177 - Pancreatic cancer",1,"2 - QS177 - Pancreatic cancer - Outcome - 1"]
[null,"QS177","Pancreatic cancer",2,null,"Adults with localised pancreatic cancer on CT have staging using fluorodeoxyglucose positron emission tomography/CT (FDG‑PET/CT) before they have surgery, radiotherapy or systemic therapy.","Proportion of adults with localised pancreatic cancer on CT who were found to have metastatic disease on FDG‑PET/CT.","Outcome","QS177 - Pancreatic cancer","2 - QS177 - Pancreatic cancer",2,"2 - QS177 - Pancreatic cancer - Outcome - 2"]
[null,"QS177","Pancreatic cancer",3,null,"Adults with resectable pancreatic cancer and obstructive jaundice have resectional surgery rather than preoperative biliary drainage unless the drainage is specifically indicated.","Evidence of local care protocols, which ensure that adults with resectable pancreatic cancer and obstructive jaundice have resectional surgery without preoperative biliary drainage unless the drainage is specifically indicated.","Structure","QS177 - Pancreatic cancer","3 - QS177 - Pancreatic cancer",1,"3 - QS177 - Pancreatic cancer - Structure - 1"]
[null,"QS177","Pancreatic cancer",3,null,"Adults with resectable pancreatic cancer and obstructive jaundice have resectional surgery rather than preoperative biliary drainage unless the drainage is specifically indicated.","Proportion of adults with resectable pancreatic cancer and obstructive jaundice with no indication for preoperative biliary drainage who had resectional surgery without the drainage.","Process","QS177 - Pancreatic cancer","3 - QS177 - Pancreatic cancer",1,"3 - QS177 - Pancreatic cancer - Process - 1","the number in the denominator who had resectional surgery without preoperative biliary drainage.","the number of adults with resectable pancreatic cancer and obstructive jaundice with no indication for preoperative biliary drainage."]
[null,"QS177","Pancreatic cancer",3,null,"Adults with resectable pancreatic cancer and obstructive jaundice have resectional surgery rather than preoperative biliary drainage unless the drainage is specifically indicated.","Time to resectional surgery for adults with resectable pancreatic cancer and obstructive jaundice.","Outcome","QS177 - Pancreatic cancer","3 - QS177 - Pancreatic cancer",1,"3 - QS177 - Pancreatic cancer - Outcome - 1"]
[null,"QS177","Pancreatic cancer",3,null,"Adults with resectable pancreatic cancer and obstructive jaundice have resectional surgery rather than preoperative biliary drainage unless the drainage is specifically indicated.","Disease-free survival in adults with resectable pancreatic cancer and obstructive jaundice who had resectable surgery without preoperative biliary drainage.","Outcome","QS177 - Pancreatic cancer","3 - QS177 - Pancreatic cancer",2,"3 - QS177 - Pancreatic cancer - Outcome - 2"]
[null,"QS177","Pancreatic cancer",3,null,"Adults with resectable pancreatic cancer and obstructive jaundice have resectional surgery rather than preoperative biliary drainage unless the drainage is specifically indicated.","Overall survival in adults with resectable pancreatic cancer.","Outcome","QS177 - Pancreatic cancer","3 - QS177 - Pancreatic cancer",3,"3 - QS177 - Pancreatic cancer - Outcome - 3"]
[null,"QS177","Pancreatic cancer",3,null,"Adults with resectable pancreatic cancer and obstructive jaundice have resectional surgery rather than preoperative biliary drainage unless the drainage is specifically indicated.","Health-related quality of life in adults with pancreatic cancer.","Outcome","QS177 - Pancreatic cancer","3 - QS177 - Pancreatic cancer",4,"3 - QS177 - Pancreatic cancer - Outcome - 4"]
[null,"QS177","Pancreatic cancer",4,null,"Adults with unresectable pancreatic cancer are prescribed enteric-coated pancreatin.","Evidence of local arrangements to ensure that adults with unresectable pancreatic cancer are prescribed enteric-coated pancreatin.","Structure","QS177 - Pancreatic cancer","4 - QS177 - Pancreatic cancer",1,"4 - QS177 - Pancreatic cancer - Structure - 1"]
[null,"QS177","Pancreatic cancer",4,null,"Adults with unresectable pancreatic cancer are prescribed enteric-coated pancreatin.","Evidence of local arrangements to ensure that adults with unresectable pancreatic cancer prescribed enteric-coated pancreatin receive advice on how to take it.","Structure","QS177 - Pancreatic cancer","4 - QS177 - Pancreatic cancer",2,"4 - QS177 - Pancreatic cancer - Structure - 2"]
[null,"QS177","Pancreatic cancer",4,null,"Adults with unresectable pancreatic cancer are prescribed enteric-coated pancreatin.","Proportion of adults with unresectable pancreatic cancer prescribed enteric-coated pancreatin.","Process","QS177 - Pancreatic cancer","4 - QS177 - Pancreatic cancer",1,"4 - QS177 - Pancreatic cancer - Process - 1","the number in the denominator prescribed enteric-coated pancreatin.","the number of adults with unresectable pancreatic cancer."]
[null,"QS177","Pancreatic cancer",4,null,"Adults with unresectable pancreatic cancer are prescribed enteric-coated pancreatin.","Malnutrition Universal Screening Tool (MUST) score in adults with unresectable pancreatic cancer.","Outcome","QS177 - Pancreatic cancer","4 - QS177 - Pancreatic cancer",1,"4 - QS177 - Pancreatic cancer - Outcome - 1"]
[null,"QS177","Pancreatic cancer",4,null,"Adults with unresectable pancreatic cancer are prescribed enteric-coated pancreatin.","Health-related quality of life in people with pancreatic cancer.","Outcome","QS177 - Pancreatic cancer","4 - QS177 - Pancreatic cancer",2,"4 - QS177 - Pancreatic cancer - Outcome - 2"]
[null,"QS178","Sexual health",1,null,"People are asked about their sexual history at key points of contact.","Evidence of local agreement on the key points of contact when people will be asked about their sexual history.","Structure","QS178 - Sexual health","1 - QS178 - Sexual health",1,"1 - QS178 - Sexual health - Structure - 1"]
[null,"QS178","Sexual health",1,null,"People are asked about their sexual history at key points of contact.","Evidence of local processes to ensure that people are asked about their sexual history at key points of contact.","Structure","QS178 - Sexual health","1 - QS178 - Sexual health",2,"1 - QS178 - Sexual health - Structure - 2"]
[null,"QS178","Sexual health",1,null,"People are asked about their sexual history at key points of contact.","Proportion of people who have a discussion about their sexual history at key points of contact.","Process","QS178 - Sexual health","1 - QS178 - Sexual health",1,"1 - QS178 - Sexual health - Process - 1","the number in the denominator who have a discussion about their sexual history.","the number of people attending a key point of contact."]
[null,"QS178","Sexual health",1,null,"People are asked about their sexual history at key points of contact.","Coverage of testing for STIs: proportion of people attending the service who are tested for STIs.","Outcome","QS178 - Sexual health","1 - QS178 - Sexual health",1,"1 - QS178 - Sexual health - Outcome - 1"]
[null,"QS178","Sexual health",2,null,"People identified as being at risk of sexually transmitted infections have a discussion about prevention and testing.","Evidence of local arrangements to ensure that trained healthcare professionals are available to discuss behaviour change with people identified as being at risk of STIs.","Structure","QS178 - Sexual health","2 - QS178 - Sexual health",1,"2 - QS178 - Sexual health - Structure - 1"]
[null,"QS178","Sexual health",2,null,"People identified as being at risk of sexually transmitted infections have a discussion about prevention and testing.","Evidence of local processes to ensure that people identified as being at risk of STIs have a discussion about prevention and testing.","Structure","QS178 - Sexual health",{"$f":"CONCATENATE(D3916, \" - \", I3916)","v":"2 - QS178 - Sexual health"},2,{"$f":"CONCATENATE(J3916, \" - \", H3916, \" - \",K3916)","v":"2 - QS178 - Sexual health - Structure - 2"}]
[null,"QS178","Sexual health",2,null,"People identified as being at risk of sexually transmitted infections have a discussion about prevention and testing.","Proportion of people identified as being at risk of STIs who have a discussion about prevention and testing.","Process","QS178 - Sexual health",{"$f":"CONCATENATE(D3917, \" - \", I3917)","v":"2 - QS178 - Sexual health"},1,{"$f":"CONCATENATE(J3917, \" - \", H3917, \" - \",K3917)","v":"2 - QS178 - Sexual health - Process - 1"},"the number in the denominator who have a discussion about prevention and testing.","the number of people identified as being at risk of STIs."]
[null,"QS178","Sexual health",2,null,"People identified as being at risk of sexually transmitted infections have a discussion about prevention and testing.","Coverage of testing for STIs: proportion of people attending the service who are tested for STIs.","Outcome","QS178 - Sexual health","2 - QS178 - Sexual health",1,"2 - QS178 - Sexual health - Outcome - 1"]
[null,"QS178","Sexual health",2,null,"People identified as being at risk of sexually transmitted infections have a discussion about prevention and testing.","New STI diagnoses (excluding chlamydia in people aged under 25) per 100,000 people aged 15 to 64.","Outcome","QS178 - Sexual health","2 - QS178 - Sexual health",2,"2 - QS178 - Sexual health - Outcome - 2"]
[null,"QS178","Sexual health",2,null,"People identified as being at risk of sexually transmitted infections have a discussion about prevention and testing.","Chlamydia detection rate per 100,000 people aged 15 to 24.","Outcome","QS178 - Sexual health","2 - QS178 - Sexual health",3,"2 - QS178 - Sexual health - Outcome - 3"]
[null,"QS178","Sexual health",3,null,"Local authorities provide a range of condom distribution schemes tailored to the needs of their populations.","Evidence of local arrangements to assess the needs of local populations for condom distribution schemes.","Structure","QS178 - Sexual health","3 - QS178 - Sexual health",1,"3 - QS178 - Sexual health - Structure - 1"]
[null,"QS178","Sexual health",3,null,"Local authorities provide a range of condom distribution schemes tailored to the needs of their populations.","Evidence of local arrangements to provide a range of condom distribution schemes tailored to the needs of the population.","Structure","QS178 - Sexual health","3 - QS178 - Sexual health",2,"3 - QS178 - Sexual health - Structure - 2"]
[null,"QS178","Sexual health",3,null,"Local authorities provide a range of condom distribution schemes tailored to the needs of their populations.","Evidence of local arrangements to publicise condom distribution schemes to people most at risk of getting an STI.","Structure","QS178 - Sexual health","3 - QS178 - Sexual health",3,"3 - QS178 - Sexual health - Structure - 3"]
[null,"QS178","Sexual health",3,null,"Local authorities provide a range of condom distribution schemes tailored to the needs of their populations.","Proportion of people who are at risk of STIs who used a condom at last intercourse.","Outcome","QS178 - Sexual health","3 - QS178 - Sexual health",1,"3 - QS178 - Sexual health - Outcome - 1"]
[null,"QS178","Sexual health",3,null,"Local authorities provide a range of condom distribution schemes tailored to the needs of their populations.","New STI diagnoses (excluding chlamydia in people aged under 25) per 100,000 people aged 15 to 64.","Outcome","QS178 - Sexual health","3 - QS178 - Sexual health",2,"3 - QS178 - Sexual health - Outcome - 2"]
[null,"QS178","Sexual health",3,null,"Local authorities provide a range of condom distribution schemes tailored to the needs of their populations.","Chlamydia detection rate per 100,000 people aged 15 to 24.","Outcome","QS178 - Sexual health","3 - QS178 - Sexual health",3,"3 - QS178 - Sexual health - Outcome - 3"]
[null,"QS178","Sexual health",4,null,"People contacting a sexual health service about a sexually transmitted infection are offered an appointment that is within 2 working days.","Evidence of local arrangements to ensure that people contacting a sexual health service about an STI are offered an appointment that is within 2 working days.","Structure",{"$f":"CONCATENATE(B3927, \" - \", C3927)","v":"QS178 - Sexual health"},{"$f":"CONCATENATE(D3927, \" - \", I3927)","v":"4 - QS178 - Sexual health"},{"$f":"IF(AND(B3927=B3926, D3927=D3926, H3927=H3926)=TRUE, K3926+1, 1)","v":1},{"$f":"CONCATENATE(J3927, \" - \", H3927, \" - \",K3927)","v":"4 - QS178 - Sexual health - Structure - 1"}]
[null,"QS178","Sexual health",4,null,"People contacting a sexual health service about a sexually transmitted infection are offered an appointment that is within 2 working days.","Proportion of contacts with a sexual health service about an STI in which an appointment that is within 2 working days, was offered.","Process","QS178 - Sexual health","4 - QS178 - Sexual health",1,"4 - QS178 - Sexual health - Process - 1","the number in the denominator in which an appointment that is within 2 working days, was offered.","the number of contacts with a sexual health service about an STI."]
[null,"QS178","Sexual health",4,null,"People contacting a sexual health service about a sexually transmitted infection are offered an appointment that is within 2 working days.","Proportion of attendances at a sexual health service walk-in clinic in which the waiting time was less than 2 hours.","Process","QS178 - Sexual health","4 - QS178 - Sexual health",2,"4 - QS178 - Sexual health - Process - 2","the number in the denominator in which the waiting time was less than 2 hours.","the number of attendances at a sexual health service walk-in clinic."]
[null,"QS178","Sexual health",4,null,"People contacting a sexual health service about a sexually transmitted infection are offered an appointment that is within 2 working days.","Satisfaction with access to services among people who contact sexual health services about an STI.","Outcome","QS178 - Sexual health","4 - QS178 - Sexual health",1,"4 - QS178 - Sexual health - Outcome - 1"]
[null,"QS178","Sexual health",4,null,"People contacting a sexual health service about a sexually transmitted infection are offered an appointment that is within 2 working days.","Coverage of testing for STIs: proportion of people attending the service who are tested for STIs.","Outcome","QS178 - Sexual health","4 - QS178 - Sexual health",2,"4 - QS178 - Sexual health - Outcome - 2"]
[null,"QS178","Sexual health",4,null,"People contacting a sexual health service about a sexually transmitted infection are offered an appointment that is within 2 working days.","New STI diagnoses (excluding chlamydia in people aged under 25) per 100,000 people aged 15 to 64.","Outcome","QS178 - Sexual health","4 - QS178 - Sexual health",3,"4 - QS178 - Sexual health - Outcome - 3"]
[null,"QS178","Sexual health",4,null,"People contacting a sexual health service about a sexually transmitted infection are offered an appointment that is within 2 working days.","Chlamydia detection rate per 100,000 people aged 15 to 24.","Outcome","QS178 - Sexual health","4 - QS178 - Sexual health",4,"4 - QS178 - Sexual health - Outcome - 4"]
[null,"QS178","Sexual health",5,null,"Men who have sex with men have repeat testing every 3 months if they are at increased risk of sexually transmitted infections.","Evidence of local arrangements to provide STI repeat testing every 3 months for men who have sex with men and are at increased risk of STIs.","Structure",{"$f":"CONCATENATE(B3934, \" - \", C3934)","v":"QS178 - Sexual health"},{"$f":"CONCATENATE(D3934, \" - \", I3934)","v":"5 - QS178 - Sexual health"},{"$f":"IF(AND(B3934=B3933, D3934=D3933, H3934=H3933)=TRUE, K3933+1, 1)","v":1},{"$f":"CONCATENATE(J3934, \" - \", H3934, \" - \",K3934)","v":"5 - QS178 - Sexual health - Structure - 1"}]
[null,"QS178","Sexual health",5,null,"Men who have sex with men have repeat testing every 3 months if they are at increased risk of sexually transmitted infections.","Evidence of local arrangements to encourage men who have sex with men to have repeat STI tests every 3 months if they are at increased risk of STIs.","Structure","QS178 - Sexual health","5 - QS178 - Sexual health",2,"5 - QS178 - Sexual health - Structure - 2"]
[null,"QS178","Sexual health",5,null,"Men who have sex with men have repeat testing every 3 months if they are at increased risk of sexually transmitted infections.","Proportion of men who have sex with men and are at increased risk of STIs who were sent a reminder to have repeat testing for STIs within the past 3 months.","Process","QS178 - Sexual health","5 - QS178 - Sexual health",1,"5 - QS178 - Sexual health - Process - 1","the number in the denominator who were sent a reminder to have repeat testing for STIs within the past 3 months.","the number of men who have sex with men and are at increased risk of STIs."]
[null,"QS178","Sexual health",5,null,"Men who have sex with men have repeat testing every 3 months if they are at increased risk of sexually transmitted infections.","Proportion of men who have sex with men and are at increased risk of STIs who were tested for STIs within the past 3 months.","Process","QS178 - Sexual health","5 - QS178 - Sexual health",2,"5 - QS178 - Sexual health - Process - 2","the number in the denominator who were tested for STIs within the past 3 months.","the number of men who have sex with men and are at increased risk of STIs."]
[null,"QS178","Sexual health",5,null,"Men who have sex with men have repeat testing every 3 months if they are at increased risk of sexually transmitted infections.","Coverage of testing for STIs: proportion of people attending the service who are tested for STIs.","Outcome","QS178 - Sexual health","5 - QS178 - Sexual health",1,"5 - QS178 - Sexual health - Outcome - 1"]
[null,"QS178","Sexual health",5,null,"Men who have sex with men have repeat testing every 3 months if they are at increased risk of sexually transmitted infections.","New STI diagnoses (excluding chlamydia in people aged under 25) per 100,000 people aged 15 to 64.","Outcome","QS178 - Sexual health","5 - QS178 - Sexual health",2,"5 - QS178 - Sexual health - Outcome - 2"]
[null,"QS178","Sexual health",5,null,"Men who have sex with men have repeat testing every 3 months if they are at increased risk of sexually transmitted infections.","Chlamydia detection rate per 100,000 people aged 15 to 24.","Outcome","QS178 - Sexual health","5 - QS178 - Sexual health",3,"5 - QS178 - Sexual health - Outcome - 3"]
[null,"QS178","Sexual health",6,null,"People diagnosed with a sexually transmitted infection are supported to notify their partners.","Evidence of local arrangements for partner notification to be discussed with people diagnosed with STIs.","Structure","QS178 - Sexual health","6 - QS178 - Sexual health",1,"6 - QS178 - Sexual health - Structure - 1"]
[null,"QS178","Sexual health",6,null,"People diagnosed with a sexually transmitted infection are supported to notify their partners.","Evidence of local arrangements for partner notification support to be provided to people diagnosed with STIs.","Structure","QS178 - Sexual health","6 - QS178 - Sexual health",2,"6 - QS178 - Sexual health - Structure - 2"]
[null,"QS178","Sexual health",6,null,"People diagnosed with a sexually transmitted infection are supported to notify their partners.","Proportion of people diagnosed with an STI who have partner notification initiated.","Process",{"$f":"CONCATENATE(B3943, \" - \", C3943)","v":"QS178 - Sexual health"},{"$f":"CONCATENATE(D3943, \" - \", I3943)","v":"6 - QS178 - Sexual health"},{"$f":"IF(AND(B3943=B3942, D3943=D3942, H3943=H3942)=TRUE, K3942+1, 1)","v":1},{"$f":"CONCATENATE(J3943, \" - \", H3943, \" - \",K3943)","v":"6 - QS178 - Sexual health - Process - 1"},"the number in the denominator who have partner notification initiated.","the number of people diagnosed with an STI."]
[null,"QS178","Sexual health",6,null,"People diagnosed with a sexually transmitted infection are supported to notify their partners.","Coverage of testing for STIs: proportion of people attending the service who are tested for STIs.","Outcome","QS178 - Sexual health","6 - QS178 - Sexual health",1,"6 - QS178 - Sexual health - Outcome - 1"]
[null,"QS178","Sexual health",6,null,"People diagnosed with a sexually transmitted infection are supported to notify their partners.","Number of people presenting as a partner of an index case diagnosed with an STI.","Outcome","QS178 - Sexual health","6 - QS178 - Sexual health",2,"6 - QS178 - Sexual health - Outcome - 2"]
[null,"QS179","Child abuse and neglect",1,null,"Children and young people who display marked changes in behaviour or emotional state are encouraged to talk about their wellbeing.","Evidence of local arrangements to ensure that people whose work brings them into contact with children or young people are trained to recognise alerting features for abuse and neglect.","Structure","QS179 - Child abuse and neglect","1 - QS179 - Child abuse and neglect",1,"1 - QS179 - Child abuse and neglect - Structure - 1"]
[null,"QS179","Child abuse and neglect",1,null,"Children and young people who display marked changes in behaviour or emotional state are encouraged to talk about their wellbeing.","Evidence of local arrangements to ensure that people whose work brings them into contact with children or young people are trained to respond to child abuse and neglect in line with local safeguarding procedures.","Structure","QS179 - Child abuse and neglect","1 - QS179 - Child abuse and neglect",2,"1 - QS179 - Child abuse and neglect - Structure - 2"]
[null,"QS179","Child abuse and neglect",1,null,"Children and young people who display marked changes in behaviour or emotional state are encouraged to talk about their wellbeing.","Evidence of local arrangements to ensure that there is a clear referral pathway to local authority children's social care, to be followed by anyone who has concerns about child abuse and neglect.","Structure","QS179 - Child abuse and neglect","1 - QS179 - Child abuse and neglect",3,"1 - QS179 - Child abuse and neglect - Structure - 3"]
[null,"QS179","Child abuse and neglect",1,null,"Children and young people who display marked changes in behaviour or emotional state are encouraged to talk about their wellbeing.","Number of children in need because of abuse or neglect.","Outcome","QS179 - Child abuse and neglect","1 - QS179 - Child abuse and neglect",1,{"$f":"CONCATENATE(J3949, \" - \", H3949, \" - \",K3949)","v":"1 - QS179 - Child abuse and neglect - Outcome - 1"}]
[null,"QS179","Child abuse and neglect",1,null,"Children and young people who display marked changes in behaviour or emotional state are encouraged to talk about their wellbeing.","Number of children who were the subject of a child protection plan.","Outcome","QS179 - Child abuse and neglect","1 - QS179 - Child abuse and neglect",2,{"$f":"CONCATENATE(J3950, \" - \", H3950, \" - \",K3950)","v":"1 - QS179 - Child abuse and neglect - Outcome - 2"}]
[null,"QS179","Child abuse and neglect",2,null,"Children and young people who have experienced abuse or neglect receive support from a consistent group of practitioners.","Evidence of local arrangements to ensure that children and young people who have experienced abuse or neglect receive support from a consistent group of practitioners.","Structure","QS179 - Child abuse and neglect","2 - QS179 - Child abuse and neglect",1,"2 - QS179 - Child abuse and neglect - Structure - 1"]
[null,"QS179","Child abuse and neglect",2,null,"Children and young people who have experienced abuse or neglect receive support from a consistent group of practitioners.","Evidence of local arrangements to ensure that practitioners supporting children and young people who have experienced abuse or neglect work closely with other agencies involved in supporting the children and young people and their families.","Structure","QS179 - Child abuse and neglect","2 - QS179 - Child abuse and neglect",2,"2 - QS179 - Child abuse and neglect - Structure - 2"]
[null,"QS179","Child abuse and neglect",2,null,"Children and young people who have experienced abuse or neglect receive support from a consistent group of practitioners.","Proportion of children and young people supported by social workers because of their experience of abuse or neglect who had a change of social worker in the past 12 months.","Process","QS179 - Child abuse and neglect","2 - QS179 - Child abuse and neglect",1,"2 - QS179 - Child abuse and neglect - Process - 1","the number in the denominator who had a change of social worker in the past 12 months.","the number of children and young people supported by a social worker because of their experience of abuse or neglect."]
[null,"QS179","Child abuse and neglect",2,null,"Children and young people who have experienced abuse or neglect receive support from a consistent group of practitioners.","Proportion of children and young people supported by mental health practitioners because of their experience of abuse or neglect who had a change of practitioner in the past 12 months.","Process","QS179 - Child abuse and neglect","2 - QS179 - Child abuse and neglect",2,"2 - QS179 - Child abuse and neglect - Process - 2","the number in the denominator who had a change of practitioner in the past 12 months.","the number of children and young people supported by a mental health practitioner because of their experience of abuse or neglect."]
[null,"QS179","Child abuse and neglect",2,null,"Children and young people who have experienced abuse or neglect receive support from a consistent group of practitioners.","Experience of care and support received by children and young people who have experienced abuse or neglect.","Outcome","QS179 - Child abuse and neglect","2 - QS179 - Child abuse and neglect",1,"2 - QS179 - Child abuse and neglect - Outcome - 1"]
[null,"QS179","Child abuse and neglect",3,null,"Children and young people who have experienced abuse or neglect have their words accurately represented in notes summarising their conversations with practitioners.","Evidence of local arrangements to ensure that children and young people who have experienced abuse or neglect have their words accurately represented in notes summarising their conversations with the practitioners.","Structure","QS179 - Child abuse and neglect","3 - QS179 - Child abuse and neglect",1,"3 - QS179 - Child abuse and neglect - Structure - 1"]
[null,"QS179","Child abuse and neglect",3,null,"Children and young people who have experienced abuse or neglect have their words accurately represented in notes summarising their conversations with practitioners.","Evidence of local arrangements to ensure that, when appropriate, children and young people have an opportunity to review what the practitioner noted.","Structure","QS179 - Child abuse and neglect","3 - QS179 - Child abuse and neglect",2,"3 - QS179 - Child abuse and neglect - Structure - 2"]
[null,"QS179","Child abuse and neglect",3,null,"Children and young people who have experienced abuse or neglect have their words accurately represented in notes summarising their conversations with practitioners.","Children and young people's experience of working with health and social care practitioners.","Outcome","QS179 - Child abuse and neglect","3 - QS179 - Child abuse and neglect",1,"3 - QS179 - Child abuse and neglect - Outcome - 1"]
[null,"QS179","Child abuse and neglect",3,null,"Children and young people who have experienced abuse or neglect have their words accurately represented in notes summarising their conversations with practitioners.","Engagement with services among children and young people who have experienced abuse or neglect.","Outcome","QS179 - Child abuse and neglect","3 - QS179 - Child abuse and neglect",2,"3 - QS179 - Child abuse and neglect - Outcome - 2"]
[null,"QS179","Child abuse and neglect",3,null,"Children and young people who have experienced abuse or neglect have their words accurately represented in notes summarising their conversations with practitioners.","Health and wellbeing of children and young people who have experienced abuse or neglect.","Outcome","QS179 - Child abuse and neglect","3 - QS179 - Child abuse and neglect",3,"3 - QS179 - Child abuse and neglect - Outcome - 3"]
[null,"QS179","Child abuse and neglect",4,null,"Children and young people who have experienced abuse or neglect agree with practitioners how they will communicate with each other.","Evidence of local arrangements to ensure that practitioners agree with children and young people who have experienced abuse or neglect how they will communicate with each other.","Structure","QS179 - Child abuse and neglect","4 - QS179 - Child abuse and neglect",1,"4 - QS179 - Child abuse and neglect - Structure - 1"]
[null,"QS179","Child abuse and neglect",4,null,"Children and young people who have experienced abuse or neglect agree with practitioners how they will communicate with each other.","Proportion of children and young people who have experienced abuse or neglect whose case file contains a record of agreed methods of communication with practitioners.","Process","QS179 - Child abuse and neglect","4 - QS179 - Child abuse and neglect",1,"4 - QS179 - Child abuse and neglect - Process - 1","the number in the denominator whose case file contains a record of agreed methods of communication with practitioners.","the number of children and young people who have experienced abuse or neglect."]
[null,"QS179","Child abuse and neglect",4,null,"Children and young people who have experienced abuse or neglect agree with practitioners how they will communicate with each other.","Engagement with services among children and young people who have experienced abuse or neglect.","Outcome","QS179 - Child abuse and neglect","4 - QS179 - Child abuse and neglect",1,"4 - QS179 - Child abuse and neglect - Outcome - 1"]
[null,"QS179","Child abuse and neglect",4,null,"Children and young people who have experienced abuse or neglect agree with practitioners how they will communicate with each other.","Satisfaction with services among children and young people who have experienced abuse or neglect.","Outcome",{"$f":"CONCATENATE(B3964, \" - \", C3964)","v":"QS179 - Child abuse and neglect"},{"$f":"CONCATENATE(D3964, \" - \", I3964)","v":"4 - QS179 - Child abuse and neglect"},{"$f":"IF(AND(B3964=B3963, D3964=D3963, H3964=H3963)=TRUE, K3963+1, 1)","v":2},{"$f":"CONCATENATE(J3964, \" - \", H3964, \" - \",K3964)","v":"4 - QS179 - Child abuse and neglect - Outcome - 2"}]
[null,"QS179","Child abuse and neglect",4,null,"Children and young people who have experienced abuse or neglect agree with practitioners how they will communicate with each other.","Health and wellbeing of children and young people who have experienced abuse or neglect.","Outcome","QS179 - Child abuse and neglect","4 - QS179 - Child abuse and neglect",3,"4 - QS179 - Child abuse and neglect - Outcome - 3"]
[null,"QS179","Child abuse and neglect",5,null,"Children and young people who have experienced abuse or neglect are offered therapeutic interventions based on a detailed assessment of therapeutic needs.","Evidence of local arrangements to ensure that children and young people who have experienced abuse or neglect have a detailed assessment of therapeutic needs.","Structure","QS179 - Child abuse and neglect","5 - QS179 - Child abuse and neglect",1,"5 - QS179 - Child abuse and neglect - Structure - 1"]
[null,"QS179","Child abuse and neglect",5,null,"Children and young people who have experienced abuse or neglect are offered therapeutic interventions based on a detailed assessment of therapeutic needs.","Evidence of local arrangements to ensure that children and young people who have experienced abuse or neglect are offered therapeutic interventions based on a detailed assessment of therapeutic need.","Structure","QS179 - Child abuse and neglect","5 - QS179 - Child abuse and neglect",2,"5 - QS179 - Child abuse and neglect - Structure - 2"]
[null,"QS179","Child abuse and neglect",5,null,"Children and young people who have experienced abuse or neglect are offered therapeutic interventions based on a detailed assessment of therapeutic needs.","Proportion of children and young people who have experienced abuse or neglect who had a detailed assessment of therapeutic needs.","Process","QS179 - Child abuse and neglect","5 - QS179 - Child abuse and neglect",1,"5 - QS179 - Child abuse and neglect - Process - 1","the number in the denominator who had a detailed assessment of therapeutic needs.","the number of children and young people who have experienced abuse or neglect."]
[null,"QS179","Child abuse and neglect",5,null,"Children and young people who have experienced abuse or neglect are offered therapeutic interventions based on a detailed assessment of therapeutic needs.","Proportion of children and young people who have experienced abuse or neglect who were offered therapeutic interventions based on a detailed assessment of therapeutic needs.","Process","QS179 - Child abuse and neglect","5 - QS179 - Child abuse and neglect",2,"5 - QS179 - Child abuse and neglect - Process - 2","the number in the denominator offered therapeutic interventions based on identified therapeutic needs.","the number of children and young people who have experienced abuse or neglect and had a detailed assessment of therapeutic needs."]
[null,"QS179","Child abuse and neglect",5,null,"Children and young people who have experienced abuse or neglect are offered therapeutic interventions based on a detailed assessment of therapeutic needs.","Proportion of children and young people who received a therapeutic intervention after experiencing abuse or neglect who had a review of how effective the therapeutic intervention was.","Process","QS179 - Child abuse and neglect","5 - QS179 - Child abuse and neglect",3,"5 - QS179 - Child abuse and neglect - Process - 3","the number in the denominator who had a review of how effective the therapeutic intervention was.","the number of children and young people who received a therapeutic intervention after experiencing abuse or neglect."]
[null,"QS179","Child abuse and neglect",5,null,"Children and young people who have experienced abuse or neglect are offered therapeutic interventions based on a detailed assessment of therapeutic needs.","Acceptability of therapeutic interventions offered to children and young people who experienced abuse and neglect.","Outcome","QS179 - Child abuse and neglect","5 - QS179 - Child abuse and neglect",1,"5 - QS179 - Child abuse and neglect - Outcome - 1"]
[null,"QS179","Child abuse and neglect",5,null,"Children and young people who have experienced abuse or neglect are offered therapeutic interventions based on a detailed assessment of therapeutic needs.","Health and wellbeing of children and young people who experienced abuse or neglect.","Outcome","QS179 - Child abuse and neglect","5 - QS179 - Child abuse and neglect",2,"5 - QS179 - Child abuse and neglect - Outcome - 2"]
[null,"QS180","Serious eye disorders",1,null,"Adults with signs of possible glaucoma or related conditions on a routine sight test have additional tests before they are referred for a diagnosis.","Evidence of the availability of equipment for performing the additional tests needed before referral for further investigation and diagnosis of COAG or related conditions.","Structure","QS180 - Serious eye disorders","1 - QS180 - Serious eye disorders",1,"1 - QS180 - Serious eye disorders - Structure - 1"]
[null,"QS180","Serious eye disorders",1,null,"Adults with signs of possible glaucoma or related conditions on a routine sight test have additional tests before they are referred for a diagnosis.","Evidence of the availability of staff trained to perform the additional tests needed before referral for further investigation and diagnosis of COAG or related conditions.","Structure","QS180 - Serious eye disorders","1 - QS180 - Serious eye disorders",2,"1 - QS180 - Serious eye disorders - Structure - 2"]
[null,"QS180","Serious eye disorders",1,null,"Adults with signs of possible glaucoma or related conditions on a routine sight test have additional tests before they are referred for a diagnosis.","Proportion of adults with signs of possible glaucoma on a routine sight test who had additional tests before referral for further investigation and diagnosis of COAG or related conditions.","Process",{"$f":"CONCATENATE(B3975, \" - \", C3975)","v":"QS180 - Serious eye disorders"},{"$f":"CONCATENATE(D3975, \" - \", I3975)","v":"1 - QS180 - Serious eye disorders"},{"$f":"IF(AND(B3975=B3974, D3975=D3974, H3975=H3974)=TRUE, K3974+1, 1)","v":1},{"$f":"CONCATENATE(J3975, \" - \", H3975, \" - \",K3975)","v":"1 - QS180 - Serious eye disorders - Process - 1"},"the number in the denominator who had additional tests before referral for further investigation and diagnosis of COAG or related conditions.","the number of adults with signs of possible glaucoma on a routine sight test referred for further investigation and diagnosis of COAG or related conditions."]
[null,"QS180","Serious eye disorders",1,null,"Adults with signs of possible glaucoma or related conditions on a routine sight test have additional tests before they are referred for a diagnosis.","Rates of false-positive referrals for further investigation and diagnosis of COAG or related conditions.","Outcome","QS180 - Serious eye disorders","1 - QS180 - Serious eye disorders",1,"1 - QS180 - Serious eye disorders - Outcome - 1"]
[null,"QS180","Serious eye disorders",2,null,"Adults with cataracts are not refused surgery based on visual acuity alone.","Evidence of local agreements to include vision difficulties affecting quality of life in the criteria for referral and access to cataract surgery. The same criteria should be used for first- and second-eye cataract surgery.","Structure","QS180 - Serious eye disorders","2 - QS180 - Serious eye disorders",1,"2 - QS180 - Serious eye disorders - Structure - 1"]
[null,"QS180","Serious eye disorders",2,null,"Adults with cataracts are not refused surgery based on visual acuity alone.","Proportion of presentations of cataract where the person has a discussion about how their vision affects their quality of life.","Process","QS180 - Serious eye disorders","2 - QS180 - Serious eye disorders",1,"2 - QS180 - Serious eye disorders - Process - 1","the number in the denominator where the person has a discussion about how their vision affects their quality of life.","the number of presentations of cataract."]
[null,"QS180","Serious eye disorders",2,null,"Adults with cataracts are not refused surgery based on visual acuity alone.","Proportion of presentations of cataract that are refused referral for surgery based on visual acuity alone.","Process","QS180 - Serious eye disorders","2 - QS180 - Serious eye disorders",2,"2 - QS180 - Serious eye disorders - Process - 2","the number in the denominator that are refused referral for surgery based on visual acuity alone.","the number of presentations of cataract."]
[null,"QS180","Serious eye disorders",2,null,"Adults with cataracts are not refused surgery based on visual acuity alone.","Proportion of referrals for cataract surgery that are not accepted based on visual acuity alone.","Process","QS180 - Serious eye disorders","2 - QS180 - Serious eye disorders",3,"2 - QS180 - Serious eye disorders - Process - 3","the number in the denominator that are not accepted based on visual acuity alone.","the number of referrals for cataract surgery."]
[null,"QS180","Serious eye disorders",2,null,"Adults with cataracts are not refused surgery based on visual acuity alone.","Health-related quality of life for adults with cataracts.","Outcome",{"$f":"CONCATENATE(B3981, \" - \", C3981)","v":"QS180 - Serious eye disorders"},{"$f":"CONCATENATE(D3981, \" - \", I3981)","v":"2 - QS180 - Serious eye disorders"},{"$f":"IF(AND(B3981=B3980, D3981=D3980, H3981=H3980)=TRUE, K3980+1, 1)","v":1},{"$f":"CONCATENATE(J3981, \" - \", H3981, \" - \",K3981)","v":"2 - QS180 - Serious eye disorders - Outcome - 1"}]
[null,"QS180","Serious eye disorders",3,null,"Adults with late age-related macular degeneration (AMD) (wet active) start treatment within 14 days of referral to the macular service.","Evidence of local arrangements and clinical protocols to ensure that adults with late AMD (wet active) start treatment within 14 days of referral to the macular service.","Structure","QS180 - Serious eye disorders","3 - QS180 - Serious eye disorders",1,"3 - QS180 - Serious eye disorders - Structure - 1"]
[null,"QS180","Serious eye disorders",3,null,"Adults with late age-related macular degeneration (AMD) (wet active) start treatment within 14 days of referral to the macular service.","Proportion of adults with late AMD (wet active) who start treatment within 14 days of referral to the macular service.","Process","QS180 - Serious eye disorders","3 - QS180 - Serious eye disorders",1,"3 - QS180 - Serious eye disorders - Process - 1","the number in the denominator who start treatment within 14 days.","the number of adults with late AMD (wet active) referred to the macular service."]
[null,"QS180","Serious eye disorders",3,null,"Adults with late age-related macular degeneration (AMD) (wet active) start treatment within 14 days of referral to the macular service.","Loss of vision (changes to visual acuity) of people with late AMD (wet active).","Outcome","QS180 - Serious eye disorders","3 - QS180 - Serious eye disorders",1,"3 - QS180 - Serious eye disorders - Outcome - 1"]
[null,"QS180","Serious eye disorders",3,null,"Adults with late age-related macular degeneration (AMD) (wet active) start treatment within 14 days of referral to the macular service.","Health-related quality of life of adults with late AMD (wet active).","Outcome","QS180 - Serious eye disorders","3 - QS180 - Serious eye disorders",2,"3 - QS180 - Serious eye disorders - Outcome - 2"]
[null,"QS180","Serious eye disorders",4,null,"Adults with late age-related macular degeneration (AMD) (wet active) have monitoring for both eyes.","Evidence of local arrangements to ensure that adults with late AMD (wet active) have monitoring for both eyes.","Structure","QS180 - Serious eye disorders","4 - QS180 - Serious eye disorders",1,"4 - QS180 - Serious eye disorders - Structure - 1"]
[null,"QS180","Serious eye disorders",4,null,"Adults with late age-related macular degeneration (AMD) (wet active) have monitoring for both eyes.","Proportion of adults with late AMD (wet active) who have a monitoring appointment scheduled.","Process","QS180 - Serious eye disorders","4 - QS180 - Serious eye disorders",1,"4 - QS180 - Serious eye disorders - Process - 1","the number in the denominator who have a monitoring appointment scheduled.","the number of adults with late AMD (wet active)."]
[null,"QS180","Serious eye disorders",4,null,"Adults with late age-related macular degeneration (AMD) (wet active) have monitoring for both eyes.","Proportion of scheduled monitoring appointments for adults with late AMD (wet active) that are cancelled or delayed by the hospital.","Process","QS180 - Serious eye disorders","4 - QS180 - Serious eye disorders",2,"4 - QS180 - Serious eye disorders - Process - 2","the number in the denominator that are cancelled or delayed by the hospital.","the number of scheduled monitoring appointments for adults with late AMD (wet active)."]
[null,"QS180","Serious eye disorders",4,null,"Adults with late age-related macular degeneration (AMD) (wet active) have monitoring for both eyes.","Proportion of hospital appointments for adults with late AMD (wet active) that occur within 25% of their intended monitoring period, including rescheduling of hospital cancellations and non-attendance by adults with late AMD (wet active).","Process","QS180 - Serious eye disorders","4 - QS180 - Serious eye disorders",3,"4 - QS180 - Serious eye disorders - Process - 3","the number in the denominator that occur within 25% of their intended monitoring period.","the number of monitoring appointments scheduled, including those rescheduled after hospital-initiated cancellation and non-attendance by adults with late AMD (wet active)."]
[null,"QS180","Serious eye disorders",4,null,"Adults with late age-related macular degeneration (AMD) (wet active) have monitoring for both eyes.","Loss of vision (changes to visual acuity) in adults with late AMD (wet active).","Outcome","QS180 - Serious eye disorders","4 - QS180 - Serious eye disorders",1,"4 - QS180 - Serious eye disorders - Outcome - 1"]
[null,"QS180","Serious eye disorders",5,null,"Adults with chronic open angle glaucoma (COAG) or related conditions have reassessment at specific intervals.","Evidence of local arrangements to ensure that adults with COAG or related conditions have reassessment appointments scheduled at specific intervals, according to their risk of conversion to COAG or progression to sight loss.","Structure","QS180 - Serious eye disorders","5 - QS180 - Serious eye disorders",1,"5 - QS180 - Serious eye disorders - Structure - 1"]
[null,"QS180","Serious eye disorders",5,null,"Adults with chronic open angle glaucoma (COAG) or related conditions have reassessment at specific intervals.","Proportion of adults with COAG or related conditions who have reassessment at specific intervals.","Process","QS180 - Serious eye disorders","5 - QS180 - Serious eye disorders",1,"5 - QS180 - Serious eye disorders - Process - 1","the number in the denominator who have reassessment at specific intervals.","the number of adults with COAG or related conditions."]
[null,"QS180","Serious eye disorders",5,null,"Adults with chronic open angle glaucoma (COAG) or related conditions have reassessment at specific intervals.","Proportion of scheduled reassessment appointments for COAG or related conditions that are cancelled or delayed by the service provider.","Process","QS180 - Serious eye disorders","5 - QS180 - Serious eye disorders",2,"5 - QS180 - Serious eye disorders - Process - 2","the number in the denominator that are cancelled or delayed by the service provider.","the number of scheduled reassessment appointments for COAG or related conditions."]
[null,"QS180","Serious eye disorders",5,null,"Adults with chronic open angle glaucoma (COAG) or related conditions have reassessment at specific intervals.","Proportion of hospital appointments for adults with COAG or related conditions that occur within 25% of their intended reassessment period, including rescheduling of hospital cancellations and non-attendance by adults with COAG or related conditions.","Process",{"$f":"CONCATENATE(B3994, \" - \", C3994)","v":"QS180 - Serious eye disorders"},{"$f":"CONCATENATE(D3994, \" - \", I3994)","v":"5 - QS180 - Serious eye disorders"},{"$f":"IF(AND(B3994=B3993, D3994=D3993, H3994=H3993)=TRUE, K3993+1, 1)","v":3},{"$f":"CONCATENATE(J3994, \" - \", H3994, \" - \",K3994)","v":"5 - QS180 - Serious eye disorders - Process - 3"},"the number in the denominator that occur within 25% of their intended reassessment period.","the number of reassessment appointments scheduled, including those rescheduled after hospital-initiated cancellation and non-attendance by adults with COAG or related conditions."]
[null,"QS180","Serious eye disorders",5,null,"Adults with chronic open angle glaucoma (COAG) or related conditions have reassessment at specific intervals.","Loss of vision for adults with COAG or related conditions (visual field loss, changes to visual acuity).","Outcome","QS180 - Serious eye disorders","5 - QS180 - Serious eye disorders",1,"5 - QS180 - Serious eye disorders - Outcome - 1"]
[null,"QS180","Serious eye disorders",5,null,"Adults with chronic open angle glaucoma (COAG) or related conditions have reassessment at specific intervals.","Health-related quality of life for adults with COAG or related conditions.","Outcome","QS180 - Serious eye disorders","5 - QS180 - Serious eye disorders",2,"5 - QS180 - Serious eye disorders - Outcome - 2"]
[null,"QS180","Serious eye disorders",6,null,"Adults with serious eye disorders are given a certificate of vision impairment (CVI) as soon as they are eligible.","Evidence of local arrangements to ensure that adults with serious eye disorders are given information about the CVI and those meeting the eligibility criteria are given a certificate.","Structure","QS180 - Serious eye disorders","6 - QS180 - Serious eye disorders",1,"6 - QS180 - Serious eye disorders - Structure - 1"]
[null,"QS180","Serious eye disorders",6,null,"Adults with serious eye disorders are given a certificate of vision impairment (CVI) as soon as they are eligible.","Proportion of adults with serious eye disorders that meet the eligibility criteria for a CVI who are given a CVI.","Process","QS180 - Serious eye disorders","6 - QS180 - Serious eye disorders",1,"6 - QS180 - Serious eye disorders - Process - 1","the number in the denominator who are given a CVI.","the number of adults with serious eye disorders that meet the eligibility criteria for a CVI."]
[null,"QS180","Serious eye disorders",6,null,"Adults with serious eye disorders are given a certificate of vision impairment (CVI) as soon as they are eligible.","Health-related quality of life for adults with serious eye disorders.","Outcome","QS180 - Serious eye disorders","6 - QS180 - Serious eye disorders",1,"6 - QS180 - Serious eye disorders - Outcome - 1"]
[null,"QS181","Air pollution: outdoor air quality and health",1,null,"Local authorities identify in the Local Plan, local transport plan and other key strategies how they will address air pollution, including enabling zero- and low-emission travel and developing buildings and spaces to reduce exposure to air pollution.","Evidence that local authorities identify in the Local Plan, local transport plan and other key strategies how they will address air pollution, including who is responsible for delivering key actions.","Structure","QS181 - Air pollution: outdoor air quality and health","1 - QS181 - Air pollution: outdoor air quality and health",1,"1 - QS181 - Air pollution: outdoor air quality and health - Structure - 1"]
[null,"QS181","Air pollution: outdoor air quality and health",1,null,"Local authorities identify in the Local Plan, local transport plan and other key strategies how they will address air pollution, including enabling zero- and low-emission travel and developing buildings and spaces to reduce exposure to air pollution.","Evidence that local authorities identify in the Local Plan, local transport plan and other key strategies how they will encourage and enable active travel.","Structure","QS181 - Air pollution: outdoor air quality and health","1 - QS181 - Air pollution: outdoor air quality and health",2,"1 - QS181 - Air pollution: outdoor air quality and health - Structure - 2"]
[null,"QS181","Air pollution: outdoor air quality and health",1,null,"Local authorities identify in the Local Plan, local transport plan and other key strategies how they will address air pollution, including enabling zero- and low-emission travel and developing buildings and spaces to reduce exposure to air pollution.","Evidence that local authorities identify in the Local Plan, local transport plan and other key strategies how they will encourage and enable travel by zero- and low-emission vehicles.","Structure",{"$f":"CONCATENATE(B4002, \" - \", C4002)","v":"QS181 - Air pollution: outdoor air quality and health"},{"$f":"CONCATENATE(D4002, \" - \", I4002)","v":"1 - QS181 - Air pollution: outdoor air quality and health"},{"$f":"IF(AND(B4002=B4001, D4002=D4001, H4002=H4001)=TRUE, K4001+1, 1)","v":3},{"$f":"CONCATENATE(J4002, \" - \", H4002, \" - \",K4002)","v":"1 - QS181 - Air pollution: outdoor air quality and health - Structure - 3"}]
[null,"QS181","Air pollution: outdoor air quality and health",1,null,"Local authorities identify in the Local Plan, local transport plan and other key strategies how they will address air pollution, including enabling zero- and low-emission travel and developing buildings and spaces to reduce exposure to air pollution.","Evidence that local authorities identify in the Local Plan, local transport plan and other key strategies how they will develop buildings and spaces to reduce exposure to air pollution.","Structure","QS181 - Air pollution: outdoor air quality and health","1 - QS181 - Air pollution: outdoor air quality and health",4,"1 - QS181 - Air pollution: outdoor air quality and health - Structure - 4"]
[null,"QS181","Air pollution: outdoor air quality and health",1,null,"Local authorities identify in the Local Plan, local transport plan and other key strategies how they will address air pollution, including enabling zero- and low-emission travel and developing buildings and spaces to reduce exposure to air pollution.","Evidence that local authorities identify key actions to address air pollution and monitor progress against them.","Structure","QS181 - Air pollution: outdoor air quality and health","1 - QS181 - Air pollution: outdoor air quality and health",5,"1 - QS181 - Air pollution: outdoor air quality and health - Structure - 5"]
[null,"QS181","Air pollution: outdoor air quality and health",1,null,"Local authorities identify in the Local Plan, local transport plan and other key strategies how they will address air pollution, including enabling zero- and low-emission travel and developing buildings and spaces to reduce exposure to air pollution.","Proportion of journeys made by local residents that are by walking, cycling, public transport or zero- or low-emission vehicles.","Outcome","QS181 - Air pollution: outdoor air quality and health","1 - QS181 - Air pollution: outdoor air quality and health",1,"1 - QS181 - Air pollution: outdoor air quality and health - Outcome - 1"]
[null,"QS181","Air pollution: outdoor air quality and health",1,null,"Local authorities identify in the Local Plan, local transport plan and other key strategies how they will address air pollution, including enabling zero- and low-emission travel and developing buildings and spaces to reduce exposure to air pollution.","Annual and hourly mean concentrations for nitrogen dioxide (NO2).","Outcome","QS181 - Air pollution: outdoor air quality and health","1 - QS181 - Air pollution: outdoor air quality and health",2,"1 - QS181 - Air pollution: outdoor air quality and health - Outcome - 2"]
[null,"QS181","Air pollution: outdoor air quality and health",1,null,"Local authorities identify in the Local Plan, local transport plan and other key strategies how they will address air pollution, including enabling zero- and low-emission travel and developing buildings and spaces to reduce exposure to air pollution.","Annual and daily mean concentrations for particulate matter of 10 micrometres or less in diameter (PM10).","Outcome","QS181 - Air pollution: outdoor air quality and health","1 - QS181 - Air pollution: outdoor air quality and health",3,"1 - QS181 - Air pollution: outdoor air quality and health - Outcome - 3"]
[null,"QS181","Air pollution: outdoor air quality and health",1,null,"Local authorities identify in the Local Plan, local transport plan and other key strategies how they will address air pollution, including enabling zero- and low-emission travel and developing buildings and spaces to reduce exposure to air pollution.","Annual mean concentration for fine particulate matter of 2.5 micrometres or less in diameter (PM2.5).","Outcome","QS181 - Air pollution: outdoor air quality and health","1 - QS181 - Air pollution: outdoor air quality and health",4,"1 - QS181 - Air pollution: outdoor air quality and health - Outcome - 4"]
[null,"QS181","Air pollution: outdoor air quality and health",2,null,"Local planning authorities assess proposals to minimise and mitigate road-traffic-related air pollution in planning applications for major developments.","Evidence of local processes and guidance that ensure planning applications for major developments include proposals to minimise and mitigate road-traffic-related air pollution.","Structure","QS181 - Air pollution: outdoor air quality and health","2 - QS181 - Air pollution: outdoor air quality and health",1,"2 - QS181 - Air pollution: outdoor air quality and health - Structure - 1"]
[null,"QS181","Air pollution: outdoor air quality and health",2,null,"Local planning authorities assess proposals to minimise and mitigate road-traffic-related air pollution in planning applications for major developments.","Evidence of a local framework for assessing proposals to minimise and mitigate road-traffic-related air pollution in planning applications for major developments.","Structure","QS181 - Air pollution: outdoor air quality and health","2 - QS181 - Air pollution: outdoor air quality and health",2,"2 - QS181 - Air pollution: outdoor air quality and health - Structure - 2"]
[null,"QS181","Air pollution: outdoor air quality and health",2,null,"Local planning authorities assess proposals to minimise and mitigate road-traffic-related air pollution in planning applications for major developments.","Proportion of planning applications for major developments granted permission with conditions or obligations to minimise and mitigate road-traffic-related air pollution.","Process","QS181 - Air pollution: outdoor air quality and health","2 - QS181 - Air pollution: outdoor air quality and health",1,"2 - QS181 - Air pollution: outdoor air quality and health - Process - 1","the number in the denominator with conditions or obligations to minimise and mitigate road-traffic-related air pollution.","the number of planning applications for major developments granted permission."]
[null,"QS181","Air pollution: outdoor air quality and health",2,null,"Local planning authorities assess proposals to minimise and mitigate road-traffic-related air pollution in planning applications for major developments.","Proportion of journeys made by local residents that are by walking, cycling, public transport or zero- or low-emission vehicles.","Outcome","QS181 - Air pollution: outdoor air quality and health","2 - QS181 - Air pollution: outdoor air quality and health",1,"2 - QS181 - Air pollution: outdoor air quality and health - Outcome - 1"]
[null,"QS181","Air pollution: outdoor air quality and health",2,null,"Local planning authorities assess proposals to minimise and mitigate road-traffic-related air pollution in planning applications for major developments.","Annual and hourly mean concentrations for nitrogen dioxide (NO2).","Outcome","QS181 - Air pollution: outdoor air quality and health","2 - QS181 - Air pollution: outdoor air quality and health",2,"2 - QS181 - Air pollution: outdoor air quality and health - Outcome - 2"]
[null,"QS181","Air pollution: outdoor air quality and health",2,null,"Local planning authorities assess proposals to minimise and mitigate road-traffic-related air pollution in planning applications for major developments.","Annual and daily mean concentrations for particulate matter of 10 micrometres or less in diameter (PM10).","Outcome","QS181 - Air pollution: outdoor air quality and health","2 - QS181 - Air pollution: outdoor air quality and health",3,"2 - QS181 - Air pollution: outdoor air quality and health - Outcome - 3"]
[null,"QS181","Air pollution: outdoor air quality and health",2,null,"Local planning authorities assess proposals to minimise and mitigate road-traffic-related air pollution in planning applications for major developments.","Annual mean concentration for fine particulate matter of 2.5 micrometres or less in diameter (PM2.5).","Outcome","QS181 - Air pollution: outdoor air quality and health","2 - QS181 - Air pollution: outdoor air quality and health",4,"2 - QS181 - Air pollution: outdoor air quality and health - Outcome - 4"]
[null,"QS181","Air pollution: outdoor air quality and health",3,null,"Public sector organisations reduce emissions from their vehicle fleets to address air pollution.","Evidence that public sector organisations identify how they will reduce emissions from their vehicle fleets to address air pollution.","Structure","QS181 - Air pollution: outdoor air quality and health","3 - QS181 - Air pollution: outdoor air quality and health",1,"3 - QS181 - Air pollution: outdoor air quality and health - Structure - 1"]
[null,"QS181","Air pollution: outdoor air quality and health",3,null,"Public sector organisations reduce emissions from their vehicle fleets to address air pollution.","Evidence that public sector organisations require commissioned transport or fleet services to reduce emissions from their vehicle fleets to address air pollution.","Structure","QS181 - Air pollution: outdoor air quality and health","3 - QS181 - Air pollution: outdoor air quality and health",2,"3 - QS181 - Air pollution: outdoor air quality and health - Structure - 2"]
[null,"QS181","Air pollution: outdoor air quality and health",3,null,"Public sector organisations reduce emissions from their vehicle fleets to address air pollution.","Proportion of zero- or ultra-low-emission vehicles in public sector vehicle fleets.","Outcome","QS181 - Air pollution: outdoor air quality and health","3 - QS181 - Air pollution: outdoor air quality and health",1,"3 - QS181 - Air pollution: outdoor air quality and health - Outcome - 1"]
[null,"QS181","Air pollution: outdoor air quality and health",3,null,"Public sector organisations reduce emissions from their vehicle fleets to address air pollution.","Overall fuel consumption for public sector vehicle fleets.","Outcome","QS181 - Air pollution: outdoor air quality and health","3 - QS181 - Air pollution: outdoor air quality and health",2,"3 - QS181 - Air pollution: outdoor air quality and health - Outcome - 2"]
[null,"QS181","Air pollution: outdoor air quality and health",4,null,"Children, young people and adults with chronic respiratory or cardiovascular conditions are given advice at routine health appointments on what to do when outdoor air quality is poor.","Evidence that healthcare professionals carrying out routine health appointments with children, young people and adults with chronic respiratory or cardiovascular conditions are aware of the advice they should provide on what to do when outdoor air quality is poor.","Structure","QS181 - Air pollution: outdoor air quality and health","4 - QS181 - Air pollution: outdoor air quality and health",1,"4 - QS181 - Air pollution: outdoor air quality and health - Structure - 1"]
[null,"QS181","Air pollution: outdoor air quality and health",4,null,"Children, young people and adults with chronic respiratory or cardiovascular conditions are given advice at routine health appointments on what to do when outdoor air quality is poor.","Evidence of local processes to ensure that children, young people and adults with chronic respiratory or cardiovascular conditions attending routine health appointments are given advice on what to do when outdoor air quality is poor.","Structure","QS181 - Air pollution: outdoor air quality and health","4 - QS181 - Air pollution: outdoor air quality and health",2,"4 - QS181 - Air pollution: outdoor air quality and health - Structure - 2"]
[null,"QS181","Air pollution: outdoor air quality and health",4,null,"Children, young people and adults with chronic respiratory or cardiovascular conditions are given advice at routine health appointments on what to do when outdoor air quality is poor.","Proportion of children, young people and adults with chronic respiratory or cardiovascular conditions attending a routine health appointment that were given advice on what to do when outdoor air quality is poor.","Process","QS181 - Air pollution: outdoor air quality and health","4 - QS181 - Air pollution: outdoor air quality and health",1,"4 - QS181 - Air pollution: outdoor air quality and health - Process - 1","the number in the denominator that were given advice on what to do when outdoor air quality is poor.","the number of children, young people and adults with chronic respiratory or cardiovascular conditions attending a routine health appointment."]
[null,"QS181","Air pollution: outdoor air quality and health",4,null,"Children, young people and adults with chronic respiratory or cardiovascular conditions are given advice at routine health appointments on what to do when outdoor air quality is poor.","Level of awareness among children, young people and adults with chronic respiratory or cardiovascular conditions on what to do when outdoor air quality is poor.","Outcome","QS181 - Air pollution: outdoor air quality and health","4 - QS181 - Air pollution: outdoor air quality and health",1,"4 - QS181 - Air pollution: outdoor air quality and health - Outcome - 1"]
[null,"QS181","Air pollution: outdoor air quality and health",4,null,"Children, young people and adults with chronic respiratory or cardiovascular conditions are given advice at routine health appointments on what to do when outdoor air quality is poor.","Rate of hospital attendance or admission for respiratory or cardiovascular exacerbations.","Outcome","QS181 - Air pollution: outdoor air quality and health","4 - QS181 - Air pollution: outdoor air quality and health",2,"4 - QS181 - Air pollution: outdoor air quality and health - Outcome - 2"]
[null,"QS182","People’s experience using adult social care services",1,null,"People's personal strengths, preferences, aspirations and needs are discussed when they have a care and support needs assessment.","Evidence of local arrangements to ensure that care and support needs assessments include documented discussion with the person on their strengths, preferences, aspirations and needs.","Structure","QS182 - People’s experience using adult social care services","1 - QS182 - People’s experience using adult social care services",1,"1 - QS182 - People’s experience using adult social care services - Structure - 1"]
[null,"QS182","People’s experience using adult social care services",1,null,"People's personal strengths, preferences, aspirations and needs are discussed when they have a care and support needs assessment.","Evidence of local arrangements to ensure that people who have substantial difficulty with involvement and no appropriate individual to support them, as defined by the Care Act 2014, have enough time with an independent advocate before the care and support needs assessment takes place so that they can prepare for it.","Structure","QS182 - People’s experience using adult social care services","1 - QS182 - People’s experience using adult social care services",2,"1 - QS182 - People’s experience using adult social care services - Structure - 2"]
[null,"QS182","People’s experience using adult social care services",1,null,"People's personal strengths, preferences, aspirations and needs are discussed when they have a care and support needs assessment.","Proportion of care and support needs assessments where a discussion and agreement of the person's strengths, preferences, aspirations and needs is documented.","Process","QS182 - People’s experience using adult social care services","1 - QS182 - People’s experience using adult social care services",1,"1 - QS182 - People’s experience using adult social care services - Process - 1","the number in the denominator where a discussion and agreement of the person's strengths, preferences, aspirations and needs is documented.","the number of care and support needs assessments."]
[null,"QS182","People’s experience using adult social care services",1,null,"People's personal strengths, preferences, aspirations and needs are discussed when they have a care and support needs assessment.","Proportion of care and support needs assessments where people who have substantial difficulty with involvement and no appropriate individual to support them, as defined by the Care Act 2014, have access to an independent advocate.","Process","QS182 - People’s experience using adult social care services","1 - QS182 - People’s experience using adult social care services",2,"1 - QS182 - People’s experience using adult social care services - Process - 2","the number in the denominator where people have access to an independent advocate.","the number of care and support needs assessments where people have substantial difficulty with involvement and no appropriate individual to support them, as defined by the Care Act 2014."]
[null,"QS182","People’s experience using adult social care services",1,null,"People's personal strengths, preferences, aspirations and needs are discussed when they have a care and support needs assessment.","Satisfaction of people with the extent to which the care and support needs assessment promoted their interests and independence.","Outcome","QS182 - People’s experience using adult social care services","1 - QS182 - People’s experience using adult social care services",1,"1 - QS182 - People’s experience using adult social care services - Outcome - 1"]
[null,"QS182","People’s experience using adult social care services",1,null,"People's personal strengths, preferences, aspirations and needs are discussed when they have a care and support needs assessment.","Satisfaction of people using adult social care services with the support they receive to achieve their self-defined outcomes.","Outcome","QS182 - People’s experience using adult social care services","1 - QS182 - People’s experience using adult social care services",2,"1 - QS182 - People’s experience using adult social care services - Outcome - 2"]
[null,"QS182","People’s experience using adult social care services",2,null,"People using adult social care services have as much control as they would like over their personal budget.","Evidence of local arrangements to inform people who have a personal budget for social care services funded by the local council and who are using adult social care services that they have the option to control their budget to buy the services that are important to them.","Structure","QS182 - People’s experience using adult social care services","2 - QS182 - People’s experience using adult social care services",1,"2 - QS182 - People’s experience using adult social care services - Structure - 1"]
[null,"QS182","People’s experience using adult social care services",2,null,"People using adult social care services have as much control as they would like over their personal budget.","Evidence of local arrangements to inform people who have a personal budget for social care services funded by the local council and who are using adult social care services of the different options for managing their budget.","Structure","QS182 - People’s experience using adult social care services","2 - QS182 - People’s experience using adult social care services",2,"2 - QS182 - People’s experience using adult social care services - Structure - 2"]
[null,"QS182","People’s experience using adult social care services",2,null,"People using adult social care services have as much control as they would like over their personal budget.","Evidence of local arrangements for providing accessible information on personal budgets and peer support on using them.","Structure","QS182 - People’s experience using adult social care services","2 - QS182 - People’s experience using adult social care services",3,"2 - QS182 - People’s experience using adult social care services - Structure - 3"]
[null,"QS182","People’s experience using adult social care services",2,null,"People using adult social care services have as much control as they would like over their personal budget.","Proportion of people using adult social care services who have a personal budget for social care services funded by the local council and whose views were included when their support was planned.","Process","QS182 - People’s experience using adult social care services","2 - QS182 - People’s experience using adult social care services",1,"2 - QS182 - People’s experience using adult social care services - Process - 1","the number in the denominator whose views were included during support planning.","the number of people using adult social care services who have a personal budget for social care services funded by the local council.","the number of people using adult social care services who have a personal budget for social care services funded by the local council."]
[null,"QS182","People’s experience using adult social care services",2,null,"People using adult social care services have as much control as they would like over their personal budget.","Satisfaction of people using adult social care services who have a personal budget for social care services funded by the local council with the help they receive to use their budget to choose the support that is the most important to them.","Outcome","QS182 - People’s experience using adult social care services","2 - QS182 - People’s experience using adult social care services",1,"2 - QS182 - People’s experience using adult social care services - Outcome - 1"]
[null,"QS182","People’s experience using adult social care services",3,null,"People using adult social care services have continuity of care and support.","Evidence of local arrangements to ensure that services are available to provide continuity of care and support for people using adult social care services.","Structure","QS182 - People’s experience using adult social care services","3 - QS182 - People’s experience using adult social care services",1,"3 - QS182 - People’s experience using adult social care services - Structure - 1"]
[null,"QS182","People’s experience using adult social care services",3,null,"People using adult social care services have continuity of care and support.","Evidence of local arrangements to ensure a consistent team of care workers for people using adult social care services.","Structure","QS182 - People’s experience using adult social care services","3 - QS182 - People’s experience using adult social care services",2,"3 - QS182 - People’s experience using adult social care services - Structure - 2"]
[null,"QS182","People’s experience using adult social care services",3,null,"People using adult social care services have continuity of care and support.","Total number of care workers providing care to a person using adult social care services.","Process","QS182 - People’s experience using adult social care services","3 - QS182 - People’s experience using adult social care services",1,"3 - QS182 - People’s experience using adult social care services - Process - 1","Local data collection","Local data collection"]
[null,"QS182","People’s experience using adult social care services",3,null,"People using adult social care services have continuity of care and support.","Satisfaction of people using adult social care services with the continuity of their care and support.","Outcome","QS182 - People’s experience using adult social care services","3 - QS182 - People’s experience using adult social care services",1,"3 - QS182 - People’s experience using adult social care services - Outcome - 1"]
[null,"QS182","People’s experience using adult social care services",3,null,"People using adult social care services have continuity of care and support.","Quality of life of people using adult social care services.","Outcome","QS182 - People’s experience using adult social care services","3 - QS182 - People’s experience using adult social care services",2,"3 - QS182 - People’s experience using adult social care services - Outcome - 2"]
[null,"QS182","People’s experience using adult social care services",4,null,"People using adult social care services have their views used to inform service improvement.","Evidence of local arrangements to ask for feedback from people using adult social care services to inform service improvement.","Structure","QS182 - People’s experience using adult social care services","4 - QS182 - People’s experience using adult social care services",1,"4 - QS182 - People’s experience using adult social care services - Structure - 1"]
[null,"QS182","People’s experience using adult social care services",4,null,"People using adult social care services have their views used to inform service improvement.","Evidence of local arrangements to implement the single complaints statement and encourage people using adult social care services to use it.","Structure","QS182 - People’s experience using adult social care services","4 - QS182 - People’s experience using adult social care services",2,"4 - QS182 - People’s experience using adult social care services - Structure - 2"]
[null,"QS182","People’s experience using adult social care services",4,null,"People using adult social care services have their views used to inform service improvement.","Evidence of local arrangements for supporting people using adult social care services to provide feedback on their experience using services.","Structure","QS182 - People’s experience using adult social care services","4 - QS182 - People’s experience using adult social care services",3,"4 - QS182 - People’s experience using adult social care services - Structure - 3"]
[null,"QS182","People’s experience using adult social care services",4,null,"People using adult social care services have their views used to inform service improvement.","Evidence of local arrangements for people who have provided feedback on adult social care services to be informed of improvements made as a result of their input.","Structure","QS182 - People’s experience using adult social care services","4 - QS182 - People’s experience using adult social care services",4,"4 - QS182 - People’s experience using adult social care services - Structure - 4"]
[null,"QS182","People’s experience using adult social care services",4,null,"People using adult social care services have their views used to inform service improvement.","Proportion of people using adult social care services who are asked to provide their opinion of a service.","Process","QS182 - People’s experience using adult social care services","4 - QS182 - People’s experience using adult social care services",1,"4 - QS182 - People’s experience using adult social care services - Process - 1","The number in the denominator who are asked to provide their opinion of a service.","The number of people using adult social care services."]
[null,"QS182","People’s experience using adult social care services",4,null,"People using adult social care services have their views used to inform service improvement.","Improvements to adult social care services which are informed by feedback from people using services.","Outcome","QS182 - People’s experience using adult social care services","4 - QS182 - People’s experience using adult social care services",1,"4 - QS182 - People’s experience using adult social care services - Outcome - 1"]
[null,"QS182","People’s experience using adult social care services",4,null,"People using adult social care services have their views used to inform service improvement.","Satisfaction of people using adult social care services with the way their feedback has been used.","Outcome","QS182 - People’s experience using adult social care services","4 - QS182 - People’s experience using adult social care services",2,"4 - QS182 - People’s experience using adult social care services - Outcome - 2"]
[null,"QS183","Physical activity: encouraging activity in the community",1,null,"Local authorities and healthcare commissioning groups have senior level physical activity champions who are responsible for developing and implementing local strategies, policies and plans.","Evidence that local authorities have a physical activity champion at a senior level.","Structure","QS183 - Physical activity: encouraging activity in the community","1 - QS183 - Physical activity: encouraging activity in the community",1,"1 - QS183 - Physical activity: encouraging activity in the community - Structure - 1"]
[null,"QS183","Physical activity: encouraging activity in the community",1,null,"Local authorities and healthcare commissioning groups have senior level physical activity champions who are responsible for developing and implementing local strategies, policies and plans.","Evidence that healthcare commissioning groups have a physical activity champion at a senior level.","Structure",{"$f":"CONCATENATE(B4049, \" - \", C4049)","v":"QS183 - Physical activity: encouraging activity in the community"},"1 - QS183 - Physical activity: encouraging activity in the community",2,"1 - QS183 - Physical activity: encouraging activity in the community - Structure - 2"]
[null,"QS183","Physical activity: encouraging activity in the community",1,null,"Local authorities and healthcare commissioning groups have senior level physical activity champions who are responsible for developing and implementing local strategies, policies and plans.","Evidence that physical activity champions are responsible for developing and implementing local strategies, policies and plans.","Structure",{"$f":"CONCATENATE(B4050, \" - \", C4050)","v":"QS183 - Physical activity: encouraging activity in the community"},{"$f":"CONCATENATE(D4050, \" - \", I4050)","v":"1 - QS183 - Physical activity: encouraging activity in the community"},{"$f":"IF(AND(B4050=B4049, D4050=D4049, H4050=H4049)=TRUE, K4049+1, 1)","v":3},{"$f":"CONCATENATE(J4050, \" - \", H4050, \" - \",K4050)","v":"1 - QS183 - Physical activity: encouraging activity in the community - Structure - 3"}]
[null,"QS183","Physical activity: encouraging activity in the community",1,null,"Local authorities and healthcare commissioning groups have senior level physical activity champions who are responsible for developing and implementing local strategies, policies and plans.","Evidence that physical activity champions ensure community engagement approaches have been used to develop and review local strategies, policies and plans.","Structure","QS183 - Physical activity: encouraging activity in the community","1 - QS183 - Physical activity: encouraging activity in the community",4,"1 - QS183 - Physical activity: encouraging activity in the community - Structure - 4"]
[null,"QS183","Physical activity: encouraging activity in the community",1,null,"Local authorities and healthcare commissioning groups have senior level physical activity champions who are responsible for developing and implementing local strategies, policies and plans.","Proportion of adults meeting the recommendations in the UK physical activity guidelines.","Outcome","QS183 - Physical activity: encouraging activity in the community","1 - QS183 - Physical activity: encouraging activity in the community",1,"1 - QS183 - Physical activity: encouraging activity in the community - Outcome - 1","The number in the denominator who meet the recommendations in the UK physical activity guidelines.","The number of adults."]
[null,"QS183","Physical activity: encouraging activity in the community",1,null,"Local authorities and healthcare commissioning groups have senior level physical activity champions who are responsible for developing and implementing local strategies, policies and plans.","Proportion of children and young people meeting the recommendations in the UK physical activity guidelines.","Outcome","QS183 - Physical activity: encouraging activity in the community","1 - QS183 - Physical activity: encouraging activity in the community",2,"1 - QS183 - Physical activity: encouraging activity in the community - Outcome - 2","The number in the denominator who meet the recommendations in the UK physical activity guidelines.","The number of children and young people."]
[null,"QS183","Physical activity: encouraging activity in the community",1,null,"Local authorities and healthcare commissioning groups have senior level physical activity champions who are responsible for developing and implementing local strategies, policies and plans.","Percentage of children aged 5 to 16 sufficiently physically active for good health.","Outcome","QS183 - Physical activity: encouraging activity in the community","1 - QS183 - Physical activity: encouraging activity in the community",3,"1 - QS183 - Physical activity: encouraging activity in the community - Outcome - 3"]
[null,"QS183","Physical activity: encouraging activity in the community",1,null,"Local authorities and healthcare commissioning groups have senior level physical activity champions who are responsible for developing and implementing local strategies, policies and plans.","Proportion of adults, children and young people who are physically inactive.","Outcome","QS183 - Physical activity: encouraging activity in the community","1 - QS183 - Physical activity: encouraging activity in the community",4,"1 - QS183 - Physical activity: encouraging activity in the community - Outcome - 4","The number in the denominator who are physically inactive.","The number of adults, children and young people."]
[null,"QS183","Physical activity: encouraging activity in the community",2,null,"Local authorities prioritise pedestrians, cyclists and people who use public transport when developing and maintaining connected travel routes.","Evidence that local authorities prioritise pedestrians, cyclists and people who use public transport when developing and maintaining connected travel routes.","Structure","QS183 - Physical activity: encouraging activity in the community","2 - QS183 - Physical activity: encouraging activity in the community",1,"2 - QS183 - Physical activity: encouraging activity in the community - Structure - 1"]
[null,"QS183","Physical activity: encouraging activity in the community",2,null,"Local authorities prioritise pedestrians, cyclists and people who use public transport when developing and maintaining connected travel routes.","Evidence that local authorities reallocate road space to support physically active modes of transport such as walking and cycling.","Structure","QS183 - Physical activity: encouraging activity in the community","2 - QS183 - Physical activity: encouraging activity in the community",2,"2 - QS183 - Physical activity: encouraging activity in the community - Structure - 2"]
[null,"QS183","Physical activity: encouraging activity in the community",2,null,"Local authorities prioritise pedestrians, cyclists and people who use public transport when developing and maintaining connected travel routes.","Evidence that local authorities implement plans to make it as easy as possible for people with limited mobility, such as older people and people with disabilities (including sensory, visual or learning disabilities), to move around their local area.","Structure","QS183 - Physical activity: encouraging activity in the community","2 - QS183 - Physical activity: encouraging activity in the community",3,"2 - QS183 - Physical activity: encouraging activity in the community - Structure - 3"]
[null,"QS183","Physical activity: encouraging activity in the community",2,null,"Local authorities prioritise pedestrians, cyclists and people who use public transport when developing and maintaining connected travel routes.","Percentage of people cycling for travel.","Outcome","QS183 - Physical activity: encouraging activity in the community","2 - QS183 - Physical activity: encouraging activity in the community",1,"2 - QS183 - Physical activity: encouraging activity in the community - Outcome - 1"]
[null,"QS183","Physical activity: encouraging activity in the community",2,null,"Local authorities prioritise pedestrians, cyclists and people who use public transport when developing and maintaining connected travel routes.","Percentage of people walking for travel.","Outcome","QS183 - Physical activity: encouraging activity in the community","2 - QS183 - Physical activity: encouraging activity in the community",2,"2 - QS183 - Physical activity: encouraging activity in the community - Outcome - 2"]
[null,"QS183","Physical activity: encouraging activity in the community",2,null,"Local authorities prioritise pedestrians, cyclists and people who use public transport when developing and maintaining connected travel routes.","Number of pedestrians and cyclists reported killed or seriously injured on the roads.","Outcome","QS183 - Physical activity: encouraging activity in the community","2 - QS183 - Physical activity: encouraging activity in the community",3,"2 - QS183 - Physical activity: encouraging activity in the community - Outcome - 3"]
[null,"QS183","Physical activity: encouraging activity in the community",3,null,"Local authorities involve community members in designing and managing public open spaces.","Evidence that local authorities and community members work in partnership to make decisions on the design and management of public open spaces.","Structure","QS183 - Physical activity: encouraging activity in the community","3 - QS183 - Physical activity: encouraging activity in the community",1,"3 - QS183 - Physical activity: encouraging activity in the community - Structure - 1"]
[null,"QS183","Physical activity: encouraging activity in the community",3,null,"Local authorities involve community members in designing and managing public open spaces.","Evidence that local authorities encourage community members to help to maintain public open spaces by reporting any problems affecting accessibility and use.","Structure","QS183 - Physical activity: encouraging activity in the community","3 - QS183 - Physical activity: encouraging activity in the community",2,"3 - QS183 - Physical activity: encouraging activity in the community - Structure - 2"]
[null,"QS183","Physical activity: encouraging activity in the community",3,null,"Local authorities involve community members in designing and managing public open spaces.","Percentage of people using outdoor space for exercise or health reasons.","Outcome","QS183 - Physical activity: encouraging activity in the community","3 - QS183 - Physical activity: encouraging activity in the community",1,"3 - QS183 - Physical activity: encouraging activity in the community - Outcome - 1"]
[null,"QS183","Physical activity: encouraging activity in the community",4,null,"Workplaces have a physical activity programme to encourage employees to move more and be more physically active.","Evidence that workplaces have a physical activity programme to encourage employees to move more and be more physically active.","Structure","QS183 - Physical activity: encouraging activity in the community","4 - QS183 - Physical activity: encouraging activity in the community",1,"4 - QS183 - Physical activity: encouraging activity in the community - Structure - 1"]
[null,"QS183","Physical activity: encouraging activity in the community",4,null,"Workplaces have a physical activity programme to encourage employees to move more and be more physically active.","Evidence that workplaces monitor their physical activity programme to encourage employees to move more and be more physically active.","Structure","QS183 - Physical activity: encouraging activity in the community","4 - QS183 - Physical activity: encouraging activity in the community",2,"4 - QS183 - Physical activity: encouraging activity in the community - Structure - 2"]
[null,"QS183","Physical activity: encouraging activity in the community",4,null,"Workplaces have a physical activity programme to encourage employees to move more and be more physically active.","Evidence that workplaces liaise with neighbouring businesses and other partners to improve and promote accessible walking and cycling routes and accessible links to work sites.","Structure","QS183 - Physical activity: encouraging activity in the community","4 - QS183 - Physical activity: encouraging activity in the community",3,"4 - QS183 - Physical activity: encouraging activity in the community - Structure - 3"]
[null,"QS183","Physical activity: encouraging activity in the community",4,null,"Workplaces have a physical activity programme to encourage employees to move more and be more physically active.","Evidence that employees receive information tailored to the workplace about accessible walking and cycling routes which include public transport options, distances involved, cycle parking, maps, routes, alternative route directions and safety.","Structure","QS183 - Physical activity: encouraging activity in the community","4 - QS183 - Physical activity: encouraging activity in the community",4,"4 - QS183 - Physical activity: encouraging activity in the community - Structure - 4"]
[null,"QS183","Physical activity: encouraging activity in the community",4,null,"Workplaces have a physical activity programme to encourage employees to move more and be more physically active.","Percentage of adults who actively travel to and from workplaces.","Outcome","QS183 - Physical activity: encouraging activity in the community","4 - QS183 - Physical activity: encouraging activity in the community",1,"4 - QS183 - Physical activity: encouraging activity in the community - Outcome - 1"]
[null,"QS183","Physical activity: encouraging activity in the community",4,null,"Workplaces have a physical activity programme to encourage employees to move more and be more physically active.","Percentage of adults cycling for travel at least 3 days a week.","Outcome","QS183 - Physical activity: encouraging activity in the community","4 - QS183 - Physical activity: encouraging activity in the community",2,"4 - QS183 - Physical activity: encouraging activity in the community - Outcome - 2"]
[null,"QS183","Physical activity: encouraging activity in the community",4,null,"Workplaces have a physical activity programme to encourage employees to move more and be more physically active.","Percentage of adults walking for travel at least 3 days a week.","Outcome","QS183 - Physical activity: encouraging activity in the community","4 - QS183 - Physical activity: encouraging activity in the community",3,"4 - QS183 - Physical activity: encouraging activity in the community - Outcome - 3"]
[null,"QS183","Physical activity: encouraging activity in the community",4,null,"Workplaces have a physical activity programme to encourage employees to move more and be more physically active.","Level of satisfaction among employees who feel supported about their health and wellbeing.","Outcome","QS183 - Physical activity: encouraging activity in the community","4 - QS183 - Physical activity: encouraging activity in the community",4,"4 - QS183 - Physical activity: encouraging activity in the community - Outcome - 4"]
[null,"QS183","Physical activity: encouraging activity in the community",5,null,"Schools and early years settings have active travel plans that are monitored and updated annually.","Evidence that schools and early years settings have travel plans that include performance targets to increase active travel.","Structure","QS183 - Physical activity: encouraging activity in the community","5 - QS183 - Physical activity: encouraging activity in the community",1,"5 - QS183 - Physical activity: encouraging activity in the community - Structure - 1"]
[null,"QS183","Physical activity: encouraging activity in the community",5,null,"Schools and early years settings have active travel plans that are monitored and updated annually.","Evidence that schools and early years settings monitor and update their travel plans annually to ensure these continue to be fully aligned with other local authority plans.","Structure","QS183 - Physical activity: encouraging activity in the community","5 - QS183 - Physical activity: encouraging activity in the community",2,"5 - QS183 - Physical activity: encouraging activity in the community - Structure - 2"]
[null,"QS183","Physical activity: encouraging activity in the community",5,null,"Schools and early years settings have active travel plans that are monitored and updated annually.","Percentage of children's travel to and from schools and early years settings that is active.","Outcome","QS183 - Physical activity: encouraging activity in the community","5 - QS183 - Physical activity: encouraging activity in the community",1,"5 - QS183 - Physical activity: encouraging activity in the community - Outcome - 1"]
[null,"QS184","Dementia",1,null,"People accessing behaviour change interventions and programmes in mid-life are advised that the risk of developing dementia can be reduced by making lifestyle changes. ","Evidence that service specifications for behaviour change interventions and programmes include actions to raise awareness of lifestyle changes that could reduce the risk of developing dementia.","Structure","QS184 - Dementia","1 - QS184 - Dementia",1,"1 - QS184 - Dementia - Structure - 1"]
[null,"QS184","Dementia",1,null,"People accessing behaviour change interventions and programmes in mid-life are advised that the risk of developing dementia can be reduced by making lifestyle changes. ","Evidence that training for practitioners delivering behaviour change interventions and programmes includes how to advise and support people to reduce the risk of developing dementia.","Structure","QS184 - Dementia","1 - QS184 - Dementia",2,"1 - QS184 - Dementia - Structure - 2"]
[null,"QS184","Dementia",1,null,"People accessing behaviour change interventions and programmes in mid-life are advised that the risk of developing dementia can be reduced by making lifestyle changes. ","Evidence that information about the link between unhealthy behaviours and the risk of developing dementia is included in local health promotion materials.","Structure","QS184 - Dementia","1 - QS184 - Dementia",3,"1 - QS184 - Dementia - Structure - 3"]
[null,"QS184","Dementia",1,null,"People accessing behaviour change interventions and programmes in mid-life are advised that the risk of developing dementia can be reduced by making lifestyle changes. ","Proportion of people attending behaviour change interventions and programmes in mid-life who are advised that the risk of developing dementia can be reduced by making lifestyle changes.","Process","QS184 - Dementia","1 - QS184 - Dementia",1,"1 - QS184 - Dementia - Process - 1","The number in the denominator who are advised that the risk of developing dementia can be reduced by making lifestyle changes.","The number of people attending behaviour change interventions and programmes in mid-life."]
[null,"QS184","Dementia",1,null,"People accessing behaviour change interventions and programmes in mid-life are advised that the risk of developing dementia can be reduced by making lifestyle changes. ","Public awareness of the link between dementia and lifestyle.","Outcome","QS184 - Dementia","1 - QS184 - Dementia",1,"1 - QS184 - Dementia - Outcome - 1"]
[null,"QS184","Dementia",1,null,"People accessing behaviour change interventions and programmes in mid-life are advised that the risk of developing dementia can be reduced by making lifestyle changes. ","Uptake of healthy lifestyle choices.","Outcome","QS184 - Dementia","1 - QS184 - Dementia",2,"1 - QS184 - Dementia - Outcome - 2"]
[null,"QS184","Dementia",2,null,"People with suspected dementia are referred to a specialist dementia diagnostic service if reversible causes of cognitive decline have been investigated.","Evidence of local referral criteria and pathways to ensure that people with suspected dementia are referred to a specialist dementia diagnostic service.","Structure","QS184 - Dementia","2 - QS184 - Dementia",1,"2 - QS184 - Dementia - Structure - 1"]
[null,"QS184","Dementia",2,null,"People with suspected dementia are referred to a specialist dementia diagnostic service if reversible causes of cognitive decline have been investigated.","Proportion of people with dementia who have a record of attending a specialist dementia diagnostic service up to 12 months before entering on to the GP practice register.","Process","QS184 - Dementia","2 - QS184 - Dementia",1,"2 - QS184 - Dementia - Process - 1","The number in the denominator who were referred to a specialist dementia diagnostic service up to 12 months before entering on to the GP practice register.","The number of people with dementia on the GP practice register."]
[null,"QS184","Dementia",2,null,"People with suspected dementia are referred to a specialist dementia diagnostic service if reversible causes of cognitive decline have been investigated.","Self-reported or carer-reported quality of life of people with dementia.","Outcome","QS184 - Dementia","2 - QS184 - Dementia",1,"2 - QS184 - Dementia - Outcome - 1"]
[null,"QS184","Dementia",3,null,"People with dementia are given the opportunity to discuss advance care planning at diagnosis and at each health and social care review. ","Evidence of local arrangements to ensure that people with dementia and people involved in their care have early and ongoing opportunities to discuss advance care planning.","Structure","QS184 - Dementia","3 - QS184 - Dementia",1,"3 - QS184 - Dementia - Structure - 1"]
[null,"QS184","Dementia",3,null,"People with dementia are given the opportunity to discuss advance care planning at diagnosis and at each health and social care review. ","Proportion of people with dementia who are given information about advance care planning at diagnosis.","Process","QS184 - Dementia","3 - QS184 - Dementia",1,"3 - QS184 - Dementia - Process - 1","The number in the denominator who were given information about advance care planning at diagnosis.","The number of people with a new diagnosis of dementia."]
[null,"QS184","Dementia",3,null,"People with dementia are given the opportunity to discuss advance care planning at diagnosis and at each health and social care review. ","Proportion of people with dementia having a health or social care review who have a documented discussion about advance care planning.","Process","QS184 - Dementia","3 - QS184 - Dementia",2,"3 - QS184 - Dementia - Process - 2","The number in the denominator who have a documented discussion about advance care planning at their health or social care review.","The number of people with dementia."]
[null,"QS184","Dementia",3,null,"People with dementia are given the opportunity to discuss advance care planning at diagnosis and at each health and social care review. ","Proportion of people with dementia who feel encouraged to make decisions about their future care.","Outcome","QS184 - Dementia","3 - QS184 - Dementia",1,"3 - QS184 - Dementia - Outcome - 1","The number in the denominator who feel encouraged to make decisions about their future care.","The number of people with dementia."]
[null,"QS184","Dementia",3,null,"People with dementia are given the opportunity to discuss advance care planning at diagnosis and at each health and social care review. ","Proportion of people with dementia who are aware they can update their advance care plan at each care review.","Outcome","QS184 - Dementia","3 - QS184 - Dementia",2,"3 - QS184 - Dementia - Outcome - 2","The number in the denominator who are aware they can update their advance care plan at each care review.","The number of people with dementia."]
[null,"QS184","Dementia",4,null,"People with dementia have a single named practitioner to coordinate their care.","Evidence of local arrangements to ensure that people with dementia have a single named health or social care practitioner to coordinate their care.","Structure","QS184 - Dementia","4 - QS184 - Dementia",1,"4 - QS184 - Dementia - Structure - 1"]
[null,"QS184","Dementia",4,null,"People with dementia have a single named practitioner to coordinate their care.","Evidence of local agreement of the role and functions of the named practitioner.","Structure","QS184 - Dementia","4 - QS184 - Dementia",2,"4 - QS184 - Dementia - Structure - 2"]
[null,"QS184","Dementia",4,null,"People with dementia have a single named practitioner to coordinate their care.","Proportion of people with dementia who have a named practitioner responsible for coordinating their care.","Process","QS184 - Dementia","4 - QS184 - Dementia",1,"4 - QS184 - Dementia - Process - 1","The number in the denominator who have a named practitioner responsible for coordinating their care.","The number of people with dementia."]
[null,"QS184","Dementia",4,null,"People with dementia have a single named practitioner to coordinate their care.","Proportion of people with dementia who have a care and support plan.","Process","QS184 - Dementia","4 - QS184 - Dementia",2,"4 - QS184 - Dementia - Process - 2","The number in the denominator who have a care and support plan.","The number of people with dementia."]
[null,"QS184","Dementia",4,null,"People with dementia have a single named practitioner to coordinate their care.","Self-reported or carer-reported quality of life of people with dementia.","Outcome","QS184 - Dementia","4 - QS184 - Dementia",1,"4 - QS184 - Dementia - Outcome - 1"]
[null,"QS184","Dementia",4,null,"People with dementia have a single named practitioner to coordinate their care.","Carer-reported quality of life of carers of people with dementia.","Outcome","QS184 - Dementia","4 - QS184 - Dementia",2,"4 - QS184 - Dementia - Outcome - 2"]
[null,"QS184","Dementia",5,null,"People with dementia are supported to choose from a range of activities to promote wellbeing that are tailored to their preferences. ","Evidence of local arrangements to ensure that a range of activities are available that promote wellbeing for people with dementia.","Structure","QS184 - Dementia","5 - QS184 - Dementia",1,"5 - QS184 - Dementia - Structure - 1"]
[null,"QS184","Dementia",5,null,"People with dementia are supported to choose from a range of activities to promote wellbeing that are tailored to their preferences. ","Evidence of local arrangements to ensure that people offering activities to promote wellbeing to people with dementia discuss the person's preferences with them and tailor the activities to these.","Structure","QS184 - Dementia","5 - QS184 - Dementia",2,"5 - QS184 - Dementia - Structure - 2"]
[null,"QS184","Dementia",5,null,"People with dementia are supported to choose from a range of activities to promote wellbeing that are tailored to their preferences. ","Evidence of local arrangements to support access to a range of activities that promote wellbeing for people with dementia, such as transport options.","Structure","QS184 - Dementia","5 - QS184 - Dementia",3,"5 - QS184 - Dementia - Structure - 3"]
[null,"QS184","Dementia",5,null,"People with dementia are supported to choose from a range of activities to promote wellbeing that are tailored to their preferences. ","Proportion of people with dementia who discuss activities to promote wellbeing at a review of their care plan.","Process","QS184 - Dementia","5 - QS184 - Dementia",1,"5 - QS184 - Dementia - Process - 1","The number in the denominator who discuss activities to promote wellbeing at a review of their care plan.","The number of people with dementia."]
[null,"QS184","Dementia",5,null,"People with dementia are supported to choose from a range of activities to promote wellbeing that are tailored to their preferences. ","Proportion of people with dementia who take part in activities to promote wellbeing that are tailored to their preferences.","Process","QS184 - Dementia","5 - QS184 - Dementia",2,"5 - QS184 - Dementia - Process - 2","The number in the denominator who take part in activities to promote wellbeing that are tailored to their preferences.","The number of people with dementia."]
[null,"QS184","Dementia",5,null,"People with dementia are supported to choose from a range of activities to promote wellbeing that are tailored to their preferences. ","Self-reported or carer-reported level of satisfaction with activities to promote wellbeing.","Outcome","QS184 - Dementia","5 - QS184 - Dementia",1,"5 - QS184 - Dementia - Outcome - 1"]
[null,"QS184","Dementia",5,null,"People with dementia are supported to choose from a range of activities to promote wellbeing that are tailored to their preferences. ","Self-reported or carer-reported quality of life of people with dementia.","Outcome","QS184 - Dementia","5 - QS184 - Dementia",2,"5 - QS184 - Dementia - Outcome - 2"]
[null,"QS184","Dementia",5,null,"People with dementia are supported to choose from a range of activities to promote wellbeing that are tailored to their preferences. ","Level of independence of people with dementia.","Outcome","QS184 - Dementia","5 - QS184 - Dementia",3,"5 - QS184 - Dementia - Outcome - 3"]
[null,"QS184","Dementia",6,null,"People with dementia have a structured assessment before starting non-pharmacological or pharmacological treatment for distress.","Evidence of local arrangements to ensure that people with dementia have a structured assessment before starting non-pharmacological or pharmacological treatment for distress.","Structure","QS184 - Dementia","6 - QS184 - Dementia",1,"6 - QS184 - Dementia - Structure - 1"]
[null,"QS184","Dementia",6,null,"People with dementia have a structured assessment before starting non-pharmacological or pharmacological treatment for distress.","Proportion of people with dementia who have started non-pharmacological or pharmacological treatment for distress who had a structured assessment before starting treatment.","Process","QS184 - Dementia","6 - QS184 - Dementia",1,"6 - QS184 - Dementia - Process - 1","The number in the denominator who had a structured assessment before starting treatment for distress.","The number of people with dementia who have started non-pharmacological or pharmacological treatment for distress."]
[null,"QS184","Dementia",6,null,"People with dementia have a structured assessment before starting non-pharmacological or pharmacological treatment for distress."," Antipsychotic prescribing rates for people with dementia.","Outcome","QS184 - Dementia","6 - QS184 - Dementia",1,"6 - QS184 - Dementia - Outcome - 1"]
[null,"QS184","Dementia",6,null,"People with dementia have a structured assessment before starting non-pharmacological or pharmacological treatment for distress.","Self-reported or carer-reported quality of life of people with dementia.","Outcome",{"$f":"CONCATENATE(B4107, \" - \", C4107)","v":"QS184 - Dementia"},{"$f":"CONCATENATE(D4107, \" - \", I4107)","v":"6 - QS184 - Dementia"},{"$f":"IF(AND(B4107=B4106, D4107=D4106, H4107=H4106)=TRUE, K4106+1, 1)","v":2},{"$f":"CONCATENATE(J4107, \" - \", H4107, \" - \",K4107)","v":"6 - QS184 - Dementia - Outcome - 2"}]
[null,"QS184","Dementia",7,null,"Carers of people with dementia are offered education and skills training.","Evidence that education and skills training are available for carers of people with dementia.","Structure","QS184 - Dementia","7 - QS184 - Dementia",1,"7 - QS184 - Dementia - Structure - 1"]
[null,"QS184","Dementia",7,null,"Carers of people with dementia are offered education and skills training.","Evidence that education and skills training are tailored to the needs and preferences of carers of people with dementia.","Structure","QS184 - Dementia","7 - QS184 - Dementia",2,"7 - QS184 - Dementia - Structure - 2"]
[null,"QS184","Dementia",7,null,"Carers of people with dementia are offered education and skills training.","Evidence that support is available for carers to be able to attend training knowing that the person they care for will be safe and cared for.","Structure","QS184 - Dementia","7 - QS184 - Dementia",3,"7 - QS184 - Dementia - Structure - 3"]
[null,"QS184","Dementia",7,null,"Carers of people with dementia are offered education and skills training.","Proportion of carers of people with dementia who have a discussion about education and skills training.","Process","QS184 - Dementia","7 - QS184 - Dementia",1,"7 - QS184 - Dementia - Process - 1","The number in the denominator who have a discussion about education and skills training.","The number of carers of people with dementia."]
[null,"QS184","Dementia",7,null,"Carers of people with dementia are offered education and skills training.","Proportion of carers of people with dementia who take part in education and skills training.","Process","QS184 - Dementia","7 - QS184 - Dementia",2,"7 - QS184 - Dementia - Process - 2","The number in the denominator who take part in education and skills training.","The number of carers of people with dementia."]
[null,"QS184","Dementia",7,null,"Carers of people with dementia are offered education and skills training.","Carer-reported quality of life of carers of people with dementia.","Outcome","QS184 - Dementia","7 - QS184 - Dementia",1,"7 - QS184 - Dementia - Outcome - 1"]
[null,"QS184","Dementia",7,null,"Carers of people with dementia are offered education and skills training.","Carer-reported level of satisfaction with the tailoring of the support to their needs and preferences.","Outcome","QS184 - Dementia","7 - QS184 - Dementia",2,"7 - QS184 - Dementia - Outcome - 2"]
[null,"QS184","Dementia",7,null,"Carers of people with dementia are offered education and skills training.","Self-reported or carer-reported quality of life of people with dementia.","Outcome","QS184 - Dementia","7 - QS184 - Dementia",3,"7 - QS184 - Dementia - Outcome - 3"]
[null,"QS185","Hearing loss in adults",1,null,"Adults with earwax that is contributing to hearing loss or other symptoms, or preventing ear examination or ear canal impressions being taken, have earwax removed in primary care or community ear care services.","Evidence of referral pathways in place to ensure adults with earwax that is contributing to hearing loss or other symptoms, or preventing ear examination or ear canal impressions being taken, have earwax removal in primary care or community ear care services.","Structure","QS185 - Hearing loss in adults","1 - QS185 - Hearing loss in adults",1,"1 - QS185 - Hearing loss in adults - Structure - 1"]
[null,"QS185","Hearing loss in adults",1,null,"Adults with earwax that is contributing to hearing loss or other symptoms, or preventing ear examination or ear canal impressions being taken, have earwax removed in primary care or community ear care services.","Evidence of local arrangements for healthcare professionals to have training to use earwax removal methods.","Structure","QS185 - Hearing loss in adults","1 - QS185 - Hearing loss in adults",2,"1 - QS185 - Hearing loss in adults - Structure - 2"]
[null,"QS185","Hearing loss in adults",1,null,"Adults with earwax that is contributing to hearing loss or other symptoms, or preventing ear examination or ear canal impressions being taken, have earwax removed in primary care or community ear care services.","Evidence of the availability of equipment to remove earwax in primary care or community ear care services.","Structure","QS185 - Hearing loss in adults","1 - QS185 - Hearing loss in adults",3,"1 - QS185 - Hearing loss in adults - Structure - 3"]
[null,"QS185","Hearing loss in adults",1,null,"Adults with earwax that is contributing to hearing loss or other symptoms, or preventing ear examination or ear canal impressions being taken, have earwax removed in primary care or community ear care services.","Proportion of attendances of adults with earwax that is contributing to hearing loss or other symptoms, or preventing ear examination or ear canal impressions being taken, in which earwax is removed in primary care or community ear care services.","Process",{"$f":"CONCATENATE(B4119, \" - \", C4119)","v":"QS185 - Hearing loss in adults"},{"$f":"CONCATENATE(D4119, \" - \", I4119)","v":"1 - QS185 - Hearing loss in adults"},{"$f":"IF(AND(B4119=B4118, D4119=D4118, H4119=H4118)=TRUE, K4118+1, 1)","v":1},{"$f":"CONCATENATE(J4119, \" - \", H4119, \" - \",K4119)","v":"1 - QS185 - Hearing loss in adults - Process - 1"},"The number in the denominator for which earwax is removed in primary care or community ear care services.","The number of attendances of adults with earwax that is contributing to hearing loss or other symptoms, or preventing ear examination or ear canal impressions being taken."]
[null,"QS185","Hearing loss in adults",1,null,"Adults with earwax that is contributing to hearing loss or other symptoms, or preventing ear examination or ear canal impressions being taken, have earwax removed in primary care or community ear care services.","Health-related quality of life for adults with earwax that has contributed to hearing loss or other symptoms, or has prevented ear examination or ear canal impressions being taken.","Outcome","QS185 - Hearing loss in adults","1 - QS185 - Hearing loss in adults",1,"1 - QS185 - Hearing loss in adults - Outcome - 1"]
[null,"QS185","Hearing loss in adults",2,null,"Adults with sudden onset of hearing loss in one or both ears that is not explained by external or middle ear causes are referred for immediate or urgent specialist medical care.","Evidence of referral pathways in place to ensure adults with sudden onset of hearing loss in one or both ears that is not explained by external or middle ear causes are seen immediately or urgently by an ear, nose and throat (ENT) service, an audiovestibular medicine service or an emergency department for specialist medical care.","Structure","QS185 - Hearing loss in adults","2 - QS185 - Hearing loss in adults",1,"2 - QS185 - Hearing loss in adults - Structure - 1"]
[null,"QS185","Hearing loss in adults",2,null,"Adults with sudden onset of hearing loss in one or both ears that is not explained by external or middle ear causes are referred for immediate or urgent specialist medical care.","Proportion of adults with hearing loss in one or both ears that has developed over 3 days or less within the past 30 days, who are referred for immediate (seen within 24 hours) specialist medical care in an ENT service or an emergency department.","Process","QS185 - Hearing loss in adults","2 - QS185 - Hearing loss in adults",1,"2 - QS185 - Hearing loss in adults - Process - 1","The number in the denominator who are referred for immediate (seen within 24 hours) specialist medical care in an ENT service or an emergency department.","The number of adults with hearing loss in one or both ears that has developed over 3 days or less within the past 30 days."]
[null,"QS185","Hearing loss in adults",2,null,"Adults with sudden onset of hearing loss in one or both ears that is not explained by external or middle ear causes are referred for immediate or urgent specialist medical care.","Proportion of adults with hearing loss in one or both ears that developed over 3 days or less more than 30 days ago who are referred for urgent (seen within 2 weeks) specialist medical care in an ENT or audiovestibular medicine service.","Process","QS185 - Hearing loss in adults","2 - QS185 - Hearing loss in adults",2,"2 - QS185 - Hearing loss in adults - Process - 2","The number in the denominator who are referred for urgent (seen within 2 weeks) specialist medical care in an ENT or audiovestibular medicine service.","The number of adults with hearing loss in one or both ears that developed over 3 days or less more than 30 days ago."]
[null,"QS185","Hearing loss in adults",2,null,"Adults with sudden onset of hearing loss in one or both ears that is not explained by external or middle ear causes are referred for immediate or urgent specialist medical care.","Morbidity rates for adults who have sudden onset of hearing loss.","Outcome","QS185 - Hearing loss in adults","2 - QS185 - Hearing loss in adults",1,"2 - QS185 - Hearing loss in adults - Outcome - 1"]
[null,"QS185","Hearing loss in adults",3,null,"Adults with rapid worsening of hearing loss in one or both ears that is not explained by external or middle ear causes are referred for urgent specialist medical care.","Evidence of referral pathways in place to ensure adults with rapid worsening of hearing loss in one or both ears that is not explained by external or middle ear causes are seen urgently by an ear, nose and throat (ENT) service or an audiovestibular medicine service for specialist medical care.","Structure","QS185 - Hearing loss in adults","3 - QS185 - Hearing loss in adults",1,"3 - QS185 - Hearing loss in adults - Structure - 1"]
[null,"QS185","Hearing loss in adults",3,null,"Adults with rapid worsening of hearing loss in one or both ears that is not explained by external or middle ear causes are referred for urgent specialist medical care.","Proportion of adults with hearing loss in one or both ears that has worsened over a period of 4 to 90 days who are referred for urgent (seen within 2 weeks) specialist medical care in an ENT or audiovestibular medicine service.","Process",{"$f":"CONCATENATE(B4126, \" - \", C4126)","v":"QS185 - Hearing loss in adults"},{"$f":"CONCATENATE(D4126, \" - \", I4126)","v":"3 - QS185 - Hearing loss in adults"},{"$f":"IF(AND(B4126=B4125, D4126=D4125, H4126=H4125)=TRUE, K4125+1, 1)","v":1},{"$f":"CONCATENATE(J4126, \" - \", H4126, \" - \",K4126)","v":"3 - QS185 - Hearing loss in adults - Process - 1"},"The number in the denominator who are referred for urgent (seen within 2 weeks) specialist medical care in an ENT or audiovestibular medicine service.","The number of adults with hearing loss in one or both ears that has worsened over a period of 4 to 90 days."]
[null,"QS185","Hearing loss in adults",3,null,"Adults with rapid worsening of hearing loss in one or both ears that is not explained by external or middle ear causes are referred for urgent specialist medical care.","Morbidity rates for adults who have rapid worsening of hearing loss.","Outcome","QS185 - Hearing loss in adults","3 - QS185 - Hearing loss in adults",1,"3 - QS185 - Hearing loss in adults - Outcome - 1"]
[null,"QS185","Hearing loss in adults",4,null,"Adults presenting for the first time with hearing difficulties not caused by impacted earwax or acute infection have an audiological assessment.","Evidence of referral pathways in place to ensure adults presenting for the first time with hearing difficulties have an audiological assessment.","Structure","QS185 - Hearing loss in adults","4 - QS185 - Hearing loss in adults",1,"4 - QS185 - Hearing loss in adults - Structure - 1"]
[null,"QS185","Hearing loss in adults",4,null,"Adults presenting for the first time with hearing difficulties not caused by impacted earwax or acute infection have an audiological assessment.","Evidence that healthcare practitioners have training and access to information to enable them to recognise hearing and communication difficulties for which referral for an audiological assessment is needed.","Structure","QS185 - Hearing loss in adults","4 - QS185 - Hearing loss in adults",2,"4 - QS185 - Hearing loss in adults - Structure - 2"]
[null,"QS185","Hearing loss in adults",4,null,"Adults presenting for the first time with hearing difficulties not caused by impacted earwax or acute infection have an audiological assessment.","Proportion of adults presenting for the first time with hearing difficulties not caused by impacted earwax or acute infection who have an audiological assessment.","Process","QS185 - Hearing loss in adults","4 - QS185 - Hearing loss in adults",1,"4 - QS185 - Hearing loss in adults - Process - 1","The number in the denominator who have an audiological assessment.","The number of adults presenting for the first time with hearing difficulties not caused by impacted earwax or acute infection."]
[null,"QS185","Hearing loss in adults",4,null,"Adults presenting for the first time with hearing difficulties not caused by impacted earwax or acute infection have an audiological assessment.","Hearing-specific health-related quality of life for adults presenting with hearing difficulties not caused by impacted earwax or acute infection.","Outcome","QS185 - Hearing loss in adults","4 - QS185 - Hearing loss in adults",1,"4 - QS185 - Hearing loss in adults - Outcome - 1"]
[null,"QS185","Hearing loss in adults",5,null,"Adults presenting with hearing loss affecting their ability to communicate and hear are offered hearing aids.","Evidence of local arrangements to ensure that adults with hearing loss affecting their ability to communicate and hear are offered hearing aids.","Structure","QS185 - Hearing loss in adults","5 - QS185 - Hearing loss in adults",1,"5 - QS185 - Hearing loss in adults - Structure - 1"]
[null,"QS185","Hearing loss in adults",5,null,"Adults presenting with hearing loss affecting their ability to communicate and hear are offered hearing aids.","Proportion of adults presenting with hearing loss affecting their ability to communicate and hear who have aidable hearing loss in one ear who are given one hearing aid.","Process","QS185 - Hearing loss in adults","5 - QS185 - Hearing loss in adults",1,"5 - QS185 - Hearing loss in adults - Process - 1","The number in the denominator who are given one hearing aid.","The number of adults presenting with hearing loss affecting their ability to communicate and hear who have aidable hearing loss in one ear."]
[null,"QS185","Hearing loss in adults",5,null,"Adults presenting with hearing loss affecting their ability to communicate and hear are offered hearing aids.","Proportion of adults presenting with hearing loss affecting their ability to communicate and hear who have aidable hearing loss in both ears who are given two hearing aids.","Process","QS185 - Hearing loss in adults","5 - QS185 - Hearing loss in adults",2,"5 - QS185 - Hearing loss in adults - Process - 2","The number in the denominator who are given two hearing aids.","The number of adults presenting with hearing loss affecting their ability to communicate and hear who have aidable hearing loss in both ears."]
[null,"QS185","Hearing loss in adults",5,null,"Adults presenting with hearing loss affecting their ability to communicate and hear are offered hearing aids.","Hearing-specific health-related quality of life for adults with hearing loss.","Outcome","QS185 - Hearing loss in adults","5 - QS185 - Hearing loss in adults",1,"5 - QS185 - Hearing loss in adults - Outcome - 1"]
[null,"QS185","Hearing loss in adults",6,null,"Adults with hearing aids have a follow-up audiology appointment 6 to 12 weeks after the hearing aids are fitted.","Evidence of local arrangements to ensure that adults with hearing aids have a follow-up audiology appointment 6 to 12 weeks after the hearing aids are fitted.","Structure","QS185 - Hearing loss in adults","6 - QS185 - Hearing loss in adults",1,"6 - QS185 - Hearing loss in adults - Structure - 1"]
[null,"QS185","Hearing loss in adults",6,null,"Adults with hearing aids have a follow-up audiology appointment 6 to 12 weeks after the hearing aids are fitted.","Evidence of local arrangements to ensure that adults with hearing aids have their personalised care plan reviewed and updated if necessary during a follow-up appointment 6 to 12 weeks after the hearing aids are fitted.","Structure",{"$f":"CONCATENATE(B4137, \" - \", C4137)","v":"QS185 - Hearing loss in adults"},{"$f":"CONCATENATE(D4137, \" - \", I4137)","v":"6 - QS185 - Hearing loss in adults"},{"$f":"IF(AND(B4137=B4136, D4137=D4136, H4137=H4136)=TRUE, K4136+1, 1)","v":2},{"$f":"CONCATENATE(J4137, \" - \", H4137, \" - \",K4137)","v":"6 - QS185 - Hearing loss in adults - Structure - 2"}]
[null,"QS185","Hearing loss in adults",6,null,"Adults with hearing aids have a follow-up audiology appointment 6 to 12 weeks after the hearing aids are fitted.","Proportion of adults who have a follow‑up audiology appointment 6 to 12 weeks after new hearing aids are fitted.","Process","QS185 - Hearing loss in adults","6 - QS185 - Hearing loss in adults",1,"6 - QS185 - Hearing loss in adults - Process - 1","The number in the denominator who have a follow‑up audiology appointment 6 to 12 weeks after the hearing aids are fitted.","The number of adults with new hearing aids."]
[null,"QS185","Hearing loss in adults",6,null,"Adults with hearing aids have a follow-up audiology appointment 6 to 12 weeks after the hearing aids are fitted.","Proportion of adults who have a face-to-face follow‑up audiology appointment 6 to 12 weeks after new hearing aids are fitted.","Process","QS185 - Hearing loss in adults","6 - QS185 - Hearing loss in adults",2,"6 - QS185 - Hearing loss in adults - Process - 2","The number in the denominator who have a face-to-face follow‑up audiology appointment 6 to 12 weeks after the hearing aids are fitted.","The number of adults with new hearing aids."]
[null,"QS185","Hearing loss in adults",6,null,"Adults with hearing aids have a follow-up audiology appointment 6 to 12 weeks after the hearing aids are fitted.","Proportion of adults who have a telephone follow‑up audiology appointment 6 to 12 weeks after new hearing aids are fitted.","Process","QS185 - Hearing loss in adults","6 - QS185 - Hearing loss in adults",3,"6 - QS185 - Hearing loss in adults - Process - 3","The number in the denominator who have a telephone follow‑up audiology appointment 6 to 12 weeks after the hearing aids are fitted.","The number of adults with new hearing aids."]
[null,"QS185","Hearing loss in adults",6,null,"Adults with hearing aids have a follow-up audiology appointment 6 to 12 weeks after the hearing aids are fitted.","Proportion of adults who have a follow‑up audiology appointment by electronic communication 6 to 12 weeks after new hearing aids are fitted.","Process",{"$f":"CONCATENATE(B4141, \" - \", C4141)","v":"QS185 - Hearing loss in adults"},{"$f":"CONCATENATE(D4141, \" - \", I4141)","v":"6 - QS185 - Hearing loss in adults"},{"$f":"IF(AND(B4141=B4140, D4141=D4140, H4141=H4140)=TRUE, K4140+1, 1)","v":4},{"$f":"CONCATENATE(J4141, \" - \", H4141, \" - \",K4141)","v":"6 - QS185 - Hearing loss in adults - Process - 4"},"The number in the denominator who have a telephone follow‑up audiology appointment 6 to 12 weeks after the hearing aids are fitted.","The number of adults with new hearing aids."]
[null,"QS185","Hearing loss in adults",6,null,"Adults with hearing aids have a follow-up audiology appointment 6 to 12 weeks after the hearing aids are fitted.","Proportion of adults continuing to wear new hearing aids after first follow-up, and at 12 and 24 months.","Outcome","QS185 - Hearing loss in adults","6 - QS185 - Hearing loss in adults",{"$f":"IF(AND(B4142=B4140, D4142=D4140, H4142=H4140)=TRUE, K4140+1, 1)","v":1},"6 - QS185 - Hearing loss in adults - Outcome - 1"]
[null,"QS185","Hearing loss in adults",6,null,"Adults with hearing aids have a follow-up audiology appointment 6 to 12 weeks after the hearing aids are fitted.","Hearing-specific health-related quality of life for adults with aidable hearing loss.","Outcome",{"$f":"CONCATENATE(B4143, \" - \", C4143)","v":"QS185 - Hearing loss in adults"},{"$f":"CONCATENATE(D4143, \" - \", I4143)","v":"6 - QS185 - Hearing loss in adults"},{"$f":"IF(AND(B4143=B4142, D4143=D4142, H4143=H4142)=TRUE, K4142+1, 1)","v":2},{"$f":"CONCATENATE(J4143, \" - \", H4143, \" - \",K4143)","v":"6 - QS185 - Hearing loss in adults - Outcome - 2"}]
[null,"QS186","Lyme disease",1,null,"People presenting with erythema migrans are diagnosed and treated for Lyme disease based on clinical assessment, without laboratory testing.","Evidence that healthcare professionals are trained to recognise symptoms of Lyme disease.","Structure","QS186 - Lyme disease","1 - QS186 - Lyme disease",1,"1 - QS186 - Lyme disease - Structure - 1"]
[null,"QS186","Lyme disease",1,null,"People presenting with erythema migrans are diagnosed and treated for Lyme disease based on clinical assessment, without laboratory testing.","Proportion of people diagnosed with Lyme disease based on erythema migrans without laboratory testing.","Process","QS186 - Lyme disease","1 - QS186 - Lyme disease",1,"1 - QS186 - Lyme disease - Process - 1","The number in the denominator who did not have laboratory testing.","The number of people diagnosed with Lyme disease who had erythema migrans."]
[null,"QS186","Lyme disease",2,null,"People with suspected Lyme disease without erythema migrans who have a negative enzyme-linked immunosorbent assay (ELISA) test carried out within 4 weeks of their symptoms starting have the test repeated 4 to 6 weeks later if Lyme disease is still suspected.","Evidence of local arrangements to provide repeat ELISA tests 4 to 6 weeks after an initial negative ELISA test result for people without erythema migrans in whom Lyme disease is still suspected.","Structure","QS186 - Lyme disease","2 - QS186 - Lyme disease",1,"2 - QS186 - Lyme disease - Structure - 1"]
[null,"QS186","Lyme disease",2,null,"People with suspected Lyme disease without erythema migrans who have a negative enzyme-linked immunosorbent assay (ELISA) test carried out within 4 weeks of their symptoms starting have the test repeated 4 to 6 weeks later if Lyme disease is still suspected.","Proportion of people without erythema migrans who had a negative initial ELISA test within 4 weeks of symptoms starting, and in whom Lyme disease is still suspected, who have a repeat ELISA test 4 to 6 weeks after the first test.","Process","QS186 - Lyme disease","2 - QS186 - Lyme disease",1,"2 - QS186 - Lyme disease - Process - 1","The number in the denominator who have a repeat ELISA test 4 to 6 weeks after the first test.","The number of people without erythema migrans who had a negative initial ELISA test within 4 weeks of symptoms starting, and in whom Lyme disease is still suspected."]
[null,"QS186","Lyme disease",3,null,"People with Lyme disease have initial antibiotic treatment, with the antibiotic, dosage and duration determined by their symptoms.","Evidence that local formularies align with NICE's recommendations on antibiotic treatment for Lyme disease, so that healthcare professionals in primary and secondary care prescribe an antibiotic to people with Lyme disease according to their symptoms.","Structure","QS186 - Lyme disease","3 - QS186 - Lyme disease",1,"3 - QS186 - Lyme disease - Structure - 1"]
[null,"QS186","Lyme disease",3,null,"People with Lyme disease have initial antibiotic treatment, with the antibiotic, dosage and duration determined by their symptoms.","Proportion of people diagnosed with Lyme disease who are given the initial antibiotic recommended by NICE for their symptoms.","Process","QS186 - Lyme disease","3 - QS186 - Lyme disease",1,"3 - QS186 - Lyme disease - Process - 1","The number in the denominator who are given the antibiotic recommended by NICE for their symptoms.","The number of people diagnosed with Lyme disease."]
[null,"QS186","Lyme disease",3,null,"People with Lyme disease have initial antibiotic treatment, with the antibiotic, dosage and duration determined by their symptoms.","Proportion of people diagnosed with Lyme disease who are given the initial antibiotic recommended by NICE for their symptoms at the recommended dosage.","Process","QS186 - Lyme disease","3 - QS186 - Lyme disease",2,"3 - QS186 - Lyme disease - Process - 2","The number in the denominator who are given the antibiotic recommended by NICE for their symptoms at the recommended dosage.","The number of people diagnosed with Lyme disease."]
[null,"QS186","Lyme disease",3,null,"People with Lyme disease have initial antibiotic treatment, with the antibiotic, dosage and duration determined by their symptoms.","Proportion of people diagnosed with Lyme disease who are given the initial antibiotic recommended by NICE for their symptoms for the recommended duration.","Process","QS186 - Lyme disease","3 - QS186 - Lyme disease",3,"3 - QS186 - Lyme disease - Process - 3","The number in the denominator who are given the antibiotic recommended by NICE for their symptoms for the recommended duration.","The number of people diagnosed with Lyme disease."]
[null,"QS186","Lyme disease",4,null,"Local authorities organise health promotion activities with organisations in their area to raise public awareness about how to prevent Lyme disease.","Evidence that local authorities have organised activities to promote awareness of how to prevent Lyme disease.","Structure","QS186 - Lyme disease","4 - QS186 - Lyme disease",1,"4 - QS186 - Lyme disease - Structure - 1"]
[null,"QS186","Lyme disease",4,null,"Local authorities organise health promotion activities with organisations in their area to raise public awareness about how to prevent Lyme disease.","Evidence that local authorities have worked with organisations in their area to promote awareness of how to prevent Lyme disease.","Structure","QS186 - Lyme disease","4 - QS186 - Lyme disease",2,"4 - QS186 - Lyme disease - Structure - 2"]
[null,"QS186","Lyme disease",4,null,"Local authorities organise health promotion activities with organisations in their area to raise public awareness about how to prevent Lyme disease.","Levels of public awareness of how to prevent Lyme disease after locally driven health promotion activities.","Outcome","QS186 - Lyme disease","4 - QS186 - Lyme disease",1,"4 - QS186 - Lyme disease - Outcome - 1"]
[null,"QS187","Learning disability: care and support of people growing older",1,null,"People growing older with a learning disability are actively involved when their care and support needs are being assessed.","Evidence of local arrangements to ensure that people growing older with a learning disability are actively involved when their care and support needs are being assessed.","Structure","QS187 - Learning disability: care and support of people growing older","1 - QS187 - Learning disability: care and support of people growing older",1,"1 - QS187 - Learning disability: care and support of people growing older - Structure - 1"]
[null,"QS187","Learning disability: care and support of people growing older",1,null,"People growing older with a learning disability are actively involved when their care and support needs are being assessed.","Evidence of local arrangements to ensure that practitioners carrying out assessments of the care and support needs of people growing older with a learning disability have access to the person's full history (medical, social, psychological and the nature of their learning disability).","Structure","QS187 - Learning disability: care and support of people growing older","1 - QS187 - Learning disability: care and support of people growing older",2,"1 - QS187 - Learning disability: care and support of people growing older - Structure - 2"]
[null,"QS187","Learning disability: care and support of people growing older",1,null,"People growing older with a learning disability are actively involved when their care and support needs are being assessed.","Proportion of people growing older with a learning disability who feel actively involved in shaping the care and support they receive.","Outcome","QS187 - Learning disability: care and support of people growing older","1 - QS187 - Learning disability: care and support of people growing older",1,"1 - QS187 - Learning disability: care and support of people growing older - Outcome - 1","The number in the denominator who feel actively involved in shaping the care and support they receive.","The number of people growing older with a learning disability who receive care and support from health and social care services."]
[null,"QS187","Learning disability: care and support of people growing older",2,null,"People growing older with a learning disability have a named lead practitioner.","Evidence of local arrangements to ensure that named lead practitioners are responsible for coordinating care and support of people growing older with a learning disability.","Structure",{"$f":"CONCATENATE(B4158, \" - \", C4158)","v":"QS187 - Learning disability: care and support of people growing older"},{"$f":"CONCATENATE(D4158, \" - \", I4158)","v":"2 - QS187 - Learning disability: care and support of people growing older"},{"$f":"IF(AND(B4158=B4157, D4158=D4157, H4158=H4157)=TRUE, K4157+1, 1)","v":1},{"$f":"CONCATENATE(J4158, \" - \", H4158, \" - \",K4158)","v":"2 - QS187 - Learning disability: care and support of people growing older - Structure - 1"}]
[null,"QS187","Learning disability: care and support of people growing older",2,null,"People growing older with a learning disability have a named lead practitioner.","Evidence of local arrangements to ensure that lead practitioners have access to all agencies involved in supporting people growing older with a learning disability.","Structure","QS187 - Learning disability: care and support of people growing older","2 - QS187 - Learning disability: care and support of people growing older",2,"2 - QS187 - Learning disability: care and support of people growing older - Structure - 2"]
[null,"QS187","Learning disability: care and support of people growing older",2,null,"People growing older with a learning disability have a named lead practitioner.","Proportion of people growing older with a learning disability who have a named lead practitioner.","Process","QS187 - Learning disability: care and support of people growing older","2 - QS187 - Learning disability: care and support of people growing older",1,"2 - QS187 - Learning disability: care and support of people growing older - Process - 1","The number in the denominator who have a named lead practitioner.","The number of people growing older with a learning disability."]
[null,"QS187","Learning disability: care and support of people growing older",2,null,"People growing older with a learning disability have a named lead practitioner.","Proportion of people growing older with a learning disability who feel they can access the support they need when they need it.","Outcome","QS187 - Learning disability: care and support of people growing older","2 - QS187 - Learning disability: care and support of people growing older",1,"2 - QS187 - Learning disability: care and support of people growing older - Outcome - 1","The number in the denominator who feel they can access the support they need when they need it.","The number of people growing older with a learning disability who receive care and support from health and social care services."]
[null,"QS187","Learning disability: care and support of people growing older",3,null,"People growing older with a learning disability are involved in developing a plan for the future and reviewing it at least annually.","Evidence of local arrangements to ensure that health and social care practitioners who have a good relationship with people growing older with a learning disability work with them and their support network to develop a plan for the future.","Structure","QS187 - Learning disability: care and support of people growing older","3 - QS187 - Learning disability: care and support of people growing older",1,"3 - QS187 - Learning disability: care and support of people growing older - Structure - 1"]
[null,"QS187","Learning disability: care and support of people growing older",3,null,"People growing older with a learning disability are involved in developing a plan for the future and reviewing it at least annually.","Proportion of people growing older with a learning disability who have a plan for the future.","Process","QS187 - Learning disability: care and support of people growing older","3 - QS187 - Learning disability: care and support of people growing older",1,"3 - QS187 - Learning disability: care and support of people growing older - Process - 1","The number in the denominator who have a plan for the future.","The number of people growing older with a learning disability."]
[null,"QS187","Learning disability: care and support of people growing older",3,null,"People growing older with a learning disability are involved in developing a plan for the future and reviewing it at least annually.","Proportion of people growing older with a learning disability who were involved in developing their plan for the future.","Process","QS187 - Learning disability: care and support of people growing older","3 - QS187 - Learning disability: care and support of people growing older",2,"3 - QS187 - Learning disability: care and support of people growing older - Process - 2","The number in the denominator who were involved in developing their plan for the future.","The number of people growing older with a learning disability who have a plan for the future."]
[null,"QS187","Learning disability: care and support of people growing older",3,null,"People growing older with a learning disability are involved in developing a plan for the future and reviewing it at least annually.","Proportion of people growing older with a learning disability who had their plan for the future reviewed in the past 12 months.","Process","QS187 - Learning disability: care and support of people growing older","3 - QS187 - Learning disability: care and support of people growing older",3,"3 - QS187 - Learning disability: care and support of people growing older - Process - 3","The number in the denominator who had the plan for the future reviewed in the past 12 months.","The number of people growing older with a learning disability who have a plan for the future."]
[null,"QS187","Learning disability: care and support of people growing older",3,null,"People growing older with a learning disability are involved in developing a plan for the future and reviewing it at least annually.","Proportion of people growing older with a learning disability who feel that their wishes are respected as their circumstances change.","Outcome","QS187 - Learning disability: care and support of people growing older","3 - QS187 - Learning disability: care and support of people growing older",1,"3 - QS187 - Learning disability: care and support of people growing older - Outcome - 1","The number in the denominator who reported feeling that their wishes were respected as their circumstances changed.","The number of people growing older with a learning disability who receive care and support from health and social care services."]
[null,"QS187","Learning disability: care and support of people growing older",4,null,"People growing older with a learning disability have an annual health check, which is used to update their health action plan.","Evidence of local arrangements to ensure that GP practices have an up-to-date register of people growing older with a learning disability.","Structure","QS187 - Learning disability: care and support of people growing older","4 - QS187 - Learning disability: care and support of people growing older",1,"4 - QS187 - Learning disability: care and support of people growing older - Structure - 1"]
[null,"QS187","Learning disability: care and support of people growing older",4,null,"People growing older with a learning disability have an annual health check, which is used to update their health action plan.","Evidence of local arrangements to ensure that GP practices offer annual health checks for people growing older with a learning disability.","Structure","QS187 - Learning disability: care and support of people growing older","4 - QS187 - Learning disability: care and support of people growing older",2,"4 - QS187 - Learning disability: care and support of people growing older - Structure - 2"]
[null,"QS187","Learning disability: care and support of people growing older",4,null,"People growing older with a learning disability have an annual health check, which is used to update their health action plan.","Evidence of local processes to ensure that health action plans for people growing older with a learning disability are updated after the annual health checks are carried out.","Structure","QS187 - Learning disability: care and support of people growing older","4 - QS187 - Learning disability: care and support of people growing older",3,"4 - QS187 - Learning disability: care and support of people growing older - Structure - 3"]
[null,"QS187","Learning disability: care and support of people growing older",4,null,"People growing older with a learning disability have an annual health check, which is used to update their health action plan.","Proportion of people growing older with a learning disability who had a health check within the past 12 months.","Process","QS187 - Learning disability: care and support of people growing older","4 - QS187 - Learning disability: care and support of people growing older",1,"4 - QS187 - Learning disability: care and support of people growing older - Process - 1","The number in the denominator who had a health check within the past 12 months.","The number of people growing older with a learning disability."]
[null,"QS187","Learning disability: care and support of people growing older",4,null,"People growing older with a learning disability have an annual health check, which is used to update their health action plan.","Proportion of people with a learning disability who had their health action plan updated after an annual health check.","Process",{"$f":"CONCATENATE(B4171, \" - \", C4171)","v":"QS187 - Learning disability: care and support of people growing older"},{"$f":"CONCATENATE(D4171, \" - \", I4171)","v":"4 - QS187 - Learning disability: care and support of people growing older"},{"$f":"IF(AND(B4171=B4170, D4171=D4170, H4171=H4170)=TRUE, K4170+1, 1)","v":2},{"$f":"CONCATENATE(J4171, \" - \", H4171, \" - \",K4171)","v":"4 - QS187 - Learning disability: care and support of people growing older - Process - 2"},"The number in the denominator who had their health action plan updated after the health check.","The number of people with a learning disability who had a health check within the past 12 months."]
[null,"QS187","Learning disability: care and support of people growing older",5,null,"People growing older with a learning disability meet hospital staff before any planned hospital admission to agree arrangements that make the stay easier for them.","Evidence of local arrangements to ensure that a learning disability is recorded in hospital case notes and electronic health records.","Structure","QS187 - Learning disability: care and support of people growing older","5 - QS187 - Learning disability: care and support of people growing older",1,"5 - QS187 - Learning disability: care and support of people growing older - Structure - 1"]
[null,"QS187","Learning disability: care and support of people growing older",5,null,"People growing older with a learning disability meet hospital staff before any planned hospital admission to agree arrangements that make the stay easier for them.","Evidence of hospital protocols to ensure that reasonable adjustments are put in place for people growing older with a learning disability before a planned hospital admission.","Structure","QS187 - Learning disability: care and support of people growing older","5 - QS187 - Learning disability: care and support of people growing older",2,"5 - QS187 - Learning disability: care and support of people growing older - Structure - 2"]
[null,"QS187","Learning disability: care and support of people growing older",5,null,"People growing older with a learning disability meet hospital staff before any planned hospital admission to agree arrangements that make the stay easier for them.","Evidence of team structure including learning disability liaison nurse.","Structure","QS187 - Learning disability: care and support of people growing older","5 - QS187 - Learning disability: care and support of people growing older",3,"5 - QS187 - Learning disability: care and support of people growing older - Structure - 3"]
[null,"QS187","Learning disability: care and support of people growing older",5,null,"People growing older with a learning disability meet hospital staff before any planned hospital admission to agree arrangements that make the stay easier for them.","Proportion of planned hospital admissions for people growing older with a learning disability that had a pre-admission planning meeting.","Process",{"$f":"CONCATENATE(B4175, \" - \", C4175)","v":"QS187 - Learning disability: care and support of people growing older"},{"$f":"CONCATENATE(D4175, \" - \", I4175)","v":"5 - QS187 - Learning disability: care and support of people growing older"},{"$f":"IF(AND(B4175=B4174, D4175=D4174, H4175=H4174)=TRUE, K4174+1, 1)","v":1},{"$f":"CONCATENATE(J4175, \" - \", H4175, \" - \",K4175)","v":"5 - QS187 - Learning disability: care and support of people growing older - Process - 1"},"The number in the denominator that had a pre-admission planning meeting.","The number of planned hospital admissions for people growing older with a learning disability"]
[null,"QS187","Learning disability: care and support of people growing older",5,null,"People growing older with a learning disability meet hospital staff before any planned hospital admission to agree arrangements that make the stay easier for them.","Proportion of people growing older with a learning disability who felt satisfied with the support provided during their planned hospital stay.","Outcome","QS187 - Learning disability: care and support of people growing older","5 - QS187 - Learning disability: care and support of people growing older",1,"5 - QS187 - Learning disability: care and support of people growing older - Outcome - 1","The number in the denominator who felt satisfied with the support provided during their planned hospital stay.","The number of people growing older with a learning disability who had a planned hospital stay."]
[null,"QS188","Coexisting severe mental illness and substance misuse",1,null,"People aged 14 and over with suspected or confirmed severe mental illness are asked about their use of alcohol and drugs.","Evidence of local arrangements to ensure that people aged 14 and over with suspected or confirmed severe mental illness are routinely asked about substance misuse.","Structure","QS188 - Coexisting severe mental illness and substance misuse","1 - QS188 - Coexisting severe mental illness and substance misuse",1,"1 - QS188 - Coexisting severe mental illness and substance misuse - Structure - 1"]
[null,"QS188","Coexisting severe mental illness and substance misuse",1,null,"People aged 14 and over with suspected or confirmed severe mental illness are asked about their use of alcohol and drugs.","Proportion of people aged 14 and over with suspected severe mental illness who are asked about their use of alcohol and drugs.","Process","QS188 - Coexisting severe mental illness and substance misuse","1 - QS188 - Coexisting severe mental illness and substance misuse",1,"1 - QS188 - Coexisting severe mental illness and substance misuse - Process - 1","The number in the denominator who are asked about their use of alcohol and drugs.","The number of people aged 14 and over with suspected severe mental illness."]
[null,"QS188","Coexisting severe mental illness and substance misuse",1,null,"People aged 14 and over with suspected or confirmed severe mental illness are asked about their use of alcohol and drugs.","Proportion of people aged 14 and over with confirmed severe mental illness who are asked about their use of alcohol and drugs.","Process","QS188 - Coexisting severe mental illness and substance misuse","1 - QS188 - Coexisting severe mental illness and substance misuse",2,"1 - QS188 - Coexisting severe mental illness and substance misuse - Process - 2","The number in the denominator who are asked about their use of alcohol and drugs.","The number of people aged 14 and over with confirmed severe mental illness."]
[null,"QS188","Coexisting severe mental illness and substance misuse",1,null,"People aged 14 and over with suspected or confirmed severe mental illness are asked about their use of alcohol and drugs.","Incidence of people aged 14 and over with severe mental illness newly identified as having coexisting substance misuse.","Outcome","QS188 - Coexisting severe mental illness and substance misuse","1 - QS188 - Coexisting severe mental illness and substance misuse",1,"1 - QS188 - Coexisting severe mental illness and substance misuse - Outcome - 1"]
[null,"QS188","Coexisting severe mental illness and substance misuse",2,null,"People aged 14 and over are not excluded from mental health services because of coexisting substance misuse or from substance misuse services because of coexisting severe mental illness.","Evidence of local arrangements to ensure that people aged 14 and over are not excluded from substance misuse services on referral or when they present because of their severe mental illness.","Structure","QS188 - Coexisting severe mental illness and substance misuse","2 - QS188 - Coexisting severe mental illness and substance misuse",1,"2 - QS188 - Coexisting severe mental illness and substance misuse - Structure - 1"]
[null,"QS188","Coexisting severe mental illness and substance misuse",2,null,"People aged 14 and over are not excluded from mental health services because of coexisting substance misuse or from substance misuse services because of coexisting severe mental illness.","Evidence of local arrangements to ensure that people aged 14 and over are not excluded from mental health services on referral or when they present because of their substance misuse.","Structure","QS188 - Coexisting severe mental illness and substance misuse","2 - QS188 - Coexisting severe mental illness and substance misuse",2,"2 - QS188 - Coexisting severe mental illness and substance misuse - Structure - 2"]
[null,"QS188","Coexisting severe mental illness and substance misuse",2,null,"People aged 14 and over are not excluded from mental health services because of coexisting substance misuse or from substance misuse services because of coexisting severe mental illness.","Proportion of referrals to substance misuse services for people aged 14 and over that are refused because of coexisting severe mental illness.","Process","QS188 - Coexisting severe mental illness and substance misuse","2 - QS188 - Coexisting severe mental illness and substance misuse",1,"2 - QS188 - Coexisting severe mental illness and substance misuse - Process - 1","The number in the denominator that are refused because of coexisting severe mental illness.","The number of referrals to substance misuse services for people aged 14 and over with coexisting severe mental illness and substance misuse."]
[null,"QS188","Coexisting severe mental illness and substance misuse",2,null,"People aged 14 and over are not excluded from mental health services because of coexisting substance misuse or from substance misuse services because of coexisting severe mental illness.","Proportion of referrals to mental health services for people aged 14 and over that are refused because of coexisting substance misuse.","Process","QS188 - Coexisting severe mental illness and substance misuse","2 - QS188 - Coexisting severe mental illness and substance misuse",2,"2 - QS188 - Coexisting severe mental illness and substance misuse - Process - 2","The number in the denominator that are refused because of coexisting substance misuse.","The number of referrals to mental health services for people aged 14 and over with coexisting severe mental illness and substance misuse."]
[null,"QS188","Coexisting severe mental illness and substance misuse",2,null,"People aged 14 and over are not excluded from mental health services because of coexisting substance misuse or from substance misuse services because of coexisting severe mental illness.","Proportion of people aged 14 and over presenting to substance misuse services who are not seen because of coexisting severe mental illness.","Process","QS188 - Coexisting severe mental illness and substance misuse","2 - QS188 - Coexisting severe mental illness and substance misuse",3,"2 - QS188 - Coexisting severe mental illness and substance misuse - Process - 3","The number in the denominator who are not seen because of coexisting severe mental illness.","The number of people aged 14 and over with coexisting severe mental illness and substance misuse presenting to substance misuse services."]
[null,"QS188","Coexisting severe mental illness and substance misuse",2,null,"People aged 14 and over are not excluded from mental health services because of coexisting substance misuse or from substance misuse services because of coexisting severe mental illness.","Proportion of people aged 14 and over presenting to mental health services who are not seen because of coexisting substance misuse.","Process","QS188 - Coexisting severe mental illness and substance misuse","2 - QS188 - Coexisting severe mental illness and substance misuse",4,"2 - QS188 - Coexisting severe mental illness and substance misuse - Process - 4","The number in the denominator who are not seen because of coexisting substance misuse.","The number of people aged 14 and over with coexisting severe mental illness and substance misuse presenting to mental health services."]
[null,"QS188","Coexisting severe mental illness and substance misuse",2,null,"People aged 14 and over are not excluded from mental health services because of coexisting substance misuse or from substance misuse services because of coexisting severe mental illness.","Levels of physical health of people aged 14 and over with coexisting severe mental illness and substance misuse.","Outcome","QS188 - Coexisting severe mental illness and substance misuse","2 - QS188 - Coexisting severe mental illness and substance misuse",1,"2 - QS188 - Coexisting severe mental illness and substance misuse - Outcome - 1"]
[null,"QS188","Coexisting severe mental illness and substance misuse",2,null,"People aged 14 and over are not excluded from mental health services because of coexisting substance misuse or from substance misuse services because of coexisting severe mental illness.","Rates of medication adherence in people aged 14 and over with coexisting severe mental illness and substance misuse.","Outcome","QS188 - Coexisting severe mental illness and substance misuse","2 - QS188 - Coexisting severe mental illness and substance misuse",2,"2 - QS188 - Coexisting severe mental illness and substance misuse - Outcome - 2"]
[null,"QS188","Coexisting severe mental illness and substance misuse",2,null,"People aged 14 and over are not excluded from mental health services because of coexisting substance misuse or from substance misuse services because of coexisting severe mental illness.","Proportion of people aged 14 and over with coexisting severe mental illness and substance misuse in stable accommodation.","Outcome","QS188 - Coexisting severe mental illness and substance misuse","2 - QS188 - Coexisting severe mental illness and substance misuse",3,"2 - QS188 - Coexisting severe mental illness and substance misuse - Outcome - 3","The number in the denominator in stable accommodation.","The number of people aged 14 and over with coexisting severe mental illness and substance misuse."]
[null,"QS188","Coexisting severe mental illness and substance misuse",3,null,"People aged 14 and over with coexisting severe mental illness and substance misuse have a care coordinator working in mental health services when they are identified as needing treatment from secondary care mental health services.","Evidence of a locally agreed specification of the role and functions of the care coordinator working in mental health services.","Structure","QS188 - Coexisting severe mental illness and substance misuse","3 - QS188 - Coexisting severe mental illness and substance misuse",1,"3 - QS188 - Coexisting severe mental illness and substance misuse - Structure - 1"]
[null,"QS188","Coexisting severe mental illness and substance misuse",3,null,"People aged 14 and over with coexisting severe mental illness and substance misuse have a care coordinator working in mental health services when they are identified as needing treatment from secondary care mental health services.","Evidence of local arrangements to ensure that people aged 14 and over with coexisting severe mental illness and substance misuse have a care coordinator working in mental health services when they are identified as needing treatment from secondary mental health services.","Structure","QS188 - Coexisting severe mental illness and substance misuse","3 - QS188 - Coexisting severe mental illness and substance misuse",2,"3 - QS188 - Coexisting severe mental illness and substance misuse - Structure - 2"]
[null,"QS188","Coexisting severe mental illness and substance misuse",3,null,"People aged 14 and over with coexisting severe mental illness and substance misuse have a care coordinator working in mental health services when they are identified as needing treatment from secondary care mental health services.","Proportion of people aged 14 and over with coexisting severe mental illness and substance misuse who have a care coordinator working in mental health services when they are identified as needing treatment from secondary care mental health services.","Process","QS188 - Coexisting severe mental illness and substance misuse","3 - QS188 - Coexisting severe mental illness and substance misuse",1,"3 - QS188 - Coexisting severe mental illness and substance misuse - Process - 1","The number in the denominator who have a care coordinator working in mental health services.","The number of people aged 14 and over with coexisting severe mental illness and substance misuse identified as needing treatment from secondary care mental health services."]
[null,"QS188","Coexisting severe mental illness and substance misuse",3,null,"People aged 14 and over with coexisting severe mental illness and substance misuse have a care coordinator working in mental health services when they are identified as needing treatment from secondary care mental health services.","Proportion of people aged 14 and over with coexisting severe mental illness and substance misuse receiving care from secondary care mental health services who are satisfied with the support they receive from services.","Outcome","QS188 - Coexisting severe mental illness and substance misuse","3 - QS188 - Coexisting severe mental illness and substance misuse",1,"3 - QS188 - Coexisting severe mental illness and substance misuse - Outcome - 1","The number in the denominator who are satisfied with the support they receive from services.","The number of people aged 14 and over with coexisting severe mental illness and substance misuse receiving care from secondary care mental health services."]
[null,"QS188","Coexisting severe mental illness and substance misuse",4,null,"People aged 14 and over with coexisting severe mental illness and substance misuse are followed up if they miss any appointment.","Evidence of local arrangements to identify people aged 14 and over with coexisting severe mental illness and substance misuse who miss any appointment.","Structure","QS188 - Coexisting severe mental illness and substance misuse","4 - QS188 - Coexisting severe mental illness and substance misuse",1,"4 - QS188 - Coexisting severe mental illness and substance misuse - Structure - 1"]
[null,"QS188","Coexisting severe mental illness and substance misuse",4,null,"People aged 14 and over with coexisting severe mental illness and substance misuse are followed up if they miss any appointment.","Evidence of local arrangements to contact people aged 14 and over with coexisting severe mental illness and substance misuse who miss any appointment.","Structure","QS188 - Coexisting severe mental illness and substance misuse","4 - QS188 - Coexisting severe mental illness and substance misuse",2,"4 - QS188 - Coexisting severe mental illness and substance misuse - Structure - 2"]
[null,"QS188","Coexisting severe mental illness and substance misuse",4,null,"People aged 14 and over with coexisting severe mental illness and substance misuse are followed up if they miss any appointment.","Evidence of flexibility when arranging appointments for people aged 14 and over with coexisting severe mental illness and substance misuse.","Structure","QS188 - Coexisting severe mental illness and substance misuse","4 - QS188 - Coexisting severe mental illness and substance misuse",3,"4 - QS188 - Coexisting severe mental illness and substance misuse - Structure - 3"]
[null,"QS188","Coexisting severe mental illness and substance misuse",4,null,"People aged 14 and over with coexisting severe mental illness and substance misuse are followed up if they miss any appointment.","Evidence of local arrangements for services to ensure that people aged 14 and over with coexisting severe mental illness and substance misuse are not automatically discharged for missing appointments.","Structure","QS188 - Coexisting severe mental illness and substance misuse","4 - QS188 - Coexisting severe mental illness and substance misuse",4,"4 - QS188 - Coexisting severe mental illness and substance misuse - Structure - 4"]
[null,"QS188","Coexisting severe mental illness and substance misuse",4,null,"People aged 14 and over with coexisting severe mental illness and substance misuse are followed up if they miss any appointment.","Proportion of people aged 14 and over with coexisting severe mental illness and substance misuse who are followed up when they miss any appointment.","Process","QS188 - Coexisting severe mental illness and substance misuse","4 - QS188 - Coexisting severe mental illness and substance misuse",1,"4 - QS188 - Coexisting severe mental illness and substance misuse - Process - 1","The number in the denominator who are followed up.","The number of people aged 14 and over with coexisting severe mental illness and substance misuse who miss any appointment."]
[null,"QS188","Coexisting severe mental illness and substance misuse",4,null,"People aged 14 and over with coexisting severe mental illness and substance misuse are followed up if they miss any appointment.","Proportion of people aged 14 and over with coexisting severe mental illness and substance misuse who were not followed up and were discharged from services because of missing any appointment.","Process","QS188 - Coexisting severe mental illness and substance misuse","4 - QS188 - Coexisting severe mental illness and substance misuse",2,"4 - QS188 - Coexisting severe mental illness and substance misuse - Process - 2","The number in the denominator who were not followed up.","The number of people aged 14 and over with coexisting severe mental illness and substance misuse discharged from services because of missing any appointment."]
[null,"QS188","Coexisting severe mental illness and substance misuse",4,null,"People aged 14 and over with coexisting severe mental illness and substance misuse are followed up if they miss any appointment.","Proportion of people aged 14 and over receiving treatment for coexisting severe mental illness and substance misuse who re-engage with services after missing an appointment.","Outcome","QS188 - Coexisting severe mental illness and substance misuse","4 - QS188 - Coexisting severe mental illness and substance misuse",1,"4 - QS188 - Coexisting severe mental illness and substance misuse - Outcome - 1","The number in the denominator who re-engage with services.","The number of people aged 14 and over receiving treatment for coexisting severe mental illness and substance misuse who miss any appointment."]
[null,"QS188","Coexisting severe mental illness and substance misuse",4,null,"People aged 14 and over with coexisting severe mental illness and substance misuse are followed up if they miss any appointment.","Proportion of people aged 14 and over with coexisting severe mental illness and substance misuse who complete their planned treatment for substance misuse.","Outcome","QS188 - Coexisting severe mental illness and substance misuse","4 - QS188 - Coexisting severe mental illness and substance misuse",2,"4 - QS188 - Coexisting severe mental illness and substance misuse - Outcome - 2","The number in the denominator who complete their planned treatment for substance misuse.","The number of people aged 14 and over with coexisting severe mental illness and substance misuse who are receiving treatment for substance misuse."]
[null,"QS188","Coexisting severe mental illness and substance misuse",4,null,"People aged 14 and over with coexisting severe mental illness and substance misuse are followed up if they miss any appointment.","Proportion of people aged 14 and over with coexisting severe mental illness and substance misuse who remain in planned treatment for severe mental illness.","Outcome","QS188 - Coexisting severe mental illness and substance misuse","4 - QS188 - Coexisting severe mental illness and substance misuse",3,"4 - QS188 - Coexisting severe mental illness and substance misuse - Outcome - 3","The number in the denominator who remain in planned treatment for severe mental illness.","The number of people aged 14 and over with coexisting severe mental illness and substance misuse."]
[null,"QS189","Suicide prevention",1,null,"Multi-agency suicide prevention partnerships have a strategic suicide prevention group and clear governance and accountability structures.","Evidence that multi-agency suicide prevention partnerships have a strategic suicide prevention group attended by senior level representatives.","Structure","QS189 - Suicide prevention","1 - QS189 - Suicide prevention",1,"1 - QS189 - Suicide prevention - Structure - 1"]
[null,"QS189","Suicide prevention",1,null,"Multi-agency suicide prevention partnerships have a strategic suicide prevention group and clear governance and accountability structures.","Evidence that multi-agency suicide prevention partnerships have clear governance and accountability structures.","Structure","QS189 - Suicide prevention","1 - QS189 - Suicide prevention",2,"1 - QS189 - Suicide prevention - Structure - 2"]
[null,"QS189","Suicide prevention",1,null,"Multi-agency suicide prevention partnerships have a strategic suicide prevention group and clear governance and accountability structures.","Evidence that multi-agency suicide prevention partnerships support people with personal experience of a suicide attempt, suicidal thoughts and feelings, or a suicide bereavement, to be involved in the partnership.","Structure","QS189 - Suicide prevention","1 - QS189 - Suicide prevention",3,"1 - QS189 - Suicide prevention - Structure - 3"]
[null,"QS189","Suicide prevention",1,null,"Multi-agency suicide prevention partnerships have a strategic suicide prevention group and clear governance and accountability structures.","Rate of emergency hospital attendance or admission for intentional self-harm.","Outcome","QS189 - Suicide prevention","1 - QS189 - Suicide prevention",1,"1 - QS189 - Suicide prevention - Outcome - 1"]
[null,"QS189","Suicide prevention",1,null,"Multi-agency suicide prevention partnerships have a strategic suicide prevention group and clear governance and accountability structures.","Rate of self-harm in the community.","Outcome","QS189 - Suicide prevention","1 - QS189 - Suicide prevention",2,"1 - QS189 - Suicide prevention - Outcome - 2"]
[null,"QS189","Suicide prevention",1,null,"Multi-agency suicide prevention partnerships have a strategic suicide prevention group and clear governance and accountability structures.","Suicide rate.","Outcome","QS189 - Suicide prevention","1 - QS189 - Suicide prevention",3,"1 - QS189 - Suicide prevention - Outcome - 3"]
[null,"QS189","Suicide prevention",2,null,"Multi-agency suicide prevention partnerships reduce access to methods of suicide based on local information.","Evidence that multi-agency suicide prevention partnerships collect and analyse local information on methods of suicide and locations.","Structure","QS189 - Suicide prevention","2 - QS189 - Suicide prevention",1,"2 - QS189 - Suicide prevention - Structure - 1"]
[null,"QS189","Suicide prevention",2,null,"Multi-agency suicide prevention partnerships reduce access to methods of suicide based on local information.","Evidence that multi-agency suicide prevention partnerships identify how they will reduce access to methods of suicide.","Structure","QS189 - Suicide prevention","2 - QS189 - Suicide prevention",2,"2 - QS189 - Suicide prevention - Structure - 2"]
[null,"QS189","Suicide prevention",2,null,"Multi-agency suicide prevention partnerships reduce access to methods of suicide based on local information.","Evidence that multi-agency suicide prevention partnerships review progress in reducing access to methods of suicide at least annually.","Structure","QS189 - Suicide prevention","2 - QS189 - Suicide prevention",3,"2 - QS189 - Suicide prevention - Structure - 3"]
[null,"QS189","Suicide prevention",2,null,"Multi-agency suicide prevention partnerships reduce access to methods of suicide based on local information.","Number of suicides by methods identified in the local suicide prevention action plan.","Outcome","QS189 - Suicide prevention","2 - QS189 - Suicide prevention",1,"2 - QS189 - Suicide prevention - Outcome - 1"]
[null,"QS189","Suicide prevention",2,null,"Multi-agency suicide prevention partnerships reduce access to methods of suicide based on local information.","Number of suicides in high-frequency locations.","Outcome","QS189 - Suicide prevention","2 - QS189 - Suicide prevention",2,"2 - QS189 - Suicide prevention - Outcome - 2"]
[null,"QS189","Suicide prevention",2,null,"Multi-agency suicide prevention partnerships reduce access to methods of suicide based on local information.","Suicide rate.","Outcome","QS189 - Suicide prevention","2 - QS189 - Suicide prevention",3,"2 - QS189 - Suicide prevention - Outcome - 3"]
[null,"QS189","Suicide prevention",3,null,"Multi-agency suicide prevention partnerships have a local media plan that identifies how they will encourage journalists and editors to follow best practice when reporting on suicide and suicidal behaviour.","Evidence that multi-agency suicide prevention partnerships have a local media plan that identifies how they will encourage best practice in reporting on suicide and suicidal behaviour.","Structure","QS189 - Suicide prevention","3 - QS189 - Suicide prevention",1,"3 - QS189 - Suicide prevention - Structure - 1"]
[null,"QS189","Suicide prevention",3,null,"Multi-agency suicide prevention partnerships have a local media plan that identifies how they will encourage journalists and editors to follow best practice when reporting on suicide and suicidal behaviour.","Evidence that multi-agency suicide prevention partnerships have a named lead for the local media plan.","Structure","QS189 - Suicide prevention","3 - QS189 - Suicide prevention",2,"3 - QS189 - Suicide prevention - Structure - 2"]
[null,"QS189","Suicide prevention",3,null,"Multi-agency suicide prevention partnerships have a local media plan that identifies how they will encourage journalists and editors to follow best practice when reporting on suicide and suicidal behaviour.","Evidence that multi-agency suicide prevention partnerships work with other organisations such as the Samaritans to give feedback to local media journalists and editors about reporting on suicide and suicidal behaviour.","Structure","QS189 - Suicide prevention","3 - QS189 - Suicide prevention",3,"3 - QS189 - Suicide prevention - Structure - 3"]
[null,"QS189","Suicide prevention",3,null,"Multi-agency suicide prevention partnerships have a local media plan that identifies how they will encourage journalists and editors to follow best practice when reporting on suicide and suicidal behaviour.","Number of local media reports of suicide or suicidal behaviour that do not meet best practice criteria.","Outcome","QS189 - Suicide prevention","3 - QS189 - Suicide prevention",1,"3 - QS189 - Suicide prevention - Outcome - 1"]
[null,"QS189","Suicide prevention",3,null,"Multi-agency suicide prevention partnerships have a local media plan that identifies how they will encourage journalists and editors to follow best practice when reporting on suicide and suicidal behaviour.","Suicide rate.","Outcome","QS189 - Suicide prevention","3 - QS189 - Suicide prevention",2,"3 - QS189 - Suicide prevention - Outcome - 2"]
[null,"QS189","Suicide prevention",4,null,"Adults presenting with suicidal thoughts or plans discuss whether they would like their family, carers or friends to be involved in their care and are made aware of the limits of confidentiality.","Evidence of local arrangements to provide training on information sharing and confidentiality based on the Department of Health and Social Care's consensus statement on information sharing and suicide prevention to practitioners in contact with adults presenting to health or care services with suicidal thoughts or plans.","Structure","QS189 - Suicide prevention","4 - QS189 - Suicide prevention",1,"4 - QS189 - Suicide prevention - Structure - 1"]
[null,"QS189","Suicide prevention",4,null,"Adults presenting with suicidal thoughts or plans discuss whether they would like their family, carers or friends to be involved in their care and are made aware of the limits of confidentiality.","Evidence of local processes to ensure that adults presenting with suicidal thoughts or plans discuss whether they would like their family, carers or friends to be involved in their care.","Structure","QS189 - Suicide prevention","4 - QS189 - Suicide prevention",2,"4 - QS189 - Suicide prevention - Structure - 2"]
[null,"QS189","Suicide prevention",4,null,"Adults presenting with suicidal thoughts or plans discuss whether they would like their family, carers or friends to be involved in their care and are made aware of the limits of confidentiality.","Evidence of local processes to ensure that adults with suicidal thoughts or plans are made aware of the limits of confidentiality.","Structure","QS189 - Suicide prevention","4 - QS189 - Suicide prevention",3,"4 - QS189 - Suicide prevention - Structure - 3"]
[null,"QS189","Suicide prevention",4,null,"Adults presenting with suicidal thoughts or plans discuss whether they would like their family, carers or friends to be involved in their care and are made aware of the limits of confidentiality.","Proportion of adults presenting with suicidal thoughts or plans who discuss whether they would like their family, carers or friends to be involved in their care.","Process","QS189 - Suicide prevention","4 - QS189 - Suicide prevention",1,"4 - QS189 - Suicide prevention - Process - 1","The number in the denominator who discuss whether they would like their family, carers or friends to be involved in their care.","The number of adults presenting with suicidal thoughts or plans."]
[null,"QS189","Suicide prevention",4,null,"Adults presenting with suicidal thoughts or plans discuss whether they would like their family, carers or friends to be involved in their care and are made aware of the limits of confidentiality.","Proportion of adults presenting with suicidal thoughts or plans who are made aware of the limits of confidentiality.","Process","QS189 - Suicide prevention","4 - QS189 - Suicide prevention",2,"4 - QS189 - Suicide prevention - Process - 2","The number in the denominator who are made aware of the limits of confidentiality.","The number of adults presenting with suicidal thoughts or plans."]
[null,"QS189","Suicide prevention",4,null,"Adults presenting with suicidal thoughts or plans discuss whether they would like their family, carers or friends to be involved in their care and are made aware of the limits of confidentiality.","Proportion of assessments for adults who presented with suicidal thoughts or plans who wanted their family, carers or friends involved, that involved family, carers or friends.","Outcome","QS189 - Suicide prevention","4 - QS189 - Suicide prevention",1,"4 - QS189 - Suicide prevention - Outcome - 1","The number in the denominator that involved family, carers or friends.","The number of assessments for adults who presented with suicidal thoughts or plans who wanted their family, carers or friends involved."]
[null,"QS189","Suicide prevention",4,null,"Adults presenting with suicidal thoughts or plans discuss whether they would like their family, carers or friends to be involved in their care and are made aware of the limits of confidentiality.","Proportion of family members, carers or friends of adults who presented with suicidal thoughts or plans who are satisfied with information sharing about suicide risk.","Outcome","QS189 - Suicide prevention","4 - QS189 - Suicide prevention",2,"4 - QS189 - Suicide prevention - Outcome - 2","The number in the denominator who are satisfied with information sharing about suicide risk.","The number of family members, carers or friends of adults who presented with suicidal thoughts or plans."]
[null,"QS189","Suicide prevention",4,null,"Adults presenting with suicidal thoughts or plans discuss whether they would like their family, carers or friends to be involved in their care and are made aware of the limits of confidentiality.","Suicide rate.","Outcome","QS189 - Suicide prevention","4 - QS189 - Suicide prevention",3,"4 - QS189 - Suicide prevention - Outcome - 3"]
[null,"QS189","Suicide prevention",5,null,"People bereaved or affected by a suspected suicide are given information and offered tailored support.","Evidence of local arrangements to use rapid intelligence gathering to identify people who may be bereaved or affected by a suspected suicide.","Structure","QS189 - Suicide prevention","5 - QS189 - Suicide prevention",1,"5 - QS189 - Suicide prevention - Structure - 1"]
[null,"QS189","Suicide prevention",5,null,"People bereaved or affected by a suspected suicide are given information and offered tailored support.","Evidence of local processes to give information to people bereaved or affected by a suspected suicide and to ask if they need help.","Structure","QS189 - Suicide prevention","5 - QS189 - Suicide prevention",2,"5 - QS189 - Suicide prevention - Structure - 2"]
[null,"QS189","Suicide prevention",5,null,"People bereaved or affected by a suspected suicide are given information and offered tailored support.","Evidence of local services that can provide support to people bereaved or affected by a suspected suicide.","Structure","QS189 - Suicide prevention","5 - QS189 - Suicide prevention",3,"5 - QS189 - Suicide prevention - Structure - 3"]
[null,"QS189","Suicide prevention",5,null,"People bereaved or affected by a suspected suicide are given information and offered tailored support.","Proportion of people bereaved or affected by a suspected suicide who are given information.","Process","QS189 - Suicide prevention","5 - QS189 - Suicide prevention",1,"5 - QS189 - Suicide prevention - Process - 1","The number in the denominator who are given information.","The number of people bereaved or affected by a suspected suicide."]
[null,"QS189","Suicide prevention",5,null,"People bereaved or affected by a suspected suicide are given information and offered tailored support.","Proportion of people bereaved or affected by a suspected suicide who are asked if they need help.","Process","QS189 - Suicide prevention","5 - QS189 - Suicide prevention",2,"5 - QS189 - Suicide prevention - Process - 2","The number in the denominator who are asked if they need help.","The number of people bereaved or affected by a suspected suicide."]
[null,"QS189","Suicide prevention",5,null,"People bereaved or affected by a suspected suicide are given information and offered tailored support.","Proportion of people bereaved or affected by a suspected suicide who access tailored support.","Process","QS189 - Suicide prevention","5 - QS189 - Suicide prevention",3,"5 - QS189 - Suicide prevention - Process - 3","The number in the denominator who access tailored support.","The number of people bereaved or affected by a suspected suicide."]
[null,"QS189","Suicide prevention",5,null,"People bereaved or affected by a suspected suicide are given information and offered tailored support.","Proportion of people bereaved or affected by a suicide who are satisfied with information and support.","Outcome","QS189 - Suicide prevention","5 - QS189 - Suicide prevention",1,"5 - QS189 - Suicide prevention - Outcome - 1","The number in the denominator who are satisfied with information and support.","The number of people bereaved or affected by a suicide."]
[null,"QS189","Suicide prevention",5,null,"People bereaved or affected by a suspected suicide are given information and offered tailored support.","Number of suicides among people bereaved or affected by a suicide.","Outcome","QS189 - Suicide prevention","5 - QS189 - Suicide prevention",2,"5 - QS189 - Suicide prevention - Outcome - 2"]
[null,"QS190","Flu vaccination: increasing uptake",1,null,"Providers use a range of different methods to invite people in eligible groups for flu vaccination.","Evidence of local arrangements to ensure that providers have systems in place to invite people in eligible groups for flu vaccination using a range of different methods.","Structure","QS190 - Flu vaccination: increasing uptake","1 - QS190 - Flu vaccination: increasing uptake",1,"1 - QS190 - Flu vaccination: increasing uptake - Structure - 1"]
[null,"QS190","Flu vaccination: increasing uptake",1,null,"Providers use a range of different methods to invite people in eligible groups for flu vaccination.","Evidence of local arrangements to ensure that providers have systems in place to identify eligible groups when inviting them for flu vaccination.","Structure","QS190 - Flu vaccination: increasing uptake","1 - QS190 - Flu vaccination: increasing uptake",2,"1 - QS190 - Flu vaccination: increasing uptake - Structure - 2"]
[null,"QS190","Flu vaccination: increasing uptake",1,null,"Providers use a range of different methods to invite people in eligible groups for flu vaccination.","Flu vaccine uptake in eligible groups.","Outcome","QS190 - Flu vaccination: increasing uptake","1 - QS190 - Flu vaccination: increasing uptake",1,"1 - QS190 - Flu vaccination: increasing uptake - Outcome - 1"]
[null,"QS190","Flu vaccination: increasing uptake",2,null,"People in eligible groups receive invitations for flu vaccination that include information about their situation or clinical risk.","Evidence of local arrangements to identify groups eligible for the flu vaccine by their situation or clinical risk.","Structure",{"$f":"CONCATENATE(B4239, \" - \", C4239)","v":"QS190 - Flu vaccination: increasing uptake"},{"$f":"CONCATENATE(D4239, \" - \", I4239)","v":"2 - QS190 - Flu vaccination: increasing uptake"},{"$f":"IF(AND(B4239=B4238, D4239=D4238, H4239=H4238)=TRUE, K4238+1, 1)","v":1},{"$f":"CONCATENATE(J4239, \" - \", H4239, \" - \",K4239)","v":"2 - QS190 - Flu vaccination: increasing uptake - Structure - 1"}]
[null,"QS190","Flu vaccination: increasing uptake",2,null,"People in eligible groups receive invitations for flu vaccination that include information about their situation or clinical risk.","Evidence of local arrangements to create information that is tailored to different groups eligible for the flu vaccine.","Structure","QS190 - Flu vaccination: increasing uptake","2 - QS190 - Flu vaccination: increasing uptake",2,"2 - QS190 - Flu vaccination: increasing uptake - Structure - 2"]
[null,"QS190","Flu vaccination: increasing uptake",2,null,"People in eligible groups receive invitations for flu vaccination that include information about their situation or clinical risk.","Evidence of local arrangements to give tailored information through a variety of different methods to eligible groups when inviting them to receive the flu vaccine.\n","Structure","QS190 - Flu vaccination: increasing uptake","2 - QS190 - Flu vaccination: increasing uptake",3,"2 - QS190 - Flu vaccination: increasing uptake - Structure - 3"]
[null,"QS190","Flu vaccination: increasing uptake",2,null,"People in eligible groups receive invitations for flu vaccination that include information about their situation or clinical risk.","Proportion of people eligible to receive the flu vaccine who receive an invitation that includes information about their situation or clinical risk.","Process","QS190 - Flu vaccination: increasing uptake","2 - QS190 - Flu vaccination: increasing uptake",1,"2 - QS190 - Flu vaccination: increasing uptake - Process - 1","The number of people in the denominator who receive information about their situation or clinical risk on invitation for vaccination.","The number of people eligible to receive the flu vaccine."]
[null,"QS190","Flu vaccination: increasing uptake",2,null,"People in eligible groups receive invitations for flu vaccination that include information about their situation or clinical risk.","Flu vaccine uptake in eligible groups.","Outcome","QS190 - Flu vaccination: increasing uptake","2 - QS190 - Flu vaccination: increasing uptake",1,"2 - QS190 - Flu vaccination: increasing uptake - Outcome - 1"]
[null,"QS190","Flu vaccination: increasing uptake",3,null,"Non-general practice providers notify the relevant GP practice when they vaccinate their eligible patients.","Evidence of local agreements for sharing information about flu vaccination status between non-general practice providers of flu vaccination and commissioners.","Structure","QS190 - Flu vaccination: increasing uptake","3 - QS190 - Flu vaccination: increasing uptake",1,"3 - QS190 - Flu vaccination: increasing uptake - Structure - 1"]
[null,"QS190","Flu vaccination: increasing uptake",3,null,"Non-general practice providers notify the relevant GP practice when they vaccinate their eligible patients.","Evidence that providers of flu vaccination give timely, accurate and consistent notification to GP practices when they vaccinate their eligible patients.","Structure","QS190 - Flu vaccination: increasing uptake","3 - QS190 - Flu vaccination: increasing uptake",2,"3 - QS190 - Flu vaccination: increasing uptake - Structure - 2"]
[null,"QS190","Flu vaccination: increasing uptake",3,null,"Non-general practice providers notify the relevant GP practice when they vaccinate their eligible patients.","Evidence of the use of audit and monitoring systems by providers within a local health economy to review uptake data or vaccination status in health records.","Structure","QS190 - Flu vaccination: increasing uptake","3 - QS190 - Flu vaccination: increasing uptake",3,"3 - QS190 - Flu vaccination: increasing uptake - Structure - 3"]
[null,"QS190","Flu vaccination: increasing uptake",3,null,"Non-general practice providers notify the relevant GP practice when they vaccinate their eligible patients.","Evidence of arrangements for GP practices to make timely, accurate and consistent updates to patient records with auditable codes when notified that their eligible patients have received flu vaccination from another provider.","Structure","QS190 - Flu vaccination: increasing uptake","3 - QS190 - Flu vaccination: increasing uptake",4,"3 - QS190 - Flu vaccination: increasing uptake - Structure - 4"]
[null,"QS190","Flu vaccination: increasing uptake",3,null,"Non-general practice providers notify the relevant GP practice when they vaccinate their eligible patients.","Flu vaccine uptake in eligible groups.","Outcome","QS190 - Flu vaccination: increasing uptake","3 - QS190 - Flu vaccination: increasing uptake",1,"3 - QS190 - Flu vaccination: increasing uptake - Outcome - 1"]
[null,"QS190","Flu vaccination: increasing uptake",4,null,"Health and social care staff who have direct contact with people using services receive flu vaccination from their employer.","Evidence of local arrangements to make flu vaccination available to health and social care staff who have direct contact with people using services.","Structure","QS190 - Flu vaccination: increasing uptake","4 - QS190 - Flu vaccination: increasing uptake",1,"4 - QS190 - Flu vaccination: increasing uptake - Structure - 1"]
[null,"QS190","Flu vaccination: increasing uptake",4,null,"Health and social care staff who have direct contact with people using services receive flu vaccination from their employer.","Evidence of local arrangements to use audit and monitoring systems to plan flu vaccine delivery to health and social care staff.","Structure","QS190 - Flu vaccination: increasing uptake","4 - QS190 - Flu vaccination: increasing uptake",2,"4 - QS190 - Flu vaccination: increasing uptake - Structure - 2"]
[null,"QS190","Flu vaccination: increasing uptake",4,null,"Health and social care staff who have direct contact with people using services receive flu vaccination from their employer.","Flu vaccine uptake rates for healthcare staff who have direct contact with people using services.","Outcome","QS190 - Flu vaccination: increasing uptake","4 - QS190 - Flu vaccination: increasing uptake",1,"4 - QS190 - Flu vaccination: increasing uptake - Outcome - 1"]
[null,"QS190","Flu vaccination: increasing uptake",4,null,"Health and social care staff who have direct contact with people using services receive flu vaccination from their employer.","Flu vaccine uptake rates for social care staff who have direct contact with people using services.","Outcome","QS190 - Flu vaccination: increasing uptake","4 - QS190 - Flu vaccination: increasing uptake",2,"4 - QS190 - Flu vaccination: increasing uptake - Outcome - 2"]
[null,"QS191","Cerebral palsy in adults",1,null,"Adults with cerebral palsy are referred to a specialist multidisciplinary team if their ability to carry out usual daily activities deteriorates or is expected to deteriorate.","Evidence of local pathways to allow adults with cerebral palsy to be referred to a specialist multidisciplinary team.","Structure","QS191 - Cerebral palsy in adults","1 - QS191 - Cerebral palsy in adults",1,"1 - QS191 - Cerebral palsy in adults - Structure - 1"]
[null,"QS191","Cerebral palsy in adults",1,null,"Adults with cerebral palsy are referred to a specialist multidisciplinary team if their ability to carry out usual daily activities deteriorates or is expected to deteriorate.","Evidence of local networks of care providing access to specialists in adult rehabilitation medicine, neurodisability, physiotherapy, occupational therapy, and speech and language therapy.","Structure","QS191 - Cerebral palsy in adults","1 - QS191 - Cerebral palsy in adults",2,"1 - QS191 - Cerebral palsy in adults - Structure - 2"]
[null,"QS191","Cerebral palsy in adults",1,null,"Adults with cerebral palsy are referred to a specialist multidisciplinary team if their ability to carry out usual daily activities deteriorates or is expected to deteriorate.","Evidence of local services with specialist multidisciplinary teams.","Structure","QS191 - Cerebral palsy in adults","1 - QS191 - Cerebral palsy in adults",3,"1 - QS191 - Cerebral palsy in adults - Structure - 3"]
[null,"QS191","Cerebral palsy in adults",1,null,"Adults with cerebral palsy are referred to a specialist multidisciplinary team if their ability to carry out usual daily activities deteriorates or is expected to deteriorate.","Proportion of adults with cerebral palsy whose ability to carry out their usual daily activities deteriorates who are referred to a specialist multidisciplinary team.","Process","QS191 - Cerebral palsy in adults","1 - QS191 - Cerebral palsy in adults",1,"1 - QS191 - Cerebral palsy in adults - Process - 1","The number in the denominator who are referred to a specialist multidisciplinary team.","The number of adults with cerebral palsy whose ability to carry out their usual daily activities deteriorates."]
[null,"QS191","Cerebral palsy in adults",1,null,"Adults with cerebral palsy are referred to a specialist multidisciplinary team if their ability to carry out usual daily activities deteriorates or is expected to deteriorate.","Proportion of adults with cerebral palsy scheduled for neurosurgical or orthopaedic procedures who are referred to a specialist multidisciplinary team.","Process","QS191 - Cerebral palsy in adults","1 - QS191 - Cerebral palsy in adults",2,"1 - QS191 - Cerebral palsy in adults - Process - 2","The number in the denominator who are referred to a specialist multidisciplinary team.","The number of adults with cerebral palsy scheduled for neurological or orthopaedic procedures."]
[null,"QS191","Cerebral palsy in adults",1,null,"Adults with cerebral palsy are referred to a specialist multidisciplinary team if their ability to carry out usual daily activities deteriorates or is expected to deteriorate.","Rate of unplanned hospital admissions of adults with cerebral palsy.","Outcome","QS191 - Cerebral palsy in adults","1 - QS191 - Cerebral palsy in adults",1,"1 - QS191 - Cerebral palsy in adults - Outcome - 1"]
[null,"QS191","Cerebral palsy in adults",2,null,"Adults with cerebral palsy who have complex needs have an annual review with a healthcare professional with expertise in neurodisabilities.","Evidence of local systems and pathways to identify adults with cerebral palsy who have complex needs and invite them to have annual reviews.","Structure","QS191 - Cerebral palsy in adults","2 - QS191 - Cerebral palsy in adults",1,"2 - QS191 - Cerebral palsy in adults - Structure - 1"]
[null,"QS191","Cerebral palsy in adults",2,null,"Adults with cerebral palsy who have complex needs have an annual review with a healthcare professional with expertise in neurodisabilities.","Proportion of adults with cerebral palsy and complex needs who have had an annual review within the last 12 months carried out by a healthcare professional with expertise in neurodisabilities.","Process","QS191 - Cerebral palsy in adults","2 - QS191 - Cerebral palsy in adults",1,"2 - QS191 - Cerebral palsy in adults - Process - 1","The number in the denominator who have had an annual review within the last 12 months carried out by a healthcare professional with expertise in neurodisabilities.","The number of adults with cerebral palsy and complex needs."]
[null,"QS191","Cerebral palsy in adults",2,null,"Adults with cerebral palsy who have complex needs have an annual review with a healthcare professional with expertise in neurodisabilities.","Proportion of adults with cerebral palsy and complex needs who are given details of a main contact for support at their annual review.","Process","QS191 - Cerebral palsy in adults","2 - QS191 - Cerebral palsy in adults",2,"2 - QS191 - Cerebral palsy in adults - Process - 2","The number in the denominator given details of a main contact for support at their annual review.","The number of adults with cerebral palsy and complex needs who had an annual review."]
[null,"QS191","Cerebral palsy in adults",2,null,"Adults with cerebral palsy who have complex needs have an annual review with a healthcare professional with expertise in neurodisabilities.","Rate of unplanned hospital admissions of adults with cerebral palsy.","Outcome","QS191 - Cerebral palsy in adults","2 - QS191 - Cerebral palsy in adults",1,"2 - QS191 - Cerebral palsy in adults - Outcome - 1"]
[null,"QS191","Cerebral palsy in adults",2,null,"Adults with cerebral palsy who have complex needs have an annual review with a healthcare professional with expertise in neurodisabilities.","Health-related quality of life of adults with cerebral palsy and complex needs.","Outcome","QS191 - Cerebral palsy in adults","2 - QS191 - Cerebral palsy in adults",2,"2 - QS191 - Cerebral palsy in adults - Outcome - 2"]
[null,"QS191","Cerebral palsy in adults",3,null,"Adults with cerebral palsy who want support to live independently are referred to a professional with expertise in independent living.","Evidence of local pathways that allow adults with cerebral palsy to be referred to a professional with expertise in independent living.","Structure","QS191 - Cerebral palsy in adults","3 - QS191 - Cerebral palsy in adults",1,"3 - QS191 - Cerebral palsy in adults - Structure - 1"]
[null,"QS191","Cerebral palsy in adults",3,null,"Adults with cerebral palsy who want support to live independently are referred to a professional with expertise in independent living.","Evidence of local networks of care providing occupational therapy services to adults with cerebral palsy.","Structure","QS191 - Cerebral palsy in adults","3 - QS191 - Cerebral palsy in adults",2,"3 - QS191 - Cerebral palsy in adults - Structure - 2"]
[null,"QS191","Cerebral palsy in adults",3,null,"Adults with cerebral palsy who want support to live independently are referred to a professional with expertise in independent living.","Proportion of adults with cerebral palsy who want support to live independently referred to a professional with expertise in independent living.","Process","QS191 - Cerebral palsy in adults","3 - QS191 - Cerebral palsy in adults",1,"3 - QS191 - Cerebral palsy in adults - Process - 1","The number in the denominator referred to a professional with expertise in independent living.","The number of adults with cerebral palsy who want support to live independently."]
[null,"QS191","Cerebral palsy in adults",3,null,"Adults with cerebral palsy who want support to live independently are referred to a professional with expertise in independent living.","Proportion of adults with cerebral palsy who feel that they live independently.","Outcome","QS191 - Cerebral palsy in adults","3 - QS191 - Cerebral palsy in adults",1,"3 - QS191 - Cerebral palsy in adults - Outcome - 1","The number in the denominator who feel that they live independently.","The number of adults with cerebral palsy."]
[null,"QS191","Cerebral palsy in adults",4,null,"Adults with cerebral palsy who want support to work are referred to a professional with expertise in vocational skills and independent living.","Evidence of local networks of care providing occupational therapy and vocational rehabilitation services to adults with cerebral palsy.","Structure","QS191 - Cerebral palsy in adults","4 - QS191 - Cerebral palsy in adults",1,"4 - QS191 - Cerebral palsy in adults - Structure - 1"]
[null,"QS191","Cerebral palsy in adults",4,null,"Adults with cerebral palsy who want support to work are referred to a professional with expertise in vocational skills and independent living.","Proportion of adults with cerebral palsy who want support to start work referred to a professional with expertise in vocational skills and independent living.","Process","QS191 - Cerebral palsy in adults","4 - QS191 - Cerebral palsy in adults",1,"4 - QS191 - Cerebral palsy in adults - Process - 1","The number in the denominator referred to a professional with expertise in vocational skills and independent living.","The number of adults with cerebral palsy who want support to start work."]
[null,"QS191","Cerebral palsy in adults",4,null,"Adults with cerebral palsy who want support to work are referred to a professional with expertise in vocational skills and independent living.","Proportion of adults with cerebral palsy who want support to continue working referred to a professional with expertise in vocational skills and independent living.","Process","QS191 - Cerebral palsy in adults","4 - QS191 - Cerebral palsy in adults",2,"4 - QS191 - Cerebral palsy in adults - Process - 2","The number in the denominator referred to a professional with expertise in vocational skills and independent living.","The number of adults with cerebral palsy who want support to continue working."]
[null,"QS191","Cerebral palsy in adults",4,null,"Adults with cerebral palsy who want support to work are referred to a professional with expertise in vocational skills and independent living.","Employment rate of adults with cerebral palsy.","Outcome","QS191 - Cerebral palsy in adults","4 - QS191 - Cerebral palsy in adults",1,"4 - QS191 - Cerebral palsy in adults - Outcome - 1"]
[null,"QS191","Cerebral palsy in adults",5,null,"Adults with cerebral palsy who have communication difficulties have their need for intervention assessed by speech and language therapy services.","Evidence of processes to identify adults with cerebral palsy who have communication difficulties.","Structure","QS191 - Cerebral palsy in adults","5 - QS191 - Cerebral palsy in adults",1,"5 - QS191 - Cerebral palsy in adults - Structure - 1"]
[null,"QS191","Cerebral palsy in adults",5,null,"Adults with cerebral palsy who have communication difficulties have their need for intervention assessed by speech and language therapy services.","Evidence of local referral pathways to speech and language therapy services for adults with cerebral palsy who have communication difficulties.","Structure","QS191 - Cerebral palsy in adults","5 - QS191 - Cerebral palsy in adults",2,"5 - QS191 - Cerebral palsy in adults - Structure - 2"]
[null,"QS191","Cerebral palsy in adults",5,null,"Adults with cerebral palsy who have communication difficulties have their need for intervention assessed by speech and language therapy services.","Proportion of adults with cerebral palsy who have communication difficulties referred to speech and language therapy services to have their need for intervention assessed.","Process","QS191 - Cerebral palsy in adults","5 - QS191 - Cerebral palsy in adults",1,"5 - QS191 - Cerebral palsy in adults - Process - 1","The number in the denominator referred to a speech and language therapy service to have their need for intervention assessed.","The number of adults with cerebral palsy who have communication difficulties."]
[null,"QS191","Cerebral palsy in adults",5,null,"Adults with cerebral palsy who have communication difficulties have their need for intervention assessed by speech and language therapy services.","Proportion of adults with cerebral palsy who have communication difficulties referred to speech and language therapy services who have their need for intervention assessed.","Process","QS191 - Cerebral palsy in adults","5 - QS191 - Cerebral palsy in adults",2,"5 - QS191 - Cerebral palsy in adults - Process - 2","The number in the denominator who have their need for intervention assessed.","The number of adults with cerebral palsy who have communication difficulties referred to speech and language therapy services."]
[null,"QS191","Cerebral palsy in adults",5,null,"Adults with cerebral palsy who have communication difficulties have their need for intervention assessed by speech and language therapy services.","Change in therapy outcome measures (TOMs) following intervention.","Outcome",{"$f":"CONCATENATE(B4276, \" - \", C4276)","v":"QS191 - Cerebral palsy in adults"},{"$f":"CONCATENATE(D4276, \" - \", I4276)","v":"5 - QS191 - Cerebral palsy in adults"},{"$f":"IF(AND(B4276=B4275, D4276=D4275, H4276=H4275)=TRUE, K4275+1, 1)","v":1},{"$f":"CONCATENATE(J4276, \" - \", H4276, \" - \",K4276)","v":"5 - QS191 - Cerebral palsy in adults - Outcome - 1"}]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",1,null,"Pregnant women with existing medical conditions or obstetric complications are involved in developing and reviewing their individualised intrapartum care plan.","Evidence of local processes to provide opportunities for pregnant women with existing medical conditions or obstetric complications to discuss and make decisions on the intrapartum management of their medical conditions or obstetric complications.","Structure","QS192 - Intrapartum care: existing medical conditions and obstetric complications","1 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",1,"1 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Structure - 1"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",1,null,"Pregnant women with existing medical conditions or obstetric complications are involved in developing and reviewing their individualised intrapartum care plan.","Evidence of local processes to ensure that pregnant women with existing medical conditions or obstetric complications are supported to develop an intrapartum care plan.","Structure","QS192 - Intrapartum care: existing medical conditions and obstetric complications","1 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",2,"1 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Structure - 2"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",1,null,"Pregnant women with existing medical conditions or obstetric complications are involved in developing and reviewing their individualised intrapartum care plan.","Evidence of local arrangements to ensure that pregnant women with existing medical conditions or obstetric complications are supported to review their intrapartum care plan throughout pregnancy, including when their conditions change, and on admission for birth.","Structure","QS192 - Intrapartum care: existing medical conditions and obstetric complications","1 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",3,"1 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Structure - 3"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",1,null,"Pregnant women with existing medical conditions or obstetric complications are involved in developing and reviewing their individualised intrapartum care plan.","Proportion of pregnant women with existing medical conditions or obstetric complications with an individualised intrapartum care plan who reported that they were involved as much as they wanted to be in discussing and making decisions about their care when developing the plan.","Process","QS192 - Intrapartum care: existing medical conditions and obstetric complications","1 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",1,"1 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Process - 1","The number in the denominator who reported that they were involved as much as they wanted to be in discussing and making decisions about their care when developing the plan.","The number of pregnant women with existing medical conditions or obstetric complications with an individualised intrapartum care plan."]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",1,null,"Pregnant women with existing medical conditions or obstetric complications are involved in developing and reviewing their individualised intrapartum care plan.","Proportion of pregnant women with existing medical conditions or obstetric complications with an individualised intrapartum care plan, who reported that they were involved as much as they wanted to be in discussing and making decisions about their care when reviewing the plan on admission for birth.","Process","QS192 - Intrapartum care: existing medical conditions and obstetric complications","1 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",2,"1 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Process - 2","The number in the denominator who reported that they were involved as much as they wanted to be in discussing and making decisions about their care when reviewing the plan on admission for birth.","The number of pregnant women with existing medical conditions or obstetric complications with an individualised intrapartum care plan."]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",1,null,"Pregnant women with existing medical conditions or obstetric complications are involved in developing and reviewing their individualised intrapartum care plan.","Proportion of pregnant women with existing medical conditions or obstetric complications with an individualised intrapartum care plan, who reported that they were involved as much as they wanted to be in discussing and making decisions about their care when updating the plan when their medical condition changed.","Process","QS192 - Intrapartum care: existing medical conditions and obstetric complications","1 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",3,"1 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Process - 3","The number in the denominator who reported that they were involved as much as they wanted to be in discussing and making decisions about their care when updating the plan when their medical condition changed.","The number of pregnant women with existing medical conditions or obstetric complications with an individualised intrapartum care plan."]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",1,null,"Pregnant women with existing medical conditions or obstetric complications are involved in developing and reviewing their individualised intrapartum care plan.","Proportion of pregnant women with existing medical conditions or obstetric complications who felt that they were involved in preparing and reviewing their intrapartum care plan.","Outcome","QS192 - Intrapartum care: existing medical conditions and obstetric complications","1 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",1,"1 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Outcome - 1","The number in the denominator who were satisfied with their involvement in preparing and reviewing their intrapartum care plan.","The number of pregnant women with existing medical conditions or obstetric complications and an intrapartum care plan."]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",2,null,"Pregnant women with existing medical conditions are cared for by a multidisciplinary team that can access expertise in managing the medical conditions in pregnancy and is led by a named healthcare professional.","Evidence that multidisciplinary teams caring for pregnant women with existing medical conditions can access expertise in managing the medical conditions in pregnancy.","Structure","QS192 - Intrapartum care: existing medical conditions and obstetric complications","2 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",1,"2 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Structure - 1"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",2,null,"Pregnant women with existing medical conditions are cared for by a multidisciplinary team that can access expertise in managing the medical conditions in pregnancy and is led by a named healthcare professional.","Evidence that a named healthcare professional is available to lead the multidisciplinary team caring for pregnant women with existing medical conditions.","Structure","QS192 - Intrapartum care: existing medical conditions and obstetric complications","2 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",2,"2 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Structure - 2"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",2,null,"Pregnant women with existing medical conditions are cared for by a multidisciplinary team that can access expertise in managing the medical conditions in pregnancy and is led by a named healthcare professional.","Proportion of pregnant women with existing medical conditions cared for by a multidisciplinary team that can access expertise in managing the medical conditions in pregnancy.","Process","QS192 - Intrapartum care: existing medical conditions and obstetric complications","2 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",1,"2 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Process - 1","The number in the denominator with a multidisciplinary team that can access expertise in managing the medical conditions in pregnancy.","The number of pregnant women with existing medical conditions."]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",2,null,"Pregnant women with existing medical conditions are cared for by a multidisciplinary team that can access expertise in managing the medical conditions in pregnancy and is led by a named healthcare professional.","Proportion of pregnant women with existing medical conditions who were cared for by a multidisciplinary team that was led by a named healthcare professional.","Process","QS192 - Intrapartum care: existing medical conditions and obstetric complications","2 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",2,"2 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Process - 2","The number in the denominator who had a multidisciplinary team that was led by a named healthcare professional.","The number of pregnant women with existing medical conditions who were cared for by a multidisciplinary team."]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",2,null,"Pregnant women with existing medical conditions are cared for by a multidisciplinary team that can access expertise in managing the medical conditions in pregnancy and is led by a named healthcare professional.","Incidence of maternal morbidity associated with an existing medical condition.","Outcome","QS192 - Intrapartum care: existing medical conditions and obstetric complications","2 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",1,"2 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Outcome - 1"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",2,null,"Pregnant women with existing medical conditions are cared for by a multidisciplinary team that can access expertise in managing the medical conditions in pregnancy and is led by a named healthcare professional.","Incidence of maternal mortality associated with an existing medical condition.","Outcome","QS192 - Intrapartum care: existing medical conditions and obstetric complications","2 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",2,"2 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Outcome - 2"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",2,null,"Pregnant women with existing medical conditions are cared for by a multidisciplinary team that can access expertise in managing the medical conditions in pregnancy and is led by a named healthcare professional.","Incidence of neonatal mortality in babies of women with existing medical conditions.","Outcome",{"$f":"CONCATENATE(B4290, \" - \", C4290)","v":"QS192 - Intrapartum care: existing medical conditions and obstetric complications"},{"$f":"CONCATENATE(D4290, \" - \", I4290)","v":"2 - QS192 - Intrapartum care: existing medical conditions and obstetric complications"},{"$f":"IF(AND(B4290=B4289, D4290=D4289, H4290=H4289)=TRUE, K4289+1, 1)","v":3},{"$f":"CONCATENATE(J4290, \" - \", H4290, \" - \",K4290)","v":"2 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Outcome - 3"}]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",3,null,"Pregnant women with heart disease have their cardiovascular risk regularly assessed during pregnancy and the intrapartum period.","Evidence of local arrangements for pregnant women with heart disease to have their cardiovascular risk regularly assessed during pregnancy and the intrapartum period by a multidisciplinary team that includes a cardiologist with expertise in managing heart disease in pregnant women.","Structure","QS192 - Intrapartum care: existing medical conditions and obstetric complications","3 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",1,"3 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Structure - 1"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",3,null,"Pregnant women with heart disease have their cardiovascular risk regularly assessed during pregnancy and the intrapartum period.","Evidence of local arrangements for pregnant women with heart disease to have their cardiovascular risk regularly assessed during pregnancy and the intrapartum period.","Structure","QS192 - Intrapartum care: existing medical conditions and obstetric complications","3 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",2,"3 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Structure - 2"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",3,null,"Pregnant women with heart disease have their cardiovascular risk regularly assessed during pregnancy and the intrapartum period.","Proportion of pregnant women with heart disease who have their cardiovascular risk regularly assessed during pregnancy and the intrapartum period.","Process","QS192 - Intrapartum care: existing medical conditions and obstetric complications","3 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",1,"3 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Process - 1","The number in the denominator who have their cardiovascular risk regularly assessed during pregnancy and the intrapartum period.","The number of pregnant women with heart disease."]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",3,null,"Pregnant women with heart disease have their cardiovascular risk regularly assessed during pregnancy and the intrapartum period.","Rates of mortality during labour, birth and the early postnatal period for women with heart disease.","Outcome","QS192 - Intrapartum care: existing medical conditions and obstetric complications","3 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",1,"3 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Outcome - 1"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",4,null,"Pregnant women in labour with sepsis have an immediate review by a senior clinical decision maker and antibiotics given within 1 hour if indicated.","Evidence of local arrangements to support escalation protocols to ensure that pregnant women in labour with sepsis are transferred from home birth and midwifery-led units to an acute setting for review and start antibiotic treatment (if indicated) within 1 hour.","Structure","QS192 - Intrapartum care: existing medical conditions and obstetric complications","4 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",1,"4 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Structure - 1"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",4,null,"Pregnant women in labour with sepsis have an immediate review by a senior clinical decision maker and antibiotics given within 1 hour if indicated.","Evidence of local arrangements to ensure availability of, or access to, a senior clinical decision maker for pregnant women in labour with sepsis to have an immediate review.","Structure","QS192 - Intrapartum care: existing medical conditions and obstetric complications","4 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",2,"4 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Structure - 2"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",4,null,"Pregnant women in labour with sepsis have an immediate review by a senior clinical decision maker and antibiotics given within 1 hour if indicated."," Evidence of local arrangements to start antibiotic treatment, if indicated, for pregnant women in labour with sepsis within 1 hour.","Structure","QS192 - Intrapartum care: existing medical conditions and obstetric complications","4 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",3,"4 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Structure - 3"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",4,null,"Pregnant women in labour with sepsis have an immediate review by a senior clinical decision maker and antibiotics given within 1 hour if indicated.","Evidence of local arrangements to document the decision to start antibiotic treatment for pregnant women in labour with sepsis.","Structure","QS192 - Intrapartum care: existing medical conditions and obstetric complications","4 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",4,"4 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Structure - 4"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",4,null,"Pregnant women in labour with sepsis have an immediate review by a senior clinical decision maker and antibiotics given within 1 hour if indicated.","Proportion of pregnant women in labour with sepsis who have an immediate review by a senior clinical decision maker.","Process","QS192 - Intrapartum care: existing medical conditions and obstetric complications","4 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",1,"4 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Process - 1","The number in the denominator who have an immediate review by a senior clinical decision maker.","The number of pregnant women in labour with sepsis."]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",4,null,"Pregnant women in labour with sepsis have an immediate review by a senior clinical decision maker and antibiotics given within 1 hour if indicated.","Proportion of pregnant women in labour with sepsis who started antibiotics within 1 hour.","Process","QS192 - Intrapartum care: existing medical conditions and obstetric complications","4 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",2,"4 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Process - 2","The number in the denominator who started antibiotics within 1 hour.","The number of pregnant women in labour with sepsis who needed antibiotics."]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",4,null,"Pregnant women in labour with sepsis have an immediate review by a senior clinical decision maker and antibiotics given within 1 hour if indicated.","Proportion of pregnant women in labour with sepsis who had the rationale for the decision to start antibiotics documented.","Process","QS192 - Intrapartum care: existing medical conditions and obstetric complications","4 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",3,"4 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Process - 3","The number in the denominator who had the rationale for the decision to start antibiotics documented.","The number of pregnant women in labour with sepsis who had antibiotics."]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",5,null,"Pregnant women who present in labour with no antenatal care have an obstetric assessment and medical examination, and assessment of their medical, psychological, and social history.","Evidence of local processes to ensure that pregnant women who present in labour with no antenatal care have an obstetric assessment and medical examination by an obstetrician.","Structure","QS192 - Intrapartum care: existing medical conditions and obstetric complications","5 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",1,"5 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Structure - 1"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",5,null,"Pregnant women who present in labour with no antenatal care have an obstetric assessment and medical examination, and assessment of their medical, psychological, and social history.","Evidence of local processes to ensure that pregnant women who present in labour with no antenatal care have an assessment of their medical, psychological and social history.","Structure",{"$f":"CONCATENATE(B4303, \" - \", C4303)","v":"QS192 - Intrapartum care: existing medical conditions and obstetric complications"},{"$f":"CONCATENATE(D4303, \" - \", I4303)","v":"5 - QS192 - Intrapartum care: existing medical conditions and obstetric complications"},{"$f":"IF(AND(B4303=B4302, D4303=D4302, H4303=H4302)=TRUE, K4302+1, 1)","v":2},{"$f":"CONCATENATE(J4303, \" - \", H4303, \" - \",K4303)","v":"5 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Structure - 2"}]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",5,null,"Pregnant women who present in labour with no antenatal care have an obstetric assessment and medical examination, and assessment of their medical, psychological, and social history.","Evidence of training for healthcare professionals on understanding multiple disadvantage, supporting women with complex social factors and trauma-informed care.","Structure","QS192 - Intrapartum care: existing medical conditions and obstetric complications","5 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",3,"5 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Structure - 3"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",5,null,"Pregnant women who present in labour with no antenatal care have an obstetric assessment and medical examination, and assessment of their medical, psychological, and social history.","Proportion of pregnant women who present in labour with no antenatal care who have an obstetric assessment and medical examination.","Process","QS192 - Intrapartum care: existing medical conditions and obstetric complications","5 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",1,"5 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Process - 1","The number in the denominator who had an obstetric assessment and medical examination.","The number of pregnant women who present in labour with no antenatal care."]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",5,null,"Pregnant women who present in labour with no antenatal care have an obstetric assessment and medical examination, and assessment of their medical, psychological, and social history.","Proportion of pregnant women who present in labour with no antenatal care who have an assessment of their medical, psychological and social history.","Process","QS192 - Intrapartum care: existing medical conditions and obstetric complications","5 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",2,"5 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Process - 2","The number in the denominator who have an assessment of their medical, psychological and social history.","The number of pregnant women who present in labour with no antenatal care."]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",5,null,"Pregnant women who present in labour with no antenatal care have an obstetric assessment and medical examination, and assessment of their medical, psychological, and social history.","Incidence of maternal mortality associated with no antenatal care on presentation in labour.","Outcome","QS192 - Intrapartum care: existing medical conditions and obstetric complications","5 - QS192 - Intrapartum care: existing medical conditions and obstetric complications",1,"5 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Outcome - 1"]
[null,"QS192","Intrapartum care: existing medical conditions and obstetric complications",5,null,"Pregnant women who present in labour with no antenatal care have an obstetric assessment and medical examination, and assessment of their medical, psychological, and social history.","Incidence of neonatal mortality associated with no antenatal care for the mother on presentation in labour.","Outcome",{"$f":"CONCATENATE(B4308, \" - \", C4308)","v":"QS192 - Intrapartum care: existing medical conditions and obstetric complications"},{"$f":"CONCATENATE(D4308, \" - \", I4308)","v":"5 - QS192 - Intrapartum care: existing medical conditions and obstetric complications"},{"$f":"IF(AND(B4308=B4307, D4308=D4307, H4308=H4307)=TRUE, K4307+1, 1)","v":2},{"$f":"CONCATENATE(J4308, \" - \", H4308, \" - \",K4308)","v":"5 - QS192 - Intrapartum care: existing medical conditions and obstetric complications - Outcome - 2"}]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",1,null,"Preterm babies having respiratory support soon after birth and before admission to the neonatal unit are given continuous positive airways pressure (CPAP), if clinically appropriate, rather than invasive ventilation.","Evidence of local arrangements to ensure that preterm babies having respiratory support soon after birth and before admission to the neonatal unit are given CPAP where clinically appropriate.","Structure","QS193 - Specialist neonatal respiratory care for babies born preterm","1 - QS193 - Specialist neonatal respiratory care for babies born preterm",1,"1 - QS193 - Specialist neonatal respiratory care for babies born preterm - Structure - 1"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",1,null,"Preterm babies having respiratory support soon after birth and before admission to the neonatal unit are given continuous positive airways pressure (CPAP), if clinically appropriate, rather than invasive ventilation.","Evidence of staff training available for neonatal CPAP.","Structure","QS193 - Specialist neonatal respiratory care for babies born preterm","1 - QS193 - Specialist neonatal respiratory care for babies born preterm",2,"1 - QS193 - Specialist neonatal respiratory care for babies born preterm - Structure - 2"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",1,null,"Preterm babies having respiratory support soon after birth and before admission to the neonatal unit are given continuous positive airways pressure (CPAP), if clinically appropriate, rather than invasive ventilation.","Proportion of preterm babies born under 28 weeks of pregnancy who had invasive ventilation in the delivery room.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","1 - QS193 - Specialist neonatal respiratory care for babies born preterm",1,"1 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 1","The number in the denominator who had invasive ventilation in the delivery room.","The number of preterm babies born under 28 weeks of pregnancy."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",1,null,"Preterm babies having respiratory support soon after birth and before admission to the neonatal unit are given continuous positive airways pressure (CPAP), if clinically appropriate, rather than invasive ventilation.","Proportion of preterm babies born between 28 weeks and 31 weeks plus 6 days of pregnancy who had invasive ventilation in the delivery room.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","1 - QS193 - Specialist neonatal respiratory care for babies born preterm",2,"1 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 2","The number in the denominator who had invasive ventilation in the delivery room.","The number of preterm babies born between 28 weeks and 31 weeks plus 6 days of pregnancy."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",1,null,"Preterm babies having respiratory support soon after birth and before admission to the neonatal unit are given continuous positive airways pressure (CPAP), if clinically appropriate, rather than invasive ventilation.","Proportion of preterm babies born between 32 weeks and 36 weeks plus 6 days of pregnancy who had invasive ventilation in the delivery room.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","1 - QS193 - Specialist neonatal respiratory care for babies born preterm",3,"1 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 3","The number in the denominator who had invasive ventilation in the delivery room.","The number of preterm babies born between 32 weeks and 36 weeks plus 6 days of pregnancy."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",1,null,"Preterm babies having respiratory support soon after birth and before admission to the neonatal unit are given continuous positive airways pressure (CPAP), if clinically appropriate, rather than invasive ventilation.","Number of preterm babies with BPD.","Outcome","QS193 - Specialist neonatal respiratory care for babies born preterm","1 - QS193 - Specialist neonatal respiratory care for babies born preterm",1,"1 - QS193 - Specialist neonatal respiratory care for babies born preterm - Outcome - 1"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",2,null,"Preterm babies who need surfactant are given it using a minimally invasive technique if they do not need invasive ventilation.","Evidence of local arrangements to ensure that preterm babies who need surfactant receive it using a minimally invasive technique if they do not need invasive ventilation.","Structure","QS193 - Specialist neonatal respiratory care for babies born preterm","2 - QS193 - Specialist neonatal respiratory care for babies born preterm",1,"2 - QS193 - Specialist neonatal respiratory care for babies born preterm - Structure - 1"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",2,null,"Preterm babies who need surfactant are given it using a minimally invasive technique if they do not need invasive ventilation.","Evidence of staff training in a minimally invasive surfactant administration technique.","Structure",{"$f":"CONCATENATE(B4316, \" - \", C4316)","v":"QS193 - Specialist neonatal respiratory care for babies born preterm"},{"$f":"CONCATENATE(D4316, \" - \", I4316)","v":"2 - QS193 - Specialist neonatal respiratory care for babies born preterm"},{"$f":"IF(AND(B4316=B4315, D4316=D4315, H4316=H4315)=TRUE, K4315+1, 1)","v":2},{"$f":"CONCATENATE(J4316, \" - \", H4316, \" - \",K4316)","v":"2 - QS193 - Specialist neonatal respiratory care for babies born preterm - Structure - 2"}]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",2,null,"Preterm babies who need surfactant are given it using a minimally invasive technique if they do not need invasive ventilation.","Proportion of preterm babies born under 28 weeks of pregnancy who are given surfactant using a minimally invasive technique.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","2 - QS193 - Specialist neonatal respiratory care for babies born preterm",1,"2 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 1","The number in the denominator who are given surfactant using a minimally invasive technique.","The number of preterm babies born under 28 weeks of pregnancy who are given surfactant."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",2,null,"Preterm babies who need surfactant are given it using a minimally invasive technique if they do not need invasive ventilation.","Proportion of preterm babies born between 28 weeks and 31 weeks plus 6 days of pregnancy who are given surfactant using a minimally invasive technique.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","2 - QS193 - Specialist neonatal respiratory care for babies born preterm",2,"2 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 2","The number in the denominator who are given surfactant using a minimally invasive technique.","The number of preterm babies born between 28 weeks and 31 weeks plus 6 days of pregnancy who are given surfactant."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",2,null,"Preterm babies who need surfactant are given it using a minimally invasive technique if they do not need invasive ventilation.","Proportion of preterm babies born between 32 weeks and 36 weeks plus 6 days of pregnancy who are given surfactant using a minimally invasive technique.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","2 - QS193 - Specialist neonatal respiratory care for babies born preterm",3,"2 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 3","The number in the denominator who are given surfactant using a minimally invasive technique.","The number of preterm babies born between 32 weeks and 36 weeks plus 6 days of pregnancy who are given surfactant."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",2,null,"Preterm babies who need surfactant are given it using a minimally invasive technique if they do not need invasive ventilation.","Incidence of pneumothorax in preterm babies.","Outcome","QS193 - Specialist neonatal respiratory care for babies born preterm","2 - QS193 - Specialist neonatal respiratory care for babies born preterm",1,"2 - QS193 - Specialist neonatal respiratory care for babies born preterm - Outcome - 1"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",2,null,"Preterm babies who need surfactant are given it using a minimally invasive technique if they do not need invasive ventilation.","Number of preterm babies with BPD.","Outcome","QS193 - Specialist neonatal respiratory care for babies born preterm","2 - QS193 - Specialist neonatal respiratory care for babies born preterm",2,"2 - QS193 - Specialist neonatal respiratory care for babies born preterm - Outcome - 2"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",3,null,"Preterm babies having invasive ventilation are given volume-targeted ventilation (VTV) in combination with synchronised ventilation.","Evidence of local arrangements to ensure that preterm babies having invasive ventilation are given VTV in combination with synchronised ventilation.","Structure","QS193 - Specialist neonatal respiratory care for babies born preterm","3 - QS193 - Specialist neonatal respiratory care for babies born preterm",1,"3 - QS193 - Specialist neonatal respiratory care for babies born preterm - Structure - 1"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",3,null,"Preterm babies having invasive ventilation are given volume-targeted ventilation (VTV) in combination with synchronised ventilation.","Proportion of preterm babies born under 28 weeks of pregnancy having invasive ventilation who were given VTV in combination with synchronised ventilation.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","3 - QS193 - Specialist neonatal respiratory care for babies born preterm",1,"3 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 1","The number in the denominator who were given VTV in combination with synchronised ventilation.","The number of preterm babies born under 28 weeks of pregnancy having invasive ventilation."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",3,null,"Preterm babies having invasive ventilation are given volume-targeted ventilation (VTV) in combination with synchronised ventilation.","Proportion of preterm babies born between 28 weeks and 31 weeks plus 6 days of pregnancy having invasive ventilation who were given VTV in combination with synchronised ventilation.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","3 - QS193 - Specialist neonatal respiratory care for babies born preterm",2,"3 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 2","The number in the denominator who were given VTV in combination with synchronised ventilation.","The number of preterm babies born between 28 weeks and 31 weeks plus 6 days of pregnancy having invasive ventilation."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",3,null,"Preterm babies having invasive ventilation are given volume-targeted ventilation (VTV) in combination with synchronised ventilation.","Proportion of preterm babies born between 32 weeks and 36 weeks plus 6 days of pregnancy having invasive ventilation who were given VTV in combination with synchronised ventilation.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","3 - QS193 - Specialist neonatal respiratory care for babies born preterm",3,"3 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 3","The number in the denominator who were given VTV in combination with synchronised ventilation.","The number of preterm babies born between 32 weeks and 36 weeks plus 6 days of pregnancy having invasive ventilation."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",3,null,"Preterm babies having invasive ventilation are given volume-targeted ventilation (VTV) in combination with synchronised ventilation.","Number of days preterm babies spend on invasive ventilation.","Outcome","QS193 - Specialist neonatal respiratory care for babies born preterm","3 - QS193 - Specialist neonatal respiratory care for babies born preterm",1,"3 - QS193 - Specialist neonatal respiratory care for babies born preterm - Outcome - 1"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",3,null,"Preterm babies having invasive ventilation are given volume-targeted ventilation (VTV) in combination with synchronised ventilation.","Incidence of pneumothorax in preterm babies.","Outcome","QS193 - Specialist neonatal respiratory care for babies born preterm","3 - QS193 - Specialist neonatal respiratory care for babies born preterm",2,"3 - QS193 - Specialist neonatal respiratory care for babies born preterm - Outcome - 2"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",3,null,"Preterm babies having invasive ventilation are given volume-targeted ventilation (VTV) in combination with synchronised ventilation.","Number of preterm babies with BPD.","Outcome","QS193 - Specialist neonatal respiratory care for babies born preterm","3 - QS193 - Specialist neonatal respiratory care for babies born preterm",3,"3 - QS193 - Specialist neonatal respiratory care for babies born preterm - Outcome - 3"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",4,null,"Preterm babies have a target oxygen saturation of 91% to 95% after stabilisation.","Evidence of local arrangements to ensure that preterm babies have a target oxygen saturation of 91% to 95% after stabilisation.","Structure","QS193 - Specialist neonatal respiratory care for babies born preterm","4 - QS193 - Specialist neonatal respiratory care for babies born preterm",1,"4 - QS193 - Specialist neonatal respiratory care for babies born preterm - Structure - 1"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",4,null,"Preterm babies have a target oxygen saturation of 91% to 95% after stabilisation.","Proportion of preterm babies who have a target oxygen saturation set at between 91% and 95% after stabilisation.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","4 - QS193 - Specialist neonatal respiratory care for babies born preterm",1,"4 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 1","The number in the denominator who have a target oxygen saturation between 91% and 95%","The number of preterm babies receiving oxygen after stabilisation."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",4,null,"Preterm babies have a target oxygen saturation of 91% to 95% after stabilisation.","Mortality rates in preterm babies.","Outcome",{"$f":"CONCATENATE(B4331, \" - \", C4331)","v":"QS193 - Specialist neonatal respiratory care for babies born preterm"},{"$f":"CONCATENATE(D4331, \" - \", I4331)","v":"4 - QS193 - Specialist neonatal respiratory care for babies born preterm"},{"$f":"IF(AND(B4331=B4330, D4331=D4330, H4331=H4330)=TRUE, K4330+1, 1)","v":1},{"$f":"CONCATENATE(J4331, \" - \", H4331, \" - \",K4331)","v":"4 - QS193 - Specialist neonatal respiratory care for babies born preterm - Outcome - 1"}]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",5,null,"Parents and carers of preterm babies who are having respiratory support are helped to care for their baby.","Evidence of local arrangements to ensure that parents and carers of preterm babies having respiratory support are involved in discussions and decisions about their baby during ward rounds.","Structure","QS193 - Specialist neonatal respiratory care for babies born preterm","5 - QS193 - Specialist neonatal respiratory care for babies born preterm",1,"5 - QS193 - Specialist neonatal respiratory care for babies born preterm - Structure - 1"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",5,null,"Parents and carers of preterm babies who are having respiratory support are helped to care for their baby.","Evidence of local arrangements to ensure that parents and carers of preterm babies having respiratory support have 24-hour access to their baby.","Structure","QS193 - Specialist neonatal respiratory care for babies born preterm","5 - QS193 - Specialist neonatal respiratory care for babies born preterm",2,"5 - QS193 - Specialist neonatal respiratory care for babies born preterm - Structure - 2"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",5,null,"Parents and carers of preterm babies who are having respiratory support are helped to care for their baby.","Evidence of local arrangements to ensure parents and carers of preterm babies having respiratory support are involved in their baby's day-to-day care and are able to use specialist equipment on discharge.","Structure","QS193 - Specialist neonatal respiratory care for babies born preterm","5 - QS193 - Specialist neonatal respiratory care for babies born preterm",3,"5 - QS193 - Specialist neonatal respiratory care for babies born preterm - Structure - 3"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",5,null,"Parents and carers of preterm babies who are having respiratory support are helped to care for their baby.","Evidence of local arrangements to ensure that parents and carers of preterm babies having respiratory support are offered psychological support while their baby is on respiratory support.","Structure","QS193 - Specialist neonatal respiratory care for babies born preterm","5 - QS193 - Specialist neonatal respiratory care for babies born preterm",4,"5 - QS193 - Specialist neonatal respiratory care for babies born preterm - Structure - 4"]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",5,null,"Parents and carers of preterm babies who are having respiratory support are helped to care for their baby.","Proportion of parents and carers of preterm babies having respiratory support who are involved in discussions and decisions about their baby during ward rounds.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","5 - QS193 - Specialist neonatal respiratory care for babies born preterm",1,"5 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 1","The number in the denominator who are involved in discussions and decisions about their baby during ward rounds.","The number of parents and carers of preterm babies having respiratory support."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",5,null,"Parents and carers of preterm babies who are having respiratory support are helped to care for their baby.","Proportion of parents and carers of preterm babies having respiratory support who have 24-hour access to their baby.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","5 - QS193 - Specialist neonatal respiratory care for babies born preterm",2,"5 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 2","The number in the denominator who have 24-hour access to their baby.","The number of parents and carers of preterm babies having respiratory support."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",5,null,"Parents and carers of preterm babies who are having respiratory support are helped to care for their baby.","Proportion of parents and carers of preterm babies having respiratory support who are involved in providing their baby's day-to-day care.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","5 - QS193 - Specialist neonatal respiratory care for babies born preterm",3,"5 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 3","The number in the denominator who are involved in providing their baby's day-to-day care.","The number of parents and carers of preterm babies having respiratory support."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",5,null,"Parents and carers of preterm babies who are having respiratory support are helped to care for their baby.","Proportion of parents and carers of preterm babies who will need respiratory support following discharge who receive training to use specialist equipment before their baby is discharged.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","5 - QS193 - Specialist neonatal respiratory care for babies born preterm",4,"5 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 4","The number in the denominator who receive training to use specialist equipment before their baby is discharged.","The number of parents and carers of preterm babies who will need respiratory support following discharge."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",5,null,"Parents and carers of preterm babies who are having respiratory support are helped to care for their baby.","Proportion of parents and carers of preterm babies having respiratory support who can access psychological support while their baby is on the neonatal unit.","Process","QS193 - Specialist neonatal respiratory care for babies born preterm","5 - QS193 - Specialist neonatal respiratory care for babies born preterm",5,"5 - QS193 - Specialist neonatal respiratory care for babies born preterm - Process - 5","The number in the denominator who can access psychological support.","The number of parents and carers of preterm babies having respiratory support on the neonatal unit."]
[null,"QS193","Specialist neonatal respiratory care for babies born preterm",5,null,"Parents and carers of preterm babies who are having respiratory support are helped to care for their baby.","Proportion of parents and carers of preterm babies who had respiratory support who feel confident to care for their preterm baby at home.","Outcome","QS193 - Specialist neonatal respiratory care for babies born preterm","5 - QS193 - Specialist neonatal respiratory care for babies born preterm",1,"5 - QS193 - Specialist neonatal respiratory care for babies born preterm - Outcome - 1","The number in the denominator who feel confident to care for their preterm baby at home.","The number of parents and carers of preterm babies who had respiratory support."]
[null,"QS195","Renal and ureteric stones",1,null,"Adults with suspected renal colic have low-dose non-contrast CT within 24 hours of presentation.","Evidence of the availability of CT scanning equipment to perform low-dose non-contrast CT scans for adults with suspected renal colic.","Structure",{"$f":"CONCATENATE(B4342, \" - \", C4342)","v":"QS195 - Renal and ureteric stones"},{"$f":"CONCATENATE(D4342, \" - \", I4342)","v":"1 - QS195 - Renal and ureteric stones"},{"$f":"IF(AND(B4342=B4341, D4342=D4341, H4342=H4341)=TRUE, K4341+1, 1)","v":1},{"$f":"CONCATENATE(J4342, \" - \", H4342, \" - \",K4342)","v":"1 - QS195 - Renal and ureteric stones - Structure - 1"}]
[null,"QS195","Renal and ureteric stones",1,null,"Adults with suspected renal colic have low-dose non-contrast CT within 24 hours of presentation.","Evidence of the availability of staff to perform low-dose non-contrast CT scans for adults within 24 hours of presentation with suspected renal colic.","Structure","QS195 - Renal and ureteric stones","1 - QS195 - Renal and ureteric stones",2,"1 - QS195 - Renal and ureteric stones - Structure - 2"]
[null,"QS195","Renal and ureteric stones",1,null,"Adults with suspected renal colic have low-dose non-contrast CT within 24 hours of presentation.","Proportion of low-dose non-contrast CT scans performed within 24 hours of presentation for adults who presented in primary care with suspected renal colic.","Process","QS195 - Renal and ureteric stones","1 - QS195 - Renal and ureteric stones",1,"1 - QS195 - Renal and ureteric stones - Process - 1","The number in the denominator performed within 24 hours of presentation.","The number of low-dose non-contrast CT scans for adults who presented in primary care with suspected renal colic."]
[null,"QS195","Renal and ureteric stones",1,null,"Adults with suspected renal colic have low-dose non-contrast CT within 24 hours of presentation.","Proportion of low-dose non-contrast CT scans performed within 24 hours of presentation for adults who presented in an emergency department with suspected renal colic.","Process","QS195 - Renal and ureteric stones","1 - QS195 - Renal and ureteric stones",2,"1 - QS195 - Renal and ureteric stones - Process - 2","The number in the denominator performed within 24 hours of presentation.","The number of low-dose non-contrast CT scans for adults who presented in an emergency department with suspected renal colic."]
[null,"QS195","Renal and ureteric stones",1,null,"Adults with suspected renal colic have low-dose non-contrast CT within 24 hours of presentation.","Average time from people presenting with suspected renal colic to having a low-dose non-contrast CT scan.","Process","QS195 - Renal and ureteric stones","1 - QS195 - Renal and ureteric stones",3,"1 - QS195 - Renal and ureteric stones - Process - 3","Numerator to be decided locally","Denominator to be decided locally"]
[null,"QS195","Renal and ureteric stones",1,null,"Adults with suspected renal colic have low-dose non-contrast CT within 24 hours of presentation.","Level of renal function for people with renal and ureteric stones.","Outcome","QS195 - Renal and ureteric stones","1 - QS195 - Renal and ureteric stones",1,"1 - QS195 - Renal and ureteric stones - Outcome - 1"]
[null,"QS195","Renal and ureteric stones",2,null,"Adults, children and young people with suspected renal colic receive a non-steroidal anti-inflammatory drug (NSAID) as first-line treatment.","Evidence of written clinical protocols to ensure that people with suspected renal colic are offered an NSAID as first-line treatment, unless it is contraindicated.","Structure","QS195 - Renal and ureteric stones","2 - QS195 - Renal and ureteric stones",1,"2 - QS195 - Renal and ureteric stones - Structure - 1"]
[null,"QS195","Renal and ureteric stones",2,null,"Adults, children and young people with suspected renal colic receive a non-steroidal anti-inflammatory drug (NSAID) as first-line treatment.","Proportion of adults, children and young people newly presenting with suspected renal colic, and no contraindications for an NSAID, who receive an NSAID as first-line treatment.","Process","QS195 - Renal and ureteric stones","2 - QS195 - Renal and ureteric stones",1,"2 - QS195 - Renal and ureteric stones - Process - 1","The number in the denominator who receive an NSAID as first-line treatment.","The number of adults, children and young people newly presenting with suspected renal colic and no contraindications for an NSAID."]
[null,"QS195","Renal and ureteric stones",2,null,"Adults, children and young people with suspected renal colic receive a non-steroidal anti-inflammatory drug (NSAID) as first-line treatment.","Self-reported pain score of people with suspected renal colic after receiving pain management.","Outcome","QS195 - Renal and ureteric stones","2 - QS195 - Renal and ureteric stones",1,"2 - QS195 - Renal and ureteric stones - Outcome - 1"]
[null,"QS195","Renal and ureteric stones",3,null,"Adults with ureteric stones and renal colic have surgical treatment within 48 hours of diagnosis or readmission, if pain is ongoing and not tolerated, or the stone is unlikely to pass.","Evidence of local referral pathways to ensure that adults with ureteric stones and renal colic have surgical treatment within 48 hours of diagnosis or readmission.","Structure","QS195 - Renal and ureteric stones","3 - QS195 - Renal and ureteric stones",1,"3 - QS195 - Renal and ureteric stones - Structure - 1"]
[null,"QS195","Renal and ureteric stones",3,null,"Adults with ureteric stones and renal colic have surgical treatment within 48 hours of diagnosis or readmission, if pain is ongoing and not tolerated, or the stone is unlikely to pass.","Evidence of the availability of lithotripters, emergency operating theatres and staff needed to perform surgical treatment for adults with ureteric stones and renal colic within 48 hours of diagnosis or readmission.","Structure","QS195 - Renal and ureteric stones","3 - QS195 - Renal and ureteric stones",2,"3 - QS195 - Renal and ureteric stones - Structure - 2"]
[null,"QS195","Renal and ureteric stones",3,null,"Adults with ureteric stones and renal colic have surgical treatment within 48 hours of diagnosis or readmission, if pain is ongoing and not tolerated, or the stone is unlikely to pass.","Proportion of adults with a new diagnosis of ureteric stones and renal colic, with ongoing pain that is not tolerated, or a stone that is unlikely to pass, who have surgical treatment within 48 hours of diagnosis.","Process","QS195 - Renal and ureteric stones","3 - QS195 - Renal and ureteric stones",1,"3 - QS195 - Renal and ureteric stones - Process - 1","The number in the denominator who have surgical treatment within 48 hours of diagnosis.","The number of adults with a new diagnosis of ureteric stones and renal colic, with ongoing pain that is not tolerated, or a stone that is unlikely to pass."]
[null,"QS195","Renal and ureteric stones",3,null,"Adults with ureteric stones and renal colic have surgical treatment within 48 hours of diagnosis or readmission, if pain is ongoing and not tolerated, or the stone is unlikely to pass.","Proportion of adults readmitted with ureteric stones and renal colic, with ongoing pain that is not tolerated, or a stone that is unlikely to pass, who have surgical treatment within 48 hours of readmission.","Process","QS195 - Renal and ureteric stones","3 - QS195 - Renal and ureteric stones",2,"3 - QS195 - Renal and ureteric stones - Process - 2","The number in the denominator who have surgical treatment within 48 hours of readmission.","The number of adults readmitted with ureteric stones and renal colic, with ongoing pain that is not tolerated, or a stone that is unlikely to pass."]
[null,"QS195","Renal and ureteric stones",3,null,"Adults with ureteric stones and renal colic have surgical treatment within 48 hours of diagnosis or readmission, if pain is ongoing and not tolerated, or the stone is unlikely to pass.","Proportion of adults who have had ureteric stones who had a primary stenting procedure.","Outcome",{"$f":"CONCATENATE(B4355, \" - \", C4355)","v":"QS195 - Renal and ureteric stones"},{"$f":"CONCATENATE(D4355, \" - \", I4355)","v":"3 - QS195 - Renal and ureteric stones"},{"$f":"IF(AND(B4355=B4354, D4355=D4354, H4355=H4354)=TRUE, K4354+1, 1)","v":1},{"$f":"CONCATENATE(J4355, \" - \", H4355, \" - \",K4355)","v":"3 - QS195 - Renal and ureteric stones - Outcome - 1"},"The number in the denominator who had a primary stenting procedure.","The number of adults who have had ureteric stones."]
[null,"QS195","Renal and ureteric stones",3,null,"Adults with ureteric stones and renal colic have surgical treatment within 48 hours of diagnosis or readmission, if pain is ongoing and not tolerated, or the stone is unlikely to pass.","Health-related quality of life in adults with ureteric stones.","Outcome","QS195 - Renal and ureteric stones","3 - QS195 - Renal and ureteric stones",2,"3 - QS195 - Renal and ureteric stones - Outcome - 2"]
[null,"QS195","Renal and ureteric stones",4,null,"Adults with renal or ureteric stones have their serum calcium measured.","Evidence of written clinical protocols to ensure that adults with renal or ureteric stones have their serum calcium measured.","Structure","QS195 - Renal and ureteric stones","4 - QS195 - Renal and ureteric stones",1,"4 - QS195 - Renal and ureteric stones - Structure - 1"]
[null,"QS195","Renal and ureteric stones",4,null,"Adults with renal or ureteric stones have their serum calcium measured.","Proportion of adults with a new diagnosis of renal or ureteric stones who have their serum calcium measured.","Process",{"$f":"CONCATENATE(B4358, \" - \", C4358)","v":"QS195 - Renal and ureteric stones"},{"$f":"CONCATENATE(D4358, \" - \", I4358)","v":"4 - QS195 - Renal and ureteric stones"},{"$f":"IF(AND(B4358=B4357, D4358=D4357, H4358=H4357)=TRUE, K4357+1, 1)","v":1},{"$f":"CONCATENATE(J4358, \" - \", H4358, \" - \",K4358)","v":"4 - QS195 - Renal and ureteric stones - Process - 1"},"The number in the denominator who have their serum calcium measured.","The number of adults with a new diagnosis of renal or ureteric stones."]
[null,"QS195","Renal and ureteric stones",4,null,"Adults with renal or ureteric stones have their serum calcium measured.","Diagnosis rates of hypercalcaemic conditions.","Outcome","QS195 - Renal and ureteric stones","4 - QS195 - Renal and ureteric stones",1,"4 - QS195 - Renal and ureteric stones - Outcome - 1"]
[null,"QS195","Renal and ureteric stones",5,null,"Adults, children and young people with renal or ureteric stones are given advice on diet and fluid intake.","Evidence of local arrangements to provide training to healthcare professionals on the advice they should give to people with renal or ureteric stones about diet and fluid intake to reduce the risk of stone recurrence.","Structure","QS195 - Renal and ureteric stones","5 - QS195 - Renal and ureteric stones",1,"5 - QS195 - Renal and ureteric stones - Structure - 1"]
[null,"QS195","Renal and ureteric stones",5,null,"Adults, children and young people with renal or ureteric stones are given advice on diet and fluid intake.","Evidence that information is available for people with renal and ureteric stones that contains advice on diet and fluid intake.","Structure","QS195 - Renal and ureteric stones","5 - QS195 - Renal and ureteric stones",2,"5 - QS195 - Renal and ureteric stones - Structure - 2"]
[null,"QS195","Renal and ureteric stones",5,null,"Adults, children and young people with renal or ureteric stones are given advice on diet and fluid intake.","Proportion of adults, children and young people with a new diagnosis of renal or ureteric stones who receive advice on diet and fluid intake.","Process","QS195 - Renal and ureteric stones","5 - QS195 - Renal and ureteric stones",1,"5 - QS195 - Renal and ureteric stones - Process - 1","The number in the denominator who receive advice on diet and fluid intake.","The number of adults, children and young people with a new diagnosis of renal or ureteric stones."]
[null,"QS195","Renal and ureteric stones",5,null,"Adults, children and young people with renal or ureteric stones are given advice on diet and fluid intake.","Proportion of adults, children and young people who have had renal or ureteric stones who had further admissions or surgical treatment for a renal or ureteric stone.","Outcome",{"$f":"CONCATENATE(B4363, \" - \", C4363)","v":"QS195 - Renal and ureteric stones"},{"$f":"CONCATENATE(D4363, \" - \", I4363)","v":"5 - QS195 - Renal and ureteric stones"},{"$f":"IF(AND(B4363=B4362, D4363=D4362, H4363=H4362)=TRUE, K4362+1, 1)","v":1},{"$f":"CONCATENATE(J4363, \" - \", H4363, \" - \",K4363)","v":"5 - QS195 - Renal and ureteric stones - Outcome - 1"},"The number in the denominator who had a further admission or surgical treatment for a renal or ureteric stone.","The number of adults, children and young people who have had renal or ureteric stones."]
[null,"QS194","Decision making and mental capacity",1,null,"People aged 16 and over who may lack capacity to make decisions are supported with decision making in a way that reﬂects their individual circumstances and meets their particular needs.","Evidence of local policy and guidance about which interventions, tools and approaches should be used to support decision making in people aged 16 and over who may lack capacity to make decisions.","Structure","QS194 - Decision making and mental capacity","1 - QS194 - Decision making and mental capacity",1,"1 - QS194 - Decision making and mental capacity - Structure - 1"]
[null,"QS194","Decision making and mental capacity",1,null,"People aged 16 and over who may lack capacity to make decisions are supported with decision making in a way that reﬂects their individual circumstances and meets their particular needs.","Evidence of local arrangements to ensure that people aged 16 and over who may lack capacity to make decisions are supported to do so in a way that reﬂects their individual circumstances and meets their particular needs.","Structure",{"$f":"CONCATENATE(B4365, \" - \", C4365)","v":"QS194 - Decision making and mental capacity"},"1 - QS194 - Decision making and mental capacity",2,"1 - QS194 - Decision making and mental capacity - Structure - 2"]
[null,"QS194","Decision making and mental capacity",1,null,"People aged 16 and over who may lack capacity to make decisions are supported with decision making in a way that reﬂects their individual circumstances and meets their particular needs.","Proportion of decisions made by people aged 16 and over who may lack capacity where the decision-making process reflected their communication needs.","Process","QS194 - Decision making and mental capacity","1 - QS194 - Decision making and mental capacity",1,"1 - QS194 - Decision making and mental capacity - Process - 1","The number in the denominator where the decision-making process reflected the person's communication needs.","The number of decisions made by people aged 16 and over who may lack capacity."]
[null,"QS194","Decision making and mental capacity",1,null,"People aged 16 and over who may lack capacity to make decisions are supported with decision making in a way that reﬂects their individual circumstances and meets their particular needs.","Proportion of decisions made by people aged 16 and over who may lack capacity where the decision-making process involved the person's significant and trusted people.","Process","QS194 - Decision making and mental capacity","1 - QS194 - Decision making and mental capacity",2,"1 - QS194 - Decision making and mental capacity - Process - 2","The number in the denominator where the decision-making process involved the person's significant and trusted people.","The number of decisions made by people aged 16 years and over who may lack capacity."]
[null,"QS194","Decision making and mental capacity",1,null,"People aged 16 and over who may lack capacity to make decisions are supported with decision making in a way that reﬂects their individual circumstances and meets their particular needs.","Proportion of decisions made by people aged 16 and over who may lack capacity and had no significant or trusted people, that involved an advocate.","Process","QS194 - Decision making and mental capacity","1 - QS194 - Decision making and mental capacity",3,"1 - QS194 - Decision making and mental capacity - Process - 3","The number in the denominator that involved an advocate.","The number of decisions made by people aged 16 and over who may lack capacity and had no significant or trusted people."]
[null,"QS194","Decision making and mental capacity",1,null,"People aged 16 and over who may lack capacity to make decisions are supported with decision making in a way that reﬂects their individual circumstances and meets their particular needs.","Proportion of people who may lack capacity who feel supported to make their own decisions.","Outcome","QS194 - Decision making and mental capacity","1 - QS194 - Decision making and mental capacity",1,"1 - QS194 - Decision making and mental capacity - Outcome - 1","The number in the denominator who feel supported to make their own decisions.","The number of people who may lack capacity."]
[null,"QS194","Decision making and mental capacity",1,null,"People aged 16 and over who may lack capacity to make decisions are supported with decision making in a way that reﬂects their individual circumstances and meets their particular needs.","Proportion of carers of people who may lack capacity who think that the person they care for is supported well to make their own decisions.","Outcome","QS194 - Decision making and mental capacity","1 - QS194 - Decision making and mental capacity",2,"1 - QS194 - Decision making and mental capacity - Outcome - 2","The number in the denominator who think that the person they care for is supported well to make their own decisions.","The number of carers of people who may lack capacity."]
[null,"QS194","Decision making and mental capacity",2,null,"People aged 16 and over at risk of losing capacity to make decisions, and those with fluctuating capacity, are given the opportunity to discuss advance care planning at each health and social care review.","Evidence of local arrangements to ensure that people aged 16 and over at risk of losing capacity to make decisions, and those with fluctuating capacity, have ongoing opportunities to discuss their advance care plans while they have capacity.","Structure","QS194 - Decision making and mental capacity","2 - QS194 - Decision making and mental capacity",1,"2 - QS194 - Decision making and mental capacity - Structure - 1"]
[null,"QS194","Decision making and mental capacity",2,null,"People aged 16 and over at risk of losing capacity to make decisions, and those with fluctuating capacity, are given the opportunity to discuss advance care planning at each health and social care review.","Proportion of health and social care reviews for people aged 16 and over who are at risk of losing capacity, with a documented discussion about advance care planning.","Process","QS194 - Decision making and mental capacity","2 - QS194 - Decision making and mental capacity",1,"2 - QS194 - Decision making and mental capacity - Process - 1","The number in the denominator with a documented discussion about advance care planning.","The number of health and social care reviews for people aged 16 and over who are at risk of losing capacity."]
[null,"QS194","Decision making and mental capacity",2,null,"People aged 16 and over at risk of losing capacity to make decisions, and those with fluctuating capacity, are given the opportunity to discuss advance care planning at each health and social care review.","Proportion of health and social care reviews for people aged 16 and over with fluctuating capacity, with a documented discussion about advance care planning.","Process","QS194 - Decision making and mental capacity","2 - QS194 - Decision making and mental capacity",2,"2 - QS194 - Decision making and mental capacity - Process - 2","The number in the denominator with a documented discussion about advance care planning.","The number of health and social care reviews for people aged 16 and over with fluctuating capacity."]
[null,"QS194","Decision making and mental capacity",2,null,"People aged 16 and over at risk of losing capacity to make decisions, and those with fluctuating capacity, are given the opportunity to discuss advance care planning at each health and social care review.","Proportion of people aged 16 and over at risk of losing capacity who have a documented discussion about making advance statements.","Process","QS194 - Decision making and mental capacity","2 - QS194 - Decision making and mental capacity",3,"2 - QS194 - Decision making and mental capacity - Process - 3","The number in the denominator who have a documented discussion about making advance statements.","The number of people aged 16 and over at risk of losing capacity."]
[null,"QS194","Decision making and mental capacity",2,null,"People aged 16 and over at risk of losing capacity to make decisions, and those with fluctuating capacity, are given the opportunity to discuss advance care planning at each health and social care review.","Proportion of people aged 16 and over with fluctuating capacity who have a documented discussion about making advance statements.","Process","QS194 - Decision making and mental capacity","2 - QS194 - Decision making and mental capacity",4,"2 - QS194 - Decision making and mental capacity - Process - 4","The number in the denominator who have a documented discussion about making advance statements.","The number of people aged 16 and over with fluctuating capacity."]
[null,"QS194","Decision making and mental capacity",2,null,"People aged 16 and over at risk of losing capacity to make decisions, and those with fluctuating capacity, are given the opportunity to discuss advance care planning at each health and social care review.","Proportion of people aged 18 and over at risk of losing capacity who have a documented discussion about making advance decisions or lasting powers of attorney.","Process","QS194 - Decision making and mental capacity","2 - QS194 - Decision making and mental capacity",5,"2 - QS194 - Decision making and mental capacity - Process - 5","The number in the denominator who have a documented discussion about making advance decisions or lasting powers of attorney.","The number of people aged 18 and over at risk of losing capacity."]
[null,"QS194","Decision making and mental capacity",2,null,"People aged 16 and over at risk of losing capacity to make decisions, and those with fluctuating capacity, are given the opportunity to discuss advance care planning at each health and social care review.","Proportion of people aged 18 and over with fluctuating capacity who have a documented discussion about making advance decisions or lasting powers of attorney.","Process","QS194 - Decision making and mental capacity","2 - QS194 - Decision making and mental capacity",6,"2 - QS194 - Decision making and mental capacity - Process - 6","The number in the denominator who have a documented discussion about making advance decisions or lasting powers of attorney.","The number of people aged 18 and over with fluctuating capacity."]
[null,"QS194","Decision making and mental capacity",2,null,"People aged 16 and over at risk of losing capacity to make decisions, and those with fluctuating capacity, are given the opportunity to discuss advance care planning at each health and social care review.","Proportion of people aged 16 and over at risk of losing capacity who feel supported to make decisions about their health and social care support.","Outcome","QS194 - Decision making and mental capacity","2 - QS194 - Decision making and mental capacity",1,"2 - QS194 - Decision making and mental capacity - Outcome - 1","The number in the denominator who feel supported to make decisions about their health and social care support.","The number of people aged 16 and over at risk of losing capacity."]
[null,"QS194","Decision making and mental capacity",2,null,"People aged 16 and over at risk of losing capacity to make decisions, and those with fluctuating capacity, are given the opportunity to discuss advance care planning at each health and social care review.",null,"Outcome","QS194 - Decision making and mental capacity","2 - QS194 - Decision making and mental capacity",2,"2 - QS194 - Decision making and mental capacity - Outcome - 2","The number in the denominator who feel supported to make decisions about their health and social care support.","The number of people aged 16 and over with fluctuating capacity."]
[null,"QS194","Decision making and mental capacity",3,null,"People aged 16 and over who are assessed as lacking capacity to make a particular decision at the time that decision needs to be made, have a clear record of the reasons why they lack capacity and the practicable steps taken to support them.","Evidence of local protocols to record practicable steps taken during the decision-making process to support people aged 16 and over who may lack capacity.","Structure",{"$f":"CONCATENATE(B4380, \" - \", C4380)","v":"QS194 - Decision making and mental capacity"},{"$f":"CONCATENATE(D4380, \" - \", I4380)","v":"3 - QS194 - Decision making and mental capacity"},{"$f":"IF(AND(B4380=B4379, D4380=D4379, H4380=H4379)=TRUE, K4379+1, 1)","v":1},{"$f":"CONCATENATE(J4380, \" - \", H4380, \" - \",K4380)","v":"3 - QS194 - Decision making and mental capacity - Structure - 1"}]
[null,"QS194","Decision making and mental capacity",3,null,"People aged 16 and over who are assessed as lacking capacity to make a particular decision at the time that decision needs to be made, have a clear record of the reasons why they lack capacity and the practicable steps taken to support them.","Evidence of local protocols to ensure mental capacity assessments are collaborative, person centred, thorough and aligned with the Mental Capacity Act 2005 and its Code of Practice.","Structure","QS194 - Decision making and mental capacity","3 - QS194 - Decision making and mental capacity",2,"3 - QS194 - Decision making and mental capacity - Structure - 2"]
[null,"QS194","Decision making and mental capacity",3,null,"People aged 16 and over who are assessed as lacking capacity to make a particular decision at the time that decision needs to be made, have a clear record of the reasons why they lack capacity and the practicable steps taken to support them.","Evidence of local arrangements to ensure that assessors can seek advice from people with specialist knowledge to help them assess whether there is evidence that the person lacks mental capacity.","Structure","QS194 - Decision making and mental capacity","3 - QS194 - Decision making and mental capacity",3,"3 - QS194 - Decision making and mental capacity - Structure - 3"]
[null,"QS194","Decision making and mental capacity",3,null,"People aged 16 and over who are assessed as lacking capacity to make a particular decision at the time that decision needs to be made, have a clear record of the reasons why they lack capacity and the practicable steps taken to support them.","Proportion of mental capacity assessments with the outcome stating that the person lacks capacity to make a particular decision, with a record of the practicable steps taken to help the person make the relevant decision.","Process","QS194 - Decision making and mental capacity","3 - QS194 - Decision making and mental capacity",1,"3 - QS194 - Decision making and mental capacity - Process - 1","The number in the denominator with a record of the practicable steps taken to help the person make the relevant decision.","The number of mental capacity assessments with the outcome stating that the person lacks capacity to make a particular decision."]
[null,"QS194","Decision making and mental capacity",3,null,"People aged 16 and over who are assessed as lacking capacity to make a particular decision at the time that decision needs to be made, have a clear record of the reasons why they lack capacity and the practicable steps taken to support them.","Proportion of mental capacity assessments carried out with people aged 16 and over with an outcome of the assessment stating that the person lacks capacity to make a particular decision, with a record of:\n\nthe impairment/disturbance of the mind or brain that has been identified\n\nthe reasons why the person is unable to make a decision (with reference to section 3 of the Mental Capacity Act 2005)\n\nthe fact that the person's inability to make a decision is a direct consequence of the impairment or disturbance identified.","Process","QS194 - Decision making and mental capacity","3 - QS194 - Decision making and mental capacity",2,"3 - QS194 - Decision making and mental capacity - Process - 2","The number in the denominator with a record of:\n\nthe impairment/disturbance of the mind or brain that has been identified\n\nthe reasons why the person is unable to make a decision (with reference to section 3 of the Mental Capacity Act 2005)\n\nthe fact that the person's inability to make a decision is a direct consequence of the impairment or disturbance identified.","The number of mental capacity assessments carried out with people aged 16 and over with an outcome of the assessment stating that the person lacks capacity to make a particular decision."]
[null,"QS194","Decision making and mental capacity",4,null,"People aged 16 and over who lack capacity to make a particular decision at the time that decision needs to be made have their wishes, feelings, values and beliefs accounted for in best interests decisions.","Evidence of local protocols to ensure that best interests decisions are being made in line with the Mental Capacity Act 2005.","Structure",{"$f":"CONCATENATE(B4385, \" - \", C4385)","v":"QS194 - Decision making and mental capacity"},{"$f":"CONCATENATE(D4385, \" - \", I4385)","v":"4 - QS194 - Decision making and mental capacity"},{"$f":"IF(AND(B4385=B4384, D4385=D4384, H4385=H4384)=TRUE, K4384+1, 1)","v":1},{"$f":"CONCATENATE(J4385, \" - \", H4385, \" - \",K4385)","v":"4 - QS194 - Decision making and mental capacity - Structure - 1"}]
[null,"QS194","Decision making and mental capacity",4,null,"People aged 16 and over who lack capacity to make a particular decision at the time that decision needs to be made have their wishes, feelings, values and beliefs accounted for in best interests decisions.","Evidence of systems and protocols that support the decision maker to identify and locate any relevant written statements made by the person when they had capacity, at the earliest possible time.","Structure","QS194 - Decision making and mental capacity","4 - QS194 - Decision making and mental capacity",2,"4 - QS194 - Decision making and mental capacity - Structure - 2"]
[null,"QS194","Decision making and mental capacity",4,null,"People aged 16 and over who lack capacity to make a particular decision at the time that decision needs to be made have their wishes, feelings, values and beliefs accounted for in best interests decisions.","Evidence of systems and protocols that ensure the decision maker reviews any relevant written statements made by the person before they make a best interests decision.","Structure","QS194 - Decision making and mental capacity","4 - QS194 - Decision making and mental capacity",3,"4 - QS194 - Decision making and mental capacity - Structure - 3"]
[null,"QS194","Decision making and mental capacity",4,null,"People aged 16 and over who lack capacity to make a particular decision at the time that decision needs to be made have their wishes, feelings, values and beliefs accounted for in best interests decisions.","Evidence of systems and protocols that ensure carers, family, friends or advocates are involved in the best interests decision-making process.","Structure","QS194 - Decision making and mental capacity","4 - QS194 - Decision making and mental capacity",4,"4 - QS194 - Decision making and mental capacity - Structure - 4"]
[null,"QS194","Decision making and mental capacity",4,null,"People aged 16 and over who lack capacity to make a particular decision at the time that decision needs to be made have their wishes, feelings, values and beliefs accounted for in best interests decisions.","Proportion of significant and trusted people, including family members, carers and independent advocates, who feel included in making best interests decisions for the person who lacks capacity.","Outcome","QS194 - Decision making and mental capacity","4 - QS194 - Decision making and mental capacity",1,"4 - QS194 - Decision making and mental capacity - Outcome - 1","The number in the denominator who feel included in making best interests decisions for the person they support.","The number of significant and trusted people, including family members, carers and independent advocates, for a person who lacks capacity."]
[null,"QS196","Community pharmacies: promoting health and wellbeing",1,null,"People who have a long-term health condition or those who look for support to improve their health and wellbeing are offered advice and education when they use community pharmacy services.","Evidence of local arrangements to ensure that people who have a long-term health condition or those who look for support to improve their health and wellbeing are offered advice and education when they use community pharmacy services.","Structure","QS196 - Community pharmacies: promoting health and wellbeing","1 - QS196 - Community pharmacies: promoting health and wellbeing",{"$f":"IF(AND(B4390=B4389, D4390=D4389, H4390=H4389)=TRUE, K4389+1, 1)","v":1},{"$f":"CONCATENATE(J4390, \" - \", H4390, \" - \",K4390)","v":"1 - QS196 - Community pharmacies: promoting health and wellbeing - Structure - 1"}]
[null,"QS196","Community pharmacies: promoting health and wellbeing",1,null,"People who have a long-term health condition or those who look for support to improve their health and wellbeing are offered advice and education when they use community pharmacy services.","Proportion of people using community pharmacy services who received health and wellbeing advice or education.","Outcome",{"$f":"CONCATENATE(B4391, \" - \", C4391)","v":"QS196 - Community pharmacies: promoting health and wellbeing"},{"$f":"CONCATENATE(D4391, \" - \", I4391)","v":"1 - QS196 - Community pharmacies: promoting health and wellbeing"},{"$f":"IF(AND(B4391=B4390, D4391=D4390, H4391=H4390)=TRUE, K4390+1, 1)","v":1},{"$f":"CONCATENATE(J4391, \" - \", H4391, \" - \",K4391)","v":"1 - QS196 - Community pharmacies: promoting health and wellbeing - Outcome - 1"},"The number in the denominator who received health and wellbeing advice or education.","The number of people using community pharmacy services."]
[null,"QS196","Community pharmacies: promoting health and wellbeing",1,null,"People who have a long-term health condition or those who look for support to improve their health and wellbeing are offered advice and education when they use community pharmacy services.","Proportion of people using community pharmacy services who were satisfied with the health and wellbeing advice or education they received.","Outcome","QS196 - Community pharmacies: promoting health and wellbeing","1 - QS196 - Community pharmacies: promoting health and wellbeing",2,"1 - QS196 - Community pharmacies: promoting health and wellbeing - Outcome - 2","The number in the denominator satisfied with the advice they received.","The number of people using community pharmacy services who received health and wellbeing advice or education."]
[null,"QS196","Community pharmacies: promoting health and wellbeing",2,null,"Community pharmacies and commissioners work together to raise awareness of the health and wellbeing expertise and services available from community pharmacy teams.","Evidence of local initiatives to raise awareness of the health and wellbeing expertise and services available from community pharmacy teams among members of the public.","Structure",{"$f":"CONCATENATE(B4393, \" - \", C4393)","v":"QS196 - Community pharmacies: promoting health and wellbeing"},{"$f":"CONCATENATE(D4393, \" - \", I4393)","v":"2 - QS196 - Community pharmacies: promoting health and wellbeing"},{"$f":"IF(AND(B4393=B4392, D4393=D4392, H4393=H4392)=TRUE, K4392+1, 1)","v":1},{"$f":"CONCATENATE(J4393, \" - \", H4393, \" - \",K4393)","v":"2 - QS196 - Community pharmacies: promoting health and wellbeing - Structure - 1"}]
[null,"QS196","Community pharmacies: promoting health and wellbeing",2,null,"Community pharmacies and commissioners work together to raise awareness of the health and wellbeing expertise and services available from community pharmacy teams.","Evidence of local initiatives to raise awareness of the health and wellbeing expertise and services available from community pharmacy teams among health and social care practitioners.","Structure","QS196 - Community pharmacies: promoting health and wellbeing","2 - QS196 - Community pharmacies: promoting health and wellbeing",2,"2 - QS196 - Community pharmacies: promoting health and wellbeing - Structure - 2"]
[null,"QS196","Community pharmacies: promoting health and wellbeing",2,null,"Community pharmacies and commissioners work together to raise awareness of the health and wellbeing expertise and services available from community pharmacy teams.","Uptake of referrals into community pharmacy.","Outcome","QS196 - Community pharmacies: promoting health and wellbeing","2 - QS196 - Community pharmacies: promoting health and wellbeing",1,"2 - QS196 - Community pharmacies: promoting health and wellbeing - Outcome - 1","Number in the denominator presenting to community pharmacy after the referral.","Number of referrals from GP practices and NHS111 into community pharmacy."]
[null,"QS196","Community pharmacies: promoting health and wellbeing",2,null,"Community pharmacies and commissioners work together to raise awareness of the health and wellbeing expertise and services available from community pharmacy teams.","Public understanding of the support available from local community pharmacies.","Outcome","QS196 - Community pharmacies: promoting health and wellbeing","2 - QS196 - Community pharmacies: promoting health and wellbeing",2,"2 - QS196 - Community pharmacies: promoting health and wellbeing - Outcome - 2"]
[null,"QS196","Community pharmacies: promoting health and wellbeing",3,null,"Community pharmacies and commissioners work together to integrate community pharmacy services into care and referral pathways.","Evidence of community pharmacies and commissioners working together to integrate community pharmacy services into care and referral pathways.","Structure",{"$f":"CONCATENATE(B4397, \" - \", C4397)","v":"QS196 - Community pharmacies: promoting health and wellbeing"},{"$f":"CONCATENATE(D4397, \" - \", I4397)","v":"3 - QS196 - Community pharmacies: promoting health and wellbeing"},{"$f":"IF(AND(B4397=B4396, D4397=D4396, H4397=H4396)=TRUE, K4396+1, 1)","v":1},{"$f":"CONCATENATE(J4397, \" - \", H4397, \" - \",K4397)","v":"3 - QS196 - Community pharmacies: promoting health and wellbeing - Structure - 1"}]
[null,"QS196","Community pharmacies: promoting health and wellbeing",3,null,"Community pharmacies and commissioners work together to integrate community pharmacy services into care and referral pathways.","Evidence of defined referral pathways between community pharmacies, primary care networks, health, social care and support service providers.","Structure","QS196 - Community pharmacies: promoting health and wellbeing","3 - QS196 - Community pharmacies: promoting health and wellbeing",2,"3 - QS196 - Community pharmacies: promoting health and wellbeing - Structure - 2"]
[null,"QS196","Community pharmacies: promoting health and wellbeing",3,null,"Community pharmacies and commissioners work together to integrate community pharmacy services into care and referral pathways.","Evidence of key performance indicators (KPIs) being agreed for the pathways defined between community pharmacies, primary care networks, health, social care and support service providers.","Structure","QS196 - Community pharmacies: promoting health and wellbeing","3 - QS196 - Community pharmacies: promoting health and wellbeing",3,"3 - QS196 - Community pharmacies: promoting health and wellbeing - Structure - 3"]
[null,"QS196","Community pharmacies: promoting health and wellbeing",3,null,"Community pharmacies and commissioners work together to integrate community pharmacy services into care and referral pathways.","Proportion of community pharmacy team members satisfied with the availability of referral pathways.","Outcome","QS196 - Community pharmacies: promoting health and wellbeing","3 - QS196 - Community pharmacies: promoting health and wellbeing",1,"3 - QS196 - Community pharmacies: promoting health and wellbeing - Outcome - 1","The number in the denominator satisfied with the availability of referral pathways.","The number of community pharmacy team members."]
[null,"QS196","Community pharmacies: promoting health and wellbeing",4,null,"Community pharmacies and commissioners work together to agree health and wellbeing interventions to support people from underserved groups.","Evidence of actions taken locally between community pharmacies and commissioners to agree health and wellbeing interventions needed to support people from underserved groups.","Structure",{"$f":"CONCATENATE(B4401, \" - \", C4401)","v":"QS196 - Community pharmacies: promoting health and wellbeing"},{"$f":"CONCATENATE(D4401, \" - \", I4401)","v":"4 - QS196 - Community pharmacies: promoting health and wellbeing"},{"$f":"IF(AND(B4401=B4400, D4401=D4400, H4401=H4400)=TRUE, K4400+1, 1)","v":1},{"$f":"CONCATENATE(J4401, \" - \", H4401, \" - \",K4401)","v":"4 - QS196 - Community pharmacies: promoting health and wellbeing - Structure - 1"}]
[null,"QS196","Community pharmacies: promoting health and wellbeing",4,null,"Community pharmacies and commissioners work together to agree health and wellbeing interventions to support people from underserved groups.","Evidence of local commissioning agreements for provision of health and wellbeing interventions according to local need.","Structure","QS196 - Community pharmacies: promoting health and wellbeing","4 - QS196 - Community pharmacies: promoting health and wellbeing",2,"4 - QS196 - Community pharmacies: promoting health and wellbeing - Structure - 2"]
[null,"QS196","Community pharmacies: promoting health and wellbeing",4,null,"Community pharmacies and commissioners work together to agree health and wellbeing interventions to support people from underserved groups.","Proportion of community pharmacy team members who agree that the health and wellbeing services that they are commissioned to deliver reflect the needs of the local population.","Outcome","QS196 - Community pharmacies: promoting health and wellbeing","4 - QS196 - Community pharmacies: promoting health and wellbeing",1,"4 - QS196 - Community pharmacies: promoting health and wellbeing - Outcome - 1","The number in the denominator who agree that the health and wellbeing services that they are commissioned to deliver reflect the needs of the local population.","The number of community pharmacy team members."]
[null,"QS197","Faltering growth",1,null,"Babies and preschool children have their measurements plotted on a growth chart if there are concerns about faltering growth.","Evidence of local arrangements to ensure that primary and community healthcare professionals are trained to weigh and to measure the length or height of babies and preschool children and plot this information on the UK–WHO growth chart.","Structure","QS197 - Faltering growth","1 - QS197 - Faltering growth",{"$f":"IF(AND(B4404=B4403, D4404=D4403, H4404=H4403)=TRUE, K4403+1, 1)","v":1},{"$f":"CONCATENATE(J4404, \" - \", H4404, \" - \",K4404)","v":"1 - QS197 - Faltering growth - Structure - 1"}]
[null,"QS197","Faltering growth",1,null,"Babies and preschool children have their measurements plotted on a growth chart if there are concerns about faltering growth.","Evidence of local arrangements to ensure that calibrated equipment is available for primary and community healthcare professionals to weigh babies and preschool children.","Structure",{"$f":"CONCATENATE(B4405, \" - \", C4405)","v":"QS197 - Faltering growth"},{"$f":"CONCATENATE(D4405, \" - \", I4405)","v":"1 - QS197 - Faltering growth"},{"$f":"IF(AND(B4405=B4404, D4405=D4404, H4405=H4404)=TRUE, K4404+1, 1)","v":2},{"$f":"CONCATENATE(J4405, \" - \", H4405, \" - \",K4405)","v":"1 - QS197 - Faltering growth - Structure - 2"}]
[null,"QS197","Faltering growth",1,null,"Babies and preschool children have their measurements plotted on a growth chart if there are concerns about faltering growth.","Evidence of local arrangements and protocols to ensure that babies and preschool children are weighed and measured at each of the mandated health visiting team contacts.","Structure","QS197 - Faltering growth","1 - QS197 - Faltering growth",3,"1 - QS197 - Faltering growth - Structure - 3"]
[null,"QS197","Faltering growth",1,null,"Babies and preschool children have their measurements plotted on a growth chart if there are concerns about faltering growth.","Proportion of babies and preschool children whose weight and height or length measurements are plotted on the UK–WHO growth chart during each of the mandated health visiting team contacts if there are concerns about faltering growth.","Process","QS197 - Faltering growth","1 - QS197 - Faltering growth",1,"1 - QS197 - Faltering growth - Process - 1","The number in the denominator whose weight and height or length measurements are plotted on the UK–WHO growth chart at every mandated health visiting contact.","The number of babies and preschool children in whom there are concerns about faltering growth."]
[null,"QS197","Faltering growth",1,null,"Babies and preschool children have their measurements plotted on a growth chart if there are concerns about faltering growth.","Proportion of babies and preschool children whose weight and height or length measurements are plotted on the UK–WHO growth chart at appropriate intervals if there are concerns about faltering growth.","Process","QS197 - Faltering growth","1 - QS197 - Faltering growth",2,"1 - QS197 - Faltering growth - Process - 2","The number in the denominator whose weight and height or length measurements are plotted on the UK–WHO growth chart at appropriate intervals.","The number of babies and preschool children in whom there are concerns about faltering growth."]
[null,"QS197","Faltering growth",2,null,"Babies and preschool children have a detailed feeding or eating history taken if there are concerns about faltering growth.","Evidence of local arrangements to ensure that healthcare professionals are trained to take a detailed feeding or eating history.","Structure",{"$f":"CONCATENATE(B4409, \" - \", C4409)","v":"QS197 - Faltering growth"},{"$f":"CONCATENATE(D4409, \" - \", I4409)","v":"2 - QS197 - Faltering growth"},{"$f":"IF(AND(B4409=B4408, D4409=D4408, H4409=H4408)=TRUE, K4408+1, 1)","v":1},{"$f":"CONCATENATE(J4409, \" - \", H4409, \" - \",K4409)","v":"2 - QS197 - Faltering growth - Structure - 1"}]
[null,"QS197","Faltering growth",2,null,"Babies and preschool children have a detailed feeding or eating history taken if there are concerns about faltering growth.","Proportion of babies and preschool children who have a detailed feeding or eating history taken if there are concerns about faltering growth.","Process","QS197 - Faltering growth","2 - QS197 - Faltering growth",1,"2 - QS197 - Faltering growth - Process - 1","The number in the denominator who have a detailed eating or feeding history taken.","The number of babies and preschool children in whom there are concerns about faltering growth."]
[null,"QS197","Faltering growth",2,null,"Babies and preschool children have a detailed feeding or eating history taken if there are concerns about faltering growth.","Proportion of parents or carers who feel supported if there are concerns that their baby or preschool child has faltering growth.","Outcome","QS197 - Faltering growth","2 - QS197 - Faltering growth",1,"2 - QS197 - Faltering growth - Outcome - 1","The number in the denominator who feel supported.","The number of parents or carers of babies or preschool children in whom there are concerns about faltering growth."]
[null,"QS197","Faltering growth",3,null,"Babies and preschool children have a management plan with specific goals if there are concerns about faltering growth.","Evidence of local arrangements and written clinical protocols to ensure that the primary care team are trained to develop a management plan for babies and preschool children if there are concerns about faltering growth.","Structure",{"$f":"CONCATENATE(B4412, \" - \", C4412)","v":"QS197 - Faltering growth"},{"$f":"CONCATENATE(D4412, \" - \", I4412)","v":"3 - QS197 - Faltering growth"},{"$f":"IF(AND(B4412=B4411, D4412=D4411, H4412=H4411)=TRUE, K4411+1, 1)","v":1},{"$f":"CONCATENATE(J4412, \" - \", H4412, \" - \",K4412)","v":"3 - QS197 - Faltering growth - Structure - 1"}]
[null,"QS197","Faltering growth",3,null,"Babies and preschool children have a management plan with specific goals if there are concerns about faltering growth.","Evidence of local arrangements and written clinical protocols to ensure that the primary care team have access to healthcare professionals with expertise in faltering growth.","Structure","QS197 - Faltering growth","3 - QS197 - Faltering growth",2,"3 - QS197 - Faltering growth - Structure - 2"]
[null,"QS197","Faltering growth",3,null,"Babies and preschool children have a management plan with specific goals if there are concerns about faltering growth.","Proportion of babies and preschool children in whom there are concerns about faltering growth who have a management plan that includes specific goals.","Process","QS197 - Faltering growth","3 - QS197 - Faltering growth",1,"3 - QS197 - Faltering growth - Process - 1","The number in the denominator who have a management plan that includes specific goals.","The number of babies and preschool children in whom there are concerns about faltering growth."]
[null,"QS197","Faltering growth",3,null,"Babies and preschool children have a management plan with specific goals if there are concerns about faltering growth.","Proportion of parents and carers who are satisfied with the way concerns about faltering growth in their baby or preschool child are being managed.","Outcome","QS197 - Faltering growth","3 - QS197 - Faltering growth",1,"3 - QS197 - Faltering growth - Outcome - 1","The number in the denominator who are satisfied with the way concerns are being managed.","The number of parents and carers with babies or preschool children in whom there are concerns about faltering growth."]
[null,"QS197","Faltering growth",4,null,"Mothers are supported to continue breastfeeding if their baby is given supplementation with formula because of concerns about faltering growth.","Evidence of local arrangements to ensure that mothers receive practical support to continue breastfeeding if there are concerns about faltering growth and supplementation with formula is recommended.","Structure",{"$f":"CONCATENATE(B4416, \" - \", C4416)","v":"QS197 - Faltering growth"},{"$f":"CONCATENATE(D4416, \" - \", I4416)","v":"4 - QS197 - Faltering growth"},{"$f":"IF(AND(B4416=B4415, D4416=D4415, H4416=H4415)=TRUE, K4415+1, 1)","v":1},{"$f":"CONCATENATE(J4416, \" - \", H4416, \" - \",K4416)","v":"4 - QS197 - Faltering growth - Structure - 1"}]
[null,"QS197","Faltering growth",4,null,"Mothers are supported to continue breastfeeding if their baby is given supplementation with formula because of concerns about faltering growth.","Proportion of mothers who are supported to continue to breastfeed if their baby is given supplementation with formula because of concerns about faltering growth.","Process","QS197 - Faltering growth","4 - QS197 - Faltering growth",1,"4 - QS197 - Faltering growth - Process - 1","The number in the denominator who are supported to continue to breastfeed.","The number of breastfeeding mothers whose baby is given supplementation with formula because of concerns about faltering growth."]
[null,"QS197","Faltering growth",4,null,"Mothers are supported to continue breastfeeding if their baby is given supplementation with formula because of concerns about faltering growth.","Proportion of mothers who are satisfied with the support they receive to continue breastfeeding if their baby has faltering growth.","Outcome","QS197 - Faltering growth","4 - QS197 - Faltering growth",1,"4 - QS197 - Faltering growth - Outcome - 1","The number in the denominator who are satisfied with the support they receive to continue breastfeeding.","The number of breastfeeding mothers whose babies have faltering growth."]
[null,"QS198","Suspected neurological conditions: recognition and referral",1,null,"Children under 12 years with headache and 'red flag' symptoms are referred immediately for neurological assessment.","Evidence of written clinical protocols to ensure that 'red flag' symptoms are recognised in children under 12 years presenting with headache.","Structure","QS198 - Suspected neurological conditions: recognition and referral","1 - QS198 - Suspected neurological conditions: recognition and referral",1,"1 - QS198 - Suspected neurological conditions: recognition and referral - Structure - 1"]
[null,"QS198","Suspected neurological conditions: recognition and referral",1,null,"Children under 12 years with headache and 'red flag' symptoms are referred immediately for neurological assessment.","Evidence of written clinical protocols to ensure that children under 12 years with headache and one or more 'red flag' symptoms are referred for neurological assessment immediately.","Structure",{"$f":"CONCATENATE(B4420, \" - \", C4420)","v":"QS198 - Suspected neurological conditions: recognition and referral"},"1 - QS198 - Suspected neurological conditions: recognition and referral",2,"1 - QS198 - Suspected neurological conditions: recognition and referral - Structure - 2"]
[null,"QS198","Suspected neurological conditions: recognition and referral",1,null,"Children under 12 years with headache and 'red flag' symptoms are referred immediately for neurological assessment.","Proportion of children under 12 years with headache and one or more 'red flag' symptoms who are referred for same-day neurological assessment.","Process","QS198 - Suspected neurological conditions: recognition and referral","1 - QS198 - Suspected neurological conditions: recognition and referral",1,"1 - QS198 - Suspected neurological conditions: recognition and referral - Process - 1","The number in the denominator who are referred for same-day neurological assessment.","The number of children under 12 years with headache and one or more 'red flag' symptoms."]
[null,"QS198","Suspected neurological conditions: recognition and referral",1,null,"Children under 12 years with headache and 'red flag' symptoms are referred immediately for neurological assessment.","Mortality rates from intracranial pathology in children under 12 years.","Outcome","QS198 - Suspected neurological conditions: recognition and referral","1 - QS198 - Suspected neurological conditions: recognition and referral",1,"1 - QS198 - Suspected neurological conditions: recognition and referral - Outcome - 1"]
[null,"QS198","Suspected neurological conditions: recognition and referral",2,null,"Children under 4 years with suspected abnormal head size or shape have their head circumference assessed using a standardised growth chart.","Local arrangements and written protocols to ensure that children aged under 4 years with suspected abnormal head shape or size have their head circumference assessed using a standardised growth chart.","Structure","QS198 - Suspected neurological conditions: recognition and referral","2 - QS198 - Suspected neurological conditions: recognition and referral",1,"2 - QS198 - Suspected neurological conditions: recognition and referral - Structure - 1"]
[null,"QS198","Suspected neurological conditions: recognition and referral",2,null,"Children under 4 years with suspected abnormal head size or shape have their head circumference assessed using a standardised growth chart.","Local arrangements and written protocols to ensure that healthcare professionals have access to the necessary training needed to assess head shape and size in children aged under 4 years.","Structure","QS198 - Suspected neurological conditions: recognition and referral","2 - QS198 - Suspected neurological conditions: recognition and referral",2,"2 - QS198 - Suspected neurological conditions: recognition and referral - Structure - 2"]
[null,"QS198","Suspected neurological conditions: recognition and referral",2,null,"Children under 4 years with suspected abnormal head size or shape have their head circumference assessed using a standardised growth chart.","Proportion of children aged under 4 years with suspected abnormal head shape or size who have the longest of 3 head measurements plotted on a standardised growth chart, corrected for gestational age.","Process","QS198 - Suspected neurological conditions: recognition and referral","2 - QS198 - Suspected neurological conditions: recognition and referral",1,"2 - QS198 - Suspected neurological conditions: recognition and referral - Process - 1","The number in the denominator who have the longest of 3 head measurements plotted on a standardised growth chart, corrected for gestational age.","Children aged under 4 years with suspected abnormal head shape or size."]
[null,"QS198","Suspected neurological conditions: recognition and referral",2,null,"Children under 4 years with suspected abnormal head size or shape have their head circumference assessed using a standardised growth chart.","Referrals for specialist neurological assessment in children aged under 4 years with suspected abnormal head shape or size, who have the longest of 3 head measurements plotted on a standardised growth chart, corrected for gestational age.","Outcome","QS198 - Suspected neurological conditions: recognition and referral","2 - QS198 - Suspected neurological conditions: recognition and referral",1,"2 - QS198 - Suspected neurological conditions: recognition and referral - Outcome - 1"]
[null,"QS198","Suspected neurological conditions: recognition and referral",3,null,"Adults with suspected dystonia are referred for neurological assessment.","Evidence of written clinical protocols to ensure that adults presenting with symptoms of dystonia are referred for neurological assessment.","Structure","QS198 - Suspected neurological conditions: recognition and referral","3 - QS198 - Suspected neurological conditions: recognition and referral",1,"3 - QS198 - Suspected neurological conditions: recognition and referral - Structure - 1"]
[null,"QS198","Suspected neurological conditions: recognition and referral",3,null,"Adults with suspected dystonia are referred for neurological assessment.","Proportion of adults with suspected dystonia who are referred for neurological assessment.","Process","QS198 - Suspected neurological conditions: recognition and referral","3 - QS198 - Suspected neurological conditions: recognition and referral",1,"3 - QS198 - Suspected neurological conditions: recognition and referral - Process - 1","The number in the denominator who are referred for neurological assessment.","The number of adults with suspected dystonia."]
[null,"QS198","Suspected neurological conditions: recognition and referral",3,null,"Adults with suspected dystonia are referred for neurological assessment.","Diagnosis rates for dystonia in adults.","Outcome","QS198 - Suspected neurological conditions: recognition and referral","3 - QS198 - Suspected neurological conditions: recognition and referral",1,"3 - QS198 - Suspected neurological conditions: recognition and referral - Outcome - 1"]
[null,"QS198","Suspected neurological conditions: recognition and referral",4,null,"Adults with transient rotational vertigo on head movement are assessed using the Hallpike manoeuvre.","Evidence of written clinical protocols to ensure that adults presenting with symptoms of transient rotational vertigo on head movement are assessed for BPPV using the Hallpike manoeuvre.","Structure","QS198 - Suspected neurological conditions: recognition and referral","4 - QS198 - Suspected neurological conditions: recognition and referral",1,"4 - QS198 - Suspected neurological conditions: recognition and referral - Structure - 1"]
[null,"QS198","Suspected neurological conditions: recognition and referral",4,null,"Adults with transient rotational vertigo on head movement are assessed using the Hallpike manoeuvre.","Proportion of adults presenting with transient rotational vertigo on head movement who are assessed using the Hallpike manoeuvre.","Process","QS198 - Suspected neurological conditions: recognition and referral","4 - QS198 - Suspected neurological conditions: recognition and referral",1,"4 - QS198 - Suspected neurological conditions: recognition and referral - Process - 1","The number in the denominator who are assessed using the Hallpike manoeuvre.","The number of adults presenting with transient rotational vertigo on head movement."]
[null,"QS198","Suspected neurological conditions: recognition and referral",4,null,"Adults with transient rotational vertigo on head movement are assessed using the Hallpike manoeuvre.","Proportion of adults presenting with transient rotational vertigo on head movement referred to ear, nose and throat services who were assessed using the Hallpike manoeuvre.","Outcome","QS198 - Suspected neurological conditions: recognition and referral","4 - QS198 - Suspected neurological conditions: recognition and referral",1,"4 - QS198 - Suspected neurological conditions: recognition and referral - Outcome - 1","The number in the denominator who were assessed using the Hallpike manoeuvre.","The number of adults presenting with transient rotational vertigo on head movement who are referred to ear, nose and throat services."]
[null,"QS198","Suspected neurological conditions: recognition and referral",4,null,"Adults with transient rotational vertigo on head movement are assessed using the Hallpike manoeuvre.","Patient satisfaction with investigation of transient rotational vertigo on head movement.","Outcome","QS198 - Suspected neurological conditions: recognition and referral","4 - QS198 - Suspected neurological conditions: recognition and referral",2,"4 - QS198 - Suspected neurological conditions: recognition and referral - Outcome - 2"]
[null,"QS198","Suspected neurological conditions: recognition and referral",5,null,"Adults diagnosed with a functional neurological disorder are supported to manage symptoms that are a part of the disorder in non-specialist care.","Evidence of written clinical protocols to ensure that adults with a functional neurological disorder have symptoms that are a part of their condition recognised and are supported to manage them in non-specialist care.","Structure","QS198 - Suspected neurological conditions: recognition and referral","5 - QS198 - Suspected neurological conditions: recognition and referral",1,"5 - QS198 - Suspected neurological conditions: recognition and referral - Structure - 1"]
[null,"QS198","Suspected neurological conditions: recognition and referral",5,null,"Adults diagnosed with a functional neurological disorder are supported to manage symptoms that are a part of the disorder in non-specialist care.","The proportion of adults diagnosed with a functional neurological disorder satisfied with symptom management support from non-specialist care.","Outcome","QS198 - Suspected neurological conditions: recognition and referral","5 - QS198 - Suspected neurological conditions: recognition and referral",1,"5 - QS198 - Suspected neurological conditions: recognition and referral - Outcome - 1","The number in the denominator who are satisfied with symptom management support from non-specialist care.","The number of adults diagnosed with a functional neurological disorder."]
[null,"QS198","Suspected neurological conditions: recognition and referral",6,null,"Adults with suspected neurological conditions using NHS services experience care and treatment that is tailored to their needs and preferences.","Evidence of local arrangements to ensure that adults with suspected neurological conditions have opportunities to discuss their health beliefs, concerns and preferences.","Structure","QS198 - Suspected neurological conditions: recognition and referral","6 - QS198 - Suspected neurological conditions: recognition and referral",1,"6 - QS198 - Suspected neurological conditions: recognition and referral - Structure - 1"]
[null,"QS198","Suspected neurological conditions: recognition and referral",6,null,"Adults with suspected neurological conditions using NHS services experience care and treatment that is tailored to their needs and preferences.","Evidence of local arrangements and written protocols to ensure that the needs and preferences of adults with suspected neurological conditions are assessed, addressed and regularly reviewed.","Structure","QS198 - Suspected neurological conditions: recognition and referral","6 - QS198 - Suspected neurological conditions: recognition and referral",2,"6 - QS198 - Suspected neurological conditions: recognition and referral - Structure - 2"]
[null,"QS198","Suspected neurological conditions: recognition and referral",6,null,"Adults with suspected neurological conditions using NHS services experience care and treatment that is tailored to their needs and preferences.","Evidence of local arrangements to ensure that care and treatment are tailored to the needs and preferences of adults with suspected neurological conditions.","Structure","QS198 - Suspected neurological conditions: recognition and referral","6 - QS198 - Suspected neurological conditions: recognition and referral",3,"6 - QS198 - Suspected neurological conditions: recognition and referral - Structure - 3"]
[null,"QS198","Suspected neurological conditions: recognition and referral",6,null,"Adults with suspected neurological conditions using NHS services experience care and treatment that is tailored to their needs and preferences.","Proportion of adults with suspected neurological conditions given the opportunity to discuss their health beliefs, concerns and preferences.","Process","QS198 - Suspected neurological conditions: recognition and referral","6 - QS198 - Suspected neurological conditions: recognition and referral",1,"6 - QS198 - Suspected neurological conditions: recognition and referral - Process - 1","The number in the denominator who were given the opportunity to discuss their health beliefs, concerns and preferences.","The number of adults with suspected neurological conditions accessing NHS services."]
[null,"QS198","Suspected neurological conditions: recognition and referral",6,null,"Adults with suspected neurological conditions using NHS services experience care and treatment that is tailored to their needs and preferences.","Proportion of adults with suspected neurological conditions with care tailored to their needs and preferences, taking into account their circumstances, ability to access services and coexisting conditions.","Process","QS198 - Suspected neurological conditions: recognition and referral","6 - QS198 - Suspected neurological conditions: recognition and referral",2,"6 - QS198 - Suspected neurological conditions: recognition and referral - Process - 2","The number in the denominator whose care was tailored to their needs and preferences, taking into account their circumstances, ability to access services and coexisting conditions.","The number of adults with suspected neurological conditions accessing NHS services."]
[null,"QS198","Suspected neurological conditions: recognition and referral",6,null,"Adults with suspected neurological conditions using NHS services experience care and treatment that is tailored to their needs and preferences.","Proportion of adults with suspected neurological conditions accessing NHS services who have their needs and preferences assessed, addressed and regularly reviewed.","Process","QS198 - Suspected neurological conditions: recognition and referral","6 - QS198 - Suspected neurological conditions: recognition and referral",3,"6 - QS198 - Suspected neurological conditions: recognition and referral - Process - 3","The number in the denominator who have their physical and psychological needs regularly assessed, addressed and regularly reviewed.","The number of adults with suspected neurological conditions accessing NHS services."]
[null,"QS198","Suspected neurological conditions: recognition and referral",6,null,"Adults with suspected neurological conditions using NHS services experience care and treatment that is tailored to their needs and preferences.","Evidence from patient experience surveys and feedback that adults with suspected neurological conditions believe their care has been informed by their health beliefs, concerns and preferences.","Outcome","QS198 - Suspected neurological conditions: recognition and referral","6 - QS198 - Suspected neurological conditions: recognition and referral",1,"6 - QS198 - Suspected neurological conditions: recognition and referral - Outcome - 1"]
[null,"QS198","Suspected neurological conditions: recognition and referral",6,null,"Adults with suspected neurological conditions using NHS services experience care and treatment that is tailored to their needs and preferences.","Evidence from patient experience surveys and feedback that the care of adults with neurological conditions was tailored to their needs and personal preferences, taking into account their circumstances, their ability to access services and their coexisting conditions.","Outcome","QS198 - Suspected neurological conditions: recognition and referral","6 - QS198 - Suspected neurological conditions: recognition and referral",2,"6 - QS198 - Suspected neurological conditions: recognition and referral - Outcome - 2"]
[null,"QS198","Suspected neurological conditions: recognition and referral",6,null,"Adults with suspected neurological conditions using NHS services experience care and treatment that is tailored to their needs and preferences.","Evidence from patient experience surveys and feedback that adults with suspected neurological conditions believe their physical and psychological needs were assessed, addressed and regularly reviewed.","Outcome","QS198 - Suspected neurological conditions: recognition and referral","6 - QS198 - Suspected neurological conditions: recognition and referral",3,"6 - QS198 - Suspected neurological conditions: recognition and referral - Outcome - 3"]
[null,"QS199","Abortion care",1,null,"Healthcare commissioners and providers work together to make abortion services easy to access.","Evidence that healthcare commissioners and providers work together to make abortion services easy to access.","Structure","QS199 - Abortion care","1 - QS199 - Abortion care",1,"1 - QS199 - Abortion care - Structure - 1"]
[null,"QS199","Abortion care",1,null,"Healthcare commissioners and providers work together to make abortion services easy to access.","Evidence of joint local arrangements to provide information about how to access abortion services.","Structure",{"$f":"CONCATENATE(B4446, \" - \", C4446)","v":"QS199 - Abortion care"},"1 - QS199 - Abortion care",2,"1 - QS199 - Abortion care - Structure - 2"]
[null,"QS199","Abortion care",1,null,"Healthcare commissioners and providers work together to make abortion services easy to access.","Evidence that women can self-refer to abortion services.","Structure","QS199 - Abortion care","1 - QS199 - Abortion care",3,"1 - QS199 - Abortion care - Structure - 3"]
[null,"QS199","Abortion care",1,null,"Healthcare commissioners and providers work together to make abortion services easy to access.","Proportion of abortions performed at under 10 weeks.","Outcome","QS199 - Abortion care","1 - QS199 - Abortion care",1,"1 - QS199 - Abortion care - Outcome - 1","The number in the denominator performed at under 10 weeks.","The number of abortions."]
[null,"QS199","Abortion care",1,null,"Healthcare commissioners and providers work together to make abortion services easy to access.","Proportion of women assessed for an abortion who are satisfied with ease of access to abortion services.","Outcome","QS199 - Abortion care","1 - QS199 - Abortion care",2,"1 - QS199 - Abortion care - Outcome - 2","The number in the denominator who are satisfied with ease of access to abortion services.","The number of women assessed for an abortion."]
[null,"QS199","Abortion care",2,null,"Women who request an abortion are given a choice between medical and surgical abortion to take place up to and including 23+6 weeks' gestation.","Evidence of local processes to support a discussion about the differences between medical and surgical abortion, including the benefits and risks, with women who request an abortion.","Structure","QS199 - Abortion care","2 - QS199 - Abortion care",1,"2 - QS199 - Abortion care - Structure - 1"]
[null,"QS199","Abortion care",2,null,"Women who request an abortion are given a choice between medical and surgical abortion to take place up to and including 23+6 weeks' gestation.","Evidence of referral pathways to alternative services that are as local as possible if a provider cannot provide an abortion by the woman's preferred method.","Structure","QS199 - Abortion care","2 - QS199 - Abortion care",2,"2 - QS199 - Abortion care - Structure - 2"]
[null,"QS199","Abortion care",2,null,"Women who request an abortion are given a choice between medical and surgical abortion to take place up to and including 23+6 weeks' gestation.","Proportion of women who had an abortion up to and including 23+6 weeks' gestation with a record of their choice of medical or surgical abortion.","Process","QS199 - Abortion care","2 - QS199 - Abortion care",1,"2 - QS199 - Abortion care - Process - 1","The number in the denominator with a record of their choice of medical or surgical abortion.","The number of women who had an abortion up to and including 23+6 weeks' gestation."]
[null,"QS199","Abortion care",2,null,"Women who request an abortion are given a choice between medical and surgical abortion to take place up to and including 23+6 weeks' gestation.","Proportion of women who had an abortion up to and including 23+6 weeks' gestation who had a medical abortion.","Process","QS199 - Abortion care","2 - QS199 - Abortion care",2,"2 - QS199 - Abortion care - Process - 2","The number in the denominator who had a medical abortion.","The number of women who had an abortion up to and including 23+6 weeks' gestation."]
[null,"QS199","Abortion care",2,null,"Women who request an abortion are given a choice between medical and surgical abortion to take place up to and including 23+6 weeks' gestation.","Proportion of women who had an abortion up to and including 23+6 weeks' gestation who had a surgical abortion.","Process","QS199 - Abortion care","2 - QS199 - Abortion care",3,"2 - QS199 - Abortion care - Process - 3","The number in the denominator who had a surgical abortion.","The number of women who had an abortion up to and including 23+6 weeks' gestation."]
[null,"QS199","Abortion care",2,null,"Women who request an abortion are given a choice between medical and surgical abortion to take place up to and including 23+6 weeks' gestation.","Proportion of women who had an abortion who were satisfied with their abortion care.","Outcome","QS199 - Abortion care","2 - QS199 - Abortion care",1,"2 - QS199 - Abortion care - Outcome - 1","The number in the denominator who were satisfied with their abortion care.","The number of women who had an abortion."]
[null,"QS199","Abortion care",3,null,"Women who decide to go ahead with an abortion have the option to have the procedure within 1 week of assessment.","Evidence of local arrangements to ensure that women who decide to go ahead with an abortion have the option to have the procedure within 1 week of assessment.","Structure","QS199 - Abortion care","3 - QS199 - Abortion care",1,"3 - QS199 - Abortion care - Structure - 1"]
[null,"QS199","Abortion care",3,null,"Women who decide to go ahead with an abortion have the option to have the procedure within 1 week of assessment.","Evidence of local referral pathways if a service cannot provide the procedure within 1 week of assessment.","Structure","QS199 - Abortion care","3 - QS199 - Abortion care",2,"3 - QS199 - Abortion care - Structure - 2"]
[null,"QS199","Abortion care",3,null,"Women who decide to go ahead with an abortion have the option to have the procedure within 1 week of assessment.","Proportion of women who decide to go ahead with an abortion who have the option to have the procedure within 1 week of assessment.","Process","QS199 - Abortion care","3 - QS199 - Abortion care",1,"3 - QS199 - Abortion care - Process - 1","The number in the denominator who have the option to have the procedure within 1 week of assessment.","The number of women who decide to go ahead with an abortion."]
[null,"QS199","Abortion care",3,null,"Women who decide to go ahead with an abortion have the option to have the procedure within 1 week of assessment.","Proportion of women who decide to go ahead with an abortion who have the procedure within 1 week of assessment.","Process","QS199 - Abortion care","3 - QS199 - Abortion care",2,"3 - QS199 - Abortion care - Process - 2","The number in the denominator who have the procedure within 1 week of assessment.","The number of women who decide to go ahead with an abortion."]
[null,"QS199","Abortion care",3,null,"Women who decide to go ahead with an abortion have the option to have the procedure within 1 week of assessment.","Average waiting time for abortion from initial referral to receipt of procedure.","Outcome","QS199 - Abortion care","3 - QS199 - Abortion care",1,"3 - QS199 - Abortion care - Outcome - 1"]
[null,"QS199","Abortion care",3,null,"Women who decide to go ahead with an abortion have the option to have the procedure within 1 week of assessment.","Proportion of abortions performed at under 10 weeks.","Outcome","QS199 - Abortion care","3 - QS199 - Abortion care",2,"3 - QS199 - Abortion care - Outcome - 2","The number in the denominator performed at under 10 weeks.","The number of abortions."]
[null,"QS199","Abortion care",4,null,"Women having a medical abortion up to and including 9+6 weeks' gestation are given the option to take misoprostol at home.","Evidence of local processes to ensure that women having a medical abortion up to and including 9+6 weeks' gestation are given the option to take misoprostol at home.","Structure","QS199 - Abortion care","4 - QS199 - Abortion care",1,"4 - QS199 - Abortion care - Structure - 1"]
[null,"QS199","Abortion care",4,null,"Women having a medical abortion up to and including 9+6 weeks' gestation are given the option to take misoprostol at home.","Proportion of women having a medical abortion up to and including 9+6 weeks' gestation who take misoprostol at home.","Process","QS199 - Abortion care","4 - QS199 - Abortion care",1,"4 - QS199 - Abortion care - Process - 1","The number in the denominator who take misoprostol at home.","The number of women having a medical abortion up to and including 9+6 weeks' gestation."]
[null,"QS199","Abortion care",4,null,"Women having a medical abortion up to and including 9+6 weeks' gestation are given the option to take misoprostol at home.","Hospital attendances for administration of misoprostol for early medical abortion.","Outcome","QS199 - Abortion care","4 - QS199 - Abortion care",1,"4 - QS199 - Abortion care - Outcome - 1"]
[null,"QS199","Abortion care",4,null,"Women having a medical abortion up to and including 9+6 weeks' gestation are given the option to take misoprostol at home.","Average waiting time for early medical abortion from initial referral to receipt of procedure.","Outcome","QS199 - Abortion care","4 - QS199 - Abortion care",2,"4 - QS199 - Abortion care - Outcome - 2"]
[null,"QS199","Abortion care",5,null,"Women having an abortion who want contraception receive their chosen method before discharge, either at the time of their abortion or as soon as possible after expulsion of the pregnancy.","Evidence that the full range of reversible contraceptive options is available for women before discharge from an abortion provider, either on the same day as their abortion or as soon as possible after expulsion of the pregnancy.","Structure","QS199 - Abortion care","5 - QS199 - Abortion care",1,"5 - QS199 - Abortion care - Structure - 1"]
[null,"QS199","Abortion care",5,null,"Women having an abortion who want contraception receive their chosen method before discharge, either at the time of their abortion or as soon as possible after expulsion of the pregnancy.","Proportion of women having an abortion who want contraception who receive their chosen method before discharge.","Process","QS199 - Abortion care","5 - QS199 - Abortion care",1,"5 - QS199 - Abortion care - Process - 1","The number in the denominator who receive their chosen method of contraception before discharge.","The number of women having an abortion who want contraception."]
[null,"QS199","Abortion care",5,null,"Women having an abortion who want contraception receive their chosen method before discharge, either at the time of their abortion or as soon as possible after expulsion of the pregnancy.","Contraception uptake rate after abortion.","Outcome","QS199 - Abortion care","5 - QS199 - Abortion care",1,"5 - QS199 - Abortion care - Outcome - 1"]
[null,"QS199","Abortion care",6,null,"Women having an abortion are given advice on how to access care and support after the abortion.","Evidence of local arrangements to provide care and support to women after an abortion, including referral pathways to counselling or psychological interventions.","Structure","QS199 - Abortion care","6 - QS199 - Abortion care",1,"6 - QS199 - Abortion care - Structure - 1"]
[null,"QS199","Abortion care",6,null,"Women having an abortion are given advice on how to access care and support after the abortion.","Evidence of local processes to ensure that women having an abortion are given advice on how to access care and support after the abortion, including how to get help out of hours.","Structure","QS199 - Abortion care","6 - QS199 - Abortion care",2,"6 - QS199 - Abortion care - Structure - 2"]
[null,"QS199","Abortion care",6,null,"Women having an abortion are given advice on how to access care and support after the abortion.","Proportion of women having an abortion who are given advice on how to access care and support after the abortion, including how to get help out of hours.","Process","QS199 - Abortion care","6 - QS199 - Abortion care",1,"6 - QS199 - Abortion care - Process - 1","The number in the denominator who are given advice on how to access care and support after the abortion, including how to get help out of hours.","The number of women having an abortion."]
[null,"QS199","Abortion care",6,null,"Women having an abortion are given advice on how to access care and support after the abortion.","Proportion of women who had an abortion who agree they were able to access care and support after the abortion if they needed to.","Outcome","QS199 - Abortion care","6 - QS199 - Abortion care",{"$f":"IF(AND(B4472=B4471, D4472=D4471, H4472=H4471)=TRUE, K4471+1, 1)","v":1},"6 - QS199 - Abortion care - Outcome - 1","The number in the denominator who agree they were able to access care and support after the abortion if they needed to.","The number of women who had an abortion."]
[null,"QS200","Supporting adult carers",1,null,"Carers are identified by health and social care organisations and encouraged to recognise their role and rights.","Evidence that health and social care organisations have strategies, policies and processes to identify carers and encourage them to recognise their role and rights.","Structure","QS200 - Supporting adult carers","1 - QS200 - Supporting adult carers",{"$f":"IF(AND(B4473=B4472, D4473=D4472, H4473=H4472)=TRUE, K4472+1, 1)","v":1},"1 - QS200 - Supporting adult carers - Structure - 1"]
[null,"QS200","Supporting adult carers",1,null,"Carers are identified by health and social care organisations and encouraged to recognise their role and rights.","Evidence that health and social care practitioners understand their responsibilities under the Care Act 2014 to identify carers.","Structure",{"$f":"CONCATENATE(B4474, \" - \", C4474)","v":"QS200 - Supporting adult carers"},{"$f":"CONCATENATE(D4474, \" - \", I4474)","v":"1 - QS200 - Supporting adult carers"},2,"1 - QS200 - Supporting adult carers - Structure - 2"]
[null,"QS200","Supporting adult carers",1,null,"Carers are identified by health and social care organisations and encouraged to recognise their role and rights.","Evidence of local arrangements to encourage carers to self‑identify and seek support.","Structure","QS200 - Supporting adult carers","1 - QS200 - Supporting adult carers",3,"1 - QS200 - Supporting adult carers - Structure - 3"]
[null,"QS200","Supporting adult carers",1,null,"Carers are identified by health and social care organisations and encouraged to recognise their role and rights.","Evidence that health and social care organisations have systems to record and share details about carers, with their consent.","Structure","QS200 - Supporting adult carers","1 - QS200 - Supporting adult carers",{"$f":"IF(AND(B4476=B4475, D4476=D4475, H4476=H4475)=TRUE, K4475+1, 1)","v":4},"1 - QS200 - Supporting adult carers - Structure - 4"]
[null,"QS200","Supporting adult carers",1,null,"Carers are identified by health and social care organisations and encouraged to recognise their role and rights.","Number of carers known to local health and care organisations.","Outcome","QS200 - Supporting adult carers","1 - QS200 - Supporting adult carers",1,"1 - QS200 - Supporting adult carers - Outcome - 1"]
[null,"QS200","Supporting adult carers",1,null,"Carers are identified by health and social care organisations and encouraged to recognise their role and rights.","Average time it takes for carers to recognise their caring role.","Outcome","QS200 - Supporting adult carers","1 - QS200 - Supporting adult carers",2,"1 - QS200 - Supporting adult carers - Outcome - 2"]
[null,"QS200","Supporting adult carers",2,null,"Carers are supported to actively participate in decision making and care planning for the person they care for.","Evidence that health and social care organisations have policies and processes to support carers to actively participate in decision making and care planning for the person they care for.","Structure","QS200 - Supporting adult carers","2 - QS200 - Supporting adult carers",1,"2 - QS200 - Supporting adult carers - Structure - 1"]
[null,"QS200","Supporting adult carers",2,null,"Carers are supported to actively participate in decision making and care planning for the person they care for.","Evidence that health and social care organisations include evidence of the carer’s contribution in care plans and discharge plans.","Structure","QS200 - Supporting adult carers","2 - QS200 - Supporting adult carers",2,{"$f":"CONCATENATE(J4480, \" - \", H4480, \" - \",K4480)","v":"2 - QS200 - Supporting adult carers - Structure - 2"}]
[null,"QS200","Supporting adult carers",2,null,"Carers are supported to actively participate in decision making and care planning for the person they care for.","Proportion of carers who feel they have been involved or consulted as much as they wanted to be in discussions about the support or services provided to the person they care for.","Outcome","QS200 - Supporting adult carers","2 - QS200 - Supporting adult carers",1,"2 - QS200 - Supporting adult carers - Outcome - 1","The number in the denominator who feel they have been involved or consulted as much as they wanted to be in discussions about the support or services provided to the person they care for.","The number of carers."]
[null,"QS200","Supporting adult carers",2,null,"Carers are supported to actively participate in decision making and care planning for the person they care for.","Proportion of carers who feel they have encouragement and support in their caring role.","Outcome","QS200 - Supporting adult carers","2 - QS200 - Supporting adult carers",2,"2 - QS200 - Supporting adult carers - Outcome - 2","The number in the denominator who feel they have encouragement and support in their caring role.","The number of carers."]
[null,"QS200","Supporting adult carers",3,null,"Carers having a carer’s assessment are given the opportunity to discuss what matters most to them, including their own health, wellbeing and social care needs, and work, education, or training.","Evidence of local processes to ensure that carers having a carer’s assessment are given the opportunity to discuss what matters most to them, including their own health, wellbeing and social care needs, and work, education, or training.","Structure","QS200 - Supporting adult carers","3 - QS200 - Supporting adult carers",1,"3 - QS200 - Supporting adult carers - Structure - 1"]
[null,"QS200","Supporting adult carers",3,null,"Carers having a carer’s assessment are given the opportunity to discuss what matters most to them, including their own health, wellbeing and social care needs, and work, education, or training.","Proportion of carers’ assessments that included the health, wellbeing, and social care needs of the carer.","Process","QS200 - Supporting adult carers","3 - QS200 - Supporting adult carers",1,"3 - QS200 - Supporting adult carers - Process - 1","The number in the denominator that included the health, wellbeing, and social care needs of the carer.","The number of carers’ assessments."]
[null,"QS200","Supporting adult carers",3,null,"Carers having a carer’s assessment are given the opportunity to discuss what matters most to them, including their own health, wellbeing and social care needs, and work, education, or training.","Proportion of carers’ assessments that included the work, education, or training needs of the carer.","Process","QS200 - Supporting adult carers","3 - QS200 - Supporting adult carers",2,"3 - QS200 - Supporting adult carers - Process - 2","The number in the denominator that included the health, wellbeing, and social care needs of the carer.","The number of carers’ assessments."]
[null,"QS200","Supporting adult carers",3,null,"Carers having a carer’s assessment are given the opportunity to discuss what matters most to them, including their own health, wellbeing and social care needs, and work, education, or training.","Proportion of carers who had a carer’s assessment who are satisfied that it reflects what matters most to them.","Outcome","QS200 - Supporting adult carers","3 - QS200 - Supporting adult carers",1,"3 - QS200 - Supporting adult carers - Outcome - 1","The number in the denominator who are satisfied that it reflects what matters most to them.","The number of carers who had a carer’s assessment."]
[null,"QS200","Supporting adult carers",3,null,"Carers having a carer’s assessment are given the opportunity to discuss what matters most to them, including their own health, wellbeing and social care needs, and work, education, or training.","Carer quality of life.","Outcome","QS200 - Supporting adult carers","3 - QS200 - Supporting adult carers",2,"3 - QS200 - Supporting adult carers - Outcome - 2"]
[null,"QS200","Supporting adult carers",3,null,"Carers having a carer’s assessment are given the opportunity to discuss what matters most to them, including their own health, wellbeing and social care needs, and work, education, or training.","Proportion of carers in paid work.","Outcome","QS200 - Supporting adult carers","3 - QS200 - Supporting adult carers",3,"3 - QS200 - Supporting adult carers - Outcome - 3","The number in the denominator who are in paid work.","The number of carers."]
[null,"QS200","Supporting adult carers",4,null,"Carers are regularly given the opportunity to discuss with health and social care practitioners the value of having a break from caring and the options available to them.","Evidence of local arrangements for health and social care practitioners to have regular discussions with carers about the value of having a break from caring and the options available to them.","Structure","QS200 - Supporting adult carers","4 - QS200 - Supporting adult carers",1,"4 - QS200 - Supporting adult carers - Structure - 1"]
[null,"QS200","Supporting adult carers",4,null,"Carers are regularly given the opportunity to discuss with health and social care practitioners the value of having a break from caring and the options available to them.","Evidence that accessible and up‑to‑date information about the local options for replacement care is available.","Structure","QS200 - Supporting adult carers","4 - QS200 - Supporting adult carers",2,"4 - QS200 - Supporting adult carers - Structure - 2"]
[null,"QS200","Supporting adult carers",4,null,"Carers are regularly given the opportunity to discuss with health and social care practitioners the value of having a break from caring and the options available to them.","Proportion of carers who used support or services to take a break from caring.","Outcome","QS200 - Supporting adult carers","4 - QS200 - Supporting adult carers",1,"4 - QS200 - Supporting adult carers - Outcome - 1","The number in the denominator who used support or services to take a break from caring.","The number of carers."]
[null,"QS200","Supporting adult carers",4,null,"Carers are regularly given the opportunity to discuss with health and social care practitioners the value of having a break from caring and the options available to them.","Carer quality of life.","Outcome","QS200 - Supporting adult carers","4 - QS200 - Supporting adult carers",2,"4 - QS200 - Supporting adult carers - Outcome - 2"]
[null,"QS200","Supporting adult carers",5,null,"Carers are offered supportive working arrangements by workplaces.","Evidence that workplaces have policies, plans and processes in place to support carers.","Structure","QS200 - Supporting adult carers","5 - QS200 - Supporting adult carers",1,"5 - QS200 - Supporting adult carers - Structure - 1"]
[null,"QS200","Supporting adult carers",5,null,"Carers are offered supportive working arrangements by workplaces.","Evidence that workplaces offer supportive working arrangements for carers.","Structure","QS200 - Supporting adult carers","5 - QS200 - Supporting adult carers",2,"5 - QS200 - Supporting adult carers - Structure - 2"]
[null,"QS200","Supporting adult carers",5,null,"Carers are offered supportive working arrangements by workplaces.","Proportion of carers in paid work.","Outcome","QS200 - Supporting adult carers","5 - QS200 - Supporting adult carers",1,"5 - QS200 - Supporting adult carers - Outcome - 1","The number in the denominator who are in paid work.","The number of carers."]
[null,"QS200","Supporting adult carers",5,null,"Carers are offered supportive working arrangements by workplaces.","Proportion of carers in paid work who feel supported by their employer.","Outcome",{"$f":"CONCATENATE(B4496, \" - \", C4496)","v":"QS200 - Supporting adult carers"},{"$f":"CONCATENATE(D4496, \" - \", I4496)","v":"5 - QS200 - Supporting adult carers"},2,"5 - QS200 - Supporting adult carers - Outcome - 2","The number in the denominator who feel supported by their employer.","The number of carers in paid work."]
[null,"QS201","Venous thromboembolism in adults",1,null,"People aged 16 and over who are in hospital and assessed as needing pharmacological venous thromboembolism (VTE) prophylaxis start it as soon as possible and within 14 hours of hospital admission.","Evidence of arrangements to ensure that people aged 16 and over who are in hospital and assessed as needing pharmacological VTE prophylaxis start it as soon as possible and within 14 hours of hospital admission.","Structure","QS201 - Venous thromboembolism in adults","1 - QS201 - Venous thromboembolism in adults",1,"1 - QS201 - Venous thromboembolism in adults - Structure - 1"]
[null,"QS201","Venous thromboembolism in adults",1,null,"People aged 16 and over who are in hospital and assessed as needing pharmacological venous thromboembolism (VTE) prophylaxis start it as soon as possible and within 14 hours of hospital admission.","Proportion of people aged 16 and over who are in hospital and assessed as needing pharmacological VTE prophylaxis who start it within 14 hours of hospital admission.","Process","QS201 - Venous thromboembolism in adults","1 - QS201 - Venous thromboembolism in adults",1,"1 - QS201 - Venous thromboembolism in adults - Process - 1","The number in the denominator who start pharmacological VTE prophylaxis within 14 hours of hospital admission.","The number of people aged 16 and over who are in hospital and assessed as needing pharmacological VTE prophylaxis."]
[null,"QS201","Venous thromboembolism in adults",1,null,"People aged 16 and over who are in hospital and assessed as needing pharmacological venous thromboembolism (VTE) prophylaxis start it as soon as possible and within 14 hours of hospital admission.","Rates of hospital-acquired thrombosis (HAT).","Outcome","QS201 - Venous thromboembolism in adults","1 - QS201 - Venous thromboembolism in adults",1,"1 - QS201 - Venous thromboembolism in adults - Outcome - 1"]
[null,"QS201","Venous thromboembolism in adults",2,null,"People aged 16 and over who are discharged with lower limb immobilisation are assessed to identify their risk of venous thromboembolism (VTE).","Evidence of written clinical protocols to ensure that people aged 16 and over who are discharged with lower limb immobilisation are assessed to identify their risk of VTE.","Structure","QS201 - Venous thromboembolism in adults","2 - QS201 - Venous thromboembolism in adults",1,"2 - QS201 - Venous thromboembolism in adults - Structure - 1"]
[null,"QS201","Venous thromboembolism in adults",2,null,"People aged 16 and over who are discharged with lower limb immobilisation are assessed to identify their risk of venous thromboembolism (VTE).","Proportion of people aged 16 and over who are discharged with lower limb immobilisation who are assessed to identify their risk of VTE.","Process","QS201 - Venous thromboembolism in adults","2 - QS201 - Venous thromboembolism in adults",1,"2 - QS201 - Venous thromboembolism in adults - Process - 1","The number in the denominator who are assessed to identify their risk of VTE.","The number of people aged 16 and over who are discharged with lower limb immobilisation."]
[null,"QS201","Venous thromboembolism in adults",2,null,"People aged 16 and over who are discharged with lower limb immobilisation are assessed to identify their risk of venous thromboembolism (VTE).","Rates of thrombosis.","Outcome","QS201 - Venous thromboembolism in adults","2 - QS201 - Venous thromboembolism in adults",1,"2 - QS201 - Venous thromboembolism in adults - Outcome - 1"]
[null,"QS201","Venous thromboembolism in adults",3,null,"People aged 18 and over with a deep vein thrombosis (DVT) Wells score of 2 points or more have a proximal leg vein ultrasound scan within 4 hours of it being requested.","Evidence of the availability of staff to perform proximal leg vein ultrasound scans for people aged 18 and over with a DVT Wells score of 2 points or more within 4 hours of it being requested.","Structure","QS201 - Venous thromboembolism in adults","3 - QS201 - Venous thromboembolism in adults",1,"3 - QS201 - Venous thromboembolism in adults - Structure - 1"]
[null,"QS201","Venous thromboembolism in adults",3,null,"People aged 18 and over with a deep vein thrombosis (DVT) Wells score of 2 points or more have a proximal leg vein ultrasound scan within 4 hours of it being requested.","Proportion of people aged 18 and over with a DVT Wells score of 2 points or more who have a proximal leg vein ultrasound scan within 4 hours of it being requested.","Process","QS201 - Venous thromboembolism in adults","3 - QS201 - Venous thromboembolism in adults",1,"3 - QS201 - Venous thromboembolism in adults - Process - 1","The number in the denominator who have a proximal leg vein ultrasound scan within 4 hours of it being requested.","The number of people aged 18 and over with a DVT Wells score of 2 points or more."]
[null,"QS201","Venous thromboembolism in adults",3,null,"People aged 18 and over with a deep vein thrombosis (DVT) Wells score of 2 points or more have a proximal leg vein ultrasound scan within 4 hours of it being requested.","Prescribing rates of interim therapeutic anticoagulation to prevent DVT.","Outcome","QS201 - Venous thromboembolism in adults","3 - QS201 - Venous thromboembolism in adults",1,"3 - QS201 - Venous thromboembolism in adults - Outcome - 1"]
[null,"QS201","Venous thromboembolism in adults",4,null,"People aged 18 and over taking anticoagulation treatment after a venous thromboembolism (VTE) have a review at 3 months and then at least once a year if they continue to take it long term. ","Evidence of local systems to identify and invite people aged 18 and over, taking anticoagulation treatment after a VTE for a review at 3 months.","Structure","QS201 - Venous thromboembolism in adults","4 - QS201 - Venous thromboembolism in adults",1,"4 - QS201 - Venous thromboembolism in adults - Structure - 1"]
[null,"QS201","Venous thromboembolism in adults",4,null,"People aged 18 and over taking anticoagulation treatment after a venous thromboembolism (VTE) have a review at 3 months and then at least once a year if they continue to take it long term. ","Evidence of local systems to identify and invite people aged 18 and over taking long-term anticoagulation treatment after a VTE for a review at least once a year.","Structure","QS201 - Venous thromboembolism in adults","4 - QS201 - Venous thromboembolism in adults",2,"4 - QS201 - Venous thromboembolism in adults - Structure - 2"]
[null,"QS201","Venous thromboembolism in adults",4,null,"People aged 18 and over taking anticoagulation treatment after a venous thromboembolism (VTE) have a review at 3 months and then at least once a year if they continue to take it long term. ","Proportion of people aged 18 and over taking anticoagulation treatment for 3 months after a VTE who have a review.","Process","QS201 - Venous thromboembolism in adults","4 - QS201 - Venous thromboembolism in adults",1,"4 - QS201 - Venous thromboembolism in adults - Process - 1","The number in the denominator who have a review at 3 months.","The number of people aged 18 and over taking anticoagulation treatment after a VTE.\n"]
[null,"QS201","Venous thromboembolism in adults",4,null,"People aged 18 and over taking anticoagulation treatment after a venous thromboembolism (VTE) have a review at 3 months and then at least once a year if they continue to take it long term. ","Proportion of people aged 18 and over taking long-term anticoagulation treatment for secondary prevention of VTE who have a review at least once a year.","Process","QS201 - Venous thromboembolism in adults","4 - QS201 - Venous thromboembolism in adults",2,"4 - QS201 - Venous thromboembolism in adults - Process - 2","The number in the denominator who had a review in the previous year.","The number of people aged 18 and over taking long-term anticoagulation treatment for secondary prevention of VTE."]
[null,"QS201","Venous thromboembolism in adults",5,null,"People aged 18 and over having outpatient treatment for suspected or confirmed low-risk pulmonary embolism (PE) have an agreed plan for monitoring and follow‑up. ","Evidence of local arrangements to ensure that people aged 18 and over having outpatient treatment for suspected or confirmed low-risk PE have an agreed plan for monitoring and follow‑up.","Structure","QS201 - Venous thromboembolism in adults","5 - QS201 - Venous thromboembolism in adults",1,"5 - QS201 - Venous thromboembolism in adults - Structure - 1"]
[null,"QS201","Venous thromboembolism in adults",5,null,"People aged 18 and over having outpatient treatment for suspected or confirmed low-risk pulmonary embolism (PE) have an agreed plan for monitoring and follow‑up. ","Evidence that information is available for people aged 18 and over having outpatient treatment for suspected or confirmed low-risk PE on symptoms and signs to look out for, and contact information for healthcare professionals they can discuss concerns with.","Structure","QS201 - Venous thromboembolism in adults","5 - QS201 - Venous thromboembolism in adults",2,"5 - QS201 - Venous thromboembolism in adults - Structure - 2"]
[null,"QS201","Venous thromboembolism in adults",5,null,"People aged 18 and over having outpatient treatment for suspected or confirmed low-risk pulmonary embolism (PE) have an agreed plan for monitoring and follow‑up. ","Proportion of people aged 18 and over having outpatient treatment for suspected or confirmed low-risk PE who have an agreed plan for monitoring and follow‑up.","Process","QS201 - Venous thromboembolism in adults","5 - QS201 - Venous thromboembolism in adults",1,"5 - QS201 - Venous thromboembolism in adults - Process - 1","The number in the denominator who have an agreed plan for monitoring and follow‑up.","The number of people aged 18 and over having outpatient treatment for suspected or confirmed low-risk PE."]
[null,"QS201","Venous thromboembolism in adults",5,null,"People aged 18 and over having outpatient treatment for suspected or confirmed low-risk pulmonary embolism (PE) have an agreed plan for monitoring and follow‑up. ","Rates of emergency admissions to hospital for people aged 18 and over having outpatient treatment for low-risk PE.","Outcome","QS201 - Venous thromboembolism in adults","5 - QS201 - Venous thromboembolism in adults",1,"5 - QS201 - Venous thromboembolism in adults - Outcome - 1"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",1,null,"Employees work in organisations that develop policies for managing sickness absence and return to work as part of a broader, strategically led approach to promoting employees' health and wellbeing.","Evidence of a strategically led approach to employee health and wellbeing.","Structure","QS202 - Workplace health: long-term sickness absence and capability to work","1 - QS202 - Workplace health: long-term sickness absence and capability to work",1,"1 - QS202 - Workplace health: long-term sickness absence and capability to work - Structure - 1"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",1,null,"Employees work in organisations that develop policies for managing sickness absence and return to work as part of a broader, strategically led approach to promoting employees' health and wellbeing.","Evidence that policies for managing sickness absence and return to work are part of a strategically led approach to employee health and wellbeing.","Structure","QS202 - Workplace health: long-term sickness absence and capability to work","1 - QS202 - Workplace health: long-term sickness absence and capability to work",2,"1 - QS202 - Workplace health: long-term sickness absence and capability to work - Structure - 2"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",1,null,"Employees work in organisations that develop policies for managing sickness absence and return to work as part of a broader, strategically led approach to promoting employees' health and wellbeing.","Rates of long-term sickness absence.","Outcome","QS202 - Workplace health: long-term sickness absence and capability to work","1 - QS202 - Workplace health: long-term sickness absence and capability to work",1,"1 - QS202 - Workplace health: long-term sickness absence and capability to work - Outcome - 1"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",1,null,"Employees work in organisations that develop policies for managing sickness absence and return to work as part of a broader, strategically led approach to promoting employees' health and wellbeing.","Rates of recurrent short-term sickness absence.","Outcome","QS202 - Workplace health: long-term sickness absence and capability to work","1 - QS202 - Workplace health: long-term sickness absence and capability to work",2,"1 - QS202 - Workplace health: long-term sickness absence and capability to work - Outcome - 2"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",1,null,"Employees work in organisations that develop policies for managing sickness absence and return to work as part of a broader, strategically led approach to promoting employees' health and wellbeing.","Employee satisfaction with organisational implementation of policies for managing sickness absence and return to work.","Outcome","QS202 - Workplace health: long-term sickness absence and capability to work","1 - QS202 - Workplace health: long-term sickness absence and capability to work",3,"1 - QS202 - Workplace health: long-term sickness absence and capability to work - Outcome - 3"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",2,null,"Employees who are assessed as 'not fit for work' are contacted by their employer as soon as possible to provide support and discuss arrangements for keeping in touch during sickness absence.","Evidence of policies or procedures to ensure that employees who are assessed as 'not fit for work' in their 'fit note' during periods of sickness absence are contacted by their employer as soon as possible during their sickness absence, and within 4 weeks of the start of the sickness absence.","Structure","QS202 - Workplace health: long-term sickness absence and capability to work","2 - QS202 - Workplace health: long-term sickness absence and capability to work",1,"2 - QS202 - Workplace health: long-term sickness absence and capability to work - Structure - 1"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",2,null,"Employees who are assessed as 'not fit for work' are contacted by their employer as soon as possible to provide support and discuss arrangements for keeping in touch during sickness absence.","Proportion of employees assessed as 'not fit for work' in their 'fit note' during periods of sickness absence who are contacted by their employer.","Process","QS202 - Workplace health: long-term sickness absence and capability to work","2 - QS202 - Workplace health: long-term sickness absence and capability to work",1,"2 - QS202 - Workplace health: long-term sickness absence and capability to work - Process - 1","The number in the denominator who are contacted by their employer.","The number of employees who are assessed as 'not fit for work' in their 'fit note'."]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",2,null,"Employees who are assessed as 'not fit for work' are contacted by their employer as soon as possible to provide support and discuss arrangements for keeping in touch during sickness absence.","Proportion of employees assessed as 'not fit for work' in their 'fit note' who were contacted by their employer within 4 weeks of the start of their sickness absence.","Process","QS202 - Workplace health: long-term sickness absence and capability to work","2 - QS202 - Workplace health: long-term sickness absence and capability to work",2,"2 - QS202 - Workplace health: long-term sickness absence and capability to work - Process - 2","The number in the denominator who were contacted by their employer within 4 weeks of the start of their sickness absence.","The number of employees assessed as 'not fit for work' in their 'fit note' during periods of sickness absence."]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",2,null,"Employees who are assessed as 'not fit for work' are contacted by their employer as soon as possible to provide support and discuss arrangements for keeping in touch during sickness absence.","Rates of long-term sickness absence.","Outcome","QS202 - Workplace health: long-term sickness absence and capability to work","2 - QS202 - Workplace health: long-term sickness absence and capability to work",1,"2 - QS202 - Workplace health: long-term sickness absence and capability to work - Outcome - 1"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",2,null,"Employees who are assessed as 'not fit for work' are contacted by their employer as soon as possible to provide support and discuss arrangements for keeping in touch during sickness absence.","Employee satisfaction with the support from their employer during their sickness absence.","Outcome","QS202 - Workplace health: long-term sickness absence and capability to work","2 - QS202 - Workplace health: long-term sickness absence and capability to work",2,"2 - QS202 - Workplace health: long-term sickness absence and capability to work - Outcome - 2"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",3,null,"Employees have information in their statement of fitness for work about how their reason for sickness absence or their treatment might affect them on their return to work.","Evidence that statements of fitness for work include information on how an employee's reason for sickness absence or their treatment might affect them at work.","Structure","QS202 - Workplace health: long-term sickness absence and capability to work","3 - QS202 - Workplace health: long-term sickness absence and capability to work",1,"3 - QS202 - Workplace health: long-term sickness absence and capability to work - Structure - 1"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",3,null,"Employees have information in their statement of fitness for work about how their reason for sickness absence or their treatment might affect them on their return to work.","Proportion of statements of fitness for work making use of the 'may be fit for work' option that include 'may be fit for work' advice.","Process","QS202 - Workplace health: long-term sickness absence and capability to work","3 - QS202 - Workplace health: long-term sickness absence and capability to work",1,"3 - QS202 - Workplace health: long-term sickness absence and capability to work - Process - 1","The number in the denominator that include 'may be fit for work' advice.","The number of statements of fitness for work making use of the 'may be fit for work' option."]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",3,null,"Employees have information in their statement of fitness for work about how their reason for sickness absence or their treatment might affect them on their return to work.","Employee satisfaction with adjustments and support on their return to work.","Outcome","QS202 - Workplace health: long-term sickness absence and capability to work","3 - QS202 - Workplace health: long-term sickness absence and capability to work",1,"3 - QS202 - Workplace health: long-term sickness absence and capability to work - Outcome - 1"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",3,null,"Employees have information in their statement of fitness for work about how their reason for sickness absence or their treatment might affect them on their return to work.","Rates of recurrent sickness absence.","Outcome","QS202 - Workplace health: long-term sickness absence and capability to work","3 - QS202 - Workplace health: long-term sickness absence and capability to work",2,"3 - QS202 - Workplace health: long-term sickness absence and capability to work - Outcome - 2"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",4,null,"Employees returning from sickness absence have any workplace adjustments recorded in a return-to-work plan that is monitored and reviewed.","Evidence of procedures to ensure that employees returning from sickness absence have any workplace adjustments recorded in a return-to-work plan.","Structure","QS202 - Workplace health: long-term sickness absence and capability to work","4 - QS202 - Workplace health: long-term sickness absence and capability to work",1,"4 - QS202 - Workplace health: long-term sickness absence and capability to work - Structure - 1"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",4,null,"Employees returning from sickness absence have any workplace adjustments recorded in a return-to-work plan that is monitored and reviewed.","Evidence of procedures to ensure that employees returning from sickness absence have their return-to-work plan monitored and reviewed.","Structure","QS202 - Workplace health: long-term sickness absence and capability to work","4 - QS202 - Workplace health: long-term sickness absence and capability to work",2,"4 - QS202 - Workplace health: long-term sickness absence and capability to work - Structure - 2"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",4,null,"Employees returning from sickness absence have any workplace adjustments recorded in a return-to-work plan that is monitored and reviewed.","Proportion of employees returning from sickness absence who need workplace adjustments and have a return-to-work plan.","Process","QS202 - Workplace health: long-term sickness absence and capability to work","4 - QS202 - Workplace health: long-term sickness absence and capability to work",1,"4 - QS202 - Workplace health: long-term sickness absence and capability to work - Process - 1","The number in the denominator who have a return-to-work plan.","The number of employees returning from sickness absence who need workplace adjustments."]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",4,null,"Employees returning from sickness absence have any workplace adjustments recorded in a return-to-work plan that is monitored and reviewed.","Proportion of employees who have workplace adjustments recorded in a return-to-work plan who have their return-to-work plan monitored and reviewed.","Process","QS202 - Workplace health: long-term sickness absence and capability to work","4 - QS202 - Workplace health: long-term sickness absence and capability to work",2,"4 - QS202 - Workplace health: long-term sickness absence and capability to work - Process - 2","The number in the denominator who have their return-to-work plan monitored and reviewed.","The number of employees who have workplace adjustments recorded in a return-to-work plan."]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",4,null,"Employees returning from sickness absence have any workplace adjustments recorded in a return-to-work plan that is monitored and reviewed.","Employee satisfaction with workplace adjustments on their return to work.","Outcome","QS202 - Workplace health: long-term sickness absence and capability to work","4 - QS202 - Workplace health: long-term sickness absence and capability to work",1,"4 - QS202 - Workplace health: long-term sickness absence and capability to work - Outcome - 1"]
[null,"QS202","Workplace health: long-term sickness absence and capability to work",4,null,"Employees returning from sickness absence have any workplace adjustments recorded in a return-to-work plan that is monitored and reviewed.","Rates of recurrent sickness absence.","Outcome","QS202 - Workplace health: long-term sickness absence and capability to work",{"$f":"CONCATENATE(D4533, \" - \", I4533)","v":"4 - QS202 - Workplace health: long-term sickness absence and capability to work"},2,"4 - QS202 - Workplace health: long-term sickness absence and capability to work - Outcome - 2"]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",1,null,"GPs have direct access to MRI for adults with suspected brain tumour.","Evidence of local arrangements to give GPs direct access to MRI for adults with suspected brain tumour.","Structure",{"$f":"CONCATENATE(B4534, \" - \", C4534)","v":"QS203 - Brain tumours (primary) and brain metastases in adults"},{"$f":"CONCATENATE(D4534, \" - \", I4534)","v":"1 - QS203 - Brain tumours (primary) and brain metastases in adults"},{"$f":"IF(AND(B4534=B4533, D4534=D4533, H4534=H4533)=TRUE, K4533+1, 1)","v":1},{"$f":"CONCATENATE(J4534, \" - \", H4534, \" - \",K4534)","v":"1 - QS203 - Brain tumours (primary) and brain metastases in adults - Structure - 1"}]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",1,null,"GPs have direct access to MRI for adults with suspected brain tumour.","Proportion of referrals for brain MRI that are GP direct referrals.","Process","QS203 - Brain tumours (primary) and brain metastases in adults","1 - QS203 - Brain tumours (primary) and brain metastases in adults",1,"1 - QS203 - Brain tumours (primary) and brain metastases in adults - Process - 1","The number in the denominator that are GP direct referrals.","The number of referrals for brain MRI."]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",1,null,"GPs have direct access to MRI for adults with suspected brain tumour.","Time from presentation at GP to brain tumour diagnosis.","Outcome","QS203 - Brain tumours (primary) and brain metastases in adults","1 - QS203 - Brain tumours (primary) and brain metastases in adults",1,"1 - QS203 - Brain tumours (primary) and brain metastases in adults - Outcome - 1"]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",2,null,"Adults with brain tumours have a named healthcare professional who coordinates their health and social care support.","Evidence of local processes to ensure that adults with brain tumours are assigned a named healthcare professional who coordinates their health and social care support at all stages of the care pathway.","Structure","QS203 - Brain tumours (primary) and brain metastases in adults","2 - QS203 - Brain tumours (primary) and brain metastases in adults",1,"2 - QS203 - Brain tumours (primary) and brain metastases in adults - Structure - 1"]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",2,null,"Adults with brain tumours have a named healthcare professional who coordinates their health and social care support.","Proportion of adults with brain tumours who have the name and contact details of a healthcare professional who coordinates their health and social care support.","Process","QS203 - Brain tumours (primary) and brain metastases in adults","2 - QS203 - Brain tumours (primary) and brain metastases in adults",1,"2 - QS203 - Brain tumours (primary) and brain metastases in adults - Process - 1","The number in the denominator who have the name and contact details of a healthcare professional who coordinates their health and social care support.","The number of adults with brain tumours."]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",2,null,"Adults with brain tumours have a named healthcare professional who coordinates their health and social care support.","Proportion of adults with brain tumours who are satisfied with the coordination of their health and social care support by their named healthcare professional.","Outcome","QS203 - Brain tumours (primary) and brain metastases in adults","2 - QS203 - Brain tumours (primary) and brain metastases in adults",1,"2 - QS203 - Brain tumours (primary) and brain metastases in adults - Outcome - 1","The number in the denominator who are satisfied with the coordination of their health and social care support by their named healthcare professional.","The number of adults with brain tumours."]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",3,null,"Adults with radiologically enhancing suspected high-grade gliomas that are suitable for resection of all enhancing tumour have 5‑aminolevulinic acid (5‑ALA)-guided resection.","Evidence that 5‑ALA-guided resection is available for adults with radiologically enhancing suspected high-grade gliomas that are suitable for resection of all enhancing tumour.","Structure","QS203 - Brain tumours (primary) and brain metastases in adults","3 - QS203 - Brain tumours (primary) and brain metastases in adults",1,"3 - QS203 - Brain tumours (primary) and brain metastases in adults - Structure - 1"]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",3,null,"Adults with radiologically enhancing suspected high-grade gliomas that are suitable for resection of all enhancing tumour have 5‑aminolevulinic acid (5‑ALA)-guided resection.","Proportion of adults with radiologically enhancing suspected high-grade gliomas that are suitable for resection of all enhancing tumour who received 5‑ALA-guided resection.","Process","QS203 - Brain tumours (primary) and brain metastases in adults","3 - QS203 - Brain tumours (primary) and brain metastases in adults",1,"3 - QS203 - Brain tumours (primary) and brain metastases in adults - Process - 1","The number in the denominator who received 5‑ALA-guided resection.","The number of adults with radiologically enhancing suspected high-grade gliomas that are suitable for resection of all enhancing tumour."]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",3,null,"Adults with radiologically enhancing suspected high-grade gliomas that are suitable for resection of all enhancing tumour have 5‑aminolevulinic acid (5‑ALA)-guided resection.","Proportion of adults with radiologically enhancing high-grade gliomas that are suitable for resection of all enhancing tumour who underwent resection where a 95% or greater reduction in tumour volume was achieved.","Outcome","QS203 - Brain tumours (primary) and brain metastases in adults","3 - QS203 - Brain tumours (primary) and brain metastases in adults",1,"3 - QS203 - Brain tumours (primary) and brain metastases in adults - Outcome - 1","The number in the denominator who underwent resection where a 95% or greater reduction in tumour volume was achieved.","The number of adults with radiologically enhancing high-grade gliomas that are suitable for resection of all enhancing tumour."]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",3,null,"Adults with radiologically enhancing suspected high-grade gliomas that are suitable for resection of all enhancing tumour have 5‑aminolevulinic acid (5‑ALA)-guided resection.","Progression-free survival in adults with radiologically enhancing high-grade gliomas that are suitable for resection of all enhancing tumour who had 5‑ALA-guided resection.","Outcome","QS203 - Brain tumours (primary) and brain metastases in adults","3 - QS203 - Brain tumours (primary) and brain metastases in adults",2,"3 - QS203 - Brain tumours (primary) and brain metastases in adults - Outcome - 2"]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",4,null,"Adults who finish treatment for brain tumours have an assessment and discussion about their risk of late effects of treatment at their first follow‑up appointment.","Evidence of local protocol to assess and discuss the risk of late effects of treatment with adults who finish treatment for brain tumours, at their first follow‑up appointment.","Structure","QS203 - Brain tumours (primary) and brain metastases in adults","4 - QS203 - Brain tumours (primary) and brain metastases in adults",1,"4 - QS203 - Brain tumours (primary) and brain metastases in adults - Structure - 1"]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",4,null,"Adults who finish treatment for brain tumours have an assessment and discussion about their risk of late effects of treatment at their first follow‑up appointment.","Proportion of adults who finish treatment for brain tumours who have an assessment for their risk of late effects of treatment at their first follow‑up appointment.","Process","QS203 - Brain tumours (primary) and brain metastases in adults","4 - QS203 - Brain tumours (primary) and brain metastases in adults",1,"4 - QS203 - Brain tumours (primary) and brain metastases in adults - Process - 1","The number in the denominator who have an assessment for their risk of late effects of treatment at their first follow‑up appointment.","The number of adults who finish treatment for brain tumours."]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",4,null,"Adults who finish treatment for brain tumours have an assessment and discussion about their risk of late effects of treatment at their first follow‑up appointment.","Proportion of adults who finish treatment for brain tumours who have a documented discussion about their risk of late effects of treatment at their first follow‑up appointment.","Process","QS203 - Brain tumours (primary) and brain metastases in adults","4 - QS203 - Brain tumours (primary) and brain metastases in adults",2,"4 - QS203 - Brain tumours (primary) and brain metastases in adults - Process - 2","The number in the denominator who have a documented discussion about their risk of late effects of treatment at their first follow‑up appointment.","The number of adults who finish treatment for brain tumours."]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",4,null,"Adults who finish treatment for brain tumours have an assessment and discussion about their risk of late effects of treatment at their first follow‑up appointment.","Adults who finish treatment for brain tumours feel informed about their risk of late effects of treatment.","Outcome","QS203 - Brain tumours (primary) and brain metastases in adults","4 - QS203 - Brain tumours (primary) and brain metastases in adults",1,"4 - QS203 - Brain tumours (primary) and brain metastases in adults - Outcome - 1"]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",5,null,"Adults with brain tumours have access to neurological rehabilitation in the community and as an outpatient or inpatient.","Evidence of local arrangements to provide neurological rehabilitation in the community and as an outpatient or inpatient, for adults with brain tumours.","Structure","QS203 - Brain tumours (primary) and brain metastases in adults","5 - QS203 - Brain tumours (primary) and brain metastases in adults",1,"5 - QS203 - Brain tumours (primary) and brain metastases in adults - Structure - 1"]
[null,"QS203","Brain tumours (primary) and brain metastases in adults",5,null,"Adults with brain tumours have access to neurological rehabilitation in the community and as an outpatient or inpatient.","Health-related quality of life for adults with brain tumours.","Outcome","QS203 - Brain tumours (primary) and brain metastases in adults","5 - QS203 - Brain tumours (primary) and brain metastases in adults",1,"5 - QS203 - Brain tumours (primary) and brain metastases in adults - Outcome - 1"]
[null,"QS204","Fetal alcohol spectrum disorder",1,null,"Pregnant women are given advice throughout pregnancy not to drink alcohol.","Evidence of local arrangements to ensure that midwives and other healthcare professionals carrying out antenatal appointments are aware of the risks of drinking alcohol in pregnancy, including FASD, and the advice in the UK Chief Medical Officers' low-risk drinking guidelines on alcohol consumption in pregnancy.","Structure",{"$f":"CONCATENATE(B4550, \" - \", C4550)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4550, \" - \", I4550)","v":"1 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4550=B4549, D4550=D4549, H4550=H4549)=TRUE, K4549+1, 1)","v":1},{"$f":"CONCATENATE(J4550, \" - \", H4550, \" - \",K4550)","v":"1 - QS204 - Fetal alcohol spectrum disorder - Structure - 1"}]
[null,"QS204","Fetal alcohol spectrum disorder",1,null,"Pregnant women are given advice throughout pregnancy not to drink alcohol.","Evidence of local arrangements to ensure that antenatal appointments include discussion of the risks of drinking alcohol in pregnancy and the advice in the UK Chief Medical Officers' low-risk drinking guidelines.","Structure","QS204 - Fetal alcohol spectrum disorder","1 - QS204 - Fetal alcohol spectrum disorder",2,"1 - QS204 - Fetal alcohol spectrum disorder - Structure - 2"]
[null,"QS204","Fetal alcohol spectrum disorder",1,null,"Pregnant women are given advice throughout pregnancy not to drink alcohol.","Proportion of antenatal appointments in which pregnant women are advised not to drink alcohol during pregnancy.","Process","QS204 - Fetal alcohol spectrum disorder","1 - QS204 - Fetal alcohol spectrum disorder",1,"1 - QS204 - Fetal alcohol spectrum disorder - Process - 1","The number in the denominator in which pregnant women are advised not to drink alcohol.","The total number of antenatal appointments attended."]
[null,"QS204","Fetal alcohol spectrum disorder",1,null,"Pregnant women are given advice throughout pregnancy not to drink alcohol.","Rate of alcohol-exposed pregnancies.","Outcome",{"$f":"CONCATENATE(B4553, \" - \", C4553)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4553, \" - \", I4553)","v":"1 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4553=B4552, D4553=D4552, H4553=H4552)=TRUE, K4552+1, 1)","v":1},{"$f":"CONCATENATE(J4553, \" - \", H4553, \" - \",K4553)","v":"1 - QS204 - Fetal alcohol spectrum disorder - Outcome - 1"}]
[null,"QS204","Fetal alcohol spectrum disorder",2,null,"Pregnant women are asked about their alcohol use throughout their pregnancy and this is recorded.","Evidence of local arrangements to ensure that antenatal appointments include discussion about drinking alcohol in pregnancy.","Structure",{"$f":"CONCATENATE(B4554, \" - \", C4554)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4554, \" - \", I4554)","v":"2 - QS204 - Fetal alcohol spectrum disorder"},1,"2 - QS204 - Fetal alcohol spectrum disorder - Structure - 1"]
[null,"QS204","Fetal alcohol spectrum disorder",2,null,"Pregnant women are asked about their alcohol use throughout their pregnancy and this is recorded.","Proportion of antenatal booking appointments where drinking of alcohol is reported.","Process",{"$f":"CONCATENATE(B4555, \" - \", C4555)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4555, \" - \", I4555)","v":"2 - QS204 - Fetal alcohol spectrum disorder"},1,"2 - QS204 - Fetal alcohol spectrum disorder - Process - 1","The number in the denominator where the weekly number of alcohol units reported is greater than 1.","The number of antenatal booking appointments."]
[null,"QS204","Fetal alcohol spectrum disorder",2,null,"Pregnant women are asked about their alcohol use throughout their pregnancy and this is recorded.","Proportion of routine antenatal appointments attended in which alcohol consumption is recorded.","Process",{"$f":"CONCATENATE(B4556, \" - \", C4556)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4556, \" - \", I4556)","v":"2 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4556=B4555, D4556=D4555, H4556=H4555)=TRUE, K4555+1, 1)","v":2},{"$f":"CONCATENATE(J4556, \" - \", H4556, \" - \",K4556)","v":"2 - QS204 - Fetal alcohol spectrum disorder - Process - 2"},"The number in the denominator in which alcohol consumption is recorded.","The total number of routine antenatal appointments attended."]
[null,"QS204","Fetal alcohol spectrum disorder",2,null,"Pregnant women are asked about their alcohol use throughout their pregnancy and this is recorded.","Diagnosis rates for FASD.","Outcome",{"$f":"CONCATENATE(B4557, \" - \", C4557)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4557, \" - \", I4557)","v":"2 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4557=B4556, D4557=D4556, H4557=H4556)=TRUE, K4556+1, 1)","v":1},{"$f":"CONCATENATE(J4557, \" - \", H4557, \" - \",K4557)","v":"2 - QS204 - Fetal alcohol spectrum disorder - Outcome - 1"}]
[null,"QS204","Fetal alcohol spectrum disorder",3,null,"Children and young people with probable prenatal alcohol exposure and significant physical, developmental or behavioural difficulties are referred for assessment.","Evidence of local pathways that refer children and young people with probable prenatal alcohol exposure to a healthcare professional with additional training in FASD.","Structure",{"$f":"CONCATENATE(B4558, \" - \", C4558)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4558, \" - \", I4558)","v":"3 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4558=B4557, D4558=D4557, H4558=H4557)=TRUE, K4557+1, 1)","v":1},{"$f":"CONCATENATE(J4558, \" - \", H4558, \" - \",K4558)","v":"3 - QS204 - Fetal alcohol spectrum disorder - Structure - 1"}]
[null,"QS204","Fetal alcohol spectrum disorder",3,null,"Children and young people with probable prenatal alcohol exposure and significant physical, developmental or behavioural difficulties are referred for assessment.","Evidence of local arrangements to increase awareness of FASD among healthcare professionals.","Structure",{"$f":"CONCATENATE(B4559, \" - \", C4559)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4559, \" - \", I4559)","v":"3 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4559=B4558, D4559=D4558, H4559=H4558)=TRUE, K4558+1, 1)","v":2},{"$f":"CONCATENATE(J4559, \" - \", H4559, \" - \",K4559)","v":"3 - QS204 - Fetal alcohol spectrum disorder - Structure - 2"}]
[null,"QS204","Fetal alcohol spectrum disorder",3,null,"Children and young people with probable prenatal alcohol exposure and significant physical, developmental or behavioural difficulties are referred for assessment.","Evidence of local services with healthcare professionals who have additional training in FASD.","Structure",{"$f":"CONCATENATE(B4560, \" - \", C4560)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4560, \" - \", I4560)","v":"3 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4560=B4559, D4560=D4559, H4560=H4559)=TRUE, K4559+1, 1)","v":3},{"$f":"CONCATENATE(J4560, \" - \", H4560, \" - \",K4560)","v":"3 - QS204 - Fetal alcohol spectrum disorder - Structure - 3"}]
[null,"QS204","Fetal alcohol spectrum disorder",3,null,"Children and young people with probable prenatal alcohol exposure and significant physical, developmental or behavioural difficulties are referred for assessment.","Proportion of children and young people with probable prenatal alcohol exposure and significant physical, developmental or behavioural difficulties referred for assessment.","Process",{"$f":"CONCATENATE(B4561, \" - \", C4561)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4561, \" - \", I4561)","v":"3 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4561=B4560, D4561=D4560, H4561=H4560)=TRUE, K4560+1, 1)","v":1},{"$f":"CONCATENATE(J4561, \" - \", H4561, \" - \",K4561)","v":"3 - QS204 - Fetal alcohol spectrum disorder - Process - 1"},"The number in the denominator referred for assessment.","The number of children and young people with probable prenatal alcohol exposure and significant physical, developmental or behavioural difficulties."]
[null,"QS204","Fetal alcohol spectrum disorder",3,null,"Children and young people with probable prenatal alcohol exposure and significant physical, developmental or behavioural difficulties are referred for assessment.","Average time to diagnosis of FASD.","Outcome",{"$f":"CONCATENATE(B4562, \" - \", C4562)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4562, \" - \", I4562)","v":"3 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4562=B4561, D4562=D4561, H4562=H4561)=TRUE, K4561+1, 1)","v":1},{"$f":"CONCATENATE(J4562, \" - \", H4562, \" - \",K4562)","v":"3 - QS204 - Fetal alcohol spectrum disorder - Outcome - 1"}]
[null,"QS204","Fetal alcohol spectrum disorder",3,null,"Children and young people with probable prenatal alcohol exposure and significant physical, developmental or behavioural difficulties are referred for assessment.","Diagnosis rates for FASD.","Outcome",{"$f":"CONCATENATE(B4563, \" - \", C4563)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4563, \" - \", I4563)","v":"3 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4563=B4562, D4563=D4562, H4563=H4562)=TRUE, K4562+1, 1)","v":2},{"$f":"CONCATENATE(J4563, \" - \", H4563, \" - \",K4563)","v":"3 - QS204 - Fetal alcohol spectrum disorder - Outcome - 2"}]
[null,"QS204","Fetal alcohol spectrum disorder",4,null,"Children and young people with confirmed prenatal alcohol exposure or all 3 facial features associated with prenatal alcohol exposure have a neurodevelopmental assessment if there are clinical concerns.","Evidence of local services with healthcare professionals with expertise in neurodevelopmental assessment who have had additional training in FASD.","Structure",{"$f":"CONCATENATE(B4564, \" - \", C4564)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4564, \" - \", I4564)","v":"4 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4564=B4563, D4564=D4563, H4564=H4563)=TRUE, K4563+1, 1)","v":1},{"$f":"CONCATENATE(J4564, \" - \", H4564, \" - \",K4564)","v":"4 - QS204 - Fetal alcohol spectrum disorder - Structure - 1"}]
[null,"QS204","Fetal alcohol spectrum disorder",4,null,"Children and young people with confirmed prenatal alcohol exposure or all 3 facial features associated with prenatal alcohol exposure have a neurodevelopmental assessment if there are clinical concerns.","Diagnosis rate for FASD.","Outcome",{"$f":"CONCATENATE(B4565, \" - \", C4565)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4565, \" - \", I4565)","v":"4 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4565=B4564, D4565=D4564, H4565=H4564)=TRUE, K4564+1, 1)","v":1},{"$f":"CONCATENATE(J4565, \" - \", H4565, \" - \",K4565)","v":"4 - QS204 - Fetal alcohol spectrum disorder - Outcome - 1"}]
[null,"QS204","Fetal alcohol spectrum disorder",5,null,"Children and young people with a diagnosis of fetal alcohol spectrum disorder (FASD) have a management plan to address their needs.","Evidence of local frameworks for managing FASD that ensure healthcare professionals coordinate care across disciplines and organisations.","Structure",{"$f":"CONCATENATE(B4566, \" - \", C4566)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4566, \" - \", I4566)","v":"5 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4566=B4565, D4566=D4565, H4566=H4565)=TRUE, K4565+1, 1)","v":1},{"$f":"CONCATENATE(J4566, \" - \", H4566, \" - \",K4566)","v":"5 - QS204 - Fetal alcohol spectrum disorder - Structure - 1"}]
[null,"QS204","Fetal alcohol spectrum disorder",5,null,"Children and young people with a diagnosis of fetal alcohol spectrum disorder (FASD) have a management plan to address their needs.","Evidence of local arrangements for communicating and sharing management plans between providers of health, education and social services.","Structure",{"$f":"CONCATENATE(B4567, \" - \", C4567)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4567, \" - \", I4567)","v":"5 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4567=B4566, D4567=D4566, H4567=H4566)=TRUE, K4566+1, 1)","v":2},{"$f":"CONCATENATE(J4567, \" - \", H4567, \" - \",K4567)","v":"5 - QS204 - Fetal alcohol spectrum disorder - Structure - 2"}]
[null,"QS204","Fetal alcohol spectrum disorder",5,null,"Children and young people with a diagnosis of fetal alcohol spectrum disorder (FASD) have a management plan to address their needs.","Proportion of children and young people diagnosed with FASD who have a management plan.","Process",{"$f":"CONCATENATE(B4568, \" - \", C4568)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4568, \" - \", I4568)","v":"5 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4568=B4567, D4568=D4567, H4568=H4567)=TRUE, K4567+1, 1)","v":1},{"$f":"CONCATENATE(J4568, \" - \", H4568, \" - \",K4568)","v":"5 - QS204 - Fetal alcohol spectrum disorder - Process - 1"},"The number in the denominator who have a management plan.","The number of children and young people diagnosed with FASD."]
[null,"QS204","Fetal alcohol spectrum disorder",5,null,"Children and young people with a diagnosis of fetal alcohol spectrum disorder (FASD) have a management plan to address their needs.","Health-related quality of life for people diagnosed with FASD.","Outcome",{"$f":"CONCATENATE(B4569, \" - \", C4569)","v":"QS204 - Fetal alcohol spectrum disorder"},{"$f":"CONCATENATE(D4569, \" - \", I4569)","v":"5 - QS204 - Fetal alcohol spectrum disorder"},{"$f":"IF(AND(B4569=B4568, D4569=D4568, H4569=H4568)=TRUE, K4568+1, 1)","v":1},{"$f":"CONCATENATE(J4569, \" - \", H4569, \" - \",K4569)","v":"5 - QS204 - Fetal alcohol spectrum disorder - Outcome - 1"}]
[null,"QS205","Neonatal parenteral nutrition",1,null,"Preterm and term babies who are prescribed neonatal parenteral nutrition are started on a standardised bag.","Evidence of local arrangements to ensure that standardised bags are available on neonatal units.","Structure",{"$f":"CONCATENATE(B4570, \" - \", C4570)","v":"QS205 - Neonatal parenteral nutrition"},{"$f":"CONCATENATE(D4570, \" - \", I4570)","v":"1 - QS205 - Neonatal parenteral nutrition"},{"$f":"IF(AND(B4570=B4569, D4570=D4569, H4570=H4569)=TRUE, K4569+1, 1)","v":1},{"$f":"CONCATENATE(J4570, \" - \", H4570, \" - \",K4570)","v":"1 - QS205 - Neonatal parenteral nutrition - Structure - 1"}]
[null,"QS205","Neonatal parenteral nutrition",1,null,"Preterm and term babies who are prescribed neonatal parenteral nutrition are started on a standardised bag.","Evidence of written clinical protocols on the administration of standardised bags, including starting preterm and term babies on standardised bags, and the volume of neonatal parenteral nutrition that should be given.","Structure","QS205 - Neonatal parenteral nutrition","1 - QS205 - Neonatal parenteral nutrition",2,"1 - QS205 - Neonatal parenteral nutrition - Structure - 2"]
[null,"QS205","Neonatal parenteral nutrition",1,null,"Preterm and term babies who are prescribed neonatal parenteral nutrition are started on a standardised bag.","Proportion of preterm and term babies who are prescribed neonatal parenteral nutrition who are started on a standardised bag.","Process","QS205 - Neonatal parenteral nutrition","1 - QS205 - Neonatal parenteral nutrition",1,"1 - QS205 - Neonatal parenteral nutrition - Process - 1","The number in the denominator who are started on a standardised bag.","The number of preterm and term babies who are prescribed neonatal parenteral nutrition."]
[null,"QS205","Neonatal parenteral nutrition",1,null,"Preterm and term babies who are prescribed neonatal parenteral nutrition are started on a standardised bag.","Number of neonatal parenteral nutrition prescribing errors.","Outcome",{"$f":"CONCATENATE(B4573, \" - \", C4573)","v":"QS205 - Neonatal parenteral nutrition"},{"$f":"CONCATENATE(D4573, \" - \", I4573)","v":"1 - QS205 - Neonatal parenteral nutrition"},{"$f":"IF(AND(B4573=B4572, D4573=D4572, H4573=H4572)=TRUE, K4572+1, 1)","v":1},{"$f":"CONCATENATE(J4573, \" - \", H4573, \" - \",K4573)","v":"1 - QS205 - Neonatal parenteral nutrition - Outcome - 1"}]
[null,"QS205","Neonatal parenteral nutrition",1,null,"Preterm and term babies who are prescribed neonatal parenteral nutrition are started on a standardised bag.","Number of delays in starting neonatal parenteral nutrition.","Outcome","QS205 - Neonatal parenteral nutrition","1 - QS205 - Neonatal parenteral nutrition",2,"1 - QS205 - Neonatal parenteral nutrition - Outcome - 2"]
[null,"QS205","Neonatal parenteral nutrition",2,null,"Preterm and term babies who are prescribed neonatal parenteral nutrition receive it through bags, infusion sets and syringes that are protected from light.","Evidence of local arrangements that ensure that light protection is available for bags, syringes and infusion sets of parenteral nutrition solutions.","Structure",{"$f":"CONCATENATE(B4575, \" - \", C4575)","v":"QS205 - Neonatal parenteral nutrition"},{"$f":"CONCATENATE(D4575, \" - \", I4575)","v":"2 - QS205 - Neonatal parenteral nutrition"},{"$f":"IF(AND(B4575=B4574, D4575=D4574, H4575=H4574)=TRUE, K4574+1, 1)","v":1},{"$f":"CONCATENATE(J4575, \" - \", H4575, \" - \",K4575)","v":"2 - QS205 - Neonatal parenteral nutrition - Structure - 1"}]
[null,"QS205","Neonatal parenteral nutrition",2,null,"Preterm and term babies who are prescribed neonatal parenteral nutrition receive it through bags, infusion sets and syringes that are protected from light.","Evidence of local arrangements and written clinical protocols to ensure that units that give neonatal parenteral nutrition use light protection.","Structure","QS205 - Neonatal parenteral nutrition","2 - QS205 - Neonatal parenteral nutrition",2,"2 - QS205 - Neonatal parenteral nutrition - Structure - 2"]
[null,"QS205","Neonatal parenteral nutrition",2,null,"Preterm and term babies who are prescribed neonatal parenteral nutrition receive it through bags, infusion sets and syringes that are protected from light.","Number of light exposure incidents while giving neonatal parenteral nutrition.","Outcome","QS205 - Neonatal parenteral nutrition","2 - QS205 - Neonatal parenteral nutrition",1,"2 - QS205 - Neonatal parenteral nutrition - Outcome - 1"]
[null,"QS205","Neonatal parenteral nutrition",3,null,"Parents and carers of preterm and term babies receiving neonatal parenteral nutrition have regular opportunities to discuss their baby's nutritional care with healthcare professionals.","Evidence of local arrangements to ensure that parents and carers of preterm and term babies receiving neonatal parenteral nutrition have regular opportunities to discuss their baby's nutritional care with their healthcare professionals.","Structure",{"$f":"CONCATENATE(B4578, \" - \", C4578)","v":"QS205 - Neonatal parenteral nutrition"},{"$f":"CONCATENATE(D4578, \" - \", I4578)","v":"3 - QS205 - Neonatal parenteral nutrition"},{"$f":"IF(AND(B4578=B4577, D4578=D4577, H4578=H4577)=TRUE, K4577+1, 1)","v":1},{"$f":"CONCATENATE(J4578, \" - \", H4578, \" - \",K4578)","v":"3 - QS205 - Neonatal parenteral nutrition - Structure - 1"}]
[null,"QS205","Neonatal parenteral nutrition",3,null,"Parents and carers of preterm and term babies receiving neonatal parenteral nutrition have regular opportunities to discuss their baby's nutritional care with healthcare professionals.","Proportion of parents and carers of preterm and term babies who received neonatal parenteral nutrition who are satisfied with communication with healthcare professionals about the nutritional care received.","Outcome","QS205 - Neonatal parenteral nutrition","3 - QS205 - Neonatal parenteral nutrition",1,"3 - QS205 - Neonatal parenteral nutrition - Outcome - 1","The number in the denominator who are satisfied with communication with healthcare professionals about the nutritional care received.","The number of parents and carers of preterm and term babies who received neonatal parenteral nutrition."]
[null,"QS205","Neonatal parenteral nutrition",4,null,"Preterm and term babies receiving neonatal parenteral nutrition are cared for by healthcare professionals who have access to a specialist nutritional multidisciplinary team.","Evidence of local arrangements to ensure a specialist nutritional multidisciplinary team is in place, either within the trust or the clinical network.","Structure",{"$f":"CONCATENATE(B4580, \" - \", C4580)","v":"QS205 - Neonatal parenteral nutrition"},{"$f":"CONCATENATE(D4580, \" - \", I4580)","v":"4 - QS205 - Neonatal parenteral nutrition"},{"$f":"IF(AND(B4580=B4579, D4580=D4579, H4580=H4579)=TRUE, K4579+1, 1)","v":1},{"$f":"CONCATENATE(J4580, \" - \", H4580, \" - \",K4580)","v":"4 - QS205 - Neonatal parenteral nutrition - Structure - 1"}]
[null,"QS205","Neonatal parenteral nutrition",4,null,"Preterm and term babies receiving neonatal parenteral nutrition are cared for by healthcare professionals who have access to a specialist nutritional multidisciplinary team.","Evidence of local arrangements to ensure that the specialist nutritional multidisciplinary team is responsible for governance around delivery of neonatal parenteral nutrition and provides support for healthcare professionals delivering it.","Structure","QS205 - Neonatal parenteral nutrition","4 - QS205 - Neonatal parenteral nutrition",2,"4 - QS205 - Neonatal parenteral nutrition - Structure - 2"]
[null,"QS205","Neonatal parenteral nutrition",4,null,"Preterm and term babies receiving neonatal parenteral nutrition are cared for by healthcare professionals who have access to a specialist nutritional multidisciplinary team.","Proportion of neonatal units that deliver parenteral nutrition and have access to a specialist nutritional multidisciplinary team.","Process","QS205 - Neonatal parenteral nutrition","4 - QS205 - Neonatal parenteral nutrition",1,"4 - QS205 - Neonatal parenteral nutrition - Process - 1","The number in the denominator that have access to a specialist nutritional multidisciplinary team.","The number of neonatal units that deliver parenteral nutrition."]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",1,null,"Adults who will have hip or knee replacement are given advice on preoperative rehabilitation when they are listed for surgery.","Evidence of local arrangements to ensure that adults who will have hip or knee replacement receive advice on preoperative rehabilitation when they are listed for surgery.","Structure",{"$f":"CONCATENATE(B4583, \" - \", C4583)","v":"QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"CONCATENATE(D4583, \" - \", I4583)","v":"1 - QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"IF(AND(B4583=B4582, D4583=D4582, H4583=H4582)=TRUE, K4582+1, 1)","v":1},{"$f":"CONCATENATE(J4583, \" - \", H4583, \" - \",K4583)","v":"1 - QS206 - Joint replacement (primary): hip, knee and shoulder - Structure - 1"}]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",1,null,"Adults who will have hip or knee replacement are given advice on preoperative rehabilitation when they are listed for surgery.","Proportion of adults who will have hip or knee replacement who receive advice on preoperative rehabilitation when they are listed for surgery. ","Process","QS206 - Joint replacement (primary): hip, knee and shoulder","1 - QS206 - Joint replacement (primary): hip, knee and shoulder",1,"1 - QS206 - Joint replacement (primary): hip, knee and shoulder - Process - 1","The number in the denominator who receive advice on preoperative rehabilitation when they are listed for surgery.","The number of adults who will have hip or knee replacement.   "]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",1,null,"Adults who will have hip or knee replacement are given advice on preoperative rehabilitation when they are listed for surgery.","Average health gain and improvement rate associated with patient-reported outcome measures (PROMs) for hip or knee replacement.","Outcome",{"$f":"CONCATENATE(B4585, \" - \", C4585)","v":"QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"CONCATENATE(D4585, \" - \", I4585)","v":"1 - QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"IF(AND(B4585=B4584, D4585=D4584, H4585=H4584)=TRUE, K4584+1, 1)","v":1},{"$f":"CONCATENATE(J4585, \" - \", H4585, \" - \",K4585)","v":"1 - QS206 - Joint replacement (primary): hip, knee and shoulder - Outcome - 1"}]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",1,null,"Adults who will have hip or knee replacement are given advice on preoperative rehabilitation when they are listed for surgery.","The percentage of patients reporting the results of their hip or knee replacement as ‘excellent’ or ‘very good’ and that their problems are ‘much better’ or a ‘little better’ after their operation.","Outcome",{"$f":"CONCATENATE(B4586, \" - \", C4586)","v":"QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"CONCATENATE(D4586, \" - \", I4586)","v":"1 - QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"IF(AND(B4586=B4585, D4586=D4585, H4586=H4585)=TRUE, K4585+1, 1)","v":2},{"$f":"CONCATENATE(J4586, \" - \", H4586, \" - \",K4586)","v":"1 - QS206 - Joint replacement (primary): hip, knee and shoulder - Outcome - 2"}]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",2,null,"Adults with isolated medial compartmental osteoarthritis who will have knee replacement are given the choice of partial or total replacement.","Evidence of local processes to support a discussion that includes the risks and benefits of partial and total knee replacement with adults who have isolated medial compartmental osteoarthritis and will be having knee replacement.","Structure",{"$f":"CONCATENATE(B4587, \" - \", C4587)","v":"QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"CONCATENATE(D4587, \" - \", I4587)","v":"2 - QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"IF(AND(B4587=B4586, D4587=D4586, H4587=H4586)=TRUE, K4586+1, 1)","v":1},{"$f":"CONCATENATE(J4587, \" - \", H4587, \" - \",K4587)","v":"2 - QS206 - Joint replacement (primary): hip, knee and shoulder - Structure - 1"}]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",2,null,"Adults with isolated medial compartmental osteoarthritis who will have knee replacement are given the choice of partial or total replacement.","Evidence of service specifications to ensure that both total and partial knee replacements are available to adults with isolated medial compartmental osteoarthritis who will be having knee replacement.","Structure","QS206 - Joint replacement (primary): hip, knee and shoulder","2 - QS206 - Joint replacement (primary): hip, knee and shoulder",2,"2 - QS206 - Joint replacement (primary): hip, knee and shoulder - Structure - 2"]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",2,null,"Adults with isolated medial compartmental osteoarthritis who will have knee replacement are given the choice of partial or total replacement.","Proportion of primary knee replacements that are partial knee replacements.","Process",{"$f":"CONCATENATE(B4589, \" - \", C4589)","v":"QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"CONCATENATE(D4589, \" - \", I4589)","v":"2 - QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"IF(AND(B4589=B4588, D4589=D4588, H4589=H4588)=TRUE, K4588+1, 1)","v":1},{"$f":"CONCATENATE(J4589, \" - \", H4589, \" - \",K4589)","v":"2 - QS206 - Joint replacement (primary): hip, knee and shoulder - Process - 1"},"The number in the denominator that are partial knee replacements.","The number of primary knee replacements."]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",3,null,"Adults having hip or knee replacement are given tranexamic acid during surgery.","Evidence of clinical protocols to ensure that adults who are having hip or knee replacement are given tranexamic acid during surgery.","Structure",{"$f":"CONCATENATE(B4590, \" - \", C4590)","v":"QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"CONCATENATE(D4590, \" - \", I4590)","v":"3 - QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"IF(AND(B4590=B4589, D4590=D4589, H4590=H4589)=TRUE, K4589+1, 1)","v":1},{"$f":"CONCATENATE(J4590, \" - \", H4590, \" - \",K4590)","v":"3 - QS206 - Joint replacement (primary): hip, knee and shoulder - Structure - 1"}]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",3,null,"Adults having hip or knee replacement are given tranexamic acid during surgery.","Proportion of hip or knee replacement operations during which tranexamic acid is given.","Process","QS206 - Joint replacement (primary): hip, knee and shoulder","3 - QS206 - Joint replacement (primary): hip, knee and shoulder",1,"3 - QS206 - Joint replacement (primary): hip, knee and shoulder - Process - 1","The number in the denominator during which tranexamic acid is given.","The number of hip or knee replacement operations."]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",3,null,"Adults having hip or knee replacement are given tranexamic acid during surgery.","Blood transfusion rates associated with hip or knee replacement surgery.  ","Outcome",{"$f":"CONCATENATE(B4592, \" - \", C4592)","v":"QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"CONCATENATE(D4592, \" - \", I4592)","v":"3 - QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"IF(AND(B4592=B4591, D4592=D4591, H4592=H4591)=TRUE, K4591+1, 1)","v":1},{"$f":"CONCATENATE(J4592, \" - \", H4592, \" - \",K4592)","v":"3 - QS206 - Joint replacement (primary): hip, knee and shoulder - Outcome - 1"}]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",4,null,"Adults having hip, knee or shoulder replacement have 2 ‘stop moments’ during surgery so that implant details and the compatibility of all components can be checked.","Evidence of surgical protocols which include 2 ‘stop moments’ for predefined and systematic checks, during intraoperative formal ‘time outs’, to confirm that implant details are correct and all components are compatible.  ","Structure",{"$f":"CONCATENATE(B4593, \" - \", C4593)","v":"QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"CONCATENATE(D4593, \" - \", I4593)","v":"4 - QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"IF(AND(B4593=B4592, D4593=D4592, H4593=H4592)=TRUE, K4592+1, 1)","v":1},{"$f":"CONCATENATE(J4593, \" - \", H4593, \" - \",K4593)","v":"4 - QS206 - Joint replacement (primary): hip, knee and shoulder - Structure - 1"}]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",4,null,"Adults having hip, knee or shoulder replacement have 2 ‘stop moments’ during surgery so that implant details and the compatibility of all components can be checked.","Proportion of hip, knee or shoulder replacement operations during which there are 2 ‘stop moments’ to check implant details and the compatibility of all components.","Process",{"$f":"CONCATENATE(B4594, \" - \", C4594)","v":"QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"CONCATENATE(D4594, \" - \", I4594)","v":"4 - QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"IF(AND(B4594=B4593, D4594=D4593, H4594=H4593)=TRUE, K4593+1, 1)","v":1},{"$f":"CONCATENATE(J4594, \" - \", H4594, \" - \",K4594)","v":"4 - QS206 - Joint replacement (primary): hip, knee and shoulder - Process - 1"},"The number in the denominator during which there are 2 ‘stop moments’ to check implant details and the compatibility of all components.","The number of hip, knee or shoulder replacement operations."]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",4,null,"Adults having hip, knee or shoulder replacement have 2 ‘stop moments’ during surgery so that implant details and the compatibility of all components can be checked.","The proportion of hip, knee or shoulder replacement operations during which an incorrect implant (wrong side or size) or incompatible components have been inserted.   ","Outcome",{"$f":"CONCATENATE(B4595, \" - \", C4595)","v":"QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"CONCATENATE(D4595, \" - \", I4595)","v":"4 - QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"IF(AND(B4595=B4594, D4595=D4594, H4595=H4594)=TRUE, K4594+1, 1)","v":1},{"$f":"CONCATENATE(J4595, \" - \", H4595, \" - \",K4595)","v":"4 - QS206 - Joint replacement (primary): hip, knee and shoulder - Outcome - 1"},"The number in the denominator during which an incorrect implant (wrong side or size) or incompatible components have been inserted.   ","The number of hip, knee or shoulder replacement operations. "]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",5,null,"Adults who have had hip, knee or shoulder replacement are given advice on postoperative rehabilitation before discharge.  ","Evidence of local arrangements to ensure that adults who have had hip, knee or shoulder replacement receive advice on postoperative rehabilitation before they are discharged from hospital.","Structure",{"$f":"CONCATENATE(B4596, \" - \", C4596)","v":"QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"CONCATENATE(D4596, \" - \", I4596)","v":"5 - QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"IF(AND(B4596=B4595, D4596=D4595, H4596=H4595)=TRUE, K4595+1, 1)","v":1},{"$f":"CONCATENATE(J4596, \" - \", H4596, \" - \",K4596)","v":"5 - QS206 - Joint replacement (primary): hip, knee and shoulder - Structure - 1"}]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",5,null,"Adults who have had hip, knee or shoulder replacement are given advice on postoperative rehabilitation before discharge.  ","Evidence of the availability of members of the physiotherapy or occupational therapy teams to discuss postoperative rehabilitation with adults who had hip, knee or shoulder replacement and give advice. ","Structure","QS206 - Joint replacement (primary): hip, knee and shoulder","5 - QS206 - Joint replacement (primary): hip, knee and shoulder",2,"5 - QS206 - Joint replacement (primary): hip, knee and shoulder - Structure - 2"]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",5,null,"Adults who have had hip, knee or shoulder replacement are given advice on postoperative rehabilitation before discharge.  ","Proportion of adults who had hip, knee or shoulder replacement who receive advice on postoperative rehabilitation during a discussion with a member of the physiotherapy or occupational therapy team, before discharge from hospital.  ","Process",{"$f":"CONCATENATE(B4598, \" - \", C4598)","v":"QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"CONCATENATE(D4598, \" - \", I4598)","v":"5 - QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"IF(AND(B4598=B4597, D4598=D4597, H4598=H4597)=TRUE, K4597+1, 1)","v":1},{"$f":"CONCATENATE(J4598, \" - \", H4598, \" - \",K4598)","v":"5 - QS206 - Joint replacement (primary): hip, knee and shoulder - Process - 1"},"The number in the denominator who receive advice on postoperative rehabilitation during a discussion with a member of the physiotherapy or occupational therapy team, before discharge from hospital.","The number of adults who have had hip, knee or shoulder replacement who are discharged from hospital."]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",5,null,"Adults who have had hip, knee or shoulder replacement are given advice on postoperative rehabilitation before discharge.  ","Average health gain and improvement rate associated with patient-reported outcome measures (PROMs) for hip and knee replacement.","Outcome",{"$f":"CONCATENATE(B4599, \" - \", C4599)","v":"QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"CONCATENATE(D4599, \" - \", I4599)","v":"5 - QS206 - Joint replacement (primary): hip, knee and shoulder"},{"$f":"IF(AND(B4599=B4598, D4599=D4598, H4599=H4598)=TRUE, K4598+1, 1)","v":1},{"$f":"CONCATENATE(J4599, \" - \", H4599, \" - \",K4599)","v":"5 - QS206 - Joint replacement (primary): hip, knee and shoulder - Outcome - 1"}]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",5,null,"Adults who have had hip, knee or shoulder replacement are given advice on postoperative rehabilitation before discharge.  ","The percentage of patients reporting the results of their hip or knee replacement as ‘excellent’ or ‘very good’ and that their problems are ‘much better’ or a ‘little better’ after their operation.","Outcome","QS206 - Joint replacement (primary): hip, knee and shoulder","5 - QS206 - Joint replacement (primary): hip, knee and shoulder",2,"5 - QS206 - Joint replacement (primary): hip, knee and shoulder - Outcome - 2"]
[null,"QS206","Joint replacement (primary): hip, knee and shoulder",5,null,"Adults who have had hip, knee or shoulder replacement are given advice on postoperative rehabilitation before discharge.  ","Average health gain and improvement rate associated with PROMs for shoulder replacement.","Outcome","QS206 - Joint replacement (primary): hip, knee and shoulder","5 - QS206 - Joint replacement (primary): hip, knee and shoulder",3,"5 - QS206 - Joint replacement (primary): hip, knee and shoulder - Outcome - 3"]
[null,"QS207","Tobacco: treating dependence",1,null,"People are asked if they use tobacco at key points of contact with a health or social care professional. ","Proportion of people who are asked if they smoke or use smokeless tobacco at a key point of contact with a health or social care professional.","Process","QS207 - Tobacco: treating dependence","1 - QS207 - Tobacco: treating dependence",1,"1 - QS207 - Tobacco: treating dependence - Process - 1","The number in the denominator who are asked if they smoke or use smokeless tobacco.","The number of people attending a key point of contact with a health or social care professional."]
[null,"QS207","Tobacco: treating dependence",2,null,"People who use tobacco receive advice on quitting.","Evidence that health and social care professionals undergo training to give advice on how to quit using tobacco.","Structure","QS207 - Tobacco: treating dependence","2 - QS207 - Tobacco: treating dependence",1,"2 - QS207 - Tobacco: treating dependence - Structure - 1"]
[null,"QS207","Tobacco: treating dependence",2,null,"People who use tobacco receive advice on quitting.","Proportion of people attending a key point of contact and reporting current smoking or use of smokeless tobacco, who receive advice on quitting.","Process","QS207 - Tobacco: treating dependence","2 - QS207 - Tobacco: treating dependence",1,"2 - QS207 - Tobacco: treating dependence - Process - 1","The number in the denominator who receive advice on quitting.","The number of people attending a key point of contact who report current smoking or use of smokeless tobacco."]
[null,"QS207","Tobacco: treating dependence",2,null,"People who use tobacco receive advice on quitting.","Quit rates.","Outcome","QS207 - Tobacco: treating dependence","2 - QS207 - Tobacco: treating dependence",1,"2 - QS207 - Tobacco: treating dependence - Outcome - 1"]
[null,"QS207","Tobacco: treating dependence",2,null,"People who use tobacco receive advice on quitting.","Smoking prevalence.","Outcome","QS207 - Tobacco: treating dependence","2 - QS207 - Tobacco: treating dependence",2,"2 - QS207 - Tobacco: treating dependence - Outcome - 2"]
[null,"QS207","Tobacco: treating dependence",3,null,"People who want to stop using tobacco are offered tobacco cessation support and treatment by a healthcare professional. ","Proportion of people attending a key point of contact who want to stop smoking or using smokeless tobacco, who are offered tobacco cessation support and treatment by a healthcare professional.","Process","QS207 - Tobacco: treating dependence","3 - QS207 - Tobacco: treating dependence",1,"3 - QS207 - Tobacco: treating dependence - Process - 1","The number in the denominator who are offered tobacco cessation support and treatment by a healthcare professional.","The number of people attending a key point of contact who want to stop smoking or using smokeless tobacco."]
[null,"QS207","Tobacco: treating dependence",3,null,"People who want to stop using tobacco are offered tobacco cessation support and treatment by a healthcare professional. ","Quit rates.","Outcome","QS207 - Tobacco: treating dependence","3 - QS207 - Tobacco: treating dependence",1,"3 - QS207 - Tobacco: treating dependence - Outcome - 1"]
[null,"QS207","Tobacco: treating dependence",3,null,"People who want to stop using tobacco are offered tobacco cessation support and treatment by a healthcare professional. ","Smoking prevalence.","Outcome","QS207 - Tobacco: treating dependence","3 - QS207 - Tobacco: treating dependence",2,"3 - QS207 - Tobacco: treating dependence - Outcome - 2"]
[null,"QS207","Tobacco: treating dependence",4,null,"People who do not want, or are not ready, to stop using tobacco in one go receive support to adopt a harm-reduction approach.","Proportion of people given advice on stopping smoking or using smokeless tobacco at a key point of contact who do not want, or are not ready, to stop in one go who receive support to adopt a harm-reduction approach.","Process","QS207 - Tobacco: treating dependence","4 - QS207 - Tobacco: treating dependence",1,"4 - QS207 - Tobacco: treating dependence - Process - 1","The number in the denominator who receive support to adopt a harm-reduction approach.","The number of people given advice on stopping smoking or using smokeless tobacco at a key point of contact who do not want, or are not ready, to stop in one go."]
[null,"QS207","Tobacco: treating dependence",5,null,"People who smoke receive treatment to stop smoking on admission to hospital. ","Evidence of local arrangements to ensure that people who smoke have access to a hospital- or community-based smoking cessation service when admitted to hospital.","Structure","QS207 - Tobacco: treating dependence","5 - QS207 - Tobacco: treating dependence",1,"5 - QS207 - Tobacco: treating dependence - Structure - 1"]
[null,"QS207","Tobacco: treating dependence",5,null,"People who smoke receive treatment to stop smoking on admission to hospital. ","Proportion of people who smoked on admission to hospital who receive stop-smoking pharmacotherapy.","Process","QS207 - Tobacco: treating dependence","5 - QS207 - Tobacco: treating dependence",1,"5 - QS207 - Tobacco: treating dependence - Process - 1","The number in the denominator who receive stop-smoking pharmacotherapy.","The number of people who smoked on admission to hospital."]
[null,"QS207","Tobacco: treating dependence",5,null,"People who smoke receive treatment to stop smoking on admission to hospital. ","Proportion of people who smoked on admission to hospital who receive behavioural support within 24 hours of admission.","Process","QS207 - Tobacco: treating dependence","5 - QS207 - Tobacco: treating dependence",2,"5 - QS207 - Tobacco: treating dependence - Process - 2","The number in the denominator who receive behavioural support within 24 hours of admission.","The number of people who smoked on admission to hospital."]
[null,"QS207","Tobacco: treating dependence",5,null,"People who smoke receive treatment to stop smoking on admission to hospital. ","Proportion of people who smoked on admission to hospital who are abstinent at 4 weeks after discharge.","Outcome","QS207 - Tobacco: treating dependence","5 - QS207 - Tobacco: treating dependence",1,"5 - QS207 - Tobacco: treating dependence - Outcome - 1","The number in the denominator who are abstinent at 4 weeks after discharge.","The number of people who smoked on admission to hospital."]
[null,"QS208","Type 1 diabetes in adults",1,null,"Adults with type 1 diabetes are offered a structured education programme. [2011, updated 2023] ","Proportion of adults with type 1 diabetes who are offered a structured education programme 6 to 12 months after diagnosis.","Process","QS208 - Type 1 diabetes in adults","1 - QS208 - Type 1 diabetes in adults",1,"1 - QS208 - Type 1 diabetes in adults - Process - 1","The number in the denominator who are offered a structured education programme 6 to 12 months after diagnosis.","The number of adults diagnosed with type 1 diabetes in the last 12 months."]
[null,"QS208","Type 1 diabetes in adults",1,null,"Adults with type 1 diabetes are offered a structured education programme. [2011, updated 2023] ","Proportion of adults with a new diagnosis of type 1 diabetes who attend a structured education programme.","Process","QS208 - Type 1 diabetes in adults","1 - QS208 - Type 1 diabetes in adults",2,"1 - QS208 - Type 1 diabetes in adults - Process - 2","The number in the denominator who attend a structured education programme.","The number of adults with a new diagnosis of type 1 diabetes."]
[null,"QS208","Type 1 diabetes in adults",1,null,"Adults with type 1 diabetes are offered a structured education programme. [2011, updated 2023] ","Proportion of adults with type 1 diabetes who complete a structured education programme.","Process","QS208 - Type 1 diabetes in adults","1 - QS208 - Type 1 diabetes in adults",3,"1 - QS208 - Type 1 diabetes in adults - Process - 3","The number in the denominator who complete a structured education programme.","The number of adults with type 1 diabetes who attend a structured education programme."]
[null,"QS208","Type 1 diabetes in adults",1,null,"Adults with type 1 diabetes are offered a structured education programme. [2011, updated 2023] ","Patient confidence to self-manage their type 1 diabetes after attending a structured education programme.","Outcome","QS208 - Type 1 diabetes in adults","1 - QS208 - Type 1 diabetes in adults",1,"1 - QS208 - Type 1 diabetes in adults - Outcome - 1"]
[null,"QS208","Type 1 diabetes in adults",2,null,"Adults with type 1 diabetes are offered a choice of real-time or intermittently scanned continuous glucose monitoring. [2023] ","Proportion of adults with type 1 diabetes who use CGM.","Process","QS208 - Type 1 diabetes in adults","2 - QS208 - Type 1 diabetes in adults",1,"2 - QS208 - Type 1 diabetes in adults - Process - 1","The number in the denominator who use CGM.","The number of adults with type 1 diabetes."]
[null,"QS208","Type 1 diabetes in adults",2,null,"Adults with type 1 diabetes are offered a choice of real-time or intermittently scanned continuous glucose monitoring. [2023] ","Proportion of adults with type 1 diabetes using CGM who use rtCGM.","Process","QS208 - Type 1 diabetes in adults","2 - QS208 - Type 1 diabetes in adults",2,"2 - QS208 - Type 1 diabetes in adults - Process - 2","The number in the denominator who use rtCGM.","The number of adults with type 1 diabetes using CGM."]
[null,"QS208","Type 1 diabetes in adults",2,null,"Adults with type 1 diabetes are offered a choice of real-time or intermittently scanned continuous glucose monitoring. [2023] ","Proportion of adults with type 1 diabetes using CGM who use isCGM.","Process","QS208 - Type 1 diabetes in adults","2 - QS208 - Type 1 diabetes in adults",3,"2 - QS208 - Type 1 diabetes in adults - Process - 3","The number in the denominator who use isCGM.","The number of adults with type 1 diabetes using CGM."]
[null,"QS208","Type 1 diabetes in adults",2,null,"Adults with type 1 diabetes are offered a choice of real-time or intermittently scanned continuous glucose monitoring. [2023] ","HbA1c levels in adults with type 1 diabetes.","Outcome","QS208 - Type 1 diabetes in adults","2 - QS208 - Type 1 diabetes in adults",1,"2 - QS208 - Type 1 diabetes in adults - Outcome - 1"]
[null,"QS208","Type 1 diabetes in adults",3,null,"Adults with type 1 diabetes aged 40 and over are offered statins for the primary prevention of cardiovascular disease (CVD). [2023]","Proportion of adults with type 1 diabetes aged 40 and over who are prescribed statins for the primary prevention of CVD.","Process","QS208 - Type 1 diabetes in adults","3 - QS208 - Type 1 diabetes in adults",1,"3 - QS208 - Type 1 diabetes in adults - Process - 1","The number in the denominator who are prescribed statins for the primary prevention of CVD.","The number of adults with type 1 diabetes aged 40 and over."]
[null,"QS208","Type 1 diabetes in adults",4,null,"Adults with type 1 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 1 diabetes who had a urine albumin to creatinine ratio (ACR) test in the previous 12 months.","Process","QS208 - Type 1 diabetes in adults","4 - QS208 - Type 1 diabetes in adults",1,"4 - QS208 - Type 1 diabetes in adults - Process - 1","The number in the denominator who had a urine ACR test in the previous 12 months.","The number of adults with type 1 diabetes."]
[null,"QS208","Type 1 diabetes in adults",4,null,"Adults with type 1 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 1 diabetes who had an HbA1c test in the previous 12 months.","Process","QS208 - Type 1 diabetes in adults","4 - QS208 - Type 1 diabetes in adults",2,"4 - QS208 - Type 1 diabetes in adults - Process - 2","The number in the denominator who had an HbA1c test in the previous 12 months.","The number of adults with type 1 diabetes."]
[null,"QS208","Type 1 diabetes in adults",4,null,"Adults with type 1 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 1 diabetes who had their blood pressure measured in the previous 12 months. ","Process","QS208 - Type 1 diabetes in adults","4 - QS208 - Type 1 diabetes in adults",3,"4 - QS208 - Type 1 diabetes in adults - Process - 3","The number in the denominator who had their blood pressure measured in the previous 12 months.","The number of adults with type 1 diabetes."]
[null,"QS208","Type 1 diabetes in adults",4,null,"Adults with type 1 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 1 diabetes who had foot surveillance and risk classification recorded in the previous 12 months. ","Process","QS208 - Type 1 diabetes in adults","4 - QS208 - Type 1 diabetes in adults",4,"4 - QS208 - Type 1 diabetes in adults - Process - 4","The number in the denominator who had foot surveillance and risk classification recorded in the previous 12 months.","The number of adults with type 1 diabetes."]
[null,"QS208","Type 1 diabetes in adults",4,null,"Adults with type 1 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 1 diabetes who had a serum creatinine test in the previous 12 months.","Process","QS208 - Type 1 diabetes in adults","4 - QS208 - Type 1 diabetes in adults",5,"4 - QS208 - Type 1 diabetes in adults - Process - 5","The number in the denominator who had a serum creatinine test in the previous 12 months.","The number of adults with type 1 diabetes."]
[null,"QS208","Type 1 diabetes in adults",4,null,"Adults with type 1 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 1 diabetes who had a serum cholesterol test in the previous 12 months.","Process","QS208 - Type 1 diabetes in adults","4 - QS208 - Type 1 diabetes in adults",6,"4 - QS208 - Type 1 diabetes in adults - Process - 6","The number in the denominator who had a serum cholesterol test in the previous 12 months.","The number of adults with type 1 diabetes."]
[null,"QS208","Type 1 diabetes in adults",4,null,"Adults with type 1 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 1 diabetes who had a record of their body mass index (BMI) in the previous 12 months.","Process","QS208 - Type 1 diabetes in adults","4 - QS208 - Type 1 diabetes in adults",7,"4 - QS208 - Type 1 diabetes in adults - Process - 7","The number in the denominator who had a record of their BMI in the previous 12 months.","The number of adults with type 1 diabetes."]
[null,"QS208","Type 1 diabetes in adults",4,null,"Adults with type 1 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 1 diabetes who had their smoking status recorded in the previous 12 months.","Process","QS208 - Type 1 diabetes in adults","4 - QS208 - Type 1 diabetes in adults",8,"4 - QS208 - Type 1 diabetes in adults - Process - 8","The number in the denominator who had their smoking status recorded in the previous 12 months.","The number of adults with type 1 diabetes."]
[null,"QS208","Type 1 diabetes in adults",4,null,"Adults with type 1 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 1 diabetes who had retinal screening in the previous 12 months.","Process","QS208 - Type 1 diabetes in adults","4 - QS208 - Type 1 diabetes in adults",9,"4 - QS208 - Type 1 diabetes in adults - Process - 9","The number in the denominator who had retinal screening in the previous 12 months.","The number of adults with type 1 diabetes."]
[null,"QS208","Type 1 diabetes in adults",4,null,"Adults with type 1 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 1 diabetes who had 9 key care processes performed in the previous 12 months.","Process","QS208 - Type 1 diabetes in adults","4 - QS208 - Type 1 diabetes in adults",10,"4 - QS208 - Type 1 diabetes in adults - Process - 10","The number in the denominator who had 9 key care processes in the previous 12 months.","The number of adults with type 1 diabetes."]
[null,"QS208","Type 1 diabetes in adults",4,null,"Adults with type 1 diabetes have 9 key care processes completed every 12 months. [new 2023]","Prevalence of cardiovascular complications, renal replacement therapy (end-stage kidney disease) or minor or major amputations in adults with type 1 diabetes.","Outcome","QS208 - Type 1 diabetes in adults","4 - QS208 - Type 1 diabetes in adults",1,"4 - QS208 - Type 1 diabetes in adults - Outcome - 1"]
[null,"QS208","Type 1 diabetes in adults",5,null,"Adults with type 1 diabetes admitted to hospital have an assessment of their risk of developing a diabetic foot problem. [new 2023] ","Evidence of local systems to identify all adults with type 1 diabetes when they are admitted to hospital.","Structure","QS208 - Type 1 diabetes in adults","5 - QS208 - Type 1 diabetes in adults",1,"5 - QS208 - Type 1 diabetes in adults - Structure - 1"]
[null,"QS208","Type 1 diabetes in adults",5,null,"Adults with type 1 diabetes admitted to hospital have an assessment of their risk of developing a diabetic foot problem. [new 2023] ","Evidence of local arrangements to ensure that foot assessments for adults with type 1 diabetes are performed by appropriately trained healthcare professionals. ","Structure","QS208 - Type 1 diabetes in adults","5 - QS208 - Type 1 diabetes in adults",2,"5 - QS208 - Type 1 diabetes in adults - Structure - 2"]
[null,"QS208","Type 1 diabetes in adults",5,null,"Adults with type 1 diabetes admitted to hospital have an assessment of their risk of developing a diabetic foot problem. [new 2023] ","Proportion of adults with type 1 diabetes admitted to hospital who have an assessment of their risk of developing a diabetic foot problem.","Process","QS208 - Type 1 diabetes in adults","5 - QS208 - Type 1 diabetes in adults",1,"5 - QS208 - Type 1 diabetes in adults - Process - 1","The number in the denominator who have an assessment of their risk of developing a diabetic foot problem.","The number of adults with type 1 diabetes admitted to hospital. "]
[null,"QS208","Type 1 diabetes in adults",5,null,"Adults with type 1 diabetes admitted to hospital have an assessment of their risk of developing a diabetic foot problem. [new 2023] ","Incidence of diabetic foot ulcer identified on hospital admission in adults with type 1 diabetes.","Outcome","QS208 - Type 1 diabetes in adults","5 - QS208 - Type 1 diabetes in adults",1,"5 - QS208 - Type 1 diabetes in adults - Outcome - 1"]
[null,"QS208","Type 1 diabetes in adults",5,null,"Adults with type 1 diabetes admitted to hospital have an assessment of their risk of developing a diabetic foot problem. [new 2023] ","Rate of diabetic foot ulcer in adults with type 1 diabetes during a hospital admission.","Outcome","QS208 - Type 1 diabetes in adults","5 - QS208 - Type 1 diabetes in adults",2,"5 - QS208 - Type 1 diabetes in adults - Outcome - 2"]
[null,"QS208","Type 1 diabetes in adults",6,null,"Adults with type 1 diabetes admitted to hospital are supported to self-manage their diabetes. [2011, updated 2023]","Evidence that organisations have a dedicated multidisciplinary team of specialist diabetes inpatient practitioners.","Structure","QS208 - Type 1 diabetes in adults","6 - QS208 - Type 1 diabetes in adults",1,"6 - QS208 - Type 1 diabetes in adults - Structure - 1"]
[null,"QS208","Type 1 diabetes in adults",6,null,"Adults with type 1 diabetes admitted to hospital are supported to self-manage their diabetes. [2011, updated 2023]","Evidence that organisations have and promote a self-management policy, which supports people who want to self-manage their type 1 diabetes to safely do so while in hospital, as clinically appropriate.","Structure","QS208 - Type 1 diabetes in adults","6 - QS208 - Type 1 diabetes in adults",2,"6 - QS208 - Type 1 diabetes in adults - Structure - 2"]
[null,"QS208","Type 1 diabetes in adults",6,null,"Adults with type 1 diabetes admitted to hospital are supported to self-manage their diabetes. [2011, updated 2023]","Proportion of hospital admissions for adults with type 1 diabetes in which they received support from a specialist multidisciplinary team with expertise in diabetes. ","Process","QS208 - Type 1 diabetes in adults","6 - QS208 - Type 1 diabetes in adults",1,"6 - QS208 - Type 1 diabetes in adults - Process - 1","The number in the denominator in which the person received support from a specialist multidisciplinary team with expertise in diabetes.","The number of hospital admissions for adults with type 1 diabetes."]
[null,"QS208","Type 1 diabetes in adults",6,null,"Adults with type 1 diabetes admitted to hospital are supported to self-manage their diabetes. [2011, updated 2023]","Patient satisfaction that they were able to self-manage their diabetes while in hospital.","Outcome","QS208 - Type 1 diabetes in adults","6 - QS208 - Type 1 diabetes in adults",1,"6 - QS208 - Type 1 diabetes in adults - Outcome - 1"]
[null,"QS209","Type 2 diabetes in adults",1,null,"Adults at high risk of type 2 diabetes are offered a referral to the NHS Diabetes Prevention Programme. [2016, updated 2023]","Proportion of adults at high risk of type 2 diabetes who are offered a referral to the NHS Diabetes Prevention Programme. ","Process","QS209 - Type 2 diabetes in adults","1 - QS209 - Type 2 diabetes in adults",1,"1 - QS209 - Type 2 diabetes in adults - Process - 1","The number in the denominator who are offered a referral to the NHS Diabetes Prevention Programme. ","The number of adults at high risk of type 2 diabetes. "]
[null,"QS209","Type 2 diabetes in adults",1,null,"Adults at high risk of type 2 diabetes are offered a referral to the NHS Diabetes Prevention Programme. [2016, updated 2023]","Proportion of adults at high risk of type 2 diabetes who complete the NHS Diabetes Prevention Programme.","Process","QS209 - Type 2 diabetes in adults","1 - QS209 - Type 2 diabetes in adults",2,"1 - QS209 - Type 2 diabetes in adults - Process - 2","The number in the denominator who complete the NHS Diabetes Prevention Programme.","The number of adults at high risk of type 2 diabetes referred to the NHS Diabetes Prevention Programme."]
[null,"QS209","Type 2 diabetes in adults",1,null,"Adults at high risk of type 2 diabetes are offered a referral to the NHS Diabetes Prevention Programme. [2016, updated 2023]","Weight loss of participants in the NHS Diabetes Prevention Programme. ","Outcome","QS209 - Type 2 diabetes in adults","1 - QS209 - Type 2 diabetes in adults",1,"1 - QS209 - Type 2 diabetes in adults - Outcome - 1"]
[null,"QS209","Type 2 diabetes in adults",1,null,"Adults at high risk of type 2 diabetes are offered a referral to the NHS Diabetes Prevention Programme. [2016, updated 2023]","Reduction in HbA1c of participants in the NHS Diabetes Prevention Programme.","Outcome","QS209 - Type 2 diabetes in adults","1 - QS209 - Type 2 diabetes in adults",2,"1 - QS209 - Type 2 diabetes in adults - Outcome - 2"]
[null,"QS209","Type 2 diabetes in adults",2,null,"Adults with type 2 diabetes are offered a structured education programme at diagnosis. [2011, updated 2023]","Proportion of adults with type 2 diabetes who are offered a structured education programme at diagnosis. ","Process","QS209 - Type 2 diabetes in adults","2 - QS209 - Type 2 diabetes in adults",1,"2 - QS209 - Type 2 diabetes in adults - Process - 1","The number in the denominator who are offered a structured education programme at diagnosis.","The number of adults with a new diagnosis of type 2 diabetes."]
[null,"QS209","Type 2 diabetes in adults",2,null,"Adults with type 2 diabetes are offered a structured education programme at diagnosis. [2011, updated 2023]","Proportion of adults with a new diagnosis of type 2 diabetes who attend a structured education programme. ","Process","QS209 - Type 2 diabetes in adults","2 - QS209 - Type 2 diabetes in adults",2,"2 - QS209 - Type 2 diabetes in adults - Process - 2","The number in the denominator who attend a structured education programme.","The number of adults with a new diagnosis of type 2 diabetes."]
[null,"QS209","Type 2 diabetes in adults",2,null,"Adults with type 2 diabetes are offered a structured education programme at diagnosis. [2011, updated 2023]","Proportion of adults with a new diagnosis of type 2 diabetes who complete a structured education programme.","Process","QS209 - Type 2 diabetes in adults","2 - QS209 - Type 2 diabetes in adults",3,"2 - QS209 - Type 2 diabetes in adults - Process - 3","The number in the denominator who complete a structured education programme.","The number of adults with type 2 diabetes who attend a structured education programme."]
[null,"QS209","Type 2 diabetes in adults",2,null,"Adults with type 2 diabetes are offered a structured education programme at diagnosis. [2011, updated 2023]","Patient confidence to self-manage their type 2 diabetes after attending a structured education programme.","Outcome","QS209 - Type 2 diabetes in adults","2 - QS209 - Type 2 diabetes in adults",1,"2 - QS209 - Type 2 diabetes in adults - Outcome - 1"]
[null,"QS209","Type 2 diabetes in adults",3,null,"Adults with type 2 diabetes who have multiple daily insulin injections and a condition or disability that means they cannot use capillary blood glucose monitoring are offered continuous glucose monitoring (CGM) to support self-monitoring. [new 2023]","Proportion of adults with type 2 diabetes who have multiple daily insulin injections and a condition or disability that means they cannot self-monitor using capillary blood glucose monitoring who use CGM. ","Process","QS209 - Type 2 diabetes in adults","3 - QS209 - Type 2 diabetes in adults",1,"3 - QS209 - Type 2 diabetes in adults - Process - 1","The number in the denominator who use CGM.","The number of adults with type 2 diabetes who have multiple daily insulin injections and a condition or disability that means they cannot self-monitor using capillary blood glucose monitoring."]
[null,"QS209","Type 2 diabetes in adults",3,null,"Adults with type 2 diabetes who have multiple daily insulin injections and a condition or disability that means they cannot use capillary blood glucose monitoring are offered continuous glucose monitoring (CGM) to support self-monitoring. [new 2023]","HbA1c levels in adults with type 2 diabetes who have multiple daily insulin injections and a condition or disability that means they cannot self-monitor using capillary blood glucose monitoring.","Outcome","QS209 - Type 2 diabetes in adults","3 - QS209 - Type 2 diabetes in adults",1,"3 - QS209 - Type 2 diabetes in adults - Outcome - 1"]
[null,"QS209","Type 2 diabetes in adults",4,null,"Adults with insulin-treated type 2 diabetes having their blood glucose monitored by a care worker or healthcare professional are offered continuous glucose monitoring (CGM). [new 2023]","Proportion of adults with insulin-treated type 2 diabetes who need help from a care worker or healthcare professional to monitor their blood glucose who use CGM. ","Process","QS209 - Type 2 diabetes in adults","4 - QS209 - Type 2 diabetes in adults",1,"4 - QS209 - Type 2 diabetes in adults - Process - 1","The number in the denominator who use CGM.","The number of adults with insulin-treated type 2 diabetes who need help from a care worker or healthcare professional to monitor their blood glucose. "]
[null,"QS209","Type 2 diabetes in adults",4,null,"Adults with insulin-treated type 2 diabetes having their blood glucose monitored by a care worker or healthcare professional are offered continuous glucose monitoring (CGM). [new 2023]","HbA1c levels for adults with insulin-treated type 2 diabetes who need help from a care worker or healthcare professional to monitor their blood glucose.","Outcome","QS209 - Type 2 diabetes in adults","4 - QS209 - Type 2 diabetes in adults",1,"4 - QS209 - Type 2 diabetes in adults - Outcome - 1"]
[null,"QS209","Type 2 diabetes in adults",5,null,"Adults with type 2 diabetes are offered an SGLT2 inhibitor if they would benefit because of co-existing chronic heart failure, cardiovascular disease or chronic kidney disease (CKD). [new 2023] ","Proportion of adults with type 2 diabetes and chronic heart failure or established atherosclerotic cardiovascular disease prescribed an SGLT2 inhibitor.","Process","QS209 - Type 2 diabetes in adults","5 - QS209 - Type 2 diabetes in adults",1,"5 - QS209 - Type 2 diabetes in adults - Process - 1","The number in the denominator who are prescribed an SGLT2 inhibitor. ","The number of adults with type 2 diabetes and chronic heart failure or established atherosclerotic cardiovascular disease."]
[null,"QS209","Type 2 diabetes in adults",5,null,"Adults with type 2 diabetes are offered an SGLT2 inhibitor if they would benefit because of co-existing chronic heart failure, cardiovascular disease or chronic kidney disease (CKD). [new 2023] ","Proportion of adults with type 2 diabetes and CKD who are taking an ARB or an ACE inhibitor and have an ACR over 30 mg/mmol prescribed an SGLT2 inhibitor.","Process","QS209 - Type 2 diabetes in adults","5 - QS209 - Type 2 diabetes in adults",2,"5 - QS209 - Type 2 diabetes in adults - Process - 2","The number in the denominator who are prescribed an SGLT2 inhibitor.","The number of adults with type 2 diabetes and CKD who are taking an ARB or an ACE inhibitor and have an ACR over 30 mg/mmol."]
[null,"QS209","Type 2 diabetes in adults",5,null,"Adults with type 2 diabetes are offered an SGLT2 inhibitor if they would benefit because of co-existing chronic heart failure, cardiovascular disease or chronic kidney disease (CKD). [new 2023] ","Prevalence of cardiovascular complications in adults with type 2 diabetes.","Outcome","QS209 - Type 2 diabetes in adults","5 - QS209 - Type 2 diabetes in adults",1,"5 - QS209 - Type 2 diabetes in adults - Outcome - 1"]
[null,"QS209","Type 2 diabetes in adults",6,null,"Adults with type 2 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 2 diabetes who had a urine albumin-to-creatinine ratio (ACR) test in the previous 12 months.","Process","QS209 - Type 2 diabetes in adults","6 - QS209 - Type 2 diabetes in adults",1,"6 - QS209 - Type 2 diabetes in adults - Process - 1","The number in the denominator who had a urine ACR test in the previous 12 months.","The number of adults with type 2 diabetes."]
[null,"QS209","Type 2 diabetes in adults",6,null,"Adults with type 2 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 2 diabetes who had an HbA1c test in the previous 12 months.","Process","QS209 - Type 2 diabetes in adults","6 - QS209 - Type 2 diabetes in adults",2,"6 - QS209 - Type 2 diabetes in adults - Process - 2","The number in the denominator who had an HbA1c test in the previous 12 months.","The number of adults with type 2 diabetes."]
[null,"QS209","Type 2 diabetes in adults",6,null,"Adults with type 2 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 2 diabetes who had their blood pressure measured in the previous 12 months. ","Process","QS209 - Type 2 diabetes in adults","6 - QS209 - Type 2 diabetes in adults",3,"6 - QS209 - Type 2 diabetes in adults - Process - 3","The number in the denominator who had their blood pressure measured in the previous 12 months.","The number of adults with type 2 diabetes."]
[null,"QS209","Type 2 diabetes in adults",6,null,"Adults with type 2 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 2 diabetes who had foot surveillance and risk classification recorded in the previous 12 months. ","Process","QS209 - Type 2 diabetes in adults","6 - QS209 - Type 2 diabetes in adults",4,"6 - QS209 - Type 2 diabetes in adults - Process - 4","The number in the denominator who had foot surveillance and risk classification recorded in the previous 12 months. ","The number of adults with type 2 diabetes. "]
[null,"QS209","Type 2 diabetes in adults",6,null,"Adults with type 2 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 2 diabetes who had a serum creatinine test in the previous 12 months.","Process",{"$f":"CONCATENATE(B4663, \" - \", C4663)","v":"QS209 - Type 2 diabetes in adults"},{"$f":"CONCATENATE(D4663, \" - \", I4663)","v":"6 - QS209 - Type 2 diabetes in adults"},{"$f":"IF(AND(B4663=B4662, D4663=D4662, H4663=H4662)=TRUE, K4662+1, 1)","v":5},{"$f":"CONCATENATE(J4663, \" - \", H4663, \" - \",K4663)","v":"6 - QS209 - Type 2 diabetes in adults - Process - 5"},"The number in the denominator who had a serum creatinine test in the previous 12 months.","The number of adults with type 2 diabetes."]
[null,"QS209","Type 2 diabetes in adults",6,null,"Adults with type 2 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 2 diabetes who had a serum cholesterol test in the previous 12 months.","Process","QS209 - Type 2 diabetes in adults","6 - QS209 - Type 2 diabetes in adults",6,"6 - QS209 - Type 2 diabetes in adults - Process - 6","The number in the denominator who had a serum cholesterol test in the previous 12 months.","The number of adults with type 2 diabetes."]
[null,"QS209","Type 2 diabetes in adults",6,null,"Adults with type 2 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 2 diabetes who had a record of their body mass index (BMI) in the previous 12 months.","Process","QS209 - Type 2 diabetes in adults","6 - QS209 - Type 2 diabetes in adults",7,"6 - QS209 - Type 2 diabetes in adults - Process - 7","The number in the denominator who had a record of their BMI in the previous 12 months.","The number of adults with type 2 diabetes."]
[null,"QS209","Type 2 diabetes in adults",6,null,"Adults with type 2 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 2 diabetes who had their smoking status recorded in the previous 12 months.","Process","QS209 - Type 2 diabetes in adults","6 - QS209 - Type 2 diabetes in adults",8,"6 - QS209 - Type 2 diabetes in adults - Process - 8","The number in the denominator who had their smoking status recorded in the previous 12 months.","The number of adults with type 2 diabetes."]
[null,"QS209","Type 2 diabetes in adults",6,null,"Adults with type 2 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 2 diabetes who had retinal screening in the previous 12 months.","Process","QS209 - Type 2 diabetes in adults","6 - QS209 - Type 2 diabetes in adults",9,"6 - QS209 - Type 2 diabetes in adults - Process - 9","The number in the denominator who had retinal screening in the previous 12 months.","The number of adults with type 2 diabetes."]
[null,"QS209","Type 2 diabetes in adults",6,null,"Adults with type 2 diabetes have 9 key care processes completed every 12 months. [new 2023]","Proportion of adults with type 2 diabetes who had 9 key care processes performed in the previous 12 months.","Process","QS209 - Type 2 diabetes in adults","6 - QS209 - Type 2 diabetes in adults",10,"6 - QS209 - Type 2 diabetes in adults - Process - 10","The number in the denominator who had 9 key care processes in the previous 12 months.","The number of adults with type 2 diabetes."]
[null,"QS209","Type 2 diabetes in adults",6,null,"Adults with type 2 diabetes have 9 key care processes completed every 12 months. [new 2023]","Prevalence of cardiovascular complications, renal replacement therapy (end-stage kidney disease) or minor or major amputations in adults with type 2 diabetes.","Outcome","QS209 - Type 2 diabetes in adults","6 - QS209 - Type 2 diabetes in adults",1,"6 - QS209 - Type 2 diabetes in adults - Outcome - 1"]
[null,"QS209","Type 2 diabetes in adults",7,null,"Adults with type 2 diabetes admitted to hospital have an assessment of their risk of developing a diabetic foot problem. [new 2023]","Evidence of local systems to identify all adults with type 2 diabetes when they are admitted to hospital.","Structure","QS209 - Type 2 diabetes in adults","7 - QS209 - Type 2 diabetes in adults",1,"7 - QS209 - Type 2 diabetes in adults - Structure - 1"]
[null,"QS209","Type 2 diabetes in adults",7,null,"Adults with type 2 diabetes admitted to hospital have an assessment of their risk of developing a diabetic foot problem. [new 2023]","Evidence of local arrangements to ensure that foot assessments for adults with type 2 diabetes are performed by appropriately trained healthcare professionals. ","Structure","QS209 - Type 2 diabetes in adults","7 - QS209 - Type 2 diabetes in adults",2,"7 - QS209 - Type 2 diabetes in adults - Structure - 2"]
[null,"QS209","Type 2 diabetes in adults",7,null,"Adults with type 2 diabetes admitted to hospital have an assessment of their risk of developing a diabetic foot problem. [new 2023]","Proportion of adults with type 2 diabetes admitted to hospital who have an assessment of their risk of developing a diabetic foot problem.","Process","QS209 - Type 2 diabetes in adults","7 - QS209 - Type 2 diabetes in adults",1,"7 - QS209 - Type 2 diabetes in adults - Process - 1","The number in the denominator who have an assessment of their risk of developing a diabetic foot problem.","The number of adults with type 2 diabetes admitted to hospital. "]
[null,"QS209","Type 2 diabetes in adults",7,null,"Adults with type 2 diabetes admitted to hospital have an assessment of their risk of developing a diabetic foot problem. [new 2023]","Incidence of diabetic foot ulcer identified on hospital admission in adults with type 2 diabetes.","Outcome","QS209 - Type 2 diabetes in adults","7 - QS209 - Type 2 diabetes in adults",1,"7 - QS209 - Type 2 diabetes in adults - Outcome - 1"]
[null,"QS209","Type 2 diabetes in adults",7,null,"Adults with type 2 diabetes admitted to hospital have an assessment of their risk of developing a diabetic foot problem. [new 2023]","Rate of diabetic foot ulcer in adults with type 2 diabetes during a hospital admission. ","Outcome","QS209 - Type 2 diabetes in adults","7 - QS209 - Type 2 diabetes in adults",2,"7 - QS209 - Type 2 diabetes in adults - Outcome - 2"]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",1,null,"Adults first presenting with suspected acute respiratory infection have a documented assessment of symptoms and signs.","Proportion of diagnoses of acute respiratory infection in adults with a documented assessment of symptoms and signs at initial presentation.","Process",{"$f":"CONCATENATE(B4675, \" - \", C4675)","v":"QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)"},{"$f":"CONCATENATE(D4675, \" - \", I4675)","v":"1 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)"},{"$f":"IF(AND(B4675=B4674, D4675=D4674, H4675=H4674)=TRUE, K4674+1, 1)","v":1},{"$f":"CONCATENATE(J4675, \" - \", H4675, \" - \",K4675)","v":"1 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Process - 1"},"The number in the denominator with a documented assessment of symptoms and signs at initial presentation.","The number of diagnoses of acute respiratory infection in adults."]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",2,null,"Adults first presenting with suspected acute respiratory infection are not routinely prescribed antimicrobials based only on remote assessment.","Proportion of prescriptions for antimicrobials for adults with an acute respiratory infection that are given without a face-to-face assessment.","Process","QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)","2 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",1,"2 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Process - 1","The number in the denominator that are given without a face-to-face assessment.","The number of prescriptions for antimicrobials for adults with an acute respiratory infection."]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",2,null,"Adults first presenting with suspected acute respiratory infection are not routinely prescribed antimicrobials based only on remote assessment.","Rate of antimicrobial prescribing for acute respiratory infection.","Outcome","QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)","2 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",1,"2 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Outcome - 1"]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",3,null,"Adults prescribed an antibiotic for an acute respiratory infection are given a 5‑day course, or 5 to 10 days if phenoxymethylpenicillin is prescribed for acute sore throat.","Proportion of antibiotic courses prescribed for community-acquired pneumonia, acute cough, acute sore throat or acute sinusitis that are for 5 days (or up to 10 days if phenoxymethylpenicillin for sore throat).","Process","QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)","3 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",1,"3 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Process - 1","The number in the denominator that are for 5 days (or up to 10 days if phenoxymethylpenicillin for sore throat).","The number of antibiotic courses prescribed for community-acquired pneumonia, acute cough, acute sore throat or acute sinusitis."]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",4,null,"Adults admitted to an acute respiratory infection virtual ward are given verbal and written information about the service.","Proportion of adult admissions to an acute respiratory infection virtual ward where verbal and written information about the service is given.","Process","QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)","4 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",1,"4 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Process - 1","The number in the denominator where verbal and written information about the service is given.","The number of adult admissions to an acute respiratory infection virtual ward."]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",4,null,"Adults admitted to an acute respiratory infection virtual ward are given verbal and written information about the service.","Proportion of adults admitted to an acute respiratory infection virtual ward who are satisfied with the information and support provided to use the service.","Outcome","QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)","4 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",1,"4 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Outcome - 1","The number in the denominator who are satisfied with the information and support provided to use the service.","The number of adults admitted to an acute respiratory virtual ward."]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",5,null,"Adults admitted to an acute respiratory infection virtual ward are cared for by a multidisciplinary team that has access to speciality advice and diagnostics and is led by a named consultant practitioner or GP with suitable expertise.","Evidence of local arrangements to ensure that a multidisciplinary team is responsible for providing care on an acute respiratory infection virtual ward.","Structure","QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)","5 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",1,"5 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Structure - 1"]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",5,null,"Adults admitted to an acute respiratory infection virtual ward are cared for by a multidisciplinary team that has access to speciality advice and diagnostics and is led by a named consultant practitioner or GP with suitable expertise.","Evidence that the acute respiratory infection virtual ward multidisciplinary team has access to speciality advice and diagnostics.","Structure","QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)","5 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",2,"5 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Structure - 2"]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",5,null,"Adults admitted to an acute respiratory infection virtual ward are cared for by a multidisciplinary team that has access to speciality advice and diagnostics and is led by a named consultant practitioner or GP with suitable expertise.","Evidence that a named consultant practitioner or GP with suitable expertise leads the acute respiratory infection virtual ward multidisciplinary team.","Structure","QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)","5 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",3,"5 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Structure - 3"]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",5,null,"Adults admitted to an acute respiratory infection virtual ward are cared for by a multidisciplinary team that has access to speciality advice and diagnostics and is led by a named consultant practitioner or GP with suitable expertise.","Proportion of adults admitted to an acute respiratory infection virtual ward who had confidence and trust in the virtual ward team.","Outcome",{"$f":"CONCATENATE(B4684, \" - \", C4684)","v":"QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)"},{"$f":"CONCATENATE(D4684, \" - \", I4684)","v":"5 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)"},{"$f":"IF(AND(B4684=B4683, D4684=D4683, H4684=H4683)=TRUE, K4683+1, 1)","v":1},{"$f":"CONCATENATE(J4684, \" - \", H4684, \" - \",K4684)","v":"5 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Outcome - 1"},"The number in the denominator who had confidence and trust in the virtual ward team.","The number of adults admitted to an acute respiratory virtual ward."]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",6,null,"Adults admitted to an acute respiratory infection virtual ward are supported to self-manage, including having a self-escalation plan.","Proportion of adult admissions to an acute respiratory infection virtual ward where advice and information to support self-management was given.","Process","QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)","6 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",1,"6 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Process - 1","The number in the denominator where advice and information to support self-management was given.","The number of adult admissions to an acute respiratory infection virtual ward."]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",6,null,"Adults admitted to an acute respiratory infection virtual ward are supported to self-manage, including having a self-escalation plan.","Proportion of adult admissions to an acute respiratory infection virtual ward with a documented self-escalation plan.","Process","QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)","6 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",2,"6 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Process - 2","The number in the denominator with a documented self-escalation plan.","The number of adult admissions to an acute respiratory infection virtual ward."]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",6,null,"Adults admitted to an acute respiratory infection virtual ward are supported to self-manage, including having a self-escalation plan.","Proportion of adults admitted to an acute respiratory infection virtual ward who felt they had enough support to manage their condition and knew what to do if they felt unwell.","Outcome",{"$f":"CONCATENATE(B4687, \" - \", C4687)","v":"QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)"},{"$f":"CONCATENATE(D4687, \" - \", I4687)","v":"6 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)"},{"$f":"IF(AND(B4687=B4686, D4687=D4686, H4687=H4686)=TRUE, K4686+1, 1)","v":1},{"$f":"CONCATENATE(J4687, \" - \", H4687, \" - \",K4687)","v":"6 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Outcome - 1"},"The number in the denominator who felt they had enough support to manage their condition and knew what to do if they felt unwell.","The number of adults admitted to an acute respiratory virtual ward."]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",7,null,"Adults discharged from an acute respiratory infection virtual ward are given a discharge summary, including follow‑up details, that is also shared with their GP.","Proportion of discharges from an acute respiratory infection virtual ward where a discharge summary including follow‑up details is given to the person.","Process","QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)","7 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",1,"7 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Process - 1","The number in the denominator where a discharge summary including follow‑up details is given to the person.","The number of discharges from an acute respiratory infection virtual ward."]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",7,null,"Adults discharged from an acute respiratory infection virtual ward are given a discharge summary, including follow‑up details, that is also shared with their GP.","Proportion of discharges from an acute respiratory infection virtual ward where a discharge summary including follow‑up details is shared with the person's GP.","Process",{"$f":"CONCATENATE(B4689, \" - \", C4689)","v":"QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)"},{"$f":"CONCATENATE(D4689, \" - \", I4689)","v":"7 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)"},{"$f":"IF(AND(B4689=B4688, D4689=D4688, H4689=H4688)=TRUE, K4688+1, 1)","v":2},{"$f":"CONCATENATE(J4689, \" - \", H4689, \" - \",K4689)","v":"7 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Process - 2"},"The number in the denominator where a discharge summary including follow‑up details is shared with the person's GP.","The number of discharges from an acute respiratory infection virtual ward."]
[null,"QS210","Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",7,null,"Adults discharged from an acute respiratory infection virtual ward are given a discharge summary, including follow‑up details, that is also shared with their GP.","Proportion of adults discharged from an acute respiratory infection virtual ward who knew what would happen next with their care.","Outcome","QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)","7 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)",1,"7 - QS210 - Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) - Outcome - 1","The number in the denominator who knew what would happen next with their care.","The number of adults discharged from an acute respiratory virtual ward."]
[null,"QS211","Epilepsies in children, young people and adults ",1,null,"People presenting with a first suspected seizure are seen by a clinician with expertise in epilepsy within 2 weeks of presentation. [2013, updated 2023]","Proportion of children and young people presenting with a first suspected seizure referred to a paediatrician with expertise in epilepsy who are seen within 2 weeks.","Process","QS211 - Epilepsies in children, young people and adults ","1 - QS211 - Epilepsies in children, young people and adults ",1,"1 - QS211 - Epilepsies in children, young people and adults  - Process - 1","The number in the denominator who are seen within 2 weeks of referral.","The number of children and young people presenting with a first suspected seizure who are seen by a paediatrician with expertise in epilepsy."]
[null,"QS211","Epilepsies in children, young people and adults ",1,null,"People presenting with a first suspected seizure are seen by a clinician with expertise in epilepsy within 2 weeks of presentation. [2013, updated 2023]","Proportion of adults presenting with a first suspected seizure referred to a clinician with expertise in epilepsy who are seen within 2 weeks of referral.","Process","QS211 - Epilepsies in children, young people and adults ","1 - QS211 - Epilepsies in children, young people and adults ",2,"1 - QS211 - Epilepsies in children, young people and adults  - Process - 2","The number in the denominator who are seen within 2 weeks of referral.","The number of adults presenting with a first suspected seizure who are seen by a clinician with expertise in epilepsy."]
[null,"QS211","Epilepsies in children, young people and adults ",2,null,"People who meet the criteria for referral to a tertiary epilepsy service are seen within 4 weeks of referral, or 2 weeks if they meet the criteria for urgent referral. [2013, updated 2023]","Proportion of children referred to a tertiary paediatric epilepsy service who meet the criteria for urgent referral who are seen within 2 weeks of referral.","Process","QS211 - Epilepsies in children, young people and adults ","2 - QS211 - Epilepsies in children, young people and adults ",1,"2 - QS211 - Epilepsies in children, young people and adults  - Process - 1","The number in the denominator who are seen within 2 weeks of referral.","The number of children referred to a tertiary paediatric epilepsy service who meet the criteria for urgent referral."]
[null,"QS211","Epilepsies in children, young people and adults ",2,null,"People who meet the criteria for referral to a tertiary epilepsy service are seen within 4 weeks of referral, or 2 weeks if they meet the criteria for urgent referral. [2013, updated 2023]","Proportion of people referred to a tertiary epilepsy service who meet the criteria for referral to be seen within 4 weeks that are seen within 4 weeks.","Process","QS211 - Epilepsies in children, young people and adults ","2 - QS211 - Epilepsies in children, young people and adults ",2,"2 - QS211 - Epilepsies in children, young people and adults  - Process - 2","The number of people in the denominator who are seen within 4 weeks of referral.","The number of people referred to a tertiary epilepsy service who meet the criteria for referral to be seen within 4 weeks."]
[null,"QS211","Epilepsies in children, young people and adults ",2,null,"People who meet the criteria for referral to a tertiary epilepsy service are seen within 4 weeks of referral, or 2 weeks if they meet the criteria for urgent referral. [2013, updated 2023]","Number of unplanned hospital attendances and admissions for people with epilepsy.","Outcome","QS211 - Epilepsies in children, young people and adults ","2 - QS211 - Epilepsies in children, young people and adults ",1,"2 - QS211 - Epilepsies in children, young people and adults  - Outcome - 1"]
[null,"QS211","Epilepsies in children, young people and adults ",3,null,"People with epilepsy have access to an epilepsy specialist nurse. [2013, updated 2023]","Evidence of availability of epilepsy specialist nurses.","Structure","QS211 - Epilepsies in children, young people and adults ","3 - QS211 - Epilepsies in children, young people and adults ",1,"3 - QS211 - Epilepsies in children, young people and adults  - Structure - 1"]
[null,"QS211","Epilepsies in children, young people and adults ",3,null,"People with epilepsy have access to an epilepsy specialist nurse. [2013, updated 2023]","Proportion of people receiving epilepsy care who are given the contact details of a named epilepsy specialist nurse or an epilepsy nurse team.","Process","QS211 - Epilepsies in children, young people and adults ","3 - QS211 - Epilepsies in children, young people and adults ",1,"3 - QS211 - Epilepsies in children, young people and adults  - Process - 1","The number of people in the denominator who are given the contact details of a named epilepsy specialist nurse or an epilepsy nurse team.","The number of people receiving care from an epilepsy service."]
[null,"QS211","Epilepsies in children, young people and adults ",3,null,"People with epilepsy have access to an epilepsy specialist nurse. [2013, updated 2023]","Proportion of people with epilepsy who continue to have seizures who have had an information and care-planning session with an epilepsy specialist nurse at least twice within the past year. ","Process","QS211 - Epilepsies in children, young people and adults ","3 - QS211 - Epilepsies in children, young people and adults ",2,"3 - QS211 - Epilepsies in children, young people and adults  - Process - 2","The number in the denominator who have had an information and care-planning session with an epilepsy specialist nurse at least twice within the past year.","The number of people with epilepsy who continue to have seizures."]
[null,"QS211","Epilepsies in children, young people and adults ",3,null,"People with epilepsy have access to an epilepsy specialist nurse. [2013, updated 2023]","Proportion of children and young people diagnosed with epilepsy who received input from an epilepsy specialist nurse within the first year of care.","Process","QS211 - Epilepsies in children, young people and adults ","3 - QS211 - Epilepsies in children, young people and adults ",3,"3 - QS211 - Epilepsies in children, young people and adults  - Process - 3","The number in the denominator who received input from an epilepsy specialist nurse.","The number of children and young people diagnosed with epilepsy in their first year of care."]
[null,"QS211","Epilepsies in children, young people and adults ",4,null,"People with epilepsy have an up-to-date and agreed comprehensive epilepsy care plan. [2013, updated 2023]","Proportion of people with epilepsy who have an up-to-date and agreed comprehensive epilepsy care plan.","Process","QS211 - Epilepsies in children, young people and adults ","4 - QS211 - Epilepsies in children, young people and adults ",1,"4 - QS211 - Epilepsies in children, young people and adults  - Process - 1","The number in the denominator who have an up-to-date and agreed comprehensive epilepsy care plan.","The number of people with epilepsy."]
[null,"QS211","Epilepsies in children, young people and adults ",4,null,"People with epilepsy have an up-to-date and agreed comprehensive epilepsy care plan. [2013, updated 2023]","Proportion of young people with epilepsy who have an epilepsy care plan that covers transition to adult services.","Process","QS211 - Epilepsies in children, young people and adults ","4 - QS211 - Epilepsies in children, young people and adults ",2,"4 - QS211 - Epilepsies in children, young people and adults  - Process - 2","The number in the denominator who have an epilepsy care plan that covers transition to adult services.","The number of young people with epilepsy."]
[null,"QS211","Epilepsies in children, young people and adults ",4,null,"People with epilepsy have an up-to-date and agreed comprehensive epilepsy care plan. [2013, updated 2023]","Proportion of women of childbearing potential who have an epilepsy care plan that covers pre-conception care and pregnancy.","Process","QS211 - Epilepsies in children, young people and adults ","4 - QS211 - Epilepsies in children, young people and adults ",3,"4 - QS211 - Epilepsies in children, young people and adults  - Process - 3","The number in the denominator who have an epilepsy care plan that covers pre-conception care and pregnancy.","The number of women of childbearing potential with epilepsy."]
[null,"QS211","Epilepsies in children, young people and adults ",4,null,"People with epilepsy have an up-to-date and agreed comprehensive epilepsy care plan. [2013, updated 2023]","Proportion of people with epilepsy who have experienced status epilepticus, repeated or cluster seizures, or prolonged seizures, who have an epilepsy care plan that covers emergency management.","Process","QS211 - Epilepsies in children, young people and adults ","4 - QS211 - Epilepsies in children, young people and adults ",4,"4 - QS211 - Epilepsies in children, young people and adults  - Process - 4","The number in the denominator who have an epilepsy care plan that covers emergency management.","The number of people with epilepsy who have experienced status epilepticus, repeated or cluster seizures, or prolonged seizures."]
[null,"QS211","Epilepsies in children, young people and adults ",5,null,"People with epilepsy are asked about their memory, mental health, and social and emotional wellbeing at epilepsy appointments. [new 2023]","Evidence of local referral pathways between epilepsy services and mental health, neuropsychology and educational psychology services.","Structure","QS211 - Epilepsies in children, young people and adults ","5 - QS211 - Epilepsies in children, young people and adults ",1,"5 - QS211 - Epilepsies in children, young people and adults  - Structure - 1"]
[null,"QS211","Epilepsies in children, young people and adults ",5,null,"People with epilepsy are asked about their memory, mental health, and social and emotional wellbeing at epilepsy appointments. [new 2023]","Proportion of epilepsy clinic appointments in which people are asked about memory, mental health, and social and emotional wellbeing.","Process","QS211 - Epilepsies in children, young people and adults ","5 - QS211 - Epilepsies in children, young people and adults ",1,"5 - QS211 - Epilepsies in children, young people and adults  - Process - 1","The number in the denominator in which people are asked about memory, mental health, and social and emotional wellbeing.","The number of clinic appointments for people with epilepsy."]
[null,"QS211","Epilepsies in children, young people and adults ",6,null,"Children and young people with epilepsy are asked at epilepsy appointments about neurodevelopment and learning difficulties or changes in their learning progress, and adults who have learning disabilities are asked at epilepsy appointments about changes in their condition and other comorbidities. [new 2023]","Evidence of agreed referral criteria for children and young people with epilepsy who have neurodevelopmental conditions and adults with epilepsy who have learning disabilities.","Structure","QS211 - Epilepsies in children, young people and adults ","6 - QS211 - Epilepsies in children, young people and adults ",1,"6 - QS211 - Epilepsies in children, young people and adults  - Structure - 1"]
[null,"QS211","Epilepsies in children, young people and adults ",6,null,"Children and young people with epilepsy are asked at epilepsy appointments about neurodevelopment and learning difficulties or changes in their learning progress, and adults who have learning disabilities are asked at epilepsy appointments about changes in their condition and other comorbidities. [new 2023]","Proportion of epilepsy clinic appointments in which children and young people with epilepsy are asked about neurodevelopment and learning difficulties or changes in their learning progress.","Process","QS211 - Epilepsies in children, young people and adults ","6 - QS211 - Epilepsies in children, young people and adults ",1,"6 - QS211 - Epilepsies in children, young people and adults  - Process - 1","The number in the denominator in which children and young people are asked about neurodevelopment and learning difficulties or change in their learning progress.","The number of clinic appointments for children and young people with epilepsy."]
[null,"QS211","Epilepsies in children, young people and adults ",6,null,"Children and young people with epilepsy are asked at epilepsy appointments about neurodevelopment and learning difficulties or changes in their learning progress, and adults who have learning disabilities are asked at epilepsy appointments about changes in their condition and other comorbidities. [new 2023]","Proportion of epilepsy clinic appointments in which adults with epilepsy who have learning disabilities are asked about changes in their condition and other comorbidities.","Process","QS211 - Epilepsies in children, young people and adults ","6 - QS211 - Epilepsies in children, young people and adults ",2,"6 - QS211 - Epilepsies in children, young people and adults  - Process - 2","The number in the denominator in which adults are asked about changes in their condition and other comorbidities.","The number of clinic appointments for adults with epilepsy who have learning disabilities."]
[null,null,null,null,null,null,null,null," - "," -  - ",1," -  -  -  - 1"]
[null,null,null,null,null,null,null,null," - "," -  - ",2," -  -  -  - 2"]

{"sheet":"Monitoring change (i)","index":4,"n_rows":88,"n_cols":11,"rows_kept":88,"cut":false,"hidden":false,"merged":[[69,1,69,4],[10,2,10,10],[1,1,1,4],[8,1,8,10],[25,1,25,4]]}
[]
[null,"Quality standard template: Monitoring change"]
[]
[null,"Instructions on use"]
[null,"The worksheet allows for up to 3 structure measures, 3 process measures and 3 outcome measures. "]
[null,"Select the measures being assessed in the lighter teal coloured cells from the dropdown menu. Dropdowns may be empty if the statement selected has no measures of that type. "]
[null,"For structure measures yes or no can be selected in the darker teal coloured cell."]
[null,"For process and outcome measures the numerator and denominator are displayed in the darker teal coloured cells and results can be recorded in the grey cells (columns D-K). "]
[null,"Caution: if a selected quality standard or statement is changed in the 'assessment and action plan', previously selected measures on the associated monitoring change worksheet will be removed and entered data may need to be deleted. "]
[null,"Quality standard",{"$f":"IF('Assessment and action plan'!$C$7=\"\",\" - \", 'Assessment and action plan'!$C$7)","v":" - "}]
[null,"Quality statement",{"$f":"IF('Assessment and action plan'!D7=\"\",\" - \", 'Assessment and action plan'!D7)","v":" - "}]
[]
[null,"Structure measure(s)"]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[null,"Process measure(s)"]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC24=\"\", \"Select process measure above\", Dropdowns!AC24)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD24=\"\", \"Select process measure above\", Dropdowns!AD24)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D29/D30, \" - \")","v":" - "},{"$f":"IFERROR(E29/E30, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K29/K30, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC25=\"\", \"Select process measure above\", Dropdowns!AC25)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD25=\"\", \"Select process measure above\", Dropdowns!AD25)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D37/D38, \" - \")","v":" - "},{"$f":"IFERROR(E37/E38, \" - \")","v":" - "}," - "," - ",{"$f":"IFERROR(H37/H38, \" - \")","v":" - "}," - "," - ",{"$f":"IFERROR(K37/K38, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC26=\"\", \"Select process measure above\", Dropdowns!AC26)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD26=\"\", \"Select process measure above\", Dropdowns!AD26)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D45/D46, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[null,"Outcome measure(s)"]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C72=\"\", \"Select outcome measure above\", IF(Dropdowns!AK24=0, \"Numerator to be decided locally\", Dropdowns!AK24))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C72=\"\", \"Select outcome measure above\", IF(Dropdowns!AL24=0, \"Denominator to be decided locally\", Dropdowns!AL24))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D74/D75, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C78=\"\", \"Select outcome measure above\", IF(Dropdowns!AK25=0, \"Numerator to be decided locally\", Dropdowns!AK25))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C78=\"\", \"Select outcome measure above\", IF(Dropdowns!AL25=0, \"Denominator to be decided locally\", Dropdowns!AL25))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D80/D81, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C84=\"\", \"Select outcome measure above\", IF(Dropdowns!AK26=0, \"Numerator to be decided locally\", Dropdowns!AK26))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C84=\"\", \"Select outcome measure above\", IF(Dropdowns!AL26=0, \"Denominator to be decided locally\", Dropdowns!AL26))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D86/D87, \" - \")","v":" - "},{"$f":"IFERROR(E86/E87, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "]

{"sheet":"Monitoring change (ii)","index":5,"n_rows":87,"n_cols":11,"rows_kept":87,"cut":false,"hidden":false,"merged":[[68,1,68,4],[25,1,25,4],[1,1,1,4],[8,1,8,10],[10,2,10,10]]}
[]
[null,"Quality standard template: Monitoring change"]
[]
[null,"Instructions on use"]
[null,"The worksheet allows for up to 3 structure measures, 3 process measures and 3 outcome measures. "]
[null,"Select the measures being assessed in the lighter teal coloured cells from the dropdown menu. Dropdowns may be empty if the statement selected has no measures of that type. "]
[null,"For structure measures yes or no can be selected in the darker teal coloured cell."]
[null,"For process and outcome measures the numerator and denominator are displayed in the darker teal coloured cells and results can be recorded in the grey cells (columns D-K). "]
[null,"Caution: if a selected quality standard or statement is changed in the 'assessment and action plan', previously selected measures on the associated monitoring change worksheet will be removed and entered data may need to be deleted. "]
[null,"Quality standard",{"$f":"IF('Assessment and action plan'!C8=\"\",\" - \", 'Assessment and action plan'!C8)","v":" - "}]
[null,"Quality statement",{"$f":"IF('Assessment and action plan'!D8=\"\",\" - \", 'Assessment and action plan'!D8)","v":" - "}]
[]
[null,"Structure measure(s)"]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[null,"Process measure(s)"]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC27=\"\", \"Select process measure above\", Dropdowns!AC27)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD27=\"\", \"Select process measure above\", Dropdowns!AD27)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D29/D30, \" - \")","v":" - "},{"$f":"IFERROR(E29/E30, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K29/K30, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure",""]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC28=\"\", \"Select process measure above\", Dropdowns!AC28)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD28=\"\", \"Select process measure above\", Dropdowns!AD28)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D37/D38, \" - \")","v":" - "},{"$f":"IFERROR(E37/E38, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K37/K38, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC29=\"\", \"Select process measure above\", Dropdowns!AC29)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD29=\"\", \"Select process measure above\", Dropdowns!AD29)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D45/D46, \" - \")","v":" - "},{"$f":"IFERROR(E45/E46, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K45/K46, \" - \")","v":" - "}]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[null,"Outcome measure(s)"]
[]
[null,"Outcome measure",""]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C71=\"\", \"Select outcome measure above\", IF(Dropdowns!AK27=0, \"Numerator to be decided locally\", Dropdowns!AK27))","v":"Select outcome measure above"},null,"-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C71=\"\", \"Select outcome measure above\", IF(Dropdowns!AL27=0, \"Denominator to be decided locally\", Dropdowns!AL27))","v":"Select outcome measure above"},null,"-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D73/D74, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C77=\"\", \"Select outcome measure above\", IF(Dropdowns!AK28=0, \"Numerator to be decided locally\", Dropdowns!AK28))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C77=\"\", \"Select outcome measure above\", IF(Dropdowns!AL27=0, \"Denominator to be decided locally\", Dropdowns!AL27))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D79/D80, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C83=\"\", \"Select outcome measure above\", IF(Dropdowns!AK29=0, \"Numerator to be decided locally\", Dropdowns!AK29))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C83=\"\", \"Select outcome measure above\", IF(Dropdowns!AL28=0, \"Denominator to be decided locally\", Dropdowns!AL28))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D85/D86, \" - \")","v":" - "},{"$f":"IFERROR(E85/E86, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "]

{"sheet":"Monitoring change (iii)","index":6,"n_rows":87,"n_cols":11,"rows_kept":87,"cut":false,"hidden":false,"merged":[[69,1,69,4],[12,1,12,4],[25,1,25,4],[1,1,1,4],[8,1,8,10],[10,2,10,10]]}
[]
[null,"Quality standard template: Monitoring change"]
[]
[null,"Instructions on use"]
[null,"The worksheet allows for up to 3 structure measures, 3 process measures and 3 outcome measures. "]
[null,"Select the measures being assessed in the lighter teal coloured cells from the dropdown menu. Dropdowns may be empty if the statement selected has no measures of that type. "]
[null,"For structure measures yes or no can be selected in the darker teal coloured cell."]
[null,"For process and outcome measures the numerator and denominator are displayed in the darker teal coloured cells and results can be recorded in the grey cells (columns D-K). "]
[null,"Caution: if a selected quality standard or statement is changed in the 'assessment and action plan', previously selected measures on the associated monitoring change worksheet will be removed and entered data may need to be deleted. "]
[null,"Quality standard",{"$f":"IF('Assessment and action plan'!C9=\"\",\" - \", 'Assessment and action plan'!C9)","v":" - "}]
[null,"Quality statement",{"$f":"IF('Assessment and action plan'!D9=\"\",\" - \", 'Assessment and action plan'!D9)","v":" - "}]
[]
[null,"Structure measure(s)"]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Process measure(s)"]
[null,"Process measure",""]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC30=\"\", \"Select process measure above\", Dropdowns!AC30)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD30=\"\", \"Select process measure above\", Dropdowns!AD30)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D29/D30, \" - \")","v":" - "},{"$f":"IFERROR(E29/E30, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K29/K30, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC31=\"\", \"Select process measure above\", Dropdowns!AC31)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD31=\"\", \"Select process measure above\", Dropdowns!AD31)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D37/D38, \" - \")","v":" - "},{"$f":"IFERROR(E37/E38, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K37/K38, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC32=\"\", \"Select process measure above\", Dropdowns!AC32)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD32=\"\", \"Select process measure above\", Dropdowns!AD32)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D45/D46, \" - \")","v":" - "},{"$f":"IFERROR(E45/E46, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K45/K46, \" - \")","v":" - "}]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[null,"Outcome measure(s)"]
[null,"Outcome measure",""]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C71=\"\", \"Select outcome measure above\", IF(Dropdowns!AK30=0, \"Numerator to be decided locally\", Dropdowns!AK30))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C71=\"\", \"Select outcome measure above\", IF(Dropdowns!AL30=0, \"Denominator to be decided locally\", Dropdowns!AL30))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D73/D74, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure",""]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C77=\"\", \"Select outcome measure above\", IF(Dropdowns!AK31=0, \"Numerator to be decided locally\", Dropdowns!AK31))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C77=\"\", \"Select outcome measure above\", IF(Dropdowns!AL31=0, \"Denominator to be decided locally\", Dropdowns!AL31))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D79/D80, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C83=\"\", \"Select outcome measure above\", IF(Dropdowns!AK32=0, \"Numerator to be decided locally\", Dropdowns!AK32))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C83=\"\", \"Select outcome measure above\", IF(Dropdowns!AL32=0, \"Denominator to be decided locally\", Dropdowns!AL32))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D85/D86, \" - \")","v":" - "},{"$f":"IFERROR(E85/E86, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "]

{"sheet":"Monitoring change (iv)","index":7,"n_rows":88,"n_cols":11,"rows_kept":88,"cut":false,"hidden":false,"merged":[[70,1,70,4],[13,1,13,4],[26,1,26,4],[1,1,1,4],[8,1,8,10],[10,2,10,10],[12,1,12,4]]}
[]
[null,"Quality standard template: Monitoring change"]
[]
[null,"Instructions on use"]
[null,"The worksheet allows for up to 3 structure measures, 3 process measures and 3 outcome measures. "]
[null,"Select the measures being assessed in the lighter teal coloured cells from the dropdown menu. Dropdowns may be empty if the statement selected has no measures of that type. "]
[null,"For structure measures yes or no can be selected in the darker teal coloured cell."]
[null,"For process and outcome measures the numerator and denominator are displayed in the darker teal coloured cells and results can be recorded in the grey cells (columns D-K). "]
[null,"Caution: if a selected quality standard or statement is changed in the 'assessment and action plan', previously selected measures on the associated monitoring change worksheet will be removed and entered data may need to be deleted. "]
[null,"Quality standard",{"$f":"IF('Assessment and action plan'!C10=\"\",\" - \", 'Assessment and action plan'!C10)","v":" - "}]
[null,"Quality statement",{"$f":"IF('Assessment and action plan'!D10=\"\",\" - \", 'Assessment and action plan'!D10)","v":" - "}]
[]
[null,"Structure measure(s)"]
[]
[null,"Structure measure",""]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Process measure(s)"]
[null,"Process measure",""]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC33=\"\", \"Select process measure above\", Dropdowns!AC33)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD33=\"\", \"Select process measure above\", Dropdowns!AD33)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D30/D31, \" - \")","v":" - "},{"$f":"IFERROR(E30/E31, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K30/K31, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure",""]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC34=\"\", \"Select process measure above\", Dropdowns!AC34)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD34=\"\", \"Select process measure above\", Dropdowns!AD34)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D38/D39, \" - \")","v":" - "},{"$f":"IFERROR(E38/E39, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K38/K39, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC35=\"\", \"Select process measure above\", Dropdowns!AC35)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD35=\"\", \"Select process measure above\", Dropdowns!AD35)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D46/D47, \" - \")","v":" - "},{"$f":"IFERROR(E46/E47, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K46/K47, \" - \")","v":" - "}]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[null,"Outcome measure(s)"]
[null,"Outcome measure",""]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C72=\"\", \"Select outcome measure above\", IF(Dropdowns!AK33=0, \"Numerator to be decided locally\", Dropdowns!AK33))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C72=\"\", \"Select outcome measure above\", IF(Dropdowns!AL33=0, \"Denominator to be decided locally\", Dropdowns!AL33))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D74/D75, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C78=\"\", \"Select outcome measure above\", IF(Dropdowns!AK34=0, \"Numerator to be decided locally\", Dropdowns!AK34))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C78=\"\", \"Select outcome measure above\", IF(Dropdowns!AL33=0, \"Denominator to be decided locally\", Dropdowns!AL33))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D80/D81, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C84=\"\", \"Select outcome measure above\", IF(Dropdowns!AK35=0, \"Numerator to be decided locally\", Dropdowns!AK35))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C84=\"\", \"Select outcome measure above\", IF(Dropdowns!AL34=0, \"Denominator to be decided locally\", Dropdowns!AL34))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D86/D87, \" - \")","v":" - "},{"$f":"IFERROR(E86/E87, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "]

{"sheet":"Monitoring change (v)","index":8,"n_rows":86,"n_cols":11,"rows_kept":86,"cut":false,"hidden":false,"merged":[[68,1,68,4],[12,1,12,4],[25,1,25,4],[1,1,1,4],[8,1,8,10],[10,2,10,10]]}
[]
[null,"Quality standard template: Monitoring change"]
[]
[null,"Instructions on use"]
[null,"The worksheet allows for up to 3 structure measures, 3 process measures and 3 outcome measures. "]
[null,"Select the measures being assessed in the lighter teal coloured cells from the dropdown menu. Dropdowns may be empty if the statement selected has no measures of that type. "]
[null,"For structure measures yes or no can be selected in the darker teal coloured cell."]
[null,"For process and outcome measures the numerator and denominator are displayed in the darker teal coloured cells and results can be recorded in the grey cells (columns D-K). "]
[null,"Caution: if a selected quality standard or statement is changed in the 'assessment and action plan', previously selected measures on the associated monitoring change worksheet will be removed and entered data may need to be deleted. "]
[null,"Quality standard",{"$f":"IF('Assessment and action plan'!C11=\"\",\" - \", 'Assessment and action plan'!C11)","v":" - "}]
[null,"Quality statement",{"$f":"IF('Assessment and action plan'!D11=\"\",\" - \", 'Assessment and action plan'!D11)","v":" - "}]
[]
[null,"Structure measure(s)"]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Process measure(s)"]
[null,"Process measure",""]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC36=\"\", \"Select process measure above\", Dropdowns!AC36)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD36=\"\", \"Select process measure above\", Dropdowns!AD36)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D29/D30, \" - \")","v":" - "},{"$f":"IFERROR(E29/E30, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K29/K30, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure",""]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC37=\"\", \"Select process measure above\", Dropdowns!AC37)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD37=\"\", \"Select process measure above\", Dropdowns!AD37)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D37/D38, \" - \")","v":" - "},{"$f":"IFERROR(E37/E38, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K37/K38, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC38=\"\", \"Select process measure above\", Dropdowns!AC38)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD38=\"\", \"Select process measure above\", Dropdowns!AD38)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D45/D46, \" - \")","v":" - "},{"$f":"IFERROR(E45/E46, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K45/K46, \" - \")","v":" - "}]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[null,"Outcome measure(s)"]
[null,"Outcome measure",""]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C70=\"\", \"Select outcome measure above\", IF(Dropdowns!AK36=0, \"Numerator to be decided locally\", Dropdowns!AK36))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C70=\"\", \"Select outcome measure above\", IF(Dropdowns!AL36=0, \"Denominator to be decided locally\", Dropdowns!AL36))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D72/D73, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C76=\"\", \"Select outcome measure above\", IF(Dropdowns!AK37=0, \"Numerator to be decided locally\", Dropdowns!AK37))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C76=\"\", \"Select outcome measure above\", IF(Dropdowns!AL37=0, \"Denominator to be decided locally\", Dropdowns!AL37))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D78/D79, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C82=\"\", \"Select outcome measure above\", IF(Dropdowns!AK38=0, \"Numerator to be decided locally\", Dropdowns!AK38))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C82=\"\", \"Select outcome measure above\", IF(Dropdowns!AL38=0, \"Denominator to be decided locally\", Dropdowns!AL38))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D84/D85, \" - \")","v":" - "},{"$f":"IFERROR(E84/E85, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "]

{"sheet":"Monitoring change (vi)","index":9,"n_rows":86,"n_cols":11,"rows_kept":86,"cut":false,"hidden":true,"merged":[[24,1,24,4],[68,1,68,4],[12,1,12,4],[25,1,25,4],[1,1,1,4],[8,1,8,10],[10,2,10,10]]}
[]
[null,"Quality standard template: Monitoring change"]
[]
[null,"Instructions on use"]
[null,"The worksheet allows for up to 3 structure measures, 3 process measures and 3 outcome measures. "]
[null,"Select the measures being assessed in the lighter teal coloured cells from the dropdown menu. Dropdowns may be empty if the statement selected has no measures of that type. "]
[null,"For structure measures yes or no can be selected in the darker teal coloured cell."]
[null,"For process and outcome measures the numerator and denominator are displayed in the darker teal coloured cells and results can be recorded in the grey cells (columns D-K). "]
[null,"Caution: if a selected quality standard or statement is changed in the 'assessment and action plan', previously selected measures on the associated monitoring change worksheet will be removed and entered data may need to be deleted. "]
[null,"Quality standard",{"$f":"IF('Assessment and action plan'!C12=\"\",\" - \", 'Assessment and action plan'!C12)","v":" - "}]
[null,"Quality statement",{"$f":"IF('Assessment and action plan'!D12=\"\",\" - \", 'Assessment and action plan'!D12)","v":" - "}]
[]
[null,"Structure measure(s)"]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[null,"Process measure(s)"]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC39=\"\", \"Select process measure above\", Dropdowns!AC39)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD39=\"\", \"Select process measure above\", Dropdowns!AD39)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D29/D30, \" - \")","v":" - "},{"$f":"IFERROR(E29/E30, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K29/K30, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC40=\"\", \"Select process measure above\", Dropdowns!AC40)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD40=\"\", \"Select process measure above\", Dropdowns!AD40)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D37/D38, \" - \")","v":" - "},{"$f":"IFERROR(E37/E38, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K37/K38, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC41=\"\", \"Select process measure above\", Dropdowns!AC41)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD41=\"\", \"Select process measure above\", Dropdowns!AD41)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D45/D46, \" - \")","v":" - "},{"$f":"IFERROR(E45/E46, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K45/K46, \" - \")","v":" - "}]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[null,"Outcome measure(s)"]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C70=\"\", \"Select outcome measure above\", IF(Dropdowns!AK38=0, \"Numerator to be decided locally\", Dropdowns!AK38))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C70=\"\", \"Select outcome measure above\", IF(Dropdowns!AL38=0, \"Denominator to be decided locally\", Dropdowns!AL38))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D72/D73, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C76=\"\", \"Select outcome measure above\", IF(Dropdowns!AK39=0, \"Numerator to be decided locally\", Dropdowns!AK39))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C76=\"\", \"Select outcome measure above\", IF(Dropdowns!AL39=0, \"Denominator to be decided locally\", Dropdowns!AL39))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D78/D79, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C82=\"\", \"Select outcome measure above\", IF(Dropdowns!AK40=0, \"Numerator to be decided locally\", Dropdowns!AK40))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C82=\"\", \"Select outcome measure above\", IF(Dropdowns!AL40=0, \"Denominator to be decided locally\", Dropdowns!AL40))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D84/D85, \" - \")","v":" - "},{"$f":"IFERROR(E84/E85, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "]

{"sheet":"Monitoring change (vii)","index":10,"n_rows":86,"n_cols":11,"rows_kept":86,"cut":false,"hidden":true,"merged":[[68,1,68,4],[12,1,12,4],[25,1,25,4],[1,1,1,4],[8,1,8,10],[10,2,10,10]]}
[]
[null,"Quality standard template: Monitoring change"]
[]
[null,"Instructions on use"]
[null,"The worksheet allows for up to 3 structure measures, 3 process measures and 3 outcome measures. "]
[null,"Select the measures being assessed in the lighter teal coloured cells from the dropdown menu. Dropdowns may be empty if the statement selected has no measures of that type. "]
[null,"For structure measures yes or no can be selected in the darker teal coloured cell."]
[null,"For process and outcome measures the numerator and denominator are displayed in the darker teal coloured cells and results can be recorded in the grey cells (columns D-K). "]
[null,"Caution: if a selected quality standard or statement is changed in the 'assessment and action plan', previously selected measures on the associated monitoring change worksheet will be removed and entered data may need to be deleted. "]
[null,"Quality standard",{"$f":"IF('Assessment and action plan'!C13=\"\",\" - \", 'Assessment and action plan'!C13)","v":" - "}]
[null,"Quality statement",{"$f":"IF('Assessment and action plan'!D13=\"\",\" - \", 'Assessment and action plan'!D13)","v":" - "}]
[]
[null,"Structure measure(s)"]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Process measure(s)"]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC42=\"\", \"Select process measure above\", Dropdowns!AC42)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD42=\"\", \"Select process measure above\", Dropdowns!AD42)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D29/D30, \" - \")","v":" - "},{"$f":"IFERROR(E29/E30, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K29/K30, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC43=\"\", \"Select process measure above\", Dropdowns!AC43)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD43=\"\", \"Select process measure above\", Dropdowns!AD43)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D37/D38, \" - \")","v":" - "},{"$f":"IFERROR(E37/E38, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K37/K38, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC44=\"\", \"Select process measure above\", Dropdowns!AC44)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD44=\"\", \"Select process measure above\", Dropdowns!AD44)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D45/D46, \" - \")","v":" - "},{"$f":"IFERROR(E45/E46, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K45/K46, \" - \")","v":" - "}]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[null,"Outcome measure(s)"]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C70=\"\", \"Select outcome measure above\", IF(Dropdowns!AK41=0, \"Numerator to be decided locally\", Dropdowns!AK41))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C70=\"\", \"Select  outcome measure above\", IF(Dropdowns!AL41=0, \"Denominator to be decided locally\", Dropdowns!AL41))","v":"Select  outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D72/D73, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C76=\"\", \"Select  outcome measure above\", IF(Dropdowns!AK42=0, \"Numerator to be decided locally\", Dropdowns!AK42))","v":"Select  outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C76=\"\", \"Select  outcome measure above\", IF(Dropdowns!AL42=0, \"Denominator to be decided locally\", Dropdowns!AL42))","v":"Select  outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D78/D79, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C82=\"\", \"Select  outcome measure above\", IF(Dropdowns!AK43=0, \"Numerator to be decided locally\", Dropdowns!AK43))","v":"Select  outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C82=\"\", \"Select  outcome measure above\", IF(Dropdowns!AL43=0, \"Denominator to be decided locally\", Dropdowns!AL43))","v":"Select  outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D84/D85, \" - \")","v":" - "},{"$f":"IFERROR(E84/E85, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "]

{"sheet":"Monitoring change (viii)","index":11,"n_rows":86,"n_cols":11,"rows_kept":86,"cut":false,"hidden":true,"merged":[[68,1,68,4],[12,1,12,4],[25,1,25,4],[1,1,1,4],[8,1,8,10],[10,2,10,10]]}
[]
[null,"Quality standard template: Monitoring change"]
[]
[null,"Instructions on use"]
[null,"The worksheet allows for up to 3 structure measures, 3 process measures and 3 outcome measures. "]
[null,"Select the measures being assessed in the lighter teal coloured cells from the dropdown menu. Dropdowns may be empty if the statement selected has no measures of that type. "]
[null,"For structure measures yes or no can be selected in the darker teal coloured cell."]
[null,"For process and outcome measures the numerator and denominator are displayed in the darker teal coloured cells and results can be recorded in the grey cells (columns D-K). "]
[null,"Caution: if a selected quality standard or statement is changed in the 'assessment and action plan', previously selected measures on the associated monitoring change worksheet will be removed and entered data may need to be deleted. "]
[null,"Quality standard",{"$f":"IF('Assessment and action plan'!C14=\"\",\" - \", 'Assessment and action plan'!C14)","v":" - "}]
[null,"Quality statement",{"$f":"IF('Assessment and action plan'!D14=\"\",\" - \", 'Assessment and action plan'!D14)","v":" - "}]
[]
[null,"Structure measure(s)"]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Process measure(s)"]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC45=\"\", \"Select process measure above\", Dropdowns!AC45)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD45=\"\", \"Select process measure above\", Dropdowns!AD45)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D29/D30, \" - \")","v":" - "},{"$f":"IFERROR(E29/E30, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K29/K30, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC46=\"\", \"Select process measure above\", Dropdowns!AC46)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD46=\"\", \"Select process measure above\", Dropdowns!AD46)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D37/D38, \" - \")","v":" - "},{"$f":"IFERROR(E37/E38, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K37/K38, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC47=\"\", \"Select process measure above\", Dropdowns!AC47)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD47=\"\", \"Select process measure above\", Dropdowns!AD47)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D45/D46, \" - \")","v":" - "},{"$f":"IFERROR(E45/E46, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K45/K46, \" - \")","v":" - "}]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[null,"Outcome measure(s)"]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C70=\"\", \"Select outcome measure above\", IF(Dropdowns!AK44=0, \"Numerator to be decided locally\", Dropdowns!AK44))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C70=\"\", \"Select outcome measure above\", IF(Dropdowns!AL44=0, \"Denominator to be decided locally\", Dropdowns!AL44))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D72/D73, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C76=\"\", \"Select outcome measure above\", IF(Dropdowns!AK45=0, \"Numerator to be decided locally\", Dropdowns!AK45))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C76=\"\", \"Select outcome measure above\", IF(Dropdowns!AL45=0, \"Denominator to be decided locally\", Dropdowns!AL45))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D78/D79, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C82=\"\", \"Select outcome measure above\", IF(Dropdowns!AK46=0, \"Numerator to be decided locally\", Dropdowns!AK46))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C82=\"\", \"Select outcome measure above\", IF(Dropdowns!AL46=0, \"Denominator to be decided locally\", Dropdowns!AL46))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D84/D85, \" - \")","v":" - "},{"$f":"IFERROR(E84/E85, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "]

{"sheet":"Monitoring change (ix)","index":12,"n_rows":86,"n_cols":11,"rows_kept":86,"cut":false,"hidden":true,"merged":[[68,1,68,4],[12,1,12,4],[25,1,25,4],[1,1,1,4],[8,1,8,10],[10,2,10,10]]}
[]
[null,"Quality standard template: Monitoring change"]
[]
[null,"Instructions on use"]
[null,"The worksheet allows for up to 3 structure measures, 3 process measures and 3 outcome measures. "]
[null,"Select the measures being assessed in the lighter teal coloured cells from the dropdown menu. Dropdowns may be empty if the statement selected has no measures of that type. "]
[null,"For structure measures yes or no can be selected in the darker teal coloured cell."]
[null,"For process and outcome measures the numerator and denominator are displayed in the darker teal coloured cells and results can be recorded in the grey cells (columns D-K). "]
[null,"Caution: if a selected quality standard or statement is changed in the 'assessment and action plan', previously selected measures on the associated monitoring change worksheet will be removed and entered data may need to be deleted. "]
[null,"Quality standard",{"$f":"IF('Assessment and action plan'!C15=\"\",\" - \", 'Assessment and action plan'!C15)","v":" - "}]
[null,"Quality statement",{"$f":"IF('Assessment and action plan'!D15=\"\",\" - \", 'Assessment and action plan'!D15)","v":" - "}]
[]
[null,"Structure measure(s)"]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Process measure(s)"]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC48=\"\", \"Select process measure above\", Dropdowns!AC48)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD48=\"\", \"Select process measure above\", Dropdowns!AD48)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D29/D30, \" - \")","v":" - "},{"$f":"IFERROR(E29/E30, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K29/K30, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC49=\"\", \"Select process measure above\", Dropdowns!AC49)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD49=\"\", \"Select process measure above\", Dropdowns!AD49)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D37/D38, \" - \")","v":" - "},{"$f":"IFERROR(E37/E38, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K37/K38, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC50=\"\", \"Select process measure above\", Dropdowns!AC50)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD50=\"\", \"Select process measure above\", Dropdowns!AD50)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D45/D46, \" - \")","v":" - "},{"$f":"IFERROR(E45/E46, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K45/K46, \" - \")","v":" - "}]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[null,"Outcome measure(s)"]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C70=\"\", \"Select outcome measure above\", IF(Dropdowns!AK47=0, \"Denominator to be decided locally\", Dropdowns!AK47))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C70=\"\", \"Select outcome measure above\", IF(Dropdowns!AL47=0, \"Denominator to be decided locally\", Dropdowns!AL47))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D72/D73, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C76=\"\", \"Select outcome measure above\", IF(Dropdowns!AK48=0, \"Denominator to be decided locally\", Dropdowns!AK48))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C76=\"\", \"Select outcome measure above\", IF(Dropdowns!AL48=0, \"Denominator to be decided locally\", Dropdowns!AL48))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D78/D79, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C82=\"\", \"Select outcome measure above\", IF(Dropdowns!AK49=0, \"Numerator to be decided locally\", Dropdowns!AK49))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C82=\"\", \"Select outcome measure above\", IF(Dropdowns!AL49=0, \"Denominator to be decided locally\", Dropdowns!AL49))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D84/D85, \" - \")","v":" - "},{"$f":"IFERROR(E84/E85, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "]

{"sheet":"Monitoring change (x)","index":13,"n_rows":86,"n_cols":11,"rows_kept":86,"cut":false,"hidden":true,"merged":[[68,1,68,4],[12,1,12,4],[25,1,25,4],[1,1,1,4],[8,1,8,10],[10,2,10,10]]}
[]
[null,"Quality standard template: Monitoring change"]
[]
[null,"Instructions on use"]
[null,"The worksheet allows for up to 3 structure measures, 3 process measures and 3 outcome measures. "]
[null,"Select the measures being assessed in the lighter teal coloured cells from the dropdown menu. Dropdowns may be empty if the statement selected has no measures of that type. "]
[null,"For structure measures yes or no can be selected in the darker teal coloured cell."]
[null,"For process and outcome measures the numerator and denominator are displayed in the darker teal coloured cells and results can be recorded in the grey cells (columns D-K). "]
[null,"Caution: if a selected quality standard or statement is changed in the 'assessment and action plan', previously selected measures on the associated monitoring change worksheet will be removed and entered data may need to be deleted. "]
[null,"Quality standard",{"$f":"IF('Assessment and action plan'!C16=\"\",\" - \", 'Assessment and action plan'!C16)","v":" - "}]
[null,"Quality statement",{"$f":"IF('Assessment and action plan'!D16=\"\",\" - \", 'Assessment and action plan'!D16)","v":" - "}]
[]
[null,"Structure measure(s)"]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Structure measure"]
[]
[]
[]
[null,"Process measure(s)"]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC51=\"\", \"Select process measure above\", Dropdowns!AC51)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!#REF!=\"\", \"Select process measure above\", Dropdowns!#REF!)","v":{"$error":"#REF!"}},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D29/D30, \" - \")","v":" - "},{"$f":"IFERROR(E29/E30, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K29/K30, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC52=\"\", \"Select process measure above\", Dropdowns!AC52)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD52=\"\", \"Select process measure above\", Dropdowns!AD52)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D37/D38, \" - \")","v":" - "},{"$f":"IFERROR(E37/E38, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K37/K38, \" - \")","v":" - "}]
[]
[]
[]
[null,"Process measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(Dropdowns!AC53=\"\", \"Select process measure above\", Dropdowns!AC53)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(Dropdowns!AD53=\"\", \"Select process measure above\", Dropdowns!AD53)","v":"Select process measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D45/D46, \" - \")","v":" - "},{"$f":"IFERROR(E45/E46, \" - \")","v":" - "}," - "," - "," - "," - "," - ",{"$f":"IFERROR(K45/K46, \" - \")","v":" - "}]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[null,"Outcome measure(s)"]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C70=\"\", \"Select outcome measure above\", IF(Dropdowns!AK50=0, \"Numerator to be decided locally\", Dropdowns!AK50))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C70=\"\", \"Select outcome measure above\", IF(Dropdowns!AL50=0, \"Denominator to be decided locally\", Dropdowns!AL50))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D72/D73, \" - \")","v":" - "},{"$f":"IFERROR(E72/E73, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C76=\"\", \"Select outcome measure above\", IF(Dropdowns!AK51=0, \"Numerator to be decided locally\", Dropdowns!AK51))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C76=\"\", \"Select outcome measure above\", IF(Dropdowns!AL51=0, \"Denominator to be decided locally\", Dropdowns!AL51))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D78/D79, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "," - "]
[]
[null,"Outcome measure"]
[null,null,null,"Date","Date","Date","Date","Date","Date","Date","Date"]
[null,"Numerator",{"$f":"IF(C82=\"\", \"Select outcome measure above\", IF(Dropdowns!AK52=0, \"Numerator to be decided locally\", Dropdowns!AK52))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,"Denominator",{"$f":"IF(C82=\"\", \"Select outcome measure above\", IF(Dropdowns!AL52=0, \"Denominator to be decided locally\", Dropdowns!AL52))","v":"Select outcome measure above"},"-","-","-","-","-","-","-","-"]
[null,null,null,{"$f":"IFERROR(D84/D85, \" - \")","v":" - "},{"$f":"IFERROR(E84/E85, \" - \")","v":" - "}," - "," - "," - "," - "," - "," - "]